Citrus Sinensis ID: 042346
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 812 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LY50 | 814 | Putative serine/threonine | yes | no | 0.934 | 0.932 | 0.512 | 0.0 | |
| Q9FIJ6 | 751 | Serine/threonine-protein | no | no | 0.802 | 0.868 | 0.340 | 1e-104 | |
| Q9LX29 | 895 | Serine/threonine-protein | no | no | 0.884 | 0.802 | 0.308 | 3e-92 | |
| O24585 | 901 | Putative receptor protein | N/A | no | 0.373 | 0.336 | 0.455 | 4e-69 | |
| Q9S7D9 | 775 | Serine/threonine-protein | no | no | 0.782 | 0.819 | 0.288 | 4e-65 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.353 | 0.308 | 0.465 | 2e-64 | |
| Q9SR05 | 850 | Receptor-like protein kin | no | no | 0.477 | 0.456 | 0.363 | 7e-61 | |
| Q3E8W4 | 858 | Receptor-like protein kin | no | no | 0.466 | 0.441 | 0.356 | 3e-60 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.359 | 0.306 | 0.425 | 3e-59 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.431 | 0.421 | 0.354 | 1e-58 |
| >sp|Q9LY50|ACCR3_ARATH Putative serine/threonine-protein kinase-like protein CCR3 OS=Arabidopsis thaliana GN=CCR3 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/814 (51%), Positives = 538/814 (66%), Gaps = 55/814 (6%)
Query: 11 IIFTIITIISSLQTFVNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIPVL-- 68
+ TI II L + V SLGS ST A++Y + TVC +I+G+ QRI CY I V
Sbjct: 13 VTVTIAVIIFFLLSPVTSLGSGSTYAVVYGSDTVCALISGQPTQRILCYDTRLNINVTLN 72
Query: 69 PNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVGGDQ 128
P SF +I+ G N+ CG+RSGG+SL CWD ++ ++S KR++ V L +SVG Q
Sbjct: 73 PGVSFSSIAAGDNFLCGIRSGGYSLLCWD--NIGSYSPNRKRIYQNDNVLLETLSVGDKQ 130
Query: 129 VCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCW 188
+CA + +KCWRG+ V D+ + P E +F +I+SG GF+CG+ N+ + CW
Sbjct: 131 ICATVNGTNSLKCWRGS-VSDQSK-----PPNE--RFRSISSGVGFSCGVSIRNNRILCW 182
Query: 189 G-DSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNV-PFSSAFEF 246
G D +++IQ GF N MV + AG+SHACGL+ G L+C G+NDSGQLNV +
Sbjct: 183 GTDPVKSNQIQTGFGNTPMVTISAGKSHACGLNTTGNLICIGNNDSGQLNVIAPDQPNLY 242
Query: 247 SGGLALGANFTCAIRQRSGLVACWGG-TNRFEFDSDVIQDVSFESIVAGLDFVCGLTTRN 305
S L+LG+NFTCA+R + V CWGG RF ++V +SFESI +G +CGL + N
Sbjct: 243 SSSLSLGSNFTCAMRISNNSVVCWGGGAERF---NNVTDSISFESISSGPGLICGLISSN 299
Query: 306 LSMICWGPGWSNKPHLERGLPLPLGQVLPGPCVESSCITC---GVYPNSESLCVGSGNVC 362
LS++CW P + R + LP +VLPGPCVESS + GVYP S+ LC G+G++C
Sbjct: 300 LSIMCWNP-----TNFSR-IFLPFPEVLPGPCVESSSSSLCSCGVYPQSDKLCSGTGSIC 353
Query: 363 NPCQIELP-----LAVPLPPLKRPPSPDLQPTSPKKDEKKISLASVVVGSAGCFAGICTV 417
C I+ P PP PP + P K + LA +VGS G FAGIC+V
Sbjct: 354 KSCPIQFPASPPSQFPLPPPPPPPPPSPSTSSPPSKALTRGLLAFAIVGSVGAFAGICSV 413
Query: 418 GYCFWAGFL---HKRINSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTF 474
YC W G K NSVQP+ S+S +S++ + R S R
Sbjct: 414 VYCLWTGVCLGKKKVHNSVQPTITRGGSNSRSNSSNSRSLSIRRQGSRMLSMR------- 466
Query: 475 GRQRSGSSSF--SVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKR 532
RQRSG+SS + KA+ F+ SELA+AT NFSLENK+G GSFG VY+GKL DGREVA+KR
Sbjct: 467 -RQRSGTSSMKHADKAEEFSFSELASATGNFSLENKIGSGSFGVVYRGKLNDGREVAIKR 525
Query: 533 EESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDH 592
E K K +EKE+AFDSE+A LSR+HHKHLV LVG+C+E++E+LLVY+YM NGAL+DH
Sbjct: 526 GEVNAKMKKFQEKETAFDSEIAFLSRLHHKHLVRLVGYCEEREEKLLVYDYMKNGALYDH 585
Query: 593 LHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652
LH+KNN EK+SS++NSWKMRI+IALDAARGI+YLHNYAVP IIHRDIKSSNILLD NW A
Sbjct: 586 LHDKNNVEKHSSLINSWKMRIKIALDAARGIEYLHNYAVPPIIHRDIKSSNILLDSNWVA 645
Query: 653 RVSDFGLSLLGSECDQEF----ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLEL 708
RVSDFGLSL+G ++ TKA GTVGYIDPEYY +NVLT K+D+YGLGVVLLEL
Sbjct: 646 RVSDFGLSLMGPVLGKDHNPYQRPTKAAGTVGYIDPEYYSLNVLTDKSDVYGLGVVLLEL 705
Query: 709 LTGKKAVFKN------EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELL 762
LTGK+A+F+N E+G P+ +V+++V I A +L +LD RVG PEL E +AVEL+
Sbjct: 706 LTGKRAIFRNNGDVEEEEGCVPVHLVDYSVPAITADELSTILDPRVGSPELGEGDAVELV 765
Query: 763 ATTAIHCVNLEGKERPNITDIVANLERALAICQD 796
A TA+HCVN EG+ RP +TDIV NLERAL +C D
Sbjct: 766 AYTAMHCVNAEGRNRPTMTDIVGNLERALDLCGD 799
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FIJ6|ACCR4_ARATH Serine/threonine-protein kinase-like protein CCR4 OS=Arabidopsis thaliana GN=CCR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (972), Expect = e-104, Method: Compositional matrix adjust.
Identities = 260/763 (34%), Positives = 377/763 (49%), Gaps = 111/763 (14%)
Query: 68 LPNASFQAISGGQNYFCGL----RSGGFSLHCWDTN-DLTNFSFQPKRLHFRKAVQLTDV 122
L N F + G + CGL S +L CW + D TN KR++ +L ++
Sbjct: 73 LRNRRFSGVVSGNGFVCGLISRLDSNTSTLLCWRFSVDGTNMLH--KRIY--HGPELEEL 128
Query: 123 SVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSN 182
G ++C E S ++CW+ + P D + +I G F CG+ +
Sbjct: 129 EAGNFRICGVERVSRRLRCWQ-----------PYYLPRPD-NYRSIALGDNFFCGLSQPP 176
Query: 183 SEVFCWGDSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSS 242
+ C G + + + + AG AC ++ + + C G S +P
Sbjct: 177 GMISCEGIAKVPSGDH-------YIAIAAGSRQACAITVDNDVECWGQTQS----LPREK 225
Query: 243 AFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFESIVAGLDFVCGLT 302
LA+G + C +R +G V CWG N F ++D+ F SI A CG+
Sbjct: 226 FL----ALAVGEDRGCGVRWSNGTVVCWGNNNNFSL-PQTLKDIHFTSIYAKGPMFCGVA 280
Query: 303 TRNLSMICWGPGWSNKPHLERGLPLPL-----GQVLPGPCVESSCITCGVYP--NSESLC 355
TRN ++ICWG + + G+ P V+PGPC C P S+SLC
Sbjct: 281 TRNYTLICWG-----NENFKSGVFTPFQGLISQVVMPGPCRRE----CPYRPLSGSQSLC 331
Query: 356 VGSGNVCNPCQIELPLAVPLPPLKRPPS--PDLQPTSPK-KDEKKISLASVVVGSAGCFA 412
+C+ LKR PD + + K K + ++A +VVG G F+
Sbjct: 332 GNELMICD--------------LKRNDGEFPDTRAQNSKNKTWSRRNIAFLVVGCVGTFS 377
Query: 413 GICTVGYCFWAGFLHKRINSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSR 472
+ + + + R+ +D L R+ + R
Sbjct: 378 LLLVISFLIFKSHCRCRV----------------------HDSGRLDDTRTIDIPKLEKR 415
Query: 473 TFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKR 532
G+ + F++ ELA AT+ FS+ +GIGSFG+VY+G L DGR VA+KR
Sbjct: 416 LCTLASLGNPG---QLMEFSIDELALATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAIKR 472
Query: 533 EESCPKT-------NKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMS 585
E T ++ +K+SAF +EL +SR++HK+LV L+GF ++ +ER+LVYEYM
Sbjct: 473 AELTNPTLSGTTMRHRRADKDSAFVNELESMSRLNHKNLVRLLGFYEDTEERILVYEYMK 532
Query: 586 NGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645
NG+L DHLHN SW+ R+ IALDAARGI YLH + VP +IHRDIKSSNIL
Sbjct: 533 NGSLADHLHNPQFDPL------SWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNIL 586
Query: 646 LDVNWTARVSDFGLSLLG--SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGV 703
LD WTA+VSDFGLS +G E D +S A GT+GYIDPEYY LT K+D+Y GV
Sbjct: 587 LDATWTAKVSDFGLSQMGPTEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGV 646
Query: 704 VLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLA 763
VLLELL+G KA+ NED P ++VE+ V IL + H +LD+R+ PP E EAV +
Sbjct: 647 VLLELLSGHKAIHNNED-ENPRNLVEYVVPYILLDEAHRILDQRIPPPTPYEIEAVAHVG 705
Query: 764 TTAIHCVNLEGKERPNITDIVANLERALAICQDCSCTDSFSTT 806
A C+ ++RP++ ++V+ LE ALA C T++ S +
Sbjct: 706 YLAAECLMPCSRKRPSMVEVVSKLESALAACLTAPKTETVSRS 748
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LX29|ACR4_ARATH Serine/threonine-protein kinase-like protein ACR4 OS=Arabidopsis thaliana GN=ACR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 260/843 (30%), Positives = 398/843 (47%), Gaps = 125/843 (14%)
Query: 11 IIFTIITIISSLQTFVNSLGSASTAAIIYKT--STVCGIIAGESIQRIQCYQNGSTI--P 66
I+ + + +S+ ++LGS S+ AI Y S CG+ + S + CY + S I
Sbjct: 12 ILLVKLVLFTSIWQLASALGSMSSIAISYGEGGSVFCGLKSDGS-HLVVCYGSNSAILYG 70
Query: 67 VLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSF-QPKRLHFRKAVQLTDVSVG 125
+ F ++GG + CGL +CW + QP K + +VS G
Sbjct: 71 TPGHLQFIGLTGGDGFMCGLLMLSHQPYCWGNSAFIQMGVPQP----MTKGAEYLEVSAG 126
Query: 126 GDQVCARE------------VNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRG 173
+C ++S +V CW ++ F F D + ++++G
Sbjct: 127 DYHLCGLRKPIVGRRKNSNIISSSLVDCWGYNMTRN----FVF-----DKQLHSLSAGSE 177
Query: 174 FTCGILRSNSEVFCWGDSGIADEIQRGFKNLSMVGLVAGESHACGL--SRNGALVCKG-- 229
F C + + VFCWGD + I K + AG H CG+ ++C G
Sbjct: 178 FNCALSSKDKSVFCWGDENSSQVISLIPKEKKFQKIAAGGYHVCGILDGLESRVLCWGKS 237
Query: 230 ----------SNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGG-TNRFEF 278
S + L++P G G + C I++ CWG NR
Sbjct: 238 LEFEEEVTGTSTEEKILDLPPKEPLLAVVG---GKFYACGIKRYDHSAVCWGFFVNR--- 291
Query: 279 DSDVIQDVSFESIVAGLDFVCG-LTTRNLSMICWGPGWSNKPHLERGLPLPLGQVLPGPC 337
+ + F + AG F CG LT ++S +CWG G+ +PL V PG C
Sbjct: 292 STPAPTGIGFYDLAAGNYFTCGVLTGTSMSPVCWGLGFPAS--------IPLA-VSPGLC 342
Query: 338 VESSCI--TCGVYPNSESLCVGSG-NVCNPCQIELPLAVPLPPLKRPPSPDL-------- 386
+++ C T + S C +G ++C PC P + + S +
Sbjct: 343 IDTPCPPGTHELSNQENSPCKFTGSHICLPCSTSCPPGMYQKSVCTERSDQVCVYNCSSC 402
Query: 387 ------------QPTSPKKDEK----KISLASVVVGSAGCFAGICTVGYCFWAGFLHKRI 430
+ K+ K ++ +A+ +G A + ++ A ++ R+
Sbjct: 403 SSHDCSSNCSSSATSGGKEKGKFWSLQLPIATAEIGFALFLVAVVSITA---ALYIRYRL 459
Query: 431 NSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADN 490
+ + S +T S DSA ++G P L R+ +A
Sbjct: 460 RNCRCSENDTRSSK--DSAFTKDNGKIRPDLDELQKRR------------------RARV 499
Query: 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD 550
FT EL A + F E+ VG GSF VYKG L DG VAVKR ++ ++ + F
Sbjct: 500 FTYEELEKAADGFKEESIVGKGSFSCVYKGVLRDGTTVAVKR---AIMSSDKQKNSNEFR 556
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
+EL LLSR++H HL+ L+G+C+E ERLLVYE+M++G+LH+HLH KN K W
Sbjct: 557 TELDLLSRLNHAHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALKEQL---DWV 613
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
R+ IA+ AARGI+YLH YA P +IHRDIKSSNIL+D ARV+DFGLSLLG
Sbjct: 614 KRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPVDSGSP 673
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAV-FKNEDGSGPLDVVE 729
++ GT+GY+DPEYY ++ LT K+D+Y GV+LLE+L+G+KA+ E+G ++VE
Sbjct: 674 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMHYEEG----NIVE 729
Query: 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
+AV I AG ++ +LD + P +E EA++ + + A CV + GK+RP++ + LER
Sbjct: 730 WAVPLIKAGDINALLDPVLKHP--SEIEALKRIVSVACKCVRMRGKDRPSMDKVTTALER 787
Query: 790 ALA 792
ALA
Sbjct: 788 ALA 790
|
Controls formative cell division in meristems, including root tips and lateral root initiation zones of the pericycle, in response to CLE40 signal. Acts with CLE40p peptide as a ligand-receptor pair in a signal transduction pathway, coordinating movement of the root tip and organization of cell divisions in the root meristem. Required during embryogenesis and development, probably for the differentiation of protoderm and epidermal cells. Involved in the regulation of cellular organization during the development of sepal margins and ovule integument outgrowth. Can phosphorylate ALE2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O24585|CRI4_MAIZE Putative receptor protein kinase CRINKLY4 OS=Zea mays GN=CR4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 144/316 (45%), Positives = 209/316 (66%), Gaps = 13/316 (4%)
Query: 487 KADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKE 546
+A F+ EL AT FS +++VG GSF V+KG L DG VAVKR K + +++
Sbjct: 489 RAQEFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAI---KASDVKKSS 545
Query: 547 SAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIV 606
F +EL LLSR++H HL+ L+G+C++ ERLLVYE+M++G+L+ HLH K+ K
Sbjct: 546 KEFHNELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRL-- 603
Query: 607 NSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC 666
+W R+ IA+ AARGI+YLH YA P +IHRDIKSSNIL+D + ARV+DFGLS+LG
Sbjct: 604 -NWARRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPAD 662
Query: 667 DQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAV-FKNEDGSGPL 725
+S GT+GY+DPEYY ++ LT K+D+Y GVVLLE+L+G+KA+ + E+G
Sbjct: 663 SGTPLSELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFEEG---- 718
Query: 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785
++VE+AV I AG + +LD + PP ++ EA++ +A+ A CV + GK+RP++ +
Sbjct: 719 NIVEWAVPLIKAGDIFAILDPVLSPP--SDLEALKKIASVACKCVRMRGKDRPSMDKVTT 776
Query: 786 NLERALAICQDCSCTD 801
LE ALA+ C +
Sbjct: 777 ALEHALALLMGSPCIE 792
|
Putative receptor protein kinase. Could play a role in a differentiation signal. The CRINKLY4 (CR4) mutation affects leaf epidermis differentiation such that cell size and morphology are altered, and surface functions are compromised, allowing graft-like fusions between organs. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S7D9|ACCR1_ARATH Serine/threonine-protein kinase-like protein CCR1 OS=Arabidopsis thaliana GN=CCR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 250 bits (638), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 221/766 (28%), Positives = 337/766 (43%), Gaps = 131/766 (17%)
Query: 72 SFQAISGGQNYFCGLRSGGFSLHCWDT------NDLTNFSFQPKRLHFRKAVQLTDVSVG 125
S +SGG + CG+ S C+ + DL ++ + + ++ G
Sbjct: 85 SMAVLSGGDGFLCGILSNTSQAFCFSSLGSSSGMDLVPLAY--------RTTAYSQIAAG 136
Query: 126 GDQVCA------REVNSGVVKCWRGTKVKDKGQLFSFSSPG------EDLKFSTITSGRG 173
VCA + +SG + CW T+ + L + +P +L F+ I SG G
Sbjct: 137 NSHVCAVRGAYYSDHDSGTIDCWEITRATNNNSLIAKENPNFYDQIVSNLVFNNIVSGDG 196
Query: 174 FTCGILRSNSEVFCWGDSGIADEIQRGFKNLS--MVGLVAGESHACG-LSRNGALVCKGS 230
F+CG +R + + C+G + GF S L AG++ C L+ + + C G
Sbjct: 197 FSCGGIR-DGGMLCFG----PNSSNLGFNTTSDNFQVLAAGKNSVCAILNLSREVKCWGE 251
Query: 231 NDSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFES 290
++S +N P + + S L G C IR+ + V CWG +N S + + F++
Sbjct: 252 DES-FVNSPMNDSRFVS--LTAGPRHFCGIREDNHEVECWGNSNF----SLIPKGSGFKA 304
Query: 291 IVAGLDFVCGLTTRNLSMICWGPGWSN----KPHLERGLPLPLGQVLPGPCVESS-CITC 345
I + VCG+ +L + CW S+ P LE P G GPC E
Sbjct: 305 IASSDFIVCGIREEDLVLDCWMVNGSSTLAYDPPLELCSP---GMCRAGPCNEKEFAFNA 361
Query: 346 GVY--PNSESLCVGSG-NVCNPCQIELP---------------LAVPLPPLKRPPSPDL- 386
+ P+ SLCV VC+PC + + P + D+
Sbjct: 362 SILNEPDLTSLCVRKELMVCSPCGSDCSHGFFLSSSCTANSDRICTPCSLCQNSSCSDIC 421
Query: 387 ---QPTSPKKDEKKISLASVVVGSAGCFAGICTVGYCFWAGFLHKRINSVQPSSANTSSD 443
P K ++ +++GS I +G C + RI V + +
Sbjct: 422 KLHNSNFPDKHWHQLQRLVLIIGSCASALLIIIIGCC-----VVPRI--VTSPNKEDGAA 474
Query: 444 SNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNF 503
+ S D PL + S + S + A F LSEL ATN F
Sbjct: 475 NQFKSCIGKPDLDTDQPLENVSP--------------APSVTPFAQVFRLSELKDATNGF 520
Query: 504 SLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH 563
N++G GS+G VYK L DGR+VAVKR + + F++EL +L + H +
Sbjct: 521 KEFNELGRGSYGFVYKAVLADGRQVAVKRANA---ATIIHTNTREFETELEILCNIRHCN 577
Query: 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI 623
+V L+G+ E ERLLVYEYM +G LHDHLH+ + SW +RI+IA+ A+G+
Sbjct: 578 IVNLLGYSTEMGERLLVYEYMPHGTLHDHLHSGFSPL-------SWSLRIKIAMQTAKGL 630
Query: 624 DYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYID 683
+YLHN A P IIH D+KSSN+LLD W ARV+DFGL +E +
Sbjct: 631 EYLHNEAEPRIIHGDVKSSNVLLDSEWVARVADFGLVTSSNEKN---------------- 674
Query: 684 PEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCV 743
L K D+Y GVVLLE+LTG+K ++ D P ++VE+ V I G+ +
Sbjct: 675 --------LDIKRDVYDFGVVLLEILTGRKRYDRDCD---PPEIVEWTVPVIREGKAAAI 723
Query: 744 LDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
+D + P E + LA A CV + ++P ++++ LE
Sbjct: 724 VDTYIALPR--NVEPLLKLADVAELCVREDPNQQPTMSELANWLEH 767
|
Serine/threonine-protein kinase with low activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 141/303 (46%), Positives = 195/303 (64%), Gaps = 16/303 (5%)
Query: 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD 550
+L L AT+NFS KVG GSFG+VY G++ DG+EVAVK P ++ R+ F
Sbjct: 596 ISLPVLEEATDNFS--KKVGRGSFGSVYYGRMKDGKEVAVKITAD-PSSHLNRQ----FV 648
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
+E+ALLSR+HH++LV L+G+C+E D R+LVYEYM NG+L DHLH ++ + W
Sbjct: 649 TEVALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLD-----WL 703
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
R++IA DAA+G++YLH PSIIHRD+KSSNILLD+N A+VSDFGLS +E D
Sbjct: 704 TRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLS-RQTEEDLTH 762
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730
+S+ A GTVGY+DPEYY LT K+D+Y GVVL ELL+GKK V ED L++V +
Sbjct: 763 VSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPV-SAEDFGPELNIVHW 821
Query: 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790
A S I G + ++D + + E+V +A A CV G RP + +++ ++ A
Sbjct: 822 ARSLIRKGDVCGIIDPCIASNV--KIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDA 879
Query: 791 LAI 793
+ I
Sbjct: 880 IRI 882
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (601), Expect = 7e-61, Method: Compositional matrix adjust.
Identities = 160/440 (36%), Positives = 232/440 (52%), Gaps = 52/440 (11%)
Query: 371 LAVPLPPLKRPPSPDLQPTSPKKDEKKISLASVVVGSAGCFAGICTVGYCFWAGFLHKRI 430
LA P P PSP KK+ K + ++GSAG + CF A +K+
Sbjct: 403 LAGPNPE----PSPMQAEEEVKKEFKNEKRHAFIIGSAGGVLAVLIGALCFTA---YKKK 455
Query: 431 NSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKA-- 488
Q ++TSS LP + +T S G+ +GS ++ A
Sbjct: 456 QGYQGGDSHTSS--------------WLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGL 501
Query: 489 -DNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNK-LREKE 546
F+L E+ T NF N +G+G FG VYKG + +VAVK+ S P + + L E
Sbjct: 502 CRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGTTKVAVKK--SNPNSEQGLNE-- 557
Query: 547 SAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIV 606
F++E+ LLSR+ HKHLV L+G+C E E LVY+YM+ G L +HL+N +
Sbjct: 558 --FETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQL----- 610
Query: 607 NSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC 666
+WK R+ IA+ AARG+ YLH A +IIHRD+K++NIL+D NW A+VSDFGLS G
Sbjct: 611 -TWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNM 669
Query: 667 DQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726
+ ++T G+ GY+DPEY+ LT K+D+Y GVVL E+L + A+ + S P +
Sbjct: 670 NGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPAL----NPSLPKE 725
Query: 727 VV---EFAVSQILAGQLHCVLDKRVGPPELN---EAEAVELLATTAIHCVNLEGKERPNI 780
V ++A++ G L ++D P L AE ++ A TA C+N G ERP +
Sbjct: 726 QVSLGDWAMNCKRKGNLEDIID-----PNLKGKINAECLKKFADTAEKCLNDSGLERPTM 780
Query: 781 TDIVANLERALAICQDCSCT 800
D++ NLE AL + + T
Sbjct: 781 GDVLWNLEFALQLQETADGT 800
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 152/426 (35%), Positives = 229/426 (53%), Gaps = 47/426 (11%)
Query: 382 PSPDLQPTSPKKDEKK-----ISLASVVVGSAGCFAGICTVGYCFWAGFLHKRINSVQPS 436
P+P P +D KK + + V+GSAG A + CF +++R S
Sbjct: 409 PNPKPSPMQANEDVKKDFQGDKRITAFVIGSAGGVAAVLFCALCF---TMYQRKRKFSGS 465
Query: 437 SANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKA---DNFTL 493
++TSS LP + T S G+ +GS ++ A F+L
Sbjct: 466 DSHTSS--------------WLPIYGNSHTSATKSTISGKSNNGSHLSNLAAGLCRRFSL 511
Query: 494 SELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNK-LREKESAFDSE 552
SE+ T+NF N +G+G FG VYKG + G +VA+K+ S P + + L E F++E
Sbjct: 512 SEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAIKK--SNPNSEQGLNE----FETE 565
Query: 553 LALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
+ LLSR+ HKHLV L+G+C E E L+Y+YMS G L +HL+N + +WK R
Sbjct: 566 IELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQL------TWKRR 619
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
+ IA+ AARG+ YLH A +IIHRD+K++NILLD NW A+VSDFGLS G + ++
Sbjct: 620 LEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVT 679
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732
T G+ GY+DPEY+ LT K+D+Y GVVL E+L + A+ + + + ++A+
Sbjct: 680 TVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKE-QVSLGDWAM 738
Query: 733 SQILAGQLHCVLDKRVGPPELN---EAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
+ G L ++D P L E ++ A TA C++ G +RP + D++ NLE
Sbjct: 739 NCKRKGTLEDIID-----PNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEF 793
Query: 790 ALAICQ 795
AL + +
Sbjct: 794 ALQLQE 799
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 230 bits (587), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 136/320 (42%), Positives = 192/320 (60%), Gaps = 28/320 (8%)
Query: 476 RQRSGSSSFSVK-ADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREE 534
R+RS +S ++ +FT +ELA AT+NF+ ++G G +G VYKG L G VA+KR +
Sbjct: 597 RKRSSKASLKIEGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQ 656
Query: 535 SCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLH 594
+ E F +E+ LLSR+HH++LV L+GFC E+ E++LVYEYM NG L D++
Sbjct: 657 EGS-----LQGEKEFLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNIS 711
Query: 595 NKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654
K + + MR+RIAL +A+GI YLH A P I HRDIK+SNILLD +TA+V
Sbjct: 712 VKLKEPLD------FAMRLRIALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKV 765
Query: 655 SDFGLSLLGSECDQEFISTKAV-----GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELL 709
+DFGLS L D E IS + V GT GY+DPEY++ + LT K+D+Y LGVVLLEL
Sbjct: 766 ADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELF 825
Query: 710 TGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGP-PELNEAEAVELLATTAIH 768
TG + + G + + A +G + +DKR+ P+ E +E AT A+
Sbjct: 826 TGMQPI---THGKNIVREINIAYE---SGSILSTVDKRMSSVPD----ECLEKFATLALR 875
Query: 769 CVNLEGKERPNITDIVANLE 788
C E RP++ ++V LE
Sbjct: 876 CCREETDARPSMAEVVRELE 895
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 228 bits (582), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 142/401 (35%), Positives = 213/401 (53%), Gaps = 51/401 (12%)
Query: 403 VVVGSA-GCFAGICTVGYCFWAGFLHKRINSVQPSSANTSSDSNVDSASMANDGSNLPPL 461
++VGSA G + +G CF L+K+ Q + T +++ SM + SN L
Sbjct: 406 LIVGSAIGSLLAVVFLGSCF---VLYKKRKRGQDGHSKTWMPFSINGTSMGSKYSNGTTL 462
Query: 462 RSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK 521
S +T F + + ATNNF +G+G FG VYKG+
Sbjct: 463 TSITTNANYRIPF-------------------AAVKDATNNFDESRNIGVGGFGKVYKGE 503
Query: 522 LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581
L DG +VAVKR PK+ ++ + F +E+ +LS+ H+HLV L+G+C E +E +L+Y
Sbjct: 504 LNDGTKVAVKR--GNPKS---QQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIY 558
Query: 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKS 641
EYM NG + HL+ +WK R+ I + AARG+ YLH +IHRD+KS
Sbjct: 559 EYMENGTVKSHLYGSGLPSL------TWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKS 612
Query: 642 SNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGL 701
+NILLD N+ A+V+DFGLS G E DQ +ST G+ GY+DPEY+ LT K+D+Y
Sbjct: 613 ANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSF 672
Query: 702 GVVLLELLTGKKAVFKNEDGSGPLDVV---EFAVSQILAGQLHCVLDK----RVGPPELN 754
GVVL E+L + + D + P ++V E+A+ GQL ++D+ + P L
Sbjct: 673 GVVLFEVLCARPVI----DPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLR 728
Query: 755 EAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795
+ A T C+ G +RP++ D++ NLE AL + +
Sbjct: 729 K------FAETGEKCLADYGVDRPSMGDVLWNLEYALQLQE 763
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 812 | ||||||
| 224054540 | 787 | predicted protein [Populus trichocarpa] | 0.955 | 0.986 | 0.659 | 0.0 | |
| 359478851 | 806 | PREDICTED: putative serine/threonine-pro | 0.963 | 0.970 | 0.624 | 0.0 | |
| 297745891 | 865 | unnamed protein product [Vitis vinifera] | 0.963 | 0.904 | 0.624 | 0.0 | |
| 356541731 | 830 | PREDICTED: putative serine/threonine-pro | 0.954 | 0.933 | 0.573 | 0.0 | |
| 356569529 | 812 | PREDICTED: putative serine/threonine-pro | 0.956 | 0.956 | 0.581 | 0.0 | |
| 356569298 | 809 | PREDICTED: putative serine/threonine-pro | 0.963 | 0.966 | 0.562 | 0.0 | |
| 225448439 | 790 | PREDICTED: putative serine/threonine-pro | 0.934 | 0.960 | 0.577 | 0.0 | |
| 357492697 | 925 | Receptor kinase-like protein [Medicago t | 0.947 | 0.831 | 0.546 | 0.0 | |
| 449510857 | 803 | PREDICTED: putative serine/threonine-pro | 0.926 | 0.936 | 0.574 | 0.0 | |
| 449463050 | 821 | PREDICTED: putative serine/threonine-pro | 0.926 | 0.915 | 0.574 | 0.0 |
| >gi|224054540|ref|XP_002298311.1| predicted protein [Populus trichocarpa] gi|222845569|gb|EEE83116.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 992 bits (2564), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/792 (65%), Positives = 617/792 (77%), Gaps = 16/792 (2%)
Query: 8 LTIIIFTIITIISSLQTFVNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIPV 67
L I+F IT V SLG+AST AI Y T T CGI+AGE QR+QCYQNG I +
Sbjct: 8 LPTILFVAITPSLLHVVVVKSLGTASTIAITYSTPTACGIVAGEPTQRVQCYQNGQAISL 67
Query: 68 LPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFS-FQPKRLHFRKAVQLTDVSVGG 126
PN SF+AISGG N+ CGLRSGG ++ CW+T +++FS QPKR+++ V+LTD++VG
Sbjct: 68 QPNISFEAISGGLNFLCGLRSGGLAILCWETAAISHFSSLQPKRIYYSNTVRLTDLTVGD 127
Query: 127 DQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVF 186
QVCAREVNSG+VKCWRG +G+ SF SPG LKFSTITSG GFTCGIL +NS V
Sbjct: 128 VQVCAREVNSGMVKCWRGV---GRGK-SSFPSPGVALKFSTITSGSGFTCGILMNNSRVH 183
Query: 187 CWGDSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEF 246
CWG+S + EI+R F NL+M+ LVAGESHACGL+ +G LVCKGSN SGQL+ PF+S FEF
Sbjct: 184 CWGNSDVGTEIERQFGNLTMLNLVAGESHACGLASSGVLVCKGSNGSGQLDAPFNSTFEF 243
Query: 247 SGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFESIVAGLDFVCGLTTRNL 306
S LALGANFTC+I QR+GLV CWG N+F+ DS + ++ S + IVAGL+F+CGLTTRNL
Sbjct: 244 SA-LALGANFTCSIEQRNGLVKCWGEANKFQLDSYISENDSLDLIVAGLNFICGLTTRNL 302
Query: 307 SMICWGPGWSNKPHLERGLPLPLGQVLPGPCVESSCITCGVYPNSESLCVGSGNVCNPCQ 366
SMICWG GWSN L G LPLG ++PG CV+SSC TCG+YPNSE+LC GSG++C CQ
Sbjct: 303 SMICWGMGWSNA--LSHGDDLPLGTIIPGSCVQSSCSTCGMYPNSETLCGGSGSICKSCQ 360
Query: 367 IELPLAVPLPPLKRPPSPDLQPTSPKKDEKKISLASVVVGSAGCFAGICTVGYCFWAGFL 426
IE PLA+PLPP+ PPS +LQP K KISL ++VGS G AGI T+ Y F + FL
Sbjct: 361 IERPLALPLPPITPPPSEELQPVLQVKSRNKISLVFLIVGSVGALAGIGTIVY-FLSIFL 419
Query: 427 HKRI-NSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFS 485
HKR N+VQPS+ +D N++ + N S PPLR FS R SR G+QR+GSSS
Sbjct: 420 HKRYSNTVQPST----TDVNLNIGASVNSDSTAPPLRLFSIRSYGSRRLGQQRNGSSSRR 475
Query: 486 V-KADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLRE 544
K NF+LSEL ATNNFSLENK+G GSFGTVYKG+L DGREVA+KR E+ K KL+E
Sbjct: 476 TEKTQNFSLSELLTATNNFSLENKIGSGSFGTVYKGELPDGREVAIKRGETGMKMRKLQE 535
Query: 545 KESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSS 604
KE AFDSELALLSR+HHKHL+GL+GFC+E DERLLVYEYMSN +LHDHLH+K NTEK+SS
Sbjct: 536 KEIAFDSELALLSRLHHKHLLGLIGFCEENDERLLVYEYMSNRSLHDHLHSKENTEKSSS 595
Query: 605 IVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664
I+NSWKMRI+IALDAARGI+YLHNYAVP IIHRDIKSSNILLD NWTA+VSDFGLSL+
Sbjct: 596 ILNSWKMRIKIALDAARGIEYLHNYAVPPIIHRDIKSSNILLDANWTAKVSDFGLSLMEP 655
Query: 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN-EDGSG 723
E DQEF+ST+A GTVGYIDPEYYV+NVLTAK+D+YGLGVVLLELLTGK+AVFKN EDG
Sbjct: 656 ESDQEFMSTRAAGTVGYIDPEYYVLNVLTAKSDVYGLGVVLLELLTGKRAVFKNDEDGVV 715
Query: 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
P+ VVE+A I G L VLDKRVG PE+ E EAVEL+A TA+H VNLEGKERPNI DI
Sbjct: 716 PMGVVEYATPLIAKGMLQNVLDKRVGLPEMQETEAVELMAYTAMHSVNLEGKERPNIIDI 775
Query: 784 VANLERALAICQ 795
VANLERALA+C+
Sbjct: 776 VANLERALALCE 787
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478851|ref|XP_003632178.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 959 bits (2478), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/805 (62%), Positives = 621/805 (77%), Gaps = 23/805 (2%)
Query: 1 MKTTSSCLTIIIFTIITIISSLQTFVNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQ 60
M+ + S +TI F + ++SS VN+LGS+ST A+ Y T TVCGI+AG +Q IQCY+
Sbjct: 1 MRISPSSVTIA-FIFVALLSSPALPVNALGSSSTIAVSYATGTVCGILAGHPLQEIQCYR 59
Query: 61 NGSTIPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLT 120
G I + P S++AISGGQ++FCGLRSGGFSL CWDT +N SF+PKR+++ V LT
Sbjct: 60 QGHIINLQPQVSYEAISGGQSFFCGLRSGGFSLLCWDTT-FSNASFRPKRIYYSDRVGLT 118
Query: 121 DVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILR 180
D++VG QVCA E +SG VKCWRG + G +F +P +F ITSG GFTCGIL+
Sbjct: 119 DLTVGNAQVCALEASSGGVKCWRGER---GGSMFP--TPEVGSEFQKITSGGGFTCGILK 173
Query: 181 SNSEVFCWGDSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPF 240
+NS V CWG S + EIQR F +LSM LVAG SHACGL+ G LVCKG+ND+GQL P
Sbjct: 174 NNSRVLCWGVSTVGAEIQRQFGDLSMSSLVAGNSHACGLTDTGILVCKGNNDTGQLGFPS 233
Query: 241 SSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRF-EFDSDVIQDVSFESIVAGLDFVC 299
SAFEFSG LALGAN TCAI++R+G+V CWGG + EF S I++VSFESIVAGLDF C
Sbjct: 234 GSAFEFSG-LALGANHTCAIQRRNGMVECWGGGTKLSEFGSQHIKNVSFESIVAGLDFTC 292
Query: 300 GLTTRNLSMICWGPGWSNKPHLERGLPLPLGQVLPGPCVESSCITCGVYPNSESLCVGSG 359
GLT+RNLS+ICWGPGW+ K G PL ++PGPCVE+SC CG+YPNSE LC GSG
Sbjct: 293 GLTSRNLSVICWGPGWTGK--RTSGSVFPLEMIIPGPCVEASCSVCGMYPNSEVLCDGSG 350
Query: 360 NVCNPCQIELPLAVPLPPLKRPPSPDLQPTSPKKDE-KKISLASVVVGSAGCFAGICTVG 418
N+C C+ +LP+ +PLP L PS DLQP SP ++ LA ++VGS G FAGIC++
Sbjct: 351 NICKSCEFDLPIPLPLPILPPQPSEDLQPNSPASPAPNRLLLAFLIVGSIGLFAGICSIV 410
Query: 419 YCFWAG---FLHKRI-NSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTF 474
YC W G F HK+I +S QP+ S +N DS ++ ++GSN+ +S S ++QSS
Sbjct: 411 YCLWTGVCAFFHKQIYDSAQPNV----SRANADSFTVIDNGSNVQVSKSSSIKRQSSLAL 466
Query: 475 GRQRSGSSSFSV--KADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKR 532
RQRSG SS +V +A+NF+LSELAAATN FSLENK+G GSFGTVYKGKL DGREVA+KR
Sbjct: 467 RRQRSGPSSRAVGDRAENFSLSELAAATNMFSLENKIGGGSFGTVYKGKLADGREVAIKR 526
Query: 533 EESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDH 592
E+ + K +EKE AF+SELALLSR+HHKHLVGLVGFC+E DERLLVYEYMSNG+LHDH
Sbjct: 527 GETGSRIKKFQEKEIAFESELALLSRLHHKHLVGLVGFCEENDERLLVYEYMSNGSLHDH 586
Query: 593 LHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652
LH+KNN ++S+I+NSWKMRI+IALDAARGI+YLH+YAVP IIHRDIKSSNILLD NWTA
Sbjct: 587 LHSKNNILESSNILNSWKMRIKIALDAARGIEYLHDYAVPPIIHRDIKSSNILLDANWTA 646
Query: 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+VSDFGLSL+G + +QE++ST+A GTVGYIDPEYYV+NVLTAK+D+YGLGVVLLELLTGK
Sbjct: 647 KVSDFGLSLMGPDSNQEYMSTRAAGTVGYIDPEYYVLNVLTAKSDVYGLGVVLLELLTGK 706
Query: 713 KAVFKNE-DGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVN 771
+AVFK E +G+ P+ +V++AV QI G+L VLD RVGPPE NEAEAVEL+A A+HCV
Sbjct: 707 RAVFKEEVEGALPIGIVDYAVPQITVGELWRVLDMRVGPPEANEAEAVELMANMAMHCVK 766
Query: 772 LEGKERPNITDIVANLERALAICQD 796
LEGKERP +TDIVANLERALA+C++
Sbjct: 767 LEGKERPTMTDIVANLERALALCEE 791
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745891|emb|CBI15947.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2474), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/805 (62%), Positives = 621/805 (77%), Gaps = 23/805 (2%)
Query: 1 MKTTSSCLTIIIFTIITIISSLQTFVNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQ 60
M+ + S +TI F + ++SS VN+LGS+ST A+ Y T TVCGI+AG +Q IQCY+
Sbjct: 60 MRISPSSVTIA-FIFVALLSSPALPVNALGSSSTIAVSYATGTVCGILAGHPLQEIQCYR 118
Query: 61 NGSTIPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLT 120
G I + P S++AISGGQ++FCGLRSGGFSL CWDT +N SF+PKR+++ V LT
Sbjct: 119 QGHIINLQPQVSYEAISGGQSFFCGLRSGGFSLLCWDTT-FSNASFRPKRIYYSDRVGLT 177
Query: 121 DVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILR 180
D++VG QVCA E +SG VKCWRG + G +F +P +F ITSG GFTCGIL+
Sbjct: 178 DLTVGNAQVCALEASSGGVKCWRGER---GGSMFP--TPEVGSEFQKITSGGGFTCGILK 232
Query: 181 SNSEVFCWGDSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPF 240
+NS V CWG S + EIQR F +LSM LVAG SHACGL+ G LVCKG+ND+GQL P
Sbjct: 233 NNSRVLCWGVSTVGAEIQRQFGDLSMSSLVAGNSHACGLTDTGILVCKGNNDTGQLGFPS 292
Query: 241 SSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRF-EFDSDVIQDVSFESIVAGLDFVC 299
SAFEFSG LALGAN TCAI++R+G+V CWGG + EF S I++VSFESIVAGLDF C
Sbjct: 293 GSAFEFSG-LALGANHTCAIQRRNGMVECWGGGTKLSEFGSQHIKNVSFESIVAGLDFTC 351
Query: 300 GLTTRNLSMICWGPGWSNKPHLERGLPLPLGQVLPGPCVESSCITCGVYPNSESLCVGSG 359
GLT+RNLS+ICWGPGW+ K G PL ++PGPCVE+SC CG+YPNSE LC GSG
Sbjct: 352 GLTSRNLSVICWGPGWTGK--RTSGSVFPLEMIIPGPCVEASCSVCGMYPNSEVLCDGSG 409
Query: 360 NVCNPCQIELPLAVPLPPLKRPPSPDLQPTSPKKDE-KKISLASVVVGSAGCFAGICTVG 418
N+C C+ +LP+ +PLP L PS DLQP SP ++ LA ++VGS G FAGIC++
Sbjct: 410 NICKSCEFDLPIPLPLPILPPQPSEDLQPNSPASPAPNRLLLAFLIVGSIGLFAGICSIV 469
Query: 419 YCFWAG---FLHKRI-NSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTF 474
YC W G F HK+I +S QP+ S +N DS ++ ++GSN+ +S S ++QSS
Sbjct: 470 YCLWTGVCAFFHKQIYDSAQPNV----SRANADSFTVIDNGSNVQVSKSSSIKRQSSLAL 525
Query: 475 GRQRSGSSSFSV--KADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKR 532
RQRSG SS +V +A+NF+LSELAAATN FSLENK+G GSFGTVYKGKL DGREVA+KR
Sbjct: 526 RRQRSGPSSRAVGDRAENFSLSELAAATNMFSLENKIGGGSFGTVYKGKLADGREVAIKR 585
Query: 533 EESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDH 592
E+ + K +EKE AF+SELALLSR+HHKHLVGLVGFC+E DERLLVYEYMSNG+LHDH
Sbjct: 586 GETGSRIKKFQEKEIAFESELALLSRLHHKHLVGLVGFCEENDERLLVYEYMSNGSLHDH 645
Query: 593 LHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652
LH+KNN ++S+I+NSWKMRI+IALDAARGI+YLH+YAVP IIHRDIKSSNILLD NWTA
Sbjct: 646 LHSKNNILESSNILNSWKMRIKIALDAARGIEYLHDYAVPPIIHRDIKSSNILLDANWTA 705
Query: 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+VSDFGLSL+G + +QE++ST+A GTVGYIDPEYYV+NVLTAK+D+YGLGVVLLELLTGK
Sbjct: 706 KVSDFGLSLMGPDSNQEYMSTRAAGTVGYIDPEYYVLNVLTAKSDVYGLGVVLLELLTGK 765
Query: 713 KAVFKNE-DGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVN 771
+AVFK E +G+ P+ +V++AV QI G+L VLD RVGPPE NEAEAVEL+A A+HCV
Sbjct: 766 RAVFKEEVEGALPIGIVDYAVPQITVGELWRVLDMRVGPPEANEAEAVELMANMAMHCVK 825
Query: 772 LEGKERPNITDIVANLERALAICQD 796
LEGKERP +TDIVANLERALA+C++
Sbjct: 826 LEGKERPTMTDIVANLERALALCEE 850
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541731|ref|XP_003539327.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2348), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/841 (57%), Positives = 605/841 (71%), Gaps = 66/841 (7%)
Query: 8 LTIIIFTIITIISSLQTFVNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQNGS-TIP 66
L++ +F+I+ + T V+ LGSA+T A+ Y T+TVCGI+AGE RIQC +NGS +P
Sbjct: 7 LSLSLFSILAV-----TAVHGLGSAATTAVTYGTATVCGIVAGEPQHRIQCSRNGSRVVP 61
Query: 67 V-LPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVG 125
+ LPNASF AISGG+++FCGLRSGG SLHCWDT T SF+PKR+ VQL DV+VG
Sbjct: 62 LTLPNASFDAISGGRSFFCGLRSGGRSLHCWDTA-ATTASFRPKRVFHSDVVQLADVAVG 120
Query: 126 GDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEV 185
QVCAREV SGVV+CWRG+ FSSP E L+F +IT G GF+CGI++ + V
Sbjct: 121 DSQVCAREVQSGVVRCWRGSGGAQ------FSSPSESLRFRSITCGCGFSCGIVKESGRV 174
Query: 186 FCWGDSG--------IADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLN 237
CWGD I+DEI R FKN +M LVAG SH CGL+ +GALVCKG+NDSGQL
Sbjct: 175 VCWGDDNEGANRKGSISDEIHREFKNFTMSSLVAGVSHVCGLTLHGALVCKGNNDSGQLG 234
Query: 238 --------VPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFE 289
V +++ + GLALG +FTC IR R+G+V CWGG FDS+V++ VSFE
Sbjct: 235 YNNNNNGGVFLTTSLDHFSGLALGEDFTCGIRTRNGVVVCWGGG----FDSNVVKGVSFE 290
Query: 290 SIVAGLDFVCGLTTRNLSMICWGPG--WSNKPHLERGLPLPLGQVLPGPCVESSCI-TCG 346
S+VAGLD+VCGLTTRNL+++CWG G + + P +PLG +LPGPCVE +C +CG
Sbjct: 291 SLVAGLDYVCGLTTRNLTVVCWGKGRFFHHVPS-----EVPLGVILPGPCVEGACSGSCG 345
Query: 347 VYPNSESLCVGSGNVCNPCQIELPLAVPL-PPLKRPPSPDL----QPTSPKKDEKKIS-- 399
YP+S +LC GSG++C CQ E+PLAVPL PP + + QP+S K +
Sbjct: 346 TYPDSGALCHGSGSICYSCQTEIPLAVPLLPPSSSTTTQAVPNQEQPSSRGGKNKNLKEF 405
Query: 400 LASVVVGSAGCFAGICTVGYCFWA---GFLHKRI---------NSVQPSSANTSSDSNVD 447
L +VGS G F G+CT+ Y W FL +R NSV+P+S+ SD+ VD
Sbjct: 406 LVFFIVGSVGAFVGLCTILYFIWICARRFLLRRKEVVVGGGNNNSVKPTSSE--SDAYVD 463
Query: 448 SASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSV-KADNFTLSELAAATNNFSLE 506
M N GSN R+FS++ + SR GR RSGSSS V + ++F+LSELA AT NFSL
Sbjct: 464 IIPMPNFGSNGTTFRTFSSKSRGSRRLGRHRSGSSSKRVDRTESFSLSELATATENFSLC 523
Query: 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNK-LREKESAFDSELALLSRVHHKHLV 565
NK+G GSFG+VYKG L DGREVA+KR +S K +EKE AFDSEL +LSR+HHKHLV
Sbjct: 524 NKIGAGSFGSVYKGMLRDGREVAIKRGDSTSTMKKKFQEKEIAFDSELTMLSRLHHKHLV 583
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
L+GFC+E DERLLVYEYMSNG+L+DHLH+KNN +K+SSI+NSW+MRI+IALDAARGI+Y
Sbjct: 584 RLIGFCEENDERLLVYEYMSNGSLYDHLHDKNNVDKSSSILNSWRMRIKIALDAARGIEY 643
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS-TKAVGTVGYIDP 684
+HNYAVP IIHRDIKSSNILLD NW ARVSDFGLS + E +QE +S TKAVGTVGYIDP
Sbjct: 644 IHNYAVPPIIHRDIKSSNILLDSNWNARVSDFGLSKIWHETEQELMSTTKAVGTVGYIDP 703
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744
EYYV+NVLT K+D+YGLGVV+LELLTGK+AVFK EDGSGP+ VVE+ +I +G+L VL
Sbjct: 704 EYYVLNVLTTKSDVYGLGVVMLELLTGKRAVFKPEDGSGPMGVVEYTGPKIASGELWSVL 763
Query: 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCSCTDSFS 804
D RVG PE+NE E+++++A TA+HCVNLEGKERP +TDIVANLERALA + + SF+
Sbjct: 764 DYRVGHPEVNEVESIQIMAYTAMHCVNLEGKERPEMTDIVANLERALAFIEGTPTSLSFA 823
Query: 805 T 805
+
Sbjct: 824 S 824
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569529|ref|XP_003552952.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 908 bits (2346), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/829 (58%), Positives = 603/829 (72%), Gaps = 52/829 (6%)
Query: 8 LTIIIFTIITIISSLQTFVNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQNGS-TIP 66
L++ +F I+TI T V+ LGSA+T A+ Y T+TVCGI+AGE RIQC ++G +P
Sbjct: 7 LSLSLFVILTI-----TAVHGLGSAATTAVTYGTATVCGIVAGEPQHRIQCSRSGRRVVP 61
Query: 67 V-LPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVG 125
+ LPN SF AISGG+++FCGLRSGG SLHCWDT N F+ KRL VQL DV+VG
Sbjct: 62 LTLPNVSFDAISGGRSFFCGLRSGGRSLHCWDTA-APNAYFRSKRLFHSDVVQLADVAVG 120
Query: 126 GDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKF--STITSGRGFTCGILRSNS 183
QVCAREV SGVV+CWRG+ FSSP E L+F ++IT G GF+CG+++ +
Sbjct: 121 DSQVCAREVQSGVVRCWRGSGG------VQFSSPSEGLRFRSNSITCGCGFSCGVIKESG 174
Query: 184 EVFCWGD-------SGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQL 236
V CWGD I+DEIQR F+N +M LVAG SH CGL+ +GALVC+G+N SGQL
Sbjct: 175 RVVCWGDGDEGANTKSISDEIQRKFENFTMSSLVAGVSHVCGLTLHGALVCRGNNASGQL 234
Query: 237 ---NVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFESIVA 293
+ SS+ EFSG LALG +FTC IR R+G+V CWGG F+SDV++ VSFES+VA
Sbjct: 235 GNNDGVLSSSLEFSG-LALGEDFTCGIRTRNGVVVCWGGG----FESDVVKGVSFESLVA 289
Query: 294 GLDFVCGLTTRNLSMICWGPG-WSNKPHLERGLPLPLGQVLPGPCVESSCI-TCGVYPNS 351
GLD+VCGLTTRNLS++CWG G + + P LPLG +LPGPCVE +C +CG YP+S
Sbjct: 290 GLDYVCGLTTRNLSVVCWGKGRFFHVPS-----ELPLGVILPGPCVEGACSGSCGTYPDS 344
Query: 352 ESLCVGSGNVCNPCQIELPLAVPL-PPLKRPPSPDLQPTSPKKDEKKISLASVVVGSAGC 410
+LC GSG++C CQ E+PLAVPL PP P + +S + L +VGS G
Sbjct: 345 GALCHGSGSICYSCQTEVPLAVPLLPPSTTQVVPKQEHSSRGGRSLREFLIFFIVGSVGV 404
Query: 411 FAGICTVGYCFWA---GFLHKRI-----NSVQPSSANTSSDSNVDSASMANDGSNLPPLR 462
F G+CT+ Y W FL R NSV+P+S+ SD+ VD M N GSN R
Sbjct: 405 FVGLCTILYFIWICARRFLLSRKEVGGNNSVKPTSSE--SDAYVDIIPMPNVGSNGTTFR 462
Query: 463 SFSTRQQSSRTFGRQRSGSSSFSV-KADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK 521
+FS++ Q+SR FGR RSGSSS V + ++F+LSELA AT+N+SL NK+G GSFG VYKG
Sbjct: 463 TFSSKSQASRRFGRHRSGSSSKHVDRTESFSLSELAMATDNYSLFNKIGAGSFGCVYKGM 522
Query: 522 LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581
L DGREVA+KR ++ K +EKE AFDSELA+LSR+HHKHLV L+GFC+E DERLLVY
Sbjct: 523 LRDGREVAIKRGDTSAMKKKFQEKEIAFDSELAMLSRLHHKHLVRLIGFCEENDERLLVY 582
Query: 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKS 641
EYMSNG+L+DHLH+KNN +++S+I+NSWKMRI+IALDAARGI+Y+HNYAVP IIHRDIKS
Sbjct: 583 EYMSNGSLYDHLHDKNNVDRSSNILNSWKMRIKIALDAARGIEYIHNYAVPPIIHRDIKS 642
Query: 642 SNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGL 701
SNILLD NW ARVSDFGLS + E +QE +S+KAVGTVGYIDPEYYV+NVLT K+D+YGL
Sbjct: 643 SNILLDSNWNARVSDFGLSKIWPETEQELMSSKAVGTVGYIDPEYYVLNVLTTKSDVYGL 702
Query: 702 GVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVEL 761
GVV+LELLTGK+AVFK EDGSGP+ VVE+ +I +G+L VLD RVG PE+NE E++E+
Sbjct: 703 GVVMLELLTGKRAVFKPEDGSGPMGVVEYTGPKIASGELWSVLDYRVGQPEVNEVESLEI 762
Query: 762 LATTAIHCVNLEGKERPNITDIVANLERALAICQDCSCTDSFSTTTFSS 810
+A TA+HCVNLEGKERP +T IVANLERALA + S S +FS+
Sbjct: 763 MAYTAMHCVNLEGKERPEMTGIVANLERALAFIE--GTPTSLSIASFSA 809
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569298|ref|XP_003552840.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2140), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/832 (56%), Positives = 586/832 (70%), Gaps = 50/832 (6%)
Query: 1 MKTTSS-----CLTIIIFTIITIISSLQTFVNSLGSASTAAIIYKTSTVCGIIAGESIQR 55
MKT S CL + + ++ I SL + GS +T A+ +STVC ++A ES +R
Sbjct: 1 MKTPPSSSVNLCLAVAVAAVL--ILSLVPSSHGFGSGATLALSDSSSTVCAVVASESTRR 58
Query: 56 IQCYQNGSTIPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRK 115
I+CY+ G +P+ PN SF +ISGG+NYFCG+RS +L CW+T+ SF+ +RL+
Sbjct: 59 IECYRQGQVVPIAPNVSFSSISGGRNYFCGIRSSNSNLLCWNTSS----SFERRRLYNDS 114
Query: 116 AVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFT 175
+V L +++VG VCA V G V+CWR G F S G D +F++I+SG GF+
Sbjct: 115 SVPLENLAVGDTHVCATAVGDGTVRCWR------TGNTFQIVS-GSD-QFASISSGSGFS 166
Query: 176 CGILRSNSEVFCWGDSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQ 235
CGIL++ S V CWGD+ ++++I+ F+N+SM+ LVAG SH CGL+ G LVC+GSN SGQ
Sbjct: 167 CGILKNGSRVRCWGDTNVSEQIENSFRNISMLSLVAGGSHVCGLNLTGFLVCRGSNGSGQ 226
Query: 236 LNVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFESIVAGL 295
++P AFE+SG LALGA CAIR+ +G V CWGG +F S+V + VSFE IV+G
Sbjct: 227 FDIPQGGAFEYSG-LALGAEHGCAIRESNGSVVCWGGNGQFSV-SNVTEGVSFEVIVSGS 284
Query: 296 DFVCGLTTRNLSMICWGPGWSNKPHLERGLPLPLGQVLPGPCVESSCITCGVYPNSESLC 355
+FVCGLTT NL+++CWGPGWSN E LPL +VLPGPCV+SSC CG Y NSE LC
Sbjct: 285 NFVCGLTTNNLTVVCWGPGWSNGSRFE----LPLPRVLPGPCVQSSCGECGSYLNSEFLC 340
Query: 356 VGSGNVCNP--CQIELPLAVPLPPLKRPPSPDLQPTSP----------KKDEKKISLASV 403
GSGN+C P C+ + + PL P PPSP P K + LA
Sbjct: 341 SGSGNICKPMTCRPQTTVPPPLLPSPPPPSPSPPPPPSLTSPSPSPSRSKTLTRGLLAFA 400
Query: 404 VVGSAGCFAGICTVGYCFWAG--FLHKRI-NSVQPSSANTSSDSNVDSASMANDGSNLPP 460
++GS G FAGICT+ YC W+G F K++ NSVQP+ SS SN AS ++ S
Sbjct: 401 IIGSVGAFAGICTIVYCLWSGVCFGKKKVHNSVQPTITRGSSGSNGGGASNNSNSSISSM 460
Query: 461 LRSFSTRQQSSRTFGRQRSGSSSFSV--KADNFTLSELAAATNNFSLENKVGIGSFGTVY 518
+ +Q+S RQRSG+SS +A+ FTL+ELAAAT+NFS ENK+G GSFG VY
Sbjct: 461 IM-----RQTSIIMRRQRSGTSSMKHPDRAEEFTLAELAAATDNFSHENKIGAGSFGVVY 515
Query: 519 KGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578
KGKL DGREVA+KR E+ K K +EKESAF+SELA LSR+HHKHLVGLVGFC+EKDERL
Sbjct: 516 KGKLTDGREVAIKRGETGSKMKKFQEKESAFESELAFLSRLHHKHLVGLVGFCEEKDERL 575
Query: 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRD 638
LVYEYM NGAL+DHLH+KNN EK SS++N+WKMRI+IALDA+RGI+YLHNYAVPSIIHRD
Sbjct: 576 LVYEYMKNGALYDHLHDKNNVEKESSVLNNWKMRIKIALDASRGIEYLHNYAVPSIIHRD 635
Query: 639 IKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDI 698
IKSSNILLD WTARVSDFGLSL+ E D++ KA GTVGYIDPEYY +NVLTAK+D+
Sbjct: 636 IKSSNILLDATWTARVSDFGLSLMSPEPDRDHRPMKAAGTVGYIDPEYYGLNVLTAKSDV 695
Query: 699 YGLGVVLLELLTGKKAVFK-NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAE 757
YGLGVVLLELLTGK+A+FK EDG PL VV+FAV ILAG+L +LD RV PP + E+E
Sbjct: 696 YGLGVVLLELLTGKRAIFKYGEDGGTPLSVVDFAVPSILAGELVKLLDPRVEPPNVTESE 755
Query: 758 AVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCSCTDSFSTTTFS 809
AVEL+A TAIHCVNLEGK+RP + DIV+NLERALAIC+ S DS S+ T S
Sbjct: 756 AVELVAYTAIHCVNLEGKDRPTMADIVSNLERALAICE--SSHDSISSGTIS 805
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225448439|ref|XP_002272022.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2123), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/793 (57%), Positives = 566/793 (71%), Gaps = 34/793 (4%)
Query: 25 FVNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIPVLPNASFQAISGG-QNYF 83
V+ LGS ST A+ Y + VCG++AGE QRI+CY+ G TI + PN S + G +++F
Sbjct: 24 LVHGLGSGSTLAVSYGSGAVCGVVAGERYQRIECYRGGETISIEPNISSFSSISGGRDFF 83
Query: 84 CGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWR 143
CGLRSGGF+L CW+T SF KR++F V L +++VG DQVCA +GVVKCWR
Sbjct: 84 CGLRSGGFALFCWNT------SFVAKRIYFNYTVLLENLAVGDDQVCATVNGTGVVKCWR 137
Query: 144 GTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQRGFKN 203
G + +FS+I+SG GF+CGIL +N V CWG + IA++IQ+ F N
Sbjct: 138 GENSSSLSE---------SSQFSSISSGLGFSCGILVNNRTVQCWGSNTIANQIQQEFGN 188
Query: 204 LSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQR 263
M+ ++AG SH CGL+ G L+C+GSNDSGQLNVP SA+EFS L+LG N +CAIRQ
Sbjct: 189 TPMLSIMAGGSHVCGLNTTGYLLCEGSNDSGQLNVPSGSAYEFSN-LSLGENHSCAIRQS 247
Query: 264 SGLVACWGGTNRFEFDSDVIQDVSFESIVAGLDFVCGLTTRNLSMICWGPGW-SNKPHLE 322
+G V CWGG EF ++ +SFESIV+GL+F CGL T N S+ICWGPGW S+
Sbjct: 248 NGSVVCWGGGG--EFSTNATNGISFESIVSGLNFTCGLITTNYSIICWGPGWPSSSVSGL 305
Query: 323 RGLPLPLGQVLPGPCVESSCITCGVYPNSESLCVGSGNVCNPCQIELPLAVPLPPLKRPP 382
PLPL +LPGPCV+SS C VYP S+ LC GS VC PC++ +P + PP
Sbjct: 306 GLSPLPLSIILPGPCVQSSSCEC-VYPGSQYLCYGSEVVCKPCRVLVPGSPVPLSPVSPP 364
Query: 383 SPDLQPTSPKKDEKKISLASVVVGSAGCFAGICTVGYCFWAGFL--HKRI-NSVQPSSAN 439
S + + + + LA +VGS G F+GICT+ YC W G HK+I NSVQP+ A
Sbjct: 365 SVSPPSSPSRALSRGL-LAFAIVGSVGAFSGICTIIYCLWTGVCCGHKKIHNSVQPTIAR 423
Query: 440 TSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSS-FSVKADNFTLSELAA 498
+S+ +S S RS + R+QSSR RQRSG+SS + +A+ F LSELAA
Sbjct: 424 GNSNGGANSNSSPPS-------RSLTIRRQSSRAMRRQRSGTSSKHTDRAEEFALSELAA 476
Query: 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
AT+NFSLENK+G GSFG VYKGKL DGREVA+KR E+ KT K +EKESAFDSELA LSR
Sbjct: 477 ATDNFSLENKIGAGSFGVVYKGKLPDGREVAIKRGETGLKTKKFQEKESAFDSELAFLSR 536
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+HHKHLV LVGFCQE DERLLVYEYM NGAL+DHLH+KNN EK+S+++NSWK+RIRI+LD
Sbjct: 537 LHHKHLVRLVGFCQEMDERLLVYEYMKNGALYDHLHDKNNIEKSSNVLNSWKLRIRISLD 596
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
AARGI+YLHNYAVP IIHRDIKSSNILLD NWTARVSDFGLSL+G + F KA GT
Sbjct: 597 AARGIEYLHNYAVPPIIHRDIKSSNILLDANWTARVSDFGLSLMGPDSSHSFRPMKAAGT 656
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN-EDGSGPLDVVEFAVSQILA 737
VGYIDPEYY +NVLTAK+D+YGLGVVLLELLTGK+A+FK+ E+G P+ VV+FAV I+A
Sbjct: 657 VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDGENGGTPISVVDFAVPAIIA 716
Query: 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDC 797
G+L VLD RVGPP+ NEAEAVEL+A TA+HCVNLEGKERP + DIVANLERALA+C+D
Sbjct: 717 GELMKVLDPRVGPPQTNEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALALCEDS 776
Query: 798 SCTDSFSTTTFSS 810
+ S T + S
Sbjct: 777 HGSISSGTISIVS 789
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492697|ref|XP_003616637.1| Receptor kinase-like protein [Medicago truncatula] gi|355517972|gb|AES99595.1| Receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2101), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/811 (54%), Positives = 564/811 (69%), Gaps = 42/811 (5%)
Query: 2 KTTSSCLTIIIFTIITIISSLQTFVNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQN 61
K + S + FT + +ISSL N+LGS +T A++ T+TVCGII+ + +I CY++
Sbjct: 3 KISLSSIIFSTFTFVILISSLPV-TNALGSGTTLAVVDSTATVCGIISSQKTHKIICYRH 61
Query: 62 GSTIPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRK--AVQL 119
G I +P SF +ISGG+NYFCG+RSG +S+ CWDT +N +F+ +RL+ V
Sbjct: 62 GHLITAVPEVSFSSISGGRNYFCGIRSGNYSILCWDTVS-SNTTFETRRLYNNNNGTVLY 120
Query: 120 TDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGIL 179
+++VG VCA VN G V CWR K F P +FS+ITSG GFTCGIL
Sbjct: 121 ENLAVGDSHVCATMVNVGNVACWRMNK--------GFVLPSGFDQFSSITSGFGFTCGIL 172
Query: 180 RSNSE--VFCWG-----DSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSND 232
+ N V C+G +S IA++I++ F N+SMV LVAGESH CGL+ G LVCKGSN+
Sbjct: 173 KKNDSGSVRCFGNVNVNESSIAEKIEKEFVNVSMVSLVAGESHVCGLNSKGFLVCKGSNN 232
Query: 233 SGQLNVPFS-SAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFESI 291
GQ+NVP E+S LALGA +CAIR+ +G V CWGG F D +V ++VSFE I
Sbjct: 233 FGQINVPNQVEPLEYSD-LALGAEHSCAIRRSNGSVVCWGGNGLF--DVNVTKNVSFEVI 289
Query: 292 VAGLDFVCGLTTRNLSMICWGPGWSNKPHLERGLPLPLGQVLPGPCVESSCITCGVYPNS 351
V+ +F CGLTT N S++CWGP W+ LPL +LPG CV+SSC CG+YP S
Sbjct: 290 VSASNFTCGLTTNNFSVVCWGPSWNGST-----FQLPLPPILPGICVQSSCSECGMYPQS 344
Query: 352 ESLCVGSGNVCNPCQIELPLAVPLPP-LKRPPSPDLQPTSPKKDEKKISLASVVVGSAGC 410
+ LC G N+C P + VP+P + PP P L P S K K L +VG G
Sbjct: 345 QYLCSGFSNICKPKPCWPQMDVPVPSQIATPPQPGL-PCSRSKTLTKGLLLFAIVGLIGA 403
Query: 411 FAGICTVGYCFWAG--FLHKRI-NSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTR 467
AG+CTV YC W+G F K++ NSVQP+ S ++ + +N P RS + R
Sbjct: 404 VAGLCTVVYCLWSGVCFGKKKVHNSVQPTITRGGS---LNCGAFSNYS---PTSRSSTIR 457
Query: 468 QQSSRTFGRQRSGSSS--FSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDG 525
+Q SR RQRSG+SS +++ FTL+EL AATNNFSLENKVG GS+G VYKGKL DG
Sbjct: 458 RQGSRIMRRQRSGTSSTKHPDRSEEFTLAELVAATNNFSLENKVGAGSYGVVYKGKLADG 517
Query: 526 REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMS 585
REVA+KR E+ +EKESAF+SELA LSR+HHKHLV LVGFC EKDERLLVYE+M
Sbjct: 518 REVAIKRGETSTMMKVFQEKESAFESELAFLSRLHHKHLVRLVGFCDEKDERLLVYEFMK 577
Query: 586 NGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645
NGAL+DHLH+KNN +KNSS++NSWKMRI++ALDA+RGI+YLHNYAVPSIIHRDIKSSNIL
Sbjct: 578 NGALYDHLHDKNNVDKNSSLLNSWKMRIKVALDASRGIEYLHNYAVPSIIHRDIKSSNIL 637
Query: 646 LDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVL 705
+D +WTARVSDFGLS+L + D ++ TKA GTVGYIDPEYY +NVLTAK+D+YGLGVVL
Sbjct: 638 IDADWTARVSDFGLSMLSPDSDHDYRPTKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVL 697
Query: 706 LELLTGKKAVFKN-EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLAT 764
LELLTGK+A+FKN E+G P+ +V+FAV I+ G+L +LD+RV PPE+NE EAVEL++
Sbjct: 698 LELLTGKRAIFKNDENGGTPISIVDFAVPIIMKGELMKILDQRVEPPEMNETEAVELVSY 757
Query: 765 TAIHCVNLEGKERPNITDIVANLERALAICQ 795
TA+HCV+LEGK+RP I+DIVANLERA +C
Sbjct: 758 TAMHCVHLEGKDRPTISDIVANLERAFTLCD 788
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449510857|ref|XP_004163787.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2100), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/781 (57%), Positives = 567/781 (72%), Gaps = 29/781 (3%)
Query: 26 VNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIPVLPNASFQAISGGQNYFCG 85
+ +LGSAST A+ Y + TVCGI+A + QRI C+++G TI + P SF A+SGG+N FCG
Sbjct: 27 IQALGSASTLAVSYGSRTVCGIVAEQPTQRILCFRDGQTIFIEPGISFSAVSGGRNTFCG 86
Query: 86 LRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWR-G 144
+RSGG+++ CW+ N LT +F +RL++ V L +++VG DQ+CA V +G V CWR G
Sbjct: 87 IRSGGYTILCWNFN-LTTAAFTRRRLYYNPNVLLENLAVGDDQICATVVGAGNVTCWRDG 145
Query: 145 TKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWG-DSGIADEIQRGFKN 203
KV + FSS L + +I+SG GF+CGIL+ N + CWG +S IA EI+ GF+N
Sbjct: 146 NKV-----IGGFSS----LLYDSISSGYGFSCGILKGNQSIRCWGRNSSIATEIENGFRN 196
Query: 204 LSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQR 263
+SM+ +VAG H CGL+ +G LVCKG+ND GQL+ P + + EFS LALG +C I
Sbjct: 197 ISMLSIVAGGFHVCGLNISGGLVCKGNNDFGQLDFPSNYSVEFSE-LALGERHSCGILVS 255
Query: 264 SGLVACWGGTNRFEFDSDVIQDVSFESIVAGLDFVCGLTTRNLSMICWGPGWSNKPHLER 323
+ V CWGG F D+I++ SFE I +G DFVCGLTT N S++CWGPGWSN
Sbjct: 256 NRSVICWGG---LGFSVDLIRETSFELISSGSDFVCGLTTSNFSVLCWGPGWSNNSLSP- 311
Query: 324 GLPLPLGQVLPGPCVESSCITCGVYPNSESLCVGSGNVCNPCQIELPLAVPLPPLKRPPS 383
L L ++LPGPCV S +CGVYP S++LC SGNVCN C +P PL P
Sbjct: 312 -SSLSLPKILPGPCVLQSSCSCGVYPLSQTLCSNSGNVCNRCFFTVPTPSSPQPLPSSPP 370
Query: 384 PDLQPTSPKKDE---KKISLASVVVGSAGCFAGICTVGYCFWAG--FLHKRI-NSVQPSS 437
T+P K+ LA +VGS G FAGICT+ YC W G F +K+I NSVQP+
Sbjct: 371 RSPPVTTPSPTPAALKRGLLAFGIVGSVGAFAGICTIIYCLWTGVCFGNKKIHNSVQPTI 430
Query: 438 ANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSS-FSVKADNFTLSEL 496
+S + + S N N PP RS + R+Q SR RQRSG+SS + +A+ FTL+EL
Sbjct: 431 TRAASSNGGTTTSNTN---NSPPSRSSTIRRQGSRIMRRQRSGTSSKHADRAEEFTLAEL 487
Query: 497 AAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALL 556
A ATN+FS ENK+G GSFG VY+GKL DGREVA+KR E+ KT K +EKESAFDSELA L
Sbjct: 488 AMATNDFSPENKIGEGSFGVVYRGKLYDGREVAIKRGETGQKTKKFQEKESAFDSELAFL 547
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
SR+HHKHLV LVG+C+EKDERLLVYEYM NGAL++HLH+KNN EK SS+VNSWKMRI+IA
Sbjct: 548 SRLHHKHLVRLVGYCEEKDERLLVYEYMKNGALYNHLHDKNNFEKASSVVNSWKMRIKIA 607
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
LDAARGI+YLHNYAVP IIHRDIKSSNILLD NWTARVSDFGLSL+ D+++ TKA
Sbjct: 608 LDAARGIEYLHNYAVPPIIHRDIKSSNILLDANWTARVSDFGLSLMSPGSDRDYRPTKAA 667
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED-GSGPLDVVEFAVSQI 735
GTVGYIDPEYY +NVLTAK+D+YGLGVVLLELLTGK+A+FK+E+ G P+ VV++AV I
Sbjct: 668 GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDEEQGGTPVSVVDYAVPVI 727
Query: 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795
+AG+L +LD+RVGPP++NEAEAVEL+A TA+HCV+LEGK+RP +TDIV+NLERAL +C
Sbjct: 728 MAGELGKILDQRVGPPQINEAEAVELVAYTAMHCVHLEGKDRPTMTDIVSNLERALNLCD 787
Query: 796 D 796
D
Sbjct: 788 D 788
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463050|ref|XP_004149247.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2099), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/781 (57%), Positives = 567/781 (72%), Gaps = 29/781 (3%)
Query: 26 VNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIPVLPNASFQAISGGQNYFCG 85
+ +LGSAST A+ Y + TVCGI+A + QRI C+++G TI + P SF A+SGG+N FCG
Sbjct: 27 IQALGSASTLAVSYGSRTVCGIVAEQPTQRILCFRDGQTIFIEPGISFSAVSGGRNTFCG 86
Query: 86 LRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWR-G 144
+RSGG+++ CW+ N LT +F +RL++ V L +++VG DQ+CA V +G V CWR G
Sbjct: 87 IRSGGYTILCWNFN-LTTAAFTRRRLYYNPNVLLENLAVGDDQICATVVGAGNVTCWRDG 145
Query: 145 TKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWG-DSGIADEIQRGFKN 203
KV + FSS L + +I+SG GF+CGIL+ N + CWG +S IA EI+ GF+N
Sbjct: 146 NKV-----IGGFSS----LLYDSISSGYGFSCGILKGNQSIRCWGRNSSIATEIENGFRN 196
Query: 204 LSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQR 263
+SM+ +VAG H CGL+ +G LVCKG+ND GQL+ P + + EFS LALG +C I
Sbjct: 197 ISMLSIVAGGFHVCGLNISGGLVCKGNNDFGQLDFPSNYSVEFSE-LALGERHSCGILVS 255
Query: 264 SGLVACWGGTNRFEFDSDVIQDVSFESIVAGLDFVCGLTTRNLSMICWGPGWSNKPHLER 323
+ V CWGG F D+I++ SFE I +G DFVCGLTT N S++CWGPGWSN
Sbjct: 256 NRSVICWGG---LGFSVDLIRETSFELISSGSDFVCGLTTSNFSVLCWGPGWSNNSLSP- 311
Query: 324 GLPLPLGQVLPGPCVESSCITCGVYPNSESLCVGSGNVCNPCQIELPLAVPLPPLKRPPS 383
L L ++LPGPCV S +CGVYP S++LC SGNVCN C +P PL P
Sbjct: 312 -SSLSLPKILPGPCVLQSSCSCGVYPLSQTLCSNSGNVCNRCFFTVPTPSSPQPLPSSPP 370
Query: 384 PDLQPTSPKKDE---KKISLASVVVGSAGCFAGICTVGYCFWAG--FLHKRI-NSVQPSS 437
T+P K+ LA +VGS G FAGICT+ YC W G F +K+I NSVQP+
Sbjct: 371 RSPPVTTPSPTPAALKRGLLAFGIVGSVGAFAGICTIIYCLWTGVCFGNKKIHNSVQPTI 430
Query: 438 ANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSS-FSVKADNFTLSEL 496
+S + + S N N PP RS + R+Q SR RQRSG+SS + +A+ FTL+EL
Sbjct: 431 TRAASSNGGTTTSNTN---NSPPSRSSTIRRQGSRIMRRQRSGTSSKHADRAEEFTLAEL 487
Query: 497 AAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALL 556
A ATN+FS ENK+G GSFG VY+GKL DGREVA+KR E+ KT K +EKESAFDSELA L
Sbjct: 488 AMATNDFSPENKIGEGSFGVVYRGKLYDGREVAIKRGETGQKTKKFQEKESAFDSELAFL 547
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
SR+HHKHLV LVG+C+EKDERLLVYEYM NGAL++HLH+KNN EK SS+VNSWKMRI+IA
Sbjct: 548 SRLHHKHLVRLVGYCEEKDERLLVYEYMKNGALYNHLHDKNNFEKASSVVNSWKMRIKIA 607
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
LDAARGI+YLHNYAVP IIHRDIKSSNILLD NWTARVSDFGLSL+ D+++ TKA
Sbjct: 608 LDAARGIEYLHNYAVPPIIHRDIKSSNILLDANWTARVSDFGLSLMSPGSDRDYRPTKAA 667
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED-GSGPLDVVEFAVSQI 735
GTVGYIDPEYY +NVLTAK+D+YGLGVVLLELLTGK+A+FK+E+ G P+ VV++AV I
Sbjct: 668 GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDEEQGGTPVSVVDYAVPVI 727
Query: 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795
+AG+L +LD+RVGPP++NEAEAVEL+A TA+HCV+LEGK+RP +TDIV+NLERAL +C
Sbjct: 728 MAGELGKILDQRVGPPQINEAEAVELVAYTAMHCVHLEGKDRPTMTDIVSNLERALNLCD 787
Query: 796 D 796
D
Sbjct: 788 D 788
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 812 | ||||||
| TAIR|locus:2082033 | 814 | CCR3 "CRINKLY4 related 3" [Ara | 0.908 | 0.906 | 0.468 | 1.3e-178 | |
| UNIPROTKB|O24585 | 901 | CR4 "Putative receptor protein | 0.362 | 0.326 | 0.433 | 4.2e-86 | |
| TAIR|locus:2160952 | 751 | CCR4 "CRINKLY4 related 4" [Ara | 0.365 | 0.395 | 0.466 | 8.2e-85 | |
| TAIR|locus:2081227 | 895 | CR4 "crinkly4" [Arabidopsis th | 0.362 | 0.328 | 0.442 | 1.5e-81 | |
| TAIR|locus:2056033 | 776 | CCR2 "CRINKLY4 related 2" [Ara | 0.195 | 0.204 | 0.508 | 2.5e-58 | |
| TAIR|locus:2075074 | 775 | CCR1 "CRINKLY4 related 1" [Ara | 0.204 | 0.214 | 0.505 | 1.2e-55 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.352 | 0.307 | 0.430 | 8.2e-55 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.349 | 0.292 | 0.419 | 3.5e-53 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.357 | 0.310 | 0.376 | 8.4e-51 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.353 | 0.334 | 0.380 | 3.4e-49 |
| TAIR|locus:2082033 CCR3 "CRINKLY4 related 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1734 (615.5 bits), Expect = 1.3e-178, P = 1.3e-178
Identities = 375/801 (46%), Positives = 492/801 (61%)
Query: 26 VNSLGSASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIPVL--PNASFQAISGGQNYF 83
V SLGS ST A++Y + TVC +I+G+ QRI CY I V P SF +I+ G N+
Sbjct: 28 VTSLGSGSTYAVVYGSDTVCALISGQPTQRILCYDTRLNINVTLNPGVSFSSIAAGDNFL 87
Query: 84 CGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWR 143
CG+RSGG+SL CWD ++ ++S KR++ V L +SVG Q+CA + +KCWR
Sbjct: 88 CGIRSGGYSLLCWD--NIGSYSPNRKRIYQNDNVLLETLSVGDKQICATVNGTNSLKCWR 145
Query: 144 GTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGI-ADEIQRGFK 202
G+ V D+ + P E +F +I+SG GF+CG+ N+ + CWG + +++IQ GF
Sbjct: 146 GS-VSDQSK-----PPNE--RFRSISSGVGFSCGVSIRNNRILCWGTDPVKSNQIQTGFG 197
Query: 203 NLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNV--PFSSAFEFSGGLALGANFTCAI 260
N MV + AG+SHACGL+ G L+C G+NDSGQLNV P +S L+LG+NFTCA+
Sbjct: 198 NTPMVTISAGKSHACGLNTTGNLICIGNNDSGQLNVIAPDQPNL-YSSSLSLGSNFTCAM 256
Query: 261 RQRSGLVACWGG-TNRFEFDSDVIQDVSFESIVAGLDFVCGLTTRNLSMICWGPGWSNKP 319
R + V CWGG RF ++V +SFESI +G +CGL + NLS++CW P ++
Sbjct: 257 RISNNSVVCWGGGAERF---NNVTDSISFESISSGPGLICGLISSNLSIMCWNPTNFSRI 313
Query: 320 HLERXXXXXXXXXXXXXCVESSC---ITCGVYPNSESLCVGSGNVCNPCQIEXXXXXXXX 376
L CVESS +CGVYP S+ LC G+G++C C I+
Sbjct: 314 FLP------FPEVLPGPCVESSSSSLCSCGVYPQSDKLCSGTGSICKSCPIQFPASPPSQ 367
Query: 377 XXXXXXX-----XXXXXTSPKKDEKKISLASVVVGSAGCFAGICTVGYCFWAGFL--HKR 429
+ P K + LA +VGS G FAGIC+V YC W G K+
Sbjct: 368 FPLPPPPPPPPPSPSTSSPPSKALTRGLLAFAIVGSVGAFAGICSVVYCLWTGVCLGKKK 427
Query: 430 I-NSVQPS-----SANTSSDSNVDSASMANDGSNLPPLXXXXXXXXXXXXXXXXXXXXXX 483
+ NSVQP+ S + S+ SN S S+ GS + +
Sbjct: 428 VHNSVQPTITRGGSNSRSNSSNSRSLSIRRQGSRMLSMRRQRSGTSSMKHAD-------- 479
Query: 484 XXVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLR 543
KA+ F+ SELA+AT NFSLENK+G GSFG VY+GKL DGREVA+KR E K K +
Sbjct: 480 ---KAEEFSFSELASATGNFSLENKIGSGSFGVVYRGKLNDGREVAIKRGEVNAKMKKFQ 536
Query: 544 EKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNS 603
EKE+AFDSE+A LSR+HHKHLV LVG+C+E++E+LLVY+YM NGAL+DHLH+KNN EK+S
Sbjct: 537 EKETAFDSEIAFLSRLHHKHLVRLVGYCEEREEKLLVYDYMKNGALYDHLHDKNNVEKHS 596
Query: 604 SIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
S++NSWKMRI+IALDAARGI+YLHNYAVP IIHRDIKSSNILLD NW ARVSDFGLSL+G
Sbjct: 597 SLINSWKMRIKIALDAARGIEYLHNYAVPPIIHRDIKSSNILLDSNWVARVSDFGLSLMG 656
Query: 664 SECDQEFIS----TKAVGTVGYIDPEYYVMNVLTAKTDIYXXXXXXXXXXTGKKAVFKN- 718
++ TKA GTVGYIDPEYY +NVLT K+D+Y TGK+A+F+N
Sbjct: 657 PVLGKDHNPYQRPTKAAGTVGYIDPEYYSLNVLTDKSDVYGLGVVLLELLTGKRAIFRNN 716
Query: 719 -----EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPXXXXXXXXXXXXXXXIHCVNLE 773
E+G P+ +V+++V I A +L +LD RVG P +HCVN E
Sbjct: 717 GDVEEEEGCVPVHLVDYSVPAITADELSTILDPRVGSPELGEGDAVELVAYTAMHCVNAE 776
Query: 774 GKERPNITDIVANLERALAIC 794
G+ RP +TDIV NLERAL +C
Sbjct: 777 GRNRPTMTDIVGNLERALDLC 797
|
|
| UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 4.2e-86, Sum P(2) = 4.2e-86
Identities = 134/309 (43%), Positives = 192/309 (62%)
Query: 487 KADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKE 546
+A F+ EL AT FS +++VG GSF V+KG L DG VAVKR K + +++
Sbjct: 489 RAQEFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKR---AIKASDVKKSS 545
Query: 547 SAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKN-NTEKNSSI 605
F +EL LLSR++H HL+ L+G+C++ ERLLVYE+M++G+L+ HLH K+ N +K
Sbjct: 546 KEFHNELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKR--- 602
Query: 606 VNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665
+N W R+ IA+ AARGI+YLH YA P +IHRDIKSSNIL+D + ARV+DFGLS+LG
Sbjct: 603 LN-WARRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPA 661
Query: 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYXXXXXXXXXXTGKKAV-FKNEDGSGP 724
+S GT+GY+DPEYY ++ LT K+D+Y +G+KA+ + E+G+
Sbjct: 662 DSGTPLSELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFEEGN-- 719
Query: 725 LDVVEFAVSQILAGQLHCVLDKRVGPPXXXXXXXXXXXXXXXIHCVNLEGKERPNITDIV 784
+VE+AV I AG + +LD + PP CV + GK+RP++ +
Sbjct: 720 --IVEWAVPLIKAGDIFAILDPVLSPPSDLEALKKIASVA--CKCVRMRGKDRPSMDKVT 775
Query: 785 ANLERALAI 793
LE ALA+
Sbjct: 776 TALEHALAL 784
|
|
| TAIR|locus:2160952 CCR4 "CRINKLY4 related 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 693 (249.0 bits), Expect = 8.2e-85, Sum P(2) = 8.2e-85
Identities = 146/313 (46%), Positives = 196/313 (62%)
Query: 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKT-------NKLR 543
F++ ELA AT+ FS+ +GIGSFG+VY+G L DGR VA+KR E T ++
Sbjct: 431 FSIDELALATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAIKRAELTNPTLSGTTMRHRRA 490
Query: 544 EKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNS 603
+K+SAF +EL +SR++HK+LV L+GF ++ +ER+LVYEYM NG+L DHLHN
Sbjct: 491 DKDSAFVNELESMSRLNHKNLVRLLGFYEDTEERILVYEYMKNGSLADHLHNPQFDPL-- 548
Query: 604 SIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
SW+ R+ IALDAARGI YLH + VP +IHRDIKSSNILLD WTA+VSDFGLS +G
Sbjct: 549 ----SWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNILLDATWTAKVSDFGLSQMG 604
Query: 664 --SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYXXXXXXXXXXTGKKAVFKNEDG 721
E D +S A GT+GYIDPEYY LT K+D+Y +G KA+ NED
Sbjct: 605 PTEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGVVLLELLSGHKAIHNNED- 663
Query: 722 SGPLDVVEFAVSQILAGQLHCVLDKRVGPPXXXXXXXXXXXXXXXIHCVNLEGKERPNIT 781
P ++VE+ V IL + H +LD+R+ PP C+ ++RP++
Sbjct: 664 ENPRNLVEYVVPYILLDEAHRILDQRIPPPTPYEIEAVAHVGYLAAECLMPCSRKRPSMV 723
Query: 782 DIVANLERALAIC 794
++V+ LE ALA C
Sbjct: 724 EVVSKLESALAAC 736
|
|
| TAIR|locus:2081227 CR4 "crinkly4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 615 (221.5 bits), Expect = 1.5e-81, Sum P(2) = 1.5e-81
Identities = 136/307 (44%), Positives = 188/307 (61%)
Query: 487 KADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKE 546
+A FT EL A + F E+ VG GSF VYKG L DG VAVKR + ++K ++
Sbjct: 496 RARVFTYEELEKAADGFKEESIVGKGSFSCVYKGVLRDGTTVAVKR--AIMSSDK-QKNS 552
Query: 547 SAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIV 606
+ F +EL LLSR++H HL+ L+G+C+E ERLLVYE+M++G+LH+HLH KN K
Sbjct: 553 NEFRTELDLLSRLNHAHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALKEQL-- 610
Query: 607 NSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC 666
W R+ IA+ AARGI+YLH YA P +IHRDIKSSNIL+D ARV+DFGLSLLG
Sbjct: 611 -DWVKRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPVD 669
Query: 667 DQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYXXXXXXXXXXTGKKAVFKN-EDGSGPL 725
++ GT+GY+DPEYY ++ LT K+D+Y +G+KA+ + E+G+
Sbjct: 670 SGSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMHYEEGN--- 726
Query: 726 DVVEFAVSQILAGQLHCVLDKRVGPPXXXXXXXXXXXXXXXIHCVNLEGKERPNITDIVA 785
+VE+AV I AG ++ +LD + P CV + GK+RP++ +
Sbjct: 727 -IVEWAVPLIKAGDINALLDPVLKHPSEIEALKRIVSVA--CKCVRMRGKDRPSMDKVTT 783
Query: 786 NLERALA 792
LERALA
Sbjct: 784 ALERALA 790
|
|
| TAIR|locus:2056033 CCR2 "CRINKLY4 related 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 407 (148.3 bits), Expect = 2.5e-58, Sum P(3) = 2.5e-58
Identities = 86/169 (50%), Positives = 108/169 (63%)
Query: 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD 550
F LSEL AT+ F N++G GSFG VYK L DG VAVKR + + F+
Sbjct: 507 FRLSELKDATHGFKEFNELGRGSFGFVYKAVLSDGIHVAVKRANAA---TIIHSNNRGFE 563
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
SEL +L ++ H ++V L+G+C E ERLLVYEYM +G LHDHLH S + W
Sbjct: 564 SELEILCKIRHNNIVNLLGYCSEMGERLLVYEYMPHGTLHDHLHGDL-----SQL--DWS 616
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659
MR++I L AARG+DYLHN P IIHRD+K+SNILLD AR++DFGL
Sbjct: 617 MRLKIMLQAARGLDYLHNEVDPPIIHRDVKTSNILLDGEMCARIADFGL 665
|
|
| TAIR|locus:2075074 CCR1 "CRINKLY4 related 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 409 (149.0 bits), Expect = 1.2e-55, Sum P(3) = 1.2e-55
Identities = 91/180 (50%), Positives = 117/180 (65%)
Query: 488 ADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCP--KTNKLREK 545
A F LSEL ATN F N++G GS+G VYK L DGR+VAVKR + TN RE
Sbjct: 505 AQVFRLSELKDATNGFKEFNELGRGSYGFVYKAVLADGRQVAVKRANAATIIHTNT-RE- 562
Query: 546 ESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSI 605
F++EL +L + H ++V L+G+ E ERLLVYEYM +G LHDHLH+ S +
Sbjct: 563 ---FETELEILCNIRHCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLHSGF-----SPL 614
Query: 606 VNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665
SW +RI+IA+ A+G++YLHN A P IIH D+KSSN+LLD W ARV+DFGL +E
Sbjct: 615 --SWSLRIKIAMQTAKGLEYLHNEAEPRIIHGDVKSSNVLLDSEWVARVADFGLVTSSNE 672
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 8.2e-55, P = 8.2e-55
Identities = 130/302 (43%), Positives = 180/302 (59%)
Query: 492 TLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDS 551
+L L AT+NFS KVG GSFG+VY G++ DG+EVAVK P ++ R+ F +
Sbjct: 597 SLPVLEEATDNFS--KKVGRGSFGSVYYGRMKDGKEVAVKITAD-PSSHLNRQ----FVT 649
Query: 552 ELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
E+ALLSR+HH++LV L+G+C+E D R+LVYEYM NG+L DHLH ++ + W
Sbjct: 650 EVALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLD-----WLT 704
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
R++IA DAA+G++YLH PSIIHRD+KSSNILLD+N A+VSDFGLS E D +
Sbjct: 705 RLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEE-DLTHV 763
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKTDIYXXXXXXXXXXTGKKAVFKNEDGSGPLDVVEFA 731
S+ A GTVGY+DPEYY LT K+D+Y +GKK V ED L++V +A
Sbjct: 764 SSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPV-SAEDFGPELNIVHWA 822
Query: 732 VSQILAGQLHCVLDKRVGPPXXXXXXXXXXXXXXXIHCVNLEGKERPNITDIVANLERAL 791
S I G + ++D + CV G RP + +++ ++ A+
Sbjct: 823 RSLIRKGDVCGIIDPCIASNVKIESVWRVAEVAN--QCVEQRGHNRPRMQEVIVAIQDAI 880
Query: 792 AI 793
I
Sbjct: 881 RI 882
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 3.5e-53, P = 3.5e-53
Identities = 125/298 (41%), Positives = 172/298 (57%)
Query: 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD 550
F+ EL TNNFS+ +++G G +G VYKG L DG VA+KR + L F
Sbjct: 626 FSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLE-----FK 680
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
+E+ LLSRVHHK+LVGLVGFC E+ E++LVYEYMSNG+L D L + S I WK
Sbjct: 681 TEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGR------SGITLDWK 734
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
R+R+AL +ARG+ YLH A P IIHRD+KS+NILLD N TA+V+DFGLS L S+C +
Sbjct: 735 RRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDCTKGH 794
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYXXXXXXXXXXTGKKAVFKNEDGSGPLDVVEF 730
+ST+ GT+GY+DPEYY LT K+D+Y T K+ + K + + +V
Sbjct: 795 VSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIKLVMN 854
Query: 731 AVSQILAGQLHCVLDKRVGPPXXXXXXXXXXXXXXXIHCVNLEGKERPNITDIVANLE 788
G L +D+ + + CV+ ERP ++++V +E
Sbjct: 855 KSDDDFYG-LRDKMDRSLRD--VGTLPELGRYMELALKCVDETADERPTMSEVVKEIE 909
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 8.4e-51, Sum P(2) = 8.4e-51
Identities = 114/303 (37%), Positives = 173/303 (57%)
Query: 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD 550
FTL E+ AT F E ++G G FG VY GK +G+E+AVK N + + F
Sbjct: 594 FTLYEIEEATKKF--EKRIGSGGFGIVYYGKTREGKEIAVK-----VLANNSYQGKREFA 646
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
+E+ LLSR+HH++LV +G+CQE+ + +LVYE+M NG L +HL+ ++ I SW
Sbjct: 647 NEVTLLSRIHHRNLVQFLGYCQEEGKNMLVYEFMHNGTLKEHLYGV--VPRDRRI--SWI 702
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
R+ IA DAARGI+YLH VP+IIHRD+K+SNILLD + A+VSDFGLS +
Sbjct: 703 KRLEIAEDAARGIEYLHTGCVPAIIHRDLKTSNILLDKHMRAKVSDFGLSKFAVD-GTSH 761
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYXXXXXXXXXXTGKKAVFKNEDGSGPLDVVEF 730
+S+ GTVGY+DPEYY+ LT K+D+Y +G++A+ G ++V++
Sbjct: 762 VSSIVRGTVGYLDPEYYISQQLTEKSDVYSFGVILLELMSGQEAISNESFGVNCRNIVQW 821
Query: 731 AVSQILAGQLHCVLDKRVGPPXXXXXXXXXXXXXXXIHCVNLEGKERPNITDIVANLERA 790
A I G + ++D + + CV G RP+++++ +++ A
Sbjct: 822 AKMHIDNGDIRGIIDPALAEDDYSLQSMWKIAEKALL-CVKPHGNMRPSMSEVQKDIQDA 880
Query: 791 LAI 793
+ I
Sbjct: 881 IRI 883
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 3.4e-49, P = 3.4e-49
Identities = 115/302 (38%), Positives = 171/302 (56%)
Query: 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD 550
FT E+ NNFS+ N VG G +G VYKG L G+ +A+KR + L F
Sbjct: 522 FTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALE-----FK 576
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
+E+ LLSRVHHK++V L+GFC ++ E++LVYEY+ NG+L D L K S I W
Sbjct: 577 TEIELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGK------SGIRLDWT 630
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
R+RIAL + +G+ YLH A P IIHRD+KSSN+LLD + TA+V+DFGLS L + ++
Sbjct: 631 RRLRIALGSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQLVEDAEKAN 690
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYXXXXXXXXXXTGKKAVFKNEDGSGPLDVVEF 730
++ + GT+GY+DPEYY+ N LT K+D+Y TGK + E+G + ++
Sbjct: 691 VTAQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPI---ENGKYVVKEMKM 747
Query: 731 AVSQIL-AGQLHCVLDKRVGPPXXXXXXXXXXXXXXXIHCVNLEGKERPNITDIVANLER 789
+++ L LD + + CV+ EG +RP++ ++V +E
Sbjct: 748 KMNKSKNLYDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEVVKEIEN 807
Query: 790 AL 791
+
Sbjct: 808 IM 809
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LY50 | ACCR3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5122 | 0.9347 | 0.9324 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00024091001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (865 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 812 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| pfam13540 | 30 | pfam13540, RCC1_2, Regulator of chromosome condens | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| COG5184 | 476 | COG5184, ATS1, Alpha-tubulin suppressor and relate | 5e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-04 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 96/289 (33%), Positives = 137/289 (47%), Gaps = 41/289 (14%)
Query: 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ L K+G GSFGTVYK K G+ VAVK K ++ +K+ E+ +L R+ H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKIL---KKRSEKSKKDQTARREIRILRRLSH 57
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++V L+ ++KD LV EY G L D+L S +IAL R
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--------PLSEDEAKKIALQILR 109
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
G++YLH+ IIHRD+K NILLD N +++DFGL+ + T VGT Y
Sbjct: 110 GLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWY 164
Query: 682 IDPE------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735
+ PE Y K D++ LGV+L ELLTG K F E+ L ++ +I
Sbjct: 165 MAPEVLLGGNGY-----GPKVDVWSLGVILYELLTG-KPPFSGENILDQLQLIR----RI 214
Query: 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784
L L K E EA +L+ C+N + +RP +I+
Sbjct: 215 LGPPLEFDEPKWSSGSE----EAKDLIKK----CLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 509 VGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G G FGTVY + G++VA+K ++ L E+ E+ +L +++H ++V L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEE---LLREIEILKKLNHPNIVKL 56
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH 627
G ++++ LV EY G+L D L S +RI L G++YLH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKL-------SEDEILRILLQILEGLEYLH 109
Query: 628 NYAVPSIIHRDIKSSNILLD-VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEY 686
+ IIHRD+K NILLD N +++DFGLS L + + VGT Y+ PE
Sbjct: 110 SN---GIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEV 164
Query: 687 YVMNV-LTAKTDIYGLGVVLLEL 708
+ + K+DI+ LGV+L EL
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 7e-44
Identities = 83/298 (27%), Positives = 135/298 (45%), Gaps = 52/298 (17%)
Query: 507 NKVGIGSFGTVYKGKLMDG----REVAVKREESCPKTNKLREKESAFDSELALLSRVHHK 562
K+G G+FG VYKGKL EVAVK K + E+ F E ++ ++ H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT----LKEDASEEERKDFLKEARVMKKLGHP 56
Query: 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN-SWKMRIRIALDAAR 621
++V L+G C E++ LV EYM G L D+L + S K + A+ A+
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
G++YL + +HRD+ + N L+ + ++SDFGLS + D T + +
Sbjct: 117 GMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL------DVVEFAVSQI 735
+ PE + T+K+D++ GV+L E+ T G+ P +V+E+ +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT---------LGATPYPGLSNEEVLEY----L 220
Query: 736 LAGQ-----LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
G +C P EL EL+ C L+ ++RP +++V LE
Sbjct: 221 RKGYRLPKPEYC-------PDELY-----ELML----SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 7e-44
Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ + K+G GSFG VY + G+ VA+K K K+++ E+ +L ++ H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKV----IKKKKIKKDRERILREIKILKKLKH 56
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIR-IALDA 619
++V L +++D+ LV EY G L D L + +E R
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED----------EARFYLRQI 106
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
++YLH+ I+HRD+K NILLD + +++DFGL+ + D T VGT
Sbjct: 107 LSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLA---RQLDPGEKLTTFVGTP 160
Query: 680 GYIDPEYYVMNVL-----TAKTDIYGLGVVLLELLTGK 712
Y+ PE VL DI+ LGV+L ELLTGK
Sbjct: 161 EYMAPE-----VLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 504 SLENKVGIGSFGTVYKGKL-----MDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+L K+G G+FG VYKG L EVAVK K + ++ F E ++ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK----TLKEDASEQQIEEFLREARIMRK 57
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ H ++V L+G C E++ ++V EYM G L D+L E + S + AL
Sbjct: 58 LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE----L--SLSDLLSFALQ 111
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
ARG++YL + + IHRD+ + N L+ N ++SDFGLS + D +
Sbjct: 112 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLP 167
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ ++ PE T+K+D++ GV+L E+ T
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 504 SLENKVGIGSFGTVYKGKL-----MDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+L K+G G+FG VYKGKL EVAVK K + ++ F E ++ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK----TLKEDASEQQIEEFLREARIMRK 57
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ H ++V L+G C E++ +V EYM G L +L + S + AL
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----L--SLSDLLSFALQ 110
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
ARG++YL + + IHRD+ + N L+ N ++SDFGLS + D + G
Sbjct: 111 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY----YRKRGG 163
Query: 679 ---VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ ++ PE T+K+D++ GV+L E+ T
Sbjct: 164 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 77/290 (26%), Positives = 132/290 (45%), Gaps = 37/290 (12%)
Query: 503 FSLENKVGIGSFGTVYKGKLMD-----GREVAVKREESCPKTNKLREKESAFDSELALLS 557
L K+G G+FG VYKG L +VAVK + + E+E F E +++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK---TLKEGASEEERE-EFLEEASIMK 56
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
++ H ++V L+G C + + +V EYM G L D L + K +++AL
Sbjct: 57 KLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL-------TLKDLLQMAL 109
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
A+G++YL + + +HRD+ + N L+ N ++SDFGLS E D
Sbjct: 110 QIAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL 166
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737
+ ++ PE T+K+D++ GV+L E+ T + + +V+E +
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE---EVLEL----LED 219
Query: 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787
G R+ PE E EL+ C + ++RP +++V +L
Sbjct: 220 G-------YRLPRPENCPDELYELML----QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 72/217 (33%), Positives = 108/217 (49%), Gaps = 31/217 (14%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKR--EESCPKTNKLREKESAFDSELALLSRV 559
F + K+G G FG VYK + G+EVA+K ES K K+ E+ +L +
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-------EIQILKKC 54
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNT--EKNSSIVNSWKMRIRIAL 617
H ++V G +KDE +V E+ S G+L D L + N T E + +
Sbjct: 55 KHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY---------VCK 105
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
+ +G++YLH+ IIHRDIK++NILL + ++ DFGLS ++ VG
Sbjct: 106 ELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLS---AQLSDTKARNTMVG 159
Query: 678 TVGYIDPEYYVMNVL--TAKTDIYGLGVVLLELLTGK 712
T ++ PE V+N K DI+ LG+ +EL GK
Sbjct: 160 TPYWMAPE--VINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
++ +G GSFG+VY D G +AVK S + E+ A + E+ +LS +
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVK---SVELSGDSEEELEALEREIRILSSLQ 57
Query: 561 HKHLVGLVGFCQEKDER-LLVY-EYMSNGALHDHLHNKNNTEKNSSIVNSWKMR---IRI 615
H ++V G +++++ L ++ EY+S G+L L K+ IR
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF------------GKLPEPVIRK 105
Query: 616 -ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFIST 673
G+ YLH+ I+HRDIK +NIL+D + +++DFG + LG E +
Sbjct: 106 YTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS 162
Query: 674 KAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
GT ++ PE DI+ LG ++E+ TGK
Sbjct: 163 V-RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 502 NFSLENKVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
N+ L + +G G+FG VYKG L G VA+K+ E + E+ LL +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS---LEKIKEEALKSIMQEIDLLKNLK 57
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H ++V +G + D ++ EY NG+L + K S+V + + L
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVY---VYQVL--- 109
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
+G+ YLH +IHRDIK++NIL + +++DFG++ ++ ++ VGT
Sbjct: 110 QGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPY 164
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
++ PE M+ + +DI+ LG ++ELLTG
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-30
Identities = 82/294 (27%), Positives = 130/294 (44%), Gaps = 28/294 (9%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-H 560
++ + K+G GSFG VY + D + VA+K K ++ F E+ +L+ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLA--KKLESKSKEVERFLREIQILASLNH 56
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
++V L F Q++ LV EY+ G+L D L S + I
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE-----SEALFILAQIL 111
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLD-VNWTARVSDFGLSLLGSECDQEFI----STKA 675
++YLH+ IIHRDIK NILLD ++ DFGL+ L + + +
Sbjct: 112 SALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 676 VGTVGYIDPEYYVMNVL---TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732
VGT GY+ PE + L ++ +DI+ LG+ L ELLTG F+ E S +
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP-FEGEKNSSATSQTLKII 227
Query: 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786
++ L L PEL A +LL + + K R + + +++
Sbjct: 228 LELPTPSLASPLSPSN--PELISKAASDLL----KKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 80/296 (27%), Positives = 128/296 (43%), Gaps = 58/296 (19%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKR---EESCPKTNKLREKESAFDSELALLS 557
+ + ++G GSFG VY + DG+ +K K E+E A +E+ +L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-----EREDAL-NEVKILK 54
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
+++H +++ +EK + +V EY G L + + K +++ L
Sbjct: 55 KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAV 676
+ YLH+ I+HRDIK NI L N ++ DFG+S +L S D T V
Sbjct: 115 ----ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTV-V 164
Query: 677 GTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730
GT Y+ PE Y K+DI+ LG VL EL T K F +G L++
Sbjct: 165 GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP-F---EGENLLELAL- 213
Query: 731 AVSQILAGQLHCVLDKRVGPPELNE---AEAVELLATTAIHCVNLEGKERPNITDI 783
+IL GQ P + +E L+++ + + +ERP+I I
Sbjct: 214 ---KILKGQ----------YPPIPSQYSSELRNLVSS----LLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 13/211 (6%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+F + NK+G GSFG V+K + V ++ K N+ RE+E A D E +L+++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAID-EARVLAKLDS 58
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+++ +K + +V EY NG LH L + V W+ I+I L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV--WRFFIQILL---- 112
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
G+ +LH+ I+HRDIKS N+ LD ++ D G++ L S D + VGT Y
Sbjct: 113 GLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYY 167
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ PE K+D++ LGVVL E TGK
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 17/216 (7%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
N+ +G G+FG VY +D GRE+AVK+ P + + +++ +A + E+ LL +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 560 HHKHLVGLVGFCQEKDERLLVY-EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H+ +V G C DE L ++ EYM G++ D L K ++ + +I
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQI----- 113
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFISTKAV 676
G++YLH+ I+HRDIK +NIL D ++ DFG S L + +
Sbjct: 114 -LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VT 168
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
GT ++ PE K D++ +G ++E+LT K
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 24/213 (11%)
Query: 507 NKVGIGSFGTVYKGKL-----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
++G G FG V + G +VAVK + + S F+ E+ +L + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKS----LNHSGEEQHRSDFEREIEILRTLDH 65
Query: 562 KHLVGLVGFCQEKDER--LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
+++V G C++ R L+ EY+ +G+L D+L + + ++ + K + +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINL-----KRLLLFSSQI 118
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT- 678
+G+DYL + IHRD+ + NIL++ ++SDFGL+ + E D+++ K G
Sbjct: 119 CKGMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPE-DKDYYYVKEPGES 174
Query: 679 -VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE + ++ +D++ GV L EL T
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 78/284 (27%), Positives = 110/284 (38%), Gaps = 56/284 (19%)
Query: 508 KVGIGSFGTVYKG--KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
+G GS G VYK K G+ A+K+ + E EL L ++V
Sbjct: 8 VLGQGSSGVVYKVRHKP-TGKIYALKKI----HVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 566 GLVG-FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI--RIALDAARG 622
G F +E + + V EYM G+L D L V + IA +G
Sbjct: 63 KCYGAFYKEGEISI-VLEYMDGGSLADLL----------KKVGKIPEPVLAYIARQILKG 111
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL---GSECDQEFISTKAVGTV 679
+DYLH IIHRDIK SN+L++ +++DFG+S + + F VGTV
Sbjct: 112 LDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-----VGTV 164
Query: 680 GY-----IDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734
Y I E Y DI+ LG+ LLE GK F ++++
Sbjct: 165 TYMSPERIQGESYSYA-----ADIWSLGLTLLECALGKFP-FLPPGQPSFFELMQ----A 214
Query: 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP 778
I G PP L E C+ + K+RP
Sbjct: 215 ICDGP----------PPSLPAEEFSPEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 508 KVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
K+G G+ G VYK G+EVA+K+ + KE + E+ ++ H ++V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKK---MRLRKQ--NKELIIN-EILIMKDCKHPNIVD 79
Query: 567 LVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
+ L +V EYM G+L D + I + + +G++Y
Sbjct: 80 YYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA-------YVCREVLQGLEY 131
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGTVGYIDP 684
LH+ V IHRDIKS NILL + + +++DFG + L E + VGT ++ P
Sbjct: 132 LHSQNV---IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR---NSVVGTPYWMAP 185
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTG 711
E K DI+ LG++ +E+ G
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREV-AVK--REESCPKTNKLREKESAFDSELALLSR 558
+F L +G G+FG V + D +++ A+K ++ C + +R + + E +L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR---NVLN-ERRILQE 56
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHL-HNKNNTEKNSSIVNSWKMRIRIAL 617
++H LV L Q+++ LV + + G L HL +E V W I +AL
Sbjct: 57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE---EQVKFWICEIVLAL 113
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
+ YLH+ IIHRDIK NILLD ++DF ++ + ++ + G
Sbjct: 114 E------YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTS-G 161
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKK 713
T GY+ PE + D + LGV E L GK+
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 502 NFSLENKVGIGSFGTVYKGKL--MDGR----EVAVK-REESCPKTNKLREKESAFDSELA 554
+ +L +G G+FG VY+G DG +VAVK ESC + ES F E
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-----EQDESDFLMEAL 61
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHL-HNKNNTEKNSSIVNSWKMR- 612
++S+ +H+++V L+G E+ R ++ E M+ G L L N+ E+ SS+ M+
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT----MKD 117
Query: 613 -IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV---SDFGLSLLGSECDQ 668
+ A D A+G YL IHRDI + N LL RV +DFG++
Sbjct: 118 LLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+A+ + ++ PE ++ + T+KTD++ GV+L E+ +
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 30/218 (13%)
Query: 507 NKVGIGSFGTVYKGKLMD-GREVAVKR---EESCPKTNKLREKESAFDSELALLSRVHHK 562
NK+G G+FG VY +D G +AVK +++ PKT K E+ +L + H
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK------EIADEMKVLELLKHP 59
Query: 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARG 622
+LV G +++ + EY S G L + L + ++ + L G
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDE--------HVIRVYTLQLLEG 111
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE----CDQEFISTKAVGT 678
+ YLH++ I+HRDIK +NI LD N ++ DFG ++ +E S GT
Sbjct: 112 LAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL--AGT 166
Query: 679 VGYIDPEYYVMNVLTAK---TDIYGLGVVLLELLTGKK 713
Y+ PE DI+ LG V+LE+ TGK+
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 80/287 (27%), Positives = 136/287 (47%), Gaps = 41/287 (14%)
Query: 504 SLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLRE---KESAFDSELALLSRVH 560
+L ++G G FG V+ G ++ R+VA+K +RE E F E ++ ++
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIK---------TIREGAMSEEDFIEEAQVMMKLS 57
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H LV L G C E+ LV+E+M +G L D+L + S + + + LD
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKF-------SQETLLGMCLDVC 110
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
G+ YL + ++IHRD+ + N L+ N +VSDFG++ + DQ ST V
Sbjct: 111 EGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVK 166
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740
+ PE + + ++K+D++ GV++ E+ + K ++N S +VVE I AG
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVE----TINAGF- 218
Query: 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787
R+ P L EL+ HC ++RP+ + ++ L
Sbjct: 219 ------RLYKPRLASQSVYELMQ----HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 29/204 (14%)
Query: 509 VGIGSFGTVYKGKLMDGREVAVK--REESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
+G G FG V G G++VAVK +++S AF +E ++++ + H +LV
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQ--------AFLAEASVMTTLRHPNLVQ 64
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
L+G + + +V EYM+ G+L D+L ++ V + ++ ALD G++YL
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRA------VITLAQQLGFALDVCEGMEYL 118
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT--VGYIDP 684
+ +HRD+ + N+L+ + A+VSDFGL+ +E + G V + P
Sbjct: 119 EE---KNFVHRDLAARNVLVSEDLVAKVSDFGLA-------KEASQGQDSGKLPVKWTAP 168
Query: 685 EYYVMNVLTAKTDIYGLGVVLLEL 708
E + K+D++ G++L E+
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 40/280 (14%)
Query: 508 KVGIGSFGTVYKGKLMDGREVAVK--REESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
K+G G+FG VYKG L EVAVK R P L+ K F E +L + H ++V
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRK---FLQEAEILKQYDHPNIV 55
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
L+G C +K +V E + G+L L K N ++ +++LDAA G++Y
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL-------QMSLDAAAGMEY 108
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT--VGYID 683
L + + IHRD+ + N L+ N ++SDFG+S E + + + + +
Sbjct: 109 LES---KNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTA 163
Query: 684 PEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCV 743
PE T+++D++ G++L E + + + +E
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY----------- 212
Query: 744 LDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
R+ P+L E L+ + C + + RP+ ++I
Sbjct: 213 ---RMPAPQLCPEEIYRLM----LQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK 562
F+LE K+G G FG V++G + VA+K +S + L++++ F E+ L R+ HK
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQD--FQKEVQALKRLRHK 62
Query: 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARG 622
HL+ L C + ++ E M G+L L + E V S I +A A G
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASL---IDMACQVAEG 116
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYI 682
+ YL + IHRD+ + NIL+ + +V+DFGL+ L + ++S+ +
Sbjct: 117 MAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWT 171
Query: 683 DPEYYVMNVLTAKTDIYGLGVVLLELLT 710
PE + K+D++ G++L E+ T
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 73/304 (24%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGRE------VAVKR-EESCPKTNKLREKESAFDSELA 554
L+ ++G G+FG V+ G+ VAVK +E+ + F+ E
Sbjct: 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-----NDARKDFEREAE 60
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR-- 612
LL+ H+++V G C E D ++V+EYM +G L+ L + + M
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLR-SHGPDAAFLKSPDSPMGEL 119
Query: 613 -----IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667
++IA+ A G+ YL A +HRD+ + N L+ + ++ DFG+S D
Sbjct: 120 TLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176
Query: 668 QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFK--NEDGSGP 724
+ + + ++ PE + T ++D++ GVVL E+ T GK+ + NE
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----- 231
Query: 725 LDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784
+V+E L + P +E +++ + C + ++R NI DI
Sbjct: 232 -EVIECITQGRL-----------LQRPRTCPSEVYDIM----LGCWKRDPQQRINIKDIH 275
Query: 785 ANLE 788
L+
Sbjct: 276 ERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 67/218 (30%), Positives = 112/218 (51%), Gaps = 29/218 (13%)
Query: 509 VGIGSFGTVYKGKLMDGRE------VAVK--REESCPKTNKLREKESAFDSELALLSRVH 560
+G G+FG VYKG+L E VA+K +E + PK + F E L+S +
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKV------QQEFRQEAELMSDLQ 66
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHL-----HNKNNTEKNSSIVNS--WKMR- 612
H ++V L+G C ++ +++EY+++G LH+ L H+ E V S
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 613 IRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
+ IA+ A G++YL H++ +HRD+ + N L+ T ++SDFGLS D
Sbjct: 127 LHIAIQIAAGMEYLSSHHF-----VHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLEL 708
+ +K++ V ++ PE + T ++DI+ GVVL E+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 75/227 (33%), Positives = 109/227 (48%), Gaps = 45/227 (19%)
Query: 509 VGIGSFGTVYK-GKLMDGREVAVK--REESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
+G GSFG V K G+ A+K +++ K E E +E +LSR++H +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK---EVEHTL-TERNILSRINHPFIV 56
Query: 566 GLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIR-----IALD 618
L + + +E+L LV EY G L HL + +E+ R R I L
Sbjct: 57 KLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE----------RARFYAAEIVL- 104
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
++YLH+ II+RD+K NILLD + +++DFGL+ S + +T GT
Sbjct: 105 ---ALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNT-FCGT 156
Query: 679 VGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGKKAVFKNED 720
Y+ PE VL K D + LGV+L E+LTG K F ED
Sbjct: 157 PEYLAPE-----VLLGKGYGKAVDWWSLGVLLYEMLTG-KPPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVK--REESCPKTNKLREKESAFDSELALLSR 558
+ LE K+G G FG V+ G +VAVK + + AF E ++ +
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE--------AFLQEAQIMKK 57
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ H LV L C E++ +V EYMS G+L D L K+ K + + +A
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL--KSGEGKKLRLPQ----LVDMAAQ 111
Query: 619 AARGIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
A G+ YL NY IHRD+ + NIL+ N +++DFGL+ L E D+ A
Sbjct: 112 IAEGMAYLESRNY-----IHRDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAK 165
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE T K+D++ G++L E++T
Sbjct: 166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 8e-22
Identities = 75/290 (25%), Positives = 133/290 (45%), Gaps = 43/290 (14%)
Query: 504 SLENKVGIGSFGTVYKGKLMD-GREVAVK--REESCPKTNKLREKESAFDSELALLSRVH 560
++++K+G G +G VY+G VAVK +E++ + E F E A++ +
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEE----FLKEAAVMKEIK 60
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H +LV L+G C + ++ E+M+ G L D+L N E N+ ++ + +A +
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL------LYMATQIS 114
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
++YL + IHRD+ + N L+ N +V+DFGLS L + D A +
Sbjct: 115 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIK 170
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740
+ PE N + K+D++ GV+L E+ T G P ++ + Q+
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATY---------GMSPYPGIDLS-------QV 214
Query: 741 HCVLDK--RVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
+ +L+K R+ PE + EL+ C +RP+ +I E
Sbjct: 215 YELLEKGYRMERPEGCPPKVYELM----RACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 8e-22
Identities = 76/230 (33%), Positives = 123/230 (53%), Gaps = 35/230 (15%)
Query: 509 VGIGSFGTVYKG-KLMDGREVAVKREE--SCPKTNKLREKE--SAFDSELALLSRVHHKH 563
+G GSFG+VY G G +AVK+ E S ++K R++ A E+ALL + H++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI 623
+V +G + D + EY+ G++ L+N E+ ++V ++ +R L +G+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE--TLVRNF---VRQIL---KGL 119
Query: 624 DYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-------V 676
+YLHN IIHRDIK +NIL+D ++SDFG+S + + +STK
Sbjct: 120 NYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS---KKLEANSLSTKTNGARPSLQ 173
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK---------KAVFK 717
G+V ++ PE T K DI+ LG +++E+LTGK +A+FK
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-21
Identities = 86/311 (27%), Positives = 138/311 (44%), Gaps = 50/311 (16%)
Query: 506 ENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL 564
EN + G G YKGK + +G + VK ++ + S SE+A + ++ H ++
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVK---------EINDVNSIPSSEIADMGKLQHPNI 745
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGID 624
V L+G C+ + L++EY+ L + L N SW+ R +IA+ A+ +
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-----------SWERRRKIAIGIAKALR 794
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP 684
+LH P+++ ++ I++D + LSL G C TK + Y+ P
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC----TDTKCFISSAYVAP 847
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH--- 741
E +T K+DIYG G++L+ELLTGK P D EF V +
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGK----------SPAD-AEFGVHGSIVEWARYCY 896
Query: 742 --CVLDKRVGPP-----ELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794
C LD + P +N+ E VE++ A+HC + RP D++ LE A
Sbjct: 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKTLESASRSS 955
Query: 795 QDCSCTDSFST 805
C FS+
Sbjct: 956 SSCVTGLKFSS 966
|
Length = 968 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 63/227 (27%), Positives = 113/227 (49%), Gaps = 24/227 (10%)
Query: 510 GIGSFGTVYKGKLM-DGR----EVAVK--REESCPKTNKLREKESAFDSELALLSRVHHK 562
G G+FGTVYKG + +G VA+K REE+ PK NK E +++ V H
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK------EILDEAYVMASVDHP 69
Query: 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARG 622
H+V L+G C + L+ + M G L D++ N + S + +W ++I A+G
Sbjct: 70 HVVRLLGICLSS-QVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQI------AKG 121
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYI 682
+ YL ++HRD+ + N+L+ +++DFGL+ L ++E+ + + ++
Sbjct: 122 MSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 683 DPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
E + + T K+D++ GV + EL+T ++ D++E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 74/277 (26%), Positives = 113/277 (40%), Gaps = 70/277 (25%)
Query: 507 NKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFD----SELALLSRVHH 561
++G G++G VYK + G VA+K K EKE F E+ LL ++ H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALK------KIRMENEKE-GFPITAIREIKLLQKLRH 57
Query: 562 KHLVGLVGFCQEKDER--LLVYEYMSNGALHDH---LHNKNN--TEKNSSIVNSWKMRIR 614
++V L K + +V+EYM HD L + TE I+
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQ----------IK 103
Query: 615 -IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFIS 672
G+ YLH+ I+HRDIK SNIL++ + +++DFGL+ ++
Sbjct: 104 CYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-- 158
Query: 673 TKAVGTVGYIDPE-------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL 725
T V T+ Y PE Y + D++ +G +L EL G K +F+ GS L
Sbjct: 159 TNRVITLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLG-KPIFQ---GSTEL 208
Query: 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELL 762
+ QL + + G P V L
Sbjct: 209 E------------QLEKIFEL-CGSPTDENWPGVSKL 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 62/240 (25%), Positives = 93/240 (38%), Gaps = 49/240 (20%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKT-----NK----LREKESAFD 550
++F +G GSF TV K +E A+K K K EKE
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKI---LDKRQLIKEKKVKYVKIEKEV--- 54
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
L L+ H ++ L Q+++ V EY NG L ++ K S+ K
Sbjct: 55 --LTRLNG--HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR------KYGSL--DEK 102
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG---------LSL 661
A + ++YLH+ IIHRD+K NILLD + +++DFG
Sbjct: 103 CTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159
Query: 662 LGSECDQEFISTKA---------VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
S VGT Y+ PE +D++ LG ++ ++LTGK
Sbjct: 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-21
Identities = 80/288 (27%), Positives = 141/288 (48%), Gaps = 43/288 (14%)
Query: 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK 562
+L +G G FG V +G+ G++VAVK + C T + AF E A+++++HHK
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQ------AFLEETAVMTKLHHK 59
Query: 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARG 622
+LV L+G +V E MS G L + L + ++V+ ++ ++ +LD A G
Sbjct: 60 NLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGR-----ALVSVIQL-LQFSLDVAEG 112
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE-CDQEFISTKAVGTVGY 681
++YL + ++HRD+ + NIL+ + A+VSDFGL+ +GS D + K +
Sbjct: 113 MEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------W 163
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741
PE ++K+D++ GV+L E+ + +A + P ++ + G
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY-------PKMSLKEVKECVEKGY-- 214
Query: 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
R+ PPE A+ L+ + C E K+RP+ + LE+
Sbjct: 215 -----RMEPPEGCPADVYVLMTS----CWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 509 VGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKE------SAFDSELALLSRVHH 561
+G G++G VY + G +AVK+ E P T R A SE+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVE-LPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 562 KHLVGLVGFCQEKDERLLVY-EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
++V +GF + +E L ++ EY+ G++ L E+ +V + ++
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE--QLVRFFTEQV------L 118
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
G+ YLH+ I+HRD+K+ N+L+D + ++SDFG+S + + G+V
Sbjct: 119 EGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 681 YIDPEYYVMNV----LTAKTDIYGLGVVLLELLTGKK 713
++ PE V++ +AK DI+ LG V+LE+ G++
Sbjct: 176 WMAPE--VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE-VAVKR---EESCPKTNKLREKESAFDSELALL 556
+++ L +G+G+ VY + E VA+KR E+ ++LR+ E+ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK-------EVQAM 53
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKN--SSIVNSWKMRIR 614
S+ +H ++V DE LV Y+S G+L D + + + I K
Sbjct: 54 SQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK---- 109
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFIS 672
+ +G++YLH+ IHRDIK+ NILL + + +++DFG+S L +
Sbjct: 110 ---EVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 673 TKAVGTVGYIDPEYYVM---NVLTAKTDIYGLGVVLLELLTGK 712
VGT ++ PE VM + K DI+ G+ +EL TG
Sbjct: 164 KTFVGTPCWMAPE--VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ L K+G G FG V++G + VAVK K + K+ F +E ++ ++
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL----KPGTMDPKD--FLAEAQIMKKLR 59
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H L+ L C ++ +V E M G+L ++L ++ I +A A
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG----GAGRAL--KLPQLIDMAAQVA 113
Query: 621 RGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
G+ YL NY IHRD+ + N+L+ N +V+DFGL+ + E E A
Sbjct: 114 SGMAYLEAQNY-----IHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFP 167
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE + N + K+D++ G++L E++T
Sbjct: 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 512 GSFGTVYKG-KLMDGREVAVKREESCPKTNKLRE--KESAFDSELALLSRVHHKHLVGLV 568
G++G V+ K G A+K K + +R+ + +E +LS+ ++V L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIK---VIKKADMIRKNQVDQVL-TERDILSQAQSPYVVKLY 59
Query: 569 GFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN 628
Q K LV EY+ G L L N + +++ + RI IA + ++YLH+
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-------RIYIA-EIVLALEYLHS 111
Query: 629 YAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS------TKAVGTVGYI 682
IIHRD+K NIL+D N +++DFGLS +G Q ++ + VGT YI
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 683 DPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
PE + + D + LG +L E L G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 507 NKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
+G GSFGTV K + DG+ + K E +EK+ SE+ +L + H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWK--EIDYGNMTEKEKQ-QLVSEVNILRELKHPNIV 62
Query: 566 GLVG-FCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNS--WKMRIRIALDAAR 621
++ L +V EY G L + + ++ I W++ ++ L
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIWRILTQLLL---- 116
Query: 622 GIDYLHNYAVPS--IIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGT 678
+ HN + P ++HRD+K +NI LD N ++ DFGL+ +LG D F T VGT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKT-YVGT 173
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
Y+ PE K+DI+ LG ++ EL
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 68/257 (26%), Positives = 110/257 (42%), Gaps = 49/257 (19%)
Query: 507 NKVGIGSFGTVYK------GKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
++G G+ G V K GK+M AVK + EL +L + +
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIM-----AVKTIRLEINE----AIQKQILRELDILHKCN 57
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
++VG G + + EYM G+L D + + I+ +IA+
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILG------KIAVAVL 110
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA---VG 677
+G+ YLH IIHRD+K SNIL++ ++ DFG+S + +++ A VG
Sbjct: 111 KGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-------GQLVNSLAKTFVG 161
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS-GPLDVVEFAVSQIL 736
T Y+ PE N + K+DI+ LG+ L+EL TG+ D G +
Sbjct: 162 TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE---------- 211
Query: 737 AGQLHCVLDKRVGPPEL 753
L ++++ PP L
Sbjct: 212 --LLQYIVNEP--PPRL 224
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 34/218 (15%)
Query: 503 FSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
F + K+G GS+G+VYK + G+ VA+K P L+E E+++L +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK---VVPVEEDLQEIIK----EISILKQCDS 57
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHD--HLHNKNNTEKNSSIVNSWKMRIRIALDA 619
++V G + + +V EY G++ D + NK TE+ + I
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA---------ILYQT 108
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA---- 675
+G++YLH+ IHRDIK+ NILL+ A+++DFG+S + T A
Sbjct: 109 LKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS-------GQLTDTMAKRNT 158
Query: 676 -VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+GT ++ PE K DI+ LG+ +E+ GK
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 9e-20
Identities = 67/225 (29%), Positives = 114/225 (50%), Gaps = 28/225 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKL-MDG--REVAVKREESCPKTNKLREKESAFDSELALLS 557
N+ ++ +G G+FG V K ++ DG + A+KR + + R+ F EL +L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD----FAGELEVLC 62
Query: 558 RV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTE---------KNSSIVN 607
++ HH +++ L+G C+ + L EY +G L D L E +S ++
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 608 SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667
S ++ + A D ARG+DYL IHRD+ + NIL+ N+ A+++DFGLS
Sbjct: 123 SQQL-LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-----G 173
Query: 668 QEFISTKAVG--TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
QE K +G V ++ E +V T +D++ GV+L E+++
Sbjct: 174 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 30/212 (14%)
Query: 508 KVGIGSFGTVYKGKLMD-GREVAVKR-----EESCPKTNKLREKESAFDSELALLSRVHH 561
VG GS+G V K K + G+ VA+K+ ++ K +RE + +L ++ H
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMRE--------IRMLKQLRH 59
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++LV L+ + K LV+E++ + L D N +++ +++ R
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI--------LR 111
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGTVG 680
GI++ H++ +IIHRDIK NIL+ + ++ DFG + L + + + T V T
Sbjct: 112 GIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRW 165
Query: 681 YIDPEYYVMNVLTAK-TDIYGLGVVLLELLTG 711
Y PE V + + DI+ +G ++ E+LTG
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 73/304 (24%), Positives = 122/304 (40%), Gaps = 47/304 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELA 554
+L ++G GSFG VY+G VA+K + E F +E +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE----FLNEAS 61
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHL--HNKNNTEKNSSIVNSWKMR 612
++ + H+V L+G L+V E M+ G L +L + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
I++A + A G+ YL +HRD+ + N ++ + T ++ DFG++ E D
Sbjct: 122 IQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-------GKKAVFKNEDGSGPL 725
K + V ++ PE V T K+D++ GVVL E+ T G NE
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL----SNE------ 228
Query: 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785
+V++F ++ G LD P + L C K RP +IV+
Sbjct: 229 EVLKF----VIDGG---HLDLPENCP--------DKLLELMRMCWQYNPKMRPTFLEIVS 273
Query: 786 NLER 789
+L+
Sbjct: 274 SLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 42/224 (18%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSELAL 555
+ K+G G++G VYK + G VA+K+ EE P T LRE ++L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA-LRE--------ISL 51
Query: 556 LSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI 615
L + H ++V L+ + + LV+EY L +L K + +++ S I
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDMD-LKKYLD-KRPGPLSPNLIKS------I 103
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTK 674
RG+ Y H++ I+HRD+K NIL++ + +++DFGL+ G T
Sbjct: 104 MYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---YTH 157
Query: 675 AVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
V T+ Y PE +Y V DI+ +G + E++TGK
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAV-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 78/303 (25%), Positives = 125/303 (41%), Gaps = 44/303 (14%)
Query: 503 FSLENKVGIGSFGTVYKGKLM--DGR--EVAVKREESCPKTNKLREKESAFDSELALLSR 558
L +G G FG+V +G+L DG +VAVK + + F SE A +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVK---TMKLDIHTYSEIEEFLSEAACMKD 57
Query: 559 VHHKHLVGLVGFCQEKDER------LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
H +++ L+G C E +++ +M +G LH L + + +
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKL-PLQTL 115
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS---LLGSECDQE 669
++ +D A G++YL N + IHRD+ + N +L + T V+DFGLS G Q
Sbjct: 116 LKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
I+ V +I E V T+K+D++ GV + E+ T G P VE
Sbjct: 173 RIAKMP---VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT---------RGQTPYPGVE 220
Query: 730 FA-VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
+ L R+ PE + ++ L C + K+RP T + LE
Sbjct: 221 NHEIYDYLRH------GNRLKQPE----DCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
Query: 789 RAL 791
L
Sbjct: 271 NIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 71/262 (27%), Positives = 124/262 (47%), Gaps = 35/262 (13%)
Query: 509 VGIGSFGTVY--KGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
VG G+FG V+ + K D + V +K+ P +++ A +E +L + H +++
Sbjct: 8 VGRGAFGIVHLCRRK-ADQKLVIIKQ---IPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
E ++V EY G L +++ + N+ + + + ++I +AL ++
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHV 117
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWT-ARVSDFGLS-LLGSECDQEFISTKAVGTVGYIDP 684
H I+HRD+K+ NILLD + ++ DFG+S +L S+ + VGT YI P
Sbjct: 118 HTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----AYTVVGTPCYISP 170
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGKKA---------VFKNEDGS-GPL-DVVEFAVS 733
E K+DI+ LG VL EL + K+A V K G+ P+ D +
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR 230
Query: 734 QILAGQLHCVLDKRVGPPELNE 755
Q++ L+ KR P+L++
Sbjct: 231 QLILSMLNLDPSKR---PQLSQ 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 43/227 (18%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDS-------EL 553
+ K+G G++ VYK + GR VA+K+ KL E++ A D E+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKI-------KLGERKEAKDGINFTALREI 53
Query: 554 ALLSRVHHKHLVGLVG-FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
LL + H +++GL+ F K LV+E+M L + +K+ + I S+ +
Sbjct: 54 KLLQELKHPNIIGLLDVFGH-KSNINLVFEFME-TDLEKVIKDKSIVLTPADI-KSYMLM 110
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFI 671
RG++YLH+ I+HRD+K +N+L+ + +++DFGL+ GS +
Sbjct: 111 T------LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS--PNRKM 159
Query: 672 STKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ + V T Y PE +Y + V D++ +G + ELL
Sbjct: 160 THQVV-TRWYRAPELLFGARHYGVGV-----DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ + K+G GSFG +Y K E V +E K ++EKE A E+ LL+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKE-ASKKEVILLAKMKH 58
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++V QE +V EY G L ++ + + + SW ++I +
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI------SL 112
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
G+ ++H+ I+HRDIKS NI L N A++ DFG++ ++ E T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYT-CVGTPY 167
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
Y+ PE KTDI+ LG VL EL T K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 77/286 (26%), Positives = 130/286 (45%), Gaps = 45/286 (15%)
Query: 508 KVGIGSFGTVYKGKLMDGREVAVK--REESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
++G G FG V GK +VA+K +E S E F E ++ ++ H+ LV
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--------SEDEFIEEAKVMMKLSHEKLV 62
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
L G C ++ +V EYMSNG L ++L + S ++ K D G+ Y
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK-------DVCEGMAY 115
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT---VGYI 682
L + IHRD+ + N L+D +VSDFGLS D E+ S+ VG+ V +
Sbjct: 116 LESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWS 168
Query: 683 DPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742
PE + + ++K+D++ GV++ E+ + K ++ + S + VE
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE-----------KV 214
Query: 743 VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
R+ P L A E + C + + +ERP +++++E
Sbjct: 215 SQGLRLYRPHL----ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 47/291 (16%)
Query: 509 VGIGSFGTVYKGKLMDG----REVAVKREESCPKTNKLREKE--SAFDSELALLSRVHHK 562
+G G FG VY G L+D AVK N++ + E F E ++ H
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVK------SLNRITDLEEVEQFLKEGIIMKDFSHP 56
Query: 563 HLVGLVGFCQEKD-ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+++ L+G C + L+V YM +G D + + N ++ K I L A+
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHG---DLRNFIRSETHNPTV----KDLIGFGLQVAK 109
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS----TKAVG 677
G++YL A +HRD+ + N +LD ++T +V+DFGL+ D+E+ S T A
Sbjct: 110 GMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKL 164
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737
V ++ E T K+D++ GV+L EL+T + + D D+ + +L
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVY----LLQ 217
Query: 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
G +R+ PE E++ + C + + + RP +++V+ +E
Sbjct: 218 G-------RRLLQPEYCPDPLYEVM----LSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 509 VGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G GSFG+VY+G L DG AVK +E + E+ALLS++ H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 568 VGFCQEKDERLLVY-EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
+G + +++ L ++ E + G+L L K + I ++ R L G++YL
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVI----RLYTRQILL---GLEYL 118
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEY 686
H+ + +HRDIK +NIL+D N +++DFG++ E F + G+ ++ PE
Sbjct: 119 HD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKS-FKGSPYWMAPEV 172
Query: 687 YV-MNVLTAKTDIYGLGVVLLELLTGK 712
DI+ LG +LE+ TGK
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 80/317 (25%), Positives = 136/317 (42%), Gaps = 54/317 (17%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKL-----------REKESAF 549
+N L+ ++G G+FG V+ + + CP+ +K+ F
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYN----------LCPEQDKILVAVKTLKDASDNARKDF 54
Query: 550 DSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHL--HNKNN---TEKNSS 604
E LL+ + H+H+V G C E D ++V+EYM +G L+ L H + E N
Sbjct: 55 HREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114
Query: 605 IVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664
+ + IA A G+ YL A +HRD+ + N L+ N ++ DFG+S
Sbjct: 115 AELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171
Query: 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSG 723
D + + + ++ PE + T ++D++ LGVVL E+ T GK+ ++ +
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-- 229
Query: 724 PLDVVEFAVSQILAGQLHCVLDKRV-GPPELNEAEAVELLATTAIHCVNLEGKERPNITD 782
+V+E C+ RV P E +L+ + C E R NI +
Sbjct: 230 --EVIE------------CITQGRVLQRPRTCPKEVYDLM----LGCWQREPHMRLNIKE 271
Query: 783 I---VANLERALAICQD 796
I + NL +A + D
Sbjct: 272 IHSLLQNLAKASPVYLD 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 23/228 (10%)
Query: 508 KVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
++G G FG V+ GK +VA+K N+ E F E ++ ++ H LV L
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIK------AINEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH 627
G C ++ +V E+M NG L ++L + S M + + D G++YL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQG-------KLSKDMLLSMCQDVCEGMEYLE 117
Query: 628 NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK-AVGTVGYIDPEY 686
S IHRD+ + N L+ +VSDFG++ D E+ S+ A V + PE
Sbjct: 118 R---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEV 172
Query: 687 YVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734
+ + ++K+D++ GV++ E+ T K F+ + +VVE +S+
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVE-MISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 508 KVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSELALLSRVH 560
K+G G++G VYK + + G VA+K+ E PKT LRE + LL ++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA-LRE--------IKLLKELN 56
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHD--HLHNKNNTEKNSSIVNSWKMRIRIALD 618
H +++ L+ + K + LV+E+M D L S++ S+ ++
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQL----- 107
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVG 677
+G+ + H++ I+HRD+K N+L++ +++DFGL+ GS T V
Sbjct: 108 -LQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPY-THYVV 160
Query: 678 TVGYIDPE-YYVMNVLTAKTDIYGLGVVLLELLTGK 712
T Y PE + DI+ +G + ELL+ +
Sbjct: 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 15/215 (6%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
N+ L +G G+FG VY D GRE+AVK+ + P++ + ++ +A + E+ LL +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 561 HKHLVGLVGFCQEKDERLL--VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H+ +V G ++ ER L E+M G++ D L + +N + + +I
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTEN--VTRKYTRQI----- 115
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVG 677
G+ YLH+ I+HRDIK +NIL D ++ DFG S L + C G
Sbjct: 116 -LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
T ++ PE K DI+ +G ++E+LT K
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 34/288 (11%)
Query: 509 VGIGSFGTVYKGKLMDGRE------VAVKREESCPKTNKLREKESAFDSELALLSRVHHK 562
+G G FG V+ K E V VK + N S F EL + ++ HK
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ----SEFRRELDMFRKLSHK 68
Query: 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLH-NKNNTEKNSSIVNSWKMRIRIALDAAR 621
++V L+G C+E + ++ EY G L L K+ EK S K ++ + A
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK-AVGTVG 680
G+D+L N +HRD+ + N L+ +VS LS + E+ + A+ +
Sbjct: 129 GMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLR 183
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740
++ PE + + K+D++ GV++ E+ T + F L E ++++ AG+L
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY------GLSDEEV-LNRLQAGKL 236
Query: 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
+ PE + +L+ C + K+RP+ +++V+ L
Sbjct: 237 ------ELPVPEGCPSRLYKLMTR----CWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 62/236 (26%), Positives = 114/236 (48%), Gaps = 40/236 (16%)
Query: 504 SLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLRE---KESAFDSELALLSRVH 560
+ ++G G FG V+ GK +VA+K +RE E F E ++ ++
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIK---------MIREGAMSEDDFIEEAKVMMKLS 57
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H +LV L G C ++ +V EYM+NG L ++L + +++ + D
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD-------MCSDVC 110
Query: 621 RGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFISTKAV 676
++YL + + IHRD+ + N L+ + +VSDFGL+ +L D ++ T +
Sbjct: 111 EAMEYLESNGF-----IHRDLAARNCLVGEDNVVKVSDFGLARYVL----DDQY--TSSQ 159
Query: 677 GT---VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
GT V + PE + + ++K+D++ GV++ E+ + K ++ S +VVE
Sbjct: 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVE 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 27/210 (12%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
L +G G FG V G G +VAVK C K + + AF +E ++++++ H
Sbjct: 7 ELKLLQTIGKGEFGDVMLGD-YRGNKVAVK----CIKNDATAQ---AFLAEASVMTQLRH 58
Query: 562 KHLVGLVG-FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
+LV L+G +EK +V EYM+ G+L D+L ++ + V ++ +LD
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS------VLGGDCLLKFSLDVC 112
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT-- 678
++YL + +HRD+ + N+L+ + A+VSDFGL+ +E ST+ G
Sbjct: 113 EAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLP 162
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLEL 708
V + PE + K+D++ G++L E+
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 509 VGIGSFGTVYKGKLMDGREVAVKR-EESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G G+FG V+KG L D VAVK +E P+ K++ F SE +L + H ++V L
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVKL 57
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH 627
+G C ++ +V E + G L K + K +V + ALDAA G+ YL
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLV-------KFALDAAAGMAYLE 110
Query: 628 NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT--VGYIDPE 685
+ + IHRD+ + N L+ N ++SDFG+S + D S+ + + + PE
Sbjct: 111 S---KNCIHRDLAARNCLVGENNVLKISDFGMS---RQEDDGIYSSSGLKQIPIKWTAPE 164
Query: 686 YYVMNVLTAKTDIYGLGVVLLELLT 710
++++D++ G++L E +
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 39/221 (17%)
Query: 503 FSLENKVGIGSFGTVYKG-KLMDGREVAVKR---EESCPKTNKLREKESAFD--SELALL 556
F+L +G GSFG VYK + VA+K EE+ ++ D E+ L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA---------EDEIEDIQQEIQFL 53
Query: 557 SRVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI 615
S+ ++ G K +L ++ EY G+ D L E + I
Sbjct: 54 SQCRSPYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---------I 103
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ-EFISTK 674
+ G++YLH IHRDIK++NILL +++DFG+S Q +K
Sbjct: 104 LREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS------GQLTSTMSK 154
Query: 675 A---VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
VGT ++ PE + K DI+ LG+ +EL G+
Sbjct: 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 78/293 (26%), Positives = 130/293 (44%), Gaps = 41/293 (13%)
Query: 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ L K+G G FG V+ G +VAVK + P T +F E ++ +
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLK--PGT----MSPESFLEEAQIMKK 57
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ H LV L E+ +V EYMS G+L D L K+ + + N M ++A
Sbjct: 58 LRHDKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVA-- 112
Query: 619 AARGIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK-A 675
G+ Y+ NY IHRD++S+NIL+ +++DFGL+ L D E+ + + A
Sbjct: 113 --AGMAYIERMNY-----IHRDLRSANILVGDGLVCKIADFGLARLIE--DNEYTARQGA 163
Query: 676 VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735
+ + PE + T K+D++ G++L EL+T + + + L+ VE
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY--- 220
Query: 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
++ C D P L+E + C + +ERP + + LE
Sbjct: 221 ---RMPCPQD---CPISLHE---------LMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+F + K+G GS+G+VYK K L D + A+K + + K E+E A + E+ +L+ V+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK--EREDAVN-EIRILASVN 57
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H +++ + ++ +V EY G L + + K W RI +
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLL 113
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
RG+ LH I+HRD+KS+NILL N ++ D G+S + + T+ +GT
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQ-IGTPH 166
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
Y+ PE + + K+DI+ LG +L E+ T
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 19/215 (8%)
Query: 501 NNFSLENKVGIGSFGTVYKGKL-MDGR-EVAVKREESCPK-TNKLREKESAFDSELALLS 557
++ + + +G G FG V++G L M GR EVAV + P T K R+ F SE +++
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---FLSEASIMG 61
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
+ H +++ L G + +++ EYM NGAL +L + + + +V +
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR------- 114
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
A G+ YL + + +HRD+ + NIL++ N +VSDFGLS + E D E T + G
Sbjct: 115 GIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGG 170
Query: 678 TVG--YIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE T+ +D++ G+V+ E+++
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 9e-18
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 509 VGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G G+FG VY +D GRE+A K+ + P++ + ++ SA + E+ LL + H+ +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 568 VGFCQEKDERLLV--YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
G +++ E+ L EYM G++ D L K S+ + +I G+ Y
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQI------LEGMSY 121
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGTVGYIDP 684
LH+ I+HRDIK +NIL D ++ DFG S L + C GT ++ P
Sbjct: 122 LHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGK 712
E K D++ LG ++E+LT K
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-18
Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 29/231 (12%)
Query: 502 NFSLENKVGIGSFGTVYKGKL--MDGR----EVAVKREESCPKTNKLREKESAFDSELAL 555
N L +G G FG V K + GR VAVK + +++LR SE L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR----DLLSEFNL 56
Query: 556 LSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTE---------KNSSIV 606
L +V+H H++ L G C + LL+ EY G+L L +NSS +
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 607 N-------SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659
+ + I A +RG+ YL A ++HRD+ + N+L+ ++SDFGL
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGL 173
Query: 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
S E D +K V ++ E ++ T ++D++ GV+L E++T
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 31/232 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGK---LMDGRE---VAVK--REESCPKTNKLREKESAFDSE 552
NN +G G+FG V++ + L+ VAVK +EE+ F E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA------DFQRE 58
Query: 553 LALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
AL++ H ++V L+G C L++EYM+ G L++ L +++ + S ++ R
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 613 --------------IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658
+ IA A G+ YL + +HRD+ + N L+ N +++DFG
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
LS D S + ++ PE N T ++D++ GVVL E+ +
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 509 VGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKE-SAFDSELALLSRVHHKHLVG 566
+G G+F + Y+ + + G +AVK+ T+ +E+ A E+ L++R++H H++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
++G E L E+M+ G++ L ++ I RG+ YL
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI--------INYTEQLLRGLSYL 119
Query: 627 HNYAVPSIIHRDIKSSNILLD-VNWTARVSDFG----LSLLGSECDQEFISTKAVGTVGY 681
H IIHRD+K +N+L+D R++DFG L+ G+ EF + +GT+ +
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG-EF-QGQLLGTIAF 174
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ PE D++ +G V++E+ T K
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 81/290 (27%), Positives = 126/290 (43%), Gaps = 41/290 (14%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ LE K+G G FG V+ G VA+K + P T AF E ++ ++ H
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGT----MSPEAFLQEAQVMKKLRH 60
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+ LV L E + +V EYMS G+L D L + + +A A
Sbjct: 61 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK------YLRLPQLVDMAAQIAS 113
Query: 622 GIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK-AVGT 678
G+ Y+ NY +HRD++++NIL+ N +V+DFGL+ L D E+ + + A
Sbjct: 114 GMAYVERMNY-----VHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFP 166
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
+ + PE + T K+D++ G++L EL T + + LD VE
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------ 220
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
++ C PPE E+ L C E +ERP + A LE
Sbjct: 221 RMPC-------PPECPES-----LHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 77/298 (25%), Positives = 142/298 (47%), Gaps = 33/298 (11%)
Query: 499 ATNNFSLENKVGIGSFGTVY----KGKLMDGRE--VAVKREESCPKTNKLREKESAFDSE 552
A ++ ++G GSFG VY KG + D E VA+K + + +RE+ F +E
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIK---TVNEAASMRER-IEFLNE 59
Query: 553 LALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN--SWK 610
+++ + H+V L+G + L++ E M+ G L +L + +N+ + S K
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
I++A + A G+ YL+ +HRD+ + N ++ ++T ++ DFG++ E D
Sbjct: 120 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730
K + V ++ PE V T +D++ GVVL E+ T + ++ G V+ F
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---GMSNEQVLRF 233
Query: 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
++ G L LDK P++ EL+ C K RP+ +I+++++
Sbjct: 234 ----VMEGGL---LDKPDNCPDM----LFELMRM----CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLRE---KESAFDSELALLS 557
L K+G G FG V+ G +VA+K L++ AF +E L+
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIK---------SLKQGSMSPEAFLAEANLMK 56
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
++ H LV L ++ ++ EYM NG+L D L T + + K+ I +A
Sbjct: 57 QLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFL----KTPEGIKL-TINKL-IDMAA 109
Query: 618 DAARGIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA 675
A G+ ++ NY IHRD++++NIL+ +++DFGL+ L E ++ A
Sbjct: 110 QIAEGMAFIERKNY-----IHRDLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGA 163
Query: 676 VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE T K+D++ G++L E++T
Sbjct: 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 66/295 (22%), Positives = 131/295 (44%), Gaps = 40/295 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKL-MDGRE---VAVKREESCPKTNKLREKESAFDSELALL 556
+ ++E +G G FG V +G+L + G++ VA+K ++ + + F +E +++
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD----FLTEASIM 59
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ H +++ L G + +++ EYM NG+L L + N K + + +
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFT-----VGQLVGML 112
Query: 617 LDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
A G+ YL NY +HRD+ + NIL++ N +VSDFGLS + + + +
Sbjct: 113 RGIASGMKYLSEMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734
+ + PE T+ +D++ G+V+ E+++ + + + + VE
Sbjct: 168 GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE----- 222
Query: 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
R+ PP + L + C + ERP + IV+ L++
Sbjct: 223 ---------DGYRLPPPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 72/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 505 LENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
L+ ++G G+FG V+ + D VAVK + P ++ F E LL+
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKD----FQREAELLTN 63
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNK--------NNTEKNSSIVNSWK 610
+ H+H+V G C + D ++V+EYM +G L+ L + + +
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
+ IA A G+ YL A +HRD+ + N L+ N ++ DFG+S D
Sbjct: 124 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVE 729
+ + + ++ PE + T ++D++ GV+L E+ T GK+ F+ +V+E
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ----LSNTEVIE 236
Query: 730 FAVSQILAGQLHCVLDKRV-GPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
C+ RV P + E +++ + C E ++R NI +I
Sbjct: 237 ------------CITQGRVLERPRVCPKEVYDIM----LGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 24/212 (11%)
Query: 508 KVGIGSFGTV-YKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
K+G GS G V + G++VAVK+ + K + +E F+ E+ ++ HH+++V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMD----LRKQQRRELLFN-EVVIMRDYHHENVVD 83
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHL-HNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
+ DE +V E++ GAL D + H + N E+ +++ L R + Y
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV----------CLSVLRALSY 133
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-VGTVGYIDP 684
LHN V IHRDIKS +ILL + ++SDFG ++ +E K+ VGT ++ P
Sbjct: 134 LHNQGV---IHRDIKSDSILLTSDGRIKLSDFGFC---AQVSKEVPKRKSLVGTPYWMAP 187
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGKKAVF 716
E + DI+ LG++++E++ G+ F
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 507 NKVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
K+G GS G V GR+VAVK+ + K + +E F+ E+ ++ H ++V
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMD----LRKQQRRELLFN-EVVIMRDYQHPNIV 79
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
+ DE +V E++ GAL D + + E+ + V L + + +
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---------CLAVLKALSF 130
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-VGTVGYIDP 684
LH V IHRDIKS +ILL + ++SDFG ++ +E K+ VGT ++ P
Sbjct: 131 LHAQGV---IHRDIKSDSILLTSDGRVKLSDFGFC---AQVSKEVPRRKSLVGTPYWMAP 184
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGKKAVF 716
E + DI+ LG++++E++ G+ F
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 9e-17
Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 48/233 (20%)
Query: 503 FSLENKVGIGSFGTVYKGKL---MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+ +E +G G++G VYK K DG+E A+K+ + K +SA E+ALL +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKG-DKEQYTGISQSAC-REIALLREL 59
Query: 560 HHKHLVGLVGFCQEKDERL--LVYEYMSNGALHDHLH------NKNNTEKNSSIVNS--W 609
H+++V LV E ++ L+++Y A HD S+V S W
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 610 KMRIRIALDAARGIDYLH-NYAVPSIIHRDIKSSNILL--DVNWTARV--SDFGLSLLGS 664
++ L+ G+ YLH N+ ++HRD+K +NIL+ + V D GL+ L +
Sbjct: 116 QI-----LN---GVHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
Query: 665 ECDQEFIS-TKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLT 710
+ V T+ Y PE +Y T DI+ +G + ELLT
Sbjct: 164 APLKPLADLDPVVVTIWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 509 VGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G G FG V ++ G+ A K+ + K K R+ E +E +L +V + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDK--KRLKKRKGEQMALNEKKILEKVSSRFIVSL 58
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH 627
+ KD+ LV M+ G L H++N + + +I G+++LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI------ICGLEHLH 112
Query: 628 NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYY 687
I++RD+K N+LLD + R+SD GL++ E GT GY+ PE
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVL 166
Query: 688 VMNVLTAKTDIYGLGVVLLELLTGK 712
V D + LG L E++ G+
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 502 NFSLENKVGIGSFGTVYKGKLM-DGREV--AVKREESCPKTNKLREKESAFDSELALLSR 558
+ E+ +G G+FG V + + DG ++ A+K + N R+ F EL +L +
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD----FAGELEVLCK 58
Query: 559 V-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN--------SW 609
+ HH +++ L+G C+ + + EY G L D L E + + +
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 610 KMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE 669
+ ++ A D A G+ YL IHRD+ + N+L+ N ++++DFGLS +E
Sbjct: 119 QQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR-----GEE 170
Query: 670 FISTKAVG--TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
K +G V ++ E +V T K+D++ GV+L E+++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 48/293 (16%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+++G G+ G+V K +L + + + + L+++ EL +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ---ILRELEINKSCK 57
Query: 561 HKHLVGLVG-FCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
++V G F E + + EY G+L D ++ K +K + K+ +IA
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKK--VKKRGGRIGE-KVLGKIAES 113
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA--- 675
+G+ YLH+ IIHRDIK SNILL ++ DFG+S E +++ A
Sbjct: 114 VLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS-------GELVNSLAGTF 163
Query: 676 VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVF----KNEDGSGPLDVVEFA 731
GT Y+ PE + +D++ LG+ LLE+ + F + E GP++++ +
Sbjct: 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR---FPFPPEGEPPLGPIELLSYI 220
Query: 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAI-----HCVNLEGKERPN 779
V + PEL + + + C+ + RP
Sbjct: 221 V--------------NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 75/287 (26%), Positives = 115/287 (40%), Gaps = 80/287 (27%)
Query: 499 ATNNFSLENKVGIGSFGTVYKG-KLMDGREVAVKR------EESCPKTNKLREKESAFDS 551
++ + K+G G+FG VYK ++ GR VA+K+ ++ P T LRE
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT-ALRE------- 57
Query: 552 ELALLSRVHHKHLVGLVGFC-----QEKDERLLVY---EYMSNGALHDH-----LHNKNN 598
+ +L ++ H ++V L+ + K +R VY YM DH L N +
Sbjct: 58 -IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM------DHDLSGLLENPSV 110
Query: 599 TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658
S I L GI+YLH I+HRDIK++NIL+D +++DFG
Sbjct: 111 KLTESQIKC-------YMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG 160
Query: 659 LSLLGSECDQEFISTKAVGTVGYID---------PEYYVMNVL-----TAKTDIYGLGVV 704
L+ GT Y + PE +L T DI+G+G V
Sbjct: 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCV 216
Query: 705 LLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPP 751
E+ T + + + G +D QLH + G P
Sbjct: 217 FAEMFTR-RPILQ---GKSDID------------QLHLIFKL-CGTP 246
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 507 NKVGIGSFGTVYKGKLM--DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL 564
++G G+FG+V KG + G+EV V + + +KE F E ++++++ H +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE--FLREASVMAQLDHPCI 58
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGID 624
V L+G C+ + +LV E G L +L + S + +A A G+
Sbjct: 59 VRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREI-PVSDLKE-------LAHQVAMGMA 109
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGT--VGY 681
YL + +HRD+ + N+LL A++SDFG+S LG+ ++ G + +
Sbjct: 110 YLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKW 164
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
PE ++K+D++ GV L E +
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 28/225 (12%)
Query: 504 SLENKVGIGSFGTVYKGKL--MDGRE----VAVK--REESCPKTNKLREKE-SAFDSELA 554
+L +G G+FG V K + +D VAVK ++++ EK+ S SE+
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-------EKDLSDLVSEME 67
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLH-NKNNTEKNSSIVN----- 607
++ + HK+++ L+G C ++ +V EY ++G L D L + E S
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 608 --SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665
+ K + A ARG+++L A IHRD+ + N+L+ + +++DFGL+
Sbjct: 128 TLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
D +T V ++ PE V T ++D++ GV+L E+ T
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 501 NNFSLENKVGIGSFGTVY----KGKL---------MDGREVAVKREESCPKTNKLREKES 547
L+ K+G G FG V+ +G DG+ V V + K +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND- 63
Query: 548 AFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNK----NNTEKNS 603
F E+ ++SR+ + +++ L+G C D ++ EYM NG L+ L + T N+
Sbjct: 64 -FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 604 SIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
S + +A+ A G+ YL A + +HRD+ + N L+ ++T +++DFG+S
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
D I +AV + ++ E ++ T +D++ GV L E+ T
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 21/225 (9%)
Query: 503 FSLENKVGIGSFGTVY----KG--KLMDGREVAVKREESCP---KTNKLREK-----ESA 548
+ + K+G G FG V+ +G K MD ++ ++ + P LRE +
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMD-KDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 549 FDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHN---KNNTEKNSSI 605
F E+ ++SR+ +++ L+ C D ++ EYM NG L+ L + EK +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 606 VNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665
S+ I +A A G+ YL + + +HRD+ + N L+ N+T +++DFG+S
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
D I +AV + ++ E ++ T +D++ GV L E+LT
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
N + + VG G++G V K + G VA+K+ + +++ E+ +L ++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL---REVKVLRQL 57
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H+++V L + K LV+EY+ L + L E + + +R
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVER-TLLELL------EASPGGLPPDAVR-SYIWQL 109
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGT 678
+ I Y H++ +IIHRDIK NIL+ + ++ DFG + L + T V T
Sbjct: 110 LQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL--TDYVAT 164
Query: 679 VGYIDPEYYVMNVLTAK-TDIYGLGVVLLELLTG 711
Y PE V + K D++ +G ++ ELL G
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 503 FSLENKVGIGSFGTVY---KGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+ L+ ++G GSFGTVY K + + V +E + N E A + E LLS++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP-NETVQA-NQEAQLLSKL 59
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H +V E+D ++ EY L L +T K S + I++ L
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL-- 117
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFISTKAVG 677
G+ Y+H I+HRD+K+ NI L N ++ DFG+S L+GS CD ++T G
Sbjct: 118 --GVHYMH---QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGS-CD---LATTFTG 167
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLEL 708
T Y+ PE +K+DI+ LG +L E+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR----EESCPKTNKLREKESAFDSELA 554
NF +E K+G G F VYK L+DGR VA+K+ E K R+ E+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA---RQD---CLKEID 54
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
LL ++ H +++ + E +E +V E G L + + ++ WK ++
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
+ ++++H+ I+HRDIK +N+ + ++ D GL S S
Sbjct: 115 LC----SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL- 166
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLEL 708
VGT Y+ PE N K+DI+ LG +L E+
Sbjct: 167 -VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 505 LENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLRE-KESA---FDSELALLSRVH 560
L+ ++G G+FG V+ L + + ++++ L+E ESA F E LL+ +
Sbjct: 9 LKWELGEGAFGKVF---LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ 65
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR-------- 612
H+H+V G C E L+V+EYM +G L+ L + ++ I+ +
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG---PDAKILAGGEDVAPGQLTLG 122
Query: 613 --IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
+ IA A G+ YL A +HRD+ + N L+ ++ DFG+S D
Sbjct: 123 QMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK 713
+ + + + ++ PE + T ++DI+ GVVL E+ T GK+
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 509 VGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLR-----EKESAFDSELALLSRVHHKH 563
+G G+FG VY+G D + LR +++ F E L+S +H +
Sbjct: 3 LGSGAFGEVYEGTATD--ILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI 623
+V L+G C + + ++ E M G L +L + ++ + K + I LD A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLL-TLKELLDICLDVAKGC 119
Query: 624 DYLHNYAVPSIIHRDIKSSNILL-----DVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
YL IHRD+ + N L+ D + ++ DFGL+ + D + +
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
V ++ PE + T ++D++ GV++ E+LT
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 31/228 (13%)
Query: 508 KVGIGSFGTVYKGKLMD---------------GREVAVKREESCPKTNKLREKESAFDSE 552
K+G G FG V+ ++++ GR + V + P NK + F E
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK--NARNDFLKE 69
Query: 553 LALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHL--HNKNNTEKNSS------ 604
+ +LSR+ +++ L+G C ++D ++ EYM NG L+ L H+ ++ E+N +
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 605 ---IVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661
S+ + +AL A G+ YL + + +HRD+ + N L+ N T +++DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELL 709
D I +AV + ++ E +M T +D++ GV L E+L
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 26/216 (12%)
Query: 509 VGIGSFGTVYKGKLM-DGREV--AVKREESCPKTNKLREKESAFDSELALLSRV-HHKHL 564
+G G+FG V K ++ DG + A+KR + + R+ F EL +L ++ HH ++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD----FAGELEVLCKLGHHPNI 58
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN--------SWKMRIRIA 616
+ L+G C+ + L EY +G L D L E + + S + + A
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
D ARG+DYL IHRD+ + NIL+ N+ A+++DFGLS QE K +
Sbjct: 119 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTM 170
Query: 677 G--TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
G V ++ E +V T +D++ GV+L E+++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 35/229 (15%)
Query: 509 VGIGSFG--TVYK----GKLMDGREVAVKREESCPKTNKLREKESAFD-SELALLSRVHH 561
+G G+FG T+Y+ L+ +EV + R L EKE +E+ +LS + H
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTR---------LSEKERRDALNEIVILSLLQH 58
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHL-HNKNNTEKNSSIVNSWKMRIRIALDAA 620
+++ + + L+ EY + G L+D + K + ++ W + +I
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVL--WYL-FQIV---- 111
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGTV 679
+ Y+H I+HRDIK+ NI L ++ DFG+S +LGSE ++ VGT
Sbjct: 112 SAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE---YSMAETVVGTP 165
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728
Y+ PE K+DI+ LG VL ELLT K+ D + PL++V
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF----DATNPLNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 55/217 (25%), Positives = 114/217 (52%), Gaps = 21/217 (9%)
Query: 508 KVGIGSFGTVYKGKL----MDGRE-VAVKREESCPKTNKLREKESAFDSELALLSRVHHK 562
++G +FG +YKG L MD + VA+K + + E F E +L++ +HH
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE----FQQEASLMAELHHP 67
Query: 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKN-------NTEKNSSIVNSWKMR--I 613
++V L+G ++ +++EY++ G LH+ L ++ +++++ ++ +S +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIST 673
IA+ A G++YL ++ +H+D+ + NIL+ ++SD GLS D +
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 674 KAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
K++ + ++ PE + ++ +DI+ GVVL E+ +
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 72/291 (24%), Positives = 140/291 (48%), Gaps = 48/291 (16%)
Query: 509 VGIGSFGTVYKGKLMDGRE-----VAVK--REESCPKTNKLREKESAFDSELALLSRVHH 561
+G G+FGTVYKG + E VA+K RE + PK NK D E +++ V +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-----EILD-EAYVMASVDN 68
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
H+ L+G C +L + + M G L D++ + + ++N W ++I A+
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQI------AK 120
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGTVG 680
G++YL ++HRD+ + N+L+ +++DFGL+ LLG++ ++E+ + +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD-EKEYHAEGGKVPIK 176
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740
++ E + + T ++D++ GV + EL+T GS P D I A ++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTF---------GSKPYD-------GIPASEI 220
Query: 741 HCVLDK--RVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
+L+K R+ P + + ++ + C ++ RP +++ +
Sbjct: 221 SSILEKGERLPQPPICTIDVYMIM----VKCWMIDADSRPKFRELIIEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-15
Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 48/280 (17%)
Query: 523 MDGREVAVK--REESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL- 579
M G EVA+K R ++ P+ R + F E AL +R++H ++V L+ + L
Sbjct: 1 MTGHEVAIKLLRTDA-PEEEHQRAR---FRRETALCARLYHPNIVALLDSGEAPPGLLFA 56
Query: 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI 639
V+EY+ L + L + R+ L + HN I+HRD+
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETG--------RLMLQVLDALACAHNQG---IVHRDL 105
Query: 640 KSSNILL---DVNWTARVSDFGLSLLGS---ECDQEFIS--TKAVGTVGYIDPEYYVMNV 691
K NI++ V A+V DFG+ L + D ++ T+ +GT Y PE
Sbjct: 106 KPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP 165
Query: 692 LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV-------VEFAVSQILAGQ----- 739
+T +D+Y G++ LE LTG++ V G+ ++ V+ ++ +AG
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQRVV----QGASVAEILYQQLSPVDVSLPPWIAGHPLGQV 221
Query: 740 LHCVLDKRVGPPELNEAEAVELLATT--AIHCVNLEGKER 777
L L+K A + LA A+ L G R
Sbjct: 222 LRKALNKDPR----QRAASAPALAERFRALELCALVGILR 257
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 508 KVGIGSFGTVYKGK-LMDGREVAVK-----REESCPKTNKLREKESAFDSELALLSRVHH 561
++G G+ G V+K K G VA+K R E LRE + L H
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE--------IKALQACQH 58
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++V L+ +LV EYM + L + L ++ + + K +R+ L
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQV----KSYMRMLLK--- 110
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
G+ Y+H I+HRD+K +N+L+ + +++DFGL+ L SE ++ + + V T Y
Sbjct: 111 GVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSE-EEPRLYSHQVATRWY 166
Query: 682 IDPE-YYVMNVLTAKTDIYGLGVVLLELLTG 711
PE Y D++ +G + ELL G
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 72/297 (24%), Positives = 133/297 (44%), Gaps = 45/297 (15%)
Query: 505 LENKVGIGSFGTVYKGKL-MDGRE---VAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+E +G G FG V +G+L + G+ VA+K +S + R+ F SE +++ +
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD----FLSEASIMGQFD 63
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H +++ L G + +++ E+M NGAL L + +V + A
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-------GIA 116
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG--- 677
G+ YL + +HRD+ + NIL++ N +VSDFGLS + + T ++G
Sbjct: 117 AGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVF--KNEDGSGPLDVVEFAVSQ 734
+ + PE T+ +D++ G+V+ E+++ G++ + N+D V A+ Q
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIEQ 226
Query: 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791
D R+ PP + L + C + RP IV+ L++ +
Sbjct: 227 ----------DYRLPPP----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
N+ L +G G+FG VY D GRE+AVK+ P + + ++ +A + E+ LL +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 561 HKHLVGLVGFCQEKDERLL--VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H +V G ++ +E+ L EYM G++ D L +N + + +I
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTEN--VTRRYTRQI----- 115
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV-G 677
+G+ YLH+ I+HRDIK +NIL D ++ DFG S K+V G
Sbjct: 116 -LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
T ++ PE K D++ + ++E+LT K
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 508 KVGIGSFG-TVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
K+G GSFG + DG++ +K + K RE+ E+A+LS + H ++V
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR---KEVAVLSNMKHPNIVQ 63
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
+E +V +Y G L+ ++ + + W ++I +AL ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------HV 117
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGTVGYIDPE 685
H+ I+HRDIKS NI L + T ++ DFG++ +L S + ++ +GT Y+ PE
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYYLSPE 171
Query: 686 YYVMNVLTAKTDIYGLGVVLLELLTGKKA 714
K+DI+ LG VL E+ T K A
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 509 VGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G G FG V ++ G+ A KR E K K R+ ES +E +L +V+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEK--KRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR---GID 624
+ KD LV M+ G L H++N N R AA G++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE---------RALFYAAEILCGLE 116
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP 684
LH + ++RD+K NILLD R+SD GL++ E + VGTVGY+ P
Sbjct: 117 DLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAP 170
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGK 712
E T D +GLG ++ E++ G+
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 508 KVGIGSFGTVYKGKL-MDGREVAVKREESCPKT--NKLREKESAFDSELALLSRVHHKHL 564
++G G+FG V+ G+L D VAVK SC +T L+ K F E +L + H ++
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK---SCRETLPPDLKAK---FLQEARILKQYSHPNI 55
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGID 624
V L+G C +K +V E + G L + K K I++ +AA G++
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLK-------VKELIQMVENAAAGME 108
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT--VGYI 682
YL + IHRD+ + N L+ ++SDFG+S E D + ST + V +
Sbjct: 109 YLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWT 163
Query: 683 DPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742
PE ++++D++ G++L E + + N + +E V
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV---------- 213
Query: 743 VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787
R+ PEL L+ C + +RP+ + + L
Sbjct: 214 ----RLPCPELCPDAVYRLM----ERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKE-SAFDSELALLSRVHHKHLV 565
+G G++GTVY G G+ +AVK+ E EKE E+ LL + H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL-----DAA 620
+G C + + + E++ G++ SSI+N +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSI-------------SSILNRFGPLPEPVFCKYTKQIL 112
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG----LSLLGSECDQEFISTKAV 676
G+ YLHN V +HRDIK +N++L N ++ DFG L+ +G +
Sbjct: 113 DGVAYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
GT ++ PE + K+DI+ +G + E+ TGK
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 508 KVGIGSFGTVYKGKLMD-GREVAVKR---EESCPKTNK--LREKESAFDSELALLSRVHH 561
K+G GS+G V+K + + G+ VA+K+ E P K LRE + +L ++ H
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE--------IRMLKQLKH 59
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+LV L+ + K + LV+EY + L++ EKN V ++ +I +
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-------LEKNPRGVPEHLIK-KIIWQTLQ 111
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
+++ H + IHRD+K NIL+ ++ DFG + + + ++ T V T Y
Sbjct: 112 AVNFCHKHNC---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWY 166
Query: 682 IDPEYYVMNV-LTAKTDIYGLGVVLLELLTG 711
PE V + D++ +G V ELLTG
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD---SELALLSRV 559
F+ K+G GSFG V+KG +D R V K L E E + E+ +LS+
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKV----VAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
++ G + + ++ EY+ G+ D L E + I +
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---------ILREI 110
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
+G+DYLH+ IHRDIK++N+LL + +++DFG++ G D + VGT
Sbjct: 111 LKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTP 165
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
++ PE + +K DI+ LG+ +EL G+
Sbjct: 166 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 66/278 (23%), Positives = 121/278 (43%), Gaps = 42/278 (15%)
Query: 517 VYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576
+YKG + +EV + R + ++E+ L R+ +++ + GF + +
Sbjct: 36 IYKGIF-NNKEVII-RTFKKFHKGHKVLID-ITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 577 RL----LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVP 632
L L+ EY + G L + L EK+ S +K ++ +A+D +G+ L+ Y
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDK----EKDLS----FKTKLDMAIDCCKGLYNLYKYT-- 142
Query: 633 SIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYY--VMN 690
+ ++++ S + L+ N+ ++ GL + S K V + Y + + +
Sbjct: 143 NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPFKNVNFMVYFSYKMLNDIFS 197
Query: 691 VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGP 750
T K DIY LGVVL E+ TG K F+N D++ +++ L LD P
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTG-KIPFENLTTKEIYDLI---INKN--NSLKLPLD---CP 248
Query: 751 PELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
E+ C + + +RPNI +I+ NL
Sbjct: 249 LEIK---------CIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 509 VGIGSFGTVYKGKLMDGRE-----VAVK--REESCPKTNKLREKESAFDSELALLSRVHH 561
+G G+FGTVYKG + E VA+K E + PK N F E +++ + H
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN------VEFMDEALIMASMDH 68
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLH-NKNNTEKNSSIVNSWKMRIRIALDAA 620
HLV L+G C +L V + M +G L D++H +K+N S ++ +W ++I A
Sbjct: 69 PHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNI--GSQLLLNWCVQI------A 119
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
+G+ YL ++HRD+ + N+L+ +++DFGL+ L ++E+ + +
Sbjct: 120 KGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
++ E T ++D++ GV + EL+T
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 508 KVGIGSFGTVY--------KGKLMDGREVAVKREESCPKTNKLREKES-----AFDSELA 554
K+G G FG V+ E LR S F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHN---KNNTEKNSSIVNSWKM 611
+LSR+ ++ L+G C ++ EYM NG L+ L + + +S S+
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 612 RIRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE 669
+ +A A G+ YL N+ +HRD+ + N L+ N+T +++DFG+S D
Sbjct: 132 LLYMATQIASGMRYLESLNF-----VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ +A + ++ E ++ T K+D++ GV L E+LT
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDS---ELALLSR 558
+ L ++G G++G VYK + + G VA+K KL + F+ E+++L
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIK-------VIKLEPGD-DFEIIQQEISMLKE 56
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H ++V G +D+ +V EY G+L D I + +
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIA-------YVCRE 109
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-VG 677
+G+ YLH IHRDIK +NILL + +++DFG+S ++ K+ +G
Sbjct: 110 TLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVS---AQLTATIAKRKSFIG 163
Query: 678 TVGYIDPEYYVMNVL-----TAKTDIYGLGVVLLEL 708
T ++ PE V V K DI+ LG+ +EL
Sbjct: 164 TPYWMAPE--VAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD---SELALLSRV 559
F+ ++G GSFG VYKG +D R +E K L E E + E+ +LS+
Sbjct: 6 FTKLERIGKGSFGEVYKG--IDNR----TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
++ G + + ++ EY+ G+ D L K + + I I +
Sbjct: 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIAT-------ILREI 110
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
+G+DYLH+ IHRDIK++N+LL +++DFG++ G D + VGT
Sbjct: 111 LKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTP 165
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
++ PE + K DI+ LG+ +EL G+
Sbjct: 166 FWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD---SELALLSRV 559
F+ ++G GSFG V+KG +D R V K L E E + E+ +LS+
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQV----VAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL-D 618
++ G + + ++ EY+ G+ D L E +I L +
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE----------FQIATMLKE 109
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
+G+DYLH+ IHRDIK++N+LL +++DFG++ G D + VGT
Sbjct: 110 ILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGT 164
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
++ PE + +K DI+ LG+ +EL G+
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 73/279 (26%), Positives = 134/279 (48%), Gaps = 37/279 (13%)
Query: 509 VGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
VG GS+G V + DG++ +K+ + RE+++A + E LLS++ H ++V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNL--RNASRRERKAA-EQEAQLLSQLKHPNIVAY 64
Query: 568 VGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
+ +D L +V + G L+ L + + V W ++I +AL YL
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ------YL 118
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGTVGYIDPE 685
H I+HRD+K+ N+ L +V D G++ +L ++CD +++ +GT Y+ PE
Sbjct: 119 HE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD---MASTLIGTPYYMSPE 172
Query: 686 YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLD 745
+ K+D++ LG + E+ T K A F +D + V +I+ G+L +
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHA-FNAKD-------MNSLVYRIIEGKLPPM-- 222
Query: 746 KRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784
P+ E EL+AT ++ ++RP++ I+
Sbjct: 223 -----PKDYSPELGELIATM----LSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 63/248 (25%), Positives = 110/248 (44%), Gaps = 43/248 (17%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ VG G+FG V+ + + + P+ +L++++ +E +L V H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHV-HNEKRVLKEVSH 60
Query: 562 KHLVGLVGFCQEKDERLL--VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
++ L F E D+R L + EY+ G L +L N ++S + I A
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRF--SNSTGLFYASEIVCA--- 113
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI--STKAVG 677
++YLH+ I++RD+K NILLD +++DFG + ++ + G
Sbjct: 114 ---LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFA-------KKLRDRTWTLCG 160
Query: 678 TVGYIDPEYYVMNVLTAK-----TDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732
T Y+ PE V+ +K D + LG+++ E+L G F P + E
Sbjct: 161 TPEYLAPE-----VIQSKGHNKAVDWWALGILIYEMLVGYPPFF----DDNPFGIYE--- 208
Query: 733 SQILAGQL 740
+ILAG+L
Sbjct: 209 -KILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 505 LENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL 564
L K+G G FG V+ G + +VAVK + P T ++ AF E L+ + H L
Sbjct: 10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLK--PGTMSVQ----AFLEEANLMKTLQHDKL 63
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGID 624
V L +++ ++ EYM+ G+L D L +++ ++ I + A G+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFL----KSDEGGKVL--LPKLIDFSAQIAEGMA 117
Query: 625 YLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK-AVGTVGY 681
Y+ NY IHRD++++N+L+ + +++DFGL+ + D E+ + + A + +
Sbjct: 118 YIERKNY-----IHRDLRAANVLVSESLMCKIADFGLARVIE--DNEYTAREGAKFPIKW 170
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
PE T K+D++ G++L E++T
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 509 VGIGSFGTVYKGK---LMD--GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH 563
+G G+FG+V + L D G VAVK+ + LR+ F+ E+ +L + H +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH-STAEHLRD----FEREIEILKSLQHDN 66
Query: 564 LVGLVGFCQEKDER--LLVYEYMSNGALHDHLH-NKNNTEKNSSIVNSWKMRIRIALDAA 620
+V G C R LV EY+ G+L D+L ++ + ++ + ++
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--------C 118
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT-- 678
+G++YL +HRD+ + NIL++ ++ DFGL+ + D+E+ + G
Sbjct: 119 KGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKV-LPQDKEYYKVREPGESP 174
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE + + +D++ GVVL EL T
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ L+ K+G G FG V+ G +VA+K + P T AF E ++ ++ H
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLK--PGT----MMPEAFLQEAQIMKKLRH 60
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTE-KNSSIVNSWKMRIRIALDAA 620
LV L E + +V E+M G+L D L + K +V+ +A A
Sbjct: 61 DKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD-------MAAQIA 112
Query: 621 RGIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK-AVG 677
G+ Y+ NY IHRD++++NIL+ N +++DFGL+ L D E+ + + A
Sbjct: 113 DGMAYIERMNY-----IHRDLRAANILVGDNLVCKIADFGLARLIE--DNEYTARQGAKF 165
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE + T K+D++ G++L EL+T
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 73/298 (24%), Positives = 132/298 (44%), Gaps = 40/298 (13%)
Query: 503 FSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
F+L +G G FG+V + +L ++VAVK ++ ++ E+ F E A +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEE---FLREAACMKE 57
Query: 559 VHHKHLVGLVGFCQEKDER------LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
H +++ L+G + +++ +M +G LH L E+ ++ +
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL--PLQTL 115
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
+R +D A G++YL + + IHRD+ + N +L+ N T V+DFGLS D
Sbjct: 116 VRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA- 731
+ V ++ E NV T +D++ GV + E++T G P VE +
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT---------RGQTPYAGVENSE 223
Query: 732 -VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
+ ++ G ++ PP+ E + EL+ C + E K RP+ + LE
Sbjct: 224 IYNYLIKG------NRLKQPPDCLE-DVYELMC----QCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 68/239 (28%), Positives = 108/239 (45%), Gaps = 29/239 (12%)
Query: 552 ELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
EL ++ ++V G ++ + E+M G+L D ++ K I+
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIP-VEILG---- 106
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
+IA+ G+ YL+N V I+HRDIK SNIL++ ++ DFG+S E I
Sbjct: 107 --KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS-------GELI 155
Query: 672 STKA---VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK-KAVFKNEDGSGPLDV 727
++ A VGT Y+ PE T K+D++ LG+ ++EL GK F N D G D
Sbjct: 156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215
Query: 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786
+ IL L ++ + PP L ++ E L C+ + ERP + A
Sbjct: 216 M-----GIL-DLLQQIVQEP--PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 503 FSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
F +G G FG V ++ G+ A K+ E K K R+ E+ +E +L +V+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEK--KRIKKRKGEAMALNEKQILEKVNS 59
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+ +V L + KD LV M+ G L H++N N + R AA
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE---------RAVFYAAE 110
Query: 622 ---GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
G++ LH I++RD+K NILLD R+SD GL++ E E I + VGT
Sbjct: 111 ITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGR-VGT 164
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
VGY+ PE T D +GLG ++ E++ GK
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 56/226 (24%)
Query: 508 KVGIGSFGTVYKGKLMD-GREVAVKR--------EESCPKTNKLREKESAFDSELALLSR 558
++G G+FG+VY + + G VA+K+ EE C LRE +S L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE-C---MNLREVKS-------LRKL 54
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H ++V L +E DE V+EYM G L+ + ++ + S++ S +I
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQI----- 108
Query: 619 AARGIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS---- 672
+G+ ++H + HRD+K N+L+ +++DFGL+ +E S
Sbjct: 109 -LQGLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLA-------REIRSRPPY 155
Query: 673 TKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
T V T Y PE Y ++ DI+ LG ++ EL T +
Sbjct: 156 TDYVSTRWYRAPEILLRSTSY-----SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 72/295 (24%), Positives = 134/295 (45%), Gaps = 39/295 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKG--KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ +E +G G FG V G KL RE+ V + K ++ F SE +++ +
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQ 61
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H +++ L G + ++V EYM NG+L D K++ + +++ M IA
Sbjct: 62 FDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQ--FTVIQLVGMLRGIA-- 116
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVG 677
G+ YL + +HRD+ + NIL++ N +VSDFGLS +L + + + +
Sbjct: 117 --SGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFK--NEDGSGPLDVVEFAVSQ 734
+ + PE T+ +D++ G+V+ E+++ G++ ++ N+D +
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----------VIKA 221
Query: 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
I G R+ P A +L+ + C + ERP IV+ L++
Sbjct: 222 IEEGY-------RLPAPMDCPAALHQLM----LDCWQKDRNERPKFEQIVSILDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 504 SLENKVGIGSFGTVYKGKLMDGR---EVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+L +G G FG+V +G+L +VAVK + T R + F SE +
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT---RSEMEDFLSEAVCMKEFD 58
Query: 561 HKHLVGLVGFCQEKDER------LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
H +++ L+G C + E +++ +M +G LH L + + +M ++
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVK 116
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
D A G++YL + S IHRD+ + N +L+ N V+DFGLS D
Sbjct: 117 FMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734
A V +I E V T K+D++ GV + E+ T + + + S D +
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG--- 230
Query: 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791
R+ P + ++ L + C L K+RP+ + LE+AL
Sbjct: 231 -----------NRLKQP----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 509 VGIGSFGTVYKGKLMDG-REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G G++G VY + + +A+K P+ + E+AL S + H+++V
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKE---IPERDS--RYVQPLHEEIALHSYLKHRNIVQY 70
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNK-NNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
+G E + E + G+L L +K + N + + +I G+ YL
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYL 124
Query: 627 HNYAVPSIIHRDIKSSNILLDV-NWTARVSDFGLS--LLG-SECDQEFISTKAVGTVGYI 682
H+ I+HRDIK N+L++ + ++SDFG S L G + C + F GT+ Y+
Sbjct: 125 HDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-----TGTLQYM 176
Query: 683 DPEYYVMNV--LTAKTDIYGLGVVLLELLTGK 712
PE A DI+ LG ++E+ TGK
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 36/223 (16%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGRE-VAVKREESCPKTNKLREKESAFDS---ELALLS 557
F N++G G++G VY+ + E VA+K K E++ S E+ LL
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALK------KVRMDNERDGIPISSLREITLLL 61
Query: 558 RVHHKHLVGL----VGFCQEKDERLLVYEYMSNGALHD--HLHNKNNTEKNSSIVNSWKM 611
+ H ++V L VG + D LV EY D L + T + S V
Sbjct: 62 NLRHPNIVELKEVVVG--KHLDSIFLVMEYCE----QDLASLLDNMPTPFSESQVKC--- 112
Query: 612 RIRIALDAARGIDYLH-NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
+ L RG+ YLH N+ IIHRD+K SN+LL +++DFGL+ +
Sbjct: 113 ---LMLQLLRGLQYLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 671 ISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGK 712
T V T+ Y PE + T D++ +G +L ELL K
Sbjct: 166 --TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 504 SLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLS 557
+L ++G GSFG VY+G D VAVK + ++ LRE+ F +E +++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVK---TVNESASLRER-IEFLNEASVMK 64
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHN-KNNTEKNS-SIVNSWKMRIRI 615
H+V L+G + L+V E M++G L +L + + E N + + I++
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA 675
A + A G+ YL+ +HRD+ + N ++ ++T ++ DFG++ E D K
Sbjct: 125 AAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 676 VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ V ++ PE V T +D++ GVVL E+ +
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 58/228 (25%), Positives = 111/228 (48%), Gaps = 40/228 (17%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSELA 554
NF K+G G++G VYK + + G VA+K+ E P T +RE ++
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST-AIRE--------IS 51
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
LL ++H ++V L+ +++ LV+E++ + L + + ++ S+ ++
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL- 109
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
+G+ + H++ V +HRD+K N+L++ +++DFGL+ + + T
Sbjct: 110 -----LQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--TH 159
Query: 675 AVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVF 716
V T+ Y PE YY V DI+ LG + E++T ++A+F
Sbjct: 160 EVVTLWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVT-RRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 72/263 (27%), Positives = 113/263 (42%), Gaps = 53/263 (20%)
Query: 512 GSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKE-SAFDSELA-LLSRVHHKHLVGLV 568
G+FG+VY K G A+K K++ + + + + +E A ++ + ++ L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIK---VLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 569 GFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR------- 621
Q KD LV EY++ G +S++ K + D A+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDC-------------ASLI---KTLGGLPEDWAKQYIAEVV 107
Query: 622 -GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
G++ LH IIHRDIK N+L+D +++DFGLS G + K VGT
Sbjct: 108 LGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPD 158
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTG--------KKAVFKN---EDGSGPLDVVE 729
Y+ PE + +D + LG V+ E L G AVF N + P +V E
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKE 218
Query: 730 FAVSQI--LAGQLHCV-LDKRVG 749
F + L +L C+ KR+G
Sbjct: 219 FCSPEAVDLINRLLCMDPAKRLG 241
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 56/247 (22%), Positives = 101/247 (40%), Gaps = 52/247 (21%)
Query: 505 LENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDS---------ELA 554
+G G++G V K + G+ VA+K+ + +N + + EL
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
+++ + H++++GLV E D LV + M L +V+ +IR
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDL---------KKVVDR---KIR 115
Query: 615 --------IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS------ 660
I L G++ LH + +HRD+ +NI ++ +++DFGL+
Sbjct: 116 LTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
Query: 661 -LLGSECDQEFIS-----TKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKK 713
+ E + T V T+ Y PE + D++ +G + ELLTG K
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-K 231
Query: 714 AVFKNED 720
+F E+
Sbjct: 232 PLFPGEN 238
|
Length = 335 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 51/228 (22%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESAFDSELALLSRV 559
++F +G GSFG V + + A+K K KL++ E +E +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA-KIVKLKQVEHVL-NEKRILQSI 58
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H LV L G Q+ LV EY+ G L HL R
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG----------------RFPEPV 102
Query: 620 AR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
AR ++YLH+ I++RD+K N+LLD + +++DFG + + +
Sbjct: 103 ARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFA--------KRV 151
Query: 672 STKA---VGTVGYIDPEYYVMNVLTAK-----TDIYGLGVVLLELLTG 711
+ GT Y+ PE ++ +K D + LG+++ E+L G
Sbjct: 152 KGRTYTLCGTPEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 74/293 (25%), Positives = 123/293 (41%), Gaps = 46/293 (15%)
Query: 504 SLENKVGIGSFGTVYKGKLMDGR----EVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+L +G G FG VY+G M VAVK +C K F E ++ +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK---TC-KNCTSPSVREKFLQEAYIMRQF 64
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLH-NKNNTEKNSSIVNSWKMRIRIALD 618
H H+V L+G E + +V E G L +L NK + + S I+ S+++ +A
Sbjct: 65 DHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA-- 121
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
YL + +HRDI + N+L+ ++ DFGLS + + + ++K
Sbjct: 122 ------YLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLP 171
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVF--KNEDGSGPLDVVEFAVSQI 735
+ ++ PE T+ +D++ GV + E+L G K KN D + +I
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND----------VIGRI 221
Query: 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
G+ R+ P N + L T C + +RP T++ A L
Sbjct: 222 ENGE-------RLPMPP-NCPPTLYSLMTK---CWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 34/238 (14%)
Query: 489 DNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKES 547
D+ LS L F L VG G++G VYKG+ + G+ A+K + ++E
Sbjct: 4 DDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK------VMDVTEDEEE 57
Query: 548 AFDSELALLSRV-HHKHLVGLVGFCQEK------DERLLVYEYMSNGALHDHLHN-KNNT 599
E+ +L + HH+++ G +K D+ LV E+ G++ D + N K N
Sbjct: 58 EIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA 117
Query: 600 EKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659
K I I + RG+ +LH + V IHRDIK N+LL N ++ DFG+
Sbjct: 118 LKEDWIA-------YICREILRGLAHLHAHKV---IHRDIKGQNVLLTENAEVKLVDFGV 167
Query: 660 SLLGSECDQEFISTKA-VGTVGYIDPEYYVMN-----VLTAKTDIYGLGVVLLELLTG 711
S ++ D+ +GT ++ PE + ++DI+ LG+ +E+ G
Sbjct: 168 S---AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 53/280 (18%)
Query: 509 VGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G G+ GTVYK L+ R +AVK + E + SEL +L + +++G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVK----VIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI----RIALDAARGI 623
G ++ + E+M G+L + K+ RIA+ +G+
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY----------------RKIPEHVLGRIAVAVVKGL 108
Query: 624 DYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFISTKAVGTVGY 681
YL + I+HRD+K SN+L++ ++ DFG+S L+ S I+ VGT Y
Sbjct: 109 TYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------IAKTYVGTNAY 159
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGK---KAVFKNEDGSGPLDVVEFAVSQILAG 738
+ PE +D++ LG+ +EL G+ + KN+ PL +
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL----------- 208
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP 778
L C++D+ PP L + E C+ + KERP
Sbjct: 209 -LQCIVDE--DPPVLPVGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 47/222 (21%)
Query: 507 NKVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSELALLSRV 559
++G G++GTVYK + L GR VA+K+ EE P + LRE +ALL ++
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-LSTLRE--------IALLKQL 55
Query: 560 ---HHKHLVGLVGFCQEKD-ER----LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
H ++V L+ C +R LV+E++ L +L + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCP-----KPGLPPETI 109
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
+ + RG+D+LH++ I+HRD+K NIL+ + +++DFGL+ + S E
Sbjct: 110 K-DLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMA 162
Query: 672 STKAVGTVGYIDPE-----YYVMNVLTAKTDIYGLGVVLLEL 708
T V T+ Y PE Y V D++ +G + EL
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPV-----DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 509 VGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLR-EKESAFDS---ELALLSRVHHKHL 564
+G G FG V ++ A + +C K NK R +K ++ E +L++VH + +
Sbjct: 1 LGKGGFGEVSACQMR-----ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI 55
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR--- 621
V L Q K + LV M+ G L H++N + E+N R A+
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVD--EENPGFPEP-----RACFYTAQIIS 108
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-VGTVG 680
G+++LH II+RD+K N+LLD + R+SD GL++ E TK GT G
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAV---ELKDGQSKTKGYAGTPG 162
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
++ PE D + LGV L E++ +
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 508 KVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
K+G GS G V + G+ VAVK+ + K + +E F+ E+ ++ H+++V
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMD----LRKQQRRELLFN-EVVIMRDYQHENVVE 81
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHL-HNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
+ DE +V E++ GAL D + H + N E+ +++ L + +
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV----------CLAVLKALSV 131
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-VGTVGYIDP 684
LH V IHRDIKS +ILL + ++SDFG ++ +E K+ VGT ++ P
Sbjct: 132 LHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFC---AQVSKEVPRRKSLVGTPYWMAP 185
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNE 719
E + DI+ LG++++E++ G+ F NE
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF-NE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 512 GSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD---SELALLSRVHHKHLVGLV 568
G+FG ++ G L+D E K EE KT K E E LL + H++++ ++
Sbjct: 17 GTFGRIFYGILID--EKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 569 GFCQEKDERLLV-YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH 627
C E E V Y YM+ G L L E N+ S + + +A+ A G+ YLH
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 628 NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS---------LLGSECDQEFISTKAVGT 678
V IH+DI + N ++D +++D LS LG D E K
Sbjct: 135 KRGV---IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG---DNENRPVK---- 184
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
++ E V ++ +D++ GV+L EL+T
Sbjct: 185 --WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 509 VGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G G FG V ++ G+ A K+ E K K R+ E+ +E +L +V+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK--KRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY-- 625
+ KD LV M+ G L H++N N D R I Y
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----------------GFDEQRAIFYAA 109
Query: 626 -----LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
L + I++RD+K NILLD R+SD GL++ E E + + VGTVG
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GETVRGR-VGTVG 166
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
Y+ PE T D +GLG ++ E++ G+ K ++
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 70/249 (28%), Positives = 114/249 (45%), Gaps = 45/249 (18%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
TN + VG+G+FG V + + G+ VA+K+ T L ++ EL LL
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY---RELKLLKH 65
Query: 559 VHHKHLVGLVG-FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
+ H++++ L F ++ V E + LH L ++ EK + + +I
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELLGTD-LHRLLTSRP-LEKQ--FIQYFLYQI---- 117
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
RG+ Y+H+ V +HRD+K SNIL++ N ++ DFGL+ + Q+ T V
Sbjct: 118 --LRGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVS 167
Query: 678 TVGYIDPEYYVMNVLT-----AKTDIYGLGVVLLELLTGKKAVFKNED------------ 720
T Y PE +M LT + DI+ G + E+L G K +F +D
Sbjct: 168 TRYYRAPE--IM--LTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQFSIITDLL 222
Query: 721 GSGPLDVVE 729
G+ P DV+
Sbjct: 223 GTPPDDVIN 231
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 51/228 (22%)
Query: 508 KVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSELALLSRVH 560
K+G G++G VYKG+ G+ VA+K+ EE P T +RE ++LL +
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPST-AIRE--------ISLLKELQ 57
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHN-KNNTEKNSSIVNSWKMRIRIALDA 619
H ++V L ++ L++E++S L +L + ++ +V S+ +I
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVKSYLYQI------ 110
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF-----ISTK 674
+GI + H+ V +HRD+K N+L+D +++DFGL+ + F + T
Sbjct: 111 LQGILFCHSRRV---LHRDLKPQNLLIDNKGVIKLADFGLA-------RAFGIPVRVYTH 160
Query: 675 AVGTVGYIDPEYYVMNVLTAKT------DIYGLGVVLLELLTGKKAVF 716
V T+ Y PE VL DI+ +G + E+ T KK +F
Sbjct: 161 EVVTLWYRAPE-----VLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 508 KVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
K+G G+ GTVY + G+EVA+K+ + + K+ +E+ ++ + ++V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNL-----QQQPKKELIINEILVMRENKNPNIVN 80
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
+ DE +V EY++ G+L D + E + V + + +D+L
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---------CRECLQALDFL 131
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEY 686
H+ V IHRDIKS NILL ++ + +++DFG ++ + VGT ++ PE
Sbjct: 132 HSNQV---IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEV 186
Query: 687 YVMNVLTAKTDIYGLGVVLLELLTGK 712
K DI+ LG++ +E++ G+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 505 LENKVGIGSFGTVY--------KGKLMDGREVAVKREESCPKTNKLREKESAFDSELALL 556
L +G G FG V K K +VAVK +S L S SE+ ++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDL----SDLISEMEMM 77
Query: 557 SRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKN--------NTEKNSSIVN 607
+ HK+++ L+G C + ++ EY S G L ++L + N +
Sbjct: 78 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 608 SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667
S+K + A ARG++YL A IHRD+ + N+L+ + +++DFGL+ D
Sbjct: 138 SFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 194
Query: 668 QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+T V ++ PE + T ++D++ GV+L E+ T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 68/249 (27%), Positives = 107/249 (42%), Gaps = 53/249 (21%)
Query: 499 ATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLS 557
T F L +G G++G VYK + G+ VA+K + ++E E +L
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILR 57
Query: 558 RV-HHKHLVGLVG-FCQEK-----DERLLVYEYMSNGALHD---HLHNKNNTEKNSSIVN 607
+ +H ++ G F ++ D+ LV E G++ D L K K I
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI-- 115
Query: 608 SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667
++ +R + RG+ YLH V IHRDIK NILL N ++ DFG+S
Sbjct: 116 AYILR-----ETLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVS------- 160
Query: 668 QEFISTKA-----VGTVGYIDPE-----YYVMNVLTAKTDIYGLGVVLLELLTGK----- 712
+ ST +GT ++ PE A++D++ LG+ +EL GK
Sbjct: 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
Query: 713 ----KAVFK 717
+A+FK
Sbjct: 221 MHPMRALFK 229
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 501 NNFSLENKVGIGSFGTVYK------GKLMDGREVAVKREESCPKTNKLREKESAFDSELA 554
NN S +G G+FG V + K +VAVK + T E+E A SEL
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP---TAHSSERE-ALMSELK 90
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
++S + +H+++V L+G C L++ EY G L + L K S + + +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE-----SFLTLEDL-L 144
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIST 673
+ A+G+ +L A + IHRD+ + N+LL ++ DFGL+ D ++
Sbjct: 145 SFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLA-RDIMNDSNYVVK 200
Query: 674 -KAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
A V ++ PE V T ++D++ G++L E+ +
Sbjct: 201 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 66/247 (26%), Positives = 118/247 (47%), Gaps = 46/247 (18%)
Query: 503 FSLENKVGIGSFGTVYKGKLMD-GREVAVKR------EESCPKTNKLREKESAFDSELAL 555
F + ++G G++G VYK + D G VA+K+ +E P T +RE + +
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPIT-AIRE--------IKI 59
Query: 556 LSRVHHKHLVGL----------VGFCQEKDERLLVYEYMSN---GALHDHLHNKNNTEKN 602
L +++H+++V L + F ++K LV+EYM + G L L + + +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE-DHI 118
Query: 603 SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662
S ++ L+ G++Y H + +HRDIK SNILL+ +++DFGL+ L
Sbjct: 119 KSF-------MKQLLE---GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
Query: 663 GSECDQEFISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG 721
+ + + K + T+ Y PE + D++ G +L EL T KK +F+
Sbjct: 166 YNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQE 223
Query: 722 SGPLDVV 728
L+++
Sbjct: 224 LAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 68/237 (28%), Positives = 115/237 (48%), Gaps = 41/237 (17%)
Query: 508 KVGIGSFGTVYKG--KLMDG-REVAVK-----REESCPKTNKLREKESAFDSELALLSRV 559
++G G+FGTV KG K+ + VAVK + K LRE ++ ++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREAN--------VMQQL 53
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLH-NKNNTEKN-SSIVNSWKMRIRIAL 617
+ ++V ++G C E + +LV E G L+ L NK+ TEKN + +V+ M
Sbjct: 54 DNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------ 106
Query: 618 DAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTK 674
G+ YL N+ +HRD+ + N+LL A++SDFGLS LG+ D+ + K
Sbjct: 107 ----GMKYLEETNF-----VHRDLAARNVLLVTQHYAKISDFGLSKALGA--DENYYKAK 155
Query: 675 AVGT--VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
G V + PE ++K+D++ GV++ E + + +K G+ ++E
Sbjct: 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 67/207 (32%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 509 VGIGSFGTVYKGK-LMDGREVAVK--REESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
+G GSFG V K DG+ AVK ++++ K E++ LL V H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK---EQKHIMAERNVLLKNVKHPFLV 59
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI-ALDAARGID 624
GL Q D+ V +Y++ G L HL E++ + R R A + A +
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQR----ERSFP-----EPRARFYAAEIASALG 110
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP 684
YLH+ +II+RD+K NILLD ++DFGL G E ++ GT Y+ P
Sbjct: 111 YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCGTPEYLAP 165
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTG 711
E D + LG VL E+L G
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 55/212 (25%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ LE K+G G FG V+ +VAVK + P + + AF +E ++ + H
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSV----EAFLAEANVMKTLQH 60
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
LV L K+ ++ E+M+ G+L D L + +++ + + +I A
Sbjct: 61 DKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AE 113
Query: 622 GIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK-AVGT 678
G+ ++ NY IHRD++++NIL+ + +++DFGL+ + D E+ + + A
Sbjct: 114 GMAFIEQRNY-----IHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFP 166
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE T K+D++ G++L+E++T
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 508 KVGIGSFGTVYKG--KLMDGR--EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH 563
K+G GSFG V +G G+ VAVK C K++KL + F E A++ + H++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVK----CLKSDKLSDIMDDFLKEAAIMHSLDHEN 57
Query: 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI 623
L+ L G ++V E G+L D L S + + ++I A G+
Sbjct: 58 LIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGM 110
Query: 624 DYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIST--KAVGTVGY 681
YL + IHRD+ + NILL + ++ DFGL + + ++ V +
Sbjct: 111 RYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAW 166
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
PE + +D++ GV L E+ T
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 43/215 (20%)
Query: 510 GIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESA-----FDSELALLSRVHHKHL 564
G G+FG VYK A +E K+ + ES F E+ +LS H ++
Sbjct: 14 GDGAFGKVYK---------AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI 64
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR-IALDAARGI 623
VGL +++ ++ E+ GAL D + + E+ + + +IR + +
Sbjct: 65 VGLYEAYFYENKLWILIEFCDGGAL-DSIMLE--LERGLT-----EPQIRYVCRQMLEAL 116
Query: 624 DYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE---FISTKAVGTVG 680
++LH++ +IHRD+K+ NILL ++ +++DFG+S Q+ FI GT
Sbjct: 117 NFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPY 168
Query: 681 YIDPEYYVMNVLT-------AKTDIYGLGVVLLEL 708
++ PE V+ T K DI+ LG+ L+EL
Sbjct: 169 WMAPE--VVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 501 NNFSLENKVGIGSFGTVY--------KGKLMDGREVAVKREESCPKTNKLREKESAFDSE 552
+ +L +G G FG V K K + VAVK K + + S SE
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML----KDDATEKDLSDLVSE 70
Query: 553 LALLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSI-VN--- 607
+ ++ + HK+++ L+G C + ++ EY S G L ++L + S +
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 608 ----SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
++K + ARG++YL A IHRD+ + N+L+ N +++DFGL+
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ D +T V ++ PE V T ++D++ GV++ E+ T
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 509 VGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G G FG V ++ G+ A K+ E K K R+ ES +E +L +V+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK--KRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR---GID 624
+ KD LV M+ G L H+++ R AA G++
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG---------RAVFYAAEICCGLE 116
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP 684
LH I++RD+K NILLD + R+SD GL++ E Q VGTVGY+ P
Sbjct: 117 DLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQTI--KGRVGTVGYMAP 170
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGK 712
E T D + LG +L E++ G+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 509 VGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+G GSFG V K +DG+ AVK + N+ +E++ LL V H LVGL
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH 627
Q ++ V ++++ G L HL + + + + R A + A + YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-------RARFYAA-EIASALGYLH 113
Query: 628 NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYY 687
+ +I++RD+K NILLD ++DFGL G Q +T GT Y+ PE
Sbjct: 114 SI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG--IAQSDTTTTFCGTPEYLAPEVI 168
Query: 688 VMNVLTAKTDIYGLGVVLLELLTG 711
D + LG VL E+L G
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 34/224 (15%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-H 560
F L VG G++G VYKG+ + G+ A+K + ++E E+ +L + H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIK------VMDVTGDEEEEIKQEINMLKKYSH 61
Query: 561 HKHLVGLVGFCQEK------DERLLVYEYMSNGALHDHLHN-KNNTEKNSSIVNSWKMRI 613
H+++ G +K D+ LV E+ G++ D + N K NT K I
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA------- 114
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIST 673
I + RG+ +LH + V IHRDIK N+LL N ++ DFG+S ++ D+
Sbjct: 115 YICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRR 168
Query: 674 KA-VGTVGYIDPEYYVMN-----VLTAKTDIYGLGVVLLELLTG 711
+GT ++ PE + K+D++ LG+ +E+ G
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 52/207 (25%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 509 VGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAF----DSELALLSRVHHKH 563
+G G FGTV+KG + +G + + KT + R F D LA+ S + H +
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIP---VAIKTIQDRSGRQTFQEITDHMLAMGS-LDHAY 70
Query: 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI 623
+V L+G C +L V + G+L DH+ ++ ++N W ++I A+G+
Sbjct: 71 IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLN-WCVQI------AKGM 122
Query: 624 DYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYID 683
YL + ++HR++ + NILL + +++DFG++ L D+++ ++ + ++
Sbjct: 123 YYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 684 PEYYVMNVLTAKTDIYGLGVVLLELLT 710
E + T ++D++ GV + E+++
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 509 VGIGSFGTVYKGKLM-DGRE----VAVK--REESCPKTNKLREKESAFDSELALLSRVHH 561
+G G+FGTVYKG + DG VA+K RE + PK NK D E +++ V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK-----EILD-EAYVMAGVGS 68
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++ L+G C +L V + M G L D++ +N S + +W ++I A+
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQI------AK 120
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
G+ YL ++HRD+ + N+L+ +++DFGL+ L + E+ + + +
Sbjct: 121 GMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ E + T ++D++ GV + EL+T
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 505 LEN--KVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
LEN K+G GS G V + GR+VAVK + K + +E F+ E+ ++ H
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD----LRKQQRRELLFN-EVVIMRDYQH 77
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+++V + +E ++ E++ GAL D + E+ + V +
Sbjct: 78 QNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCE---------SVLQ 128
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-VGTVG 680
+ YLH+ V IHRDIKS +ILL ++ ++SDFG ++ ++ K+ VGT
Sbjct: 129 ALCYLHSQGV---IHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRKSLVGTPY 182
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN 718
++ PE + DI+ LG++++E++ G+ F +
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFD--SELALLSR 558
NF +E K+G G F VY+ L+DG VA+K+ + L + ++ D E+ LL +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ----IFDLMDAKARADCIKEIDLLKQ 58
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
++H +++ E +E +V E G L + + ++ WK +++
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC-- 116
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA--- 675
++++H+ ++HRDIK +N+ + ++ D GL F S+K
Sbjct: 117 --SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG--------RFFSSKTTAA 163
Query: 676 ---VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLEL 708
VGT Y+ PE N K+DI+ LG +L E+
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 7e-13
Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 66/247 (26%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKR-------EESCPKTNKLREKESAFDSELA 554
+ L +G G++G V GR+VA+K+ + LRE +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI--LRE--------IK 51
Query: 555 LLSRVHHKHLVGLV---------GFCQEKDERLLVYEYM-SNGALHDHLHNKNN-TEKNS 603
LL + H++++GL+ F ++ +V E M ++ LH + + T+
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDF----NDVYIVTELMETD--LHKVIKSPQPLTDD-- 103
Query: 604 SIVNSWKMRIR-IALDAARGIDYLHNYAVPS--IIHRDIKSSNILLDVNWTARVSDFGLS 660
I+ RG+ YLH S +IHRD+K SNIL++ N ++ DFGL+
Sbjct: 104 --------HIQYFLYQILRGLKYLH-----SANVIHRDLKPSNILVNSNCDLKICDFGLA 150
Query: 661 LLGSECDQEFIS--TKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGKK 713
G + D++ T+ V T Y PE ++ L++ DI+ +G + ELLT K
Sbjct: 151 -RGVDPDEDEKGFLTEYVVTRWYRAPE--LL--LSSSRYTKAIDIWSVGCIFAELLTR-K 204
Query: 714 AVFKNED 720
+F D
Sbjct: 205 PLFPGRD 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 67/296 (22%), Positives = 122/296 (41%), Gaps = 43/296 (14%)
Query: 502 NFSLENKVGIGSFGTVYK-------GKLMDGREVAVKREESCPKTNK-LREKESAFD--- 550
+++ +G G+FG VYK L+ +E+ V P K RE++ +
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHN----PAFGKDKRERDKSIGDIV 56
Query: 551 SELALL-SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSW 609
SE+ ++ ++ H ++V E D +V + + L +H ++ ++ + W
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 610 KMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE 669
+ +++ L A R YLH I+HRD+ +NI+L + ++DFGL+ E
Sbjct: 117 NIFVQMVL-ALR---YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP---E 167
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
T VGT+ Y PE K D++ G +L ++ T + + S +VE
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785
AV + L E E + C+ + + RP+I + A
Sbjct: 228 -AVYE-----------------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-12
Identities = 51/222 (22%), Positives = 105/222 (47%), Gaps = 20/222 (9%)
Query: 492 TLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLRE-KESAFD 550
T+ + ++ K+G G+ GTV+ +VA +E + + N ++ K+
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAI-----DVATGQEVAIKQINLQKQPKKELII 64
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
+E+ ++ + + ++V + DE +V EY++ G+L D + E + V
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---- 120
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
+ + +++LH +IHRDIKS N+LL ++ + +++DFG ++
Sbjct: 121 -----CRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQS 170
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ VGT ++ PE K DI+ LG++ +E++ G+
Sbjct: 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 57/228 (25%), Positives = 110/228 (48%), Gaps = 52/228 (22%)
Query: 508 KVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSELALLSRVH 560
K+G G++G VYK + + G VA+K+ +E P T +RE ++LL ++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPST-AIRE--------ISLLKELN 56
Query: 561 HKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H ++V L+ + +L LV+E++ + L ++ + T + ++ S+ ++
Sbjct: 57 HPNIVRLLDVVHS-ENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQL------ 108
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF-----ISTK 674
+GI Y H++ ++HRD+K N+L+D +++DFGL+ + F T
Sbjct: 109 LQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-------RAFGVPVRTYTH 158
Query: 675 AVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVF 716
V T+ Y PE Y V DI+ +G + E++ ++ +F
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPV-----DIWSIGCIFAEMVN-RRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-12
Identities = 53/206 (25%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 508 KVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
K+G G+ GTVY + G+EVA+++ + + K+ +E+ ++ + ++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELIINEILVMRENKNPNIVN 81
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
+ DE +V EY++ G+L D + E + V + + +++L
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---------CRECLQALEFL 132
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEY 686
H+ V IHRDIKS NILL ++ + +++DFG ++ + VGT ++ PE
Sbjct: 133 HSNQV---IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEV 187
Query: 687 YVMNVLTAKTDIYGLGVVLLELLTGK 712
K DI+ LG++ +E++ G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 509 VGIGSFGTVYKGKLMD-GREVAVKREESC--PKTNKLREKESAFDSELALLSRVHHKH-- 563
+G G FG VY + D G+ A+K C K K+++ E+ +E +LS V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 564 -LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARG 622
+V + D+ + + M+ G LH HL + + +MR A + G
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-------SQHGVFSEAEMRF-YAAEIILG 109
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK---AVGTV 679
++++HN V ++RD+K +NILLD + R+SD GL+ CD F K +VGT
Sbjct: 110 LEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA-----CD--FSKKKPHASVGTH 159
Query: 680 GYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTG 711
GY+ PE V + D + LG +L +LL G
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 71/233 (30%), Positives = 103/233 (44%), Gaps = 56/233 (24%)
Query: 509 VGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREK-ESAFDS-----ELALLSRVHH 561
VG G++G V GR+VA+K KL +SA + EL LL + H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIK---------KLSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 562 KHLVGLVG-FCQEKDERL-------LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM-- 611
++++GL+ F L LV M GA L+N IV K+
Sbjct: 74 ENVIGLLDVFT--PASSLEDFQDVYLVTHLM--GA---DLNN---------IVKCQKLSD 117
Query: 612 -RIR-IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE 669
I+ + RG+ Y+H+ IIHRD+K SNI ++ + ++ DFGL+ D E
Sbjct: 118 DHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDE 171
Query: 670 FISTKAVGTVGYIDPE--YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
T V T Y PE M+ DI+ +G ++ ELLTG K +F D
Sbjct: 172 M--TGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTG-KTLFPGSD 220
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 508 KVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
K+G G+ GTVY + G+EVA+K+ + + K+ +E+ ++ H ++V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNL-----QQQPKKELIINEILVMRENKHPNIVN 80
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
+ DE +V EY++ G+L D + E + V R L A +++L
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV------CRECLQA---LEFL 131
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ----EFISTKAVGTVGYI 682
H+ V IHRDIKS NILL ++ + +++DFG C Q + + VGT ++
Sbjct: 132 HSNQV---IHRDIKSDNILLGMDGSVKLTDFGF------CAQITPEQSKRSTMVGTPYWM 182
Query: 683 DPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
PE K DI+ LG++ +E++ G+
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 77/255 (30%), Positives = 107/255 (41%), Gaps = 31/255 (12%)
Query: 509 VGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESA--FDSELALLSRVHHKHLV 565
+G GSFG V K DG AVK + K L++KE LL + H LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQ---KKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI-ALDAARGID 624
GL Q ++ V +Y++ G L HL + + R R A + A I
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP---------RARFYAAEVASAIG 110
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP 684
YLH+ +II+RD+K NILLD ++DFGL G E E ++ GT Y+ P
Sbjct: 111 YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCGTPEYLAP 165
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG-------SGPLDVV---EFAVSQ 734
E D + LG VL E+L G + + PL + A
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACD 225
Query: 735 ILAGQLHCVLDKRVG 749
+L G LH +R+G
Sbjct: 226 LLVGLLHKDQRRRLG 240
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 37/217 (17%)
Query: 507 NKVGIGSFGTVYKG--KLMDG----REVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+K+G G++ TVYKG KL D +E+ ++ EE P T +RE ++LL +
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCT-AIRE--------VSLLKDLK 62
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H ++V L + LV+EY+ L +L + N +N +++ +
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGN------SINMHNVKLFL-FQLL 114
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA----V 676
RG++Y H V +HRD+K N+L++ +++DFGL+ S I TK V
Sbjct: 115 RGLNYCHRRKV---LHRDLKPQNLLINERGELKLADFGLARAKS------IPTKTYSNEV 165
Query: 677 GTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGK 712
T+ Y P+ + + + + D++G+G + E+ TG+
Sbjct: 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 75/276 (27%), Positives = 109/276 (39%), Gaps = 73/276 (26%)
Query: 458 LPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTV 517
LPP S S+ SS S S S A + SEL N++G G+ GTV
Sbjct: 47 LPPPSSSSSSSSSS-------SASGSAPSAAKSL--SELERV-------NRIGSGAGGTV 90
Query: 518 YKGKLM-DGREVAVK----------REESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
YK GR A+K R + C E+ +L V+H ++V
Sbjct: 91 YKVIHRPTGRLYALKVIYGNHEDTVRRQIC--------------REIEILRDVNHPNVVK 136
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR----G 622
E ++ E+M G+L + D AR G
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADE----------------QFLADVARQILSG 180
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGTVGY 681
I YLH I+HRDIK SN+L++ +++DFG+S +L D +VGT+ Y
Sbjct: 181 IAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAY 234
Query: 682 IDPEYYVMNVLTAK-----TDIYGLGVVLLELLTGK 712
+ PE ++ DI+ LGV +LE G+
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
NF +E K+G G F VY+ L+D + VA+K+ + + ++ E+ LL +++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV--KEIDLLKQLN 60
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H +++ + E +E +V E G L + ++ WK +++
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC---- 116
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA----- 675
++++H+ ++HRDIK +N+ + ++ D GL F S+K
Sbjct: 117 SAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG--------RFFSSKTTAAHS 165
Query: 676 -VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLEL 708
VGT Y+ PE N K+DI+ LG +L E+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 65/238 (27%), Positives = 96/238 (40%), Gaps = 55/238 (23%)
Query: 509 VGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESAFD-SELALLSRVHHKHLVG 566
+G G+FG V+ + D +V A+K K++ ++ + A +E +L+ +V
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLR---KSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA-LDAARGIDY 625
L Q+++ LV EYM G L + L K+ R IA L A +D
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD------VFPEET-ARFYIAELVLA--LDS 116
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS------------------LLGSECD 667
+H IHRDIK NIL+D + +++DFGL LL +
Sbjct: 117 VHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 668 QEFISTK---------AVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTG 711
VGT YI PE VL D + LGV+L E+L G
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPE-----VLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 52/193 (26%), Positives = 97/193 (50%), Gaps = 25/193 (12%)
Query: 525 GREVAVKREESCPKTNKLREKESA-FDSELALLSRVHHKHLVGLVGFCQEKDER--LLVY 581
G +VAVK + P++ A E+ +L ++H+++V G C E L+
Sbjct: 33 GEQVAVKSLK--PES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 87
Query: 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL--HNYAVPSIIHRDI 639
E++ +G+L ++L +N + +N K +++ A+ +G+DYL Y +HRD+
Sbjct: 88 EFLPSGSLKEYL------PRNKNKIN-LKQQLKYAVQICKGMDYLGSRQY-----VHRDL 135
Query: 640 KSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK--AVGTVGYIDPEYYVMNVLTAKTD 697
+ N+L++ ++ DFGL+ E D+E+ + K V + PE + + +D
Sbjct: 136 AARNVLVESEHQVKIGDFGLT-KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASD 194
Query: 698 IYGLGVVLLELLT 710
++ GV L ELLT
Sbjct: 195 VWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 509 VGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHH---KHL 564
+G G FG VY + D G+ A+K + K K+++ E+ +E +LS V +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK--KRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGID 624
V + D+ + + M+ G LH HL + + +MR A + G++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHL-------SQHGVFSEKEMRF-YATEIILGLE 111
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK---AVGTVGY 681
++HN V ++RD+K +NILLD + R+SD GL+ CD F K +VGT GY
Sbjct: 112 HMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA-----CD--FSKKKPHASVGTHGY 161
Query: 682 IDPEYYVMNVLTA---KTDIYGLGVVLLELLTG 711
+ PE V+ TA D + LG +L +LL G
Sbjct: 162 MAPE--VLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 34/240 (14%)
Query: 508 KVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
+G G G VY + R VA+K+ N L +K F E + + + H +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR--FLREAKIAADLIHPGIVP 66
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHN---KNNTEKNSSIVNSWKMRIRIALDAARGI 623
+ C + D Y+ L L + K + K + S + I I
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 624 DYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL--GSECDQEFIST-------- 673
+Y+H+ ++HRD+K NILL + + D+G ++ E D I
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 674 ------KAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT---------GKKAVFKN 718
K VGT Y+ PE + + TDIY LGV+L ++LT G+K +++
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRD 243
|
Length = 932 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 41/227 (18%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREV----AVKREESCPKTNKLREKESAFDSELALLS 557
NF L +G G++G V+ + + G + A+K + K + E +E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT-RTERNVLE 59
Query: 558 RVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
V + + + + + +L L+ +Y+S G + HL+ ++N ++ V + I +A
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE--VRFYSGEIILA 117
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA- 675
L+ +LH I++RDIK NILLD ++DFGLS +EF+S +
Sbjct: 118 LE------HLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS-------KEFLSEEKE 161
Query: 676 -----VGTVGYIDPEYYVMNVLTAKT------DIYGLGVVLLELLTG 711
GT+ Y+ PE ++ K D + LG+++ ELLTG
Sbjct: 162 RTYSFCGTIEYMAPE-----IIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 508 KVGIGSFGTVYKGKLMDGRE-VAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
++G GSFG VY + + E VA+K+ K + EK E+ L ++ H + +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQQLRHPNTIE 79
Query: 567 LVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR------IALDA 619
G C ++ LV EY A S I+ K ++ I A
Sbjct: 80 YKG-CYLREHTAWLVMEYCLGSA--------------SDILEVHKKPLQEVEIAAICHGA 124
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
+G+ YLH++ IHRDIK+ NILL T +++DFG + L S F VGT
Sbjct: 125 LQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-NSF-----VGTP 175
Query: 680 GYIDPEYYV-MN--VLTAKTDIYGLGVVLLELLTGKKAVF 716
++ PE + M+ K D++ LG+ +EL K +F
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 76/281 (27%), Positives = 120/281 (42%), Gaps = 55/281 (19%)
Query: 509 VGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFD--SELALLSRVHHKHLV 565
+G G++G VY+GK + GR VA+K N + D E+ALLS++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALK------IINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 566 GLVGF--CQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARG 622
+ + K RL ++ EY G++ + EK S++ IR L A
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVI------IREVLVA--- 113
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL---GSECDQEFISTKAVGTV 679
+ Y+H +IHRDIK++NIL+ ++ DFG++ L S F VGT
Sbjct: 114 LKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-----VGTP 165
Query: 680 GYIDPEYYVMNVLT--AKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL-DVVEFAVSQIL 736
++ PE + K DI+ LG+ + E+ T G+ P DV F ++
Sbjct: 166 YWMAPE-VITEGKYYDTKADIWSLGITIYEMAT----------GNPPYSDVDAFRAMMLI 214
Query: 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKER 777
+ PP L + +LL C++ E KER
Sbjct: 215 P---------KSKPPRLEDNGYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 52/237 (21%)
Query: 496 LAAATNNFSLENKVGIGSFGTVYKG-KLMDGREVAVK-----REESCPKTNKLREKESAF 549
AAT+ +LE K+G GS+ TVYKG ++G+ VA+K EE P T +RE
Sbjct: 1 FGAATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFT-AIREA---- 54
Query: 550 DSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSN----------GALHDHLHNKNNT 599
+LL + H ++V L K+ V+EYM G LH +
Sbjct: 55 ----SLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY------- 103
Query: 600 EKNSSIVNSWKMRIRIAL-DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658
+R+ + RG+ Y+H I+HRD+K N+L+ +++DFG
Sbjct: 104 ------------NVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG 148
Query: 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGKKA 714
L+ S Q + S V T+ Y P+ + ++ DI+G G + +E+L G+ A
Sbjct: 149 LARAKSIPSQTYSS--EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 26/227 (11%)
Query: 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESAFD- 550
+++L +F + +G G+FG V + ++V A+K K ++ +SAF
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL---LSKFEMIKRSDSAFFW 91
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLL--VYEYMSNGALHDHLHNKNNTEKNSSIVNS 608
E +++ + + +V L +D++ L V EYM G L + + N + EK +
Sbjct: 92 EERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARF--- 146
Query: 609 WKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ 668
+ + +ALDA +H+ IHRD+K N+LLD + +++DFG + + + +
Sbjct: 147 YTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFG-TCMKMDANG 196
Query: 669 EFISTKAVGTVGYIDPEYY----VMNVLTAKTDIYGLGVVLLELLTG 711
AVGT YI PE + D + +GV L E+L G
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 509 VGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD-SELALLSRVHHKH---L 564
+G G+FG VY+ + D R + + S K + +KE A E +L R +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS--KKEIVAKKEVAHTIGERNILVRTLLDESPFI 58
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGID 624
VGL Q + LV +YMS G L HL + ++ + + IA + ++
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-------RAKFYIA-ELVLALE 110
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP 684
+LH Y I++RD+K NILLD + DFGLS + + GT Y+ P
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAP 165
Query: 685 EYYVMNV-LTAKTDIYGLGVVLLELLTG 711
E + T D + LGV++ E+ G
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 67/237 (28%), Positives = 103/237 (43%), Gaps = 37/237 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE-VAVKR--EESCPKTNKLREKESAFDSELALLS 557
+F + +VG G +G V+ K D E VA+KR + K N++R +E +L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRH----VLTERDILT 56
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
+ LV L+ Q+ + L EY+ G L+N ++ + R +A
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-------RFYMA- 108
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
+ +D LH IHRD+K N L+D + +++DFGLS + + T A
Sbjct: 109 EMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLS-------KGIV-TYANS 157
Query: 678 TVGYIDPEYYVMNVLTAK-----TDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
VG P+Y VL K D + LG +L E L G F GS P + E
Sbjct: 158 VVG--SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG----FPPFSGSTPNETWE 208
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 57/232 (24%), Positives = 109/232 (46%), Gaps = 31/232 (13%)
Query: 508 KVGIGSFGTVYKGKL-MDGRE--VAVK----REESCPKTNKLREKESAFDSELALLSRVH 560
++G G+FG V KG M ++ VA+K E + +RE E ++ ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAE--------IMHQLD 53
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
+ ++V ++G C E + +LV E S G L+ L K + S++V + +
Sbjct: 54 NPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV-------ELMHQVS 105
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGT- 678
G+ YL + +HRD+ + N+LL A++SDFGLS LG+ D + ++ G
Sbjct: 106 MGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA--DDSYYKARSAGKW 160
Query: 679 -VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
+ + PE ++++D++ G+ + E + + +K G + +E
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE 212
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 46/160 (28%), Positives = 84/160 (52%), Gaps = 27/160 (16%)
Query: 508 KVGIGSFGTVYKGKLMDGRE-VAVKR------EESCPKTNKLREKESAFDSELALLSRVH 560
K+G G++GTV+K K + E VA+KR +E P ++ LRE + LL +
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP-SSALRE--------ICLLKELK 57
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
HK++V L + LV+EY L + + N + + IV S+ ++
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQD-LKKYFDSCNG-DIDPEIVKSFMFQL------L 109
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660
+G+ + H++ +++HRD+K N+L++ N +++DFGL+
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 29/213 (13%)
Query: 507 NKVGIGSFGTVYKGK------LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+K+G G++ TV+KG+ L+ +E+ ++ EE P T +RE ++LL +
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT-AIRE--------VSLLKNLK 61
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H ++V L + LV+EY+ + L +L N N +++ ++I
Sbjct: 62 HANIVTLHDIIHTERCLTLVFEYLDSD-LKQYLDNCGN------LMSMHNVKI-FMFQLL 113
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
RG+ Y H I+HRD+K N+L++ +++DFGL+ S + + + V T+
Sbjct: 114 RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY--SNEVVTLW 168
Query: 681 YIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGK 712
Y P+ + + + D++G+G +L E+ TG+
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 40/219 (18%)
Query: 508 KVGIGSFGTVYKGKLMDGRE-VAVKR------EESCPKTNKLREKESAFDSELALLSRVH 560
K+G G++G VYK + E +A+K+ +E P T +RE ++LL +
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPST-AIRE--------ISLLKEMQ 59
Query: 561 HKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H ++V L ++RL LV+EY+ + L H+ + + KN ++ ++ +I
Sbjct: 60 HGNIVRLQDVVH-SEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQI------ 111
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA-RVSDFGLSLLGSECDQEFISTKAVGT 678
RGI Y H++ V +HRD+K N+L+D A +++DFGL+ + F T V T
Sbjct: 112 LRGIAYCHSHRV---LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVT 166
Query: 679 VGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
+ Y PE +L ++ DI+ +G + E++ K
Sbjct: 167 LWYRAPEI----LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 34/224 (15%)
Query: 502 NFSLENKVGIGSFGTVY----KGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLS 557
NF L +G G++G V+ G G+ A+K + K + E +E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR-TERQVLE 59
Query: 558 RVHHK-HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
V LV L Q + L+ +Y++ G L HL+ + + ++ ++R+ IA
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-------EVRVYIA 112
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFISTK 674
+ +D+LH II+RDIK NILLD ++DFGLS L E ++ +
Sbjct: 113 -EIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---S 165
Query: 675 AVGTVGYIDPEYYVMNVLTAKT-------DIYGLGVVLLELLTG 711
GT+ Y+ PE V+ + D + LGV+ ELLTG
Sbjct: 166 FCGTIEYMAPE-----VIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 552 ELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
EL +L + ++VG G E + E+M G+L L +K I +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KKAGRIPENILG 102
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
+I IA+ RG+ YL I+HRD+K SNIL++ ++ DFG+S + I
Sbjct: 103 KISIAV--LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLI 151
Query: 672 STKA---VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ A VGT Y+ PE T ++DI+ LG+ L+E+ G+
Sbjct: 152 DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 53/190 (27%), Positives = 91/190 (47%), Gaps = 21/190 (11%)
Query: 525 GREVAVKREES-CPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER--LLVY 581
G VAVK + C + N S + E+ +L ++H+++V G C E+ + L+
Sbjct: 33 GEMVAVKTLKRECGQQN-----TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87
Query: 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKS 641
EY+ G+L D+L K+ +N ++ + A G+ YLH+ IHRD+ +
Sbjct: 88 EYVPLGSLRDYL-PKHK-------LNLAQLLL-FAQQICEGMAYLHS---QHYIHRDLAA 135
Query: 642 SNILLDVNWTARVSDFGLSLLGSECDQEF-ISTKAVGTVGYIDPEYYVMNVLTAKTDIYG 700
N+LLD + ++ DFGL+ E + + + V + E N + +D++
Sbjct: 136 RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWS 195
Query: 701 LGVVLLELLT 710
GV L ELLT
Sbjct: 196 FGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 509 VGIGSFGTV------YKGKLMDGREVAVKR-EESCPKTNKLREKESAFDSELALLSRVHH 561
+G G FG V GK+ +++ KR ++ + L EKE +L +V+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--------ILEKVNS 52
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+V L + K LV M+ G L H++N V + +I
Sbjct: 53 PFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI------TC 106
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
GI +LH+ I++RD+K N+LLD R+SD GL++ E T+ GT GY
Sbjct: 107 GILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGY 160
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN 718
+ PE + D + +G + E++ G+ FK+
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP-FKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 53/226 (23%), Positives = 103/226 (45%), Gaps = 22/226 (9%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELA-LLSRV 559
+ L +G G FG V + + + R + K++A D +LA L+S +
Sbjct: 12 DRLVLGKPLGEGCFGQVVRA---EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 560 H-------HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKN--------NTEKNSS 604
HK+++ L+G C ++ ++ EY + G L + L + + K
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 605 IVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664
S+K + A ARG++YL + IHRD+ + N+L+ + +++DFGL+
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ D ++ V ++ PE V T ++D++ G+++ E+ T
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 24/225 (10%)
Query: 503 FSLENKVGIGSFGTVY--------KGKLMDGREVAVKREESCPKTNKLREKESAFDSELA 554
+L +G G FG V K K VAVK K + + S SE+
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML----KDDATDKDLSDLVSEME 69
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKN--------NTEKNSSI 605
++ + HK+++ L+G C + ++ EY S G L ++L + +T K
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129
Query: 606 VNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665
++K + A ARG++YL A IHRD+ + N+L+ + +++DFGL+
Sbjct: 130 QLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186
Query: 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
D +T V ++ PE V T ++D++ GV+L E+ T
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 28/224 (12%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGR--EVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+F+ +G GSFG V + VA+KR E K K ++ + F SE +L+ +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS-KIIKQKQVDHVF-SERKILNYI 88
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
+H V L G +++ LV E++ G L + N + + + +I + +
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVLIFE- 145
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA---V 676
YL + +I++RD+K N+LLD + +++DFG + + + T+
Sbjct: 146 -----YLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFA--------KVVDTRTYTLC 189
Query: 677 GTVGYIDPEYYVMNVLTAK-TDIYGLGVVLLELLTGKKAVFKNE 719
GT YI PE ++NV K D + LG+ + E+L G + NE
Sbjct: 190 GTPEYIAPE-ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232
|
Length = 340 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 508 KVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
++G G+FG VYK K +E +T E E + E+ +L+ +H ++V L
Sbjct: 19 ELGDGAFGKVYKAK---NKETGALAAAKVIETKSEEELED-YMVEIEILATCNHPYIVKL 74
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH 627
+G + ++ E+ GA+ + + I ++ R L+A + YLH
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI----QVICRQMLEA---LQYLH 127
Query: 628 NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYY 687
+ IIHRD+K+ N+LL ++ +++DFG+S + Q S +GT ++ PE
Sbjct: 128 SM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF--IGTPYWMAPEVV 182
Query: 688 VMNVLTA-----KTDIYGLGVVLLEL 708
+ + K DI+ LG+ L+E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 44/227 (19%)
Query: 509 VGIGSFGTV----YKG-------KLMDGREVAVKREE-SCPKTNKLREKESAFDSELALL 556
+G GSFG V KG K++ ++V ++ ++ C T K LAL
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLK-KDVILQDDDVECTMTEK---------RVLALA 52
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ H L L Q KD V EY++ G L H+ ++ + A
Sbjct: 53 GK--HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF--------YA 102
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS---LLGSECDQEFIST 673
+ G+ +LH II+RD+K N+LLD +++DFG+ +LG F
Sbjct: 103 AEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF--- 156
Query: 674 KAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
GT YI PE D + LGV+L E+L G ++ F+ +D
Sbjct: 157 --CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG-QSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 49/229 (21%)
Query: 509 VGIGSFGTV-----------YKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLS 557
+G G+FG V Y K++ +EV + ++E + R +L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTESR-----------VLK 50
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI-A 616
H L L Q KD V EY++ G L HL + ++ R R
Sbjct: 51 NTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED---------RTRFYG 101
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
+ +DYLH+ I++RD+K N++LD + +++DFGL +E I+ A
Sbjct: 102 AEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLC-------KEGITDAAT 151
Query: 677 -----GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
GT Y+ PE N D +GLGVV+ E++ G+ F N+D
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 50/171 (29%), Positives = 72/171 (42%), Gaps = 29/171 (16%)
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ H LV L Q +D V EY + G L H+H +E R
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------------RAV 104
Query: 617 LDAAR---GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC--DQEFI 671
AA G+ YLH I++RD+K N+LLD +++DFGL C F
Sbjct: 105 FYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL------CKEGMGFG 155
Query: 672 STKAV--GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
+ GT ++ PE T D +GLGV++ E+L G+ F +D
Sbjct: 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP-FPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKE--SAFDSELALLSRV 559
+F L ++G G++G VYK + ++ E+A K KL E + E+ ++
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAI------KVIKLEPGEDFAVVQQEIIMMKDC 63
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H ++V G +D+ + E+ G+L D H T S ++ R +
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV---TGPLSESQIAYVSR-----ET 115
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-VGT 678
+G+ YLH+ +HRDIK +NILL N +++DFG+S ++ K+ +GT
Sbjct: 116 LQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS---AQITATIAKRKSFIGT 169
Query: 679 VGYIDPEYYVMNV---LTAKTDIYGLGVVLLEL 708
++ PE + DI+ +G+ +EL
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 509 VGIGSFGTVYKGKLMDGRE------VAVKREESCPKTNKLREKESAFDSELALLSRVHHK 562
+G GSFG V+ + + G + + V ++ + +++R K E +L+ V+H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK-----MERDILAEVNHP 58
Query: 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIALDAAR 621
+V L Q + + L+ +++ G L L + TE++ ++ +A + A
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--------VKFYLA-ELAL 109
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
+D+LH+ II+RD+K NILLD +++DFGLS D E + GTV Y
Sbjct: 110 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEY 164
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
+ PE T D + GV++ E+LTG
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 63/244 (25%), Positives = 113/244 (46%), Gaps = 48/244 (19%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFD----SELALL 556
+ N++ G++G VY+ + G VA+K+ K+ +++ F E+ +L
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-------KMEKEKEGFPITSLREINIL 58
Query: 557 SRVHHKHLVGL----VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
++ H ++V + VG D+ +V EY+ HD L + T K + + K
Sbjct: 59 LKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVE----HD-LKSLMETMKQPFLQSEVKCL 111
Query: 613 IRIALDAARGIDYLH-NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
+ L G+ +LH N+ I+HRD+K+SN+LL+ ++ DFGL+ + +
Sbjct: 112 MLQLL---SGVAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY- 163
Query: 672 STKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL 725
T+ V T+ Y PE Y + D++ +G + ELLT KK +F G +
Sbjct: 164 -TQLVVTLWYRAPELLLGAKEY-----STAIDMWSVGCIFAELLT-KKPLFP---GKSEI 213
Query: 726 DVVE 729
D +
Sbjct: 214 DQLN 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 509 VGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL 564
+G G+FGTV K M G +AVKR S ++ +K D ++ + S ++
Sbjct: 12 IGRGAFGTVNK---MLHKPSGTIMAVKRIRS--TVDEKEQKRLLMDLDVVMRSS-DCPYI 65
Query: 565 VGLVGFCQEKDERLLVYEYM--SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARG 622
V G + + + E M S + +++ + I+ +IA+ +
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG------KIAVATVKA 119
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFISTKAVGTVG 680
++YL IIHRD+K SNILLD N ++ DFG+S L+ S T+ G
Sbjct: 120 LNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-----IAKTRDAGCRP 172
Query: 681 YIDPEYYVMNVLTA---KTDIYGLGVVLLELLTGK 712
Y+ PE + ++D++ LG+ L E+ TGK
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/230 (25%), Positives = 105/230 (45%), Gaps = 23/230 (10%)
Query: 495 ELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNK------LREKESA 548
E+ +T F E +G FG VYKG L G + + KT K LRE+
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLF-GTAPGEQTQAVAIKTLKDKAEGPLREE--- 54
Query: 549 FDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHL-----HNKNNTEKNS 603
F E + SR+ H ++V L+G ++ +++ Y S+ LH+ L H+ + +
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 604 SIVNSWKMR---IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660
V S + I A G+++L ++ V +H+D+ + N+L+ ++SD GL
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLF 171
Query: 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
D + ++ + ++ PE + + +DI+ GVVL E+ +
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 66/247 (26%), Positives = 109/247 (44%), Gaps = 41/247 (16%)
Query: 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNK-LREKE-SAFDSELALLSR 558
+F + +G GSFG V K G A+K C K + L+ K+ E ++L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIK----CLKKREILKMKQVQHVAQEKSILME 74
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ H +V ++ Q+++ + E++ G L HL + + + + +A
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPND--VAKFYHAELVLAF- 131
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
+YLH+ II+RD+K N+LLD +V+DFG + D+ F GT
Sbjct: 132 -----EYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFA--KKVPDRTF---TLCGT 178
Query: 679 VGYIDPEYYVMNVLTAK-----TDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733
PEY V+ +K D + +GV+L E + G F D + P + E
Sbjct: 179 -----PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF---DDT-PFRIYE---- 225
Query: 734 QILAGQL 740
+ILAG+L
Sbjct: 226 KILAGRL 232
|
Length = 329 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 503 FSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESAFDSELALLSRVHH 561
F+ ++G GSFG VY + + EV A+K+ K + EK E+ L R+ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN--EKWQDIIKEVKFLQRIKH 84
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+ + G + LV EY G+ D L + I I A +
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-------AITHGALQ 136
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
G+ YLH++ ++IHRDIK+ NILL +++DFG + + S + VGT +
Sbjct: 137 GLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYW 187
Query: 682 IDPEYYVM---NVLTAKTDIYGLGVVLLELLTGKKAVF 716
+ PE + K D++ LG+ +EL K +F
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 509 VGIGSFGTV-----------YKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLS 557
+G G+FG V Y K++ +EV V ++E + R +L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENR-----------VLQ 50
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
H L L Q D V EY + G L HL + + + R A
Sbjct: 51 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-------SRERVFSEDRARFYGA- 102
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
+ +DYLH + ++++RD+K N++LD + +++DFGL G + D + T G
Sbjct: 103 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-FCG 158
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
T Y+ PE N D +GLGVV+ E++ G+ F N+D
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 55/224 (24%)
Query: 509 VGIGSFGTVYKGKL-MDGREVAVKR-------EESCPKTNKLREKESAFDSELALLSRVH 560
+G+G FG V K+ R A+K E + + EKE +L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQE-HIFSEKE--------ILEECN 51
Query: 561 HKHLVGLVGFCQEKDERLLVY---EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
H +V L + KD++ +Y EY G L L ++ ++ + R IA
Sbjct: 52 HPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDE-------YTARFYIAC 101
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKA- 675
+YLHN II+RD+K N+LLD N ++ DFG + L S K
Sbjct: 102 -VVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-------GQKTW 150
Query: 676 --VGTVGYIDPEYYVMNVLTAK-----TDIYGLGVVLLELLTGK 712
GT Y+ PE ++ K D + LG++L ELLTG+
Sbjct: 151 TFCGTPEYVAPE-----IILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 508 KVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKE-SAFDS--ELALLSRVHHKH 563
K+G GS+ TVYKGK ++G+ VA+K +L+E+E + F + E +LL + H +
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALK-------VIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI 623
+V L K+ LV+EY +H L + + K+ + RG+
Sbjct: 65 IVLLHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFL---FQLLRGL 116
Query: 624 DYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYID 683
Y+H I+HRD+K N+L+ +++DFGL+ S + + V T+ Y
Sbjct: 117 SYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY--SNEVVTLWYRP 171
Query: 684 PEYYVMNV-LTAKTDIYGLGVVLLELLTGKKA 714
P+ + + + D++G+G + +E++ G A
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREV----AVKREESCPKTNKLREKESAFDSELALLS 557
NF L +G G++G V+ + + G + A+K + K + E +E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLE 59
Query: 558 RVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ + + + + D +L L+ +Y++ G L HL + ++ V + I +A
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQE--VQIYSGEIVLA 117
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA- 675
L+ +LH II+RDIK NILLD N ++DFGLS +EF +
Sbjct: 118 LE------HLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS-------KEFHEDEVE 161
Query: 676 -----VGTVGYIDPEYYVMNVLTAKT------DIYGLGVVLLELLTG 711
GT+ Y+ P+ V D + +GV++ ELLTG
Sbjct: 162 RAYSFCGTIEYMAPDI----VRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 507 NKVGIGSFGTVYKG--KLMDG----REVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
K+G G++ TV+KG KL + +E+ ++ EE P T +RE ++LL +
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT-AIRE--------VSLLKDLK 62
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H ++V L LV+EY+ K + +I++ ++I +
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDKDL-------KQYMDDCGNIMSMHNVKIFL-YQIL 114
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
RG+ Y H V +HRD+K N+L++ +++DFGL+ S + + + V T+
Sbjct: 115 RGLAYCHRRKV---LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY--SNEVVTLW 169
Query: 681 YIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGK 712
Y P+ + + + + D++G+G + E+ +G+
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRD 638
LV +Y + G L + ++ T + + + I++ L +H+ +IHRD
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA-------VHHVHSKHMIHRD 168
Query: 639 IKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDI 698
IKS+NILL N ++ DFG S + + + + GT Y+ PE + + K D+
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM 228
Query: 699 YGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739
+ LGV+L ELLT K+ F E+ +E + + LAG+
Sbjct: 229 FSLGVLLYELLTLKRP-FDGEN-------MEEVMHKTLAGR 261
|
Length = 496 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 52/223 (23%)
Query: 507 NKVGIGSFGTVYKGK-LMDGREVAVKREESCPKT----NKLREKESAFDSELALLSRV-H 560
K+G G+F V K + G+ A+K + K+ N LR E+ L R+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR--------EIQALRRLSP 56
Query: 561 HKHLVGLVGFC-QEKDERL-LVYEYMSNGALHDHLHNKNN--TEKNSSIVNSWKMRIRIA 616
H +++ L+ K RL LV+E M + L++ + + EK V S+ ++
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKR---VKSYMYQL--- 109
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ---EFIST 673
+ +D++H I HRDIK NIL+ + +++DFG S G E+IST
Sbjct: 110 ---LKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFG-SCRGIYSKPPYTEYIST 161
Query: 674 KAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLT 710
+ Y PE YY K DI+ +G V E+L+
Sbjct: 162 R-----WYRAPECLLTDGYY-----GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMD---GREVAVK---REESCPKTNK--LREKESAFDSEL 553
+ +G G++G V +D G++VA+K P K LRE L
Sbjct: 6 RYKPIENIGSGAYGVVCSA--IDTRSGKKVAIKKIPHAFDVPTLAKRTLRE--------L 55
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERL----LVYEYMSNGALHDHLHNKNNTEKNSSIVNSW 609
+L H +++ + + +V + M + LH +H+ +
Sbjct: 56 KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESD-LHHIIHSDQPLTEE------- 107
Query: 610 KMRIRIAL-DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL--SLLGSEC 666
IR L RG+ Y+H+ ++IHRD+K SN+L++ + R+ DFG+ L S
Sbjct: 108 --HIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162
Query: 667 DQEFISTKAVGTVGYIDPE-YYVMNVLTAKTDIYGLGVVLLELLTGKKAVF 716
+ ++ T+ V T Y PE + T D++ +G + E+L G++ +F
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESA-FDSELALLSRVH 560
+F + +G G+FG V KL + +V + + K L+ E+A F E +L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVNGD 59
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
++ + L Q+++ LV +Y G L L +K + + + IA+D+
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
+ Y +HRDIK NIL+D+N R++DFG L E D S+ AVGT
Sbjct: 119 HQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPD 168
Query: 681 YIDPEYYVMNVLT-------AKTDIYGLGVVLLELLTGKKAVF 716
YI PE ++ + + D + LGV + E+L G+ +
Sbjct: 169 YISPE--ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 509 VGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLV 568
VG GSFG + ++ + +E PK++ E E LL+++ H ++V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR---KEAVLLAKMKHPNIVAFK 64
Query: 569 GFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN 628
+ +V EY G L + + + W +++ + G+ ++H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHE 118
Query: 629 YAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV 688
V +HRDIKS NI L N ++ DFG + L + + T VGT Y+ PE +
Sbjct: 119 KRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACT-YVGTPYYVPPEIWE 173
Query: 689 MNVLTAKTDIYGLGVVLLELLTGK 712
K+DI+ LG +L EL T K
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 507 NKVGIGSFGTVYKGKLMDGRE-VAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
+++G GSFG VY E VAVK+ K + EK E+ L ++ H + +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--QTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
G ++ LV EY G+ D L + I I A +G+ Y
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-------AITHGALQGLAY 136
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPE 685
LH++ +IHRDIK+ NILL +++DFG + S + VGT ++ PE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPE 187
Query: 686 YYVM---NVLTAKTDIYGLGVVLLELLTGKKAVF 716
+ K D++ LG+ +EL K +F
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 37/215 (17%)
Query: 509 VGIGSFGTV-----------YKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLS 557
+G GSFG V Y K++ + + K+EE + + E+ LL
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEK----HIMSERN-------VLLK 51
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI-A 616
V H LVGL Q D+ V +Y++ G L HL + + R R A
Sbjct: 52 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF---------LEPRARFYA 102
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
+ A + YLH+ +I++RD+K NILLD ++DFGL + ++
Sbjct: 103 AEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFC 157
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
GT Y+ PE D + LG VL E+L G
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 61/244 (25%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKR-----EESCPKTNKLREKESAFDSELAL 555
NF K+G G++ TVYKG+ G VA+K EE P T +RE ++L
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPST-AIRE--------ISL 51
Query: 556 LSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI 615
+ + H+++V L +++ +LV+EYM L ++ R
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGV---------------RG 95
Query: 616 ALDAA----------RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665
ALD +GI + H V +HRD+K N+L++ +++DFGL+
Sbjct: 96 ALDPNTVKSFTYQLLKGIAFCHENRV---LHRDLKPQNLLINKRGELKLADFGLA----- 147
Query: 666 CDQEF---IST--KAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFK-- 717
+ F ++T V T+ Y P+ + + DI+ +G ++ E++TG + +F
Sbjct: 148 --RAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGT 204
Query: 718 -NED 720
NED
Sbjct: 205 NNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 49/229 (21%)
Query: 509 VGIGSFGTV-----------YKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLS 557
+G G+FG V Y K++ +EV + ++E + R +L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESR-----------VLQ 50
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIA 616
H L L Q D V EY + G L HL + TE+ + +
Sbjct: 51 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-------- 102
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
+ ++YLH+ +++RDIK N++LD + +++DFGL C +E IS A
Sbjct: 103 -EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL------C-KEGISDGAT 151
Query: 677 -----GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
GT Y+ PE N D +GLGVV+ E++ G+ F N+D
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 63/238 (26%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREES------CPKTNKLREKESAFDSELA 554
+ + +G G++G V G +VA+K+ C +T LRE +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT--LRE--------IK 55
Query: 555 LLSRVHHKHLVGLV------GFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNS 608
+L R H++++G++ F D +V E M L+ T+ S+
Sbjct: 56 ILRRFKHENIIGILDIIRPPSFESFND-VYIVQELMET-----DLYKLIKTQHLSN---- 105
Query: 609 WKMRIRIALDAA--------RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660
D RG+ Y+H+ V +HRD+K SN+LL+ N ++ DFGL+
Sbjct: 106 ---------DHIQYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLA 153
Query: 661 -LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
+ E D T+ V T Y PE +M L +K DI+ +G +L E+L+ +
Sbjct: 154 RIADPEHDHTGFLTEYVATRWYRAPE--IM--LNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 509 VGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESAFD-SELALLSRVHHKHLVG 566
+G GSFG V + + D + + A+K + K + + E +E +L++V+ +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALK---TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP 57
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
L Q ++ LV +++ G L HL + + + R A + ++ L
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQREGR-------FDLSRARFYTA-ELLCALENL 109
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEY 686
H + V I+RD+K NILLD + DFGL L + D + + GT Y+ PE
Sbjct: 110 HKFNV---IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPEL 164
Query: 687 YVMNVLTAKTDIYGLGVVLLELLTG 711
+ + T D + LGV+L E+LTG
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 69/227 (30%), Positives = 109/227 (48%), Gaps = 44/227 (19%)
Query: 509 VGIGSFGTVYKGKLMDGR---EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
VG G++GTV +D R +VA+K+ P ++L K + EL LL + H++++
Sbjct: 23 VGSGAYGTVCSA--LDRRTGAKVAIKKLYR-PFQSELFAKRAY--RELRLLKHMKHENVI 77
Query: 566 GLVGFCQEKDERL-------LVYEYMSN--GALHDHLHNKNNTEKNSSIVNSWKMRIR-I 615
GL+ D L LV +M G L H EK S + RI+ +
Sbjct: 78 GLLDVFT-PDLSLDRFHDFYLVMPFMGTDLGKLMKH-------EKLS------EDRIQFL 123
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA 675
+G+ Y+H IIHRD+K N+ ++ + ++ DFGL+ + D E T
Sbjct: 124 VYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEM--TGY 175
Query: 676 VGTVGYIDPEYYVMNVL--TAKTDIYGLGVVLLELLTGKKAVFKNED 720
V T Y PE ++N + T DI+ +G ++ E+LTG K +FK D
Sbjct: 176 VVTRWYRAPE-VILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 34/235 (14%)
Query: 496 LAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD-SELA 554
L ++ + +G G+FG V + ++V + S K ++ +SAF E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERD 95
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLL--VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
+++ + +V L FC +D++ L V EYM G L + + N + EK + +
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF---YTAE 150
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
+ +ALDA +H+ +IHRD+K N+LLD + +++DFG + E
Sbjct: 151 VVLALDA------IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 673 TKAVGTVGYIDPE---------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN 718
T AVGT YI PE YY + D + +GV L E+L G + +
Sbjct: 202 T-AVGTPDYISPEVLKSQGGDGYY-----GRECDWWSVGVFLFEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 65/226 (28%), Positives = 96/226 (42%), Gaps = 42/226 (18%)
Query: 509 VGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESAFDSELALLSR------VHH 561
+G GSFG V +L E A+K K + + E + D E ++ R H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIK----ALKKDVVLEDD---DVECTMVERRVLALAWEH 55
Query: 562 KHLVGLVGFC--QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI-ALD 618
L L FC Q K+ V EY++ G L H+ + ++ R R A +
Sbjct: 56 PFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA---------RARFYAAE 104
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI-STKA-- 675
G+ +LH II+RD+K N+LLD + +++DFG+ C + KA
Sbjct: 105 IICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGM------CKENMNGEGKAST 155
Query: 676 -VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
GT YI PE D + GV+L E+L G+ F ED
Sbjct: 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP-FHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 53/220 (24%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 507 NKVGIGSFGTVYKGK---LMDGREVAVK--REESCPKTNKLREKESAFDSELALLSRVHH 561
+++G G FG V G+ M V VK R + P ++ F E+ ++H
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD------EQLLFLQEVQPYRELNH 54
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+++ +G C E LLV E+ G L ++L + + + R+A + A
Sbjct: 55 PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA---QKDVLQRMACEVAS 111
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK--AVGTV 679
G+ +LH IH D+ N L + + ++ D+GL+L + +++ TK +
Sbjct: 112 GLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLAL--EQYPEDYYITKDCHAVPL 166
Query: 680 GYIDPEYYVMNVL---------TAKTDIYGLGVVLLELLT 710
++ PE ++ + T K++I+ LGV + EL T
Sbjct: 167 RWLAPE--LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 49/229 (21%)
Query: 509 VGIGSFGTV-----------YKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLS 557
+G G+FG V Y K++ +EV + ++E + R +L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILK-KEVIIAKDEVAHTLTESR-----------VLQ 50
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHL-HNKNNTEKNSSIVNSWKMRIRIA 616
H L L Q D V EY + G L HL + +E + + I A
Sbjct: 51 NTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---YGAEIVSA 107
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
L YLH+ +++RD+K N++LD + +++DFGL C +E IS A
Sbjct: 108 LG------YLHS---CDVVYRDLKLENLMLDKDGHIKITDFGL------C-KEGISDGAT 151
Query: 677 -----GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
GT Y+ PE N D +GLGVV+ E++ G+ F N+D
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 34/222 (15%)
Query: 509 VGIGSFGTV---YKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
VG G++G+V Y +L ++VAVK+ S P + + + + EL LL + H++++
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKL-SRPFQSLIHARRTY--RELRLLKHMKHENVI 77
Query: 566 GLVGF------CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
GL+ + +E LV M GA + NN K + + + L
Sbjct: 78 GLLDVFTPATSIENFNEVYLVTNLM--GA------DLNNIVKCQKLSDEHVQFLIYQL-- 127
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
RG+ Y+H+ IIHRD+K SN+ ++ + R+ DFGL+ + D E T V T
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEM--TGYVATR 179
Query: 680 GYIDPEYYVMNVLTAKT-DIYGLGVVLLELLTGKKAVFKNED 720
Y PE + + +T DI+ +G ++ ELL G KA+F D
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG-KALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 8e-10
Identities = 64/240 (26%), Positives = 104/240 (43%), Gaps = 68/240 (28%)
Query: 503 FSLENKVGIGSFGTVYKGKLMD---GREVAVKREESCPKTNKLREKESAFDS-------- 551
+ + K+G G++G V+K +D VA+K+ FD+
Sbjct: 9 YEILQKLGKGAYGIVWKA--IDRRTKEVVALKK---------------IFDAFRNATDAQ 51
Query: 552 ----ELALLSRV-HHKHLVGLVGFCQEKDER--LLVYEYMSNGALHDHLHN---KNNTEK 601
E+ L + H ++V L+ + ++++ LV+EYM D LH N
Sbjct: 52 RTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET----D-LHAVIRAN---- 102
Query: 602 NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL-- 659
I+ R I + + Y+H+ V IHRD+K SNILL+ + +++DFGL
Sbjct: 103 ---ILEDVHKRY-IMYQLLKALKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLAR 155
Query: 660 SLL-GSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKT------DIYGLGVVLLELLTGK 712
SL E + + T V T Y PE +L T D++ +G +L E+L GK
Sbjct: 156 SLSELEENPENPVLTDYVATRWYRAPE-----ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 503 FSLENKVGIGSFGTVYKGKLMDGREV-AVKREE-SCPKTNKLREKESAFDSELALLSRVH 560
FS ++G GSFG VY + + EV A+K+ S ++N EK E+ L ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLR 73
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H + + G + LV EY G+ D L + I + A
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-------AVTHGAL 125
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
+G+ YLH++ ++IHRD+K+ NILL ++ DFG + + + + VGT
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPY 176
Query: 681 YIDPEYYVM---NVLTAKTDIYGLGVVLLELLTGKKAVF 716
++ PE + K D++ LG+ +EL K +F
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 512 GSFGTVYKGKLMDGRE-VAVKREESCPKTNK----LREK-ESAFDSELALLSRVHHKHLV 565
G++G VY + + R+ A+K K NK LR + + F E +L+ + +V
Sbjct: 12 GAYGAVYLVRHKETRQRFAMK------KINKQNLILRNQIQQVF-VERDILTFAENPFVV 64
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
+ + K +V EY+ G L KN + R+ A + ++Y
Sbjct: 65 SMFCSFETKRHLCMVMEYVEGGDCATLL-------KNIGALPVDMARMYFA-ETVLALEY 116
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG------------SECD-QEFIS 672
LHNY I+HRD+K N+L+ +++DFGLS +G E D +EF+
Sbjct: 117 LHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
+ GT YI PE + D + +G++L E L G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 50/227 (22%)
Query: 507 NKVGIGSFGTVYK------GKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+++G G++G+VYK G M +E+ ++ +ES K + EL +L +
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES---------KFNQIIMELDILHKAV 57
Query: 561 HKHLVGLVG-FCQEKDERLLVY---EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
++V G F E VY EYM G+L D L+ + + +R RI
Sbjct: 58 SPYIVDFYGAFFIEGA----VYMCMEYMDAGSL-DKLYAGGVA---TEGIPEDVLR-RIT 108
Query: 617 LDAARGIDYL---HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFI 671
+G+ +L HN IIHRD+K +N+L++ N ++ DFG+S L+ S +
Sbjct: 109 YAVVKGLKFLKEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS------L 157
Query: 672 STKAVGTVGYIDPEYYVMN------VLTAKTDIYGLGVVLLELLTGK 712
+ +G Y+ PE T ++D++ LG+ +LE+ G+
Sbjct: 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 47/220 (21%)
Query: 508 KVGIGSFGTVYKGK-LMDGREVAVK-----REESCPKTNKLREKESAFDSELALLSRVHH 561
K+G GS+ TVYKG+ + G+ VA+K EE P T +RE +LL + H
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFT-AIRE--------ASLLKDLKH 62
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++V L K LV+EY+ L K + ++ +R+ R
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYL-----DTDL--KQYMDDCGGGLSMHNVRL-FLFQLLR 114
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA----VG 677
G+ Y H ++HRD+K N+L+ +++DFGL+ S + +K V
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS------VPSKTYSNEVV 165
Query: 678 TVGYIDPEYYVMNVLTAKT------DIYGLGVVLLELLTG 711
T+ Y P+ VL T D++G+G + E+ TG
Sbjct: 166 TLWYRPPD-----VLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 508 KVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
++G G+FG VYK + +E V T E E + E+ +L+ H ++V L
Sbjct: 12 ELGDGAFGKVYKAQ---NKETGVLAAAKVIDTKSEEELED-YMVEIDILASCDHPNIVKL 67
Query: 568 V-GFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
+ F E + +L+ E+ + GA+ + I ++ + L+A ++YL
Sbjct: 68 LDAFYYENNLWILI-EFCAGGAVDAVMLELERPLTEPQI----RVVCKQTLEA---LNYL 119
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEY 686
H IIHRD+K+ NIL ++ +++DFG+S + Q S +GT ++ PE
Sbjct: 120 HE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMAPEV 174
Query: 687 YVMNV-----LTAKTDIYGLGVVLLEL 708
+ K D++ LG+ L+E+
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 508 KVGIGSFGTVYKGKLMD--GREVAVKR------EESCPKTNKLREKESAFDSELALLSRV 559
++G G++G V+K + + GR VA+KR EE P + +RE + L L
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREV-----AVLRHLETF 61
Query: 560 HHKHLVGLVGFCQ----EKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
H ++V L C +++ +L LV+E++ L +L + +
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKD------ 114
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
+ RG+D+LH++ V +HRD+K NIL+ + +++DFGL+ + S + T
Sbjct: 115 MMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTS 168
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
V T+ Y PE + + D++ +G + E+ K + D
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 58/239 (24%), Positives = 94/239 (39%), Gaps = 52/239 (21%)
Query: 489 DNFTLSELAAATNNFSLENKVGI--GSFGTVYKGKLMDGREVAVKREESCPKTNKL---- 542
+ +LSEL N + K+ + G FG V V + T KL
Sbjct: 2 MDKSLSELVQFLKNCEIVKKLKLIDGKFGKVS---------VLKHKP-----TQKLFVQK 47
Query: 543 REKESAFDSELALLSRVH-----HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKN 597
K F+ A+ VH + + + L +L+ +Y+ +G L D L +
Sbjct: 48 IIKAKNFN---AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG 104
Query: 598 --NTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARV 654
+ + I+ ++ AL+ LH + IIH DIK N+L D +
Sbjct: 105 KLSEAEVKKII----RQLVEALND------LHKHN---IIHNDIKLENVLYDRAKDRIYL 151
Query: 655 SDFGLS-LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
D+GL ++G+ + GT+ Y PE + D + +GV+ ELLTGK
Sbjct: 152 CDYGLCKIIGTPSCYD-------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 55/240 (22%)
Query: 501 NNFSLENKVGIGSFGTV-----------YKGKLMDGREVAVKREESCPKTNKLREKESAF 549
++F + +G G+FG V Y K+++ E+ + E +C + E+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR----EERNVLV 56
Query: 550 DSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSW 609
+ + ++ +H+ Q+++ LV +Y G L L
Sbjct: 57 NGDCQWITTLHYAF--------QDENYLYLVMDYYVGGDLLTLLS--------------- 93
Query: 610 KMRIRIALDAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661
K R+ D AR I +H +HRDIK N+LLD+N R++DFG S
Sbjct: 94 KFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG-SC 149
Query: 662 LGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVF 716
L D S+ AVGT YI PE M + D + LGV + E+L G+ +
Sbjct: 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 552 ELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
EL +L + ++VG G E + E+M G+L L + ++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE--------EI 104
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
++++ RG+ YL I+HRD+K SNIL++ ++ DFG+S G D +
Sbjct: 105 LGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 158
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ VGT Y+ PE + ++DI+ +G+ L+EL G+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 509 VGIGSFGTVYKGK-LMDGREVAVKREESCPKT-NKLREKESAFDSELALLSRVHHKHLVG 566
+G G+FG V+ DG+ VA+K+ P L + F EL +L H +++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKK---MPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM---RIRIAL-DAARG 622
+ Q Y+ + LH IV+ + +++ L RG
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSDLHK--------IIVSPQPLSSDHVKVFLYQILRG 115
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYI 682
+ YLH+ I+HRDIK N+L++ N ++ DFGL+ + E D+ T+ V T Y
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYR 171
Query: 683 DPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
PE +Y T+ DI+ +G + ELL +
Sbjct: 172 APEILMGSRHY-----TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 525 GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGF------CQEKDERL 578
G VAVK+ S P N+ K + EL LL V+HK+++ L+ +E +
Sbjct: 46 GINVAVKKL-SRPFQNQTHAKRAY--RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102
Query: 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRD 638
LV E M + L +H + + E+ S ++ ++M GI +LH+ IIHRD
Sbjct: 103 LVMELM-DANLCQVIHMELDHERMSYLL--YQMLC--------GIKHLHS---AGIIHRD 148
Query: 639 IKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDI 698
+K SNI++ + T ++ DFGL+ F+ T V T Y PE + DI
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVILGMGYKENVDI 205
Query: 699 YGLGVVLLELLTGKKAVFKNED 720
+ +G ++ EL+ G +F+ D
Sbjct: 206 WSVGCIMGELVKG-SVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 36/101 (35%), Positives = 60/101 (59%), Gaps = 7/101 (6%)
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
RG+ Y+H+ +++HRD+K SN+LL+ N ++ DFGL+ SE +F+ T+ V T
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-KGDFM-TEYVVTRW 173
Query: 681 YIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
Y PE + + T D++ +G + ELL G+K +F +D
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKD 213
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 544 EKESAF-DSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHN--KNNTE 600
E+++A+ SEL L+ H +V + D+ LL+ EY S G L+ + K +
Sbjct: 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP 165
Query: 601 KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660
V +I +ALD +H+ ++HRD+KS+NI L ++ DFG S
Sbjct: 166 FQEYEVGLLFYQIVLALDE------VHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFS 216
Query: 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
S+ +++ GT Y+ PE + + K D++ LGV+L ELLT
Sbjct: 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 43/199 (21%)
Query: 507 NKVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSELALLSRV 559
K+G G+FG V+K + + VA+K+ +E P T LRE + +L +
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT-ALRE--------IKILQLL 68
Query: 560 HHKHLVGLVGFCQEKDER--------LLVYEYMSNGALHD---HLHNKNNTEKNSSIVNS 608
H+++V L+ C+ K LV+E+ HD L NKN S I
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE----HDLAGLLSNKNVKFTLSEI--- 121
Query: 609 WKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSEC 666
K +++ L+ G+ Y+H I+HRD+K++NIL+ + +++DFGL+ S+
Sbjct: 122 -KKVMKMLLN---GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 667 DQEFISTKAVGTVGYIDPE 685
+ T V T+ Y PE
Sbjct: 175 SKPNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 33/151 (21%)
Query: 509 VGIGSFGTVYKGK---LMDGREVAV---------KREESCPKTNKLREKESAFDSELALL 556
+G G+F ++KG + D E+ K + ES F++ +++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNY--------SESFFEAA-SMM 53
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN-SWKMRIRI 615
S++ HKHLV G C DE ++V EY+ G+L +L +KN +++N SWK+ +
Sbjct: 54 SQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL------KKNKNLINISWKLEVAK 107
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646
L A LH + H ++ + N+LL
Sbjct: 108 QLAWA-----LHFLEDKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKE--SAFDSELALLSR 558
+++ L +VG G++G VYK + + E+A K KL + S E+ ++
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAV------KIIKLEPGDDFSLIQQEIFMVKE 62
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL- 617
H ++V G +++ + EY G+L D H V ++IA
Sbjct: 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-----------VTGPLSELQIAYV 111
Query: 618 --DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA 675
+ +G+ YLH+ +HRDIK +NILL N +++DFG++ ++ K+
Sbjct: 112 CRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA---AKITATIAKRKS 165
Query: 676 -VGTVGYIDPEYYVMNV---LTAKTDIYGLGVVLLEL 708
+GT ++ PE + DI+ +G+ +EL
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 5e-09
Identities = 61/262 (23%), Positives = 95/262 (36%), Gaps = 67/262 (25%)
Query: 503 FSLENKVGIGSFGTVY----KG-------KLMDGREVAVKREESCPKTNKLREKESAFDS 551
F +G G G V+ KG K++D +E+ K NK++ +
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI--------KRNKVKRVLT---- 50
Query: 552 ELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
E +L+ + H L L Q + LV +Y G L L + + + +
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE------ 665
+ +AL+ YLH I++RD+K NILL + +SDF LS
Sbjct: 111 EVLLALE------YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 666 ---------------------CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVV 704
+ F S VGT YI PE + + D + LG++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221
Query: 705 LLELLTG--------KKAVFKN 718
L E+L G + F N
Sbjct: 222 LYEMLYGTTPFKGSNRDETFSN 243
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 35/224 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKT-NKLREKESAFDSELALLSR 558
N+ ++G G+ G VYK + V AVK+ +T NK K D ++ L S
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQ---MRRTGNKEENKRILMDLDVVLKS- 70
Query: 559 VHH-KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
H ++V G+ + + E MS D L + I+ ++ +
Sbjct: 71 -HDCPYIVKCYGYFITDSDVFICMELMSTCL--DKLLKRIQGPIPEDILG------KMTV 121
Query: 618 DAARGIDYL---HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFIS 672
+ + YL H +IHRD+K SNILLD + ++ DFG+S L+ S+
Sbjct: 122 AIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-----K 171
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDI----YGLGVVLLELLTGK 712
T++ G Y+ PE K DI + LG+ L+EL TG+
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 36/134 (26%), Positives = 58/134 (43%), Gaps = 21/134 (15%)
Query: 614 RIALDAA--------RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665
+ +D A G+ YLH IIHRD+K+ NI ++ + D G ++
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG----AAQ 205
Query: 666 C---DQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS 722
F+ GTV PE + +K DI+ G+VL E+L +F++ S
Sbjct: 206 FPVVAPAFLGL--AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP-S 262
Query: 723 GPLDVVEFAVSQIL 736
P + V+ S +L
Sbjct: 263 TPEEYVKSCHSHLL 276
|
Length = 357 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 62/289 (21%), Positives = 128/289 (44%), Gaps = 40/289 (13%)
Query: 439 NTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAA 498
+ D +++ N +N F + R + ++ + +++
Sbjct: 3 DWPIDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINR 62
Query: 499 ATN-NFSLENKVGIGSFGTVYKGKLMDGRE-VAVKREESCPKTNKLREKESAFDSELALL 556
+ N ++ L N +G GSFG VY+ +D E VA+K+ P+ + EL ++
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---------NRELLIM 113
Query: 557 SRVHHKHLVGLVGF----CQEKDERLL----VYEYMSNGALHDHL--HNKNNTEKNSSIV 606
++H +++ L + C +K+E+ + V E++ +H ++ + +NN +V
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLV 172
Query: 607 NSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARVSDFGLS--LLG 663
+ ++ R + Y+H+ I HRD+K N+L+D N T ++ DFG + LL
Sbjct: 173 KLYSYQL------CRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTG 711
+ +I ++ Y PE + T D++ LG ++ E++ G
Sbjct: 224 GQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 552 ELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
EL +L + ++VG G E + E+M G+L L +K I
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILG 106
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
++ IA+ +G+ YL I+HRD+K SNIL++ ++ DFG+S G D +
Sbjct: 107 KVSIAV--IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 158
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ VGT Y+ PE + ++DI+ +G+ L+E+ G+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 25/111 (22%)
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFI 671
+IA+ + ++YLH + S+IHRD+K SN+L++ N ++ DFG+S L+ S
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-----VA 159
Query: 672 STKAVGTVGY-----IDPE-----YYVMNVLTAKTDIYGLGVVLLELLTGK 712
T G Y I+PE Y V K+D++ LG+ ++EL TG+
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDV------KSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 34/232 (14%)
Query: 490 NFTLSELAAATNNFSLENKVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESA 548
N T+ E+ N S VG G++G+V G VAVK+ S P + + K +
Sbjct: 9 NKTIWEVPERYQNLS---PVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY 64
Query: 549 FDSELALLSRVHHKHLVGLVGF------CQEKDERLLVYEYMSNGALHDHLHNKNNTEKN 602
EL LL + H++++GL+ +E ++ LV M GA + NN K
Sbjct: 65 --RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GA------DLNNIVKC 114
Query: 603 SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662
+ + ++ I RG+ Y+H+ IIHRD+K SN+ ++ + ++ DFGL+
Sbjct: 115 QKLTDD-HVQFLI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA-- 167
Query: 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVL--TAKTDIYGLGVVLLELLTGK 712
D E T V T Y PE ++N + DI+ +G ++ ELLTG+
Sbjct: 168 -RHTDDEM--TGYVATRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 60/252 (23%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 484 FSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYK-GKLMDGREVAVKREESCPKTNKL 542
F + L L T+ + + +G G++G VYK DG AVK + +
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK------ILDPI 58
Query: 543 REKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERL-----LVYEYMSNGALHDHLHN- 595
+ + ++E +L + +H ++V G + D+ + LV E + G++ + +
Sbjct: 59 SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL 118
Query: 596 -KNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654
+ ++++ I A G+ +LHN IIHRD+K +NILL ++
Sbjct: 119 LICGQRLDEAMISY------ILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKL 169
Query: 655 SDFGLSLLGSECDQEFISTK-----AVGTVGYIDPEYYVMN-----VLTAKTDIYGLGVV 704
DFG+S + ST+ +VGT ++ PE A+ D++ LG+
Sbjct: 170 VDFGVS-------AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222
Query: 705 LLELLTGKKAVF 716
+EL G +F
Sbjct: 223 AIELGDGDPPLF 234
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 78/283 (27%), Positives = 115/283 (40%), Gaps = 61/283 (21%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESA-FDSELALLSR 558
++F + +G G+FG V K+ + +V A+K K L+ E+A F E +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN---KWEMLKRAETACFREERDVLVN 57
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ + L Q+++ LV +Y G L L K R+ D
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLS---------------KFEDRLPED 102
Query: 619 AAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
AR ID +H +HRDIK N+LLD N R++DFG S L D
Sbjct: 103 MARFYLAEMVLAIDSVHQLGY---VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTV 158
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTA----------KTDIYGLGVVLLELLTGK-------- 712
S AVGT YI PE +L A + D + LGV + E+L G+
Sbjct: 159 QSNVAVGTPDYISPE-----ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 713 -----KAVFKNEDGSGPLDVVEF-AVSQILAGQLHCVLDKRVG 749
K + E P DV + ++ L +L C + R+G
Sbjct: 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLG 256
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 509 VGIGSFGTV---YKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
+G G+ G V Y G+ VA+K+ S P N K A+ EL L+ V+HK+++
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKL-SRPFQNVTHAKR-AY-RELVLMKLVNHKNII 78
Query: 566 GLVG-FCQEKD-----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
GL+ F +K + LV E M + L + + E+ S ++ ++M
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYLL--YQMLC------ 129
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
GI +LH+ IIHRD+K SNI++ + T ++ DFGL+ F+ T V T
Sbjct: 130 --GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTR 181
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
Y PE + DI+ +G ++ E++ G
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 62/246 (25%)
Query: 509 VGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESA--FDSELALLSRVHHKHLV 565
+G G+FG V + D G A+K+ + +++ EKE +E +L+ + +V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKL----RKSEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIALDAARGID 624
L Q+++ L+ EY+ G + L K+ TE+ + R IA + ID
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET--------RFYIA-ETILAID 115
Query: 625 YLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE----FISTKA--- 675
+H Y IHRDIK N+LLD ++SDFGL G + I + A
Sbjct: 116 SIHKLGY-----IHRDIKPDNLLLDAKGHIKLSDFGLC-TGLKKSHRTEFYRILSHALPS 169
Query: 676 ------------------------------VGTVGYIDPEYYVMNVLTAKTDIYGLGVVL 705
VGT YI PE ++ + D + LGV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 706 LELLTG 711
E+L G
Sbjct: 230 YEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 508 KVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
KVG G++G VYK K DG++ ++E + + SA E+ALL + H +++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKD---EKEYALKQIEGTGISMSAC-REIALLRELKHPNVIAL 63
Query: 568 VG-FCQEKDERL-LVYEYMSNGALHDHLH----------NKNNTEKNSSIVNSWKMRIRI 615
F D ++ L+++Y A HD H NK + S+V S +I
Sbjct: 64 QKVFLSHSDRKVWLLFDY----AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI-- 117
Query: 616 ALDAARGIDYLH-NYAVPSIIHRDIKSSNILLDVNWTAR----VSDFGLS-LLGSECDQE 669
LD GI YLH N+ ++HRD+K +NIL+ R ++D G + L S
Sbjct: 118 -LD---GIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 670 FISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGK 712
V T Y PE + T DI+ +G + ELLT +
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 66/243 (27%), Positives = 112/243 (46%), Gaps = 35/243 (14%)
Query: 483 SFSVKADNFTLSELAAAT----NNFSLENKVGIGSFGTV---YKGKLMDGREVAVKREES 535
S S + +NF E+ +T + +G G+ G V Y L R VA+K+ S
Sbjct: 2 SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKL-S 58
Query: 536 CPKTNKLREKESAFDSELALLSRVHHKHLVGLVGF------CQEKDERLLVYEYMSNGAL 589
P N+ K + EL L+ V+HK+++GL+ +E + +V E M + L
Sbjct: 59 RPFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 590 HDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649
+ + + E+ S ++ ++M GI +LH+ IIHRD+K SNI++ +
Sbjct: 116 CQVIQMELDHERMSYLL--YQMLC--------GIKHLHS---AGIIHRDLKPSNIVVKSD 162
Query: 650 WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELL 709
T ++ DFGL+ F+ T V T Y PE + DI+ +G ++ E++
Sbjct: 163 CTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
Query: 710 TGK 712
G
Sbjct: 220 KGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
+H LVGL Q + V EY++ G L H+ + + + + I +AL+
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA--RFYSAEISLALN- 110
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
YLH II+RD+K N+LLD +++D+G+ G ++ GT
Sbjct: 111 -----YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTP 160
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739
YI PE D + LGV++ E++ G+ P E + Q+
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV---- 216
Query: 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKER 777
+L+K++ P +A +L + +N + KER
Sbjct: 217 ---ILEKQIRIPRSLSVKAASVLKSF----LNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 37/220 (16%)
Query: 508 KVGIGSFGTVYKGKLMD-GREVAVKR------EESCPKTNKLREKESAFDSELALLSRVH 560
++G+G++GTVYK + G VA+K E+ P + +RE +ALL R+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP-LSTVRE--------VALLKRLE 57
Query: 561 ---HKHLVGLVGFC-----QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
H ++V L+ C + + LV+E++ L +L + + K
Sbjct: 58 AFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQD-LRTYL---DKVPPPGLPAETIKDL 113
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
+R L RG+D+LH I+HRD+K NIL+ +++DFGL+ + S C
Sbjct: 114 MRQFL---RGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMAL-- 164
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
T V T+ Y PE + + D++ +G + E+ K
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 19/155 (12%)
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H L L Q K+ V EY++ G L H+ + + + + A +
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--------YAAEII 106
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL---SLLGSECDQEFISTKAVG 677
G+ +LH+ I++RD+K NILLD + +++DFG+ ++LG F G
Sbjct: 107 CGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF-----CG 158
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
T YI PE + D + GV+L E+L G+
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 61/236 (25%), Positives = 98/236 (41%), Gaps = 54/236 (22%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKL-------------REKES 547
+F +++ VG G FG EV V RE++ T + +E S
Sbjct: 1 KDFDVKSLVGRGHFG-----------EVQVVREKA---TGDIYAMKVMKKSVLLAQETVS 46
Query: 548 AFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN 607
F+ E +LS + + L Q+KD LV EY G L L N+ + + +
Sbjct: 47 FFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQ 105
Query: 608 SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667
+ + +A+ + + Y +HRDIK N+L+D +++DFG S +
Sbjct: 106 FYLAELVLAIHSVHQMGY---------VHRDIKPENVLIDRTGHIKLADFG-SAARLTAN 155
Query: 668 QEFISTKAVGTVGYIDPEYYVMNVLTA-----------KTDIYGLGVVLLELLTGK 712
+ S VGT YI PE VLT + D + LGV+ E++ G+
Sbjct: 156 KMVNSKLPVGTPDYIAPE-----VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 37/216 (17%)
Query: 509 VGIGSFGTVYKGKLMDGREV-AVK--REES--------CPKTNKLREKESAFDSELALLS 557
+G GSFG V +L EV A+K +++ C T K LAL +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEK---------RILALAA 53
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI-A 616
+ H L L Q KD V EY++ G L + ++ R R A
Sbjct: 54 K--HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP---------RSRFYA 102
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
+ + +LH + V I+RD+K NILLD +++DFG+ G +T
Sbjct: 103 AEVTLALMFLHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFC 157
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
GT YI PE D + LGV++ E++ G+
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 33/100 (33%), Positives = 44/100 (44%), Gaps = 4/100 (4%)
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP 684
YLH IIHRD+K+ NI LD A + DFG + GT+ P
Sbjct: 200 YLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSP 256
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGKKAVF-KNEDGSG 723
E ++ AKTDI+ G+VL E+ +F K S
Sbjct: 257 ELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296
|
Length = 392 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 44/243 (18%)
Query: 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD-S 551
+ +L ++ + +G G+FG V + R+V + S K ++ +SAF
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWE 92
Query: 552 ELALLSRVHHKHLVGLVGFCQEKDERLL--VYEYMSNGALHDHLHNKNNTEKNSSIVNSW 609
E +++ + +V L F +D+R L V EYM G L + + N + EK + +
Sbjct: 93 ERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF---Y 147
Query: 610 KMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE---- 665
+ +ALDA + + IHRD+K N+LLD + +++DFG + ++
Sbjct: 148 TAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 666 -CDQEFISTKAVGTVGYIDPE---------YYVMNVLTAKTDIYGLGVVLLELLTGKKAV 715
CD AVGT YI PE YY + D + +GV L E+L G
Sbjct: 199 RCD------TAVGTPDYISPEVLKSQGGDGYY-----GRECDWWSVGVFLYEMLVGDTPF 247
Query: 716 FKN 718
+ +
Sbjct: 248 YAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE-VAVKREESCPKTNKLREKESAFDSELALLSRV 559
N F + VG G++G V K + + +E VA+K+ + + +++E EL +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTL---RELKMLRTL 57
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALH--DHLHNKNNTEKNSSIVNSWKMRIRIAL 617
+++V L + + + LV+EY+ L + + N EK S +
Sbjct: 58 KQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI----------Y 107
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE-CDQEFISTKAV 676
+ I + H I+HRDIK N+L+ N ++ DFG + SE + + T+ V
Sbjct: 108 QLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY--TEYV 162
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
T Y PE + D++ +G +L EL G+
Sbjct: 163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 509 VGIGSFGTVYKGKLMDGRE----VAVKREESCPKTNKLR-EKESAF-DSELALLSRVHHK 562
+G G +G V++ + + G + A+K K +R +K++A +E +L V H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMK---VLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARG 622
+V L+ Q + L+ EY+S G L HL + ++++ + I +AL+
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF--YLSEISLALE---- 114
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV-----G 677
+LH II+RD+K NILLD +++DFGL C +E I V G
Sbjct: 115 --HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGL------C-KESIHEGTVTHTFCG 162
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
T+ Y+ PE + + D + LG ++ ++LTG
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 22/153 (14%)
Query: 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV 631
Q D V EY++ G L + ++ ++ + ++ I G+ +LH+
Sbjct: 71 QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI--------GLFFLHS--- 119
Query: 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF---ISTKA-VGTVGYIDPEYY 687
II+RD+K N++LD +++DFG+ C + ++TK GT YI PE
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM------CKENMWDGVTTKTFCGTPDYIAPEII 173
Query: 688 VMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
D + GV+L E+L G +A F+ ED
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAG-QAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 73/260 (28%), Positives = 111/260 (42%), Gaps = 41/260 (15%)
Query: 509 VGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKE-SAFDSELALLSRVH-HKHLV 565
+G GSFG V +L GR AVK K L++ + +E +LS H L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVK---VLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI-ALDAARGID 624
L Q D V E+++ G L H+ ++ R R A + +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---------RARFYAAEITSALM 110
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP 684
+LH+ II+RD+K N+LLD +++DFG+ G + + ST GT YI P
Sbjct: 111 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI-FNGKTTST-FCGTPDYIAP 165
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGKKAVF--KNEDGSGPLDVVEFAVSQILAGQLHC 742
E + D + +GV+L E+L G A F +NED D+ E
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG-HAPFEAENED-----DLFE------------A 207
Query: 743 VLDKRVGPPELNEAEAVELL 762
+L+ V P +AV++L
Sbjct: 208 ILNDEVVYPTWLSQDAVDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL---LGSECDQEFISTKAVG 677
G+ Y+H+ V +HRD+K N+L++ + ++ DFGL+ + F+ T+ V
Sbjct: 116 CGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVA 171
Query: 678 TVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGKKAVFKNED 720
T Y PE + T D++ +G +L ELL G+K VFK +D
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKD 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 66/229 (28%), Positives = 100/229 (43%), Gaps = 47/229 (20%)
Query: 508 KVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDS-----ELALLSRVHHK 562
KVG G++G VYK K DG++ + L++ E S E+ALL + H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKD---------DRDYALKQIEGTGISMSACREIALLRELKHP 58
Query: 563 HLVGLVG-FCQEKDERL-LVYEYMSNGALHDHLH----------NKNNTEKNSSIVNSWK 610
+++ L F D ++ L+++Y A HD H NK + +V S
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDY----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 611 MRIRIALDAARGIDYLH-NYAVPSIIHRDIKSSNILLDVNWTAR----VSDFGLS-LLGS 664
+I LD GI YLH N+ ++HRD+K +NIL+ R ++D G + L S
Sbjct: 115 YQI---LD---GIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 665 ECDQEFISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGK 712
V T Y PE + T DI+ +G + ELLT +
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-08
Identities = 63/306 (20%), Positives = 120/306 (39%), Gaps = 44/306 (14%)
Query: 427 HKRINSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSV 486
H+ + P+ SN D + A DG S + +S + ++ V
Sbjct: 80 HRALEDAAPAGELLVPRSNADLFASAGDGP------SGAEDSDASHLDFDEAPPDAAGPV 133
Query: 487 KADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKR------EESCPKTN 540
L +F + + + G+FG ++ L E A R + PK
Sbjct: 134 PLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCE 193
Query: 541 KLREK--------ESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV--------YEYM 584
+L K ++E+ L R++H++++ + + + ++ Y +M
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM 253
Query: 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNI 644
+ A K+ ++ + R I ++Y+H+ +IHRDIK NI
Sbjct: 254 YDEAFD---------WKDRPLL--KQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENI 298
Query: 645 LLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVV 704
L+ + + DFG + + E ++E VGTV PE + TDI+ G++
Sbjct: 299 FLNCDGKIVLGDFG-TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLI 357
Query: 705 LLELLT 710
LL++L+
Sbjct: 358 LLDMLS 363
|
Length = 501 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 63/251 (25%), Positives = 101/251 (40%), Gaps = 50/251 (19%)
Query: 548 AFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN 607
AF +L+S++ HKHLV L G C +DE ++V EY+ G L LH + N ++
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKN-----NVSL 100
Query: 608 SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWT----ARVSDFG-- 658
WK+ + L A + YL + ++H ++ NIL+ +N ++SD G
Sbjct: 101 HWKLDVAKQL--ASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155
Query: 659 LSLLGSECDQEFISTKAVGTVGYIDPEYY--VMNVLTAKTDIYGLGVVLLELLTGKKAVF 716
+++L E E I +I PE LT D + G LLE+ + +
Sbjct: 156 ITVLSREERVERIP--------WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL 207
Query: 717 KNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKE 776
S + Q L P + AE LA C + +
Sbjct: 208 STLSSS----------EKERFYQDQHRL------PMPDCAE----LANLINQCWTYDPTK 247
Query: 777 RPNITDIVANL 787
RP+ I+ +L
Sbjct: 248 RPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 495 ELAAATNNFSLENKVGIGSFGTVYKG--KLMDGRE--VAVKR-EESCPKTNKLREKESAF 549
EL + +E +G G FG + +G KL RE VA+ C + F
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRR-----GF 53
Query: 550 DSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSW 609
+E L + H ++V L G + ++V EYMSNGAL L + +V
Sbjct: 54 LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR-----KHEGQLVAGQ 108
Query: 610 KMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE 669
M + L A G+ YL + +H+ + + +L++ + ++S F E E
Sbjct: 109 LMGMLPGL--ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSE 160
Query: 670 FISTKAVG--TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
I T G V + PE + ++ +D++ G+V+ E+++
Sbjct: 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 49/174 (28%), Positives = 72/174 (41%), Gaps = 28/174 (16%)
Query: 553 LALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
LAL + L L Q D V EY++ G L H+ V +K
Sbjct: 54 LALPGKPPF--LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ----------QVGKFKEP 101
Query: 613 IRI--ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
+ A + A G+ +LH+ II+RD+K N++LD +++DFG+ C +
Sbjct: 102 HAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM------CKENI 152
Query: 671 ISTKAV----GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
K GT YI PE D + GV+L E+L G + F ED
Sbjct: 153 FGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG-QPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 45/225 (20%)
Query: 508 KVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSELALLSRVH 560
K+G G++G VYK + G+ VA+K+ EE P T LRE S L +LS
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPT-ALREI-----SLLQMLS--E 59
Query: 561 HKHLVGL--VGFCQEKDERL---LVYEYMSNG--ALHDHLHNKNNTEKNSSIVNSWKMRI 613
++V L V +EK+ + LV+EY+ + D + + S+ ++
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD-VNWTARVSDFGLSLLGSECDQEFIS 672
G+ + H + V +HRD+K N+L+D +++D GL S + +
Sbjct: 120 LK------GVAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY-- 168
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKT------DIYGLGVVLLELLTG 711
T + T+ Y PE VL T DI+ +G + E+
Sbjct: 169 THEIVTLWYRAPE-----VLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 16/150 (10%)
Query: 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV 631
Q D V EY++ G L H+ ++ ++ A + + G+ +LH
Sbjct: 71 QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF--------YAAEISVGLFFLHRRG- 121
Query: 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-VGTVGYIDPEYYVMN 690
II+RD+K N++LD +++DFG+ E + ++T+ GT YI PE
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMC---KEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 691 VLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
D + GV+L E+L G+ F ED
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPP-FDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 4/106 (3%)
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
R I YLH IIHRDIK+ NI ++ + DFG + + + A GT+
Sbjct: 193 RAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIA 248
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726
PE + DI+ G+VL E+ T ++F+ + G D
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294
|
Length = 391 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 45/154 (29%), Positives = 67/154 (43%), Gaps = 18/154 (11%)
Query: 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARG 622
++V L + +D LV ++ G L H+ N + V W + +ALDA
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEE--CVKRWAAEMVVALDA--- 100
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG-LSLLGSECDQEFISTKAVGTVGY 681
LH I+ RD+ +NILLD +++ F S + CD E + Y
Sbjct: 101 ---LHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------Y 148
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAV 715
PE ++ T D + LG +L ELLTGK V
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI 623
LVGL Q LV EY++ G L H+ + + + + I IAL+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA--RFYAAEICIALN----- 110
Query: 624 DYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYID 683
+LH II+RD+K N+LLD + +++D+G+ G ++ GT YI
Sbjct: 111 -FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIA 164
Query: 684 PEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
PE D + LGV++ E++ G+
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 28/156 (17%)
Query: 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR---GIDYLHN 628
Q K+ V E+++ G L H+ +K + R AA G+ +LH+
Sbjct: 66 QTKEHLFFVMEFLNGGDLMFHIQDKGRFD-----------LYRATFYAAEIVCGLQFLHS 114
Query: 629 YAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI----STKAVGTVGYIDP 684
II+RD+K N++LD + +++DFG+ C + ++ GT YI P
Sbjct: 115 ---KGIIYRDLKLDNVMLDRDGHIKIADFGM------CKENVFGDNRASTFCGTPDYIAP 165
Query: 685 EYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
E T D + GV+L E+L G+ F +D
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSP-FHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 509 VGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
VG G++G+V G +VA+K+ S P +++ K A+ EL LL + H++++GL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKR-AY-RELTLLKHMQHENVIGL 79
Query: 568 VGF------CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+ E + LV YM L + + + +K +V ++M
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTD-LQKIMGHPLSEDKVQYLV--YQM--------LC 128
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
G+ Y+H+ IIHRD+K N+ ++ + ++ DFGL+ D E T V T Y
Sbjct: 129 GLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RHADAEM--TGYVVTRWY 180
Query: 682 IDPEYYVMNVL--TAKTDIYGLGVVLLELLTGKKAVFKNED 720
PE ++N + DI+ +G ++ E+LTG K +FK +D
Sbjct: 181 RAPE-VILNWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKD 219
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 66/245 (26%), Positives = 113/245 (46%), Gaps = 34/245 (13%)
Query: 484 FSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKG--KLMDGREVAVKREESCPKTNK 541
+SV+ + T + L N +G G+ G V ++D R VA+K+ S P N+
Sbjct: 4 YSVEVGDSTFTVLKRYQN----LKPIGSGAQGIVCAAYDAVLD-RNVAIKKL-SRPFQNQ 57
Query: 542 LREKESAFDSELALLSRVHHKHLVGLVGF------CQEKDERLLVYEYMSNGALHDHLHN 595
K + EL L+ V+HK+++ L+ +E + LV E M + L +
Sbjct: 58 THAKRAY--RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM 114
Query: 596 KNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655
+ + E+ S ++ ++M GI +LH+ IIHRD+K SNI++ + T ++
Sbjct: 115 ELDHERMSYLL--YQMLC--------GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 161
Query: 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAV 715
DFGL+ F+ T V T Y PE + DI+ +G ++ E++ K +
Sbjct: 162 DFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKIL 217
Query: 716 FKNED 720
F D
Sbjct: 218 FPGRD 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 508 KVGIGSFGTVYKGKLMDG---REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL 564
++G G FG V G++ G +V VK + + +++ F E + H +L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKEL----RVSASVQEQMKFLEEAQPYRSLQHSNL 57
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGID 624
+ +G C E LLV E+ G L +L + E + R+A + A G+
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE---LMTPDPTTLQRMACEIALGLL 114
Query: 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP 684
+LH + IH D+ N LL + T ++ D+GLS + D + + +I P
Sbjct: 115 HLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171
Query: 685 EY-------YVMNVLTAKTDIYGLGVVLLELL 709
E ++ T +++++ LGV + EL
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 64/270 (23%), Positives = 106/270 (39%), Gaps = 74/270 (27%)
Query: 505 LENKVGIGSFGTVYK------GKLMDGREVAVK--REESCPKTNKLREKESAFDSELALL 556
L +G G+FG V + K R VAVK +E + K A +EL +L
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYK------ALMTELKIL 64
Query: 557 SRV-HHKHLVGLVGFCQEKDERLLV-YEYMSNGALHDHLHNKNN---------------- 598
+ HH ++V L+G C + L+V EY G L ++L +K
Sbjct: 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMK 124
Query: 599 ------------TEKNSSIVNSWKMR-------------------------IRIALDAAR 621
+ SS + + I + AR
Sbjct: 125 QKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVAR 184
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI-STKAVGTVG 680
G+++L A IHRD+ + NILL N ++ DFGL+ + D +++ A +
Sbjct: 185 GMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARLPLK 240
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
++ PE V T ++D++ GV+L E+ +
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 508 KVGIGSFGTVYKGKLMDGREVA--VKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
++G G FG V ++ VA V +E K N ++++ F + + H +++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKEL---KANASSKEQNEFLQQGDPYRILQHPNIL 58
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
+G C E LLV+EY G L +L + +NS ++ +M A + A G+ +
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM----ACEIAAGVTH 114
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIST--KAVGTVGYID 683
+H + + +H D+ N L + T +V D+G+ S +++I T + ++
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGP--SRYKEDYIETEDDKCVPLRWLA 169
Query: 684 PEY---YVMNVLTAK----TDIYGLGVVLLELL 709
PE + ++TA+ ++++ LGV L EL
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 75/308 (24%), Positives = 129/308 (41%), Gaps = 66/308 (21%)
Query: 500 TNNFSLENKVGIGSFGTVYK-GKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
++ + + +G G++G V+K +G + AVK + P + E E+ ++ AL
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKALSD- 73
Query: 559 VHHKHLVGLVGFCQEKDER-----LLVYEYMSNGALHDHLHN--KNNTEKNSSIVNSWKM 611
H ++V G +KD + LV E + G++ D + K I+
Sbjct: 74 --HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII----- 126
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
I +A G+ +LH IHRD+K +NILL ++ DFG+S +
Sbjct: 127 -AYILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVS-------AQLT 175
Query: 672 STK-----AVGTVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG 721
ST+ +VGT ++ PE + A+ D++ LG+ +EL DG
Sbjct: 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL----------GDG 225
Query: 722 SGPLDVVEFAVSQILAGQLHCV--LDK--RVGPPELNEAEAVELLATTAIH-CVNLEGKE 776
PL LH + L K R PP L++ E I C+ + ++
Sbjct: 226 DPPL------------ADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEK 273
Query: 777 RPNITDIV 784
RP ++D++
Sbjct: 274 RPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 23/168 (13%)
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H LVGL Q + V E++S G L H+ + + + + I +AL+
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHA--RFYSAEISLALN-- 110
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
+LH II+RD+K N+LLD +++D+G+ G + ST GT
Sbjct: 111 ----FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTST-FCGTPN 161
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728
YI PE D + LGV++ E++ G+ P D+V
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS----------PFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 57/247 (23%)
Query: 509 VGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESA-FDSELALLSRVHHKHLVG 566
+GIG+FG V + +D + A+K K + L ++A +E +L+ ++ +V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLR---KADVLMRNQAAHVKAERDILAEADNEWVVK 65
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
L Q+KD V +Y+ G + L E++ + R IA + I+ +
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-------RFYIA-ELTCAIESV 117
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL--------------------------- 659
H IHRDIK NIL+D + +++DFGL
Sbjct: 118 HKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 660 SLLGSECDQEFISTKA--------------VGTVGYIDPEYYVMNVLTAKTDIYGLGVVL 705
+ VGT YI PE + T D + +GV+L
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234
Query: 706 LELLTGK 712
E+L G+
Sbjct: 235 YEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 55/238 (23%), Positives = 90/238 (37%), Gaps = 49/238 (20%)
Query: 509 VGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESA--FDSELALLSRVHHKHLVG 566
+G G+FG V +L+ ++ + + EKE +E +L +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK 65
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL 626
+ Q+K L+ E++ G + L K+ + + + IA + ID +
Sbjct: 66 MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEET-------QFYIA-ETVLAIDSI 117
Query: 627 HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL-------------LGSECDQEF--- 670
H IHRDIK N+LLD ++SDFGL L +F
Sbjct: 118 HQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 671 -----------------ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
++ VGT YI PE ++ D + LGV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 56/247 (22%), Positives = 93/247 (37%), Gaps = 51/247 (20%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESA--FDSELALLSR 558
++F +G G+FG V +L+ ++ + + EKE +E +L
Sbjct: 1 DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIAL 617
+V + Q+K L+ E++ G + L K+ +E+ + +
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA--------- 108
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL-LGSECDQEF------ 670
+ ID +H IHRDIK N+LLD ++SDFGL L EF
Sbjct: 109 ETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165
Query: 671 --------------------------ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVV 704
++ VGT YI PE ++ D + LGV+
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 705 LLELLTG 711
+ E+L G
Sbjct: 226 MYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 16/160 (10%)
Query: 503 FSLENKVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNK-LREKESAFDSELALLSRVH 560
F + + G+FG VY G K + + AVK + NK + + A LAL S+
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL-SK-- 62
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
+V L Q + LV EY+ G + LH ++ +M ++ + A
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKYISEVA 114
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660
+DYLH + IIHRD+K N+L+ +++DFGLS
Sbjct: 115 LALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG-SECDQEFISTKAVGTV 679
R + Y+H V HRD+K NIL + + ++ DFGL+ + ++ T V T
Sbjct: 114 RALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 680 GYIDPEY--YVMNVLTAKTDIYGLGVVLLELLTGK 712
Y PE + T DI+ +G + E+LTGK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 26/210 (12%)
Query: 512 GSFGTVYKGKLMDGREVAVKRE--ESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVG 569
+ K K VAVK+ +SC K E E+ ++ H +++ V
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSK-----EDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 570 FCQEKDERLLVYEYMSNGALHDHLHNK-NNTEKNSSIVNSWKMRIRIALDAARGIDYLHN 628
E +V M+ G+ D L +I I D +DY+H+
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-------ILKDVLNALDYIHS 119
Query: 629 YAVPSIIHRDIKSSNILLDVNWTARVSDF--GLSLLGSECDQEFI---STKAVGTVGYID 683
IHR +K+S+ILL + +S +S++ Q + +V + ++
Sbjct: 120 KG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 684 PEYYVMNVL--TAKTDIYGLGVVLLELLTG 711
PE N+ K+DIY +G+ EL G
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 48/250 (19%)
Query: 548 AFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN 607
AF +L+S+V H HL + G C E ++V E++ +G L L ++ +
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-----KEKGRVPV 116
Query: 608 SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA-------RVSDFGLS 660
+WK+ +A A + YL + +++H ++ + NILL A ++SD G+S
Sbjct: 117 AWKI--TVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171
Query: 661 L--LGSECDQEFISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFK 717
L E + V + +I PE N L+ D + G LLE+
Sbjct: 172 FTALSRE--------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF------- 216
Query: 718 NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKER 777
DG PL + + + +K+ PE + E LAT C+ E +R
Sbjct: 217 --DGEVPLK------ERTPSEKER-FYEKKHRLPEPSCKE----LATLISQCLTYEPTQR 263
Query: 778 PNITDIVANL 787
P+ I+ +L
Sbjct: 264 PSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 60/276 (21%), Positives = 93/276 (33%), Gaps = 105/276 (38%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMD-----GREVAVKR---------------EESCPKTNK 541
+F L K+G G+FG VYK L++ + +K+ +CP
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPN--- 189
Query: 542 LREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKN---N 598
S D L V K ++DE LV+ Y L D + +K N
Sbjct: 190 -----SCADFVYGFLEPVSSK----------KEDEYWLVWRYEGESTLADLMQSKEFPYN 234
Query: 599 TE---------------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSN 643
E + + I+ + +I ALD I+HRD+K N
Sbjct: 235 VEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---------GIVHRDVKPQN 285
Query: 644 ILLDVNWTARVSDFGLSLLGSECD---------QEFISTKAVGTVGYIDPEYYVMN---- 690
I+ F + LG+ D +EF+ Y PE Y+M+
Sbjct: 286 IIFS----EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPR-----YAAPEQYIMSTQTP 336
Query: 691 ------VLTA------------KTDIYGLGVVLLEL 708
V TA + DIY G++ L++
Sbjct: 337 SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 37/146 (25%), Positives = 66/146 (45%), Gaps = 18/146 (12%)
Query: 509 VGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKL-----REKESAFDSELALLSRVH 560
+G G+ +Y G L D + E+ K+ R+ AF +++ +V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
HKH+V L G C E ++V E++ G L +H K++ + WK ++A A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV-----LTTPWKF--KVAKQLA 115
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILL 646
+ YL + ++H ++ + NILL
Sbjct: 116 SALSYLED---KDLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 68/300 (22%), Positives = 114/300 (38%), Gaps = 72/300 (24%)
Query: 509 VGIGSFGTVYKGKLMDGREVAVKREESCPKTNKL-REKESAFDSELALLSRVHHKHLVGL 567
+GIG+FG V +D A+ ++ K + L R + + +E +L+ ++ +V L
Sbjct: 9 LGIGAFGEVCLACKVDTH--ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH 627
Q+KD V +Y+ G + L + R IA + I+ +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL-------IRMEVFPEVLARFYIA-ELTLAIESVH 118
Query: 628 NYAVPSIIHRDIKSSNILLDVNWTARVSDFGL----------------------SLLGSE 665
IHRDIK NIL+D++ +++DFGL S+ S+
Sbjct: 119 KMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 666 -------C----------------DQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLG 702
C Q ++ VGT YI PE + T D + +G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 703 VVLLELLTGKKAVFKNEDGSGPLDVVEFA-----VSQI--------LAGQLHCVLDKRVG 749
V+L E+L G+ L V+ + Q+ L +L C ++R+G
Sbjct: 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLG 295
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 59/288 (20%), Positives = 106/288 (36%), Gaps = 65/288 (22%)
Query: 509 VGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567
+GIG+FG V + +D + + A+K K LR + + +E +L+ ++ +V L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRK--KDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH 627
Q+KD V +Y+ G + L + + + + A+++ + +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE--DLARFYIAELTCAVESVHKMGF-- 122
Query: 628 NYAVPSIIHRDIKSSNILLDVNWTARVSDFG----------------------------- 658
IHRDIK NIL+D + +++DFG
Sbjct: 123 -------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 659 ----------------LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLG 702
L + Q ++ VGT YI PE + T D + +G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 703 VVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGP 750
V+L E+L G+ + V+ + S LH ++ P
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTS------LHIPPQAKLSP 277
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 26/95 (27%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARVSDFGLS-LLGSECDQEFISTKAVGT 678
RG+ Y+H+ V +HRD+K +N+ ++ + ++ DFGL+ ++ + ++ + T
Sbjct: 125 RGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 679 VGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGK 712
Y P + N T D++ G + E+LTGK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 22/170 (12%)
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIST-K 674
+ ARG+++L A IHRD+ + NILL N ++ DFGL+ + D +++
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGS 235
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734
A + ++ PE V T ++D++ GV+L E+ + G+ P V+ +++
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LGASPYPGVQ--INE 284
Query: 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784
+L R+ PE E ++ + C + KERP + +V
Sbjct: 285 EFCQRLKD--GTRMRAPENATPEIYRIM----LACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 42/175 (24%), Positives = 81/175 (46%), Gaps = 26/175 (14%)
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIST-K 674
+ A+G+++L A IHRD+ + NILL N ++ DFGL+ + D +++
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGD 240
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734
A + ++ PE V T ++D++ GV+L E+ + G+ P V+
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGVK----- 286
Query: 735 ILAGQLHCVLDK--RVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787
+ + L + R+ P+ E + T + C + E +RP +++V +L
Sbjct: 287 -IDEEFCRRLKEGTRMRAPDYTTPEMYQ----TMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 501 NNFSLENKVGIGSFGTVYK------GKLMDGREVAVKREESCPKTNKLREKESAFDSELA 554
+N +G G+FG V + GK + VAVK ++ T+ E+E A SEL
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD---ERE-ALMSELK 93
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNT 599
+LS + HK++V L+G C L++ EY G L + L K T
Sbjct: 94 ILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAET 139
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 34/116 (29%), Positives = 48/116 (41%), Gaps = 11/116 (9%)
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYI 682
IDY+H IIHRDIK+ N+L++ + DFG + GTV
Sbjct: 273 IDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 683 DPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFK--NEDGSGPLDVVEFAVSQIL 736
PE + T DI+ G+V+ E ++F D P D +QIL
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD------AQIL 379
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 42/173 (24%), Positives = 84/173 (48%), Gaps = 27/173 (15%)
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG-T 678
ARG+++L A + +HRD+ + N+LL ++ DFGL+ D ++S +
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLA-RDIMHDSNYVSKGSTFLP 302
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV-SQILA 737
V ++ PE N+ T +D++ G++L E+ + + P +V+ ++I +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY-------PGMIVDSTFYNKIKS 355
Query: 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN---ITDIVANL 787
G R+ P+ E +++ + C N E ++RP+ ++DIV +L
Sbjct: 356 GY-------RMAKPDHATQEVYDIM----VKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 59/259 (22%), Positives = 97/259 (37%), Gaps = 63/259 (24%)
Query: 501 NNFSLENKVGIGSFGTV-YKGKLMDGREVAVKREESCPKTNKLREKESA-FDSELALLSR 558
+F +G G+FG V K G+ A+K + K+ ++ + A +E +L+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK---TLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM-RIRIAL 617
+V L Q+ L+ E++ G L L + S V + M +A+
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML---IKYDTFSEDVTRFYMAECVLAI 114
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--------------LLG 663
+A + + IHRDIK NIL+D ++SDFGLS LL
Sbjct: 115 EAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 664 SECDQEFISTK-------------------------------AVGTVGYIDPEYYVMNVL 692
+ ++ I + VGT YI PE ++
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
Query: 693 TAKTDIYGLGVVLLELLTG 711
+ D + LG ++ E L G
Sbjct: 226 GQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 62/256 (24%), Positives = 106/256 (41%), Gaps = 52/256 (20%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKE-SAFDSELALLSRV 559
N + + K+G G FG V+ K +E + S L+E+E S E+ ++ +
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAIS---YRGLKEREKSQLVIEVNVMREL 69
Query: 560 HHKHLVGLVG-FCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA- 616
HK++V + F + +++L ++ E+ G L + +I +KM +I
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDL------------SRNIQKCYKMFGKIEE 117
Query: 617 ---LDAAR----GIDYLHNYAV----PSIIHRDIKSSNILLDVNW--------------- 650
+D R + Y HN ++HRD+K NI L
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 651 --TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLT--AKTDIYGLGVVLL 706
A++ DFGLS E ++ VGT Y PE + + K+D++ LG ++
Sbjct: 178 RPIAKIGDFGLS---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 707 ELLTGKKAVFKNEDGS 722
EL +GK K + S
Sbjct: 235 ELCSGKTPFHKANNFS 250
|
Length = 1021 |
| >gnl|CDD|205718 pfam13540, RCC1_2, Regulator of chromosome condensation (RCC1) repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 5e-04
Identities = 11/29 (37%), Positives = 16/29 (55%)
Query: 207 VGLVAGESHACGLSRNGALVCKGSNDSGQ 235
V + AG+ H L+ +G + C G N GQ
Sbjct: 2 VSIAAGDYHTLALTSDGTVYCWGDNSYGQ 30
|
Length = 30 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 26/175 (14%)
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
A+G+ +L A + IHRD+ + NILL ++ DFGL+ + A V
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP---LDVVEFAVSQIL 736
++ PE V T ++D++ G++L E+ + GS P + V I
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---------LGSSPYPGMPVDSKFYKMIK 331
Query: 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791
G R+ PE +E +++ + C + + +RP IV +E+ L
Sbjct: 332 EGY-------RMLSPECAPSEMYDIMKS----CWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|227511 COG5184, ATS1, Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 53/275 (19%), Positives = 85/275 (30%), Gaps = 57/275 (20%)
Query: 133 EVNSGVVKCWR---GTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWG 189
+ N + T K G + S L+ + G + IL ++ V+ WG
Sbjct: 147 QNNDIIDFDDYELESTPFKVPGGSSAKSH----LRVVKLACGWEISV-ILTADGRVYSWG 201
Query: 190 DSGIADEIQRGFKN---------------LSMVGLVAGESHACGLSRNGALVCKGSNDSG 234
+ Q +KN ++V L AG H L+ G + GSN G
Sbjct: 202 TFRCGELGQGSYKNSQKTSIQFTPLKVPKKAIVQLAAGADHLIALTNEGKVYGWGSNQKG 261
Query: 235 QLNVPFSSAFEFSGGL------------ALGANFTCAIRQRSGLVACWGGTNRF-----E 277
QL P S + + A G + + A+ + G + WG N F
Sbjct: 262 QLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDHSLALDE-DGEIYAWGV-NIFGQLGAG 319
Query: 278 FDSDVIQDVSFESIVAGLDFVCGLTTRNLSMICWGPGWSNKPHL-ERGLPLPLG-----Q 331
D ++ + + L V + I G S+ L + G G Q
Sbjct: 320 SDGEIGALTTKPNYKQLLSGVT------ICSISA--GESHSLILRKDGTLYAFGRGDRGQ 371
Query: 332 VLPGPCVESSCITCGVYPNSESLC-VGSGNVCNPC 365
+ + T + L V G N
Sbjct: 372 LGIQEEITIDVSTPTKLSVAIKLEQVACGTHHNIA 406
|
Length = 476 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 31/115 (26%), Positives = 47/115 (40%), Gaps = 23/115 (20%)
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA----------------RVSDF 657
+I +DY H ++H D+K NIL++ + T R+ D
Sbjct: 235 QIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD- 291
Query: 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
LG CD+ T V T Y PE + TD++ +G ++ EL TGK
Sbjct: 292 ----LGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 812 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| COG5184 | 476 | ATS1 Alpha-tubulin suppressor and related RCC1 dom | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| COG5184 | 476 | ATS1 Alpha-tubulin suppressor and related RCC1 dom | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1427 | 443 | consensus Uncharacterized conserved protein, conta | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1427 | 443 | consensus Uncharacterized conserved protein, conta | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| KOG1428 | 3738 | consensus Inhibitor of type V adenylyl cyclases/Ne | 99.49 | |
| KOG0783 | 1267 | consensus Uncharacterized conserved protein, conta | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG0783 | 1267 | consensus Uncharacterized conserved protein, conta | 99.42 | |
| KOG1428 | 3738 | consensus Inhibitor of type V adenylyl cyclases/Ne | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| PF13540 | 30 | RCC1_2: Regulator of chromosome condensation (RCC1 | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| PF13540 | 30 | RCC1_2: Regulator of chromosome condensation (RCC1 | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| PF00415 | 51 | RCC1: Regulator of chromosome condensation (RCC1) | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.45 | |
| PF00415 | 51 | RCC1: Regulator of chromosome condensation (RCC1) | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.26 | |
| KOG0941 | 850 | consensus E3 ubiquitin protein ligase [Posttransla | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.15 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.12 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.06 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| KOG0941 | 850 | consensus E3 ubiquitin protein ligase [Posttransla | 97.99 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.98 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.91 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.83 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.78 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.72 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.63 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.58 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.45 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.38 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.25 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.23 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.16 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.14 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.12 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.06 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.01 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.87 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.69 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.57 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.41 | |
| PLN02236 | 344 | choline kinase | 96.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.1 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=455.78 Aligned_cols=293 Identities=48% Similarity=0.774 Sum_probs=251.2
Q ss_pred cCCCCCHHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceE
Q 042346 487 KADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566 (812)
Q Consensus 487 ~~~~~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~ 566 (812)
....|++.|+..++++|...++||+|+||.||+|.+.+++.||||++....... ..+|.+|++++.+++|||||+
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-----~~eF~~Ei~~ls~l~H~Nlv~ 135 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-----EREFLNEVEILSRLRHPNLVK 135 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-----hhHHHHHHHHHhcCCCcCccc
Confidence 456799999999999999999999999999999999999999999876422111 345999999999999999999
Q ss_pred EEEEEEeCC-eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEE
Q 042346 567 LVGFCQEKD-ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645 (812)
Q Consensus 567 l~~~~~~~~-~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 645 (812)
|+|||.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+...|+||||||||+|||
T Consensus 136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL 209 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL 209 (361)
T ss_pred EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence 999999999 499999999999999999875532 4599999999999999999999998889999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCccccccccc-ccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 042346 646 LDVNWTARVSDFGLSLLGSECDQEFISTKA-VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP 724 (812)
Q Consensus 646 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~ 724 (812)
||+++++||+|||+++..... .. ..... .||.+|+|||++..+..+.|+|||||||+|+||+||+++..... ....
T Consensus 210 LD~~~~aKlsDFGLa~~~~~~-~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~ 286 (361)
T KOG1187|consen 210 LDEDFNAKLSDFGLAKLGPEG-DT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGE 286 (361)
T ss_pred ECCCCCEEccCccCcccCCcc-cc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-Cccc
Confidence 999999999999999665431 11 11122 89999999999999999999999999999999999998876543 2344
Q ss_pred chhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 725 LDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
..+++|++..+.++.+.+++|+++........+....+.+++.+|++.+|.+||+|.||++.|+.+...
T Consensus 287 ~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 287 LSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 458999999999999999999998743333335666788999999999999999999999999766544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=405.23 Aligned_cols=265 Identities=37% Similarity=0.545 Sum_probs=214.1
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-eEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD-ERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~lV~ 581 (812)
+.+.+.||+|+||+||+|.++....||||++......... .+.|.+|+.+|.+++|||||+|+|++.+.. ...+||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 4455679999999999999954444999998754333222 778999999999999999999999999987 789999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC-cEEEEeeccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW-TARVSDFGLS 660 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DfGla 660 (812)
||+++|+|.++|+... ...+++..+++++.|||+||.|||+++ | ||||||||+|||++.++ ++||+|||++
T Consensus 120 Ey~~~GsL~~~l~~~~------~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKR------KRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred EeCCCCcHHHHHhhcc------cCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCccc
Confidence 9999999999998751 123488999999999999999999998 3 99999999999999997 9999999999
Q ss_pred ccCCCCcccccccccccCCCccCccccc--cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYV--MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+...... ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||..... ..+. ......+
T Consensus 192 r~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~---~~v~~~~ 262 (362)
T KOG0192|consen 192 REKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVA---SAVVVGG 262 (362)
T ss_pred eeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHH---HHHHhcC
Confidence 8655422 2334478999999999999 66999999999999999999999999965432 1111 1111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
. |...+ .+++..+..|+.+||..||.+||++.|++..|+.+........
T Consensus 263 ~-------Rp~~p----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~ 311 (362)
T KOG0192|consen 263 L-------RPPIP----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG 311 (362)
T ss_pred C-------CCCCC----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence 1 11111 2266678899999999999999999999999999988766544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=391.76 Aligned_cols=272 Identities=26% Similarity=0.408 Sum_probs=208.1
Q ss_pred CcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHh--ccCCCceEEEEEEEeCC----
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSR--VHHKHLVGLVGFCQEKD---- 575 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~~---- 575 (812)
.+++.++||+|+||.||+|++ +++.||||++. .+..+.|.+|-+|++. |+|+||++|+++.+...
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp--------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFP--------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecC--------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 356678999999999999999 56999999986 3445677777777665 68999999999987666
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCC------CCeEeeccCCCCEEEcCC
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV------PSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~------~~ivHrDlKp~NILl~~~ 649 (812)
+++||+||++.|+|.+||..+. .+|....+|+..+++||+|||+... |+|+|||||++||||.+|
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt---------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT---------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 7899999999999999997653 3899999999999999999998654 789999999999999999
Q ss_pred CcEEEEeecccccCCCCcccccccccccCCCccCccccccCc-CC-----CcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 650 WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV-LT-----AKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 650 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
+++.|+|||||..+.........-..+||.+|||||++.+.. +. .+.||||+|+|||||+++...++....+..
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 999999999998877654444445589999999999997642 22 368999999999999998766542111111
Q ss_pred --Cch-------hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 724 --PLD-------VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 724 --~~~-------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
+++ -.+..+......+.. +.++..-. .-.....|.+.+..||+.|++.|.|+.=+.+.+.++....
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~R----P~~p~~W~-~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQR----PKIPDAWR-KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccC----CCChhhhh-cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 110 011111111111111 11111111 1245677899999999999999999999999999988777
Q ss_pred cc
Q 042346 795 QD 796 (812)
Q Consensus 795 ~~ 796 (812)
+.
T Consensus 508 ~~ 509 (534)
T KOG3653|consen 508 ED 509 (534)
T ss_pred Cc
Confidence 65
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=380.63 Aligned_cols=251 Identities=29% Similarity=0.414 Sum_probs=206.7
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-eEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD-ERLLV 580 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~lV 580 (812)
++..+.||+|..|+|||++++ +++.+|+|++.. ....+..+++.+|+++++..+||+||++++.|.++. +..|+
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~----~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL----NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc----cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 445689999999999999986 578899999843 233556778999999999999999999999999999 59999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh-cCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN-YAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||++|+|.+++...... +....-+|+.++++||.|||+ ++ ||||||||+|||++..|++||+|||.
T Consensus 157 mEYMDgGSLd~~~k~~g~i--------~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRI--------PEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred hhhcCCCCHHHHHhhcCCC--------CHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence 9999999999999765332 345567899999999999996 55 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCC-CCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNE-DGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~ 738 (812)
+..+... .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+-... ......+++.. +
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~----I--- 294 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA----I--- 294 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH----H---
Confidence 9765442 4567899999999999999999999999999999999999999986541 12222222222 2
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
++. .+|......+.++++.++..||++||.+|||++|+++|
T Consensus 295 -----v~~--ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 295 -----VDE--PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -----hcC--CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 221 12333334678889999999999999999999999986
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=382.54 Aligned_cols=273 Identities=24% Similarity=0.395 Sum_probs=207.7
Q ss_pred CCHHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHH--HHHHHHhccCCCceEEE
Q 042346 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDS--ELALLSRVHHKHLVGLV 568 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~--Ei~~l~~l~H~nIv~l~ 568 (812)
.++-.......++++.+.||+|+||+||+|+| .|+.||||+|... ++. .+.+ |+.....|+|+||+.|+
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr-------dE~-SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR-------DER-SWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc-------chh-hhhhHHHHHHHHHhccchhhhhh
Confidence 34445556778899999999999999999999 6899999999763 222 3334 55555567999999999
Q ss_pred EEEEeCC----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-----CCCCeEeecc
Q 042346 569 GFCQEKD----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-----AVPSIIHRDI 639 (812)
Q Consensus 569 ~~~~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-----~~~~ivHrDl 639 (812)
+....++ ++|||+||++.|||+|||..... +....+++++.+|.||+|||.+ +.|.|.||||
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv---------~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTV---------TTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhhccC---------CHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 9987765 46999999999999999976432 4566789999999999999964 4599999999
Q ss_pred CCCCEEEcCCCcEEEEeecccccCCCCcc--cccccccccCCCccCccccccCc----CC--CcchhHHHHHHHHHHHcC
Q 042346 640 KSSNILLDVNWTARVSDFGLSLLGSECDQ--EFISTKAVGTVGYIDPEYYVMNV----LT--AKTDIYGLGVVLLELLTG 711 (812)
Q Consensus 640 Kp~NILl~~~~~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~~--~ksDVwS~Gvvl~elltG 711 (812)
|++|||+++|+++.|+|+|||........ ....+..+||.+|||||++.... +. ..+||||||+||||+.-.
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999987655432 23456779999999999986432 22 359999999999999753
Q ss_pred ----------CCCCCCCCCCCCCchhHHHHHHHHHhcccccccc-ccCC---CCCCChHHHHHHHHHHHHHccccCCCCC
Q 042346 712 ----------KKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLD-KRVG---PPELNEAEAVELLATTAIHCVNLEGKER 777 (812)
Q Consensus 712 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~~~---~~~~~~~~~~~~l~~li~~Cl~~dP~~R 777 (812)
+.||...-+.+-..+.+ .+++. +++. ++.-...+....+.+|++.||..+|.-|
T Consensus 423 c~~ggi~eey~~Pyyd~Vp~DPs~eeM------------rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 423 CESGGIVEEYQLPYYDVVPSDPSFEEM------------RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred hhcCCEehhhcCCcccCCCCCCCHHHH------------hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence 24554332222111111 12221 1221 1223346778889999999999999999
Q ss_pred CCHHHHHHHHHHHHHh
Q 042346 778 PNITDIVANLERALAI 793 (812)
Q Consensus 778 Pt~~evl~~Le~~~~~ 793 (812)
.|+-.|.+.|.++.+.
T Consensus 491 ltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 491 LTALRIKKTLAKLSNS 506 (513)
T ss_pred hHHHHHHHHHHHHhcC
Confidence 9999999999988753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=405.40 Aligned_cols=273 Identities=26% Similarity=0.446 Sum_probs=228.2
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ 572 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 572 (812)
...+.++.+.||+|.||+||+|+.. +...||||.++. ....+..++|++|++++..|+|||||+|+|.|.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd----~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD----KAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc----cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 3455777899999999999999742 356799999863 233446789999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCccc------cccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEKNS------SIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~------~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
+++..++|+|||..|+|.+||.......... +..++-.+.+.||.|||.||+||-++. +|||||..+|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence 9999999999999999999998765433221 334678899999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCc
Q 042346 647 DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPL 725 (812)
Q Consensus 647 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 725 (812)
.++..|||+||||++.....+++....+..-..+||+||.++.+.|+.+||||||||+|||+++ |+.|++...+
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----- 711 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----- 711 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----
Confidence 9999999999999998777666655556667889999999999999999999999999999998 8888865442
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccC
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDC 797 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~ 797 (812)
+.+...+..+++. . .++.++..+.+|+..||+.+|++||+++||-..|+...+..+..
T Consensus 712 ---~EVIe~i~~g~lL-------~----~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~ 769 (774)
T KOG1026|consen 712 ---QEVIECIRAGQLL-------S----CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY 769 (774)
T ss_pred ---HHHHHHHHcCCcc-------c----CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence 2355556666542 1 23456667889999999999999999999999999988776544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=376.57 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=210.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHH--HHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLR--EKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
..+.|.+.+.||+|+||.|-+|.. ++++.||||++.........+ .......+|+++|++|+|||||+++++|++.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345688999999999999999975 579999999997644333222 22334579999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC---CcE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN---WTA 652 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~ 652 (812)
..||||||+++|+|.+++-.+....+. ....+++|++.|+.|||+++ |+||||||+|||+..+ ..+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed--------~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~ll 318 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLRED--------LGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLL 318 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccc--------hhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEE
Confidence 999999999999999999877665443 22468999999999999999 9999999999999666 789
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCc---CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV---LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
||+|||+|+..... ..+.+..||+.|.|||++.... +..++|+||+|||||-+|+|..||..... ...
T Consensus 319 KItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~---~~s--- 389 (475)
T KOG0615|consen 319 KITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT---DPS--- 389 (475)
T ss_pred Eecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC---Ccc---
Confidence 99999999886532 3456789999999999998653 33488999999999999999999965332 111
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...++..|++ ........++.++..+||.+||..||++|||+.|+|++
T Consensus 390 -l~eQI~~G~y--------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 -LKEQILKGRY--------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -HHHHHhcCcc--------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2334455543 23334567888889999999999999999999999976
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=384.53 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=210.4
Q ss_pred CcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
.+.+.+.||+|-||+||+|.++...+||+|.+... ....+.|.+|+++|++|+|+|||+++++|..++.++|||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~------~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG------SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc------ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 36668999999999999999987779999988642 223467889999999999999999999999988999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
|||+.|+|.+||+..... .+...+.+.++.|||+||+||++++ +|||||..+||||+++..+||+|||||+
T Consensus 281 E~m~~GsLl~yLr~~~~~------~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGG------LLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EecccCcHHHHhhhcCCC------ccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccc
Confidence 999999999999873322 2355777899999999999999999 9999999999999999999999999999
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
...+ +.........-...|.|||.+....++.|||||||||+||||+| |+.|+.. . . ...+...+..|
T Consensus 352 ~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-m---s----n~ev~~~le~G-- 420 (468)
T KOG0197|consen 352 LIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-M---S----NEEVLELLERG-- 420 (468)
T ss_pred ccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-C---C----HHHHHHHHhcc--
Confidence 5443 33333444556779999999999999999999999999999999 5555422 1 1 12234444444
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
.|++.|.. ++..+.+|+..||+.+|++|||++.+...|+++...
T Consensus 421 -----yRlp~P~~----CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 421 -----YRLPRPEG----CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -----CcCCCCCC----CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 35666654 455577788899999999999999999999887654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=385.15 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=209.0
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
..|...+.||+|+|..+|.++. ..|+.||+|++.+ .........+.+.+||+|.+.|+|||||+|+++|++.+..||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk--~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPK--KLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeeh--HHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 4599999999999999999997 7899999999864 222233445678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
|.|+|++++|.++++..... +..+...+..||+.||.|||+++ |+|||||..|+||+++.++||+||||
T Consensus 96 vLELC~~~sL~el~Krrk~l--------tEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPL--------TEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred EEEecCCccHHHHHHhcCCC--------CcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccce
Confidence 99999999999999855443 33556789999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
|......+. ...+..|||.|+|||++....++..+||||+|||||-||.|++||+... +......+....
T Consensus 165 At~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------vkety~~Ik~~~ 234 (592)
T KOG0575|consen 165 ATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------VKETYNKIKLNE 234 (592)
T ss_pred eeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------HHHHHHHHHhcC
Confidence 987765332 3456799999999999999999999999999999999999999996543 223333333322
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
...|. .+...-++||.++|+.||.+|||+++|+.+=
T Consensus 235 --------Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 235 --------YSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred --------ccccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 12222 3334456788889999999999999999763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=366.66 Aligned_cols=201 Identities=28% Similarity=0.466 Sum_probs=176.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..+|.+.+.||+|+|++||+|+++ ++.+||||.+.... -..+..+.+..|+.+|+.++|||||+|+++++.++..|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~---l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK---LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc---cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 356888899999999999999975 58999999986421 13445667789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC------CcE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN------WTA 652 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~------~~~ 652 (812)
||||||++|+|.+||+.+... +......++.|||.||++||+++ ||||||||+||||+.+ -.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l--------~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRL--------PEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCC--------CHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceE
Confidence 999999999999999987643 33555789999999999999999 9999999999999765 468
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCC
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 717 (812)
||+|||+|+.... ........|++-|||||+++..+|+.|+|+||+|+|||||++|+.||..
T Consensus 155 KIADFGfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 155 KIADFGFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred EecccchhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999998764 2345567899999999999999999999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=358.92 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=213.2
Q ss_pred CcceeeeeccCCcEEEEEEE-EcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEE-EEEeCCe-EE
Q 042346 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVG-FCQEKDE-RL 578 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~-~~~~~~~-~~ 578 (812)
+|+++++||+|.||+||++. ..+|..+|.|.+. ...-+.+..++...|+.+|++|+|||||++++ .|.++++ ++
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~---f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ---FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcc---hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 48889999999999999997 4689999999886 33344566778899999999999999999998 5555555 78
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCC--eEeeccCCCCEEEcCCCcEEEEe
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPS--IIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~--ivHrDlKp~NILl~~~~~~kl~D 656 (812)
|||||+..|+|...++....... ..+.+..++++.|+++||.++|++. |. |+||||||.||+|+.+|.+||+|
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr----~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKR----LIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccc----cCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeecc
Confidence 99999999999999976543322 2356777899999999999999954 44 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|||++++.... ......+|||.||+||.+...+|+.||||||+||++|||..-+.||..+. + ......+.
T Consensus 172 fGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~-~~L~~KI~ 241 (375)
T KOG0591|consen 172 FGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------L-LSLCKKIE 241 (375)
T ss_pred chhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------H-HHHHHHHH
Confidence 99999876532 34556799999999999999999999999999999999999999997642 1 12333444
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
.+.+ +.....-+++.|.+||..|+..||+.||+.-.+++.++.-
T Consensus 242 qgd~----------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 242 QGDY----------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred cCCC----------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 4432 2334467788899999999999999999976666665553
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=375.99 Aligned_cols=276 Identities=27% Similarity=0.453 Sum_probs=221.1
Q ss_pred CHHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEE
Q 042346 492 TLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFC 571 (812)
Q Consensus 492 ~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~ 571 (812)
+.+++.+..+++.+.+.||+|+||+||+|+|.. .||||++... ....+..+.|++|+..|++-+|.||+-|+|+|
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~---~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVD---DPTPEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecC---CCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 346677777788899999999999999999953 6999998753 23345788999999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
.+... .+|+.+|++-+|+.+||..... +.+.+.++||.||++||.|||.++ |||||||+.||+|.++++
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~etk-------fdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQETK-------FDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhhh-------hhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCc
Confidence 98776 9999999999999999876532 356777899999999999999999 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
|||+||||+.....-..........|...|||||+++ ..+|++.+||||||+++|||++|..||. ....++..-
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIif-- 603 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIF-- 603 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEE--
Confidence 9999999996543333333344557889999999997 3679999999999999999999999986 222111110
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.+-.|.+ ++........+++++++|+..||..++++||.+.+|+..|+.++...++.+
T Consensus 604 -----mVGrG~l-------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~ 661 (678)
T KOG0193|consen 604 -----MVGRGYL-------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN 661 (678)
T ss_pred -----Eeccccc-------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence 0011111 011122235667788999999999999999999999999999888765555
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=345.41 Aligned_cols=269 Identities=26% Similarity=0.343 Sum_probs=202.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+.|+.+.++|+|+||.||++++++ |+.||||++... ..+....+-..+|+++|++|+|+|+|.++++|..+...+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es---edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES---EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC---CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 357778899999999999999864 999999998642 2334445566899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
|+||++. ++.+-|....... +-....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+
T Consensus 79 VFE~~dh-TvL~eLe~~p~G~-------~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 79 VFEYCDH-TVLHELERYPNGV-------PSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred Eeeecch-HHHHHHHhccCCC-------CHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchh
Confidence 9999987 5555565544332 23445789999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH----
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ---- 734 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---- 734 (812)
|+.+.... ...+..+.|..|+|||.+.+ .+|...+||||+||++.||++|...|-...+-++ +..+......
T Consensus 148 AR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~pr 224 (396)
T KOG0593|consen 148 ARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIPR 224 (396)
T ss_pred hHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCHH
Confidence 99877422 34567789999999999987 7899999999999999999999877644332111 1111111111
Q ss_pred ---HH-hc-cccccccccCCCCCCCh---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ---IL-AG-QLHCVLDKRVGPPELNE---AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ---~~-~~-~~~~~~d~~~~~~~~~~---~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+. .. .+..+.-+....++..+ ......+.++++.||+.||++|++-+|++.+
T Consensus 225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00 00 11111111111111111 3345678899999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=352.82 Aligned_cols=265 Identities=25% Similarity=0.362 Sum_probs=206.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|+++++||+|+||+||.++.+ .++.+|+|++.+... ....+.+...+|..+|.+++||+||+++-.|++.+.+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~i--v~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKI--VEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHh--hhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 356999999999999999999865 488999999875322 22334566788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
||+||+.||.|+-+|++.....+. ...=++..|+.||.|||+++ ||||||||+|||||.+|+++|+|||
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~--------~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSED--------RARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchh--------HHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 999999999999999876654332 22347889999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
|++..... ...+....||+.|||||++.+..|+..+|.||||++||||++|.+||...+. ......+..+
T Consensus 171 L~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~ 240 (357)
T KOG0598|consen 171 LCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKG 240 (357)
T ss_pred cchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcC
Confidence 99854332 2234557999999999999999999999999999999999999999965431 1122222232
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH-------HHHHHHhcccCC
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP----NITDIVAN-------LERALAICQDCS 798 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP----t~~evl~~-------Le~~~~~~~~~~ 798 (812)
+ ...++.. .....++++.+.|..||++|. .+.+|.++ ++++++.-..+|
T Consensus 241 k-------~~~~p~~----ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~Pp 300 (357)
T KOG0598|consen 241 K-------LPLPPGY----LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPP 300 (357)
T ss_pred c-------CCCCCcc----CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCC
Confidence 2 1122222 223456778889999999995 56665543 355555544444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=360.65 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=208.2
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeC
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEK 574 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 574 (812)
..-.++|.+.+.||+|+|++|++|+.+ .++++|||++.+ +....+.+...+..|-+.|.+| .||.|++|+-.|+++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K--~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDK--RYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhH--HHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 334567999999999999999999864 589999999864 2223334456677899999999 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
..+|+|+||+++|+|.++|++.+... ......++.+|+.+|+|||+++ ||||||||+|||||+|+++||
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfd--------e~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikI 215 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFD--------ETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKI 215 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcch--------HHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEE
Confidence 99999999999999999998876543 2334579999999999999999 999999999999999999999
Q ss_pred EeecccccCCCCccc---------ccc--cccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 655 SDFGLSLLGSECDQE---------FIS--TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 655 ~DfGla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
+|||.|+.+...... ... ...+||..|.+||++.....++.+|+|+||||||+|+.|++||...++
T Consensus 216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--- 292 (604)
T KOG0592|consen 216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--- 292 (604)
T ss_pred eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---
Confidence 999999876543221 111 447999999999999999999999999999999999999999965432
Q ss_pred CchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
+. ..+.++. -....+ +.+++...+|+.+.|..||.+|+|.++|.+|.
T Consensus 293 -yl----iFqkI~~--------l~y~fp----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 293 -YL----IFQKIQA--------LDYEFP----EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -HH----HHHHHHH--------hcccCC----CCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 1112221 112222 23345677889999999999999999998874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=358.09 Aligned_cols=267 Identities=25% Similarity=0.376 Sum_probs=214.0
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..+...+.++||+|-||+|.++....+.+||||+++.. .......+|.+|+++|.+|+||||++++++|..++.++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~----a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD----ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcc----cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 44567788999999999999999977899999998642 23344678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+|+|||++|+|.+||..+..... .-...++|+.||+.||+||.+.+ +|||||.++|+|+|.++++||+|||
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~------~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfg 682 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTA------ETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFG 682 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCccc------ccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcc
Confidence 99999999999999988754331 12334679999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc--CCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT--GKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
+++-+...+........+-..+|||||.+..++++.++|||+||++|||+++ ..+||....+ .++++.....+.
T Consensus 683 msR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~ 758 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFR 758 (807)
T ss_pred cccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcC
Confidence 9987666666655666778899999999999999999999999999999866 5567643221 123332222221
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
.+. ..++ ...+.-++..|.+++.+||+.|.++||+++++..+|++.
T Consensus 759 ~~~-~~~~-------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 759 DQG-RQVV-------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCC-ccee-------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111 1111 112234556677999999999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=364.14 Aligned_cols=269 Identities=25% Similarity=0.359 Sum_probs=205.2
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE------cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL------MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFC 571 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 571 (812)
..++|++.++||+|+||.||+|.+ .+++.||+|++.... .......+.+|++++..+ +||||+++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 346799999999999999999974 235679999985321 123345688999999999 899999999988
Q ss_pred EeCC-eEEEEEEecCCCchhhhhhcCCCCCc-------------------------------------------------
Q 042346 572 QEKD-ERLLVYEYMSNGALHDHLHNKNNTEK------------------------------------------------- 601 (812)
Q Consensus 572 ~~~~-~~~lV~ey~~~gsL~~~l~~~~~~~~------------------------------------------------- 601 (812)
...+ ..++||||+++|+|.+++........
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7654 57899999999999999976432100
Q ss_pred -----cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccc
Q 042346 602 -----NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676 (812)
Q Consensus 602 -----~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 676 (812)
.....+++...++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 00123577888999999999999999998 9999999999999999999999999997653322222223345
Q ss_pred cCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCCh
Q 042346 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNE 755 (812)
Q Consensus 677 gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 755 (812)
++..|+|||++.+..++.++||||||++||||++ |+.||...... +.....+..+.. ...+
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~-------~~~~---- 299 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDGTR-------MRAP---- 299 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcCCC-------CCCC----
Confidence 6788999999998899999999999999999997 88888542211 111112222211 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 756 AEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 756 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
...+..+.+|+.+||+.||++|||+.|+++.|+++++
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 300 ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2234568899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.51 Aligned_cols=265 Identities=22% Similarity=0.351 Sum_probs=207.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..+.|++.++||.|..+.||+|+. ..++.||||++.. ++..+....+.+|+..|+.++||||++++..|..+..+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inL----Ekc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINL----EKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeeh----hhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 456799999999999999999985 4679999999864 22334467888999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
|+||.||.+|++.+.++.......++. ....|++++++||.|||.++ .||||||+.||||+.+|.+||+||
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~------~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEA------SIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHH------HHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCc
Confidence 999999999999999988776665433 34678999999999999999 999999999999999999999999
Q ss_pred cccccCCC-Cccccc-ccccccCCCccCccccc--cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 658 GLSLLGSE-CDQEFI-STKAVGTVGYIDPEYYV--MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 658 Gla~~~~~-~~~~~~-~~~~~gt~~y~aPE~~~--~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|.+-.+.. ...... ....+||+.|||||+++ ...|+.|+||||||++.+||.+|..||.+..+ ++....
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl~ 243 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLLL 243 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHHH
Confidence 98753322 222211 26679999999999965 35699999999999999999999999965432 111111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+ .+.-.... -...+......+...+++++..||.+||++|||+++++++
T Consensus 244 tL-qn~pp~~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 244 TL-QNDPPTLL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred Hh-cCCCCCcc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11 11111000 0011122234455678999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=368.49 Aligned_cols=260 Identities=23% Similarity=0.458 Sum_probs=214.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
+...++++||.|.||+||+|+++ ....||||.++. ........+|..|..||.+++||||++|.|+......
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~----GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA----GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeecc----CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 45678899999999999999875 245799999864 3334556789999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++|+|||+||+|+.||+.+... +++.+.+-|+++||.||.||-+++ +|||||..+|||++.|..+|++|
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGq-------ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsD 774 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQ-------FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSD 774 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCc-------eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEecc
Confidence 99999999999999999877643 266777899999999999999999 99999999999999999999999
Q ss_pred ecccccCCCCcc-cccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSECDQ-EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||++.+.++.. ......-.-..+|.|||.+..++++..|||||||++|||.++ |.+|+..-.+ +.+...
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--------QdVIka 846 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVIKA 846 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--------HHHHHH
Confidence 999997765442 122222233579999999999999999999999999999887 8888754221 122333
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+.+ +.|+++|. +++..|.+|++.||++|..+||.+.+|+..|++++..
T Consensus 847 Ie~-------gyRLPpPm----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 847 IEQ-------GYRLPPPM----DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHh-------ccCCCCCC----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 333 34666654 4566688899999999999999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=346.28 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=201.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC--eE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--ER 577 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~ 577 (812)
.++...+.||+|+||.||++...+ |+..|||...... ....+.+.+|+.+|++|+|||||+++|...... .+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~-----~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED-----SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc-----chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 346778999999999999998754 8999999886431 111566889999999999999999999855444 58
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC-CCcEEEEe
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARVSD 656 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~D 656 (812)
++.|||+++|+|.+++..... . ++.....++..||++||+|||+++ |||+||||+|||++. ++.+||+|
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~-~------l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG-K------LPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC-C------CCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEecc
Confidence 899999999999999987764 2 134556789999999999999998 999999999999999 79999999
Q ss_pred ecccccCCC-CcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSE-CDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
||++..... ...........||+.|||||++..+ ....++|||||||++.||+||+.||... ....++....
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~i 235 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLI 235 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHH
Confidence 999986653 1122334467899999999999853 3345999999999999999999998542 1112222221
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
...+. .| ..+...++...+++.+|+..||++|||++++|++.-...
T Consensus 236 g~~~~----------~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 236 GREDS----------LP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred hccCC----------CC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 11111 11 122336667889999999999999999999999875533
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=380.68 Aligned_cols=273 Identities=28% Similarity=0.449 Sum_probs=221.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC--Cc----EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD--GR----EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ 572 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--g~----~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 572 (812)
..++.++.+.||+|.||+||.|...+ +. .||||.+... ...+++.+|.+|..+|+.++|||||+++|++.
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 34567889999999999999998643 43 4888887542 23566789999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
+....++++|||++|+|..||++.+...... ..++.+..+.++.|||+|+.||++++ +|||||..+|+||+....+
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~-~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQP-SNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCC-CCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcE
Confidence 9889999999999999999999876655443 34488999999999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcC-CCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG-KKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||||+.+...+.........-..+|||||.++...++.|+|||||||+|||++|. ..||- .. ...+++..
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~-~~---~n~~v~~~- 916 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP-SR---SNFEVLLD- 916 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC-Cc---chHHHHHH-
Confidence 99999999965554544433334556799999999999999999999999999999995 45542 22 22222222
Q ss_pred HHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 732 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.+++ .|+.+|.. +++.+.++|.+||+.+|++||++..|++.++.+++......
T Consensus 917 ---~~~g-------gRL~~P~~----CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 917 ---VLEG-------GRLDPPSY----CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred ---HHhC-------CccCCCCC----CChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 2222 24445543 45567789999999999999999999999999988877665
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=348.82 Aligned_cols=270 Identities=26% Similarity=0.382 Sum_probs=203.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-----------------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-----------------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK 562 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~ 562 (812)
.++|++.++||+|+||.||++.+++ +..||+|.+.... .......|.+|++++.+++||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCC
Confidence 3568899999999999999997643 3369999876421 233456788999999999999
Q ss_pred CceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCcc-----------ccccccHHHHHHHHHHHHHHHHHHhhcCC
Q 042346 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKN-----------SSIVNSWKMRIRIALDAARGIDYLHNYAV 631 (812)
Q Consensus 563 nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~-----------~~~~~~~~~~l~ia~~ia~gL~yLH~~~~ 631 (812)
||+++++++.+.+..++||||+++++|.+++......... ....++|...++++.||+.||.|||+.+
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 158 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN- 158 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 9999999999999999999999999999999764322111 1123478888999999999999999998
Q ss_pred CCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcC
Q 042346 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711 (812)
Q Consensus 632 ~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG 711 (812)
|+||||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||+++
T Consensus 159 --ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 --FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred --ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 999999999999999999999999999765443322223344567899999999888899999999999999999874
Q ss_pred --CCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 712 --KKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 712 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
..||.... ................ .... ... ....+..+.+|+.+||+.||++|||++||.+.|+
T Consensus 237 ~~~~p~~~~~----~~~~~~~~~~~~~~~~-~~~~---~~~----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 237 CKEQPYGELT----DEQVIENAGEFFRDQG-RQVY---LFR----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCCCCCcCC----HHHHHHHHHHHhhhcc-cccc---ccC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 45554322 1112222211111110 0000 000 1123456889999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.86 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=200.4
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--CeE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--DER 577 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 577 (812)
+.|+.+++||+|.||.||+|+. .+|+.||+|++..... ..+......+||.||++|+||||++|.+...+. ..+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~---~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE---KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC---CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 4588889999999999999985 5799999999874322 223344567899999999999999999998776 578
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
|||+|||+. +|.-++...... ++..+...++.||+.||+|+|+++ |+|||||.+|||||.+|.+||+||
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vk-------ft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDF 262 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVK-------FTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADF 262 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcc-------cChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccc
Confidence 999999987 898888654322 245667889999999999999999 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|||+++..... ...+..+-|..|+|||.+.+ ..|+..+|+||.||||.||++|+..|....+ .+..+.+....-
T Consensus 263 GLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE----veQl~kIfklcG 337 (560)
T KOG0600|consen 263 GLARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE----VEQLHKIFKLCG 337 (560)
T ss_pred cceeeccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH----HHHHHHHHHHhC
Confidence 99997665332 33677789999999999986 5799999999999999999999988755432 111211111100
Q ss_pred ---hcccc--ccccccCCCC-CCCh-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 ---AGQLH--CVLDKRVGPP-ELNE-------AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ---~~~~~--~~~d~~~~~~-~~~~-------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..+. ++.......+ .... ..++....+|+..+|..||.+|.|+.++|+.
T Consensus 338 SP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 338 SPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00111 1111011011 1101 1233445678889999999999999998864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.61 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=205.2
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
++..+.+..++-||.|+.|.||+|++ .++.||||+++. .-+.+|+-|++|+||||+.|.|+|....-
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCce
Confidence 33344456678999999999999999 578999998641 11358899999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
++||||||..|.|+..|+...... -...+.+..+||.||.|||.+. |||||||+-||||+.+..+||+|
T Consensus 187 yCIiMEfCa~GqL~~VLka~~~it--------p~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsD 255 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGRPIT--------PSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISD 255 (904)
T ss_pred eEEeeeccccccHHHHHhccCccC--------HHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEecc
Confidence 999999999999999998765432 2334677889999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||-++..... .......||..|||||++...+.++|+|||||||||||||||..||....... +.
T Consensus 256 FGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------------II 320 (904)
T KOG4721|consen 256 FGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------------II 320 (904)
T ss_pred ccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------------eE
Confidence 9999776543 23456789999999999999999999999999999999999999985433211 00
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
-| +-...+. ...+.++++-++-|+++||+..|.+||++.+|+.||+-+-......+
T Consensus 321 wG----VGsNsL~--LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~t 376 (904)
T KOG4721|consen 321 WG----VGSNSLH--LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTT 376 (904)
T ss_pred Ee----ccCCccc--ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhccc
Confidence 01 0001111 11235667778888999999999999999999999986554444443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=353.87 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=215.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.++. ..+++.+.+.+|++|++.|+|||||.+++.|+...+.|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g---r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG---RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC---CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 56888999999999999999865 57889999987543 334456778899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
|+||+.+ +|+.+|....... ......|+.++..||.|||+.+ |+|||+||.|||++..+.+|++|||+
T Consensus 79 Vte~a~g-~L~~il~~d~~lp--------Ee~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLP--------EEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCC--------HHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhh
Confidence 9999976 9999998776543 3455789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
|+.... +....+...|||.|||||...+.+|+..+|.||+|||||||++|++||+... +......+..+
T Consensus 147 Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d- 215 (808)
T KOG0597|consen 147 ARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKD- 215 (808)
T ss_pred hhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcC-
Confidence 987654 3345667789999999999999999999999999999999999999996532 11122222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHHhcccCC
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN--LERALAICQDCS 798 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~~~~~~~ 798 (812)
+...+.++...+..++...|.+||.+|.|-.+++.| .+..+...+...
T Consensus 216 -----------~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~ 265 (808)
T KOG0597|consen 216 -----------PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPA 265 (808)
T ss_pred -----------CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccc
Confidence 122234677778899999999999999999999976 355555544444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=352.44 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=203.8
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~ 576 (812)
...+|.+.+.||+|.||.|+.|++. +++.||+|++.............+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4567999999999999999999764 6899999976542111111133455668999999999 9999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-CcEEEE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARVS 655 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~ 655 (812)
.++||||+.+|+|++++.......+ .+..+++.|++.|++|+|+++ |+||||||+|||+|.+ +++||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E--------~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKE--------DEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCCh--------HHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEe
Confidence 9999999999999999988544332 445689999999999999999 9999999999999999 999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCc-CC-CcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV-LT-AKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||++.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..... .....
T Consensus 164 DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--------~~l~~ 233 (370)
T KOG0583|consen 164 DFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--------PNLYR 233 (370)
T ss_pred ccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------HHHHH
Confidence 999998763 1223456779999999999999987 87 679999999999999999999965221 11122
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 784 (812)
.+..+. ...|.... ...+..|+.+||..||.+|+|+.||+
T Consensus 234 ki~~~~--------~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 234 KIRKGE--------FKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHhcCC--------ccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 233332 22232221 55678899999999999999999999
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=355.12 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=206.4
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
..|...++||+|..|.||.|+. .+++.||||++.... +..++-+.+|+.+|+.++|+|||++++.|..++++|.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-----Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-----QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-----CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 4688889999999999999974 468899999987522 2344567899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
|||||++|+|.|.+..... +..+...|++.+++||+|||.++ |+|||||.+|||++.++.+||+|||+
T Consensus 348 VMEym~ggsLTDvVt~~~~---------~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTRM---------TEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGF 415 (550)
T ss_pred EEeecCCCchhhhhhcccc---------cHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeee
Confidence 9999999999999976542 34555789999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
...+..... .....+||+.|||||+...+.|.+|.||||||++++||+-|.+||..+.. +. +...+....
T Consensus 416 caqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lr----AlyLIa~ng 485 (550)
T KOG0578|consen 416 CAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LR----ALYLIATNG 485 (550)
T ss_pred eeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----HH----HHHHHhhcC
Confidence 876554322 34567999999999999999999999999999999999999999875332 11 111222111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+..-........|++++.+||..|+++||+++|+|+|
T Consensus 486 ---------~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 ---------TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---------CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11222235566779999999999999999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.05 Aligned_cols=266 Identities=21% Similarity=0.288 Sum_probs=201.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCC-
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKD- 575 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~- 575 (812)
.-++|.+.++||.|.||.||+|+. ..++.||||+++..-.. + ++-.-.+|++-|++|+ |||||++.+.+.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~---ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-W---EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-H---HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 345799999999999999999975 46899999998642111 1 1122357999999998 999999999999888
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
.+|+|||||+. +|+++++.++. .++......|+.||++||+|+|.+| +.|||+||+|||+..+..+||+
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r-------~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKia 152 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNR-------LFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIA 152 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCC-------cCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEec
Confidence 89999999965 99999987643 2355677899999999999999999 9999999999999988899999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccc-cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||||+.+... ...+..+.|..|+|||++. ...|+.+.|||++|||++||.+-+..|-...+- +.+-.+...
T Consensus 153 DFGLARev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~----Dqi~KIc~V 225 (538)
T KOG0661|consen 153 DFGLAREVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI----DQIYKICEV 225 (538)
T ss_pred ccccccccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH----HHHHHHHHH
Confidence 99999876542 2456778999999999886 567999999999999999999998777443321 111111111
Q ss_pred HHh---------ccccccccccCCC------CCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 735 ILA---------GQLHCVLDKRVGP------PELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 735 ~~~---------~~~~~~~d~~~~~------~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
+-. ..+...+.-+++. .... ..+.....+++.+|+..||.+|||++|.+++-
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 100 0111111111111 1111 22556677999999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=318.09 Aligned_cols=265 Identities=22% Similarity=0.312 Sum_probs=200.2
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.+|..+++||+|.||.||+|++ ++|+.||||++...... ........+|++.|+.++|+||+.+++.|-+.+...|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k---dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK---DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc---cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 4588889999999999999985 56999999998753221 1223456789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
|+|||+. +|+..|+.+.. +++-.....++.++++||+|+|++. |+||||||.|+|++++|.+||+|||+
T Consensus 79 VfEfm~t-dLe~vIkd~~i-------~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKNI-------ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred EEEeccc-cHHHHhccccc-------ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccc
Confidence 9999976 99999976543 3345566789999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++.+...+.. .+..+-|..|+|||.+.+ +.|+..+||||.|||+.||+-|.+-|..+. . .+......+.+-..
T Consensus 148 Ar~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-D---idQL~~If~~LGTP 221 (318)
T KOG0659|consen 148 ARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-D---IDQLSKIFRALGTP 221 (318)
T ss_pred hhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-h---HHHHHHHHHHcCCC
Confidence 9987764443 334488999999998875 679999999999999999998765443222 1 12222222211111
Q ss_pred ------ccccccccc----CCCC---CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 ------QLHCVLDKR----VGPP---ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ------~~~~~~d~~----~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+..+.|.. .+.+ ... ..+.....+|+.+++..||.+|+|+.|.+++
T Consensus 222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 222 TPDQWPEMTSLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CcccCccccccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111110 1111 111 2233344699999999999999999999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=321.12 Aligned_cols=239 Identities=25% Similarity=0.359 Sum_probs=196.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|+..+.||.|+||.|.+.+.+ ++..+|+|++... ........+...+|..+|+.+.||+++++++.|.+.+.+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~--~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ--KVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHH--HHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 35888999999999999999875 5888999998752 22223344566789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|.|+.+|++.....+ +...=+|.+|+.||+|||+.. |++|||||+|||||++|.+||+|||.
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e--------~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSE--------PHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCc--------hhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccc
Confidence 9999999999999988765443 333458999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
|+..... .-+..|||.|+|||+++..+|...+|.|||||++|||+.|..||..... .. ....+.+++
T Consensus 191 AK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~----iY~KI~~~~ 257 (355)
T KOG0616|consen 191 AKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQ----IYEKILEGK 257 (355)
T ss_pred eEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HH----HHHHHHhCc
Confidence 9876552 4567899999999999999999999999999999999999999976542 22 223344443
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCC
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKER 777 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 777 (812)
+..|.... ..+++|+.+.|+.|-.+|
T Consensus 258 --------v~fP~~fs----~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 --------VKFPSYFS----SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------ccCCcccC----HHHHHHHHHHHhhhhHhh
Confidence 33333333 346677778888888888
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=355.38 Aligned_cols=271 Identities=27% Similarity=0.431 Sum_probs=216.3
Q ss_pred HHHHHhcCCcceeeeeccCCcEEEEEEEEcC--C--cE-EEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEE
Q 042346 494 SELAAATNNFSLENKVGIGSFGTVYKGKLMD--G--RE-VAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLV 568 (812)
Q Consensus 494 ~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~--g--~~-vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~ 568 (812)
..++..-++..+.++||+|.||+||+|+++. + .. ||||.... .....++...+|.+|.++|+.++|||||+||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~--~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG--SSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc--cccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 3445556677788999999999999998743 2 23 89998763 1224466788999999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 569 GFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 569 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
|+...+..+++|||+|.||+|.+||++.... ++..++++++.++|+||+|||+++ +|||||..+|+|++.
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~-------v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKS-------LPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSK 297 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCCC-------CCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecC
Confidence 9999999999999999999999999877541 367889999999999999999999 999999999999999
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchh
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 727 (812)
++.+||+||||++.... .........-..+|+|||.+....|++++|||||||++||+++ |..||.... ..
T Consensus 298 ~~~vKISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~----~~-- 369 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK----NY-- 369 (474)
T ss_pred CCeEEeCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC----HH--
Confidence 99999999999876541 1111112246789999999999999999999999999999999 777874322 11
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
.+...+.... .++..+. ..+..+..++.+|+..+|++||+|.++.+.|+.+.+....
T Consensus 370 --~v~~kI~~~~------~r~~~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 370 --EVKAKIVKNG------YRMPIPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred --HHHHHHHhcC------ccCCCCC----CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 2222332221 2233222 4556677888899999999999999999999998887664
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=348.09 Aligned_cols=265 Identities=21% Similarity=0.223 Sum_probs=197.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..+|.+.+.||+|+||.||++.+. .++.||||.... ..+.+|++++++|+|+||+++++++..++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 457999999999999999999875 478899996421 23567999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
|||||+. ++|.+++..... .++|..++.|+.||++||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 237 lv~e~~~-~~L~~~l~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFG 305 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLR-------PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFG 305 (461)
T ss_pred EEEEccC-CCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccC
Confidence 9999995 699998865422 2478889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+++...............||+.|+|||++.+..++.++|||||||+||||++|..+++..................+...
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~ 385 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA 385 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence 99765432222222345799999999999999999999999999999999999887654332111111111111111111
Q ss_pred ccc--ccc----------------cc-cCCCCCCC---hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLH--CVL----------------DK-RVGPPELN---EAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~--~~~----------------d~-~~~~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ... .. +....... .......+.+|+.+||+.||++|||+.|+|++
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 100 000 00 00000000 01223467889999999999999999999976
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=351.57 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=207.2
Q ss_pred CcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
-|.+.+.||+|+.|.|-+|++ .+|+.+|||++.... .........+++||-||+.+.|||++.+|++++++.++|||
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeecccc--ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 378899999999999999987 569999999987532 22233455788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
.||+++|.|++||-.++...+ ++..+++.||+.|+.|.|..+ |+||||||+|+|||.++++||+|||||
T Consensus 91 lEyv~gGELFdylv~kG~l~e--------~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMA 159 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPE--------REAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMA 159 (786)
T ss_pred EEecCCchhHHHHHhhCCCCC--------HHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeecccee
Confidence 999999999999988776543 455789999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCC-CcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLT-AKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
.+-.. .....+..|++.|.+||++.+.+|+ .++||||.|||||.||||+.||..++ +......+..|.
T Consensus 160 sLe~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--------ir~LLlKV~~G~ 228 (786)
T KOG0588|consen 160 SLEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--------IRVLLLKVQRGV 228 (786)
T ss_pred ecccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcCc
Confidence 65332 2234567899999999999999987 57999999999999999999996332 222333333443
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
++ .+.+++....+|+.+||..||++|.|++||++|-
T Consensus 229 f~------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 FE------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cc------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 21 1234455577888999999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.07 Aligned_cols=255 Identities=27% Similarity=0.325 Sum_probs=200.3
Q ss_pred CcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.|+..+.||+|+||.||++.+ .+++.||+|++.... .........+.+|+++++.++|+||+++++++.+++..++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhh--hhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 378889999999999999986 468999999876321 11222344677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++|+|.+++...... .+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 79 ~e~~~~g~L~~~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNP------GFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred EEecCCCcHHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999888643221 1366778899999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
....... ......||..|+|||++.+..++.++|||||||+||||++|+.||....... ..+.....+....
T Consensus 150 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~- 221 (285)
T cd05631 150 VQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV----KREEVDRRVKEDQ- 221 (285)
T ss_pred EEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch----hHHHHHHHhhccc-
Confidence 7643321 1234578999999999999999999999999999999999999996543211 1111111111110
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 786 (812)
.. ........+.+|+.+||+.||++||+ ++|++++
T Consensus 222 -------~~----~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 -------EE----YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -------cc----CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11 11234556889999999999999997 8899886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.61 Aligned_cols=266 Identities=25% Similarity=0.366 Sum_probs=203.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEE------cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL------MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQ 572 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 572 (812)
.++|++.+.||+|+||.||++++ .++..||||++.... .....+.+.+|+++++.+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc----CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 44688899999999999999964 235689999985321 122345688899999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCc---------------------------------------------------
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEK--------------------------------------------------- 601 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~--------------------------------------------------- 601 (812)
+.+..++||||+++|+|.++++.......
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999975431100
Q ss_pred ----------------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCC
Q 042346 602 ----------------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665 (812)
Q Consensus 602 ----------------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~ 665 (812)
.....+++...++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 00123578889999999999999999998 99999999999999999999999999976543
Q ss_pred CcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
...........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ......+..+.
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~----- 334 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYKMIKEGY----- 334 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHHHHHHHhCc-----
Confidence 222212223345678999999999999999999999999999998 77777432211 11111111111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
+...+. ..+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus 335 --~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 --RMLSPE----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --cCCCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111111 1234688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.47 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=197.1
Q ss_pred eeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe----CCeEEEEEE
Q 042346 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE----KDERLLVYE 582 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lV~e 582 (812)
..|++|+++.||+|.+ +++.||||++.... .......+.|.+|+++|++++||||+++++++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFH--KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccc--cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 6799999999999998 78999999986422 1222334678899999999999999999999877 346789999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
|+++|+|.+++..... +++...++++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++
T Consensus 103 y~~~g~L~~~l~~~~~--------~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 103 YCTRGYLREVLDKEKD--------LSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred eCCCCcHHHHHhhCCC--------CChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHh
Confidence 9999999999975432 36778889999999999999985 5 7899999999999999999999999987
Q ss_pred cCCCCcccccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..++. ..+..+.
T Consensus 172 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~----~~~~~----~~i~~~~ 238 (283)
T PHA02988 172 ILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT----TKEIY----DLIINKN 238 (283)
T ss_pred hhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC----HHHHH----HHHHhcC
Confidence 54331 123468899999999976 679999999999999999999999985432 11111 1111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
. +...+ ...++.+.+++.+||+.||++|||++|+++.|+..-
T Consensus 239 ~------~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 N------SLKLP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred C------CCCCC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1 11111 234566889999999999999999999999998864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=389.66 Aligned_cols=275 Identities=27% Similarity=0.432 Sum_probs=216.9
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
..|...++||+|+||.||+|++ .+++.||||++..... ...+|++++++++||||++++++|.+++..++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 3467788999999999999987 4789999998753211 11246888999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.++++. ++|.++++|+.|+++||+|||....++|+||||||+|||++.++..++. |+.
T Consensus 761 v~Ey~~~g~L~~~l~~-----------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN-----------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred EEeCCCCCcHHHHHhc-----------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 9999999999999952 3788999999999999999997655669999999999999999888876 665
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
...... .....+|+.|||||++.+..++.++|||||||++|||+||+.||.... .....+.+|.........
T Consensus 829 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~ 900 (968)
T PLN00113 829 PGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF--GVHGSIVEWARYCYSDCH 900 (968)
T ss_pred cccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc--CCCCcHHHHHHHhcCccc
Confidence 533221 123368899999999999999999999999999999999999985332 222345555544333344
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCC
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCSCTDSFS 804 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~~~~~~~ 804 (812)
....+|+.+........+....+.+++.+|++.||++||||+|+++.|+++.+....+-+..+++
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~~~~ 965 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTGLKFS 965 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccccCcccc
Confidence 44555655543333344555668899999999999999999999999999988777666555543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=356.66 Aligned_cols=267 Identities=27% Similarity=0.421 Sum_probs=204.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQ 572 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 572 (812)
.++|++.+.||+|+||.||++++. +++.||+|++..... .+....+.+|+++++.+ +|+||+++++++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH----TDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC----HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 346899999999999999998742 245799999864221 23345688899999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCC----------------------------------------------------
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTE---------------------------------------------------- 600 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~---------------------------------------------------- 600 (812)
..+..++||||+++|+|.++++......
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999986532100
Q ss_pred ----------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccc
Q 042346 601 ----------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670 (812)
Q Consensus 601 ----------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 670 (812)
......+++.+.++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 001123577888999999999999999998 9999999999999999999999999987543322211
Q ss_pred cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCC
Q 042346 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVG 749 (812)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 749 (812)
......++..|||||++....++.++||||||+++|||++ |+.||....... . ......... +..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~-----~~~~~~~~~------~~~ 335 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---K-----FYKMVKRGY------QMS 335 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---H-----HHHHHHccc------Ccc
Confidence 2223345678999999998899999999999999999997 999985432111 0 111111110 111
Q ss_pred CCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 750 PPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 750 ~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
.+. ..+..+.+++.+||+.||++|||++||++.|++++
T Consensus 336 ~~~----~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPD----FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111 12356889999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.00 Aligned_cols=262 Identities=27% Similarity=0.380 Sum_probs=203.1
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhH---------HHHHHHHHHHHHHHHhccCCCceEE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKL---------REKESAFDSELALLSRVHHKHLVGL 567 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~---------~~~~~~~~~Ei~~l~~l~H~nIv~l 567 (812)
...++|++.+.||+|.||.|-+|+. .+++.||||++.+.+..... ....+...+||.+|++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999986 46899999998753322111 0112467899999999999999999
Q ss_pred EEEEEeC--CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEE
Q 042346 568 VGFCQEK--DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645 (812)
Q Consensus 568 ~~~~~~~--~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 645 (812)
+++..+. +.+|||+|||..|.+...=..... ++..+..+++.++..||+|||.++ ||||||||+|+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~e--------ls~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLL 242 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPE--------LSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLL 242 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCccc--------ccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheE
Confidence 9998764 468999999998887654322211 366777899999999999999999 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCcc---cccccccccCCCccCccccccC---cC-CCcchhHHHHHHHHHHHcCCCCCCCC
Q 042346 646 LDVNWTARVSDFGLSLLGSECDQ---EFISTKAVGTVGYIDPEYYVMN---VL-TAKTDIYGLGVVLLELLTGKKAVFKN 718 (812)
Q Consensus 646 l~~~~~~kl~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~-~~ksDVwS~Gvvl~elltG~~p~~~~ 718 (812)
|++++++||+|||.+........ .......+|||.|||||...+. .+ ..+.||||+||+||-|+.|+.||+.+
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 99999999999999976532211 2233457999999999998762 23 45789999999999999999999764
Q ss_pred CCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 719 EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
.. +.+ +.+++...+..|.. .+..+.+++||+++|.+||++|.+..||..|.-
T Consensus 323 ~~----~~l------------~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 323 FE----LEL------------FDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred hH----HHH------------HHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 42 111 12233334444432 356778999999999999999999999988763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=340.10 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=200.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.||+|++... ........+.+.+|+++++.++||||+++++++.+++..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP--EVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHH--HHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 36889999999999999999875 5889999998531 11122334568889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... ++....+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGR--------FSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred EEeCCCCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCc
Confidence 9999999999999976532 245666789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+...... .....||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. ....+..+.
T Consensus 148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~----~~~~i~~~~ 214 (291)
T cd05612 148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP----FG----IYEKILAGK 214 (291)
T ss_pred chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HH----HHHHHHhCC
Confidence 8765331 2234689999999999988899999999999999999999999854321 11 122222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVANL 787 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L 787 (812)
...+ ......+.+|+.+||+.||.+||+ ++|++++-
T Consensus 215 --------~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 215 --------LEFP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred --------cCCC----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 1111 122445789999999999999995 99988773
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=335.82 Aligned_cols=263 Identities=27% Similarity=0.461 Sum_probs=207.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
++|++.+.||+|+||.||+|.+.. .+.|++|.+.... .......|.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA----EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC----CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 358889999999999999998643 2579999875321 233455788999999999999999999999998
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCc--------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEK--------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
...+++|||+++++|.+++........ .....+++...+.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 899999999999999999976533211 01123477888999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCc
Q 042346 647 DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPL 725 (812)
Q Consensus 647 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 725 (812)
++++.+||+|||+++.....+.........+++.|+|||.+....++.++||||||+++|||++ |..||..... .
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~----~ 233 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN----Q 233 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----H
Confidence 9999999999999976544333233344567889999999988889999999999999999998 9999854321 1
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
++ ...+..+... ......+..+.+|+.+||+.||++||+++||+++|++
T Consensus 234 ~~----~~~i~~~~~~-----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EV----IEMIRSRQLL-----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH----HHHHHcCCcC-----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 1122222111 1123456778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=332.00 Aligned_cols=257 Identities=21% Similarity=0.380 Sum_probs=202.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|++.+.||+|+||.||+|.++ .+..||+|++.... .......|.+|++++++++||||+++++++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 356899999999999999999763 35689999886421 1233457889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.+++..... .+++..+++++.|++.||+|||+++ ++||||||+|||++.++.+|++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~-------~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~ 149 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEG-------QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKIS 149 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEEC
Confidence 99999999999999999975432 2367888999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||.+....... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .. ....
T Consensus 150 dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~----~~----~~~~ 220 (266)
T cd05064 150 GFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG----QD----VIKA 220 (266)
T ss_pred CCcccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HH----HHHH
Confidence 999875432211 111222345678999999999999999999999999999875 9988854321 11 1111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
+..+. .... ...++..+.+++.+||+.+|++||++++|++.|+++
T Consensus 221 ~~~~~-------~~~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 VEDGF-------RLPA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHCCC-------CCCC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11111 1111 223456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.06 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=206.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
..|+..++||+|.||.||+|.+. .++.||+|++.. .......+++.+|+.+|..++++||.++|+.+..+..+++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~L----e~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDL----EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEech----hhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 34777899999999999999864 588999999864 2334456678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+||||.+|++.+.|+......+... .-|+.+++.||.|||.++ .+|||||+.|||+..+|.+||+|||.
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i--------~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgV 157 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEI--------AVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGV 157 (467)
T ss_pred HHHHhcCcchhhhhccCCCCcccee--------eeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecce
Confidence 9999999999999987766432221 237789999999999999 89999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+..+..... .....+||+.|||||++....|+.|+||||||++.+||.+|.+|+.+..+.. .+
T Consensus 158 a~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-vl-------------- 220 (467)
T KOG0201|consen 158 AGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-VL-------------- 220 (467)
T ss_pred eeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-EE--------------
Confidence 976554332 2367899999999999998899999999999999999999999986544311 00
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+-++-.+|.+.. .+...+++++..||++||+.||++.+++++
T Consensus 221 ---flIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 221 ---FLIPKSAPPRLDG-DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---EeccCCCCCcccc-ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1112223343333 677789999999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.69 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=199.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|+++++||+|+||+||+++-+ .|+.+|+|++.+. ........+.+..|-.+|...++|+||+|+..|++.+.+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS--~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS--EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHH--HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 3467999999999999999999865 5899999999752 233345566778899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
||||||++||++..+|.......+ ....-++.+++.||+-||+.+ ||||||||+|+|||.+|++||+||
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e--------~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTE--------DWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCch--------HHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccc
Confidence 999999999999999987765543 223457889999999999999 999999999999999999999999
Q ss_pred cccccCCC----------------------Cccc-----c------------------cccccccCCCccCccccccCcC
Q 042346 658 GLSLLGSE----------------------CDQE-----F------------------ISTKAVGTVGYIDPEYYVMNVL 692 (812)
Q Consensus 658 Gla~~~~~----------------------~~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~ 692 (812)
||+.-... .+.. . .....+|||.|||||++.+..|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 99842110 0000 0 0113479999999999999999
Q ss_pred CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHcccc
Q 042346 693 TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNL 772 (812)
Q Consensus 693 ~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~ 772 (812)
+...|.|||||||||||.|.+||..+.....-..++.|.. .+..|. +.....+-.+||.+|+.
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------------~l~fP~--~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE--------------TLKFPE--EVDLSDEAKDLITRLLC- 428 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------------hccCCC--cCcccHHHHHHHHHHhc-
Confidence 9999999999999999999999977654332222222211 111111 12223556788888998
Q ss_pred CCCCCC---CHHHHHHH
Q 042346 773 EGKERP---NITDIVAN 786 (812)
Q Consensus 773 dP~~RP---t~~evl~~ 786 (812)
||++|. .++||.+|
T Consensus 429 d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKKH 445 (550)
T ss_pred CHHHhcCcccHHHHhcC
Confidence 999996 46666554
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=344.08 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=199.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++++ +++.||+|++... ..........+.+|++++++++||||+++++++.+++..++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR--EILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 46999999999999999999875 5889999998631 11122334568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++...... +......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRF--------PNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred EEcCCCCChHHHHHHHcCCC--------CHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999999765322 34556678999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .....+..+.
T Consensus 165 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~----~~~~~i~~~~ 231 (329)
T PTZ00263 165 AKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----F----RIYEKILAGR 231 (329)
T ss_pred ceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----H----HHHHHHhcCC
Confidence 9765332 1234789999999999999999999999999999999999999854321 1 1122222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 786 (812)
+..+.. ....+.+|+.+||+.||.+||+ ++|++.+
T Consensus 232 --------~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 --------LKFPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --------cCCCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111211 2345789999999999999986 7888866
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=332.01 Aligned_cols=252 Identities=33% Similarity=0.502 Sum_probs=193.0
Q ss_pred ceeeeeccCCcEEEEEEEEc-----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 504 SLENKVGIGSFGTVYKGKLM-----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 504 ~~~~~LG~G~fG~Vy~a~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.+.+.||.|.||.||+|.+. .+..|+||++... ...+..+.|.+|++++++++||||+++++++.+.+..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----cccccceeeeeccccccccccccccccccccccccccc
Confidence 45789999999999999986 2678999998531 22334667889999999999999999999999888899
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++|+|.++|+..... .+++..+++|+.||++||+|||+.+ |+|+||+++|||+++++.+||+|||
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~------~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~ 148 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKE------PLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFG 148 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTT------TSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTT
T ss_pred ccccccccccccccccccccc------ccccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence 999999999999999877221 2378889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++....................|+|||.+....++.++||||||+++|||++ |+.|+.... . ......+.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~-~~~~~~~~~ 220 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------N-EEIIEKLKQ 220 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------H-HHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------c-ccccccccc
Confidence 9976633333333344567789999999999889999999999999999999 567753221 1 112222222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
+.. ... ...++..+.+++.+||+.||++|||++++++.|
T Consensus 221 ~~~-------~~~----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 GQR-------LPI----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TEE-------TTS----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccc-------cee----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 221 111 122345578899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=342.73 Aligned_cols=256 Identities=22% Similarity=0.266 Sum_probs=202.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+|++. +++.||+|++... ..........+.+|++++..++||||+++++++.+.+..++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKS--LLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 46899999999999999999976 4889999998631 11222344567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... ++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~e~~~g~~L~~~l~~~~~--------l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGV--------LSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred EEeCCCCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcC
Confidence 9999999999999975432 245667789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .+ ....+....
T Consensus 148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~----~~~~i~~~~ 214 (333)
T cd05600 148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP----NE----TWENLKYWK 214 (333)
T ss_pred Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH----HH----HHHHHHhcc
Confidence 975433 23445799999999999988999999999999999999999999854321 11 111111110
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+... ............+.+++.+||..+|.+||+++|++++
T Consensus 215 --~~~~~~--~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 --ETLQRP--VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --ccccCC--CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 001100 0000012345668899999999999999999999977
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=338.09 Aligned_cols=266 Identities=23% Similarity=0.329 Sum_probs=201.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++. ++..+|+|++.... .......+.+|++++++++||||+++++++.+++..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 467999999999999999999875 57889999876321 1234567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... +++....+++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKR--------IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred EEeecCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCc
Confidence 99999999999999976432 245667889999999999999864 29999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++...... ......+++.|+|||++.+..++.++|||||||+||||++|+.||..... .++..........+
T Consensus 150 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~~~~~~~~~~~ 221 (331)
T cd06649 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRPVVDG 221 (331)
T ss_pred cccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHhccccccc
Confidence 98754321 12345689999999999998999999999999999999999999853221 00000000000000
Q ss_pred cc------------------------------cccccc--cCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QL------------------------------HCVLDK--RVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~------------------------------~~~~d~--~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. .+.++. ....+..........+.+|+.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 222 EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 000000 0001111112345678999999999999999999999987
Q ss_pred H
Q 042346 787 L 787 (812)
Q Consensus 787 L 787 (812)
.
T Consensus 302 ~ 302 (331)
T cd06649 302 T 302 (331)
T ss_pred h
Confidence 5
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.85 Aligned_cols=268 Identities=22% Similarity=0.324 Sum_probs=210.5
Q ss_pred HhcCCcceeeeeccCCcEEEEEEE-EcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD- 575 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~- 575 (812)
...++|++.++||+|+|..||+++ ..+++.+|+|++.-.. .+..+...+|++..++++|||+++++++...+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 456789999999999999999997 4578999999986421 344566788999999999999999998875433
Q ss_pred ----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 576 ----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 576 ----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
+.||+++|...|+|.+.+....... ...+..+.++|+.+|.+||++||+.. |+++||||||.|||+.+.+.
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg----~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKG----NFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcC----CccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCc
Confidence 4899999999999999998655433 13366788999999999999999987 78999999999999999999
Q ss_pred EEEEeecccccCCCCccc----c---cccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCC
Q 042346 652 ARVSDFGLSLLGSECDQE----F---ISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG 721 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~----~---~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~ 721 (812)
++|.|||.+....-.-.. . .-.....|..|+|||.+. +...++++|||||||+||+|+.|..||......
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 999999998643221110 0 011235789999999886 456889999999999999999999999654432
Q ss_pred CCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 722 SGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
.....+ .+....+..|.... +++.+.++++.|++.||.+||++.+++.+++.++
T Consensus 248 GgSlaL--------------Av~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 GGSLAL--------------AVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CCeEEE--------------eeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 222111 12222333333322 7788999999999999999999999999998865
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.28 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=208.6
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.+|++.+.||+|.||.|-+|.. ..|+.||||.+.+. ..+.....-.+.+||+||+.|+||||+.++++|++.+...|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKd--kIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKD--KIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhh--hcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 4688999999999999999974 67999999988653 22334445678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||..+|.|+||+...... +..+..+++.||..++.|.|.++ ++|||||.+|||||.|+++||+||||
T Consensus 131 vMEYaS~GeLYDYiSer~~L--------sErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSL--------SEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred EEEecCCccHHHHHHHhccc--------cHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccch
Confidence 99999999999999877654 34556789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCC-CcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLT-AKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+.++... ...+...|++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||...+ ....++++..|
T Consensus 200 SNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQIs~G 268 (668)
T KOG0611|consen 200 SNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQISRG 268 (668)
T ss_pred hhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHHhhcc
Confidence 9776542 245677999999999999999986 67999999999999999999996533 22345566666
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.+.+ | +.+..-.-||+.||..||++|.|++||..+.
T Consensus 269 aYrE--------P-----~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 AYRE--------P-----ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccC--------C-----CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 5432 1 1112244678889999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.55 Aligned_cols=269 Identities=23% Similarity=0.351 Sum_probs=206.8
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFC 571 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~ 571 (812)
..++|++.++||+|+||.||+|++.. ...||||++.... .....+.|.+|+++++++. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA----RSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 35678999999999999999998531 3479999985321 1233457889999999996 99999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCc--------------------------------------------------
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEK-------------------------------------------------- 601 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~-------------------------------------------------- 601 (812)
.+....+|||||+++|+|.++|+.......
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999999976421100
Q ss_pred --------------------------------------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCC
Q 042346 602 --------------------------------------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSN 643 (812)
Q Consensus 602 --------------------------------------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~N 643 (812)
.....+++..+++++.||++||+|||+.+ |+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence 00112467888899999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 042346 644 ILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGS 722 (812)
Q Consensus 644 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~ 722 (812)
||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++||||++ |+.||......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~- 346 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD- 346 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-
Confidence 9999999999999999976543222222233457789999999998899999999999999999997 88887532210
Q ss_pred CCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 723 GPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
......+..+. ++. .....+..+.+++.+||+.||++|||+.+|.+.|++++.
T Consensus 347 ------~~~~~~~~~~~-------~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 ------STFYNKIKSGY-------RMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------HHHHHHHhcCC-------CCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111111111 111 112345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=327.08 Aligned_cols=258 Identities=24% Similarity=0.477 Sum_probs=204.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
++|++.+.||+|+||.||+|.+.. ...|++|++... ........|.+|+.++++++||||+++++++.+++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 568899999999999999998743 457999987532 123345578889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.+++|||+++++|.+++..... .+++..+++++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~d 149 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDG-------KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSD 149 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECc
Confidence 9999999999999999976432 2367888999999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
||++................++..|+|||.+....++.++||||||+++|||++ |..||..... ......+
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~ 221 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKAV 221 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHHH
Confidence 999987653222222233345678999999998899999999999999999998 8888743221 1111111
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
..+. +...+ ...++.+.+++.+|++.+|++||+++||+++|++++
T Consensus 222 ~~~~-------~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 222 EDGY-------RLPPP----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HcCC-------CCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1111 11111 223456889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.15 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=194.7
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecC
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMS 585 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 585 (812)
+.||+|+||.||+++.+ +++.||+|++... ..........+.+|++++++++||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKE--VIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 46999999999999874 6889999998631 11223344567789999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCC
Q 042346 586 NGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665 (812)
Q Consensus 586 ~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~ 665 (812)
+++|.+++..... +++.+...++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 79 GGELFFHLSRERV--------FSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred CCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 9999999975432 256677789999999999999998 99999999999999999999999999865322
Q ss_pred CcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccccc
Q 042346 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLD 745 (812)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 745 (812)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... +.....+..+.
T Consensus 148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~------ 211 (323)
T cd05571 148 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEE------ 211 (323)
T ss_pred CC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCC------
Confidence 11 122345799999999999999999999999999999999999999854321 11111122111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 746 KRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 746 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
...+ ......+.+++.+||+.||++|| ++++++++
T Consensus 212 --~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 --IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred --CCCC----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1111 22345678999999999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.01 Aligned_cols=265 Identities=24% Similarity=0.402 Sum_probs=203.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ 572 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 572 (812)
..++|++.+.||+|+||.||+|.+. .++.||+|++.... .......|.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567999999999999999999753 24679999875321 1223456889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCcc--ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEKN--SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~--~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
++...++||||+++++|.++++........ .....++..++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCC
Confidence 989999999999999999999764322111 1123467888999999999999999988 99999999999999999
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 729 (812)
.+||+|||++................++..|+|||++....++.++||||||+++|||++ |+.||..... ..
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----~~--- 229 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----EQ--- 229 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HH---
Confidence 999999999875543322222223355788999999998889999999999999999999 6777643211 11
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.......+... .. ....+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 230 -~~~~~~~~~~~-------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 230 -VLRFVMEGGLL-------DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -HHHHHHcCCcC-------CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111222111 01 12234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=340.28 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=191.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|+..++||+|+||.||++++. +++.||||++.... .......+.+|+++++.++|+||+++++++.+++..++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 34667889999999999999875 58999999985321 22345578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+... .......+++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 150 v~e~~~~~~L~~~~~------------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 150 LLEFMDGGSLEGTHI------------ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred EEecCCCCccccccc------------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccccc
Confidence 999999999875431 123455689999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-----CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
++....... ......||..|+|||++.. ...+.++|||||||+||||++|+.||...... +.... ...
T Consensus 215 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~----~~~~~-~~~ 287 (353)
T PLN00034 215 SRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG----DWASL-MCA 287 (353)
T ss_pred ceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc----cHHHH-HHH
Confidence 976543211 1234579999999998743 23456899999999999999999998632211 11111 111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+.... +..........+.+|+.+||+.||++|||++|++++
T Consensus 288 ~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 ICMSQ-----------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HhccC-----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11000 011112345568899999999999999999999987
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.56 Aligned_cols=263 Identities=25% Similarity=0.455 Sum_probs=206.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
.+|.+.+.||+|+||.||+|.+.+ ++.||+|++.... ..+..+.+.+|+++++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA----SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC----CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 458888999999999999998643 4789999876421 123456788999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCC------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTE------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
...++||||+++++|.++++...... ......+.+...+.++.|++.+|+|||+.+ |+||||||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcC
Confidence 99999999999999999997654211 111223478888999999999999999998 999999999999999
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchh
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 727 (812)
++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----~~- 232 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----EE- 232 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH----HH-
Confidence 99999999999875433322222334456789999999999999999999999999999998 9999854331 11
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
....+..+... . .....+..+.+++.+||..||++||+++||++.|++
T Consensus 233 ---~~~~~~~~~~~--------~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 ---VIECITQGRLL--------Q---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---HHHHHHcCCcC--------C---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11222222111 0 012344568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.64 Aligned_cols=260 Identities=22% Similarity=0.411 Sum_probs=201.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCc----EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGR----EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.+|++.+.||+|+||.||+|++. +++ .||+|++... ......+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 45899999999999999999864 333 3899987532 1123445688899999999999999999999864
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++++||+++|+|.+++...... +++...++++.||++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~-------~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~ 151 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDN-------IGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKIT 151 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcccc-------CCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEc
Confidence 568999999999999999765321 256777899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++................+..|+|||++....++.++||||||+++|||++ |+.||..... .+ .. .
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-------~~-~~-~ 222 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SE-IS-S 222 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HH-HH-H
Confidence 9999986654333222233345678999999999999999999999999999998 8888743210 11 11 1
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
+.... .+...+. .....+.+++.+||..+|++||++.+++..|.++.+..
T Consensus 223 ~~~~~------~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 223 ILEKG------ERLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHhCC------CCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 11111 1111111 12335778999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.14 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=203.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|-||.||.|+.+ ++-.||+|++.+.. ......+.++.+|++|-+.|+||||++++++|.++...||
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 45888999999999999999864 57789999987522 2333456788999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
++||..+|+|+..|........++. ....+..|+|.||.|+|..+ ++||||||+|+|++.++.+||+|||.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~------~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQ------RAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred EEEecCCchHHHHHHhccccccccc------chhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCc
Confidence 9999999999999985544333222 22468999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+..... ..-....||..|++||...+..++..+|+|++|++.||++.|..||..... +.....+..-
T Consensus 171 sV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~k~- 237 (281)
T KOG0580|consen 171 SVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIRKV- 237 (281)
T ss_pred eeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHHHc-
Confidence 865432 123456899999999999999999999999999999999999999964331 1122222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
++..| ..+....+++|.+|+.++|.+|.+..|++++-
T Consensus 238 -------~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 238 -------DLKFP----STISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -------cccCC----cccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 12222 33445577889999999999999999998763
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=355.00 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=208.9
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCC-cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEE-EEe--
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDG-REVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGF-CQE-- 573 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~-~~~-- 573 (812)
...++++.+.|.+|+|+.||+|+...+ .++|+|++... +.+..+.+.+|+++|+.|+ |+|||.+++. ...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 445688899999999999999998766 99999998652 3455678899999999997 9999999993 322
Q ss_pred ----CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC
Q 042346 574 ----KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 574 ----~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 649 (812)
.-+.+|.||||++|.|-|++..+.... ++..+.++|+.|+++|+++||... |||||||||-+||||+.+
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~------lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~ 182 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR------LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSAD 182 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhcc------CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCC
Confidence 135689999999999999998665433 355778999999999999999987 789999999999999999
Q ss_pred CcEEEEeecccccCCCCc-c-cc-----cccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCC
Q 042346 650 WTARVSDFGLSLLGSECD-Q-EF-----ISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNE 719 (812)
Q Consensus 650 ~~~kl~DfGla~~~~~~~-~-~~-----~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~ 719 (812)
++.||||||.+.-..... . .. ..-...-|+.|+|||.+. +.++++|+|||+|||+||-|+....||....
T Consensus 183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 999999999985322111 1 00 011235699999999874 7789999999999999999999999995432
Q ss_pred CCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 720 DGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
. ..+++.+...|. ...+...|.+||+.||+.||++||++-+|++++.+++..-
T Consensus 263 ~--------------------laIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 K--------------------LAILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred c--------------------eeEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1 122333333332 2567888999999999999999999999999998877543
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=330.05 Aligned_cols=266 Identities=25% Similarity=0.417 Sum_probs=208.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
.+|.+.+.||+|+||.||+++.. +...+++|.+... .....+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 35888999999999999999752 3456888887531 123345688999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCC--------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTE--------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~--------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
+..++||||+++++|.+++....... ......+++..+++++.||+.+|+|||+++ |+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEE
Confidence 99999999999999999997654211 011123578899999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCc
Q 042346 647 DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPL 725 (812)
Q Consensus 647 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 725 (812)
+.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||..... .
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~ 232 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----T 232 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----H
Confidence 9999999999999976544332222334557889999999998899999999999999999999 9988754331 1
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
. ....+..+.... . ....+..+.+++.+||+.+|++|||+++|++.|+++.+.
T Consensus 233 ~----~~~~~~~~~~~~-------~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 E----VIECITQGRVLE-------R----PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H----HHHHHhCCCCCC-------C----CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 122222222111 0 112345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=343.38 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=196.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..+|++.+.||+|+||.||++... .++.||+|+.. ...+.+|++++++|+||||+++++++..+...+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 467999999999999999999874 58899999642 124568999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+|+||+. ++|.+++..... +++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 160 lv~e~~~-~~L~~~l~~~~~--------l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG 227 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRN--------IAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG 227 (391)
T ss_pred EEEecCC-CCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCC
Confidence 9999995 689998865432 256778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCch---hHHHHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD---VVEFAVSQI 735 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~---~~~~~~~~~ 735 (812)
++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||+.......... .........
T Consensus 228 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~ 306 (391)
T PHA03212 228 AACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS 306 (391)
T ss_pred cccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh
Confidence 9965332111 122345799999999999998999999999999999999999998765332111100 000000000
Q ss_pred Hh----------cccccc-------ccccCC-CCC-CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LA----------GQLHCV-------LDKRVG-PPE-LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~----------~~~~~~-------~d~~~~-~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ..+... ...... .+. ....+.+..+.+|+.+||+.||++|||++|++++
T Consensus 307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 000000 000000 000 0112345678899999999999999999999964
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=340.67 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=198.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC--CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD--GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
++|++.+.||+|+||.||+|++++ +..||+|++.... .......+.+.+|+++++.++||||+++++++.+++..+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK--IIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 469999999999999999998643 3689999885311 112233456788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++|+|.+++..... +++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKR--------FPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCC
Confidence 99999999999999976532 255667889999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++...... .....||+.|||||++.+..++.++|||||||+||||++|+.||..... . .....+..+
T Consensus 177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~----~~~~~i~~~ 243 (340)
T PTZ00426 177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----L----LIYQKILEG 243 (340)
T ss_pred CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----H----HHHHHHhcC
Confidence 99765321 2345789999999999988899999999999999999999999864321 1 112222222
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
. ...+. .....+.+++.+||+.||++|+ +++|++++
T Consensus 244 ~--------~~~p~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 I--------IYFPK----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C--------CCCCC----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1 11122 2234567899999999999995 89999886
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.42 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=199.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
++|++.+.||+|+||.||+++++++..+|+|.+.... .....|.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4588899999999999999999888899999875321 1234678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.++++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 78 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 78 TEFMENGCLLNYLRQRQG-------KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred EEcCCCCcHHHHHHhCcc-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCc
Confidence 999999999999975432 1367788999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+....... .......++..|+|||.+....++.++||||||+++|||++ |+.||..... .+. ...+..+.
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~----~~~i~~~~ 218 (256)
T cd05114 148 RYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEV----VEMISRGF 218 (256)
T ss_pred cccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHH----HHHHHCCC
Confidence 75433221 11222345678999999988889999999999999999999 8888744321 111 11222211
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
+...+. .....+.+++.+||+.+|++||+++|+++.|
T Consensus 219 -------~~~~~~----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 -------RLYRPK----LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -------CCCCCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111111 1234578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.04 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=202.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.++|++.++||+|+||.||+|...+++.|++|.+... ....+.+.+|+.+++.++|+||+++++.+.+.+..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 3569999999999999999999888889999987531 1124578889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+|||+++++|.++++..... ..++..++.++.|++++|+|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 79 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGG------KVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred EEecCCCCcHHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCcc
Confidence 99999999999999754322 2366778899999999999999988 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+......... ......++..|+|||++....++.++||||||+++|||+| |+.||..... ......+..+
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~ 220 (261)
T cd05072 150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSALQRG 220 (261)
T ss_pred ceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcC
Confidence 9765432211 1223345678999999988889999999999999999998 8888743221 1111111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
. +... ....+..+.+++.+|+..+|++||+++++.+.|++
T Consensus 221 ~-------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 221 Y-------RMPR----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C-------CCCC----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 0111 11234568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=329.14 Aligned_cols=268 Identities=26% Similarity=0.431 Sum_probs=208.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
.++|.+.+.||+|+||.||++... ++..+++|.+... .......+.+|++++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 356889999999999999999742 3456899987532 12345578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCC-----ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTE-----KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~-----~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
.+..++||||+++++|.+++....... ......+++..+++++.|++.+|+|||+++ |+||||||+|||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~ 155 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGE 155 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEcc
Confidence 999999999999999999997543211 111223578889999999999999999998 999999999999999
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchh
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 727 (812)
++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~------- 228 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------- 228 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence 99999999999975543322222233456788999999998889999999999999999998 8888744321
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
......+..+.... .+ ...+..+.+|+.+||+.||.+|||++|+++.|+++.+..
T Consensus 229 -~~~~~~i~~~~~~~-------~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 229 -NEVIECITQGRVLQ-------RP----RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred -HHHHHHHHcCCcCC-------CC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 11122222222110 01 112345889999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.68 Aligned_cols=271 Identities=21% Similarity=0.252 Sum_probs=197.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++++ +++.||+|++..... .....+.+.+|+++++.++||||+++++++..++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE---NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc---cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 46999999999999999999985 578899999864221 12234567789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||++++.|..+..... .+++...+.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 78 v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 78 VFEYVEKNMLELLEEMPN--------GVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred EEecCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccC
Confidence 999999876665543221 1255677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH-------HH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF-------AV 732 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~-------~~ 732 (812)
+........ .......+++.|+|||++.+..++.++|||||||++|||++|+.||...........+... ..
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 147 ARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred ccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 976543221 1223456899999999999888999999999999999999999998543211100000000 00
Q ss_pred HHHHh-ccccccccccCCCCCC----ChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILA-GQLHCVLDKRVGPPEL----NEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~-~~~~~~~d~~~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... ........+....+.. .....+..+.+|+.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 0000000000000000 011245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.21 Aligned_cols=269 Identities=22% Similarity=0.344 Sum_probs=193.8
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-----
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD----- 575 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 575 (812)
+|++.++||+|+||.||+++.. +++.||||++.... ........+.+|+++++.++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF---EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh---ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 4889999999999999999864 68999999875321 11223346788999999999999999999886432
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+. ++|.+++..... +++.....++.||++||.|||+++ |+||||||+|||++.++.+||+
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKANDD--------LTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhccc--------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEc
Confidence 4799999995 689999865432 366778899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcc-cccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH----
Q 042346 656 DFGLSLLGSECDQ-EFISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV---- 728 (812)
Q Consensus 656 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~---- 728 (812)
|||+++....... ........+|+.|+|||++.. ..++.++|||||||++|||++|+.||....... ....+
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~ 224 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLL 224 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHh
Confidence 9999975432211 112234579999999999865 678999999999999999999999985432100 00000
Q ss_pred ----HHHHHHHHhccccccc---cccCCCC-CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 729 ----EFAVSQILAGQLHCVL---DKRVGPP-ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 729 ----~~~~~~~~~~~~~~~~---d~~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......+........+ .+....+ ..........+.+++.+||+.||++|||++|++++
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000 0000000 00001223557899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.48 Aligned_cols=268 Identities=24% Similarity=0.374 Sum_probs=203.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQ 572 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 572 (812)
.++|++.+.||+|+||.||+|.+. .++.||+|++.... .....+.+.+|++++.++ +|+||+++++++.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 457999999999999999999642 24789999885321 122345677899999999 8999999999886
Q ss_pred eC-CeEEEEEEecCCCchhhhhhcCCCCC---------------------------------------------------
Q 042346 573 EK-DERLLVYEYMSNGALHDHLHNKNNTE--------------------------------------------------- 600 (812)
Q Consensus 573 ~~-~~~~lV~ey~~~gsL~~~l~~~~~~~--------------------------------------------------- 600 (812)
.. ...+++|||+++++|.++|.......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 45789999999999999986532110
Q ss_pred --ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccC
Q 042346 601 --KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678 (812)
Q Consensus 601 --~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt 678 (812)
......++|..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++................++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 000124588999999999999999999998 999999999999999999999999999765433222223334567
Q ss_pred CCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHH
Q 042346 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAE 757 (812)
Q Consensus 679 ~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 757 (812)
..|+|||++.+..++.++|||||||+||||++ |+.||...... + .....+..+. +... +..
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~---~~~~~~~~~~-------~~~~----~~~ 300 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----E---EFCRRLKEGT-------RMRA----PEY 300 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----H---HHHHHHhccC-------CCCC----Ccc
Confidence 78999999999999999999999999999998 98887542211 1 1111111111 0111 122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 758 AVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 758 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
....+.+++.+||+.+|++||+++|++++|+++++
T Consensus 301 ~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 301 ATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 34568899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=330.61 Aligned_cols=271 Identities=25% Similarity=0.410 Sum_probs=209.2
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc--------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM--------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGF 570 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 570 (812)
..+|.+.+.||+|+||.||++++. ++..|++|.+... ........+.+|+++++.+ +||||++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 456888999999999999999742 2457999987531 1123346788999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCcc--------ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEKN--------SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~--------~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
+......++||||+++++|.+++......... ....+++..+++++.||++||+|||+++ |+||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 99999999999999999999999865432111 1123578888999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDG 721 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~ 721 (812)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||++||||++ |..||....
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-- 244 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-- 244 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--
Confidence 99999999999999999976544332222233456778999999988889999999999999999998 677763221
Q ss_pred CCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 722 SGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
.......+..+. +... ....+..+.+++.+||+.+|++|||+.|+++.|++++....+
T Consensus 245 ------~~~~~~~~~~~~-------~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 245 ------VEELFKLLKEGH-------RMDK----PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred ------HHHHHHHHHcCC-------cCCC----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 111122222211 1111 123455688999999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.14 Aligned_cols=266 Identities=22% Similarity=0.346 Sum_probs=192.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc--CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc---cCCCceEEEEEEEe--
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM--DGREVAVKREESCPKTNKLREKESAFDSELALLSRV---HHKHLVGLVGFCQE-- 573 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~-- 573 (812)
++|++.+.||+|+||.||+++.. +++.||+|++....... .....+.+|+++++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC---CchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 36899999999999999999863 46789999876422211 1123445666666655 69999999999853
Q ss_pred ---CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 574 ---KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 574 ---~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
....++||||++ ++|.+++...... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEP------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG 147 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCC
Confidence 345789999996 5999998754322 1366778899999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
.+||+|||++...... .......+|+.|+|||.+....++.++||||||+++|||++|+.||..... .+....
T Consensus 148 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~----~~~~~~ 220 (290)
T cd07862 148 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGK 220 (290)
T ss_pred CEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH----HHHHHH
Confidence 9999999999754332 223345789999999999888899999999999999999999999865332 111111
Q ss_pred HHHHHHh---ccc-------cccccccCCCC-CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 731 AVSQILA---GQL-------HCVLDKRVGPP-ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 731 ~~~~~~~---~~~-------~~~~d~~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
....... ..+ ...+..+...+ ......+...+.+++.+||+.||++|||+.|++++
T Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 221 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 1111000 000 00000000000 00001245667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=330.09 Aligned_cols=267 Identities=25% Similarity=0.401 Sum_probs=206.0
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFC 571 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 571 (812)
..++|++.+.||+|+||.||++.+.+ ...+++|++.... ..+....+.+|+++++++ +|+||+++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 44568999999999999999998642 3679999876321 122345688899999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCc--------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCC
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEK--------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSN 643 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~N 643 (812)
..++..+++|||+++++|.++++....... .....+++..+++++.|++.||+|||+.+ |+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 999999999999999999999976432111 11223578889999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 042346 644 ILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGS 722 (812)
Q Consensus 644 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~ 722 (812)
||++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 9999999999999999986554332222223345678999999988889999999999999999998 8888743221
Q ss_pred CCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 723 GPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
......+..+. .... .......+.+|+.+|++.||++|||++|+++.|+.++
T Consensus 241 ------~~~~~~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 ------EELFKLLKEGY-------RMEK----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HHHHHHHHcCC-------cCCC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111111 1111 1123446789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=327.49 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=201.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
.++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ....+..|.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4569999999999999999998753 5678888765321 12334568889999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC---
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW--- 650 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~--- 650 (812)
.+..++||||+++++|.++++........ ...+++..+++++.||+.+|+|||+.+ ++||||||+|||++.++
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPER-PSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCc
Confidence 88999999999999999999776533222 223588999999999999999999998 99999999999998764
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 729 (812)
.+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----~~~~~ 232 (277)
T cd05036 157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----QEVME 232 (277)
T ss_pred ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 599999999976533222111222334568999999998889999999999999999997 8888753221 11111
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
.+... .+... ...++..+.+++.+|++.+|++||++.+|+++|+
T Consensus 233 ----~~~~~-------~~~~~----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 ----FVTGG-------GRLDP----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----HHHcC-------CcCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111 01111 1223456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=326.46 Aligned_cols=269 Identities=24% Similarity=0.400 Sum_probs=209.4
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC-----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD-----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
..++|++.+.||+|+||.||+|.+.+ +..|++|++... ........+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 34679999999999999999998765 688999987532 223345678889999999999999999998776
Q ss_pred -CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 574 -KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 574 -~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
+...++++||+++++|.+++.............+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQV 156 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcE
Confidence 456799999999999999997654322222234578889999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||+++.....+.........++..|+|||++....++.++||||||+++||+++ |+.||.... +.++..
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~-- 230 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID----PFEMAA-- 230 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC----HHHHHH--
Confidence 9999999976544332222233456778999999998889999999999999999999 998885422 111111
Q ss_pred HHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 732 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
.+..+. +... ...+++.+.+++.+||..||++|||+.|+++.|+.+.+.
T Consensus 231 --~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 231 --YLKDGY-------RLAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred --HHHcCC-------CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 111110 1111 112345688999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.42 Aligned_cols=263 Identities=22% Similarity=0.348 Sum_probs=207.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+....+.+|+++++.++||||+++++++.+.+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE--MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc--cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 46899999999999999999864 68999999875321 1223445678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+|||+++++|.+++....... ..++....+.++.|+++||+|||+.+ |+|+||||+|||++.++.++|+|||+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~ 152 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQK----RLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred EEEecCCCcHHHHHHHhhhcc----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECcccc
Confidence 999999999999986432211 12355677899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ..+...
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~~~-~~~~~~- 223 (267)
T cd08228 153 GRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFSLC-QKIEQC- 223 (267)
T ss_pred ceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHHHH-HHHhcC-
Confidence 876543221 122346888999999998888999999999999999999999998543211 11111 111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
..+..........+.+++.+||+.+|++||+++|+++.|+++
T Consensus 224 ---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 ---------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---------CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111222344567789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=326.79 Aligned_cols=263 Identities=23% Similarity=0.414 Sum_probs=202.8
Q ss_pred CCcceeeeeccCCcEEEEEEEE-----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
++|++.+.||+|+||.||+|.+ .+++.+++|.+.... ..+....|.+|++++++++||||+++++++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4588899999999999999975 246789999886321 1233457888999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCC---------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTE---------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~---------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
..++||||+++++|.+++....... ......+++.+.+.++.|++.+|+|||+++ |+||||||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili 157 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILI 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEE
Confidence 9999999999999999996443211 011123477888999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCc
Q 042346 647 DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPL 725 (812)
Q Consensus 647 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 725 (812)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||++||||++ |..||.... ..
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~----~~ 233 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS----NQ 233 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----HH
Confidence 9999999999999976543322222333456778999999988889999999999999999999 888874322 11
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.+ ...+..... +.. ...++..+.+++.+|++.||++||++.+|+++|..
T Consensus 234 ~~----~~~~~~~~~-------~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EV----IEMVRKRQL-------LPC----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH----HHHHHcCCc-------CCC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 111111111 111 12234568889999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=327.85 Aligned_cols=266 Identities=27% Similarity=0.420 Sum_probs=204.1
Q ss_pred CcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
+|++.+.||+|+||.||+|+.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4788899999999999999753 23568888875321 1223457889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCc----------------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeecc
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEK----------------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI 639 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~----------------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl 639 (812)
..+++|||+.+++|.+++........ .....+++...+.++.|++.+|+|||+.+ |+||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 99999999999999999875432110 11123578888999999999999999988 999999
Q ss_pred CCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCC
Q 042346 640 KSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKN 718 (812)
Q Consensus 640 Kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~ 718 (812)
||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999975433222212223345678999999988889999999999999999998 88887432
Q ss_pred CCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 719 EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
. +..+ +...... . +...+ ......+.+++.+||+.+|++||++.|+++.|++++..
T Consensus 234 ~----~~~~----~~~~~~~-~------~~~~~----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 234 A----PERL----FNLLKTG-Y------RMERP----ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred C----HHHH----HHHHhCC-C------CCCCC----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1 1111 1111111 0 11111 22345688999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=336.65 Aligned_cols=243 Identities=24% Similarity=0.299 Sum_probs=192.2
Q ss_pred eccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCC
Q 042346 509 VGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNG 587 (812)
Q Consensus 509 LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 587 (812)
||+|+||.||+++.. +++.||+|++... ..........+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKA--HIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 799999999999875 5789999998531 1122334456788999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCc
Q 042346 588 ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667 (812)
Q Consensus 588 sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~ 667 (812)
+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 79 ELFHHLQREGR--------FDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred cHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 99999975432 255677889999999999999998 9999999999999999999999999987533221
Q ss_pred ccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccccccc
Q 042346 668 QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKR 747 (812)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 747 (812)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 148 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~~-------- 209 (312)
T cd05585 148 --DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQEP-------- 209 (312)
T ss_pred --CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCC--------
Confidence 123345799999999999999999999999999999999999999854321 11112222211
Q ss_pred CCCCCCChHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 042346 748 VGPPELNEAEAVELLATTAIHCVNLEGKERPN---ITDIVAN 786 (812)
Q Consensus 748 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~ 786 (812)
... +......+.+++.+||+.||++||+ +.|++.+
T Consensus 210 ~~~----~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 210 LRF----PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCC----CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 111 1234456789999999999999975 6777654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=336.05 Aligned_cols=204 Identities=25% Similarity=0.360 Sum_probs=171.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||+||+++.. +++.||+|++... .....+....+.+|++++.+++|+||+++++.+.++...+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKA--DMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHH--HHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 46899999999999999999875 5889999998631 11223344567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... ++......++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~E~~~gg~L~~~l~~~~~--------l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDT--------LTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred EEcCCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccC
Confidence 9999999999999976432 255667889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCccc---------------------------------ccccccccCCCccCccccccCcCCCcchhHHHHHHHH
Q 042346 660 SLLGSECDQE---------------------------------FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLL 706 (812)
Q Consensus 660 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ 706 (812)
++........ .......||+.|+|||++.+..++.++|||||||+||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 8754321100 0012347999999999999999999999999999999
Q ss_pred HHHcCCCCCCC
Q 042346 707 ELLTGKKAVFK 717 (812)
Q Consensus 707 elltG~~p~~~ 717 (812)
||++|+.||..
T Consensus 228 ell~G~~Pf~~ 238 (363)
T cd05628 228 EMLIGYPPFCS 238 (363)
T ss_pred HHHhCCCCCCC
Confidence 99999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.08 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=194.3
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecC
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMS 585 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 585 (812)
+.||+|+||.||+++.. +++.||+|++... ..........+.+|+++++.++||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKE--VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 46999999999999864 6899999998631 11122344567789999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCC
Q 042346 586 NGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665 (812)
Q Consensus 586 ~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~ 665 (812)
+++|.+++..... +++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 79 GGELFFHLSRERV--------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred CCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 9999999865432 256777889999999999999998 99999999999999999999999999865322
Q ss_pred CcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccccc
Q 042346 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLD 745 (812)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 745 (812)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ......+....
T Consensus 148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~~------ 211 (323)
T cd05595 148 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE------ 211 (323)
T ss_pred CC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCC------
Confidence 11 122345789999999999988999999999999999999999999854321 11111111111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 746 KRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 746 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
...+ ......+.+++.+||+.||++|| ++.+++++
T Consensus 212 --~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 212 --IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --CCCC----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1111 12345678999999999999998 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=353.19 Aligned_cols=261 Identities=24% Similarity=0.303 Sum_probs=203.3
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
....++|++.+.||+|+||.||+++. .+++.||||++..... .......+.+|+.++..++|+||++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 33457899999999999999999986 4689999999864221 2334456788999999999999999988775433
Q ss_pred --------eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc
Q 042346 576 --------ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD 647 (812)
Q Consensus 576 --------~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~ 647 (812)
..++||||+++|+|.++|+...... ..++......++.|++.||.|||+.+ |+||||||+|||++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~----~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~ 177 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTN----RTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLC 177 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEe
Confidence 2579999999999999997543221 12356677889999999999999998 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 648 VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 648 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
.++.+||+|||+++...............||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-------- 249 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-------- 249 (496)
T ss_pred CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------
Confidence 999999999999976544322233345679999999999999999999999999999999999999985322
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..........+.... .+...+..+.+++.+||+.||.+||++.+++.+
T Consensus 250 ~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 250 MEEVMHKTLAGRYDP-----------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHHhcCCCCC-----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111222222222110 112334568899999999999999999999875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=320.35 Aligned_cols=257 Identities=24% Similarity=0.288 Sum_probs=205.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+.|++++.||.|.-|+||++++++ +..+|+|++.+ .....+++..+...|-+||+.++||.+..||..|+.++..+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK--~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDK--ESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecH--HHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 347788999999999999999865 58999999975 333445666777889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+||||+||+|+.+++++...... .....=++..++.||+|||..+ ||.|||||+||||.++|++.|+||.|
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fs------e~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDL 225 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFS------ESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDL 225 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccc------hhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccc
Confidence 99999999999999887665433 2333458889999999999999 99999999999999999999999999
Q ss_pred cccCCC---------------------------------Ccc---------------------cccccccccCCCccCcc
Q 042346 660 SLLGSE---------------------------------CDQ---------------------EFISTKAVGTVGYIDPE 685 (812)
Q Consensus 660 a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE 685 (812)
+..... ... ...+...+||-+|+|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 742110 000 01123457999999999
Q ss_pred ccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHH
Q 042346 686 YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATT 765 (812)
Q Consensus 686 ~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l 765 (812)
++.+...+.++|.|+|||+|||||.|+.||..........+ ++-+.+..|.. .+.....++|
T Consensus 306 vI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N----------------Iv~~~l~Fp~~--~~vs~~akDL 367 (459)
T KOG0610|consen 306 VIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN----------------IVGQPLKFPEE--PEVSSAAKDL 367 (459)
T ss_pred eeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH----------------HhcCCCcCCCC--CcchhHHHHH
Confidence 99999999999999999999999999999976554332211 22222333332 2556678999
Q ss_pred HHHccccCCCCCCC----HHHHHHH
Q 042346 766 AIHCVNLEGKERPN----ITDIVAN 786 (812)
Q Consensus 766 i~~Cl~~dP~~RPt----~~evl~~ 786 (812)
|++.|.+||++|.- +.||.+|
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcC
Confidence 99999999999998 8888765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=338.13 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=194.4
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecC
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMS 585 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 585 (812)
++||+|+||.||+++.. +++.||+|++... ..........+.+|+++++.++||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKE--VIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999864 5899999998642 11123344577889999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCC
Q 042346 586 NGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665 (812)
Q Consensus 586 ~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~ 665 (812)
+++|.+++..... +++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~g~L~~~l~~~~~--------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 79 GGELFFHLSRERV--------FSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred CCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 9999999865432 256777889999999999999998 99999999999999999999999999875322
Q ss_pred CcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccccc
Q 042346 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLD 745 (812)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 745 (812)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ......+...
T Consensus 148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~~~------- 210 (328)
T cd05593 148 DA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILME------- 210 (328)
T ss_pred cc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhccC-------
Confidence 11 122345799999999999988999999999999999999999999854321 1111111111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 746 KRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 746 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
....+ ......+.+++.+||..||++|| +++|++++
T Consensus 211 -~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 211 -DIKFP----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CccCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11111 12345578899999999999997 89999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=334.37 Aligned_cols=200 Identities=25% Similarity=0.373 Sum_probs=170.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.++||+|+||.||++.+. +++.+|+|++.... .......+.+|+++++.++||||++++++|.+++..+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 467999999999999999999875 57888999875421 1234457889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... +.+....+++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGR--------IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred EEEecCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCC
Confidence 99999999999999975432 245666789999999999999853 29999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCC
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 717 (812)
++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 150 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred cchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 98654321 12334689999999999988899999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=330.93 Aligned_cols=270 Identities=26% Similarity=0.399 Sum_probs=206.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc--------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM--------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGF 570 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 570 (812)
.++|.+.+.||+|+||.||++++. +...+|+|.+.... .......+.+|+++++.+ +||||++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 356999999999999999999753 23569999886421 122345678899999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCc--------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEK--------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
+.+.+..++||||+++++|.+++........ .....+++..+++++.|++.||+|||+.+ ++||||||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 169 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHH
Confidence 9999999999999999999999976543210 11123578899999999999999999988 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDG 721 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~ 721 (812)
|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-- 247 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-- 247 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC--
Confidence 99999999999999999875543221111222234578999999998889999999999999999998 777763221
Q ss_pred CCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcc
Q 042346 722 SGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795 (812)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 795 (812)
.+.....+..+. +... .......+.+|+.+||..+|++|||+.|+++.|+++++...
T Consensus 248 ------~~~~~~~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 248 ------VEELFKLLKEGH-------RMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ------HHHHHHHHHcCC-------CCCC----CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 111111111111 1111 12334568889999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=343.49 Aligned_cols=256 Identities=23% Similarity=0.302 Sum_probs=193.3
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.|++.+.||+|+||.||++++. +++.||+|++... .....+....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK--DVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 5889999999999999999864 5789999998631 112233456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++|+|.+++..... ++......++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++
T Consensus 80 ~E~~~gg~L~~~l~~~~~--------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEV--------FPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred EecCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 999999999999976532 244556678899999999999998 999999999999999999999999997
Q ss_pred ccCCCCcc---------------------------------------------cccccccccCCCccCccccccCcCCCc
Q 042346 661 LLGSECDQ---------------------------------------------EFISTKAVGTVGYIDPEYYVMNVLTAK 695 (812)
Q Consensus 661 ~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k 695 (812)
........ ........||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 53211000 001123479999999999998889999
Q ss_pred chhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHH--ccccC
Q 042346 696 TDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIH--CVNLE 773 (812)
Q Consensus 696 sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~--Cl~~d 773 (812)
+|||||||++|||++|+.||...... .....+.... ..+..+. .......+.+|+.+ |+..+
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~--------~~~~~i~~~~------~~~~~~~--~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPT--------ETQLKVINWE------NTLHIPP--QVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHH--------HHHHHHHccc------cccCCCC--CCCCCHHHHHHHHHHccCccc
Confidence 99999999999999999998653311 0111111100 0111111 11123345566666 55667
Q ss_pred CCCCCCHHHHHHH
Q 042346 774 GKERPNITDIVAN 786 (812)
Q Consensus 774 P~~RPt~~evl~~ 786 (812)
+..||+++|++.+
T Consensus 293 ~~~R~~~~~~l~h 305 (381)
T cd05626 293 RLGRNGADDIKAH 305 (381)
T ss_pred ccCCCCHHHHhcC
Confidence 7779999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.67 Aligned_cols=258 Identities=21% Similarity=0.392 Sum_probs=198.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCc----EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGR----EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
++|++.+.||+|+||.||+|++. +++ ++++|.+... .......++..|+.++++++||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR----SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc----cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 35788899999999999999874 344 4777776421 112334567788999999999999999998754 4
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++++||+++|+|.+++..... .+++...++++.||+.||+|||+.+ ++||||||+|||+++++.+||+
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~ 151 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRD-------SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIA 151 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEc
Confidence 57899999999999999975432 1367788899999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||..... ... ...
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~----~~~ 223 (279)
T cd05111 152 DFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEV----PDL 223 (279)
T ss_pred CCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHH----HHH
Confidence 9999976544333333344567789999999998889999999999999999998 8888754321 111 111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
+..+. +...+.. ....+.+++.+|+..||++|||+.|+++.|+.+.+
T Consensus 224 ~~~~~-------~~~~~~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 224 LEKGE-------RLAQPQI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHCCC-------cCCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11111 1111111 22346788999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=350.08 Aligned_cols=254 Identities=22% Similarity=0.245 Sum_probs=199.3
Q ss_pred CcceeeeeccCCcEEEEEEEEc-C-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-D-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.|.+.+.||+|+||.||+|... + ++.|++|.+... .......+.+|+++++.++||||+++++++..++..+|
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 3889999999999999999753 3 577888876431 12233467789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.++|+..... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 143 v~E~~~gg~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgl 215 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKE----HLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGF 215 (478)
T ss_pred EEECCCCCCHHHHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcC
Confidence 99999999999998653211 112356677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++...............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~ 287 (478)
T PTZ00267 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYGK 287 (478)
T ss_pred ceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence 9765443222233455799999999999999999999999999999999999999853221 11222222222
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. .. +......+.+++.+||..||++||++++++.+
T Consensus 288 ~~-------~~----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 288 YD-------PF----PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CC-------CC----CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11 00 11234568899999999999999999998753
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.34 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=198.2
Q ss_pred cceeeeeccCCcEEEEEEEEcCCc---EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC-----
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGR---EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK----- 574 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~---~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----- 574 (812)
|.+.+.||+|+||.||+|++.+.. .+|+|.+.... ......+.+.+|+++++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 346789999999999999875432 68999875421 1233456788899999999999999999987532
Q ss_pred -CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 575 -DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 575 -~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
...+++|||+++++|.+++...... .....+++...+.++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 152 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLG--DCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVC 152 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhccc--CCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEE
Confidence 2358999999999999988543221 11223478888999999999999999988 99999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|+|||+++................++.|++||.+....++.++||||||+++|||++ |+.||.... ... ..
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~----~~ 224 (272)
T cd05075 153 VADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE----NSE----IY 224 (272)
T ss_pred ECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC----HHH----HH
Confidence 999999976543222112223346778999999999899999999999999999999 677764321 111 12
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
..+..+.. ...+ ...++.+.+++.+||+.||++|||++|+++.|++++
T Consensus 225 ~~~~~~~~-------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 225 DYLRQGNR-------LKQP----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred HHHHcCCC-------CCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 22222211 1111 123455889999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=343.68 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=198.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.++||+|+||.||+++.. +++.||+|++... ..........+.+|+++++.++||||+++++++.+++..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF--EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4567999999999999999999875 5889999998531 111123344577899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++|+|.+++..... +......++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l---------~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDI---------PEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCC---------CHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEec
Confidence 999999999999999965421 33455678999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccC----cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN----VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|++........ .......||+.|+|||++... .++.++|||||||+||||++|+.||..... .....
T Consensus 187 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~ 257 (370)
T cd05596 187 GTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYS 257 (370)
T ss_pred cceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHH
Confidence 99876433211 122345799999999998653 478899999999999999999999864331 11112
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKE--RPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 786 (812)
.+..... .+..+. ....+..+.+++.+||+.+|++ ||+++|++++
T Consensus 258 ~i~~~~~------~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 258 KIMDHKN------SLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHcCCC------cCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 2222110 111111 1224556788999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.57 Aligned_cols=267 Identities=23% Similarity=0.293 Sum_probs=194.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ......+.+|+++++.++||||+++++++.+++..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE----EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc----cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 467999999999999999999875 688999999864221 112235678999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+. ++|.+++...... +.......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg 148 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHPGG-------LHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFG 148 (303)
T ss_pred EEEECCC-cCHHHHHHhCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCC
Confidence 9999995 6888888654321 244566789999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++....... .......+|+.|+|||++.+ ..++.++|||||||+||||++|+.||....+. .............
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~ 223 (303)
T cd07869 149 LARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI---QDQLERIFLVLGT 223 (303)
T ss_pred cceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhCC
Confidence 986543221 12234568999999998865 45888999999999999999999998643211 1111111100000
Q ss_pred cc---c------cccccccCC--CCCCCh-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQ---L------HCVLDKRVG--PPELNE-----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~---~------~~~~d~~~~--~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. + ......+.. .+.... ......+.+|+.+||+.||++|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 0 000000000 000000 0122457799999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.07 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=202.1
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..++|++.+.||+|+||.||++.+.+++.||+|.+.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc------ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 345699999999999999999998788899999876421 12346888999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
++|||+++++|.+++..... ..+++..+.+++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 78 lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAG------RALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred eeeecccCCcHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcc
Confidence 99999999999999975431 12367888999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++........ ........+..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+..
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~ 219 (261)
T cd05068 149 LARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQ 219 (261)
T ss_pred eEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc
Confidence 9976542211 11111223458999999998899999999999999999999 8888743221 111111111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.. .... ....+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 220 ~~-------~~~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 220 GY-------RMPC----PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CC-------CCCC----CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 10 0111 12334568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.29 Aligned_cols=265 Identities=22% Similarity=0.296 Sum_probs=195.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.++||+|+||.||+++.+ +++.||+|++..... ......+.+|+++++.++||||+++++++.+++..++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE----EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc----CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 46999999999999999999875 588999998854211 1123456789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++ +|.+++..... .+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 v~e~~~~-~l~~~l~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGN-------LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred EEeCCCc-CHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcc
Confidence 9999975 99999865432 1256677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH---
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI--- 735 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--- 735 (812)
++...... .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+.........
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~ 223 (288)
T cd07871 150 ARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV----KEELHLIFRLLGTP 223 (288)
T ss_pred eeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCC
Confidence 86543221 12234568999999998865 5689999999999999999999999854321 11111111100
Q ss_pred --------Hhc-cccccccccCCC-C-CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 --------LAG-QLHCVLDKRVGP-P-ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 --------~~~-~~~~~~d~~~~~-~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... .+.....+.... + ..........+.+|+.+||+.||.+|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 224 TEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000000000000 0 00001123457799999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=341.91 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=197.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.||||++... ..........+.+|+++++.++||||+++++++.+++..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS--EMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 46899999999999999999875 5889999998631 11122344567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... ++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~E~~~~g~L~~~l~~~~~--------l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDT--------FTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred EECCCCCcHHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeeccc
Confidence 9999999999999976432 255667789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccc------------------------------------cccccccCCCccCccccccCcCCCcchhHHHHH
Q 042346 660 SLLGSECDQEF------------------------------------ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGV 703 (812)
Q Consensus 660 a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv 703 (812)
+.......... ......||+.|+|||++....++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 86532211000 011246999999999999989999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC---H
Q 042346 704 VLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN---I 780 (812)
Q Consensus 704 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~ 780 (812)
++|||++|+.||..... .. ....+.... ..+..+. .....+.+.+++.+|+. +|.+|++ +
T Consensus 228 il~el~~G~~Pf~~~~~----~~----~~~~i~~~~------~~~~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 228 IMYEMLVGYPPFCSDNP----QE----TYRKIINWK------ETLQFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred HHHHhhcCCCCCCCCCH----HH----HHHHHHcCC------CccCCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 99999999999854321 11 111111111 1111111 11234457788888986 9999997 9
Q ss_pred HHHHHH
Q 042346 781 TDIVAN 786 (812)
Q Consensus 781 ~evl~~ 786 (812)
+|++++
T Consensus 291 ~~ll~h 296 (364)
T cd05599 291 NEIKSH 296 (364)
T ss_pred HHHhcC
Confidence 999885
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=341.99 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=199.3
Q ss_pred HHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 496 LAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 496 l~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
+....++|++.+.||+|+||.||++++. +++.+|+|++... ..........+.+|+.+++.++||||+++++++.++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 3444578999999999999999999875 4788999998531 111223345678899999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
+..++||||+++|+|.+++.... ++......++.||+.||+|||+++ |+||||||+|||+++++.+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~---------~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL 183 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNYD---------VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKL 183 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEE
Confidence 99999999999999999996542 134556789999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccC----cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN----VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
+|||++........ .......||+.|+|||++... .++.++|||||||+||||++|+.||..... ..
T Consensus 184 ~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~ 254 (370)
T cd05621 184 ADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VG 254 (370)
T ss_pred EecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HH
Confidence 99999976543221 122345799999999998754 378899999999999999999999964321 11
Q ss_pred HHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKE--RPNITDIVAN 786 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 786 (812)
....+..... .+..+. ..+....+.+++.+||..++.+ ||+++|++++
T Consensus 255 ~~~~i~~~~~------~~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 255 TYSKIMDHKN------SLNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHhCCc------ccCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1122222110 111111 2234566778888899755543 8999999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.60 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=201.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.||+|++... ..........+.+|++++..++||||+++++++.+++..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS--DMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHH--HHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 46999999999999999999875 6899999998631 11122345678889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... ++....+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~e~~~~~~L~~~l~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDV--------FPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred EEcCCCCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCC
Confidence 9999999999999976522 245667789999999999999988 99999999999999999999999999
Q ss_pred cccCCCCc---------------------------ccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCC
Q 042346 660 SLLGSECD---------------------------QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712 (812)
Q Consensus 660 a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~ 712 (812)
+....... .........||+.|+|||++.+..++.++|||||||+||||++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 97654322 001223457999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 042346 713 KAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-ITDIVAN 786 (812)
Q Consensus 713 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~ 786 (812)
.||..... ......+.... .....+.. ...+..+.+++.+|+. ||.+||+ ++|++++
T Consensus 228 ~Pf~~~~~--------~~~~~~i~~~~------~~~~~p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 228 PPFYSDTL--------QETYNKIINWK------ESLRFPPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCH--------HHHHHHHhccC------CcccCCCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99864331 11111111100 11111111 1145567889999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=342.22 Aligned_cols=269 Identities=25% Similarity=0.371 Sum_probs=206.0
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGF 570 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~ 570 (812)
...++|.+.++||+|+||.||++++. .++.||+|++..... ....+.+.+|++++.++. ||||++++++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR----SSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC----hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 34456888999999999999999863 246899999864211 222346889999999997 9999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCC--------------------------------------------------
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTE-------------------------------------------------- 600 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~-------------------------------------------------- 600 (812)
+..++..++||||+++|+|.++|+......
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999997643210
Q ss_pred ----------------------------------------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccC
Q 042346 601 ----------------------------------------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIK 640 (812)
Q Consensus 601 ----------------------------------------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlK 640 (812)
......+++...++++.||+.||+|||+.+ |+|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCC
Confidence 001123577888999999999999999987 9999999
Q ss_pred CCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCC
Q 042346 641 SSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNE 719 (812)
Q Consensus 641 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~ 719 (812)
|+|||+++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999975433222112223457789999999998889999999999999999998 788874322
Q ss_pred CCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 720 DGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
. .+.....+..+. ++..+ ......+.+|+.+||..+|.+||+++||++.|++++
T Consensus 347 ~-------~~~~~~~~~~~~-------~~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 M-------NEQFYNAIKRGY-------RMAKP----AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred c-------hHHHHHHHHcCC-------CCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 111111111111 11111 123456889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=327.11 Aligned_cols=262 Identities=22% Similarity=0.358 Sum_probs=202.6
Q ss_pred CcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
+|++.+.||+|+||.||+|.+.+ ++.||+|++.... .....+.|.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 47778999999999999998632 5789999986422 1233456888999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCC--------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTE--------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD 647 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~--------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~ 647 (812)
..++++||+.+++|.+++....... ......+++..+++++.|++.||+|||+.+ |+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 9999999999999999986432111 011123467788899999999999999998 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCch
Q 042346 648 VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLD 726 (812)
Q Consensus 648 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~ 726 (812)
+++.+||+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------ 232 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 232 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999999876544332222334456789999999988889999999999999999998 7777643221
Q ss_pred hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
......+..+... .....++..+.+++.+||+.+|++||++++|+..|+.
T Consensus 233 --~~~~~~i~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 --QDVIEMIRNRQVL-----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHHHHHcCCcC-----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1112222222111 0112345668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=327.18 Aligned_cols=267 Identities=25% Similarity=0.403 Sum_probs=204.0
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ 572 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 572 (812)
..++|++.++||+|+||.||+|..++ +..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA----SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 45679999999999999999997532 4579999875321 1223346788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCcc--ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEKN--SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~--~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
+.+..++||||+++|+|.+++......... ......+...++++.|++.||.|||+++ |+||||||+|||+++++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~ 156 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDF 156 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCC
Confidence 999999999999999999999764322111 1122356777899999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 729 (812)
.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||..... .+
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~--- 229 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQ--- 229 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HH---
Confidence 999999999876543332222233345778999999998889999999999999999999 6777643211 11
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
....+..+... ..+ ...+..+.+++.+||+.||++|||+.|+++.|++.+
T Consensus 230 -~~~~~~~~~~~-------~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 230 -VLKFVMDGGYL-------DQP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -HHHHHHcCCCC-------CCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111111110 011 122456889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=327.36 Aligned_cols=255 Identities=27% Similarity=0.328 Sum_probs=200.2
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||++... +++.||+|++.... .........+.+|+++++.++||||+++++.+..++..++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhh--hhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 4788999999999999999864 68899999986321 11223345677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++...... .+++...+.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++
T Consensus 79 ~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNP------GFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EeccCCCcHHHHHHhcCcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999988653221 1366778899999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
....... ......|++.|+|||++....++.++||||||+++|||++|+.||...... ...+.....+....
T Consensus 150 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~- 221 (285)
T cd05605 150 VEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK----VKREEVERRVKEDQ- 221 (285)
T ss_pred eecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh----hHHHHHHHHhhhcc-
Confidence 7643221 123447899999999999888999999999999999999999998643211 11111111111110
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
.......+..+.+|+.+||..||++|| ++++++++
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011233556688999999999999999 88899776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.11 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=201.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.+|++.+.||+|+||.||++.+. .++.|++|++... ......+.+|+++++.++|+||+++++++..++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 45888999999999999999875 4889999987532 1123468889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+|||+++++|.+++...... .+++..++.++.|++++|+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCC------CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcc
Confidence 99999999999999654321 2367778899999999999999988 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+......... .......+..|+|||.+.+..++.++||||||+++|||++ |..||.... .+.....+..+
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~~~~ 221 (263)
T cd05052 151 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKG 221 (263)
T ss_pred ccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCC
Confidence 8765432211 1112234668999999998899999999999999999998 888874322 11111222111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
. +... ....+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 222 -~------~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 -Y------RMER----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -C------CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0 1111 122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=336.08 Aligned_cols=256 Identities=24% Similarity=0.276 Sum_probs=196.7
Q ss_pred CcceeeeeccCCcEEEEEEEE----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 502 NFSLENKVGIGSFGTVYKGKL----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
+|++.+.||+|+||.||+++. .+++.||+|++..... .......+.+.+|+++++.+ +||||+++++++.+++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 488999999999999999975 3578999999863211 11122345677899999999 59999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++|+|.+++..... +++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDN--------FSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEee
Confidence 9999999999999999975432 245667789999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
||+++........ ......||+.|+|||++.+. .++.++|||||||+||||++|+.||........ .......+
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~ 223 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRI 223 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHH
Confidence 9998754332211 22345799999999998765 478899999999999999999999864332111 11111111
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
... +. .. .......+.+++.+||+.||++|| ++++++++
T Consensus 224 ~~~------~~--~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 224 LKC------DP--PF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred hcC------CC--CC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111 11 11 122345678899999999999999 78888875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=323.53 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=204.2
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
...+|++.++||+|+||.||+|.+.+++.+++|.+.... ......+.+|+++++.++|+||+++++++.+.+..+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 345688999999999999999999889999999976421 223446888999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.++++..... .+++..+++++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQ------VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred EEEeecccCCHHHHHhcCCCC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEcccc
Confidence 999999999999999764321 2367788899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++........ ......++..|+|||.+....++.++||||||+++|||++ |+.||..... .. ....+..
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~----~~~~~~~ 219 (261)
T cd05148 150 LARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HE----VYDQITA 219 (261)
T ss_pred chhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HH----HHHHHHh
Confidence 9976533211 1223346778999999988889999999999999999998 7888743221 11 1111111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
+. +... +...++.+.+++.+||+.||++|||++++++.|+.
T Consensus 220 ~~-------~~~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 220 GY-------RMPC----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CC-------cCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 10 1111 12334568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.06 Aligned_cols=269 Identities=24% Similarity=0.339 Sum_probs=199.6
Q ss_pred cceeeeeccCCcEEEEEEEE-----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--C
Q 042346 503 FSLENKVGIGSFGTVYKGKL-----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--D 575 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~ 575 (812)
|++.+.||+|+||.||++.. .+++.||+|.+.... .......|.+|+++++.++||||+++++++... .
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 48889999999999988653 357889999876421 122345688899999999999999999988754 3
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..+++|||+++++|.+++.... +++..++.++.|+++||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~---------l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~ 149 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHK---------LNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIG 149 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEe
Confidence 5789999999999999996532 367888999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccc-cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEF-ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||++.......... ......++..|+|||.+....++.++||||||+++|||++|+.|+....... .+........
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~ 227 (283)
T cd05080 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQ 227 (283)
T ss_pred ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccc
Confidence 999997654322211 1122345667999999988889999999999999999999999975422110 0000000000
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
.....+....+.....+ .+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 228 MTVVRLIELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cchhhhhhhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00001111111111111 11234567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.23 Aligned_cols=264 Identities=25% Similarity=0.334 Sum_probs=204.8
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
..++|.++++||+|.||+|+++.++ +++.+|||.+++... -.++..+....|-+|+... +||.|+.++..|+.+++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I--l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI--LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce--eccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3467999999999999999999875 578999999876332 2234455667788888777 59999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
+|+||||+.||++..+++.... +.....=++..|+.||.|||+++ ||+||||.+|||||.+|.+||+|
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F---------~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiAD 511 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVF---------SEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIAD 511 (694)
T ss_pred EEEEEEecCCCcEEEEEecccc---------cHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecc
Confidence 9999999999996666554332 22333458999999999999999 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|||.+..... ...+.+..|||.|||||++.+..|+..+|.|||||+|||||.|..||..+++. .....++
T Consensus 512 FGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------e~FdsI~ 581 (694)
T KOG0694|consen 512 FGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------EVFDSIV 581 (694)
T ss_pred cccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHh
Confidence 9999864422 22466789999999999999999999999999999999999999999755431 1222222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH-------HHHHHHhcccCC
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI-----TDIVAN-------LERALAICQDCS 798 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~-------Le~~~~~~~~~~ 798 (812)
. .....| ..++.+...|+.++|.++|++|.-+ ++|.++ .+++.+.-.++|
T Consensus 582 ~--------d~~~yP----~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PP 643 (694)
T KOG0694|consen 582 N--------DEVRYP----RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPP 643 (694)
T ss_pred c--------CCCCCC----CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCC
Confidence 2 122223 3344455677788999999999855 555543 355666665554
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=338.58 Aligned_cols=256 Identities=24% Similarity=0.303 Sum_probs=199.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKS--VLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 46899999999999999999874 6889999998641 11223445678889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~e~~~~~~L~~~l~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYED-------QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred EECCCCCCCHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCC
Confidence 9999999999999976522 1255666789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccc------cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYV------MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
+........ .......+|+.|+|||++. ...++.++||||||++||||++|+.||..... .....
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~ 219 (330)
T cd05601 149 AARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYN 219 (330)
T ss_pred CeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHH
Confidence 976543222 1223457899999999986 45678999999999999999999999854321 11111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.... ..+..+. .......+.+|+.+||+ +|.+|||+++++.+
T Consensus 220 ~i~~~~------~~~~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 220 NIMNFQ------RFLKFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHcCC------CccCCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 222111 0011111 11234557788889998 99999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=316.35 Aligned_cols=265 Identities=21% Similarity=0.246 Sum_probs=197.8
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe--CCeEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE--KDERL 578 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~ 578 (812)
+|+.+++|++|.||.||+|+++ +++.||+|+++........ ...-.+||.+|.+.+|||||.+.++... -+..|
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF---PItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF---PITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC---cchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4888999999999999999874 5889999998754322211 2234689999999999999999888754 34689
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
||||||+. +|...|+..... +...+..-+..|+++||+|||... |+|||||++|+|++..|.+||+|||
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~-------F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQP-------FLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCC-------CchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccc
Confidence 99999987 999999876522 244556678999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
||+.+... ....+..+-|..|+|||.+.+ ..|+...|+||+|||+.||+++++.|....+ .+..+.+...+-.
T Consensus 223 LAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE----~dQl~~If~llGt 296 (419)
T KOG0663|consen 223 LAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE----IDQLDKIFKLLGT 296 (419)
T ss_pred hhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch----HHHHHHHHHHhCC
Confidence 99977653 234667789999999999986 5699999999999999999999887754332 2223322222111
Q ss_pred cc------ccccccc-cCCCCCCCh---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQ------LHCVLDK-RVGPPELNE---------AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~------~~~~~d~-~~~~~~~~~---------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. +.++... .+..+.... ....+.=++|+...|..||.+|-|++|.|++
T Consensus 297 Pte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 297 PSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 0000000 011111111 1123455688889999999999999999875
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.45 Aligned_cols=261 Identities=27% Similarity=0.387 Sum_probs=199.5
Q ss_pred cceeeeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe--
Q 042346 503 FSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE-- 576 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-- 576 (812)
|.+.+.||+|+||.||+|.+.. +..||+|++..... .......+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 5678999999999999998642 36799998864211 12334578899999999999999999998876554
Q ss_pred ----EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 577 ----RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 577 ----~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
.+++|||+++++|.+++........ ...+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGL--PEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTV 152 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCC--cccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeE
Confidence 6899999999999999865432211 123477888999999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||+++................+..|+|||.+....++.++||||||+++|||++ |..||..... .+..
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~--- 225 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIY--- 225 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHH---
Confidence 9999999976543322222222345678999999988889999999999999999999 7777643221 1111
Q ss_pred HHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 732 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
..+..+. .... .......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 226 -~~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 226 -DYLRHGN-------RLKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -HHHHcCC-------CCCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111 1111 123445688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=341.76 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=194.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.++||+|+||.||+++.. +++.||||++... .....+....+.+|+++++.++||||+++++++.+.+..|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS--EMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--HHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 46899999999999999999864 6889999998531 11123345678889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... ++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~E~~~gg~L~~~l~~~~~--------~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDT--------FSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred EEeCCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999975432 244556678999999999999998 99999999999999999999999999
Q ss_pred cccCCCCccc---------------------------------------------ccccccccCCCccCccccccCcCCC
Q 042346 660 SLLGSECDQE---------------------------------------------FISTKAVGTVGYIDPEYYVMNVLTA 694 (812)
Q Consensus 660 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 694 (812)
++........ .......||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 8632211000 0001246999999999999989999
Q ss_pred cchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCC
Q 042346 695 KTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEG 774 (812)
Q Consensus 695 ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP 774 (812)
++|||||||+||||++|+.||..... .+ ....+.... ..+..+. .......+.+++.+||. +|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~----~~----~~~~i~~~~------~~~~~p~--~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENS----HE----TYRKIINWR------ETLYFPD--DIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCH----HH----HHHHHHccC------CccCCCC--CCCCCHHHHHHHHHHhc-CH
Confidence 99999999999999999999854321 11 111111110 0111111 11233457788888997 66
Q ss_pred CCC---CCHHHHHHH
Q 042346 775 KER---PNITDIVAN 786 (812)
Q Consensus 775 ~~R---Pt~~evl~~ 786 (812)
.+| +++.|++++
T Consensus 291 ~~r~~r~~~~~~l~h 305 (377)
T cd05629 291 ENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCHHHHhcC
Confidence 665 599999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.57 Aligned_cols=269 Identities=25% Similarity=0.416 Sum_probs=205.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-Cc--EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GR--EVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
++|++.+.||+|+||.||+|.+++ +. .+++|.+.... .....+.|.+|++++.++ +||||+++++++.+.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA----SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC----CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 568999999999999999998754 33 46888765311 122345688899999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCcc--------ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKN--------SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~--------~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
.+++|||+++++|.++++........ ....+++...++++.|++.||+|||+.+ |+||||||+|||+++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~ 154 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGE 154 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECC
Confidence 99999999999999999764422111 1123578888999999999999999988 999999999999999
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchh
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 727 (812)
++.+||+|||++...... ........+..|+|||++....++.++||||||+++|||++ |+.||..... .+
T Consensus 155 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----~~- 226 (297)
T cd05089 155 NLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----AE- 226 (297)
T ss_pred CCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HH-
Confidence 999999999998642211 11111233567999999998889999999999999999998 9888854321 11
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
....+..+. ....+ ..++..+.+|+.+||+.+|.+|||++++++.|+.++.......
T Consensus 227 ---~~~~~~~~~-------~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 227 ---LYEKLPQGY-------RMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred ---HHHHHhcCC-------CCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 111111110 11111 2234568899999999999999999999999999988765433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=328.59 Aligned_cols=270 Identities=24% Similarity=0.353 Sum_probs=200.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC---------------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCce
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD---------------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv 565 (812)
++|++.+.||+|+||.||+++..+ ...||+|++.... .......|.+|++++++++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 569999999999999999987642 2358999875321 123445788999999999999999
Q ss_pred EEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCC----ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCC
Q 042346 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTE----KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKS 641 (812)
Q Consensus 566 ~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp 641 (812)
++++++...+..++||||+++++|.+++....... ......+.+..+++++.|+++||+|||+.+ ++||||||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp 157 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLAT 157 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccCh
Confidence 99999999999999999999999999996543111 011112478888999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc--CCCCCCCCC
Q 042346 642 SNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT--GKKAVFKNE 719 (812)
Q Consensus 642 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt--G~~p~~~~~ 719 (812)
+|||+++++.+||+|||++................++..|+|||++....++.++||||||+++|||++ +..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999999875543222222233455778999999988889999999999999999998 445553321
Q ss_pred CCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 720 DGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
. ............... .... ... ....+..+.+|+.+|++.||++||++++|++.|++
T Consensus 238 ~----~~~~~~~~~~~~~~~-~~~~---~~~----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 D----EQVIENTGEFFRNQG-RQIY---LSQ----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred h----HHHHHHHHHhhhhcc-cccc---CCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1 111111111111000 0000 000 11234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.74 Aligned_cols=287 Identities=23% Similarity=0.332 Sum_probs=205.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe----
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE---- 573 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~---- 573 (812)
....|...+.||+|+||.|+.+.. .+|+.||||++.. .....-..++-.+|+++|+.++|+||+.+++.+.-
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~---~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN---PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh---hhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 344566689999999999999986 4689999999752 12223334566789999999999999999999865
Q ss_pred -CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 574 -KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 574 -~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
-+..|+|+|+|+ -+|...|+.+.... -....-+++||++||.|+|+.+ |+||||||+|+|++.+..+
T Consensus 97 ~f~DvYiV~elMe-tDL~~iik~~~~L~--------d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 97 KFNDVYLVFELME-TDLHQIIKSQQDLT--------DDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred ccceeEEehhHHh-hHHHHHHHcCcccc--------HHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCE
Confidence 345799999995 59999998765332 2334568899999999999999 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccc-cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH---
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV--- 728 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~--- 728 (812)
||+|||||+...........+..+.|..|.|||++. ...|+...||||.||||.||++|+..|-..+.- .+..++
T Consensus 165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-~Ql~lI~~~ 243 (359)
T KOG0660|consen 165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-HQLQLILEL 243 (359)
T ss_pred EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-HHHHHHHHh
Confidence 999999999775543334456778999999999886 567999999999999999999999887543211 111111
Q ss_pred -----HHHHHHHHhccccccccccCCCCCCC-h---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH--HHHHHhcccC
Q 042346 729 -----EFAVSQILAGQLHCVLDKRVGPPELN-E---AEAVELLATTAIHCVNLEGKERPNITDIVANL--ERALAICQDC 797 (812)
Q Consensus 729 -----~~~~~~~~~~~~~~~~d~~~~~~~~~-~---~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L--e~~~~~~~~~ 797 (812)
+.....+...+....+......+... . ..+...-.+|+.+||..||.+|+|++|.+++- +..-+...++
T Consensus 244 lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 244 LGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred cCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 11111111111111111001111111 1 12334456888999999999999999999874 5555555555
Q ss_pred CCCC
Q 042346 798 SCTD 801 (812)
Q Consensus 798 ~~~~ 801 (812)
.+..
T Consensus 324 ~~~~ 327 (359)
T KOG0660|consen 324 VCQP 327 (359)
T ss_pred CCCC
Confidence 4433
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.26 Aligned_cols=263 Identities=25% Similarity=0.401 Sum_probs=204.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
.++|++.+.||+|+||.||++.+.+ +..|++|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4578999999999999999998643 3689999975321 12334567889999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCcc--ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKN--SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~--~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
....++||||+++++|.+++......... ....+.+...+.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCC
Confidence 99999999999999999999764432210 1123477888999999999999999988 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHH
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 730 (812)
+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||.... ...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~~~---- 229 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS----NEE---- 229 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC----HHH----
Confidence 99999999875544332222334456789999999988889999999999999999998 888874322 111
Q ss_pred HHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
....+..+. ....+. ..+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 230 ~~~~~~~~~-------~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 VLKFVIDGG-------HLDLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHhcCC-------CCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111221111 111111 12556889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.61 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=199.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
++|++.+.||+|+||.||++++.++..+|+|.+..... ....|.+|+.++++++||||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 35888999999999999999987777899998753211 134688899999999999999999999988889999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++..... .+++..+++++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 78 ~e~~~~~~l~~~i~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK-------RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred EEcCCCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccc
Confidence 999999999999975432 1367888999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+....... .......++..|++||.+....++.++||||||+++|||++ |+.||..... .. ....+..+.
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~----~~~~~~~~~ 218 (256)
T cd05113 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SE----TVEKVSQGL 218 (256)
T ss_pred eecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HH----HHHHHhcCC
Confidence 75433221 11222345678999999988889999999999999999999 8888743221 11 111222211
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
+...+. .....+.+++.+||+.+|++||++.++++.|+
T Consensus 219 -------~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 -------RLYRPH----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------CCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111111 12456889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.88 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=192.4
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecC
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMS 585 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 585 (812)
+.||+|+||.||++++. +++.+|+|..... ...+....+.+|++++++++||||+++++++..+...++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 46999999999999874 6889999986531 113344678899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCC
Q 042346 586 NGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665 (812)
Q Consensus 586 ~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~ 665 (812)
+++|.+++..... .+++...+.++.|++.+|+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~L~~~~~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 77 GGDFLTFLRTEGP-------RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEED 146 (252)
T ss_pred CCcHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccc
Confidence 9999999965432 1367778899999999999999998 99999999999999999999999999865432
Q ss_pred CcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
............+..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+...
T Consensus 147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~~~~~~------ 212 (252)
T cd05084 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQG------ 212 (252)
T ss_pred ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHHHHHcC------
Confidence 111111111123457999999998889999999999999999998 7777643211 0111111111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
.+.. .....+..+.+++.+|++.+|++|||++|+++.|+
T Consensus 213 -~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 213 -VRLP----CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CCCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0111 11233456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=355.25 Aligned_cols=274 Identities=22% Similarity=0.309 Sum_probs=210.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.++||+|+||.||+|++. +++.||+|++..... ......+.|.+|++++++++||||+++++++.+++..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 47999999999999999999875 589999999864221 223345578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCC---CccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 580 VYEYMSNGALHDHLHNKNNT---EKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
+|||+++++|.+++...... ........++...++++.||++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEe
Confidence 99999999999999753211 1111223367778899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcc----------------cccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCC
Q 042346 657 FGLSLLGSECDQ----------------EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720 (812)
Q Consensus 657 fGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 720 (812)
||+++....... ........||+.|||||++.+..++.++|||||||++|||+||+.||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 999976521110 0011234699999999999999999999999999999999999999854221
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHHhccc
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-NITDIVANLERALAICQD 796 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~Le~~~~~~~~ 796 (812)
. ... ... . ..++. ......+.+..+.+++.+|++.||++|| +++++++.|+..++..++
T Consensus 237 ~----ki~---~~~----~---i~~P~---~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 237 R----KIS---YRD----V---ILSPI---EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred h----hhh---hhh----h---ccChh---hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 1 000 000 0 00000 0001134456688999999999999995 788899999988875443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=340.88 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=191.8
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.|++.++||+|+||.||+++.. +++.||+|++... ..........+.+|+++++.++||||+++++.+.+++..++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK--DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH--HhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 5889999999999999999874 5789999998631 112234456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++|+|.+++..... ++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 80 ~E~~~gg~L~~~l~~~~~--------~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGI--------FPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred EeCCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCC
Confidence 999999999999976432 134455678999999999999998 999999999999999999999999997
Q ss_pred ccCCCCcc---------------------------------------------cccccccccCCCccCccccccCcCCCc
Q 042346 661 LLGSECDQ---------------------------------------------EFISTKAVGTVGYIDPEYYVMNVLTAK 695 (812)
Q Consensus 661 ~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k 695 (812)
........ ........||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 53211000 000123468999999999999999999
Q ss_pred chhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCC
Q 042346 696 TDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGK 775 (812)
Q Consensus 696 sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~ 775 (812)
+|||||||+||||++|+.||..... .. ....+... ......+. .......+.+++.+++ .+|.
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~----~~----~~~~i~~~------~~~~~~p~--~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTP----LE----TQMKVINW------QTSLHIPP--QAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCH----HH----HHHHHHcc------CCCcCCCC--cccCCHHHHHHHHHHc-cCHh
Confidence 9999999999999999999854321 11 11111110 01111111 1122334556666665 4999
Q ss_pred CCCC---HHHHHHH
Q 042346 776 ERPN---ITDIVAN 786 (812)
Q Consensus 776 ~RPt---~~evl~~ 786 (812)
+|++ ++|++++
T Consensus 292 ~R~~~~~~~ei~~h 305 (382)
T cd05625 292 DRLGKNGADEIKAH 305 (382)
T ss_pred HcCCCCCHHHHhcC
Confidence 9987 8888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.25 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=192.5
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHH---HhccCCCceEEEEEEEeCCeEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALL---SRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l---~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
|++.+.||+|+||.||++.+. +++.||||++.... .......+.+.+|++++ +.++||||+++++++.+.+..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGD--IIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 677899999999999999874 58999999986321 11122334556665554 5668999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|..+++... +++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 79 lv~E~~~~~~L~~~~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTDV---------FSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred EEEcCCCCCcHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCccc
Confidence 9999999999998886432 367778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++....... .......|++.|||||.+.+..++.++|||||||++|||++|+.||..... ......+..+
T Consensus 147 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~ 216 (324)
T cd05589 147 LCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVND 216 (324)
T ss_pred CCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC
Confidence 986432211 122345789999999999998999999999999999999999999854321 1111122221
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
. ...+ ...+..+.+++.+||+.||.+|| ++++++++
T Consensus 217 ~--------~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 E--------VRYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred C--------CCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1 1111 12345577899999999999999 67787775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.87 Aligned_cols=270 Identities=24% Similarity=0.358 Sum_probs=202.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-----------------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-----------------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK 562 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~ 562 (812)
.++|++.+.||+|+||.||++++.+ +..||+|++..... ....+.+.+|++++++++||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS----DNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC----HHHHHHHHHHHHHHHhcCCC
Confidence 3568999999999999999997643 24589998764211 23456788999999999999
Q ss_pred CceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCc---cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeecc
Q 042346 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEK---NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI 639 (812)
Q Consensus 563 nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~---~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl 639 (812)
||+++++++..++..+++|||+++++|.+++........ .....+++...+.++.|++.||+|||+.+ |+||||
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dl 156 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDL 156 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccccc
Confidence 999999999999999999999999999999976542111 01123478888999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc--CCCCCCC
Q 042346 640 KSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT--GKKAVFK 717 (812)
Q Consensus 640 Kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt--G~~p~~~ 717 (812)
||+|||++.++.++|+|||+++.....+.........++..|+|||++....++.++||||||+++|||++ +..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999876543332222334456789999999988889999999999999999998 5566633
Q ss_pred CCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 718 NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
.. ..+............ +.....+ .....+..+.+++.+||+.||++|||+.||++.|+
T Consensus 237 ~~----~~~~~~~~~~~~~~~------~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 237 LT----DQQVIENAGHFFRDD------GRQIYLP--RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cC----hHHHHHHHHhccccc------cccccCC--CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21 111111111110000 0010000 11223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=333.80 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=208.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe-EE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE-RL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-~~ 578 (812)
++|...++||+|+||.++..+++ +++.+++|.+........ .+....+|+.++++++|||||.+.+.|++++. .+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~---~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP---ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch---hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 46888999999999999998764 578999999875433322 22366789999999999999999999999888 89
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
|||+|++||+|.+.|....... ++..+.++++.||+.|+.|||++. |+|||||+.||+++.+..+||.|||
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~------f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVL------FPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhcc------ccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchh
Confidence 9999999999999998776332 245666889999999999999887 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+|+.....+ ......+||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+. ......+..+
T Consensus 152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~ 221 (426)
T KOG0589|consen 152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRG 221 (426)
T ss_pred hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhc
Confidence 999876543 245667999999999999999999999999999999999999999865432 1122222222
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+. ..+......|+.++..||+.+|..||++.++|.+
T Consensus 222 ~~~-----------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYS-----------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCC-----------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 211 1134455668899999999999999999999987
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.29 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=192.6
Q ss_pred eeeccCCcEEEEEEEE----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEE
Q 042346 507 NKVGIGSFGTVYKGKL----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 582 (812)
++||+|+||.||+++. .+++.||+|++..... .........+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 6899999999999975 3578999999863211 1112234567789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
|+++++|.+++...... .......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~~L~~~~~~~~~~--------~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 81 YLSGGELFMHLEREGIF--------MEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CCCCchHHHHHHHcCCC--------CHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999999765421 34556678999999999999998 99999999999999999999999999864
Q ss_pred CCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccc
Q 042346 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742 (812)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (812)
..... .......||+.|+|||++.+..++.++||||||++||||++|+.||..... ......+..+.
T Consensus 150 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~~~--- 216 (323)
T cd05584 150 SIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGK--- 216 (323)
T ss_pred cccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC---
Confidence 32211 122345789999999999988899999999999999999999999854321 11122222221
Q ss_pred cccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 743 VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 743 ~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
...+ ......+.+++.+||+.||++|| ++++++++
T Consensus 217 -----~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 -----LNLP----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -----CCCC----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111 12334578999999999999999 89998875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=316.25 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=201.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|.+.+.||+|+||.||++... +++.+++|.+...............+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999864 58999999876433223333345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... ++.....+++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~ 150 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA--------LTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGA 150 (263)
T ss_pred EEEECCCCcHHHHHHHhCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 9999999999999975432 245666789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCccccc-ccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFI-STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~-~~~~ 222 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIFK-IATQ 222 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHHHHH-Hhcc
Confidence 875433221111 1334678899999999998899999999999999999999999853221 111111 1111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. . ...+......+.+++.+||..+|++|||++|++++
T Consensus 223 ~~------~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PT------N----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CC------C----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 10 0 01122345568899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.89 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=193.7
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||.||+++.. +++.+|+|++.... .........+.+|+.++.++ +||||+++++++..++..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH--hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 47999999999999875 57899999986421 11223345677888888776 8999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... +++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~L~~~~~~~~~--------l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 79 NGGDLMFHMQRQRK--------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred CCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 99999998865432 255677889999999999999998 9999999999999999999999999986532
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCC-chhHHHHHHHHHhcccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP-LDVVEFAVSQILAGQLHCV 743 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 743 (812)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .....+....+....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 221 (329)
T cd05618 148 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 221 (329)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----
Confidence 211 1223457899999999999999999999999999999999999998542221111 111222222222221
Q ss_pred ccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 042346 744 LDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN------ITDIVAN 786 (812)
Q Consensus 744 ~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~~ 786 (812)
...| ......+.+++.+||+.||++||+ +.|++++
T Consensus 222 ----~~~p----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 222 ----IRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ----CCCC----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111 123445778999999999999998 5777766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=342.22 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=193.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.||+|++... ..........+.+|++++++++||||+++++.+.+++..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA--DVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHH--HHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 36899999999999999999864 5889999998531 11122334567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++...... +......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~E~~~~g~L~~~i~~~~~~--------~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIF--------EEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCC--------CHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 99999999999999765321 34455678999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcc-----------------------------------------cccccccccCCCccCccccccCcCCCcchh
Q 042346 660 SLLGSECDQ-----------------------------------------EFISTKAVGTVGYIDPEYYVMNVLTAKTDI 698 (812)
Q Consensus 660 a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV 698 (812)
+........ ........||+.|||||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 743210000 000123479999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC
Q 042346 699 YGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP 778 (812)
Q Consensus 699 wS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 778 (812)
|||||+||||++|+.||...... .. ...+.... .....+. .......+.+++.+|+ .+|.+|+
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~----~~----~~~i~~~~------~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPA----ET----QLKVINWE------TTLHIPS--QAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHH----HH----HHHHhccC------ccccCCC--CCCCCHHHHHHHHHHh-cCHhhcC
Confidence 99999999999999998543311 11 11111100 0011110 1123344666777765 4999999
Q ss_pred ---CHHHHHHH
Q 042346 779 ---NITDIVAN 786 (812)
Q Consensus 779 ---t~~evl~~ 786 (812)
++.|++.+
T Consensus 291 ~~~t~~ell~h 301 (376)
T cd05598 291 GKNGADEIKAH 301 (376)
T ss_pred CCCCHHHHhCC
Confidence 89999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.70 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=194.5
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
++||+|+||.||++++. +++.||+|++... .....+....+.+|..++..+ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKE--LVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 46999999999999875 5889999998641 111223345677899999988 7999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~g~L~~~~~~~~~--------l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 79 SGGDLMFHMQRQRK--------LPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred CCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 99999999865432 256777889999999999999998 9999999999999999999999999986422
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCc-hhHHHHHHHHHhcccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL-DVVEFAVSQILAGQLHCV 743 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 743 (812)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........+. ...++....+....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 221 (329)
T cd05588 148 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---- 221 (329)
T ss_pred cCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----
Confidence 211 12234578999999999999999999999999999999999999986422111111 11122222222221
Q ss_pred ccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 042346 744 LDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN------ITDIVAN 786 (812)
Q Consensus 744 ~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~~ 786 (812)
...|. .....+.+++.+||+.||.+||+ ++|++++
T Consensus 222 ----~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 222 ----IRIPR----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ----CCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11111 23345788999999999999997 7788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.13 Aligned_cols=251 Identities=23% Similarity=0.283 Sum_probs=193.8
Q ss_pred eccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCC
Q 042346 509 VGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNG 587 (812)
Q Consensus 509 LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 587 (812)
||+|+||+||++.+. +++.+|+|++.... .......+.+..|+++++.++|+||+++.+++..+...++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR--LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHH--HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 799999999999864 68899999975321 112223356778999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCc
Q 042346 588 ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667 (812)
Q Consensus 588 sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~ 667 (812)
+|.+++....... ..+++...+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~L~~~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 151 (280)
T cd05608 79 DLRYHIYNVDEEN----PGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ 151 (280)
T ss_pred CHHHHHHhccccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC
Confidence 9998885432211 12367788899999999999999998 9999999999999999999999999987543322
Q ss_pred ccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccccccc
Q 042346 668 QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKR 747 (812)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 747 (812)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .......+.. ..
T Consensus 152 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~--------~~ 217 (280)
T cd05608 152 S--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRILN--------DS 217 (280)
T ss_pred c--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh----HHHHHHhhcc--------cC
Confidence 1 12345789999999999999999999999999999999999999864332111 0111111111 11
Q ss_pred CCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 748 VGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 748 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
. ..+...+..+.+++.+||+.||++|| ++++++++
T Consensus 218 ~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 218 V----TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred C----CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1 11223455688999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.03 Aligned_cols=250 Identities=23% Similarity=0.289 Sum_probs=191.9
Q ss_pred eccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCC
Q 042346 509 VGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNG 587 (812)
Q Consensus 509 LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 587 (812)
||+|+||.||+++.+ +++.+|+|++.... .........+..|++++++++||||++++++++++...++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR--LKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHH--hhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 799999999999864 58999999985311 111222344567999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCc
Q 042346 588 ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667 (812)
Q Consensus 588 sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~ 667 (812)
+|.+++....... +++...+.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~L~~~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 79 DLKYHIYNVGERG------LEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred CHHHHHHhccccC------CCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence 9999886543221 366777889999999999999998 9999999999999999999999999987654321
Q ss_pred ccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccccccc
Q 042346 668 QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKR 747 (812)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 747 (812)
......++..|+|||++.+..++.++|||||||++|||++|+.||........ ............
T Consensus 150 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~-------- 214 (277)
T cd05607 150 ---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTLEDE-------- 214 (277)
T ss_pred ---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhhccc--------
Confidence 22345689999999999988899999999999999999999999854322111 011111111111
Q ss_pred CCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 748 VGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 748 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
+.. ........+.+|+.+||+.||++||+++|+++.+
T Consensus 215 ~~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 215 VKF---EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccc---ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 110 1123455688999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.41 Aligned_cols=270 Identities=26% Similarity=0.392 Sum_probs=202.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-----------------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-----------------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH 563 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n 563 (812)
++|++.++||+|+||.||++.+. +...+|+|++... ........|.+|+++++.++|+|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCC
Confidence 56999999999999999998643 2346899987532 12334567889999999999999
Q ss_pred ceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCc---cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccC
Q 042346 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEK---NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIK 640 (812)
Q Consensus 564 Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~---~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlK 640 (812)
|+++++++..++..+++|||+++++|.+++........ .....+++...++++.|++.||+|||+.+ |+|||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlk 157 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLA 157 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCC
Confidence 99999999999999999999999999999976543221 11123477888999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc--CCCCCCCC
Q 042346 641 SSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT--GKKAVFKN 718 (812)
Q Consensus 641 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt--G~~p~~~~ 718 (812)
|+|||++.++.++|+|||++.................+..|++||......++.++||||||+++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999875533222112223345678999999888889999999999999999998 66776432
Q ss_pred CCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 719 EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.. .+............. ... ....+ ..++..+.+|+.+||+.||++||++.||++.|++
T Consensus 238 ~~----~~~~~~~~~~~~~~~-~~~---~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SD----EQVIENTGEFFRDQG-RQV---YLPKP----ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred Ch----HHHHHHHHHHHhhcc-ccc---cCCCC----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 21 111111111111100 000 00111 1233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=325.83 Aligned_cols=271 Identities=24% Similarity=0.408 Sum_probs=206.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc--------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM--------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGF 570 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 570 (812)
.++|.+.+.||+|+||.||+++.. ....+|+|++.... .......+.+|+++++++ +||||++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 356889999999999999999752 24578999875321 123345688899999999 69999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCC--------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTE--------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~--------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
+.+++..+++|||+++++|.+++....... ......+++...++++.|++.||.|||+++ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccce
Confidence 999888999999999999999997653211 011123588889999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDG 721 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~ 721 (812)
|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-- 241 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-- 241 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999999999999976543222111222334568999999998889999999999999999999 787774321
Q ss_pred CCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 722 SGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
. +.....+..+. .+..+ ...+..+.+++.+||..+|++|||++|+++.|+++.....+
T Consensus 242 --~----~~~~~~~~~~~-------~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 242 --V----EELFKLLREGH-------RMDKP----SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred --H----HHHHHHHHcCC-------CCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 1 11111222211 11111 22344677999999999999999999999999998765544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.40 Aligned_cols=256 Identities=28% Similarity=0.409 Sum_probs=200.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.++|++.++||+|+||.||+|++.+...|++|++..... ..+.|.+|++++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 356999999999999999999987777899999864211 23467889999999999999999998754 55799
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++...... .+++..++.++.|++.+|+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 78 v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~ 148 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGK------YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 148 (262)
T ss_pred EEEcCCCCcHHHHHhhcccc------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCc
Confidence 99999999999999753221 2367888999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+......... ......++..|+|||++....++.++||||||+++|||+| |+.||..... ......+..+
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~ 219 (262)
T cd05071 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERG 219 (262)
T ss_pred eeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcC
Confidence 9765432211 1123346778999999988889999999999999999999 6767643221 1111111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
. . .....+.+..+.+++.+|++.||++||+++++++.|+..+
T Consensus 220 ~---------~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 220 Y---------R--MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred C---------C--CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0 0 0112345667889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=325.09 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=202.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQE 573 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 573 (812)
++|.+.+.||+|+||.||++... .+..+|+|++..... ....+.+.+|+++++++ +||||+++++++..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----SSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC----hHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 46889999999999999999742 345799998764221 23345788999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
.+..+++|||+.+++|.++++..... .+++.+.++++.|++.||+|||+++ |+|+||||+|||++.++.+|
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~------~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRES------FLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCC------CCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEE
Confidence 99999999999999999999754321 1377888999999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|+|||++................++..|+|||.+....++.++||||||+++|||++ |+.||...... +...
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~~~ 254 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SKFY 254 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HHHH
Confidence 999999975543222112223456788999999998889999999999999999998 88887543211 1111
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
..+..+. +... ....++.+.+++.+||..+|++|||+.|+++.|++++
T Consensus 255 ~~~~~~~-------~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 255 KLIKEGY-------RMAQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred HHHHcCC-------cCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 1111110 0111 1123456889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.79 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=207.3
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++. .+++.++||.+.... .........+.+|+++++.++||||+++++++.+++..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD--LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh--hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 4688889999999999999986 478999999875321 1223344678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+|||+++++|.+++...... ...+++...+.++.||+.+|.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~ 152 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQ----KRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred EEEecCCCCHHHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchh
Confidence 99999999999998743221 122467888899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....+...
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~- 223 (267)
T cd08229 153 GRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYS-LCKKIEQC- 223 (267)
T ss_pred hhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHH-HhhhhhcC-
Confidence 876543221 122346889999999998888999999999999999999999998543211 111 11111110
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
..+........+.+.+++.+||..||++||||++|++.++++
T Consensus 224 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 ---------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---------CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111122234566789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.95 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=204.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
.++|++.+.||+|+||.||++.+. ++..+|+|++.... .......|.+|++++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 456899999999999999999863 46789999875321 12334578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCcc--------------ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeecc
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKN--------------SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI 639 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~--------------~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl 639 (812)
++..+++|||+++++|.+++......... ....+++..++.++.|++.+|+|||+.+ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 99999999999999999999754321111 1123477888999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCC
Q 042346 640 KSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKN 718 (812)
Q Consensus 640 Kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~ 718 (812)
||+|||++.++.+||+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999875433222212223345678999999988889999999999999999998 77787532
Q ss_pred CCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 719 EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.. +.....+..+... .. ....+..+.+++.+||+.+|++|||++|+++.|++
T Consensus 237 ~~--------~~~~~~~~~~~~~-------~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AH--------EEVIYYVRDGNVL-------SC----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CH--------HHHHHHHhcCCCC-------CC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 21 1122222222211 00 11234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.37 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=207.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+|... +++.|++|.+..... ........+.+|++++++++|+||+++++++.+++..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM--MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 57999999999999999999886 789999998753221 112335678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++...... ...+++..++.++.+++++|.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 80 v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~ 152 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQ----KRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred EEecCCCCCHHHHHHHhccc----CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccce
Confidence 99999999999998653221 112367788899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+ ....+..+.
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~-~~~~~~~~~ 224 (267)
T cd08224 153 GRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYS-LCKKIEKCD 224 (267)
T ss_pred eeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHH-HHhhhhcCC
Confidence 875433211 12334688899999999888899999999999999999999999854331 1111 111111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
. +..........+.+++.+||..+|++|||+.+|++.|+++
T Consensus 225 ~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 Y----------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C----------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 1111234556788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.81 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=200.2
Q ss_pred HHHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEE
Q 042346 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFC 571 (812)
Q Consensus 493 ~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~ 571 (812)
+.++....++|++.+.||+|+||.||++++. +++.+|+|++... ..........+.+|+.+++.++||||+++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~--~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHH--HhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3445555688999999999999999999875 5788999987531 111223345678899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
.+++..++||||+++|+|.+++..... +......++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~~~~---------~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSNYDV---------PEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhcCC---------CHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCC
Confidence 999999999999999999999965421 33455678999999999999998 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccccC----cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN----VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
+||+|||++....... ........||+.|||||++... .++.++|||||||+||||++|+.||.....
T Consensus 181 ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------- 252 (371)
T cd05622 181 LKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------- 252 (371)
T ss_pred EEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------
Confidence 9999999997653321 1122345799999999998753 378899999999999999999999864321
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKE--RPNITDIVANL 787 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~L 787 (812)
......+.... ..+..+. .......+.+++.+||..++.+ ||+++|++++.
T Consensus 253 -~~~~~~i~~~~------~~~~~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 253 -VGTYSKIMNHK------NSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -HHHHHHHHcCC------CcccCCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11112222111 0011111 1234556788899999844443 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=329.40 Aligned_cols=271 Identities=25% Similarity=0.394 Sum_probs=207.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC--------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD--------GREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGF 570 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 570 (812)
..+|++.+.||+|+||.||++++.. ...||+|.+... ........+.+|+++++++ +||||++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3468999999999999999997521 236899987531 1123346788999999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCc--------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEK--------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
+.+++..+++|||+++++|.++|........ .....+.|..+++++.|++.||+|||+.+ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 9999999999999999999999976432110 11223578889999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDG 721 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~ 721 (812)
|||++.++.+||+|||+++...............++..|+|||++....++.++||||||++||||++ |+.||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-- 241 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-- 241 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence 99999999999999999876543222212222344568999999999899999999999999999998 777764321
Q ss_pred CCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 722 SGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
.+.....+..+. .... ...++..+.+++.+|++.+|++|||+.|+++.|+++......
T Consensus 242 ------~~~~~~~~~~~~-------~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 242 ------VEELFKLLKEGH-------RMDK----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred ------HHHHHHHHHcCC-------CCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 111122222211 1111 112345688999999999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.60 Aligned_cols=269 Identities=25% Similarity=0.389 Sum_probs=202.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEE------cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL------MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQ 572 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 572 (812)
.++|++.++||+|+||.||+|.+ .+++.||||++.... .......+.+|++++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 35699999999999999999974 346789999986321 123345678899999999 6899999999886
Q ss_pred eC-CeEEEEEEecCCCchhhhhhcCCCCCc--------------------------------------------------
Q 042346 573 EK-DERLLVYEYMSNGALHDHLHNKNNTEK-------------------------------------------------- 601 (812)
Q Consensus 573 ~~-~~~~lV~ey~~~gsL~~~l~~~~~~~~-------------------------------------------------- 601 (812)
.. ...+++|||+++|+|.++++.......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 457899999999999999975421100
Q ss_pred ---------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccc
Q 042346 602 ---------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672 (812)
Q Consensus 602 ---------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 672 (812)
.....+++..+++++.||++||+|||+++ |+||||||+|||++.++++||+|||++............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 00123578888999999999999999998 999999999999999999999999998765332222222
Q ss_pred cccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCC
Q 042346 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPP 751 (812)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 751 (812)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ......+..+. +...+
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~-------~~~~~ 304 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGT-------RMRAP 304 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccC-------CCCCC
Confidence 23345678999999988889999999999999999997 88887432210 11111111111 11111
Q ss_pred CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 752 ELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 752 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
.. ....+.+++.+||+.||++|||+.||+++|+++++.
T Consensus 305 ~~----~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 305 DY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11 234578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=319.50 Aligned_cols=259 Identities=22% Similarity=0.366 Sum_probs=199.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCc----EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGR----EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
++|++.++||+|+||.||+|++. +++ .||+|++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT----SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC----CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 46888999999999999999863 444 48999875321 23334578889999999999999999999875 4
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..+++|||+++|+|.++++.... .+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKD-------RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEEC
Confidence 57899999999999999975432 1366778899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+. ..
T Consensus 152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~----~~ 223 (279)
T cd05109 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIP----DL 223 (279)
T ss_pred CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHH----HH
Confidence 9999976543222222222345678999999988889999999999999999998 7888743211 1111 11
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+..+. .... ....+..+.+++.+||..||++||++.|+++.|+++.+.
T Consensus 224 ~~~~~-------~~~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 224 LEKGE-------RLPQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHCCC-------cCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11111 1111 122345678999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=334.88 Aligned_cols=245 Identities=25% Similarity=0.324 Sum_probs=192.8
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecC
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMS 585 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 585 (812)
+.||+|+||.||+++.. +++.||+|++... ..........+.+|+++++.++||||+++++++.+++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999864 6889999998631 11122334567789999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh-cCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 586 NGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN-YAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 586 ~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
+++|.+++..... +++.....++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~L~~~l~~~~~--------l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 79 GGELFFHLSRERV--------FSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred CCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9999999865432 3567778899999999999997 56 9999999999999999999999999986432
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..... +.....+....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~~~~----- 212 (325)
T cd05594 148 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEE----- 212 (325)
T ss_pred CCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHhcCC-----
Confidence 211 112345699999999999988999999999999999999999999854321 11111111111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
...+. .....+.+++.+||+.||++|+ ++++++++
T Consensus 213 ---~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 ---IRFPR----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CCCCC----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11111 2334578899999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.00 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=197.2
Q ss_pred CcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
+|++.+.||+|+||.||+++++++..+++|++..... ....|.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 4788899999999999999987778899998753211 1235778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++..... .+++...++++.|++.+|+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 79 e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 79 EYMANGCLLNYLRERKG-------KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred ecCCCCCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccce
Confidence 99999999999975432 2367888999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+ ....+..+.
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~----~~~~~~~~~- 218 (256)
T cd05059 149 YVLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN----SE----VVESVSAGY- 218 (256)
T ss_pred ecccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH----HH----HHHHHHcCC-
Confidence 5432111 11122234568999999998899999999999999999999 7877743221 11 111111110
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
+...+ ...+..+.+++.+||..+|++|||++|+++.|
T Consensus 219 ------~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 ------RLYRP----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ------cCCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11111 12455688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=324.75 Aligned_cols=268 Identities=28% Similarity=0.475 Sum_probs=203.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCc--EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGR--EVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
++|++.+.||+|+||.||+|.++ ++. .+++|.+... ........+.+|++++.++ +||||+++++++.+++.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 46889999999999999999874 344 4577765421 1233456788899999999 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCcc--------ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKN--------SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~--------~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
.++||||+++++|.++++........ ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecC
Confidence 99999999999999999765432211 1123478888999999999999999998 999999999999999
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchh
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 727 (812)
++.+||+|||++...... ........+..|+|||++....++.++||||||++||||+| |..||..... .+.
T Consensus 160 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~ 232 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AEL 232 (303)
T ss_pred CCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh----HHH
Confidence 999999999998532211 11112234668999999988889999999999999999998 8888853221 111
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccC
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDC 797 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~ 797 (812)
......+ .+...+ ...+..+.+|+.+||+.+|++||+++++++.|++++..-.+.
T Consensus 233 ----~~~~~~~-------~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 233 ----YEKLPQG-------YRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred ----HHHHhcC-------CcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 1111111 011111 123445789999999999999999999999999887665433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=334.24 Aligned_cols=264 Identities=21% Similarity=0.260 Sum_probs=198.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
..+|.+.+.||+|+||.||++... .++.|++|.+... ..+.+|++++++++||||+++++++.....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 457999999999999999999753 3578999987531 234579999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.+++|||+. ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~--------~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~D 228 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSG--------PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGD 228 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcc
Confidence 999999995 68999884332 2367888999999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||++................||+.|+|||++....++.++|||||||+||||++|+.||+........ .........+.
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~l~~i~~~~~ 307 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS-SQLRSIIRCMQ 307 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH-HHHHHHHHHhc
Confidence 99997654433322233467999999999999999999999999999999999999999764432211 11111111110
Q ss_pred hcc-----------------ccccccccCCCCC-CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQ-----------------LHCVLDKRVGPPE-LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~-----------------~~~~~d~~~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... +.....+....+. .....+...+.++|.+||..||++|||+.|++.+
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000000000000 0111234567889999999999999999999986
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=317.11 Aligned_cols=258 Identities=24% Similarity=0.444 Sum_probs=201.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-C---cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-G---REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g---~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
++|+..+.||+|+||.||++++.. + ..+++|++.... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 468889999999999999998753 3 368999875321 12234568899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++++|.+++..... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDG-------EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECC
Confidence 9999999999999999975432 1367788899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccc-cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSECDQEF-ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
||++.......... .......+..|+|||++....++.++||||||+++|||++ |+.||..... ......
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~ 222 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKA 222 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHH
Confidence 99987554322211 1112233567999999988889999999999999999997 9999854321 111222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
+..+. +... ....+..+.+++.+|++.+|++||++.+|++.|++++
T Consensus 223 i~~~~-------~~~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 223 INDGF-------RLPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred HhcCC-------CCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 22110 1111 1234456889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=327.81 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=194.0
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC-CceEEEEEEEeCCeEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK-HLVGLVGFCQEKDERLL 579 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~l 579 (812)
+|++.+.||+|+||.||+|+.. +++.||+|++.... .......+.+..|.+++..++|+ +|+++++++.+.+..|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--IIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 4888999999999999999875 47789999986311 11223345677899999999765 58889999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... +++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~E~~~~g~L~~~~~~~~~--------~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGK--------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred EEcCCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCc
Confidence 9999999999999975432 245667889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 148 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~- 216 (324)
T cd05587 148 CKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIMEH- 216 (324)
T ss_pred ceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC-
Confidence 86432211 122345789999999999999999999999999999999999999854321 1111112211
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI-----TDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 786 (812)
....+. .....+.+++.+||..||.+|++. ++++++
T Consensus 217 -------~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 -------NVSYPK----SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -------CCCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111111 234457789999999999999976 677765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=320.79 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=201.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
.++|++.++||+|+||.||++... ++..+++|.+... .......|.+|+++++.++|+||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 356888999999999999999642 3567888886531 12334578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCC-------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTE-------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~-------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
.+..+++|||+++++|.+++....... ......+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~ 155 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLV 155 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEE
Confidence 999999999999999999997654211 011123478888999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCc
Q 042346 647 DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPL 725 (812)
Q Consensus 647 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 725 (812)
++++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~ 231 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----T 231 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH----H
Confidence 9999999999999875433222222233345788999999998899999999999999999998 8888743221 1
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
+.. .....+. .... ...++..+.+++.+||+.||++||+++||++.|+
T Consensus 232 ~~~----~~~~~~~-------~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 EAI----ECITQGR-------ELER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHH----HHHHcCc-------cCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111 1111111 0001 1123455889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.17 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=211.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~ 576 (812)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... .......+.+|+.+|+++. ||||+.+++.|++.+.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~--~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR--GKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc--ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34569999999999999999998765 999999998753221 1224467889999999998 9999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC----CcE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN----WTA 652 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~----~~~ 652 (812)
.++|||++.+|.|++.|.... .+......++.|++.++.|||+.+ |+||||||+|+|+... +.+
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~---------~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKH---------YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEEEEEecCCchHHHHHHHcc---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence 999999999999999997761 244566789999999999999998 9999999999999543 479
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|++|||++..... .......+||+.|+|||++....|+...||||+|+++|.|++|..||....... ..
T Consensus 179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------~~ 247 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------IF 247 (382)
T ss_pred EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--------HH
Confidence 9999999987665 234566799999999999999999999999999999999999999997654321 11
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+..+.+ ..+........+...+++.+++..||.+|+|+.++++|
T Consensus 248 ~~i~~~~~--------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 248 LAILRGDF--------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHcCCC--------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 23333332 23333446667889999999999999999999999996
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=329.26 Aligned_cols=265 Identities=26% Similarity=0.398 Sum_probs=214.3
Q ss_pred HHHHHhcCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE
Q 042346 494 SELAAATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ 572 (812)
Q Consensus 494 ~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 572 (812)
++++....++.+.++||-|.||+||.|.|+. .-.||||.++. +.-..++|..|..+|+.++|||+|+|+|+|.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE------DtMeveEFLkEAAvMKeikHpNLVqLLGVCT 333 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 333 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh------cchhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence 4555566778899999999999999999864 66799998752 2334678999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
.+...|||+|||.+|+|.|||+........ -...+.||.||+.||+||..++ +|||||..+|+|+.++..+
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~------avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiV 404 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECNRSEVP------AVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIV 404 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhchhhcc------hhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceE
Confidence 999999999999999999999987665433 2345789999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+||||++++..+.+. ......-...|.|||-+..+.++.|+|||+|||+||||.| |-.|+-..+ .. .
T Consensus 405 KvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----lS-----q 474 (1157)
T KOG4278|consen 405 KVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----LS-----Q 474 (1157)
T ss_pred EeeccchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----HH-----H
Confidence 99999999987654332 1222334678999999999999999999999999999988 555652211 11 1
Q ss_pred HHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 732 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+..+++. +.||..|+ .+++.+.+|++.||+.+|.+||++.|+-+.+|.++..
T Consensus 475 VY~LLEk------gyRM~~Pe----GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 475 VYGLLEK------GYRMDGPE----GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHHhc------cccccCCC----CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 1222222 34555554 4556677888999999999999999999999987754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.47 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=201.6
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||++..+ +++.|++|.+.... ........+.+|+++++.++||||+++++++.+++..++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK---MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh---CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 4788899999999999999874 58899999875321 1133456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.++++..... .+++...++++.+++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++
T Consensus 78 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGR------PLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEeCCCCcHHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence 9999999999999764221 2366777899999999999999988 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
........ ......+++.|+|||++....++.++||||||+++|||++|+.||..... ......+..+..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~ 218 (256)
T cd08529 149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGVF 218 (256)
T ss_pred eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCC
Confidence 76543221 12334688899999999988899999999999999999999999854321 111112222111
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+. ........+.+++.+||+.+|++||++.+++++
T Consensus 219 ----------~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 ----------PP-VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----------CC-CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01 112445668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=317.37 Aligned_cols=258 Identities=26% Similarity=0.473 Sum_probs=200.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-C---cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-G---REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g---~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
..|++.+.||+|+||.||+|.+.. + ..|++|++.... .......|..|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 347889999999999999998753 3 369999875321 23345678999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++++|.+++...... +++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~d 149 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQ-------FTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSD 149 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCC-------CCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECC
Confidence 99999999999999999754321 367788899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccc---cCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAV---GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||++................ .+..|+|||++....++.++||||||+++|||++ |+.||..... .+...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~--- 222 (269)
T cd05065 150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVIN--- 222 (269)
T ss_pred CccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHH---
Confidence 99987554322211111111 2457999999998899999999999999999986 9888854321 11111
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
.+... .+...+ .+.+..+.+++.+||..+|++||++++|+..|++++
T Consensus 223 -~i~~~-------~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 223 -AIEQD-------YRLPPP----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred -HHHcC-------CcCCCc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 11111 111111 234456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=339.61 Aligned_cols=268 Identities=22% Similarity=0.312 Sum_probs=188.0
Q ss_pred HHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc------CCCceEE
Q 042346 495 ELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH------HKHLVGL 567 (812)
Q Consensus 495 el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~l 567 (812)
++....++|++.++||+|+||.||++.+. .++.||||++..... ....+..|+++++.++ |.+++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK------YTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh------hHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 34455688999999999999999999874 578899999863211 1223445666666654 4568999
Q ss_pred EEEEEeC-CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEE
Q 042346 568 VGFCQEK-DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNIL 645 (812)
Q Consensus 568 ~~~~~~~-~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NIL 645 (812)
++++..+ ...++|||++ +++|.+++..... +.+.....|+.||+.||+|||++ + ||||||||+|||
T Consensus 197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~--------l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NIL 264 (467)
T PTZ00284 197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKHGP--------FSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENIL 264 (467)
T ss_pred EEEEEcCCceEEEEEecc-CCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 9998765 4678999988 6789999875432 35677789999999999999984 7 999999999999
Q ss_pred EcCCC----------------cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHH
Q 042346 646 LDVNW----------------TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELL 709 (812)
Q Consensus 646 l~~~~----------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ell 709 (812)
++.++ .+||+|||++..... ......||+.|+|||++.+..++.++|||||||+||||+
T Consensus 265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred EecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence 98765 499999998753221 233567999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCCchhHHHHHH----------------HHHh--cccccccccc----CCC-CCCChHHHHHHHHHHH
Q 042346 710 TGKKAVFKNEDGSGPLDVVEFAVS----------------QILA--GQLHCVLDKR----VGP-PELNEAEAVELLATTA 766 (812)
Q Consensus 710 tG~~p~~~~~~~~~~~~~~~~~~~----------------~~~~--~~~~~~~d~~----~~~-~~~~~~~~~~~l~~li 766 (812)
+|+.||...... .....+..... .+.. +.+....++. +.. ...........+.+||
T Consensus 340 tG~~pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 418 (467)
T PTZ00284 340 TGKLLYDTHDNL-EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLI 418 (467)
T ss_pred hCCCCCCCCChH-HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHH
Confidence 999998543211 00000000000 0000 0000000000 000 0000011134577999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 042346 767 IHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 767 ~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+||+.||++|||++|+++|
T Consensus 419 ~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 419 YGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHhCCcChhhCCCHHHHhcC
Confidence 99999999999999999984
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=328.30 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=191.1
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||.||+++.+ +++.||+|++... ..........+..|.+++..+ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKD--VILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHH--HHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 46999999999999875 5789999998631 111223345667788888876 6999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... ++....+.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~g~L~~~i~~~~~--------l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 79 NGGDLMFHIQKSRR--------FDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred CCchHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 99999999976543 245666789999999999999998 9999999999999999999999999986532
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~----- 212 (320)
T cd05590 148 FNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDE----- 212 (320)
T ss_pred cCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCC-----
Confidence 211 123345799999999999988999999999999999999999999854321 11122222221
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI------TDIVAN 786 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 786 (812)
...+. .....+.+++.+||+.||++||++ ++++++
T Consensus 213 ---~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 213 ---VVYPT----WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred ---CCCCC----CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11111 234557889999999999999998 666664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=326.89 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=194.5
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 579 (812)
+|++.+.||+|+||.||+++.. +++.||+|++... ..........+..|.+++..+ +|++|+++++++.+.+..++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD--VVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 4888999999999999999875 4789999998642 111122334566678888777 58999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 79 v~E~~~~g~L~~~~~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGR--------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred EEcCCCCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCC
Confidence 9999999999999865432 245677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 148 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~~ 217 (323)
T cd05616 148 CKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHN 217 (323)
T ss_pred ceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence 86432211 123345789999999999999999999999999999999999999854321 11122222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI-----TDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 786 (812)
...+ ......+.+++.+||+.||++|++. ++++++
T Consensus 218 --------~~~p----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 --------VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --------CCCC----CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1111 1234567889999999999999974 677654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.29 Aligned_cols=245 Identities=23% Similarity=0.282 Sum_probs=192.0
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
++||+|+||.||+|+.. +++.||+|++... .....+....+..|.+++..+ +||||+++++++.+++..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKD--VILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHH--HhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 46999999999999875 4789999998631 111223345567788888866 7999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... +++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 79 NGGDLMFQIQRSRK--------FDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred CCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999875432 255667789999999999999998 9999999999999999999999999986532
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~----- 212 (321)
T cd05591 148 LNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDD----- 212 (321)
T ss_pred cCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC-----
Confidence 211 122345689999999999988999999999999999999999999854321 11112222211
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-------NITDIVAN 786 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-------t~~evl~~ 786 (812)
...+. .....+.+++.+||+.||++|| ++++++++
T Consensus 213 ---~~~p~----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 ---VLYPV----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ---CCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11111 1234577899999999999999 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.83 Aligned_cols=264 Identities=22% Similarity=0.396 Sum_probs=197.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC-
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK- 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~- 574 (812)
++|++.+.||+|+||.||++..+ +++.|++|++... .....+.|.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 46888999999999999999742 5789999997542 123345788999999999999999999987543
Q ss_pred -CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 575 -DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 575 -~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~-------~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRE-------RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVK 148 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCc-------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEE
Confidence 457899999999999999965432 1367888899999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCcccc-cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCC-------CCC-
Q 042346 654 VSDFGLSLLGSECDQEF-ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG-------SGP- 724 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~-------~~~- 724 (812)
|+|||++.......... ......++..|+|||++.+..++.++||||||+++|||++|..++...... ...
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc
Confidence 99999998654322211 111223445699999999888999999999999999999988765322110 000
Q ss_pred chhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 725 LDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
......... ..... .+... ....+..+.+|+.+||..+|++|||++||++.|+.+
T Consensus 229 ~~~~~~~~~-~~~~~------~~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 229 QMIVYHLIE-LLKNN------GRLPA----PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccchHHHHH-HHhcC------CcCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000000 01000 01111 123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=314.51 Aligned_cols=255 Identities=32% Similarity=0.448 Sum_probs=198.0
Q ss_pred cceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|++.+.||+|+||.||+++... ++.+|+|++..... .........+|+.++++++||||+++++++.++...++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI---EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH---HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc---cccccchhhhhhhccccccccccccccccccccccccccc
Confidence 6789999999999999999865 56899999875322 2222334456999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++.... .+++..++.++.|++++|.|||+.+ |+|+||||+|||+++++.++|+|||++.
T Consensus 78 ~~~~~~~L~~~l~~~~--------~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNK--------PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEETTEBHHHHHHHHS--------SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccccc--------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 9999999999998222 2367788999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCCccCccccc-cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
... ..........++..|+|||++. ...++.++||||||+++|+|++|+.||.... ..-.............
T Consensus 147 ~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~ 219 (260)
T PF00069_consen 147 KLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILKRPL 219 (260)
T ss_dssp EST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHHTHH
T ss_pred ccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhcccccc
Confidence 541 1122344567899999999998 7889999999999999999999999985431 0111111111111111
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... . .........+.+++.+||+.||++||++++++++
T Consensus 220 ~~~----~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 220 PSS----S----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHH----T----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccc----c----cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 0011112678899999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.09 Aligned_cols=268 Identities=21% Similarity=0.284 Sum_probs=199.5
Q ss_pred CcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC-ceEEEEEEEeCC----
Q 042346 502 NFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH-LVGLVGFCQEKD---- 575 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~---- 575 (812)
.|...++||+|.||+||+|+. .+|+.||+|++......+ -......+|+.+++.|+|+| |+++++++...+
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E---G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE---GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc---CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 466778899999999999986 468999999987533221 12334568999999999999 999999998877
Q ss_pred --eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 576 --ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 576 --~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
..+|||||++. +|.+|+....... ..++-....+++.||++||+|||+++ |+||||||+||||+++|.+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~----~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKP----QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEe
Confidence 68899999965 9999998766421 11123556789999999999999999 99999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|+|||+|+...... ...++.+.|..|+|||++.+. .|+...||||+|||+.||++++..|....+ .+......
T Consensus 161 laDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~If 234 (323)
T KOG0594|consen 161 LADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFRIF 234 (323)
T ss_pred eeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHHHH
Confidence 99999998655322 235677899999999999875 799999999999999999998877754432 11111111
Q ss_pred HHHHh---cc---ccccccccCCCCCCC-----hHHHH---HHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILA---GQ---LHCVLDKRVGPPELN-----EAEAV---ELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~---~~---~~~~~d~~~~~~~~~-----~~~~~---~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+-. .. .....+.+...+... ..... ....+++.+||+.+|.+|.|++..+++
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 11 111112221111111 11111 256788999999999999999999987
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.08 Aligned_cols=245 Identities=27% Similarity=0.339 Sum_probs=187.6
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHH-HHHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELA-LLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||+||++++. +++.||+|++... ..........+.+|.. +++.++||||+++++.+.+.+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKK--AILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 46999999999999875 6899999998631 1111222334444544 567899999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... +.......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~g~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 79 NGGELFFHLQRERS--------FPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred CCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 99999999975432 245666789999999999999998 9999999999999999999999999986532
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~----- 212 (323)
T cd05575 148 EHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNKP----- 212 (323)
T ss_pred cCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCC-----
Confidence 211 123345789999999999999999999999999999999999999854321 11112222211
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH----HHHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT----DIVAN 786 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~----evl~~ 786 (812)
...+ ...+..+.+++.+||+.||++||++. |++++
T Consensus 213 ---~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 213 ---LRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred ---CCCC----CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 1111 12245678899999999999999874 65543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.21 Aligned_cols=244 Identities=24% Similarity=0.302 Sum_probs=186.3
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHh-ccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSR-VHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||.||++++. +++.||+|++.... .......+.+..|.+++.. .+||||+++++++..++..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDV--VLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999875 47889999986311 1112223344556666665 48999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... ++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 79 ~gg~L~~~~~~~~~--------~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 79 NGGDLMFHIQSSGR--------FDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 99999999975432 244566789999999999999998 9999999999999999999999999997543
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~------ 211 (316)
T cd05592 148 NGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILND------ 211 (316)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC------
Confidence 222 223345789999999999998999999999999999999999999854321 1111111111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT-DIVA 785 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 785 (812)
....+ ......+.+++.+||+.||++||++. ++++
T Consensus 212 --~~~~~----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 --RPHFP----RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred --CCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11111 12344577889999999999999875 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.83 Aligned_cols=272 Identities=21% Similarity=0.294 Sum_probs=192.7
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe----
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE---- 576 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~---- 576 (812)
.|...+++|.|+||.||+|... +++.||||+.-...+ .-.+|+++|+.++|||||+++-+|....+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 4777899999999999999875 469999999764222 12369999999999999999998875432
Q ss_pred -EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-CcEEE
Q 042346 577 -RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARV 654 (812)
Q Consensus 577 -~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl 654 (812)
..||||||+. +|+++++......... +.....-+..||.+||+|||+.+ |+||||||+|||+|.+ +.+||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~m----p~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRM----PLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCC----ceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEe
Confidence 2489999987 9999998532111111 11122348899999999999988 9999999999999987 99999
Q ss_pred EeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH--
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA-- 731 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-- 731 (812)
+|||.|+.....+. ......|..|+|||.+.+ ..|+.+.||||.|||+.||+-|+..|..+....+...+....
T Consensus 168 cDFGSAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred ccCCcceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 99999987765443 245578899999999876 579999999999999999999998875543222111111100
Q ss_pred --HHHH--HhccccccccccCCCCC---CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHHh
Q 042346 732 --VSQI--LAGQLHCVLDKRVGPPE---LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN--LERALAI 793 (812)
Q Consensus 732 --~~~~--~~~~~~~~~d~~~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~~ 793 (812)
...+ +..+..+...+.+.... ...........+|+.++|..+|.+|.++.|++.+ .+++.+.
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0000 01111111112221111 1223344556789999999999999999999965 3444433
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=316.31 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=198.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.++|++.++||+|+||.||++.+.++..+++|.+..... ....+.+|+.++++++|+|++++++++. ....++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM------SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC------CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 346888999999999999999988888999999864211 1245889999999999999999999875 456799
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+|||+++++|.++++..... .+++..+++++.+++.+|+|||+.+ |+||||||+|||+++++.++|+|||+
T Consensus 78 v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~ 148 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGR------ALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGL 148 (260)
T ss_pred EEEecCCCcHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCcee
Confidence 99999999999999754321 2367888999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+......... ......++..|+|||.+....++.++||||||+++|||++ |+.||.... ..+.. ..+..+
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~~~~----~~~~~~ 219 (260)
T cd05070 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----NREVL----EQVERG 219 (260)
T ss_pred eeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----HHHHH----HHHHcC
Confidence 9764432211 1122345668999999988889999999999999999999 777774322 11111 111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
. +.. .+...+..+.+++.+|+..+|++|||+.++++.|++
T Consensus 220 ~-------~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 Y-------RMP----CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred C-------CCC----CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 011 122345568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=315.98 Aligned_cols=257 Identities=25% Similarity=0.454 Sum_probs=201.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
.+|++.+.||+|+||.||+|.+. ....+|+|.+.... .....+.|.+|+.++++++||||+++++++.+++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 46888999999999999999864 23378999875321 12335678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++++|.+++..... .+++.+.++++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~d 149 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDG-------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSD 149 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCC
Confidence 9999999999999999975432 1367788899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccc-cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSECDQEF-ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
||++.......... .......+..|+|||.+.+..++.++||||||+++||+++ |+.||..... .+. ...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~~~----~~~ 221 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----QDV----IKA 221 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----HHH----HHH
Confidence 99997654322211 1122234568999999998889999999999999999887 9999854321 111 111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
+..+. +... ....+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 222 ~~~~~-------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 222 IEEGY-------RLPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HhCCC-------cCCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11110 1111 122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=300.90 Aligned_cols=258 Identities=25% Similarity=0.350 Sum_probs=209.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcch---hhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKT---NKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEK 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~---~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 574 (812)
.+.|...+.||.|..+.|-++.+ ..++++|+|++...... ....+..+.-.+|+.||+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677889999999999998876 46889999987642211 22344455667899999998 699999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
...++|+|.|+.|.|+|||...- .++.+...+|+.|+..|++|||..+ ||||||||+|||+|+|.++||
T Consensus 96 sF~FlVFdl~prGELFDyLts~V--------tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV--------TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe--------eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEE
Confidence 99999999999999999996543 2355666789999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCcccccccccccCCCccCcccccc------CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM------NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
+|||++..+.... ......|||+|+|||.+.- ..|+..+|+|+.|||||-||.|..||.... .
T Consensus 165 sDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------Q 233 (411)
T KOG0599|consen 165 SDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------Q 233 (411)
T ss_pred eccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------H
Confidence 9999998776543 2456789999999998863 357889999999999999999999985432 1
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
-...+.+++|++. .......+.....++||.+||+.||.+|.|.+|.|.+-
T Consensus 234 mlMLR~ImeGkyq--------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 234 MLMLRMIMEGKYQ--------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHHHHHHHhcccc--------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 1234556666542 22233467777899999999999999999999999863
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=313.74 Aligned_cols=248 Identities=26% Similarity=0.457 Sum_probs=195.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE-eCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ-EKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~-~~~~~~l 579 (812)
++|++.+.||+|+||.||++.. .++.+++|.+... ...+.|.+|+.++++++|+|++++++++. +++..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 4688999999999999999987 4788999987531 12346888999999999999999999765 4456899
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+|||+++++|.++++..... ..++..+++++.|++.+|+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 78 v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRS------VLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred EEECCCCCcHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCcc
Confidence 99999999999999764321 2367788899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+....... .....+..|+|||++....++.++||||||+++|||++ |+.||.... .......+..+
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~~ 215 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKG 215 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhcC
Confidence 86543211 22344568999999988889999999999999999998 888874321 11111122111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
. .. ......+..+.+++.+|++.+|++|||++++++.|++
T Consensus 216 ~-------~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 216 Y-------KM----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred C-------CC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1 00 0112335568899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.19 Aligned_cols=244 Identities=24% Similarity=0.304 Sum_probs=191.5
Q ss_pred eeeccCCcEEEEEEEE----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEE
Q 042346 507 NKVGIGSFGTVYKGKL----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 582 (812)
+.||+|+||.||+++. .+++.+|+|++... .........+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA---TLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHH---HhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 6799999999999875 35789999998631 1112233456789999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
|+++++|.+++..... +++...+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~~~L~~~l~~~~~--------l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 79 FLRGGDLFTRLSKEVM--------FTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred CCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 9999999999965432 356777899999999999999998 99999999999999999999999999875
Q ss_pred CCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccc
Q 042346 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742 (812)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (812)
..... .......|++.|+|||.+....++.++||||||+++|||++|+.||..... ......+....
T Consensus 148 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~~~--- 214 (318)
T cd05582 148 SIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILKAK--- 214 (318)
T ss_pred cCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHcCC---
Confidence 43321 122345789999999999988899999999999999999999999854321 11111222211
Q ss_pred cccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042346 743 VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVAN 786 (812)
Q Consensus 743 ~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 786 (812)
...+ ......+.+++.+||+.||++||+ +++++.+
T Consensus 215 -----~~~p----~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 215 -----LGMP----QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred -----CCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 1111 123455788999999999999999 5556543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.35 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=192.2
Q ss_pred eeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 508 KVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 508 ~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
.||+|+||.||+|.+. ++..||+|++.... .....+.|.+|++++++++||||+++++++.. +..++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN----EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc----ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeC
Confidence 4899999999999764 35579999875421 13344578899999999999999999998864 5689999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... .+++..+++++.|++.+|+|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 77 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 146 (257)
T cd05115 77 SGGPLNKFLSGKKD-------EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALG 146 (257)
T ss_pred CCCCHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCcccccc
Confidence 99999999975332 2367788999999999999999998 9999999999999999999999999997544
Q ss_pred CCcccc-cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccccc
Q 042346 665 ECDQEF-ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742 (812)
Q Consensus 665 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (812)
...... ......++..|+|||.+....++.++||||||+++|||++ |+.||..... .+ ....+..+.
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~----~~~~~~~~~--- 215 (257)
T cd05115 147 ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PE----VMSFIEQGK--- 215 (257)
T ss_pred CCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HH----HHHHHHCCC---
Confidence 322211 1122234678999999988889999999999999999996 9988854321 11 111122211
Q ss_pred cccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 743 VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 743 ~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
+... +...++.+.+++.+||..+|++||++.+|.+.|+..
T Consensus 216 ----~~~~----~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 ----RLDC----PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111 122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=314.94 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=200.1
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..++|++.++||+|+||.||+|..++++.+|+|.+..... ....+.+|++++++++|+||+++++++. .+..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 3457999999999999999999988899999998864221 2346888999999999999999999874 45689
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
++|||+++++|.+++...... .+++.+++.++.|++.+|+|||+.+ ++||||||+||++++++.++|+|||
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGI------KLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCc
Confidence 999999999999998654322 2367788899999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++........ .......++..|+|||++....++.++||||||+++|||++ |+.||..... ... ...+..
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~----~~~~~~ 218 (260)
T cd05067 148 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEV----IQNLER 218 (260)
T ss_pred ceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHH----HHHHHc
Confidence 9876542211 11123345678999999988889999999999999999999 8888853221 111 111111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
+. +...+ ...+..+.+++.+|+..+|++||+++++++.|+.
T Consensus 219 ~~-------~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 219 GY-------RMPRP----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CC-------CCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 10 11111 1234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=325.33 Aligned_cols=244 Identities=23% Similarity=0.302 Sum_probs=188.0
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||.||+++++ +++.||+|++.... .........+..|..++..+ +||||+++++++.+++..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDV--VLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--hhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 47999999999999875 58899999986311 11122334556677777754 8999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... +++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~g~L~~~i~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 79 NGGDLMFHIQDKGR--------FDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred CCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 99999999876432 245667789999999999999998 9999999999999999999999999986432
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~~~~~----- 212 (316)
T cd05620 148 FGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESIRVDT----- 212 (316)
T ss_pred cCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-----
Confidence 211 123345789999999999999999999999999999999999999854321 11111111111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT-DIVA 785 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 785 (812)
...+. .....+.+++.+||+.||++||++. ++++
T Consensus 213 ---~~~~~----~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 213 ---PHYPR----WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred ---CCCCC----CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11111 2344578899999999999999984 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=314.24 Aligned_cols=256 Identities=28% Similarity=0.454 Sum_probs=202.8
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..++|++.++||+|+||.||++.+++++.+++|.+..... ....+.+|++++++++|+||+++++++..+...+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 4567999999999999999999988888999998864221 2346888999999999999999999999888999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++...... .+++..++.++.+++.+|.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~------~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGK------KLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred EEEeccCCCCHHHHHhccccC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccc
Confidence 999999999999999764321 2367788899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++........ ........+..|+|||.+.+..++.++||||||+++|||++ |+.||..... .. ....+..
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~----~~~~~~~ 219 (261)
T cd05034 149 LARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----RE----VLEQVER 219 (261)
T ss_pred cceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HH----HHHHHHc
Confidence 9876543111 11122335678999999998889999999999999999999 8888743221 11 1111111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
+. +...+ ...+..+.+++.+|+..+|++||+++++++.|+.
T Consensus 220 ~~-------~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 GY-------RMPRP----PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC-------CCCCC----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 10 11111 1224568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.74 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=198.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
++|.+.++||+|+||.||++.+.++..+++|++.... ...+.+.+|++++++++|+|++++++++. .+..+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT------MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC------ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 4588999999999999999998777789999875321 12346788999999999999999999875 4567899
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.++++..... ..++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++
T Consensus 79 ~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGK------YLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred EEcCCCCCHHHHHhhCCCC------CCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccc
Confidence 9999999999999754321 2367888899999999999999988 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .. ....+..+.
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~----~~~~~~~~~ 220 (260)
T cd05069 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----RE----VLEQVERGY 220 (260)
T ss_pred eEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HH----HHHHHHcCC
Confidence 765332211 1122346678999999988889999999999999999999 8888743221 11 111111110
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.. ......+..+.+++.+||..||++||++++|++.|++
T Consensus 221 -------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 -------RM----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------CC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 1112345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.39 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=189.6
Q ss_pred eeeccCCcEEEEEEEEcC---CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEe
Q 042346 507 NKVGIGSFGTVYKGKLMD---GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
+.||+|+||.||+|.+.+ +..+++|.+.... .......+.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 368999999999998643 4578999875422 122344688899999999999999999999998889999999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccC
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
+++++|.++++...... ....++...++++.|++++|+|||+.+ ++||||||+|||++.++++||+|||++...
T Consensus 77 ~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 77 CPLGDLKGYLRSCRKAE---LMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred CCCCcHHHHHHHhhhcc---cccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999997643221 112256677789999999999999998 999999999999999999999999998654
Q ss_pred CCCcccccccccccCCCccCccccccC-------cCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 664 SECDQEFISTKAVGTVGYIDPEYYVMN-------VLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
.............++..|+|||++... .++.++||||||+++|||++ |+.||..... .+.... .
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~~~~~~----~ 222 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD----EQVLTY----T 222 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh----HHHHHH----H
Confidence 332222222334578899999988642 35789999999999999996 9988843221 111111 1
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
..+... ++..+.. .....+.+.+++.+|+ .+|++|||++||+..|+
T Consensus 223 ~~~~~~-----~~~~~~~-~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 VREQQL-----KLPKPRL-KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hhcccC-----CCCCCcc-CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 1111111 1122345778888998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.25 Aligned_cols=264 Identities=22% Similarity=0.353 Sum_probs=200.5
Q ss_pred CcceeeeeccCCcEEEEEEEE-----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--
Q 042346 502 NFSLENKVGIGSFGTVYKGKL-----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK-- 574 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-- 574 (812)
.|++.+.||+|+||.||++++ .+++.|++|.+.... .......+.+|+++++.++||||+++++++.+.
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 478899999999999999974 247889999975321 123345788999999999999999999998875
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
...++||||+++++|.+++..... .+++..++.++.|++.+|+|||+.+ |+||||||+|||++.++.+||
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~-------~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l 150 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKN-------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKI 150 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEE
Confidence 467899999999999999965422 2377888999999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCC-------CCCch
Q 042346 655 SDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG-------SGPLD 726 (812)
Q Consensus 655 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~-------~~~~~ 726 (812)
+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++++.|....... .....
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05079 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230 (284)
T ss_pred CCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccc
Confidence 999999765432221 1122345677899999998888999999999999999999987764321100 00000
Q ss_pred hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
........+..+. +... ...++..+.+|+.+||+.+|++|||++|+++.|+.+
T Consensus 231 ~~~~~~~~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 231 TVTRLVRVLEEGK-------RLPR----PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cHHHHHHHHHcCc-------cCCC----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0111111111111 1111 122456688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=324.00 Aligned_cols=244 Identities=25% Similarity=0.322 Sum_probs=188.1
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHh-ccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSR-VHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||+||++++. +++.||+|++.... .........+..|..++.. ++||||+++++++.+++..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--hhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 46999999999999875 47899999986311 1112223445667777776 48999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++|+|.+++..... +++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~g~L~~~l~~~~~--------~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 79 NGGDLMFHIQSCHK--------FDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred CCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 99999999975432 255677889999999999999998 9999999999999999999999999986432
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~----- 212 (316)
T cd05619 148 LGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSIRMDN----- 212 (316)
T ss_pred CCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-----
Confidence 211 122345789999999999998999999999999999999999999854321 11111111111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT-DIVA 785 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 785 (812)
...+ ......+.+++.+||+.||++||++. ++++
T Consensus 213 ---~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 213 ---PCYP----RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---CCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0111 12344578899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=316.22 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=196.7
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++++++||||+++++++..++..++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 4689999999999999999986 4688999998864211 223457789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.++++.... ++......++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~ 152 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGP--------LSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGV 152 (267)
T ss_pred EEeCCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999865432 255677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
+........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||..........
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----------- 219 (267)
T cd06646 153 AAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----------- 219 (267)
T ss_pred ceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-----------
Confidence 875432111 122346889999999884 3457889999999999999999999985432111000
Q ss_pred hccccccccccCCCCCC-ChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPEL-NEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.+.......+.. .....+..+.+++.+||..+|++|||+++++++|
T Consensus 220 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 220 -----LMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -----eeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000011111111 1123456788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.98 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=196.3
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.++||+|+||.||++.+ .+++.||+|++.... ..+....+.+|++++++++||||+++++++..++..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 3578899999999999999986 468899999875321 23344578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|..+.. +++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 77 v~e~~~~~~l~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~ 141 (279)
T cd06619 77 CTEFMDGGSLDVYRK------------IPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGV 141 (279)
T ss_pred EEecCCCCChHHhhc------------CCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 999999999976531 134556789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+...... ......++..|+|||++.+..++.++||||||+++|||++|+.||.............. ....+....
T Consensus 142 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 216 (279)
T cd06619 142 STQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ-LLQCIVDED 216 (279)
T ss_pred ceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHH-HHHHHhccC
Confidence 8654322 12345789999999999988899999999999999999999999865332111111111 111111110
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
. +..........+.+++.+|++.+|++||+++|++++.
T Consensus 217 -----~-----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 217 -----P-----PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred -----C-----CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0 1111122344578999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=324.82 Aligned_cols=245 Identities=25% Similarity=0.330 Sum_probs=192.7
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||.||++++. +++.||+|++... ..........+.+|.+++..+ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKD--VILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999875 4789999998631 111223345567888888888 7999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... +++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 79 ~~~~L~~~~~~~~~--------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 79 NGGDLMFHIQRSGR--------FDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred CCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 99999999876532 256777889999999999999998 9999999999999999999999999986432
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......+++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 148 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~~~----- 212 (318)
T cd05570 148 LGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILEDE----- 212 (318)
T ss_pred cCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCC-----
Confidence 211 112334689999999999999999999999999999999999999854321 11112222211
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI-----TDIVAN 786 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 786 (812)
...+ ......+.+|+.+||+.||++||++ .+++++
T Consensus 213 ---~~~~----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 213 ---VRYP----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ---CCCC----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1111 1234567899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.52 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=194.4
Q ss_pred eeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCC
Q 042346 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSN 586 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 586 (812)
++||+|+||.||++...+++.+|+|++.... ..+....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 4699999999999998889999999875321 123345688999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCC
Q 042346 587 GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC 666 (812)
Q Consensus 587 gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~ 666 (812)
++|.+++...... +.+..+++++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 77 ~~L~~~~~~~~~~-------~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 77 GDFLSFLRKKKDE-------LKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CcHHHHHHhcCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccc
Confidence 9999998654321 367788899999999999999998 999999999999999999999999998653321
Q ss_pred cccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhcccccccc
Q 042346 667 DQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLD 745 (812)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 745 (812)
.. .......++..|+|||++....++.++||||||+++|||++ |..||..... ......+..+.
T Consensus 147 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~~~~~~~~------ 211 (250)
T cd05085 147 IY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAREQVEKGY------ 211 (250)
T ss_pred cc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHHcCC------
Confidence 11 11112234668999999998889999999999999999999 8888743221 11111111111
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 746 KRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 746 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
+... ....+..+.+++.+|+..+|++||++.|+++.|.
T Consensus 212 -~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 -RMSC----PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -CCCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1111 1123456889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.06 Aligned_cols=254 Identities=27% Similarity=0.472 Sum_probs=191.6
Q ss_pred eeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe-CCeEEEEE
Q 042346 507 NKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE-KDERLLVY 581 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~lV~ 581 (812)
+.||+|+||.||+|.+.+ ...+|+|++.... .....+.+.+|+.+++.++||||+++++++.. ++..+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC----CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 468999999999998642 4579999874311 12334577889999999999999999998764 45578999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+.+++|.+++...... ..+...+.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 77 e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~ 146 (262)
T cd05058 77 PYMKHGDLRNFIRSETHN-------PTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLAR 146 (262)
T ss_pred ecCCCCCHHHHHHhcCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccc
Confidence 999999999999754321 245667889999999999999988 9999999999999999999999999987
Q ss_pred cCCCCccc--ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 662 LGSECDQE--FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 662 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
........ .......++..|+|||.+....++.++||||||+++|||++|+.|++.... ..+... ....+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~----~~~~~~ 219 (262)
T cd05058 147 DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITV----YLLQGR 219 (262)
T ss_pred cccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH----HHhcCC
Confidence 54321111 111233457789999999888899999999999999999997655433221 111111 111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
....+ ...+..+.+++.+||+.+|++||++.||++.|++++.
T Consensus 220 -------~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 -------RLLQP----EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -------CCCCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11111 1234568899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.63 Aligned_cols=256 Identities=28% Similarity=0.474 Sum_probs=194.8
Q ss_pred eeeccCCcEEEEEEEEcC-Cc--EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEEEEE
Q 042346 507 NKVGIGSFGTVYKGKLMD-GR--EVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 582 (812)
+.||+|+||.||++++.+ +. .+++|.+... ...+....+.+|++++.++ +||||+++++++...+..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 468999999999998754 33 4688876521 1123345788899999999 89999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCc--------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 583 YMSNGALHDHLHNKNNTEK--------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
|+++++|.++++....... .....+++..+++++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEE
Confidence 9999999999976542211 11123478888999999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
+|||++..... .........+..|+|||++....++.++||||||+++|||++ |+.||..... .+ ...
T Consensus 154 ~dfgl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~----~~~ 222 (270)
T cd05047 154 ADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AE----LYE 222 (270)
T ss_pred CCCCCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH----HH----HHH
Confidence 99999853221 111112234567999999988889999999999999999997 8888743221 01 111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
.+..+ .++..+ ......+.+++.+|++.||.+|||+.|++..|++++
T Consensus 223 ~~~~~-------~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 KLPQG-------YRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHhCC-------CCCCCC----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111 011111 123446789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.57 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=192.1
Q ss_pred eeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 508 KVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 508 ~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
.||+|+||.||+|.++ +++.+|+|++.... ......+.+.+|+.+++.++||||+++++++.. +..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecC
Confidence 6899999999999753 57889999875322 223345678899999999999999999998864 5678999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... +++...++++.|++.+|+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 78 ~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 78 ELGPLNKFLQKNKH--------VTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred CCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccC
Confidence 99999999965432 256777899999999999999998 9999999999999999999999999997654
Q ss_pred CCcccc-cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccccc
Q 042346 665 ECDQEF-ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742 (812)
Q Consensus 665 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (812)
...... ......++..|+|||.+....++.++||||||+++|||++ |+.||..... ... ...+..+.
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~----~~~i~~~~--- 215 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEV----TQMIESGE--- 215 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHH----HHHHHCCC---
Confidence 322211 1122334679999999988889999999999999999998 8888854221 111 11121111
Q ss_pred cccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 743 VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 743 ~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
+...+ ...+..+.++|.+||+.||++||++.+|.+.|++
T Consensus 216 ----~~~~~----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 216 ----RMECP----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ----CCCCC----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11111 1234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.66 Aligned_cols=258 Identities=25% Similarity=0.318 Sum_probs=193.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.||+|++.. .........+.+.+|+.++..++|+||+++++++.+++..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~--~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK--WEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEH--HHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 46899999999999999999875 588999999853 111223345568889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++...... ++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~e~~~g~~L~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDR-------LPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred EEecCCCCcHHHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCc
Confidence 99999999999999753221 245566789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-----CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+........ .......||+.|||||++.. ..++.++|||||||++|||++|+.||..... .+ ....
T Consensus 149 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~~-~~~~ 219 (331)
T cd05597 149 CLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VE-TYGK 219 (331)
T ss_pred eeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------HH-HHHH
Confidence 865433221 11223468999999999863 4578899999999999999999999854321 11 1111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCC--CCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEG--KERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP--~~RPt~~evl~~ 786 (812)
+.... .....+.. ....++.+.+++.+|+..++ ..||++++++++
T Consensus 220 i~~~~------~~~~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 220 IMNHK------EHFQFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHcCC------CcccCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11111 00111110 11244556777777765433 448899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.65 Aligned_cols=254 Identities=26% Similarity=0.317 Sum_probs=197.4
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|+..+.||+|+||.||++.+. +++.+|+|.+.... .........+.+|+.+++.++|+||+++++.+.+++..++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh--ccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 777899999999999999874 58899999876421 111223345678999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++...... .++...++.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++.
T Consensus 80 e~~~g~~L~~~l~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEA------GFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAV 150 (285)
T ss_pred EecCCCcHHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeecccee
Confidence 999999999998654321 1356777889999999999999988 9999999999999999999999999986
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
...... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ........... ..
T Consensus 151 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~-~~ 221 (285)
T cd05630 151 HVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKE-VQ 221 (285)
T ss_pred ecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhh-hh
Confidence 543221 1223478999999999998899999999999999999999999996533211 00111111110 00
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVAN 786 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 786 (812)
. . ........+.+|+.+||+.||++||| ++|++++
T Consensus 222 ~----~------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 E----E------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred h----h------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0 0 01123445789999999999999999 8899884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=333.54 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=195.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+....+.+|++++..++||||+++++.+.+++..+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKA--DMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--HHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 36889999999999999999875 5889999998631 11223345677889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... ++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~E~~~gg~L~~~l~~~~~--------l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDT--------LSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred EEeCCCCccHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999999976432 245566789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCccc---------------------------------ccccccccCCCccCccccccCcCCCcchhHHHHHHHH
Q 042346 660 SLLGSECDQE---------------------------------FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLL 706 (812)
Q Consensus 660 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ 706 (812)
+......... .......||+.|+|||++.+..++.++|||||||+||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8643221100 0012347999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 042346 707 ELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN---ITDI 783 (812)
Q Consensus 707 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~ev 783 (812)
||++|+.||..... . .....+.... ..+..+. .....+.+.+++.+++ .||.+|++ ++|+
T Consensus 228 el~tG~~Pf~~~~~----~----~~~~~i~~~~------~~~~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 290 (360)
T cd05627 228 EMLIGYPPFCSETP----Q----ETYRKVMNWK------ETLVFPP--EVPISEKAKDLILRFC-TDSENRIGSNGVEEI 290 (360)
T ss_pred ecccCCCCCCCCCH----H----HHHHHHHcCC------CceecCC--CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH
Confidence 99999999854321 1 1111122111 0111111 0113345667777766 49999984 7888
Q ss_pred HHH
Q 042346 784 VAN 786 (812)
Q Consensus 784 l~~ 786 (812)
+++
T Consensus 291 ~~h 293 (360)
T cd05627 291 KSH 293 (360)
T ss_pred hcC
Confidence 877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.49 Aligned_cols=269 Identities=21% Similarity=0.267 Sum_probs=194.5
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC--
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD-- 575 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-- 575 (812)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF---QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc---cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 3467999999999999999999874 58999999986421 12233456778999999999999999999986543
Q ss_pred ----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 576 ----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 576 ----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
..++||||+++ +|.+.++.. ++......++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHME----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhcc----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCC
Confidence 46899999975 677766432 244566789999999999999998 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC--------
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG-------- 723 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~-------- 723 (812)
+||+|||+++..... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 162 ~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 238 (359)
T cd07876 162 LKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238 (359)
T ss_pred EEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999999654321 123345789999999999999999999999999999999999999864321100
Q ss_pred ---CchhHHHH---HHHHHhc--cc-----cccccccC-CCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 724 ---PLDVVEFA---VSQILAG--QL-----HCVLDKRV-GPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 724 ---~~~~~~~~---~~~~~~~--~~-----~~~~d~~~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
........ ....... .. .+.+.... .............+.+|+.+||..||++|||++|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000000 0000000 00 00000000 000000112245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=334.76 Aligned_cols=265 Identities=23% Similarity=0.327 Sum_probs=194.9
Q ss_pred CcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-----
Q 042346 502 NFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD----- 575 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 575 (812)
+|++.++||+|+||.||++.. .+++.||+|++.... ......+.+.+|+++++.++||||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 478899999999999999986 468999999875321 11223456788999999999999999999998776
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+. ++|.+++..... +++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~--------l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~ 145 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVSPQP--------LSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKIC 145 (372)
T ss_pred eEEEEeeccc-cCHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEec
Confidence 7899999996 588888754322 356777889999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||..... .+..+.....
T Consensus 146 Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~ 220 (372)
T cd07853 146 DFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP----IQQLDLITDL 220 (372)
T ss_pred cccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHH
Confidence 9999976433221 122344688999999998764 578999999999999999999999854321 1111111100
Q ss_pred H-----------HhccccccccccCCCCC-----CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 I-----------LAGQLHCVLDKRVGPPE-----LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~-----------~~~~~~~~~d~~~~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. ..+....+......++. ....+..+.+.+|+.+||+.||++|||++|++++
T Consensus 221 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 221 LGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred cCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 00000000000000110 0011234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.23 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=194.2
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||.||+++.. +++.+|+|++... .....+....+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKE--LVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 47999999999999874 5789999998642 112233445678899999888 6999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~L~~~~~~~~~--------l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 79 NGGDLMFHMQRQRK--------LPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred CCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 99999999865432 356777889999999999999998 9999999999999999999999999986432
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++||||||++||||++|+.||....... .....+.....+....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~----- 219 (327)
T cd05617 148 GPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILEKP----- 219 (327)
T ss_pred CCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHhCC-----
Confidence 211 12234579999999999999999999999999999999999999996433211 1112222222222211
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN------ITDIVAN 786 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt------~~evl~~ 786 (812)
...+. ..+..+.+++.+||..||++||+ +++++++
T Consensus 220 ---~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 ---IRIPR----FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ---CCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11111 23345778999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=303.66 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=202.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++-+.||+|.|+.||++.+ ..|+.+|+|++....... ...+++.+|+.|-+.|+||||++|.+.+.+....|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~---~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc---ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 45688899999999999999865 469999999876432222 24567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC---CCcEEEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV---NWTARVS 655 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kl~ 655 (812)
||+|+|++++|..-|-.+. +.+....-+.+.||+.+|.|.|.++ |||||+||+|+|+-. .--+||+
T Consensus 87 lvFe~m~G~dl~~eIV~R~--------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVARE--------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred EEEecccchHHHHHHHHHH--------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeec
Confidence 9999999999987765441 1233444578999999999999999 999999999999943 2458999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||++..+.. ....-..+|||.|||||++...+|+..+|||+.|||||-||.|+.||..... .....++
T Consensus 156 ~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------~rlye~I 224 (355)
T KOG0033|consen 156 DFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYEQI 224 (355)
T ss_pred ccceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--------HHHHHHH
Confidence 9999987662 2233456899999999999999999999999999999999999999965331 2233444
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+.+ .++.+ ......+.-++|+++||..||.+|.|+.|.|.+
T Consensus 225 ~~g~y------d~~~~--~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 225 KAGAY------DYPSP--EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred hcccc------CCCCc--ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 44432 12222 234455667899999999999999999998754
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=313.38 Aligned_cols=259 Identities=23% Similarity=0.426 Sum_probs=201.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-Cc----EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GR----EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~----~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.+|++.+.||+|+||.||+|.+++ ++ .+++|.+..... ......+.+|++++++++||||+++++++.. .
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS----PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 458889999999999999998643 33 588998754221 3445678899999999999999999999987 6
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.+++...... +++...++++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~ 151 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDN-------IGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKIT 151 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCC-------CCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEEC
Confidence 789999999999999999764322 367788999999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||..... .+ ....
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~----~~~~ 223 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VE----IPDL 223 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HH----HHHH
Confidence 9999976554332222222334678999999988889999999999999999999 9998754221 11 1111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+..+. ....+.. ....+.+++.+||..+|++||++.++++.|+++++.
T Consensus 224 ~~~~~-------~~~~~~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 224 LEKGE-------RLPQPPI----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HhCCC-------CCCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11111 1111211 223477889999999999999999999999998663
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.99 Aligned_cols=254 Identities=27% Similarity=0.327 Sum_probs=197.7
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|+..+.||+|+||+||++.+. +++.+|+|.+.... .........+.+|+++++.++|+||+.+++.+..++..+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR--IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhh--hhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 777899999999999999874 68899999875421 112223445778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++...... .+++...+.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 80 e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNP------GFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred EeccCccHHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcce
Confidence 999999999988653321 2367888999999999999999998 9999999999999999999999999986
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
...... ......|+..|+|||++.+..++.++|+||||+++|||++|+.||...... ...+..........
T Consensus 151 ~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~----~~~~~~~~~~~~~~-- 221 (285)
T cd05632 151 KIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK----VKREEVDRRVLETE-- 221 (285)
T ss_pred ecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhhhccc--
Confidence 543211 123457899999999999888999999999999999999999998543210 01111111111110
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVAN 786 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 786 (812)
. .........+.+|+.+|++.||++||+ ++|++.+
T Consensus 222 ------~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 ------E----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ------c----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 011233455788999999999999999 7788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=309.48 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=200.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.++|++.+.||+|+||.||++.. .++.|++|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 34688899999999999999987 488999999864211 34578889999999999999999999999889999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++...... .+++...+.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 78 v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRA------VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred EEEecCCCcHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccc
Confidence 99999999999999765421 2367888999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++...... .....+..|+|||++....++.++||||||+++|||++ |+.||..... ......+..+
T Consensus 149 ~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~ 215 (256)
T cd05039 149 AKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEKG 215 (256)
T ss_pred cccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhcC
Confidence 97653211 12334668999999988889999999999999999997 8888743211 1111111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
. +... ....++.+.+++.+||..+|++|||++|+++.|++
T Consensus 216 ~-------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 Y-------RMEA----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred C-------CCCC----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0 1111 12335668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=320.23 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=190.4
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc---cCCCceEEEEEEEeC---
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV---HHKHLVGLVGFCQEK--- 574 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~--- 574 (812)
+|++.+.||+|+||.||+++.. +++.||+|.+....... .....+.+|+++++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED---GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC---CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 4888999999999999999875 58899999876422111 1122344566666655 799999999988642
Q ss_pred --CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 575 --DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 575 --~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
...+++|||+.+ +|.+++...... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 78 RETKVTLVFEHVDQ-DLRTYLDKVPPP------GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQV 147 (288)
T ss_pred CCceEEEEEccccc-CHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 347899999974 899988754321 1366778899999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||+|||++....... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... +......
T Consensus 148 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~~~~~~~ 220 (288)
T cd07863 148 KLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----DQLGKIF 220 (288)
T ss_pred EECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----HHHHHHH
Confidence 999999997654321 223456899999999999888999999999999999999999888543211 1111111
Q ss_pred HHHHh---ccccc-------cccccCC-CCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILA---GQLHC-------VLDKRVG-PPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~---~~~~~-------~~d~~~~-~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... ..+.. .+..... .......+..+.+.+++.+||+.||++|||++|++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 221 DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 10000 00000 0000000 0000012345668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=323.58 Aligned_cols=258 Identities=26% Similarity=0.334 Sum_probs=194.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.++||+|+||.||+++++. ++.+|+|++... ..........+.+|+.++..++|+||+++++++.+.+..++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHH--HHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 468999999999999999998754 778999997531 11223334567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++...... +++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~ey~~~g~L~~~l~~~~~~-------l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDR-------LPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred EEeccCCCcHHHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecch
Confidence 99999999999999763221 255667789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+....... ........||+.|+|||++. ...++.++|||||||+||||++|+.||..... .+ ....
T Consensus 149 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~-~~~~ 219 (332)
T cd05623 149 CLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VE-TYGK 219 (332)
T ss_pred heecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HH-HHHH
Confidence 86543221 11223457999999999986 34688999999999999999999999854321 11 1112
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGK--ERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~--~RPt~~evl~~ 786 (812)
+.... .+...+.. .......+.+|+.+|+..+++ .|++++|++++
T Consensus 220 i~~~~------~~~~~p~~-~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 220 IMNHK------ERFQFPAQ-VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HhCCC------ccccCCCc-cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 21111 01111110 123345577788887755444 47899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.86 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=199.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..+|++.+.||+|+||.||++.. .+++.+++|.+..... .....+.+|+++++.++|+||+++++.+..+...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 35799999999999999999986 4688999998764221 12356788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++.... +++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg 161 (296)
T cd06654 94 VVMEYLAGGSLTDVVTETC---------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFG 161 (296)
T ss_pred EeecccCCCCHHHHHHhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccc
Confidence 9999999999999986432 256777899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++........ ......+++.|+|||.+....++.++|||||||++|||++|+.||....... ... .....
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~-~~~~~ 231 (296)
T cd06654 162 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALY-LIATN 231 (296)
T ss_pred cchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHH-HHhcC
Confidence 9875433221 1233468899999999988889999999999999999999999985433110 000 01100
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. .++..........+.+++.+||..+|++|||++|++++
T Consensus 232 ~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 232 G---------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred C---------CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0 00111123455668899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.56 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=187.5
Q ss_pred eeeccCCcEEEEEEEEcC---CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEe
Q 042346 507 NKVGIGSFGTVYKGKLMD---GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
+.||+|+||.||+|...+ ...+++|.+... ........|.+|+++++.++||||+++++.+.+....++||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 369999999999997543 346788876431 1223345688899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccC
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
+++|+|.+++........ ....+...++++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++...
T Consensus 77 ~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVA---QMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred CCCCcHHHHHHhcccccc---ccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 999999999976543221 11245667889999999999999998 999999999999999999999999998653
Q ss_pred CCCcccccccccccCCCccCcccccc-------CcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 664 SECDQEFISTKAVGTVGYIDPEYYVM-------NVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
.............++..|+|||++.. ..++.++||||||+++|||++ |+.||....+ .+ .....
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~----~~~~~ 222 (269)
T cd05042 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD----EQ----VLKQV 222 (269)
T ss_pred ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH----HH----HHHHH
Confidence 32221112233456778999998743 356789999999999999999 6666643221 11 11111
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
.... +..+..+. ......+.+.+++..|+ .||++|||++||++.|.
T Consensus 223 ~~~~-----~~~~~~~~-~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 223 VREQ-----DIKLPKPQ-LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred hhcc-----CccCCCCc-ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 11111111 12334556677888888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.54 Aligned_cols=240 Identities=28% Similarity=0.319 Sum_probs=184.8
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHH-HHHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELA-LLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||+||+++.. +++.+|+|++... ..........+..|.. +++.++||||+++++++..++..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKK--IVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 46999999999999864 6899999998632 1112223344555554 577799999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... +++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 79 NGGELFFHLQRERS--------FPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred CCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 99999999865432 255667789999999999999998 9999999999999999999999999986432
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....+
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~~~~---- 213 (325)
T cd05604 148 AQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILHKPL---- 213 (325)
T ss_pred CCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHcCCc----
Confidence 211 123345799999999999999999999999999999999999999864321 111122222111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT 781 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 781 (812)
..+ ......+.+++.+||+.+|.+||++.
T Consensus 214 ----~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 214 ----VLR----PGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred ----cCC----CCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 111 11234567888999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.33 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=196.6
Q ss_pred eeeccCCcEEEEEEEEcC-------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 507 NKVGIGSFGTVYKGKLMD-------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+.||+|+||.||++++.+ ++.+++|.+... ........+.+|+++++.++||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc----cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 369999999999998643 257899986431 112334578889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC-----cEEE
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW-----TARV 654 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-----~~kl 654 (812)
||||+++++|.+++........ ....+++..++.++.|++.+|+|||+.+ ++|+||||+|||++.+. .+||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERF-GPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEeccCCCcHHHHHHHhhhccc-CCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999976543221 1223478888999999999999999988 99999999999999887 8999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
+|||++................++..|+|||++....++.++||||||+++|||++ |+.||..... .+.. .
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~----~ 224 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVL----Q 224 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHH----H
Confidence 99999875433222222223355788999999998899999999999999999998 8888743221 1111 1
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.+..+. ++.. ....+..+.+++.+||..+|++||++++|++.|++
T Consensus 225 ~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 225 HVTAGG-------RLQK----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHhcCC-------ccCC----cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111 1111 12345678899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.44 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=193.0
Q ss_pred eeeeeccC--CcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 505 LENKVGIG--SFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 505 ~~~~LG~G--~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
++++||+| +|++||+++. .+++.||+|++..... ..+....+.+|+++++.++||||+++++++..++..++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC---TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc---cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 46789999 7899999986 4689999999864211 1233456778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++...... .+++..+++++.|++.||+|||+++ |+||||||+|||++.++.++++||+...
T Consensus 79 e~~~~~~l~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 79 SFMAYGSAKDLICTHFMD------GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred eccCCCcHHHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999999654321 1366778899999999999999998 9999999999999999999999998654
Q ss_pred cCCCCccc-----ccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 662 LGSECDQE-----FISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 662 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
........ .......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .. ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~----~~ 221 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ----ML----LE 221 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH----HH----HH
Confidence 32211110 11122356778999999876 458999999999999999999999985422110 00 00
Q ss_pred HHhccccccccc-------------------cC---------------CCCCCChHHHHHHHHHHHHHccccCCCCCCCH
Q 042346 735 ILAGQLHCVLDK-------------------RV---------------GPPELNEAEAVELLATTAIHCVNLEGKERPNI 780 (812)
Q Consensus 735 ~~~~~~~~~~d~-------------------~~---------------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 780 (812)
...+.....++. .. ........+....+.+++.+||+.||++|||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 301 (327)
T cd08227 222 KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA 301 (327)
T ss_pred HhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH
Confidence 011111100000 00 00001123345678899999999999999999
Q ss_pred HHHHHH
Q 042346 781 TDIVAN 786 (812)
Q Consensus 781 ~evl~~ 786 (812)
+|++++
T Consensus 302 ~ell~~ 307 (327)
T cd08227 302 STLLNH 307 (327)
T ss_pred HHHhcC
Confidence 999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=317.56 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=198.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++.+. +++.+++|.+.... ..+....+.+|++++++++||||+++++++.+++..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 36899999999999999999875 57788888875321 12344568889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
||||+++++|.++++.... +++.....++.|+++||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 77 v~ey~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg 145 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGR--------IPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 145 (308)
T ss_pred EeeccCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCC
Confidence 9999999999999976432 24566788999999999999984 5 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .............
T Consensus 146 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~ 217 (308)
T cd06615 146 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK----ELEAMFGRPVSEG 217 (308)
T ss_pred Cccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh----hHHHhhcCccccc
Confidence 98654321 123456889999999998888999999999999999999999998532210 0000000000000
Q ss_pred ------------------------cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 739 ------------------------QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 739 ------------------------~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.....+.. ..+..........+.+++.+||..+|++|||++|++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNE--PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cccCCcccccCCCCCccchhhHHHHHHHHhcC--CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000 001111122455688999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=323.76 Aligned_cols=263 Identities=20% Similarity=0.303 Sum_probs=195.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.+ +++.||+|++..... ......+.+|++++++++||||+++++++..++..++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc----CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 56999999999999999999875 578899998864221 1123356789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++ +|.+++..... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 v~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 150 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGN-------IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGL 150 (309)
T ss_pred EEeCCCC-CHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcccc
Confidence 9999975 88888865432 1256667789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH-----
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS----- 733 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~----- 733 (812)
+........ ......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...... +.......
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~----~~~~~~~~~~~~~ 224 (309)
T cd07872 151 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE----DELHLIFRLLGTP 224 (309)
T ss_pred ceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCC
Confidence 865432211 1233467899999998865 46889999999999999999999998543321 11111110
Q ss_pred ------HHHhccccccccccCCCCC-----CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 ------QILAGQLHCVLDKRVGPPE-----LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ------~~~~~~~~~~~d~~~~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.... ...+....... .........+.+++.+||+.||.+|||++|++++
T Consensus 225 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 225 TEETWPGISSND--EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CHHHHhhhcchh--hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000 00000000000 0011244567899999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.91 Aligned_cols=202 Identities=26% Similarity=0.366 Sum_probs=159.6
Q ss_pred eeeeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe--CCeEEEE
Q 042346 506 ENKVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE--KDERLLV 580 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lV 580 (812)
.++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|++++++++||||+++++++.. +...+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 468999999999999864 46789999885321 12345689999999999999999998864 3457899
Q ss_pred EEecCCCchhhhhhcCCCCCc-cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE----cCCCcEEEE
Q 042346 581 YEYMSNGALHDHLHNKNNTEK-NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTARVS 655 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kl~ 655 (812)
|||+. ++|.+++........ .....++......++.||+.||+|||+++ |+||||||+|||+ +.++.+||+
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 99996 489888864432211 11223467778899999999999999998 9999999999999 456789999
Q ss_pred eecccccCCCCccc-ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCC
Q 042346 656 DFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKN 718 (812)
Q Consensus 656 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~ 718 (812)
|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99999765432221 12234578999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=321.82 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=193.8
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~l 579 (812)
+|+..+.||+|+||.||+++.. +++.||+|++... ........+.+..|.+++..+. |++|+++++++.+.+..++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD--VVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 3778899999999999999875 5889999998631 1112233456677888888885 5778889999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... +++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~i~~~~~--------l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGK--------FKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred EEcCCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccc
Confidence 9999999999999965432 356778899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++...... .......||+.|+|||++.+..++.++||||||++||||++|+.||..... ......+....
T Consensus 148 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~ 217 (323)
T cd05615 148 CKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHN 217 (323)
T ss_pred ccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence 87532211 122345689999999999988999999999999999999999999854321 11122222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI-----TDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 786 (812)
...+ ......+.+++.+||+.+|.+|++. +|++++
T Consensus 218 --------~~~p----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 218 --------VSYP----KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred --------CCCC----ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 1111 1233457789999999999999974 566554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.89 Aligned_cols=256 Identities=29% Similarity=0.455 Sum_probs=200.4
Q ss_pred eeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEE
Q 042346 507 NKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 582 (812)
+.||+|+||.||++.... +..+++|++...... .....+.+|+++++.++|+||+++++++..+...++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE----EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch----hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 479999999999998754 788999998643221 145678899999999999999999999999889999999
Q ss_pred ecCCCchhhhhhcCCCCC-ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 583 YMSNGALHDHLHNKNNTE-KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
|+++++|.+++....... ......+++..+++++.|+++||+|||+++ |+||||||+|||+++++.+||+|||++.
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccc
Confidence 999999999997652210 000122377888999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
...............++..|+|||.+....++.++||||||+++|||++ |+.||.... .. .....+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~----~~~~~~~~~~- 224 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----NE----EVLEYLRKGY- 224 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC----HH----HHHHHHHcCC-
Confidence 6654332223344567889999999988889999999999999999999 588875431 11 1111221111
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
+... ....+..+.+++.+||+.||++|||++|++++|+
T Consensus 225 ------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ------RLPK----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCC----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111 1233566889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=309.75 Aligned_cols=255 Identities=24% Similarity=0.417 Sum_probs=200.8
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..++|++.++||+|+||.||++.+.++..+++|.+... ....+.+.+|++++++++|+||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 45679999999999999999999878888999987531 1234568889999999999999999999887 6789
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
++|||+++++|.+++...... ..++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGS------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFG 147 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCcc------ccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCc
Confidence 999999999999999764321 2367778899999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++........ .......++..|+|||++....++.++||||||+++|||++ |+.||..... .. ....+..
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~----~~~~~~~ 218 (260)
T cd05073 148 LARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PE----VIRALER 218 (260)
T ss_pred ceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HH----HHHHHhC
Confidence 9875433211 11222345678999999998889999999999999999999 8888743221 11 1111111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
+. ... .....+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 219 ~~-------~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 219 GY-------RMP----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CC-------CCC----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 111 112344568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=326.67 Aligned_cols=240 Identities=28% Similarity=0.348 Sum_probs=183.2
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHH-HHHHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSEL-ALLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei-~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
++||+|+||.||++++. +++.||+|++.... .........+.+|. .+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT--ILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 47999999999999875 58899999986311 11122233444554 4678899999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++...... .......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~L~~~l~~~~~~--------~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 79 NGGELFFHLQRERCF--------LEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred CCCCHHHHHHHcCCC--------CHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 999999988654321 34455678999999999999998 9999999999999999999999999986532
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~------ 211 (321)
T cd05603 148 EPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNILHK------ 211 (321)
T ss_pred CCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHhcC------
Confidence 211 123345789999999999988999999999999999999999999854321 1111122211
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT 781 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 781 (812)
....+. .....+.+++.+||+.||.+||+..
T Consensus 212 --~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 --PLQLPG----GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCC----CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111111 2234577899999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.13 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=198.5
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||+++.. +++.+++|.+..... ....+.+.+|+.+++.++|+||+++++.+.+++..+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS----SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 4788999999999999999875 588999998753211 22345677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++...... .++....+.++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++
T Consensus 77 ~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGK------LFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred EeeCCCCcHHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcc
Confidence 9999999999998653321 1245667889999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
........ ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||..... ......+..+..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~ 217 (255)
T cd08219 148 RLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKVCQGSY 217 (255)
T ss_pred eeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHHhcCCC
Confidence 75433221 12345688999999999888899999999999999999999999854221 111112222221
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. . +......+.+++.+||+.||++|||++|++..
T Consensus 218 ~~-------~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 KP-------L----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC-------C----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 10 0 12234557899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.94 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=200.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|.||.||++.+.+ ++.+++|.+... ...+.+.+|++++++++||||+++++++.++...++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 568889999999999999999865 789999987531 115678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
++||+++++|.+++..... .+++...+.++.|++.+|.|||+.+ |+||||+|+||+++.++.+||+|||+
T Consensus 76 ~~e~~~~~~L~~~l~~~~~-------~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~ 145 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNK-------TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGV 145 (256)
T ss_pred EEecCCCCcHHHHHHhCcc-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEccccc
Confidence 9999999999999965332 2367888899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+........ ......++..|+|||++.+..++.++||||||+++|||++|+.||....... .. .....
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~----~~~~~-- 213 (256)
T cd06612 146 SGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AI----FMIPN-- 213 (256)
T ss_pred chhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hh----hhhcc--
Confidence 876543221 1233457889999999998899999999999999999999999985432110 00 00000
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...............+.+++.+|++.||++|||++|++++
T Consensus 214 -------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 214 -------KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -------CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0000111123345668899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=311.73 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=200.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|.+.+.||+|+||.||+|.+.+ ...|++|+...... .+..+.+.+|+++++.++||||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS----PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC----HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3458889999999999999998643 24689998754221 2344578899999999999999999999875 4
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.+++..... .+++..++.++.+++.||+|||+.+ ++||||||+|||++.++.+||+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~ 149 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKY-------SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLG 149 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEc
Confidence 57899999999999999975432 1367888899999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||...... .. ...
T Consensus 150 d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~----~~~ 220 (270)
T cd05056 150 DFGLSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DV----IGR 220 (270)
T ss_pred cCceeeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HH----HHH
Confidence 9999876543221 11222344568999999988889999999999999999986 99998543211 11 111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+..+. +...+ ...+..+.+++.+|+..+|++|||+.++++.|++++..
T Consensus 221 ~~~~~-------~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 221 IENGE-------RLPMP----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHcCC-------cCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111 11111 22345688999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.40 Aligned_cols=195 Identities=23% Similarity=0.304 Sum_probs=164.5
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
...+|++.+.||+|+||.||+|+.. +++.||+|+... .....|+.++++++||||+++++++.+....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 3457999999999999999999875 467899997432 1224589999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+. ++|.+++..... .+++..+++|+.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 133 ~lv~e~~~-~~l~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df 201 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKRSR-------PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDL 201 (357)
T ss_pred EEEEEccC-CcHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecC
Confidence 99999995 699998865332 2367888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCC
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN 718 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~ 718 (812)
|++....... ......||+.|+|||++.+..++.++|||||||+||||+++..+++..
T Consensus 202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 202 GAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 9987532211 123456899999999999989999999999999999999987776543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=327.50 Aligned_cols=241 Identities=27% Similarity=0.333 Sum_probs=183.8
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHH-HHHHHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSE-LALLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~E-i~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||.||++++. +++.||+|++.... .........+.+| ..+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKA--ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--HHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 46999999999999875 57789999986311 1111222334444 44578899999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++...... .......++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~L~~~~~~~~~~--------~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 79 NGGELFYHLQRERCF--------LEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred CCCcHHHHHHhcCCC--------CHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 999999999764322 33445678999999999999998 9999999999999999999999999986532
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+.....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~----~~~~i~~~~~---- 213 (325)
T cd05602 148 EHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AE----MYDNILNKPL---- 213 (325)
T ss_pred cCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----HH----HHHHHHhCCc----
Confidence 211 123345799999999999999999999999999999999999999864321 11 1111211111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITD 782 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 782 (812)
.. .......+.+++.+||+.||.+||++.+
T Consensus 214 ----~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 214 ----QL----KPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred ----CC----CCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 11 1123456788999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.05 Aligned_cols=265 Identities=23% Similarity=0.393 Sum_probs=202.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe--
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE-- 573 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-- 573 (812)
..|++.+.||+|+||.||++++. +++.+|+|++...... .....|.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 35777899999999999999864 3688999998643221 345678999999999999999999999887
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
+...+++|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~ 149 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRD-------QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVK 149 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCcc-------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEE
Confidence 5578999999999999999976532 2377888999999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCC-------c
Q 042346 654 VSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP-------L 725 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~-------~ 725 (812)
|+|||++......... .......++..|++||.+....++.++||||||+++|||++|+.|+......... .
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 9999999765532221 1112234566799999998888999999999999999999999987543211100 0
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
......... .... .+... ...++..+.+++.+||+.+|++|||+.||+++|+++
T Consensus 230 ~~~~~~~~~-~~~~------~~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 230 MIVTRLLEL-LKEG------ERLPR----PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccHHHHHHH-HHcC------CcCCC----CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 001111111 1111 11111 123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=305.79 Aligned_cols=249 Identities=28% Similarity=0.436 Sum_probs=194.7
Q ss_pred eeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCC
Q 042346 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSN 586 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 586 (812)
++||+|+||.||++.+.+++.|++|++..... .+....+.+|++++++++|+||+++++++.+....++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP----PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 47999999999999987799999998764221 13445788999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCC
Q 042346 587 GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC 666 (812)
Q Consensus 587 gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~ 666 (812)
++|.+++..... .+++...+.++.+++.+|+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 77 ~~l~~~l~~~~~-------~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 77 GSLLTFLRKKKN-------RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred CcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 999999965432 1256777899999999999999998 999999999999999999999999998754322
Q ss_pred cccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhcccccccc
Q 042346 667 DQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLD 745 (812)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 745 (812)
...........+..|+|||.+.+..++.++||||||+++|||++ |..||..... .. ....+...
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----~~----~~~~~~~~------- 211 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----QQ----TRERIESG------- 211 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----HH----HHHHHhcC-------
Confidence 11111122234667999999988889999999999999999999 7777643221 00 11111110
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 746 KRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 746 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
.+... ....+..+.+++.+|+..+|++|||++|+++.|+
T Consensus 212 ~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 212 YRMPA----PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCC----CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 01111 1234456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=307.36 Aligned_cols=249 Identities=24% Similarity=0.418 Sum_probs=193.0
Q ss_pred eeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEE
Q 042346 507 NKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 582 (812)
++||+|+||.||+|++.. +..+++|.+..... ....+.+.+|+++++.++||||+++++++. .+..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI----AAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 479999999999997532 26899998764221 134567889999999999999999999876 456799999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
|+++++|.+++..... +++..+++++.|++.+|+|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~ 144 (257)
T cd05060 76 LAPLGPLLKYLKKRRE--------IPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRA 144 (257)
T ss_pred eCCCCcHHHHHHhCCC--------CCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccce
Confidence 9999999999976541 267788999999999999999998 99999999999999999999999999875
Q ss_pred CCCCcccc-cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 663 GSECDQEF-ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 663 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
........ ......++..|+|||.+....++.++||||||+++|||++ |+.||.... ..++. ..+....
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~----~~~~~----~~~~~~~- 215 (257)
T cd05060 145 LGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK----GAEVI----AMLESGE- 215 (257)
T ss_pred eecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC----HHHHH----HHHHcCC-
Confidence 54322211 1112234568999999998889999999999999999998 888874322 11111 1111111
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
+... ....+..+.+++.+||..+|++||++.++++.|+++
T Consensus 216 ------~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 216 ------RLPR----PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ------cCCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1111 122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.19 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=199.5
Q ss_pred CcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchh-hHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTN-KLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|+..+.||+|+||+||++...+++.+|+|.+....... ........+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999876432221 2233345688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++..... +++.....++.|++.+|+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 81 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 149 (265)
T cd06631 81 MEFVPGGSISSILNRFGP--------LPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCA 149 (265)
T ss_pred EecCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhh
Confidence 999999999999975432 245666789999999999999998 999999999999999999999999998
Q ss_pred ccCCCCc----ccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 661 LLGSECD----QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 661 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
....... .........++..|+|||++.+..++.++||||||+++|||++|+.||..... .... ..+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~-~~~~ 221 (265)
T cd06631 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAM-FYIG 221 (265)
T ss_pred HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHH-HHhh
Confidence 6542211 11122345689999999999988899999999999999999999999854221 0000 0111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... . .. +. ........+.+++.+||+.+|++||++.|++++
T Consensus 222 ~~~--~-~~-----~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 222 AHR--G-LM-----PR-LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred hcc--C-CC-----CC-CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 100 0 00 00 112345567899999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=321.51 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=195.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.||+|++... ..........+.+|+.++..++|+||+++++++.+++..|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--HHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 46999999999999999999875 5788999988531 11223344567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++...... ++......++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~-------l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDR-------LPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccc
Confidence 99999999999999763221 245566789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-----CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+........ .......||+.|+|||++.. ..++.++||||||++||||++|+.||..... . .....
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~-~~~~~ 219 (331)
T cd05624 149 CLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------V-ETYGK 219 (331)
T ss_pred eeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------H-HHHHH
Confidence 875433221 12233569999999999875 4678899999999999999999999854321 1 11111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKE--RPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 786 (812)
+.... .+...+.. ....++.+.+++.+|+..++++ |+++++++++
T Consensus 220 i~~~~------~~~~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 220 IMNHE------ERFQFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHcCC------CcccCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 21111 11111111 1223456778888888866544 4689999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.83 Aligned_cols=264 Identities=20% Similarity=0.250 Sum_probs=194.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC--
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD-- 575 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-- 575 (812)
..++|++.+.||+|+||.||++... .++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc---cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 4468999999999999999999864 58899999886422 12233456778999999999999999999886543
Q ss_pred ----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 576 ----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 576 ----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
..++||||+++ +|.+++... +++.....++.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~ 157 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQME----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 157 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhhc----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCC
Confidence 46899999965 777776432 245666789999999999999998 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||...... +.....
T Consensus 158 ~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~ 230 (355)
T cd07874 158 LKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI----DQWNKV 230 (355)
T ss_pred EEEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence 999999999754321 1223457899999999999989999999999999999999999998543211 111100
Q ss_pred HHH------------------HHhc--cccc-----ccccc-CCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 732 VSQ------------------ILAG--QLHC-----VLDKR-VGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 732 ~~~------------------~~~~--~~~~-----~~d~~-~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
... .... .... .+... ..............+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000 0000 0000 00000 00000111223456789999999999999999999998
Q ss_pred H
Q 042346 786 N 786 (812)
Q Consensus 786 ~ 786 (812)
+
T Consensus 311 h 311 (355)
T cd07874 311 H 311 (355)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=328.15 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=193.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK---- 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---- 574 (812)
.++|++.+.||+|+||.||++... .++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc---cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 467999999999999999999864 58899999986421 1123345677899999999999999999987543
Q ss_pred --CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 575 --DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 575 --~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
...++||||+++ +|.+++... +++.....++.|+++||+|||+++ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQME----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHhc----------CCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcE
Confidence 346999999965 787777432 245667789999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||+|||+++..... .......+|+.|+|||++.+..++.++|||||||+||||++|+.||..... ........
T Consensus 166 kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~~~ 238 (364)
T cd07875 166 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVI 238 (364)
T ss_pred EEEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 99999999754331 123345789999999999999999999999999999999999999854321 11111111
Q ss_pred HHHH----------hcccccccccc--------------CCCCC--CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQIL----------AGQLHCVLDKR--------------VGPPE--LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~----------~~~~~~~~d~~--------------~~~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+. ..........+ ...+. .........+++|+.+||+.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 00000000000 00000 0011123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.38 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=196.8
Q ss_pred ceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe--EEEE
Q 042346 504 SLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE--RLLV 580 (812)
Q Consensus 504 ~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~--~~lV 580 (812)
...++||+|+|-+||+|.+. +|.+||=-.+.. .+.....+..+.|..|+.+|+.|+||||++|+.++.+... ..+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~-~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKI-RDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhH-HHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 34678999999999999874 466665322111 0112224445789999999999999999999999987665 6799
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-CcEEEEeecc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARVSDFGL 659 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DfGl 659 (812)
+|.+..|+|..|+++.+.. ..+...+++.||++||.|||++. |||||||||-+||+|+.+ |.|||+|+||
T Consensus 122 TEL~TSGtLr~Y~kk~~~v--------n~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRV--------NIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred eecccCCcHHHHHHHhccC--------CHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhH
Confidence 9999999999999877653 44566789999999999999987 889999999999999766 8999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
|.+.... .....+|||.|||||.+. ..|++.+||||||+.|+||+|+..||..- ..+-++...+...+....
T Consensus 193 Atl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC---~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 193 ATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC---TNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred HHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh---CCHHHHHHHHHcCCCHHH
Confidence 9875542 244579999999999987 67999999999999999999999998432 233444444443333333
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+.++.| ..++++|.+||.. ..+|||+.|+|.+
T Consensus 265 l~kV~d--------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 265 LSKVKD--------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hhccCC--------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 333333 2388999999999 9999999999975
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.67 Aligned_cols=239 Identities=25% Similarity=0.406 Sum_probs=183.6
Q ss_pred eeeccCCcEEEEEEEEcC-------------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 507 NKVGIGSFGTVYKGKLMD-------------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
+.||+|+||.||+|++.. ..+|++|.+.. ........|.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh-----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 468999999999998532 23588887653 123344578889999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc--
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT-- 651 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-- 651 (812)
+...++||||+++++|..++..... .+++..+++++.||++||+|||+++ |+||||||+|||++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~ 145 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSD-------VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDG 145 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccC
Confidence 9899999999999999999865432 1366777899999999999999998 999999999999987664
Q ss_pred -----EEEEeecccccCCCCcccccccccccCCCccCccccc-cCcCCCcchhHHHHHHHHHHH-cCCCCCCCCCCCCCC
Q 042346 652 -----ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELL-TGKKAVFKNEDGSGP 724 (812)
Q Consensus 652 -----~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~ell-tG~~p~~~~~~~~~~ 724 (812)
+|++|||++..... .....++..|+|||.+. ...++.++||||||++||||+ +|+.|+.....
T Consensus 146 ~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---- 215 (262)
T cd05077 146 ECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL---- 215 (262)
T ss_pred CCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch----
Confidence 89999999865432 12345788999999886 567899999999999999998 47666533211
Q ss_pred chhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 725 LDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.+ ......+.. ... ....+.+.+|+.+||+.||++||++++|++.|
T Consensus 216 ---~~--~~~~~~~~~------~~~------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 216 ---AE--KERFYEGQC------MLV------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---hH--HHHHHhcCc------cCC------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 011111110 011 11234578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=336.56 Aligned_cols=264 Identities=20% Similarity=0.276 Sum_probs=188.9
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC---
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--- 574 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--- 574 (812)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 3467999999999999999999874 58899999875311 1234699999999999999999987532
Q ss_pred -----CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC
Q 042346 575 -----DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 575 -----~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 649 (812)
...++||||+++ +|.+++....... ..+++...+.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~----~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~ 206 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNN----HALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPN 206 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCC
Confidence 135689999975 7887775432111 12356777889999999999999998 9999999999999866
Q ss_pred C-cEEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 650 W-TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 650 ~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
+ .+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||||+||||++|+.||...... +.
T Consensus 207 ~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~ 279 (440)
T PTZ00036 207 THTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQ 279 (440)
T ss_pred CCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HH
Confidence 4 79999999997654322 1234578999999999865 46899999999999999999999998543221 11
Q ss_pred HHHHHHHHH----------hccccccccccCCCCC---CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 728 VEFAVSQIL----------AGQLHCVLDKRVGPPE---LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 728 ~~~~~~~~~----------~~~~~~~~d~~~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.......+. ...+..+.-+...... ..+...+..+.+|+.+||..||.+|||+.|++++
T Consensus 280 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 111111000 0000000000000000 0011234567899999999999999999999965
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.49 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=198.1
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC-CeEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK-DERLL 579 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~l 579 (812)
+|++.+.||+|+||.||+++.+ +++.+++|++... .......+.+.+|++++++++|+|++++++.+... ...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR---NASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehh---hcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 4889999999999999999864 4788999997531 11233445678899999999999999999987644 45789
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+|||+++++|.+++...... .+++.+.++++.+++.+|+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 78 v~e~~~~~~l~~~l~~~~~~------~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGK------LLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred EecccCCCcHHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccc
Confidence 99999999999999753221 2367788899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+....... .......+++.|+|||++.+..++.++||||||+++|||++|+.||.... ... ....+..+.
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-------~~~-~~~~~~~~~ 218 (257)
T cd08223 149 ARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNS-LVYRIIEGK 218 (257)
T ss_pred eEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHH-HHHHHHhcC
Confidence 87653321 12234568899999999999889999999999999999999999975322 111 111222222
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+. .........+.+++.+|++.||++|||+.|++++
T Consensus 219 ~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 LP-----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CC-----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11 0113345668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=305.85 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=201.7
Q ss_pred CcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|+..+.||+|+||.||.++. .+++.+++|++.... ........+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR---LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc---cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 488899999999999999976 458899999875321 1123345678999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++..... ..+++.+++.++.|++++|.|||+.+ ++|+||||+||++++++.+||+|||++
T Consensus 78 ~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 78 MEYANGGTLYDKIVRQKG------QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EEecCCCcHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence 999999999999975431 12367788899999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... .. .....+..+..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~----~~~~~~~~~~~ 218 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN----PL----NLVVKIVQGNY 218 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC----HH----HHHHHHHcCCC
Confidence 76533221 2234568999999999988888999999999999999999999984322 11 11112222221
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.. .....+..+.+++.+||..+|++||+++|+++++
T Consensus 219 ~~-----------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 TP-----------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CC-----------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11 1133455688999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.85 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=210.2
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEcC---Cc--EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLMD---GR--EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ 572 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~---g~--~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 572 (812)
...+.+++.+.||+|-||.||+|.+.+ |+ .||||.-+.. ...+..+.|..|..+|+.++||||++++|.|.
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d----~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD----CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC----CChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 344557778899999999999998633 33 4777875431 22344678999999999999999999999998
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
+. ..|+|||.++-|.|.+||+.+... ++....+.+++||..+|+|||+.. +|||||..+|||+...--+
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk~s-------L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNKDS-------LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCV 530 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhcccc-------chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCccee
Confidence 64 689999999999999999876543 255666789999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+||||++.+.+..... .....-...|||||.+..+.++.++|||-|||.+||++. |..||+...+.+-
T Consensus 531 KLaDFGLSR~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------- 601 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------- 601 (974)
T ss_pred eecccchhhhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------
Confidence 999999999887755443 335556789999999999999999999999999999876 8899976554321
Q ss_pred HHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 732 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
...+..| .|++- ++.++..|..|+.+||..||.+||++.|+...|+.+++.
T Consensus 602 I~~iEnG-------eRlP~----P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 602 IGHIENG-------ERLPC----PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred EEEecCC-------CCCCC----CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 1111111 23333 345566688899999999999999999999999998883
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.95 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=194.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeC--
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEK-- 574 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~-- 574 (812)
+.+.|++.+.||+|+||.||+|.+. +++.+|+|++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 4567888999999999999999875 57889999986421 1234677899999998 799999999998753
Q ss_pred ----CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 575 ----DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 575 ----~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
...+++|||+++++|.+++...... .+++.....++.|++.||+|||+++ |+||||||+||++++++
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~ 148 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGN------TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 148 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCC
Confidence 3578999999999999999764321 2356777889999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCc
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL 725 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~ 725 (812)
.+||+|||++....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 149 ~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---- 222 (272)
T cd06637 149 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---- 222 (272)
T ss_pred CEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----
Confidence 99999999987543321 1223456899999999986 345888999999999999999999998532210
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. ......... ... ......+..+.+|+.+||..||.+|||++|++++
T Consensus 223 --~--~~~~~~~~~-----~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 223 --R--ALFLIPRNP-----APR-----LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --H--HHHHHhcCC-----CCC-----CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 001111110 111 1112234568899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=307.17 Aligned_cols=252 Identities=29% Similarity=0.489 Sum_probs=197.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.+|++.+.||+|+||.||++.+.+++.+++|++..... ....|.+|++++++++||||+++++++......++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 45888999999999999999987788999998753221 124578899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++...... +.+..++.++.+++.+|+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 78 ~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGK-------FSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred EEcCCCCcHHHHHHhCccC-------CCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcce
Confidence 9999999999999754321 256777899999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..+.
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~ 218 (256)
T cd05112 148 RFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAGF 218 (256)
T ss_pred eecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCCC
Confidence 65432111 11122335678999999998889999999999999999998 8888743221 11111221111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
+...+.. .++.+.+|+.+||+.+|++|||++|++++|.
T Consensus 219 -------~~~~~~~----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 219 -------RLYKPRL----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -------CCCCCCC----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1111111 2356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.75 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=201.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||+||++.+. +++.+|+|++.... ..+....+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 45888899999999999999874 58889999875321 12335678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
||||+++++|.+++..... +++.....++.+++.+|.|||+. + |+||||||+||+++.++.++|+|||
T Consensus 81 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGP--------IPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred EEecCCCCCHHHHHHhccC--------CCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCC
Confidence 9999999999999865432 36777789999999999999974 5 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC----CchhHHHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG----PLDVVEFAVSQ 734 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~----~~~~~~~~~~~ 734 (812)
++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.+.. ..
T Consensus 150 l~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~ 224 (284)
T cd06620 150 VSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL-QQ 224 (284)
T ss_pred cccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH-HH
Confidence 98643221 12235689999999999888899999999999999999999999865432211 11111111 11
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
+.... .+.....+.+..+.+|+.+|++.||++|||++|++++.
T Consensus 225 ~~~~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 225 IVQEP----------PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred Hhhcc----------CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11110 11112233566788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=308.59 Aligned_cols=255 Identities=20% Similarity=0.300 Sum_probs=185.2
Q ss_pred eeccCCcEEEEEEEEcCCc---EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 508 KVGIGSFGTVYKGKLMDGR---EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 508 ~LG~G~fG~Vy~a~~~~g~---~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
.||+|+||.||++...++. .+++|.+... ........|.+|+.+++.++||||+++++.+.+....++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 6999999999999764433 4556665431 11234567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.++++....... .......+.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 78 ~~~~L~~~l~~~~~~~~----~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 78 ELGDLKSYLSQEQWHRR----NSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred CCCcHHHHHHhhhcccc----cccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccC
Confidence 99999999976432211 1244556789999999999999988 9999999999999999999999999985432
Q ss_pred CCcccccccccccCCCccCcccccc-------CcCCCcchhHHHHHHHHHHHcC-CCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVM-------NVLTAKTDIYGLGVVLLELLTG-KKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
............++..|+|||++.. ..++.++||||||+++|||+++ ..||.... ..+... ...
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----~~~~~~----~~~ 222 (268)
T cd05086 151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS----DREVLN----HVI 222 (268)
T ss_pred cchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC----HHHHHH----HHH
Confidence 2221122234567889999998753 2457899999999999999975 45553221 111111 222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
.+......++.+.. ...+.+.+++..|+ .+|++||++++|++.|.
T Consensus 223 ~~~~~~~~~~~~~~------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 223 KDQQVKLFKPQLEL------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred hhcccccCCCccCC------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222223322221 13345777888899 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=323.14 Aligned_cols=247 Identities=27% Similarity=0.397 Sum_probs=202.5
Q ss_pred cceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|+-++.||.|+||.||-|++ .+.+.||||++.. ......++-.++..|+..|++++|||++.+.++|..+...||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsy--SGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccc--cccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 66678999999999999986 4678899999864 23344566678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
|||- |+-.|+|.-..... .-.....|..+.+.||+|||+.+ .||||||..||||++.+.|||+|||.|.
T Consensus 106 EYCl-GSAsDlleVhkKpl-------qEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVHKKPL-------QEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSAS 174 (948)
T ss_pred HHHh-ccHHHHHHHHhccc-------hHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchh
Confidence 9995 58888876543321 22344578999999999999999 8999999999999999999999999997
Q ss_pred cCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+..+ .+..+|||.|||||++. .+.|+-|+||||||++..||.-.++|++.-+ .+. +...+..+
T Consensus 175 i~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-------AMS-ALYHIAQN 240 (948)
T KOG0577|consen 175 IMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMS-ALYHIAQN 240 (948)
T ss_pred hcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-------HHH-HHHHHHhc
Confidence 6554 45679999999999986 5789999999999999999999999976432 111 11222211
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..|.+...+-.+.+.+++..||++-|.+|||.++++.+
T Consensus 241 ----------esPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ----------ESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----------CCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 23556667888889999999999999999999998875
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=315.54 Aligned_cols=251 Identities=23% Similarity=0.380 Sum_probs=199.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 35799999999999999999986 468999999885421 122345788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++.... +++.++++++.|++.+|.|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 93 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg 160 (297)
T cd06656 93 VVMEYLAGGSLTDVVTETC---------MDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFG 160 (297)
T ss_pred EeecccCCCCHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCc
Confidence 9999999999999986432 256677899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .....
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------~~~~~ 230 (297)
T cd06656 161 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATN 230 (297)
T ss_pred cceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------eeccC
Confidence 9865433221 1233468889999999998889999999999999999999999985433211000 00000
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. .++..........+.+++.+||+.+|++||++++++++
T Consensus 231 -------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 231 -------G--TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -------C--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 01111123455668899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=315.85 Aligned_cols=260 Identities=24% Similarity=0.417 Sum_probs=198.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCc----EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGR----EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
++|+..+.||+|+||.||++.+. +++ .+|+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT----GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45788899999999999999864 343 47888775321 122334688899999999999999999998764
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++++||+++|+|.+++..... .+++...+.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~ 151 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKD-------NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKIT 151 (303)
T ss_pred CceeeehhcCCCCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEc
Confidence 46799999999999999975432 1256777899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .... ...
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~----~~~~----~~~ 223 (303)
T cd05110 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP----TREI----PDL 223 (303)
T ss_pred cccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHH----HHH
Confidence 9999976544332222233445778999999998899999999999999999997 888874321 0111 111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
+..+ .+...+. .....+.+++.+|+..+|++||+++|+++.|+++....
T Consensus 224 ~~~~-------~~~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 224 LEKG-------ERLPQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHCC-------CCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1111 1111111 12345778999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=309.30 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=198.5
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchh----hHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTN----KLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~----~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
+|.+.+.||+|+||.||+|... +++.+++|.+....... ...+..+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677899999999999999864 57899999876432221 122334678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.+++|||+++++|.+++..... +++.....++.|++.+|+|||+.+ ++||||||+|||+++++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--------l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~d 149 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA--------FEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISD 149 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC--------ccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecc
Confidence 9999999999999999965432 245667789999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCccc----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 657 FGLSLLGSECDQE----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 657 fGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||+++........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .. ..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~-~~ 221 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQ-AI 221 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HH-HH
Confidence 9998765421111 111234578899999999988899999999999999999999999854221 11 11
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...... .... .+...++.+.+++.+||+.||++||++.|++++
T Consensus 222 ~~~~~~-----~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 222 FKIGEN-----ASPE------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHhcc-----CCCc------CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111111 0001 112345668899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.72 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=195.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--CeE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--DER 577 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 577 (812)
.+|+..+.||+|+||.||++... +++.|++|++..........+....+.+|+++++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999874 588999998764332223334456788999999999999999999998763 567
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+++|||+++++|.+++..... +++...+.++.|++.+|+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~--------l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~df 150 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA--------LTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 150 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 899999999999999975432 255667789999999999999988 999999999999999999999999
Q ss_pred cccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ...
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~-~~~ 222 (266)
T cd06651 151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIF-KIA 222 (266)
T ss_pred CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHH-HHh
Confidence 998754332111 112234588999999999988899999999999999999999999853211 11111 110
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ..+. .+....+.+.+++ +|+..+|++||+++||+++
T Consensus 223 ~~~---------~~~~-~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 223 TQP---------TNPQ-LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred cCC---------CCCC-CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 000 0011 1223445566666 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=301.10 Aligned_cols=273 Identities=23% Similarity=0.326 Sum_probs=220.1
Q ss_pred CHHHHHHhcCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCce
Q 042346 492 TLSELAAATNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565 (812)
Q Consensus 492 ~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv 565 (812)
...++.....++++..++-+|.||+||.|.|++ .+.|.+|.+.. ...+-....+..|-.++..+.|||++
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCcc
Confidence 456777778889999999999999999996643 45677776643 22233345677888889999999999
Q ss_pred EEEEEEEeCC-eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCE
Q 042346 566 GLVGFCQEKD-ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNI 644 (812)
Q Consensus 566 ~l~~~~~~~~-~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NI 644 (812)
.+.+.+.++. ..+.+|.++.-|+|..||...+..........+-.+.+.++.|++.|++|||+++ |||.||..+|.
T Consensus 351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNC 427 (563)
T KOG1024|consen 351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNC 427 (563)
T ss_pred ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcc
Confidence 9999987655 4688999999999999998655544444455566788899999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 042346 645 LLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSG 723 (812)
Q Consensus 645 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~ 723 (812)
+||+..++||+|=.+++.+.+.+.............||+||.+....|+..+|||||||+||||+| |+.|+..-+
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID---- 503 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID---- 503 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC----
Confidence 999999999999999998888888877788888999999999999999999999999999999998 777764322
Q ss_pred CchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
+.+ ....+.+| +|+..| .+++++|..++.-||..+|++||++++++.-|.+-
T Consensus 504 PfE----m~~ylkdG-------yRlaQP----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 504 PFE----MEHYLKDG-------YRLAQP----FNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHH----HHHHHhcc-------ceecCC----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 222 12223333 244444 34566688888899999999999999999988763
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.92 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=200.0
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.+|+++.. +++.+++|++..... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM---SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC---ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 4888999999999999999864 688999998763211 122345788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++...... .+++...++++.|++.+|.|||+.+ ++|+||+|+|||++.++.++|+|||++
T Consensus 78 ~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGV------LFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred EecCCCCcHHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence 9999999999999754321 1256777899999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
........ ......+++.|+|||++.+..++.++||||||+++|||++|+.||..... .+ ....+..+..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~-~~~~~~~~~~ 218 (256)
T cd08218 149 RVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KN-LVLKIIRGSY 218 (256)
T ss_pred eecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HH-HHHHHhcCCC
Confidence 75543221 12334688899999999988899999999999999999999999853221 11 1112222211
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. .........+.+++.+||+.+|++||+++||+++
T Consensus 219 ~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 P-----------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred C-----------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 0122345568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=309.34 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=197.3
Q ss_pred cceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 503 FSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
|.+.+.||+|+||.||+|.+. .++.||+|++..... .....+.+.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF---SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC---ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 566789999999999999763 368899998864221 1233456888999999999999999999886542
Q ss_pred ---eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 576 ---ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 576 ---~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
..++++||+++++|.+++........ ...+++...++++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEE--PFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTV 152 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCE
Confidence 23789999999999998864332111 122467788999999999999999988 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||+++...............+++.|++||.+....++.++||||||+++|||++ |+.||..... .+.
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~---- 224 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEI---- 224 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHH----
Confidence 9999999876543222222233445678999999998889999999999999999999 7777643221 111
Q ss_pred HHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 732 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
...+..+. ....+ ...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 225 ~~~~~~~~-------~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 225 YNYLIKGN-------RLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHcCC-------cCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111 01111 12345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.89 Aligned_cols=251 Identities=22% Similarity=0.395 Sum_probs=200.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||.|+||.||++.. .+++.|++|.+.... ....+.+.+|+++++.++||||+++++++...+..+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 45699999999999999999986 468999999885421 122346788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++.... +++.+++.++.+++.+|+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 93 lv~e~~~~~~L~~~~~~~~---------l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg 160 (296)
T cd06655 93 VVMEYLAGGSLTDVVTETC---------MDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFG 160 (296)
T ss_pred EEEEecCCCcHHHHHHhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999986432 267888999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++........ ......++..|+|||.+....++.++|||||||++|||++|+.||..... ... ...+...
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~~~-~~~~~~~ 230 (296)
T cd06655 161 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRA-LYLIATN 230 (296)
T ss_pred cchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHH-HHHHHhc
Confidence 9875433221 12334688999999999988899999999999999999999999854331 111 1111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. +...........+.++|.+||..||++||++.+++.+
T Consensus 231 ~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 231 GT---------PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CC---------cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 10 0001122344568899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.46 Aligned_cols=244 Identities=25% Similarity=0.323 Sum_probs=185.6
Q ss_pred eccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc---cCCCceEEEEEEEeCCeEEEEEEec
Q 042346 509 VGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV---HHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 509 LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
||+|+||.||+++.. +++.||+|++... ..........+..|..++..+ +||||+++++.+.+.+..++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK--EIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHH--HHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 799999999999875 5899999998531 111122233445566666655 6999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... ++......++.||++||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~g~L~~~l~~~~~--------~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 79 SGGELFWHLQKEGR--------FSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred CCChHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 99999999875432 245667789999999999999998 9999999999999999999999999986532
Q ss_pred CCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCV 743 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (812)
... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||..... ......+..+..
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~--- 214 (330)
T cd05586 148 TDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFGKV--- 214 (330)
T ss_pred CCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcCCC---
Confidence 211 123345799999999998754 589999999999999999999999854321 111222222211
Q ss_pred ccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 042346 744 LDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP----NITDIVAN 786 (812)
Q Consensus 744 ~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP----t~~evl~~ 786 (812)
++. .......+.+++.+||+.||++|| +++|++++
T Consensus 215 ---~~~-----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 215 ---RFP-----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ---CCC-----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 111 112345677899999999999998 57777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.88 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=192.5
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK-- 574 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-- 574 (812)
...++|++.+.||+|+||.||++... +++.||||++... .........+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP---FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch---hhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 34578999999999999999999864 6789999998632 11122344577899999999999999999987543
Q ss_pred ----CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 575 ----DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 575 ----~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
...++++|++ +++|.+++.... ++......++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~ 155 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKCQK---------LSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDC 155 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCC
Confidence 3468999998 779988875322 256677889999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+...
T Consensus 156 ~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~ 226 (343)
T cd07878 156 ELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY----IDQLK 226 (343)
T ss_pred CEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHH
Confidence 9999999999764331 234578999999999876 5689999999999999999999999854321 11111
Q ss_pred HHHH-----------HHHhccccccccccCC-CCCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 730 FAVS-----------QILAGQLHCVLDKRVG-PPELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 730 ~~~~-----------~~~~~~~~~~~d~~~~-~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... .+........+. .+. .+.... ......+.+|+.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 227 RIMEVVGTPSPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhCCCCHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000000 000 000000 0123346799999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.93 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=195.7
Q ss_pred eeeccCCcEEEEEEEEcC--C--cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEE
Q 042346 507 NKVGIGSFGTVYKGKLMD--G--REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~--g--~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 582 (812)
++||+|+||.||++.+.+ + ..||+|.+...... +..+.+.+|++++++++||||+++++++.+ ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 468999999999998743 2 36899988642221 456688899999999999999999999988 88899999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
|+++++|.+++..... ..+++...+.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~ 146 (257)
T cd05040 76 LAPLGSLLDRLRKDAL------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRA 146 (257)
T ss_pred ecCCCcHHHHHHhccc------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccc
Confidence 9999999999976542 12367888899999999999999998 99999999999999999999999999976
Q ss_pred CCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 663 GSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 663 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
....... .......++..|+|||++....++.++||||||+++|||++ |+.||..... .+... .+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~----~~~~~~- 217 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILK----KIDKEG- 217 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHH----HHHhcC-
Confidence 5442221 11223457789999999998889999999999999999999 9999743221 11111 111100
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
..... ....+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 -----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 -----ERLER----PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CcCCC----CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01111 1233456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=313.17 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=196.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.+.|++.++||+|+||.||++++. +++.+++|.+... ..+..+.+.+|+++++.++||||+++++.+..+...+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 356899999999999999999875 4889999997532 2334567888999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|..++..... .+++..++.++.|++.+|+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 86 lv~e~~~~~~l~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg 155 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDR-------GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFG 155 (292)
T ss_pred EEEecCCCCcHHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCc
Confidence 99999999999988764332 1366778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
++....... .......+++.|+|||++. ...++.++||||||+++|||++|+.||..... .. ...
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~-~~~ 225 (292)
T cd06644 156 VSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MR-VLL 225 (292)
T ss_pred cceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HH-HHH
Confidence 886432211 1123446788999999985 34578899999999999999999999754221 11 111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.... ... ..........+.+++.+||..+|++||+++|++++
T Consensus 226 ~~~~~~-----~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 226 KIAKSE-----PPT----LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHhcCC-----Ccc----CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111111 001 11122344557889999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=313.55 Aligned_cols=263 Identities=21% Similarity=0.350 Sum_probs=197.7
Q ss_pred HHHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEE
Q 042346 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGF 570 (812)
Q Consensus 493 ~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 570 (812)
++.+..+.++|++.+.||+|+||.||++... +++.+++|++... ......+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI------HDIDEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc------cchHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 4555667889999999999999999999874 5789999987531 11234577899999999 69999999998
Q ss_pred EE-----eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEE
Q 042346 571 CQ-----EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645 (812)
Q Consensus 571 ~~-----~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 645 (812)
+. .++..++||||+++++|.+++....... ..+++.....++.|+++||.|||+.+ |+||||||+||+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil 156 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG----ERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNIL 156 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccC----ccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEE
Confidence 84 3346799999999999999986432111 12356677889999999999999988 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCcccccccccccCCCccCcccccc-----CcCCCcchhHHHHHHHHHHHcCCCCCCCCCC
Q 042346 646 LDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720 (812)
Q Consensus 646 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 720 (812)
++.++.+||+|||++....... .......+++.|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 157 LTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred ECCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 9999999999999987543321 12234468999999998753 4578899999999999999999999854321
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
. .. ........ ......+ ......+.+++.+||+.||++|||++|+++++
T Consensus 235 ~-------~~-~~~~~~~~-----~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 235 M-------RA-LFKIPRNP-----PPTLHQP----ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred h-------HH-HhhccccC-----CCcccCC----CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 00 00000000 0011111 11234588999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=318.26 Aligned_cols=202 Identities=26% Similarity=0.368 Sum_probs=159.4
Q ss_pred eeeeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe--CCeEEEE
Q 042346 506 ENKVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE--KDERLLV 580 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lV 580 (812)
..+||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 468999999999999865 35789999875321 12346789999999999999999998854 4567899
Q ss_pred EEecCCCchhhhhhcCCCCCc-cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE----cCCCcEEEE
Q 042346 581 YEYMSNGALHDHLHNKNNTEK-NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTARVS 655 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kl~ 655 (812)
|||+.+ +|.+++........ .....+++....+++.||+.||.|||+.+ |+||||||+|||+ +.++++||+
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 999864 88888764332211 11223467788899999999999999998 9999999999999 566799999
Q ss_pred eecccccCCCCccc-ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCC
Q 042346 656 DFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKN 718 (812)
Q Consensus 656 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~ 718 (812)
|||+++........ .......+|+.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99999765432221 12234578999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=313.56 Aligned_cols=271 Identities=20% Similarity=0.247 Sum_probs=194.3
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||+|+.. +++.|++|++..... .......+.+|+.++++++||||+++++++.+++..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE---EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc---cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 4788999999999999999875 689999998754211 112234677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||++ ++|.+++...... ..+++...+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 78 ~e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKG-----QYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred EecCC-CCHHHHHhcCCCC-----CcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccce
Confidence 99997 6899988654321 12366777889999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH-------HHH
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE-------FAV 732 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~-------~~~ 732 (812)
....... .......+++.|+|||++.+ ..++.++||||||+++|||+||+.||.............. ..+
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 149 RAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 6543221 12233467889999998865 4578899999999999999999999864321100000000 000
Q ss_pred HHHHh-ccccccccccCCC-CCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILA-GQLHCVLDKRVGP-PELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~-~~~~~~~d~~~~~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... ..+...++..... ...........+.+++.+||..||++|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0000000000000 000001234567799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.28 Aligned_cols=256 Identities=25% Similarity=0.345 Sum_probs=195.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--CeE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--DER 577 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 577 (812)
++|++.+.||+|+||.||++... +++.|++|.+...............+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46899999999999999999874 589999998754322222233456788899999999999999999998764 457
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+++|||+++++|.+++..... +++...++++.|++.+|+|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Df 150 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA--------LTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDF 150 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcC
Confidence 899999999999999975432 244566789999999999999998 999999999999999999999999
Q ss_pred cccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ... .....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~-~~~~~ 222 (265)
T cd06652 151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAA-IFKIA 222 (265)
T ss_pred ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHH-HHHHh
Confidence 998754332111 112334688999999999888899999999999999999999999853211 111 11111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... . ....+......+.+++.+|+. +|++||+++||+++
T Consensus 223 ~~~-------~---~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 TQP-------T---NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred cCC-------C---CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 110 0 011123445567788888985 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=310.54 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=195.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++++. +++.|++|.+.... ......+.+|+.+++.++||||+++++.+.+.+..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 46888899999999999999864 58899999875421 1223457789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... ++....+.++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGP--------LSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGV 152 (267)
T ss_pred EEeccCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccee
Confidence 9999999999999865432 256677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
+...... ........++..|+|||++. ...++.++|||||||++|||++|+.||....... . .. ...
T Consensus 153 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~----~---~~-~~~ 222 (267)
T cd06645 153 SAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----A---LF-LMT 222 (267)
T ss_pred eeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh----h---HH-hhh
Confidence 8654321 11223457899999999874 4568899999999999999999999985433211 0 00 011
Q ss_pred hccccccccccCCCCCC-ChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPEL-NEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ..++.. .....+..+.+++.+||..+|++||++++|+++
T Consensus 223 ~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 223 KSN--------FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccC--------CCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 111 001100 011234557899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=310.25 Aligned_cols=239 Identities=26% Similarity=0.418 Sum_probs=182.0
Q ss_pred eeccCCcEEEEEEEEcC-------------------------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC
Q 042346 508 KVGIGSFGTVYKGKLMD-------------------------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK 562 (812)
Q Consensus 508 ~LG~G~fG~Vy~a~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~ 562 (812)
.||+|+||.||+|.+.. ...|++|++.. ...+....|.+|+.+++.++||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence 59999999999997521 13588888753 1223345688899999999999
Q ss_pred CceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 563 nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
||+++++++.++...++||||+++++|.+++..... .+++..+++++.||++||+|||+++ |+||||||+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~ 146 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-------RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAK 146 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcc
Confidence 999999999999999999999999999999865322 1256778899999999999999988 999999999
Q ss_pred CEEEcCCC-------cEEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHH-cCCC
Q 042346 643 NILLDVNW-------TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELL-TGKK 713 (812)
Q Consensus 643 NILl~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~ell-tG~~ 713 (812)
|||+++++ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.
T Consensus 147 Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 220 (274)
T cd05076 147 NILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV 220 (274)
T ss_pred cEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99997653 4899999987543221 22357788999998865 56899999999999999995 6888
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 714 AVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 714 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
||...... .... ..... ..+ +. .....+.+++.+||+.+|++|||+++|++.|.
T Consensus 221 p~~~~~~~----~~~~-----~~~~~------~~~--~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 221 PLKERTPS----EKER-----FYEKK------HRL--PE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred CccccChH----HHHH-----HHHhc------cCC--CC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 87543211 1111 00100 011 11 11234788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=310.99 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=194.7
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|++.+.||+|+||.||++.+. ++..+++|.+... .....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence 677889999999999999875 4677888887532 1233456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++..... .+++..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 82 e~~~~~~l~~~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~ 151 (282)
T cd06643 82 EFCAGGAVDAVMLELER-------PLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSA 151 (282)
T ss_pred EecCCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccc
Confidence 99999999998865321 2367788899999999999999998 9999999999999999999999999986
Q ss_pred cCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
...... .......++..|+|||++. ...++.++|||||||++|||++|+.||..... ... ...+.
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~----~~~~~ 221 (282)
T cd06643 152 KNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP----MRV----LLKIA 221 (282)
T ss_pred cccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH----HHH----HHHHh
Confidence 543211 1223456899999999984 34578899999999999999999999754221 111 11111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
... ...+. .+...+..+.+++.+||+.||++||++.+++++-
T Consensus 222 ~~~-----~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 222 KSE-----PPTLA----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred hcC-----CCCCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 111 00111 1123445688999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=309.79 Aligned_cols=260 Identities=22% Similarity=0.371 Sum_probs=199.2
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcch-----hhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKT-----NKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~-----~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
+|.+.+.||+|+||.||+|... +++.+|+|.+...... .......+.+.+|+++++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999764 6889999987532111 111223456788999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.+++..... +++..+..++.||+.+|.|||+.+ ++||||||+||+++.++.++|+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~--------l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~ 150 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGR--------FEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKIS 150 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccC--------CCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEe
Confidence 99999999999999999976522 255667789999999999999988 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCc--CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV--LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||++................++..|+|||.+.... ++.++|+||||+++|||++|+.||..... .... .
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~-~ 222 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAM-F 222 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHH-H
Confidence 999987644322222233456889999999987654 88999999999999999999999843211 1111 1
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
....... ....+.....+++..+.+++.+||..+|++|||++||+++
T Consensus 223 ~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 223 KLGNKRS------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred Hhhcccc------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111110 1111111223456778899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=306.12 Aligned_cols=247 Identities=30% Similarity=0.485 Sum_probs=194.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
++|++.+.||+|+||.||++.. +++.+++|+.... .....+.+|+.+++.++||||+++++++..+ ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 4588999999999999999976 6788999987531 1234678899999999999999999998764 47999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++...... ..++..+++++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 77 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~ 147 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRA------LVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLA 147 (254)
T ss_pred EECCCCCCHHHHHHhcCcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccc
Confidence 9999999999999764321 1256778899999999999999988 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
...... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+ ....+..+
T Consensus 148 ~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~-~~~~~~~~- 213 (254)
T cd05083 148 RVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KE-VKECVEKG- 213 (254)
T ss_pred eecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HH-HHHHHhCC-
Confidence 653321 122234578999999988889999999999999999998 8888743221 11 11111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.++.. ....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 214 ------~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 ------YRMEP----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ------CCCCC----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01111 12345668899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.63 Aligned_cols=264 Identities=24% Similarity=0.366 Sum_probs=201.4
Q ss_pred CCHHHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEE
Q 042346 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLV 568 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~ 568 (812)
+++.++..+.++|++.+.||+|+||.||++... +++.+|+|++... ......+.+|+.+++++ +|||+++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------~~~~~~~~~e~~~l~~l~~h~ni~~~~ 85 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------SDVDEEIEAEYNILQSLPNHPNVVKFY 85 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------ccHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 555666777889999999999999999999874 6889999987532 11234567899999998 899999999
Q ss_pred EEEEeCC-----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCC
Q 042346 569 GFCQEKD-----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSN 643 (812)
Q Consensus 569 ~~~~~~~-----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~N 643 (812)
+++...+ ..++||||+++++|.++++...... ..+++..++.++.|++.+|+|||+.+ |+||||||+|
T Consensus 86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~n 158 (291)
T cd06639 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG----QRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNN 158 (291)
T ss_pred EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 9987543 5799999999999999986532111 12367788899999999999999988 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccC-----cCCCcchhHHHHHHHHHHHcCCCCCCCC
Q 042346 644 ILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-----VLTAKTDIYGLGVVLLELLTGKKAVFKN 718 (812)
Q Consensus 644 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVwS~Gvvl~elltG~~p~~~~ 718 (812)
|++++++.+||+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 159 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 159 ILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999875443221 12334688999999988643 3688999999999999999999998543
Q ss_pred CCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 719 EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ... ...+..+... .+. ...+....+.+++.+||+.+|++||++.|++++
T Consensus 237 ~~-------~~~-~~~~~~~~~~-----~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 237 HP-------VKT-LFKIPRNPPP-----TLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cH-------HHH-HHHHhcCCCC-----CCC----cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 21 011 1111111110 111 112334568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=313.56 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=197.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++++ +++.||+|++..... .....+.+.+|+++++.++||||+++++++......++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED---DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc---CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 46889999999999999999876 589999998753211 11223457889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||++++.|..++..... +++..++.++.|++.+|+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 78 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRG--------VPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred EEeccCccHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECcccc
Confidence 9999999888877653321 367888999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... +....... ....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~ 219 (286)
T cd07847 147 ARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV----DQLYLIRK-TLGD 219 (286)
T ss_pred ceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHH-HhCC
Confidence 976544221 1223457889999999875 55789999999999999999999998543321 11110000 0000
Q ss_pred ccc---ccccc-----c--CCCCCC------ChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLH---CVLDK-----R--VGPPEL------NEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~---~~~d~-----~--~~~~~~------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ..++. . ...+.. ........+.+++.+||+.+|++||++.|++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 220 LIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 00000 0 000000 001235668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.01 Aligned_cols=255 Identities=21% Similarity=0.365 Sum_probs=203.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~ 577 (812)
....|+++++||+|+.+.||++...+.+.+|+|++.. ...+.....-|.+|+++|.+|+ |.+||+|++|-..++.+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~---~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVL---LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHH---hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3456999999999999999999988888899987652 2333455678999999999995 99999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
||||||=+ -+|..+|+.+..... .| .+.-+..|++.++.++|+++ |||-||||.|+|+- .|.+||+||
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~------~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDF 503 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDP------DW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDF 503 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCc------hH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeee
Confidence 99999974 599999987765331 34 34568899999999999999 99999999999994 579999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCc-----------CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCch
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV-----------LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~ 726 (812)
|+|..+............+||+.||+||.+.... .+.++||||+|||||+|+.|+.||.....
T Consensus 504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------ 577 (677)
T KOG0596|consen 504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------ 577 (677)
T ss_pred chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------
Confidence 9998887766666777889999999999986432 45789999999999999999999843210
Q ss_pred hHHHHHHHHHhcccccccccc--CCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 727 VVEFAVSQILAGQLHCVLDKR--VGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+ .++..+.|+. +..|...+... +.++++.||..||++|||..|+|++
T Consensus 578 ----~~-----aKl~aI~~P~~~Iefp~~~~~~~---li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 ----QI-----AKLHAITDPNHEIEFPDIPENDE---LIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HH-----HHHHhhcCCCccccccCCCCchH---HHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11 1223334442 23333333222 7789999999999999999999975
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=347.94 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=196.2
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK-- 574 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-- 574 (812)
...++|++.+.||+|+||.||++++. .++.+|+|.+..... .......|..|+.+++.|+||||++++++|.+.
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l---~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34567999999999999999999875 467889998754211 123346788899999999999999999988653
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCC----CCeEeeccCCCCEEEcC--
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV----PSIIHRDIKSSNILLDV-- 648 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~----~~ivHrDlKp~NILl~~-- 648 (812)
...||||||+++++|.++|....... ..+++...+.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~----g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMF----GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 46899999999999999997532211 123677788999999999999998542 24999999999999964
Q ss_pred ---------------CCcEEEEeecccccCCCCcccccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcC
Q 042346 649 ---------------NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTG 711 (812)
Q Consensus 649 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG 711 (812)
...+||+|||++....... ......||+.|+|||++.. ..++.++||||||||||||++|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 2358999999997653321 1234579999999999864 4588999999999999999999
Q ss_pred CCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 712 KKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 712 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+.||..... .......+..+. .+ .....+..+.+||.+||..+|.+||++.|++.+
T Consensus 240 k~PF~~~~~-------~~qli~~lk~~p-------~l-----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 240 KTPFHKANN-------FSQLISELKRGP-------DL-----PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCCCcCCc-------HHHHHHHHhcCC-------CC-----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 999854321 111111111110 11 111234568899999999999999999999954
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.10 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=198.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++.+. .++.|++|.+... ..........+.+|+++++.++||||+++++.+..++..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQ--NLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehh--hhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 36889999999999999999875 4789999987532 11223344578889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... +++.....++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGA--------LPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred EEecCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCC
Confidence 9999999999999965432 256677789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCc-------------ccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCch
Q 042346 660 SLLGSECD-------------QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726 (812)
Q Consensus 660 a~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~ 726 (812)
++...... .........++..|+|||.+....++.++||||||+++|||++|+.||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------ 221 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------ 221 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 86421100 00111224578899999999888899999999999999999999999853221
Q ss_pred hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.........+.. ..+.. ....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 222 --~~~~~~~~~~~~--------~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 222 --EELFGQVISDDI--------EWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --HHHHHHHHhccc--------CCCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111112111111 00111 11345568899999999999999996656555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.16 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=184.6
Q ss_pred eeeccCCcEEEEEEEEcC--------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 507 NKVGIGSFGTVYKGKLMD--------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
+.||+|+||.||+|.... ..++++|.+.. ......+.+.+|+.+++.++||||+++++++..++..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 469999999999997632 23477787642 12334457888999999999999999999999989999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc-------
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT------- 651 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~------- 651 (812)
+||||+++|+|.++++.... .+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~ 145 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-------LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPP 145 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCc
Confidence 99999999999999976543 1266778899999999999999998 999999999999987765
Q ss_pred -EEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 652 -ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 652 -~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
++++|||++..... .....++..|+|||++.+ ..++.++||||||+++|||++|..+++.... .. .
T Consensus 146 ~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---~~---~ 213 (258)
T cd05078 146 FIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---SQ---K 213 (258)
T ss_pred eEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc---HH---H
Confidence 69999998865432 123457889999999976 4589999999999999999999654432211 00 0
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
....... +...+. .....+.+++.+||+.||++|||++++++.|+
T Consensus 214 --~~~~~~~--------~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 214 --KLQFYED--------RHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --HHHHHHc--------cccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111111 111111 12245789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.62 Aligned_cols=265 Identities=21% Similarity=0.330 Sum_probs=194.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.+ +++.||+|.+..... ......+.+|+++++.++||||+++++++..++..++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc----cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 46999999999999999999875 578999998754221 1122356689999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||++ ++|.+++...... +++.....++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||+
T Consensus 82 v~e~~~-~~l~~~l~~~~~~-------~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNS-------INMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred EEeccc-cCHHHHHHhcCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcc
Confidence 999997 5999988654321 255677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH--
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL-- 736 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-- 736 (812)
+........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..........+.
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~----~~~~~~~~~~~~~~ 224 (301)
T cd07873 151 ARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV----EEQLHFIFRILGTP 224 (301)
T ss_pred hhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCC
Confidence 865432211 1223457889999998865 4578899999999999999999999854321 111111110000
Q ss_pred -hccccccccc----cCCCCCC-------ChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 -AGQLHCVLDK----RVGPPEL-------NEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 -~~~~~~~~d~----~~~~~~~-------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...+....+. ....+.. ........+.+|+.+||+.||.+|||++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000 0000000 011234567899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.80 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=195.6
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
+.+++++.....||+|+||.||++++. +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++..++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 345566666789999999999999864 57789999875321 223457889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC-CCcEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARV 654 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl 654 (812)
..++||||+++++|.+++....... .......+.++.||+.||+|||+.+ |+||||||+||+++. ++.+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l 150 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPL-----KDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKI 150 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccC-----CCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEE
Confidence 9999999999999999997542211 0144566788999999999999988 999999999999976 679999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccC--cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN--VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
+|||++........ ......+++.|+|||++... .++.++||||||+++|||++|+.||....... ...+.
T Consensus 151 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~~~~- 223 (268)
T cd06624 151 SDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AAMFK- 223 (268)
T ss_pred ecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hhHhh-
Confidence 99999865432211 12234688999999998654 37889999999999999999999985322110 00000
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...... . + ..+....+.+.+++.+||+.+|++|||++|++++
T Consensus 224 -~~~~~~-------~---~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 224 -VGMFKI-------H---P-EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -hhhhcc-------C---C-CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000000 0 0 0122345568899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.64 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=204.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..-|.+++.||+|.|..|-+|++ -.|++||||++.+.+.. ......+++|++.|+.++|||||+||++......+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD---~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD---TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc---hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 34588899999999999999975 47999999999753322 333456788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc-CCCcEEEEee
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD-VNWTARVSDF 657 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kl~Df 657 (812)
||+|+=++|+|+|||.++.... ......+++.||+.+|.|.|+.. +|||||||+||.+- +-|-+||+||
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl-------~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGL-------NEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred EEEEecCCchHHHHHHhhhccc-------cHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeec
Confidence 9999999999999998765432 23344689999999999999998 99999999998774 5589999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCC-CcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLT-AKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|++..+.+.. ..+...|+..|-|||++.+..|+ +.+||||||||||.|+.|+.||+..++.+. ..
T Consensus 164 GFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------LT--- 229 (864)
T KOG4717|consen 164 GFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------LT--- 229 (864)
T ss_pred cccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------hh---
Confidence 9997665533 24567899999999999999887 568999999999999999999977654322 12
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.++|-+...| .....+.++||..||..||.+|.+.+||...
T Consensus 230 -----mImDCKYtvP----shvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 230 -----MIMDCKYTVP----SHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -----hhhcccccCc----hhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2233333333 4456668899999999999999999998753
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.39 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=200.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++... +++.+++|.+.... .+....+.+|++++++++||||+++++++.+++..+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 357999999999999999999874 57889999886421 124467889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
++|||+++++|.+++..... .++......++.|++.+|.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 77 l~~e~~~~~~l~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g 146 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRG-------PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFG 146 (262)
T ss_pred EEEeCCCCCcHHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccc
Confidence 99999999999999876421 1245677889999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccC---cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMN---VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
++........ ......++..|+|||.+... .++.++||||||+++|||++|+.||..... . +. ....
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~----~---~~-~~~~ 216 (262)
T cd06613 147 VSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----M---RA-LFLI 216 (262)
T ss_pred cchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH----H---HH-HHHH
Confidence 9875443211 12334688899999998776 789999999999999999999999854321 0 10 1111
Q ss_pred HhccccccccccCCCCC-CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPE-LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... +..+. ......+..+.+++.+||..+|.+|||++||+.+
T Consensus 217 ~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 217 SKSN--------FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred Hhcc--------CCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1110 00111 1123456678999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.90 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=199.9
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|+..+.||+|+||.||+|... +++.|++|.+..........+..+.+.+|+++++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999876 789999998765333333344566788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++..... +++...+.++.|++.+|+|||+.+ |+|+||||+||+++.++.+||+|||++
T Consensus 81 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~ 149 (258)
T cd06632 81 LELVPGGSLAKLLKKYGS--------FPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMA 149 (258)
T ss_pred EEecCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999975432 256677889999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCc-CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
....... ......++..|++||.+.... ++.++|+||||+++|||++|+.||..... ............
T Consensus 150 ~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~ 219 (258)
T cd06632 150 KQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKE 219 (258)
T ss_pred eeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhccc
Confidence 7543322 123456889999999987766 89999999999999999999999854221 111111110011
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. +. ........+.+++.+||+.+|++||++++++.+
T Consensus 220 ~----------~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 L----------PP-IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred C----------CC-cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0 00 112234567889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=309.29 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=199.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||.|+||.||++++. +++.+++|++.... .......+.+|+++++.++|+||+++++++.++...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 36888899999999999999875 58899999876421 12234567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
|+||+++++|.+++... .+++.....++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 77 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGV 144 (274)
T ss_pred EEEeeCCCcHHHHHhhc---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccc
Confidence 99999999999999754 2356778899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++...... .......++..|+|||++.+..++.++||||||+++|||++|+.||..... .. ....+....
T Consensus 145 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----~~----~~~~~~~~~ 214 (274)
T cd06609 145 SGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----MR----VLFLIPKNN 214 (274)
T ss_pred ceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch----HH----HHHHhhhcC
Confidence 97654422 122344688899999999988899999999999999999999999854321 11 111111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+......++..+.+++.+||..+|++|||+++++++
T Consensus 215 ----------~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 215 ----------PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ----------CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111111145568899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.63 Aligned_cols=262 Identities=25% Similarity=0.412 Sum_probs=201.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
++|++.+.||+|+||.||+++.+ +.+.+++|.+... ........+.+|++++++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 56888999999999999999864 2467899987532 1122455788999999999999999999999998
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCC-ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTE-KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
+..++||||+++++|.+++....... ......+++..++.++.|++.+|+|||+.+ |+||||||+|||++.++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 89999999999999999997654221 111223478889999999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|+|||++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||..... ....
T Consensus 158 l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~ 228 (275)
T cd05046 158 VSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVL 228 (275)
T ss_pred EcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHH
Confidence 99999986433211 112233456778999999988888999999999999999999 6777743221 1111
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
.....+.... . ....++..+.+++.+||+.+|++|||+.|++..|+
T Consensus 229 ~~~~~~~~~~------~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 229 NRLQAGKLEL------P----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHcCCcCC------C----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1222221110 0 11234456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.32 Aligned_cols=257 Identities=25% Similarity=0.291 Sum_probs=200.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++...+ ++.+|+|.+..... ......+.+.+|+++++.++||||+++++.+.+....++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM--IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc--chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 368899999999999999998754 89999999864221 212345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+.+++|.+++...... .+++...+.++.|++++|+|||+.+ ++|+||||+|||++.++.++|+|||+
T Consensus 79 v~e~~~~~~L~~~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGK------CLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred EEEecCCCCHHHHHHhCCCC------ccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecch
Confidence 99999999999999754321 2356677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCccc---------------------------ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCC
Q 042346 660 SLLGSECDQE---------------------------FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712 (812)
Q Consensus 660 a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~ 712 (812)
+......... .......|+..|+|||++.+..++.++||||||+++|||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 8643221110 0112346889999999999888999999999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 042346 713 KAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN----ITDIVAN 786 (812)
Q Consensus 713 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt----~~evl~~ 786 (812)
.||...... .....+. +.....+. ....+..+.+++.+||..||++||+ ++|++.+
T Consensus 230 ~pf~~~~~~--------~~~~~~~--------~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 230 TPFKGSNRD--------ETFSNIL--------KKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCchH--------HHHHHHh--------cCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 998543211 1111111 11111111 1225667899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=326.11 Aligned_cols=257 Identities=23% Similarity=0.398 Sum_probs=206.2
Q ss_pred cceeeeeccCCcEEEEEEEE-cCCc----EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 503 FSLENKVGIGSFGTVYKGKL-MDGR----EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~-~~g~----~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
....++||.|+||+||+|.| .+++ +||||++... ...+...++.+|+.+|.+|+||||++|+++|.... .
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~----t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF----TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc----CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 34468999999999999986 3343 5788887542 33445567899999999999999999999998876 7
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
.||++||+.|+|.||++.++... --+..+.+..|||+||.|||++. +|||||..+||||++-..+||.||
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~i-------gsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdf 842 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNI-------GSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDF 842 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccc-------cHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEec
Confidence 89999999999999998765432 33556789999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|+++....++.++......-.+.|||=|.+....|+.++|||||||.+||||| |.+|++.... +. ...++
T Consensus 843 gla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~e-I~dll 913 (1177)
T KOG1025|consen 843 GLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------EE-IPDLL 913 (1177)
T ss_pred chhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------HH-hhHHH
Confidence 99999888777766666666789999999999999999999999999999998 7788754321 11 11222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+. -.|+..|..... .+..++.+||..|+..||+++++...+.+..+.
T Consensus 914 e~------geRLsqPpiCti----DVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 914 EK------GERLSQPPICTI----DVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred hc------cccCCCCCCccH----HHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 21 123444444444 466777889999999999999999988876543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.42 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=199.4
Q ss_pred CCHHHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEE
Q 042346 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLV 568 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~ 568 (812)
.++.++....+.|++.+.||+|+||.||++++. +++.+|+|++... ......+..|+.+++++ +|+||++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~ 79 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYY 79 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence 345566667788999999999999999999874 5889999987531 12234577899999998 799999999
Q ss_pred EEEEe------CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 569 GFCQE------KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 569 ~~~~~------~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
+++.. .+..+++|||+++++|.+++....... +.....+.++.||+.+|+|||+.+ |+|+||||+
T Consensus 80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~------~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~ 150 (282)
T cd06636 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA------LKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQ 150 (282)
T ss_pred eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCC------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH
Confidence 99853 456799999999999999997543221 245666789999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 717 (812)
||++++++.++|+|||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 151 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 151 NVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred HEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 99999999999999999865432111 123456889999999886 34678899999999999999999999854
Q ss_pred CCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 718 NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... .. ..+.. ...+.......+..+.+++.+||+.||.+|||+.|++++
T Consensus 229 ~~~~~----~~----~~~~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 229 MHPMR----AL----FLIPR----------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred cCHHh----hh----hhHhh----------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 32110 00 00100 011111223455678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=322.78 Aligned_cols=198 Identities=26% Similarity=0.334 Sum_probs=166.9
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-C-----CCceEEEEE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-H-----KHLVGLVGF 570 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~nIv~l~~~ 570 (812)
....+|.+++.||+|.||.|-+|.+ .+++.||||+++..+ ....+-..|+.+|..|+ | -|+|+++++
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 3444799999999999999999975 469999999997532 22233456899999997 4 389999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN- 649 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~- 649 (812)
|...++.+||+|.++. +|+++|+.+.... ++......|+.||+.+|.+||+.+ |||.||||+||||.+-
T Consensus 257 F~fr~HlciVfELL~~-NLYellK~n~f~G------lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLST-NLYELLKNNKFRG------LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPK 326 (586)
T ss_pred cccccceeeeehhhhh-hHHHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCC
Confidence 9999999999999965 9999999877654 366777899999999999999998 9999999999999543
Q ss_pred -CcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCC
Q 042346 650 -WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVF 716 (812)
Q Consensus 650 -~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~ 716 (812)
..+||+|||.+......-. ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|-
T Consensus 327 r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 4799999999977554221 4567889999999999999999999999999999999965553
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=313.26 Aligned_cols=266 Identities=20% Similarity=0.276 Sum_probs=194.9
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||++++. +|+.+++|++..... .......+.+|++++++++||||+++++++.+....++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc---cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 4888999999999999999875 588999998864211 122334577899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
+||++ ++|.+++..... .+++...+.++.||++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 78 ~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 78 FEYCD-QDLKKYFDSCNG-------DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred EecCC-CCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchh
Confidence 99997 588888764322 1366778899999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh--
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA-- 737 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 737 (812)
+....... ......++..|+|||.+.+. .++.++||||||+++|||+||+.|++...+.. ...+........
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~ 221 (284)
T cd07839 147 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPT 221 (284)
T ss_pred hccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH---HHHHHHHHHhCCCC
Confidence 75433211 12334678899999988764 47899999999999999999999975433211 111110000000
Q ss_pred ----ccccccccccCCC--CC-C----ChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 ----GQLHCVLDKRVGP--PE-L----NEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ----~~~~~~~d~~~~~--~~-~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+....+....+ +. . ......+.+.+++.+||+.||.+|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000100000 00 0 001234667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.42 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=198.8
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.|+..+.||+|+||.||+|.+. +++.||+|++.... .......+.+|++++++++||||+++++++.++...++|
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4777899999999999999875 58899999875321 123456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++.... ++......++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~e~~~~~~L~~~i~~~~---------l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 81 MEYLGGGSALDLLRAGP---------FDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EecCCCCcHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccc
Confidence 99999999999986532 244566789999999999999988 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
........ ......++..|+|||++.+..++.++||||||+++|||++|+.||...... .... .+..+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~----~~~~~-- 216 (277)
T cd06640 149 GQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RVLF----LIPKN-- 216 (277)
T ss_pred eeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----hHhh----hhhcC--
Confidence 65433221 223346788999999998888999999999999999999999998543211 1000 00000
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. +.......+..+.+++.+||+.+|++||+++|++.+
T Consensus 217 --------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 --------N-PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --------C-CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0 111234566778899999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=310.48 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=198.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++.+. +++.+++|++... .....+.|.+|++++++++||||+++++++..+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 356889999999999999999874 5889999987532 1233457888999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... .+++...++++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 79 lv~e~~~~~~L~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g 148 (280)
T cd06611 79 ILIEFCDGGALDSIMLELER-------GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFG 148 (280)
T ss_pred EEeeccCCCcHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCc
Confidence 99999999999999875432 1356777899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
++........ ......+++.|++||.+. ...++.++||||||+++|||++|+.||..... .. ...
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~----~~----~~~ 218 (280)
T cd06611 149 VSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP----MR----VLL 218 (280)
T ss_pred cchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH----HH----HHH
Confidence 9865433211 123346889999999875 34577899999999999999999999854321 11 111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+..+.. +.+. .+......+.+++.+||+.+|.+||++++++++
T Consensus 219 ~~~~~~~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 219 KILKSEP-----PTLD----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHhcCCC-----CCcC----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1111110 0111 112334567889999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=303.27 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=201.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||.|+||.||++... ++..+++|++..... ......+.+|+++++.++|+||+++++.+..++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc----chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 46899999999999999999864 578899998753211 1245678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+|||+++++|.++++..... ..+++.....++.|++.+|+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 77 v~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPR-----GGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred EEeccCCCcHHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccch
Confidence 99999999999999764321 11256777889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCccc--ccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 660 SLLGSECDQE--FISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 660 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
+......... .......++..|+|||++... .++.++|+||||+++|||++|+.||...... ... ....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~----~~~~ 220 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----KVL----MLTL 220 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----hhH----HHHh
Confidence 8755443222 122344688999999998876 7899999999999999999999998543221 111 1111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ..... ........++.+.+++.+||..||++||+++|++++
T Consensus 221 ~~~-----~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 221 QND-----PPSLE-TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCC-----CCCcC-CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 110 00110 001113455678899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=301.41 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=198.2
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||++... +++.+++|++.... ...+....+.+|++++++++||||+++++.+..++..++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ---MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc---cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 5888999999999999999864 68899999986422 1223456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-CcEEEEeecc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARVSDFGL 659 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DfGl 659 (812)
|||+++++|.+++...... .+++..+++++.+++++|+|||+++ |+|+||||+||+++++ ..+||+|||+
T Consensus 78 ~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNS------LLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EecCCCCCHHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 9999999999999764321 1356777899999999999999998 9999999999999865 4689999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+....... ......++..|+|||.+....++.++||||||+++|+|++|+.||..... .... ..+..+.
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~----~~~~~~~ 217 (256)
T cd08220 149 SKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL----PALV----LKIMSGT 217 (256)
T ss_pred ceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch----HHHH----HHHHhcC
Confidence 87654322 12235688899999999988899999999999999999999999843221 1111 1111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ........+.+++.+||+.+|++|||++|++++
T Consensus 218 ~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 FAP-----------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCC-----------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 110 011244568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=313.56 Aligned_cols=268 Identities=23% Similarity=0.307 Sum_probs=198.4
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||+|... +++.|++|++...............+..|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999875 589999999875433222233445677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+ +++|.+++..... .+++..+++++.||++||.|||+++ |+|+||||+|||++.++.+||+|||++
T Consensus 81 ~e~~-~~~L~~~i~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~ 149 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSI-------VLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA 149 (298)
T ss_pred Eccc-CCCHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceee
Confidence 9999 8999999975431 2367788899999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh--
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA-- 737 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 737 (812)
........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|..+|..... .............
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~----~~~~~~~~~~~~~~~ 223 (298)
T cd07841 150 RSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD----IDQLGKIFEALGTPT 223 (298)
T ss_pred eeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc----HHHHHHHHHHcCCCc
Confidence 76543221 1223456788999998854 5678999999999999999999766643221 1111111111000
Q ss_pred -------ccccccccccCCCC---CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 -------GQLHCVLDKRVGPP---ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 -------~~~~~~~d~~~~~~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+..........+ ..........+.+++.+||+.||++|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 00112335678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=310.40 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=196.6
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... .......+.+|++++++++||||+++++++..++..++|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 3677789999999999999864 57889999875321 123345788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++.... +.+.....++.|++++|.|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 81 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 81 MEYLGGGSALDLLKPGP---------LEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEccCCCcHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999999986432 256677889999999999999988 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
........ ......++..|+|||++.+..++.++||||||+++|||++|+.|+...... ... ..+..+.
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~----~~~~~~~- 217 (277)
T cd06642 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVL----FLIPKNS- 217 (277)
T ss_pred ccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHH----hhhhcCC-
Confidence 76543221 122346788999999999888999999999999999999999997532211 111 0011110
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+ ......+..+.+++.+||+.+|++||++.|++++
T Consensus 218 ---------~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 ---------PP-TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---------CC-CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01 1112345568899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.97 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=203.2
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|.++++||+|+||.||+|.++ .|+.+|||.+.. ....+++..|+.||++.+.|++|++||.|.....+|+||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 677899999999999999875 599999999764 334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
|||--|++.|.++.++... +..+.-.++.+.++||+|||... -||||||..||||+-+|.+||+|||.+-
T Consensus 108 EYCGAGSiSDI~R~R~K~L-------~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPL-------SEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred hhcCCCcHHHHHHHhcCCc-------cHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccc
Confidence 9999999999998665432 44555678999999999999988 7999999999999999999999999985
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
.+.+. ....+...||+-|||||++..-.|+.++||||||+...||..|++|+....+-.. .
T Consensus 178 QLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-----------------I 238 (502)
T KOG0574|consen 178 QLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-----------------I 238 (502)
T ss_pred hhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-----------------e
Confidence 44332 1223467899999999999999999999999999999999999999854322110 0
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
-++....++..-.+++-...+.+++++||-++|++|-|+.+++++
T Consensus 239 FMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 239 FMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred EeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 111222222223345667788999999999999999999998876
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.89 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=197.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++++. +++.+|+|.+... ........+.+|++++++++||||+++++.+..++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 35888999999999999999875 6899999987532 112334578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
||||+++++|.+++...... ..+++.....++.+++.+|.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 77 v~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVAT-----EGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred EEeecCCCCHHHHHHhcccc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecC
Confidence 99999999999998754211 1236778889999999999999974 5 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccC------cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMN------VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
++...... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||..... .... ...
T Consensus 149 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~-~~~ 219 (286)
T cd06622 149 VSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIF-AQL 219 (286)
T ss_pred CcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHH-HHH
Confidence 98654321 12334678899999998543 357899999999999999999999854321 1111 111
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+..+.. +. ...++...+.+++.+||+.+|++||++++++.+
T Consensus 220 ~~~~~~~~----------~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 220 SAIVDGDP----------PT-LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHhhcCC----------CC-CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111110 11 122356678899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=332.94 Aligned_cols=279 Identities=18% Similarity=0.283 Sum_probs=190.0
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC--CcEEEEEeeccC------------cchhhHHHHHHHHHHHHHHHHhccCCCc
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD--GREVAVKREESC------------PKTNKLREKESAFDSELALLSRVHHKHL 564 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--g~~vavK~~~~~------------~~~~~~~~~~~~~~~Ei~~l~~l~H~nI 564 (812)
..++|++.+.||+|+||+||++.++. +...++|.+... ............+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34689999999999999999987542 222222211000 0001112234567899999999999999
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCE
Q 042346 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNI 644 (812)
Q Consensus 565 v~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NI 644 (812)
+++++++.+.+..|+|+|++. ++|.+++.......... ......++|+.||+.||+|||+++ |+||||||+||
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~---~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDR---PLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccccccc---ccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 999999999999999999985 58888876543221111 124456789999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 042346 645 LLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP 724 (812)
Q Consensus 645 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~ 724 (812)
|++.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||+||||++|+.++.........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999999976543221 1223457999999999999999999999999999999999998655432221111
Q ss_pred chhHHHHHHHHH--hccc-------cccccc-cCC------CCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 725 LDVVEFAVSQIL--AGQL-------HCVLDK-RVG------PPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 725 ~~~~~~~~~~~~--~~~~-------~~~~d~-~~~------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+.+ ....+. ...+ ...++. .+. ++..........+.+++.+||+.||++|||+.|++++
T Consensus 378 ~~~~~-~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLK-IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHH-HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111 000000 0000 000000 000 0000011123456778899999999999999999975
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.79 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=198.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++.+. +++.+|+|++... .....+....+.+|++++++++||||+++++++.+++..++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 46899999999999999999875 5899999987531 11122345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... ++...++.++.|++.+|.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 79 v~e~~~~~~L~~~~~~~~~--------l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGR--------FPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred EEecCCCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999976532 245667789999999999999988 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+...... .....+++.|+|||.+....++.++||||||+++|||++|+.||..... ......+..+.
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~ 214 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGK 214 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCC
Confidence 8765432 2334688999999999888889999999999999999999999854321 11111222211
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
...+ ......+.+++.+||..||.+|| +++|++++
T Consensus 215 --------~~~~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 --------VRFP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --------ccCC----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1111 12245688999999999999999 78888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=302.06 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=199.6
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||++... +++.+++|.+...... ......+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 4888999999999999999864 6889999998643221 34567789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
+||+++++|.+++..... +++..+..++.++++||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 78 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 78 MEYCSGGTLEELLEHGRI--------LDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred EecCCCCcHHHHHhhcCC--------CChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccc
Confidence 999999999999975432 245667889999999999999998 999999999999999999999999998
Q ss_pred ccCCCCccccc--ccccccCCCccCccccccCc---CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 661 LLGSECDQEFI--STKAVGTVGYIDPEYYVMNV---LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 661 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
........... .....++..|++||++.... ++.++||||||+++|||++|+.||..... .... .. .+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~~~~---~~-~~ 219 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---EFQI---MF-HV 219 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---hHHH---HH-HH
Confidence 76544322111 12346788999999998766 88999999999999999999999854321 1110 00 01
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+. ...+ + ........+.+++.+||+.+|++|||++|++.+
T Consensus 220 ~~~~-----~~~~--~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 220 GAGH-----KPPI--P--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred hcCC-----CCCC--C--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1110 1111 1 112235567799999999999999999998853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=302.23 Aligned_cols=238 Identities=28% Similarity=0.436 Sum_probs=184.6
Q ss_pred eeeccCCcEEEEEEEEcCCc-----------EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 507 NKVGIGSFGTVYKGKLMDGR-----------EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
+.||+|+||.||+|.+.+.. .+++|.+.... .....|.+|+++++.++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH------RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch------hhHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence 46999999999999886433 57777764311 115678899999999999999999999988 7
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC-----
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW----- 650 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----- 650 (812)
..++||||+++++|.+++..... .+++..+++++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~ 143 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-------NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGY 143 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCC
Confidence 78999999999999999976542 2366778899999999999999988 99999999999999887
Q ss_pred --cEEEEeecccccCCCCcccccccccccCCCccCccccccC--cCCCcchhHHHHHHHHHHHcC-CCCCCCCCCCCCCc
Q 042346 651 --TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN--VLTAKTDIYGLGVVLLELLTG-KKAVFKNEDGSGPL 725 (812)
Q Consensus 651 --~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~ 725 (812)
.+||+|||++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+..... .
T Consensus 144 ~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-~--- 213 (259)
T cd05037 144 VPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-S--- 213 (259)
T ss_pred ceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-h---
Confidence 799999999875433 2234567789999999876 789999999999999999995 555533221 0
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
..... .... .....+. ...+.+++.+||..+|++|||+.|+++.|+
T Consensus 214 ~~~~~----~~~~-------~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 214 EKERF----YQDQ-------HRLPMPD------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hHHHH----HhcC-------CCCCCCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11110 0000 0111111 156889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.30 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=200.2
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|+..+.||+|+||.||++.+. +++.+++|++..... .+....+.+|++++++++||||+++++.+..++..+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 5778899999999999999875 588999998864221 24456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh-cCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN-YAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+||+++++|.+++..... .++.....+++.|++.+|+|||+ .+ ++|+||||+||++++++.+||+|||+
T Consensus 78 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 78 MEYMDGGSLDKILKEVQG-------RIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEecCCCcHHHHHHHccC-------CCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999976531 12456667899999999999999 77 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+. ...+....
T Consensus 148 ~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~-~~~~~~~~ 220 (265)
T cd06605 148 SGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP--DGIFEL-LQYIVNEP 220 (265)
T ss_pred chhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc--ccHHHH-HHHHhcCC
Confidence 86543211 112568889999999998899999999999999999999999986432111 111111 11111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+..........+.++|.+||..||++|||+.|++.+
T Consensus 221 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 221 ----------PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ----------CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1112222256678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=302.37 Aligned_cols=259 Identities=21% Similarity=0.360 Sum_probs=198.6
Q ss_pred CcceeeeeccCCcEEEEEEEEcC--CcEEEEEeeccCcch-----hhHHHHHHHHHHHHHHHHh-ccCCCceEEEEEEEe
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMD--GREVAVKREESCPKT-----NKLREKESAFDSELALLSR-VHHKHLVGLVGFCQE 573 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~--g~~vavK~~~~~~~~-----~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~ 573 (812)
+|++.+.||+|+||.||++.+.. ++.+|+|.+...... ........++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999865 688999987532111 1122334566778888875 799999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh-cCCCCeEeeccCCCCEEEcCCCcE
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN-YAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
++..+++|||+++++|.+++....... ..+++..+++++.|++.+|.|||+ .+ |+|+||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKK----QRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcE
Confidence 999999999999999999985422111 123667788999999999999996 55 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||+|||++....... ......++..|++||.+.+..++.++||||||+++|||++|+.||..... .. ..
T Consensus 154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~-~~ 222 (269)
T cd08528 154 TITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LS-LA 222 (269)
T ss_pred EEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HH-HH
Confidence 999999997644322 23345688999999999988899999999999999999999999853221 11 11
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
..+..+... + .........+.+++.+||+.||++||++.|+.++++
T Consensus 223 ~~~~~~~~~--------~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 223 TKIVEAVYE--------P--LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHhhccCC--------c--CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111111 0 001123456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.74 Aligned_cols=266 Identities=21% Similarity=0.295 Sum_probs=198.0
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||+|++. +++.|++|++..... .......+.+|+.++++++||||+++++++.++...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL---EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc---cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 4888999999999999999874 689999999864221 123345788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+ +++|.+++..... .+++.++++++.||+++|+|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 78 ~e~~-~~~L~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 78 MEYM-PSDLSEVLRDEER-------PLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred eccc-CCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 9999 9999999875432 1367788899999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc-
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG- 738 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 738 (812)
........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.+|..... ..............
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~ 221 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFRTLGTPN 221 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHHHcCCCC
Confidence 76544221 123345789999999998654 468999999999999999999766643221 11111111100000
Q ss_pred -----cccccccc-cCCCCCC-------ChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 -----QLHCVLDK-RVGPPEL-------NEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 -----~~~~~~d~-~~~~~~~-------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.++.+. .+..+.. ...+....+.+++.+||+.+|++|||+++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 0000000 001234778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=306.98 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=196.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+.|+..+.||+|+||.||+++.. +++.|++|++.... ....+....+.+|+++++.++||||+++++++.+++..++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc--cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 45888999999999999999874 58999999875321 1223344568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||++ |+|.+++..... .+++..+..++.|++.+|.|||+.+ |+||||+|+||+++.++.+||+|||+
T Consensus 93 v~e~~~-g~l~~~~~~~~~-------~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 93 VMEYCL-GSASDILEVHKK-------PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred EHHhhC-CCHHHHHHHccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCc
Confidence 999997 588887754322 1367778899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
+...... ....++..|+|||++. ...++.++||||||+++|||++|+.||..... ... ...+.
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-------~~~-~~~~~ 227 (307)
T cd06607 162 ASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSA-LYHIA 227 (307)
T ss_pred ceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-------HHH-HHHHh
Confidence 8654321 2346788999999874 45688999999999999999999999854321 110 11111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ..+........+.+.+++.+||..+|++||++.+++.+
T Consensus 228 ~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 228 QN----------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred cC----------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11 11222233456678999999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.39 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=197.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++.++ +++.+|+|++..... .....+.+.+|+++++.++||||+++++++..++..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC---cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 46889999999999999999985 489999998753221 12234567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.++...... +++...+.++.|++++|+|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 78 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNG--------LDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred EEecCCccHHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeee
Confidence 9999999988887654321 367888999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH---
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI--- 735 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--- 735 (812)
+....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... .+.........
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~ 220 (286)
T cd07846 147 ARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNL 220 (286)
T ss_pred eeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCC
Confidence 87654322 12233467899999999875 4578899999999999999999988753321 11111111000
Q ss_pred -------Hh-cc-ccccccccCCCCC---CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 -------LA-GQ-LHCVLDKRVGPPE---LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 -------~~-~~-~~~~~d~~~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. .. ...+..+...... ......+..+.+++.+||+.+|++||++++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred chhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 00 0000000000000 0011345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.08 Aligned_cols=252 Identities=29% Similarity=0.482 Sum_probs=197.4
Q ss_pred cceeeeeccCCcEEEEEEEEcC-----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMD-----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
|++.+.||.|+||.||++++.+ +..||+|++..... .+..+.+.+|+++++.++|+||+++++++.+.+..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD----EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC----hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 4567899999999999998754 38899999854221 22456788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+++|||+++++|.+++....... +++.+.+.++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~------~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~df 147 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKE------LSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDF 147 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhcc------CCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEccc
Confidence 99999999999999997644311 367888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|++.......... .....++..|+|||.+....++.++||||||+++|||++ |+.||.... ... ......
T Consensus 148 g~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~----~~~----~~~~~~ 218 (258)
T smart00219 148 GLSRDLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS----NEE----VLEYLK 218 (258)
T ss_pred CCceecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----HHH----HHHHHh
Confidence 9997655432211 112347789999999988889999999999999999999 666664311 111 111111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.+. ....+ ...+..+.+++.+|+..||++|||+.|+++.|
T Consensus 219 ~~~-------~~~~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 219 KGY-------RLPKP----ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCC-------CCCCC----CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111 11111 12455688899999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=304.58 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=198.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC--eE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--ER 577 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~ 577 (812)
++|...+.||.|.+|.||++.+. +++.+|+|++..... ......+.+|++++++++||||+++++++.+.. ..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 36888999999999999999874 588999998764211 234567888999999999999999999986543 67
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++++|.+++....... ..++......++.||+.+|.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRG----GRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeec
Confidence 99999999999999876432211 12356677899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCC-CCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG-SGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~ 736 (812)
|++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+... .+.
T Consensus 150 g~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~ 221 (287)
T cd06621 150 GVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----YIV 221 (287)
T ss_pred cccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH----HHh
Confidence 9986543211 12345788999999999889999999999999999999999998654321 11111111 111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...... +...........+.+.+++.+||+.+|++|||+.|++++
T Consensus 222 ~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 222 NMPNPE-----LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCCchh-----hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 111110 110111112345678899999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.49 Aligned_cols=265 Identities=23% Similarity=0.317 Sum_probs=197.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++.++ +++.|++|++.... ........+.+|+++++.++|+||+++++++..++..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE---DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc---ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 36899999999999999999875 57899999875321 122334678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+|||++++.|..++..... +++.....++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 78 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 78 VFEYVERTLLELLEASPGG--------LPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred EEecCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeec
Confidence 9999998777665543221 256777889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+........ .......++..|+|||++... .++.++||||||+++|||++|+.||...... +.... ..... +
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~-~~~~~-~ 219 (288)
T cd07833 147 ARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI----DQLYL-IQKCL-G 219 (288)
T ss_pred ccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHHHh-C
Confidence 876554322 122345678899999999887 8899999999999999999999887533211 10000 00000 0
Q ss_pred ccc----ccc--cc-----cCCCCC-------CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLH----CVL--DK-----RVGPPE-------LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~----~~~--d~-----~~~~~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+. ..+ +. ++.... ..+...+..+.++|.+||..+|++||++++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 220 PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 000 00 000000 0011236778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=299.20 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=202.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.|++|++..... ......+.+|++++.+++|+||+++++++...+..++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD----EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 36888999999999999999876 489999999864221 1345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh-cCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN-YAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
||||+++++|.+++..... ++...+++++.|++++|+|||+ .+ ++||||+|+||+++.++.++|+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~--------l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~ 145 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGK--------IPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFG 145 (264)
T ss_pred EEEecCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999976421 2567778999999999999999 88 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++......... .....++..|+|||.+....++.++||||||+++|||++|+.||..... . ...+ ....+...
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~---~~~~-~~~~~~~~ 218 (264)
T cd06623 146 ISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-P---SFFE-LMQAICDG 218 (264)
T ss_pred cceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-c---CHHH-HHHHHhcC
Confidence 98765432221 1244678999999999988899999999999999999999999855432 0 1111 11111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. +.......+..+.+++.+||..+|++||++.|++++
T Consensus 219 ~~----------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 PP----------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CC----------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 10 111111155678899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=304.05 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=191.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHH-HHhccCCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELAL-LSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
++|++.+.||+|+||.||++++. +++.||+|++..... .+....+..|+.+ ++.++||||+++++++..++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN----SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC----cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 46889999999999999999875 589999998864221 1122344455554 66679999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++|||++ ++|.+++....... ..+++...++++.||+.||+|||++ + ++||||||+|||++.++.+||+||
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKG----LTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 9999996 68988886533211 2347788889999999999999987 6 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCcccccc----CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVM----NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|++...... .......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..... ... ...
T Consensus 149 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~---~~~- 218 (283)
T cd06617 149 GISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---PFQ---QLK- 218 (283)
T ss_pred ccccccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---CHH---HHH-
Confidence 998754321 11233467889999998864 4568899999999999999999999853221 111 111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
....+. . +.......++.+.+++.+||..+|++||++++++++
T Consensus 219 ~~~~~~-----~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 219 QVVEEP-----S-----PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHhcC-----C-----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 0 111122345668899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.66 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=194.5
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|.....||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 444567999999999999864 5889999987531 1234456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++.... +++...+.++.||+.||+|||+++ |+||||||+||++++++.+||+|||++.
T Consensus 99 e~~~~~~L~~~~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 99 EFLEGGALTDIVTHTR---------MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred eCCCCCcHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 9999999999885432 256677899999999999999998 9999999999999999999999999986
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
....... ......++..|+|||.+....++.++||||||+++|||++|+.||..... ..... .+.. .
T Consensus 167 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~----~~~~-~-- 233 (292)
T cd06658 167 QVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAMR----RIRD-N-- 233 (292)
T ss_pred hcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH----HHHh-c--
Confidence 5432211 12335688999999999888899999999999999999999999854221 11111 1111 0
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+...... .......+.+++.+|+..||++|||++|++++
T Consensus 234 --~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 234 --LPPRVKD----SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --CCCcccc----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111 12234568889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=299.00 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=198.5
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe--CCeEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE--KDERL 578 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~ 578 (812)
+|++.+.||+|+||.||++... +++.+++|++.... ......+.+.+|+++++.++||||+++++++.. +...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc---CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 4788999999999999999864 67899999875321 123345678889999999999999999998764 34578
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHh-----hcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH-----NYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH-----~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
++|||+++++|.+++...... ...+++...+.++.+|+.+|.||| +.+ |+|+||||+||+++.++.+|
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~k 150 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKE----RKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVK 150 (265)
T ss_pred EEehhccCCCHHHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEE
Confidence 999999999999999764221 122467788999999999999999 666 99999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|+|||++........ ......+++.|+|||.+....++.++||||||+++|+|++|+.||..... .....
T Consensus 151 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~ 220 (265)
T cd08217 151 LGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLAS 220 (265)
T ss_pred EecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHH
Confidence 999999876544221 12334689999999999988899999999999999999999999854321 11112
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+..+... .........+.+++.+|++.+|++||++++|+++
T Consensus 221 ~~~~~~~~-----------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 KIKEGKFR-----------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHhcCCCC-----------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 22222111 1122345668899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=301.28 Aligned_cols=259 Identities=23% Similarity=0.399 Sum_probs=200.3
Q ss_pred CcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchh-hHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTN-KLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+|+..+.||+|+||.||+++. .+++.+|+|++....... ......+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 568999999886432221 222345788899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC-cEEEEeec
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW-TARVSDFG 658 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DfG 658 (812)
||||+++++|.+++..... +++...+.++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||
T Consensus 81 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg 149 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGA--------FKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFG 149 (268)
T ss_pred EEeccCCCcHHHHHHHhCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccc
Confidence 9999999999999975432 256677889999999999999998 99999999999998775 69999999
Q ss_pred ccccCCCCccc--ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 659 LSLLGSECDQE--FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 659 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... . ....... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~---~~~~~~~-~~~ 224 (268)
T cd06630 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-S---NHLALIF-KIA 224 (268)
T ss_pred cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-c---chHHHHH-HHh
Confidence 98765432111 112234678899999999888899999999999999999999999854321 1 1111111 110
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... .....+......+.+++.+|+..+|++||++.|++.+
T Consensus 225 ~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 225 SAT----------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ccC----------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 000 0111223455678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.34 Aligned_cols=267 Identities=19% Similarity=0.276 Sum_probs=194.1
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|+..+.||+|+||.||+|+.. +++.|+||++..... .......+.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc---ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 4888999999999999999875 588999998753221 122335678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+. ++|.+++...... .+++...+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 78 ~e~~~-~~l~~~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLS------GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred eeccc-cCHHHHHHhCCCC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccch
Confidence 99996 6899998654322 1367778899999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH-------HH
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF-------AV 732 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~-------~~ 732 (812)
........ ......++..|+|||.+.+. .++.++||||||+++|||+||+.||.............+. .+
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 148 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 65433211 12334568899999988754 4688999999999999999999998543211100000000 00
Q ss_pred HHHH-----hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQIL-----AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~-----~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+... ............. .........+.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFS---KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCHH---HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 0000000000000 0001233557789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.29 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=192.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.+ +++.||+|.+...... .....+.+|+++++.++|+||+++++++.+++..++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE----GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc----CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 57999999999999999999875 6889999987642211 112345679999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+.+ +|.+++..... .+.+.....++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 v~e~~~~-~L~~~~~~~~~-------~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGG-------GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred EEecCCC-CHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccc
Confidence 9999985 99999875432 1255667889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh-
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA- 737 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 737 (812)
++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .+...........
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~ 224 (291)
T cd07844 150 ARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV---EDQLHKIFRVLGTP 224 (291)
T ss_pred ccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHhcCCC
Confidence 865332111 1223356889999998875 45889999999999999999999998543211 1111111100000
Q ss_pred --ccc------cccccccCCC--CCC-----ChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 --GQL------HCVLDKRVGP--PEL-----NEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 --~~~------~~~~d~~~~~--~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+ .......... +.. ........+.+++.+||+.+|++|||++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 225 TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0000000000 000 000111556789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >COG5184 ATS1 Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.56 Aligned_cols=243 Identities=19% Similarity=0.289 Sum_probs=195.6
Q ss_pred ccEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCCC---------------------CceecccC------CceEEEEE
Q 042346 71 ASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQ---------------------PKRLHFRK------AVQLTDVS 123 (812)
Q Consensus 71 ~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~~---------------------~~~~~~~~------~~~v~~ia 123 (812)
..++.++||+.|+++|..|| .||.||.|..|+||.. .+|..++. ..+|++++
T Consensus 104 ~~i~~~acGg~hsl~ld~Dg-~lyswG~N~~G~Lgr~~~~~~~~~~~~~~~~~~~~~~~tP~~v~~~s~~~s~~~vv~l~ 182 (476)
T COG5184 104 ASIIKIACGGNHSLGLDHDG-NLYSWGDNDDGALGRDIHKDICDQNNDIIDFDDYELESTPFKVPGGSSAKSHLRVVKLA 182 (476)
T ss_pred eeeEEeecCCceEEeecCCC-CEEEeccCcccccccccccccccccccccccchhhcccCCceeeccccccCChheEEee
Confidence 58999999999999999999 7999999999999922 12333333 34799999
Q ss_pred ccCceEEEEEeCCCeEEEecCCCCCCCCCCcccCC--------CCC--CCceEEEeecCCeEEEEEccCCeEEEeecCCC
Q 042346 124 VGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSS--------PGE--DLKFSTITSGRGFTCGILRSNSEVFCWGDSGI 193 (812)
Q Consensus 124 ~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~~--------~~~--~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~ 193 (812)
||..++++++ ++|+||.||.+..+.++.+...+. |.. ...++++|+|.+|..+| +.+|+||.||++..
T Consensus 183 cg~e~svil~-~~G~V~~~gt~r~~e~~~g~~~~s~k~~~~~~p~~v~~~~i~qla~G~dh~i~l-t~~G~vy~~Gs~qk 260 (476)
T COG5184 183 CGWEISVILT-ADGRVYSWGTFRCGELGQGSYKNSQKTSIQFTPLKVPKKAIVQLAAGADHLIAL-TNEGKVYGWGSNQK 260 (476)
T ss_pred cCCceEEEEc-cCCcEEEecCccccccccccccccccceeeeeeeecCchheeeeccCCceEEEE-ecCCcEEEecCCcc
Confidence 9999999998 999999999999988887733221 111 35799999999999998 89999999999877
Q ss_pred CCccccc-------------ccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCCC---------------Ccce
Q 042346 194 ADEIQRG-------------FKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFS---------------SAFE 245 (812)
Q Consensus 194 ~~~~~~~-------------~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~---------------~~~~ 245 (812)
+|...+. +....+..|+||.+|+.||+++|.+|+||.|.+||||.++. ....
T Consensus 261 gqlG~~~~e~~~~~~lv~~~f~i~~i~~vacG~~h~~al~~~G~i~a~G~n~fgqlg~~~~~~~~a~~tk~~~~~~~~~~ 340 (476)
T COG5184 261 GQLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDHSLALDEDGEIYAWGVNIFGQLGAGSDGEIGALTTKPNYKQLLSGV 340 (476)
T ss_pred cccCCchhhhcccccccCChhhhhhhhhcccCcceEEEEcCCCeEEEeccchhcccccCcccccceeeccccccccCCCc
Confidence 6654332 22233677999999999999999999999999999997611 1111
Q ss_pred eeeeeeeccceeEEEEecCCeEEEecCCCCCccccCC-----------cc-ccceeEEEeccceEEEEEcCCCeEEEecC
Q 042346 246 FSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDV-----------IQ-DVSFESIVAGLDFVCGLTTRNLSMICWGP 313 (812)
Q Consensus 246 ~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~-----------~~-~~~~~~i~ag~~~~c~~~~~~~~v~cWG~ 313 (812)
.+.+|++|..|+.+|+. +|.||.||++.+||||... .. ...+.++++|..|.-+.+. +++||+||.
T Consensus 341 ~i~~is~ge~H~l~L~~-~G~l~a~Gr~~~~qlg~~~~~~~~~~~~~~ls~~~~~~~v~~gt~~~~~~t~-~gsvy~wG~ 418 (476)
T COG5184 341 TICSISAGESHSLILRK-DGTLYAFGRGDRGQLGIQEEITIDVSTPTKLSVAIKLEQVACGTHHNIARTD-DGSVYSWGW 418 (476)
T ss_pred eEEEEecCcceEEEEec-CceEEEecCCccccccCcccceeecCCccccccccceEEEEecCccceeecc-CCceEEecC
Confidence 12369999999999998 5999999999999999844 11 1358899999999999985 669999998
Q ss_pred CCCCC
Q 042346 314 GWSNK 318 (812)
Q Consensus 314 ~~~~~ 318 (812)
|..++
T Consensus 419 ge~gn 423 (476)
T COG5184 419 GEHGN 423 (476)
T ss_pred chhhh
Confidence 75443
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.07 Aligned_cols=268 Identities=24% Similarity=0.286 Sum_probs=192.9
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
++++|++.+.||+|+||.||+|... +++.|++|++..... ......+.+|+++++.++|+||+++++++.+++..
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE----EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc----CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence 3567999999999999999999864 688999999854221 11223567899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+. ++|.+++...... +.+.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Df 147 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHPGG-------LHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADF 147 (291)
T ss_pred EEEEeccc-CCHHHHHHhCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecc
Confidence 99999996 6888777543221 245566789999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..+.....+..+-
T Consensus 148 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~---~~~~~~~~~~~~~ 222 (291)
T cd07870 148 GLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD---VFEQLEKIWTVLG 222 (291)
T ss_pred ccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh---HHHHHHHHHHHcC
Confidence 99875433221 1233457899999999875 3578899999999999999999999854321 1111111111000
Q ss_pred h---------ccccccccccC--CCCCCC-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 A---------GQLHCVLDKRV--GPPELN-----EAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~---------~~~~~~~d~~~--~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. ..+........ ..+... .......+.+++.+|+..||++|||++|++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred CCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 00000000000 000000 00113457789999999999999999999854
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.56 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=194.4
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|.....||+|+||.||++... +++.|++|++.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 444568999999999999864 68999999975321 122345788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++.... +++...+.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 98 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 98 EFLQGGALTDIVSQTR---------LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred ecCCCCCHHHHHhhcC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHh
Confidence 9999999999875422 256777899999999999999998 9999999999999999999999999986
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
....... ......++..|+|||++.+..++.++||||||+++|||++|+.||..... .... ..+....
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~----~~~~~~~-- 233 (297)
T cd06659 166 QISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAM----KRLRDSP-- 233 (297)
T ss_pred hcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH----HHHhccC--
Confidence 5433211 12335688999999999988899999999999999999999999864321 1111 1111110
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. ............+.+++.+||+.+|++||+++|++++
T Consensus 234 ---~----~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 ---P----PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---C----CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0000112234557889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=305.46 Aligned_cols=250 Identities=23% Similarity=0.396 Sum_probs=198.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.+|.+.+.||+|+||.||++... +++.+++|.+.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 56889999999999999999864 67899999875321 1223567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
|+||+++++|.+++.... +++..++.++.|++.+|.|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 94 v~e~~~~~~L~~~~~~~~---------l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~ 161 (293)
T cd06647 94 VMEYLAGGSLTDVVTETC---------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 161 (293)
T ss_pred EEecCCCCcHHHHHhhcC---------CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcc
Confidence 999999999999996532 256677889999999999999998 99999999999999999999999998
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+........ ......+++.|++||.+....++.++||||||+++|||++|+.||.......... .+..
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--------~~~~-- 229 (293)
T cd06647 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIAT-- 229 (293)
T ss_pred eeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--------ehhc--
Confidence 865443222 1233468889999999988889999999999999999999999985433211000 0000
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... +...........+.+++.+||..+|++||++++++.+
T Consensus 230 -----~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 -----NGT--PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -----CCC--CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0111123345668899999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=303.23 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=197.2
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCC-
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKD- 575 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~- 575 (812)
..++|++.+.||+|+||.||++..+ +++.+++|++.... .....+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 4578999999999999999999875 57889999876421 1335688999999999 7999999999997654
Q ss_pred -----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 576 -----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 576 -----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
..++||||+++++|.+++....... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKG----KRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNA 150 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCC
Confidence 4799999999999999986533111 12356777899999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCcccccc-----CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCc
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL 725 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~ 725 (812)
.+||+|||++....... .......++..|+|||++.. ..++.++||||||++||||++|+.||..... .
T Consensus 151 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~ 224 (275)
T cd06608 151 EVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP----M 224 (275)
T ss_pred eEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch----H
Confidence 99999999986543321 12234568899999998753 3467899999999999999999999853221 0
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. ....+..+. .+.........+.+.+++.+||..||++|||++|++++
T Consensus 225 ---~-~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 225 ---R-ALFKIPRNP---------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ---H-HHHHhhccC---------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 111111111 11111123356678899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.38 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=197.0
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|++.+.||+|+||.||++... +++.+|+|..... ........+.+|++++++++||||+++++++..++..++||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 777899999999999999864 6889999987532 11233457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++.... +++...+.++.+++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 82 e~~~~~~l~~~i~~~~---------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 82 EYLGGGSALDLLEPGP---------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred EeCCCCcHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccce
Confidence 9999999999986431 256778899999999999999988 9999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
....... ......++..|+|||.+....++.++||||||+++|||++|+.||..... ... ...+....
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~----~~~~~~~~-- 217 (277)
T cd06641 150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKV----LFLIPKNN-- 217 (277)
T ss_pred ecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHH----HHHHhcCC--
Confidence 5543211 12234678899999999888889999999999999999999999743221 111 11111111
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+.......+..+.+++.+||+.+|.+||++.+++++
T Consensus 218 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 ---------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001112344568899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=298.68 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=197.8
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||++..+ ++..+++|.+.... ........+.+|+++++.++|+||+++++.+.+....++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK---MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh---ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 4788999999999999999875 58899999875421 1112345678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC-cEEEEeecc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW-TARVSDFGL 659 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DfGl 659 (812)
+||+++++|.+++...... .+++..++.++.|++.+|.|||+.+ |+|+||||+||++++++ .+||+|||.
T Consensus 78 ~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGV------LFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EecCCCCcHHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence 9999999999999754321 2367888999999999999999998 99999999999999885 469999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+........ ......+++.|+|||++....++.++||||||+++|||++|+.||.... ..+... ....+.
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~-~~~~~~ 218 (257)
T cd08225 149 ARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVL-KICQGY 218 (257)
T ss_pred chhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHH-HHhccc
Confidence 876543221 1233468899999999988889999999999999999999999984322 111111 111211
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ........+.+++.+|+..+|++|||++|++.+
T Consensus 219 ~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 219 FAP-----------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCC-----------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 110 011234468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=302.37 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=195.6
Q ss_pred CcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc---CCCceEEEEEEEeCCeE
Q 042346 502 NFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH---HKHLVGLVGFCQEKDER 577 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~ 577 (812)
.|+..+.||+|+||.||+|.+ .+++.+++|.+.... .......+.+|+++++.++ |||++++++++.++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 477889999999999999986 468999999875321 1223456778999999997 99999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++++|.+++... .+++...+.++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+||
T Consensus 78 ~lv~e~~~~~~L~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAG---------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred EEEEecCCCCcHHHHHHcc---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccC
Confidence 9999999999999998643 1256777899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...... ... ..+.
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~----~~~~ 215 (277)
T cd06917 146 GVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF----RAM----MLIP 215 (277)
T ss_pred CceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh----hhh----hccc
Confidence 99876544321 1233468899999998865 45789999999999999999999998543211 000 0000
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. ..++..........+.+++.+||+.||++||++.|++.+
T Consensus 216 ~----------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 216 K----------SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred c----------CCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0 011111122245668899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.12 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=201.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|+..+.||+|+||.||++.+. +++.+++|++..... ..+.+.+|+++++.++|+||+++++++...+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 4567888999999999999999886 688999999864221 345678899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++++||+++++|.+++.... ..+++..++.++.+++.+|+|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~ 160 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADF 160 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECcc
Confidence 99999999999999998654 12367788899999999999999988 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|++........ ......++..|++||.+.+..++.++||||||+++|||++|+.||..... ... ...+..
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----~~~----~~~~~~ 230 (286)
T cd06614 161 GFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----LRA----LFLITT 230 (286)
T ss_pred chhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----HHH----HHHHHh
Confidence 98865433211 12334578899999999888899999999999999999999999743221 111 111111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... +......++..+.+++.+||+.+|.+||++.+++++
T Consensus 231 ~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 231 KGIP---------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred cCCC---------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1110 111112245678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.31 Aligned_cols=265 Identities=17% Similarity=0.210 Sum_probs=184.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHH------HHHHHHHHHHHHHhccCCCceEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLRE------KESAFDSELALLSRVHHKHLVGLVG 569 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~~ 569 (812)
.++|++.++||+|+||.||+|.+.+ +..+++|+............ .......+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999998754 34566665332111111110 0112233445566778999999999
Q ss_pred EEEeCC----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEE
Q 042346 570 FCQEKD----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645 (812)
Q Consensus 570 ~~~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 645 (812)
.+.... ..++++|++.. ++.+.+...... ++...+.|+.|+++||+|||+.+ |+||||||+|||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--------~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nil 158 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCK--------NKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIM 158 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhccC--------CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 766543 34678887743 666666443211 34556789999999999999998 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCC
Q 042346 646 LDVNWTARVSDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720 (812)
Q Consensus 646 l~~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 720 (812)
++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999765322211 111234699999999999999999999999999999999999999965432
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
.. ........... ..+...... ...+++.+.+++..|++.+|++||+++++++.|+
T Consensus 239 ~~---~~~~~~~~~~~----~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NG---NLIHAAKCDFI----KRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred ch---HHHHHhHHHHH----HHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 21 11111111110 001111111 1223466889999999999999999999998763
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=306.97 Aligned_cols=269 Identities=19% Similarity=0.236 Sum_probs=193.9
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|++.+.||+|.+|.||++.+. +++.|++|++..... .......+.+|+++++.++||||+++++++.+++..+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc---cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 567889999999999999874 699999998864211 1122346778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||++ ++|.+++..... ..+++..+++++.|++++|+|||+++ ++||||+|+||+++.++.++|+|||++.
T Consensus 78 e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 78 EFLD-LDLKKYMDSSPL------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eccC-cCHHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 9995 699999876542 12367888999999999999999988 9999999999999999999999999986
Q ss_pred cCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH-------HHH
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF-------AVS 733 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~-------~~~ 733 (812)
....... ......++..|+|||++.+. .++.++||||||+++|||++|+.||...........+.+. .+.
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 148 AFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 5432211 12334568899999988654 5789999999999999999999998543321100000000 000
Q ss_pred HH--HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QI--LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~--~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ..+.......................+.+++.+|++.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000000000000000000011233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=293.60 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=202.7
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--CeEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--DERL 578 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~ 578 (812)
+|++.+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++++++++||||+++++.+.+. +..+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 4778899999999999999886 6899999998643221 34456788999999999999999999999988 8899
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
++|||+++++|.+++.... .+++..++.++.+++++|+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 78 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~ 146 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG--------KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFG 146 (260)
T ss_pred EEEEecCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccc
Confidence 9999999999999997654 2367888999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
.+................++..|++||.+....++.++||||||+++|||++|+.||..... ....... +...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~~ 219 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYK-IGSS 219 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHh-cccc
Confidence 98765543321123345688999999999888899999999999999999999999854331 1111111 1100
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. . ....+......+.+++.+|+..+|++||++.|++.+
T Consensus 220 ~--------~--~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 G--------E--PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred C--------C--CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0 0 001112335678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.24 Aligned_cols=250 Identities=29% Similarity=0.438 Sum_probs=199.8
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.|+..+.||+|+||.||++.+. +++.+++|++..... .....+.+|+++++.++|+|++++++++..+...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3778899999999999999885 688999999864221 3456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
+||+++++|.+++..... .+++.....++.+++.+|.|||+.+ ++||||+|+||++++++.++|+|||.+
T Consensus 76 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~ 145 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQ-------TLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLS 145 (253)
T ss_pred EecCCCCcHHHHHhhcCC-------CCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccc
Confidence 999999999999876531 2367778899999999999999988 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
........ .....++..|++||.+....++.++||||||+++|||++|+.||..... ..... .......
T Consensus 146 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~----~~~~~~~ 214 (253)
T cd05122 146 AQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP----MKALF----KIATNGP 214 (253)
T ss_pred cccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch----HHHHH----HHHhcCC
Confidence 76544321 2345688999999999888899999999999999999999999854321 11111 1111110
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ..........+.+++.+||+.||++|||+.|++++
T Consensus 215 ~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 215 PG---------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CC---------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00112224568899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=306.19 Aligned_cols=265 Identities=19% Similarity=0.253 Sum_probs=195.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--CeE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--DER 577 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 577 (812)
++|++.+.||+|+||.||+|.++ +++.+++|.+...... ......+.+|++++++++||||+++++++... +..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 46888999999999999999975 5889999988642221 22334567899999999999999999999877 789
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++ +|.+++..... .+++...++++.|++.||+|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~ 150 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQ-------PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDF 150 (293)
T ss_pred EEEehhcCc-CHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeec
Confidence 999999974 99999875432 2367788899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH---
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS--- 733 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--- 733 (812)
|++........ ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||..... .........
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~----~~~~~~~~~~~~ 224 (293)
T cd07843 151 GLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE----IDQLNKIFKLLG 224 (293)
T ss_pred CceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhC
Confidence 99876543221 12334678899999988754 468999999999999999999999854321 111111100
Q ss_pred --------HHHh------ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 --------QILA------GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 --------~~~~------~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... ..........+ ..........+.+.+++.+||+.||++|||++|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 225 TPTEKIWPGFSELPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred CCchHHHHHhhccchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 00000000000 0000111135668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.67 Aligned_cols=250 Identities=28% Similarity=0.349 Sum_probs=200.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.+.|+.-++||+|+||+||-++.+ +|+.+|.|++.+ +..+.+..+....+|-.||.+++.+.||.+--.|+..+.++
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~K--KRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDK--KRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHH--HHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 356888999999999999999764 599999998864 33344455566678999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
||+..|.||+|.-+|.+...... +....+=++.+|+.||++||++. ||.|||||+|||||++|+++|+|+|
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF------~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGF------DEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCC------chHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccc
Confidence 99999999999999987764332 34555668999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
||..+.... .....+||.+|||||++.+..|+...|.|||||+||||+.|+.||.+..+.... +.+-+..++
T Consensus 333 LAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----eEvdrr~~~- 404 (591)
T KOG0986|consen 333 LAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----EEVDRRTLE- 404 (591)
T ss_pred eEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----HHHHHHHhc-
Confidence 998766533 234459999999999999999999999999999999999999999654432111 111111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN 779 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 779 (812)
.+...+..+.+..+.|....|.+||.+|.-
T Consensus 405 -----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 405 -----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred -----------chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 122233556677778888899999999963
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=299.29 Aligned_cols=251 Identities=24% Similarity=0.278 Sum_probs=198.2
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||.|+||.||++++. +++.+++|++.... .......+.+.+|++++++++||||+++++.+.+++..++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK--CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh--hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 5889999999999999999875 58999999986321 11223456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
+||+++++|.+++..... +.....+.++.|++++|.|||+.+ |+|+||||+||++++++.++|+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~--------l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVK--------FSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred EeCCCCCCHHHHHHhcCC--------cCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccc
Confidence 999999999999976521 245667889999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
....... ......++..|+|||.+....++.++|+||||+++|+|++|+.||...... ...........
T Consensus 148 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--- 216 (258)
T cd05578 148 TKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET--- 216 (258)
T ss_pred cccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc---
Confidence 7654322 123346888999999998888999999999999999999999998643321 11111111110
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI--TDIVA 785 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~evl~ 785 (812)
.... .+...+..+.+++.+||+.||.+||++ +|+++
T Consensus 217 -----~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 -----ADVL----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -----cccc----CcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0111 112344678899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.46 Aligned_cols=272 Identities=22% Similarity=0.305 Sum_probs=195.4
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCC-
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKD- 575 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~- 575 (812)
..++|++.+.||+|+||.||+|.+. +++.+++|++.... ........+.+|+.+++++ +||||+++++++...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF---RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc---CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 3467889999999999999999875 58899999875321 1122234567899999999 9999999999986543
Q ss_pred -eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 576 -ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 576 -~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
..++||||++ ++|.+++... .+.+..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl 148 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN---------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKL 148 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEE
Confidence 5799999997 5999988653 1256677889999999999999988 999999999999999999999
Q ss_pred EeecccccCCCCccc---ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh---
Q 042346 655 SDFGLSLLGSECDQE---FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV--- 727 (812)
Q Consensus 655 ~DfGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~--- 727 (812)
+|||++......... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 228 (337)
T cd07852 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228 (337)
T ss_pred eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999765433221 12234568999999998764 56788999999999999999999998532211000000
Q ss_pred --------HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 728 --------VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 728 --------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
............+................+.+..+.+++.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000001111111111112245678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.87 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=194.4
Q ss_pred eeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCC
Q 042346 508 KVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSN 586 (812)
Q Consensus 508 ~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 586 (812)
+||+|.||+||-|++.+ ...+|||.+.. +.....+-+.+||.+-++|+|.|||+++|.+.+++..-+.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe-----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE-----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc-----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 79999999999999765 56789998753 2233456778899999999999999999999999988999999999
Q ss_pred CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc-CCCcEEEEeecccccCCC
Q 042346 587 GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD-VNWTARVSDFGLSLLGSE 665 (812)
Q Consensus 587 gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kl~DfGla~~~~~ 665 (812)
|+|.++|+.+-....... ...--+-+||++||.|||++. |||||||-+|+|++ -.|.+||+|||-++.+..
T Consensus 657 GSLSsLLrskWGPlKDNE-----stm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNE-----STMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred CcHHHHHHhccCCCccch-----hHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 999999987644322211 222347789999999999998 99999999999994 569999999999876554
Q ss_pred CcccccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccc
Q 042346 666 CDQEFISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCV 743 (812)
Q Consensus 666 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (812)
.+. .+....||..|||||++.. +.|...+|||||||.+.||.||++||....++. . + .+.-|-+
T Consensus 729 inP--~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----A---A--MFkVGmy--- 794 (1226)
T KOG4279|consen 729 INP--CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----A---A--MFKVGMY--- 794 (1226)
T ss_pred CCc--cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----H---h--hhhhcce---
Confidence 322 3456689999999999975 458999999999999999999999996543321 0 1 1111111
Q ss_pred ccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 744 LDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 744 ~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
+. -...+.++....+.+|.+|+..||.+||+++++|+
T Consensus 795 ---Kv--HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 795 ---KV--HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ---ec--CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11 11235778888899999999999999999999986
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.43 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=195.0
Q ss_pred cceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|...+.||+|+||.||++.. .+++.+++|++... .....+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 44567999999999999986 46889999987531 1223456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++.... +++.....++.|++.+|+|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 96 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 96 EFLEGGALTDIVTHTR---------MNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred eccCCCCHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccch
Confidence 9999999999987621 255677889999999999999998 9999999999999999999999999886
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.... +.... ..+....
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~~~~~----~~~~~~~-- 231 (285)
T cd06648 164 QVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----PLQAM----KRIRDNL-- 231 (285)
T ss_pred hhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----HHHHH----HHHHhcC--
Confidence 5433211 1223468899999999988889999999999999999999999985422 11111 1111111
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... .....+..+.+++.+||+.+|++||++++++++
T Consensus 232 ---~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 232 ---PPKLK----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ---CCCCc----ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 00110 011244568899999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=294.00 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=197.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--CeE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--DER 577 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 577 (812)
.+|++.+.||+|+||.||++.+. +++.+++|++..........+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46899999999999999999864 589999998753222222334456788999999999999999999998764 457
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+++|||+++++|.+++..... +++...++++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~--------l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~df 150 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA--------LTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 150 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcc
Confidence 899999999999999975432 245667789999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcc-cccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQ-EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|+++....... ........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ...
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~-~~~ 222 (264)
T cd06653 151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAAIF-KIA 222 (264)
T ss_pred ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHHHH-HHH
Confidence 99975432111 1112334688999999999988899999999999999999999999853211 11111 111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... .+...+....+.+.+++.+|+. +|.+||+..+++.+
T Consensus 223 ~~~----------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 TQP----------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred cCC----------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 110 0111223455678899999999 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=302.65 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=196.6
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.|...+.||+|+||.||+++.. +++.+++|++..... ...+....+.+|+++++.++|||++++++++.+++..++|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 3777889999999999999864 588999998764221 2233445788899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+. |+|.+++..... .+++.++..++.+++.+|.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 104 ~e~~~-g~l~~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 104 MEYCL-GSASDLLEVHKK-------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred EeCCC-CCHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence 99997 588888754322 1367888899999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
..... .....++..|+|||++. ...++.++||||||+++|||++|+.||..... .. ....+..
T Consensus 173 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~----~~~~~~~ 238 (317)
T cd06635 173 SIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MS----ALYHIAQ 238 (317)
T ss_pred cccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH----HH----HHHHHHh
Confidence 65432 22346888999999974 45688999999999999999999999854321 01 1111111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
+.. +..........+.+++.+||+.+|.+||++.++++++-.
T Consensus 239 ~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 239 NES----------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ccC----------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 110 111123345568899999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.91 Aligned_cols=245 Identities=25% Similarity=0.339 Sum_probs=193.3
Q ss_pred eccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCC
Q 042346 509 VGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNG 587 (812)
Q Consensus 509 LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 587 (812)
||+|+||.||+++.. +++.+++|++.... .......+.+.+|+++++.++||||+++++++.+++..+++|||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH--IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhc--chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 689999999999975 48899999986422 122234567889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCc
Q 042346 588 ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667 (812)
Q Consensus 588 sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~ 667 (812)
+|.+++..... ++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 79 ~L~~~l~~~~~--------l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 79 ELWTILRDRGL--------FDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred cHHHHHhhcCC--------CCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 99999976432 255677889999999999999988 9999999999999999999999999997654422
Q ss_pred ccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccccccc
Q 042346 668 QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKR 747 (812)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 747 (812)
......++..|++||.+....++.++|+||||+++|||++|+.||..... +.... ...+..+. ..
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~----~~~~~~~~------~~ 212 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPMEI----YNDILKGN------GK 212 (262)
T ss_pred ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHHHH----HHHHhccC------CC
Confidence 12234678899999999888899999999999999999999999865432 11111 11111111 11
Q ss_pred CCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 042346 748 VGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVA 785 (812)
Q Consensus 748 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 785 (812)
...+ ......+.+++.+||+.+|++||+ ++|+++
T Consensus 213 ~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 213 LEFP----NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCC----cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1111 122556889999999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=310.58 Aligned_cols=268 Identities=21% Similarity=0.281 Sum_probs=194.5
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC--
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD-- 575 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-- 575 (812)
..++|+..+.||+|+||.||+++.. +++.||+|++..... .......+.+|++++++++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 4577999999999999999999864 689999998753211 1223345678999999999999999999886443
Q ss_pred ----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 576 ----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 576 ----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
..++||||+. ++|.+++... ++......++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCC
Confidence 4699999996 5888888543 245566789999999999999998 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC--------
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG-------- 723 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~-------- 723 (812)
+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+....
T Consensus 157 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 233 (353)
T cd07850 157 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233 (353)
T ss_pred EEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999997643321 12334678999999999999999999999999999999999999854321000
Q ss_pred ---CchhHHH---HHHHHHhcc-------ccccccccCCCC--CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 724 ---PLDVVEF---AVSQILAGQ-------LHCVLDKRVGPP--ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 724 ---~~~~~~~---~~~~~~~~~-------~~~~~d~~~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+..+. ......... +.+.+.....+. ..........+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000000000 000000000000 00012345667899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=302.88 Aligned_cols=276 Identities=21% Similarity=0.283 Sum_probs=195.3
Q ss_pred CcceeeeeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--Ce
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--DE 576 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~ 576 (812)
+|++.+.||+|+||.||+|... +++.||+|.+..... ........+.+|+.+++.++||||+++++++.+. ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 4788999999999999999875 478999999864221 1122234567899999999999999999999988 77
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC----CCcE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV----NWTA 652 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~----~~~~ 652 (812)
.++||||+++ +|.+++........ ..++......++.|++.||.|||+.+ |+||||||+|||++. ++.+
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKR---VSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCC---cCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceE
Confidence 8999999975 77777754332211 12355677889999999999999998 999999999999999 8999
Q ss_pred EEEeecccccCCCCcc-cccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh-HH
Q 042346 653 RVSDFGLSLLGSECDQ-EFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV-VE 729 (812)
Q Consensus 653 kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~-~~ 729 (812)
||+|||++........ ........++..|+|||.+.+ ..++.++||||||++||||++|+.||............ ..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 9999999976543322 122334567899999998765 45889999999999999999999998654332210000 00
Q ss_pred HHHHHHHh----------------cccccc--ccccCCCCCCCh-H------HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042346 730 FAVSQILA----------------GQLHCV--LDKRVGPPELNE-A------EAVELLATTAIHCVNLEGKERPNITDIV 784 (812)
Q Consensus 730 ~~~~~~~~----------------~~~~~~--~d~~~~~~~~~~-~------~~~~~l~~li~~Cl~~dP~~RPt~~evl 784 (812)
.....+.. ..+... .......+.... . .....+.+++.+||+.||++|||+.|++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 00000000 000000 000000110000 1 2234578999999999999999999998
Q ss_pred HH
Q 042346 785 AN 786 (812)
Q Consensus 785 ~~ 786 (812)
++
T Consensus 312 ~~ 313 (316)
T cd07842 312 EH 313 (316)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=305.39 Aligned_cols=269 Identities=18% Similarity=0.233 Sum_probs=194.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCe--
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDE-- 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~-- 576 (812)
++|++.+.||+|+||.||++.+. +++.||+|++..... .......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD---EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc---ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 46889999999999999999875 589999998754211 1122346778999999995 6999999999987665
Q ss_pred ---EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC-CCcE
Q 042346 577 ---RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTA 652 (812)
Q Consensus 577 ---~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~ 652 (812)
.++||||+++ +|.+++....... ...+++...+.++.||++||.|||+.+ |+||||||+||+++. ++.+
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~ 150 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGP---GRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLL 150 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeE
Confidence 7999999985 8999987543221 112367888999999999999999998 999999999999998 8999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||++........ ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||...... ......
T Consensus 151 kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~ 224 (295)
T cd07837 151 KIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL----QQLLHI 224 (295)
T ss_pred EEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHH
Confidence 9999999875432211 1223456889999998865 45789999999999999999999998543211 111101
Q ss_pred HHHHHhccccccc-------c----ccCCCC--CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 732 VSQILAGQLHCVL-------D----KRVGPP--ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 732 ~~~~~~~~~~~~~-------d----~~~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...+.... .... + ....+. ..........+.++|.+||..||.+||+++|++.+
T Consensus 225 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 225 FKLLGTPT-EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHHhCCCC-hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 11000000 0000 0 000000 00012345668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.59 Aligned_cols=248 Identities=24% Similarity=0.302 Sum_probs=191.3
Q ss_pred eccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCC
Q 042346 509 VGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNG 587 (812)
Q Consensus 509 LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 587 (812)
||+|+||+||++... +++.+++|.+... ..........+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKK--RLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehh--hhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 689999999999764 5889999987631 1122233456678999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCc
Q 042346 588 ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667 (812)
Q Consensus 588 sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~ 667 (812)
+|.+++...... .+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 79 ~L~~~l~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~- 148 (277)
T cd05577 79 DLKYHIYNVGEP------GFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG- 148 (277)
T ss_pred cHHHHHHHcCcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC-
Confidence 999999765431 1356777889999999999999998 999999999999999999999999998754331
Q ss_pred ccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccccccc
Q 042346 668 QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKR 747 (812)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 747 (812)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ... +.... ....
T Consensus 149 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~----~~~~~----~~~~ 214 (277)
T cd05577 149 --KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEE----LKRRT----LEMA 214 (277)
T ss_pred --CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHH----HHhcc----cccc
Confidence 112334678899999999888899999999999999999999999854332110 010 11110 0001
Q ss_pred CCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 748 VGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 748 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
. .........+.+++.+||+.||++|| ++.+++.+
T Consensus 215 ~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 215 V----EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred c----cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 1 11122355688999999999999999 77777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.94 Aligned_cols=245 Identities=23% Similarity=0.286 Sum_probs=184.7
Q ss_pred eeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHH---HHhccCCCceEEEEEEEeCCeEEEEEEe
Q 042346 508 KVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELAL---LSRVHHKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 508 ~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~---l~~l~H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
.||+|+||.||++... +++.+|+|.+....... ......+.+|..+ +...+||||+.+++++..++..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc--chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999874 58899999876422111 1112233344433 3345799999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccC
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
+++++|.+++..... +++.....++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++...
T Consensus 79 ~~~~~L~~~i~~~~~--------l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 79 MNGGDLHYHLSQHGV--------FSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred CCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 999999999875432 367778899999999999999998 999999999999999999999999998654
Q ss_pred CCCcccccccccccCCCccCccccc-cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccc
Q 042346 664 SECDQEFISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742 (812)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (812)
.... .....++..|+|||.+. +..++.++||||||+++|||++|+.||....... ..........
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~~~----- 213 (279)
T cd05633 148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLT----- 213 (279)
T ss_pred cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-----HHHHHHHhhc-----
Confidence 3211 22346899999999886 4568999999999999999999999986543211 0111100000
Q ss_pred cccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 743 VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 743 ~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
.. ...+...+..+.+++.+||+.||++|| +++|++++
T Consensus 214 -~~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 214 -VN------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -CC------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00 011223456688999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.65 Aligned_cols=266 Identities=20% Similarity=0.279 Sum_probs=193.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|.||.||++++. +++.|++|++..... .......+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc---cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 46899999999999999999875 688999998753211 12234567789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC-CCcEEEEeec
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARVSDFG 658 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DfG 658 (812)
||||++ ++|.+++....... .++.....++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFA------KNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCC------cCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccc
Confidence 999996 58888875443221 145666789999999999999998 999999999999985 5679999999
Q ss_pred ccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++....... .......+++.|+|||++.+ ..++.++||||||+++|||+||+.||...... +......... .
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~~~~-~ 221 (294)
T PLN00009 149 LARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIFRIL-G 221 (294)
T ss_pred cccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHh-C
Confidence 996543211 11234467889999998865 45789999999999999999999998543211 1111110000 0
Q ss_pred cccccc-------ccc-----cCCCCC--CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCV-------LDK-----RVGPPE--LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~-------~d~-----~~~~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...... .+. +..... ....+..+.+.+++.+|++.+|++||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 222 TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000 000000 0011234557899999999999999999999974
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.06 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=195.9
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|++|.||+|++. +++.||+|++..... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE----EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc----ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 4888999999999999999985 588999998764221 12234567899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++ +|.+++...... ..+++...++++.|++.+|+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 77 ~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVR-----GALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred EecCCc-cHHHHHHhcCCC-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence 999985 899988654421 12367888999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH---
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL--- 736 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 736 (812)
........ ......++..|++||.+.+ ..++.++||||||+++|||++|+.||...... +..........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~ 221 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIFRIMGTPT 221 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCC
Confidence 65433211 1233467889999998865 45788999999999999999999998543321 11111100000
Q ss_pred hc---ccc--ccccccCCCCC-----CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AG---QLH--CVLDKRVGPPE-----LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~---~~~--~~~d~~~~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. .+. ..+........ ......+..+.+++.+|++.||.+||+++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 000 00000000000 0011235668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.79 Aligned_cols=267 Identities=24% Similarity=0.300 Sum_probs=194.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--Ce
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--DE 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~ 576 (812)
.++|++.+.||+|.||.||++.+. +++.||+|++...... ......+.+|++++++++|+||+++++++.+. +.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER---DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC---CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 356999999999999999999875 5899999987632111 11223456799999999999999999998765 45
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+.+ +|.+++..... .+++...+.++.||++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~d 151 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMPT-------PFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIAD 151 (309)
T ss_pred EEEEEecCCC-CHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence 7999999964 89888865431 2367888899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .+.........
T Consensus 152 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~----~~~~~~~~~~~ 225 (309)
T cd07845 152 FGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE----IEQLDLIIQLL 225 (309)
T ss_pred cceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhc
Confidence 999976543221 1223356788999999865 5688999999999999999999999854321 11111111100
Q ss_pred Hh--cccc---------ccccccCCCCCCC---hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LA--GQLH---------CVLDKRVGPPELN---EAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~--~~~~---------~~~d~~~~~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. .... ..+.......... .....+.+.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0000 0000000000000 01235667899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=285.90 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=199.5
Q ss_pred eeeeccCCcEEEEEEE-EcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEEEEEEe
Q 042346 506 ENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
.+.||+|+|+.|-.+. ..++.++|||++.+.+ ...+..+.+|++++...+ |+||++|+++|+++...|||||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC-----chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 4689999999999986 5689999999987643 234557789999999985 99999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC---cEEEEeeccc
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW---TARVSDFGLS 660 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DfGla 660 (812)
|.+|+|..+|+++.... ..+.-++..+|+.||.|||.++ |.||||||+|||..+.. -+||+||.|.
T Consensus 158 m~GGplLshI~~~~~F~--------E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKHFN--------EREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred ccCchHHHHHHHhhhcc--------HHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccc
Confidence 99999999998776543 2344579999999999999999 99999999999996554 4899999987
Q ss_pred ccCCCCcc-----cccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCC---C----
Q 042346 661 LLGSECDQ-----EFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS---G---- 723 (812)
Q Consensus 661 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~---~---- 723 (812)
.-...... .......+|+..|||||+.. ...|+.+-|.||||||||-||+|..||......+ +
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 43221111 11223568999999999763 3568999999999999999999999997643211 1
Q ss_pred CchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
-..-.+.....+.+|+ ...|+.....+..+-.+|+...|..|+.+|.++.+++.
T Consensus 307 Cr~CQ~~LFesIQEGk--------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGK--------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cHHHHHHHHHHHhccC--------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1112233333344444 33444445677788889999999999999999999887
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.22 Aligned_cols=275 Identities=21% Similarity=0.341 Sum_probs=197.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
.++|++.++||+|+||.||++++. +++.||+|++.... .......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 467999999999999999999864 68999999875311 1223445778999999999999999999876543
Q ss_pred --eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 576 --ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 576 --~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
..++++||+.+ +|.+++.... +++.....++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~~~---------l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKTQH---------LSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred cceEEEEehhccc-CHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEE
Confidence 47999999975 8888875432 256677889999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc-ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 654 VSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
|+|||++......... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~----~~~~~~~ 222 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY----LHQLNLI 222 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 9999998754332211 11233568999999998754 5688999999999999999999999853221 0000000
Q ss_pred HHHHHh---cccccccc-------ccCC-CCCCC----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHHhc
Q 042346 732 VSQILA---GQLHCVLD-------KRVG-PPELN----EAEAVELLATTAIHCVNLEGKERPNITDIVAN--LERALAIC 794 (812)
Q Consensus 732 ~~~~~~---~~~~~~~d-------~~~~-~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~~~ 794 (812)
...... ..+..+.+ .... .+... .......+.+++.+||+.+|++|||+.|++++ ++...+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~ 302 (336)
T cd07849 223 LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS 302 (336)
T ss_pred HHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCC
Confidence 000000 00000000 0000 00000 01234568899999999999999999999998 67665543
Q ss_pred c
Q 042346 795 Q 795 (812)
Q Consensus 795 ~ 795 (812)
.
T Consensus 303 ~ 303 (336)
T cd07849 303 D 303 (336)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.30 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=190.4
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~l 579 (812)
+|...+.||+|+||.||++.+. +++.+|+|++..... ......+.+|+.++.++. |+||+++++++..+...++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC----hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 4556789999999999999874 589999998763211 134556788999999996 9999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+|||+.. +|.++....... ....+++....+++.+++.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEV---LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred EEecccC-CHHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecc
Confidence 9999864 555543211000 001235677789999999999999975 6 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccC---cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMN---VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
++....... ......++..|+|||++... .++.++||||||+++|||++|+.||.... ...+. ....
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~-~~~~ 223 (288)
T cd06616 154 ISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQ-LTQV 223 (288)
T ss_pred hhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHH-Hhhh
Confidence 986543211 12334688899999998765 68999999999999999999999985322 11111 1111
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+. .+.+. ......++..+.+|+.+||+.||++|||++||+.+
T Consensus 224 ~~~~-----~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 224 VKGD-----PPILS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCC-----CCcCC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 01111 11113356678899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.15 Aligned_cols=283 Identities=21% Similarity=0.301 Sum_probs=203.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
.++|.+.+.||+|+||.||+++.. +++.||||.+..... .......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 457999999999999999999864 589999998753211 1222345678999999999999999999886543
Q ss_pred --eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 576 --ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 576 --~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
..++||||+. ++|.+++..... ++......++.|++.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQT--------LSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEE
Confidence 4799999996 689998865432 255677889999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|+|||++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...+. ........
T Consensus 149 L~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~ 222 (337)
T cd07858 149 ICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY----VHQLKLIT 222 (337)
T ss_pred ECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHH
Confidence 99999997654322 12234467889999998864 5688999999999999999999999854321 00000000
Q ss_pred HH-----------HHhcccccccccc--CCCC--CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHHhcc
Q 042346 733 SQ-----------ILAGQLHCVLDKR--VGPP--ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN--LERALAICQ 795 (812)
Q Consensus 733 ~~-----------~~~~~~~~~~d~~--~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~~~~ 795 (812)
.. +......+.+... ...+ ......+...+.+++.+||+.+|++|||++|++++ ++.+.+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred HHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 00 0000000000000 0000 00012345668899999999999999999999998 777666555
Q ss_pred cCCCCCCC
Q 042346 796 DCSCTDSF 803 (812)
Q Consensus 796 ~~~~~~~~ 803 (812)
....+.++
T Consensus 303 ~~~~~~~~ 310 (337)
T cd07858 303 EPVCQTPF 310 (337)
T ss_pred CccCCCcc
Confidence 54444443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=305.34 Aligned_cols=263 Identities=20% Similarity=0.235 Sum_probs=191.8
Q ss_pred ceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEe
Q 042346 504 SLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 504 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
.+.+.+|.|+++.||+++. +++.||+|++.... ...+....+.+|+++++.++|+||+++++++.+++..+++|||
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccc---cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 3445556666666666655 68999999986421 1233456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccC
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
+++++|.+++....... ++......++.|+++||+|||+++ |+||||||+|||++.++.+||+||+.+...
T Consensus 81 ~~~~~l~~~l~~~~~~~------~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 81 MAYGSCEDLLKTHFPEG------LPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred cCCCCHHHHHHHhcccC------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceee
Confidence 99999999997643221 245566789999999999999998 999999999999999999999999988643
Q ss_pred CCCcc-----cccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 664 SECDQ-----EFISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 664 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
..... ........++..|+|||++.. ..++.++||||||+++|||++|+.||....... ...+ . .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~----~-~ 223 (314)
T cd08216 152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLE----K-V 223 (314)
T ss_pred ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----H-H
Confidence 32111 111233457789999999875 358899999999999999999999986432110 1111 1 1
Q ss_pred hccccccccc----------------------cCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 737 AGQLHCVLDK----------------------RVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 737 ~~~~~~~~d~----------------------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.+.....++. ....+..........+.+++.+||..||++|||+++++++-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 224 RGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred hccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 1111110000 00011112234456788999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=291.58 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=200.9
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||+++.. +++.+++|++.... ........+.+|+++++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS---MSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh---ccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 4888999999999999999764 67899999876321 1223345677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++....... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKR----KLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccch
Confidence 99999999999987632111 12367778899999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
...... ......++..|++||.+.+..++.++|+||||+++|||++|+.||..... .+ ....+..+..
T Consensus 151 ~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~-~~~~~~~~~~ 218 (256)
T cd08530 151 KVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-------QD-LRYKVQRGKY 218 (256)
T ss_pred hhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH-HHHHHhcCCC
Confidence 765442 22334678899999999988899999999999999999999999853321 11 1111111111
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+.. .......+.+++.+|+..+|++||++.|++++
T Consensus 219 ----------~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 ----------PPI-PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----------CCC-chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111 12456678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.78 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=202.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
...|.+...||+|.|+.|.++++. .+.+||||.+.+.. .+....+.+.+|+++|+.|+|||||+++.+.+....+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~---ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ---LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc---cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 456999999999999999999864 58999999987532 22333445889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+.+|.+++||.++....+ .....++.|+.++++|+|+++ |+|||||.+||||+.+.++||+|||
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e--------~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKE--------KEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred EEEEeccCchhHHHHHhcccchh--------hhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccc
Confidence 99999999999999998876553 233568999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCC-CcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLT-AKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++.++.. ........|++.|.|||++.+..|+ ++.|+||+|++||-|+.|..||....-.. + ..
T Consensus 201 fS~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~----L----r~---- 265 (596)
T KOG0586|consen 201 FSTFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE----L----RP---- 265 (596)
T ss_pred cceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc----c----cc----
Confidence 9987653 3345677899999999999987764 78999999999999999999996433111 0 11
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+++-.++..+.. +.....+|++++|-.+|.+|++++++.++
T Consensus 266 ----rvl~gk~rIp~~----ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 266 ----RVLRGKYRIPFY----MSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ----hheeeeecccce----eechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111112222222 23346678888999999999999999875
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=293.53 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=184.7
Q ss_pred eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHH-HHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELAL-LSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
+.||+|+||.||+|... +++.||+|++..... ........+..|..+ ...++|+|++++++++..++..++||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 57999999999999874 588999998753211 112222334445444 44558999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++..... ++.....+++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 80 ~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 80 NGGDCASLIKTLGG--------LPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999999975432 245667789999999999999998 9999999999999999999999999986543
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
. .....++..|++||.+.+..++.++||||||+++|||++|..||..... . .....+..+..
T Consensus 149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~----~~~~~~~~~~~---- 210 (260)
T cd05611 149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----D----AVFDNILSRRI---- 210 (260)
T ss_pred c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----H----HHHHHHHhccc----
Confidence 2 2234678899999999888899999999999999999999999853221 1 11111211111
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+......++..+.+++.+||..+|++||++.++.+.
T Consensus 211 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 211 ----NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred ----CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 11111112345668899999999999999977544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=279.01 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=190.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~ 578 (812)
++++.+..||.|..|.||+++++ .|...|||.+... .+.++.+++...+.++.+-+ .|.||+.+|||..+...+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt----~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT----GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc----CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 34555678999999999999875 4889999998643 23445566777777766654 899999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+.||.|.. .+..+|...... .+....=++...+.+||.||.++. +|+|||+||+|||+|+.|++||+|||
T Consensus 168 IcMelMs~-C~ekLlkrik~p-------iPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 168 ICMELMST-CAEKLLKRIKGP-------IPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred HHHHHHHH-HHHHHHHHhcCC-------chHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccc
Confidence 99999843 555555443221 122333478889999999999887 49999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCcccccc---CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVM---NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
++-++-+ ....+...|-+.|||||.+.- ..|+-++||||||+.|+||.||+.||.... ..++.. ..+
T Consensus 238 IsGrlvd---SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~---tdFe~l----tkv 307 (391)
T KOG0983|consen 238 ISGRLVD---SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK---TDFEVL----TKV 307 (391)
T ss_pred ccceeec---ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC---ccHHHH----HHH
Confidence 9965433 234566789999999999863 468999999999999999999999985533 222222 222
Q ss_pred HhccccccccccCCCCCCCh-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNE-AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
++. . +|.+.. ..+...+.+++..||.+|+.+||...+++++
T Consensus 308 ln~--------e--PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 308 LNE--------E--PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Hhc--------C--CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 221 1 122222 2267778899999999999999999999875
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.31 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=201.8
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|+||.||++.+. +++.+++|++..... ..+....+.+|+++++.++|||++++++.+..++..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM---SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC---ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 4888999999999999999875 588999999864221 123455678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
+||+++++|.+++...... ...+++...+.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 78 ~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKE----GKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEecCCCcHHHHHHHhhcc----CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccce
Confidence 9999999999999765321 122467888999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
....... .......+++.|+|||.+....++.++||||||+++|+|++|+.||..... .. ..........
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~----~~~~~~~~~~ 220 (258)
T cd08215 151 KVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL----LE----LALKILKGQY 220 (258)
T ss_pred eecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH----HH----HHHHHhcCCC
Confidence 7654432 122334688999999999888899999999999999999999999743321 11 1111111111
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. + .......+.+++.+||..+|++|||+.|++++
T Consensus 221 ~~-----~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PP-----I------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CC-----C------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 0 11334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=302.32 Aligned_cols=269 Identities=23% Similarity=0.304 Sum_probs=195.2
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD- 575 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~- 575 (812)
...++|++.+.||+|+||.||+|.++ +++.|++|++..... .......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc---ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 34567999999999999999999985 588999999864221 1122346678999999999999999999987655
Q ss_pred ---------eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 576 ---------ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 576 ---------~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
..++|+||+++ +|.+++..... .+++...+.++.||+.||+|||+.+ |+||||||+||++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili 149 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLV-------HFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILL 149 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 68999999976 78777765421 2367788999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCc
Q 042346 647 DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL 725 (812)
Q Consensus 647 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~ 725 (812)
++++.+||+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+. .
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~----~ 224 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE----L 224 (302)
T ss_pred CCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----H
Confidence 9999999999999876543222 11223356788999998864 4578899999999999999999988854321 1
Q ss_pred hhHHHHHHHHHhccccc----c--------ccccCCCCC---CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHC----V--------LDKRVGPPE---LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~----~--------~d~~~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
........ ........ + .+....... ......+..+.+++.+||+.||.+||++++++++
T Consensus 225 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 225 AQLELISR-LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHHHH-HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111111 10000000 0 000000000 0001235668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=299.50 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=190.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
.++|++.+.||+|+||.||+++.. +++.||+|++...... ......+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc---CCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 346999999999999999999875 5889999987532211 112234567999999999999999999987654
Q ss_pred -----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 576 -----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 576 -----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
..++||||+.+ +|.+++..... .+++...++++.||+.||+|||+++ |+|+||||+|||++.++
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNV-------KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDG 156 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCC
Confidence 34999999964 88888865421 1367778899999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCccc--ccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 651 TARVSDFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
.+||+|||++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~----~~~ 232 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE----QHQ 232 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHH
Confidence 9999999999765432221 112234678899999988654 478899999999999999999988754321 111
Q ss_pred HHHHHHHHHhccccccccc---------cCCCCCCChH---------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 728 VEFAVSQILAGQLHCVLDK---------RVGPPELNEA---------EAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~---------~~~~~~~~~~---------~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... .+ .+.....+.+ .+..+..... .....+.+++.+||..||.+|||++|++++
T Consensus 233 ~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 233 LTLIS-QL-CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHH-HH-hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 11000 00 0100000000 0000000000 012456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.27 Aligned_cols=261 Identities=20% Similarity=0.223 Sum_probs=190.1
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeC--CeEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEK--DERL 578 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~--~~~~ 578 (812)
|++.+.||+|+||.||++... +++.+|+|++...... .......+|+.++.++. |+||+++++++.++ +..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS----LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC----chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 567899999999999999864 6889999987642111 11123456888888885 99999999999987 7889
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||++ ++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++. +.+||+|||
T Consensus 77 lv~e~~~-~~l~~~l~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 77 LVFELMD-MNLYELIKGRKR-------PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred EEEecCC-ccHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecc
Confidence 9999997 588888865431 2367888999999999999999998 999999999999999 999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccc-cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH-
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL- 736 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 736 (812)
++....... ......++..|+|||.+. ...++.++|||||||++|||++|+.||..... .+.+........
T Consensus 145 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~----~~~~~~~~~~~~~ 217 (282)
T cd07831 145 SCRGIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE----LDQIAKIHDVLGT 217 (282)
T ss_pred cccccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH----HHHHHHHHHHcCC
Confidence 997653321 122345788999999765 45678899999999999999999999854321 111111111000
Q ss_pred -----hccc--cccccccCCCCC-----CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 -----AGQL--HCVLDKRVGPPE-----LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 -----~~~~--~~~~d~~~~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... ....+....... ......+..+.+++.+||+.+|++||+++|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 000000000000 0012346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=297.02 Aligned_cols=265 Identities=22% Similarity=0.267 Sum_probs=194.5
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--CeEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--DERLL 579 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~l 579 (812)
|++.+.||+|+||.||+++.. +++.+++|++.... ........+.+|+++++.++|+|++++++++.+. +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 567899999999999999875 48899999987432 1122345678899999999999999999999988 78999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++ +|.+++..... .+++...+.++.||++||+|||+.+ ++|+||||+|||+++++.+||+|||+
T Consensus 78 v~e~~~~-~l~~~~~~~~~-------~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~ 146 (287)
T cd07840 78 VFEYMDH-DLTGLLDSPEV-------KFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGL 146 (287)
T ss_pred Eeccccc-cHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccc
Confidence 9999975 89988865421 2367778899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh-
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA- 737 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 737 (812)
+........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~----~~~~~~~~~~~~~ 221 (287)
T cd07840 147 ARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL----EQLEKIFELCGSP 221 (287)
T ss_pred eeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCC
Confidence 976544321 11233456889999998764 45789999999999999999999998543321 111111110000
Q ss_pred --ccc---cc-----cccccCCCCCCC---hHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 --GQL---HC-----VLDKRVGPPELN---EAE-AVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 --~~~---~~-----~~d~~~~~~~~~---~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... .. ........+... ... .+..+.+++.+||+.+|++||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000 00 000000000000 011 25568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=297.37 Aligned_cols=259 Identities=24% Similarity=0.268 Sum_probs=196.3
Q ss_pred CcceeeeeccCCcEEEEEEEE----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 502 NFSLENKVGIGSFGTVYKGKL----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
+|++.+.||+|+||.||+++. .+++.||||++..... .........+.+|++++.++ +||||+++++.+..+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 478899999999999999975 2578899998763211 11123345678899999999 59999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++++|.+++..... +++...+.++.|++++|.|||+.+ ++||||||+|||++.++.++|+|
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREH--------FTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCC--------cCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEE
Confidence 9999999999999999865322 255667789999999999999988 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCc--CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV--LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
||++........ .......++..|+|||.+.+.. .+.++||||||+++|||++|+.||....... ...+ ....
T Consensus 149 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~-~~~~ 223 (288)
T cd05583 149 FGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSE-ISRR 223 (288)
T ss_pred Cccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHH-HHHH
Confidence 999876443221 1122346889999999987654 7889999999999999999999985322111 1111 1111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.... ....+ ..+...+.+++.+||+.||++|||++++.+.|+.
T Consensus 224 ~~~~--------~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 ILKS--------KPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHcc--------CCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111 11111 2234557889999999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=297.20 Aligned_cols=256 Identities=24% Similarity=0.300 Sum_probs=194.0
Q ss_pred CcceeeeeccCCcEEEEEEEE----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 502 NFSLENKVGIGSFGTVYKGKL----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
+|++.+.||+|+||.||+++. .+++.||+|++..... .......+.+.+|+++++++ +|+||+++++.+..+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 478899999999999999986 3688999999853211 11122345678899999999 59999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++++|.+++..... +.+.....++.|++++|.|||+.+ ++||||||+|||++.++.+||+|
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~--------l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRER--------FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEee
Confidence 9999999999999999975432 245666778889999999999988 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
||++........ .......++..|+|||.+.. ..++.++||||||+++|||++|+.||....... ...+ ....
T Consensus 149 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~-~~~~ 223 (290)
T cd05613 149 FGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAE-ISRR 223 (290)
T ss_pred Cccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHH-HHHH
Confidence 999876433211 11223468899999999875 347889999999999999999999985332211 1111 1111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
.... ... ....+...+.+++.+||+.||++|| ++++++.+
T Consensus 224 ~~~~--------~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 224 ILKS--------EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred hhcc--------CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1111 000 1123455678999999999999997 78888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=294.42 Aligned_cols=249 Identities=27% Similarity=0.342 Sum_probs=193.4
Q ss_pred eccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCC
Q 042346 509 VGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNG 587 (812)
Q Consensus 509 LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 587 (812)
||+|+||.||++++.+ ++.+++|++.... .......+.+.+|++++++++||||+++++.+..++..+++|||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh--hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 6899999999999864 8999999886421 222345567889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCc
Q 042346 588 ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667 (812)
Q Consensus 588 sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~ 667 (812)
+|.+++..... +++..+++++.|++.+|+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 79 ~L~~~l~~~~~--------~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 79 DLASLLENVGS--------LDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred cHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 99999976431 256777899999999999999998 9999999999999999999999999986543321
Q ss_pred c------cccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 668 Q------EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 668 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
. ........++..|++||.+....++.++||||||+++|||++|+.||..... +........+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~-- 217 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILNGK-- 217 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCC--
Confidence 1 1122344678899999999888899999999999999999999999854321 11111111111
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
...+.. ...+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 218 ------~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 ------IEWPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ------cCCCcc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111111 113566889999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=288.62 Aligned_cols=209 Identities=24% Similarity=0.348 Sum_probs=171.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe-C
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE-K 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~ 574 (812)
..|+....||+|.||.||+|...+ .+.+|+|+++...+.. ......-+|+.+++.++||||+.|..+|.. +
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t---GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT---GISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC---CcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 458889999999999999995422 3478999987532211 112345689999999999999999999877 6
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC----C
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN----W 650 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~----~ 650 (812)
...+|++||.+. +|.+.|+-+..... ..++-.+...|+.||+.|+.|||++. |+||||||.|||+..+ |
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~---~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKA---KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchh---ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccC
Confidence 778999999987 99999986655433 23356777899999999999999999 9999999999999877 9
Q ss_pred cEEEEeecccccCCCCcccc-cccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCC
Q 042346 651 TARVSDFGLSLLGSECDQEF-ISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNE 719 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~ 719 (812)
.+||+|||+++++...-... .....+-|..|+|||.+.+ +.||++.|||+.|||+.||||-++.|...+
T Consensus 174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999999999876654443 4566788999999999986 579999999999999999999988876543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=310.13 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=200.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC--C--cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD--G--REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~--g--~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
+++.+.++||+|.||.|++|.|.. | ..||||.+..... .....+|.+|+.+|.+|+|||+++|||...+ ..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l----~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL----NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc----chhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 456778999999999999999853 3 4689999864322 2256789999999999999999999999887 66
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
..||||+++.|+|.+.|++.... .+.......++.|||.||.||..++ +|||||..+|+||-....+||+|
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~------~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKA------ILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred hhHHhhhcccchHHHHHhhcccc------ceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeec
Confidence 88999999999999999872221 2234556789999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccc-cccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSECDQEFIS-TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||.+.+...+..+.. ....-...|.|||.+..+.++.++|||+|||+||||+| |..|+.... ..++.+ .
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----g~qIL~----~ 327 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----GIQILK----N 327 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC----HHHHHH----h
Confidence 9999977665554433 33455678999999999999999999999999999999 455653322 112211 1
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
+.+ .+++..| ..+++.|.+++++||..+|++|||+..|.+.+
T Consensus 328 iD~-------~erLpRP----k~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 328 IDA-------GERLPRP----KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccc-------cccCCCC----CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 111 1234444 34566788899999999999999999998554
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.02 Aligned_cols=264 Identities=22% Similarity=0.290 Sum_probs=193.0
Q ss_pred cceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc---cCCCceEEEEEEEeCCe--
Q 042346 503 FSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRV---HHKHLVGLVGFCQEKDE-- 576 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~~~-- 576 (812)
|++.+.||+|+||.||+++++. ++.+|+|++..... .......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 6678999999999999999864 89999999864222 112233455677776665 59999999999988776
Q ss_pred ---EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 577 ---RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 577 ---~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
.+++|||+.+ +|.+++...... .+++..++.++.|+++||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 78 ~~~~~l~~e~~~~-~l~~~l~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 78 ELKLTLVFEHVDQ-DLATYLSKCPKP------GLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred CceeEEEehhccc-CHHHHHHHccCC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEE
Confidence 8999999974 899988754321 2367888999999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... +.......
T Consensus 148 l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~----~~~~~~~~ 220 (287)
T cd07838 148 IADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA----DQLDKIFD 220 (287)
T ss_pred EeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH----HHHHHHHH
Confidence 99999987653321 122335788999999999888999999999999999999998887543211 11111111
Q ss_pred HHHh-cccc---c------cccccC-CCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILA-GQLH---C------VLDKRV-GPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~-~~~~---~------~~d~~~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... .... . .+.... ........+....+.+++.+||+.||++||+++|++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000 0000 0 000000 00011112445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=304.18 Aligned_cols=261 Identities=18% Similarity=0.255 Sum_probs=190.5
Q ss_pred eeeeccC--CcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEE
Q 042346 506 ENKVGIG--SFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 506 ~~~LG~G--~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 582 (812)
.+.||+| +|++||++++. +++.||+|++..... ..+..+.+.+|+.+++.++||||++++++|..++..++|||
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 3567777 89999999874 689999999764221 12344678889999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
|+.+++|.+++....... +++.....++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+....
T Consensus 80 ~~~~~~l~~~l~~~~~~~------~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 80 FMAYGSANSLLKTYFPEG------MSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred cccCCCHHHHHHhhcccC------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 999999999997653221 256667789999999999999988 99999999999999999999999986532
Q ss_pred CCCCccc-----ccccccccCCCccCccccccC--cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 663 GSECDQE-----FISTKAVGTVGYIDPEYYVMN--VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 663 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
....... .......++..|+|||++.+. .++.++||||||+++|||++|+.||....... . ....+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~----~~~~~ 223 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---M----LLQKL 223 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH---H----HHHHh
Confidence 2111110 001112356679999998763 47899999999999999999999985432100 0 00000
Q ss_pred Hhcc------------------------------------ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC
Q 042346 736 LAGQ------------------------------------LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN 779 (812)
Q Consensus 736 ~~~~------------------------------------~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 779 (812)
.... ...+.+..+. ..........+.+|+.+||+.||++|||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpt 301 (328)
T cd08226 224 KGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPS 301 (328)
T ss_pred cCCCCCCccccccchhhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCC
Confidence 0000 0000001111 1112446677899999999999999999
Q ss_pred HHHHHHHH
Q 042346 780 ITDIVANL 787 (812)
Q Consensus 780 ~~evl~~L 787 (812)
++|++++-
T Consensus 302 a~e~l~~~ 309 (328)
T cd08226 302 ASSLLSHA 309 (328)
T ss_pred HHHHhhCH
Confidence 99998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.17 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=192.5
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|...+.||+|+||.||+|+.. +++.|++|++..... ........+.+|+++++.++|||++++++++.+.+..++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc--CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 666788999999999999864 588999998864222 12233456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+. ++|.+++..... .+++..++.++.||+.+|.|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 101 e~~~-~~l~~~l~~~~~-------~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 101 EYCL-GSASDLLEVHKK-------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred ecCC-CCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 9996 588888764332 1367778899999999999999998 9999999999999999999999999885
Q ss_pred cCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
.... .....++..|+|||++. ...++.++||||||+++|||++|+.||..... ..... .....
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~----~~~~~----~~~~~ 235 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALY----HIAQN 235 (313)
T ss_pred ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHH----HHHhc
Confidence 4322 22346888999999984 45688899999999999999999999854321 11111 11111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. .+..........+.+++.+||+.+|.+||++.+++.+
T Consensus 236 ~----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 D----------SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C----------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 0111122334568899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=289.60 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=199.3
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|++.+.||+|.||.||+++.. +++.+++|.+...... ......+.+|++++++++|+|++++++++.+++..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC---HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 4788999999999999999875 5789999998653221 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++.... .+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 78 ~e~~~~~~L~~~~~~~~--------~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 78 LEYAENGSLRQIIKKFG--------PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EecCCCCcHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccc
Confidence 99999999999997542 1367788899999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
......... .....++..|+|||.+....++.++|||+||+++|||++|+.||..... ...... .....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~-~~~~~- 215 (254)
T cd06627 147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFR-IVQDD- 215 (254)
T ss_pred eecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHH-HhccC-
Confidence 765443221 2334678899999999887889999999999999999999999853221 111111 11111
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... .+....+.+.+++.+||..+|++|||+.|++.+
T Consensus 216 ------~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 216 ------HPP----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ------CCC----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 000 112335568899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=296.36 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=197.8
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|+..+.||+|++|.||++... +++.+++|++..... .......+.+|++++++++|+||+++++++.+++..++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE---SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 566789999999999999874 688999998764221 1133456778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++ +|.+++..... .+++..++.++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||.+.
T Consensus 78 e~~~~-~l~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 78 EFMDT-DLYKLIKDRQR-------GLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred eccCC-CHHHHHHhhcc-------cCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 99975 89888866431 2367788899999999999999998 9999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc--
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG-- 738 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 738 (812)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... .+........+...
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~ 220 (283)
T cd05118 147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE----IDQLFKIFRTLGTPDP 220 (283)
T ss_pred ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCch
Confidence 654432 122334678899999998776 789999999999999999999988854321 11111111110000
Q ss_pred -ccccc-----------ccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 -QLHCV-----------LDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 -~~~~~-----------~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+... .+...........+.+..+.+++.+||+.||.+||++++++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 0000000011123467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=299.16 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=192.1
Q ss_pred eeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 506 ENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
..+||+|+||.||++..+ +++.|++|++... .......+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 468999999999999874 6899999987531 1234556888999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
++++|.+++.... +++...+.++.|++.+|+|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 100 ~~~~L~~~~~~~~---------~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 100 EGGALTDIVTHTR---------MNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167 (292)
T ss_pred CCCcHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecc
Confidence 9999999885432 256677889999999999999998 9999999999999999999999999886543
Q ss_pred CCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccc
Q 042346 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVL 744 (812)
Q Consensus 665 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (812)
.... ......++..|++||.+....++.++||||||+++|||++|+.||..... .... ..+.. .+
T Consensus 168 ~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~----~~~~~-~~---- 232 (292)
T cd06657 168 KEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAM----KMIRD-NL---- 232 (292)
T ss_pred cccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH----HHHHh-hC----
Confidence 3211 12334688999999999888889999999999999999999999853221 1111 11111 10
Q ss_pred cccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 745 DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 745 d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... ........+.+++.+||+.+|.+||++.|++++
T Consensus 233 ~~~~~----~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 233 PPKLK----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CcccC----CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 11110 112234457788999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=307.47 Aligned_cols=268 Identities=19% Similarity=0.312 Sum_probs=195.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe----CC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE----KD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~ 575 (812)
.+|++.+.||+|+||.||++... +++.|++|++..... .......+.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 67999999999999999999864 589999998864211 12234566789999999999999999998763 34
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+. ++|.+++..... +++....+++.||+.||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQP--------LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEec
Confidence 5799999996 689999864432 366778899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCccc--ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 656 DFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 656 DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|||++......... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..... ........
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~----~~~~~~~~ 225 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY----VHQLKLIL 225 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh----HHHHHHHH
Confidence 99998654332211 11234478899999998865 4688999999999999999999999854221 11111000
Q ss_pred H-----------HHHhccccccccccCCCCCCC----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 733 S-----------QILAGQLHCVLDKRVGPPELN----EAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 733 ~-----------~~~~~~~~~~~d~~~~~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
. ......+.+..+......... ....+..+.+++.+||+.+|++||++++++.+-
T Consensus 226 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred HHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0 000000111010000000110 122456789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.85 Aligned_cols=250 Identities=23% Similarity=0.242 Sum_probs=188.9
Q ss_pred HHHHHhcCCcceeeee--ccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEE
Q 042346 494 SELAAATNNFSLENKV--GIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVG 569 (812)
Q Consensus 494 ~el~~~~~~~~~~~~L--G~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~ 569 (812)
.+.....++|++.+.+ |+|+||.||++..+ +++.+++|....... . . .|+.....+ +||||+++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~----~----~--~e~~~~~~~~~h~~iv~~~~ 76 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF----N----A--IEPMVHQLMKDNPNFIKLYY 76 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc----c----h--hhHHHHHHhhcCCCEEEEEE
Confidence 3444445667777776 99999999999864 578899998753110 0 0 122222222 7999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC
Q 042346 570 FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 570 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 649 (812)
.+..++..++||||+++++|.+++.... .+++...+.++.|+++||.|||+.+ |+||||||+||+++.+
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 77 SVTTLKGHVLIMDYIKDGDLFDLLKKEG--------KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRA 145 (267)
T ss_pred EEecCCeeEEEEEcCCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCC
Confidence 9999999999999999999999997653 2367888899999999999999998 9999999999999999
Q ss_pred C-cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 650 W-TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 650 ~-~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
+ .++|+|||++...... ....++..|+|||++.+..++.++||||||+++|||++|+.||..... ...+..
T Consensus 146 ~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~ 217 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLE 217 (267)
T ss_pred CCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHH
Confidence 8 9999999998654321 234688999999999988899999999999999999999999864322 111111
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-ITDIVAN 786 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~~ 786 (812)
.+.. ... ... .........+.+++.+||+.+|.+||+ ++|++++
T Consensus 218 ~~~~--~~~--------~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 218 SLLK--RQQ--------KKL----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHH--hhc--------ccC----CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 1111 000 111 111245566889999999999999995 6998853
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.05 Aligned_cols=254 Identities=23% Similarity=0.390 Sum_probs=190.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~ 577 (812)
.++|++.+.||+|+||.||++.+++ ++.||||++..... ......+.+|+.++.++. ||||+++++++.++...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 3568889999999999999999865 89999999864221 223345566777666664 99999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
+++|||+. ++|.+++..... .+++..+.+++.|++++|+|||+. + |+||||||+|||+++++.+||+|
T Consensus 90 ~~v~e~~~-~~l~~l~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~d 158 (296)
T cd06618 90 FICMELMS-TCLDKLLKRIQG-------PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCD 158 (296)
T ss_pred EEEeeccC-cCHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECc
Confidence 99999985 477777654321 236777889999999999999974 5 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCc----CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV----LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||++........ .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... .. + ..
T Consensus 159 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~---~-~~ 228 (296)
T cd06618 159 FGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT---EF---E-VL 228 (296)
T ss_pred cccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh---HH---H-HH
Confidence 999865433211 12335788999999987553 78899999999999999999999843211 01 1 11
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
......... .+.. .....+.+.+++.+||..||++||++++++++-
T Consensus 229 ~~~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 229 TKILQEEPP-----SLPP----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HHHhcCCCC-----CCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 111111110 0110 112345688999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=295.52 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=200.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~ 578 (812)
++|.+.+.||+|+||.||++... +++.|++|++.... .........+.+|++++++++ ||||+++++++.+++..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ--LIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHh--ccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 46899999999999999999875 68999999875411 122334467888999999998 999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++.... .+++...+.++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 79 lv~e~~~~~~L~~~l~~~~--------~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYG--------SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred EEEcCCCCCcHHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCc
Confidence 9999999999999997653 2367788999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCccc------------------ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCC
Q 042346 659 LSLLGSECDQE------------------FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720 (812)
Q Consensus 659 la~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 720 (812)
++......... .......++..|++||.+....++.++||||||++++||++|+.||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 98755432211 122234678899999999888899999999999999999999999854321
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI----TDIVAN 786 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~----~evl~~ 786 (812)
.. ........ ....+ ...++.+.+++.+||+.+|.+||++ +|++.+
T Consensus 228 ----~~----~~~~~~~~--------~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 ----YL----TFQKILKL--------EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ----HH----HHHHHHhc--------CCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 01 11111111 11111 2235568899999999999999999 777753
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=303.10 Aligned_cols=268 Identities=22% Similarity=0.308 Sum_probs=193.5
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe-C
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE-K 574 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~ 574 (812)
..+.++|++.+.||+|+||.||++... +++.||+|++..... .....+.+.+|+++++.++||||+++++++.. .
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS---TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 346788999999999999999999865 689999998753211 12234567789999999999999999999876 4
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
...+++|||+ +++|.++++... +.......++.|+++||.|||+.+ |+||||||+|||+++++.+||
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~~~---------~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l 149 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTSRP---------LEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKI 149 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEe
Confidence 5688999999 568998886432 134455678999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH----
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE---- 729 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~---- 729 (812)
+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......
T Consensus 150 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~ 223 (328)
T cd07856 150 CDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLG 223 (328)
T ss_pred CccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 999998653321 123467889999998765 578999999999999999999999885432100 000000
Q ss_pred ----HHHHHHHhccccccc-cccCCCCCCCh---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 730 ----FAVSQILAGQLHCVL-DKRVGPPELNE---AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 730 ----~~~~~~~~~~~~~~~-d~~~~~~~~~~---~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.....+......+.+ ......+.... ....+.+.++|.+||+.+|++|||+++++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 00000000000 1234678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=325.30 Aligned_cols=255 Identities=27% Similarity=0.370 Sum_probs=189.4
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe----
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE---- 573 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~---- 573 (812)
-.++|+.++.||+|+||.||+++.+ ||+.+|||++.... .......+.+|++.+.+|+|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 3456888899999999999999864 89999999987522 34456678899999999999999999875210
Q ss_pred -------------------------------------------------------------C------------------
Q 042346 574 -------------------------------------------------------------K------------------ 574 (812)
Q Consensus 574 -------------------------------------------------------------~------------------ 574 (812)
+
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence 0
Q ss_pred ------------------------------------CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHH
Q 042346 575 ------------------------------------DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618 (812)
Q Consensus 575 ------------------------------------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ 618 (812)
..+||-||||+.-.|.++++.+.... .-...++++.+
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-------~~d~~wrLFre 705 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-------QRDEAWRLFRE 705 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-------hhHHHHHHHHH
Confidence 01367889998888888887665432 12345689999
Q ss_pred HHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC----CCc------------ccccccccccCCCcc
Q 042346 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS----ECD------------QEFISTKAVGTVGYI 682 (812)
Q Consensus 619 ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~----~~~------------~~~~~~~~~gt~~y~ 682 (812)
|+.||.|+|+++ ||||||||.||+||++..+||+|||+|.... ..+ .....+..+||.-|+
T Consensus 706 IlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 706 ILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred HHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence 999999999999 9999999999999999999999999997621 000 011345678999999
Q ss_pred CccccccC---cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHH
Q 042346 683 DPEYYVMN---VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAV 759 (812)
Q Consensus 683 aPE~~~~~---~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 759 (812)
|||++.+. .|+.|+|+||||+||+||+. ||...++ -+ .+...+..+.+... +.+...+++
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME------Ra-~iL~~LR~g~iP~~-------~~f~~~~~~ 845 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME------RA-SILTNLRKGSIPEP-------ADFFDPEHP 845 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH------HH-HHHHhcccCCCCCC-------cccccccch
Confidence 99999754 59999999999999999994 5643221 11 12222333332221 112233444
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 760 ELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 760 ~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
. =+.+|.++++.||.+|||+.|+|.
T Consensus 846 ~-e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 846 E-EASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred H-HHHHHHHHhcCCCccCCCHHHHhh
Confidence 3 347889999999999999999884
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=307.06 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=195.3
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcE-EEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGRE-VAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~-vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
+.++..||.|+||.||+|..++... .|.|++.. ...+..++|.-||+||..++||+||+|++.|+.++.+|+..
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 5667889999999999998765444 45566543 33566778899999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
|||.||.....+-.-.. .+.-.+..-+++|++.+|.|||+++ |||||||..|||++-+|.++|+|||.+.
T Consensus 109 EFC~GGAVDaimlEL~r-------~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGR-------VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred eecCCchHhHHHHHhcc-------ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccc
Confidence 99999999888754433 2244566679999999999999999 9999999999999999999999999985
Q ss_pred cCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
..... ........|||+|||||+.. ..+|+.++||||||+.|.||..+.+|-.... .+.... .+.
T Consensus 179 Kn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVll-Kia 248 (1187)
T KOG0579|consen 179 KNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLL-KIA 248 (1187)
T ss_pred cchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHH-HHh
Confidence 43221 12234678999999999875 5689999999999999999999988853322 121111 111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. .-++....+..-...+.+++.+||.+||..||++.+++++
T Consensus 249 K---------SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 249 K---------SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred h---------cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1 1112222334455668899999999999999999999875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=296.98 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=193.5
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.|+..+.||+|+||.||+++.. +++.+++|.+..... ........+.+|+++++.++|+|++++++++......++|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc--cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 3777889999999999999875 578899998753211 1223345677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+. ++|.+++..... .+++..++.++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 94 ~e~~~-~~l~~~~~~~~~-------~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 162 (308)
T cd06634 94 MEYCL-GSASDLLEVHKK-------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (308)
T ss_pred EEccC-CCHHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccc
Confidence 99996 688888754322 1256677889999999999999988 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
..... .....++..|+|||.+. ...++.++||||||+++|||++|+.||..... .+ ....+..
T Consensus 163 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~-~~~~~~~ 228 (308)
T cd06634 163 SIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS-ALYHIAQ 228 (308)
T ss_pred eeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HH-HHHHHhh
Confidence 65432 22346788999999874 35678899999999999999999999754221 01 1111111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
+.. +..........+.+++.+||..+|++||++++++.+..
T Consensus 229 ~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 229 NES----------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cCC----------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 110 11112234566889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=303.74 Aligned_cols=283 Identities=24% Similarity=0.306 Sum_probs=206.5
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-----
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD----- 575 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 575 (812)
+|++.+.||.|+||.||+++.. +++.+++|++.... ......+.+.+|+++++.++|+||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc---ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 4888999999999999999875 48999999886421 11334457888999999999999999999998775
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..+++|||++ ++|.+++.... .+++..++.++.+|+.||+|||+.+ |+||||||+|||++.++.++|+
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~--------~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKSPQ--------PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred ceEEEecchh-hhHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEc
Confidence 6899999997 48999886543 2366777889999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCccc-ccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... +.......
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~ 221 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI----DQLNLIVE 221 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHH
Confidence 99999765443210 112334678899999999877 8899999999999999999999998543311 11110000
Q ss_pred HH-----------Hhcccccccc---ccCCCC-CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHHhccc
Q 042346 734 QI-----------LAGQLHCVLD---KRVGPP-ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN--LERALAICQD 796 (812)
Q Consensus 734 ~~-----------~~~~~~~~~d---~~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~~~~~ 796 (812)
.. ........+. .....+ .....+.+..+.+++.+||+.+|++||++++++++ +++..+...+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 222 VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred hcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 00 0000000000 000000 00011245668899999999999999999999986 6666555555
Q ss_pred CCCCCCC
Q 042346 797 CSCTDSF 803 (812)
Q Consensus 797 ~~~~~~~ 803 (812)
.+...++
T Consensus 302 ~~~~~~~ 308 (330)
T cd07834 302 PVAKPPF 308 (330)
T ss_pred CCCCCcc
Confidence 5544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.42 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=184.1
Q ss_pred eeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHH---HHHHHhccCCCceEEEEEEEeCCeEEEEEEe
Q 042346 508 KVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSE---LALLSRVHHKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 508 ~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~E---i~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
.||+|+||.||++... +++.||+|.+....... ......+..| +++++...||||+++++++.+.+..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeecccccc--chhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 4899999999999864 58899999876422111 1111223333 3445556899999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccC
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
+++++|.+++.... .+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 79 ~~g~~L~~~l~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 79 MNGGDLHYHLSQHG--------VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred CCCCcHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 99999999986432 2367888999999999999999988 999999999999999999999999998654
Q ss_pred CCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccc
Q 042346 664 SECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742 (812)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (812)
.... .....|+..|+|||.+... .++.++||||||+++|||++|+.||....... . .........
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~----~-~~~~~~~~~----- 213 (278)
T cd05606 148 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----K-HEIDRMTLT----- 213 (278)
T ss_pred CccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc----h-HHHHHHhhc-----
Confidence 3221 2234689999999998754 68999999999999999999999986532211 0 011111100
Q ss_pred cccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 743 VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 743 ~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
.... .+ ...+..+.+++.+|+..+|.+|| +++|++++
T Consensus 214 -~~~~--~~----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 214 -MAVE--LP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -cCCC--CC----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0111 11 12245688899999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=295.13 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=193.0
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV 580 (812)
|++.+.||+|+||.||+|+.. +++.|++|++..... ........+|+..+++++ |+||+++++++.+++..++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY----SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc----chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 567899999999999999985 478899998753211 112233456899999999 99999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+ +++|.+++..... ..+++..++.++.|++.+|.|||+.+ |+|+||||+||++++++.++|+|||++
T Consensus 77 ~e~~-~~~l~~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKG------KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred EecC-CCCHHHHHHhccc------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccc
Confidence 9999 7899999876541 12367888999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccc-cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh---------HHH
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV---------VEF 730 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~---------~~~ 730 (812)
....... ......++..|+|||++. ...++.++|+||||+++|||++|+.||............ ..+
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 147 REIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred eeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 7554321 123356788999999875 455789999999999999999999887543211100000 000
Q ss_pred HHHHHHhccccccccccCCCCCCC--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELN--EAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.........+...+..... .... .......+.+++.+||+.||++|||++|++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAP-TSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhHhhhhcccccccccccc-ccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0001111111111100000 0000 00113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >COG5184 ATS1 Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=285.15 Aligned_cols=241 Identities=20% Similarity=0.270 Sum_probs=196.2
Q ss_pred cceeEEeeCCceEEEEEeCCccceEEEccCCCc----------------------------cc--CCC------CccEEE
Q 042346 32 ASTAAIIYKTSTVCGIIAGESIQRIQCYQNGST----------------------------IP--VLP------NASFQA 75 (812)
Q Consensus 32 ~~~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~----------------------------~~--~~~------~~~~~~ 75 (812)
..++.+++|+.|+.+|..|| .+|.||.|.. .| ++. ..+|++
T Consensus 104 ~~i~~~acGg~hsl~ld~Dg---~lyswG~N~~G~Lgr~~~~~~~~~~~~~~~~~~~~~~~tP~~v~~~s~~~s~~~vv~ 180 (476)
T COG5184 104 ASIIKIACGGNHSLGLDHDG---NLYSWGDNDDGALGRDIHKDICDQNNDIIDFDDYELESTPFKVPGGSSAKSHLRVVK 180 (476)
T ss_pred eeeEEeecCCceEEeecCCC---CEEEeccCcccccccccccccccccccccccchhhcccCCceeeccccccCChheEE
Confidence 45778999999999999999 8999986543 11 111 126999
Q ss_pred EEccCceEEEEEeCCCeEEEccCCCCCCCCCC-----------CceecccCCceEEEEEccCceEEEEEeCCCeEEEecC
Q 042346 76 ISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQ-----------PKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRG 144 (812)
Q Consensus 76 i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~~-----------~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~ 144 (812)
++||+.++++|+++| .||.||.+..+.++.. ..++.++ ...++++|+|..|..+|+ .+|+||.||.
T Consensus 181 l~cg~e~svil~~~G-~V~~~gt~r~~e~~~g~~~~s~k~~~~~~p~~v~-~~~i~qla~G~dh~i~lt-~~G~vy~~Gs 257 (476)
T COG5184 181 LACGWEISVILTADG-RVYSWGTFRCGELGQGSYKNSQKTSIQFTPLKVP-KKAIVQLAAGADHLIALT-NEGKVYGWGS 257 (476)
T ss_pred eecCCceEEEEccCC-cEEEecCccccccccccccccccceeeeeeeecC-chheeeeccCCceEEEEe-cCCcEEEecC
Confidence 999999999999999 6999999888777744 4455443 458999999999999998 9999999999
Q ss_pred CCCCCCCCCcccCC--------CCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccc----------------c
Q 042346 145 TKVKDKGQLFSFSS--------PGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQR----------------G 200 (812)
Q Consensus 145 n~~gqlG~~~~~~~--------~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~----------------~ 200 (812)
|..||||..+.... +.....+..|+||.+|+.|| +++|++|+||.|-.+|.... .
T Consensus 258 ~qkgqlG~~~~e~~~~~~lv~~~f~i~~i~~vacG~~h~~al-~~~G~i~a~G~n~fgqlg~~~~~~~~a~~tk~~~~~~ 336 (476)
T COG5184 258 NQKGQLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDHSLAL-DEDGEIYAWGVNIFGQLGAGSDGEIGALTTKPNYKQL 336 (476)
T ss_pred CcccccCCchhhhcccccccCChhhhhhhhhcccCcceEEEE-cCCCeEEEeccchhcccccCcccccceeecccccccc
Confidence 99999998765432 11224577899999999999 99999999999776665543 2
Q ss_pred ccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCC-----------CCcceeeeeeeeccceeEEEEecCCeEEE
Q 042346 201 FKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPF-----------SSAFEFSGGLALGANFTCAIRQRSGLVAC 269 (812)
Q Consensus 201 ~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~-----------~~~~~~~~~ia~G~~ht~al~~~~g~v~~ 269 (812)
+.+..|.+|++|..|+.+|+.||.||.||++..||||.+. .........++||..|+.+.+. +|+||+
T Consensus 337 ~~~~~i~~is~ge~H~l~L~~~G~l~a~Gr~~~~qlg~~~~~~~~~~~~~~ls~~~~~~~v~~gt~~~~~~t~-~gsvy~ 415 (476)
T COG5184 337 LSGVTICSISAGESHSLILRKDGTLYAFGRGDRGQLGIQEEITIDVSTPTKLSVAIKLEQVACGTHHNIARTD-DGSVYS 415 (476)
T ss_pred CCCceEEEEecCcceEEEEecCceEEEecCCccccccCcccceeecCCccccccccceEEEEecCccceeecc-CCceEE
Confidence 2345589999999999999999999999999999999655 1111111259999999999996 699999
Q ss_pred ecCCCCCcccc
Q 042346 270 WGGTNRFEFDS 280 (812)
Q Consensus 270 WG~n~~gqlg~ 280 (812)
||+|++||||.
T Consensus 416 wG~ge~gnlG~ 426 (476)
T COG5184 416 WGWGEHGNLGN 426 (476)
T ss_pred ecCchhhhccC
Confidence 99999999996
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.08 Aligned_cols=256 Identities=26% Similarity=0.335 Sum_probs=194.2
Q ss_pred CcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|.+.+.||+|+||.||++++.. +..+++|.+...............+..|+++++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 48889999999999999998743 44566665543222222222334566799999999999999999999998899999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.+++....... ..+++...+.++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~ 152 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTG----KTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVS 152 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcc----cccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCce
Confidence 99999999999987532211 12477888999999999999999998 999999999999975 56999999998
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
........ ......++..|+|||.+....++.++|+||||+++|+|++|+.||.... ... .......+.
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~-~~~~~~~~~- 221 (260)
T cd08222 153 RLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLS-VVLRIVEGP- 221 (260)
T ss_pred eecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHH-HHHHHHcCC-
Confidence 76533221 2234467889999999988889999999999999999999999984221 111 111111111
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
....+...+..+.+++.+||+.+|++||++.|++++
T Consensus 222 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 ----------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ----------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 011123455678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.99 Aligned_cols=267 Identities=21% Similarity=0.294 Sum_probs=193.2
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
.++|...+.||+|+||.||+|++. +++.||+|++..... .......+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 468999999999999999999864 689999998764211 1222345778999999999999999999987543
Q ss_pred ---eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 576 ---ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 576 ---~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
..++|+||+.. +|.+++.. .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIMGH----------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred CCceEEEEeccccc-CHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 45899999964 77766521 1255677889999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .......
T Consensus 157 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~----~~~~~~~ 227 (342)
T cd07879 157 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQI 227 (342)
T ss_pred EEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 99999998754321 223467889999999876 4688999999999999999999999864321 1111111
Q ss_pred HHH-----------HHhcccccccc--ccCCCCCCC--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHH
Q 042346 732 VSQ-----------ILAGQLHCVLD--KRVGPPELN--EAEAVELLATTAIHCVNLEGKERPNITDIVAN--LERALA 792 (812)
Q Consensus 732 ~~~-----------~~~~~~~~~~d--~~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~ 792 (812)
... ........... ......... .......+.+++.+||+.||++||+++|++.+ ++...+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 00000000000 000000000 01234557899999999999999999999966 777654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=318.65 Aligned_cols=272 Identities=25% Similarity=0.389 Sum_probs=210.8
Q ss_pred HHHHhcCCcceeeeeccCCcEEEEEEEEc--------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCce
Q 042346 495 ELAAATNNFSLENKVGIGSFGTVYKGKLM--------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLV 565 (812)
Q Consensus 495 el~~~~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv 565 (812)
.++...++..+.+.||+|.||.|++|... ....||||.+.... .....+.+..|+++|+.+ +|+||+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~----~~~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA----SSSEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc----CcHHHHHHHHHHHHHHHhcCCcchh
Confidence 34445556667779999999999999743 14579999986422 224567889999999999 699999
Q ss_pred EEEEEEEeCCeEEEEEEecCCCchhhhhhcCC-CCCcccc-------ccccHHHHHHHHHHHHHHHHHHhhcCCCCeEee
Q 042346 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKN-NTEKNSS-------IVNSWKMRIRIALDAARGIDYLHNYAVPSIIHR 637 (812)
Q Consensus 566 ~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~-~~~~~~~-------~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHr 637 (812)
.++++|.++...++|+||++.|+|.+||+.++ ....... ..++....+.++.|||.|++||++.. +|||
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 99999999889999999999999999999877 1111111 23578889999999999999999998 9999
Q ss_pred ccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccc--cCCCccCccccccCcCCCcchhHHHHHHHHHHHcC-CCC
Q 042346 638 DIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV--GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG-KKA 714 (812)
Q Consensus 638 DlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG-~~p 714 (812)
||..+|||++++..+||+|||+++.....+.... .... -...|||||.+....|+.|+||||||++||||+|. ..|
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence 9999999999999999999999986555433321 1112 35579999999999999999999999999999994 455
Q ss_pred CCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 715 VFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
+.. ..........+..|. ++..|... ...+.++++.||+.+|++||++.|+.+.++..+.
T Consensus 522 Yp~-------~~~~~~l~~~l~~G~-------r~~~P~~c----~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 522 YPG-------IPPTEELLEFLKEGN-------RMEQPEHC----SDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCC-------CCcHHHHHHHHhcCC-------CCCCCCCC----CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 422 111112233444443 44444444 4446688889999999999999999999999765
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=301.19 Aligned_cols=268 Identities=22% Similarity=0.297 Sum_probs=192.8
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD- 575 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~- 575 (812)
...++|++.+.||+|+||.||++.. .+++.||||++.... ........+.+|++++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3567899999999999999999986 468999999875321 12223446778999999999999999999987654
Q ss_pred -----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 576 -----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 576 -----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
..++||||+ +++|.+++.... +++...+.++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~~---------l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~ 155 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHEK---------LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDC 155 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 358999999 679988885321 256777889999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
.+||+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+..
T Consensus 156 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07880 156 ELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230 (343)
T ss_pred CEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999998754321 123467889999999875 4588999999999999999999999864321100000000
Q ss_pred -------HHHHHHHhcccccccc--ccCCCCCC--ChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 730 -------FAVSQILAGQLHCVLD--KRVGPPEL--NEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 730 -------~~~~~~~~~~~~~~~d--~~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.....+.......... +....... ........+.+++.+|++.||++|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000 00000000 001234457899999999999999999999943
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=334.99 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=200.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
.+-+++...+||.|.||.||.|.. .+|+-.|+|-+..++.. ......+.+|+.++..|+|||+|+++|+-.+++..
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 344667788999999999999975 56888999987765544 33445677899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+|.||||++|+|.+.+...+...+ ..-..+-.|++.|++|||+++ ||||||||.||||+.+|.+|++||
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE--------~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDE--------MVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhh--------hHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecc
Confidence 999999999999999976543321 122347789999999999999 999999999999999999999999
Q ss_pred cccccCCCCccc--ccccccccCCCccCccccccC---cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 658 GLSLLGSECDQE--FISTKAVGTVGYIDPEYYVMN---VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 658 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|.|+.+....+. .......||+.|||||++.+. ....++||||+|||++||+||++|+...+.+ +.++-.
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~-- 1453 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYH-- 1453 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhH--
Confidence 999876654322 223467899999999999753 3456799999999999999999999654432 222211
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.-.|+ .|.. +..+..+=++++.+||..||++|.++.|++++
T Consensus 1454 --V~~gh----------~Pq~-P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 --VAAGH----------KPQI-PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --HhccC----------CCCC-chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11122 1121 22366677899999999999999988877765
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=300.18 Aligned_cols=270 Identities=21% Similarity=0.293 Sum_probs=196.7
Q ss_pred CHHHHHHhcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEE
Q 042346 492 TLSELAAATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGF 570 (812)
Q Consensus 492 ~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 570 (812)
...++....++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+.+|++++++++||||++++++
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc---hhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3456667789999999999999999999986 468899999886421 112234567789999999999999999998
Q ss_pred EEeC------CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCE
Q 042346 571 CQEK------DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNI 644 (812)
Q Consensus 571 ~~~~------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NI 644 (812)
+... ...+++++++ +++|.+++.... +++..+..++.|+++||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NI 151 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNL 151 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHE
Confidence 8643 2367888887 779988875432 256777889999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 645 LLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 645 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
++++++.+||+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 152 ll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~--- 223 (345)
T cd07877 152 AVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--- 223 (345)
T ss_pred EEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 999999999999999875432 1233467889999998866 5688999999999999999999999843221
Q ss_pred CchhHHHHHHHH-----------Hhc---cccccccccCCCCCCC--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 724 PLDVVEFAVSQI-----------LAG---QLHCVLDKRVGPPELN--EAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 724 ~~~~~~~~~~~~-----------~~~---~~~~~~d~~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
........... ... .+...+. ........ .......+.+++.+||+.||.+||++.+++.+=
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 224 -IDQLKLILRLVGTPGAELLKKISSESARNYIQSLT-QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred -HHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhc-ccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 11111000000 000 0000000 00000000 011244578999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.93 Aligned_cols=269 Identities=25% Similarity=0.300 Sum_probs=191.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
.++|++.+.||+|+||.||++++. +++.+++|++....... .....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD---GFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC---CcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 467999999999999999999875 58899999875422111 11234568999999999999999999875433
Q ss_pred -----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 576 -----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 576 -----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
..++||||+.. +|.+.+..... .+++.+...++.|++++|+|||+++ |+|+||||+|||+++++
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~-------~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~ 152 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSV-------KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQG 152 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 35899999965 77777754321 2367788899999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCccc---------ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCC
Q 042346 651 TARVSDFGLSLLGSECDQE---------FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 720 (812)
.+||+|||++......... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999754332211 11123467888999998765 4588999999999999999999998854321
Q ss_pred CCCCchhHHHHHHHHH---h------ccccccccccCC--CCCCC---hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 721 GSGPLDVVEFAVSQIL---A------GQLHCVLDKRVG--PPELN---EAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~---~------~~~~~~~d~~~~--~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. ...+....... . ..+....+.... .+... .......+.+++.+||+.||++|||+.|++.+
T Consensus 233 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 233 I----DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred H----HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1 11111110000 0 000000000000 00000 01223568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=305.67 Aligned_cols=273 Identities=23% Similarity=0.345 Sum_probs=201.4
Q ss_pred cceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC------
Q 042346 503 FSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD------ 575 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 575 (812)
+...+.||+|+||.||++++ ..|+.||||.+.... .....+...+|+++|++|+|+|||++++.-+...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 45578999999999999995 469999999986422 1223445678999999999999999999866544
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc--CCC--c
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD--VNW--T 651 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~--~~~--~ 651 (812)
...+|||||.+|||+..|....... -++-.+.+.++.++..||.|||+++ |+||||||.||++- .++ .
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~-----GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAY-----GLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred cceEEEeecCCCcHHHHhcCccccc-----CCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceE
Confidence 4589999999999999997654332 2355677899999999999999998 99999999999992 333 4
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
-||+|||.|+...+.. .....+||..|++||.+.. ..|+...|.|||||++||++||..||.....+.....++
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~-- 237 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM-- 237 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh--
Confidence 7999999999876643 4667899999999999984 889999999999999999999999997654433222222
Q ss_pred HHHHHHhc--cccccc----------cccCCCCCCChHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHHHHh
Q 042346 731 AVSQILAG--QLHCVL----------DKRVGPPELNEAEAVELLATTAIHCVNLEGKERP--NITDIVANLERALAI 793 (812)
Q Consensus 731 ~~~~~~~~--~~~~~~----------d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP--t~~evl~~Le~~~~~ 793 (812)
+..+... ...... ...++.+..........+-.++..+|..+|++|- ...+....+..++..
T Consensus 238 -~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 238 -WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred -hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 2221111 000111 1112223322334444555666778888888888 666777666666654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=321.85 Aligned_cols=148 Identities=28% Similarity=0.404 Sum_probs=128.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|.+.++||+|+||.||+|.+. +++.||||++..... ........+.+|+.++..++||||+++++++...+..+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc--cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 57999999999999999999875 589999999864221 123344678889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+.+++|.+++..... +.+...++|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 82 VmEy~~g~~L~~li~~~~~--------l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGY--------FDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred EEeCCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 9999999999999975432 245666889999999999999998 99999999999999999999999999
Q ss_pred cc
Q 042346 660 SL 661 (812)
Q Consensus 660 a~ 661 (812)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 85
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=300.73 Aligned_cols=269 Identities=22% Similarity=0.274 Sum_probs=192.1
Q ss_pred CCcc-eeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHH---------HHHHHHHHHHHHHhccCCCceEEEE
Q 042346 501 NNFS-LENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLRE---------KESAFDSELALLSRVHHKHLVGLVG 569 (812)
Q Consensus 501 ~~~~-~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~---------~~~~~~~Ei~~l~~l~H~nIv~l~~ 569 (812)
++|. +.+.||+|+||.||++.+. +++.||+|++........... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 4578999999999999865 689999998754322111000 1124678999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC
Q 042346 570 FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 570 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 649 (812)
++..++..++||||+. ++|.+++..... ++....+.++.|++.+|+|||+.+ |+|+||||+|||++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR--------LTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSK 155 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCC
Confidence 9999999999999997 699999865322 255677889999999999999998 9999999999999999
Q ss_pred CcEEEEeecccccCCCCc------------ccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCC
Q 042346 650 WTARVSDFGLSLLGSECD------------QEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVF 716 (812)
Q Consensus 650 ~~~kl~DfGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~ 716 (812)
+.+||+|||++....... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999987543110 01111233568889999998754 47899999999999999999999985
Q ss_pred CCCCCCCCchhHHHHHHHHHhccccccccccC-----------CCCCC--ChHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 042346 717 KNEDGSGPLDVVEFAVSQILAGQLHCVLDKRV-----------GPPEL--NEAEAVELLATTAIHCVNLEGKERPNITDI 783 (812)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-----------~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 783 (812)
.... .+.......... ......+.... .++.. ........+.+++.+||+.+|++|||++|+
T Consensus 236 ~~~~----~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 310 (335)
T PTZ00024 236 GENE----IDQLGRIFELLG-TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310 (335)
T ss_pred CCCH----HHHHHHHHHHhC-CCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence 4332 111111111110 00000000000 00000 001224567899999999999999999999
Q ss_pred HHH
Q 042346 784 VAN 786 (812)
Q Consensus 784 l~~ 786 (812)
+.+
T Consensus 311 l~~ 313 (335)
T PTZ00024 311 LKH 313 (335)
T ss_pred hcC
Confidence 974
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=297.09 Aligned_cols=266 Identities=23% Similarity=0.279 Sum_probs=188.9
Q ss_pred CcceeeeeccCCcEEEEEEEEc-C--CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeC---
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-D--GREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEK--- 574 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~--g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~--- 574 (812)
+|++.+.||+|+||.||+++.. . ++.||+|++.... ......+.+.+|+++++++ +||||+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 4788999999999999999874 3 6789999875321 1122345677899999999 599999999876432
Q ss_pred -CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 575 -DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 575 -~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
...++++||+. ++|.+++..... +++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRSGQP--------LTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEE
Confidence 34688899986 689999864332 256777889999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc--ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 654 VSDFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 654 l~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
|+|||++......... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ......
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~----~~~~~~ 221 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY----VDQLNQ 221 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH----HHHHHH
Confidence 9999999754432211 11233578999999998765 5689999999999999999999988754221 011110
Q ss_pred HH-----------HHHHhcccc---ccccccCCCC-CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 731 AV-----------SQILAGQLH---CVLDKRVGPP-ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 731 ~~-----------~~~~~~~~~---~~~d~~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ..+...... .........+ ..........+.+++.+||+.||++|||++|++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 222 ILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 000000000 0000000000 00001124568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=293.15 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=195.5
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|+..+.||+|.||.||+++.. +++.+++|++.... ......+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 566789999999999999875 48999999986432 11223456778999999999999999999999999999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||++ ++|.+++..... .+++..+++++.+++++|+|||+.+ |+||||+|+||++++++.+||+|||++.
T Consensus 78 e~~~-~~l~~~i~~~~~-------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 78 EYCD-MDLKKYLDKRPG-------PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred cCcC-cCHHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccc
Confidence 9997 599999976531 2367888999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH---h
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL---A 737 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~ 737 (812)
....... .......+..|+|||.+... .++.++||||||+++|||++|+.||..... ............ .
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 220 (282)
T cd07829 147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE----IDQLFKIFQILGTPTE 220 (282)
T ss_pred ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHHHhCCCcH
Confidence 6543221 22334567889999998766 789999999999999999999888754321 111111110000 0
Q ss_pred cc---cccc--ccccCCCC--C---CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQ---LHCV--LDKRVGPP--E---LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~---~~~~--~d~~~~~~--~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. +... .+...... . .........+.+++.+||..||++||++++++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 221 ESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 0000 00000000 0 0001225668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-33 Score=278.15 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=194.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|..+++||+|.||.|.+++-+ .++.+|+|++++... ..+++...-..|-++|+..+||.+..+.-.|+..+.+++
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi--iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI--IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe--eehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 45788999999999999999864 589999999875322 223334445678999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||..+|.|+-+|...+...+.+ ..-+-..|..+|.|||+++ ||.||||.+|+|+|+||++||+||||
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~R--------tRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDR--------TRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred EEEEccCceEeeehhhhhcccchh--------hhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeeccc
Confidence 999999999999997655433222 1235678999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
.+.... .........|||.|+|||++..+.|...+|.|.+||+||||+.|+.||...+.+ .....++.+
T Consensus 315 CKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--------kLFeLIl~e- 383 (516)
T KOG0690|consen 315 CKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--------KLFELILME- 383 (516)
T ss_pred chhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--------HHHHHHHhh-
Confidence 875332 233456789999999999999999999999999999999999999999754421 111122221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
.+..|.....+ -+.|+...|.+||.+|. .++||.++
T Consensus 384 -------d~kFPr~ls~e----AktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 -------DLKFPRTLSPE----AKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -------hccCCccCCHH----HHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 12223333333 44566678999999995 45555554
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=298.40 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=193.2
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe-
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE- 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~- 576 (812)
..++|++.+.||+|+||.||++++. +++.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 4678999999999999999999875 57899999875321 112233456789999999999999999988876554
Q ss_pred -----EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 577 -----RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 577 -----~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
.++|+||+ +++|.+++.... +++....+++.|++++|+|||+.+ |+||||||+||+++.++.
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~~---------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~ 156 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQK---------LSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCE 156 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCC
Confidence 79999999 569999986421 366778899999999999999998 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
+||+|||++...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||..... ......
T Consensus 157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~----~~~~~~ 227 (343)
T cd07851 157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH----IDQLKR 227 (343)
T ss_pred EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHH
Confidence 999999998754331 233467889999998865 4678999999999999999999999854321 111111
Q ss_pred HHHHH-------Hh----ccccccccc--cCCCCCCC--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 731 AVSQI-------LA----GQLHCVLDK--RVGPPELN--EAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 731 ~~~~~-------~~----~~~~~~~d~--~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... .. ......+.. ....+... .......+.+++.+||..+|++|||+.||+++
T Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 228 IMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 00 000000000 00000000 01125678899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=280.00 Aligned_cols=239 Identities=28% Similarity=0.336 Sum_probs=189.2
Q ss_pred eccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCC
Q 042346 509 VGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNG 587 (812)
Q Consensus 509 LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 587 (812)
||+|+||.||++... +++.+++|++.... .........+.+|+++++.++||||+++++.+..++..++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK--IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhh--hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 689999999999875 48899999876422 122234557888999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCc
Q 042346 588 ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667 (812)
Q Consensus 588 sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~ 667 (812)
+|.+++..... +++.....++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~L~~~l~~~~~--------l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 79 ELFSHLSKEGR--------FSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred cHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 99999976532 256777889999999999999988 9999999999999999999999999987654321
Q ss_pred ccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccccccc
Q 042346 668 QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKR 747 (812)
Q Consensus 668 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 747 (812)
.......++..|++||.+.+..++.++|+||||+++|||++|+.||...+. ......+... +
T Consensus 148 --~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~--------~ 209 (250)
T cd05123 148 --SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKD--------P 209 (250)
T ss_pred --CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcC--------C
Confidence 123345678899999999888889999999999999999999999854321 1111111111 1
Q ss_pred CCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHH
Q 042346 748 VGPPELNEAEAVELLATTAIHCVNLEGKERPNITD 782 (812)
Q Consensus 748 ~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 782 (812)
...+. ..+..+.+++.+||..||++||++.+
T Consensus 210 ~~~~~----~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 LRFPE----FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCC----CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11111 12456789999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=297.05 Aligned_cols=265 Identities=18% Similarity=0.266 Sum_probs=188.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK---- 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---- 574 (812)
..+|++.+.||+|+||.||+|... +++.|++|++..... +..+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 367999999999999999999874 588999998754321 2345677899999999999999999876543
Q ss_pred ----------CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCE
Q 042346 575 ----------DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNI 644 (812)
Q Consensus 575 ----------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NI 644 (812)
...++||||++ ++|.+++.... +++.....++.||+.||.|||+.+ |+||||||+||
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Ni 145 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQGP---------LSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANV 145 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHE
Confidence 34689999997 58988885432 245667789999999999999998 99999999999
Q ss_pred EEc-CCCcEEEEeecccccCCCCccc-ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCC
Q 042346 645 LLD-VNWTARVSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG 721 (812)
Q Consensus 645 Ll~-~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~ 721 (812)
|++ +++.+||+|||++......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......
T Consensus 146 li~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 225 (342)
T cd07854 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225 (342)
T ss_pred EEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 997 4567899999998754322111 11123467889999998654 56888999999999999999999998543211
Q ss_pred CCCchhHHHHHHH----------HHhccccccccccCCCCCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 722 SGPLDVVEFAVSQ----------ILAGQLHCVLDKRVGPPELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 722 ~~~~~~~~~~~~~----------~~~~~~~~~~d~~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......... .....+..........+.... ......+.+++.+||..||++|||++|++.+
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 226 ----EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ----HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000000 000000000000000000001 1234567899999999999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=293.68 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=197.0
Q ss_pred eeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 506 ENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
.+.||.|.||+||-|++ ++|+.||||++.+... ..+.+..+++|+.||+.++||.||.|.-.|+..+..++|||.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrF---p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRF---PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccC---CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 68999999999999987 4699999999875322 2344578899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC---CcEEEEeecccc
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN---WTARVSDFGLSL 661 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DfGla~ 661 (812)
. |+..+.|-........ ...-.-+..||+.+|.|||.++ |+|.||||+|||+.+. -.+||+|||.|+
T Consensus 646 ~-GDMLEMILSsEkgRL~------er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 646 H-GDMLEMILSSEKGRLP------ERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred c-chHHHHHHHhhcccch------HHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecccccee
Confidence 5 4666666443322221 1222346789999999999999 9999999999999544 579999999999
Q ss_pred cCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
++.+.. .....+||+.|+|||+++.+.|...-|+||.|||+|--|+|..||..+++ +.+. +.
T Consensus 716 iIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd------IndQ----IQ----- 777 (888)
T KOG4236|consen 716 IIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED------INDQ----IQ----- 777 (888)
T ss_pred ecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc------hhHH----hh-----
Confidence 876532 34567999999999999999999999999999999999999999965443 1111 11
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..+..|.....|+...-.+||...|+..=.+|-|.++-+.+
T Consensus 778 ---NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 778 ---NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ---ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 223344555667777778899999999999999999887654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=273.46 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=199.9
Q ss_pred hcCCccee-eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEe--
Q 042346 499 ATNNFSLE-NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQE-- 573 (812)
Q Consensus 499 ~~~~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~-- 573 (812)
.+++|++. ++||-|-.|.|-.+.++ .++++|+|++...+ ..++|+++--.. .|||||.++++|++
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----------KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----------KARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----------HHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 34556553 67999999999999764 68999999985321 234577764444 69999999999865
Q ss_pred --CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC---
Q 042346 574 --KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV--- 648 (812)
Q Consensus 574 --~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--- 648 (812)
...+++|||.|+||.|+..++.+..... +.++.-.|..||..++.|||+.+ |.||||||+|+|.+.
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~af------TErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~ 199 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAF------TEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSP 199 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccc------hHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCC
Confidence 3346899999999999999988765432 44666789999999999999999 999999999999954
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
|-.+||+|||+|+.... ........-|+.|.|||++....|+..-|+||+||++|-||.|.+||+.... ..+.
T Consensus 200 na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~ais 272 (400)
T KOG0604|consen 200 NAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAIS 272 (400)
T ss_pred CcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCC
Confidence 45799999999976443 2234566789999999999999999999999999999999999999976442 1122
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.-..+.+..|. ...|.....+.++..+++|+.+|+.+|.+|.|++|++.+
T Consensus 273 pgMk~rI~~gq--------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 273 PGMKRRIRTGQ--------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhHHhHhhccC--------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 22333444443 234555567888999999999999999999999999865
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=282.34 Aligned_cols=267 Identities=21% Similarity=0.293 Sum_probs=199.6
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-C-C----CceEEEEE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-H-K----HLVGLVGF 570 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H-~----nIv~l~~~ 570 (812)
..+++|.+...+|+|.||.|-.+.++ .+..||||+++.. ....+.-.-|++++.++. + | -++.+.++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 34788999999999999999999764 3689999998642 233445566999999994 2 2 36788889
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC--
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-- 648 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-- 648 (812)
|+..+..++|+|.+ |-|++|+|..+.... .+......|+.|++++++|||+.. ++|.||||+|||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~------fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIP------FPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSE 229 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccc------cchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccc
Confidence 99999999999998 559999998765433 355677899999999999999998 999999999999921
Q ss_pred ------------------CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc
Q 042346 649 ------------------NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710 (812)
Q Consensus 649 ------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt 710 (812)
+..+||+|||.|+..... ....+.|..|+|||++.+-.++.+.||||+||||+||.|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 345899999999764432 245688999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCchhHHHHHHHH--------------Hhcccc-----------ccc--cccCCCCCCChHHHHHHHH
Q 042346 711 GKKAVFKNEDGSGPLDVVEFAVSQI--------------LAGQLH-----------CVL--DKRVGPPELNEAEAVELLA 763 (812)
Q Consensus 711 G~~p~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~-----------~~~--d~~~~~~~~~~~~~~~~l~ 763 (812)
|...|+..++ .+.+..++.+...+ ..+.+. .++ ++.+........+....|.
T Consensus 305 G~~LFqtHen-~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 305 GETLFQTHEN-LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred cceecccCCc-HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 9999877652 22222332222111 011100 000 0000001122234455688
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 042346 764 TTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 764 ~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+|+.+||..||.+|+|+.|++++
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHccCccccccHHHHhcC
Confidence 99999999999999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-33 Score=274.85 Aligned_cols=255 Identities=23% Similarity=0.297 Sum_probs=188.0
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHH-hccCCCceEEEEEEEeCCeEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLS-RVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~-~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.+-+..||.|.||+|+|-.++ .|+..|||+++.... ..+.+++..|.+... .-+.||||+++|.+..++..|+.
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 334678999999999999875 599999999875322 344567777887544 45799999999999999999999
Q ss_pred EEecCCCchhhhhh---cCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 581 YEYMSNGALHDHLH---NKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 581 ~ey~~~gsL~~~l~---~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
||.|+- ||..+-+ ....... +....-+|..-..+||.||-+.- .||||||||+|||||..|.+||+||
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~i------pE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRI------PENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccC------cHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecc
Confidence 999954 6654432 2111111 22233467778899999998776 4999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|+.-.+.. ....+.-.|-..|||||.+.. ..|+-+|||||||++|||+.||+.|+.+-++ +-....++
T Consensus 213 GIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~V 282 (361)
T KOG1006|consen 213 GICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQV 282 (361)
T ss_pred cchHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHH
Confidence 99844322 233456689999999999963 4599999999999999999999999854331 22233333
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..|.-..+. ......+....+.++|..||.+|..+||.+.+++++
T Consensus 283 v~gdpp~l~------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 283 VIGDPPILL------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HcCCCCeec------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 334321111 111123456678899999999999999999999865
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=291.59 Aligned_cols=241 Identities=23% Similarity=0.312 Sum_probs=195.0
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
.++.|.+...+|.|+|+.|-.+.+ .+++..++|++... ..+-.+|+.++... +||||+++.+.+.+..+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc---------ccccccccchhhhhcCCCcceeecceecCCce
Confidence 356788888999999999999876 46889999998642 11233567666555 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE-cCCCcEEEE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL-DVNWTARVS 655 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl-~~~~~~kl~ 655 (812)
.|+|||++.++-|.+.+...... . ..+..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~--------~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrlt 458 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEF--------C-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLT 458 (612)
T ss_pred eeeeehhccccHHHHHHHhcchh--------H-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEE
Confidence 99999999999999988765432 1 445679999999999999998 9999999999999 588999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||.++..... ..+..-|..|.|||++....|+++.|+||||++|||||+|+.||.....+ ......+
T Consensus 459 yFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i 526 (612)
T KOG0603|consen 459 YFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRI 526 (612)
T ss_pred EechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhh
Confidence 99999765542 33446688999999999999999999999999999999999999765432 1122222
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+. . ....++..++|+.+||+.||.+||+|.++..+
T Consensus 527 ~~~~-------------~-s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 527 QMPK-------------F-SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cCCc-------------c-ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2221 1 15566778899999999999999999999865
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=295.82 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=206.0
Q ss_pred HHHHHHhcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEE
Q 042346 493 LSELAAATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGF 570 (812)
Q Consensus 493 ~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 570 (812)
++.+...+.-|++.+.||+|.+|.||+++. ++++..|+|++... .+..++++.|.++++.+ .|||++.++++
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~------~d~deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT------EDEEEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC------ccccHHHHHHHHHHHhccCCCCcceEEEE
Confidence 344444566799999999999999999985 46889999997642 23345667799999988 69999999999
Q ss_pred EEe-----CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEE
Q 042346 571 CQE-----KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645 (812)
Q Consensus 571 ~~~-----~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 645 (812)
|.. ++.+|||||||.+|+..|+++.-... .+.|.....|+..+++||.|||... ++|||||-.|||
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~------rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiL 155 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGN------RLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVL 155 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhhccc------chhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEE
Confidence 874 45789999999999999999765522 2366777889999999999999998 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCcccccccccccCCCccCcccccc-----CcCCCcchhHHHHHHHHHHHcCCCCCCCCCC
Q 042346 646 LDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720 (812)
Q Consensus 646 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 720 (812)
++.++.+||.|||++..+.... ......+||+.|||||++.. ..|+.++|+||||++..||--|.+|+....+
T Consensus 156 LT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 156 LTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred EeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 9999999999999986554422 23345689999999999963 3478899999999999999999999865332
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCC-hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELN-EAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
-. .+ ..-+|-++|.+. +..-.+.+.++|..||.+|.++||++.+++++
T Consensus 234 mr-----------aL-------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 234 MR-----------AL-------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hh-----------hh-------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 10 00 112333444444 45667788999999999999999999998864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=314.43 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=204.3
Q ss_pred HHHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEE
Q 042346 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFC 571 (812)
Q Consensus 493 ~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~ 571 (812)
+.++....++|.++++||+|+||+|...+++ .++.||.|++.+ ...-.+..-..|.+|-.+|..-+.+=|+.+.-.|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK--~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNK--WEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhH--HHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 4566777789999999999999999999985 478889999864 1111133445778899999988999999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
++++++|||||||+||+|..+|.+.....+ .| ..=++..|.-||.-||+.+ +|||||||+|||||.+|+
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~~~pE------~~--ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFDRLPE------DW--ARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcCCChH------HH--HHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCc
Confidence 999999999999999999999977652211 33 3447788999999999999 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccc----c-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCch
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV----M-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~ 726 (812)
+||+|||....+.. +........+|||.|++||++. + +.|.+..|.||+||++||||.|..||+.+.
T Consensus 214 ikLADFGsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------- 285 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------- 285 (1317)
T ss_pred EeeccchhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-------
Confidence 99999998765543 3344567789999999999996 2 578999999999999999999999996543
Q ss_pred hHHHHHHHHHhccccccccc--cCCCCCCChHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 042346 727 VVEFAVSQILAGQLHCVLDK--RVGPPELNEAEAVELLATTAIHCVNLEGKERPN---ITDIVANL 787 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~~L 787 (812)
+++. +.++.+. .+..| .+.+.++..++||.+.+. +|+.|.. ++|+..|.
T Consensus 286 lveT---------Y~KIm~hk~~l~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 286 LVET---------YGKIMNHKESLSFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred HHHH---------HHHHhchhhhcCCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 1211 1112222 23333 233466667777777665 7888887 88887764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=279.59 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=195.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHH----HHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKE----SAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~----~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
..++|-++.+||+|+|++||+|.+ ...+.||||+-.. ...+..++. +...+|.+|-+.|+||.||++|+||.-
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHql--NK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQL--NKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehh--ccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 345688899999999999999974 4578899998543 223333333 344579999999999999999999965
Q ss_pred C-CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc---CC
Q 042346 574 K-DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD---VN 649 (812)
Q Consensus 574 ~-~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~ 649 (812)
+ +..+-|+|||++.+|.-||+.+... +.++...|+.||..+|.||.+.. |||||-||||.||||- .-
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklm--------SEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLM--------SEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhh--------hHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccc
Confidence 4 4567899999999999999876543 44666789999999999999876 7899999999999993 45
Q ss_pred CcEEEEeecccccCCCCccc-----ccccccccCCCccCcccccc----CcCCCcchhHHHHHHHHHHHcCCCCCCCCCC
Q 042346 650 WTARVSDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVM----NVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720 (812)
Q Consensus 650 ~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 720 (812)
|.+||+||||++++...... ..+....||..|++||.+.- ..++.|+||||+|||+|..|.|+.||-.+..
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 88999999999987665432 23445689999999998853 3478899999999999999999999954432
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
..++.++ ..+.. ...+..|. ......+...+|++||..-.++|....++..
T Consensus 690 ---QQdILqe-------NTIlk--AtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 690 ---QQDILQE-------NTILK--ATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ---HHHHHhh-------hchhc--ceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1112111 11110 11111111 1222334567889999999999998877654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=248.98 Aligned_cols=269 Identities=20% Similarity=0.291 Sum_probs=196.5
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|...++||+|.||+||+|+.+ .++.||+|+++.....+. ......+|+-+++.|+|+|||++++....++.+-||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg---vpssalreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC---CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 3556789999999999999854 578899999875433322 234567899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
+|||.. +|..|...-.... +......++.|+++||.|.|+++ +.||||||+|+||+.||++||+|||++
T Consensus 80 fe~cdq-dlkkyfdslng~~-------d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 80 FEFCDQ-DLKKYFDSLNGDL-------DPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred HHHhhH-HHHHHHHhcCCcC-------CHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchh
Confidence 999965 8888886654432 34555688999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc-
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG- 738 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 738 (812)
+.+.-.- ......+-|..|.+|.++.+ .-|+...|+||.|||+.||....+|.+...+-.+++.-+.+......++
T Consensus 149 rafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 149 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred hhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 8654422 12344578999999999886 4588999999999999999987777654332111111111111111111
Q ss_pred --cccccccccCCC---CCCChHHHHHHH----HHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 --QLHCVLDKRVGP---PELNEAEAVELL----ATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 --~~~~~~d~~~~~---~~~~~~~~~~~l----~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+..+.|....+ +.....++...| ++|+.+.|.-+|.+|.++++.+++
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 122333333221 112223333322 677888899999999999988764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=274.12 Aligned_cols=219 Identities=21% Similarity=0.209 Sum_probs=171.9
Q ss_pred CCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCCchh
Q 042346 512 GSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALH 590 (812)
Q Consensus 512 G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 590 (812)
|.|+.||++++. +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 889999999874 68899999986311 2334555555667999999999999999999999999999999
Q ss_pred hhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccc
Q 042346 591 DHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670 (812)
Q Consensus 591 ~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 670 (812)
+++..... +++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 74 ~~l~~~~~--------l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---- 138 (237)
T cd05576 74 SHISKFLN--------IPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---- 138 (237)
T ss_pred HHHHHhcC--------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----
Confidence 99965432 356777899999999999999998 999999999999999999999999987554331
Q ss_pred cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCC
Q 042346 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGP 750 (812)
Q Consensus 671 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 750 (812)
.....++..|+|||.+....++.++||||+|+++|||++|+.|+....... ... ..+..
T Consensus 139 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~~~------~~~~~ 197 (237)
T cd05576 139 -CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------NTH------TTLNI 197 (237)
T ss_pred -cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------ccc------cccCC
Confidence 122345678999999988889999999999999999999998764221100 000 00011
Q ss_pred CCCChHHHHHHHHHHHHHccccCCCCCCCH
Q 042346 751 PELNEAEAVELLATTAIHCVNLEGKERPNI 780 (812)
Q Consensus 751 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 780 (812)
+ ......+.+++.+|++.||++||++
T Consensus 198 ~----~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 198 P----EWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred c----ccCCHHHHHHHHHHccCCHHHhcCC
Confidence 1 2234568899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=292.74 Aligned_cols=273 Identities=19% Similarity=0.234 Sum_probs=181.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-----------------cCCcEEEEEeeccCcchhhH---------HHHHHHHHHHH
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-----------------MDGREVAVKREESCPKTNKL---------REKESAFDSEL 553 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-----------------~~g~~vavK~~~~~~~~~~~---------~~~~~~~~~Ei 553 (812)
.++|++.++||+|+||.||+|.+ .+++.||||++......... ....+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56799999999999999999964 23568999998642211100 00122344577
Q ss_pred HHHHhccCCCc-----eEEEEEEEe--------CCeEEEEEEecCCCchhhhhhcCCCCC----------------cccc
Q 042346 554 ALLSRVHHKHL-----VGLVGFCQE--------KDERLLVYEYMSNGALHDHLHNKNNTE----------------KNSS 604 (812)
Q Consensus 554 ~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lV~ey~~~gsL~~~l~~~~~~~----------------~~~~ 604 (812)
.++.+++|.++ ++++++|.. +...+|||||+++++|.++|+...... ....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 88888877655 677777753 346799999999999999997532110 0011
Q ss_pred ccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCc
Q 042346 605 IVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP 684 (812)
Q Consensus 605 ~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 684 (812)
...+|..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++....... ........+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence 12367788899999999999999998 9999999999999999999999999996543321 1112223458899999
Q ss_pred cccccCc--------------------C--CCcchhHHHHHHHHHHHcCCC-CCCCCCCCCCCch---hHHHHHHHHHhc
Q 042346 685 EYYVMNV--------------------L--TAKTDIYGLGVVLLELLTGKK-AVFKNEDGSGPLD---VVEFAVSQILAG 738 (812)
Q Consensus 685 E~~~~~~--------------------~--~~ksDVwS~Gvvl~elltG~~-p~~~~~~~~~~~~---~~~~~~~~~~~~ 738 (812)
|.+.... + ..+.||||+||+||||+++.. |+........... .....+......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1 134799999999999999875 5432111000000 000011111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEG---KERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP---~~RPt~~evl~~ 786 (812)
....+ ......+...+|+.++|..+| .+|+|++|+++|
T Consensus 460 --------~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 --------KYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --------CCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111 122345567788889998766 689999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=268.08 Aligned_cols=205 Identities=25% Similarity=0.397 Sum_probs=163.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC-----
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK----- 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----- 574 (812)
+.|....+||+|.||+||+|+.+ .+++||+|+........ .....-.+|+++|..|+|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe---GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc---CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 34666789999999999999865 47888998754311111 1123446799999999999999999887532
Q ss_pred ---CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 575 ---DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 575 ---~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
...||||++|+. +|.-+|..... .++.....++..+++.||.|+|... |+|||+|+.|+||+.++.
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~v-------r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgi 162 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKV-------RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGI 162 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccc-------cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCce
Confidence 247999999987 89888865432 2356677889999999999999998 999999999999999999
Q ss_pred EEEEeecccccCCCCccc--ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCC
Q 042346 652 ARVSDFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNE 719 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~ 719 (812)
+||+|||+++.++..++. ...++.+-|..|++||.+.+ +.|+++.|||..||||.||+|+.+.++.+.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt 233 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT 233 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence 999999999765543332 23456778999999999875 679999999999999999999987776543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=302.00 Aligned_cols=266 Identities=21% Similarity=0.307 Sum_probs=167.4
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC-----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEE---
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD-----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGF--- 570 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~--- 570 (812)
..++|++.++||+|+||.||+|++.+ +..||+|++..... . +.+..| .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~-e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------V-EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------h-HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 35679999999999999999998754 68999998753111 0 011111 1111222222222211
Q ss_pred ---EEeCCeEEEEEEecCCCchhhhhhcCCCCCc------------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 042346 571 ---CQEKDERLLVYEYMSNGALHDHLHNKNNTEK------------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSII 635 (812)
Q Consensus 571 ---~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~------------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~iv 635 (812)
..++...+|||||+.+++|.++++....... .............++.||+.||+|||+++ |+
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---Ii 277 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IV 277 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 2455678999999999999999975432100 00001122334579999999999999998 99
Q ss_pred eeccCCCCEEEcC-CCcEEEEeecccccCCCCcccccccccccCCCccCccccccC----------------------cC
Q 042346 636 HRDIKSSNILLDV-NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN----------------------VL 692 (812)
Q Consensus 636 HrDlKp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 692 (812)
||||||+|||++. ++.+||+|||+++...... ........+++.|||||.+... .+
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999999986 5799999999997554322 2233456789999999966422 23
Q ss_pred CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc-----ccccccccCCCCCC----ChHHHHHHHH
Q 042346 693 TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ-----LHCVLDKRVGPPEL----NEAEAVELLA 763 (812)
Q Consensus 693 ~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~d~~~~~~~~----~~~~~~~~l~ 763 (812)
+.++|||||||+||||+++..++... +..+ ...+.... +...+..+...... ..........
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~--------~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSN--------LIQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchH--------HHHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHH
Confidence 45679999999999999876553210 1111 00000000 00011111000000 0000122345
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 042346 764 TTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 764 ~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+|+.+||+.||++|||++|+++|
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCC
Confidence 89999999999999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=269.09 Aligned_cols=269 Identities=22% Similarity=0.313 Sum_probs=191.3
Q ss_pred cceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-----e
Q 042346 503 FSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD-----E 576 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~ 576 (812)
++..+.||.|.||.||..++ ++|+.|+.|++.. ....-..-+.+.+|+++|..++|.|++..++..+-.. +
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn---vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN---VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch---HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 45578999999999999876 5799999999763 3333445567889999999999999999988765443 3
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.|+++|.|. .+|...|-...... -.-..-+.+||++||.|||+.+ |.||||||.|+|++.|..+||+|
T Consensus 132 iYV~TELmQ-SDLHKIIVSPQ~Ls--------~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 132 LYVLTELMQ-SDLHKIIVSPQALT--------PDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred HHHHHHHHH-hhhhheeccCCCCC--------cchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecc
Confidence 578889884 48887775443322 2233457889999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH-----
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF----- 730 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~----- 730 (812)
||+++.... +.....+..+-|..|+|||++++ +.|+...||||.|||+.||+-.+..|+... +.+.++++..
T Consensus 200 FGLARvee~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 200 FGLARTWDQ-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-PIEQLQMIIDLLGTP 277 (449)
T ss_pred cccccccch-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-hHHHHHHHHHHhCCC
Confidence 999986544 34445666788999999999986 679999999999999999997776665432 2222222211
Q ss_pred ---HHHHHHhccccccccccCCCCCCC------h-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 731 ---AVSQILAGQLHCVLDKRVGPPELN------E-AEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 731 ---~~~~~~~~~~~~~~d~~~~~~~~~------~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
..+..-+|--..++......|... . ....-.-..+..+++..||++|.+.++.+.++.
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111222122222222222111 0 111111235667799999999999999998863
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=271.54 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=188.1
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
...+|..+.+||+|+||.|.++..+. .+.+|||++++...... +..+--..|-++|... +-|.++++...|+.-+.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd--DDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD--DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec--CcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34568889999999999999997654 66799999875322211 1112223466666655 56789999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
+|+||||+.+|+|--+|++.....+.- .+-+|..||-||-|||+++ ||.||||.+|||||.+|++||+|
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~--------AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPV--------AVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCch--------hhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence 999999999999999998776654432 2348889999999999999 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||+.+..-... ..+....|||.|+|||++...+|...+|.|||||+|||||.|+.||..+++ +...+.+.
T Consensus 494 FGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--------~elF~aI~ 563 (683)
T KOG0696|consen 494 FGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQAIM 563 (683)
T ss_pred cccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHH
Confidence 99997543322 245667899999999999999999999999999999999999999966442 12223333
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP 778 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 778 (812)
+.....|.....|+. .+.+..|.+.|.+|.
T Consensus 564 --------ehnvsyPKslSkEAv----~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 --------EHNVSYPKSLSKEAV----AICKGLLTKHPGKRL 593 (683)
T ss_pred --------HccCcCcccccHHHH----HHHHHHhhcCCcccc
Confidence 333444554455554 455567888999884
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=264.39 Aligned_cols=239 Identities=27% Similarity=0.356 Sum_probs=189.1
Q ss_pred CcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCCchhh
Q 042346 513 SFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD 591 (812)
Q Consensus 513 ~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~ 591 (812)
+||.||++.+.+ ++.+++|++...... .....+.+|++.+++++|+||+++++++......+++|||+++++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK----KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc----cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 589999999864 899999998642221 115678899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCccccc
Q 042346 592 HLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671 (812)
Q Consensus 592 ~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 671 (812)
++..... .++...+.++.+++++|.|||+.+ |+|+||+|+||+++.++.++|+|||++....... .
T Consensus 77 ~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~ 142 (244)
T smart00220 77 LLKKRGR--------LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---L 142 (244)
T ss_pred HHHhccC--------CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---c
Confidence 9976432 366778899999999999999998 9999999999999999999999999997654422 2
Q ss_pred ccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCC
Q 042346 672 STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPP 751 (812)
Q Consensus 672 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 751 (812)
.....++..|++||.+....++.++||||||+++|||++|+.||..... .+........+... .
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------~~~~~~~~~~~~~~---------~ 206 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------LLELFKKIGKPKPP---------F 206 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHhccCCC---------C
Confidence 3345678899999999888899999999999999999999999854211 11111111111100 0
Q ss_pred CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 752 ELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 752 ~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
.......+..+.+++.+|+..+|++||++.++++
T Consensus 207 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0000114566889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=289.84 Aligned_cols=248 Identities=29% Similarity=0.402 Sum_probs=187.4
Q ss_pred cceeeeeccCCcEE-EEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEEE
Q 042346 503 FSLENKVGIGSFGT-VYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 503 ~~~~~~LG~G~fG~-Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 580 (812)
|.-.+++|+|+.|+ ||+|.. ++++||||++. .+......+|+..|+.- +|||||++++.-.++...|+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 55567899999876 699999 78999999974 23344557899999988 599999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC---C--CcEEEE
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV---N--WTARVS 655 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~--~~~kl~ 655 (812)
.|.|. .+|.|++............ ...+.+..|+++||+|||+.+ ||||||||.||||+. + .+++|+
T Consensus 582 lELC~-~sL~dlie~~~~d~~~~~~----i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 582 LELCA-CSLQDLIESSGLDVEMQSD----IDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred ehHhh-hhHHHHHhccccchhhccc----ccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEec
Confidence 99995 5999999875211111111 122568899999999999988 999999999999966 3 579999
Q ss_pred eecccccCCCCcccc-cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcC-CCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQEF-ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG-KKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||+++......... ......||.+|+|||++....-+..+||||||||+|+.++| ..||..... ...
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~----------R~~ 723 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE----------RQA 723 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH----------hhh
Confidence 999998776544432 23456899999999999988888899999999999999997 788744221 111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.++.+...-.. +. +. .+. +-.+||.+|++.+|..||++.+|+.|
T Consensus 724 NIl~~~~~L~~---L~-~~---~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 724 NILTGNYTLVH---LE-PL---PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hhhcCccceee---ec-cC---chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 22222211100 00 00 111 46689999999999999999999753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=275.83 Aligned_cols=217 Identities=26% Similarity=0.407 Sum_probs=176.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.-|..++.||-|+||+|.+++.. ....+|.|.+++. ....+........|-.||..-+.+=||+|+-.|++++.+|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKa--DVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKA--DVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHH--HHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 34677889999999999999653 4667899988652 22233444566789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||++||++-.+|-+.....+. ...-++..+.+++++.|..+ +|||||||+|||||.+|++||+||||
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~--------LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEED--------LARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHH--------HHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccc
Confidence 99999999999998776544322 22236678999999999999 99999999999999999999999999
Q ss_pred cccC---------CCCcc-------------------------------cccccccccCCCccCccccccCcCCCcchhH
Q 042346 660 SLLG---------SECDQ-------------------------------EFISTKAVGTVGYIDPEYYVMNVLTAKTDIY 699 (812)
Q Consensus 660 a~~~---------~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVw 699 (812)
..-+ ...+. .......+||+.|+|||++....|+...|.|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 7321 11000 0011234799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 700 GLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 700 S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
|.|||||||+.|+.||..+...+....+..|
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence 9999999999999999988887777777665
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=255.93 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=190.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 577 (812)
.++|.++++||+|+|..|..++++ ..+.+|+|++++. .....+.......|-.+..+- +||.+|.+..+|+.+..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkke--l~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKE--LVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHH--hcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 356889999999999999999875 4778999987642 111223344555566666555 799999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++|.||+++|+|--++++++...++-. .-+...|..+|.|||+++ ||.||||.+|+|+|..|.+||+|+
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeha--------rfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHA--------RFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHh--------hhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeeccc
Confidence 999999999999988877665443221 235678899999999999 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|+.+..-.. ...+....|||.|+|||++.+..|...+|.|+|||+|+||+.|+.||.-........+-.++..+.+++
T Consensus 396 gmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile 473 (593)
T KOG0695|consen 396 GMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE 473 (593)
T ss_pred chhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh
Confidence 998754332 234567899999999999999999999999999999999999999996433222222333445555555
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP 778 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 778 (812)
..+. .|...... ...+++.-|.+||.+|.
T Consensus 474 kqir--------iprslsvk----as~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 474 KQIR--------IPRSLSVK----ASHVLKGFLNKDPKERL 502 (593)
T ss_pred hccc--------ccceeehh----hHHHHHHhhcCCcHHhc
Confidence 4321 22222222 33455667999999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=273.21 Aligned_cols=263 Identities=21% Similarity=0.241 Sum_probs=202.5
Q ss_pred CcceeeeeccCCcEEEEEEEEcCCc-EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMDGR-EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~g~-~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
++.....||-|+||.|=+.+.+..+ .+|+|++++... .....++.+..|-+||...+.|.||++|-.|.++...|+.
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI--VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI--VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc--cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 4555678999999999998875433 378888765322 2234455677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
||-|-+|.|...|+.+........ .-++..+++|++|||+++ ||.|||||+|.|||.+|-+||.|||+|
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~ta--------rF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTA--------RFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchh--------hhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhH
Confidence 999999999999988776543322 236778999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
+.+.... .+....|||.|.|||++..+..+..+|.||||+++||||+|.+||...++ ... ...++.|-
T Consensus 568 Kki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----mkt----Yn~ILkGi- 635 (732)
T KOG0614|consen 568 KKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----MKT----YNLILKGI- 635 (732)
T ss_pred HHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----HHH----HHHHHhhh-
Confidence 8776533 34567899999999999999999999999999999999999999965432 222 22233331
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH-------HHHHHhcccCC
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVANL-------ERALAICQDCS 798 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L-------e~~~~~~~~~~ 798 (812)
.. +..| ..+...-.+||++.++.+|.+|.- +.||.+|- +.+......+|
T Consensus 636 d~-----i~~P----r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pP 696 (732)
T KOG0614|consen 636 DK-----IEFP----RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPP 696 (732)
T ss_pred hh-----hhcc----cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCC
Confidence 10 1111 223334557788889999999975 67777663 55555555555
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=237.85 Aligned_cols=204 Identities=22% Similarity=0.349 Sum_probs=158.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 577 (812)
.+...-.+.||+|+||.|-+-++ .+|+..|+|++..... .+..+...+|+.+..+. ..|.+|.|+|....+...
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 34455568899999999988876 4699999999864322 33445667788765554 799999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
|+.||.|+. ||..+-..--..... .+....=+|+..+.+||.|||++- .++|||+||+|||++.+|++|++||
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~----ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGT----IPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCc----CchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence 999999965 777664432211111 122334589999999999999987 4999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCcccccc----CcCCCcchhHHHHHHHHHHHcCCCCCCC
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVM----NVLTAKTDIYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVwS~Gvvl~elltG~~p~~~ 717 (812)
|++-.+.+ ....+...|...|||||.+.. ..|+-|+||||||+.+.||.+++.|+..
T Consensus 194 GIsG~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 194 GISGYLVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccceeehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 99865433 122233578899999998853 3689999999999999999999999843
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=238.51 Aligned_cols=261 Identities=18% Similarity=0.321 Sum_probs=192.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCe-
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDE- 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~- 576 (812)
.++|++.+++|+|.|++||.|.. .++++++||+++. -+.+.+.+|+.||..|. ||||+++++...+...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 46799999999999999999974 5788999999863 34567889999999997 9999999999877554
Q ss_pred -EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-CcEEE
Q 042346 577 -RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARV 654 (812)
Q Consensus 577 -~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl 654 (812)
..||+||+++-+...+...- +-.....++.++++||.|.|+++ |+|||+||.|++||.. ..++|
T Consensus 109 tpaLiFE~v~n~Dfk~ly~tl-----------~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYPTL-----------TDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred CchhHhhhhccccHHHHhhhh-----------chhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeee
Confidence 57999999997776655322 22334568899999999999999 9999999999999865 57999
Q ss_pred EeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
+|+|||.+...... .+-.+.+..|--||.+.. ..|+..-|+|||||+|.+|+..+.||+...++.+++..+..+..
T Consensus 175 IDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred eecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 99999988765332 234567788899999874 56899999999999999999999999876654432211111100
Q ss_pred -HHHh---ccccccccccCC---------------CCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 -QILA---GQLHCVLDKRVG---------------PPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 -~~~~---~~~~~~~d~~~~---------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+. .++.-.+|++.. .++.... ...+..+|+.+.|..|-.+|||++|.+.+
T Consensus 252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl-~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHL-VSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccccc-CChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0000 011111222211 1111111 12334578888999999999999999876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=250.80 Aligned_cols=131 Identities=28% Similarity=0.411 Sum_probs=109.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-----C---CCceEEEEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-----H---KHLVGLVGFC 571 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~nIv~l~~~~ 571 (812)
.+|.+.++||.|.|++||++.+. +.+.||+|+.+.. +...+.-..||++|++++ | .+||+|+++|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA------QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh------hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 67999999999999999999764 5788999998642 233445667999999984 2 3699999999
Q ss_pred EeC----CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 572 QEK----DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 572 ~~~----~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
... .+.+||+|++ |.+|..+|........ +.....+|+.||+.||.|||++. +|||.||||+|||+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGl------pl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGL------PLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCC------cHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 864 4679999999 6799999987765443 56777899999999999999987 59999999999999
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=236.79 Aligned_cols=212 Identities=33% Similarity=0.536 Sum_probs=180.1
Q ss_pred eccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCC
Q 042346 509 VGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNG 587 (812)
Q Consensus 509 LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 587 (812)
||+|.+|.||++...+ ++++++|++....... ....+.+|++.++.++|++|+++++++......+++|||++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 6899999999999854 8999999986422111 3467889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC-CCcEEEEeecccccCCCC
Q 042346 588 ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARVSDFGLSLLGSEC 666 (812)
Q Consensus 588 sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DfGla~~~~~~ 666 (812)
+|.+++.... ...++..++.++.+++++|.|||+.+ ++|+||+|.||+++. ++.++|+||+.+......
T Consensus 77 ~l~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 77 SLKDLLKENE-------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred cHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 9999997653 11256778899999999999999998 999999999999999 899999999998765442
Q ss_pred cccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcccccccc
Q 042346 667 DQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLD 745 (812)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 745 (812)
.. ......+...|++||.+... .++.+.|+|++|+++++|
T Consensus 147 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------- 187 (215)
T cd00180 147 KS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------- 187 (215)
T ss_pred cc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence 21 12335678899999998877 788999999999999999
Q ss_pred ccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 746 KRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 746 ~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 --------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2477899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=265.29 Aligned_cols=202 Identities=25% Similarity=0.353 Sum_probs=166.2
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcch--hhHHH-HHHHHHHHHHHHHhcc---CCCceEEEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKT--NKLRE-KESAFDSELALLSRVH---HKHLVGLVGFCQ 572 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~--~~~~~-~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~ 572 (812)
...|+..+.||+|+||.|++|.++ +..+|+||.+.+...- .+.++ +.-.+..||+||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 456899999999999999999875 4678899987542111 11111 1223456999999997 999999999999
Q ss_pred eCCeEEEEEEec-CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 573 EKDERLLVYEYM-SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 573 ~~~~~~lV~ey~-~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
+++.+||+||.. ++-+|+++|..+....+ .+...|+.|++.|+++||+++ |||||||-+|+.++.+|-
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E--------~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDE--------PEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF 708 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccch--------HHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence 999999999976 55699999988776543 334569999999999999999 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccccCcCCC-cchhHHHHHHHHHHHcCCCCCC
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTA-KTDIYGLGVVLLELLTGKKAVF 716 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-ksDVwS~Gvvl~elltG~~p~~ 716 (812)
+||+|||.+..... ......+||..|.|||++.+..|-- .-|||++|++||-++....||+
T Consensus 709 ~klidfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEEeeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999865443 2345678999999999999988765 5899999999999999888874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-28 Score=242.62 Aligned_cols=260 Identities=22% Similarity=0.259 Sum_probs=188.2
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC----
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD---- 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---- 575 (812)
.+|.-+..++.|.- .|-.+.+ -.++.||+|++... .. ....-+...+|..++..++|+||++++.+|.-..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~--n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQ--NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cc--cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 45777788999988 5555543 35889999987643 21 1223345568999999999999999999985433
Q ss_pred --eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 576 --ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 576 --~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
+.|+|||||. .+|...++.... =.....|+.|+++|++|||+.+ |+||||||+||++..+..+|
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~~elD----------H~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVILMELD----------HETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHHHhcc----------hHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhhee
Confidence 4699999995 599999873221 1334579999999999999999 99999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|.|||+++..... ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|.... .+.+|...
T Consensus 159 i~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d------~idQ~~ki 229 (369)
T KOG0665|consen 159 ILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD------HIDQWNKI 229 (369)
T ss_pred eccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch------HHHHHHHH
Confidence 9999999764332 45677889999999999999889999999999999999999998774221 11111111
Q ss_pred HHHhcc---------------------------cccc-ccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 734 QILAGQ---------------------------LHCV-LDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 734 ~~~~~~---------------------------~~~~-~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
....|. ..+. .|.........+.--....++++.+||-.||++|-+++++|+
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 100000 0000 011111111111122345778899999999999999999998
Q ss_pred HH
Q 042346 786 NL 787 (812)
Q Consensus 786 ~L 787 (812)
|-
T Consensus 310 HP 311 (369)
T KOG0665|consen 310 HP 311 (369)
T ss_pred CC
Confidence 73
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=229.95 Aligned_cols=200 Identities=31% Similarity=0.449 Sum_probs=169.1
Q ss_pred cceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
|.+.+.||+|++|.||++...+ ++.+++|.+...... .....+.+|++.+++++|+|++++++++......++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 5677899999999999999865 889999998642211 24567888999999999999999999999989999999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++++|.+++...... +++.....++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 77 e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGK-------LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred eccCCCCHHHHHHhcccC-------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 999999999999765421 356778899999999999999998 9999999999999999999999999987
Q ss_pred cCCCCcccccccccccCCCccCcccc-ccCcCCCcchhHHHHHHHHHHHcCCCCCCC
Q 042346 662 LGSECDQEFISTKAVGTVGYIDPEYY-VMNVLTAKTDIYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 662 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 717 (812)
....... .......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 6544321 122345678899999998 667788899999999999999999999843
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=244.43 Aligned_cols=269 Identities=26% Similarity=0.370 Sum_probs=196.0
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEE
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFC 571 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 571 (812)
....+.|...++||+|.|+.||++.+. ..+.||+|.+.. ......+.+|+++|..+ -+.||+++.+++
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~-------ts~p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR-------TSSPSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc-------ccCchHHHHHHHHHHHhccchhhhcchhhh
Confidence 344567899999999999999999753 467899998764 23344578899999999 499999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-C
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-W 650 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~ 650 (812)
..++...+|+||++.....+++..- +......++..+.++|.|+|.++ ||||||||+|+|.+.. +
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~l-----------~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~ 170 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRSL-----------SLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQ 170 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhcC-----------CHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccC
Confidence 9999999999999999998888543 34566789999999999999999 9999999999999754 6
Q ss_pred cEEEEeecccccCCCCc----------------------------------ccc--------cccccccCCCccCccccc
Q 042346 651 TARVSDFGLSLLGSECD----------------------------------QEF--------ISTKAVGTVGYIDPEYYV 688 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~----------------------------------~~~--------~~~~~~gt~~y~aPE~~~ 688 (812)
.-.|.|||||....... ... ..-...||++|.|||++.
T Consensus 171 rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~ 250 (418)
T KOG1167|consen 171 RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF 250 (418)
T ss_pred CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh
Confidence 78999999996210000 000 011236999999999987
Q ss_pred c-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCC-chhHHH-HH-----HHHHhcc--ccc------c---------
Q 042346 689 M-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP-LDVVEF-AV-----SQILAGQ--LHC------V--------- 743 (812)
Q Consensus 689 ~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~-~~-----~~~~~~~--~~~------~--------- 743 (812)
. ...++++||||.|||++-+++++.||++..+.... .+++.. .. -....|. +.+ .
T Consensus 251 k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s 330 (418)
T KOG1167|consen 251 RCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFET 330 (418)
T ss_pred hccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhc
Confidence 5 45788999999999999999999999875543221 111100 00 0011122 111 0
Q ss_pred cc-ccCC-------CCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 744 LD-KRVG-------PPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 744 ~d-~~~~-------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
++ ..+. ......+..+..+.+|+.+|+..||.+|.|++|.|++
T Consensus 331 ~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 331 LHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 0000 0111112334467899999999999999999999876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-27 Score=247.12 Aligned_cols=276 Identities=21% Similarity=0.249 Sum_probs=202.1
Q ss_pred CCHHHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc------CCC
Q 042346 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH------HKH 563 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~------H~n 563 (812)
|.+.--+..-.+|.+....|+|-|+.|.+|.+. .|..||||++... ....+.=..|++||++|+ .-|
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN------E~M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN------EVMHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc------hHHhhhhhHHHHHHHHhhccCchhhhH
Confidence 444444556678999999999999999999864 4889999999752 222334457999999995 348
Q ss_pred ceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCC
Q 042346 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSN 643 (812)
Q Consensus 564 Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~N 643 (812)
+++|+-.|.+.++++||||.+. .+|.+.|++.+.... +.++....++.|+.-+|.+|-..+ |+|.||||.|
T Consensus 496 clrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvG-----L~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDN 566 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVG-----LHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDN 566 (752)
T ss_pred HHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccc-----eeehHHHHHHHHHHHHHHHHHhcC---eeecccCccc
Confidence 9999999999999999999884 599999987765332 345666789999999999999998 9999999999
Q ss_pred EEEcCC-CcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCC
Q 042346 644 ILLDVN-WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS 722 (812)
Q Consensus 644 ILl~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~ 722 (812)
||+++. ..+||||||.|-.....+ .+...-+.-|.|||++.+.+|+...|+||.||.||||.||+..|-...++.
T Consensus 567 iLVNE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 567 ILVNESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred eEeccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 999876 568999999997665432 223345668999999999999999999999999999999999885433221
Q ss_pred CCchhHHHH-----HHHHHhccc-cccccccC----------------------CC-------------CCCChHHHHHH
Q 042346 723 GPLDVVEFA-----VSQILAGQL-HCVLDKRV----------------------GP-------------PELNEAEAVEL 761 (812)
Q Consensus 723 ~~~~~~~~~-----~~~~~~~~~-~~~~d~~~----------------------~~-------------~~~~~~~~~~~ 761 (812)
.+.+.... ...+..+.+ ..-+|+.+ .+ ...........
T Consensus 643 -MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~ 721 (752)
T KOG0670|consen 643 -MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ 721 (752)
T ss_pred -HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence 11111000 000000000 00111110 00 01112345677
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 042346 762 LATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 762 l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
|++|+.+||..||++|.|..+.|.|
T Consensus 722 ~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 722 LRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHHHhccChhhcCCHHHHhcC
Confidence 8999999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=228.30 Aligned_cols=250 Identities=20% Similarity=0.269 Sum_probs=180.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEE-EEEeCCe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVG-FCQEKDE 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~-~~~~~~~ 576 (812)
.+.|.+.+.||+|.||.+-++.++. .+.+++|-+.. ......+|.+|...--.| .|.||+.-++ .|+..+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 3569999999999999999999864 67889997753 134466888888766666 5999998776 4677777
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE-cC-CCcEEE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL-DV-NWTARV 654 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl-~~-~~~~kl 654 (812)
.++++||++.|+|.+-+...+..+ ....+++.|++++|.|||+++ +||||||.+|||| +. ..++||
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE---------~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGE---------ANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred EEEeeccCccchhhhhcCcccccH---------HHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEe
Confidence 889999999999999887644322 223579999999999999999 9999999999999 33 358999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccC-----cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-----VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
+|||+.+.....- ....-+..|.+||..... ...+.+|||.||+|+|.+|||+.|+++......+ +.
T Consensus 165 cDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~--Y~- 236 (378)
T KOG1345|consen 165 CDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP--YW- 236 (378)
T ss_pred eecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch--HH-
Confidence 9999986543321 222346679999977532 3467899999999999999999999865433322 22
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 784 (812)
.+.+...+....+.+ . -..+.+.+.++.++-|..++++|=-..++.
T Consensus 237 -~~~~w~~rk~~~~P~-------~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 237 -EWEQWLKRKNPALPK-------K-FNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred -HHHHHhcccCccCch-------h-hcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 222333332221111 1 122334455777788999999994433433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-26 Score=252.91 Aligned_cols=265 Identities=24% Similarity=0.374 Sum_probs=202.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..+|.+..++|.|.||.|||+++. .++..|+|+++..+... .+-+.+|+-+++..+||||+.+++.+...+..|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-----~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-----FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-----ccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 456899999999999999999864 58899999987644332 234567999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+.|||+.+|+|.|.-+.-... +..+.-.+.+..++||+|||+++ -+|||||-.|||+++.+.+|++|||
T Consensus 89 icMEycgggslQdiy~~Tgpl--------selqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfg 157 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPL--------SELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFG 157 (829)
T ss_pred EEEEecCCCcccceeeecccc--------hhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccC
Confidence 999999999999987655443 23344567889999999999998 6999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
.+-.+... ........||+.|||||+.. ...|..+.|||++|+...|+---+.|.+.... .....+
T Consensus 158 vsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---------mr~l~L 226 (829)
T KOG0576|consen 158 VSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---------MRALFL 226 (829)
T ss_pred chhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------HHHHHH
Confidence 87543321 11234568999999999874 46799999999999999999888887654331 111112
Q ss_pred HhccccccccccCCCCCCCh-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH-----------HHHHHHhcccCC
Q 042346 736 LAGQLHCVLDKRVGPPELNE-AEAVELLATTAIHCVNLEGKERPNITDIVAN-----------LERALAICQDCS 798 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~-----------Le~~~~~~~~~~ 798 (812)
+... ...+|...+ ..-.+.+-++++.|+.++|++|||++.++++ ..++++.+..++
T Consensus 227 mTkS-------~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 227 MTKS-------GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred hhcc-------CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence 2211 112222222 2334567889999999999999999988764 345666666665
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=270.58 Aligned_cols=197 Identities=17% Similarity=0.198 Sum_probs=135.3
Q ss_pred hccC-CCceEEEEEE-------EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc
Q 042346 558 RVHH-KHLVGLVGFC-------QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY 629 (812)
Q Consensus 558 ~l~H-~nIv~l~~~~-------~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~ 629 (812)
.++| +||++++++| .+.+..++++||+ +++|+++|..... .+++.++++++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR-------SVDAFECFHVFRQIVEIVNAAHSQ 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc-------cccHHHHHHHHHHHHHHHHHHHhC
Confidence 3455 5788888877 2334567888988 5599999964321 136778899999999999999999
Q ss_pred CCCCeEeeccCCCCEEEcCC-------------------CcEEEEeecccccCCCCcc--------------cccccccc
Q 042346 630 AVPSIIHRDIKSSNILLDVN-------------------WTARVSDFGLSLLGSECDQ--------------EFISTKAV 676 (812)
Q Consensus 630 ~~~~ivHrDlKp~NILl~~~-------------------~~~kl~DfGla~~~~~~~~--------------~~~~~~~~ 676 (812)
+ |+||||||+||||+.. +.+||+|||+++....... ........
T Consensus 100 g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (793)
T PLN00181 100 G---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAM 176 (793)
T ss_pred C---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccC
Confidence 8 9999999999999654 4556666666643211000 00011235
Q ss_pred cCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChH
Q 042346 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEA 756 (812)
Q Consensus 677 gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 756 (812)
||+.|||||++.+..++.++|||||||+||||+++..|+.... .. ...+... .+.... ..
T Consensus 177 gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~----~~~~~~~----~~~~~~------~~ 236 (793)
T PLN00181 177 EMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RT----MSSLRHR----VLPPQI------LL 236 (793)
T ss_pred CCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HH----HHHHHHh----hcChhh------hh
Confidence 8889999999999999999999999999999999887753111 01 1111110 011000 01
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 757 EAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 757 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. ......++.+||+.||.+||+|.|++++
T Consensus 237 ~-~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 237 N-WPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred c-CHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 1 1224577889999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=210.35 Aligned_cols=170 Identities=21% Similarity=0.182 Sum_probs=126.4
Q ss_pred CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCC
Q 042346 587 GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC 666 (812)
Q Consensus 587 gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~ 666 (812)
|+|.++++.+.. .+++..+++|+.|+++||+|||+++ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEVRGR-------PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 689999975432 2377888999999999999999875 999999999999999 9998764431
Q ss_pred cccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccc
Q 042346 667 DQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDK 746 (812)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 746 (812)
...||+.|||||++.+..++.++|||||||++|||+||+.||...... ....... ......
T Consensus 63 -------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~---~~~~~~~----~~~~~~----- 123 (176)
T smart00750 63 -------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL---SAILEIL----LNGMPA----- 123 (176)
T ss_pred -------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---cHHHHHH----HHHhcc-----
Confidence 126899999999999999999999999999999999999998543211 1111111 111100
Q ss_pred cCCCCCCChHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 747 RVGPPELNEAEAVE--LLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 747 ~~~~~~~~~~~~~~--~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
.............+ .+.+++.+||..||++||++.|+++++..+...
T Consensus 124 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 124 DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 00000111233333 589999999999999999999999999876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1427 consensus Uncharacterized conserved protein, contains RCC1 domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=209.91 Aligned_cols=238 Identities=15% Similarity=0.180 Sum_probs=177.6
Q ss_pred ccEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCCC-------CceecccCCceEEEEEccCceEEEEEeCCCeEEEec
Q 042346 71 ASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQ-------PKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWR 143 (812)
Q Consensus 71 ~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~~-------~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG 143 (812)
+++++--+-..|+.+|+.+| ..|.||+|..||||.. |+-+..+.-..+++-|+|..||++|+ ++|+|+.+|
T Consensus 58 iR~VasG~~aaH~vli~meg-k~~~wGRNekGQLGhgD~k~~e~Ptvi~gL~~~~iv~AA~GrnHTl~lt-dtG~v~afG 135 (443)
T KOG1427|consen 58 IRFVASGCAAAHCVLIDMEG-KCYTWGRNEKGQLGHGDMKQRERPTVISGLSKHKIVKAAAGRNHTLVLT-DTGQVLAFG 135 (443)
T ss_pred EEEEecccchhhEEEEeccc-ceeecccCccCccCccchhhccCCchhhhhhhhhHHHHhhccCcEEEEe-cCCcEEEec
Confidence 34544445578999999999 7999999999999943 55554444447889999999999998 999999999
Q ss_pred CCCCCCCCCCcccC----CCCCC---CceEEEeecCCeEEEEEccCCeEEEeecCCCCCcc-------------------
Q 042346 144 GTKVKDKGQLFSFS----SPGED---LKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEI------------------- 197 (812)
Q Consensus 144 ~n~~gqlG~~~~~~----~~~~~---~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~------------------- 197 (812)
+|.+||||-+.... ++++. ..|..|+||.+|+.-| +..+.+...|-..++|..
T Consensus 136 eNK~GQlGlgn~~~~v~s~~~~~~~~~~v~~v~cga~ftv~l-~~~~si~t~glp~ygqlgh~td~~~~~~~~~~~~~~e 214 (443)
T KOG1427|consen 136 ENKYGQLGLGNAKNEVESTPLPCVVSDEVTNVACGADFTVWL-SSTESILTAGLPQYGQLGHGTDNEFNMKDSSVRLAYE 214 (443)
T ss_pred ccccccccccccccccccCCCccccCccceeeccccceEEEe-ecccceeecCCccccccccCcchhhccccccceeeee
Confidence 99999999776432 22222 6789999999999998 888999999973322221
Q ss_pred -------cccccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCC--------CCcceee-----eeeeecccee
Q 042346 198 -------QRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPF--------SSAFEFS-----GGLALGANFT 257 (812)
Q Consensus 198 -------~~~~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~--------~~~~~~~-----~~ia~G~~ht 257 (812)
.....+..++.++||.+|+.|+.+++.||.||.+.||.||..+ ..++... .++-+|...+
T Consensus 215 ~~pr~~~i~~~dgvqiv~~acg~nhtvavd~nkrVysWGFGGyGRLGHaEqKDEmvpRlik~Fd~~~rg~~~~~~g~t~S 294 (443)
T KOG1427|consen 215 AQPRPKAIASLDGVQIVKVACGTNHTVAVDKNKRVYSWGFGGYGRLGHAEQKDEMVPRLIKVFDRNNRGPPNAILGYTGS 294 (443)
T ss_pred cCCCccccccccceeeEEEeccCcceeeecCCccEEEeccccccccccccchhhHHHHHHHHhcCCCCCCcceeeecccc
Confidence 1134577789999999999999999999999999999999321 1111100 1588898888
Q ss_pred EEEEecCCeEEEecCCCCCcccc----CC--ccccceeEEEeccceEEEEEcCCCeEEEecCC
Q 042346 258 CAIRQRSGLVACWGGTNRFEFDS----DV--IQDVSFESIVAGLDFVCGLTTRNLSMICWGPG 314 (812)
Q Consensus 258 ~al~~~~g~v~~WG~n~~gqlg~----~~--~~~~~~~~i~ag~~~~c~~~~~~~~v~cWG~~ 314 (812)
+.+.. -|.++.||.+..---.. +. ....+++-+.+|..| |.+..++ +.+.||..
T Consensus 295 l~v~e-~G~Lf~~g~~k~~ge~~mypkP~~dlsgwnl~~~~~~~~h-~~v~ad~-s~i~wg~~ 354 (443)
T KOG1427|consen 295 LNVAE-GGQLFMWGKIKNNGEDWMYPKPMMDLSGWNLRWMDSGSMH-HFVGADS-SCISWGHA 354 (443)
T ss_pred eeecc-cceeEEeeccccCcccccCCCchhhcCCccCCCcCcccee-eeecccc-cccccccc
Confidence 88875 69999999765432111 11 222356777888777 7777644 99999964
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=213.08 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=189.0
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 582 (812)
..+..+|.+...|+.|+|+| .|..+++|++.. ........++|.+|.-.|+.+.||||+.+++.|.....+.++..
T Consensus 192 lnl~tkl~e~hsgelwrgrw-qgndivakil~v---r~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNV---REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhccCCCcccccccc-cCcchhhhhhhh---hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 34456888999999999999 466777787753 22333445688999999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
||+.|+|+..|+..... +.+-.+.++++.++|+|++|||+.. |-|.---|.+..+++|++.+++|+= +-.++
T Consensus 268 ~mp~gslynvlhe~t~v------vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf 339 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSV------VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF 339 (448)
T ss_pred eccchHHHHHHhcCccE------EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee
Confidence 99999999999876543 2355677899999999999999987 3344556899999999999988751 11111
Q ss_pred CCCCcccccccccccCCCccCccccccCcCC---CcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVLT---AKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
.+......-.|.||+||.++..+-+ ..+|+|||.++||||.|...||....+- +-.....++|-
T Consensus 340 ------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm-------ecgmkialegl 406 (448)
T KOG0195|consen 340 ------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM-------ECGMKIALEGL 406 (448)
T ss_pred ------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-------hhhhhhhhccc
Confidence 1111222346889999999876644 3689999999999999999999654321 11122222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
|... +......+.+|+.-|+..||.+||.++.|+-.||+++
T Consensus 407 -------rv~i----ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 407 -------RVHI----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -------cccC----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1111 1234455778888899999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=224.78 Aligned_cols=170 Identities=21% Similarity=0.157 Sum_probs=129.1
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEc--CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceE-EEEEEEeC
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLM--DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG-LVGFCQEK 574 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~-l~~~~~~~ 574 (812)
....+|++.+.||+|+||+||+|.++ +++.+|||++.............+.|.+|+++|++++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34567999999999999999999874 4777899986532110011233556899999999999999985 4432
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeecc-CCCCEEEcCCCcEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI-KSSNILLDVNWTAR 653 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl-Kp~NILl~~~~~~k 653 (812)
+..+|||||+++++|... ... . ..+++.+++++|.|||+.+ |+|||| ||+|||++.++++|
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~---~-----------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH---G-----------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc---c-----------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 457999999999999732 100 0 1357889999999999998 999999 99999999999999
Q ss_pred EEeecccccCCCCccccc------ccccccCCCccCcccccc
Q 042346 654 VSDFGLSLLGSECDQEFI------STKAVGTVGYIDPEYYVM 689 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 689 (812)
|+|||+++.......... .....+++.|+|||.+..
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999986554322111 135578889999998864
|
|
| >KOG1427 consensus Uncharacterized conserved protein, contains RCC1 domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=193.83 Aligned_cols=256 Identities=11% Similarity=0.096 Sum_probs=188.3
Q ss_pred CCceEEEEEeCCccceEEEccCCCcccCC----------------CCccEEEEEccCceEEEEEeCCCeEEEccCCCCCC
Q 042346 40 KTSTVCGIIAGESIQRIQCYQNGSTIPVL----------------PNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTN 103 (812)
Q Consensus 40 g~~~~c~l~~~g~~~~~~~~g~~~~~~~~----------------~~~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gq 103 (812)
-.+|+.+|.-+| +++-||+|...++. ...++++.++|+.||++|+++| +|+.+|.|-+||
T Consensus 66 ~aaH~vli~meg---k~~~wGRNekGQLGhgD~k~~e~Ptvi~gL~~~~iv~AA~GrnHTl~ltdtG-~v~afGeNK~GQ 141 (443)
T KOG1427|consen 66 AAAHCVLIDMEG---KCYTWGRNEKGQLGHGDMKQRERPTVISGLSKHKIVKAAAGRNHTLVLTDTG-QVLAFGENKYGQ 141 (443)
T ss_pred chhhEEEEeccc---ceeecccCccCccCccchhhccCCchhhhhhhhhHHHHhhccCcEEEEecCC-cEEEeccccccc
Confidence 357888888888 89999998773311 1127888999999999999999 899999999999
Q ss_pred CCCC--------CceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccC----------------C-
Q 042346 104 FSFQ--------PKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFS----------------S- 158 (812)
Q Consensus 104 lg~~--------~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~----------------~- 158 (812)
||.. |.+.-+ ....|+.|+||..++.-|. ..+.+.+.|--.|||||+++... +
T Consensus 142 lGlgn~~~~v~s~~~~~~-~~~~v~~v~cga~ftv~l~-~~~si~t~glp~ygqlgh~td~~~~~~~~~~~~~~e~~pr~ 219 (443)
T KOG1427|consen 142 LGLGNAKNEVESTPLPCV-VSDEVTNVACGADFTVWLS-STESILTAGLPQYGQLGHGTDNEFNMKDSSVRLAYEAQPRP 219 (443)
T ss_pred ccccccccccccCCCccc-cCccceeeccccceEEEee-cccceeecCCccccccccCcchhhccccccceeeeecCCCc
Confidence 9954 222222 3457899999999998887 88999999999999999886421 0
Q ss_pred ----CCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccccc--------------cCceEEEEEeCCceeEEEe
Q 042346 159 ----PGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQRGF--------------KNLSMVGLVAGESHACGLS 220 (812)
Q Consensus 159 ----~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~~~--------------~~~~~~~i~aG~~h~~al~ 220 (812)
+.....++.+|||.+||.|+ +.++.||.||-.+++...-... .+..-.++-+|...+..+.
T Consensus 220 ~~i~~~dgvqiv~~acg~nhtvav-d~nkrVysWGFGGyGRLGHaEqKDEmvpRlik~Fd~~~rg~~~~~~g~t~Sl~v~ 298 (443)
T KOG1427|consen 220 KAIASLDGVQIVKVACGTNHTVAV-DKNKRVYSWGFGGYGRLGHAEQKDEMVPRLIKVFDRNNRGPPNAILGYTGSLNVA 298 (443)
T ss_pred cccccccceeeEEEeccCcceeee-cCCccEEEeccccccccccccchhhHHHHHHHHhcCCCCCCcceeeecccceeec
Confidence 22336788999999999999 8999999999866655433222 1222357889999999999
Q ss_pred eCCcEEEEecCCCCC-CC----cCCCCcceeeeeeeeccceeEEEEecCCeEEEecCCCCCcccc--------CCccc--
Q 042346 221 RNGALVCKGSNDSGQ-LN----VPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDS--------DVIQD-- 285 (812)
Q Consensus 221 ~~G~v~~WG~n~~gq-lg----~~~~~~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~--------~~~~~-- 285 (812)
.-|.+|.||.+...- -- +......-...-+-+|..| |.+..| .+...||...+|.+.- ..|+.
T Consensus 299 e~G~Lf~~g~~k~~ge~~mypkP~~dlsgwnl~~~~~~~~h-~~v~ad-~s~i~wg~~~~g~~lggp~~Qkss~~Pk~v~ 376 (443)
T KOG1427|consen 299 EGGQLFMWGKIKNNGEDWMYPKPMMDLSGWNLRWMDSGSMH-HFVGAD-SSCISWGHAQYGELLGGPNGQKSSAAPKKVD 376 (443)
T ss_pred ccceeEEeeccccCcccccCCCchhhcCCccCCCcCcccee-eeeccc-ccccccccccccccccCccccccccCccccc
Confidence 999999999875432 11 1111111111127777776 566664 7999999988887643 12222
Q ss_pred ----cceeEEEeccceEEEEEcC
Q 042346 286 ----VSFESIVAGLDFVCGLTTR 304 (812)
Q Consensus 286 ----~~~~~i~ag~~~~c~~~~~ 304 (812)
+.+..++.|..|+..+.++
T Consensus 377 ~l~~i~v~~VamGysHs~vivd~ 399 (443)
T KOG1427|consen 377 MLEGIHVMGVAMGYSHSMVIVDR 399 (443)
T ss_pred hhcceeccceeeccceEEEEEcc
Confidence 3466889999999998753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-20 Score=203.85 Aligned_cols=265 Identities=27% Similarity=0.396 Sum_probs=195.7
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC-CceEEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK-HLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ 581 (812)
|.+.+.||.|.|+.||++.+. ..+++|.+....... ......+.+|+.++..+.|+ +|+++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESK--SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccc--hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 677899999999999999886 789999886422211 12466788999999999988 7999999997777789999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC-cEEEEeeccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW-TARVSDFGLS 660 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DfGla 660 (812)
+|+.+++|.+++...... ..........++.|++.++.|+|+.+ ++||||||+|||++.+. .++++|||++
T Consensus 78 ~~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRK-----GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred ecCCCCcHHHHHHhcccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 999999999777654321 12245666789999999999999998 99999999999999998 7999999999
Q ss_pred ccCCCCcccc----cccccccCCCccCcccccc---CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 661 LLGSECDQEF----ISTKAVGTVGYIDPEYYVM---NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 661 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
.......... ......++..|++||.+.. ..+....|+||+|+++++++++..|+...... ........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~ 225 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLK 225 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHH
Confidence 7544433221 3466789999999999987 57888999999999999999999996443321 01111111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+...... .......... .......+.+++.+++..+|..|.++.+....
T Consensus 226 ~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 226 IILELPTP-SLASPLSPSN--PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHhcCCc-ccccccCccc--cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111110 0000000000 02233567788889999999999999888775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=210.89 Aligned_cols=263 Identities=22% Similarity=0.224 Sum_probs=190.3
Q ss_pred CcceeeeeccCCcEEEEEEEEcCC--cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC----CCceEEEEEE-EeC
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMDG--REVAVKREESCPKTNKLREKESAFDSELALLSRVHH----KHLVGLVGFC-QEK 574 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~g--~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H----~nIv~l~~~~-~~~ 574 (812)
+|.+.+.||+|+||.||++...+. +.+|+|......... ...+..|..++..+.+ +++..+++.. ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-----CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 799999999999999999987553 478888765321111 1145668888888763 5899999998 477
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-----
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN----- 649 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~----- 649 (812)
...++||+.+ +.+|.++....... .++..+.++|+.|++.+|++||+.+ ++||||||.|+++...
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~------~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~ 163 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPG------RFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEV 163 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCC------CcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCccc
Confidence 7889999988 77999988655421 2356777899999999999999999 9999999999999754
Q ss_pred CcEEEEeecccccCC--CCccc--c---c-ccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCC
Q 042346 650 WTARVSDFGLSLLGS--ECDQE--F---I-STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG 721 (812)
Q Consensus 650 ~~~kl~DfGla~~~~--~~~~~--~---~-~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~ 721 (812)
..+.|.|||+++... ..... . . .....||.+|.+++...+...+.+.|+||++.++.|++.|..|+......
T Consensus 164 ~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 164 RTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred ceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 469999999998322 22211 1 1 12346999999999999999999999999999999999999998554432
Q ss_pred CCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 722 SGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
.. ... ....... ..... .....+..+.++...+-..+..++|....+...|+.+....
T Consensus 244 ~~---~~~--~~~~~~~---~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 244 DL---KSK--FEKDPRK---LLTDR-------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ch---HHH--HHHHhhh---hcccc-------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 21 111 1111110 01110 01112233444444555589999999999999998888776
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=198.56 Aligned_cols=268 Identities=22% Similarity=0.250 Sum_probs=201.8
Q ss_pred CCcceeeeeccCCcEEEEEEE-EcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~ 578 (812)
-.|.+.++||+|.||+++.|+ +-+++.||||..... .+.-++..|.+.++.|. .+.|...+-|-.++....
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-------CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 358999999999999999997 458999999975431 12235667888888884 789999998888888889
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-----CcEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-----WTAR 653 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-----~~~k 653 (812)
||+|++ +-+|.|++.-.... ++.+..+.+|.|++.-++|+|++. +|.|||||+|+||..- ..+.
T Consensus 101 LVidLL-GPSLEDLFD~CgR~-------FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~Ih 169 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRR-------FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIH 169 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCc-------ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEE
Confidence 999998 77999998766543 267888999999999999999999 9999999999999543 4689
Q ss_pred EEeecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 654 VSDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
|+|||+|+...+.... .......||.+||+---..++..+.+.|+=|||-+++..|-|..||+....... .+
T Consensus 170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~-- 246 (449)
T KOG1165|consen 170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-KE-- 246 (449)
T ss_pred EEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-HH--
Confidence 9999999876554432 223456899999999999999999999999999999999999999976443211 00
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
....+-+. ++..+.+..-+.+++++..-+.-.=..+-++-|..+.+...+..+++...+..
T Consensus 247 --kYeKIGe~-------Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~ 307 (449)
T KOG1165|consen 247 --KYEKIGET-------KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETD 307 (449)
T ss_pred --HHHHhccc-------cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence 11111111 01111111113344455555555556677888999999999999988766554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-22 Score=192.26 Aligned_cols=260 Identities=22% Similarity=0.266 Sum_probs=189.4
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC-CCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH-KHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~ 576 (812)
...+|.+.++||.|+||.+|.|.. .+|++||||+... ......+..|..+++.|+| ..|..+.-|..+++.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-------~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-------KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-------cCCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 346799999999999999999974 5799999998654 2233456678899999975 457777777788888
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC---CcEE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN---WTAR 653 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~k 653 (812)
..||||.+ +.+|.+++.-.... .+.++.+-++-|++.-++|+|.++ +|||||||+|+|+.-+ ..+.
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~-------ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~ 154 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRR-------FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLY 154 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhh-------hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEE
Confidence 89999998 78999998654432 267788899999999999999999 9999999999999543 5789
Q ss_pred EEeecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 654 VSDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
|+||||++...+.... .......||.+|.+--...+...+.+.|+=|+|.+|..+.-|..||+....... .+
T Consensus 155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-~Q-- 231 (341)
T KOG1163|consen 155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-KQ-- 231 (341)
T ss_pred EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-HH--
Confidence 9999999866543321 234566899999998888888888999999999999999999999976443221 11
Q ss_pred HHHHHHHHhcccc---ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 729 EFAVSQILAGQLH---CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 729 ~~~~~~~~~~~~~---~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
....+.+.++. ++++ ..++.++...+.-|=..--++-|....+.+.+.-++
T Consensus 232 --KyEkI~EkK~s~~ie~LC----------~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 232 --KYEKISEKKMSTPIEVLC----------KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred --HHHHHHHhhcCCCHHHHh----------CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 11222222211 1111 122333444455566666666677666655554443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=234.83 Aligned_cols=259 Identities=19% Similarity=0.226 Sum_probs=188.9
Q ss_pred ceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCc-chhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 504 SLENKVGIGSFGTVYKGKLM-DGREVAVKREESCP-KTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 504 ~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~-~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
...+++|.|.+|.|+..... ..+..+.|.+.... .....+.....+..|+-+-..|+|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34688999999988877542 34444444432110 11111222223667888889999999998888887777777779
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
||+++ +|+.++...... ....+-.++.|++.|+.|||+.+ |.|||||++|+|++.++.+||+|||.+.
T Consensus 401 E~~~~-Dlf~~~~~~~~~--------~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKL--------TPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAAS 468 (601)
T ss_pred hcccH-HHHHHHhccccc--------chhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcce
Confidence 99999 999999765222 23344578999999999999999 9999999999999999999999999987
Q ss_pred cCCCCccc--ccccccccCCCccCccccccCcCCCc-chhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 662 LGSECDQE--FISTKAVGTVGYIDPEYYVMNVLTAK-TDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 662 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
.+.-.... ......+|+..|+|||++.+..|+++ .||||.|+++..|++|+.||.......+.. ......
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~ 541 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYS 541 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccc
Confidence 65443333 45667789999999999999999986 899999999999999999986544332221 000000
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
. ... ....+.......+...+.++.++|+.||.+|-|+++|++
T Consensus 542 ~---~~~-~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 542 D---QRN-IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c---ccc-cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 000 011122223556677788999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-20 Score=187.33 Aligned_cols=175 Identities=17% Similarity=0.112 Sum_probs=134.6
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHH------HHHHHHHHHHHhccCCCceEEEEEE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKE------SAFDSELALLSRVHHKHLVGLVGFC 571 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~------~~~~~Ei~~l~~l~H~nIv~l~~~~ 571 (812)
...++|...++||.|+||.||+... ++..+|+|.+....... .... ..+++|++.+.+++|++|..+.+++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~--~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT--ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch--HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 3468999999999999999999766 67789999986422211 1221 2368899999999999999999887
Q ss_pred EeC--------CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCC
Q 042346 572 QEK--------DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSN 643 (812)
Q Consensus 572 ~~~--------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~N 643 (812)
... ...+|+|||++|.+|.++... + .....+++.+|..||+.+ ++||||||+|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~------------~----~~~~~~i~~~l~~lH~~g---i~H~Dikp~N 165 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPEI------------S----EDVKAKIKASIESLHQHG---MVSGDPHKGN 165 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhhc------------c----HHHHHHHHHHHHHHHHcC---CccCCCChHH
Confidence 643 247899999999999887421 0 124569999999999999 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHH
Q 042346 644 ILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELL 709 (812)
Q Consensus 644 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ell 709 (812)
||++.++ ++|+|||........... ..+...+.|..++|+|+||+.|..+.
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999998 999999987654321111 11344556778999999999987665
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.5e-20 Score=204.03 Aligned_cols=220 Identities=25% Similarity=0.336 Sum_probs=166.1
Q ss_pred HHhccCCCceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 042346 556 LSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSII 635 (812)
Q Consensus 556 l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~iv 635 (812)
|+.+.|.|+.+|+|.+.++...+.|.+|+..|+|.|.+..... -++|.....+.++|++||+|||... -..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~-------~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~ 71 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI-------KLDYFFILSFIRDISKGLAYLHNSP--IGY 71 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc-------CccHHHHHHHHHHHHHHHHHHhcCc--cee
Confidence 3568899999999999999999999999999999999976332 2377888899999999999999865 139
Q ss_pred eeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccC-------cCCCcchhHHHHHHHHHH
Q 042346 636 HRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-------VLTAKTDIYGLGVVLLEL 708 (812)
Q Consensus 636 HrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDVwS~Gvvl~el 708 (812)
|+.+++.|.++|..+.+||+|||+..+..............-..-|.|||.+... ..+.+.||||||++++|+
T Consensus 72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999999998766431111112222345679999998753 146779999999999999
Q ss_pred HcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCCh-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 709 LTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNE-AEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 709 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~-~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
++.+.||........+.+++.. +.. ... ....|.... .+..+.+..++.+||..+|.+||++++|-..+
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~----~~~-~~~-----~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILR----VKK-GGS-----NPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred HhccCccccccccCChHHHHHH----HHh-cCC-----CCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 9999999764433333222222 222 111 111122221 25556788999999999999999999999999
Q ss_pred HHHHHhc
Q 042346 788 ERALAIC 794 (812)
Q Consensus 788 e~~~~~~ 794 (812)
+.+....
T Consensus 222 ~~~~~~~ 228 (484)
T KOG1023|consen 222 LTINKGG 228 (484)
T ss_pred hhhcccc
Confidence 8877654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=178.53 Aligned_cols=195 Identities=16% Similarity=0.185 Sum_probs=144.3
Q ss_pred ceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEEEEEE
Q 042346 504 SLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 504 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 582 (812)
.....|++|+||+||.+.. .+.+++.+.+...+..... -....|.+|+++|++|. |+++.+++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~-~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRG-VAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhh-HHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3467899999999997766 6888888877643321111 11225788999999995 5889999886 34699999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeecc-CCCCEEEcCCCcEEEEeecccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI-KSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl-Kp~NILl~~~~~~kl~DfGla~ 661 (812)
|+++.+|.+.+... .+.++.|++++|.++|+++ |+|||| ||+|||++.++.++|+|||++.
T Consensus 79 yI~G~~L~~~~~~~---------------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 79 YLAGAAMYQRPPRG---------------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred eecCccHHhhhhhh---------------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 99999987543210 1347789999999999999 999999 7999999999999999999998
Q ss_pred cCCCCccc----c-------cccccccCCCccCccccccC-cCC-CcchhHHHHHHHHHHHcCCCCCCCCCCCC
Q 042346 662 LGSECDQE----F-------ISTKAVGTVGYIDPEYYVMN-VLT-AKTDIYGLGVVLLELLTGKKAVFKNEDGS 722 (812)
Q Consensus 662 ~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~ksDVwS~Gvvl~elltG~~p~~~~~~~~ 722 (812)
........ . .......++.|++|+..... ..+ .+.+.++-|.-+|.++|++.++..+.++.
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~~ 214 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEGQ 214 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCCC
Confidence 65443210 0 01122467888888854321 223 45789999999999999999987665544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-21 Score=218.59 Aligned_cols=250 Identities=21% Similarity=0.246 Sum_probs=177.7
Q ss_pred CcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
+|...+.||.++|=+|.+|++++|. |+||++.+.......+...+++ +|++ ...++|||.+++.-.-..+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 5778899999999999999998776 9999987544333333333333 3444 66679999999988766666778999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
+|..+ +|+|.|..++.. ...+..-|+.|+++||.-.|..+ |.|||||.+||||+.-.-+.|+||..-+
T Consensus 101 qyvkh-nLyDRlSTRPFL--------~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFL--------VLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHHhh-hhhhhhccchHH--------HHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 99966 999999766543 34455569999999999999999 9999999999999999999999997654
Q ss_pred c--CCCCcc---cccccccccCCCccCcccccc----------Cc-CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCc
Q 042346 662 L--GSECDQ---EFISTKAVGTVGYIDPEYYVM----------NV-LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL 725 (812)
Q Consensus 662 ~--~~~~~~---~~~~~~~~gt~~y~aPE~~~~----------~~-~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~ 725 (812)
. +..++. .+...+...-..|+|||.+.. .. ++++.||||+||+++||++-.+|.+...
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------ 242 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------ 242 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------
Confidence 2 222111 122333344558999998753 12 6789999999999999988644433211
Q ss_pred hhHHHHHH--HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 726 DVVEFAVS--QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 726 ~~~~~~~~--~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
++..+... ...+..++++-| ..+++++..|++.||.+|.++++.|+.
T Consensus 243 QL~aYr~~~~~~~e~~Le~Ied--------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 243 QLLAYRSGNADDPEQLLEKIED--------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhHhccCccCHHHHHHhCcC--------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00100000 000001111111 138899999999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=178.89 Aligned_cols=144 Identities=17% Similarity=0.166 Sum_probs=106.4
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHH---------------------HHHHHHHHHHHHHHhccCCCc
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLR---------------------EKESAFDSELALLSRVHHKHL 564 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~---------------------~~~~~~~~Ei~~l~~l~H~nI 564 (812)
.+.||+|+||.||+|...+|+.||||++.......... ........|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999998889999999986432110000 011233469999999988876
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHH-hhcCCCCeEeeccCCCC
Q 042346 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL-HNYAVPSIIHRDIKSSN 643 (812)
Q Consensus 565 v~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yL-H~~~~~~ivHrDlKp~N 643 (812)
.....+... ..+|||||+++++|...+.... .++....++++.|++.+|.|| |+.+ |+||||||+|
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~--------~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~N 148 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA--------PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYN 148 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC--------CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 443333222 2389999999877765532221 124566789999999999999 6888 9999999999
Q ss_pred EEEcCCCcEEEEeecccccC
Q 042346 644 ILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 644 ILl~~~~~~kl~DfGla~~~ 663 (812)
||++ ++.++|+|||++...
T Consensus 149 Ili~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 149 LLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEE-CCcEEEEEccccccC
Confidence 9998 478999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.2e-19 Score=176.05 Aligned_cols=145 Identities=16% Similarity=0.151 Sum_probs=109.5
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchh---------------------hHHHHHHHHHHHHHHHHhccCCCc
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTN---------------------KLREKESAFDSELALLSRVHHKHL 564 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~---------------------~~~~~~~~~~~Ei~~l~~l~H~nI 564 (812)
.+.||+|+||.||+|++.+|+.||||++....... ........+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999998789999999987532110 011112345679999999999988
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchhhh-hhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh-cCCCCeEeeccCCC
Q 042346 565 VGLVGFCQEKDERLLVYEYMSNGALHDH-LHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN-YAVPSIIHRDIKSS 642 (812)
Q Consensus 565 v~l~~~~~~~~~~~lV~ey~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlKp~ 642 (812)
.....+... ..+|||||++++++... +.... ++.....+++.+++.+|.+||+ .+ |+||||||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~---------~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~ 147 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVP---------LEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEY 147 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhcc---------CCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChh
Confidence 554444333 24899999998755443 32211 1345567899999999999999 87 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSE 665 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~ 665 (812)
|||++ ++.++|+|||++.....
T Consensus 148 NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 148 NILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hEEEE-CCCEEEEEcccceecCC
Confidence 99999 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-19 Score=184.14 Aligned_cols=240 Identities=19% Similarity=0.226 Sum_probs=150.9
Q ss_pred CcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc----------CCCceEEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVH----------HKHLVGLVGF 570 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~----------H~nIv~l~~~ 570 (812)
.+...+.||.|+|+.||.+++.+ ++++|+|++.... .......+.+.+|.-....+. |-.++-.++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 35668899999999999999864 8999999987544 222334555666654444432 2222222222
Q ss_pred EE---------eCC--------eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCC
Q 042346 571 CQ---------EKD--------ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPS 633 (812)
Q Consensus 571 ~~---------~~~--------~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ 633 (812)
.. ... ..+++|+-+ .++|.+++..-...... ...+....++.+..|+++.+++||.++
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~G--- 165 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYG--- 165 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcc---
Confidence 21 111 136788877 45888886431111111 122356677888899999999999999
Q ss_pred eEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCcccccc--------CcCCCcchhHHHHHHH
Q 042346 634 IIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM--------NVLTAKTDIYGLGVVL 705 (812)
Q Consensus 634 ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwS~Gvvl 705 (812)
|+|+||||+|+|++.+|.++|+||+......... .. ...+..|.+||.... -.++.+.|.|++|+++
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 9999999999999999999999998775433211 11 345578999997643 2578899999999999
Q ss_pred HHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCC
Q 042346 706 LELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKER 777 (812)
Q Consensus 706 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 777 (812)
|.|.+++.||........... . -..+. ++++.++.||..+|+.||.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~--------------------~---f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEW--------------------D---FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGG--------------------G---GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCccccccc--------------------c---chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999854332111100 0 11234 788889999999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=180.33 Aligned_cols=197 Identities=20% Similarity=0.251 Sum_probs=135.8
Q ss_pred cCCCceEEEEEEEeC---------------------------CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHH
Q 042346 560 HHKHLVGLVGFCQEK---------------------------DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612 (812)
Q Consensus 560 ~H~nIv~l~~~~~~~---------------------------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~ 612 (812)
+|||||++..+|.++ ..+|+||...+. +|.+||..+.. +...+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~---------s~r~~ 343 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHR---------SYRTG 343 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCC---------chHHH
Confidence 599999999987542 235899988754 99999976543 33445
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE--cCCC--cEEEEeecccccCCC--C--cccccccccccCCCccCc
Q 042346 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL--DVNW--TARVSDFGLSLLGSE--C--DQEFISTKAVGTVGYIDP 684 (812)
Q Consensus 613 l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl--~~~~--~~kl~DfGla~~~~~--~--~~~~~~~~~~gt~~y~aP 684 (812)
.-|+.|+++|+.|||.++ |.|||+|++|||+ |+|. .+.|+|||...--.. - ......-..-|...-|||
T Consensus 344 ~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 344 RVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence 568999999999999999 9999999999999 4443 578999997632111 0 011111223467789999
Q ss_pred cccccCc------CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHH
Q 042346 685 EYYVMNV------LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEA 758 (812)
Q Consensus 685 E~~~~~~------~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 758 (812)
|+....+ --.|+|.|+.|.+.||+++...||++..+ ..++.-.+ .+..+.. .+...
T Consensus 421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~r~Y-----qe~qLPa-----------lp~~v 482 (598)
T KOG4158|consen 421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDTRTY-----QESQLPA-----------LPSRV 482 (598)
T ss_pred hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heechhhh-----hhhhCCC-----------CcccC
Confidence 9886432 12589999999999999999999976321 11111111 1111111 12334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 759 VELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 759 ~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
+..+++++...|+.||.+|++.+-....|
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 45688889999999999999876544443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.9e-20 Score=201.52 Aligned_cols=234 Identities=24% Similarity=0.244 Sum_probs=176.7
Q ss_pred eeccCCcEEEEEEE----EcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEEEEEE
Q 042346 508 KVGIGSFGTVYKGK----LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 508 ~LG~G~fG~Vy~a~----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 582 (812)
.+|+|.||.|++.+ .+.+.-+|.|.+.........+. ....|..++...+ ||.++++...++.+...+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 37899999999764 33577788887764322222221 3445778888886 9999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
|..+|.|...+....... ......+...++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++.
T Consensus 78 ~~rgg~lft~l~~~~~f~--------~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVMFD--------ELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hcccchhhhccccCCchH--------HHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhH
Confidence 999999999886554332 2223346678899999999999 99999999999999999999999999976
Q ss_pred CCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccc
Q 042346 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742 (812)
Q Consensus 663 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (812)
.-... ...||..|||||++. .....+|.||||++++||+||..||.. + ....++..
T Consensus 147 ~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~----~~~~Il~~---- 202 (612)
T KOG0603|consen 147 AVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------D----TMKRILKA---- 202 (612)
T ss_pred hHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------H----HHHHHhhh----
Confidence 54322 227899999999988 577889999999999999999999854 1 12222221
Q ss_pred cccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHH
Q 042346 743 VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI--TDIVANL 787 (812)
Q Consensus 743 ~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~evl~~L 787 (812)
. ...+.++.....+++.+++..+|.+|.-. ..+.+..
T Consensus 203 ----~----~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 203 ----E----LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred ----c----cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 1 12245666677788888999999999654 3444443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=167.07 Aligned_cols=135 Identities=13% Similarity=0.123 Sum_probs=102.1
Q ss_pred eeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-----cCCCceEEEEEEEeCC---e
Q 042346 505 LENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-----HHKHLVGLVGFCQEKD---E 576 (812)
Q Consensus 505 ~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~l~~~~~~~~---~ 576 (812)
-.+.||+|+|+.||. +.+....+||++..... ...+.+.+|+++++.+ +||||++++++++++. .
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 357899999999996 44333347998754211 1335688999999999 5799999999999874 3
Q ss_pred EE-EEEEe--cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHH-HHHhhcCCCCeEeeccCCCCEEEcCC---
Q 042346 577 RL-LVYEY--MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI-DYLHNYAVPSIIHRDIKSSNILLDVN--- 649 (812)
Q Consensus 577 ~~-lV~ey--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL-~yLH~~~~~~ivHrDlKp~NILl~~~--- 649 (812)
.+ +|+|| +++++|.+++..... +.. ..++.+++.++ +|||+++ |+||||||+|||++.+
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~~~---------~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~ 144 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQCRY---------EED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISES 144 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcccc---------cHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCC
Confidence 33 78999 667999999965321 111 24577888777 9999999 9999999999999743
Q ss_pred -CcEEEEeeccc
Q 042346 650 -WTARVSDFGLS 660 (812)
Q Consensus 650 -~~~kl~DfGla 660 (812)
..++|+||+.+
T Consensus 145 ~~~~~LiDg~G~ 156 (210)
T PRK10345 145 EVIPVVCDNIGE 156 (210)
T ss_pred CCcEEEEECCCC
Confidence 47999995433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.9e-18 Score=198.36 Aligned_cols=258 Identities=23% Similarity=0.266 Sum_probs=178.0
Q ss_pred HHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc---CCCceEEEEE
Q 042346 494 SELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH---HKHLVGLVGF 570 (812)
Q Consensus 494 ~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~ 570 (812)
.+.+.-.+.|.+.+.||+|+||.||+|...+++.||+|+-..... + +|.-=.+++.+|+ -+-|..+...
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--W------EfYI~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--W------EFYICLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--e------eeeehHHHHHhhchhhhcchHHHHHH
Confidence 344445567999999999999999999988899999998543111 1 1111112233333 2344455555
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc---
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD--- 647 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~--- 647 (812)
+.-.+..+||+||.+.|+|.|++.... ..+|...+.++.|+++-+++||..+ |||+||||+|+||.
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~--------~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~ 831 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLINTNK--------VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREI 831 (974)
T ss_pred HccCCcceeeeeccccccHHHhhccCC--------CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeeccc
Confidence 556677899999999999999997322 2356667889999999999999999 99999999999993
Q ss_pred ----CCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 648 ----VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 648 ----~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
.+.-++|+|||-+..+..............|-.+-.+|...+++++...|-|.|.-+++-||.|+..=..
T Consensus 832 ~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~------ 905 (974)
T KOG1166|consen 832 CADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVK------ 905 (974)
T ss_pred CCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhc------
Confidence 2346899999998644333333345566789999999999999999999999999999999999854211
Q ss_pred CchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcc
Q 042346 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 795 (812)
.|. ...++.. .+.....++...+++ .+|..|-..=|...++...|++.++...
T Consensus 906 -------------~g~-~~~~~~~--~~Ry~~~~~W~~~F~---~lLN~~~~~~p~l~~lr~~~~~~~~~~~ 958 (974)
T KOG1166|consen 906 -------------NGS-SWMVKTN--FPRYWKRDMWNKFFD---LLLNPDCDTLPNLQELRTELEEVLAEHF 958 (974)
T ss_pred -------------CCc-ceecccc--chhhhhHHHHHHHHH---HHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence 111 1111111 112223444444444 3455444444777777777777666543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=162.39 Aligned_cols=139 Identities=20% Similarity=0.327 Sum_probs=114.1
Q ss_pred eeeccCCcEEEEEEEEcCCcEEEEEeeccCcchh---hHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEe
Q 042346 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTN---KLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
+.||+|++|.||+|.+ ++..+++|+........ ........+.+|++++..++|++|.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 77889999765322111 1122235678899999999999998777777777788999999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
+++++|.+++.... + .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-----------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985431 1 55789999999999999998 99999999999999 78999999998854
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=185.31 Aligned_cols=141 Identities=21% Similarity=0.281 Sum_probs=112.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcch-h--hHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKT-N--KLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~-~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..|...++||+|+||.||++.+.+. .+++|+....... . ......+.+.+|+++++.++|++++..+.++.+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3456688999999999999988544 4444443211111 1 1122345688999999999999999888888877788
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++++|.+++. .+.+++.+++++|.|||+.+ |+||||||+|||+ .++.++|+||
T Consensus 412 ~lv~E~~~g~~L~~~l~----------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred EEEEEecCCCcHHHHHH----------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 99999999999999885 13578999999999999998 9999999999999 6779999999
Q ss_pred ccccc
Q 042346 658 GLSLL 662 (812)
Q Consensus 658 Gla~~ 662 (812)
|+++.
T Consensus 472 Gla~~ 476 (535)
T PRK09605 472 GLGKY 476 (535)
T ss_pred ccccc
Confidence 99865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=159.55 Aligned_cols=150 Identities=21% Similarity=0.168 Sum_probs=113.8
Q ss_pred HHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchh-----------------hHHHHHHHHHHHHHHH
Q 042346 494 SELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTN-----------------KLREKESAFDSELALL 556 (812)
Q Consensus 494 ~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~-----------------~~~~~~~~~~~Ei~~l 556 (812)
.++......|.+.+.||+|+||.||++...+++.||||++....... ........+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 44555555588899999999999999998889999999865321100 0011223467799999
Q ss_pred HhccCCC--ceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042346 557 SRVHHKH--LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSI 634 (812)
Q Consensus 557 ~~l~H~n--Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~i 634 (812)
..+.|++ +...++. ...++||||+++++|.+.... ....+++.+++.++.++|+.+ |
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------------~~~~~~~~~i~~~l~~lh~~g---i 146 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------------EDPEEVLDEILEEIVKAYKHG---I 146 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------------ccHHHHHHHHHHHHHHHHHCC---C
Confidence 9998874 4455442 345899999999998776431 012468899999999999988 9
Q ss_pred EeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 635 IHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 635 vHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
+||||||+|||+++++.++|+|||++....
T Consensus 147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999999999995543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=164.07 Aligned_cols=147 Identities=16% Similarity=0.144 Sum_probs=110.2
Q ss_pred CcceeeeeccCCcEEEEEEE--EcCCcEEEEEeeccCcchh-------------------hHHHHHHHHHHHHHHHHhcc
Q 042346 502 NFSLENKVGIGSFGTVYKGK--LMDGREVAVKREESCPKTN-------------------KLREKESAFDSELALLSRVH 560 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~--~~~g~~vavK~~~~~~~~~-------------------~~~~~~~~~~~Ei~~l~~l~ 560 (812)
-|.+.+.||+|+||.||+|. ..+|+.||+|++....... ........+.+|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 4689999999986432110 01112345678999999997
Q ss_pred CCC--ceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeec
Q 042346 561 HKH--LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRD 638 (812)
Q Consensus 561 H~n--Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrD 638 (812)
+.. +.+++++ ...+|||||+++.+|..++...... ...+...++.||+.+|.|||+.+ .|+|||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~--------~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D 174 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEP--------EEEEEFELYDDILEEMRKLYKEG--ELVHGD 174 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCc--------chHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence 633 3444543 2358999999998887765322211 22344689999999999999987 399999
Q ss_pred cCCCCEEEcCCCcEEEEeecccccC
Q 042346 639 IKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 639 lKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
|||+|||++ +++++|+|||++...
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999 889999999998643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-16 Score=159.94 Aligned_cols=135 Identities=24% Similarity=0.349 Sum_probs=108.4
Q ss_pred eeccCCcEEEEEEEEcCCcEEEEEeeccCcchh---hHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEec
Q 042346 508 KVGIGSFGTVYKGKLMDGREVAVKREESCPKTN---KLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 508 ~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 584 (812)
.||+|+||.||++.+ ++..+++|+........ ........+.+|++++..++|+++.....++.+.+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 67899999865322111 11223456788999999999987665555566667779999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
++++|.+++.... ..++.+++++|.+||+.+ ++|||+||+|||++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~---------------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---------------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---------------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875321 068899999999999998 99999999999999 88999999998855
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-17 Score=190.40 Aligned_cols=208 Identities=24% Similarity=0.374 Sum_probs=141.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|..++.|..|+||.||..+++. .+++|+|+-+. ..+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq-----------~lilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-----------NLILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccccc-----------chhhhc--cccccCCccee--------------
Confidence 458889999999999999998864 67788854221 000000 22222333333
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
|+=...++...... .+++.+++|||+.+ |+|||+||+|.||+.-|++|+.|||+
T Consensus 136 -------gDc~tllk~~g~lP----------------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLP----------------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGL 189 (1205)
T ss_pred -------chhhhhcccCCCCc----------------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhh
Confidence 34444443322211 12378899999998 99999999999999999999999999
Q ss_pred cccCCCC-------------cccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCch
Q 042346 660 SLLGSEC-------------DQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726 (812)
Q Consensus 660 a~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~ 726 (812)
+++.-.. ..++..+...||+.|+|||++....|...+|.|++|+|+||.+-|+.||+.+... +
T Consensus 190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe----e 265 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----E 265 (1205)
T ss_pred hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH----H
Confidence 8653211 1122334558999999999999999999999999999999999999999876432 2
Q ss_pred hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC
Q 042346 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP 778 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 778 (812)
+....+... +..++. +.....+.++++.+.|+.+|..|-
T Consensus 266 lfg~visd~------------i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 266 LFGQVISDD------------IEWPEE-DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHhhhhhhh------------cccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence 222221111 011111 223334567888889999999994
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.3e-17 Score=178.97 Aligned_cols=172 Identities=26% Similarity=0.337 Sum_probs=127.1
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..|+.|++++..+|.++|..+...... +|...++++.|++.+++| ++ .+|||+||.||+...+..+||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~-----s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEER-----SLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCccccc-----chhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhh
Confidence 468999999999999999866554432 566778999999999999 55 8999999999999999999999
Q ss_pred eecccccCCCCc----ccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHH
Q 042346 656 DFGLSLLGSECD----QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 656 DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 730 (812)
|||+........ .....+...||..||+||.+.+..|+.|+||||||+||+||+. =..++.. ..
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------~~ 467 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------IA 467 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------HH
Confidence 999987655443 1123456689999999999999999999999999999999997 2222210 11
Q ss_pred HHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI 780 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 780 (812)
....+.++.+.+ ....+.++.. .|+.+++...|.+||++
T Consensus 468 t~~d~r~g~ip~----------~~~~d~p~e~-~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 468 TLTDIRDGIIPP----------EFLQDYPEEY-TLLQQLLSPSPEERPSA 506 (516)
T ss_pred hhhhhhcCCCCh----------HHhhcCcHHH-HHHHHhcCCCcccCchH
Confidence 222233333221 1112222222 56778999999999943
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.6e-14 Score=136.77 Aligned_cols=135 Identities=19% Similarity=0.170 Sum_probs=111.7
Q ss_pred eeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC--CCceEEEEEEEeCCeEEEEEE
Q 042346 505 LENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH--KHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 505 ~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e 582 (812)
+.+.||+|.++.||++... ++.+++|....... ...+.+|+..++.++| .++.+++.++...+..+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence 3578999999999999984 47899998754211 3467889999999976 589999998888888999999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
|+++..+..+ +......++.+++++|++||....++++|+||||+|||+++++.+++.||+++..
T Consensus 74 ~~~g~~~~~~---------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV---------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC---------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9998777655 1234457899999999999986545599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.8e-14 Score=149.48 Aligned_cols=139 Identities=18% Similarity=0.132 Sum_probs=104.8
Q ss_pred eeec-cCCcEEEEEEEEcCCcEEEEEeeccCcchh--------hHHHHHHHHHHHHHHHHhccCCCc--eEEEEEEEeCC
Q 042346 507 NKVG-IGSFGTVYKGKLMDGREVAVKREESCPKTN--------KLREKESAFDSELALLSRVHHKHL--VGLVGFCQEKD 575 (812)
Q Consensus 507 ~~LG-~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~--------~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~~~~~~~~ 575 (812)
..|| .|+.|+||+... ++..++||++....... ........+.+|++++..|+|++| +..+++...+.
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 888999999887 47889999875311100 111234567889999999998885 67777654432
Q ss_pred e----EEEEEEecCC-CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 576 E----RLLVYEYMSN-GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 576 ~----~~lV~ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
. .++||||+++ .+|.+++..... + ...+.+|+.+|.+||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l---------~----~~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPL---------S----EEQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDG 179 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCC---------C----HHHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCC
Confidence 2 2599999997 689988864321 1 124678999999999999 99999999999999999
Q ss_pred cEEEEeeccccc
Q 042346 651 TARVSDFGLSLL 662 (812)
Q Consensus 651 ~~kl~DfGla~~ 662 (812)
.++|+|||.+..
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999998854
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=144.77 Aligned_cols=141 Identities=19% Similarity=0.206 Sum_probs=98.6
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHH-------------------HHHHHHHHHHHHhccCCC--c
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREK-------------------ESAFDSELALLSRVHHKH--L 564 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~-------------------~~~~~~Ei~~l~~l~H~n--I 564 (812)
.+.||+|+||.||++.+.+++.||||++............ ......|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999987642211111110 011245677777775443 4
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchhhh-hhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh-cCCCCeEeeccCCC
Q 042346 565 VGLVGFCQEKDERLLVYEYMSNGALHDH-LHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN-YAVPSIIHRDIKSS 642 (812)
Q Consensus 565 v~l~~~~~~~~~~~lV~ey~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlKp~ 642 (812)
.+.++. ...++||||++++.+... +..... . ....+++.+++.++.++|. .+ |+||||||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~---------~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~ 144 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL---------L-EDPEELYDQILELMRKLYREAG---LVHGDLSEY 144 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhh---------c-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChh
Confidence 555543 235899999998554321 111100 0 2346789999999999999 77 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~ 664 (812)
||+++ ++.++|+|||.+....
T Consensus 145 Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 145 NILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hEEEE-CCcEEEEECccccccc
Confidence 99999 8999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.9e-16 Score=182.14 Aligned_cols=256 Identities=21% Similarity=0.284 Sum_probs=184.5
Q ss_pred CcceeeeeccCCcEEEEEEEEcC--CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMD--GREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~ 578 (812)
.|.+.+.||+|.|+.|-...... ...+++|.+.... ...........|..+-+.+. |+|++.+++...+.+..+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 36677889999999998886533 4456666655432 11222334445777777776 999999999999999999
Q ss_pred EEEEecCCCchhhhh-hcCCCCCccccccccHHHHHHHHHHHHHHHHHHh-hcCCCCeEeeccCCCCEEEcCCC-cEEEE
Q 042346 579 LVYEYMSNGALHDHL-HNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH-NYAVPSIIHRDIKSSNILLDVNW-TARVS 655 (812)
Q Consensus 579 lV~ey~~~gsL~~~l-~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH-~~~~~~ivHrDlKp~NILl~~~~-~~kl~ 655 (812)
+++||..++++++.+ +........ ...-.++.|+..++.|+| ..+ +.||||||+|.+++..+ ..+++
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~-------~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~ 167 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSS-------SSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIA 167 (601)
T ss_pred cccCcccccccccccccCCccCCCC-------cchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCC
Confidence 999999999999999 433211111 111358899999999999 777 99999999999999999 99999
Q ss_pred eecccccCCC-Cccccccccccc-CCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 656 DFGLSLLGSE-CDQEFISTKAVG-TVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 656 DfGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|||+|..... ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--------- 238 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--------- 238 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---------
Confidence 9999987665 444445556678 9999999999884 456779999999999999999999765432221
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
.+..+...+................++..+++..+|..|.+.+++..
T Consensus 239 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 239 ------RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ------cceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 11111111100011112333444567778889999999999988764
|
|
| >KOG1428 consensus Inhibitor of type V adenylyl cyclases/Neuronal presynaptic protein Highwire/PAM/RPM-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7e-13 Score=152.51 Aligned_cols=199 Identities=16% Similarity=0.171 Sum_probs=136.6
Q ss_pred ccEEEEEccCceEEEEE--eCCCeEEEccCCCCCCCCCCCceecccCCceEEEEEccCceEEEEEeCCCeEEEecCC---
Q 042346 71 ASFQAISGGQNYFCGLR--SGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGT--- 145 (812)
Q Consensus 71 ~~~~~i~~G~~~~~al~--~~g~~v~~WG~n~~gqlg~~~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n--- 145 (812)
..+++|+.|-+-..++. .+| .+..-|+... .|..-+.++ ....+|+.+ +|..|+..+..++|++|-.|.-
T Consensus 525 ~~IVq~SVG~D~~~~~~~A~~G-~I~~v~D~k~--~~~~Rr~~P-~n~rKIv~v-~~s~~VY~~vSenGkifM~G~~tm~ 599 (3738)
T KOG1428|consen 525 EPIVQISVGIDTIMFRSGAGHG-WIASVDDKKR--NGRLRRLVP-SNRRKIVHV-CASGHVYGYVSENGKIFMGGLHTMR 599 (3738)
T ss_pred CceEEEEeccchhheeeccCcc-eEEeccCccc--ccchhhcCC-CCcceeEEE-eeeeEEEEEEccCCeEEeecceeEE
Confidence 48999999976555554 455 4555554221 121111121 134467666 7778999988899999998742
Q ss_pred --CCCCCCCCcccCCCCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCc---------------------------
Q 042346 146 --KVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADE--------------------------- 196 (812)
Q Consensus 146 --~~gqlG~~~~~~~~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~--------------------------- 196 (812)
...|+=+ ...+.-|.++|-|..|+||+ +.+|.||.||-|+.+|.
T Consensus 600 ~n~SSqmln------~L~~~~isslAlGKsH~~av-~rNG~l~T~GlNN~~QCGRVEs~sTt~s~~~s~~~e~~iCP~G~ 672 (3738)
T KOG1428|consen 600 VNVSSQMLN------GLDNVMISSLALGKSHGVAV-TRNGHLFTWGLNNMNQCGRVESTSTTSSPRHSGRQEYQICPIGE 672 (3738)
T ss_pred ecchHHHhh------ccccceeehhhccccceeEE-EeCCeEEEEecCCcccccccccccccCCcccccceeecccCCcc
Confidence 2222111 11224477899999999999 89999999996311110
Q ss_pred ----------------------------------------------------------ccc-------------------
Q 042346 197 ----------------------------------------------------------IQR------------------- 199 (812)
Q Consensus 197 ----------------------------------------------------------~~~------------------- 199 (812)
+.+
T Consensus 673 HtW~~dt~~VCa~CG~Cs~~GvaC~~~~RP~G~mC~CG~GES~C~~CG~Cr~C~e~tE~~QPG~aqHvQ~~staa~QR~~ 752 (3738)
T KOG1428|consen 673 HTWLTDTPSVCAQCGLCSARGVACGRVPRPKGTMCHCGVGESTCLRCGLCRPCGEVTEPAQPGRAQHVQFSSTAAPQRST 752 (3738)
T ss_pred ceeecCCcchhhhcccccccccccccCCCCCCcccccCCCcccceeccccccccCcCCcCCCCHHHhheecccccccccc
Confidence 000
Q ss_pred ----------cccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCCC-----------CcceeeeeeeeccceeE
Q 042346 200 ----------GFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFS-----------SAFEFSGGLALGANFTC 258 (812)
Q Consensus 200 ----------~~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~-----------~~~~~~~~ia~G~~ht~ 258 (812)
.+...++++|+||..|+..|.+||+||.+|.|.+||||+... .......+|++|.+||.
T Consensus 753 ~HPs~V~~sq~~Hdvkv~sVSCG~~HtVlL~sd~~VfTFG~~~HGQLG~GDt~Sk~~Pq~V~~~~~t~~vQVaAGSNHT~ 832 (3738)
T KOG1428|consen 753 LHPSRVILSQGPHDVKVSSVSCGNFHTVLLASDRRVFTFGSNCHGQLGVGDTLSKNTPQQVILPSDTVIVQVAAGSNHTI 832 (3738)
T ss_pred cCchheeeccCCcceeEEEEeccCceEEEEecCCcEEEecCCcccccCcCccccCCCcceEEcCCCCceEEEecCCCceE
Confidence 113457889999999999999999999999999999994211 11111225999999999
Q ss_pred EEEecCCeEEEecCCCCCccccCC
Q 042346 259 AIRQRSGLVACWGGTNRFEFDSDV 282 (812)
Q Consensus 259 al~~~~g~v~~WG~n~~gqlg~~~ 282 (812)
.+.. ||+|+.+|.-..|||+.+.
T Consensus 833 l~~~-DGsVFTFGaF~KGQL~RP~ 855 (3738)
T KOG1428|consen 833 LRAN-DGSVFTFGAFGKGQLARPA 855 (3738)
T ss_pred EEec-CCcEEEeccccCccccCcc
Confidence 9887 5999999999999998743
|
|
| >KOG0783 consensus Uncharacterized conserved protein, contains ankyrin and BTB/POZ domains [Function unknown] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.1e-13 Score=151.87 Aligned_cols=183 Identities=16% Similarity=0.146 Sum_probs=133.4
Q ss_pred EEEeCCCeEEEccCCCCCCCCCC-------CceecccCCc--eEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcc
Q 042346 85 GLRSGGFSLHCWDTNDLTNFSFQ-------PKRLHFRKAV--QLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFS 155 (812)
Q Consensus 85 al~~~g~~v~~WG~n~~gqlg~~-------~~~~~~~~~~--~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~ 155 (812)
+++.-. .||.||.|-...||.+ |..|.+.... =+.+|+.|..|+..++ +.|.||.-|.+.-|.||.|..
T Consensus 137 ~~d~pn-dvy~wG~N~N~tLGign~~~~~~Pe~Vdlf~~Sg~~~~qV~l~kfHSvfl~-~kgqvY~cGhG~GGRlG~gde 214 (1267)
T KOG0783|consen 137 VLDLPN-DVYGWGTNVNNTLGIGNGKEPSSPERVDLFKTSGQLFSQVQLSKFHSVFLT-EKGQVYVCGHGAGGRLGFGDE 214 (1267)
T ss_pred ccCCcc-ceeEecccccccccccCCCCCCChHHhHHHHhccHHHHHHHHhhceeeEec-CCCcEEEeccCCCCccCcCcc
Confidence 344445 7999999999999943 5555543322 3467999999999998 999999999999999998854
Q ss_pred cCCCC-------CCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccccc---------------cCc-eEEEEEeC
Q 042346 156 FSSPG-------EDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQRGF---------------KNL-SMVGLVAG 212 (812)
Q Consensus 156 ~~~~~-------~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~~~---------------~~~-~~~~i~aG 212 (812)
...+. .+.++.+||+-..|+.+| |.+|.||.||-|+..|...... .+. .++.++||
T Consensus 215 q~~~iPkrV~gL~gh~~~qisvs~~HslvL-T~~g~Vys~GlN~~hqLG~~~~~~~~~~p~qI~a~r~kg~~~iIgvaAg 293 (1267)
T KOG0783|consen 215 QYNFIPKRVPGLIGHKVIQISVSHTHSLVL-TKFGSVYSWGLNGSHQLGLSNDELKKDDPIQITARRIKGFKQIIGVAAG 293 (1267)
T ss_pred cccccccccccccccceEEEEeecceeEEE-eecceEEEeecCcccccCCcCchhhcCchhhhhhHhhcchhhhhhhhcc
Confidence 43322 236899999999999998 8999999999987766543211 233 47789999
Q ss_pred CceeEEEeeCCcEEEEecCCCCCCCcCCCCcce-----------eeeeeeeccceeEEEEecCCeEEEecCC
Q 042346 213 ESHACGLSRNGALVCKGSNDSGQLNVPFSSAFE-----------FSGGLALGANFTCAIRQRSGLVACWGGT 273 (812)
Q Consensus 213 ~~h~~al~~~G~v~~WG~n~~gqlg~~~~~~~~-----------~~~~ia~G~~ht~al~~~~g~v~~WG~n 273 (812)
..|+.|-++ -.||.||-| .||||........ .+.-++|-..-|.-++. ++.++|.-+-
T Consensus 294 ~~hsVawt~-~~VY~wGlN-~GQlGi~~n~~~Vt~Pr~l~~~~~~v~~v~a~~~ATVc~~~-~~~i~~~ady 362 (1267)
T KOG0783|consen 294 KSHSVAWTD-TDVYSWGLN-NGQLGISDNISVVTTPRRLAGLLSPVIHVVATTRATVCLLQ-NNSIIAFADY 362 (1267)
T ss_pred cceeeeeec-ceEEEeccc-CceecCCCCCceeecchhhcccccceEEEEecCccEEEEec-CCcEEEEecc
Confidence 999999965 479999988 6999932211110 01125565666666664 6999998753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.5e-14 Score=144.84 Aligned_cols=208 Identities=21% Similarity=0.316 Sum_probs=139.0
Q ss_pred HHHHHhccCCCceEEEEEEEeCC-----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHh
Q 042346 553 LALLSRVHHKHLVGLVGFCQEKD-----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH 627 (812)
Q Consensus 553 i~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH 627 (812)
...+-.+.|.|||++..|+.+.. +..+++|||+.|+|..+|++...... .+......+++-||..||.|||
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~----a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQK----ALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhh----hhhHHHHHHHHHHHHhhhhhhh
Confidence 34455667999999999876543 46899999999999999986543322 1233344579999999999999
Q ss_pred hcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCc--ccccccccccCCCccCccccccCcCCCcchhHHHHHHH
Q 042346 628 NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD--QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVL 705 (812)
Q Consensus 628 ~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl 705 (812)
+.. |+|+|+++.-+.|++..++-+|+.----........ .........+-++|.+||+-.....+..+|||+||+-.
T Consensus 194 s~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 SCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred ccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 987 889999999999999999888874211110000000 01111223467899999987777778899999999999
Q ss_pred HHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 706 LELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 706 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
+||.-+..-... ......++........+. . + ..=+.++.+|++.+|..||+|++++.
T Consensus 273 lemailEiq~tn----seS~~~~ee~ia~~i~~l-e---n--------------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 273 LEMAILEIQSTN----SESKVEVEENIANVIIGL-E---N--------------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHHHheeccCC----Ccceeehhhhhhhheeec-c---C--------------ccccCcCcccccCCCCCCcchhhhhc
Confidence 999887643211 111111111111111000 0 0 01235677899999999999999987
Q ss_pred HH
Q 042346 786 NL 787 (812)
Q Consensus 786 ~L 787 (812)
|.
T Consensus 331 Hp 332 (458)
T KOG1266|consen 331 HP 332 (458)
T ss_pred Cc
Confidence 63
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.2e-12 Score=144.18 Aligned_cols=146 Identities=23% Similarity=0.234 Sum_probs=101.5
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhH-----------------------------H------HHHHHHH
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKL-----------------------------R------EKESAFD 550 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~-----------------------------~------~~~~~~~ 550 (812)
.+.||.|++|.||+|++++|++||||+.......... . ..+-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4689999999999999999999999987532111100 0 0112355
Q ss_pred HHHHHHHhcc----CCCceEEEEEE-EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHH-HHH
Q 042346 551 SELALLSRVH----HKHLVGLVGFC-QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR-GID 624 (812)
Q Consensus 551 ~Ei~~l~~l~----H~nIv~l~~~~-~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~-gL~ 624 (812)
+|.+.+.+++ |.+-+.+-..+ ......+|||||+++++|.+++....... .+.+++..++. .+.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~----------~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL----------DRKALAENLARSFLN 271 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC----------CHHHHHHHHHHHHHH
Confidence 6666666653 33333332233 23445799999999999998875321110 12356666666 468
Q ss_pred HHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 625 YLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 625 yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
.+|..+ ++|+|+||.||+++.+++++|+|||++....
T Consensus 272 ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 889888 9999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0783 consensus Uncharacterized conserved protein, contains ankyrin and BTB/POZ domains [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.7e-13 Score=147.94 Aligned_cols=175 Identities=17% Similarity=0.159 Sum_probs=128.8
Q ss_pred CCCeEEEecCCCCCCCCCCcccCCCCCC---------CceEEEeecCCeEEEEEccCCeEEEeecCCCCC----------
Q 042346 135 NSGVVKCWRGTKVKDKGQLFSFSSPGED---------LKFSTITSGRGFTCGILRSNSEVFCWGDSGIAD---------- 195 (812)
Q Consensus 135 ~~g~v~~WG~n~~gqlG~~~~~~~~~~~---------~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~---------- 195 (812)
.-..||.||.|.+..||.|....+..|- .-+.+|+.|..|+..+ ++.|.||.-|-...+.
T Consensus 140 ~pndvy~wG~N~N~tLGign~~~~~~Pe~Vdlf~~Sg~~~~qV~l~kfHSvfl-~~kgqvY~cGhG~GGRlG~gdeq~~~ 218 (1267)
T KOG0783|consen 140 LPNDVYGWGTNVNNTLGIGNGKEPSSPERVDLFKTSGQLFSQVQLSKFHSVFL-TEKGQVYVCGHGAGGRLGFGDEQYNF 218 (1267)
T ss_pred CccceeEecccccccccccCCCCCCChHHhHHHHhccHHHHHHHHhhceeeEe-cCCCcEEEeccCCCCccCcCcccccc
Confidence 5589999999999999988765442221 3366799999999998 8999999998632111
Q ss_pred cc--cccccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCC---------C------CcceeeeeeeeccceeE
Q 042346 196 EI--QRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPF---------S------SAFEFSGGLALGANFTC 258 (812)
Q Consensus 196 ~~--~~~~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~---------~------~~~~~~~~ia~G~~ht~ 258 (812)
.| +....+-++.+|++.-.|+.+||.+|.||.||-|..+|||+-. . ..+.....+++|..|+.
T Consensus 219 iPkrV~gL~gh~~~qisvs~~HslvLT~~g~Vys~GlN~~hqLG~~~~~~~~~~p~qI~a~r~kg~~~iIgvaAg~~hsV 298 (1267)
T KOG0783|consen 219 IPKRVPGLIGHKVIQISVSHTHSLVLTKFGSVYSWGLNGSHQLGLSNDELKKDDPIQITARRIKGFKQIIGVAAGKSHSV 298 (1267)
T ss_pred cccccccccccceEEEEeecceeEEEeecceEEEeecCcccccCCcCchhhcCchhhhhhHhhcchhhhhhhhcccceee
Confidence 11 2233566799999999999999999999999999999999311 0 01111225899999999
Q ss_pred EEEecCCeEEEecCCCCCccccC-------Cc-----cccceeEEEeccceEEEEEcCCCeEEEecCC
Q 042346 259 AIRQRSGLVACWGGTNRFEFDSD-------VI-----QDVSFESIVAGLDFVCGLTTRNLSMICWGPG 314 (812)
Q Consensus 259 al~~~~g~v~~WG~n~~gqlg~~-------~~-----~~~~~~~i~ag~~~~c~~~~~~~~v~cWG~~ 314 (812)
|-++ ..||.||.| .||||.. +| ....+..++|-...|.-++. ++.++|.-+.
T Consensus 299 awt~--~~VY~wGlN-~GQlGi~~n~~~Vt~Pr~l~~~~~~v~~v~a~~~ATVc~~~-~~~i~~~ady 362 (1267)
T KOG0783|consen 299 AWTD--TDVYSWGLN-NGQLGISDNISVVTTPRRLAGLLSPVIHVVATTRATVCLLQ-NNSIIAFADY 362 (1267)
T ss_pred eeec--ceEEEeccc-CceecCCCCCceeecchhhcccccceEEEEecCccEEEEec-CCcEEEEecc
Confidence 9983 689999998 5999972 11 12345566676666555554 5699999864
|
|
| >KOG1428 consensus Inhibitor of type V adenylyl cyclases/Neuronal presynaptic protein Highwire/PAM/RPM-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.9e-12 Score=145.16 Aligned_cols=231 Identities=18% Similarity=0.243 Sum_probs=154.0
Q ss_pred EEEEEccCceEEEEEeCCCeEEEccCCCCC---CCCCCCceecccCCceEEEEEccCceEEEEE-eCCCeEEEecCCCCC
Q 042346 73 FQAISGGQNYFCGLRSGGFSLHCWDTNDLT---NFSFQPKRLHFRKAVQLTDVSVGGDQVCARE-VNSGVVKCWRGTKVK 148 (812)
Q Consensus 73 ~~~i~~G~~~~~al~~~g~~v~~WG~n~~g---qlg~~~~~~~~~~~~~v~~ia~G~~h~~al~-~~~g~v~~WG~n~~g 148 (812)
-+.+-.|..+...-+..| .||-=|..... |-|..-.++.. +..|++|+.|-+-..++. .++|-+..-|...
T Consensus 481 tv~L~~~RE~A~iqa~sG-KvYYaGn~t~~Gl~e~G~nWmEL~l--~~~IVq~SVG~D~~~~~~~A~~G~I~~v~D~k-- 555 (3738)
T KOG1428|consen 481 TVDLHFTREMAFIQARSG-KVYYAGNGTRFGLFETGNNWMELCL--PEPIVQISVGIDTIMFRSGAGHGWIASVDDKK-- 555 (3738)
T ss_pred heecccchhhhhhhhcCc-cEEEecCccEEeEEccCCceEEecC--CCceEEEEeccchhheeeccCcceEEeccCcc--
Confidence 344555666665556778 78887765331 21222223322 357889999977666644 1445454444321
Q ss_pred CCCCCcccCCCCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCC----CcccccccCceEEEEEeCCceeEEEeeCCc
Q 042346 149 DKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIA----DEIQRGFKNLSMVGLVAGESHACGLSRNGA 224 (812)
Q Consensus 149 qlG~~~~~~~~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~----~~~~~~~~~~~~~~i~aG~~h~~al~~~G~ 224 (812)
..|.- +...|....+++.+ +|..|.-+...+||++|..|..... ..-.....+.-|.+++-|-.|.||++.+|.
T Consensus 556 ~~~~~-Rr~~P~n~rKIv~v-~~s~~VY~~vSenGkifM~G~~tm~~n~SSqmln~L~~~~isslAlGKsH~~av~rNG~ 633 (3738)
T KOG1428|consen 556 RNGRL-RRLVPSNRRKIVHV-CASGHVYGYVSENGKIFMGGLHTMRVNVSSQMLNGLDNVMISSLALGKSHGVAVTRNGH 633 (3738)
T ss_pred cccch-hhcCCCCcceeEEE-eeeeEEEEEEccCCeEEeecceeEEecchHHHhhccccceeehhhccccceeEEEeCCe
Confidence 11110 01112223455554 6777888877999999999973221 122234456678999999999999999999
Q ss_pred EEEEecCCCCCCC----------------------------------------------------c--CC----------
Q 042346 225 LVCKGSNDSGQLN----------------------------------------------------V--PF---------- 240 (812)
Q Consensus 225 v~~WG~n~~gqlg----------------------------------------------------~--~~---------- 240 (812)
||.||-|..||.| + |.
T Consensus 634 l~T~GlNN~~QCGRVEs~sTt~s~~~s~~~e~~iCP~G~HtW~~dt~~VCa~CG~Cs~~GvaC~~~~RP~G~mC~CG~GE 713 (3738)
T KOG1428|consen 634 LFTWGLNNMNQCGRVESTSTTSSPRHSGRQEYQICPIGEHTWLTDTPSVCAQCGLCSARGVACGRVPRPKGTMCHCGVGE 713 (3738)
T ss_pred EEEEecCCcccccccccccccCCcccccceeecccCCccceeecCCcchhhhcccccccccccccCCCCCCcccccCCCc
Confidence 9999999999987 0 00
Q ss_pred -------------------------------------------------CC-cceeeeeeeeccceeEEEEecCCeEEEe
Q 042346 241 -------------------------------------------------SS-AFEFSGGLALGANFTCAIRQRSGLVACW 270 (812)
Q Consensus 241 -------------------------------------------------~~-~~~~~~~ia~G~~ht~al~~~~g~v~~W 270 (812)
+. .... .+|+||..||..|.. ||+||.+
T Consensus 714 S~C~~CG~Cr~C~e~tE~~QPG~aqHvQ~~staa~QR~~~HPs~V~~sq~~Hdvkv-~sVSCG~~HtVlL~s-d~~VfTF 791 (3738)
T KOG1428|consen 714 STCLRCGLCRPCGEVTEPAQPGRAQHVQFSSTAAPQRSTLHPSRVILSQGPHDVKV-SSVSCGNFHTVLLAS-DRRVFTF 791 (3738)
T ss_pred ccceeccccccccCcCCcCCCCHHHhheecccccccccccCchheeeccCCcceeE-EEEeccCceEEEEec-CCcEEEe
Confidence 00 1111 269999999999986 6999999
Q ss_pred cCCCCCccccC------------CccccceeEEEeccceEEEEEcCCCeEEEecC
Q 042346 271 GGTNRFEFDSD------------VIQDVSFESIVAGLDFVCGLTTRNLSMICWGP 313 (812)
Q Consensus 271 G~n~~gqlg~~------------~~~~~~~~~i~ag~~~~c~~~~~~~~v~cWG~ 313 (812)
|.|.|||||.+ .+.++..++++||.+||.... .||+|+.+|.
T Consensus 792 G~~~HGQLG~GDt~Sk~~Pq~V~~~~~t~~vQVaAGSNHT~l~~-~DGsVFTFGa 845 (3738)
T KOG1428|consen 792 GSNCHGQLGVGDTLSKNTPQQVILPSDTVIVQVAAGSNHTILRA-NDGSVFTFGA 845 (3738)
T ss_pred cCCcccccCcCccccCCCcceEEcCCCCceEEEecCCCceEEEe-cCCcEEEecc
Confidence 99999999883 223445789999999988776 5889999995
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=3e-11 Score=137.75 Aligned_cols=150 Identities=20% Similarity=0.188 Sum_probs=95.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchh-----------------------------hHHHH----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTN-----------------------------KLREK---- 545 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~-----------------------------~~~~~---- 545 (812)
...|.. +.||.|++|.||+|++++ |++||||+........ ...+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 799999999999999987 9999999986321100 00111
Q ss_pred --HHHHHHHHHHHHhcc----CCCceEEEEEEEe-CCeEEEEEEecCCCchhhh--hhcCCCCCccccccccHHHHHHHH
Q 042346 546 --ESAFDSELALLSRVH----HKHLVGLVGFCQE-KDERLLVYEYMSNGALHDH--LHNKNNTEKNSSIVNSWKMRIRIA 616 (812)
Q Consensus 546 --~~~~~~Ei~~l~~l~----H~nIv~l~~~~~~-~~~~~lV~ey~~~gsL~~~--l~~~~~~~~~~~~~~~~~~~l~ia 616 (812)
+-+|.+|...+.+++ +.+.+.+-..+.+ ....+|||||++|+.|.++ +...... . .+++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d---~---------~~la 265 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD---M---------KLLA 265 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC---H---------HHHH
Confidence 123445555555553 4444444344332 4457899999999999875 3222110 0 1122
Q ss_pred HHHHHH-HHHHhhcCCCCeEeeccCCCCEEEcCCC----cEEEEeecccccCCC
Q 042346 617 LDAARG-IDYLHNYAVPSIIHRDIKSSNILLDVNW----TARVSDFGLSLLGSE 665 (812)
Q Consensus 617 ~~ia~g-L~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kl~DfGla~~~~~ 665 (812)
...+.. +.-++..+ ++|+|+||.||+++.++ ++++.|||+......
T Consensus 266 ~~~v~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 266 ERGVEVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 222211 22334566 99999999999999988 999999999865543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.9e-11 Score=117.07 Aligned_cols=131 Identities=15% Similarity=0.113 Sum_probs=96.5
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCce-EEEEEEEeCCeEEEEEEec
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV-GLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~ 584 (812)
.+.|+.|.++.||+.+. .++.+++|+...... ....+.+|+++++.+.+.+++ +++.+. ....++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEec
Confidence 46789999999999987 478899998653211 122456789999988766654 444443 33458999999
Q ss_pred CCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCC--CCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV--PSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 585 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~--~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
++.++.+.. .. ...++.++++.|+.||.... +.++|+|+||.||+++ ++.++++||+.+..
T Consensus 74 ~G~~l~~~~-------~~---------~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTED-------FS---------DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCcccccc-------cc---------CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 998876530 00 02356789999999999872 2369999999999999 66899999998743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.8e-12 Score=138.94 Aligned_cols=249 Identities=20% Similarity=0.231 Sum_probs=174.1
Q ss_pred cceeeeecc--CCcEEEEEEEE---cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 503 FSLENKVGI--GSFGTVYKGKL---MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 503 ~~~~~~LG~--G~fG~Vy~a~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
|...+.+|. |.+|.||.+.. .++..+|+|+-.......... ..=.+|+.....+ .|+|.++....++..+.
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~---~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS---KRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc---ccccchhhcccccCccccccccCcccccCCc
Confidence 566788999 99999999976 468889999743322211111 1112456666666 49999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHH----HHHHHhhcCCCCeEeeccCCCCEEEcCC-Cc
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR----GIDYLHNYAVPSIIHRDIKSSNILLDVN-WT 651 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~----gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~ 651 (812)
.++-+|++. .+|.++.+........ .....+..+..+ ||.++|+.. |+|-|+||.||++..+ ..
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~-------~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPD-------NLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCc-------hhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence 999999995 6898888766543221 222456666666 999999998 9999999999999999 88
Q ss_pred EEEEeecccccCCCCccc---ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 652 ARVSDFGLSLLGSECDQE---FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
.+++|||+...+....-. .......+...|++||...+ .++..+|+|++|.+..|-.++-.++......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------- 333 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------- 333 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC-------
Confidence 999999998766554321 11233368889999998665 5888999999999999999987765432110
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
.|.++. +...+.+. -......+...+.++++.+|..|++.+.+..
T Consensus 334 --~W~~~r---------~~~ip~e~-~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 --SWSQLR---------QGYIPLEF-CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --Cccccc---------cccCchhh-hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111 11111111 1122334555788899999999999887764
|
|
| >PF13540 RCC1_2: Regulator of chromosome condensation (RCC1) repeat; PDB: 3QI0_D 1JTD_B 3QHY_B | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.3e-11 Score=79.98 Aligned_cols=30 Identities=37% Similarity=0.813 Sum_probs=26.0
Q ss_pred EEEEEeCCceeEEEeeCCcEEEEecCCCCC
Q 042346 206 MVGLVAGESHACGLSRNGALVCKGSNDSGQ 235 (812)
Q Consensus 206 ~~~i~aG~~h~~al~~~G~v~~WG~n~~gq 235 (812)
|++|++|..|+|||++||+|||||+|.+||
T Consensus 1 V~~ia~G~~ht~al~~~g~v~~wG~n~~GQ 30 (30)
T PF13540_consen 1 VVQIACGGYHTCALTSDGEVYCWGDNNYGQ 30 (30)
T ss_dssp EEEEEEESSEEEEEE-TTEEEEEE--TTST
T ss_pred CEEEEecCCEEEEEEcCCCEEEEcCCcCCC
Confidence 679999999999999999999999999998
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.3e-09 Score=122.40 Aligned_cols=166 Identities=16% Similarity=0.209 Sum_probs=122.2
Q ss_pred EcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCc
Q 042346 522 LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEK 601 (812)
Q Consensus 522 ~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~ 601 (812)
..++.+|.|........ +......+-++.|+.|+||||+++++.++.+...|||+|-+ -.|..++.+...
T Consensus 34 k~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~~--- 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELGK--- 103 (690)
T ss_pred eccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhHH---
Confidence 44688888887654322 23345567888999999999999999999999999999998 377778765441
Q ss_pred cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCc
Q 042346 602 NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681 (812)
Q Consensus 602 ~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 681 (812)
...--.+.||+.||.|||+.+ .++|++|.-..|+++..|.-||.+|-+......... ......--..|
T Consensus 104 --------~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~ 171 (690)
T KOG1243|consen 104 --------EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESF 171 (690)
T ss_pred --------HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcc
Confidence 112346789999999999766 399999999999999999999999998755443221 01111222345
Q ss_pred cCccccccCcCCCcchhHHHHHHHHHHHcC
Q 042346 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711 (812)
Q Consensus 682 ~aPE~~~~~~~~~ksDVwS~Gvvl~elltG 711 (812)
..|+.+.... -..|.|-||++++|++.|
T Consensus 172 ~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 172 DDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 6666543221 246999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-09 Score=107.94 Aligned_cols=142 Identities=14% Similarity=0.135 Sum_probs=97.6
Q ss_pred eeeccCCcEEEEEEEEcC-------CcEEEEEeeccCcc---------------------hhhHHHHHHHHHHHHHHHHh
Q 042346 507 NKVGIGSFGTVYKGKLMD-------GREVAVKREESCPK---------------------TNKLREKESAFDSELALLSR 558 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~-------g~~vavK~~~~~~~---------------------~~~~~~~~~~~~~Ei~~l~~ 558 (812)
..||.|--+.||.|...+ +..+|||+...... ..+.......-++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 47999997653210 01111112233489999999
Q ss_pred ccC--CCceEEEEEEEeCCeEEEEEEecCCCchhh-hhhcCCCCCccccccccHHHHHHHHHHHHHHHHHH-hhcCCCCe
Q 042346 559 VHH--KHLVGLVGFCQEKDERLLVYEYMSNGALHD-HLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYL-HNYAVPSI 634 (812)
Q Consensus 559 l~H--~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yL-H~~~~~~i 634 (812)
+.. -++.+.+++ ...+|||||+.+..+.. .|+... ++..+..++..+++..|.+| |..+ |
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~---------~~~~~~~~i~~~i~~~l~~l~H~~g---l 146 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAK---------LNDEEMKNAYYQVLSMMKQLYKECN---L 146 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccc---------cCHHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 864 456677754 45689999997654422 222111 11223356788999999999 7887 9
Q ss_pred EeeccCCCCEEEcCCCcEEEEeecccccCCC
Q 042346 635 IHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665 (812)
Q Consensus 635 vHrDlKp~NILl~~~~~~kl~DfGla~~~~~ 665 (812)
||+||++.|||++ ++.+.|+|||.+.....
T Consensus 147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 147 VHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred ecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999999997 46899999998865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.4e-09 Score=111.49 Aligned_cols=275 Identities=18% Similarity=0.207 Sum_probs=170.4
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEE------EeCC
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFC------QEKD 575 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~------~~~~ 575 (812)
+.+.+.||+|+-+.+|.--- -...+.|+....+-....+ .++.|... .||-+-.=+.+= -++.
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq--------k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~ 82 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ--------KVAELAATPDAPLLNYRVAWPQATLHGGRRG 82 (637)
T ss_pred cCCCccccCCccceeeecch--hhchhheeecCCCchHHHH--------HHHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence 44568899999999996421 2223456665433222211 22233333 455332211111 1122
Q ss_pred e-EEEEEEecCCCc-hhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 576 E-RLLVYEYMSNGA-LHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 576 ~-~~lV~ey~~~gs-L~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
. .-+.|..+.+.. +.+++.. ...........|...++.+..++.+.+-||+.+ .+-+|+.++|+|+.+++.+.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p--~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~ 157 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSP--ATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVV 157 (637)
T ss_pred ceeEEecccCCCccchhhhcCc--hhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEE
Confidence 2 457788776642 2222221 111222334489999999999999999999999 89999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcC-CCCCCCCCCCCCCchh
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTG-KKAVFKNEDGSGPLDV 727 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~~~ 727 (812)
|.|-..-.+. .+.......+|.++|.+||... +..-+...|.|.|||++++||.| ++||...........-
T Consensus 158 LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 158 LVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred EEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 9985533222 2223345568999999999765 33456789999999999999887 8898653221111111
Q ss_pred HHHHHHHHHhccccccccccC---CCC-CCChHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 728 VEFAVSQILAGQLHCVLDKRV---GPP-ELNEAEAVELLATTAIHCVNLE--GKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~---~~~-~~~~~~~~~~l~~li~~Cl~~d--P~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.+ ..+..+.+..-.|.+. ..| ...-.-.+..+..|..+|+... +.-|||++-++..|..+.+...+|.
T Consensus 235 ~E---~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 235 LE---TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred ch---hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 11 1223333333333322 112 2222444566777778887654 5689999999999999988887776
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=9.5e-11 Score=130.37 Aligned_cols=256 Identities=18% Similarity=0.152 Sum_probs=175.9
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEE--cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEe
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKL--MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQE 573 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 573 (812)
.....+|.++..||.+.|+.|+.... .++..+++|.+..... .......-..|+.+...+ .|.+++++...+..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~---~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA---TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc---chHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 33456789999999999999998753 4688899997653211 111122234566666666 59999998888887
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-CcE
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTA 652 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~ 652 (812)
.+..|+=-||++++++...+..... +....++++..|++.++.++|+.. ++|+|+||+||++..+ +..
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~--------~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQM--------LDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHh--------cCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhh
Confidence 7888899999999988877622211 133445788999999999999988 9999999999999886 888
Q ss_pred EEEeecccccCCCCcccccccccccCCCcc--CccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYI--DPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
++.||+....+... .......-+++ +|+......+-.+.|+||||+-+.|.+++........ +
T Consensus 407 ~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~------- 471 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---Q------- 471 (524)
T ss_pred hcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---c-------
Confidence 99999988532111 11112233444 5555556678889999999999999999875432111 0
Q ss_pred HHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
+..+..+.+. .. .... +.+..+.+.+...++..||.+.++..+.+...+.+
T Consensus 472 -~~~i~~~~~p----------~~-~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~~ 522 (524)
T KOG0601|consen 472 -SLTIRSGDTP----------NL-PGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDSR 522 (524)
T ss_pred -ceeeeccccc----------CC-CchH-HhhhhhhhhhcCCccccchhhhhhcccchhhhhcc
Confidence 1111122111 00 1111 44667777899999999999999988877655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.6e-09 Score=100.85 Aligned_cols=136 Identities=22% Similarity=0.326 Sum_probs=102.4
Q ss_pred eeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhH-HH--HHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEe
Q 042346 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKL-RE--KESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~-~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
..+.+|+-..+|.+.+. |..+++|.-......... .+ ....-.+|..++.+++--.|.-.+=++.+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999774 445777743222221111 11 233456799999998766666556566777788999999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
+++-.|.++|.... ..++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+.+
T Consensus 81 I~G~~lkd~l~~~~---------------~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEAR---------------PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcc---------------hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999996541 357778888899999999 99999999999997764 99999999964
|
|
| >PF13540 RCC1_2: Regulator of chromosome condensation (RCC1) repeat; PDB: 3QI0_D 1JTD_B 3QHY_B | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.3e-10 Score=76.14 Aligned_cols=30 Identities=30% Similarity=0.636 Sum_probs=25.9
Q ss_pred EEEEEccCceEEEEEeCCCeEEEccCCCCCC
Q 042346 73 FQAISGGQNYFCGLRSGGFSLHCWDTNDLTN 103 (812)
Q Consensus 73 ~~~i~~G~~~~~al~~~g~~v~~WG~n~~gq 103 (812)
|++|++|..|+|||++|| +|||||.|.+||
T Consensus 1 V~~ia~G~~ht~al~~~g-~v~~wG~n~~GQ 30 (30)
T PF13540_consen 1 VVQIACGGYHTCALTSDG-EVYCWGDNNYGQ 30 (30)
T ss_dssp EEEEEEESSEEEEEE-TT-EEEEEE--TTST
T ss_pred CEEEEecCCEEEEEEcCC-CEEEEcCCcCCC
Confidence 689999999999999999 899999999998
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.1e-09 Score=99.39 Aligned_cols=148 Identities=22% Similarity=0.251 Sum_probs=107.6
Q ss_pred eeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchh-hH--HHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEE
Q 042346 505 LENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTN-KL--REKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581 (812)
Q Consensus 505 ~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~-~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 581 (812)
...+|-+|+-+.|+++.+ .|+...||.-....... .. +-......+|.+.+.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 367899999999999998 67887887533211111 11 222445678999999987666655555666777778999
Q ss_pred EecCC-CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC---cEEEEee
Q 042346 582 EYMSN-GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW---TARVSDF 657 (812)
Q Consensus 582 ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kl~Df 657 (812)
||+++ .++.+++........... ....++..|-+.|.-||..+ |+|+||..+||+|..++ .+.++||
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~------~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDE------GLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred EeccchhHHHHHHHHHccCcccch------hHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEee
Confidence 99976 488888876554332221 11568889999999999998 99999999999996554 4589999
Q ss_pred ccccc
Q 042346 658 GLSLL 662 (812)
Q Consensus 658 Gla~~ 662 (812)
|++..
T Consensus 161 gls~~ 165 (229)
T KOG3087|consen 161 GLSSV 165 (229)
T ss_pred cchhc
Confidence 99854
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.5e-09 Score=108.62 Aligned_cols=143 Identities=20% Similarity=0.271 Sum_probs=104.0
Q ss_pred eeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC--CCceEEEEEEEeCC---eEEEEE
Q 042346 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH--KHLVGLVGFCQEKD---ERLLVY 581 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~---~~~lV~ 581 (812)
+.|+.|.++.||+....+|+.+++|+....... .....+.+|.++++.+++ .++.+++.+..... ..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 678999999999998866789999986532111 123457789999999976 34577777766543 568999
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYA------------------------------- 630 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~------------------------------- 630 (812)
||+++.+|.+.+... . .+...+..++.++++.|.+||+..
T Consensus 80 e~i~G~~l~~~~~~~-~--------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 80 ERVDGRVLRDRLLRP-E--------LSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred EEeCCEecCCCCCCC-C--------CCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 999998888765310 0 133444567777777777777421
Q ss_pred ----------------------CCCeEeeccCCCCEEEcC--CCcEEEEeeccccc
Q 042346 631 ----------------------VPSIIHRDIKSSNILLDV--NWTARVSDFGLSLL 662 (812)
Q Consensus 631 ----------------------~~~ivHrDlKp~NILl~~--~~~~kl~DfGla~~ 662 (812)
...++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135899999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=9.3e-08 Score=104.34 Aligned_cols=175 Identities=18% Similarity=0.201 Sum_probs=124.7
Q ss_pred CcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE----eCCeEEEEEEecCC-
Q 042346 513 SFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ----EKDERLLVYEYMSN- 586 (812)
Q Consensus 513 ~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~----~~~~~~lV~ey~~~- 586 (812)
.-.+.|++.. .||..|++|++......... ....-+++++++.|.|+|+|.++|. .+..+.|||+|.++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-----k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-----KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-----cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 3456799975 57999999998432111111 1123578899999999999999887 34457899999876
Q ss_pred CchhhhhhcCCCCC-------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 587 GALHDHLHNKNNTE-------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 587 gsL~~~l~~~~~~~-------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
++|.++-....... ............+.++.|+..||.++|+.| +.-+-|.|++||++.+.+++|+..|+
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i 439 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGI 439 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccc
Confidence 57887654433222 111112244556789999999999999999 88899999999999999999998888
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCC
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKA 714 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p 714 (812)
......+.. |-+. -..+-|.=.||.+++.|.||..-
T Consensus 440 ~Dvl~~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 440 MDVLQEDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eeeecCCCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 765544220 1111 12357899999999999999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.7e-10 Score=130.07 Aligned_cols=251 Identities=19% Similarity=0.243 Sum_probs=161.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+.|.+.+-+-.+.|+.++.++-. .+.-.++|.....+.... ...+....+-.++-.-+||-+++..--+.-....+|
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~--~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT--NDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhcc--ccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 44666677888888888877532 233333333222111111 011122223333333345666655544455667899
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
+++|..+++|...|+.......... ...+..+...++|||... +.|||+||.|+|...++..+++||+.
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepa--------Rs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPA--------RSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccc--------cchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence 9999999999999988764332211 124556778899999987 89999999999999999999999984
Q ss_pred cccCCCC---------------------cc--------cccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc
Q 042346 660 SLLGSEC---------------------DQ--------EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710 (812)
Q Consensus 660 a~~~~~~---------------------~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt 710 (812)
....... .. ........+|+.|.+||.+.+......+|.|++|++++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 3211000 00 011223478999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH
Q 042346 711 GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT 781 (812)
Q Consensus 711 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 781 (812)
|..||....... + ... ++...+..+ ..+.+......+++.+.+..+|.+|-.+.
T Consensus 1031 g~pp~na~tpq~----~----f~n--------i~~~~~~~p-~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQ----I----FEN--------ILNRDIPWP-EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchhh----h----hhc--------cccCCCCCC-CCccccChhhhhhhhhhhccCchhccCcc
Confidence 999986543211 1 111 111122222 22344455567788888999999997766
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-07 Score=100.11 Aligned_cols=146 Identities=15% Similarity=0.150 Sum_probs=98.6
Q ss_pred eeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHH------HHHHHHHHHHHHHhccCCCc--eEEEEEEEe-----
Q 042346 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLRE------KESAFDSELALLSRVHHKHL--VGLVGFCQE----- 573 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~------~~~~~~~Ei~~l~~l~H~nI--v~l~~~~~~----- 573 (812)
+.+-+-....|++..+ +|+.+.||+..........+. -...+.+|.+.+.+|...+| .+.+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445777766 688999998643211110111 01136789988888854443 345666543
Q ss_pred CCeEEEEEEecCCC-chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC----
Q 042346 574 KDERLLVYEYMSNG-ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV---- 648 (812)
Q Consensus 574 ~~~~~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---- 648 (812)
....+||||++++- +|.+++........ .-..+.+++.+++..+.-||..+ |+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~------~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPP------DPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG 177 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCC------CHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence 23468999999886 89999853211110 22345679999999999999999 999999999999975
Q ss_pred ---CCcEEEEeeccccc
Q 042346 649 ---NWTARVSDFGLSLL 662 (812)
Q Consensus 649 ---~~~~kl~DfGla~~ 662 (812)
+..+.|+||+.+..
T Consensus 178 ~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 178 REEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCceEEEEECCcccc
Confidence 47899999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=9.2e-08 Score=94.88 Aligned_cols=131 Identities=24% Similarity=0.235 Sum_probs=83.6
Q ss_pred EEEEEEEcCCcEEEEEeeccCc---------------------chhhHHHHHHHHHHHHHHHHhccCC--CceEEEEEEE
Q 042346 516 TVYKGKLMDGREVAVKREESCP---------------------KTNKLREKESAFDSELALLSRVHHK--HLVGLVGFCQ 572 (812)
Q Consensus 516 ~Vy~a~~~~g~~vavK~~~~~~---------------------~~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~ 572 (812)
.||.|...++..+|||+..... ...+.........+|.+.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999754210 1112233345667899999999866 456666542
Q ss_pred eCCeEEEEEEecC--CCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHH-HhhcCCCCeEeeccCCCCEEEcCC
Q 042346 573 EKDERLLVYEYMS--NGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY-LHNYAVPSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 573 ~~~~~~lV~ey~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~y-LH~~~~~~ivHrDlKp~NILl~~~ 649 (812)
...|||||++ +..+..+...... . .....++.+++..+.. +|..+ |+|+||.+.|||++++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~-~---------~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~ 143 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLS-P---------EEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG 143 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGG-G---------STHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT
T ss_pred ---CCEEEEEecCCCccchhhHHhcccc-c---------hhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc
Confidence 3479999998 5555443322211 0 1123577788886655 56877 9999999999999988
Q ss_pred CcEEEEeecccccCC
Q 042346 650 WTARVSDFGLSLLGS 664 (812)
Q Consensus 650 ~~~kl~DfGla~~~~ 664 (812)
.+.|+|||.+....
T Consensus 144 -~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 144 -KVYIIDFGQAVDSS 157 (188)
T ss_dssp -CEEE--GTTEEETT
T ss_pred -eEEEEecCcceecC
Confidence 99999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF00415 RCC1: Regulator of chromosome condensation (RCC1) repeat; InterPro: IPR000408 The regulator of chromosome condensation (RCC1) [] is a eukaryotic protein which binds to chromatin and interacts with ran, a nuclear GTP-binding protein IPR002041 from INTERPRO, to promote the loss of bound GDP and the uptake of fresh GTP, thus acting as a guanine-nucleotide dissociation stimulator (GDS) | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.4e-08 Score=75.99 Aligned_cols=43 Identities=26% Similarity=0.524 Sum_probs=37.0
Q ss_pred CCCeEEEccCCCCCCCC-CC-------CceecccCCceEEEEEccCceEEEE
Q 042346 89 GGFSLHCWDTNDLTNFS-FQ-------PKRLHFRKAVQLTDVSVGGDQVCAR 132 (812)
Q Consensus 89 ~g~~v~~WG~n~~gqlg-~~-------~~~~~~~~~~~v~~ia~G~~h~~al 132 (812)
|| .||+||.|.+|||| .. |+++......+|++|+||..|++||
T Consensus 1 dG-~vy~wG~n~~GqLG~~~~~~~~~~P~~v~~~~~~~i~~va~G~~ht~~l 51 (51)
T PF00415_consen 1 DG-RVYSWGSNDYGQLGSGGDNKNVSVPTKVPFLSGVRIVQVACGSDHTLAL 51 (51)
T ss_dssp TS-EEEEEEEETTSTTSSSSSSSEEEEEEEEGGGTTSEEEEEEEESSEEEEE
T ss_pred CC-cEEEEECCCCCCCCCCCCCCceeEEEEECCCCCCCEEEEEeCcceEEEC
Confidence 67 79999999999999 33 6667776667899999999999986
|
The interaction of RCC1 with ran probably plays an important role in the regulation of gene expression. RCC1, known as PRP20 or SRM1 in yeast, pim1 in fission yeast and BJ1 in Drosophila, is a protein that contains seven tandem repeats of a domain of about 50 to 60 amino acids. As shown in the following schematic representation, the repeats make up the major part of the length of the protein. Outside the repeat region, there is just a small N-terminal domain of about 40 to 50 residues and, in the Drosophila protein only, a C-terminal domain of about 130 residues. +----+-------+-------+-------+-------+-------+-------+-------+-------------+ |N-t.|Rpt. 1 |Rpt. 2 |Rpt. 3 |Rpt. 4 |Rpt. 5 |Rpt. 6 |Rpt. 7 | C-terminal | +----+-------+-------+-------+-------+-------+-------+-------+-------------+ The RCC1-type of repeat is also found in the X-linked retinitis pigmentosa GTPase regulator []. The RCC repeats form a beta-propeller structure.; PDB: 3MVD_L 3OF7_A 1I2M_D 1A12_B 3KCI_A 4DNV_B 4DNU_A 4D9S_B 4DNW_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.2e-07 Score=94.62 Aligned_cols=141 Identities=21% Similarity=0.198 Sum_probs=99.0
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeeccC-----------------cchhhHHHHHHHHHHHHHHHHhccCC--C
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESC-----------------PKTNKLREKESAFDSELALLSRVHHK--H 563 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~-----------------~~~~~~~~~~~~~~~Ei~~l~~l~H~--n 563 (812)
..+.++||.|--+.||.|...+|.+++||.-... ....+.........+|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 5567899999999999999999999999942211 01112222334556899999999654 6
Q ss_pred ceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCC
Q 042346 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSN 643 (812)
Q Consensus 564 Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~N 643 (812)
+.+.+++ +...+||||+++-.|...-- ..++ . -.|+..|++-+.-+-..+ |||+|+.+-|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~----~~en------~---~~il~~il~~~~~~~~~G---iVHGDlSefN 232 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL----DVEN------P---DEILDKILEEVRKAYRRG---IVHGDLSEFN 232 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC----cccC------H---HHHHHHHHHHHHHHHHcC---ccccCCchhe
Confidence 7777764 45589999999866654431 1111 1 134455555555444666 9999999999
Q ss_pred EEEcCCCcEEEEeecccccC
Q 042346 644 ILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 644 ILl~~~~~~kl~DfGla~~~ 663 (812)
||+++||.+.++||-.+...
T Consensus 233 IlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 233 ILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EEEecCCCEEEEeCcccccC
Confidence 99999999999999766443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.6e-08 Score=112.58 Aligned_cols=152 Identities=18% Similarity=0.304 Sum_probs=103.0
Q ss_pred HHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcc-----cc--cccccccCCCccCcccccc
Q 042346 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ-----EF--ISTKAVGTVGYIDPEYYVM 689 (812)
Q Consensus 617 ~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~-----~~--~~~~~~gt~~y~aPE~~~~ 689 (812)
.+++.||.|+|... .+||++|.|++|.++.++..||+.|+.......... .. ...-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999875 599999999999999999999999998764433111 11 1112245668999999999
Q ss_pred CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHc
Q 042346 690 NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHC 769 (812)
Q Consensus 690 ~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~C 769 (812)
...+.++|+||+|+++|-+..+..+.......... . ....... .. . ......+.+.++++=+.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---~--~~~~~~~-~~------~---~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---Y--SFSRNLL-NA------G---AFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch---h--hhhhccc-cc------c---cccccccCcHHHHHHHHHH
Confidence 88999999999999999999555544332211111 1 1111000 00 0 0111244556677777889
Q ss_pred cccCCCCCCCHHHHHH
Q 042346 770 VNLEGKERPNITDIVA 785 (812)
Q Consensus 770 l~~dP~~RPt~~evl~ 785 (812)
+..++..||++.+++.
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998887764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.6e-06 Score=85.12 Aligned_cols=141 Identities=18% Similarity=0.106 Sum_probs=100.4
Q ss_pred ccCCcEEEEEEEEcCCcEEEEEeeccCcchhhH-HHHHHHHHHHHHHHHhccCC--CceEEEEEEE-eC----CeEEEEE
Q 042346 510 GIGSFGTVYKGKLMDGREVAVKREESCPKTNKL-REKESAFDSELALLSRVHHK--HLVGLVGFCQ-EK----DERLLVY 581 (812)
Q Consensus 510 G~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~-~~----~~~~lV~ 581 (812)
|+|+.+-|++-.+ +|+.+-+|+.......... .--+..|.+|+..+.+|..- .+.+.+ ++. .. ...+||+
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 4688899999877 4567999986533222221 22456788999999998533 345555 333 21 1358999
Q ss_pred EecCC-CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc--EEEEeec
Q 042346 582 EYMSN-GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT--ARVSDFG 658 (812)
Q Consensus 582 ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--~kl~DfG 658 (812)
|-+.+ -+|.+++........ +..++..++.++++.|+-||+.+ +.|+|+-+.|||++.++. ++++||-
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~------~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPY------SDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCc------chHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 97753 588888865432211 23455689999999999999999 999999999999986666 9999997
Q ss_pred ccc
Q 042346 659 LSL 661 (812)
Q Consensus 659 la~ 661 (812)
-++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 654
|
|
| >PF00415 RCC1: Regulator of chromosome condensation (RCC1) repeat; InterPro: IPR000408 The regulator of chromosome condensation (RCC1) [] is a eukaryotic protein which binds to chromatin and interacts with ran, a nuclear GTP-binding protein IPR002041 from INTERPRO, to promote the loss of bound GDP and the uptake of fresh GTP, thus acting as a guanine-nucleotide dissociation stimulator (GDS) | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.1e-07 Score=73.21 Aligned_cols=43 Identities=14% Similarity=0.180 Sum_probs=33.7
Q ss_pred CCeEEEecCCCCCCCC-CCcccCC-------CCCCCceEEEeecCCeEEEE
Q 042346 136 SGVVKCWRGTKVKDKG-QLFSFSS-------PGEDLKFSTITSGRGFTCGI 178 (812)
Q Consensus 136 ~g~v~~WG~n~~gqlG-~~~~~~~-------~~~~~~~~~ia~G~~h~cal 178 (812)
||+||+||.|.+|||| ....... .....+|++|+||..||++|
T Consensus 1 dG~vy~wG~n~~GqLG~~~~~~~~~~P~~v~~~~~~~i~~va~G~~ht~~l 51 (51)
T PF00415_consen 1 DGRVYSWGSNDYGQLGSGGDNKNVSVPTKVPFLSGVRIVQVACGSDHTLAL 51 (51)
T ss_dssp TSEEEEEEEETTSTTSSSSSSSEEEEEEEEGGGTTSEEEEEEEESSEEEEE
T ss_pred CCcEEEEECCCCCCCCCCCCCCceeEEEEECCCCCCCEEEEEeCcceEEEC
Confidence 7999999999999999 4443222 22226799999999999986
|
The interaction of RCC1 with ran probably plays an important role in the regulation of gene expression. RCC1, known as PRP20 or SRM1 in yeast, pim1 in fission yeast and BJ1 in Drosophila, is a protein that contains seven tandem repeats of a domain of about 50 to 60 amino acids. As shown in the following schematic representation, the repeats make up the major part of the length of the protein. Outside the repeat region, there is just a small N-terminal domain of about 40 to 50 residues and, in the Drosophila protein only, a C-terminal domain of about 130 residues. +----+-------+-------+-------+-------+-------+-------+-------+-------------+ |N-t.|Rpt. 1 |Rpt. 2 |Rpt. 3 |Rpt. 4 |Rpt. 5 |Rpt. 6 |Rpt. 7 | C-terminal | +----+-------+-------+-------+-------+-------+-------+-------+-------------+ The RCC1-type of repeat is also found in the X-linked retinitis pigmentosa GTPase regulator []. The RCC repeats form a beta-propeller structure.; PDB: 3MVD_L 3OF7_A 1I2M_D 1A12_B 3KCI_A 4DNV_B 4DNU_A 4D9S_B 4DNW_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=2e-06 Score=87.31 Aligned_cols=106 Identities=24% Similarity=0.246 Sum_probs=81.5
Q ss_pred HHHHHHHHHHHHhccCC--CceEEEEEEEeCC----eEEEEEEecCCC-chhhhhhcCCCCCccccccccHHHHHHHHHH
Q 042346 546 ESAFDSELALLSRVHHK--HLVGLVGFCQEKD----ERLLVYEYMSNG-ALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618 (812)
Q Consensus 546 ~~~~~~Ei~~l~~l~H~--nIv~l~~~~~~~~----~~~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ 618 (812)
.....+|.+.+..|... ...+.+++.+... ..+||+|++++- +|.+++...... +-..+..++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~--------~~~~~~~ll~~ 126 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQL--------DPSQRRELLRA 126 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhccc--------chhhHHHHHHH
Confidence 34567788888887543 3456677766533 358999999884 799998763321 12334679999
Q ss_pred HHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC---cEEEEeeccccc
Q 042346 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNW---TARVSDFGLSLL 662 (812)
Q Consensus 619 ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DfGla~~ 662 (812)
++..++-||+.+ |+|+|+++.|||++.+. .+.|+||+-++.
T Consensus 127 l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 127 LARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999 99999999999998887 899999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.7e-06 Score=96.82 Aligned_cols=146 Identities=21% Similarity=0.211 Sum_probs=93.5
Q ss_pred eeeccCCcEEEEEEEEcCCcEEEEEeeccCcch-----------------------------h------hHHHHHHHHHH
Q 042346 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKT-----------------------------N------KLREKESAFDS 551 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~-----------------------------~------~~~~~~~~~~~ 551 (812)
+.|+.++-|.||+|++++|++||||+....-.. . ..-..+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 789999999999999999999999965421100 0 00111223445
Q ss_pred HHHHHHhcc-----CCCceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHH-HH
Q 042346 552 ELALLSRVH-----HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI-DY 625 (812)
Q Consensus 552 Ei~~l~~l~-----H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL-~y 625 (812)
|...+.+++ .+++.=-.=|.+-.....|+|||++|-.+.+......... + +..|+..+++.. ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~-d---------~k~ia~~~~~~f~~q 280 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGI-D---------RKELAELLVRAFLRQ 280 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCC-C---------HHHHHHHHHHHHHHH
Confidence 555555552 3333322223333556799999999999998843222111 1 123444443332 22
Q ss_pred HhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCC
Q 042346 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665 (812)
Q Consensus 626 LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~ 665 (812)
+=..+ ++|.|..|.||+++.++++.+.|||+......
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22344 89999999999999999999999999876554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.4e-05 Score=78.47 Aligned_cols=141 Identities=17% Similarity=0.183 Sum_probs=93.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHH-----HHHHHHHHHHhccCCCc---eEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKES-----AFDSELALLSRVHHKHL---VGLVGF 570 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~-----~~~~Ei~~l~~l~H~nI---v~l~~~ 570 (812)
...+|...+++-......|.+-.. +++.+.+|........ ..+.... ...+++..+.+++...+ ..++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 457888888888888888877766 6899999987642211 1111111 12345555555543322 232222
Q ss_pred EEe-----CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEE
Q 042346 571 CQE-----KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645 (812)
Q Consensus 571 ~~~-----~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 645 (812)
.+. ....+|+|||++|-.|.++..-. -.++..+...|.-||+.+ ++|+|..|.|++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~----------------e~~~~ki~~~ikqlH~~G---~~HGD~hpgNFl 167 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIEDID----------------EDLAEKIVEAIKQLHKHG---FYHGDPHPGNFL 167 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchhcC----------------HHHHHHHHHHHHHHHHcC---CccCCCCcCcEE
Confidence 222 22346899999998887765211 024566778899999999 999999999999
Q ss_pred EcCCCcEEEEeecccc
Q 042346 646 LDVNWTARVSDFGLSL 661 (812)
Q Consensus 646 l~~~~~~kl~DfGla~ 661 (812)
++.+ .++++||+..+
T Consensus 168 v~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 168 VSNN-GIRIIDTQGKR 182 (229)
T ss_pred EECC-cEEEEECcccc
Confidence 9865 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0941 consensus E3 ubiquitin protein ligase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.9e-08 Score=111.30 Aligned_cols=122 Identities=20% Similarity=0.299 Sum_probs=101.6
Q ss_pred cEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCCC-------CceecccCCceEEEEEccCceEEEEEe------CCCe
Q 042346 72 SFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQ-------PKRLHFRKAVQLTDVSVGGDQVCAREV------NSGV 138 (812)
Q Consensus 72 ~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~~-------~~~~~~~~~~~v~~ia~G~~h~~al~~------~~g~ 138 (812)
.+.+++||..|+.|+..+| .++.||.|.+||+|.. |.++....+....+|++|..|++|+.. .+|.
T Consensus 15 ~~lq~~cGn~hclal~~~g-~~~~wg~~~~g~~~~~~~~~~~~p~~~~sl~g~p~a~v~~g~~hs~~lS~~~~~lt~e~~ 93 (850)
T KOG0941|consen 15 HILQVGCGNNHCLALSCAG-ELFVWGMNNNGQLGRALYFPDAKPEPVESLKGVPLAQVSAGEAHSFALSSHTVLLTDEGK 93 (850)
T ss_pred hhhhhccccHHHHhhhccC-CeeeccCCccchhhhhccCCCCCCccchhhcCCcHHHHhcCCCcchhhhhchhhcchhcc
Confidence 6789999999999999999 8999999999999966 777777777788999999999998761 3899
Q ss_pred EEEecCCCCCCCCCCcccCCCCC-------CCceEEEeecCCeEEEEEccCCeEEEeecCCCC
Q 042346 139 VKCWRGTKVKDKGQLFSFSSPGE-------DLKFSTITSGRGFTCGILRSNSEVFCWGDSGIA 194 (812)
Q Consensus 139 v~~WG~n~~gqlG~~~~~~~~~~-------~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~ 194 (812)
++..|....||+|+........+ ...+..|+||..|+.+....-|.++..|.+..+
T Consensus 94 ~fs~Ga~~~~q~~h~~~~~~~~~~~v~e~i~~~~t~ia~~~~ht~a~v~~l~qsf~~~~~~sG 156 (850)
T KOG0941|consen 94 VFSFGAGSTGQLGHSLTENEVLPLLVLELIGSRVTRIACVRGHTLAIVPRLGQSFSFGKGASG 156 (850)
T ss_pred ccccCCcccccccccccccccccHHHHHHHhhhhHHHHHHHHHHHhhhhhhcceeecccCCCC
Confidence 99999999999998544332222 267889999999999986666888998875443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.6e-05 Score=81.86 Aligned_cols=145 Identities=13% Similarity=0.151 Sum_probs=83.9
Q ss_pred eeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc--eEEEEEEEeCCeEEEEEEec
Q 042346 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL--VGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~~~~~~~~~~~lV~ey~ 584 (812)
.+||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.+.+....+...+|||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 57899999999983 35567888865311 12235679999988864443 57777777777788999999
Q ss_pred CCCc-hhhh---------------------hhcCCCCCccccc-cccHHHHHH----HHHHHHH-HHHHHhhc-CCCCeE
Q 042346 585 SNGA-LHDH---------------------LHNKNNTEKNSSI-VNSWKMRIR----IALDAAR-GIDYLHNY-AVPSII 635 (812)
Q Consensus 585 ~~gs-L~~~---------------------l~~~~~~~~~~~~-~~~~~~~l~----ia~~ia~-gL~yLH~~-~~~~iv 635 (812)
+|.. +.+. ||........... ...+...+. ....+.. ...+|... ..+.++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8863 2111 1111000000000 000000000 0000111 12222211 124588
Q ss_pred eeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 636 HRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 636 HrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999997743
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.15 E-value=7.1e-05 Score=74.60 Aligned_cols=104 Identities=20% Similarity=0.315 Sum_probs=81.5
Q ss_pred HHHHHHHHhccC-CCceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh
Q 042346 550 DSELALLSRVHH-KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN 628 (812)
Q Consensus 550 ~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~ 628 (812)
..|.-+++.+++ +++.+++|+|- .+++.||...+++...-.. .......+|..|.+||.++++.+.+|++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-----l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-----LSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-----cccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358888999976 69999999993 4789999987766543000 0000112899999999999999999988
Q ss_pred cCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 629 YAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 629 ~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
.-...+.-.|++++|+-+++++++|++|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 5544488999999999999999999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.12 E-value=7.7e-05 Score=75.71 Aligned_cols=159 Identities=19% Similarity=0.181 Sum_probs=103.8
Q ss_pred CCCCHHHHHHhcCCcceeee---eccCCcEEEEEEEEcCCcEEEEEeeccCcchhhH-------------------HHHH
Q 042346 489 DNFTLSELAAATNNFSLENK---VGIGSFGTVYKGKLMDGREVAVKREESCPKTNKL-------------------REKE 546 (812)
Q Consensus 489 ~~~~~~el~~~~~~~~~~~~---LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~-------------------~~~~ 546 (812)
+..+++.+....++..+.+. |..|.-..||+|.-.++..+|||++......... ....
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 34566667777666666555 4567778899998878999999987643211111 1112
Q ss_pred HHHHHHHHHHHhcc--CCCceEEEEEEEeCCeEEEEEEecCCC-chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHH
Q 042346 547 SAFDSELALLSRVH--HKHLVGLVGFCQEKDERLLVYEYMSNG-ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI 623 (812)
Q Consensus 547 ~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL 623 (812)
.+...|+.-|+++. +-.+.+-+.+. ...|||||+... .-.-.|..-.. .......+..++++.+
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~---------e~~e~~~~~~~~v~~~ 179 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPL---------ELEEAEGLYEDVVEYM 179 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCCc---------CchhHHHHHHHHHHHH
Confidence 33456888888874 44455666554 348999999553 11111211111 1112345677788888
Q ss_pred HHHhh-cCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCC
Q 042346 624 DYLHN-YAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 624 ~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~ 664 (812)
.-|-. .+ +||+||..=|||+. ++.+.|+||+.|....
T Consensus 180 ~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 180 RRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 77766 44 99999999999999 8899999999886544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=8.1e-07 Score=99.39 Aligned_cols=189 Identities=17% Similarity=0.113 Sum_probs=133.8
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC-ceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH-LVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~~~ 577 (812)
.++-+...+-+++++++.+||.+....+...++.+... ....-++++|.+++||| .+..++-++.++..
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 33445556678899999999987644555556655321 23345889999999999 67777777777778
Q ss_pred EEEEEecCCC-chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 578 LLVYEYMSNG-ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 578 ~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
+++++|+..+ +-.+.... ....+...+...+...-+++++|||+.. =+|+| |||..+ ...|..|
T Consensus 310 ~i~~~i~s~~rs~~~~~~~-------se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~ 374 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTV-------SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLD 374 (829)
T ss_pred chhhhhhcCCccccccCCh-------hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccccc
Confidence 9999999877 22211110 0111112223456667788999999874 38998 888766 5889999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCC
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAV 715 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~ 715 (812)
|+....+.... ..+...+++.++|||+...+.+..+.|+|++++--.+|--|-.|-
T Consensus 375 ~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 375 FAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 99886554432 345668999999999999999999999999998777777676653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.2e-05 Score=77.70 Aligned_cols=144 Identities=16% Similarity=0.105 Sum_probs=84.5
Q ss_pred eeccCCc-EEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEEEEEEecC
Q 042346 508 KVGIGSF-GTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERLLVYEYMS 585 (812)
Q Consensus 508 ~LG~G~f-G~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~ 585 (812)
.|-.|.. ..||+.... +..+.+|+..... ...+.+|+++++.+. +--+.+++.+....+..++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence 4445555 788998764 4788889875321 224567888888874 4345577877776667899999999
Q ss_pred CCchhhhh-------------------hcCCCCCccccccccHHHHHHHHH--------------------HHHHHHHHH
Q 042346 586 NGALHDHL-------------------HNKNNTEKNSSIVNSWKMRIRIAL--------------------DAARGIDYL 626 (812)
Q Consensus 586 ~gsL~~~l-------------------~~~~~~~~~~~~~~~~~~~l~ia~--------------------~ia~gL~yL 626 (812)
|.+|.+.. |........ ....+..++.... .+...+..|
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 153 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCP--FDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAEL 153 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCC--cchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHH
Confidence 87776432 111100000 0000000000000 011112222
Q ss_pred hh----cCCCCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 627 HN----YAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 627 H~----~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
-. ...|.++|+|+.|.|||++.+....|+||+.+..
T Consensus 154 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 154 EATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 11 1225699999999999999987889999987743
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0941 consensus E3 ubiquitin protein ligase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.1e-07 Score=106.20 Aligned_cols=123 Identities=19% Similarity=0.297 Sum_probs=98.0
Q ss_pred eEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccCC-------CCCCCceEEEeecCCeEEEEEccCCeEEEeec
Q 042346 118 QLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSS-------PGEDLKFSTITSGRGFTCGILRSNSEVFCWGD 190 (812)
Q Consensus 118 ~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~~-------~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~ 190 (812)
.+.+++||..|+.|+. .+|+++.||.|.+||+|.+..... ...+....+|++|.+|+|++ ..
T Consensus 15 ~~lq~~cGn~hclal~-~~g~~~~wg~~~~g~~~~~~~~~~~~p~~~~sl~g~p~a~v~~g~~hs~~l-S~--------- 83 (850)
T KOG0941|consen 15 HILQVGCGNNHCLALS-CAGELFVWGMNNNGQLGRALYFPDAKPEPVESLKGVPLAQVSAGEAHSFAL-SS--------- 83 (850)
T ss_pred hhhhhccccHHHHhhh-ccCCeeeccCCccchhhhhccCCCCCCccchhhcCCcHHHHhcCCCcchhh-hh---------
Confidence 6779999999999998 999999999999999997622211 11225677899999999998 33
Q ss_pred CCCCCcccccccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCCC------------CcceeeeeeeeccceeE
Q 042346 191 SGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFS------------SAFEFSGGLALGANFTC 258 (812)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~------------~~~~~~~~ia~G~~ht~ 258 (812)
|+..++.+|++...|....||+|.... ..-... .|+||..|+.
T Consensus 84 ------------------------~~~~lt~e~~~fs~Ga~~~~q~~h~~~~~~~~~~~v~e~i~~~~t-~ia~~~~ht~ 138 (850)
T KOG0941|consen 84 ------------------------HTVLLTDEGKVFSFGAGSTGQLGHSLTENEVLPLLVLELIGSRVT-RIACVRGHTL 138 (850)
T ss_pred ------------------------chhhcchhccccccCCcccccccccccccccccHHHHHHHhhhhH-HHHHHHHHHH
Confidence 999999999999999999999995110 011111 4999999999
Q ss_pred EEEecCCeEEEecCCCCC
Q 042346 259 AIRQRSGLVACWGGTNRF 276 (812)
Q Consensus 259 al~~~~g~v~~WG~n~~g 276 (812)
++...-|.++..|.+..|
T Consensus 139 a~v~~l~qsf~~~~~~sG 156 (850)
T KOG0941|consen 139 AIVPRLGQSFSFGKGASG 156 (850)
T ss_pred hhhhhhcceeecccCCCC
Confidence 987666899999988887
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.1e-05 Score=76.66 Aligned_cols=148 Identities=18% Similarity=0.190 Sum_probs=83.8
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC--ceEEEEEEEeC---CeEEEE
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH--LVGLVGFCQEK---DERLLV 580 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~---~~~~lV 580 (812)
++.|+.|..+.||+....+ ..+++|.... ......+.+|.++++.|.... +.+++.+.... ...+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~-------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRP-------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESS-------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCC-------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 4689999999999999866 6999998653 123445667888888885333 45666654332 346899
Q ss_pred EEecCCCchhh----------------h---hhcCCCCCccccc-----cccHHHHHHH------------HHHHHH-HH
Q 042346 581 YEYMSNGALHD----------------H---LHNKNNTEKNSSI-----VNSWKMRIRI------------ALDAAR-GI 623 (812)
Q Consensus 581 ~ey~~~gsL~~----------------~---l~~~~~~~~~~~~-----~~~~~~~l~i------------a~~ia~-gL 623 (812)
|+++++..+.+ . |+........... ...+...... ...+.+ .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999988877 1 1111100000000 0000000000 112222 33
Q ss_pred HHHhhc----CCCCeEeeccCCCCEEEc-CCCcEEEEeecccc
Q 042346 624 DYLHNY----AVPSIIHRDIKSSNILLD-VNWTARVSDFGLSL 661 (812)
Q Consensus 624 ~yLH~~----~~~~ivHrDlKp~NILl~-~~~~~kl~DfGla~ 661 (812)
+.+++. ..+.++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333321 234599999999999999 66777899998663
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=5.9e-05 Score=72.40 Aligned_cols=131 Identities=17% Similarity=0.236 Sum_probs=89.0
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCce-EEEEEEEeCCeEEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV-GLVGFCQEKDERLLVY 581 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ 581 (812)
....+.|++|.+|.||++.+ .|.++|+|+-.. ......+..|.++|..+.-.++- +++.|.+ .++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~-------ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRR-------DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeec-cCceEEEEEecC-------CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhh
Confidence 34467899999999999999 466899998653 22345677899999998877765 4444432 34559
Q ss_pred EecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccC-CCCEEEcCCCcEEEEeeccc
Q 042346 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIK-SSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 582 ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlK-p~NILl~~~~~~kl~DfGla 660 (812)
||++|-.|.+.-.... .+-...++..---|...+ |-|+.|. |..++|-.+..+.|+||..|
T Consensus 92 e~i~G~~L~~~~~~~~---------------rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~A 153 (201)
T COG2112 92 EYIDGRPLGKLEIGGD---------------RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSA 153 (201)
T ss_pred hhhcCcchhhhhhccc---------------HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccch
Confidence 9999888877654221 122334444434455555 8888886 55555555559999999988
Q ss_pred ccC
Q 042346 661 LLG 663 (812)
Q Consensus 661 ~~~ 663 (812)
.+.
T Consensus 154 t~k 156 (201)
T COG2112 154 TFK 156 (201)
T ss_pred hhc
Confidence 643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=7.3e-05 Score=85.03 Aligned_cols=146 Identities=21% Similarity=0.251 Sum_probs=89.7
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchh-------------------------h-HHH------HHHHHHHHH
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTN-------------------------K-LRE------KESAFDSEL 553 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~-------------------------~-~~~------~~~~~~~Ei 553 (812)
.+.|+.-+.+.||+|++++|+.||||+-+..-+.. + ..+ .+-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 47899999999999999999999999754221111 0 001 122344555
Q ss_pred HHHHh----ccCCCceE---EEEEEE-eCCeEEEEEEecCCCchhhh--hhcCCCCCccccccccHHHHHHHHHHHHHHH
Q 042346 554 ALLSR----VHHKHLVG---LVGFCQ-EKDERLLVYEYMSNGALHDH--LHNKNNTEKNSSIVNSWKMRIRIALDAARGI 623 (812)
Q Consensus 554 ~~l~~----l~H~nIv~---l~~~~~-~~~~~~lV~ey~~~gsL~~~--l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL 623 (812)
+-..+ +.|-++.. +=.++. ......|+||||+|..+.|. |.+..... ..|+..+.++.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~------------~~i~~~l~~~~ 313 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISP------------HDILNKLVEAY 313 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCH------------HHHHHHHHHHH
Confidence 44443 34555211 112222 23467999999999888765 33322211 13444444432
Q ss_pred HHHhhcCCCCeEeeccCCCCEEEcC----CCcEEEEeecccccCCC
Q 042346 624 DYLHNYAVPSIIHRDIKSSNILLDV----NWTARVSDFGLSLLGSE 665 (812)
Q Consensus 624 ~yLH~~~~~~ivHrDlKp~NILl~~----~~~~kl~DfGla~~~~~ 665 (812)
++..-..+++|.|-.|.|||++. +..+.+-|||+......
T Consensus 314 --~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 314 --LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 22221223899999999999984 67899999999876554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00019 Score=88.15 Aligned_cols=156 Identities=17% Similarity=0.336 Sum_probs=94.2
Q ss_pred eeeeccCCcEEEEEEEEcCC---cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCc--eEEEEEEEeC---Ce
Q 042346 506 ENKVGIGSFGTVYKGKLMDG---REVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHL--VGLVGFCQEK---DE 576 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nI--v~l~~~~~~~---~~ 576 (812)
.+.|+.|.+..+|+....++ ..+++|+...... ......+.+|+++|+.+. |.++ .+++.++.+. +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~----~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL----LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc----CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 57889999999999877554 4677777542111 111235778999999995 6765 7888887664 35
Q ss_pred EEEEEEecCCCchhhh-----------------------hhcCCCCC-------cc----ccccccHHHHHHH-------
Q 042346 577 RLLVYEYMSNGALHDH-----------------------LHNKNNTE-------KN----SSIVNSWKMRIRI------- 615 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~-----------------------l~~~~~~~-------~~----~~~~~~~~~~l~i------- 615 (812)
.|+||||+++..+.+. ||...... .. ...+..|.....-
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 6899999987643221 22211100 00 0011122221111
Q ss_pred --HHHHHHHHHHHhhcCC--------CCeEeeccCCCCEEEcCC-Cc-EEEEeecccccCCC
Q 042346 616 --ALDAARGIDYLHNYAV--------PSIIHRDIKSSNILLDVN-WT-ARVSDFGLSLLGSE 665 (812)
Q Consensus 616 --a~~ia~gL~yLH~~~~--------~~ivHrDlKp~NILl~~~-~~-~kl~DfGla~~~~~ 665 (812)
.-.+.+.+++|..+.. +.++|+|+++.|||++.+ .. .-|.||.++.....
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 1123444667754332 249999999999999753 33 57999999865433
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00038 Score=69.76 Aligned_cols=133 Identities=19% Similarity=0.226 Sum_probs=91.1
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchh-----------hHHHHHHHHHHHHHHHHhcc------CCCceEEE
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTN-----------KLREKESAFDSELALLSRVH------HKHLVGLV 568 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~-----------~~~~~~~~~~~Ei~~l~~l~------H~nIv~l~ 568 (812)
...||+|+.-.||. +++.....||+........ .......++.+|+..+..+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46799999999997 6667778889876433000 00012345556666666665 88999999
Q ss_pred EEEEeCCeEEEEEEecCC------CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 569 GFCQEKDERLLVYEYMSN------GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 569 ~~~~~~~~~~lV~ey~~~------gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
|+.+.+...-+|+|.+.+ -+|.+++....... ++...+-+-..||-+.+ |+.+||+|.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-------------~~~~~L~~f~~~l~~~~---Iv~~dl~~~ 147 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-------------ELRQALDEFKRYLLDHH---IVIRDLNPH 147 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-------------HHHHHHHHHHHHHHHcC---CeecCCCcc
Confidence 999999999999998643 36888885443211 23333344456777777 999999999
Q ss_pred CEEEcCC---C-cEEEEe
Q 042346 643 NILLDVN---W-TARVSD 656 (812)
Q Consensus 643 NILl~~~---~-~~kl~D 656 (812)
||++..+ . .+.|+|
T Consensus 148 NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 148 NIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cEEEEecCCCceEEEEEe
Confidence 9999543 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.0002 Score=74.29 Aligned_cols=73 Identities=14% Similarity=0.209 Sum_probs=44.3
Q ss_pred eeeccCCcE-EEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC---CceEEEEEEEeCC---eEEE
Q 042346 507 NKVGIGSFG-TVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK---HLVGLVGFCQEKD---ERLL 579 (812)
Q Consensus 507 ~~LG~G~fG-~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~~~~~~~~---~~~l 579 (812)
+.|+.|+.. .||+. +..+++|.... ......+.+|.+++..|... -+.++++.....+ ..++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 567767666 58875 23577786542 11233577899888887532 2344444433221 3488
Q ss_pred EEEecCCCchh
Q 042346 580 VYEYMSNGALH 590 (812)
Q Consensus 580 V~ey~~~gsL~ 590 (812)
+||+++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00084 Score=69.57 Aligned_cols=74 Identities=18% Similarity=0.125 Sum_probs=48.1
Q ss_pred eeeeccCCcEEEEEEEEcC--CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc-eEEEEEEEeCCeEEEEEE
Q 042346 506 ENKVGIGSFGTVYKGKLMD--GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL-VGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e 582 (812)
.+.|..|-...+|+....+ ++.+++|+...... ......+|+.+++.+....+ .+++..+. ..++||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEE
Confidence 4678888899999988754 67899997643111 11123468888888854444 44444332 247999
Q ss_pred ecCCCch
Q 042346 583 YMSNGAL 589 (812)
Q Consensus 583 y~~~gsL 589 (812)
|+++-++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00078 Score=66.99 Aligned_cols=130 Identities=25% Similarity=0.384 Sum_probs=91.7
Q ss_pred CCcceeeeeccCCc-EEEEEEEEcCCcEEEEEeeccCcchhh----------H------HHHHHHHHHHHHHHHhcc---
Q 042346 501 NNFSLENKVGIGSF-GTVYKGKLMDGREVAVKREESCPKTNK----------L------REKESAFDSELALLSRVH--- 560 (812)
Q Consensus 501 ~~~~~~~~LG~G~f-G~Vy~a~~~~g~~vavK~~~~~~~~~~----------~------~~~~~~~~~Ei~~l~~l~--- 560 (812)
..|+.++.||.|.- |.||+++. +|+.+|+|++..-..... . ......|..|.+.+.+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56888999999999 99999998 688999999321100000 0 012346788988877774
Q ss_pred CCCc--eEEEEEEEeCC------------------eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHH
Q 042346 561 HKHL--VGLVGFCQEKD------------------ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620 (812)
Q Consensus 561 H~nI--v~l~~~~~~~~------------------~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia 620 (812)
+.++ ++.+||..-.. ...||.||++... . ...+-+.+|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~------------~~~~~~~~~~ 174 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------P------------LQIRDIPQML 174 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------c------------cchhHHHHHH
Confidence 5566 89999874221 1247777775533 0 0123466788
Q ss_pred HHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 621 ~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
+-|..+|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 175 ~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8899999998 999999999987 4589999854
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0015 Score=70.26 Aligned_cols=79 Identities=11% Similarity=0.078 Sum_probs=56.7
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC---CCceEEEEEEEeC---Ce
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH---KHLVGLVGFCQEK---DE 576 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~~~~~~~---~~ 576 (812)
..-.+.||+|..+.||+....++ ++.+|.... ......|..|.+.|+.|.. -.+.++++++... +.
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-------~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS-------FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc-------cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 44467899999999999876555 466676432 0112467889999988853 3577888877543 55
Q ss_pred EEEEEEecCCCch
Q 042346 577 RLLVYEYMSNGAL 589 (812)
Q Consensus 577 ~~lV~ey~~~gsL 589 (812)
.+||||++++.++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0025 Score=70.78 Aligned_cols=81 Identities=15% Similarity=0.146 Sum_probs=52.4
Q ss_pred eeeeccCCcEEEEEEEEcCC-cEEEEEeeccCcchh-hH-HHHHHHHHHHHHHHHhcc---CCCceEEEEEEEeCCeEEE
Q 042346 506 ENKVGIGSFGTVYKGKLMDG-REVAVKREESCPKTN-KL-REKESAFDSELALLSRVH---HKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g-~~vavK~~~~~~~~~-~~-~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~l 579 (812)
.+.||.|.+..||+....+| +.++||.-....... .. .-....+..|.+.|+.+. -.++.+++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 46799999999999998776 589999853211100 00 112234555777777753 24567777663 345789
Q ss_pred EEEecCCCc
Q 042346 580 VYEYMSNGA 588 (812)
Q Consensus 580 V~ey~~~gs 588 (812)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00084 Score=70.64 Aligned_cols=139 Identities=14% Similarity=0.103 Sum_probs=76.3
Q ss_pred eccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc-eEEEEEEEeCCeEEEEEEecCCC
Q 042346 509 VGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL-VGLVGFCQEKDERLLVYEYMSNG 587 (812)
Q Consensus 509 LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ey~~~g 587 (812)
+..|-...+|+... +++.+++|+....... ......+|.++++.+....+ .+++..+. .++||||+++.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~-----~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKA-----LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCccccc-----ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45677888998874 6778888875421110 00124568888888864333 34444332 37899999986
Q ss_pred chhhh-----------------hhcCCCCCccccccccHHHHH-HHH---------HHHHHHHHHHhhc-----CCCCeE
Q 042346 588 ALHDH-----------------LHNKNNTEKNSSIVNSWKMRI-RIA---------LDAARGIDYLHNY-----AVPSII 635 (812)
Q Consensus 588 sL~~~-----------------l~~~~~~~~~~~~~~~~~~~l-~ia---------~~ia~gL~yLH~~-----~~~~iv 635 (812)
.+... ||....... ......++ +.. ..+.+-+..+-.. ..+.++
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~----~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGY----PLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 65421 222211110 00111111 111 1111112222111 113589
Q ss_pred eeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 636 HRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 636 HrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
|+|+.|.|||+++++ ++|+||..+..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999876 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00095 Score=80.40 Aligned_cols=201 Identities=20% Similarity=0.216 Sum_probs=136.3
Q ss_pred HHHHHHHHHHHHhccCCCceEEEEEEEeCCeE----EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHH
Q 042346 546 ESAFDSELALLSRVHHKHLVGLVGFCQEKDER----LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621 (812)
Q Consensus 546 ~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~----~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~ 621 (812)
....+-|++.+..+.|+|++.++.|-.++... .+..||+..-++...++..... +....+.+..++.+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i--------~~~~~r~~~~~~~~ 297 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSI--------PLETLRILHQKLLE 297 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcccc--------CHHHHHHHHHHHhh
Confidence 34445678888889999999999987665433 2445777777777777654332 34555678889999
Q ss_pred HHHHHhhcCCCCeEeeccCCC---CEEEcCCCcEEEE--eecccccCCCCcccccccccccCCCccCccccccCcCCCc-
Q 042346 622 GIDYLHNYAVPSIIHRDIKSS---NILLDVNWTARVS--DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAK- 695 (812)
Q Consensus 622 gL~yLH~~~~~~ivHrDlKp~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k- 695 (812)
||.|+|+.. ..|.-|..+ +-..+.++...++ ||+.+......... ....-+..+.+||....+.++.+
T Consensus 298 GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r 371 (1351)
T KOG1035|consen 298 GLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSR 371 (1351)
T ss_pred hHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhh
Confidence 999999986 566655555 5555667777777 89888765543332 22234566788888877666654
Q ss_pred -chhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCC
Q 042346 696 -TDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEG 774 (812)
Q Consensus 696 -sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP 774 (812)
.|+|.+|.++..+..+..+...... + .. +++ ......+.+...+|+..++
T Consensus 372 ~~dL~~lgll~~~~~~~~~i~~~~~~-------~----~~--------~l~----------~~~~~~~~d~~~~~~~~~~ 422 (1351)
T KOG1035|consen 372 LTDLWCLGLLLLQLSQGEDISEKSAV-------P----VS--------LLD----------VLSTSELLDALPKCLDEDS 422 (1351)
T ss_pred hhHHHHHHHHHhhhhhcCcccccccc-------h----hh--------hhc----------cccchhhhhhhhhhcchhh
Confidence 7999999999999998765321110 0 00 001 0001135566778999999
Q ss_pred CCCCCHHHHHHHHHH
Q 042346 775 KERPNITDIVANLER 789 (812)
Q Consensus 775 ~~RPt~~evl~~Le~ 789 (812)
++|++..+++.+.-.
T Consensus 423 ~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 423 EERLSALELLTHPFL 437 (1351)
T ss_pred hhccchhhhhhchhc
Confidence 999999999987644
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.004 Score=67.40 Aligned_cols=148 Identities=17% Similarity=0.194 Sum_probs=80.9
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC--ceEEEEE------EEeCCeE
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH--LVGLVGF------CQEKDER 577 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~------~~~~~~~ 577 (812)
.+.++.|....+|+....++ .+++|+...... ...+..|++++..|.... +.+++.. ....+..
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~-------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK-------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC-------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 45677777789999876444 677887643110 122344566666664222 3344332 1223456
Q ss_pred EEEEEecCCCchhh--------------hhhcCCCCC-ccc---cccccHHHHH------------HHHHHHHHHHHHHh
Q 042346 578 LLVYEYMSNGALHD--------------HLHNKNNTE-KNS---SIVNSWKMRI------------RIALDAARGIDYLH 627 (812)
Q Consensus 578 ~lV~ey~~~gsL~~--------------~l~~~~~~~-~~~---~~~~~~~~~l------------~ia~~ia~gL~yLH 627 (812)
++++||++|..+.. .+|...... ... .....|.... .....+.+.++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 89999998854321 122111100 000 0111232211 11122334555554
Q ss_pred h----cCCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 628 N----YAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 628 ~----~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
. ...+.++|+|+++.||+++.++...|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3 122469999999999999998877899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0023 Score=68.19 Aligned_cols=76 Identities=18% Similarity=0.309 Sum_probs=48.3
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc---CCCceEEEEEEEeCCeEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH---HKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~l 579 (812)
++-.+.|+.|....+|+.. .+++.+.||+-.. .....|..|.+-|+.|. --.+.+.+++...++..+|
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~--------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL 89 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE--------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL 89 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG--------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh--------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence 5557789999999999987 5788999998642 12235677888888883 3457788888887777899
Q ss_pred EEEecCCC
Q 042346 580 VYEYMSNG 587 (812)
Q Consensus 580 V~ey~~~g 587 (812)
||||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0023 Score=68.86 Aligned_cols=147 Identities=17% Similarity=0.163 Sum_probs=84.2
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC--ceEEEEE------EEeCCeE
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH--LVGLVGF------CQEKDER 577 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~------~~~~~~~ 577 (812)
.+.|..|....+|+.... +..+++|+.... ....+..|++++..|.+.. +.+++.. ....+..
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~--------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV--------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCC--------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 567778888899998764 457888986531 1223556777777775332 4444432 1234456
Q ss_pred EEEEEecCCCchhh--------------hhhcCCCC---CccccccccHHHHH----------HHHHHHHHHHHHHhhc-
Q 042346 578 LLVYEYMSNGALHD--------------HLHNKNNT---EKNSSIVNSWKMRI----------RIALDAARGIDYLHNY- 629 (812)
Q Consensus 578 ~lV~ey~~~gsL~~--------------~l~~~~~~---~~~~~~~~~~~~~l----------~ia~~ia~gL~yLH~~- 629 (812)
++|++|++|..+.. .||..... .........|.... .....+...+.++.+.
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999998876532 11111100 00011111232211 0111233444555431
Q ss_pred ---CCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 630 ---AVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 630 ---~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
-...++|+|+.|.|||++++..+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 11359999999999999998778999998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.003 Score=68.19 Aligned_cols=147 Identities=21% Similarity=0.234 Sum_probs=82.6
Q ss_pred eeeeccCCcEEEEEEEEcC-------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc-eEEEEEEEeCCeE
Q 042346 506 ENKVGIGSFGTVYKGKLMD-------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL-VGLVGFCQEKDER 577 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~ 577 (812)
.+.|..|-...+|+....+ ++.+++|+...... ......+|.+++..+....+ .+++.++..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~---- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE------LLIDRERELVVFARLSERNLGPKLYGIFPN---- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc------ceechHHHHHHHHHHHhCCCCCceEEEeCC----
Confidence 3566677778999987654 57899998653211 11234568888888754333 355555432
Q ss_pred EEEEEecCCCchhhh-----------------hhcCCCCC-c-c-ccccc------cHHHHHH-----------------
Q 042346 578 LLVYEYMSNGALHDH-----------------LHNKNNTE-K-N-SSIVN------SWKMRIR----------------- 614 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~-----------------l~~~~~~~-~-~-~~~~~------~~~~~l~----------------- 614 (812)
.+|+||++|..+... ||...... . . ..... .|.....
T Consensus 73 ~~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (302)
T cd05156 73 GRIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVE 152 (302)
T ss_pred CchhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhh
Confidence 358999988766431 12211110 0 0 00000 1111100
Q ss_pred ---HHHHHHHHHHHHhh------cCCCCeEeeccCCCCEEEcCC----CcEEEEeeccccc
Q 042346 615 ---IALDAARGIDYLHN------YAVPSIIHRDIKSSNILLDVN----WTARVSDFGLSLL 662 (812)
Q Consensus 615 ---ia~~ia~gL~yLH~------~~~~~ivHrDlKp~NILl~~~----~~~kl~DfGla~~ 662 (812)
+...+..-+.+|-. .....++|+|+.+.|||++++ +.++|+||..+..
T Consensus 153 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 153 LSLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 11222233344432 122458999999999999885 8899999988743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0091 Score=64.99 Aligned_cols=30 Identities=23% Similarity=0.399 Sum_probs=25.8
Q ss_pred CCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 632 ~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
+.++|+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 469999999999999977666899999774
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0009 Score=70.17 Aligned_cols=140 Identities=19% Similarity=0.174 Sum_probs=96.8
Q ss_pred CcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccC-----------------cchhhHHHHHHHHHHHHHHHHhcc-CC-
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESC-----------------PKTNKLREKESAFDSELALLSRVH-HK- 562 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~-----------------~~~~~~~~~~~~~~~Ei~~l~~l~-H~- 562 (812)
-+.+.++||-|--+.+|.+-..+|++.++|.-... ....|..-......+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 36778999999999999999989999999842210 011122122233457888888884 33
Q ss_pred CceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 563 nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
-+.+.+++ +..++|||++.+-.|...-+-... -.+...++.-|--|-.++ +||+|..-=
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d~--------------~~ly~~lm~~Iv~la~~G---lIHgDFNEF 231 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVEDP--------------PTLYDDLMGLIVRLANHG---LIHGDFNEF 231 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCCh--------------HHHHHHHHHHHHHHHHcC---ceecccchh
Confidence 24455544 345889999988777655322211 134555566666777778 999999999
Q ss_pred CEEEcCCCcEEEEeeccccc
Q 042346 643 NILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~ 662 (812)
||+++++..++++||-....
T Consensus 232 Nimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 232 NIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred eeEEecCCCEEEeechHhhc
Confidence 99999999999999975443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.013 Score=62.31 Aligned_cols=32 Identities=22% Similarity=0.454 Sum_probs=26.3
Q ss_pred CCeEeeccCCCCEEEcCCCc-EEEEeecccccC
Q 042346 632 PSIIHRDIKSSNILLDVNWT-ARVSDFGLSLLG 663 (812)
Q Consensus 632 ~~ivHrDlKp~NILl~~~~~-~kl~DfGla~~~ 663 (812)
+.++|+|++|.|||++++++ .-|+||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997555 569999988543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.068 Score=58.33 Aligned_cols=83 Identities=20% Similarity=0.206 Sum_probs=47.2
Q ss_pred eeccCCcEEEEEEEEcCC-cEEEEEeeccCcch---hhHHHHHHHHHHHHHHHHhcc--CCC-ceEEEEEEEeCCeEEEE
Q 042346 508 KVGIGSFGTVYKGKLMDG-REVAVKREESCPKT---NKLREKESAFDSELALLSRVH--HKH-LVGLVGFCQEKDERLLV 580 (812)
Q Consensus 508 ~LG~G~fG~Vy~a~~~~g-~~vavK~~~~~~~~---~~~~~~~~~~~~Ei~~l~~l~--H~n-Iv~l~~~~~~~~~~~lV 580 (812)
.||.|....||++...++ +.|+||.-...... .+ .-...+..-|.+.|+... -|. +.+++.+ +.+...+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~w-pl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESW-PLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCC-CCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 579999999999998654 68999974321111 00 011122234666665542 343 4445443 34456799
Q ss_pred EEecCCC-chhhhh
Q 042346 581 YEYMSNG-ALHDHL 593 (812)
Q Consensus 581 ~ey~~~g-sL~~~l 593 (812)
||+++.. .|.+.|
T Consensus 79 MEdL~~~~ilR~~L 92 (370)
T TIGR01767 79 MEDLSHHKIARKGL 92 (370)
T ss_pred HhhCccchHHHHHH
Confidence 9998553 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0017 Score=79.91 Aligned_cols=163 Identities=12% Similarity=0.041 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHHhccCCCceEEEEEEE--eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHH-HHH
Q 042346 546 ESAFDSELALLSRVHHKHLVGLVGFCQ--EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA-ARG 622 (812)
Q Consensus 546 ~~~~~~Ei~~l~~l~H~nIv~l~~~~~--~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~i-a~g 622 (812)
.+....|...++...|+++.....-.. +..+.+..++|+..|.+++.|-+......... -.. .....++ ...
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld----~~~-v~~~~kvsvl~ 1347 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD----RSP-VHLRHKVSVLN 1347 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch----hch-HHHHHHHHHhc
Confidence 334445666666778998876655443 23356899999999999999976543322111 111 1222232 444
Q ss_pred HHHHhhcCC--CCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHH
Q 042346 623 IDYLHNYAV--PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYG 700 (812)
Q Consensus 623 L~yLH~~~~--~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS 700 (812)
..-.|+... ..-+|+++|+-|.+|..+..+|+.++|+.++..+. ........+++.|+.|++...-.++.|+|+|.
T Consensus 1348 ~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1348 RNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILR 1425 (2724)
T ss_pred cchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHH
Confidence 444443322 34689999999999999999999999999833221 11223456788999999988888999999999
Q ss_pred HHHHHHHHHcCCCCC
Q 042346 701 LGVVLLELLTGKKAV 715 (812)
Q Consensus 701 ~Gvvl~elltG~~p~ 715 (812)
.++.+|++--|..+|
T Consensus 1426 ~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1426 RSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHhcccHHH
Confidence 999999988877664
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.023 Score=57.12 Aligned_cols=76 Identities=22% Similarity=0.325 Sum_probs=55.3
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC---CCceEEEEEEEeCCeEEEEEE
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH---KHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~~~~~~~~~~~lV~e 582 (812)
.+.+.-|.--+.|...+ +..++-||+-. ++....|..|+.-|..|.- -++.+.+.+..+.+..|||||
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n~--------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle 91 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCNQ--------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE 91 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEecc--------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence 44555555555565544 56789999743 4556678888888777743 457788888888999999999
Q ss_pred ecCCCchh
Q 042346 583 YMSNGALH 590 (812)
Q Consensus 583 y~~~gsL~ 590 (812)
|++-+.+.
T Consensus 92 ~L~~~~~d 99 (286)
T COG3001 92 YLPTGPLD 99 (286)
T ss_pred eccCCCCC
Confidence 99987665
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.033 Score=59.88 Aligned_cols=156 Identities=17% Similarity=0.276 Sum_probs=85.4
Q ss_pred eeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC--CceEEEEEEEeCC--eEEEE
Q 042346 505 LENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK--HLVGLVGFCQEKD--ERLLV 580 (812)
Q Consensus 505 ~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~~~~--~~~lV 580 (812)
..+.+..|..-.+|..... ++++++.+ .. ............+|+++++.+.-- -+...++.|.++. ..|.|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~-P~---~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLRK-PP---RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEec-CC---ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3444544544555555443 67777772 21 111122333455678888776431 2334566666665 56999
Q ss_pred EEecCCCchhhhhhcCCCC--------------------------C----ccccccccHHHHHHHH--------HHHHHH
Q 042346 581 YEYMSNGALHDHLHNKNNT--------------------------E----KNSSIVNSWKMRIRIA--------LDAARG 622 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~--------------------------~----~~~~~~~~~~~~l~ia--------~~ia~g 622 (812)
|+|+++..+.+.+...... . .....+..|....+.+ -....-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 9999884333322211100 0 0011111233222111 112233
Q ss_pred HHHHhhcCC-----CCeEeeccCCCCEEEcCCCcEEEEeecccccCCC
Q 042346 623 IDYLHNYAV-----PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665 (812)
Q Consensus 623 L~yLH~~~~-----~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~ 665 (812)
..+|+.... +.++|+|+.+.||+++.+.-+-|.||+++....+
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 455544432 5699999999999999998899999999976544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.042 Score=60.45 Aligned_cols=145 Identities=17% Similarity=0.145 Sum_probs=79.6
Q ss_pred eeeeccCCcEEEEEEEEcC-----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCce-EEEEEEEeCCeEEE
Q 042346 506 ENKVGIGSFGTVYKGKLMD-----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV-GLVGFCQEKDERLL 579 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~l 579 (812)
.+.|-.|-.-.+|+..+.+ ++.+++|+...... ..-.-.+|.++++.+...++- ++++.+... .
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~------~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~ 110 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE------LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----R 110 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC------eeechHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence 3456568888999987532 36788998653211 111224688888888644443 556655332 5
Q ss_pred EEEecCCCchhhh-----------------hhcCCCCCccccccccHHHHHHHHH-----------------HHHHHHHH
Q 042346 580 VYEYMSNGALHDH-----------------LHNKNNTEKNSSIVNSWKMRIRIAL-----------------DAARGIDY 625 (812)
Q Consensus 580 V~ey~~~gsL~~~-----------------l~~~~~~~~~~~~~~~~~~~l~ia~-----------------~ia~gL~y 625 (812)
|+||+++.+|... +|....... .....|.+..++.. .+..-+..
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~--~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGP--KNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCC--CCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 8999977666421 222111110 00111222112211 11111222
Q ss_pred H----hh-cCCCCeEeeccCCCCEEEcC-CCcEEEEeeccccc
Q 042346 626 L----HN-YAVPSIIHRDIKSSNILLDV-NWTARVSDFGLSLL 662 (812)
Q Consensus 626 L----H~-~~~~~ivHrDlKp~NILl~~-~~~~kl~DfGla~~ 662 (812)
| .. .....++|+|+++.|||+++ ++.++|+||..+..
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2 21 11134899999999999986 47899999988743
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.08 Score=56.94 Aligned_cols=145 Identities=18% Similarity=0.203 Sum_probs=90.8
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCc---------------------chhhHHHHHHHHHHHHHHHHhccCCCc
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCP---------------------KTNKLREKESAFDSELALLSRVHHKHL 564 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~---------------------~~~~~~~~~~~~~~Ei~~l~~l~H~nI 564 (812)
...|..|--..||.+.-.+|..+|||++.... +.+...-...+.+.|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 45678899999999999899999999765321 111111223355678999999875544
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCch-hhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCC
Q 042346 565 VGLVGFCQEKDERLLVYEYMSNGAL-HDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSN 643 (812)
Q Consensus 565 v~l~~~~~~~~~~~lV~ey~~~gsL-~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~N 643 (812)
.-.--... ....|||+|+....- .-.|+.-. ++......+-.+++.-|.-|-+.. .+||.||.--|
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~---------ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN 295 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKDAS---------LSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFN 295 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccccccc---------CChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhh
Confidence 32111111 134799999843111 11121111 122233456666777777775554 39999999999
Q ss_pred EEEcCCCcEEEEeecccccCC
Q 042346 644 ILLDVNWTARVSDFGLSLLGS 664 (812)
Q Consensus 644 ILl~~~~~~kl~DfGla~~~~ 664 (812)
+|+ .+|.+.|+|.+.+....
T Consensus 296 ~Ly-hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 296 LLY-HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred heE-ECCEEEEEEccccccCC
Confidence 998 56799999998876543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 812 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-45 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-123
Identities = 122/330 (36%), Positives = 186/330 (56%), Gaps = 17/330 (5%)
Query: 465 STRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMD 524
S +++ + S S ++ L +L ATNNF + +G G FG VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 525 GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYM 584
G +VA+KR + +E F++E+ LS H HLV L+GFC E++E +L+Y+YM
Sbjct: 63 GAKVALKRRTP---ESSQGIEE--FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 585 SNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNI 644
NG L HL+ + ++ SW+ R+ I + AARG+ YLH +IIHRD+KS NI
Sbjct: 118 ENGNLKRHLYGSDL----PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINI 170
Query: 645 LLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVV 704
LLD N+ +++DFG+S G+E DQ +ST GT+GYIDPEY++ LT K+D+Y GVV
Sbjct: 171 LLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230
Query: 705 LLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKR-VGPPELNEAEAVELLA 763
L E+L + A+ ++ +++ E+AV GQL ++D
Sbjct: 231 LFEVLCARSAIVQSLP-REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKF---G 286
Query: 764 TTAIHCVNLEGKERPNITDIVANLERALAI 793
TA+ C+ L ++RP++ D++ LE AL +
Sbjct: 287 DTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-110
Identities = 112/299 (37%), Positives = 169/299 (56%), Gaps = 12/299 (4%)
Query: 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD 550
F+L EL A++NFS +N +G G FG VYKG+L DG VAVKR K + + E F
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL----KEERTQGGELQFQ 75
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
+E+ ++S H++L+ L GFC ERLLVY YM+NG++ L + S W
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER----PESQPPLDWP 131
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
R RIAL +ARG+ YLH++ P IIHRD+K++NILLD + A V DFGL+ L
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTH 190
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAV-FKNEDGSGPLDVVE 729
++T GT+G+I PEY + KTD++G GV+LLEL+TG++A + +++
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
+ + +L ++D + + E +L+ A+ C ERP ++++V LE
Sbjct: 251 WVKGLLKEKKLEALVDVDLQ-GNYKDEEVEQLIQ-VALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 329 bits (847), Expect = e-107
Identities = 107/307 (34%), Positives = 168/307 (54%), Gaps = 28/307 (9%)
Query: 491 FTLSELAAATNNFSLE------NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLR- 543
F+ EL TNNF NK+G G FG VYKG + + VAVK+ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 544 EKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNS 603
+++ FD E+ ++++ H++LV L+GF + D+ LVY YM NG+L D L + T
Sbjct: 74 KQQ--FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP--- 128
Query: 604 SIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
SW MR +IA AA GI++LH IHRDIKS+NILLD +TA++SDFGL+
Sbjct: 129 --PLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723
+ Q ++++ VGT Y+ PE + +T K+DIY GVVLLE++TG AV ++ +
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--- 239
Query: 724 PLDVVEFAVSQILA--GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT 781
P +++ +I + +DK++ + EA+ + A C++ + +RP+I
Sbjct: 240 PQLLLDIK-EEIEDEEKTIEDYIDKKMNDADSTSVEAM---YSVASQCLHEKKNKRPDIK 295
Query: 782 DIVANLE 788
+ L+
Sbjct: 296 KVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 2e-75
Identities = 76/318 (23%), Positives = 118/318 (37%), Gaps = 35/318 (11%)
Query: 490 NFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAF 549
+ L + L G FG V+K + + VAVK K + E E
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYE--- 68
Query: 550 DSELALLSRVHHKHLVGLVGFCQEKD----ERLLVYEYMSNGALHDHLHNKNNTEKNSSI 605
+ L + H++++ +G + + L+ + G+L D L
Sbjct: 69 ---VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--------- 116
Query: 606 VNSWKMRIRIALDAARGIDYLHNYAV-------PSIIHRDIKSSNILLDVNWTARVSDFG 658
V SW IA ARG+ YLH P+I HRDIKS N+LL N TA ++DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 659 LSLLGSECDQEFISTKAVGTVGYIDPEY-----YVMNVLTAKTDIYGLGVVLLELLTGKK 713
L+L + VGT Y+ PE + D+Y +G+VL EL +
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 714 AVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPP---ELNEAEAVELLATTAIHCV 770
A D E L V+ K+ P + + +L T C
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 771 NLEGKERPNITDIVANLE 788
+ + + R + + +
Sbjct: 297 DHDAEARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 3e-64
Identities = 80/332 (24%), Positives = 127/332 (38%), Gaps = 52/332 (15%)
Query: 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFD 550
SE + +N L +G G +G VYKG L D R VAVK + N + EK
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN---- 57
Query: 551 SELALLSRVHHKHLVGLVGFCQE-----KDERLLVYEYMSNGALHDHLHNKNNTEKNSSI 605
+ + + H ++ + + + E LLV EY NG+L +L
Sbjct: 58 --IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--------- 106
Query: 606 VNSWKMRIRIALDAARGIDYLHN------YAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659
+ W R+A RG+ YLH + P+I HRD+ S N+L+ + T +SDFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 660 SLLGSEC------DQEFISTKAVGTVGYIDPEY-------YVMNVLTAKTDIYGLGVVLL 706
S+ + +++ + VGT+ Y+ PE + D+Y LG++
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 707 ELLTGKKAVFKNEDGSG---PL-DVVEFAVSQILAGQLHCVLDKRVGPPELNEA-----E 757
E+ +F E V + L +R P+ EA
Sbjct: 227 EIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR---PKFPEAWKENSL 283
Query: 758 AVELLATTAIHCVNLEGKERPNITDIVANLER 789
AV L T C + + + R +
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-62
Identities = 85/290 (29%), Positives = 140/290 (48%), Gaps = 32/290 (11%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKR-EESCPKTNKLREKESAFDSELALLSRV 559
+ +++ K+G GSFGTV++ + G +VAVK E ++ E F E+A++ R+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE----FLREVAIMKRL 91
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H ++V +G + +V EY+S G+L+ LH E+ + R+ +A D
Sbjct: 92 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD-----ERRRLSMAYDV 146
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
A+G++YLHN P I+HR++KS N+L+D +T +V DFGLS L + S A GT
Sbjct: 147 AKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTP 203
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739
++ PE K+D+Y GV+L EL T ++ + N + P VV +
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP-WGNLN---PAQVVAAVGFK----- 254
Query: 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
KR+ P + ++ C E +RP+ I+ L
Sbjct: 255 -----CKRLEIPRNLNPQVAAIIE----GCWTNEPWKRPSFATIMDLLRP 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 7e-62
Identities = 74/292 (25%), Positives = 128/292 (43%), Gaps = 42/292 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKES--AFDSELALLSR 558
+E VG G+FG V K K ++VA+K ++ + AF EL LSR
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIK---------QIESESERKAFIVELRQLSR 57
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
V+H ++V L G C LV EY G+L++ LH + + L
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYT-----AAHAMSWCLQ 110
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT-ARVSDFGLSLLGSECDQEFISTKAVG 677
++G+ YLH+ ++IHRD+K N+LL T ++ DFG + CD + T G
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKG 165
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737
+ ++ PE + + + K D++ G++L E++T +K F + F + +
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP-FDE------IGGPAFRIMWAVH 218
Query: 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
L K + P + L+ C + + +RP++ +IV +
Sbjct: 219 NGTRPPLIKNL-PKPI-----ESLMT----RCWSKDPSQRPSMEEIVKIMTH 260
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-59
Identities = 62/297 (20%), Positives = 115/297 (38%), Gaps = 47/297 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKR-EESCPKTNKLREKESAFDSELALLSRV 559
+ K+ G ++KG+ G ++ VK + T K R+ F+ E L
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRD----FNEECPRLRIF 64
Query: 560 HHKHLVGLVGFCQEKDERLL--VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
H +++ ++G CQ + +M G+L++ LH N V ++ AL
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN------FVVDQSQAVKFAL 118
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
D ARG+ +LH P I + S ++++D + TAR+S + F S +
Sbjct: 119 DMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMY 170
Query: 678 TVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732
++ PE + + D++ V+L EL+T + F + +++
Sbjct: 171 APAWVAPE--ALQKKPEDTNRRSADMWSFAVLLWELVTREVP-FADLS---NMEIGMKVA 224
Query: 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
+ R P +L+ C+N + +RP IV LE+
Sbjct: 225 LE----------GLRPTIPPGISPHVSKLMK----ICMNEDPAKRPKFDMIVPILEK 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 6e-59
Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 45/301 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVK--REESCPKTNKLREKESAFDSELALLS 557
N E ++G G FG V+KG+L+ D VA+K ++ EK F E+ ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
++H ++V L G + +V E++ G L+ L +K + W +++R+ L
Sbjct: 79 NLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPI-------KWSVKLRLML 129
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLD-----VNWTARVSDFGLSLLGSECDQEFIS 672
D A GI+Y+ N P I+HRD++S NI L A+V+DFGLS
Sbjct: 130 DIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSV 183
Query: 673 TKAVGTVGYIDPEYYVMNVL----TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728
+ +G ++ PE + T K D Y ++L +LTG+ P D
Sbjct: 184 SGLLGNFQWMAPE--TIGAEEESYTEKADTYSFAMILYTILTGEG----------PFD-- 229
Query: 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
E++ +I + R PE ++ C + + K+RP+ + IV L
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIE----LCWSGDPKKRPHFSYIVKELS 285
Query: 789 R 789
Sbjct: 286 E 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-57
Identities = 80/292 (27%), Positives = 125/292 (42%), Gaps = 41/292 (14%)
Query: 505 LENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL 564
LE +GIG FG VY+ G EVAVK P + + E+ E L + + H ++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIEN-VRQEAKLFAMLKHPNI 68
Query: 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGID 624
+ L G C ++ LV E+ G L+ L K + + A+ ARG++
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI---------PPDILVNWAVQIARGMN 119
Query: 625 YLHNYAVPSIIHRDIKSSNILLD--------VNWTARVSDFGLSLLGSECDQEFISTKAV 676
YLH+ A+ IIHRD+KSSNIL+ N +++DFGL+ A
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAA 175
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736
G ++ PE ++ + +D++ GV+L ELLTG+ F+ D L V
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV-PFRGID---GLAVAYGVAMN-- 229
Query: 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
+ P +L+ C N + RP+ T+I+ L
Sbjct: 230 --------KLALPIPSTCPEPFAKLME----DCWNPDPHSRPSFTNILDQLT 269
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-55
Identities = 77/356 (21%), Positives = 138/356 (38%), Gaps = 56/356 (15%)
Query: 458 LPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTV 517
+PP S + S++ SGS S T+++ + ++G G +G V
Sbjct: 5 IPPGESLRDLIEQSQS-----SGSGSGLPLLVQRTIAK------QIQMVKQIGKGRYGEV 53
Query: 518 YKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577
+ GK G +VAVK + + + RE E + + H++++G + +
Sbjct: 54 WMGKW-RGEKVAVKVFFTTEEASWFRETE------IYQTVLMRHENILGFIAADIKGTGS 106
Query: 578 ----LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV-- 631
L+ +Y NG+L+D+L + K +++A + G+ +LH
Sbjct: 107 WTQLYLITDYHENGSLYDYLKST---------TLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 632 ---PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC--DQEFISTKAVGTVGYIDPEY 686
P+I HRD+KS NIL+ N T ++D GL++ + + VGT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE- 216
Query: 687 YVMNVL-----------TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL-DVVEFAVSQ 734
VL D+Y G++L E+ + E+ P D+V S
Sbjct: 217 ----VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 735 ILAGQLHCVLDKRVG-PPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
++ C+ R P + E + + C R + L +
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-55
Identities = 74/306 (24%), Positives = 113/306 (36%), Gaps = 39/306 (12%)
Query: 505 LENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL 564
L VG G +G V++G G VAVK S + + RE E L + H+++
Sbjct: 12 LLECVGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFRETE------LYNTVMLRHENI 64
Query: 565 VGLVGFCQEKD----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
+G + + L+ Y G+L+D+L +RI L A
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---------TLDTVSCLRIVLSIA 115
Query: 621 RGIDYLHNYAV-----PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ--EFIST 673
G+ +LH P+I HRD+KS NIL+ N ++D GL+++ S+ + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 674 KAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP-LD 726
VGT Y+ PE + DI+ G+VL E+ + ED P D
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235
Query: 727 VVEFAVSQILAGQLHCVLDKRVGPP---ELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
VV S V + P + LA C R I
Sbjct: 236 VVPNDPS--FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 784 VANLER 789
L +
Sbjct: 294 KKTLTK 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-54
Identities = 82/299 (27%), Positives = 138/299 (46%), Gaps = 47/299 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKR-EESCPKTNKLREKESAFDSELALLSRV 559
++ ++G GSFGTVYKGK +VAVK + P +L+ F +E+ +L +
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQA----FKNEVGVLRKT 77
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H +++ +G+ + +V ++ +L+ HLH K I IA
Sbjct: 78 RHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKF-------EMKKLIDIARQT 129
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
ARG+DYLH SIIHRD+KS+NI L + T ++ DFGL+ S + G++
Sbjct: 130 ARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 680 GYIDPE---YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ-- 734
++ PE N + ++D+Y G+VL EL+TG+ + N + D + V +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSNIN---NRDQIIEMVGRGS 242
Query: 735 ----ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
+ + +C P + L+A C+ + ERP+ I+A +E
Sbjct: 243 LSPDLSKVRSNC-------PKRM-----KRLMA----ECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 4e-54
Identities = 71/353 (20%), Positives = 134/353 (37%), Gaps = 56/353 (15%)
Query: 469 QSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREV 528
S+R+F R+ S +S F L E + +G G FG VY G+ EV
Sbjct: 9 LSARSFPRKASQTSIF--------LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EV 58
Query: 529 AVKR-EESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNG 587
A++ + ++L+ F E+ + H+++V +G C ++
Sbjct: 59 AIRLIDIERDNEDQLKA----FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114
Query: 588 ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD 647
L+ + + IV +IA + +G+ YLH I+H+D+KS N+ D
Sbjct: 115 TLYSVVRDAK-------IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD 164
Query: 648 VNWTARVSDFGLS---LLGSECDQEFISTKAVGTVGYIDPEYYVMNVL---------TAK 695
N ++DFGL + +E G + ++ PE +
Sbjct: 165 -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH 223
Query: 696 TDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNE 755
+D++ LG + EL + FK + P + + + + + P L++
Sbjct: 224 SDVFALGTIWYELHAREWP-FKTQ----PAEAIIWQMGT----------GMK---PNLSQ 265
Query: 756 AEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCSCTDSFSTTTF 808
+ ++ + C E +ERP T ++ LE+ + S F +
Sbjct: 266 IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKSAE 318
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-53
Identities = 86/344 (25%), Positives = 137/344 (39%), Gaps = 51/344 (14%)
Query: 470 SSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVA 529
+ SGS S T++ L+ +G G FG V++GK G EVA
Sbjct: 17 KDLIYDMTTSGSGSGLPLLVQRTIAR------TIVLQESIGKGRFGEVWRGKW-RGEEVA 69
Query: 530 VKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD----ERLLVYEYMS 585
VK S + + RE E + + H++++G + + + + LV +Y
Sbjct: 70 VKIFSSREERSWFREAE------IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123
Query: 586 NGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV-----PSIIHRDIK 640
+G+L D+L+ + + I++AL A G+ +LH V P+I HRD+K
Sbjct: 124 HGSLFDYLNRY---------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 641 SSNILLDVNWTARVSDFGLSLLGSECDQ--EFISTKAVGTVGYIDPEYYVMNVL------ 692
S NIL+ N T ++D GL++ + VGT Y+ PE VL
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-----VLDDSINM 229
Query: 693 -----TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP-LDVVEFAVSQILAGQLHCVLDK 746
+ DIY +G+V E+ +ED P D+V S ++ C
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 289
Query: 747 RVG-PPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
R P EA+ ++A C G R I L +
Sbjct: 290 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 6e-50
Identities = 62/297 (20%), Positives = 111/297 (37%), Gaps = 45/297 (15%)
Query: 505 LENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH 563
+G G FG K G + +K E + F E+ ++ + H +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKE-----LIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 564 LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGI 623
++ +G + + EY+ G L + + ++ W R+ A D A G+
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY-------PWSQRVSFAKDIASGM 121
Query: 624 DYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD------------QEFI 671
YLH+ +IIHRD+ S N L+ N V+DFGL+ L +
Sbjct: 122 AYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731
VG ++ PE K D++ G+VL E++ A + P ++F
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRT-MDFG 233
Query: 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
++ +C PP + + C +L+ ++RP+ + LE
Sbjct: 234 LNVRGFLDRYC-------PPNCPPS-----FFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 66/319 (20%), Positives = 124/319 (38%), Gaps = 77/319 (24%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
++F +G G+FG V K + +D R A+K K EK S SE+ LL+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIK------KIRHTEEKLSTILSEVMLLAS 58
Query: 559 VHHKHLVGLVGFCQEKDERL-------------LVYEYMSNGALHDHLHNKNNTEKNSSI 605
++H+++V E+ + + EY NG L+D +H++N N
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQR 115
Query: 606 VNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS----- 660
W++ +I + Y+H+ IIHRD+K NI +D + ++ DFGL+
Sbjct: 116 DEYWRLFRQILE----ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 661 -------LLGSECDQEFISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLE 707
+ T A+GT Y+ E +Y K D+Y LG++ E
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFE 223
Query: 708 LLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNE---AEAVELLAT 764
++ + L ++ + + PP+ ++ +++
Sbjct: 224 MIYP---FSTGMERVNILK-------KLRSVSIEF-------PPDFDDNKMKVEKKIIR- 265
Query: 765 TAIHCVNLEGKERPNITDI 783
++ + +RP +
Sbjct: 266 ---LLIDHDPNKRPGARTL 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 60/330 (18%), Positives = 103/330 (31%), Gaps = 49/330 (14%)
Query: 463 SFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKG-K 521
F + Q R +S + +F +++G GS+G V+K
Sbjct: 19 YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRS 78
Query: 522 LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581
DGR AVK S +++ + H V L +E L
Sbjct: 79 KEDGRLYAVK--RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136
Query: 582 EYMSNGALHDHLHNKNN--TEKNSSIVNSWKMRIR-IALDAARGIDYLHNYAVPSIIHRD 638
E +L H E ++ D + +LH+ ++H D
Sbjct: 137 EL-CGPSLQQHCEAWGASLPEA----------QVWGYLRDTLLALAHLHSQ---GLVHLD 182
Query: 639 IKSSNILLDVNWTARVSDFGLS--LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKT 696
+K +NI L ++ DFGL L + + G Y+ PE +
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-----EGDPRYMAPE-LLQGSYGTAA 236
Query: 697 DIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEA 756
D++ LG+ +LE+ + E Q+ G L L+
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYLPPEF-----TAGLSS- 279
Query: 757 EAVELLATTAIHCVNLEGKERPNITDIVAN 786
E +L + + K R ++A
Sbjct: 280 ELRSVLVM----MLEPDPKLRATAEALLAL 305
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 64/287 (22%), Positives = 123/287 (42%), Gaps = 34/287 (11%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
NF +E K+G G F VY+ L+DG VA+K + + + E+ LL ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALK-KVQIFDLMDAKARADCI-KEIDLLKQL 89
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNS--WKMRIRIAL 617
+H +++ E +E +V E G L + K+ ++ I WK +++
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCS 147
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAV 676
++++H+ ++HRDIK +N+ + ++ D GL S+ + V
Sbjct: 148 ----ALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHS-LV 197
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736
GT Y+ PE N K+DI+ LG +L E+ + F + + + +I
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP-FYGDKMN-----LYSLCKKIE 251
Query: 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
+ P + E +L+ C+N + ++RP++T +
Sbjct: 252 QCDYPPL------PSDHYSEELRQLVN----MCINPDPEKRPDVTYV 288
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-34
Identities = 73/326 (22%), Positives = 113/326 (34%), Gaps = 55/326 (16%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV- 559
N E +G GS GTV GR VAVKR L + E+ LL+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR--------MLIDFCDIALMEIKLLTESD 66
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H +++ + E N L D + +KN +++N + + +
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQI 124
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDV-------------NWTARVSDFGLS--LLGS 664
A G+ +LH+ IIHRD+K NIL+ N +SDFGL L
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 665 ECDQEFISTKAVGTVGYIDPE-------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFK 717
+ GT G+ PE LT DI+ +G V +L+
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK------ 235
Query: 718 NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKER 777
G P S I+ G K + L EA +L++ ++ + +R
Sbjct: 236 ---GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIA-EATDLIS----QMIDHDPLKR 287
Query: 778 PNITDIVA-----NLERALAICQDCS 798
P ++ + L S
Sbjct: 288 PTAMKVLRHPLFWPKSKKLEFLLKVS 313
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 72/308 (23%), Positives = 131/308 (42%), Gaps = 46/308 (14%)
Query: 481 SSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKT 539
SS + +N + + K+G GSFG K DGR+ +K E + +
Sbjct: 8 SSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIK-EINISRM 62
Query: 540 NKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNT 599
+ +E+E + E+A+L+ + H ++V +E +V +Y G L ++ +
Sbjct: 63 SS-KEREESR-REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV 120
Query: 600 EKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659
+ ++I L + ++H+ I+HRDIKS NI L + T ++ DFG+
Sbjct: 121 LFQEDQI--LDWFVQICL----ALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGI 171
Query: 660 S-LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN 718
+ +L S + +GT Y+ PE K+DI+ LG VL EL T K A F+
Sbjct: 172 ARVLNSTVE--LARA-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA-FEA 227
Query: 719 EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNE---AEAVELLATTAIHCVNLEGK 775
++ V +I++G P ++ + L++ +
Sbjct: 228 GS-------MKNLVLKIISGS----------FPPVSLHYSYDLRSLVS----QLFKRNPR 266
Query: 776 ERPNITDI 783
+RP++ I
Sbjct: 267 DRPSVNSI 274
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 71/312 (22%), Positives = 124/312 (39%), Gaps = 50/312 (16%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-H 560
+F ++ +G G+ GT+ + D R+VAVKR L E S D E+ LL
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR--------ILPECFSFADREVQLLRESDE 76
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H +++ +++ + + E + L +++ K+ I +
Sbjct: 77 HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEP-------ITLLQQTT 128
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILL-----DVNWTARVSDFGLSLLGSECDQEFISTK- 674
G+ +LH+ +I+HRD+K NIL+ A +SDFGL + F
Sbjct: 129 SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 675 AVGTVGYIDPEYYVMNV---LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731
GT G+I PE + T DI+ G V +++ GS P
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE---------GSHPFGKSLQR 236
Query: 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA-----N 786
+ IL G + P + + A EL+ + ++ ++RP+ ++ +
Sbjct: 237 QANILLGACS---LDCLHPEKHEDVIARELIE----KMIAMDPQKRPSAKHVLKHPFFWS 289
Query: 787 LERALAICQDCS 798
LE+ L QD S
Sbjct: 290 LEKQLQFFQDVS 301
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 20/222 (9%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
++ + +G GS+G K + DG+ + K E + EK+ SE+ LL +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWK-ELDYGSMTE-AEKQMLV-SEVNLLREL 62
Query: 560 HHKHLVGLVG-FCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNS--WKMRIRI 615
H ++V + L +V EY G L + T++ + ++ ++
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQL 120
Query: 616 ALDAARGIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFIS 672
L + H + +++HRD+K +N+ LD ++ DFGL+ +L D F
Sbjct: 121 TL----ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAK 174
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKA 714
T VGT Y+ PE K+DI+ LG +L EL
Sbjct: 175 TF-VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 70/319 (21%), Positives = 140/319 (43%), Gaps = 46/319 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE------VAVKREESCPKTNKLREKESAFDSELA 554
++ ++G GSFG VY+G + VA+K + + +RE+ F +E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRERI-EFLNEAS 80
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR-- 612
++ + H+V L+G + L++ E M+ G L +L + N+ ++ +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 613 IRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
I++A + A G+ YL + + +HRD+ + N ++ ++T ++ DFG++ E D
Sbjct: 141 IQMAGEIADGMAYLNANKF-----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK--AVFKNEDGSGPLDV 727
K + V ++ PE V T +D++ GVVL E+ T ++ NE V
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QV 249
Query: 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787
+ F ++ G + P+ EL+ C K RP+ +I++++
Sbjct: 250 LRF----VMEGG-------LLDKPDNCPDMLFELM----RMCWQYNPKMRPSFLEIISSI 294
Query: 788 ERALAICQDCSCTDSFSTT 806
+ + + SF +
Sbjct: 295 KEEM---EPGFREVSFYYS 310
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 52/240 (21%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+F +G G FG V+K K +DG+ +K + EK + E+ L+++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK------RVKYNNEKA---EREVKALAKL 61
Query: 560 HHKHLVGLVGFCQEKDERL----------------LVYEYMSNGALHDHLHNKNNTEKNS 603
H ++V G D + E+ G L + + + +
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 604 SIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LL 662
+ ++ +I G+DY+H+ +I+RD+K SNI L ++ DFGL L
Sbjct: 122 VLA--LELFEQITK----GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 663 GSECDQEFISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVF 716
++ + T++ GT+ Y+ PE Y + D+Y LG++L ELL F
Sbjct: 173 KNDGKR----TRSKGTLRYMSPEQISSQDY------GKEVDLYALGLILAELLHVCDTAF 222
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 508 KVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
++G GSF TVYKG EVA + + F E +L + H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCE---LQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 567 LVGFC---QEKDERLLVY-EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARG 622
+ + +++ E M++G L +L K ++ SW +I +G
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQI------LKG 141
Query: 623 IDYLHNYAVPSIIHRDIKSSNILLD-VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
+ +LH P IIHRD+K NI + + ++ D GL+ L F +GT +
Sbjct: 142 LQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKA-VIGTPEF 196
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ PE Y D+Y G+ +LE+ T +
Sbjct: 197 MAPEMY-EEKYDESVDVYAFGMCMLEMATSE 226
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 67/303 (22%), Positives = 118/303 (38%), Gaps = 59/303 (19%)
Query: 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+ L ++G G+FG V+ G+L D VAVK + + ++ F E +L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQY 169
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H ++V L+G C +K +V E + G L + K +++ DA
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARL-------RVKTLLQMVGDA 222
Query: 620 ARGIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
A G++YL IHRD+ + N L+ ++SDFG+S ++ A G
Sbjct: 223 AAGMEYLESKCC-----IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-----ASG 272
Query: 678 TVGYI-----DPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP------LD 726
+ + PE ++++D++ G++L E + G+ P
Sbjct: 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS---------LGASPYPNLSNQQ 323
Query: 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786
E + G R+ PEL L+ C E +RP+ + I
Sbjct: 324 TRE----FVEKGG-------RLPCPELCPDAVFRLM----EQCWAYEPGQRPSFSTIYQE 368
Query: 787 LER 789
L+
Sbjct: 369 LQS 371
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 47/239 (19%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+F +G G FG V++ K +D A+KR N+ +E E+ L+++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR---IRLPNRELAREKVM-REVKALAKL 60
Query: 560 HHKHLVGLVGFCQEKDE---------RLLVY---EYMSNGALHDHLHNKNNTEKNSSIVN 607
H +V EK+ ++ +Y + L D N T +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSV 119
Query: 608 SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSEC 666
+ ++IA +++LH+ ++HRD+K SNI ++ +V DFGL + +
Sbjct: 120 CLHIFLQIAE----AVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 667 D---------QEFISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLT 710
+ T VGT Y+ PE Y + K DI+ LG++L ELL
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY------SHKVDIFSLGLILFELLY 225
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 72/307 (23%), Positives = 121/307 (39%), Gaps = 46/307 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE----VAVKREESCPKTNKLREKESAFDSELALL 556
F+L +G G FG+V + +L VAVK F E A +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVK---MLKADIIASSDIEEFLREAACM 79
Query: 557 SRVHHKHLVGLVGFCQEKDER------LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
H H+ LVG + +++ +M +G LH L E ++ +
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL--PLQ 137
Query: 611 MRIRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ 668
+R +D A G++YL N+ IHRD+ + N +L + T V+DFGLS D
Sbjct: 138 TLVRFMVDIACGMEYLSSRNF-----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP---L 725
+ V ++ E N+ T +D++ GV + E++T G P +
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR---------GQTPYAGI 243
Query: 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785
+ E + ++ G R+ P E +L+ C + + K+RP+ T +
Sbjct: 244 ENAE-IYNYLIGGN-------RLKQPPECMEEVYDLMY----QCWSADPKQRPSFTCLRM 291
Query: 786 NLERALA 792
LE L
Sbjct: 292 ELENILG 298
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 31/231 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVK--------REESCPKTNKLREKESAFDS- 551
N++ + + G F + + D + A+K ++ K+N + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 552 ---ELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNS 608
EL +++ + +++ + G DE ++YEYM N ++ +KN +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 609 WKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ 668
++ I Y+HN +I HRD+K SNIL+D N ++SDFG S +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--- 204
Query: 669 EFISTKAVGTVGYIDPE-------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ I + GT ++ PE Y AK DI+ LG+ L +
Sbjct: 205 KKIKG-SRGTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNV 249
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 51/282 (18%), Positives = 92/282 (32%), Gaps = 43/282 (15%)
Query: 459 PPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVY 518
P+ S+ + + K + F L + + +G G+F VY
Sbjct: 36 KPVSSYPNTFEWQCKL-------PAIKPKTE-FQLGS-----KLVYVHHLLGEGAFAQVY 82
Query: 519 KGK------LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ 572
+ + ++ +K ++ + + L +
Sbjct: 83 EATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ-----LMERLKPSMQHMFMKFYSAHL 137
Query: 573 EKDERLLVYEYMSNGALHDHL-HNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV 631
++ +LV E S G L + + KN EK + I A+ I+ +H+
Sbjct: 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ----GLVISFAMRMLYMIEQVHDC-- 191
Query: 632 PSIIHRDIKSSNILL-----------DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
IIH DIK N +L D++ + D G S+ + I T T G
Sbjct: 192 -EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS 722
+ E + D +G+ + +L G KNE G
Sbjct: 251 FQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 21/221 (9%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGR------EVAVKREESCPKTNKLREKESAFDSELA 554
N +L +G G+FG VY+G++ +VAVK + P+ +++ F E
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDEL-DFLMEAL 85
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
++S+ +H+++V +G + R ++ E M+ G L L S + + +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL-LH 144
Query: 615 IALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDV---NWTARVSDFGLSLLGSECDQE 669
+A D A G YL +++ IHRDI + N LL A++ DFG++
Sbjct: 145 VARDIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
A+ V ++ PE ++ + T+KTD + GV+L E+ +
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 31/224 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE-----VAVK--REESCPKTNKLREKESAFDSEL 553
F +G G+FGTVYKG + E VA+K RE + PK NK E
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK------EILDEA 68
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
+++ V + H+ L+G C L+ + M G L D++ + + ++N
Sbjct: 69 YVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN------ 121
Query: 614 RIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEF 670
+ A+G++YL +HRD+ + N+L+ +++DFGL+ LLG+E ++E+
Sbjct: 122 -WCVQIAKGMNYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEY 174
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK 713
+ + ++ E + + T ++D++ GV + EL+T G K
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 76/310 (24%), Positives = 127/310 (40%), Gaps = 45/310 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE----VAVKREESCPKTNKLREKESAFDSELALL 556
N L +G G FG+V +G L VAVK + N + + F SE A +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK---TMKLDNSSQREIEEFLSEAACM 90
Query: 557 SRVHHKHLVGLVGFCQEKD-----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
H +++ L+G C E + +++ +M G LH +L I +
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI--PLQT 148
Query: 612 RIRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE 669
++ +D A G++YL N+ +HRD+ + N +L + T V+DFGLS D
Sbjct: 149 LLKFMVDIALGMEYLSNRNF-----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK--AVFKNEDGSGPLD 726
A V +I E V T+K+D++ GV + E+ T G +N +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------E 257
Query: 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786
+ ++ +L G R+ PE E E++ C + +RP + +
Sbjct: 258 MYDY----LLHGH-------RLKQPEDCLDELYEIM----YSCWRTDPLDRPTFSVLRLQ 302
Query: 787 LERALAICQD 796
LE+ L D
Sbjct: 303 LEKLLESLPD 312
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 62/298 (20%), Positives = 115/298 (38%), Gaps = 30/298 (10%)
Query: 427 HKRINSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSV 486
H + + +S S + S S + S + + +
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69
Query: 487 KADNFTLSELAAAT-----NNFSLENKVGIGSFGTVYKGKLMDGRE----VAVKREESCP 537
+ + + +G G FG VY G L+D AVK S
Sbjct: 70 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLN 126
Query: 538 KTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE-RLLVYEYMSNGALHDHLHNK 596
+ + E F +E ++ H +++ L+G C + L+V YM +G L + + N+
Sbjct: 127 RITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185
Query: 597 NNTEKNSSIVNSWKMRIRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARV 654
+ + I L A+G+ +L + +HRD+ + N +LD +T +V
Sbjct: 186 THNPTVKDL-------IGFGLQVAKGMKFLASKKF-----VHRDLAARNCMLDEKFTVKV 233
Query: 655 SDFGLSLLGSECDQEFISTKAVGT--VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+DFGL+ + + + + K V ++ E T K+D++ GV+L EL+T
Sbjct: 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 69/301 (22%), Positives = 127/301 (42%), Gaps = 49/301 (16%)
Query: 504 SLENKVGIGSFGTVYKGKLMDGRE----VAVKREESCPKTNKLREKESAFDSELALLSRV 559
+G G FG VY G L+D AVK S + + E F +E ++
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGEVSQ-FLTEGIIMKDF 83
Query: 560 HHKHLVGLVGFCQEKDE-RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H +++ L+G C + L+V YM +G L + + N+ + + I L
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQ 136
Query: 619 AARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
A+G+ YL + +HRD+ + N +LD +T +V+DFGL+ + + + K
Sbjct: 137 VAKGMKYLASKKF-----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 677 GT--VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK--AVFKNEDGSGPLDVVEFA 731
V ++ E T K+D++ GV+L EL+T G D+ +
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITVY- 244
Query: 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791
+L G+ R+ PE E++ + C + + + RP+ +++V+ +
Sbjct: 245 ---LLQGR-------RLLQPEYCPDPLYEVM----LKCWHPKAEMRPSFSELVSRISAIF 290
Query: 792 A 792
+
Sbjct: 291 S 291
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 38/231 (16%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+ + L + +G G+ V++G+ G A+K E +L ++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIK----VFNNISFLRPVDVQMREFEVLKKL 64
Query: 560 HHKHLVGLVGFCQEKDERL--LVYEYMSNGALHDHLHNKNN----TEKNSSIVNSWKMRI 613
+HK++V L +E R L+ E+ G+L+ L +N E IV +R
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV----LR- 119
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTARVSDFGLSLLGSECDQE 669
D G+++L I+HR+IK NI+ D +++DFG + E + +
Sbjct: 120 ----DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDD 169
Query: 670 FISTKAVGTVGYIDPEYYVMNVL--------TAKTDIYGLGVVLLELLTGK 712
GT Y+ P+ Y VL A D++ +GV TG
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 56/271 (20%), Positives = 102/271 (37%), Gaps = 27/271 (9%)
Query: 448 SASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLS-ELAAATNNFSLE 506
S S S +++S+ + G + + + + E + + +
Sbjct: 4 SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ 63
Query: 507 NKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
+VG GSFG V++ K G + AVK+ E EL + + +V
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR----------LEVFRVEELVACAGLSSPRIV 113
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
L G +E + E + G+L + + + A G++Y
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALY-------YLGQALEGLEY 165
Query: 626 LHNYAVPSIIHRDIKSSNILLDVN-WTARVSDFGLS--LLGSECDQEFISTKA-VGTVGY 681
LH I+H D+K+ N+LL + A + DFG + L + ++ GT +
Sbjct: 166 LHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ PE + AK DI+ ++L +L G
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 21/221 (9%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGR------EVAVKREESCPKTNKLREKESAFDSELA 554
N +L +G G+FG VY+G++ +VAVK + P+ +++ F E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDEL-DFLMEAL 126
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
++S+ +H+++V +G + R ++ E M+ G L L S + + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL-LH 185
Query: 615 IALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDV---NWTARVSDFGLSLLGSECDQE 669
+A D A G YL +++ IHRDI + N LL A++ DFG++
Sbjct: 186 VARDIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
A+ V ++ PE ++ + T+KTD + GV+L E+ +
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 505 LENKVGIGSFGTVYKGKLMDGRE----VAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ +G G FG VY G+ +D + A+K S + ++++ E AF E L+ ++
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK---SLSRITEMQQVE-AFLREGLLMRGLN 80
Query: 561 HKHLVGLVGFCQEKDERLL-VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H +++ L+G + + YM +G L + + + I L
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-------ISFGLQV 133
Query: 620 ARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
ARG++YL + +HRD+ + N +LD ++T +V+DFGL+ + + +
Sbjct: 134 ARGMEYLAEQKF-----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 678 T--VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
V + E T K+D++ GV+L ELLT
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
L +G G FG V G G +VAVK K AF +E ++++++
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVK-------CIKNDATAQAFLAEASVMTQLR 244
Query: 561 HKHLVGLVGFC-QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H +LV L+G +EK +V EYM+ G+L D+L ++ + ++ +LD
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL------GGDCLLKFSLDV 298
Query: 620 ARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
++YL +N+ +HRD+ + N+L+ + A+VSDFGL+ +
Sbjct: 299 CEAMEYLEGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKL 348
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
V + PE + K+D++ G++L E+ +
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 44/251 (17%), Positives = 93/251 (37%), Gaps = 31/251 (12%)
Query: 476 RQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREES 535
SS + +N ++ +S+ ++G G V++ + A+K
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY--- 59
Query: 536 CPKTNKLREKESAFDSELALLSRVHHK--HLVGLVGFCQEKDERLLVYEYMSNGALHDHL 593
+ ++ +E+A L+++ ++ L + +V E N L+ L
Sbjct: 60 VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL 118
Query: 594 HNKNN-TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652
K + R + + +H + I+H D+K +N L+ +
Sbjct: 119 KKKKSIDP---------WERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML 165
Query: 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPE-----------YYVMNVLTAKTDIYGL 701
++ DFG++ + VGTV Y+ PE + ++ K+D++ L
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 702 GVVLLELLTGK 712
G +L + GK
Sbjct: 226 GCILYYMTYGK 236
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 39/291 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ LE K+G G FG V+ G VA+K + E F E ++ ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEA---FLQEAQVMKKLR 237
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H+ LV L ++ +V EYMS G+L D L K T K + + +A A
Sbjct: 238 HEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFL--KGETGKYLRL----PQLVDMAAQIA 290
Query: 621 RGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
G+ Y+ NY +HRD++++NIL+ N +V+DFGL+ L + + A
Sbjct: 291 SGMAYVERMNY-----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFP 344
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
+ + PE + T K+D++ G++L EL T + + +V++ Q+ G
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERG 397
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
R+ P +L+ C E +ERP + A LE
Sbjct: 398 Y-------RMPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLED 437
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLRE---KESAFDSELALLS 557
+ + ++G G FG V+ G ++ +VA+K +RE E F E ++
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIK---------TIREGAMSEEDFIEEAEVMM 58
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
++ H LV L G C E+ LV E+M +G L D+L + +++ + L
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG-------MCL 111
Query: 618 DAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA 675
D G+ YL IHRD+ + N L+ N +VSDFG++ + DQ ST
Sbjct: 112 DVCEGMAYLEEACV-----IHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGT 165
Query: 676 VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
V + PE + + ++K+D++ GV++ E+ +
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE-----VAVK--REESCPKTNKLREKESAFDSEL 553
F +G G+FGTVYKG + E VA+K RE + PK NK E
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK------EILDEA 68
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
+++ V + H+ L+G C L+ + M G L D++ + + ++N
Sbjct: 69 YVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN------ 121
Query: 614 RIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
+ A+G++YL +HRD+ + N+L+ +++DFGL+ L ++E+
Sbjct: 122 -WCVQIAKGMNYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + ++ E + + T ++D++ GV + EL+T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-30
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKL-REKESAFDSELALLSR 558
+ ++++K+G G +G VY+G VAVK T K + F E A++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-------TLKEDTMEVEEFLKEAAVMKE 272
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ H +LV L+G C + ++ E+M+ G L D+L N E S + + +A
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV------SAVVLLYMATQ 326
Query: 619 AARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
+ ++YL N+ IHR++ + N L+ N +V+DFGLS L + D A
Sbjct: 327 ISSAMEYLEKKNF-----IHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAK 380
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE N + K+D++ GV+L E+ T
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 60/309 (19%), Positives = 114/309 (36%), Gaps = 56/309 (18%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
++ K+G G F V + L DG A+KR ++ +++E A E + +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC----HEQQDREEAQ-READMHRLFN 84
Query: 561 HKHLVGLVGFCQEKDER----LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM---RI 613
H +++ LV +C + L+ + G L + + + +I
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI--------ERLKDKGNFLTEDQI 136
Query: 614 -RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-------LLGSE 665
+ L RG++ +H HRD+K +NILL + D G +
Sbjct: 137 LWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 666 CDQEFISTKAVGTVGYIDPE---YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS 722
T+ Y PE V+ +TD++ LG VL ++ G+ +
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-YDMVFQK 252
Query: 723 GPLDVVEFAVSQILAGQLHCVLDKRVGPPELNE--AEAVELLATTAIHCVNLEGKERPNI 780
G V+ + QL P+ + +LL + + ++ +RP+I
Sbjct: 253 GDS------VALAVQNQLS--------IPQSPRHSSALWQLLNS----MMTVDPHQRPHI 294
Query: 781 TDIVANLER 789
+++ LE
Sbjct: 295 PLLLSQLEA 303
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 38/231 (16%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+ + L + +G G+ V++G+ G A+K E +L ++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIK----VFNNISFLRPVDVQMREFEVLKKL 64
Query: 560 HHKHLVGLVGFCQEKDERL--LVYEYMSNGALHDHLHNKNN----TEKNSSIVNSWKMRI 613
+HK++V L +E R L+ E+ G+L+ L +N E IV +R
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV----LR- 119
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTARVSDFGLSLLGSECDQE 669
D G+++L I+HR+IK NI+ D +++DFG + E + +
Sbjct: 120 ----DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDD 169
Query: 670 FISTKAVGTVGYIDPEYYVMNVL--------TAKTDIYGLGVVLLELLTGK 712
GT Y+ P+ Y VL A D++ +GV TG
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE-----VAVK--REESCPKTNKLREKESAFDSEL 553
+G G FGTV+KG + E V +K ++S ++ + A +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ------AVTDHM 66
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
+ + H H+V L+G C LV +Y+ G+L DH+ ++N
Sbjct: 67 LAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN------ 119
Query: 614 RIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
+ A+G+ YL H +HR++ + N+LL +V+DFG++ L D++ +
Sbjct: 120 -WGVQIAKGMYYLEEHGM-----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
++A + ++ E T ++D++ GV + EL+T
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 58/228 (25%), Positives = 88/228 (38%), Gaps = 48/228 (21%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMD-GREVAVK---REESCPKTNKLREKESAFDSELALLS 557
+ +G G F ++ D A K + REK E+++
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREK---MSMEISIHR 70
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
+ H+H+VG GF ++ D +V E +L + K R +
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----------------KRRKALTE 114
Query: 618 DAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE 669
AR G YLH V IHRD+K N+ L+ + ++ DFGL+ E D E
Sbjct: 115 PEARYYLRQIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGE 170
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
GT YI PE VL+ K D++ +G ++ LL GK
Sbjct: 171 RKKV-LCGTPNYIAPE-----VLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 69/316 (21%), Positives = 128/316 (40%), Gaps = 48/316 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE--------VAVKREESCPKTNKLREKESAFDSE 552
+ +L +G G+FG V + + + VAVK ++ SE
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLS-DLVSE 90
Query: 553 LALLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN---- 607
+ ++ + HK+++ L+G C + ++ EY S G L ++L + S
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 608 ----SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
++K + ARG++YL A IHRD+ + N+L+ N +++DFGL+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723
+ D +T V ++ PE V T ++D++ GV++ E+ T G
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---------GGS 258
Query: 724 P---LDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI 780
P + V E + G R+ P E ++ C + +RP
Sbjct: 259 PYPGIPVEEL-FKLLKEGH-------RMDKPANCTNELYMMMR----DCWHAVPSQRPTF 306
Query: 781 TDIVANLERALAICQD 796
+V +L+R L + +
Sbjct: 307 KQLVEDLDRILTLTTN 322
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 24/225 (10%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE------VAVKREESCPKTNKLREKESAFDSELA 554
NN +G G+FG V + + VAVK T EKE A SEL
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADEKE-ALMSELK 101
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR- 612
++S + H+++V L+G C L++ EY G L + L K+ +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 613 -----IRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665
+ + A+G+ +L N IHRD+ + N+LL A++ DFGL+
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ A V ++ PE V T ++D++ G++L E+ +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-30
Identities = 64/283 (22%), Positives = 115/283 (40%), Gaps = 40/283 (14%)
Query: 467 RQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDG 525
+ F S+ + + K+G G++G V + +
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62
Query: 526 REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMS 585
E A+K KT+ S E+A+L + H +++ L F ++K LV E
Sbjct: 63 VERAIK---IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 586 NGALHDHLHNKNN-TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNI 644
G L D + ++ E +++++ I+ L + YLH + +I+HRD+K N+
Sbjct: 120 GGELFDEIIHRMKFNEVDAAVI------IKQVLSG---VTYLHKH---NIVHRDLKPENL 167
Query: 645 LL---DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL----TAKTD 697
LL + + ++ DFGLS + + + + +GT YI PE VL K D
Sbjct: 168 LLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPE-----VLRKKYDEKCD 219
Query: 698 IYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740
++ +GV+L LL G F + L ++ G+
Sbjct: 220 VWSIGVILFILLAGYPP-FGGQTDQEILR-------KVEKGKY 254
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVK--REESCPKTNKLREKESAFDSELALLSR 558
+ + ++G G FG V GK +VA+K +E S E F E ++
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--------MSEDEFIEEAKVMMN 75
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ H+ LV L G C ++ ++ EYM+NG L ++L + + ++ + D
Sbjct: 76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-------MCKD 128
Query: 619 AARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
++YL + +HRD+ + N L++ +VSDFGLS + + T +V
Sbjct: 129 VCEAMEYLESKQF-----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----TSSV 179
Query: 677 GT---VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
G+ V + PE + + ++K+DI+ GV++ E+ +
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLRE---KESAFDSELALLS 557
+L ++G G FG V GK +VAVK ++E E F E +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVK---------MIKEGSMSEDEFFQEAQTMM 58
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
++ H LV G C ++ +V EY+SNG L ++L + + S ++ +
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE-------MCY 111
Query: 618 DAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA 675
D G+ +L H + IHRD+ + N L+D + +VSDFG++ + DQ S
Sbjct: 112 DVCEGMAFLESHQF-----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGT 165
Query: 676 VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
V + PE + ++K+D++ G+++ E+ +
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 73/291 (25%), Positives = 121/291 (41%), Gaps = 39/291 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ LE K+G G FG V+ G VA+K + E F E ++ ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEA---FLQEAQVMKKLR 320
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H+ LV L E + +V EYMS G+L D L + + +A A
Sbjct: 321 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK------YLRLPQLVDMAAQIA 373
Query: 621 RGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
G+ Y+ NY +HRD++++NIL+ N +V+DFGL+ L + + A
Sbjct: 374 SGMAYVERMNY-----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFP 427
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
+ + PE + T K+D++ G++L EL T + + +V++ Q+ G
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERG 480
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
R+ P +L+ C E +ERP + A LE
Sbjct: 481 Y-------RMPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLED 520
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 33/234 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE------VAVK--REESCPKTNKLREKESAFDSE 552
N L +G G FG V K + VAVK +E + P SE
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE------LRDLLSE 76
Query: 553 LALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
+L +V+H H++ L G C + LL+ EY G+L L +
Sbjct: 77 FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 613 ----------------IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656
I A ++G+ YL A ++HRD+ + NIL+ ++SD
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
FGLS E D ++ V ++ E ++ T ++D++ GV+L E++T
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 35/223 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVK---REESCPKTNKLREKESAFDSELALL 556
+F + N +G GSF VY+ + + G EVA+K ++ + ++ +E+ +
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQR---VQNEVKIH 65
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN--TEKNSSIVNSWKMRIR 614
++ H ++ L + ++ + LV E NG ++ +L N+ +E +
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR---------H 116
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
G+ YLH++ I+HRD+ SN+LL N +++DFGL+ + E T
Sbjct: 117 FMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ-LKMPHEKHYT- 171
Query: 675 AVGTVGYIDPEYYVMNVLT-----AKTDIYGLGVVLLELLTGK 712
GT YI PE + T ++D++ LG + LL G+
Sbjct: 172 LCGTPNYISPE-----IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 52/228 (22%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE------VAVK--REESCPKTNKLREKESAFDSE 552
+ ++G FG VYKG L VA+K ++++ LRE+ F E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREE---FRHE 62
Query: 553 LALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
L +R+ H ++V L+G + +++ Y S+G LH+ L ++ S + ++
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 613 --------IRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662
+ + A G++YL H+ +H+D+ + N+L+ ++SD GL
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
D + ++ + ++ PE + + +DI+ GVVL E+ +
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 60/262 (22%), Positives = 109/262 (41%), Gaps = 37/262 (14%)
Query: 467 RQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDG 525
+ GR+ ++ + + ++ K+G G++G V K
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 526 REVAVK--------REESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577
E A+K + + + +E++LL + H +++ L ++K
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 578 LLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIH 636
LV E+ G L + + N++ E +++ + ++ L I YLH + +I+H
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDAANI------MKQILSG---ICYLHKH---NIVH 169
Query: 637 RDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL- 692
RDIK NILL + ++ DFGLS S +++ +GT YI PE VL
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAYYIAPE-----VLK 221
Query: 693 ---TAKTDIYGLGVVLLELLTG 711
K D++ GV++ LL G
Sbjct: 222 KKYNEKCDVWSCGVIMYILLCG 243
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 30/226 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE---VAVKREESCPKTNKLREKESAFDSELALLS 557
N+ ++ +G G+FG V K ++ A+K + + F EL +L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDDHR-DFAGELEVLC 80
Query: 558 RV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR---- 612
++ HH +++ L+G C+ + L EY +G L D L E + + +
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 613 ----IRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC 666
+ A D ARG+DYL + IHRD+ + NIL+ N+ A+++DFGLS
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQF-----IHRDLAARNILVGENYVAKIADFGLSR----- 190
Query: 667 DQEFISTKAVGT--VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
QE K +G V ++ E +V T +D++ GV+L E+++
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 33/216 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
L +G G FG V G G +VAVK K AF +E ++++++
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVK-------CIKNDATAQAFLAEASVMTQLR 72
Query: 561 HKHLVGLVGFC-QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H +LV L+G +EK +V EYM+ G+L D+L ++ + ++ +LD
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL------GGDCLLKFSLDV 126
Query: 620 ARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
++YL +N+ +HRD+ + N+L+ + A+VSDFGL+ + S+
Sbjct: 127 CEAMEYLEGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLT--------KEASSTQDT 173
Query: 678 T---VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
V + PE + K+D++ G++L E+ +
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGR-EVAVKREESCPKTNKLRE---KESAFDSELALL 556
+ ++++K+G G +G VY+G VAVK L+E + F E A++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---------TLKEDTMEVEEFLKEAAVM 63
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ H +LV L+G C + ++ E+M+ G L D+L N E ++ ++ + +A
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL------LYMA 117
Query: 617 LDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
+ ++YL N+ IHRD+ + N L+ N +V+DFGLS L + D
Sbjct: 118 TQISSAMEYLEKKNF-----IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAG 171
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
A + + PE N + K+D++ GV+L E+ T
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 68/311 (21%), Positives = 123/311 (39%), Gaps = 48/311 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE--------VAVKREESCPKTNKLREKESAFDSE 552
+ +L +G G FG V + + + VAVK ++ SE
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLS-DLVSE 136
Query: 553 LALLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
+ ++ + HK+++ L+G C + ++ EY S G L ++L + S +
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 612 R--------IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
+ ARG++YL A IHRD+ + N+L+ N +++DFGL+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723
+ D +T V ++ PE V T ++D++ GV++ E+ T G
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---------GGS 304
Query: 724 P---LDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI 780
P + V E + G R+ P E ++ C + +RP
Sbjct: 305 PYPGIPVEEL-FKLLKEGH-------RMDKPANCTNELYMMMR----DCWHAVPSQRPTF 352
Query: 781 TDIVANLERAL 791
+V +L+R L
Sbjct: 353 KQLVEDLDRIL 363
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 57/228 (25%), Positives = 88/228 (38%), Gaps = 48/228 (21%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMD-GREVAVK---REESCPKTNKLREKESAFDSELALLS 557
+ +G G F ++ D A K + REK E+++
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREK---MSMEISIHR 96
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
+ H+H+VG GF ++ D +V E +L + K R +
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH----------------KRRKALTE 140
Query: 618 DAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE 669
AR G YLH +IHRD+K N+ L+ + ++ DFGL+ E D E
Sbjct: 141 PEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGE 196
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
GT YI PE VL+ K D++ +G ++ LL GK
Sbjct: 197 RKKV-LCGTPNYIAPE-----VLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE------VAVK--REESCPKTNKLREKESAFDSE 552
+ L+ ++G G+FG V+ + + VAVK +E S F E
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-------ESARQDFQRE 93
Query: 553 LALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHL-----HNKNNTEKNSSIVN 607
LL+ + H+H+V G C E L+V+EYM +G L+ L K
Sbjct: 94 AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 608 SWKMR--IRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
+ + +A A G+ YL ++ +HRD+ + N L+ ++ DFG+S
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDI 208
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
D + + + + ++ PE + T ++D++ GVVL E+ T
Sbjct: 209 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 30/228 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE------VAVK--REESCPKTNKLREKESAFDSE 552
+ L+ ++G G+FG V+ + + VAVK ++ + F E
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-------AARKDFQRE 67
Query: 553 LALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
LL+ + H+H+V G C + D ++V+EYM +G L+ L + +
Sbjct: 68 AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 613 --------IRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662
+ IA A G+ YL ++ +HRD+ + N L+ N ++ DFG+S
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
D + + + ++ PE + T ++D++ GV+L E+ T
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-29
Identities = 47/269 (17%), Positives = 98/269 (36%), Gaps = 35/269 (13%)
Query: 462 RSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATN----NFSLENKVGIGSFGTV 517
R ++ ++ F RQ S D+ S + +S+ ++G G V
Sbjct: 13 RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKV 72
Query: 518 YKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK--HLVGLVGFCQEKD 575
++ + A+K + ++ +E+A L+++ ++ L +
Sbjct: 73 FQVLNEKKQIYAIKY---VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129
Query: 576 ERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSI 634
+V E N L+ L K + R + + +H + I
Sbjct: 130 YIYMVMEC-GNIDLNSWLKKKKSIDP---------WERKSYWKNMLEAVHTIHQH---GI 176
Query: 635 IHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPE--------- 685
+H D+K +N L+ + ++ DFG++ + VG V Y+ PE
Sbjct: 177 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 686 --YYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ ++ K+D++ LG +L + GK
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 22/215 (10%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREK-ESAFDSELALLSR 558
+F + +G G FG VY + +A+K K + E E+ + S
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIAL 617
+ H +++ L G+ + L+ EY G ++ L + E+ ++
Sbjct: 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA---------TYIT 116
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
+ A + Y H+ +IHRDIK N+LL +++DFG S + G
Sbjct: 117 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTD-LCG 169
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
T+ Y+ PE + K D++ LGV+ E L GK
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 23/226 (10%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELA 554
+ L +G G+FG V + R VAVK + E A SEL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHR-ALMSELK 82
Query: 555 LLSRV-HHKHLVGLVGFC-QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
+L + HH ++V L+G C + +++ E+ G L +L +K N + +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 613 --------IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGS 664
I + A+G+++L A IHRD+ + NILL ++ DFGL+
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ A + ++ PE V T ++D++ GV+L E+ +
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 24/227 (10%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE------VAVKREESCPKTNKLREKESAFDSELA 554
N S +G G+FG V + + VAVK + L E+E A SEL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTERE-ALMSELK 78
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR- 612
+LS + +H ++V L+G C L++ EY G L + L K ++ S +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 613 ---------IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
+ + A+G+ +L A + IHRD+ + NILL ++ DFGL+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ A V ++ PE V T ++D++ G+ L EL +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-28
Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 33/225 (14%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ ++ ++G G FG V + G +VA+K C + + +E E+ ++ +++
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIK---QCRQELSPKNRERWC-LEIQIMKKLN 70
Query: 561 HKHLVGLVGFCQEK------DERLLVYEYMSNGALHDHLHNKNN----TEKNSSIVNSWK 610
H ++V D LL EY G L +L+ N E +
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL---- 126
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR---VSDFGLSLLGSECD 667
+ D + + YLH IIHRD+K NI+L + D G + E D
Sbjct: 127 LS-----DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA---KELD 175
Query: 668 QEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
Q + T+ VGT+ Y+ PE T D + G + E +TG
Sbjct: 176 QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 33/234 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE------VAVKREESCPKTNKLREKESAFDSELA 554
NN +G G+FG V++ + VAVK + + F E A
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQA-DFQREAA 102
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR-- 612
L++ + ++V L+G C L++EYM+ G L++ L + + S + R
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 613 --------------IRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSD 656
+ IA A G+ YL + +HRD+ + N L+ N +++D
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF-----VHRDLATRNCLVGENMVVKIAD 217
Query: 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
FGLS D + ++ PE N T ++D++ GVVL E+ +
Sbjct: 218 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 509 VGIGSFGTVYKGK-LMDGREVAVK--REESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
+G G++G VY G+ L + +A+K E + L E E+AL + HK++V
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE-------EIALHKHLKHKNIV 82
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNT-EKNSSIVNSWKMRIRIALDAARGID 624
+G E + E + G+L L +K + N + + +I L G+
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI---L---EGLK 136
Query: 625 YLHNYAVPSIIHRDIKSSNILLD-VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYID 683
YLH+ I+HRDIK N+L++ + ++SDFG S + + + GT+ Y+
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMA 191
Query: 684 PEYYVMNVL--TAKTDIYGLGVVLLELLTGK 712
PE DI+ LG ++E+ TGK
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 28/218 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE----VAVK--REESCPKTNKLREKESAFDSELA 554
L +G G FG V++G M VA+K + + + F E
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE------KFLQEAL 68
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
+ + H H+V L+G ++ ++ E + G L L + + +S++
Sbjct: 69 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL------- 120
Query: 615 IALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
A + + YL + +HRDI + N+L+ N ++ DFGLS + + +
Sbjct: 121 YAYQLSTALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKA 174
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+K + ++ PE T+ +D++ GV + E+L
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 67/317 (21%), Positives = 123/317 (38%), Gaps = 52/317 (16%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE------VAVKREESCPKTNKLREKESAFDSELA 554
N +G G+FG V + VAVK + E+E A SEL
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSERE-ALMSELK 100
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR- 612
+++++ H+++V L+G C L++EY G L ++L +K I + R
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 613 --------------IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658
+ A A+G+++L S +HRD+ + N+L+ ++ DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN 718
L+ + A V ++ PE + T K+D++ G++L E+ +
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL------- 270
Query: 719 EDGSGP---LDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGK 775
G P + V I G ++ P E ++ C + +
Sbjct: 271 --GVNPYPGIPVDANFYKLIQNGF-------KMDQPFYATEEIYIIMQ----SCWAFDSR 317
Query: 776 ERPNITDIVANLERALA 792
+RP+ ++ + L LA
Sbjct: 318 KRPSFPNLTSFLGCQLA 334
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE-----VAVK--REESCPKTNKLREKESAFDSEL 553
+ + + +G G FG VYKG L VA+K + T K R F E
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVD---FLGEA 97
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
++ + H +++ L G + +++ EYM NGAL L K+ +V
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG------ 151
Query: 614 RIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEF 670
+ A G+ YL NY +HRD+ + NIL++ N +VSDFGLS +L + + +
Sbjct: 152 -MLRGIAAGMKYLANMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK 713
++ + + PE T+ +D++ G+V+ E++T G++
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 69/316 (21%), Positives = 126/316 (39%), Gaps = 48/316 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD--------GREVAVKREESCPKTNKLREKESAFDSE 552
+ L +G G+FG V + + +VAVK ++ SE
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLS-DLISE 124
Query: 553 LALLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
+ ++ + HK+++ L+G C + ++ EY S G L ++L + S S
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 612 R--------IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
+ A ARG++YL A IHRD+ + N+L+ + +++DFGL+
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723
D +T V ++ PE + T ++D++ GV+L E+ T G
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL---------GGS 292
Query: 724 P---LDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI 780
P + V E + G R+ P E ++ C + +RP
Sbjct: 293 PYPGVPVEEL-FKLLKEGH-------RMDKPSNCTNELYMMMR----DCWHAVPSQRPTF 340
Query: 781 TDIVANLERALAICQD 796
+V +L+R +A+ +
Sbjct: 341 KQLVEDLDRIVALTSN 356
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 30/219 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE----VAVKREESCPKTNKLREKESAFDSELALL 556
+ L +G G FG VY+G + + VAVK K + + + F SE ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK----TCKKDCTLDNKEKFMSEAVIM 67
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ H H+V L+G E++ ++ E G L +L N+ K ++V +
Sbjct: 68 KNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-------YS 119
Query: 617 LDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
L + + YL N +HRDI NIL+ ++ DFGLS + D K
Sbjct: 120 LQICKAMAYLESINC-----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY----YK 170
Query: 675 AVGT---VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
A T + ++ PE T +D++ V + E+L+
Sbjct: 171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 54/254 (21%), Positives = 89/254 (35%), Gaps = 46/254 (18%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ L+ +G GS+G V A+K + +E+ L+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL- 617
+HH ++ L +++ LV E G L D L+ + ++ K +I
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 618 ------------------------DAAR-------GIDYLHNYAVPSIIHRDIKSSNILL 646
+ + YLHN I HRDIK N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 647 --DVNWTARVSDFGLS--LLGSECDQEFISTKAVGTVGYIDPEYYVMNVL----TAKTDI 698
+ ++ ++ DFGLS + + T GT ++ PE V+N K D
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE--VLNTTNESYGPKCDA 259
Query: 699 YGLGVVLLELLTGK 712
+ GV+L LL G
Sbjct: 260 WSAGVLLHLLLMGA 273
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 53/239 (22%), Positives = 83/239 (34%), Gaps = 46/239 (19%)
Query: 500 TNNFSLENKVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
T F K+G G FG+V+K K +DG A+K S ++++A A
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK--RSKKPLAGSVDEQNALREVYAHAVL 67
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H H+V E D L+ EY + G+L D + + L
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD----LLLQ 123
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVN-------------------WTARVSDFGL 659
RG+ Y+H+ S++H DIK SNI + ++ D G
Sbjct: 124 VGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL------TAKTDIYGLGVVLLELLTGK 712
S E G ++ E VL K DI+ L + ++ +
Sbjct: 181 VTRISSPQVE------EGDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 505 LENKVGIGSFGTVYKGKLMDGRE---VAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ ++G G+FG+V +G ++ VA+K K + E ++ ++ +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIK----VLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++V L+G CQ + +LV E G LH L K S++ + +
Sbjct: 70 PYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-------LLHQVSM 121
Query: 622 GIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGT 678
G+ YL N+ +HRD+ + N+LL A++SDFGLS LG++ +
Sbjct: 122 GMKYLEEKNF-----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE ++++D++ GV + E L+
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 35/241 (14%)
Query: 482 SSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTN 540
F A ++ + + +G GSFG V K + G+E AVK
Sbjct: 7 DHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVK----VISKR 62
Query: 541 KLREKESAFD--SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN 598
++++K E+ LL ++ H +++ L F ++K LV E + G L D + ++
Sbjct: 63 QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 122
Query: 599 -TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARV 654
+E +++ + IR L I Y+H I+HRD+K N+LL + R+
Sbjct: 123 FSEVDAARI------IRQVLSG---ITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170
Query: 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL----TAKTDIYGLGVVLLELLT 710
DFGLS + + +GT YI PE VL K D++ GV+L LL+
Sbjct: 171 IDFGLS---THFEASKKMKDKIGTAYYIAPE-----VLHGTYDEKCDVWSTGVILYILLS 222
Query: 711 G 711
G
Sbjct: 223 G 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 42/226 (18%), Positives = 87/226 (38%), Gaps = 31/226 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV- 559
+S+ ++G G V++ + A+K + ++ +E+A L+++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY---VNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 560 -HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIAL 617
H ++ L + +V E N L+ L K + R
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---------WERKSYWK 115
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
+ + +H + I+H D+K +N L+ + ++ DFG++ + VG
Sbjct: 116 NMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 678 TVGYIDPE-----------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
TV Y+ PE + ++ K+D++ LG +L + GK
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 30/222 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM-----DGREVAVK--REESCPKTNKLREKESAFDSEL 553
+G G FG V + G +VAVK + ES E+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA------DLKKEI 74
Query: 554 ALLSRVHHKHLVGLVGFCQEKDER--LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
+L ++H+++V G C E L+ E++ +G+L ++L N +
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK---- 130
Query: 612 RIRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQ 668
A+ +G+DYL Y +HRD+ + N+L++ ++ DFGL+ + ++ +
Sbjct: 131 ---YAVQICKGMDYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ V + PE + + +D++ GV L ELLT
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 55/303 (18%)
Query: 501 NNFSLENKVGIGSFGTVYKG--KLMDGRE--VAVK--REESCPKTNKLREKESAFDSELA 554
N S++ VG G FG V G KL +E VA+K + T K R F E +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRD---FLGEAS 98
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
++ + H +++ L G + ++V EYM NG+L L + +V
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG------- 151
Query: 615 IALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFI 671
+ A G+ YL Y +HRD+ + NIL++ N +VSDFGL +L + + +
Sbjct: 152 MLRGIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731
+ + + PE T+ +D++ G+VL E+++ + + DV++
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIK-- 261
Query: 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIH-----CVNLEGKERPNITDIVAN 786
+ G R+ PP A++ C + RP IV+
Sbjct: 262 --AVDEGY-------RLPPPM---------DCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 787 LER 789
L++
Sbjct: 304 LDK 306
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 69/301 (22%), Positives = 122/301 (40%), Gaps = 51/301 (16%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE----VAVKREESCPKTNKLREKESAFDSELALL 556
+ +E +G G G V G+L + VA+K + K + F SE +++
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK---AL-KAGYTERQRRDFLSEASIM 104
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ H +++ L G ++V EYM NG+L L + +V +
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG-------ML 157
Query: 617 LDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFIST 673
G+ YL Y +HRD+ + N+L+D N +VSDFGLS +L + D + +T
Sbjct: 158 RGVGAGMRYLSDLGY-----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 674 KAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733
+ + PE ++ +D++ GVV+ E+L + + N DV+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVIS---- 265
Query: 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIH-----CVNLEGKERPNITDIVANLE 788
+ G R+ P A+H C + + +RP + IV+ L+
Sbjct: 266 SVEEGY-------RLPAPM---------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
Query: 789 R 789
Sbjct: 310 A 310
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 31/225 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM----DGREVAVK--REESCPKTNKLREKESAFDSELA 554
+ L K+G GSFG V +G+ VAVK + + + + + F E+
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----FIREVN 73
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
+ + H++L+ L G +V E G+L D L ++
Sbjct: 74 AMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR------- 125
Query: 615 IALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
A+ A G+ YL + IHRD+ + N+LL ++ DFGL + D ++
Sbjct: 126 YAVQVAEGMGYLESKRF-----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 673 TKAVGT---VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK 713
+ + PE + +D + GV L E+ T G++
Sbjct: 181 QE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 32/222 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD-----GREVAVK--REESCPKTNKLREKESAFDSEL 553
+G G FG V G VAVK + ++ P+ + E+
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS------GWKQEI 84
Query: 554 ALLSRVHHKHLVGLVGFCQEKDER--LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
+L ++H+H++ G C++ LV EY+ G+L D+L +
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIG---------LAQ 135
Query: 612 RIRIALDAARGIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQ 668
+ A G+ YLH +Y IHRD+ + N+LLD + ++ DFGL+ + +
Sbjct: 136 LLLFAQQICEGMAYLHAQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ V + PE +D++ GV L ELLT
Sbjct: 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-28
Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 28/218 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGRE----VAVK--REESCPKTNKLREKESAFDSELA 554
L +G G FG V++G M VA+K + + + F E
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE------KFLQEAL 443
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
+ + H H+V L+G ++ ++ E + G L L + + +S++
Sbjct: 444 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL------- 495
Query: 615 IALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
A + + YL + +HRDI + N+L+ N ++ DFGLS + + +
Sbjct: 496 YAYQLSTALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKA 549
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+K + ++ PE T+ +D++ GV + E+L
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 28/225 (12%)
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVK----REESCPKTNKLREKESAFDSELA 554
N+ + +G G V + +E AVK +++E A E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMR 612
+L +V H +++ L + LV++ M G L D+L K +EK + +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI------ 129
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
+R L+ I LH +I+HRD+K NILLD + +++DFG S + D
Sbjct: 130 MRALLEV---ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKL 180
Query: 673 TKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTG 711
+ GT Y+ PE + D++ GV++ LL G
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKL-REKESAFDSELALLSRV 559
+ LE K+G G FG V+ +VAVK T K AF +E ++ +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVK-------TMKPGSMSVEAFLAEANVMKTL 240
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H LV L K+ ++ E+M+ G+L D L + ++ I +
Sbjct: 241 QHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK------QPLPKLIDFSAQI 293
Query: 620 ARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
A G+ ++ NY IHRD++++NIL+ + +++DFGL+ + E ++ A
Sbjct: 294 AEGMAFIEQRNY-----IHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKF 347
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE T K+D++ G++L+E++T
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+++ +G GSFG V K K + +E AVK K + + S E+ LL +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKK 77
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIAL 617
+ H +++ L ++ +V E + G L D + + +E +++ + I+
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI------IKQVF 131
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEFISTK 674
I Y+H + +I+HRD+K NILL + + ++ DFGLS + Q
Sbjct: 132 SG---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKD 182
Query: 675 AVGTVGYIDPEYYVMNVL----TAKTDIYGLGVVLLELLTG 711
+GT YI PE VL K D++ GV+L LL+G
Sbjct: 183 RIGTAYYIAPE-----VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM-----DGREVAVK--REESCPKTNKLREKESAFDSEL 553
+ +++G G+FG+V + G VAVK + +++ F E+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-------DQQRDFQREI 75
Query: 554 ALLSRVHHKHLVGLVGFCQEKDER--LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
+L +H +V G + LV EY+ +G L D L S ++
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL---- 131
Query: 612 RIRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQ 668
+ +G++YL +HRD+ + NIL++ +++DFGL+ LL + D
Sbjct: 132 ---YSSQICKGMEYLGSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + + PE N+ + ++D++ GVVL EL T
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
L ++G G FG V+ G +VAVK S + + + AF +E L+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVK---SLKQGSMSPD---AFLAEANLMKQLQ 66
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H+ LV L ++ ++ EYM NG+L D L + + + + + +A A
Sbjct: 67 HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL------LDMAAQIA 119
Query: 621 RGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
G+ ++ NY IHRD++++NIL+ + +++DFGL+ L + + T G
Sbjct: 120 EGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGA 170
Query: 679 ---VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE T K+D++ G++L E++T
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 70/302 (23%), Positives = 116/302 (38%), Gaps = 37/302 (12%)
Query: 427 HKRINSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSV 486
+ ++ S+ +D S L + + + ++ G + S
Sbjct: 20 RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79
Query: 487 KADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVK---REESCPKTNKL 542
+ + + + ++ +G G V + G E AVK +L
Sbjct: 80 EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139
Query: 543 REKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TE 600
E A E +L +V H H++ L+ + LV++ M G L D+L K +E
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 601 KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660
K + + +R L+A + +LH +I+HRD+K NILLD N R+SDFG S
Sbjct: 200 KETRSI------MRSLLEA---VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS 247
Query: 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKT-----------DIYGLGVVLLELL 709
E + GT GY+ PE +L D++ GV+L LL
Sbjct: 248 CHLEP--GEKLRE-LCGTPGYLAPE-----ILKCSMDETHPGYGKEVDLWACGVILFTLL 299
Query: 710 TG 711
G
Sbjct: 300 AG 301
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 501 NNFSLENKV-GIGSFGTVYKGKLMDGR---EVAVK--REESCPKTNKLREKESAFDSELA 554
+LE+K G G+FGTV KG + VAVK + E+ K +E
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK-----DELLAEAN 70
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
++ ++ + ++V ++G C+ + +LV E G L+ +L + K I
Sbjct: 71 VMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHV--------KDKNIIE 121
Query: 615 IALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFI 671
+ + G+ YL N+ +HRD+ + N+LL A++SDFGLS L ++ +
Sbjct: 122 LVHQVSMGMKYLEESNF-----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK 713
T V + PE ++K+D++ GV++ E + G+K
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+++ +G GSFG V K K + +E AVK K + + S E+ LL +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKK 77
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIAL 617
+ H +++ L ++ +V E + G L D + + +E +++ + I+
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI------IKQVF 131
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEFISTK 674
I Y+H + +I+HRD+K NILL + + ++ DFGLS + Q
Sbjct: 132 SG---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKD 182
Query: 675 AVGTVGYIDPEYYVMNVL----TAKTDIYGLGVVLLELLTG 711
+GT YI PE VL K D++ GV+L LL+G
Sbjct: 183 RIGTAYYIAPE-----VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM-----DGREVAVKR-EESCPKTNKLREKESAFDSELA 554
+ ++G G+FG+V + G VAVK+ + S + + F+ E+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR------DFEREIE 63
Query: 555 LLSRVHHKHLVGLVGFCQEKDER--LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
+L + H ++V G C R L+ EY+ G+L D+L + ++
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ----- 118
Query: 613 IRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQE 669
+G++YL Y IHRD+ + NIL++ ++ DFGL+ +L + +
Sbjct: 119 --YTSQICKGMEYLGTKRY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF 171
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + + PE + + +D++ GVVL EL T
Sbjct: 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM-----DGREVAVKR-EESCPKTNKLREKESAFDSELA 554
+ ++G G+FG+V + G VAVK+ + S + + F+ E+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR------DFEREIE 94
Query: 555 LLSRVHHKHLVGLVGFCQEKDER--LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
+L + H ++V G C R L+ EY+ G+L D+L + ++
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ----- 149
Query: 613 IRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQE 669
+G++YL Y IHRD+ + NIL++ ++ DFGL+ +L + +
Sbjct: 150 --YTSQICKGMEYLGTKRY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY 202
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + + PE + + +D++ GVVL EL T
Sbjct: 203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 22/215 (10%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREK-ESAFDSELALLSR 558
++F + +G G FG VY + + +A+K K+ +E E E+ + S
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF---KSQLEKEGVEHQLRREIEIQSH 70
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIAL 617
+ H +++ + + ++ L+ E+ G L+ L E+ S+
Sbjct: 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA---------TFME 121
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
+ A + Y H +IHRDIK N+L+ +++DFG S+ T G
Sbjct: 122 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRT-MCG 174
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
T+ Y+ PE K D++ GV+ E L G
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
F +G G+F V+ K + G+ A+K C K + S + E+A+L +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK----CIKKSPAFRDSSLEN-EIAVLKK 62
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIAL 617
+ H+++V L + LV + +S G L D + + TEK++S+V I+ L
Sbjct: 63 IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV------IQQVL 116
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEFISTK 674
A + YLH I+HRD+K N+L + N ++DFGLS + +ST
Sbjct: 117 SA---VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMST- 166
Query: 675 AVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTG 711
A GT GY+ PE VL K D + +GV+ LL G
Sbjct: 167 ACGTPGYVAPE-----VLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 505 LENKVGIGSFGTVYKGK-LMDGREVAVK--REESCPKTNKLREKESA---FDSELALLSR 558
+ +K+G G TVY + + +VA+K REKE F+ E+ S+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-------PREKEETLKRFEREVHNSSQ 67
Query: 559 VHHKHLVGL--VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ H+++V + V +E D LV EY+ L +++ + + S I
Sbjct: 68 LSHQNIVSMIDVD--EEDDCYYLVMEYIEGPTLSEYIE------SHGPL--SVDTAINFT 117
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
GI + H+ I+HRDIK NIL+D N T ++ DFG++ S + T V
Sbjct: 118 NQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHV 172
Query: 677 -GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
GTV Y PE TDIY +G+VL E+L G+
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 27/240 (11%)
Query: 481 SSSFSVKADNFTLSELAAATNNFSLENKV-GIGSFGTVYKGK-LMDGREVAVKREESCPK 538
SS + +N + N + L +K G G F V + G+E A K K
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK---FLKK 64
Query: 539 TNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKN 597
+ ++ + E+A+L ++ L + E +L+ EY + G + +
Sbjct: 65 RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124
Query: 598 N---TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWT 651
+E + + I+ L+ G+ YLH +I+H D+K NILL
Sbjct: 125 AEMVSENDVIRL------IKQILE---GVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172
Query: 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
++ DFG+S + + +GT Y+ PE + +T TD++ +G++ LLT
Sbjct: 173 IKIVDFGMS---RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 49/212 (23%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 505 LENKVGIGSFGTVYKGKLMDGRE---VAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ ++G G+FG+V +G ++ VA+K K + E ++ ++ +
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIK----VLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++V L+G C + + +LV E G LH L K S++ + +
Sbjct: 396 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-------LLHQVSM 447
Query: 622 GIDYL--HNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGT 678
G+ YL N+ +HR++ + N+LL A++SDFGLS LG++ +
Sbjct: 448 GMKYLEEKNF-----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ + PE ++++D++ GV + E L+
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 47/243 (19%), Positives = 82/243 (33%), Gaps = 70/243 (28%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGR--------EVAVK--REESCPKTNKLREKESAFD 550
+ +G G+F ++KG + EV +K + R +F
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-------RNYSESFF 60
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
+++S++ HKHLV G C DE +LV E++ G+L +L N +
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE--- 117
Query: 611 MRIRIALDAARGIDYL--HNYAVPSIIHRDIKSSNILLDVNWTAR--------VSDFGLS 660
+A A + +L + IH ++ + NILL + +SD G+S
Sbjct: 118 ----VAKQLAAAMHFLEENTL-----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
Query: 661 LLGSECDQEFISTKAVGTVGYIDPEYYVM-------------NVLTAKTDIYGLGVVLLE 707
V + + L TD + G L E
Sbjct: 169 -------------ITV-----LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210
Query: 708 LLT 710
+ +
Sbjct: 211 ICS 213
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 505 LENKVGIGSFGTVYKGK-LMDGREVAVK--REESCPKTNKLREKESA---FDSELALLSR 558
L +G G V+ + L D R+VAVK R + L S F E +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-------LARDPSFYLRFRREAQNAAA 68
Query: 559 VHHKHLVGL--VGFCQEKDERL--LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
++H +V + G + L +V EY+ L D +H + + K I
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH------TEGPM--TPKRAIE 120
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
+ DA + +++ H IIHRD+K +NI++ +V DFG++ ++ T
Sbjct: 121 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 675 AV-GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
AV GT Y+ PE + + A++D+Y LG VL E+LTG+
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 52/225 (23%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ F + K+G G+FG V+ + G E +K ++ + ++E+ +L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK----TINKDRSQVPMEQIEAEIEVLKS 76
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-----TEKNSSIVNSWKMRI 613
+ H +++ + ++ +V E G L + + + +E + + +
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL------M 130
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEF 670
+ ++A + Y H+ ++H+D+K NIL + ++ DFGL+ L D+
Sbjct: 131 KQMMNA---LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHS 183
Query: 671 ISTKAVGTVGYIDPEYYVMNVL----TAKTDIYGLGVVLLELLTG 711
T A GT Y+ PE V T K DI+ GVV+ LLTG
Sbjct: 184 --TNAAGTALYMAPE-----VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFD-----SEL 553
+++ + ++G G F V K + G+E A K K +L E+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAK----FIKKRRLSSSRRGVSREEIEREV 59
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMR 612
+L + H +++ L + K + +L+ E +S G L D L K + TE ++
Sbjct: 60 NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF------ 113
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTARVSDFGLSLLGSECDQ 668
++ LD G+ YLH+ I H D+K NI+L N ++ DFG++ + +
Sbjct: 114 LKQILD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEA 164
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
GT ++ PE L + D++ +GV+ LL+G
Sbjct: 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 48/232 (20%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVK---REESCPKTNKLREKESAFDSELALLS 557
+ + + +G GS+G V + AVK ++ K ++ E+ E+ LL
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKK----KLRRIPNGEANVKKEIQLLR 61
Query: 558 RVHHKHLVGL--VGFCQEKDERLLVYEYMSNGA--LHDHLHNKNNTEKNSSIVNSWKMRI 613
R+ HK+++ L V + +EK + +V EY G + D + K
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----------------- 104
Query: 614 RIALDAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGS 664
R + A G++YLH+ I+H+DIK N+LL T ++S G++ L
Sbjct: 105 RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
Query: 665 ECDQEFISTKAVGTVGYIDPEYYVMNVLT----AKTDIYGLGVVLLELLTGK 712
+ T + G+ + PE + N L K DI+ GV L + TG
Sbjct: 162 FAADDTCRT-SQGSPAFQPPE--IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 48/221 (21%), Positives = 91/221 (41%), Gaps = 34/221 (15%)
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSR 558
++LEN +G GS+G V A K + + + F E+ ++
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK----KIPKYFVEDVDR-FKQEIEIMKS 62
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIAL 617
+ H +++ L ++ + LV E + G L + + +K E +++ + ++ L
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI------MKDVL 116
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEFISTK 674
A + Y H ++ HRD+K N L + ++ DFGL+ + +
Sbjct: 117 SA---VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA---ARFKPGKMMRT 167
Query: 675 AVGTVGYIDPEYYVMNVL----TAKTDIYGLGVVLLELLTG 711
VGT Y+ P+ VL + D + GV++ LL G
Sbjct: 168 KVGTPYYVSPQ-----VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 52/217 (23%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ + + ++G G+FG V++ GR K T +K + +E++++++
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAK----FINTPYPLDKYT-VKNEISIMNQ 104
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN--TEKNSSIVNSWKMRIRIA 616
+HH L+ L ++K E +L+ E++S G L D + ++ +E +R A
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY------MRQA 158
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV--SDFGLSLLGSECDQEFISTK 674
+ G+ ++H + SI+H DIK NI+ + + V DFGL+ ++ + + I
Sbjct: 159 CE---GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKV 209
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
T + PE + TD++ +GV+ LL+G
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 8e-26
Identities = 36/286 (12%), Positives = 80/286 (27%), Gaps = 41/286 (14%)
Query: 460 PLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYK 519
P + T + ++ +S ++ SEL +G +
Sbjct: 37 PQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLE 96
Query: 520 GK-LMDGREVAVK--REESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD- 575
G V P +N +++ + L + K + F D
Sbjct: 97 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156
Query: 576 ----------------------ERLLVYEYM--SNGALHDHLHNKNNTEKNSSIVNSWKM 611
R +Y M + + L + ++T K+
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV----HHA 212
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
R+++ L R + LH+Y ++H ++ +I+LD ++ F +
Sbjct: 213 RLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-SAVSP 268
Query: 672 STKAVGTVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGK 712
+ ++T D + LG+ + +
Sbjct: 269 IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 55/248 (22%), Positives = 99/248 (39%), Gaps = 39/248 (15%)
Query: 504 SLENKVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HH 561
+ +G GSF K + AVK K E+ E+ L H
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVK---IISK-----RMEANTQKEITALKLCEGH 65
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIALDAA 620
++V L ++ LV E ++ G L + + K + +E +S + +R + A
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI------MRKLVSA- 118
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
+ ++H+ ++HRD+K N+L + N ++ DFG + L +Q
Sbjct: 119 --VSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCF 171
Query: 678 TVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732
T+ Y PE +L D++ LGV+L +L+G + F++ D S +
Sbjct: 172 TLHYAAPE-----LLNQNGYDESCDLWSLGVILYTMLSG-QVPFQSHDRSLTCTSAVEIM 225
Query: 733 SQILAGQL 740
+I G
Sbjct: 226 KKIKKGDF 233
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFD-----SEL 553
+ + + ++G G F V K + G E A K K + R E+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK----FIKKRQSRASRRGVSREEIEREV 66
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMR 612
++L +V H +++ L + + + +L+ E +S G L D L K + +E+ ++
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF------ 120
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTARVSDFGLSLLGSECDQ 668
I+ LD G++YLH I H D+K NI+L ++ DFGL+ E +
Sbjct: 121 IKQILD---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIED 171
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
GT ++ PE L + D++ +GV+ LL+G
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 34/300 (11%), Positives = 73/300 (24%), Gaps = 52/300 (17%)
Query: 455 GSNLPP----LRS-FSTRQQSSRTFGRQRSGSSSFSVKADNFTL----------SELAAA 499
GS++ +R ++ + + V+A T+ S L+
Sbjct: 1 GSHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQG 60
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVK-----REESCPKTNKLREKESA----- 548
L + +G V+ + ++ + A+K E S + +L E A
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 549 ------------FDSELALLSRVHHKHLVGLVGFCQEKD--ERLLVYEYMSNGALHDHLH 594
++ L + LL+ S L
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFS 179
Query: 595 NKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654
+ + R L + ++H N+ + + +
Sbjct: 180 TLDFVYVFRGDE-GILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLML 235
Query: 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV--MNVLTAKTDIYGLGVVLLELLTGK 712
D V Y E+ T + + LG+ + +
Sbjct: 236 GDVSALWKVGTRGPAS-----SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 51/211 (24%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
++ K+G G+ GTVY + G+EVA+++ + K+ +E+ ++ +
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQ---MNLQQQ--PKKELIINEILVMRENKN 76
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++V + DE +V EY++ G+L D + E + + + +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCRECLQ 127
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
+++LH+ +IHRDIKS NILL ++ + +++DFG ++ + VGT +
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYW 182
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ PE K DI+ LG++ +E++ G+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFD-----SEL 553
+ + + ++G G F V K + G E A K K + R E+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK----FIKKRQSRASRRGVCREEIEREV 66
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMR 612
++L +V H +++ L + + + +L+ E +S G L D L K + +E+ ++
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF------ 120
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTARVSDFGLSLLGSECDQ 668
I+ LD G++YLH I H D+K NI+L ++ DFGL+ E +
Sbjct: 121 IKQILD---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIED 171
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
GT ++ PE L + D++ +GV+ LL+G
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 64/317 (20%), Positives = 111/317 (35%), Gaps = 61/317 (19%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV- 559
+ + G F VY+ + + GRE A+KR + K R E+ + ++
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQ----EVCFMKKLS 83
Query: 560 HHKHLVGLVGFCQEKDER-------LLVYEYMSNGALHDHLHNKNNTEK--NSSIVNSWK 610
H ++V E L+ + G L + L + +++
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL---- 139
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
+I R + ++H P IIHRD+K N+LL T ++ DFG + S
Sbjct: 140 ---KIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 671 ISTKA----------VGTVGYIDPE---YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFK 717
S + T Y PE Y + K DI+ LG +L L + F
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-F- 253
Query: 718 NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNE-AEAVELLATTAIHCVNLEGKE 776
+ L +I+ G+ PP + L+ + + +E
Sbjct: 254 --EDGAKL--------RIVNGKYSI-------PPHDTQYTVFHSLIR----AMLQVNPEE 292
Query: 777 RPNITDIVANLERALAI 793
R +I ++V L+ A
Sbjct: 293 RLSIAEVVHQLQEIAAA 309
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVK---REESCPKTNKLREKESAFDSELAL 555
+ + + +G G+ G V ++VA++ + + + + + ++E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 556 LSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIR 614
L +++H ++ + F +D +V E M G L D + E +
Sbjct: 194 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLY------FY 246
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEFI 671
L A + YLH IIHRD+K N+LL + + +++DFG S + E +
Sbjct: 247 QMLLA---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLM 298
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKT--------DIYGLGVVLLELLTG 711
T GT Y+ PE VL + D + LGV+L L+G
Sbjct: 299 RT-LCGTPTYLAPE-----VLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 35/223 (15%)
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKE-SAFDSELALLS 557
++N+ ++ ++G G+F V + G E A K T KL ++ + E +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK----IINTKKLSARDFQKLEREARICR 60
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIA 616
++ H ++V L QE+ LV++ ++ G L + + + +E ++S I+
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC------IQQI 114
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEFIST 673
L++ I Y H+ I+HR++K N+LL +++DFGL++ ++ E
Sbjct: 115 LES---IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 166
Query: 674 KAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTG 711
GT GY+ PE VL DI+ GV+L LL G
Sbjct: 167 F-AGTPGYLSPE-----VLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
K+G GS G V + GR+VAVK + ++ +E+ ++ H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKM---MDLRKQ--QRRELLFNEVVIMRDYQH 101
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++V + +E ++ E++ GAL D + E+ + + +
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT---------VCEAVLQ 152
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-----V 676
+ YLH +IHRDIKS +ILL ++ ++SDFG + V
Sbjct: 153 ALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFC-------AQISKDVPKRKSLV 202
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
GT ++ PE ++ + DI+ LG++++E++ G+
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 62/304 (20%), Positives = 131/304 (43%), Gaps = 29/304 (9%)
Query: 417 VGYCFWAGFLHKRINSVQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQ--QSSRTF 474
+G+ + + + + + DS S N+ + + R +S RT
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTS 60
Query: 475 GRQRSGSSSFSVKADNFTLSELAAATNNFSLENK--VGIGSFGTVYKGKLMD-GREVAVK 531
+ + ++ A + +++ +G G FG V+K + G ++A K
Sbjct: 61 ALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK 120
Query: 532 REESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD 591
KT +++KE +E+++++++ H +L+ L + K++ +LV EY+ G L D
Sbjct: 121 ----IIKTRGMKDKEE-VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175
Query: 592 HLHNKNN--TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649
+ +++ TE ++ + ++ + GI ++H I+H D+K NIL
Sbjct: 176 RIIDESYNLTELDTILF------MKQICE---GIRHMHQM---YILHLDLKPENILCVNR 223
Query: 650 WTARV--SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLE 707
++ DFGL+ GT ++ PE + ++ TD++ +GV+
Sbjct: 224 DAKQIKIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYM 280
Query: 708 LLTG 711
LL+G
Sbjct: 281 LLSG 284
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVK---REESCPKTNKLREKESAFDSELAL 555
+ + + +G G+ G V ++VA+K + + + + + ++E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 556 LSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIR 614
L +++H ++ + F +D +V E M G L D + E +
Sbjct: 69 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLY------FY 121
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLS-LLGSECDQEF 670
L A + YLH IIHRD+K N+LL + + +++DFG S +LG +
Sbjct: 122 QMLLA---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSL 172
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKT--------DIYGLGVVLLELLTG 711
+ T GT Y+ PE VL + D + LGV+L L+G
Sbjct: 173 MRT-LCGTPTYLAPE-----VLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 40/224 (17%)
Query: 500 TNNFSLENKVGIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
T+ + ++ +G+GS+ + E AVK +K E E+ +L R
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK----IIDKSKRDPTE-----EIEILLR 71
Query: 559 -VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIA 616
H +++ L + +V E M G L D + + +E+ +S V +
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV------LFTI 125
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTARVSDFGLSLLGSECDQEFIS 672
++YLH ++HRD+K SNIL + R+ DFG + +
Sbjct: 126 TKT---VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL-- 177
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTG 711
T ++ PE VL + DI+ LGV+L +LTG
Sbjct: 178 MTPCYTANFVAPE-----VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 40/296 (13%), Positives = 86/296 (29%), Gaps = 54/296 (18%)
Query: 458 LPPLRSFSTRQQSSRTFGRQRSGSSSFSVKAD-NFTL-SELAAATNNFSLENKVGIGSFG 515
+ + R S S S+ F + SEL +G
Sbjct: 28 FNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPY 87
Query: 516 TVYKGK-LMDGREVAVK-----REESCPKTNKLREKESA------------------FDS 551
+ G V +++E+ F
Sbjct: 88 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147
Query: 552 ELALLSRVHHKHLVGLVGFCQEKD--ERLLVYEYM--SNGALHDHLHNKNNTEKNSSIVN 607
L+ K ++ + ++ R +Y M + + L + ++T K+
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV--- 204
Query: 608 SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667
R+++ L R + LH+Y ++H ++ +I+LD ++ F +
Sbjct: 205 -HHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-- 258
Query: 668 QEFISTKAVGTVGYIDPEY-----------YVMNVLTAKTDIYGLGVVLLELLTGK 712
+ + G+ PE ++T D + LG+V+ +
Sbjct: 259 ----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
F + K+G GS+G+VYK G+ VA+K+ + E++++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-------VESDLQEIIKEISIMQQ 80
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H+V G + + +V EY G++ D + +N T I I
Sbjct: 81 CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA-------TILQS 133
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA--- 675
+G++YLH IHRDIK+ NILL+ A+++DFG++ + T A
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA-------GQLTDTMAKRN 183
Query: 676 --VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
+GT ++ PE DI+ LG+ +E+ GK
Sbjct: 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 49/228 (21%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVK---REESCPKTNKLREKESAFDSELALLS 557
++ L +G G++G V + VAVK + + E E+ +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPEN---IKKEICINK 60
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
++H+++V G +E + + L EY S G L D I I +
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDR------------IEP----DIGMPE 104
Query: 618 DAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE 669
A+ G+ YLH I HRDIK N+LLD ++SDFGL+ + ++E
Sbjct: 105 PDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 670 FISTKAVGTVGYIDPEYYVMNVLT------AKTDIYGLGVVLLELLTG 711
+ K GT+ Y+ PE +L D++ G+VL +L G
Sbjct: 162 RLLNKMCGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 57/249 (22%), Positives = 100/249 (40%), Gaps = 42/249 (16%)
Query: 479 SGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCP 537
+ S++ +F +G GSF TV + + RE A+K
Sbjct: 8 PRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK---ILE 64
Query: 538 KTNKLREKESAF-DSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNK 596
K + ++E + + E ++SR+ H V L Q+ ++ Y NG L ++
Sbjct: 65 KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI 124
Query: 597 NNTEKNSSIVNSWKMRIRIALDAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDV 648
R ++YLH IIHRD+K NILL+
Sbjct: 125 G----------------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNE 165
Query: 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAK-----TDIYGLGV 703
+ +++DFG + + S ++ + VGT Y+ PE +LT K +D++ LG
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-----LLTEKSACKSSDLWALGC 220
Query: 704 VLLELLTGK 712
++ +L+ G
Sbjct: 221 IIYQLVAGL 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 63/297 (21%), Positives = 113/297 (38%), Gaps = 58/297 (19%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVK---REESCPKTNKLREKESAFDSELALLS 557
+S + +G G+FG V+ +EV VK +E+ K E+A+LS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGA-LHDHLHNKNN-TEKNSSIVNSWKMRIRI 615
RV H +++ ++ + + LV E +G L + E +S I
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS---------YI 135
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA 675
+ YL IIHRDIK NI++ ++T ++ DFG + + T
Sbjct: 136 FRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYT-F 189
Query: 676 VGTVGYIDPEYYVMNVLT------AKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
GT+ Y PE VL + +++ LGV L L+ P +E
Sbjct: 190 CGTIEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVF----------EENPFCELE 234
Query: 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786
+ + +H P +++ E + L++ + + R + +V +
Sbjct: 235 ----ETVEAAIHP-------PYLVSK-ELMSLVS----GLLQPVPERRTTLEKLVTD 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 37/220 (16%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKR---EESCPKTNKLREKESAFDSELALLSR 558
F+ K+G GSFG V+KG + VA+K EE+ + +++ E+ +LS+
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ-------EITVLSQ 76
Query: 559 VHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
++ G KD +L ++ EY+ G+ D L E + + +R L
Sbjct: 77 CDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI------LREIL 129
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-- 675
+G+DYLH+ IHRDIK++N+LL + +++DFG++ + T+
Sbjct: 130 ---KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA-------GQLTDTQIKR 176
Query: 676 ---VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
VGT ++ PE + +K DI+ LG+ +EL G+
Sbjct: 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFD-----SEL 553
+ + ++G G F V K + G + A K K + + E+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAK----FIKKRRTKSSRRGVSREDIEREV 65
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMR 612
++L + H +++ L + K + +L+ E ++ G L D L K + TE+ ++
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF------ 119
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTARVSDFGLSLLGSECDQ 668
++ L+ + YLH+ I H D+K NI+L ++ DFGL+
Sbjct: 120 LKQILNG---VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GN 172
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
EF GT ++ PE L + D++ +GV+ LL+G
Sbjct: 173 EF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 35/217 (16%), Positives = 87/217 (40%), Gaps = 26/217 (11%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ + +G G FG V++ + K + E+++L+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK---FVKVKGTDQVL---VKKEISILNI 57
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN--TEKNSSIVNSWKMRIRIA 616
H++++ L + +E ++++E++S + + ++ E+ +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY------VHQV 111
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV--SDFGLSLLGSECDQEFISTK 674
+ + +LH++ +I H DI+ NI+ ++ + +FG + +
Sbjct: 112 CE---ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRL 162
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711
Y PE + +V++ TD++ LG ++ LL+G
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 45/226 (19%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
N+ L +G G+F V + ++ GREVA+K KT E+ ++ ++
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H ++V L + + L+ EY S G + D+L R+ A
Sbjct: 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG----------------RMKEKEA 116
Query: 621 R--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
R + Y H I+HRD+K+ N+LLD + +++DFG S + +
Sbjct: 117 RSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLD 171
Query: 673 TKAVGTVGYIDPEYYVMNVLTAK------TDIYGLGVVLLELLTGK 712
G Y PE + K D++ LGV+L L++G
Sbjct: 172 A-FCGAPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 49/222 (22%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSR 558
T + L ++G G+F V + + G+E A + E +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM---IINTKKLSARDHQKLEREARICRL 66
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIAL 617
+ H ++V L E+ L+++ ++ G L + + + +E ++S I+ L
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC------IQQIL 120
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEFISTK 674
+A + + H ++HR++K N+LL +++DFGL++ Q +
Sbjct: 121 EA---VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FG 172
Query: 675 AVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTG 711
GT GY+ PE VL D++ GV+L LL G
Sbjct: 173 FAGTPGYLSPE-----VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 55/277 (19%), Positives = 92/277 (33%), Gaps = 70/277 (25%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+F +G G FG V++ K +D A+KR N+ +E E+ L+++
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKR---IRLPNRELAREKVM-REVKALAKL 61
Query: 560 HHKHLVGLVGFCQEKDERLLV-----------------------YEYMSNGALHDHLHNK 596
H +V E D K
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 597 NNTEKNSSIVNSWKMRI-----------------------------RIALDAARGIDYLH 627
N + + I I + A +++LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 628 NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFIS---------TKAVG 677
+ ++HRD+K SNI ++ +V DFGL + + +++ + T VG
Sbjct: 182 S---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKA 714
T Y+ PE N + K DI+ LG++L ELL
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 58/242 (23%), Positives = 105/242 (43%), Gaps = 35/242 (14%)
Query: 481 SSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKT 539
+ F ++ ++N+ ++ ++G G+F V + G E A K T
Sbjct: 9 GGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK----IINT 64
Query: 540 NKLREKE-SAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN 598
KL ++ + E + ++ H ++V L QE+ LV++ ++ G L + + +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 599 -TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARV 654
+E ++S I+ L++ I Y H+ I+HR++K N+LL ++
Sbjct: 125 YSEADASHC------IQQILES---IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 172
Query: 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELL 709
+DFGL+ E + GT GY+ PE VL DI+ GV+L LL
Sbjct: 173 ADFGLA---IEVNDSEAWHGFAGTPGYLSPE-----VLKKDPYSKPVDIWACGVILYILL 224
Query: 710 TG 711
G
Sbjct: 225 VG 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 39/221 (17%)
Query: 510 GIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGL 567
G G+ V L+ +E AVK + + F E+ +L + H++++ L
Sbjct: 22 GEGAHARVQTCINLITSQEYAVK----IIEKQPGHIRSRVF-REVEMLYQCQGHRNVLEL 76
Query: 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIALDAARGIDYL 626
+ F +E+D LV+E M G++ H+H + + E +S+V ++ A +D+L
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV------VQDVASA---LDFL 127
Query: 627 HNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLS------LLGSECDQEFISTKAVG 677
HN I HRD+K NIL + ++ DF L S + T G
Sbjct: 128 HN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP-CG 183
Query: 678 TVGYIDPEYYVMNVLTAKTDIYG-------LGVVLLELLTG 711
+ Y+ PE V+ + + IY LGV+L LL+G
Sbjct: 184 SAEYMAPE--VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 59/244 (24%), Positives = 103/244 (42%), Gaps = 51/244 (20%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVK--------REESCPKTNKLREKESAFDS 551
N ++L++++G GS+G V D A+K R+ P+ R A
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 552 -------------ELALLSRVHHKHLVGL--VGFCQEKDERLLVYEYMSNGALHDHLHNK 596
E+A+L ++ H ++V L V +D +V+E ++ G + + K
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 597 NNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656
+E + D +GI+YLH IIHRDIK SN+L+ + +++D
Sbjct: 133 PLSEDQA---------RFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLT--------AKTDIYGLGVVLLEL 708
FG+S + +S VGT ++ PE L+ D++ +GV L
Sbjct: 181 FGVSNE-FKGSDALLSN-TVGTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 709 LTGK 712
+ G+
Sbjct: 234 VFGQ 237
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 51/219 (23%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+++ + ++G G+FG V++ G A K T +KE+ E+ +S
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAK----FVMTPHESDKET-VRKEIQTMSV 210
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN--TEKNSSIVNSWKMRIRIA 616
+ H LV L ++ +E +++YE+MS G L + + +++N +E + +R
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY------MRQV 264
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV--SDFGLSLLGSECDQEFISTK 674
G+ ++H + +H D+K NI+ + + DFGL+ + D +
Sbjct: 265 CK---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKV 315
Query: 675 AVGTVGYIDPEYYVMN--VLTAKTDIYGLGVVLLELLTG 711
GT + PE V + TD++ +GV+ LL+G
Sbjct: 316 TTGTAEFAAPE--VAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 41/227 (18%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKES----AFDSELALLS 557
+ L +G G F V + G++ AVK K E ++
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVK----IVDVAKFTSSPGLSTEDLKREASICH 81
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-----TEKNSSIVNSWKMR 612
+ H H+V L+ +V+E+M L + + + +E +S
Sbjct: 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY------ 135
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQE 669
+R L+A + Y H+ +IIHRD+K +LL + + ++ FG+++ E
Sbjct: 136 MRQILEA---LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTG 711
VGT ++ PE V+ + D++G GV+L LL+G
Sbjct: 190 A--GGRVGTPHFMAPE-----VVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 53/223 (23%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ + ++G G+FG VYK K G A K E K E+ + E+ +L+ H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 75
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
++V L+G + ++ E+ GA+ + + I +
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-------VVCRQMLE 128
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA-----V 676
+++LH+ IIHRD+K+ N+L+ + R++DFG+S + + T +
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS-------AKNLKTLQKRDSFI 178
Query: 677 GTVGYIDPEYYVMNVLT-------AKTDIYGLGVVLLELLTGK 712
GT ++ PE V+ T K DI+ LG+ L+E+ +
Sbjct: 179 GTPYWMAPE--VVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 49/228 (21%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVK---REESCPKTNKLREKESAFDSELALLS 557
++ L +G G++G V + VAVK + + E E+ +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK----RAVDCPEN---IKKEICINK 60
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
++H+++V G +E + + L EY S G L D I I +
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDR------------IEP----DIGMPE 104
Query: 618 DAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE 669
A+ G+ YLH I HRDIK N+LLD ++SDFGL+ + ++E
Sbjct: 105 PDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 670 FISTKAVGTVGYIDPEYYVMNVLT------AKTDIYGLGVVLLELLTG 711
+ K GT+ Y+ PE +L D++ G+VL +L G
Sbjct: 162 RLLNKMCGTLPYVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 62/246 (25%), Positives = 108/246 (43%), Gaps = 34/246 (13%)
Query: 477 QRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR--- 532
+ S + +S+ D++ L E +G G+ V +VA+KR
Sbjct: 3 EDSSALPWSINRDDYELQE------------VIGSGATAVVQAAYCAPKKEKVAIKRINL 50
Query: 533 EESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDH 592
E+ ++L + E+ +S+ HH ++V KDE LV + +S G++ D
Sbjct: 51 EKCQTSMDELLK-------EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDI 103
Query: 593 LHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652
+ + ++ S V I + G++YLH IHRD+K+ NILL + +
Sbjct: 104 IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSV 160
Query: 653 RVSDFGLSLLGSECDQEFISTKA---VGTVGYIDPEYYVMNVLT---AKTDIYGLGVVLL 706
+++DFG+S + + VGT ++ PE VM + K DI+ G+ +
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE--VMEQVRGYDFKADIWSFGITAI 218
Query: 707 ELLTGK 712
EL TG
Sbjct: 219 ELATGA 224
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 52/257 (20%), Positives = 88/257 (34%), Gaps = 36/257 (14%)
Query: 63 STIPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTND---LTNFSFQPKRLHFRKAVQL 119
+T+P + AI+GG + L+ G + W N LT + +
Sbjct: 16 ATVPAEAQSGVDAIAGGYFHGLALKGG--KVLGWGANLNGQLTMPAATQSGV-------- 65
Query: 120 TDVSVGGDQVCAREVNSGVVKCW-RGTKVKDKGQLFSFSSPGEDL-KFSTITSGRGFTCG 177
++ G A + G V W + GQ + P E I +G +
Sbjct: 66 DAIAAGNYHSLA--LKDGEVIAWGGN----EDGQT---TVPAEARSGVDAIAAGAWASYA 116
Query: 178 ILRSNSEVFCWGDSGIADEIQRG--FKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQ 235
+ + +V WGD + Q + S V + G + +NG ++ G N GQ
Sbjct: 117 L--KDGKVIAWGDD---SDGQTTVPAEAQSGVTALDGGVYTALAVKNGGVIAWGDNYFGQ 171
Query: 236 LNVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFESIVAGL 295
VP + +A G + A+ + G V WG + +I +G
Sbjct: 172 TTVPAEAQSGVD-DVAGGIFHSLAL--KDGKVIAWGDNRYKQTTVPTEALSGVSAIASGE 228
Query: 296 DFVCGLTTRNLSMICWG 312
+ L +I WG
Sbjct: 229 WYSLALKNG--KVIAWG 243
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 41/211 (19%), Positives = 76/211 (36%), Gaps = 38/211 (18%)
Query: 63 STIPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDV 122
+T+P + AI+ G L+ G + W + + + +T +
Sbjct: 94 TTVPAEARSGVDAIAAGAWASYALKDG--KVIAWGDDSDGQTTVPAEAQS-----GVTAL 146
Query: 123 SVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDL-KFSTITSGRGFTCGILRS 181
G A + +G V W G GQ + P E + G + +
Sbjct: 147 DGGVYTALAVK--NGGVIAW-GDN--YFGQT---TVPAEAQSGVDDVAGGIFHSLAL--K 196
Query: 182 NSEVFCWGD-----SGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQL 236
+ +V WGD + + E G ++ +GE ++ L +NG ++ GS+ +
Sbjct: 197 DGKVIAWGDNRYKQTTVPTEALSGVSAIA-----SGEWYSLAL-KNGKVIAWGSSRTAPS 250
Query: 237 NVPFSSAFEFSG--GLALGANFTCAIRQRSG 265
+V SG + G N A++ SG
Sbjct: 251 SVQ-------SGVSSIEAGPNAAYALKGGSG 274
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 35/142 (24%), Positives = 53/142 (37%), Gaps = 31/142 (21%)
Query: 184 EVFCWGDSG------IADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLN 237
V WG + + E Q G ++ G H L + G ++ G+N +GQL
Sbjct: 3 SVVAWGGNNDWGEATVPAEAQSGVDAIA-----GGYFHGLAL-KGGKVLGWGANLNGQLT 56
Query: 238 VPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRF-------EFDSDVIQDVSFES 290
+P ++ +A G + A+ + G V WGG N E S V
Sbjct: 57 MPAATQSGVD-AIAAGNYHSLAL--KDGEVIAWGG-NEDGQTTVPAEARSGVDA------ 106
Query: 291 IVAGLDFVCGLTTRNLSMICWG 312
I AG L + +I WG
Sbjct: 107 IAAGAWASYALK--DGKVIAWG 126
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 19/91 (20%), Positives = 31/91 (34%), Gaps = 6/91 (6%)
Query: 223 GALVCKGSNDSGQL-NVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSD 281
++V G N+ VP + +A G A+ + G V WG +
Sbjct: 2 TSVVAWGGNNDWGEATVPAEAQSGVD-AIAGGYFHGLAL--KGGKVLGWGANLNGQLTMP 58
Query: 282 VIQDVSFESIVAGLDFVCGLTTRNLSMICWG 312
++I AG L + +I WG
Sbjct: 59 AATQSGVDAIAAGNYHSLALK--DGEVIAWG 87
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 51/238 (21%), Positives = 90/238 (37%), Gaps = 38/238 (15%)
Query: 493 LSELAAATNNFSLENKVGIG--SFGTVYKGK-LMDGREVAVKRE--ESCPKTNKLREKES 547
+S + L +G G TV + G V V+R E+C E +
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-----EMVT 71
Query: 548 AFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHL-HNKNNTEKNSSIV 606
EL + +H ++V +E +V +M+ G+ D + + + +I
Sbjct: 72 FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA 131
Query: 607 NSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC 666
I + +DY+H+ +HR +K+S+IL+ V+ +S +L
Sbjct: 132 Y-------ILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISH 181
Query: 667 DQ-----EFISTKAVGTVGYIDPEYYVMNVLT-------AKTDIYGLGVVLLELLTGK 712
Q +V + ++ PE VL AK+DIY +G+ EL G
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPE-----VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 60/270 (22%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 453 NDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTL-SELAAATNNFSLENKVGI 511
+ + S + + + S+ D + S A ++ F +E+++G
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGR 63
Query: 512 GSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGF 570
G+ VY+ K + A+K K + +E+ +L R+ H +++ L
Sbjct: 64 GATSIVYRCKQKGTQKPYALK---VLKK----TVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 571 CQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRIALDAARGIDYLHNY 629
+ E LV E ++ G L D + K +E++++ ++ L+A + YLH
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA------VKQILEA---VAYLHEN 167
Query: 630 AVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEY 686
I+HRD+K N+L + +++DFGLS + Q + T GT GY PE
Sbjct: 168 ---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKT-VCGTPGYCAPE- 220
Query: 687 YVMNVLTAKT-----DIYGLGVVLLELLTG 711
+L D++ +G++ LL G
Sbjct: 221 ----ILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 33/218 (15%)
Query: 505 LENKVGIGSFGTVYKGK-LMDGREVAVK--REESCPKTNKLREKESA---FDSELALLSR 558
L VG G G VY+ + + R VA+K E L E R
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSET-------LSSDPVFRTRMQREARTAGR 90
Query: 559 VHHKHLVGL--VGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI 615
+ H+V + G E D +L + ++ L L + + + + I
Sbjct: 91 LQEPHVVPIHDFG---EIDGQLYVDMRLINGVDLAAMLR------RQGPL--APPRAVAI 139
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA 675
+D H HRD+K NIL+ + A + DFG++ + D++
Sbjct: 140 VRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGN 194
Query: 676 V-GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
GT+ Y+ PE + + T + DIY L VL E LTG
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 51/221 (23%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
++F +++G G+ G V+K G +A K K + EL +L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ----IIRELQVLHEC 88
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
+ ++VG G E + E+M G+L L + ++ ++++
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIAV 140
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA---V 676
+G+ YL I+HRD+K SNIL++ ++ DFG+S + I + A V
Sbjct: 141 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-------QLIDSMANSFV 191
Query: 677 GTVGY-----IDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
GT Y + +Y + ++DI+ +G+ L+E+ G+
Sbjct: 192 GTRSYMSPERLQGTHY-----SVQSDIWSMGLSLVEMAVGR 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 46/227 (20%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVK-REESCPKTNKLREKESAFDSELALLSRV 559
++ L + +G+G+FG V G+ + G +VAVK ++ + K E+ L
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK---IKREIQNLKLF 68
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H H++ L + +V EY+S G L D++ R+
Sbjct: 69 RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG----------------RVEEME 112
Query: 620 AR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
AR +DY H + ++HRD+K N+LLD + A+++DFGLS + D EF+
Sbjct: 113 ARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFL 167
Query: 672 STKAVGTVGYIDPEYYVMNVLT------AKTDIYGLGVVLLELLTGK 712
T + G+ Y PE V++ + DI+ GV+L LL G
Sbjct: 168 RT-SCGSPNYAAPE-----VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 55/227 (24%), Positives = 81/227 (35%), Gaps = 50/227 (22%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ +G G+FG + + VAVK + + E E+ +
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YIERGAAIDEN---VQREIINHRSLR 74
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H ++V ++ EY S G L++ + N R + D A
Sbjct: 75 HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG----------------RFSEDEA 118
Query: 621 R--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR--VSDFGLSLLGSECDQEF 670
R G+ Y H+ I HRD+K N LLD + R + DFG S S
Sbjct: 119 RFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYS--KSSVLHSQ 173
Query: 671 ISTKAVGTVGYIDPEYYVMNVLT------AKTDIYGLGVVLLELLTG 711
+ VGT YI PE VL D++ GV L +L G
Sbjct: 174 PKS-TVGTPAYIAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 62/260 (23%), Positives = 103/260 (39%), Gaps = 41/260 (15%)
Query: 469 QSSRTFGRQRSGSSSFSVKADNFTLSELAAATNN------FSLENKVGIGSFGTVYKGK- 521
+ + + +A + ++A FS ++G GSFG VY +
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARD 75
Query: 522 LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581
+ + VA+K+ K + EK E+ L ++ H + + G + LV
Sbjct: 76 VRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133
Query: 582 EYMSNGALHD-HLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIK 640
EY A +H K E + V AL +G+ YLH++ ++IHRD+K
Sbjct: 134 EYCLGSASDLLEVHKKPLQEVEIAAV------THGAL---QGLAYLHSH---NMIHRDVK 181
Query: 641 SSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA---VGTVGYIDPEYYVMNVLT---- 693
+ NILL ++ DFG A VGT ++ PE V+ +
Sbjct: 182 AGNILLSEPGLVKLGDFGS------ASIM---APANSFVGTPYWMAPE--VILAMDEGQY 230
Query: 694 -AKTDIYGLGVVLLELLTGK 712
K D++ LG+ +EL K
Sbjct: 231 DGKVDVWSLGITCIELAERK 250
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 58/259 (22%), Positives = 107/259 (41%), Gaps = 53/259 (20%)
Query: 500 TNNFSLENKV-GIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSELALLS 557
T+++ L +V G+G G V + G++ A+K + K R+ E+
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQ-------EVDHHW 76
Query: 558 RV-HHKHLVGLVGFCQEKDER----LLVYEYMSNGALHDHLHNKNN---TEKNSSIVNSW 609
+ H+V ++ + L++ E M G L + + + TE+ ++ +
Sbjct: 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI--- 133
Query: 610 KMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLLGSEC 666
+R A I +LH++ +I HRD+K N+L + + +++DFG + E
Sbjct: 134 ---MRDIGTA---IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA---KET 181
Query: 667 DQEFISTKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGKKAVFKNEDG 721
Q + T T Y+ PE VL + D++ LGV++ LL G F + G
Sbjct: 182 TQNALQT-PCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCG-FPPFYSNTG 234
Query: 722 SGPLDVVEFAVSQILAGQL 740
+ +I GQ
Sbjct: 235 QAISPGM---KRRIRLGQY 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 48/220 (21%), Positives = 76/220 (34%), Gaps = 42/220 (19%)
Query: 505 LENKVGIGSFGTVYKGK--LMDGREVAVKREESCPKTNKLREKESA-----FDSELALLS 557
++ + G G +Y ++GR V +K L A +E L+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKG---------LVHSGDAEAQAMAMAERQFLA 134
Query: 558 RVHHKHLVGLVGFCQEKDERL-----LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
V H +V + F + D +V EY+ +L K
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL----------PVAEA 184
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
I L+ + YLH+ +++ D+K NI+L ++ D G S +
Sbjct: 185 IAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV---SRINS---F 234
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
GT G+ PE V T TDIY +G L L
Sbjct: 235 GYLYGTPGFQAPEI-VRTGPTVATDIYTVGRTLAALTLDL 273
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 65/371 (17%), Positives = 124/371 (33%), Gaps = 107/371 (28%)
Query: 439 NTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAA 498
+S + S+ + GS++ P + +
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES------------------ 43
Query: 499 ATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDS------ 551
+ + +G G FG+VY G + D VA+K K R +
Sbjct: 44 ---QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH------VEKDRISDWGELPNGTRVP 94
Query: 552 -ELALLSRVHHK--HLVGLVGFCQEKDERLLVYEYMSN-GALHDHLHNKNNTEKNSSIVN 607
E+ LL +V ++ L+ + + D +L+ E L D + +
Sbjct: 95 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---------- 144
Query: 608 SWKMRIRIALDAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARVSDFG 658
+ + AR + + HN ++HRDIK NIL+D+N ++ DFG
Sbjct: 145 ------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195
Query: 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAK------TDIYGLGVVLLELLTGK 712
+ + GT Y PE + ++ LG++L +++ G
Sbjct: 196 SG---ALLKDTVYTD-FDGTRVYSPPE-----WIRYHRYHGRSAAVWSLGILLYDMVCGD 246
Query: 713 KAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNL 772
F++++ +I+ GQ+ ++ E L+ C+ L
Sbjct: 247 IP-FEHDE-------------EIIRGQVFF-------RQRVSS-ECQHLIR----WCLAL 280
Query: 773 EGKERPNITDI 783
+RP +I
Sbjct: 281 RPSDRPTFEEI 291
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 63/257 (24%), Positives = 104/257 (40%), Gaps = 54/257 (21%)
Query: 481 SSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKT 539
S S + D LS L F L VG G++G VYKG+ + G+ A+K
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK------VM 57
Query: 540 NKLREKESAFDSELALLSRV-HHKHLVG-----LVGFCQEKDERL-LVYEYMSNGALHDH 592
+ ++E E+ +L + HH+++ + D++L LV E+ G++ D
Sbjct: 58 DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 593 LHNKNN---TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649
+ N E+ + + R L RG+ +LH +IHRDIK N+LL N
Sbjct: 118 IKNTKGNTLKEEWIAYI------CREIL---RGLSHLHQ---HKVIHRDIKGQNVLLTEN 165
Query: 650 WTARVSDFGLS-LLGSECDQ-------------EFISTKAVGTVGYIDPEYYVMNVLTAK 695
++ DFG+S L + E I+ Y K
Sbjct: 166 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-----------DFK 214
Query: 696 TDIYGLGVVLLELLTGK 712
+D++ LG+ +E+ G
Sbjct: 215 SDLWSLGITAIEMAEGA 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 9e-22
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 46/227 (20%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVK-REESCPKTNKLREKESAFDSELALLSRV 559
++ L + +G+G+FG V GK + G +VAVK ++ + K E+ L
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK---IRREIQNLKLF 73
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H H++ L + +V EY+S G L D+ I + ++
Sbjct: 74 RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDY------------ICKNGRLDE----KE 117
Query: 620 AR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
+R G+DY H + ++HRD+K N+LLD + A+++DFGLS + D EF+
Sbjct: 118 SRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFL 172
Query: 672 STKAVGTVGYIDPEYYVMNVLT------AKTDIYGLGVVLLELLTGK 712
T + G+ Y PE V++ + DI+ GV+L LL G
Sbjct: 173 RT-SCGSPNYAAPE-----VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 59/294 (20%), Positives = 105/294 (35%), Gaps = 56/294 (19%)
Query: 436 SSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSE 495
+S S + + + Q S +K +
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII--- 60
Query: 496 LAAATNNFSLENKV-GIGSFGTVYKG-KLMDGREVAVKREESCPKTNKLREKESAFDSEL 553
+++ + ++V G+G G V + + A+K K R E+
Sbjct: 61 -----DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARR-------EV 105
Query: 554 ALLSRV-HHKHLVGLVGFCQEKDER----LLVYEYMSNGALHDHLHNKNN---TEKNSSI 605
L R H+V +V + L+V E + G L + ++ + TE+ +S
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165
Query: 606 VNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLSLL 662
+ ++ +A I YLH+ +I HRD+K N+L N +++DFG +
Sbjct: 166 I------MKSIGEA---IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA-- 211
Query: 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTG 711
E T T Y+ PE VL + D++ LGV++ LL G
Sbjct: 212 -KETTSHNSLTTPCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 68/310 (21%), Positives = 120/310 (38%), Gaps = 88/310 (28%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDS-------EL 553
+ L +G G FGTV+ G L D +VA+K + R + S E+
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKV------IPRNRVLGWSPLSDSVTCPLEV 85
Query: 554 ALLSRVH----HKHLVGLVGFCQEKDERLLVYEYMSNGA-LHDHLHNKNNTEKNSSIVNS 608
ALL +V H ++ L+ + + ++ +LV E L D++ K
Sbjct: 86 ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG----------- 134
Query: 609 WKMRIRIALDAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARVSDFGL 659
+ +R I + H+ V +HRDIK NIL+D+ A++ DFG
Sbjct: 135 -----PLGEGPSRCFFGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGS 186
Query: 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLT------AKTDIYGLGVVLLELLTGKK 713
L D+ + T GT Y PE ++ ++ LG++L +++ G
Sbjct: 187 GALLH--DEPY--TDFDGTRVYSPPE-----WISRHQYHALPATVWSLGILLYDMVCG-D 236
Query: 714 AVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLE 773
F+ + +IL +LH P ++ + L+ C+ +
Sbjct: 237 IPFERDQ-------------EILEAELHF-------PAHVSP-DCCALIR----RCLAPK 271
Query: 774 GKERPNITDI 783
RP++ +I
Sbjct: 272 PSSRPSLEEI 281
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 59/279 (21%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREV-AVK--REESCPKTNKLREKESAFDSELALLS 557
++F + +G GSFG V + D +++ A+K ++ C + N E + F EL ++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN---EVRNVF-KELQIMQ 70
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIR-- 614
+ H LV L Q++++ +V + + G L HL + E+ ++
Sbjct: 71 GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE----------TVKLF 120
Query: 615 ---IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFI 671
+ + +DYL N IIHRD+K NILLD + ++DF ++ + +E
Sbjct: 121 ICELVM----ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA---AMLPRETQ 170
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKT--------DIYGLGVVLLELLTGKKAVFKNEDGSG 723
T GT Y+ PE + +++ D + LGV ELL G++ + +
Sbjct: 171 ITTMAGTKPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP-YHIRSSTS 224
Query: 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELL 762
++V + P ++ E V LL
Sbjct: 225 SKEIVH----TFETTVVTY-------PSAWSQ-EMVSLL 251
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 4e-21
Identities = 77/296 (26%), Positives = 114/296 (38%), Gaps = 53/296 (17%)
Query: 433 VQPSSANTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFT 492
Q + S ++ +D D N PLR + S + ++F
Sbjct: 18 AQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFE 77
Query: 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESA-FD 550
+ ++ +G G+FG V KL + +V A+K K L+ E+A F
Sbjct: 78 ILKV------------IGRGAFGEVAVVKLKNADKVFAMK---ILNKWEMLKRAETACFR 122
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
E +L K + L Q+ + LV +Y G L L K
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS---------------K 167
Query: 611 MRIRIALDAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662
R+ + AR ID +H +HRDIK NIL+D+N R++DFG L
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYG-------LGVVLLELLTG 711
E D S+ AVGT YI PE ++ + YG LGV + E+L G
Sbjct: 225 LME-DGTVQSSVAVGTPDYISPE--ILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVK-REESCPKTNKLREKESAFDSELALLSRV 559
+ + +G GSFG V ++VA+K K + + + + E++ L +
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR---VEREISYLKLL 66
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H H++ L + ++V EY + G L D+ IV +M
Sbjct: 67 RHPHIIKLYDVITTPTDIVMVIEY-AGGELFDY------------IVEKKRMTEDEGRRF 113
Query: 620 AR----GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA 675
+ I+Y H + I+HRD+K N+LLD N +++DFGLS + D F+ T +
Sbjct: 114 FQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKT-S 167
Query: 676 VGTVGYIDPEYYVMNVLT------AKTDIYGLGVVLLELLTGK 712
G+ Y PE V+ + D++ G+VL +L G+
Sbjct: 168 CGSPNYAAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 498 AATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR-----EESCPKTNKLREKESAFDS 551
++++ F K+G G++ TVYKG G VA+K EE P T +RE
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IRE------- 53
Query: 552 ELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSN---GALHDHLHNKNNTEKNSSIVNS 608
++L+ + H+++V L +++ LV+E+M N + ++V
Sbjct: 54 -ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 609 WKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ 668
++ ++ +G+ + H I+HRD+K N+L++ ++ DFGL+
Sbjct: 113 FQWQL------LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163
Query: 669 EFISTKAVGTVGYIDPEYYVMNVL------TAKTDIYGLGVVLLELLTGK 712
F + V T+ Y P+ VL + DI+ G +L E++TGK
Sbjct: 164 TF--SSEVVTLWYRAPD-----VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-21
Identities = 57/250 (22%), Positives = 90/250 (36%), Gaps = 41/250 (16%)
Query: 480 GSSSFSVKA---DNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVK--RE 533
GSS S K A N+ ++G G+ G V+K + G +AVK R
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 534 ESCPKTNK--LREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD 591
+ NK L + + +L ++V G + + E M
Sbjct: 61 SGNKEENKRILMDLD-------VVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEK 112
Query: 592 HLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651
+ ++ + + + YL +IHRD+K SNILLD
Sbjct: 113 LKKRMQGPIPERILG-------KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQ 163
Query: 652 ARVSDFGLSLLGSECDQEFISTKA----VGTVGY-----IDPEYYVMNVLTAKTDIYGLG 702
++ DFG+S + KA G Y IDP + D++ LG
Sbjct: 164 IKLCDFGIS-------GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216
Query: 703 VVLLELLTGK 712
+ L+EL TG+
Sbjct: 217 ISLVELATGQ 226
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-21
Identities = 64/277 (23%), Positives = 109/277 (39%), Gaps = 51/277 (18%)
Query: 463 SFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKL 522
+ S + + V A + E ++ +G GSFG V++ KL
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGE--QREIAYTNCKVIGNGSFGVVFQAKL 61
Query: 523 MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL---- 578
++ EVA+K+ K K R EL ++ V H ++V L F ++
Sbjct: 62 VESDEVAIKKVLQ-DKRFKNR--------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112
Query: 579 --LVYEYMSNGALHDHL--HNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSI 634
LV EY+ ++ + K ++ + ++ R + Y+H+ I
Sbjct: 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL------LRSLAYIHSI---GI 162
Query: 635 IHRDIKSSNILLDVN-WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYY----VM 689
HRDIK N+LLD ++ DFG + + I+ + V YI YY ++
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSA-------KILIAGEP--NVSYICSRYYRAPELI 213
Query: 690 NVLTAKT-----DIYGLGVVLLELLTGKKAVFKNEDG 721
A DI+ G V+ EL+ G + +F E G
Sbjct: 214 --FGATNYTTNIDIWSTGCVMAELMQG-QPLFPGESG 247
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 9e-21
Identities = 54/237 (22%), Positives = 94/237 (39%), Gaps = 60/237 (25%)
Query: 501 NNFSLENKVGIGSFGTVY----KG-------KLMDGREVAVKREESCPKTNKLREKESAF 549
+ F +G G FG V+ K K ++ + + ++ EK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV----EKK--- 237
Query: 550 DSELALLSRVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNS 608
+L++VH + +V L + E L LV M+ G + H++N +
Sbjct: 238 -----ILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP------- 284
Query: 609 WKMRIRIALDAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660
A G+++LH +II+RD+K N+LLD + R+SD GL+
Sbjct: 285 -----GFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA 336
Query: 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
+ Q GT G++ PE +L + D + LGV L E++ +
Sbjct: 337 VELKA-GQTKTKGY-AGTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 1e-20
Identities = 50/272 (18%), Positives = 91/272 (33%), Gaps = 65/272 (23%)
Query: 501 NNFSLENKVGIGSFGTVYKGKL--MDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ L +G G+FG V + +D K + A SEL +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 559 V-HHKHLVGLVGFC-QEKDERLLVYEYMSNGAL-----------HDHLHNKNNTEKNSSI 605
+ HH ++V L+G C + +++ E+ G L + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 606 VNSWKMR-----------------------------------------------IRIALD 618
V + + I +
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
A+G+++L A IHRD+ + NILL ++ DFGL+ + A
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710
+ ++ PE V T ++D++ GV+L E+ +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 46/232 (19%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSEL 553
+ K+G G++GTV+K K VA+KR +E P + LRE +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-ALRE--------I 52
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD--HLHNKNNTEKNSSIVNSWKM 611
LL + HK++V L + LV+E+ D + N + + IV S+
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEF 670
++ +G+ + H+ +++HRD+K N+L++ N ++++FGL+ G + +
Sbjct: 109 QL------LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCY 158
Query: 671 ISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVF 716
+ V T+ Y P+ Y ++ D++ G + EL + +F
Sbjct: 159 --SAEVVTLWYRPPDVLFGAKLYSTSI-----DMWSAGCIFAELANAGRPLF 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 46/228 (20%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSEL 553
+ K+G GS+G V+K + G+ VA+K+ + K LRE +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA-LRE--------I 53
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD--HLHNKNNTEKNSSIVNSWKM 611
+L ++ H +LV L+ + K LV+EY H H ++ +V S
Sbjct: 54 RMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITW 109
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEF 670
+ + +++ H + + IHRD+K NIL+ + ++ DFG + LL D
Sbjct: 110 QT------LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-- 158
Query: 671 ISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
V T Y PE Y V D++ +G V ELL+G
Sbjct: 159 -YDDEVATRWYRSPELLVGDTQYGPPV-----DVWAIGCVFAELLSGV 200
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 70/256 (27%), Positives = 96/256 (37%), Gaps = 43/256 (16%)
Query: 476 RQRSGSSSFSVKADNFT--LSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREV-AVKR 532
Q + F A+ L E+ ++F + +G G+F V K+ +V A+K
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMK- 92
Query: 533 EESCPKTNKLREKESA-FDSELALLSRVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALH 590
K + L+ E + F E +L + + L F + + L LV EY G L
Sbjct: 93 --IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLL 149
Query: 591 DHLHNKNNTEKNSSIVNSWKMRIRIALDAAR--------GIDYLHNYAVPSIIHRDIKSS 642
L K RI + AR ID +H +HRDIK
Sbjct: 150 TLLS---------------KFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPD 191
Query: 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYG-- 700
NILLD R++DFG L D S AVGT Y+ PE T YG
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRA-DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 701 -----LGVVLLELLTG 711
LGV E+ G
Sbjct: 251 CDWWALGVFAYEMFYG 266
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 45/227 (19%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKR------EESCPKTNKLREKESAFDSELA 554
+ KVG G++G VYK K GR VA+KR +E P T +RE ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPST-AIRE--------IS 71
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD--HLHNKNNTEKNSSIVNSWKMR 612
LL +HH ++V L+ + LV+E+M D + ++N T S + + +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFI 671
+ RG+ + H + I+HRD+K N+L++ + +++DFGL+ G
Sbjct: 128 L------LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--- 175
Query: 672 STKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
T V T+ Y P+ Y +V DI+ +G + E++TGK
Sbjct: 176 YTHEVVTLWYRAPDVLMGSKKYSTSV-----DIWSIGCIFAEMITGK 217
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 4e-20
Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 54/233 (23%)
Query: 501 NNFSLENKVGIGSFGTV-----------YKGKLMDGREVAVKREESCPKTNKLREKESAF 549
N+FS+ +G G FG V Y K +D + + +K+ E+ L E+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL----ALNERIM-- 242
Query: 550 DSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNS 608
L+L+S +V + D+ + + M+ G LH HL +E
Sbjct: 243 ---LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA------- 292
Query: 609 WKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ 668
MR A + G++++HN +++RD+K +NILLD + R+SD GL+
Sbjct: 293 -DMRFYAA-EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-------C 340
Query: 669 EFISTKA---VGTVGYIDPEYYVMNVLTAKT------DIYGLGVVLLELLTGK 712
+F K VGT GY+ PE VL D + LG +L +LL G
Sbjct: 341 DFSKKKPHASVGTHGYMAPE-----VLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 52/226 (23%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKR------EESCPKTNKLREKESAFDSELA 554
+ K+G G++G VYK + G A+K+ +E P T +RE ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IRE--------IS 52
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD--HLHNKNNTEKNSSIVNSWKMR 612
+L + H ++V L K +LV+E++ D L + S S+ ++
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
+ GI Y H+ ++HRD+K N+L++ +++DFGL+ +++
Sbjct: 109 L------LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-- 157
Query: 673 TKAVGTVGYIDPEYYVMNVL------TAKTDIYGLGVVLLELLTGK 712
T + T+ Y P+ VL + DI+ +G + E++ G
Sbjct: 158 THEIVTLWYRAPD-----VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 53/255 (20%), Positives = 96/255 (37%), Gaps = 57/255 (22%)
Query: 477 QRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVK--RE 533
+ S + A++ ++G G++G+V K G+ +AVK R
Sbjct: 10 KISPEQHWDFTAEDLKDLG------------EIGRGAYGSVNKMVHKPSGQIMAVKRIRS 57
Query: 534 ESCPKTNK--LREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD 591
K K L + + ++ ++V G + + + E M + +
Sbjct: 58 TVDEKEQKQLLMDLD-------VVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDK 109
Query: 592 HLHNKNNTEKNSSIVNSWKMRI------RIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645
+ + I +I L + +++L IIHRDIK SNIL
Sbjct: 110 FYKY---------VYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNIL 158
Query: 646 LDVNWTARVSDFGLSLLGSECDQEFISTKA----VGTVGYIDPE----YYVMNVLTAKTD 697
LD + ++ DFG+S + + + A G Y+ PE ++D
Sbjct: 159 LDRSGNIKLCDFGIS-------GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSD 211
Query: 698 IYGLGVVLLELLTGK 712
++ LG+ L EL TG+
Sbjct: 212 VWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 69/320 (21%), Positives = 122/320 (38%), Gaps = 83/320 (25%)
Query: 483 SFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVK--REESCPKT 539
S VKAD+ ++G G++G V K + + G+ +AVK R +
Sbjct: 1 SMEVKADDLEPIM------------ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE 48
Query: 540 NK--LREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKN 597
K L + + + V V G + + + E M + +L K
Sbjct: 49 QKRLLMDLD-------ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY--KQ 98
Query: 598 NTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657
+K +I + +IA+ + +++LH+ S+IHRD+K SN+L++ ++ DF
Sbjct: 99 VIDKGQTI--PEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDF 154
Query: 658 GLSLLGSECDQEFISTKA----VGTVGYIDPE----------YYVMNVLTAKTDIYGLGV 703
G+S + A G Y+ PE Y + K+DI+ LG+
Sbjct: 155 GIS-------GYLVDDVAKDIDAGCKPYMAPERINPELNQKGY------SVKSDIWSLGI 201
Query: 704 VLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNE----AEAV 759
++EL + F + P + Q++ P+L AE V
Sbjct: 202 TMIELAILR---FPYDSWGTPFQQ----LKQVVEEP----------SPQLPADKFSAEFV 244
Query: 760 ELLATTAIHCVNLEGKERPN 779
+ + C+ KERP
Sbjct: 245 DFTSQ----CLKKNSKERPT 260
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 49/230 (21%)
Query: 508 KVGIGSFGTVYKGKLMD---GREVAVK--REESCPKTNKLREKESAFDSELALLSRVHHK 562
KVG G++G VYK K D ++ A+K + RE +ALL + H
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-CRE--------IALLRELKHP 78
Query: 563 HLVGLVGFCQEKDERL--LVYEYMSN---GALHDHLHNKNNTEKNS---SIVNSWKMRIR 614
+++ L +R L+++Y + + H +K N + +V S +I
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI- 137
Query: 615 IALDAARGIDYLH-NYAVPSIIHRDIKSSNILLDVNWTAR----VSDFGLS-LLGSECDQ 668
GI YLH N+ ++HRD+K +NIL+ R ++D G + L S
Sbjct: 138 -----LDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 669 EFISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
V T Y PE +Y T DI+ +G + ELLT +
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSE 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 56/264 (21%), Positives = 109/264 (41%), Gaps = 52/264 (19%)
Query: 471 SRTFGRQRSGSSSFSVKADNFTLSELAAATN--NFSLENKVGIGSFGTVYKGK-LMDGRE 527
+ + + + ++S +AT+ + K+G G++G VYK +
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET 61
Query: 528 VAVKR------EESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVY 581
VA+KR EE P T +RE ++LL + H++++ L L++
Sbjct: 62 VAIKRIRLEHEEEGVPGT-AIRE--------VSLLKELQHRNIIELKSVIHHNHRLHLIF 112
Query: 582 EYMSNGALHDHLHN--KNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI 639
EY +D L N + + ++ S+ ++ G+++ H+ +HRD+
Sbjct: 113 EYAE----ND-LKKYMDKNPDVSMRVIKSFLYQL------INGVNFCHS---RRCLHRDL 158
Query: 640 KSSNILLDVNWTAR-----VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-- 692
K N+LL V+ + + DFGL+ ++F T + T+ Y PE +L
Sbjct: 159 KPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPE-----ILLG 211
Query: 693 ----TAKTDIYGLGVVLLELLTGK 712
+ DI+ + + E+L
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 46/228 (20%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSEL 553
+ VG GS+G V K + GR VA+K+ ++ K +RE +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA-MRE--------I 75
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD--HLHNKNNTEKNSSIVNSWKM 611
LL ++ H++LV L+ C++K LV+E++ H + +V +
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLF 131
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEF 670
+I GI + H++ +IIHRDIK NIL+ + ++ DFG + L + +
Sbjct: 132 QI------INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-- 180
Query: 671 ISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
V T Y PE Y V D++ +G ++ E+ G+
Sbjct: 181 -YDDEVATRWYRAPELLVGDVKYGKAV-----DVWAIGCLVTEMFMGE 222
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-20
Identities = 65/292 (22%), Positives = 112/292 (38%), Gaps = 60/292 (20%)
Query: 439 NTSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAA 498
+SD +D + P LR + + +KA+++ + ++
Sbjct: 19 EVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKV-- 76
Query: 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESA-FDSELALL 556
+G G+FG V + R+V A+K K ++ +SA F E ++
Sbjct: 77 ----------IGRGAFGEVQLVRHKSTRKVYAMK---LLSKFEMIKRSDSAFFWEERDIM 123
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ + +V L Q+ +V EYM G L + + +
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-----------------SNYDVP 166
Query: 617 LDAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ 668
AR +D +H+ IHRD+K N+LLD + +++DFG + ++ +
Sbjct: 167 EKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EG 222
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAK--TDIYG-------LGVVLLELLTG 711
AVGT YI PE VL ++ YG +GV L E+L G
Sbjct: 223 MVRCDTAVGTPDYISPE-----VLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 58/240 (24%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR------EESCPKTNKLREKESAFDSEL 553
+ + K+G G+FG V+K + G++VA+K+ +E P T LR E+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA-LR--------EI 67
Query: 554 ALLSRVHHKHLVGLVGFCQEKDERL--------LVYEYMSNGALHD---HLHNKNNTEKN 602
+L + H+++V L+ C+ K LV+++ HD L N
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTL 123
Query: 603 SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL--- 659
S I K +++ L G+ Y+H I+HRD+K++N+L+ + +++DFGL
Sbjct: 124 SEI----KRVMQMLL---NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 660 -SLLGSECDQEFISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
SL + + T V T+ Y PE Y D++G G ++ E+ T
Sbjct: 174 FSLAKNSQPNRY--TNRVVTLWYRPPELLLGERDY-----GPPIDLWGAGCIMAEMWTRS 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKR-----EESCPKTNKLREKESAFDSELA 554
+ +K+G G++ TVYKGK VA+K EE P T +RE ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA-IRE--------VS 52
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD--HLHNKNNTEKNSSIVNSWKMR 612
LL + H ++V L + LV+EY+ D + N V + +
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
+ RG+ Y H ++HRD+K N+L++ +++DFGL+ S + +
Sbjct: 109 L------LRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-- 157
Query: 673 TKAVGTVGYIDPEYYVMNVL------TAKTDIYGLGVVLLELLTGK 712
V T+ Y P+ +L + + D++G+G + E+ TG+
Sbjct: 158 DNEVVTLWYRPPD-----ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 62/249 (24%), Positives = 107/249 (42%), Gaps = 60/249 (24%)
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKR--EESCPKTNKLREKESAFDSELALL 556
+ F +E G G+FGTV GK G VA+K+ ++ + RE + L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNREL-----QIMQDL 73
Query: 557 SRVHHKHLVGL------VGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSW 609
+ +HH ++V L +G +D L +V EY+ D LH N +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR--------CCRNYY 120
Query: 610 KMRIRIALD--------AARGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARVSDFGL- 659
+ ++ R I LH +V ++ HRDIK N+L++ + T ++ DFG
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 660 -SLLGSECDQEFISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
L SE + +I ++ Y PE +Y T DI+ +G + E++ G
Sbjct: 180 KKLSPSEPNVAYICSRY-----YRAPELIFGNQHY-----TTAVDIWSVGCIFAEMMLG- 228
Query: 713 KAVFKNEDG 721
+ +F+ ++
Sbjct: 229 EPIFRGDNS 237
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 69/293 (23%)
Query: 462 RSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAA---------TNNFSLENKVGIG 512
R+ S + GS S D ++ + A +++ +G G
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNG 65
Query: 513 SFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFC 571
SFG VY+ KL D G VA+K+ K K R EL ++ ++ H ++V L F
Sbjct: 66 SFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNR--------ELQIMRKLDHCNIVRLRYFF 116
Query: 572 QEKDERL------LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD------- 618
E+ LV +Y+ + ++ + + + + +
Sbjct: 117 YSSGEKKDEVYLNLVLDYVP-----ETVYR--------VARHYSRAKQTLPVIYVKLYMY 163
Query: 619 -AARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARVSDFGL--SLLGSECDQEFISTK 674
R + Y+H++ I HRDIK N+LLD + ++ DFG L+ E + +I ++
Sbjct: 164 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 675 AVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG 721
Y PE Y T+ D++ G VL ELL G + +F + G
Sbjct: 221 Y-----YRAPELIFGATDY-----TSSIDVWSAGCVLAELLLG-QPIFPGDSG 262
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-19
Identities = 66/243 (27%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESAFDSELALLSRV 559
N F +G G FG V ++ ++ A K+ E K K R+ E+ +E +L +V
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK--KRIKKRKGEAMALNEKQILEKV 241
Query: 560 HHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ + +V L + E + L LV M+ G L H+++ +
Sbjct: 242 NSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMG--------------QAGFPEA 286
Query: 619 AAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
A G++ LH I++RD+K NILLD + R+SD GL++ E
Sbjct: 287 RAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--- 340
Query: 671 ISTKA-VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
+ K VGTVGY+ PE T D + LG +L E++ G ++ F+ + VE
Sbjct: 341 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG-QSPFQQRKKKIKREEVE 398
Query: 730 FAV 732
V
Sbjct: 399 RLV 401
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 55/234 (23%), Positives = 102/234 (43%), Gaps = 50/234 (21%)
Query: 501 NNFSLENKVGIGSFGTVYKGK--LMDGREVAVKR------EESCPKTNKLREKESAFDSE 552
+ ++G G++G V+K + GR VA+KR EE P + +RE +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS-TIREV-----AV 64
Query: 553 LALLSRVHHKHLVGL----VGFCQEKDERL-LVYEYMSNGALHD---HLHNKNNTEKNSS 604
L L H ++V L +++ +L LV+E++ D +L +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTE 120
Query: 605 IVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLG 663
+ ++ RG+D+LH++ ++HRD+K NIL+ + +++DFGL+ +
Sbjct: 121 TIKDMMFQL------LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
+ T V T+ Y PE VL + D++ +G + E+ K
Sbjct: 172 FQMAL----TSVVVTLWYRAPE-----VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 57/237 (24%), Positives = 98/237 (41%), Gaps = 50/237 (21%)
Query: 499 ATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR---------EESCPKTNKLREKESA 548
AT+ + ++G+G++GTVYK + G VA+K P + +RE
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIS-TVREV--- 62
Query: 549 FDSELALLSRVHHKHLVGL----VGFCQEKDERL-LVYEYMSNGALHD---HLHNKNNTE 600
+ L L H ++V L +++ ++ LV+E++ D +L
Sbjct: 63 --ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPG 116
Query: 601 KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660
+ + + RG+D+LH I+HRD+K NIL+ T +++DFGL
Sbjct: 117 LPAETIKDLMRQF------LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL- 166
Query: 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
+ T V T+ Y PE VL T D++ +G + E+ K
Sbjct: 167 --ARIYSYQMALTPVVVTLWYRAPE-----VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-18
Identities = 54/305 (17%), Positives = 94/305 (30%), Gaps = 65/305 (21%)
Query: 65 IPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDL-------TNFSFQPKRLHFRKAV 117
+ L +++ G ++ G ++ W D ++ F P + +
Sbjct: 62 LSALDGHQIVSVTCGADHTVAYSQSGMEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGI 121
Query: 118 QLTDVSVGGDQVCAREV-NSGVVKCW-RGTKVKDKGQL-----FSFSSP-----GEDLKF 165
++ ++ G A V G V+ W R GQL P E ++
Sbjct: 122 RIKQIACGDSHCLA--VTMEGEVQSWGRN----QNGQLGLGDTEDSLVPQKIQAFEGIRI 175
Query: 166 STITSGRGFTCGILRSNSEVFCWGDS-----GIADEIQR-------GFKNLSMVGLVAGE 213
+ +G T + + +++ WG G+ D R M + G
Sbjct: 176 KMVAAGAEHTA-AVTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGW 234
Query: 214 SHACGLSRNGALVCKGSNDSGQL--------NVPFSSAFEFSGG----LALGANFTCAIR 261
H +S +GAL G + GQL +P S ++ G T A+
Sbjct: 235 RHTISVSYSGALYTYGWSKYGQLGHGDLEDHLIPHKLE-ALSNSFISQISGGWRHTMALT 293
Query: 262 QRSGLVACWG-------GTNRFEFDS-----DVIQDVSFESIVAGLDFVCGLTTRNLSMI 309
G + WG G D + G +T RN ++
Sbjct: 294 S-DGKLYGWGWNKFGQVGVGNNLDQCSPVQVRFPDDQKVVQVSCGWRHTLAVTERN-NVF 351
Query: 310 CWGPG 314
WG G
Sbjct: 352 AWGRG 356
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-17
Identities = 55/300 (18%), Positives = 88/300 (29%), Gaps = 61/300 (20%)
Query: 66 PVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDL-------TNFSFQPKRLHFRKAVQ 118
P IS G ++ L SG + W + P +L Q
Sbjct: 11 VTAPPRKVLIISAGASHSVALLSGD-IVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQ 69
Query: 119 LTDVSVGGDQVCAREVNSGVVKCW-RGTKVKDKGQL-----FSFSSP-----GEDLKFST 167
+ V+ G D A + V W G D G+L +P ++
Sbjct: 70 IVSVTCGADHTVAYSQSGMEVYSWGWG----DFGRLGHGNSSDLFTPLPIKALHGIRIKQ 125
Query: 168 ITSGRGFTCGILRSNSEVFCWGDS-----GIADEIQR-------GFKNLSMVGLVAGESH 215
I G + EV WG + G+ D F+ + + + AG H
Sbjct: 126 IACGDSHCL-AVTMEGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAAGAEH 184
Query: 216 ACGLSRNGALVCKGSNDSGQL------NVPFSSAFEFSGGL-----ALGANFTCAIRQRS 264
++ +G L G G L + +GG A G T ++ S
Sbjct: 185 TAAVTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVSY-S 243
Query: 265 GLVACWG-------GTNRFEFDS-----DVIQDVSFESIVAGLDFVCGLTTRNLSMICWG 312
G + +G G E + + + I G LT+ + WG
Sbjct: 244 GALYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALTSDG-KLYGWG 302
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 34/185 (18%), Positives = 57/185 (30%), Gaps = 39/185 (21%)
Query: 168 ITSGRGFTCGILRSNSEVFCWGDS-----GIADEIQR-------GFKNLSMVGLVAGESH 215
I++G + L S V WG G D R +V + G H
Sbjct: 21 ISAGASHSV-ALLSGDIVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQIVSVTCGADH 79
Query: 216 ACGLSRNGALV-CKGSNDSGQL------NVPFSSAFEFSGG-----LALGANFTCAIRQR 263
S++G V G D G+L ++ + G +A G + A+
Sbjct: 80 TVAYSQSGMEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSHCLAVT-M 138
Query: 264 SGLVACWGG-----------TNRFEFDS-DVIQDVSFESIVAGLDFVCGLTTRNLSMICW 311
G V WG + + + + + AG + +T + + W
Sbjct: 139 EGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAAGAEHTAAVTE-DGDLYGW 197
Query: 312 GPGWS 316
G G
Sbjct: 198 GWGRY 202
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 49/231 (21%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR---------EESCPKTNKLREKESAFD 550
+ + +G G F TVYK + + VA+K+ ++ +T LRE
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA-LRE------ 62
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHD--HLHNKNNTEKNSSIVNS 608
+ LL + H +++GL+ K LV+++M D + N+ S + +
Sbjct: 63 --IKLLQELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKA 116
Query: 609 WKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECD 667
+ + +G++YLH + I+HRD+K +N+LLD N +++DFGL+ GS +
Sbjct: 117 YMLMT------LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-N 166
Query: 668 QEFISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ + T V T Y PE Y + V D++ +G +L ELL
Sbjct: 167 RAY--THQVVTRWYRAPELLFGARMYGVGV-----DMWAVGCILAELLLRV 210
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 54/272 (19%), Positives = 99/272 (36%), Gaps = 63/272 (23%)
Query: 476 RQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREES 535
+ + ++ + A+ + ++++ + GS+G V G +G VA+KR
Sbjct: 3 QAKGEAAMRDLIAELHAMQS------PYTVQRFISSGSYGAVCAGVDSEGIPVAIKR--- 53
Query: 536 CPKTNKLREKESAFDS---------ELALLSRVHHKHLVGLVG-FCQEKDERL----LVY 581
T + E+ LL+ HH +++GL F ++ + LV
Sbjct: 54 VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113
Query: 582 EYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA----------RGIDYLHNYAV 631
E M D L +++ ++ + G+ LH
Sbjct: 114 ELMRT----D-LAQ---------VIHDQRI----VISPQHIQYFMYHILLGLHVLHE--- 152
Query: 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-- 689
++HRD+ NILL N + DF L+ E + T V Y PE ++
Sbjct: 153 AGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHYVTHRWYRAPE--LVMQ 207
Query: 690 -NVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
T D++ G V+ E+ KA+F+
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNR-KALFRGST 238
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 73/325 (22%), Positives = 129/325 (39%), Gaps = 72/325 (22%)
Query: 476 RQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREE 534
++ + S + FT+ + +G G+ G V + R VA+K
Sbjct: 6 KRDNNFYSVEIGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--- 56
Query: 535 SCPKTNKLREKESAFDS---------ELALLSRVHHKHLVGLVG-FCQEKDERL-----L 579
KL F + EL L+ V+HK+++GL+ F +K +
Sbjct: 57 ------KLSR---PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107
Query: 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI 639
V E M L + + + E+ S ++ ++M GI +LH+ IIHRD+
Sbjct: 108 VMELMDA-NLCQVIQMELDHERMSYLL--YQM--------LCGIKHLHS---AGIIHRDL 153
Query: 640 KSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIY 699
K SNI++ + T ++ DFGL+ F+ T V T Y PE + DI+
Sbjct: 154 KPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210
Query: 700 GLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAV 759
+G ++ E++ G +F G+ +D Q + V++ ++G P E +
Sbjct: 211 SVGCIMGEMIKG-GVLFP---GTDHID------------QWNKVIE-QLGTP---CPEFM 250
Query: 760 ELLATTAIHCV-NLEGKERPNITDI 783
+ L T V N + +
Sbjct: 251 KKLQPTVRTYVENRPKYAGYSFEKL 275
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 68/286 (23%), Positives = 109/286 (38%), Gaps = 36/286 (12%)
Query: 440 TSSDSNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAA 499
++ + + + RS S S V + F +L
Sbjct: 99 WTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKL--- 155
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMDGREV-AVK--REESCPKTNKLREKESAFDSELALL 556
+G G+FG V K A+K ++E + E +E +L
Sbjct: 156 ---------LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD---EVAHTL-TENRVL 202
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRI 615
H L L Q D V EY + G L HL + +E R R
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----------RARF 252
Query: 616 -ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
+ +DYLH+ ++++RD+K N++LD + +++DFGL G + D + T
Sbjct: 253 YGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT- 308
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
GT Y+ PE N D +GLGVV+ E++ G + F N+D
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLPFYNQD 353
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 63/269 (23%), Positives = 110/269 (40%), Gaps = 52/269 (19%)
Query: 468 QQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGR 526
+ + + + + S V FT+ + + +G G+ G V + R
Sbjct: 35 KHYNMSKSKVDNQFYSVEVGDSTFTVLK------RYQNLKPIGSGAQGIVCAAYDAVLDR 88
Query: 527 EVAVKREESCPKTNKLREKESAFDS---------ELALLSRVHHKHLVGLV------GFC 571
VA+K KL F + EL L+ V+HK+++ L+
Sbjct: 89 NVAIK---------KLSR---PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV 631
+E + LV E M L + + + E+ S ++ ++M GI +LH+
Sbjct: 137 EEFQDVYLVMELMDAN-LCQVIQMELDHERMSYLL--YQM--------LCGIKHLHS--- 182
Query: 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV 691
IIHRD+K SNI++ + T ++ DFGL+ F+ T V T Y PE +
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 692 LTAKTDIYGLGVVLLELLTGKKAVFKNED 720
DI+ +G ++ E++ K +F D
Sbjct: 240 YKENVDIWSVGCIMGEMVRH-KILFPGRD 267
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 38/295 (12%), Positives = 77/295 (26%), Gaps = 69/295 (23%)
Query: 505 LENKVGIGSFGTVYKGKLMD---GREVAVK---REESCPKTNKLREKESAFDSELALLSR 558
L G ++ D R+VA+ + P S LSR
Sbjct: 35 LLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQE-----TLSRTLRLSR 87
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ + ++ + L+V E++ G+L + + IR
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG----------AIRAMQS 137
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
A D H + S + + ++ ++
Sbjct: 138 LAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
M + DI G+G L LL + L
Sbjct: 175 ---------TMPDANPQDDIRGIGASLYALLVNRWP-LPEAGVRSGLAPA---------- 214
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793
+ P + + ++ A V +G R + ++ +++A A+
Sbjct: 215 --ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSA-STLLNLMQQATAV 266
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 54/265 (20%), Positives = 97/265 (36%), Gaps = 66/265 (24%)
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ +SL +G GSFG V + ++ G+ A+K+ P+ K RE L ++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-KNRE--------LDIMKV 56
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSS-------------- 604
+ H +++ LV + + + N + S
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 605 -----------IVNSWKMRIRIALD--------AARGIDYLHNYAVPSIIHRDIKSSNIL 645
+ + + I ++ R + ++H+ I HRDIK N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLL 173
Query: 646 LDVN-WTARVSDFGL--SLLGSECDQEFISTKAVGTVGYIDPE------YYVMNVLTAKT 696
++ T ++ DFG L+ SE +I ++ Y PE Y T
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY-----TPSI 223
Query: 697 DIYGLGVVLLELLTGKKAVFKNEDG 721
D++ +G V EL+ G K +F E
Sbjct: 224 DLWSIGCVFGELILG-KPLFSGETS 247
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 38/172 (22%), Positives = 66/172 (38%), Gaps = 35/172 (20%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
++ + ++G GSFG +++G L++ ++VA+K E R E
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE-------PRRSDAPQLRDEYRTY--- 59
Query: 560 HHKHLVGLVGFC------QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
K L G G QE +LV + + G + L + + S+ K
Sbjct: 60 --KLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCG--RKFSV----KTVA 109
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR-----VSDFGLS 660
A + +H S+++RDIK N L+ + V DFG+
Sbjct: 110 MAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 63/280 (22%)
Query: 448 SASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLEN 507
+A+ A GS ++ F + + F ++ S + + D F +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKED--FLKKWETPSQNTAQLDQFDRIKT----------- 48
Query: 508 KVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESA-FDSELALLSRVHHKHLV 565
+G GSFG V K + G A+K + K ++ K+ +E +L V+ LV
Sbjct: 49 -LGTGSFGRVMLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR---- 621
L ++ +V EY++ G + HL R + AR
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----------------RFSEPHARFYAA 148
Query: 622 ----GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV- 676
+YLH+ +I+RD+K N+L+D +V+DFG + T +
Sbjct: 149 QIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF------AKRVKGRTWTLC 199
Query: 677 GTVGYIDPEYYVMNVLTAK-----TDIYGLGVVLLELLTG 711
GT + PE ++ +K D + LGV++ E+ G
Sbjct: 200 GTPEALAPE-----IILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 54/268 (20%), Positives = 109/268 (40%), Gaps = 64/268 (23%)
Query: 477 QRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREES 535
+ + V+ F + ++ + +G G++G V ++ VA+K
Sbjct: 9 AAAAAGPEMVRGQVFDVGP------RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---- 58
Query: 536 CPKTNKLREKESAFDS---------ELALLSRVHHKHLVGLV-----GFCQEKDERLLVY 581
K S F+ E+ +L R H++++G+ ++ + +V
Sbjct: 59 ---------KISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109
Query: 582 EYM-SNGALHDHLHNKNNTEKNSSIVNSWKMRIR-IALDAARGIDYLHNYAVPSIIHRDI 639
+ M ++ L+ L ++ + I RG+ Y+H+ +++HRD+
Sbjct: 110 DLMETD--LYKLLKTQHLSND----------HICYFLYQILRGLKYIHS---ANVLHRDL 154
Query: 640 KSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKAVGTVGYIDPE------YYVMNVL 692
K SN+LL+ ++ DFGL+ + + D T+ V T Y PE Y
Sbjct: 155 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY----- 209
Query: 693 TAKTDIYGLGVVLLELLTGKKAVFKNED 720
T DI+ +G +L E+L+ + +F +
Sbjct: 210 TKSIDIWSVGCILAEMLSN-RPIFPGKH 236
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 37/172 (21%), Positives = 64/172 (37%), Gaps = 35/172 (20%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
NF + K+G G+FG + GK L VA+K E ++ + E
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE-------PMKSRAPQLHLEYRFY--- 58
Query: 560 HHKHLVGLVGFC------QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
K L G +V E + G + L + + + S+ K +
Sbjct: 59 --KQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCD--RTFSL----KTVL 108
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS-----DFGLS 660
IA+ ++Y+H+ ++I+RD+K N L+ DF L+
Sbjct: 109 MIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 4e-15
Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 50/231 (21%)
Query: 501 NNFSLENKVGIGSFGTVY---KGKLMDGREV-AVK--REESCPKTNKLREKESAFDSELA 554
+ F L +G GSFG V+ K D R++ A+K ++ + +++R K E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK-----MERD 78
Query: 555 LLSRVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMR 612
+L V+H +V L + + + +L L+ +++ G L L + TE+
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE----------D 127
Query: 613 IR-----IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECD 667
++ +AL +D+LH+ II+RD+K NILLD +++DFGLS + +
Sbjct: 128 VKFYLAELAL----ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180
Query: 668 QEFISTKAV-GTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
+ + GTV Y+ PE V+ + D + GV++ E+LTG
Sbjct: 181 K---KAYSFCGTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 5e-15
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 49/227 (21%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESA-FDSELALLSR 558
+F + +G GSFG V+ + A+K + K +R K+ + E +LS
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK---KEIVVRLKQVEHTNDERLMLSI 62
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
V H ++ + G Q+ + ++ +Y+ G L L R
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----------------RFPNP 106
Query: 619 AAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEF 670
A+ ++YLH+ II+RD+K NILLD N +++DFG
Sbjct: 107 VAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGF------AKYVP 157
Query: 671 ISTKAV-GTVGYIDPEYYVMNVLTAK-----TDIYGLGVVLLELLTG 711
T + GT YI PE V++ K D + G+++ E+L G
Sbjct: 158 DVTYTLCGTPDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 40/181 (22%), Positives = 69/181 (38%), Gaps = 40/181 (22%)
Query: 505 LENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHK 562
+G+G G V + + A+K K R E+ L R
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARR-------EVELHWRASQCP 71
Query: 563 HLVGLVGFCQEKDER----LLVYEYMSNGALHDHLHNKNN---TEKNSSIVNSWKMRIRI 615
H+V +V + L+V E + G L + ++ + TE+ +S + ++
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI------MKS 125
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSDFGLS--LL----GSEC 666
+A I YLH+ +I HRD+K N+L N +++DFG + C
Sbjct: 126 IGEA---IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSC 179
Query: 667 D 667
D
Sbjct: 180 D 180
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 61/256 (23%)
Query: 480 GSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVY---KGKLMDGREV-AVK--RE 533
GSS SV + F L +G G +G V+ K + ++ A+K ++
Sbjct: 1 GSSETSVNRGPEKIR-----PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK 55
Query: 534 ESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDH 592
+ ++ +E +L V H +V L+ + + +L L+ EY+S G L
Sbjct: 56 AMIVR--NAKDTAHTK-AERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQ 111
Query: 593 LHNKNN-TEKNSSIVNSWKMRIR-----IALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646
L + E I++ + +LH II+RD+K NI+L
Sbjct: 112 LEREGIFMED----------TACFYLAEISM----ALGHLHQK---GIIYRDLKPENIML 154
Query: 647 DVNWTARVSDFGLSLLGSECDQEFISTKAV-----GTVGYIDPEYYVMNVLTAKT----- 696
+ +++DFGL +E I V GT+ Y+ PE +L
Sbjct: 155 NHQGHVKLTDFGLC-------KESIHDGTVTHTFCGTIEYMAPE-----ILMRSGHNRAV 202
Query: 697 DIYGLGVVLLELLTGK 712
D + LG ++ ++LTG
Sbjct: 203 DWWSLGALMYDMLTGA 218
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 54/305 (17%), Positives = 94/305 (30%), Gaps = 93/305 (30%)
Query: 467 RQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDG 525
SS G + V +N+ +++ +G GS+G VY
Sbjct: 5 HHHSSGRENLYFQGIKNVHV-------------PDNYIIKHLIGRGSYGYVYLAYDKNTE 51
Query: 526 REVAVKREESCPKTNKLREKESAFDS---------ELALLSRVHHKHLVGLVGFCQEKDE 576
+ VA+K K+ F+ E+ +L+R+ +++ L D
Sbjct: 52 KNVAIK---------KV---NRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99
Query: 577 RL-----LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA----------R 621
+V E + D L + + I L
Sbjct: 100 LKFDELYIVLEIADS----D-LKK---------LFKT-----PIFLTEEHIKTILYNLLL 140
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
G +++H IIHRD+K +N LL+ + + +V DFGL+ + I
Sbjct: 141 GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 682 IDPEYYVMNVLT---------------------AKTDIYGLGVVLLELLTGKKAVFKNED 720
+ LT DI+ G + ELL ++ +
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 721 GSGPL 725
PL
Sbjct: 258 NRFPL 262
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 33/170 (19%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
N + L K+G GSFG +Y G + G EVA+K E ++ K E +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-------CVKTKHPQLHIESKIY--- 58
Query: 560 HHKHLVGLVGFCQ------EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
K + G VG E D ++V E + G + L N + + S+ K +
Sbjct: 59 --KMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCS--RKFSL----KTVL 108
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA---RVSDFGLS 660
+A I+Y+H+ + IHRD+K N L+ + + DFGL+
Sbjct: 109 LLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 62/267 (23%), Positives = 108/267 (40%), Gaps = 65/267 (24%)
Query: 476 RQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREE 534
++ G V + L + + VG G++G+V G +VA+K
Sbjct: 5 IRKKGFYKQDVNKTAWELPK------TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--- 55
Query: 535 SCPKTNKLREKESAFDS---------ELALLSRVHHKHLVGLV------GFCQEKDERLL 579
KL F S EL LL + H++++GL+ + + L
Sbjct: 56 ------KLSR---PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106
Query: 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI 639
V +M L + K + EK +V ++M +G+ Y+H+ ++HRD+
Sbjct: 107 VMPFMQTD-LQKIMGLKFSEEKIQYLV--YQM--------LKGLKYIHS---AGVVHRDL 152
Query: 640 KSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPE------YYVMNVLT 693
K N+ ++ + ++ DFGL+ T V T Y PE +Y
Sbjct: 153 KPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHY-----N 202
Query: 694 AKTDIYGLGVVLLELLTGKKAVFKNED 720
DI+ +G ++ E+LTG K +FK +D
Sbjct: 203 QTVDIWSVGCIMAEMLTG-KTLFKGKD 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 63/271 (23%), Positives = 108/271 (39%), Gaps = 52/271 (19%)
Query: 465 STRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVY---KGK 521
+ + G ++ + ++ N T NF L +G G++G V+ K
Sbjct: 18 AAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKIS 77
Query: 522 LMDGREV-AVK--REESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDER 577
D ++ A+K ++ + K + E +E +L + LV L + + + +
Sbjct: 78 GHDTGKLYAMKVLKKATI--VQKAKTTEHTR-TERQVLEHIRQSPFLVTLH-YAFQTETK 133
Query: 578 L-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR--------GIDYLHN 628
L L+ +Y++ G L HL R R + +++LH
Sbjct: 134 LHLILDYINGGELFTHL----------------SQRERFTEHEVQIYVGEIVLALEHLHK 177
Query: 629 YAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV 688
II+RDIK NILLD N ++DFGLS + E GT+ Y+ P+
Sbjct: 178 L---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPD--- 230
Query: 689 MNVLTAKT-------DIYGLGVVLLELLTGK 712
++ D + LGV++ ELLTG
Sbjct: 231 --IVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 46/233 (19%), Positives = 96/233 (41%), Gaps = 43/233 (18%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+++ L K+G G + V++ + + +V VK +++K+ E+ +L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIK--REIKILEN 86
Query: 559 V-HHKHLVGLVGFCQEKDER--LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI 615
+ +++ L ++ R LV+E+++N + IR
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD------------YDIRF 134
Query: 616 AL-DAARGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARVSDFGLSLLGSECDQEFIST 673
+ + + +DY H+ I+HRD+K N+++D + R+ D+GL+ QE+
Sbjct: 135 YMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEY--N 188
Query: 674 KAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
V + + PE Y D++ LG +L ++ K+ F D
Sbjct: 189 VRVASRYFKGPELLVDYQMY-----DYSLDMWSLGCMLASMIFRKEPFFHGHD 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 66/236 (27%), Positives = 102/236 (43%), Gaps = 47/236 (19%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREV-AVK--REESCPKTNKLREKESAFDSELALLS 557
N+F +G G+FG V + A+K R+E + E +E +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD---EVAHTV-TESRVLQ 60
Query: 558 RVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIRI 615
H L L + + +RL V EY + G L HL + TE+ R R
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE----------RARF 109
Query: 616 -ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTK 674
+ ++YLH+ +++RDIK N++LD + +++DFGL +E IS
Sbjct: 110 YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC-------KEGISDG 159
Query: 675 AV-----GTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGKKAVFKNED 720
A GT Y+ PE VL D +GLGVV+ E++ G+ F N+D
Sbjct: 160 ATMKTFCGTPEYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD 209
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 63/268 (23%), Positives = 102/268 (38%), Gaps = 66/268 (24%)
Query: 476 RQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREE 534
RSG V + + + VG G++G V G +VA+K
Sbjct: 6 PARSGFYRQEVTKTAWEV------RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--- 56
Query: 535 SCPKTNKLREKESAFDS---------ELALLSRVHHKHLVGLV------GFCQEKDERLL 579
KL F S EL LL + H++++GL+ + + L
Sbjct: 57 ------KLYR---PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107
Query: 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR-IALDAARGIDYLHNYAVPSIIHRD 638
V +M L + ++ E RI+ + +G+ Y+H IIHRD
Sbjct: 108 VMPFMGTD-LGKLMKHEKLGED----------RIQFLVYQMLKGLRYIHA---AGIIHRD 153
Query: 639 IKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPE------YYVMNVL 692
+K N+ ++ + ++ DFGL+ T V T Y PE Y
Sbjct: 154 LKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRY----- 203
Query: 693 TAKTDIYGLGVVLLELLTGKKAVFKNED 720
T DI+ +G ++ E++TG K +FK D
Sbjct: 204 TQTVDIWSVGCIMAEMITG-KTLFKGSD 230
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 24/180 (13%), Positives = 66/180 (36%), Gaps = 33/180 (18%)
Query: 501 NNFSLENKVGIGSFGTVYKGK---------LMDGREVAVKREESCPKTNKLRE-----KE 546
+ L++ + G +Y+ ++ ++K + K +L +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLD---AKDGRLFNEQNFFQR 98
Query: 547 SAFDSELALLSRVHHKHLVG---LVGF-CQEKDERLLVYEYMSNGALHDHLHNKNNTEKN 602
+A ++ +++ L+ +GF + R LV + G + +
Sbjct: 99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVL 156
Query: 603 SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV--SDFGLS 660
S + +++A +++LH +H ++ + NI +D ++V + +G +
Sbjct: 157 SE-----RSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 33/170 (19%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
N F L K+G GSFG +Y G + EVA+K E ++ K E +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLE-------NVKTKHPQLLYESKIY--- 56
Query: 560 HHKHLVGLVGFCQ------EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
+ L G G E D +LV + + G + L N + + S+ K +
Sbjct: 57 --RILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCS--RKLSL----KTVL 106
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR---VSDFGLS 660
+A ++++H+ S +HRDIK N L+ + A + DFGL+
Sbjct: 107 MLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 51/250 (20%), Positives = 96/250 (38%), Gaps = 59/250 (23%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR-----EESCPKTNKLREKESAFDSEL 553
+ + +G G G V+ + VA+K+ +S LRE +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA--LRE--------I 59
Query: 554 ALLSRVHHKHLVGL--------------VGFCQEKDERLLVYEYMSNGALHDHLHNKNNT 599
++ R+ H ++V + VG E + +V EYM L + L
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLL 118
Query: 600 EKNSSIVNSWKMRIR-IALDAARGIDYLHNYAVPSIIHRDIKSSNILLD-VNWTARVSDF 657
E+ R RG+ Y+H+ +++HRD+K +N+ ++ + ++ DF
Sbjct: 119 EE----------HARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDF 165
Query: 658 GLS-LLGSECDQEFISTKAVGTVGYIDPE------YYVMNVLTAKTDIYGLGVVLLELLT 710
GL+ ++ + ++ + T Y P Y T D++ G + E+LT
Sbjct: 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLT 220
Query: 711 GKKAVFKNED 720
G K +F
Sbjct: 221 G-KTLFAGAH 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 47/242 (19%), Positives = 95/242 (39%), Gaps = 65/242 (26%)
Query: 444 SNVDSASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNF 503
S+ ++A+ S S S ++ R ++S ++ + + +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD------RY 55
Query: 504 SLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDS---------EL 553
+ + +G GS+G V + ++ R VA+K K+ F+ E+
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIK---------KILR---VFEDLIDCKRILREI 103
Query: 554 ALLSRVHHKHLVGLVGFCQ----EKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNS 608
A+L+R++H H+V ++ EK + L +V E D + +
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SD-FKK---------LFRT 149
Query: 609 WKMRIRIALDAA----------RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658
+ L G+ Y+H+ I+HRD+K +N L++ + + +V DFG
Sbjct: 150 -----PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFG 201
Query: 659 LS 660
L+
Sbjct: 202 LA 203
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 74/283 (26%), Positives = 105/283 (37%), Gaps = 83/283 (29%)
Query: 459 PPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKV-GIGSFGTV 517
P L + + + + SS+ K +F KV G GSFG V
Sbjct: 8 PELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFL-------------KVIGKGSFGKV 54
Query: 518 YKGKLMDGREV-AVK----------REESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566
+ AVK +EE + E+ LL V H LVG
Sbjct: 55 LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS----ERN-------VLLKNVKHPFLVG 103
Query: 567 LVGFCQEKDERL-LVYEYMSNGALHDHLHNKNN-TEKNSSIVNSWKMRIR-----IALDA 619
L F + ++L V +Y++ G L HL + E R R IA
Sbjct: 104 LH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----------RARFYAAEIAS-- 150
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV--- 676
+ YLH+ +I++RD+K NILLD ++DFGL +E I +
Sbjct: 151 --ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLC-------KENIEHNSTTST 198
Query: 677 --GTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
GT Y+ PE VL + D + LG VL E+L G
Sbjct: 199 FCGTPEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 34/178 (19%), Positives = 64/178 (35%), Gaps = 29/178 (16%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESC---PKTNKLREKESAFDSELA--- 554
+ + +G G FG +Y + V P N E F A
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 555 LLSRVHHKHLVGLVGFC----------QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSS 604
+ + + +G K R ++ + G+ ++ N K S
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANA--KRFS 150
Query: 605 IVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV--SDFGLS 660
K ++++L ++Y+H + +H DIK+SN+LL+ +V D+GL+
Sbjct: 151 R----KTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 54/249 (21%), Positives = 98/249 (39%), Gaps = 59/249 (23%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDS------- 551
+++F L++ +G G++G V G VA+K K FD
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-------------KIEPFDKPLFALRT 56
Query: 552 --ELALLSRVHHKHLVGLV-----GFCQEKDERLLVYEYM-SNGALHDHLHNKNNTEKNS 603
E+ +L H++++ + + +E ++ E M ++ LH + + ++
Sbjct: 57 LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDD-- 112
Query: 604 SIVNSWKMRIR-IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-- 660
I+ R + LH ++IHRD+K SN+L++ N +V DFGL+
Sbjct: 113 --------HIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 661 ------LLGSECDQEFISTKAVGTVGYIDPEYYVM---NVLTAKTDIYGLGVVLLELLTG 711
Q+ + V T Y PE VM + D++ G +L EL
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPE--VMLTSAKYSRAMDVWSCGCILAELFLR 219
Query: 712 KKAVFKNED 720
+ +F D
Sbjct: 220 -RPIFPGRD 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 59/277 (21%), Positives = 107/277 (38%), Gaps = 83/277 (29%)
Query: 465 STRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKV-GIGSFGTVYKGKLM 523
S ++ + SG +S S+ +F L +V G GS+ V +L
Sbjct: 28 SGIEEEKEAMNTRESGKASSSLGLQDFDLL-------------RVIGRGSYAKVLLVRLK 74
Query: 524 DGREV-AVKREESCPKTNKLREKESAFDSELA--------LLSRVHHKHLVGLVGFCQEK 574
+ A++ ++++ D ++ +H LVGL C +
Sbjct: 75 KTDRIYAMR---------VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQT 124
Query: 575 DERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR--------GIDY 625
+ RL V EY++ G L H+ + ++ + AR ++Y
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQR----------------KLPEEHARFYSAEISLALNY 168
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV-----GTVG 680
LH II+RD+K N+LLD +++D+G+ +E + GT
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTSTFCGTPN 218
Query: 681 YIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
YI PE +L + D + LGV++ E++ G+
Sbjct: 219 YIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 55/236 (23%), Positives = 96/236 (40%), Gaps = 61/236 (25%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESAFDSELA----- 554
+F L +G GS+ V +L + A+K ++++ D ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK---------VVKKELVNDDEDIDWVQTE 59
Query: 555 ---LLSRVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
+H LVGL C + + RL V EY++ G L H+ +
Sbjct: 60 KHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQR------------- 105
Query: 611 MRIRIALDAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662
++ + AR ++YLH II+RD+K N+LLD +++D+G+
Sbjct: 106 ---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159
Query: 663 GSECDQEFISTKAV-GTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
G +T GT YI PE +L + D + LGV++ E++ G+
Sbjct: 160 GLRPGD---TTSTFCGTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 61/268 (22%), Positives = 106/268 (39%), Gaps = 66/268 (24%)
Query: 476 RQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREE 534
++R + + + + + VG G++G+V G VAVK
Sbjct: 10 QERPTFYRQELNKTIWEV------PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--- 60
Query: 535 SCPKTNKLREKESAFDS---------ELALLSRVHHKHLVGLV------GFCQEKDERLL 579
KL F S EL LL + H++++GL+ +E ++ L
Sbjct: 61 ------KLSR---PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111
Query: 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR-IALDAARGIDYLHNYAVPSIIHRD 638
V M L++ + + T+ ++ + RG+ Y+H+ IIHRD
Sbjct: 112 VTHLMGAD-LNNIVKCQKLTDD----------HVQFLIYQILRGLKYIHS---ADIIHRD 157
Query: 639 IKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPE------YYVMNVL 692
+K SN+ ++ + ++ DFGL+ T V T Y PE +Y
Sbjct: 158 LKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNWMHY----- 207
Query: 693 TAKTDIYGLGVVLLELLTGKKAVFKNED 720
DI+ +G ++ ELLTG + +F D
Sbjct: 208 NQTVDIWSVGCIMAELLTG-RTLFPGTD 234
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 34/176 (19%), Positives = 66/176 (37%), Gaps = 28/176 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELA---LL 556
N + L K+G G FG +Y + A + + N E F +A +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 557 SRVHHKHLVGLVGF----------CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIV 606
+ + + +G + + R +V E + G + +N T
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTF------ 148
Query: 607 NSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV--SDFGLS 660
+++ + ++Y+H +H DIK++N+LL +V +D+GLS
Sbjct: 149 -KKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 48/285 (16%), Positives = 84/285 (29%), Gaps = 65/285 (22%)
Query: 75 AISGGQNYFCGLRSGGFSLHCWDTNDL-------TNFSFQPKRLHFRKAVQLTDVSVGGD 127
A++ G + L S G ++ W + + +P+ + + +++ DV+ GG
Sbjct: 111 AVNSGGKHCLALSSEG-EVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGA 169
Query: 128 QVCAREVNSGVVKCW-RGTKVKDKGQL-----FSFSSP-------GEDLKFSTITSGRGF 174
+G + W +G G+L P G + SG
Sbjct: 170 HSACV-TAAGDLYTWGKG----RYGRLGHSDSEDQLKPKLVEALQGHRVVDIACGSGDAQ 224
Query: 175 TCGILRSNSEVFCWGDS-----GIADEIQR-------GFKNLSMVGLVAGESHACGLSRN 222
T L + V+ WGD G L +V + G + L+++
Sbjct: 225 TL-CLTDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTKS 283
Query: 223 GALVCKGSNDSGQL--------NVPFSSAFEFSGG----LALGANFTCAIRQRSGLVACW 270
GA+ G D +L P G +A G+ + G V W
Sbjct: 284 GAVYTWGKGDYHRLGHGSDDHVRRP-RQVQGLQGKKVIAIATGSLHCVCCTE-DGEVYTW 341
Query: 271 G-------GTNRFEFDS-----DVIQDVSFESIVAGLDFVCGLTT 303
G G +Q + G +T
Sbjct: 342 GDNDEGQLGDGTTNAIQRPRLVAALQGKKVNRVACGSAHTLAWST 386
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 31/182 (17%), Positives = 51/182 (28%), Gaps = 40/182 (21%)
Query: 168 ITSGRGFTCGILRSNSEVFCWGDS-----GIADEIQR-------GFKNLSMVGLVAGESH 215
S + + ++ WG + G + + L V L+ GE
Sbjct: 6 HHSSGRENL-YFQGSGTIYGWGHNHRGQLGGIEGAKVKVPTPCEALATLRPVQLIGGEQT 64
Query: 216 ACGLSRNGALVCKGSNDSGQL--------NVP-----FSSAFEFSGGLALGANFTCAIRQ 262
++ +G L G G+L + P F + G A+
Sbjct: 65 LFAVTADGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLALS- 123
Query: 263 RSGLVACWG---------GTNRFEFDSDVIQDVSFESIV---AGLDFVCGLTTRNLSMIC 310
G V WG G VI+ + +V AG +T +
Sbjct: 124 SEGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAHSACVTAAG-DLYT 182
Query: 311 WG 312
WG
Sbjct: 183 WG 184
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 2e-12
Identities = 69/393 (17%), Positives = 118/393 (30%), Gaps = 50/393 (12%)
Query: 336 PCVESSCITCGVYPNSESLCVGSGNVCNPCQIELPLAVPLPPLKRPPSPDLQPTSPKKDE 395
G+ L + Q + L P S K
Sbjct: 181 AKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRR 240
Query: 396 KKISLASVVVGSAGCFAGICTVGYCFWAGFLHKRINSVQPSSANTSSDSNVDSASMANDG 455
+ + + S F G + G + + V +
Sbjct: 241 LSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNE 300
Query: 456 SNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFG 515
Q + + + S F + + +F+ +G GSFG
Sbjct: 301 ELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMK-----LTDFNFLMVLGKGSFG 355
Query: 516 TVYKGKLMDGREV-AVKREESCPKTNKLREKESAFDSELA--------LLSRVHHKHLVG 566
V + E+ AVK L++ D ++ L L
Sbjct: 356 KVMLSERKGTDELYAVK---------ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI-ALDAARGIDY 625
L Q D V EY++ G L H+ ++ A + A G+ +
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---------HAVFYAAEIAIGLFF 457
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV-GTVGYIDP 684
L + II+RD+K N++LD +++DFG+ +TK GT YI P
Sbjct: 458 LQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAP 511
Query: 685 EYYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
E ++ + D + GV+L E+L G+
Sbjct: 512 E-----IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 56/239 (23%), Positives = 92/239 (38%), Gaps = 69/239 (28%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREV-AVKREESCPKTNKLREKESAFDSELA----- 554
+F L +G GSFG V+ + + A+K L++ D ++
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIK---------ALKKDVVLMDDDVECTMVE 67
Query: 555 ---LLSRVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
L H L + + E L V EY++ G L H+ + +
Sbjct: 68 KRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCH------------- 113
Query: 611 MRIRIALDAAR--------GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662
+ L A G+ +LH+ I++RD+K NILLD + +++DFG+
Sbjct: 114 ---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC-- 165
Query: 663 GSECDQEFISTKAV-----GTVGYIDPEYYVMNVLTAKT-----DIYGLGVVLLELLTG 711
+E + A GT YI PE +L + D + GV+L E+L G
Sbjct: 166 -----KENMLGDAKTNTFCGTPDYIAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 47/271 (17%), Positives = 91/271 (33%), Gaps = 70/271 (25%)
Query: 63 STIPVLPNASFQAISGGQNYFCGLRSGGFSLHCW-----------DTNDLTNFSFQPKRL 111
S P+ ++ N C L S G ++ W D P ++
Sbjct: 140 SFPPLAEGHKVVQLAATDNMSCALFSNG-EVYAWGTFRCNEGILGFYQDKIKIQKTPWKV 198
Query: 112 HFRKAVQLTDVSVGGDQVCAREVNSGVVKCW-RGTKVKDKGQL-----FSFSSPGEDLKF 165
+ ++ G D + G+V W G + QL F D +
Sbjct: 199 PTFSKYNIVQLAPGKDHILFL-DEEGMVFAWGNG----QQNQLGRKVMERFRLKTLDPRP 253
Query: 166 ST------ITSGRGFTCGILRSNSEVFCWGDS-----GIADEIQR-----------GFKN 203
I SG L ++++ WG + G++++++ N
Sbjct: 254 FGLRHVKYIASGENHCF-ALTKDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDN 312
Query: 204 LSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEFSGG-------------- 249
+ + + AGE H+ LS++G L G D ++ +P + E++
Sbjct: 313 VVIRSIAAGEHHSLILSQDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTK 372
Query: 250 ---------LALGANFTCAIRQRSGLVACWG 271
+A G++ + A+ Q +G+ WG
Sbjct: 373 LNNVPKFKSVAAGSHHSVAVAQ-NGIAYSWG 402
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 30/256 (11%), Positives = 71/256 (27%), Gaps = 66/256 (25%)
Query: 65 IPVLPNASFQAISGGQNYFCGLRSGGFSLHCW-----------DTNDLTNFSFQPKRLHF 113
+P + ++ G+++ L G + W + P+
Sbjct: 198 VPTFSKYNIVQLAPGKDHILFLDEEG-MVFAWGNGQQNQLGRKVMERFRLKTLDPRPFGL 256
Query: 114 RKAVQLTDVSVGGDQVCAREVNSGVVKCW---------RGTKVKDKGQLFS--FSSPGED 162
R ++ G + A + W V+D + + ++
Sbjct: 257 RHVKY---IASGENHCFAL-TKDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDN 312
Query: 163 LKFSTITSGRGFTCGILRSNSEVFCWGDS-----GIADEIQRGFKNLSMVGLV------- 210
+ +I +G + IL + +++ G GI + + + G
Sbjct: 313 VVIRSIAAGEHHSL-ILSQDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPT 371
Query: 211 ------------AGESHACGLSRNGALVCKGSNDSGQL---------NVPFSSAFEFSGG 249
AG H+ +++NG G ++ + VP +
Sbjct: 372 KLNNVPKFKSVAAGSHHSVAVAQNGIAYSWGFGETYAVGLGPFEDDTEVPTRIKNTATQD 431
Query: 250 -----LALGANFTCAI 260
+ G F+ +
Sbjct: 432 HNIILVGCGGQFSVSG 447
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 41/259 (15%), Positives = 60/259 (23%), Gaps = 84/259 (32%)
Query: 168 ITSGRGFTCGILRSNSEVFCWG--------DSGIADEIQRGF---------KNLSMVGLV 210
+ ++FCWG +A + ++
Sbjct: 15 AQEDYKHMY-LSVQPLDIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEAKIISFA 73
Query: 211 AGESHACGLSRNGALVCKGSNDSGQL---------------------------------- 236
G H L + G ND G L
Sbjct: 74 VGGMHTLALDEESNVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTP 133
Query: 237 -NVPFSSAFEFSGG-----LALGANFTCAIRQRSGLVACWGGTNRFE-----FDSDVIQD 285
+P S + G LA N +CA+ +G V W GT R F D I+
Sbjct: 134 AKIPRESFPPLAEGHKVVQLAATDNMSCALFS-NGEVYAW-GTFRCNEGILGFYQDKIKI 191
Query: 286 VS------------FESIVAGLDFVCGLTTRNLSMICWGPGWS----NKPHLERGLPLPL 329
+ G D + L + WG G K L
Sbjct: 192 QKTPWKVPTFSKYNIVQLAPGKDHILFLDEEG-MVFAWGNGQQNQLGRKVMERFRLKTLD 250
Query: 330 GQVLPGPCVESSCITCGVY 348
+ V+ I G
Sbjct: 251 PRPFGLRHVKY--IASGEN 267
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 63/272 (23%), Positives = 97/272 (35%), Gaps = 81/272 (29%)
Query: 469 QSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKV-GIGSFGTVYKGKLMDGRE 527
+ S G +SS + DNF +V G GSFG V ++ + +
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFI-------------RVLGKGSFGKVMLARVKETGD 49
Query: 528 V-AVKREESCPKTNKLREKESAFDSELA--------LLSRVHHKHLVGLVGFCQEKDERL 578
+ AVK L++ D ++ L +H L L Q D
Sbjct: 50 LYAVK---------VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100
Query: 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR--------GIDYLHNYA 630
V E+++ G L H+ R AR + +LH+
Sbjct: 101 FVMEFVNGGDLMFHIQKSR----------------RFDEARARFYAAEIISALMFLHDK- 143
Query: 631 VPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV-----GTVGYIDPE 685
II+RD+K N+LLD +++DFG+ +E I GT YI PE
Sbjct: 144 --GIIYRDLKLDNVLLDHEGHCKLADFGMC-------KEGICNGVTTATFCGTPDYIAPE 194
Query: 686 YYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
+L D + +GV+L E+L G
Sbjct: 195 -----ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 6e-12
Identities = 36/195 (18%), Positives = 59/195 (30%), Gaps = 36/195 (18%)
Query: 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVK---------REESCPKTNKLREKESAF 549
T K+G G FG V++ D VA+K S KT + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 550 DSELALLS---RVHHKHLVGLVGF--CQEKDERLLVYEYM----SNGALHDHLHNKNNT- 599
EL+LLS + +GL Q LL+ + + G+ +D +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 600 --------------EKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645
E+ + ++S I + HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVL 194
Query: 646 LDVNWTARVSDFGLS 660
L ++
Sbjct: 195 LKKTSLKKLHYTLNG 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 58/272 (21%), Positives = 95/272 (34%), Gaps = 83/272 (30%)
Query: 470 SSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKV-GIGSFGTVYKGKLMDGREV 528
++ T + + + +K +F V G GSFG V + E+
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFL-------------MVLGKGSFGKVMLSERKGTDEL 47
Query: 529 -AVKREESCPKTNKLREKESAFDSELA--------LLSRVHHKHLVGLVGFCQEKDERL- 578
AVK L++ D ++ L L L C + +RL
Sbjct: 48 YAVK---------ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLY 97
Query: 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR--------GIDYLHNYA 630
V EY++ G L H+ R A G+ +L +
Sbjct: 98 FVMEYVNGGDLMYHIQQVG----------------RFKEPHAVFYAAEIAIGLFFLQSK- 140
Query: 631 VPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV-----GTVGYIDPE 685
II+RD+K N++LD +++DFG+ +E I GT YI PE
Sbjct: 141 --GIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTKTFCGTPDYIAPE 191
Query: 686 YYVMNVLTAKT-----DIYGLGVVLLELLTGK 712
++ + D + GV+L E+L G+
Sbjct: 192 -----IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 57/246 (23%), Positives = 95/246 (38%), Gaps = 59/246 (23%)
Query: 508 KVGIGSFGTVYKGK-LMDGREVAVK--REESCPKTNKLREKESAFDSELALLSRVH---- 560
K+G G F TV+ K +++ VA+K R E+A D E+ LL RV+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAED-EIKLLQRVNDADN 77
Query: 561 -------HKHLVGLVG---FCQEKDERL-LVYEYMS-NGALHDHLHNKNNTEKNSSIVNS 608
H++ L+ + +V+E + N L + + V
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKKYEHRGIPLIYVK- 134
Query: 609 WKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD------VNWTARVSDFGLSLL 662
+I+ G+DY+H IIH DIK N+L++ +++D G +
Sbjct: 135 -----QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVL-----TAKTDIYGLGVVLLELLTGKKAVFK 717
E I T+ Y PE VL DI+ ++ EL+TG +F+
Sbjct: 188 YDEHYTNSIQTRE-----YRSPE-----VLLGAPWGCGADIWSTACLIFELITG-DFLFE 236
Query: 718 NEDGSG 723
++G
Sbjct: 237 PDEGHS 242
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 46/321 (14%), Positives = 87/321 (27%), Gaps = 82/321 (25%)
Query: 66 PVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTND---------LTNFSFQPKR-LHFRK 115
V G + L G ++ + ND + P + K
Sbjct: 54 LVSIPEDVVQAEAGGMHTVCLSKSG-QVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEK 112
Query: 116 AVQLTDVSVGGDQVCAREV-NSGVVKCWRGTKVKDKGQL-----FSFSSP----GEDLKF 165
VQ VS G A + + G V W G+ + G + S D+
Sbjct: 113 VVQ---VSAGDSHTAA--LTDDGRVFLW-GSFRDNNGVIGLLEPMKKSMVPVQVQLDVPV 166
Query: 166 STITSGRGFTCGILRSNSEVFCWGDSG----------------------------IADEI 197
+ SG +L ++ +++ G + +
Sbjct: 167 VKVASGNDHLV-MLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKS 225
Query: 198 QRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQL--------NVP-----FSSAF 244
+ ++ G +S G + G ++ QL +P F ++
Sbjct: 226 RGSRGHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNST 285
Query: 245 EFSGGLALGANFTCAIRQRSGLVACWG-------GTNRFEFDSDVIQDVS----FESIVA 293
+ G + G + T + G G G + + +S S+
Sbjct: 286 KSWVGFSGGQHHTVCMDS-EGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVAC 344
Query: 294 GLDFVCGLTTRNLSMICWGPG 314
G +T + WG G
Sbjct: 345 GASVGYAVTKDG-RVFAWGMG 364
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 32/187 (17%), Positives = 52/187 (27%), Gaps = 49/187 (26%)
Query: 158 SPGEDLKFSTITSGRGFTCGILRSNSEVFCWGDS-----GIADEIQRGFK------NLSM 206
SP D + V G G+ + + K +
Sbjct: 3 SPPADAIPKSKKVKVSHRS-HSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDV 61
Query: 207 VGLVAGESHACGLSRNGALVCKGSNDSGQL------NVPFSSAFEFSGG-----LALGAN 255
V AG H LS++G + G ND G L + ++ G +
Sbjct: 62 VQAEAGGMHTVCLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDS 121
Query: 256 FTCAIRQRSGLVACWG-GTNRF------------------EFDSDVIQDVSFESIVAGLD 296
T A+ G V WG + + D V++ + +G D
Sbjct: 122 HTAALT-DDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVK------VASGND 174
Query: 297 FVCGLTT 303
+ LT
Sbjct: 175 HLVMLTA 181
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 37/258 (14%), Positives = 70/258 (27%), Gaps = 67/258 (25%)
Query: 65 IPVLPNASFQAISGGQNYFCGLRSGGFSLHCW------------------DTNDLTNFSF 106
+ V + ++ G ++ L + G L+
Sbjct: 158 VQVQLDVPVVKVASGNDHLVMLTADG-DLYTLGCGEQGQLGRVPELFANRGGRQGLERLL 216
Query: 107 QPKRLHF-----RKAVQLTDVSVGGDQVCAREVNSGVVKCW-RGTKVKDKGQL-----FS 155
PK + R V+ D G A + G V + + QL S
Sbjct: 217 VPKCVMLKSRGSRGHVRFQDAFCGAYFTFAI-SHEGHVYGFGLS----NYHQLGTPGTES 271
Query: 156 FSSP-------GEDLKFSTITSGRGFTCGILRSNSEVFCWGDS-----GIADEIQRGF-- 201
P + + G+ T + S + + G + G+ + +
Sbjct: 272 CFIPQNLTSFKNSTKSWVGFSGGQHHTV-CMDSEGKAYSLGRAEYGRLGLGEGAEEKSIP 330
Query: 202 ---KNLSMVGLVA-GESHACGLSRNGALVCKGSNDSGQL--------NVP---FSSAFEF 246
L V VA G S ++++G + G + QL P E
Sbjct: 331 TLISRLPAVSSVACGASVGYAVTKDGRVFAWGMGTNYQLGTGQDEDAWSPVEMMGKQLEN 390
Query: 247 SG--GLALGANFTCAIRQ 262
++ G T + +
Sbjct: 391 RVVLSVSSGGQHTVLLVK 408
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 60/258 (23%), Positives = 102/258 (39%), Gaps = 67/258 (25%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDS------- 551
+ L K+G G++G V+K G VAVK K+ + AF +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---------KIFD---AFQNSTDAQRT 55
Query: 552 --ELALLSRVH-HKHLVGLVG-FCQEKDERL-LVYEYM-SNGALHDHLHNKNNTEKNSSI 605
E+ +L+ + H+++V L+ + D + LV++YM ++ LH +
Sbjct: 56 FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPV---- 109
Query: 606 VNSWKMRIR-IALDAARGIDYLHNYAVPS--IIHRDIKSSNILLDVNWTARVSDFGLSLL 662
+ + + I YLH S ++HRD+K SNILL+ +V+DFGLS
Sbjct: 110 ------HKQYVVYQLIKVIKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158
Query: 663 GSECDQEFISTKAVGTVGYIDPEY-------YVMN-------VL------TAKTDIYGLG 702
+ + + + YV +L T D++ LG
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218
Query: 703 VVLLELLTGKKAVFKNED 720
+L E+L G K +F
Sbjct: 219 CILGEILCG-KPIFPGSS 235
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 36/208 (17%), Positives = 66/208 (31%), Gaps = 45/208 (21%)
Query: 148 KDKGQLFSFSSPGE------DLKFSTITSGRGFTCGILRSNSEVFCWGDS-----GIADE 196
+ L + ++ GE K + I V G+ G+ ++
Sbjct: 3 PRRKALTNNNNAGEAEQQPPKAKRARIAFHLELPK-RRTVLGNVLVCGNGDVGQLGLGED 61
Query: 197 IQRGFK------NLSMVGLVAGESHACGLSRNGALVCKGSNDSGQL------NVPFSSAF 244
I + V + AG H L+++G + G ND G L + S
Sbjct: 62 ILERKRLSPVAGIPDAVDISAGGMHNLVLTKSGDIYSFGCNDEGALGRDTSEDGSESKPD 121
Query: 245 EFSGG-----LALGANFTCAIRQRSGLVACWGGTNRFEF-------DSD------VIQDV 286
++ G + + + + G V W G+ R D + +++
Sbjct: 122 LIDLPGKALCISAGDSHSACLLE-DGRVFAW-GSFRDSHGNMGLTIDGNKRTPIDLMEGT 179
Query: 287 SFESIVAGLDFVCGLTTRNLSMICWGPG 314
SI +G D + LTT + G
Sbjct: 180 VCCSIASGADHLVILTTAG-KVFTVGCA 206
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 37/304 (12%), Positives = 74/304 (24%), Gaps = 68/304 (22%)
Query: 65 IPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTND-------LTNFSFQPKRLHFRKAV 117
+ IS G ++ L G + W + LT + + +
Sbjct: 121 DLIDLPGKALCISAGDSHSACLLEDG-RVFAWGSFRDSHGNMGLTIDGNKRTPIDLMEGT 179
Query: 118 QLTDVSVGGDQVCAREVNSGVVKCW---------RGTKVKDKGQLFSFSSP--------- 159
++ G D + +G V R ++ G+
Sbjct: 180 VCCSIASGADHLVIL-TTAGKVFTVGCAEQGQLGRLSERSISGEGRRGKRDLLRPTQLII 238
Query: 160 GEDLKFSTITSGRGFTCGILRSNSEVFCWGDS-----GIADEIQR--------GFKNLSM 206
F I + T ++ G + + + K++
Sbjct: 239 TRAKPFEAIWATNYCTFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRH 298
Query: 207 VGLVAGESHACGLSRNGALVCKGSNDSGQL-------NVPFSSAFEFSGG----LALGAN 255
+ G+ H L+ + G + G+L V + + + G
Sbjct: 299 I--AGGQHHTVILTTDLKCSVVGRPEYGRLGLGDVKDVVEKPTIVKKLTEKIVSVGCGEV 356
Query: 256 FTCAIRQRSGLVACWG-----------GTNRFEF---DSDVIQDVSFESIVAGLDFVCGL 301
+ A+ G + WG G + E S Q G L
Sbjct: 357 CSYAVT-IDGKLYSWGSGVNNQLGVGDGDDELEPIVVVSKNTQGKHMLLASGGGQHAIFL 415
Query: 302 TTRN 305
+
Sbjct: 416 VKAD 419
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 61/245 (24%), Positives = 93/245 (37%), Gaps = 79/245 (32%)
Query: 509 VGIGSFGTVYKGK-LMDGREVAVK--REESCPKTNKLREKESAFDSELALLSRV------ 559
+G GSFG V K + VA+K R N+ R A + E+ +L +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAE-EIRILEHLRKQDKD 156
Query: 560 -------------HHKHLVGLVGFCQEKDERLLVYEYMS-NGALHDHLHNKNNTEKNSSI 605
H+ C + +E +S N L++ + K N + S+
Sbjct: 157 NTMNVIHMLENFTFRNHI------C-------MTFELLSMN--LYELI--KKNKFQGFSL 199
Query: 606 VNSWKMRIR-IALDAARGIDYLHNYAVPSIIHRDIKSSNILL-DVNWTA-RVSDFGLSLL 662
+R A + +D LH IIH D+K NILL + +V DF
Sbjct: 200 P-----LVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF----- 246
Query: 663 GSEC-DQEFISTKAVGTVGYIDPEYY----VMNVL--TAKTDIYGLGVVLLELLTGKKAV 715
GS C + + + T YI +Y V+ D++ LG +L ELLTG +
Sbjct: 247 GSSCYEHQRVYT-------YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPL 298
Query: 716 FKNED 720
ED
Sbjct: 299 LPGED 303
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 59/297 (19%), Positives = 91/297 (30%), Gaps = 99/297 (33%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ + K+G G F TV+ + + VA+K + E+A D E+ LL
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-----VVKSAEHYTETALD-EIRLLKS 89
Query: 559 VH--------HKHLVGLVG-F----------CQEKDERLLVYEYMSNGA-LHDHLHNKNN 598
V + +V L+ F C +V+E + G L + N
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVL--GHHLLKWIIKSNY 140
Query: 599 TEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN--------- 649
V +I +G+DYLH IIH DIK NILL VN
Sbjct: 141 QGLPLPCVK------KIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192
Query: 650 ----------------------------------------WTARVSDFGLSLLGSECDQE 669
+++D G + + E
Sbjct: 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE 252
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726
I T+ Y E + + DI+ + EL TG +F+ G
Sbjct: 253 DIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATG-DYLFEPHSGEEYTR 303
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 51/241 (21%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVK--REESCPKTNKLREKESAFDSELALL 556
+ + +++ +G GSFG V K ++ VA+K + NK A E+ LL
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQI-EVRLL 104
Query: 557 SRV------HHKHLVGLVGFCQEKDERLLVYEYMS-NGALHDHLHNKNNTEKNSSIVNSW 609
+ ++V L ++ LV+E +S N L+D L +N + S+
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN--LYDLL--RNTNFRGVSLN--- 157
Query: 610 KMRIR-IALDAARGIDYLHNYAVPSIIHRDIKSSNILL--DVNWTARVSDFGLSLLGSEC 666
R A + +L + SIIH D+K NILL ++ DF GS C
Sbjct: 158 --LTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDF-----GSSC 209
Query: 667 -DQEFISTKAVGTVGYIDPEYY----VMNVL--TAKTDIYGLGVVLLELLTGKKAVFKNE 719
+ I YI +Y V+ + D++ LG +L+E+ TG + +F
Sbjct: 210 QLGQRIYQ-------YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGA 261
Query: 720 D 720
+
Sbjct: 262 N 262
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 6e-07
Identities = 53/372 (14%), Positives = 109/372 (29%), Gaps = 131/372 (35%)
Query: 461 LRSFSTRQQSSRTFG----RQRSGSSSF---SVKAD-NFTLSELAAATNNFSLENKVGIG 512
+ S + R F +Q F ++ + F +S + S+ ++ I
Sbjct: 55 IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE 114
Query: 513 SFGTVYKGKLMDGREV----AVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV--G 566
+ +L + +V V R + KLR+ ALL K+++ G
Sbjct: 115 -----QRDRLYNDNQVFAKYNVSRLQ---PYLKLRQ---------ALLELRPAKNVLIDG 157
Query: 567 LVGF---------CQEKDERLL------VYEYMSNGALHDH---LHNKNNT----EKNSS 604
++G C ++ ++ +++ + L + N +
Sbjct: 158 VLGSGKTWVALDVCL--SYKVQCKMDFKIF-WLNLKNCNSPETVLEMLQKLLYQIDPNWT 214
Query: 605 IVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD-VNWTARVSD-FGLSLL 662
+ I++ + + + L + + ++ ++L V A+ + F LS
Sbjct: 215 SRSDHSSNIKLRIHSIQ--AELRRL----LKSKPYENCLLVLLNV-QNAKAWNAFNLS-- 265
Query: 663 GSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS 722
C K L L T K V
Sbjct: 266 ---C----------------------------KI---------L-LTTRFKQVT------ 278
Query: 723 GPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITD 782
D + A + H LD L E LL ++ ++ P +
Sbjct: 279 ---DFLSAATTT------HISLDHHSMT--LTPDEVKSLLLK----YLDCRPQDLPR--E 321
Query: 783 IVANLERALAIC 794
++ R L+I
Sbjct: 322 VLTTNPRRLSII 333
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 1e-05
Identities = 74/526 (14%), Positives = 136/526 (25%), Gaps = 161/526 (30%)
Query: 360 NVCNPCQIELPLAVPLPP--------LKRPPSPDLQPTSPKKDEKKISLASVVVGSAGC- 410
+ N Q+ V L L+P K + ++ G G
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALLE-----LRP------AKNV----LIDGVLGSG 162
Query: 411 ----FAGIC----------------TVGYCFWAGFLHKRINSVQPSSANTSSDSNVDSAS 450
+C + C + + + + D N S S
Sbjct: 163 KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL-----LYQIDPNWTSRS 217
Query: 451 MANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVG 510
D S+ LR S + + R + + + V N ++ A F+L K+
Sbjct: 218 ---DHSSNIKLRIHSIQAELRRLL-KSKPYENCLLV-LLNVQNAKAWNA---FNLSCKIL 269
Query: 511 IGSFGTVYKGKLMDGREVAVKREESCPKTNK-LREKESAFDSELALLSRV---------- 559
+ T +K + D A S + L E +LL +
Sbjct: 270 LT---TRFKQ-VTDFLSAATTTHISLDHHSMTLTPDEV-----KSLLLKYLDCRPQDLPR 320
Query: 560 ----HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR--I 613
+ + ++ + + T N VN K+ I
Sbjct: 321 EVLTTNPRRLSIIA------------------ES---IRDGLATWDNWKHVNCDKLTTII 359
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD---------FGLSLLGS 664
+L+ +Y + S+ ILL + W + SL+
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV-- 417
Query: 665 ECDQEFISTKAVGTVGYIDPEYYVMNV---LTAKTD-IYGLGVVLLELLTGKKAVFKNED 720
E + + + ++ L K + Y L +++ K F ++D
Sbjct: 418 EKQPK-------------ESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT-FDSDD 463
Query: 721 GSGP-------------LDVVEFAVSQILAGQLHCVLD--------KRVGPPELNEAEAV 759
P L +E L + LD + +
Sbjct: 464 LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF--LDFRFLEQKIRHDSTAWNASGSIL 521
Query: 760 ELLATTAIH----CVNLEGKERPNITDIVANLERALAICQDCSCTD 801
L + C N ER + I+ L + TD
Sbjct: 522 NTLQQLKFYKPYICDNDPKYER-LVNAILDFLPKIEENLICSKYTD 566
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 50/272 (18%), Positives = 90/272 (33%), Gaps = 97/272 (35%)
Query: 500 TNNFSLENKVGIGSFGTVYKG--KLMDGREVAVK--REESCPKTNKLREKESAFDSELAL 555
+ + +G G+FG V + +VA+K R N + +E+A E+ +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARL-EINV 69
Query: 556 LSRV-------------------HHKHLVGLVGFCQEKDERLLVYEYMS-NGALHDHLHN 595
L ++ H H+ C + +E + N + L
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHM------C-------IAFELLGKN--TFEFL-- 112
Query: 596 KNNTEKNSSIVNSWKMRIR-IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA-- 652
K N + + +R +A + +LH + H D+K NIL +
Sbjct: 113 KENNFQPYPLP-----HVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETL 164
Query: 653 -----------------RVSDFGLSLLGSEC-DQEFISTKAVGTVGYIDPEYY----VMN 690
RV+DF GS D E +T + +Y V+
Sbjct: 165 YNEHKSCEEKSVKNTSIRVADF-----GSATFDHEHHTT-------IVATRHYRPPEVIL 212
Query: 691 VL--TAKTDIYGLGVVLLELLTGKKAVFKNED 720
L D++ +G +L E G +F+ +
Sbjct: 213 ELGWAQPCDVWSIGCILFEYYRG-FTLFQTHE 243
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 51/263 (19%), Positives = 94/263 (35%), Gaps = 75/263 (28%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVK--REESCPKTNKLREKESAFDSELALL 556
N F + K+G G+FG V + + + + AVK R N + SA E +L
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKI-EADIL 85
Query: 557 SRV-----HHKHLVGLVGFCQEKDERLLVYEYMS-NGALHDHLHNKNNTEKNSSIVNSWK 610
++ ++ ++V G D L++E + + L++ + N I
Sbjct: 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPS--LYEII--TRNNYNGFHIE---- 137
Query: 611 MRIR-IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL-------- 661
I+ ++ + ++YL S+ H D+K NILLD + + +
Sbjct: 138 -DIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 662 ------------LGSEC-DQEFISTKAVGTVGYI------DPEYYVMNVL-----TAKTD 697
G ++ + I PE V+ +D
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGS-------IINTRQYRAPE-----VILNLGWDVSSD 241
Query: 698 IYGLGVVLLELLTGKKAVFKNED 720
++ G VL EL TG +F+ +
Sbjct: 242 MWSFGCVLAELYTG-SLLFRTHE 263
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 54/267 (20%), Positives = 94/267 (35%), Gaps = 87/267 (32%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK--LMDGREVAVK--REESCPKTNKLREKESAFDSELAL 555
+ + + + +G G+FG V + GR VAVK + N R E+A E+ +
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARS-EIQV 64
Query: 556 LSRV-------------------HHKHLVGLVGFCQEKDERLLVYEYMS-NGALHDHLHN 595
L + HH H+ C +V+E + + +D +
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHI------C-------IVFELLGLS--TYDFI-- 107
Query: 596 KNNTEKNSSIVNSWKMRIR-IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654
K N + IR +A + +++LH+ + H D+K NIL +
Sbjct: 108 KENGFLPFRLD-----HIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA 159
Query: 655 SDFGLSL--------------LGSEC-DQEFISTKAVGTVGYIDPEYY----VMNVL--T 693
+ + GS D E ST + +Y V+ L +
Sbjct: 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHST-------LVSTRHYRAPEVILALGWS 212
Query: 694 AKTDIYGLGVVLLELLTGKKAVFKNED 720
D++ +G +L+E G VF D
Sbjct: 213 QPCDVWSIGCILIEYYLG-FTVFPTHD 238
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 812 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4d9s_A | 406 | UVB-resistance protein UVR8; UV resistance, UV-B p | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3mvd_K | 423 | Regulator of chromosome condensation; protein-DNA | 100.0 | |
| 3qhy_B | 282 | Beta-lactamase inhibitory protein II; enyzme-inhib | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1a12_A | 413 | RCC1, regulator of chromosome condensation 1; guan | 100.0 | |
| 3qhy_B | 282 | Beta-lactamase inhibitory protein II; enyzme-inhib | 100.0 | |
| 3kci_A | 389 | Probable E3 ubiquitin-protein ligase HERC2; WD40, | 100.0 | |
| 3of7_A | 473 | Regulator of chromosome condensation; beta-propell | 100.0 | |
| 3kci_A | 389 | Probable E3 ubiquitin-protein ligase HERC2; WD40, | 100.0 | |
| 3mvd_K | 423 | Regulator of chromosome condensation; protein-DNA | 100.0 | |
| 4d9s_A | 406 | UVB-resistance protein UVR8; UV resistance, UV-B p | 100.0 | |
| 1a12_A | 413 | RCC1, regulator of chromosome condensation 1; guan | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3of7_A | 473 | Regulator of chromosome condensation; beta-propell | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.71 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.71 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.4 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.53 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.35 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.3 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.74 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.69 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.81 | |
| 1p22_A | 435 | F-BOX/WD-repeat protein 1A; ubiquitination, degrad | 94.18 | |
| 1p22_A | 435 | F-BOX/WD-repeat protein 1A; ubiquitination, degrad | 93.57 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.51 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.74 | |
| 4gbf_A | 400 | Phikz131; 7-bladed beta-propeller, possibly partic | 92.3 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.2 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.89 | |
| 4gbf_A | 400 | Phikz131; 7-bladed beta-propeller, possibly partic | 88.08 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.66 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.19 | |
| 2ovr_B | 445 | FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 | 85.7 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=458.24 Aligned_cols=266 Identities=26% Similarity=0.418 Sum_probs=208.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
++|.+.++||+|+||+||+|+++ +++.||||++... .....+.|.+|+++|++|+|||||+++++|.++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 56888999999999999999874 4788999998642 233456799999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCc-------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEK-------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD 647 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~-------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~ 647 (812)
+..+||||||++|+|.++|+....... .....++|.++++|+.||++||+|||+++ ||||||||+||||+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEEC
Confidence 999999999999999999987643221 11234689999999999999999999988 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCch
Q 042346 648 VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLD 726 (812)
Q Consensus 648 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~ 726 (812)
+++++||+|||+++.....+.........||+.|||||++.+..|+.++|||||||+||||+| |+.||.... ..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~----~~- 267 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS----NT- 267 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC----HH-
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC----HH-
Confidence 999999999999987655444444556789999999999999999999999999999999999 899985432 11
Q ss_pred hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
.....+..+. ++..|. .+++.+.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 268 ---~~~~~i~~g~-------~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 268 ---EAIDCITQGR-------ELERPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HHHHHHHHTC-------CCCCCT----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HHHHHHHcCC-------CCCCcc----cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1222333332 222222 3445688999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=455.79 Aligned_cols=269 Identities=27% Similarity=0.432 Sum_probs=216.2
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
.++|.+.++||+|+||+||+|++. +++.||||++... ..+..++|.+|+++|++|+|||||+++++|.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 356899999999999999999874 4778999998642 13345679999999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCC-----CccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNT-----EKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
++..+||||||++|+|.++|+..... .......++|.++++|+.||++||+|||+++ ||||||||+||||++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGE 163 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECC
Confidence 99999999999999999999875421 1112234589999999999999999999998 999999999999999
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchh
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 727 (812)
++++||+|||+++.....+.........||+.|||||++.+..|+.++|||||||+||||+| |+.||.... .
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~----~--- 236 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS----N--- 236 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----H---
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----H---
Confidence 99999999999986555443334445679999999999999999999999999999999999 899985432 1
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcc
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 795 (812)
......+..+. ++..|. .+++.+.+|+.+||+.||++||||+||++.|+++.+..+
T Consensus 237 -~~~~~~i~~~~-------~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 237 -NEVIECITQGR-------VLQRPR----TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp -HHHHHHHHHTC-------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -HHHHHHHHcCC-------CCCCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 12223333332 112222 344568899999999999999999999999999877543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=449.05 Aligned_cols=269 Identities=29% Similarity=0.444 Sum_probs=207.0
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
...++|++.++||+|+||+||+|+++ ..||||+++... ...+..+.|.+|++++++++|||||++++++.+ +..
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~---~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVD---PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 34567899999999999999999874 369999986432 223445689999999999999999999998864 568
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+||||||++|+|.++|+.... .++|.++++|+.||++||+|||+++ ||||||||+||||++++++||+||
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~-------~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQET-------KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCC-------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCC
T ss_pred EEEEEcCCCCCHHHHHhhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeec
Confidence 999999999999999976432 2478899999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCcccccc---CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVM---NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|+|+...............||+.|||||++.+ .+|+.++|||||||+||||+||+.||..... . ......
T Consensus 177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----~---~~~~~~ 249 (307)
T 3omv_A 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----R---DQIIFM 249 (307)
T ss_dssp SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----H---HHHHHH
T ss_pred cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----H---HHHHHH
Confidence 99987655444444556789999999999863 4689999999999999999999999854321 1 111122
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
+..+.. .+.+ .....++++.+.+|+.+||+.||++||||.||+++|+.+....++
T Consensus 250 ~~~~~~----~p~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 250 VGRGYA----SPDL---SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp HHTTCC----CCCS---TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred HhcCCC----CCCc---ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 222211 1111 111234556788999999999999999999999999987655443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=451.53 Aligned_cols=264 Identities=23% Similarity=0.370 Sum_probs=212.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
+++++.++||+|+||+||+|++. +++.||||++.... .....++|.+|+.++++|+|||||+++++|.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~----~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA----EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C----CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc----ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 34778899999999999999873 46789999986422 123346799999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCC--------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTE--------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~--------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
+..+||||||++|+|.++|+...... ......++|..+++|+.|||+||+|||+++ ||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence 99999999999999999997654321 112234689999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCc
Q 042346 647 DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPL 725 (812)
Q Consensus 647 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~ 725 (812)
++++++||+|||+++.....+.........||+.|||||++.+..|+.++|||||||+||||+| |+.||.... ..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~----~~ 254 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----NQ 254 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC----HH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC----HH
Confidence 9999999999999987655444444556789999999999999999999999999999999999 888985422 11
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
+ ....+..+. +++.| .+++..+.+|+.+||+.||++||||+||+++|+..
T Consensus 255 ~----~~~~i~~~~-------~~~~p----~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 D----VVEMIRNRQ-------VLPCP----DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H----HHHHHHTTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H----HHHHHHcCC-------CCCCc----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 222333332 12222 23456688999999999999999999999999753
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=446.79 Aligned_cols=282 Identities=17% Similarity=0.262 Sum_probs=230.9
Q ss_pred ccceeEEeeCCceEEEEEeCCccceEEEccCCCcc------------c----CCCCccEEEEEccCceEEEEEeCCCeEE
Q 042346 31 SASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTI------------P----VLPNASFQAISGGQNYFCGLRSGGFSLH 94 (812)
Q Consensus 31 ~~~~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~~------------~----~~~~~~~~~i~~G~~~~~al~~~g~~v~ 94 (812)
...++.|++|..|+|+|.++| +++|||.|... | ...+.+|++|+||..|++||+.+|..||
T Consensus 15 ~~~v~~ia~G~~hs~al~~~g---~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~i~~va~G~~ht~al~~~gg~v~ 91 (406)
T 4d9s_A 15 PRKVLIISAGASHSVALLSGD---IVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQIVSVTCGADHTVAYSQSGMEVY 91 (406)
T ss_dssp CCCEEEEEECSSEEEEEETTT---EEEEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEETTTTEEE
T ss_pred ccceEEEecCCCeEEEEEeCC---EEEEEeCCCCCCCCCCCcccCcCCEEecccCCCCEEEEEeCcceEEEEECCCCEEE
Confidence 457899999999999999999 89999988752 1 1223479999999999999998753799
Q ss_pred EccCCCCCCCCCC-------CceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccCCC-------C
Q 042346 95 CWDTNDLTNFSFQ-------PKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSP-------G 160 (812)
Q Consensus 95 ~WG~n~~gqlg~~-------~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~~~-------~ 160 (812)
+||.|.+||||.. |.++..+...+|++|+||..|++||+ ++|+||+||.|.+||||.+...... .
T Consensus 92 ~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~ia~G~~h~~alt-~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~ 170 (406)
T 4d9s_A 92 SWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSHCLAVT-MEGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAF 170 (406)
T ss_dssp EEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEE-TTSCEEEEECCTTSTTCSSSCCCEEEEEECGGG
T ss_pred EEcCCCCcCCCCCCCCccccceEecccCCCCEEEEEEChhheEEEc-CCCcEEEeCCCCCccCCCCCCCCcccceEeccc
Confidence 9999999999954 44555555668999999999999998 9999999999999999987654331 1
Q ss_pred CCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCccc------------ccccCceEEEEEeCCceeEEEeeCCcEEEE
Q 042346 161 EDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQ------------RGFKNLSMVGLVAGESHACGLSRNGALVCK 228 (812)
Q Consensus 161 ~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~------------~~~~~~~~~~i~aG~~h~~al~~~G~v~~W 228 (812)
...+|++|+||..|+||| +++|+||+||.+..++... ..+...++++|+||..|+++|+++|+||+|
T Consensus 171 ~~~~i~~va~G~~hs~al-t~~G~v~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~i~~va~G~~ht~~l~~~G~v~~w 249 (406)
T 4d9s_A 171 EGIRIKMVAAGAEHTAAV-TEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVSYSGALYTY 249 (406)
T ss_dssp TTCCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTCSSSSCCEEEEEECCCSTTCCEEEEEECSSEEEEEETTCCEEEE
T ss_pred CCCcEEEEecCCCeEEEE-eCCCCEEEeeCCCCCCCCCCCCCCcCccEEecccCCceEEEEEECCCcEEEEcCCCCEEEe
Confidence 235799999999999999 8999999999977665421 122346799999999999999999999999
Q ss_pred ecCCCCCCCcCCC-----------CcceeeeeeeeccceeEEEEecCCeEEEecCCCCCccccCCc------------cc
Q 042346 229 GSNDSGQLNVPFS-----------SAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVI------------QD 285 (812)
Q Consensus 229 G~n~~gqlg~~~~-----------~~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~~------------~~ 285 (812)
|.|.+||||.... .....+.+|+||.+|++||+. ||+||+||+|.+||||.+.. ..
T Consensus 250 G~n~~GqlG~g~~~~~~~p~~v~~~~~~~v~~i~~G~~hs~alt~-~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~ 328 (406)
T 4d9s_A 250 GWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALTS-DGKLYGWGWNKFGQVGVGNNLDQCSPVQVRFPDD 328 (406)
T ss_dssp ECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEET-TSCEEEEECCTTSTTCSSSSSCEEEEEEECCGGG
T ss_pred eCCCCCCCCCCCCcCccccEEecccCCCCEEEEEecCCEEEEEcC-CCeEEEeeCCCCCCCCCCCCCCCccCEEEeccCC
Confidence 9999999984221 111112369999999999996 69999999999999987322 22
Q ss_pred cceeEEEeccceEEEEEcCCCeEEEecCCCCCCC
Q 042346 286 VSFESIVAGLDFVCGLTTRNLSMICWGPGWSNKP 319 (812)
Q Consensus 286 ~~~~~i~ag~~~~c~~~~~~~~v~cWG~~~~~~~ 319 (812)
..+.+|++|..|+++++. +++||+||+|..++.
T Consensus 329 ~~v~~va~G~~hs~alt~-~G~v~~wG~n~~GqL 361 (406)
T 4d9s_A 329 QKVVQVSCGWRHTLAVTE-RNNVFAWGRGTNGQL 361 (406)
T ss_dssp CCEEEEEECSSEEEEEET-TSCEEEEECCTTSTT
T ss_pred CcEEEEEeCCCeEEEEeC-CCCEEEecCCCCCcc
Confidence 367899999999999985 779999999866654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=447.17 Aligned_cols=280 Identities=24% Similarity=0.367 Sum_probs=223.2
Q ss_pred CCHHHHHHhcCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC-CC
Q 042346 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHH-KH 563 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~n 563 (812)
+..++++...++|++.++||+|+||+||+|++.. ++.||||++.... .....+.|.+|+++|.+++| ||
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~----~~~~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----ChHHHHHHHHHHHHHHHcCCCCc
Confidence 4456677778899999999999999999998743 3579999986422 23345679999999999965 89
Q ss_pred ceEEEEEEEeC-CeEEEEEEecCCCchhhhhhcCCCCC--------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042346 564 LVGLVGFCQEK-DERLLVYEYMSNGALHDHLHNKNNTE--------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSI 634 (812)
Q Consensus 564 Iv~l~~~~~~~-~~~~lV~ey~~~gsL~~~l~~~~~~~--------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~i 634 (812)
||+++++|.+. +..+||||||++|+|.++|+...... ......++|..++.++.|||+||+|||+++ |
T Consensus 130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i 206 (353)
T 4ase_A 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 206 (353)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence 99999999765 46899999999999999998654311 111234689999999999999999999998 9
Q ss_pred EeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCC
Q 042346 635 IHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK 713 (812)
Q Consensus 635 vHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~ 713 (812)
|||||||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 9999999999999999999999999987655444444556689999999999999999999999999999999998 899
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 714 AVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 714 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
||...... +.....+..+. ++..|.. ++..+.+|+.+||+.||++|||+.||+++|+++++.
T Consensus 287 Pf~~~~~~-------~~~~~~i~~g~-------~~~~p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 287 PYPGVKID-------EEFCRRLKEGT-------RMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp SSTTCCCS-------HHHHHHHHHTC-------CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHH-------HHHHHHHHcCC-------CCCCCcc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 98543211 11222233322 2222322 344578899999999999999999999999999876
Q ss_pred cc
Q 042346 794 CQ 795 (812)
Q Consensus 794 ~~ 795 (812)
..
T Consensus 349 ~~ 350 (353)
T 4ase_A 349 NA 350 (353)
T ss_dssp TC
T ss_pred hh
Confidence 43
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=443.51 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=202.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|+++++||+|+||+||+|++. +++.||||++..... .....+.|.+|+++|++|+|||||++++++++++..||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM---SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC---CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 57999999999999999999975 589999999865322 22345678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.++|....... ++..+.+.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~------~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVL------FQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCC------CCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTE
T ss_pred EEeCCCCCcHHHHHHHcCCCC------CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccc
Confidence 999999999999997654322 245666789999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
|+...... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.... .......+..+.
T Consensus 172 a~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~ 241 (350)
T 4b9d_A 172 ARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIISGS 241 (350)
T ss_dssp ESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTC
T ss_pred ceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCC
Confidence 98764321 22345679999999999999999999999999999999999999995432 112223333332
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ....++..+.+||.+||+.||++|||++|++++
T Consensus 242 ~~~-----------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 FPP-----------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCC-----------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 211 112344568899999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=437.08 Aligned_cols=272 Identities=27% Similarity=0.380 Sum_probs=205.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC----e
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD----E 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~ 576 (812)
++|.+.++||+|+||+||+|++ +|+.||||++... ......++.|+..+.+++|||||++++++.+++ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 4688999999999999999998 6899999998641 112223445777778899999999999998764 5
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcC-----CCCeEeeccCCCCEEEcCCCc
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYA-----VPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~-----~~~ivHrDlKp~NILl~~~~~ 651 (812)
.+||||||++|+|.++|+... ++|..+++++.|+++||+|||++. .|+||||||||+||||+.+++
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~---------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~ 146 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYT---------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCC---------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred EEEEecCCCCCcHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence 799999999999999997643 378899999999999999999872 245999999999999999999
Q ss_pred EEEEeecccccCCCCccc--ccccccccCCCccCccccccC------cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 652 ARVSDFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVMN------VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
+||+|||+++........ .......||+.|||||++.+. .++.++|||||||+||||+||+.|+........
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 999999999765433221 123346799999999998754 478899999999999999999888754332222
Q ss_pred Cch-------hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 724 PLD-------VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 724 ~~~-------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+.. ..+.....+..+.+ ++.++ ......+.++.+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~----rp~~p-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRKVVCEQKL----RPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCC----CCCCC-GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchhcccccchHHHHHHHHhcccC----CCCCC-ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 211 11222222222211 11111 1112246677899999999999999999999999999997653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=441.37 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=205.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+.|++.++||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+++|+.++|||||+++++|++++..||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56999999999999999999985 589999999864221 123457889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++.... +++.....++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 149 vmEy~~gg~L~~~l~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl 216 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHTR---------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGF 216 (346)
T ss_dssp EECCCTTEEHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEeCCCCCcHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcC
Confidence 999999999999997543 256677899999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++....... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ..+ ....+..+.
T Consensus 217 a~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~----~~~~i~~~~ 286 (346)
T 4fih_A 217 CAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLK----AMKMIRDNL 286 (346)
T ss_dssp CEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHH----HHHHHHHSS
T ss_pred ceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHH----HHHHHHcCC
Confidence 987654222 2345789999999999999999999999999999999999999995432 111 122222211
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.......+++.+.+|+.+||..||++|||++|++++
T Consensus 287 ---------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 287 ---------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp ---------CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111223455678899999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=423.91 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=198.0
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe----CCeE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE----KDER 577 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~ 577 (812)
|++.++||+|+||+||+|++. +++.||+|++.... ......+.|.+|++++++|+|||||+++++|++ ++..
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 467789999999999999985 58899999986422 223345679999999999999999999999875 2357
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC-CCcEEEEe
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARVSD 656 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~D 656 (812)
|||||||++|+|.++|+.... +++...+.++.||++||+|||+++ ++||||||||+||||+. ++.+||+|
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~--------l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~D 175 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKV--------MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEe
Confidence 999999999999999976532 366778899999999999999987 56999999999999974 79999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||+|+..... ......||+.|||||++.+ .|+.++|||||||+||||+||+.||..... .......+.
T Consensus 176 FGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i~ 243 (290)
T 3fpq_A 176 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVT 243 (290)
T ss_dssp TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHT
T ss_pred CcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHHH
Confidence 9999764331 2345689999999998865 699999999999999999999999954321 111222222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.....+ +...+..+.+|+.+||..||++|||++|+++|
T Consensus 244 ~~~~~~~~----------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 244 SGVKPASF----------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTCCCGGG----------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCCCCC----------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22211111 12223458899999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=432.34 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=207.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||+||+|++. +++.||||++... .....+..+.+.+|+++|++|+|||||+++++|++++..||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~--~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHH--HCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45999999999999999999874 5899999998631 11122345678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.++|...... +......++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 110 vmEy~~gG~L~~~i~~~~~l--------~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSF--------DETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSC--------CHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEecCCCCCHHHHHHHcCCC--------CHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 99999999999999765432 44566789999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
|+..............+||+.|||||++.+..|+.++|||||||+||||++|+.||.... .......+..+.
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~ 250 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKLE 250 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC
Confidence 987765444444556789999999999999999999999999999999999999995432 112233333332
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
+ ..+. ..++.+++||.+||..||++|||++|++.
T Consensus 251 ~--------~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 Y--------DFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp C--------CCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred C--------CCCc----ccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 2 1122 23445789999999999999999998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=433.96 Aligned_cols=258 Identities=22% Similarity=0.242 Sum_probs=207.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+.|++.++||+|+||+||+|+++ +|+.||||++.... .+.+|+++++.|+|||||++++++++++..||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----------FRVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46888999999999999999985 58999999986421 12469999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC-cEEEEeec
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW-TARVSDFG 658 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DfG 658 (812)
||||+++|+|.++|+.... +++...+.++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||
T Consensus 128 vmEy~~gg~L~~~l~~~~~--------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFG 196 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGC--------LPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFG 196 (336)
T ss_dssp EECCCTTCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCT
T ss_pred EEeccCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCC
Confidence 9999999999999976542 356778899999999999999998 99999999999999997 69999999
Q ss_pred ccccCCCCccc---ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 659 LSLLGSECDQE---FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 659 la~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
+|+........ ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...... .+... +
T Consensus 197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~----i 268 (336)
T 4g3f_A 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG----PLCLK----I 268 (336)
T ss_dssp TCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS----CCHHH----H
T ss_pred CCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----HHHHH----H
Confidence 99876543221 1223457999999999999999999999999999999999999999654322 12221 1
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
..+... . .. .+..++..+.+|+.+||++||++|||+.|++++|+++++....
T Consensus 269 ~~~~~~-~--~~------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 269 ASEPPP-I--RE------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp HHSCCG-G--GG------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred HcCCCC-c--hh------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 222110 0 00 1123456688999999999999999999999999999886543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=414.04 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=190.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||+||+|++. +++.||||++.... ....+....+.+|++++++++|||||++++++++++..||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKV--LAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHH--cCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 68999999986422 1223345678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+ +|+|.++|..+.. ++......++.||+.||+|||+++ |+||||||+|||+++++++||+|||+
T Consensus 91 vmEy~-~g~L~~~l~~~~~--------l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDK--------MSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp EEECC-CEEHHHHHHHSCS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred EEeCC-CCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCC
Confidence 99999 6899999976543 255677899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcC-CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
|+...... ......||+.|||||++.+..| +.++|||||||+||||+||+.||.... .......+..+
T Consensus 159 a~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~~i~~~ 227 (275)
T 3hyh_A 159 SNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFKNISNG 227 (275)
T ss_dssp C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHT
T ss_pred CeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcC
Confidence 97654322 2345689999999999998876 579999999999999999999995422 11222333333
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ..+. ..++.+.+|+.+||+.||++|||++|++++
T Consensus 228 ~~--------~~p~----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 228 VY--------TLPK----FLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CC--------CCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CC--------CCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 21 1121 234567899999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=439.72 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=205.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.+.|++.++||+|+||.||+|+++ +|+.||||++..... ...+.+.+|+++|+.|+|||||+++++|++++..|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-----hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence 356999999999999999999985 589999999864322 12345789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
||||||++|+|.+++.... ++..+...|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||
T Consensus 225 iVmEy~~gG~L~~~i~~~~---------l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFG 292 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHTR---------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG 292 (423)
T ss_dssp EEEECCTTEEHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCT
T ss_pred EEEeCCCCCcHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCc
Confidence 9999999999999997543 255677889999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+++....... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ... ....+..+
T Consensus 293 la~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~----~~~~i~~~ 362 (423)
T 4fie_A 293 FCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLK----AMKMIRDN 362 (423)
T ss_dssp TCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHH----HHHHHHHS
T ss_pred cceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHH----HHHHHHcC
Confidence 9987654222 2345689999999999999999999999999999999999999995432 111 22222222
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. ...+.. ...++..+.+||.+||..||++|||++|+++|
T Consensus 363 ~-----~~~~~~----~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 363 L-----PPRLKN----LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp C-----CCCCSC----TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C-----CCCCcc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 111111 12344568899999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=421.08 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=195.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
++|++.+.||+|+||+||+|+.. .++.||||++........ ....+.+|+++|++++|||||++++++++++.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE---ECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH---HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 46999999999999999999863 468899999864322111 12357789999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.||||||+++|+|.++|..... ++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~--------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVM--------FTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEES
T ss_pred EEEEEEcCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecc
Confidence 9999999999999999976543 255667889999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||+|+...... .......||+.|||||++.+..|+.++|||||||+||||+||+.||.... . ......+.
T Consensus 170 FGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~----~----~~~~~~i~ 239 (304)
T 3ubd_A 170 FGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD----R----KETMTMIL 239 (304)
T ss_dssp SEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----H----HHHHHHHH
T ss_pred cccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC----H----HHHHHHHH
Confidence 99998644322 22345689999999999999999999999999999999999999995432 1 11222333
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 786 (812)
.+. ...|. ..+..+.+|+.+||+.||++||| ++|+++|
T Consensus 240 ~~~--------~~~p~----~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 240 KAK--------LGMPQ----FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HCC--------CCCCT----TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred cCC--------CCCCC----cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 332 11222 23455789999999999999998 5788764
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=427.82 Aligned_cols=280 Identities=16% Similarity=0.106 Sum_probs=223.7
Q ss_pred cceeEEeeCCceEEEEEeCCccceEEEccCCCccc---------------CCCCccEEEEEccCceEEEEEeCCCeEEEc
Q 042346 32 ASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIP---------------VLPNASFQAISGGQNYFCGLRSGGFSLHCW 96 (812)
Q Consensus 32 ~~~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~~~---------------~~~~~~~~~i~~G~~~~~al~~~g~~v~~W 96 (812)
..+..|++|..|+|++..+| .|+|||.|...+ +....++++|+||..|+|+|+.|| .||+|
T Consensus 24 ~~~~~ia~g~~~~~~l~~~G---~v~~wG~n~~GqLG~g~~~~~~~~p~~v~~l~~v~~va~G~~h~~~l~~~G-~v~~w 99 (423)
T 3mvd_K 24 AKRARIAFHLELPKRRTVLG---NVLVCGNGDVGQLGLGEDILERKRLSPVAGIPDAVDISAGGMHNLVLTKSG-DIYSF 99 (423)
T ss_dssp -----CCCCCCCCCCCCCCE---EEEEEEECTTSTTCSCSSCCEEEEEEECCSCSSEEEEEECSSEEEEEETTS-CEEEE
T ss_pred ceeeEEecCCccceeecCCC---cEEEEeCCCCCCCCCCCCCccCcCCeEccCCCCceEEeeCCCeEEEEeCCC-eEEEe
Confidence 34667999999999999999 899999876421 222237999999999999999999 79999
Q ss_pred cCCCCCCCCCC-------CceecccCCceEEEEEccCceEEEEEeCCCeEEEecC--CCCCCCCCCcccCC-----CCCC
Q 042346 97 DTNDLTNFSFQ-------PKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRG--TKVKDKGQLFSFSS-----PGED 162 (812)
Q Consensus 97 G~n~~gqlg~~-------~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~--n~~gqlG~~~~~~~-----~~~~ 162 (812)
|.|.+||||.. ..|..+....+|++|+||..|++||+ +||+||+||. |.+||||.+..... ....
T Consensus 100 G~n~~GqLG~~~~~~~~~~~P~~v~~~~~i~~va~G~~hs~al~-~~G~v~~wG~~~n~~GqlG~~~~~~~~~p~~~~~~ 178 (423)
T 3mvd_K 100 GCNDEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACLL-EDGRVFAWGSFRDSHGNMGLTIDGNKRTPIDLMEG 178 (423)
T ss_dssp ECCSSSTTCSCCCSTTSSSSCEECCCSSCEEEEEECSSEEEEEE-TTSCEEEEECEECSSSEEESBTTBCEEEEEESSTT
T ss_pred ECCCCcCCCCCCcCCccccCCeEEcCCCCEEEEEcCcCeEEEEe-CCCeEEEEeCCCCCCCCcCcCCCCCCceeeEecCC
Confidence 99999999954 22333333458999999999999998 9999999999 99999997754432 2234
Q ss_pred CceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccc-----------------------cccCceEEEEEeCCceeEEE
Q 042346 163 LKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQR-----------------------GFKNLSMVGLVAGESHACGL 219 (812)
Q Consensus 163 ~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~-----------------------~~~~~~~~~i~aG~~h~~al 219 (812)
.+|++|+||..|+||| +++|+||+||.|..+|.... ......|++|+||..|++++
T Consensus 179 ~~i~~va~G~~hs~al-t~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~p~~v~~~~~~~v~~i~~g~~~~~~~ 257 (423)
T 3mvd_K 179 TVCCSIASGADHLVIL-TTAGKVFTVGCAEQGQLGRLSERSISGEGRRGKRDLLRPTQLIITRAKPFEAIWATNYCTFMR 257 (423)
T ss_dssp CCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTSSCCTTTTTSCSTTTTTTTSSCEEECCTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEecCCCeEEEE-ecCCeEEEeeCCcCCccCCCcccccccccccccccccCCeEEeecCCccEEEEEECCcEEEEE
Confidence 6899999999999999 89999999999766654321 11235689999999999999
Q ss_pred -eeCCcEEEEecCCCCCCCcCC-C---------CcceeeeeeeeccceeEEEEecCCeEEEecCCCCCccccCCcccc--
Q 042346 220 -SRNGALVCKGSNDSGQLNVPF-S---------SAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDV-- 286 (812)
Q Consensus 220 -~~~G~v~~WG~n~~gqlg~~~-~---------~~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~~~~~-- 286 (812)
+++|+||+||.|.+||||... . .....+..|+||.+|+|||+. +|+||+||+|.+||||.+...+.
T Consensus 258 ~~~~g~v~~wG~n~~gqlg~~~~~~~~~~~p~~~~~~~v~~ia~G~~ht~alt~-~G~v~~wG~n~~GqLG~g~~~~~~~ 336 (423)
T 3mvd_K 258 ESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRHIAGGQHHTVILTT-DLKCSVVGRPEYGRLGLGDVKDVVE 336 (423)
T ss_dssp ETTTCCEEEEEECTTCTTSSCCTTCSEEEEEEEECCCSEEEEEECSSEEEEEET-TCCEEEEECCGGGTTCSSSCCSCEE
T ss_pred ECCCCeEEEEeCCCCCcCCCCCCCCceeeeeEEcCCCCeEEEEcccCeEEEEeC-CCcEEEEECCCCCCCCCCCcccccc
Confidence 699999999999999999621 1 111223369999999999996 69999999999999998432221
Q ss_pred ----------ceeEEEeccceEEEEEcCCCeEEEecCCCCCCC
Q 042346 287 ----------SFESIVAGLDFVCGLTTRNLSMICWGPGWSNKP 319 (812)
Q Consensus 287 ----------~~~~i~ag~~~~c~~~~~~~~v~cWG~~~~~~~ 319 (812)
.+.+|++|..|+|+++ ++|+|||||.|..++.
T Consensus 337 ~p~~v~~l~~~v~~ia~G~~hs~alt-~~G~v~~wG~n~~GqL 378 (423)
T 3mvd_K 337 KPTIVKKLTEKIVSVGCGEVCSYAVT-IDGKLYSWGSGVNNQL 378 (423)
T ss_dssp EEEECTTCCSCEEEEEEETTEEEEEE-TTSCEEEEECCTTSCS
T ss_pred CceEeccCCCCEEEEEcCCCeEEEEc-CCCCEEEECCCCCCCC
Confidence 5789999999999997 4789999999866543
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=396.09 Aligned_cols=241 Identities=20% Similarity=0.312 Sum_probs=208.1
Q ss_pred eEEEccCCCc-----ccCCCCccEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCCCCceecccCCceEEEEEccCceE
Q 042346 55 RIQCYQNGST-----IPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVGGDQV 129 (812)
Q Consensus 55 ~~~~~g~~~~-----~~~~~~~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~~~~~~~~~~~~~v~~ia~G~~h~ 129 (812)
.|.|||.|.. .|+....+|++|++|..|+++|+ || .||+||.|.+||||.+.. ...+|++|++|..|+
T Consensus 3 ~v~~WG~n~~~~~~~~p~~~~~~i~~ia~G~~h~~~l~-~G-~v~~wG~n~~Gqlg~p~~-----~~~~i~~ia~G~~hs 75 (282)
T 3qhy_B 3 SVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLALK-GG-KVLGWGANLNGQLTMPAA-----TQSGVDAIAAGNYHS 75 (282)
T ss_dssp EEEEECSCCTTSTTCCCGGGSSSCCEEEECSSEEEEEE-TT-EEEEEECCSSSTTSCCGG-----GGSCCCEEEECSSEE
T ss_pred EEEEeCCCCCcCcccCCccccCCCcEEEeCCCeEEEEE-CC-EEEEEeCCCCCCCCCCcc-----CCCCEEEEEeCCCEE
Confidence 6899997743 23333448999999999999998 99 899999999999996432 234799999999999
Q ss_pred EEEEeCCCeEEEecCCCCCCCCCCcccCCCCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccccccCceEEEE
Q 042346 130 CAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQRGFKNLSMVGL 209 (812)
Q Consensus 130 ~al~~~~g~v~~WG~n~~gqlG~~~~~~~~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~~~~~~~~~~i 209 (812)
+|| + ||+||+||.|.+||||.... ...+|++|+||..|+|+| + +|+||+||.+..++.+.+.....+|++|
T Consensus 76 ~~l-~-~G~v~~wG~n~~Gqlg~P~~-----~~~~v~~ia~G~~hs~al-~-~G~v~~wG~n~~gqlg~~~~~~~~i~~i 146 (282)
T 3qhy_B 76 LAL-K-DGEVIAWGGNEDGQTTVPAE-----ARSGVDAIAAGAWASYAL-K-DGKVIAWGDDSDGQTTVPAEAQSGVTAL 146 (282)
T ss_dssp EEE-E-TTEEEEEECCTTSTTCCCGG-----GSSSEEEEEEETTEEEEE-E-TTEEEEEECCTTSTTSCCGGGGSSEEEE
T ss_pred EEE-E-CCEEEEeeCCCCCCCCCCcc-----cCCCeEEEECcCCEEEEE-e-CCeEEEecCCCCCcCCCCccCCCCeEEE
Confidence 999 4 89999999999999996322 125799999999999999 8 9999999999888887666667789999
Q ss_pred EeCCceeEEEeeCCcEEEEecCCCCCCCcCCCCcceeeeeeeeccceeEEEEecCCeEEEecCCCCCccccCCcccccee
Q 042346 210 VAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFE 289 (812)
Q Consensus 210 ~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~~~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~~~~~~~~ 289 (812)
+||..|+++|+ ||+||+||.|.+||||.|........ .|+||.+|++|| + +|+||+||.|.+||||.+......+.
T Consensus 147 ~~G~~~~~~l~-~G~v~~wG~n~~gqlg~p~~~~~~v~-~i~~G~~hs~al-~-~G~v~~wG~n~~gqlg~p~~~~~~v~ 222 (282)
T 3qhy_B 147 DGGVYTALAVK-NGGVIAWGDNYFGQTTVPAEAQSGVD-DVAGGIFHSLAL-K-DGKVIAWGDNRYKQTTVPTEALSGVS 222 (282)
T ss_dssp EECSSEEEEEE-TTEEEEEECCTTSTTSCCGGGGSSEE-EEEECSSEEEEE-E-TTEEEEEECCTTSTTCCCGGGGSSCC
T ss_pred EcccCEEEEEE-CCEEEEecCCCCCCCCCceecCCCeE-EEEecCCEEEEE-E-CCeEEEEECCCCCCCCCCcccCCCce
Confidence 99999999999 89999999999999998876544444 599999999999 6 59999999999999998776667899
Q ss_pred EEEeccceEEEEEcCCCeEEEecCCCCC
Q 042346 290 SIVAGLDFVCGLTTRNLSMICWGPGWSN 317 (812)
Q Consensus 290 ~i~ag~~~~c~~~~~~~~v~cWG~~~~~ 317 (812)
+|++|..|+|+++ +++||+||.|...
T Consensus 223 ~i~~G~~h~~al~--~g~v~~wG~n~~g 248 (282)
T 3qhy_B 223 AIASGEWYSLALK--NGKVIAWGSSRTA 248 (282)
T ss_dssp EEEECSSCEEEEE--TTEEEEESTTCCC
T ss_pred EEEcCCCEEEEEE--CCEEEEecCCCCc
Confidence 9999999999998 6799999987544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=408.63 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=188.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe---
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE--- 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~--- 576 (812)
++|++.+.||+|+||+||+|+++ +++.||||++.... .....+.+.+|+++|++|+|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 35899999999999999999975 68999999986432 12334578899999999999999999999876543
Q ss_pred ---------EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc
Q 042346 577 ---------RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD 647 (812)
Q Consensus 577 ---------~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~ 647 (812)
.||||||+++|+|.+++........ ..+...++|+.||+.||+|||+++ |+||||||+||||+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~-----~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~ 152 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-----RERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFT 152 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGG-----SCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCCh-----hHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEEC
Confidence 6899999999999999987654322 245567789999999999999998 99999999999999
Q ss_pred CCCcEEEEeecccccCCCCcccc----------cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCC
Q 042346 648 VNWTARVSDFGLSLLGSECDQEF----------ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 648 ~~~~~kl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 717 (812)
.++.+||+|||+|+......... .....+||+.|||||++.+..|+.++|||||||+||||++ ||..
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999999999998765432211 1234579999999999999999999999999999999996 6632
Q ss_pred CCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 718 NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. +.. .....+.... .|. ...+....+.+|+.+||+.||++|||+.|++++
T Consensus 230 ~~------~~~-~~~~~~~~~~----------~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 230 QM------ERV-RTLTDVRNLK----------FPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH------HHH-HHHHHHHTTC----------CCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc------HHH-HHHHHHhcCC----------CCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 111 1111111111 111 123344456789999999999999999999874
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=420.94 Aligned_cols=274 Identities=16% Similarity=0.186 Sum_probs=219.9
Q ss_pred EEeeCCceEEEEEeCCccceEEEccCCCcc-------------c--CCCCccEEEEEccCceEEEEEeCCCeEEEccCCC
Q 042346 36 AIIYKTSTVCGIIAGESIQRIQCYQNGSTI-------------P--VLPNASFQAISGGQNYFCGLRSGGFSLHCWDTND 100 (812)
Q Consensus 36 ~~~~g~~~~c~l~~~g~~~~~~~~g~~~~~-------------~--~~~~~~~~~i~~G~~~~~al~~~g~~v~~WG~n~ 100 (812)
+.+.+..|+|+|..+| .+++||.|... | +....+|++|+||..|+++|+.+| .||+||.|.
T Consensus 12 ~~~~~~~h~~~l~~~g---~v~~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~i~~va~G~~hs~~l~~~G-~v~~wG~n~ 87 (413)
T 1a12_A 12 SKKVKVSHRSHSTEPG---LVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKSG-QVYSFGCND 87 (413)
T ss_dssp -CCCCCCCTTCCCCCB---EEEEEEECTTSTTCSCTTCCEEEEEEEECCSSCEEEEEECSSEEEEEETTS-CEEEEECCT
T ss_pred hhhhccccceeecCCC---cEEEEECCCCCcCCCCCCccccccceEccCCCCeEEEEeCCCeEEEEcCCC-CEEEEECCC
Confidence 4556688999999999 89999987542 2 222358999999999999999999 799999999
Q ss_pred CCCCCCC---------CceecccCCceEEEEEccCceEEEEEeCCCeEEEecC--CCCCCCCCCcccCC------CCCCC
Q 042346 101 LTNFSFQ---------PKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRG--TKVKDKGQLFSFSS------PGEDL 163 (812)
Q Consensus 101 ~gqlg~~---------~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~--n~~gqlG~~~~~~~------~~~~~ 163 (812)
+||||.. |..+.+ ..+|++|+||..|++||+ +||+||+||. |.+||||.+..... .....
T Consensus 88 ~GqLG~~~~~~~~~~~P~~v~l--~~~i~~va~G~~hs~alt-~~G~v~~wG~~~n~~GqlG~~~~~~~~~~P~~v~~~~ 164 (413)
T 1a12_A 88 EGALGRDTSVEGSEMVPGKVEL--QEKVVQVSAGDSHTAALT-DDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDV 164 (413)
T ss_dssp TSTTCSCCCSTTGGGSCEECCC--CSCEEEEEECSSEEEEEE-TTSCEEEEECEEETTEEEESSBBTBCEEEEEEECCSS
T ss_pred CCCCCCCCCCCccccCCeEecC--CCcEEEEecCCCeEEEEc-CCCcEEEeeCCcCCCCccCcCCccccccCCEEecCCC
Confidence 9999954 233322 348999999999999998 9999999999 99999997654321 12346
Q ss_pred ceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccc---------------------c-c------cCceEEEEEeCCce
Q 042346 164 KFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQR---------------------G-F------KNLSMVGLVAGESH 215 (812)
Q Consensus 164 ~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~---------------------~-~------~~~~~~~i~aG~~h 215 (812)
+|++|+||..|+|+| +++|+||+||.|..+|.... . . ...+|++|+||..|
T Consensus 165 ~i~~ia~G~~hs~al-t~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~P~~v~~~~~g~~~~~~i~~ia~G~~h 243 (413)
T 1a12_A 165 PVVKVASGNDHLVML-TADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYF 243 (413)
T ss_dssp CEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTE
T ss_pred CEEEEEecCceEEEE-cCCCCEEEeeCCCCCccCCCccccccccccccccccccCceEeeccccccCCccEEEEEeCCCE
Confidence 899999999999999 89999999999876654211 0 0 23569999999999
Q ss_pred eEEEeeCCcEEEEecCCCCCCCcCCC--------C-cc----eeeeeeeeccceeEEEEecCCeEEEecCCCCCccccCC
Q 042346 216 ACGLSRNGALVCKGSNDSGQLNVPFS--------S-AF----EFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDV 282 (812)
Q Consensus 216 ~~al~~~G~v~~WG~n~~gqlg~~~~--------~-~~----~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~ 282 (812)
++||+++|+||+||.|.+||||.... . .+ ..+..|+||.+|++||+. +|+||+||.|.+||||.+.
T Consensus 244 s~alt~~G~v~~wG~n~~gqLG~~~~~~~~~P~~v~~l~~~~~~v~~ia~G~~hs~al~~-~G~v~~wG~n~~GqLG~g~ 322 (413)
T 1a12_A 244 TFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDS-EGKAYSLGRAEYGRLGLGE 322 (413)
T ss_dssp EEEEETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEEECSSEEEEEET-TSCEEEEECCGGGTTCSCT
T ss_pred EEEEeCCCCEEEEeCCCCcCCCCCCCCcccccEEchhccCCCceEEEEecccceEEEEeC-CCCEEEeeCCCCCccCCCC
Confidence 99999999999999999999994221 1 01 113369999999999996 6999999999999999741
Q ss_pred -------ccc----cceeEEEeccceEEEEEcCCCeEEEecCCCCCCC
Q 042346 283 -------IQD----VSFESIVAGLDFVCGLTTRNLSMICWGPGWSNKP 319 (812)
Q Consensus 283 -------~~~----~~~~~i~ag~~~~c~~~~~~~~v~cWG~~~~~~~ 319 (812)
|.. ..+.+|++|..|+++++. +++||+||.|..++.
T Consensus 323 ~~~~~~~P~~v~~l~~v~~v~~G~~hs~alt~-~G~v~~wG~n~~gqL 369 (413)
T 1a12_A 323 GAEEKSIPTLISRLPAVSSVACGASVGYAVTK-DGRVFAWGMGTNYQL 369 (413)
T ss_dssp TCCCEEEEEECCSSSSEEEEEECSSEEEEEET-TSCEEEEECCTTSTT
T ss_pred CCccccCCEEecccCceeEEEECcceEEEEeC-CCCEEEecCCCCCCC
Confidence 111 167899999999999985 779999999865543
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=390.22 Aligned_cols=246 Identities=17% Similarity=0.242 Sum_probs=211.3
Q ss_pred ccceeEEeeCCceEEEEEeCCccceEEEccCCCccc----CCCCccEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCC
Q 042346 31 SASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIP----VLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSF 106 (812)
Q Consensus 31 ~~~~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~~~----~~~~~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~ 106 (812)
...++.|++|..|+|+|. +| .+++||.|...+ .....+|++|+||..|+++|+ || .||+||.|.+||||.
T Consensus 23 ~~~i~~ia~G~~h~~~l~-~G---~v~~wG~n~~Gqlg~p~~~~~~i~~ia~G~~hs~~l~-~G-~v~~wG~n~~Gqlg~ 96 (282)
T 3qhy_B 23 QSGVDAIAGGYFHGLALK-GG---KVLGWGANLNGQLTMPAATQSGVDAIAAGNYHSLALK-DG-EVIAWGGNEDGQTTV 96 (282)
T ss_dssp SSSCCEEEECSSEEEEEE-TT---EEEEEECCSSSTTSCCGGGGSCCCEEEECSSEEEEEE-TT-EEEEEECCTTSTTCC
T ss_pred cCCCcEEEeCCCeEEEEE-CC---EEEEEeCCCCCCCCCCccCCCCEEEEEeCCCEEEEEE-CC-EEEEeeCCCCCCCCC
Confidence 346889999999999997 88 899999987743 323348999999999999996 99 899999999999996
Q ss_pred CCceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccCCCCCCCceEEEeecCCeEEEEEccCCeEE
Q 042346 107 QPKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVF 186 (812)
Q Consensus 107 ~~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~~~~~~~~~~~ia~G~~h~cal~~~~g~v~ 186 (812)
| .++ ..+|++|++|..|++||+ +|+||+||.|.+||||... ....+|++|+||..|+|+| + ||+||
T Consensus 97 P-~~~----~~~v~~ia~G~~hs~al~--~G~v~~wG~n~~gqlg~~~-----~~~~~i~~i~~G~~~~~~l-~-~G~v~ 162 (282)
T 3qhy_B 97 P-AEA----RSGVDAIAAGAWASYALK--DGKVIAWGDDSDGQTTVPA-----EAQSGVTALDGGVYTALAV-K-NGGVI 162 (282)
T ss_dssp C-GGG----SSSEEEEEEETTEEEEEE--TTEEEEEECCTTSTTSCCG-----GGGSSEEEEEECSSEEEEE-E-TTEEE
T ss_pred C-ccc----CCCeEEEECcCCEEEEEe--CCeEEEecCCCCCcCCCCc-----cCCCCeEEEEcccCEEEEE-E-CCEEE
Confidence 3 332 347999999999999997 8999999999999998532 2336799999999999998 6 89999
Q ss_pred EeecCCCCCcccccccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCCCCcceeeeeeeeccceeEEEEecCCe
Q 042346 187 CWGDSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGL 266 (812)
Q Consensus 187 ~WG~~~~~~~~~~~~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~~~~~~~~~ia~G~~ht~al~~~~g~ 266 (812)
+||.+..++...+.....+|++|+||..|++|| +||+||+||.|.+||||.|....... .+|+||.+|+|||+ + |+
T Consensus 163 ~wG~n~~gqlg~p~~~~~~v~~i~~G~~hs~al-~~G~v~~wG~n~~gqlg~p~~~~~~v-~~i~~G~~h~~al~-~-g~ 238 (282)
T 3qhy_B 163 AWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLAL-KDGKVIAWGDNRYKQTTVPTEALSGV-SAIASGEWYSLALK-N-GK 238 (282)
T ss_dssp EEECCTTSTTSCCGGGGSSEEEEEECSSEEEEE-ETTEEEEEECCTTSTTCCCGGGGSSC-CEEEECSSCEEEEE-T-TE
T ss_pred EecCCCCCCCCCceecCCCeEEEEecCCEEEEE-ECCeEEEEECCCCCCCCCCcccCCCc-eEEEcCCCEEEEEE-C-CE
Confidence 999998888766555567899999999999999 99999999999999999876433233 35999999999999 5 99
Q ss_pred EEEecCCCCCccccCCccccceeEEEeccceEEEEEcC
Q 042346 267 VACWGGTNRFEFDSDVIQDVSFESIVAGLDFVCGLTTR 304 (812)
Q Consensus 267 v~~WG~n~~gqlg~~~~~~~~~~~i~ag~~~~c~~~~~ 304 (812)
||+||+|.+||++. + ..+.+|++|..|+|+|+.+
T Consensus 239 v~~wG~n~~gq~~v--~--~~v~~iaaG~~h~~al~~~ 272 (282)
T 3qhy_B 239 VIAWGSSRTAPSSV--Q--SGVSSIEAGPNAAYALKGG 272 (282)
T ss_dssp EEEESTTCCCCGGG--S--SCEEEEEECSSCEEEEEC-
T ss_pred EEEecCCCCccccC--C--CCcEEEEECcCeEEEEecC
Confidence 99999999999986 2 3688999999999999864
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=415.82 Aligned_cols=271 Identities=15% Similarity=0.204 Sum_probs=207.1
Q ss_pred CceEEEEEeCCccceEEEccCCCcccCC----------------CCccEEEEEccCceEEEEEeCCCeEEEccCCCCCCC
Q 042346 41 TSTVCGIIAGESIQRIQCYQNGSTIPVL----------------PNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNF 104 (812)
Q Consensus 41 ~~~~c~l~~~g~~~~~~~~g~~~~~~~~----------------~~~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gql 104 (812)
..+..+|.++| +|+|||.|...++. .+.++++|++|..|+++|+.|| +||+||.|.+|||
T Consensus 10 ~~~~~~l~~~G---~v~~wG~n~~GqLG~~~~~~~~~p~~v~~~~~~~i~~i~~G~~~~~~l~~~G-~v~~wG~n~~GqL 85 (389)
T 3kci_A 10 GRENLYFQGSG---TIYGWGHNHRGQLGGIEGAKVKVPTPCEALATLRPVQLIGGEQTLFAVTADG-KLYATGYGAGGRL 85 (389)
T ss_dssp --------------CEEEEEECTTSTTSSCSCSEEEEEEECHHHHHTCEEEEEEETTEEEEEETTS-CEEEEECCGGGTT
T ss_pred cccceeECCCC---eEEEeeCCCCccCCCCcCccccCCEecccccCCceEEEEeCCCeEEEEcCCC-cEEEEECCCCCCC
Confidence 45678899999 89999988753321 1237899999999999999999 7999999999999
Q ss_pred CCC-------CceecccCCc--eEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccCC--C-----CCCCceEEE
Q 042346 105 SFQ-------PKRLHFRKAV--QLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSS--P-----GEDLKFSTI 168 (812)
Q Consensus 105 g~~-------~~~~~~~~~~--~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~~--~-----~~~~~~~~i 168 (812)
|.+ |..+...... ++++|++|..|++||+ +||+||+||.|.+||||.+..... | ....+|++|
T Consensus 86 G~g~~~~~~~p~~v~~~~~~~~~~v~i~~G~~h~~al~-~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~v 164 (389)
T 3kci_A 86 GIGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLALS-SEGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDV 164 (389)
T ss_dssp SSSSSCCEEEEEECGGGTTSCEEEEEECTTCSEEEEEE-TTSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTSCEEEE
T ss_pred CCCCcCCccCCEEcccccCCceeEEEECcCCCeEEEEc-CCCCEEEEeCCCCCcCCCCCCccCcCCeEecccCCCeEEEE
Confidence 954 3333332332 5589999999999998 999999999999999998765432 1 122489999
Q ss_pred eecCCeEEEEEccCCeEEEeecCCCCCccc------------ccccCceEEEEEeCC--ceeEEEeeCCcEEEEecCCCC
Q 042346 169 TSGRGFTCGILRSNSEVFCWGDSGIADEIQ------------RGFKNLSMVGLVAGE--SHACGLSRNGALVCKGSNDSG 234 (812)
Q Consensus 169 a~G~~h~cal~~~~g~v~~WG~~~~~~~~~------------~~~~~~~~~~i~aG~--~h~~al~~~G~v~~WG~n~~g 234 (812)
+||..|+||| +++|+||+||.|..+|... ..+.+.++++|+||. .|+++|++||+||+||.|.+|
T Consensus 165 a~G~~hs~al-t~~G~v~~wG~n~~GqLG~~~~~~~~~p~~v~~~~~~~v~~ia~G~g~~~t~~l~~~G~v~~wG~n~~G 243 (389)
T 3kci_A 165 AAGGAHSACV-TAAGDLYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDIACGSGDAQTLCLTDDDTVWSWGDGDYG 243 (389)
T ss_dssp EECSSEEEEE-ETTSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTSCEEEEEECCSSCEEEEEETTTEEEEEECCGGG
T ss_pred EeCcCeEEEE-eCCCeEEEeCCCCCCCcCCCCCcccccceEecccCCCeEEEEEEcCCCcEEEEEccCCEEEEEeCCCCC
Confidence 9999999999 8999999999976555321 223456799999995 899999999999999999999
Q ss_pred CCCcCC--------CC---cceeeeeeeeccceeEEEEecCCeEEEecCCCCCccccCCcc------------ccceeEE
Q 042346 235 QLNVPF--------SS---AFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQ------------DVSFESI 291 (812)
Q Consensus 235 qlg~~~--------~~---~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~~~------------~~~~~~i 291 (812)
|||... .. ....+.+|+||.+|++||+. +|+||+||.|.+||||.+... +..+.+|
T Consensus 244 qLG~g~~~~~~~p~~v~~~~~~~v~~v~~G~~hs~alt~-~G~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~v~~i 322 (389)
T 3kci_A 244 KLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTK-SGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAI 322 (389)
T ss_dssp TTSSSSCCCEEEEEECGGGTTSCEEEEEEETTEEEEEET-TSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEE
T ss_pred CCCCCCCCCccccEEecccCCCcEEEEeCCCCEEEEEeC-CCeEEEEeCCCCCCCCCCCCccccCCeEeccCCCCCEEEE
Confidence 998321 11 11112369999999999996 699999999999999974221 2357899
Q ss_pred EeccceEEEEEcCCCeEEEecCCCCCCC
Q 042346 292 VAGLDFVCGLTTRNLSMICWGPGWSNKP 319 (812)
Q Consensus 292 ~ag~~~~c~~~~~~~~v~cWG~~~~~~~ 319 (812)
++|..|+++++. +++|||||.|..++.
T Consensus 323 a~G~~h~~al~~-~G~v~~wG~n~~GqL 349 (389)
T 3kci_A 323 ATGSLHCVCCTE-DGEVYTWGDNDEGQL 349 (389)
T ss_dssp EECSSEEEEEET-TCCEEEEECCTTSTT
T ss_pred EeccCeEEEECC-CCCEEEeeCCCCCcC
Confidence 999999999985 779999999865544
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=420.35 Aligned_cols=278 Identities=18% Similarity=0.248 Sum_probs=219.6
Q ss_pred eeEEeeCCceEEEEEeCCccceEEEccCCCcc-------------------cCC--CCccEEEEEccCceEEEEEeCCCe
Q 042346 34 TAAIIYKTSTVCGIIAGESIQRIQCYQNGSTI-------------------PVL--PNASFQAISGGQNYFCGLRSGGFS 92 (812)
Q Consensus 34 ~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~~-------------------~~~--~~~~~~~i~~G~~~~~al~~~g~~ 92 (812)
.+...++..|+|++..+| .|+|||.|... |.. ...+|++|+||..|+|||+.+| .
T Consensus 12 ~~~~~~~~~h~~~~~~~g---~v~~wG~n~~GqLG~G~~~~~~~~~~P~~~~~~~~~~~~i~~va~G~~Ht~alt~~G-~ 87 (473)
T 3of7_A 12 IINAQEDYKHMYLSVQPL---DIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEAKIISFAVGGMHTLALDEES-N 87 (473)
T ss_dssp CCCCGGGGHHHHCCSSCC---EEEEEEECTTSTTCSCSCGGGGEEEEEEECTTSCTTTTCEEEEEECSSEEEEEETTC-C
T ss_pred hhhhcccccccccCCCCc---cEEEEcCCCCCccCCCCCcccccccCcccccccccCCCCEEEEEeCCCeEEEEecCC-e
Confidence 344566788999999999 89999987541 111 2348999999999999999999 7
Q ss_pred EEEccCCCCCCCCCCC------------------------------ceecc--c----CCceEEEEEccCceEEEEEeCC
Q 042346 93 LHCWDTNDLTNFSFQP------------------------------KRLHF--R----KAVQLTDVSVGGDQVCAREVNS 136 (812)
Q Consensus 93 v~~WG~n~~gqlg~~~------------------------------~~~~~--~----~~~~v~~ia~G~~h~~al~~~~ 136 (812)
||+||.|.+||||... ..+.. . ...+|++|+||..|+|||+ ++
T Consensus 88 v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~l~~~~~~~~i~~va~G~~hs~alt-~~ 166 (473)
T 3of7_A 88 VWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTPAKIPRESFPPLAEGHKVVQLAATDNMSCALF-SN 166 (473)
T ss_dssp EEEEECCTTSTTCSCCC---------------------CCHHHHSCEECCGGGCHHHHTTCCEEEEEECSSEEEEEE-TT
T ss_pred EEEeECCCCCCCCCCCcccccccccccccccCccccccccccccCceecccccCCcccCCCcEEEEEccCCEEEEEe-CC
Confidence 9999999999999542 22221 1 2468999999999999998 99
Q ss_pred CeEEEecC--CCCCCCCCCcccCC---------CCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccc------
Q 042346 137 GVVKCWRG--TKVKDKGQLFSFSS---------PGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQR------ 199 (812)
Q Consensus 137 g~v~~WG~--n~~gqlG~~~~~~~---------~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~------ 199 (812)
|+||+||. |.+||||.+..... .....+|++|+||..|+||| +++|+||+||.+..+|....
T Consensus 167 G~vy~wG~n~~~~GqLG~~~~~~~~~~~P~~v~~l~~~~i~~va~G~~hs~al-t~~G~v~~wG~n~~GqLG~~~~~~~~ 245 (473)
T 3of7_A 167 GEVYAWGTFRCNEGILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILFL-DEEGMVFAWGNGQQNQLGRKVMERFR 245 (473)
T ss_dssp SCEEEEECEEETTEEEESBTTTBSCEEEEEECCCCCSSCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTSSCCCGGGT
T ss_pred CeEEEeeCCcCCCCccCCCCCCCccccCcEEccccCCCCEEEEEecCCeEEEE-eCCCeEEEEeCCCCCCCCCCcccccc
Confidence 99999998 67899997432110 11224699999999999999 89999999999876664321
Q ss_pred -------cccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCCCC---------------cceeeeeeeecccee
Q 042346 200 -------GFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSS---------------AFEFSGGLALGANFT 257 (812)
Q Consensus 200 -------~~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~~---------------~~~~~~~ia~G~~ht 257 (812)
......|++|+||..|++||+++|+||+||.|.+||||..... ....+.+|+||.+|+
T Consensus 246 ~~~~~p~~~~~~~v~~Ia~G~~hs~alt~~G~v~~wG~n~~GqlG~~~~~~~~~~~~~P~~v~~~~~~~i~~ia~G~~hs 325 (473)
T 3of7_A 246 LKTLDPRPFGLRHVKYIASGENHCFALTKDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDNVVIRSIAAGEHHS 325 (473)
T ss_dssp TTTCSCEECSCCSEEEEEECSSEEEEEETTSCEEEEEECTTSTTCCCSCCCTTCEEEEEEECCCCTTCCEEEEEECSSEE
T ss_pred ccccCceecCCcceEEEecCCCeEEEEecCCCEEEeCCCCCCCcCCCCcccCCceeeccccccccCCccEEEEEeCCCeE
Confidence 1122469999999999999999999999999999999954321 001123699999999
Q ss_pred EEEEecCCeEEEecCCCCCccccCCc--------------------c---cc-ceeEEEeccceEEEEEcCCCeEEEecC
Q 042346 258 CAIRQRSGLVACWGGTNRFEFDSDVI--------------------Q---DV-SFESIVAGLDFVCGLTTRNLSMICWGP 313 (812)
Q Consensus 258 ~al~~~~g~v~~WG~n~~gqlg~~~~--------------------~---~~-~~~~i~ag~~~~c~~~~~~~~v~cWG~ 313 (812)
++|+. +|+||+||.|.+||||.+.. . .. .+..|++|..|+|+++. +|+||+||.
T Consensus 326 ~~lt~-~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~~v~~Ia~G~~hs~al~~-~G~vy~wG~ 403 (473)
T 3of7_A 326 LILSQ-DGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKLNNVPKFKSVAAGSHHSVAVAQ-NGIAYSWGF 403 (473)
T ss_dssp EEEET-TSCEEEEEECTTCTTCCCGGGCCTTCEECTTSCEEEEEEEEECCSSCCEEEEEECSSEEEEEET-TSCEEEEEC
T ss_pred EEEeC-CCeEEEEECCCCCccCCCccccccccccccCCceeeeccCcccCCCCceEEEEeCCCeEEEEeC-CCcEEEeeC
Confidence 99996 69999999999999995321 1 11 67899999999999985 779999999
Q ss_pred CCCCCC
Q 042346 314 GWSNKP 319 (812)
Q Consensus 314 ~~~~~~ 319 (812)
|..++.
T Consensus 404 n~~GqL 409 (473)
T 3of7_A 404 GETYAV 409 (473)
T ss_dssp CTTCTT
T ss_pred CCCCCC
Confidence 866544
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=409.07 Aligned_cols=264 Identities=16% Similarity=0.270 Sum_probs=214.1
Q ss_pred ceeEEeeCCceEEEEEeCCccceEEEccCCCcccC----------------CCC--ccEEEEEccCceEEEEEeCCCeEE
Q 042346 33 STAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIPV----------------LPN--ASFQAISGGQNYFCGLRSGGFSLH 94 (812)
Q Consensus 33 ~~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~~~~----------------~~~--~~~~~i~~G~~~~~al~~~g~~v~ 94 (812)
.++.|++|..|+|+|..+| +|+|||.|...++ ..+ +++++|++|..|++||+.+| .||
T Consensus 54 ~i~~i~~G~~~~~~l~~~G---~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~~~~v~i~~G~~h~~al~~~G-~v~ 129 (389)
T 3kci_A 54 RPVQLIGGEQTLFAVTADG---KLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLALSSEG-EVY 129 (389)
T ss_dssp CEEEEEEETTEEEEEETTS---CEEEEECCGGGTTSSSSSCCEEEEEECGGGTTSCEEEEEECTTCSEEEEEETTS-CEE
T ss_pred ceEEEEeCCCeEEEEcCCC---cEEEEECCCCCCCCCCCcCCccCCEEcccccCCceeEEEECcCCCeEEEEcCCC-CEE
Confidence 4778999999999999999 8999998765211 111 25589999999999999999 799
Q ss_pred EccCCCCCCCCCC-------CceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccCC-------CC
Q 042346 95 CWDTNDLTNFSFQ-------PKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSS-------PG 160 (812)
Q Consensus 95 ~WG~n~~gqlg~~-------~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~~-------~~ 160 (812)
+||.|.+||||.. |..+..+...+|++|+||..|++||+ ++|+||+||.|.+||||.+..... ..
T Consensus 130 ~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~va~G~~hs~alt-~~G~v~~wG~n~~GqLG~~~~~~~~~p~~v~~~ 208 (389)
T 3kci_A 130 SWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAHSACVT-AAGDLYTWGKGRYGRLGHSDSEDQLKPKLVEAL 208 (389)
T ss_dssp EEECCGGGTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEE-TTSCEEEEECCGGGTTCSSSCCCEEEEEECGGG
T ss_pred EEeCCCCCcCCCCCCccCcCCeEecccCCCeEEEEEeCcCeEEEEe-CCCeEEEeCCCCCCCcCCCCCcccccceEeccc
Confidence 9999999999954 44454445558999999999999998 999999999999999998765432 11
Q ss_pred CCCceEEEeecC--CeEEEEEccCCeEEEeecCCCCCccc------------ccccCceEEEEEeCCceeEEEeeCCcEE
Q 042346 161 EDLKFSTITSGR--GFTCGILRSNSEVFCWGDSGIADEIQ------------RGFKNLSMVGLVAGESHACGLSRNGALV 226 (812)
Q Consensus 161 ~~~~~~~ia~G~--~h~cal~~~~g~v~~WG~~~~~~~~~------------~~~~~~~~~~i~aG~~h~~al~~~G~v~ 226 (812)
...++++|+||. .|+++| +++|+||+||++..++... ..+.+..+++|+||..|++||++||+||
T Consensus 209 ~~~~v~~ia~G~g~~~t~~l-~~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~v~~v~~G~~hs~alt~~G~v~ 287 (389)
T 3kci_A 209 QGHRVVDIACGSGDAQTLCL-TDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTKSGAVY 287 (389)
T ss_dssp TTSCEEEEEECCSSCEEEEE-ETTTEEEEEECCGGGTTSSSSCCCEEEEEECGGGTTSCEEEEEEETTEEEEEETTSCEE
T ss_pred CCCeEEEEEEcCCCcEEEEE-ccCCEEEEEeCCCCCCCCCCCCCCccccEEecccCCCcEEEEeCCCCEEEEEeCCCeEE
Confidence 236799999995 899998 8999999999976655321 1234556999999999999999999999
Q ss_pred EEecCCCCCCCcCCCC-----------cceeeeeeeeccceeEEEEecCCeEEEecCCCCCccccCCcc-----------
Q 042346 227 CKGSNDSGQLNVPFSS-----------AFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQ----------- 284 (812)
Q Consensus 227 ~WG~n~~gqlg~~~~~-----------~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~~~----------- 284 (812)
+||.|.+||||..... ....+.+|+||.+|++||+. ||+||+||+|.+||||.+...
T Consensus 288 ~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~v~~ia~G~~h~~al~~-~G~v~~wG~n~~GqLG~g~~~~~~~P~~v~~~ 366 (389)
T 3kci_A 288 TWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIATGSLHCVCCTE-DGEVYTWGDNDEGQLGDGTTNAIQRPRLVAAL 366 (389)
T ss_dssp EEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEET-TCCEEEEECCTTSTTCSSSCCCEEEEEECGGG
T ss_pred EEeCCCCCCCCCCCCccccCCeEeccCCCCCEEEEEeccCeEEEECC-CCCEEEeeCCCCCcCCCCCCCCccCcEEeccc
Confidence 9999999999842111 11112369999999999996 699999999999999984322
Q ss_pred -ccceeEEEeccceEEEEEc
Q 042346 285 -DVSFESIVAGLDFVCGLTT 303 (812)
Q Consensus 285 -~~~~~~i~ag~~~~c~~~~ 303 (812)
+..+.+|++|..|++++++
T Consensus 367 ~~~~v~~va~G~~ht~al~~ 386 (389)
T 3kci_A 367 QGKKVNRVACGSAHTLAWST 386 (389)
T ss_dssp TTSCCCEEEEETTEEEEECC
T ss_pred CCCCEEEEEecCCcEEEEec
Confidence 2257799999999999975
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=403.54 Aligned_cols=268 Identities=13% Similarity=0.128 Sum_probs=218.2
Q ss_pred cceeEEeeCCceEEEEEeCCccceEEEccCCCc--------------cc--CCCCccEEEEEccCceEEEEEeCCCeEEE
Q 042346 32 ASTAAIIYKTSTVCGIIAGESIQRIQCYQNGST--------------IP--VLPNASFQAISGGQNYFCGLRSGGFSLHC 95 (812)
Q Consensus 32 ~~~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~--------------~~--~~~~~~~~~i~~G~~~~~al~~~g~~v~~ 95 (812)
..++.|++|..|+|+|..+| .|+|||.|.. .| +....+|++|+||..|++||+.+| .||+
T Consensus 75 ~~v~~va~G~~h~~~l~~~G---~v~~wG~n~~GqLG~~~~~~~~~~~P~~v~~~~~i~~va~G~~hs~al~~~G-~v~~ 150 (423)
T 3mvd_K 75 PDAVDISAGGMHNLVLTKSG---DIYSFGCNDEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACLLEDG-RVFA 150 (423)
T ss_dssp SSEEEEEECSSEEEEEETTS---CEEEEECCSSSTTCSCCCSTTSSSSCEECCCSSCEEEEEECSSEEEEEETTS-CEEE
T ss_pred CCceEEeeCCCeEEEEeCCC---eEEEeECCCCcCCCCCCcCCccccCCeEEcCCCCEEEEEcCcCeEEEEeCCC-eEEE
Confidence 34789999999999999999 8999998754 12 222348999999999999999999 7999
Q ss_pred ccC--CCCCCCCCC-----CceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccC-----------
Q 042346 96 WDT--NDLTNFSFQ-----PKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFS----------- 157 (812)
Q Consensus 96 WG~--n~~gqlg~~-----~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~----------- 157 (812)
||. |.+||||.. +.++.+....+|++|+||..|++||+ ++|+||+||.|.+||||.+....
T Consensus 151 wG~~~n~~GqlG~~~~~~~~~p~~~~~~~~i~~va~G~~hs~alt-~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~ 229 (423)
T 3mvd_K 151 WGSFRDSHGNMGLTIDGNKRTPIDLMEGTVCCSIASGADHLVILT-TAGKVFTVGCAEQGQLGRLSERSISGEGRRGKRD 229 (423)
T ss_dssp EECEECSSSEEESBTTBCEEEEEESSTTCCEEEEEECSSEEEEEE-TTSCEEEEECCTTSTTSSCCTTTTTSCSTTTTTT
T ss_pred EeCCCCCCCCcCcCCCCCCceeeEecCCCcEEEEecCCCeEEEEe-cCCeEEEeeCCcCCccCCCccccccccccccccc
Confidence 999 999999954 44566666678999999999999998 99999999999999999865321
Q ss_pred --CC-----CCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccc-----------cccCceEEEEEeCCceeEEE
Q 042346 158 --SP-----GEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQR-----------GFKNLSMVGLVAGESHACGL 219 (812)
Q Consensus 158 --~~-----~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~-----------~~~~~~~~~i~aG~~h~~al 219 (812)
.| ....+|++|+||..|++++++++|+||+||.|..++.... .....+|++|+||..|++||
T Consensus 230 ~~~p~~v~~~~~~~v~~i~~g~~~~~~~~~~~g~v~~wG~n~~gqlg~~~~~~~~~~~p~~~~~~~v~~ia~G~~ht~al 309 (423)
T 3mvd_K 230 LLRPTQLIITRAKPFEAIWATNYCTFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRHIAGGQHHTVIL 309 (423)
T ss_dssp TSSCEEECCTTCCCEEEEEEETTEEEEEETTTCCEEEEEECTTCTTSSCCTTCSEEEEEEEECCCSEEEEEECSSEEEEE
T ss_pred ccCCeEEeecCCccEEEEEECCcEEEEEECCCCeEEEEeCCCCCcCCCCCCCCceeeeeEEcCCCCeEEEEcccCeEEEE
Confidence 11 1225789999999999998679999999999877665431 11234689999999999999
Q ss_pred eeCCcEEEEecCCCCCCCcCCCCc----------ce-eeeeeeeccceeEEEEecCCeEEEecCCCCCccccCCc-----
Q 042346 220 SRNGALVCKGSNDSGQLNVPFSSA----------FE-FSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVI----- 283 (812)
Q Consensus 220 ~~~G~v~~WG~n~~gqlg~~~~~~----------~~-~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~~----- 283 (812)
++||+||+||+|.+||||...... +. .+.+|+||.+|++||+. +|+||+||+|.+||||.+..
T Consensus 310 t~~G~v~~wG~n~~GqLG~g~~~~~~~~p~~v~~l~~~v~~ia~G~~hs~alt~-~G~v~~wG~n~~GqLG~g~~~~~~~ 388 (423)
T 3mvd_K 310 TTDLKCSVVGRPEYGRLGLGDVKDVVEKPTIVKKLTEKIVSVGCGEVCSYAVTI-DGKLYSWGSGVNNQLGVGDGDDELE 388 (423)
T ss_dssp ETTCCEEEEECCGGGTTCSSSCCSCEEEEEECTTCCSCEEEEEEETTEEEEEET-TSCEEEEECCTTSCSSSSSSCCEEE
T ss_pred eCCCcEEEEECCCCCCCCCCCccccccCceEeccCCCCEEEEEcCCCeEEEEcC-CCCEEEECCCCCCCCCCCCCCCccc
Confidence 999999999999999999432111 00 22369999999999996 69999999999999998321
Q ss_pred ---------cccceeEEEeccceEEEEEcCC
Q 042346 284 ---------QDVSFESIVAGLDFVCGLTTRN 305 (812)
Q Consensus 284 ---------~~~~~~~i~ag~~~~c~~~~~~ 305 (812)
....+.+|++|..|+++++.++
T Consensus 389 P~~v~~~~~~~~~v~~va~G~~ht~~l~~~~ 419 (423)
T 3mvd_K 389 PIVVVSKNTQGKHMLLASGGGQHAIFLVKAD 419 (423)
T ss_dssp EEECCSTTTTTCCEEEEEECSSEEEEEEECC
T ss_pred CeEEeCcccCCCEEEEEEECCCcEEEEEccc
Confidence 2234789999999999998643
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=401.44 Aligned_cols=246 Identities=20% Similarity=0.269 Sum_probs=200.4
Q ss_pred CCccEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCCC-------CceecccCCceEEEEEccCceEEEEEeCC-CeEE
Q 042346 69 PNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQ-------PKRLHFRKAVQLTDVSVGGDQVCAREVNS-GVVK 140 (812)
Q Consensus 69 ~~~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~~-------~~~~~~~~~~~v~~ia~G~~h~~al~~~~-g~v~ 140 (812)
+..+|++|+||..|+|||+.|| +||+||.|.+||||.. |.++......+|++|++|..|++||+ ++ |+||
T Consensus 14 ~~~~v~~ia~G~~hs~al~~~g-~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~i~~va~G~~ht~al~-~~gg~v~ 91 (406)
T 4d9s_A 14 PPRKVLIISAGASHSVALLSGD-IVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQIVSVTCGADHTVAYS-QSGMEVY 91 (406)
T ss_dssp -CCCEEEEEECSSEEEEEETTT-EEEEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEE-TTTTEEE
T ss_pred CccceEEEecCCCeEEEEEeCC-EEEEEeCCCCCCCCCCCcccCcCCEEecccCCCCEEEEEeCcceEEEEE-CCCCEEE
Confidence 4459999999999999999999 8999999999999954 34444445558999999999999998 65 5999
Q ss_pred EecCCCCCCCCCCcccCC--C-----CCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCccc------------ccc
Q 042346 141 CWRGTKVKDKGQLFSFSS--P-----GEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQ------------RGF 201 (812)
Q Consensus 141 ~WG~n~~gqlG~~~~~~~--~-----~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~------------~~~ 201 (812)
+||.|.+||||.+..... | ....+|++|+||..|+||| +++|+||+||.|..+|... ..+
T Consensus 92 ~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~ia~G~~h~~al-t~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~ 170 (406)
T 4d9s_A 92 SWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSHCLAV-TMEGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAF 170 (406)
T ss_dssp EEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTCSSSCCCEEEEEECGGG
T ss_pred EEcCCCCcCCCCCCCCccccceEecccCCCCEEEEEEChhheEEE-cCCCcEEEeCCCCCccCCCCCCCCcccceEeccc
Confidence 999999999998765432 1 1225799999999999999 8999999999987666421 123
Q ss_pred cCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCCC-----------CcceeeeeeeeccceeEEEEecCCeEEEe
Q 042346 202 KNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFS-----------SAFEFSGGLALGANFTCAIRQRSGLVACW 270 (812)
Q Consensus 202 ~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~-----------~~~~~~~~ia~G~~ht~al~~~~g~v~~W 270 (812)
.+.+|++|+||..|++||+++|+||+||.|.+||||.... .....+..|+||.+|+++|+. +|+||+|
T Consensus 171 ~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~i~~va~G~~ht~~l~~-~G~v~~w 249 (406)
T 4d9s_A 171 EGIRIKMVAAGAEHTAAVTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVSY-SGALYTY 249 (406)
T ss_dssp TTCCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSSSSCCEEEEEECCCSTTCCEEEEEECSSEEEEEET-TCCEEEE
T ss_pred CCCcEEEEecCCCeEEEEeCCCCEEEeeCCCCCCCCCCCCCCcCccEEecccCCceEEEEEECCCcEEEEcC-CCCEEEe
Confidence 4557999999999999999999999999999999983211 111122369999999999996 6999999
Q ss_pred cCCCCCccccCCcc------------ccceeEEEeccceEEEEEcCCCeEEEecCCCCCCC
Q 042346 271 GGTNRFEFDSDVIQ------------DVSFESIVAGLDFVCGLTTRNLSMICWGPGWSNKP 319 (812)
Q Consensus 271 G~n~~gqlg~~~~~------------~~~~~~i~ag~~~~c~~~~~~~~v~cWG~~~~~~~ 319 (812)
|+|.+||||.+... +..+.+|++|..|+|+++. +++||+||+|..++.
T Consensus 250 G~n~~GqlG~g~~~~~~~p~~v~~~~~~~v~~i~~G~~hs~alt~-~G~v~~wG~n~~GqL 309 (406)
T 4d9s_A 250 GWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALTS-DGKLYGWGWNKFGQV 309 (406)
T ss_dssp ECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEET-TSCEEEEECCTTSTT
T ss_pred eCCCCCCCCCCCCcCccccEEecccCCCCEEEEEecCCEEEEEcC-CCeEEEeeCCCCCCC
Confidence 99999999974221 2248899999999999985 779999999865543
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=400.15 Aligned_cols=266 Identities=17% Similarity=0.263 Sum_probs=215.1
Q ss_pred cceeEEeeCCceEEEEEeCCccceEEEccCCCc--------------cc--CCCCccEEEEEccCceEEEEEeCCCeEEE
Q 042346 32 ASTAAIIYKTSTVCGIIAGESIQRIQCYQNGST--------------IP--VLPNASFQAISGGQNYFCGLRSGGFSLHC 95 (812)
Q Consensus 32 ~~~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~--------------~~--~~~~~~~~~i~~G~~~~~al~~~g~~v~~ 95 (812)
..++.|++|..|+|+|.++| .|++||.|.. .| +....+|++|+||..|++||+.+| .||+
T Consensus 59 ~~i~~va~G~~hs~~l~~~G---~v~~wG~n~~GqLG~~~~~~~~~~~P~~v~l~~~i~~va~G~~hs~alt~~G-~v~~ 134 (413)
T 1a12_A 59 EDVVQAEAGGMHTVCLSKSG---QVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDG-RVFL 134 (413)
T ss_dssp SCEEEEEECSSEEEEEETTS---CEEEEECCTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEEETTS-CEEE
T ss_pred CCeEEEEeCCCeEEEEcCCC---CEEEEECCCCCCCCCCCCCCccccCCeEecCCCcEEEEecCCCeEEEEcCCC-cEEE
Confidence 46888999999999999999 8999998753 12 111338999999999999999999 7999
Q ss_pred ccC--CCCCCCCCCC------ceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccC----------
Q 042346 96 WDT--NDLTNFSFQP------KRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFS---------- 157 (812)
Q Consensus 96 WG~--n~~gqlg~~~------~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~---------- 157 (812)
||. |.+||||... .|..+....+|++|+||..|++||+ ++|+||+||.|.+||||.+....
T Consensus 135 wG~~~n~~GqlG~~~~~~~~~~P~~v~~~~~i~~ia~G~~hs~alt-~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~ 213 (413)
T 1a12_A 135 WGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLT-ADGDLYTLGCGEQGQLGRVPELFANRGGRQGLE 213 (413)
T ss_dssp EECEEETTEEEESSBBTBCEEEEEEECCSSCEEEEEECSSEEEEEE-TTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHH
T ss_pred eeCCcCCCCccCcCCccccccCCEEecCCCCEEEEEecCceEEEEc-CCCCEEEeeCCCCCccCCCcccccccccccccc
Confidence 999 9999999542 2444455678999999999999998 99999999999999999764210
Q ss_pred ---CC--C--------CCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccc------------cccC--ceEEEEE
Q 042346 158 ---SP--G--------EDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQR------------GFKN--LSMVGLV 210 (812)
Q Consensus 158 ---~~--~--------~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~------------~~~~--~~~~~i~ 210 (812)
.| . ...+|++|+||..|++|| +++|+||+||.|..+|.... .+.+ .+|++|+
T Consensus 214 ~~~~P~~v~~~~~g~~~~~~i~~ia~G~~hs~al-t~~G~v~~wG~n~~gqLG~~~~~~~~~P~~v~~l~~~~~~v~~ia 292 (413)
T 1a12_A 214 RLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAI-SHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFS 292 (413)
T ss_dssp HHHSCEECCCBCSSCCSBCCEEEEEEETTEEEEE-ETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEE
T ss_pred ccccCceEeeccccccCCccEEEEEeCCCEEEEE-eCCCCEEEEeCCCCcCCCCCCCCcccccEEchhccCCCceEEEEe
Confidence 11 1 236799999999999999 89999999999876664211 1122 4599999
Q ss_pred eCCceeEEEeeCCcEEEEecCCCCCCCcCCCC----------cceeeeeeeeccceeEEEEecCCeEEEecCCCCCcccc
Q 042346 211 AGESHACGLSRNGALVCKGSNDSGQLNVPFSS----------AFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDS 280 (812)
Q Consensus 211 aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~~----------~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~ 280 (812)
||..|++||++||+||+||.|.+||||..... .+..+.+|+||.+|++||+. +|+||+||+|.+||||.
T Consensus 293 ~G~~hs~al~~~G~v~~wG~n~~GqLG~g~~~~~~~~P~~v~~l~~v~~v~~G~~hs~alt~-~G~v~~wG~n~~gqLG~ 371 (413)
T 1a12_A 293 GGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVTK-DGRVFAWGMGTNYQLGT 371 (413)
T ss_dssp ECSSEEEEEETTSCEEEEECCGGGTTCSCTTCCCEEEEEECCSSSSEEEEEECSSEEEEEET-TSCEEEEECCTTSTTCS
T ss_pred cccceEEEEeCCCCEEEeeCCCCCccCCCCCCccccCCEEecccCceeEEEECcceEEEEeC-CCCEEEecCCCCCCCCC
Confidence 99999999999999999999999999853110 11123369999999999996 69999999999999997
Q ss_pred CCc--------------cccceeEEEeccceEEEEEcC
Q 042346 281 DVI--------------QDVSFESIVAGLDFVCGLTTR 304 (812)
Q Consensus 281 ~~~--------------~~~~~~~i~ag~~~~c~~~~~ 304 (812)
+.. .+..+.+|++|..|+++++.+
T Consensus 372 g~~~~~~~P~~v~~~~~~~~~v~~v~~G~~ht~~l~~~ 409 (413)
T 1a12_A 372 GQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLLVKD 409 (413)
T ss_dssp SSCSCEEEEEECCSTTTTTEEEEEEEECSSEEEEEEEE
T ss_pred CCCCCcccCeEccccccCCCeEEEEeeCCCcEEEEEec
Confidence 421 123578999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=405.02 Aligned_cols=202 Identities=24% Similarity=0.415 Sum_probs=168.8
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEE
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFC 571 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 571 (812)
....++|++.++||+|+||+||+|+.+ .++.||+|++.... ....+.+|+++|+.+ +||||++++++|
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-------HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-------CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-------CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 345678999999999999999999863 46789999886421 233567899999998 699999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-C
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-W 650 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~ 650 (812)
++++..||||||+++|+|.+++.. ++..+...++.||+.||+|||+++ |+||||||+|||++.+ +
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~~-----------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~ 155 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILNS-----------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLK 155 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHTT-----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTT
T ss_pred EECCEEEEEEeCCCcccHHHHHcC-----------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCC
Confidence 999999999999999999999842 245667889999999999999999 9999999999999877 7
Q ss_pred cEEEEeecccccCCCCccc--------------------------ccccccccCCCccCccccccC-cCCCcchhHHHHH
Q 042346 651 TARVSDFGLSLLGSECDQE--------------------------FISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGV 703 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv 703 (812)
.+||+|||+|+........ ......+||+.|||||++.+. .|+.++||||+||
T Consensus 156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 9999999999754432110 112345799999999999875 5899999999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 042346 704 VLLELLTGKKAVFKNE 719 (812)
Q Consensus 704 vl~elltG~~p~~~~~ 719 (812)
+||||++|+.||+...
T Consensus 236 il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 236 IFLSLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHHHHTCSSSSCCS
T ss_pred HHHHHHHCCCCCCCCC
Confidence 9999999999997544
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=406.92 Aligned_cols=265 Identities=17% Similarity=0.238 Sum_probs=213.8
Q ss_pred cceeEEeeCCceEEEEEeCCccceEEEccCCCccc-------------------------------------CC------
Q 042346 32 ASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIP-------------------------------------VL------ 68 (812)
Q Consensus 32 ~~~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~~~-------------------------------------~~------ 68 (812)
..++.|++|..|+|+|..+| .|+|||.|...+ ++
T Consensus 67 ~~i~~va~G~~Ht~alt~~G---~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~l~~ 143 (473)
T 3of7_A 67 AKIISFAVGGMHTLALDEES---NVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTPAKIPRESFPP 143 (473)
T ss_dssp TCEEEEEECSSEEEEEETTC---CEEEEECCTTSTTCSCCC---------------------CCHHHHSCEECCGGGCHH
T ss_pred CCEEEEEeCCCeEEEEecCC---eEEEeECCCCCCCCCCCcccccccccccccccCccccccccccccCceecccccCCc
Confidence 46889999999999999999 899999765421 11
Q ss_pred --CCccEEEEEccCceEEEEEeCCCeEEEccC--CCCCCCCCC---------CceecccCCceEEEEEccCceEEEEEeC
Q 042346 69 --PNASFQAISGGQNYFCGLRSGGFSLHCWDT--NDLTNFSFQ---------PKRLHFRKAVQLTDVSVGGDQVCAREVN 135 (812)
Q Consensus 69 --~~~~~~~i~~G~~~~~al~~~g~~v~~WG~--n~~gqlg~~---------~~~~~~~~~~~v~~ia~G~~h~~al~~~ 135 (812)
.+.+|++|+||..|+|||+.+| .||+||. |.+||||.. |..+......+|++|+||..|++||+ +
T Consensus 144 ~~~~~~i~~va~G~~hs~alt~~G-~vy~wG~n~~~~GqLG~~~~~~~~~~~P~~v~~l~~~~i~~va~G~~hs~alt-~ 221 (473)
T 3of7_A 144 LAEGHKVVQLAATDNMSCALFSNG-EVYAWGTFRCNEGILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILFLD-E 221 (473)
T ss_dssp HHTTCCEEEEEECSSEEEEEETTS-CEEEEECEEETTEEEESBTTTBSCEEEEEECCCCCSSCEEEEEECSSEEEEEE-T
T ss_pred ccCCCcEEEEEccCCEEEEEeCCC-eEEEeeCCcCCCCccCCCCCCCccccCcEEccccCCCCEEEEEecCCeEEEEe-C
Confidence 2468999999999999999999 7999998 689999952 23333333446999999999999998 9
Q ss_pred CCeEEEecCCCCCCCCCCcccC----C----CCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccc--------
Q 042346 136 SGVVKCWRGTKVKDKGQLFSFS----S----PGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQR-------- 199 (812)
Q Consensus 136 ~g~v~~WG~n~~gqlG~~~~~~----~----~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~-------- 199 (812)
+|+||+||.|.+||||.+.... . +....+|++|+||..|+||| +++|+||+||.|..+|....
T Consensus 222 ~G~v~~wG~n~~GqLG~~~~~~~~~~~~~p~~~~~~~v~~Ia~G~~hs~al-t~~G~v~~wG~n~~GqlG~~~~~~~~~~ 300 (473)
T 3of7_A 222 EGMVFAWGNGQQNQLGRKVMERFRLKTLDPRPFGLRHVKYIASGENHCFAL-TKDNKLVSWGLNQFGQCGVSEDVEDGAL 300 (473)
T ss_dssp TSCEEEEECCTTSTTSSCCCGGGTTTTCSCEECSCCSEEEEEECSSEEEEE-ETTSCEEEEEECTTSTTCCCSCCCTTCE
T ss_pred CCeEEEEeCCCCCCCCCCccccccccccCceecCCcceEEEecCCCeEEEE-ecCCCEEEeCCCCCCCcCCCCcccCCce
Confidence 9999999999999999875332 1 11226899999999999999 89999999999776654211
Q ss_pred --------cccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCCC----------------------C-cceeee
Q 042346 200 --------GFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFS----------------------S-AFEFSG 248 (812)
Q Consensus 200 --------~~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~----------------------~-~~~~~~ 248 (812)
.+.+..|++|+||..|+++|+++|+||+||.|.+||||.+.. . ....+.
T Consensus 301 ~~~P~~v~~~~~~~i~~ia~G~~hs~~lt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~~v~ 380 (473)
T 3of7_A 301 VTKPKRLALPDNVVIRSIAAGEHHSLILSQDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKLNNVPKFK 380 (473)
T ss_dssp EEEEEECCCCTTCCEEEEEECSSEEEEEETTSCEEEEEECTTCTTCCCGGGCCTTCEECTTSCEEEEEEEEECCSSCCEE
T ss_pred eeccccccccCCccEEEEEeCCCeEEEEeCCCeEEEEECCCCCccCCCccccccccccccCCceeeeccCcccCCCCceE
Confidence 123457999999999999999999999999999999995321 0 110223
Q ss_pred eeeeccceeEEEEecCCeEEEecCCCCCccccCC-cc--------------ccceeEEEeccceEEEEEc
Q 042346 249 GLALGANFTCAIRQRSGLVACWGGTNRFEFDSDV-IQ--------------DVSFESIVAGLDFVCGLTT 303 (812)
Q Consensus 249 ~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~-~~--------------~~~~~~i~ag~~~~c~~~~ 303 (812)
+|+||.+|++||+. +|+||+||+|.+||||.+. .. +..+..|++|..|++++..
T Consensus 381 ~Ia~G~~hs~al~~-~G~vy~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~~~~~v~~v~cG~~~s~~~~~ 449 (473)
T 3of7_A 381 SVAAGSHHSVAVAQ-NGIAYSWGFGETYAVGLGPFEDDTEVPTRIKNTATQDHNIILVGCGGQFSVSGGV 449 (473)
T ss_dssp EEEECSSEEEEEET-TSCEEEEECCTTCTTCCCSCCSCEEEEEECCCTTTTTEEEEEEEECSSEEEEEEE
T ss_pred EEEeCCCeEEEEeC-CCcEEEeeCCCCCCCCCCCCCccccCCeEecccccCCCeEEEEeeCCCeEEEEEe
Confidence 69999999999996 6999999999999999844 11 1247799999999999964
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=400.82 Aligned_cols=266 Identities=18% Similarity=0.315 Sum_probs=199.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe-----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE----- 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----- 573 (812)
.++|++.+.||+|+||+||+|++. +|+.||||++..... .....+.+.+|+++|+.|+|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD---VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc---chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 357999999999999999999974 699999999864322 22334568899999999999999999999764
Q ss_pred -CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 574 -KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 574 -~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
.+..|||||||+ |+|.++|..... ++......++.||+.||+|||+++ ||||||||+|||++.++.+
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~~--------l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~ 197 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQP--------LTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCEL 197 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSSC--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCE
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCE
Confidence 356899999996 689999976532 356777899999999999999999 9999999999999999999
Q ss_pred EEEeecccccCCCCc--ccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 653 RVSDFGLSLLGSECD--QEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 653 kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
||+|||+++.+.... ........+||+.|||||++.+. .++.++||||+||+||||++|+.||..... .+...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~----~~~l~ 273 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY----VHQLQ 273 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHH
T ss_pred EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH----HHHHH
Confidence 999999998654322 12234567899999999998875 569999999999999999999999954321 11111
Q ss_pred HHHHHHHhccccccc------------cccCCCCC-CChH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 730 FAVSQILAGQLHCVL------------DKRVGPPE-LNEA----EAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~------------d~~~~~~~-~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...... +...... ...+.... .... .....+.+|+.+||..||++|||++|+++|
T Consensus 274 ~I~~~~--g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 274 LIMMVL--GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHHH--CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHhc--CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111110 1000000 00000000 0001 124567799999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=392.86 Aligned_cols=290 Identities=41% Similarity=0.724 Sum_probs=237.8
Q ss_pred CCHHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEE
Q 042346 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGF 570 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 570 (812)
+++.++....++|++.+.||+|+||.||+|++++++.||||++..... ...+.+.+|+++++.++||||++++++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 103 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-----QGIEEFETEIETLSFCRHPHLVSLIGF 103 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-----SHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 444555667889999999999999999999988899999998764321 234568899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
+.+.+..++||||+++++|.+++....... ..+++..+++++.|+++||+|||+++ |+||||||+|||++.++
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~ 176 (321)
T 2qkw_B 104 CDERNEMILIYKYMENGNLKRHLYGSDLPT----MSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF 176 (321)
T ss_dssp CCCTTCCEEEEECCTTCBTGGGSSSSCCCS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTC
T ss_pred EcCCCeEEEEEEcCCCCcHHHHHhccCCCc----cccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCC
Confidence 999999999999999999999997654221 22478889999999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........+
T Consensus 177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~-~~~~~~~~~ 255 (321)
T 2qkw_B 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEW 255 (321)
T ss_dssp CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS-SSCCCHHHH
T ss_pred CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc-HHHHHHHHH
Confidence 9999999999765443333334455689999999999988999999999999999999999999875443 233445555
Q ss_pred HHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcc
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 795 (812)
.......+.+...+++.... ....+.++.+.+++.+||+.||++|||++|++++|+.+++..+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 256 AVESHNNGQLEQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp THHHHTTTCCCSSSSSSCTT--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred hhhccccccHHHhcChhhcc--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 55555555555555554432 2346788889999999999999999999999999999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=415.67 Aligned_cols=252 Identities=19% Similarity=0.291 Sum_probs=205.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|+++|+.|+|||||+++++|++++..||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999885 58999999986422 2234568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC--CcEEEEee
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN--WTARVSDF 657 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~--~~~kl~Df 657 (812)
|||||++|+|.++|..... .++..+...++.||+.||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 232 v~E~~~gg~L~~~i~~~~~-------~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHN-------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp EEECCCCCBHHHHHTCTTS-------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEeecCCCcHHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeec
Confidence 9999999999999965432 1356777899999999999999999 9999999999999854 89999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|+++...... ......||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......+..
T Consensus 302 G~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~ 370 (573)
T 3uto_A 302 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKS 370 (573)
T ss_dssp SSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHT
T ss_pred cceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHh
Confidence 9998765432 23456899999999999999999999999999999999999999954321 112223333
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ..+......+++.+.+||.+||+.||++|||++|+++|
T Consensus 371 ~~~--------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 371 CDW--------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TCC--------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC--------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 221 11111123345568899999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=408.16 Aligned_cols=266 Identities=23% Similarity=0.262 Sum_probs=203.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhH-HHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKL-REKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
++|++.++||+|+||+||+|+.+ +|+.||||++......... ........+++.+++.++|||||+++++|++++.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999985 5899999998642111110 111122234566777889999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
|||||+++|+|.++|...... +......++.||+.||+|||+++ ||||||||+||||+.++.+||+|||
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l--------~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFG 337 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVF--------SEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG 337 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCC--------CHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCcHHHHHHhcCCC--------CHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccc
Confidence 999999999999999865432 44566789999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
+|+..... .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||....... . ......+..
T Consensus 338 lA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~----~-~~i~~~i~~ 408 (689)
T 3v5w_A 338 LACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----K-HEIDRMTLT 408 (689)
T ss_dssp TCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC----H-HHHHHHHHH
T ss_pred eeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----H-HHHHHhhcC
Confidence 99865432 2345689999999999974 579999999999999999999999996533211 1 111222222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH-------HHHHHhcccCC
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVANL-------ERALAICQDCS 798 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~L-------e~~~~~~~~~~ 798 (812)
.. +..+ ..++..+.+||.+||..||++|++ ++||++|- +.+...-..+|
T Consensus 409 ~~--------~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP 469 (689)
T 3v5w_A 409 MA--------VELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPP 469 (689)
T ss_dssp CC--------CCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCS
T ss_pred CC--------CCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcC
Confidence 21 1112 223456789999999999999998 78888752 55554444444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=383.88 Aligned_cols=290 Identities=39% Similarity=0.638 Sum_probs=231.8
Q ss_pred CCCCHHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEE
Q 042346 489 DNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLV 568 (812)
Q Consensus 489 ~~~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~ 568 (812)
..|++.++....++|++.+.||+|+||.||++++.+++.||||++.... .......+.+|+++++.++||||++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEecccc----CchHHHHHHHHHHHHHhccCCCccceE
Confidence 4678899999999999999999999999999998889999999986421 122233688999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 569 GFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 569 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
+++.+.+..++||||+++++|.+++....... ..+++..++.++.|++.||+|||++..++|+||||||+|||++.
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQ----PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTC----CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence 99999999999999999999999998654322 22478889999999999999999992223999999999999999
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCC-CCCCCchh
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNE-DGSGPLDV 727 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~-~~~~~~~~ 727 (812)
++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ........
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248 (326)
T ss_dssp TCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBH
T ss_pred CCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhH
Confidence 99999999999986543222 23344569999999999998899999999999999999999999985211 11122233
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
.++.........+....+..... ....+..+.+.+++.+||+.||++|||++||+++|+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 249 LDWVKGLLKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHTTTTSSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHhhchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 34433333334444444444332 2346677889999999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=383.83 Aligned_cols=271 Identities=24% Similarity=0.412 Sum_probs=215.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc--------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM--------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGF 570 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 570 (812)
.++|++.+.||+|+||.||+|++. ++..||||++.... .....+.+.+|+++++++ +||||++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC----BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc----CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 467999999999999999999863 34579999986421 233456788999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCc--------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEK--------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
+.+++..++||||+++|+|.+++........ .....+++..+++++.||++||+|||+++ |+||||||+
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 232 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 232 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchh
Confidence 9999999999999999999999987653210 01123478889999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDG 721 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~ 721 (812)
|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||++||||++ |+.||....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-- 310 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-- 310 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC--
Confidence 99999999999999999986554333333444567889999999999999999999999999999999 888885422
Q ss_pred CCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 722 SGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
...+. ..+..+. +...+ ..++..+.+++.+||+.||++|||++|+++.|++++....+
T Consensus 311 --~~~~~----~~~~~~~-------~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 311 --VEELF----KLLKEGH-------RMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp --GGGHH----HHHHTTC-------CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --HHHHH----HHHhcCC-------CCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 11111 1222221 11111 23345688999999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=374.18 Aligned_cols=275 Identities=29% Similarity=0.431 Sum_probs=205.9
Q ss_pred HHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 494 SELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 494 ~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
.++....++|++.+.||+|+||.||++++ +++.||||++..... ..+..+.+.+|++++++++||||+++++++.+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF---HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 33444567899999999999999999987 688999999864322 23445678899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
.+..++||||+++++|.+++...... ..+++..+++++.||++||+|||+++ ++|+||||||+|||++.++.+|
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~k 179 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAR-----EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVK 179 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHH-----HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEE
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEE
Confidence 99999999999999999999764321 12467888999999999999999987 4599999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+ ...
T Consensus 180 L~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~-~~~ 249 (309)
T 3p86_A 180 VCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-------AQ-VVA 249 (309)
T ss_dssp ECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-------HH-HHH
T ss_pred ECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH-HHH
Confidence 99999997543321 223456799999999999999999999999999999999999999854321 11 111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.+... ..+...+ ...+..+.+|+.+||+.||++|||++|+++.|+.+++.....+
T Consensus 250 ~~~~~------~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 250 AVGFK------CKRLEIP----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp HHHHS------CCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred HHHhc------CCCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 11111 0111111 2234568899999999999999999999999999988765444
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=377.15 Aligned_cols=271 Identities=25% Similarity=0.314 Sum_probs=208.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
..++|++.++||+|+||.||+|++. ++.||||++... ......+.+|+.++++++||||+++++++.+..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 3467999999999999999999884 799999998632 122334566999999999999999999998754
Q ss_pred -eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc----------CCCCeEeeccCCCCE
Q 042346 576 -ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY----------AVPSIIHRDIKSSNI 644 (812)
Q Consensus 576 -~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~----------~~~~ivHrDlKp~NI 644 (812)
..++||||+++|+|.++++... +++..+++++.|+++||+|||+. + |+||||||+||
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Ni 162 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKANV---------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNV 162 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHCC---------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGE
T ss_pred ceEEEEEecCCCCCHHHHHHhcC---------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhE
Confidence 3699999999999999997642 37788899999999999999998 6 99999999999
Q ss_pred EEcCCCcEEEEeecccccCCCCcccccccccccCCCccCcccccc-----CcCCCcchhHHHHHHHHHHHcCCCCCCCCC
Q 042346 645 LLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGKKAVFKNE 719 (812)
Q Consensus 645 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~ 719 (812)
|++.++.+||+|||+++...............||+.|+|||++.+ ..++.++||||||++||||+||+.||....
T Consensus 163 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp EECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred EECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999976554333333444679999999999886 456778999999999999999999986543
Q ss_pred CCCCCchh--------HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 720 DGSGPLDV--------VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 720 ~~~~~~~~--------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
........ .............. +.+ .........++.+.+|+.+||+.||++|||++||++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKR----PVL-RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCC----CCC-CGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhccchhhhhccCCchhhhhhhhhcccCC----CCc-cccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 32211100 01111111111111 000 011112345667999999999999999999999999999987
Q ss_pred Hh
Q 042346 792 AI 793 (812)
Q Consensus 792 ~~ 793 (812)
+.
T Consensus 318 ~~ 319 (322)
T 3soc_A 318 RL 319 (322)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=371.74 Aligned_cols=267 Identities=23% Similarity=0.416 Sum_probs=209.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|++.+.||+|+||.||+|++. .+..||||++.... .....+.|.+|+++++.++||||+++++++.+++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 456999999999999999999984 34569999986421 2334567889999999999999999999999988
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~ 193 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDG-------QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVS 193 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ccEEEeeCCCCCcHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEEC
Confidence 99999999999999999965432 1367888999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcc-cccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQ-EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||+++....... ........+|+.|+|||++.+..++.++||||||++||||++ |+.||..... .....
T Consensus 194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~ 265 (325)
T 3kul_A 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVIS 265 (325)
T ss_dssp CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHH
T ss_pred CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHH
Confidence 9999986544322 122333456789999999998999999999999999999999 9999854321 11122
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCCC
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCSC 799 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~~ 799 (812)
.+..+. +... ...++..+.+|+.+||..||++|||++||++.|+.+++.......
T Consensus 266 ~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~ 320 (325)
T 3kul_A 266 SVEEGY-------RLPA----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320 (325)
T ss_dssp HHHTTC-------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC----
T ss_pred HHHcCC-------CCCC----CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccc
Confidence 222211 1111 123445688999999999999999999999999999887665543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=366.26 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=210.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.++||+|+||.||++++. +++.||+|++... ..+..+.|.+|++++++++||||+++++++.+++..++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 56999999999999999999985 5899999987532 23445678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++...... +++..+++++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQ-------YPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTT-------SCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTT
T ss_pred EEEecCCCcHHHHHHhccCC-------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccc
Confidence 99999999999999764321 367888999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccc------------cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 660 SLLGSECDQEF------------ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 660 a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
+.......... ......||+.|+|||++.+..++.++||||||++||||++|..|+............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~ 234 (310)
T 3s95_A 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234 (310)
T ss_dssp CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB
T ss_pred ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh
Confidence 97654322211 111457999999999999999999999999999999999999987643322211111
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccC
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDC 797 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~ 797 (812)
.. ....... .. ..++..+.+++.+||+.||++|||++|+++.|+++.......
T Consensus 235 ~~---~~~~~~~----~~----------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 235 NV---RGFLDRY----CP----------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp CH---HHHHHHT----CC----------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred hh---hcccccc----CC----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence 10 0000000 00 112234889999999999999999999999999988765543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=363.07 Aligned_cols=288 Identities=38% Similarity=0.601 Sum_probs=227.1
Q ss_pred CCCCHHHHHHhcCCccee------eeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC
Q 042346 489 DNFTLSELAAATNNFSLE------NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK 562 (812)
Q Consensus 489 ~~~~~~el~~~~~~~~~~------~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~ 562 (812)
..|++.++..++++|... +.||+|+||.||+|++ +++.||||++...... ...+..+.+.+|+++++.++||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI-TTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTS-CTTTHHHHHHHHHHHHHHCCCT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCc-chHHHHHHHHHHHHHHHhcCCC
Confidence 457889999999988876 8999999999999987 6889999998643211 1123456788999999999999
Q ss_pred CceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 563 nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
||+++++++.+.+..++||||+++++|.+++...... ..+++..+++++.|++.||+|||+.+ |+||||||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~ 162 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-----PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSA 162 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHH
Confidence 9999999999999999999999999999999753221 12478888999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS 722 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~ 722 (812)
|||++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999999976654333333445679999999998865 58999999999999999999999986544322
Q ss_pred CCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 723 GPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
....+.+... .....+...++..+. ......++.+.+++.+||+.||.+|||++|++++|+++.+
T Consensus 242 ~~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 LLLDIKEEIE--DEEKTIEDYIDKKMN---DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BTTHHHHHHH--TTSCCHHHHSCSSCS---CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHhh--hhhhhhhhhcccccc---ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222111110 011122333343332 2246677889999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=376.45 Aligned_cols=280 Identities=24% Similarity=0.367 Sum_probs=219.9
Q ss_pred CCCHHHHHHhcCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCC
Q 042346 490 NFTLSELAAATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHK 562 (812)
Q Consensus 490 ~~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~ 562 (812)
.+...++....++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+.+|++++.++ +||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp 86 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHL 86 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC----CHHHHHHHHHHHHHHHhhcCCc
Confidence 3556777778889999999999999999999752 35789999986422 233456788999999999 799
Q ss_pred CceEEEEEEEeCCe-EEEEEEecCCCchhhhhhcCCCCCcc---------------------------------------
Q 042346 563 HLVGLVGFCQEKDE-RLLVYEYMSNGALHDHLHNKNNTEKN--------------------------------------- 602 (812)
Q Consensus 563 nIv~l~~~~~~~~~-~~lV~ey~~~gsL~~~l~~~~~~~~~--------------------------------------- 602 (812)
||+++++++.+.+. .++||||+++|+|.++++........
T Consensus 87 niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp TBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred ceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 99999999988655 89999999999999999876431100
Q ss_pred -------------------ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccC
Q 042346 603 -------------------SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 603 -------------------~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
....+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 0112578889999999999999999998 999999999999999999999999999866
Q ss_pred CCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhccccc
Q 042346 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742 (812)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (812)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... . .....+..+.
T Consensus 244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~---~~~~~~~~~~--- 313 (359)
T 3vhe_A 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----E---EFCRRLKEGT--- 313 (359)
T ss_dssp TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----H---HHHHHHHHTC---
T ss_pred cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----H---HHHHHHHcCC---
Confidence 54433334455678999999999999999999999999999999998 99998543211 1 1112222221
Q ss_pred cccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 743 VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 743 ~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
....+ ...+..+.+++.+||+.||++|||++|++++|+++++..
T Consensus 314 ----~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 314 ----RMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp ----CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 11111 123345788999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=356.80 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=209.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.++|++.+.||+|+||.||++++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc------CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence 456999999999999999999998899999999864322 12458899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... .+++..+++++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRG-------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 152 (269)
T ss_dssp EEECCTTCBHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred EEEeCCCCcHHHHHHhcCc-------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccc
Confidence 9999999999999975432 2367788899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+....... ........+|+.|+|||.+....++.++||||||+++|||++ |+.||..... ......+..+
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~ 223 (269)
T 4hcu_A 153 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTG 223 (269)
T ss_dssp GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT
T ss_pred cccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcC
Confidence 97654321 122334567888999999998899999999999999999999 8888753221 1122222222
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
. +...+ ...+..+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 224 ~-------~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 224 F-------RLYKP----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp C-------CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred c-------cCCCC----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1 11111 12245588999999999999999999999999998864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=364.15 Aligned_cols=251 Identities=22% Similarity=0.388 Sum_probs=203.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+.+++.++||||+++++++..++..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence 45799999999999999999986 4689999999864221 22346788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++.... ++......++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 94 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg 161 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTETC---------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFG 161 (297)
T ss_dssp EEEECCTTCBHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEECCCCCCHHHHHhhcC---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999997642 256777899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..... .+...
T Consensus 162 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~-~~~~~ 231 (297)
T 3fxz_A 162 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALY-LIATN 231 (297)
T ss_dssp TCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHH-HHHHH
T ss_pred CceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH-HHHhC
Confidence 9876544222 23456799999999999999999999999999999999999999854321 11111 11111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. +........+..+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 232 GT---------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CS---------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC---------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 10 0111123455668899999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=374.20 Aligned_cols=274 Identities=26% Similarity=0.400 Sum_probs=219.0
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc--------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM--------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVG 569 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~ 569 (812)
..++|++.++||+|+||.||+|++. +++.||||++.... .......+.+|+++++++ +||||+++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc----CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 3467999999999999999999863 23579999986432 233456788999999999 9999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhhcCCCCCc--------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCC
Q 042346 570 FCQEKDERLLVYEYMSNGALHDHLHNKNNTEK--------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKS 641 (812)
Q Consensus 570 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp 641 (812)
++.+++..++||||+++++|.+++........ .....+++..+++++.||++||+|||+.+ |+||||||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 219 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA 219 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCc
Confidence 99999999999999999999999987653211 11123578899999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCC
Q 042346 642 SNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNED 720 (812)
Q Consensus 642 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~ 720 (812)
+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~- 298 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 298 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 999999999999999999986654433333445567899999999999999999999999999999999 888874322
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.......+..+. +...+ ..++..+.+|+.+||+.||++|||++||+++|+++++...+..
T Consensus 299 -------~~~~~~~~~~~~-------~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 299 -------VEELFKLLKEGH-------RMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp -------HHHHHHHHHTTC-------CCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred -------HHHHHHHHHcCC-------CCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 112222222221 11111 1234568899999999999999999999999999998876655
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=378.78 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=209.5
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||+|++. +++.||||++.... ..+....|.+|++++++++||||+++++++.+++..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS----CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 4467999999999999999999986 68999999986421 233445788999999999999999999999998899
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++|+|.++++.... .+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGA-------RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCG
T ss_pred EEEEEcCCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcC
Confidence 999999999999999975432 2367788999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|+++...............+++.|+|||.+....++.++||||||++||||++ |+.||..... ......+.
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~ 329 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVE 329 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHH
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 99976443222111122345778999999998899999999999999999999 8888743221 11111222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
.+. ++..+. .+++.+.+|+.+||+.||++|||+++|++.|+++.+.
T Consensus 330 ~~~-------~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 330 KGG-------RLPCPE----LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTC-------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC-------CCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 211 122222 2345688999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=366.38 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=204.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||+|++ .+++.||||++.... ......+.+.+|+++++.++||||+++++++.+.+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ---LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 346799999999999999999998 579999999986422 1233456788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++++|.+++..... ++......++.||++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~--------l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECST
T ss_pred EEEEECCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeec
Confidence 999999999999999976543 255677899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCC-CcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLT-AKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|++....... ......||+.|+|||++.+..++ .++|||||||+||||++|+.||.... .......+.
T Consensus 159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~ 227 (328)
T 3fe3_A 159 GFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVL 227 (328)
T ss_dssp TCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred cCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence 9997554322 23456799999999999887775 78999999999999999999985432 112222333
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.. ..|. ..+..+.+|+.+||..||.+|||++|++++
T Consensus 228 ~~~~--------~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 228 RGKY--------RIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HCCC--------CCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred hCCC--------CCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 3321 1122 133457789999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=365.57 Aligned_cols=284 Identities=25% Similarity=0.354 Sum_probs=204.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe-----C
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE-----K 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-----~ 574 (812)
.++|++.+.||+|+||.||+|++ +++.||||++.... ......+.|+..+..++||||+++++.+.. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 46799999999999999999987 78999999986311 111112234445556899999999986643 2
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc---------CCCCeEeeccCCCCEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY---------AVPSIIHRDIKSSNIL 645 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~---------~~~~ivHrDlKp~NIL 645 (812)
...++||||+++|+|.+++..... ++..+++++.||++||+|||+. + |+||||||+|||
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nil 152 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHTS---------DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVL 152 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCCB---------CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEE
T ss_pred ceEEEEEecCCCCcHHHHHhhccc---------chhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEE
Confidence 246899999999999999975532 5677789999999999999998 6 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCcc------cccccccccCCCccCcccccc-------CcCCCcchhHHHHHHHHHHHcCC
Q 042346 646 LDVNWTARVSDFGLSLLGSECDQ------EFISTKAVGTVGYIDPEYYVM-------NVLTAKTDIYGLGVVLLELLTGK 712 (812)
Q Consensus 646 l~~~~~~kl~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gvvl~elltG~ 712 (812)
++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++||||||++||||++|+
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999999999999976543221 112234579999999999876 46778999999999999999999
Q ss_pred CCCCCCCCCCCCchhH----------HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHH
Q 042346 713 KAVFKNEDGSGPLDVV----------EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITD 782 (812)
Q Consensus 713 ~p~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 782 (812)
.||+............ +.......... ....+..........++.+.+|+.+||+.||++|||++|
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHH
Confidence 8876544322211111 00111111111 111122222223456778999999999999999999999
Q ss_pred HHHHHHHHHHhcccCCCCCCCCcc
Q 042346 783 IVANLERALAICQDCSCTDSFSTT 806 (812)
Q Consensus 783 vl~~Le~~~~~~~~~~~~~~~~~~ 806 (812)
+++.|++++..+.....+++.+..
T Consensus 309 ~l~~L~~ll~~~~~~~~~~~~~~~ 332 (336)
T 3g2f_A 309 AEERMAELMMIWERNKSVSPTAHH 332 (336)
T ss_dssp HHHHHHHHHHCCCC----------
T ss_pred HHHHHHHHHHHHHhcccCCCcccc
Confidence 999999999999999977765543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=360.78 Aligned_cols=277 Identities=19% Similarity=0.252 Sum_probs=214.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC--e
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--E 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~ 576 (812)
.++|++.++||+|+||.||+|++.. ++.||||++..... ....+.+.+|++++++++||||+++++++.... .
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 3569999999999999999999864 89999999864221 122456778999999999999999999998765 6
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE----cCCCcE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTA 652 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~ 652 (812)
.++||||+++++|.+++....... .+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAY-----GLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEE
T ss_pred EEEEEeCCCCCCHHHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceE
Confidence 799999999999999997643221 1477888999999999999999998 9999999999999 888889
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccc--------cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV--------MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP 724 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~ 724 (812)
||+|||+++...... ......||+.|+|||++. +..++.++||||||+++|||++|+.||.........
T Consensus 156 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 999999998654432 223457999999999986 467899999999999999999999999654433322
Q ss_pred chhHHHHHHHHHhccccc---------cccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 725 LDVVEFAVSQILAGQLHC---------VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~---------~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
...+...........+.. .....+.............+.+++.+||+.||++|||++|++++..+..
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 222222221111111000 0111233333445788889999999999999999999999999998643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=371.89 Aligned_cols=276 Identities=24% Similarity=0.359 Sum_probs=214.6
Q ss_pred HHHHHhcCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEE
Q 042346 494 SELAAATNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGL 567 (812)
Q Consensus 494 ~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 567 (812)
.++....++|++.+.||+|+||.||++++.+ ++.||||++.... ..+..+.|.+|++++++++||||+++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~ 115 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKL 115 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3344556789999999999999999998753 4889999986422 23345678999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCc----------------cccccccHHHHHHHHHHHHHHHHHHhhcCC
Q 042346 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEK----------------NSSIVNSWKMRIRIALDAARGIDYLHNYAV 631 (812)
Q Consensus 568 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~----------------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~ 631 (812)
++++.+++..++||||+++++|.+++........ .....+++..+++++.||++||.|||+++
T Consensus 116 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~- 194 (343)
T 1luf_A 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK- 194 (343)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 9999999999999999999999999987532110 00123578889999999999999999998
Q ss_pred CCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-
Q 042346 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT- 710 (812)
Q Consensus 632 ~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt- 710 (812)
|+||||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++
T Consensus 195 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 195 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence 99999999999999999999999999975543322223344578899999999998899999999999999999999
Q ss_pred CCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 711 GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 711 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
|+.||.... .......+..+... ..+ ...+..+.+|+.+||+.||++|||+.|++++|+++
T Consensus 273 g~~p~~~~~--------~~~~~~~~~~~~~~-------~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 273 GLQPYYGMA--------HEEVIYYVRDGNIL-------ACP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp TCCTTTTSC--------HHHHHHHHHTTCCC-------CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCcCCCCC--------hHHHHHHHhCCCcC-------CCC----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 998985422 11222223333211 111 22345688999999999999999999999999998
Q ss_pred HHhcc
Q 042346 791 LAICQ 795 (812)
Q Consensus 791 ~~~~~ 795 (812)
.+...
T Consensus 334 ~~~~~ 338 (343)
T 1luf_A 334 CERAE 338 (343)
T ss_dssp TC---
T ss_pred Hhhhh
Confidence 76554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=359.32 Aligned_cols=263 Identities=25% Similarity=0.368 Sum_probs=199.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHh--ccCCCceEEEEEEEeC--
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSR--VHHKHLVGLVGFCQEK-- 574 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~-- 574 (812)
..++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++.+.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 346799999999999999999998 7899999998631 12334456666655 7999999999987653
Q ss_pred --CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHh--------hcCCCCeEeeccCCCCE
Q 042346 575 --DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH--------NYAVPSIIHRDIKSSNI 644 (812)
Q Consensus 575 --~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH--------~~~~~~ivHrDlKp~NI 644 (812)
...++||||+++|+|.++++... +++..+++++.||+.||+||| +.+ |+||||||+||
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Ni 144 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLTT---------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNI 144 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTCC---------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGE
T ss_pred CCceeEEehhhccCCCHHHHHhhcc---------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhE
Confidence 34789999999999999995432 367888999999999999999 766 99999999999
Q ss_pred EEcCCCcEEEEeecccccCCCCccc--ccccccccCCCccCccccccC------cCCCcchhHHHHHHHHHHHcC-----
Q 042346 645 LLDVNWTARVSDFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVMN------VLTAKTDIYGLGVVLLELLTG----- 711 (812)
Q Consensus 645 Ll~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDVwS~Gvvl~elltG----- 711 (812)
|++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 145 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~ 224 (301)
T 3q4u_A 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224 (301)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcc
Confidence 9999999999999999754332221 112345799999999999876 566799999999999999999
Q ss_pred -----CCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 712 -----KKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 712 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+.||............. ........ ....+ ++.......+..+.+|+.+||+.||++|||++||++.
T Consensus 225 ~~~~~~~pf~~~~~~~~~~~~~---~~~~~~~~----~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 225 IVEDYKPPFYDVVPNDPSFEDM---RKVVCVDQ----QRPNI-PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHH---HHHHTTSC----CCCCC-CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccccccccCCCCcchhhh---hHHHhccC----CCCCC-ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 77775543322222111 11111111 01111 1111234577889999999999999999999999999
Q ss_pred HHHH
Q 042346 787 LERA 790 (812)
Q Consensus 787 Le~~ 790 (812)
|+++
T Consensus 297 L~~i 300 (301)
T 3q4u_A 297 LTKI 300 (301)
T ss_dssp HHHH
T ss_pred Hhcc
Confidence 9875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=376.66 Aligned_cols=272 Identities=25% Similarity=0.376 Sum_probs=212.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
.++|++.+.||+|+||.||+|++. +++.||||++.... .......+.+|+.++++++||||+++++++.+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc----ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 457999999999999999999853 46789999985321 23344568889999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC---
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW--- 650 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~--- 650 (812)
....++||||+++|+|.+++......... ...+++..+++++.||++||+|||+++ |+||||||+|||++.++
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQ-PSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCc-cccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCc
Confidence 99999999999999999999876543222 123478889999999999999999998 99999999999999554
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 729 (812)
.+||+|||+++...............+|+.|+|||++.+..++.++|||||||+||||++ |+.||..... .
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~ 293 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------Q 293 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------H
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 599999999974322222222334568999999999999999999999999999999998 8888854321 1
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.....+..+. +...+ ..++..+.+|+.+||+.||++|||+.||+++|+.+.+.....+
T Consensus 294 ~~~~~i~~~~-------~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~ 351 (367)
T 3l9p_A 294 EVLEFVTSGG-------RMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351 (367)
T ss_dssp HHHHHHHTTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHT
T ss_pred HHHHHHHcCC-------CCCCC----ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhcc
Confidence 1222222221 11111 2234458899999999999999999999999999887655444
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=365.04 Aligned_cols=269 Identities=25% Similarity=0.387 Sum_probs=214.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ 572 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 572 (812)
..++|.+.+.||+|+||.||++++. +++.||||++.... .....+.+.+|+++++.++||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 4567999999999999999999862 35789999986422 2334567889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCc----------------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEK----------------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIH 636 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~----------------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivH 636 (812)
+.+..++||||+++++|.+++........ .....+++..+++++.||++||+|||+++ |+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 99999999999999999999987543210 01123578889999999999999999998 999
Q ss_pred eccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCC
Q 042346 637 RDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAV 715 (812)
Q Consensus 637 rDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~ 715 (812)
|||||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986654433333344567889999999999999999999999999999999 99988
Q ss_pred CCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 716 FKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
..... ..+. ..+..+. .... ....++.+.+++.+||+.||++|||+.|++++|+++++.
T Consensus 254 ~~~~~----~~~~----~~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 254 PGIPP----ERLF----NLLKTGH-------RMER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TTCCG----GGHH----HHHHTTC-------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCH----HHHH----HHhhcCC-------cCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 54321 1111 1122211 1111 123345688999999999999999999999999998874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=360.92 Aligned_cols=269 Identities=21% Similarity=0.351 Sum_probs=204.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
.++|++.+.||+|+||.||++++ .+++.||||++... ..+..+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 35699999999999999999985 25889999998642 233456788999999999999999999998653
Q ss_pred --CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 575 --DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 575 --~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
...++||||+++++|.+++..... .+++..+++++.|++.||+|||+.+ |+||||||+|||++.++++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 153 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEE
T ss_pred CCCceEEEEEeCCCCCHHHHHHhccc-------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeE
Confidence 457999999999999999976532 2367788999999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCC--------CCC
Q 042346 653 RVSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED--------GSG 723 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~--------~~~ 723 (812)
||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... ...
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~ 233 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCC
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccc
Confidence 99999999865443221 223344577889999999999999999999999999999999988743210 000
Q ss_pred CchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
...........+..+. +... +..+++.+.+|+.+||+.||++|||++|+++.|+++++..
T Consensus 234 ~~~~~~~~~~~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 234 GQMIVFHLIELLKNNG-------RLPR----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp THHHHHHHHHHHHTTC-------CCCC----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cchhHHHHHHHHhccC-------cCCC----CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0111111111111111 1111 1234456889999999999999999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=361.47 Aligned_cols=266 Identities=26% Similarity=0.374 Sum_probs=206.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++. +++.||+|++..... ...+..+.|.+|++++++++||||+++++++.+++..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR--EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc--ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 467999999999999999999874 589999999854322 22344567899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGP--------LSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEeCCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999976532 367788899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+..... ...
T Consensus 157 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~~~-~~~ 227 (294)
T 4eqm_A 157 IAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-------VSIAIKH-IQD 227 (294)
T ss_dssp SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-------HHHHHHH-HSS
T ss_pred Ccccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHH-hhc
Confidence 997654322 1223345799999999999999999999999999999999999999854321 1111111 111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHHhc
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-NITDIVANLERALAIC 794 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~Le~~~~~~ 794 (812)
...... .......++.+.+++.+||+.||++|| +++++.+.|++++...
T Consensus 228 ~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 228 SVPNVT-------TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CCCCHH-------HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred cCCCcc-------hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 111000 000123456688999999999999998 9999999988766543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=363.11 Aligned_cols=274 Identities=24% Similarity=0.358 Sum_probs=216.2
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEE------cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKL------MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGF 570 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 570 (812)
...++|++.+.||+|+||.||+|++ .+++.||+|++.... .....+.+.+|+++++++ +||||++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 3456799999999999999999985 246789999986422 123456788999999999 99999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCC----------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccC
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTE----------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIK 640 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlK 640 (812)
+.+++..++||||+++++|.+++....... ......+++..+++++.||++||+|||+++ |+|||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 999999999999999999999998764321 011123578889999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCC
Q 042346 641 SSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNE 719 (812)
Q Consensus 641 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~ 719 (812)
|+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||++||||++ |+.||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999987655433333444567889999999999899999999999999999999 888885432
Q ss_pred CCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 720 DGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
.. .. ....+..+ .. ... ....+..+.+++.+||+.||.+|||++|++++|+++++...+
T Consensus 253 ~~----~~---~~~~~~~~-~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 253 VD----SK---FYKMIKEG-FR------MLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp SS----HH---HHHHHHHT-CC------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred ch----hH---HHHHhccC-CC------CCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 11 11 11111111 11 011 122345688999999999999999999999999999887554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=356.92 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=206.5
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..++|++.+.||+|+||.||++++.+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+++..+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC------CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 4567999999999999999999998888999999874322 1245789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... .+++..+++++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRH-------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGG-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTT
T ss_pred EEEeccCCCcHHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccc
Confidence 99999999999999975322 1367788999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+..
T Consensus 166 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~ 236 (283)
T 3gen_A 166 LSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQ 236 (283)
T ss_dssp GGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHT
T ss_pred ccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHHhc
Confidence 997654321 122334457788999999998899999999999999999998 9989854321 111222222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+. +...+. ..++.+.+++.+||+.||++|||++|++++|+++++.
T Consensus 237 ~~-------~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 237 GL-------RLYRPH----LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TC-------CCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cc-------CCCCCC----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11 111111 1234588999999999999999999999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=367.28 Aligned_cols=259 Identities=22% Similarity=0.425 Sum_probs=198.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcE----EEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGRE----VAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
++|++.++||+|+||.||+|++. +++. ||+|++.. .......+.|.+|++++++++||||+++++++.++.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 46999999999999999999874 3443 57777642 122334567889999999999999999999998754
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
.++|+||+++|+|.+++...... +++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~ 159 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDN-------IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTS-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEEC
T ss_pred -eEEEEEecCCCcHHHHHHhcCCC-------CCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEc
Confidence 78999999999999999765432 367788999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+. ..
T Consensus 160 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~----~~ 231 (327)
T 3poz_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEIS----SI 231 (327)
T ss_dssp CTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHH----HH
T ss_pred cCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH----HHHH----HH
Confidence 9999976554433333444567889999999999999999999999999999999 9999854321 1111 11
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+..+. +...+ ...+..+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 232 ~~~~~-------~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 232 LEKGE-------RLPQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHTTC-------CCCCC----TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHcCC-------CCCCC----ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11111 11111 22344588899999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=362.97 Aligned_cols=261 Identities=23% Similarity=0.343 Sum_probs=209.1
Q ss_pred CCCHHHHHHhcCC----------cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHh
Q 042346 490 NFTLSELAAATNN----------FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSR 558 (812)
Q Consensus 490 ~~~~~el~~~~~~----------~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 558 (812)
.++.+++..+.+. |...+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRD 98 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CSHHHHHHHHHHHTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-----hHHHHHHHHHHHHHh
Confidence 4566666665543 777889999999999999986 699999999864221 223467899999999
Q ss_pred ccCCCceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeec
Q 042346 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRD 638 (812)
Q Consensus 559 l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrD 638 (812)
++||||+++++++...+..++||||+++++|.+++.... +++..++.++.|+++||+|||+.+ |+|||
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 166 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---------LNEEQIATVCEAVLQALAYLHAQG---VIHRD 166 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 999999999999999999999999999999999986432 367888999999999999999998 99999
Q ss_pred cCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCC
Q 042346 639 IKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN 718 (812)
Q Consensus 639 lKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~ 718 (812)
|||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876544221 234567999999999999999999999999999999999999998543
Q ss_pred CCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 719 EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. . .....+.... .+.+ ......+..+.+++.+||+.||++|||++|++++
T Consensus 245 ~~----~----~~~~~~~~~~-----~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 245 SP----V----QAMKRLRDSP-----PPKL----KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CH----H----HHHHHHHHSS-----CCCC----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CH----H----HHHHHHhcCC-----CCCc----CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 21 1 1112222211 1111 1122345568899999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=372.73 Aligned_cols=262 Identities=24% Similarity=0.459 Sum_probs=198.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|++.+.||+|+||.||+|++. ++..||||++.... .....+.|.+|++++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 356999999999999999999875 57789999986421 2334567899999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.++++.... .+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~ 189 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDA-------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 189 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred ceEEEEeCCCCCcHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEEC
Confidence 99999999999999999975432 1367888999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||+++........ .......+++.|+|||++....++.++||||||++||||++ |+.||..... .....
T Consensus 190 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~ 261 (373)
T 2qol_A 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIK 261 (373)
T ss_dssp CC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHH
T ss_pred cCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 99999765442221 11222345788999999999999999999999999999998 9999854321 11112
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
.+..+. +...+ ...+..+.+++.+||+.||++||+++||++.|+++++..
T Consensus 262 ~i~~~~-------~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 262 AVDEGY-------RLPPP----MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHTTE-------ECCCC----TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHcCC-------CCCCC----ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 222211 11111 233456889999999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=365.61 Aligned_cols=255 Identities=24% Similarity=0.299 Sum_probs=202.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++. +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc----ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 467999999999999999999886 68999999986421 1223456789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... +++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIG--------MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 150 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTB--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHhhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEee
Confidence 99999999999999965432 366778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcC-CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++................||+.|+|||++.+..+ +.++||||||++||||++|+.||....... .. ......
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~-----~~~~~~ 223 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QE-----YSDWKE 223 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--HH-----HHHHHT
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--HH-----HHHHhc
Confidence 9976544333333456689999999999987765 778999999999999999999996543211 11 111111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ...........+.+|+.+||+.||++|||++|++++
T Consensus 224 ~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 224 KKT----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TCT----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccc----------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 110 001123345567899999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=352.77 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=208.2
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..++|++.+.||+|+||.||+++++++..||+|++..... ..+.+.+|++++++++||||+++++++.+++..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC------cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 3467999999999999999999998888999999864221 1245889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg 149 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGK-------GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFG 149 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCc
Confidence 99999999999999976422 2367888999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~ 220 (268)
T 3sxs_A 150 MTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEVVLKVSQ 220 (268)
T ss_dssp CEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHT
T ss_pred cceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHHHHHHHc
Confidence 9976544322 22334456788999999999899999999999999999999 9988843221 111112222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
+. ....+. ..++.+.+++.+||+.||++|||++|++++|+.+.+
T Consensus 221 ~~-------~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 221 GH-------RLYRPH----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TC-------CCCCCT----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CC-------CCCCCC----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11 111111 123458899999999999999999999999988654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=366.36 Aligned_cols=277 Identities=25% Similarity=0.379 Sum_probs=197.2
Q ss_pred HHHHhcCCcceeeeeccCCcEEEEEEEEcCC----cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEE
Q 042346 495 ELAAATNNFSLENKVGIGSFGTVYKGKLMDG----REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGF 570 (812)
Q Consensus 495 el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 570 (812)
++....++|++.+.||+|+||.||+|++... ..||||++.... ......+.+.+|++++++++||||++++++
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI---IASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc---cCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 3344567899999999999999999986543 279999986421 122335678899999999999999999999
Q ss_pred EEeCCeE------EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCE
Q 042346 571 CQEKDER------LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNI 644 (812)
Q Consensus 571 ~~~~~~~------~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NI 644 (812)
+...... ++||||+++++|.+++........ ...+++..+++++.||++||+|||+++ |+||||||+||
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NI 168 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN--PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNC 168 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhcccc--ccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceE
Confidence 9887665 999999999999999975432211 112477888999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 042346 645 LLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSG 723 (812)
Q Consensus 645 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~ 723 (812)
|++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--- 245 (323)
T 3qup_A 169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--- 245 (323)
T ss_dssp EECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---
T ss_pred EEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh---
Confidence 999999999999999976554333333344567889999999999999999999999999999999 8888754321
Q ss_pred CchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.... ..+..+. .... ....++.+.+|+.+||+.||++|||+.|+++.|+++++...-.+
T Consensus 246 -~~~~----~~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 246 -AEIY----NYLIGGN-------RLKQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp -GGHH----HHHHTTC-------CCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred -HHHH----HHHhcCC-------CCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 1111 1122211 1111 12334568899999999999999999999999999987654444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=361.16 Aligned_cols=273 Identities=25% Similarity=0.405 Sum_probs=214.4
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc--------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM--------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVG 569 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~ 569 (812)
..++|++.+.||+|+||.||+|++. +++.||+|++.... .......+.+|+++++++ +||||+++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 3467999999999999999999873 46789999986422 233456788999999999 8999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhhcCCCCCcc--------ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCC
Q 042346 570 FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKN--------SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKS 641 (812)
Q Consensus 570 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~--------~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp 641 (812)
++.+.+..++||||+++++|.+++......... ....+++..+++++.||++||+|||+.+ |+||||||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 185 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCcc
Confidence 999999999999999999999999875432110 1123478889999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCC
Q 042346 642 SNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNED 720 (812)
Q Consensus 642 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~ 720 (812)
+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~- 264 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP- 264 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-
Confidence 999999999999999999986654333333344567889999999998899999999999999999999 888884322
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccC
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDC 797 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~ 797 (812)
.......+..+.. ...+ ...+..+.+++.+||+.||++|||++|+++.|++++....+.
T Consensus 265 -------~~~~~~~~~~~~~-------~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 265 -------VEELFKLLKEGHR-------MDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp -------HHHHHHHHHHTCC-------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -------HHHHHHHHhcCCC-------CCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 1112222222211 1111 223456889999999999999999999999999999876653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=360.52 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=203.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.+ +++.||+|++... ..........+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE--VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHH--HhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 56999999999999999999985 5899999998631 11122334567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... ++....+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 v~E~~~gg~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERV--------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EEECCTTCBHHHHHHHHSC--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeCCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999976432 255677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+..+.
T Consensus 152 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~ 221 (337)
T 1o6l_A 152 CKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE 221 (337)
T ss_dssp CBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC
T ss_pred hhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC
Confidence 97543221 12345679999999999999999999999999999999999999985432 111222222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
+..+. ..+..+.+|+.+||+.||++|| +++|++++
T Consensus 222 --------~~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 --------IRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------CCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------CCCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11121 2345678899999999999999 99999886
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=363.13 Aligned_cols=253 Identities=17% Similarity=0.247 Sum_probs=204.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++. +++.+|+|++... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 467999999999999999999985 5889999988642 123346789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC--CCcEEEEe
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV--NWTARVSD 656 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--~~~~kl~D 656 (812)
+||||+++++|.+++..... .+++...+.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|
T Consensus 78 lv~e~~~g~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~D 147 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAF-------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEE
Confidence 99999999999999965432 1366778899999999999999998 999999999999987 78999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||++....... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.
T Consensus 148 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~ 216 (321)
T 1tki_A 148 FGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIM 216 (321)
T ss_dssp CTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH
T ss_pred CCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHH
Confidence 99998765422 23345789999999999998899999999999999999999999854321 11222222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.+.. ..+.....+.+..+.+|+.+||..||++|||+.|++++-
T Consensus 217 ~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 217 NAEY--------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HTCC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cCCC--------CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 2221 111101123456688999999999999999999999853
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=381.26 Aligned_cols=263 Identities=24% Similarity=0.401 Sum_probs=210.0
Q ss_pred HHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 496 LAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 496 l~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
++...++|++.+.||+|+||.||+|++++++.||||++.... ...+.|.+|++++++++||||+++++++. .+
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS------MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS------BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC------ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 344567799999999999999999999889999999986422 12457889999999999999999999986 56
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++|+|.++|+.... ..+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~ 326 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEG------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIA 326 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHH------HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEEC
T ss_pred ccEEEEeecCCCcHHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEe
Confidence 78999999999999999975421 12356778899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++...... ........++..|+|||++....++.++||||||++||||+| |+.||.... ..+ ....
T Consensus 327 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~----~~~----~~~~ 397 (454)
T 1qcf_A 327 DFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPE----VIRA 397 (454)
T ss_dssp STTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHH----HHHH
T ss_pred eCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC----HHH----HHHH
Confidence 999998654321 112233456789999999998899999999999999999999 999985322 111 1222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
+..+. ++..+ ..+++.+.+|+.+||+.||++|||+++|++.|+.+....
T Consensus 398 i~~~~-------~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 398 LERGY-------RMPRP----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHHTC-------CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHcCC-------CCCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 22221 12222 234556889999999999999999999999999876544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.87 Aligned_cols=280 Identities=24% Similarity=0.361 Sum_probs=219.0
Q ss_pred CCHHHHHHhcCCcceeeeeccCCcEEEEEEEE------cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCC
Q 042346 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKL------MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKH 563 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~n 563 (812)
+...++....++|++.+.||+|+||.||++++ .+++.||||++.... .....+.+.+|+++++++ +|||
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----CcHHHHHHHHHHHHHHhcccCCC
Confidence 44556666778899999999999999999985 246889999986422 223445788999999999 7999
Q ss_pred ceEEEEEEEeCCe-EEEEEEecCCCchhhhhhcCCCCCcc--------ccccccHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042346 564 LVGLVGFCQEKDE-RLLVYEYMSNGALHDHLHNKNNTEKN--------SSIVNSWKMRIRIALDAARGIDYLHNYAVPSI 634 (812)
Q Consensus 564 Iv~l~~~~~~~~~-~~lV~ey~~~gsL~~~l~~~~~~~~~--------~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~i 634 (812)
|+++++++.+.+. .++||||+++++|.+++......... ....+++..++.++.||++||.|||+.+ |
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 9999999887654 89999999999999999876532110 0112478889999999999999999998 9
Q ss_pred EeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCC
Q 042346 635 IHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK 713 (812)
Q Consensus 635 vHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~ 713 (812)
+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986654333333445578899999999999999999999999999999998 998
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 714 AVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 714 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
||...... +.....+..+.. ...+. ..+..+.+++.+||+.||.+|||+.|++++|+.+++.
T Consensus 250 p~~~~~~~-------~~~~~~~~~~~~-------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 250 PYPGVKID-------EEFCRRLKEGTR-------MRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp SSTTCCCS-------HHHHHHHHHTCC-------CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccchh-------HHHHHHhccCcc-------CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 88543211 111222222211 11111 1334578899999999999999999999999999876
Q ss_pred cc
Q 042346 794 CQ 795 (812)
Q Consensus 794 ~~ 795 (812)
..
T Consensus 312 ~~ 313 (316)
T 2xir_A 312 NA 313 (316)
T ss_dssp HC
T ss_pred hc
Confidence 54
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=367.73 Aligned_cols=280 Identities=18% Similarity=0.164 Sum_probs=209.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHH------HHHHHHHHHHHHHHhccCCCceE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLR------EKESAFDSELALLSRVHHKHLVG 566 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~ 566 (812)
..++|++.+.||+|+||.||+|++.+ ++.||||++.......... .....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34579999999999999999998865 4789999986533211110 01123445677788889999999
Q ss_pred EEEEEEeC----CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 567 LVGFCQEK----DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 567 l~~~~~~~----~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
+++++.+. ...+|||||+ +++|.+++..... .+++..+++|+.||+.||+|||+++ |+||||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~-------~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~ 181 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK-------RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKAS 181 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHH
Confidence 99998764 3479999999 9999999976432 2377888999999999999999998 999999999
Q ss_pred CEEEc--CCCcEEEEeecccccCCCCcccc-----cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCC
Q 042346 643 NILLD--VNWTARVSDFGLSLLGSECDQEF-----ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAV 715 (812)
Q Consensus 643 NILl~--~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~ 715 (812)
|||++ .++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||++||||++|+.||
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999 88999999999997654322211 113345999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcc
Q 042346 716 FKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795 (812)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 795 (812)
...... ........ ......+..+++..+.. ...+..+.+++.+||+.||++||++++|++.|+++++...
T Consensus 262 ~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 262 EDNLKD---PKYVRDSK-IRYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp GGGTTC---HHHHHHHH-HHHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccccC---HHHHHHHH-HHhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 643221 11111111 11112223333322211 1224568899999999999999999999999999998765
Q ss_pred cCC
Q 042346 796 DCS 798 (812)
Q Consensus 796 ~~~ 798 (812)
...
T Consensus 333 ~~~ 335 (364)
T 3op5_A 333 SKD 335 (364)
T ss_dssp CCC
T ss_pred CCc
Confidence 443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=366.59 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=205.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhH-HHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKL-REKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
..++|++.+.||+|+||.||+++.. +++.||+|++......... ....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3457999999999999999999985 5899999998753322110 1124568899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC----cE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW----TA 652 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~ 652 (812)
.++||||+++++|.+++..... +++...+.++.||+.||.|||+++ |+||||||+|||++.++ .+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKES--------LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSC--------CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCE
T ss_pred EEEEEEcCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCE
Confidence 9999999999999999965432 366778899999999999999998 99999999999998877 79
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....
T Consensus 159 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~ 227 (361)
T 2yab_A 159 KLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETL 227 (361)
T ss_dssp EECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHH
T ss_pred EEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 999999997654422 23456799999999999998999999999999999999999999854321 1122
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+..+.+ ..+.......++.+.+||.+||..||++|||++|++++
T Consensus 228 ~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 228 ANITAVSY--------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHTTCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhcCC--------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22222211 11100112334568899999999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.65 Aligned_cols=261 Identities=24% Similarity=0.393 Sum_probs=196.9
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
..++|++.+.||+|+||.||+|++.. +..||+|++.... .....+.+.+|+.++++++||||+++++++. +
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 44679999999999999999998743 4569999876421 2344567889999999999999999999984 4
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
+..++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKY-------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKL 157 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT-------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEE
T ss_pred CccEEEEecCCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEE
Confidence 568999999999999999976532 1367788899999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
+|||+++....... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||..... .+.. .
T Consensus 158 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~----~~~~----~ 228 (281)
T 1mp8_A 158 GDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVI----G 228 (281)
T ss_dssp CC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHH----H
T ss_pred CccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH----HHHH----H
Confidence 99999976543221 12234457789999999998899999999999999999997 8888854321 1111 1
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
.+..+. +... ....+..+.+++.+||+.||++|||+.|++++|+++++.-
T Consensus 229 ~i~~~~-------~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 229 RIENGE-------RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHTTC-------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHcCC-------CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 222221 1111 1233456889999999999999999999999999988753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.13 Aligned_cols=277 Identities=22% Similarity=0.331 Sum_probs=204.7
Q ss_pred CHHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHh--ccCCCceEEEE
Q 042346 492 TLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSR--VHHKHLVGLVG 569 (812)
Q Consensus 492 ~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~ 569 (812)
.........++|++.+.||+|+||.||+|++. ++.||||++... ....+.+|.+++.. ++||||+++++
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--------~~~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT--------EEASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG--------GHHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc--------ccchhhhHHHHHHHHhhcCCCeeeEEE
Confidence 34444455678999999999999999999984 899999998531 11233345555544 49999999999
Q ss_pred EEEeC----CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcC-----CCCeEeeccC
Q 042346 570 FCQEK----DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYA-----VPSIIHRDIK 640 (812)
Q Consensus 570 ~~~~~----~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~-----~~~ivHrDlK 640 (812)
++.+. ...++||||+++++|.++++... +++..+++++.|++.||+|||++. .++|+|||||
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHHCC---------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCC
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccc
Confidence 99987 67899999999999999996542 367788999999999999999981 1129999999
Q ss_pred CCCEEEcCCCcEEEEeecccccCCCCccc--ccccccccCCCccCccccccCcCCCc------chhHHHHHHHHHHHcC-
Q 042346 641 SSNILLDVNWTARVSDFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVMNVLTAK------TDIYGLGVVLLELLTG- 711 (812)
Q Consensus 641 p~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k------sDVwS~Gvvl~elltG- 711 (812)
|+|||++.++.+||+|||++......... .......||+.|+|||++.+..++.+ +||||||+++|||++|
T Consensus 170 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 99999999999999999999765432221 11234579999999999987766665 9999999999999999
Q ss_pred ---------CCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHH
Q 042346 712 ---------KKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITD 782 (812)
Q Consensus 712 ---------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 782 (812)
+.||........... ..........+ .... +......++++.+.+|+.+||+.||++|||++|
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~----~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (337)
T 3mdy_A 250 VSGGIVEEYQLPYHDLVPSDPSYE---DMREIVCIKKL----RPSF-PNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321 (337)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHH---HHHHHHTTSCC----CCCC-CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CcccccccccccHhhhcCCCCchh---hhHHHHhhhcc----Cccc-cccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence 555543322221111 11111111111 1111 111123477888999999999999999999999
Q ss_pred HHHHHHHHHHhc
Q 042346 783 IVANLERALAIC 794 (812)
Q Consensus 783 vl~~Le~~~~~~ 794 (812)
|+++|+++.+..
T Consensus 322 ll~~L~~l~~~~ 333 (337)
T 3mdy_A 322 VKKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHhhc
Confidence 999999988754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.84 Aligned_cols=275 Identities=23% Similarity=0.366 Sum_probs=210.6
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEE
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVG 569 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~ 569 (812)
....++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+.+|+++++++ +||||+++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 345578999999999999999999862 35689999986321 223346788999999999 8999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhhcCCCCCc---------------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042346 570 FCQEKDERLLVYEYMSNGALHDHLHNKNNTEK---------------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSI 634 (812)
Q Consensus 570 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~---------------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~i 634 (812)
++.+.+..++||||+++|+|.+++........ .....+++..+++++.||+.||+|||+++ |
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 193 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---C 193 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 99999999999999999999999986543210 01123578889999999999999999998 9
Q ss_pred EeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCC
Q 042346 635 IHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKK 713 (812)
Q Consensus 635 vHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~ 713 (812)
+||||||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||++||||+| |+.
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999976544333333445567889999999998899999999999999999998 999
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 714 AVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 714 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
||...... .. ....+..+ . +...+ ...++.+.+|+.+||+.||.+|||+.|++++|+.+++.
T Consensus 274 p~~~~~~~----~~---~~~~~~~~-~------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 274 PYPGIPVD----AN---FYKLIQNG-F------KMDQP----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SSTTCCCS----HH---HHHHHHTT-C------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcccCCcH----HH---HHHHHhcC-C------CCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 98543211 11 11111111 1 11111 12345688999999999999999999999999998876
Q ss_pred ccc
Q 042346 794 CQD 796 (812)
Q Consensus 794 ~~~ 796 (812)
..+
T Consensus 336 ~~~ 338 (344)
T 1rjb_A 336 AEE 338 (344)
T ss_dssp ---
T ss_pred HHH
Confidence 654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=367.96 Aligned_cols=260 Identities=24% Similarity=0.337 Sum_probs=202.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 577 (812)
.++|++.++||+|+||.||+++++ +++.||+|++.... ....+....+.+|..++.++ +||||+++++++.+++..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~--~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL--VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGG--TC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh--ccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 356999999999999999999986 47889999986421 11223344677899999887 899999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+|||||+++|+|.+++..... +++.....++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~--------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRK--------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeec
Confidence 999999999999999976532 356777889999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCC-chhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP-LDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~ 736 (812)
|+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||......... ....+.....+.
T Consensus 198 Gla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~ 275 (396)
T 4dc2_A 198 GMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275 (396)
T ss_dssp TTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred ceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence 9997533221 2244568999999999999999999999999999999999999999643322111 111222233333
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI------TDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 786 (812)
... +..|. .....+.+|+.+||+.||++||++ +|++++
T Consensus 276 ~~~--------~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 276 EKQ--------IRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HCC--------CCCCT----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ccc--------cCCCC----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 322 11222 234457889999999999999985 677664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=361.65 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=201.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|.+.+.||+|+||.||+|++ .+++.||+|++... .....+....+.+|+++++.++||||+++++++.+.+..+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehH--HccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 35799999999999999999997 46899999998631 1111122356889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+ +|+|.+++..... +++...++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 86 lv~E~~-~g~l~~~l~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKR--------MTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EEEECC-CCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEec
Confidence 999999 7899999876532 356778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcC-CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++....... ......||+.|+|||++.+..+ ++++||||||++||||++|+.||........
T Consensus 154 ~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------- 216 (336)
T 3h4j_B 154 LSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------- 216 (336)
T ss_dssp CTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--------------
T ss_pred cceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--------------
Confidence 997654422 2345579999999999988776 6899999999999999999999965332110
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
...+.......+ ...+..+.+|+.+||..||.+|||++|++++-
T Consensus 217 --~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 217 --FKKVNSCVYVMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp --BCCCCSSCCCCC----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred --HHHHHcCCCCCc----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 011111111112 22345578999999999999999999999763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=369.58 Aligned_cols=260 Identities=21% Similarity=0.316 Sum_probs=202.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++++. +++.||||++.............+.+.+|+++++.++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46999999999999999999875 58999999985311111101124578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc---EEEEe
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT---ARVSD 656 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kl~D 656 (812)
||||+++++|.+++....... ..++......++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAG----FVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECC
T ss_pred EEeCCCCCCHHHHHHHhcccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEec
Confidence 999999999999886542211 12356777899999999999999998 999999999999987654 99999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||++....... .......||+.|+|||++.+..++.++||||||++||||++|+.||.... +.....+.
T Consensus 177 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~ 245 (351)
T 3c0i_A 177 FGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGII 245 (351)
T ss_dssp CTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHH
T ss_pred CcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHH
Confidence 99997654422 12345579999999999999999999999999999999999999985421 11222222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+... .+.......++.+.+|+.+||..||++|||+.|++++
T Consensus 246 ~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 246 KGKYK--------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HTCCC--------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCC--------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22211 0000011235668899999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=373.55 Aligned_cols=256 Identities=19% Similarity=0.283 Sum_probs=205.0
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||++... +++.+|+|++..... .....+.+.+|+++++.++||||+++++++.+++..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC---HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 3456999999999999999999874 689999999865322 233456788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc---CCCcEEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD---VNWTARV 654 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kl 654 (812)
++||||+++|+|.+++..... ++......++.||+.||+|||+++ |+||||||+|||++ .++.+||
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~--------~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREY--------YSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSC--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEE
T ss_pred EEEEEeCCCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEE
Confidence 999999999999999976543 256777899999999999999998 99999999999998 4678999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+|||++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||.... .......
T Consensus 155 ~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~~~~~ 224 (444)
T 3soa_A 155 ADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------QHRLYQQ 224 (444)
T ss_dssp CCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH
T ss_pred ccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHHHHHH
Confidence 99999976554222 2345679999999999999899999999999999999999999985432 1122233
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..+... .+.......++.+.+|+.+||+.||++|||+.|++++
T Consensus 225 i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 225 IKAGAYD--------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHTCCC--------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCCCC--------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 3333221 1111112345568899999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=375.06 Aligned_cols=255 Identities=26% Similarity=0.451 Sum_probs=206.1
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-e
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD-E 576 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~ 576 (812)
...++|++.+.||+|+||.||+|++ .++.||||++.... ..+.|.+|++++++++||||+++++++.+.+ .
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 3456799999999999999999998 47899999986421 2356889999999999999999999988765 6
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++|+|.++++..... .+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D 332 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRS------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD 332 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEEecCCCcHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEee
Confidence 89999999999999999865432 2356778899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
||+++..... .....+++.|+|||.+.+..++.++||||||++||||++ |+.||..... .++. ..+
T Consensus 333 fG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~----~~i 399 (450)
T 1k9a_A 333 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVV----PRV 399 (450)
T ss_dssp CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT----TTHH----HHH
T ss_pred CCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHH----HHH
Confidence 9999754321 122367889999999999999999999999999999998 9999854322 1222 222
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
..+. ++..+ ..++..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 400 ~~~~-------~~~~p----~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 400 EKGY-------KMDAP----DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HTTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HcCC-------CCCCC----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 2221 12222 23445688999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=365.66 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=205.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||++.+. +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+++..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3457999999999999999999875 589999999864322 223445788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC---CcEEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN---WTARV 654 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl 654 (812)
++||||+++++|.+++..... +++...+.++.||+.||+|||+++ |+||||||+|||++.+ +.+||
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~--------~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREF--------YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSC--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEE
Confidence 999999999999999975432 356778899999999999999998 9999999999999765 45999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~ 241 (362)
T 2bdw_A 173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQ 241 (362)
T ss_dssp CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred eecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 9999997655322 23346799999999999998999999999999999999999999854321 112223
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..+.. ..+.......+..+.+|+.+||..||++|||+.|++++
T Consensus 242 i~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 242 IKAGAY--------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHTCC--------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHhCCC--------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 333321 11111123445668899999999999999999999876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.86 Aligned_cols=264 Identities=29% Similarity=0.471 Sum_probs=196.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..++|++.++||+|+||.||++++. ..||+|++..... .....+.|.+|++++++++||||+++++++ .....+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 4567999999999999999999863 4699999864322 234456788999999999999999999965 456689
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... .+++..+++++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASET-------KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp EEEECCCEEEHHHHHTTC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC
T ss_pred EEEEecCCCcHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccce
Confidence 99999999999999965432 2367888999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
++................||+.|+|||.+. ...++.++||||||+++|||++|+.||..... .+.....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~ 238 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIEMV 238 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-------HHHHHHHH
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-------HHHHHHHh
Confidence 997654433333344567999999999986 56788899999999999999999999854321 11122222
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
..+.....+ ......+++.+.+|+.+||+.||++|||++|+++.|+++.+
T Consensus 239 ~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 239 GRGSLSPDL-------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHTSCCCCT-------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccccCcch-------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 222211111 11112345678899999999999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=363.58 Aligned_cols=252 Identities=24% Similarity=0.298 Sum_probs=199.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 577 (812)
.++|++.+.||+|+||.||+++++ +++.||||++... ........+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~--~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD--VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--HHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHH--HhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 467999999999999999999975 5899999998631 112233445678899999988 799999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+|||||+++|+|.+++..... ++......++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRR--------FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeCCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccc
Confidence 999999999999999976533 256777889999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ......+..
T Consensus 169 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~ 238 (353)
T 3txo_A 169 GMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILN 238 (353)
T ss_dssp TTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH
T ss_pred cceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHc
Confidence 9997533221 223456799999999999999999999999999999999999999854321 122223333
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI------TDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 786 (812)
+. ...+. .....+.+|+.+||+.||++||++ +|++++
T Consensus 239 ~~--------~~~p~----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 239 DE--------VVYPT----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CC--------CCCCT----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CC--------CCCCC----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 22 11222 234457789999999999999998 788764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=346.73 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=209.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.++|++.+.||+|+||.||++++.+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+++..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence 457999999999999999999998899999999875322 12468899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... .+++..+++++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 v~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRG-------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp EECCCTTCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred EEeCCCCCcHHHHHhhCcc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccc
Confidence 9999999999999976532 1366778899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+...... .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+..+
T Consensus 151 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~~~ 221 (267)
T 3t9t_A 151 TRFVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTG 221 (267)
T ss_dssp GGGBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTT
T ss_pred ccccccc-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHhcC
Confidence 9765431 1122234467889999999998899999999999999999999 888875322 11122222222
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
. +...+ ...+..+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 222 ~-------~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 222 F-------RLYKP----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp C-------CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C-------cCCCC----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 11111 12345688999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=366.23 Aligned_cols=275 Identities=20% Similarity=0.248 Sum_probs=203.0
Q ss_pred cCCcceeeeeccC--CcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 500 TNNFSLENKVGIG--SFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G--~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
.++|++.++||+| +||.||++++. +++.||||++.... ...+..+.+.+|+++++.++||||+++++++.+++.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA---CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 4569999999999 99999999986 68999999986422 223455678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++++|.+++....... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDG------MNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTC------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred EEEEEEccCCCCHHHHHhhhcccC------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 999999999999999997653222 366778899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcc-----cccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 657 FGLSLLGSECDQ-----EFISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 657 fGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 998864322111 112233478999999999987 6799999999999999999999999965332211000000
Q ss_pred HHHHHHHhc-------------------cccccccc---c----CCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 042346 730 FAVSQILAG-------------------QLHCVLDK---R----VGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783 (812)
Q Consensus 730 ~~~~~~~~~-------------------~~~~~~d~---~----~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 783 (812)
.....+... .+...+.. + ..........+...+.+|+.+||+.||++|||++|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 000000000 00000000 0 000001123345678899999999999999999999
Q ss_pred HHH
Q 042346 784 VAN 786 (812)
Q Consensus 784 l~~ 786 (812)
+++
T Consensus 332 l~h 334 (389)
T 3gni_B 332 LNH 334 (389)
T ss_dssp TTS
T ss_pred hcC
Confidence 976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=347.57 Aligned_cols=258 Identities=29% Similarity=0.477 Sum_probs=194.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.++|++.+.||+|+||.||++++ .++.||||++...... ......+.+.+|+++++.++||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 46799999999999999999998 4899999997642211 112334678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC--------CCc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV--------NWT 651 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--------~~~ 651 (812)
||||+++++|.+++.... +++...++++.|+++||+|||+++..+|+||||||+|||++. ++.
T Consensus 84 v~e~~~~~~L~~~~~~~~---------~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGKR---------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EEECCTTEEHHHHHTSSC---------CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEEcCCCCCHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 999999999999996432 256778899999999999999998556899999999999986 778
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
+||+|||++....... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||..... .. .
T Consensus 155 ~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~ 222 (271)
T 3dtc_A 155 LKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------LA-V 222 (271)
T ss_dssp EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-------HH-H
T ss_pred eEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH-H
Confidence 9999999997544322 2245789999999999998999999999999999999999999854221 11 1
Q ss_pred HHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 732 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
.......... ... +...++.+.+++.+||+.||++|||++|++++|+++
T Consensus 223 ~~~~~~~~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 AYGVAMNKLA------LPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHTSCCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHhhhcCCCC------CCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111111 111 123345688999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.79 Aligned_cols=268 Identities=22% Similarity=0.261 Sum_probs=200.4
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
..++|++.++||+|+||.||++++.+++.||+|++.... ........+.+|++++++++||||+++++++.+++..+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc---ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 456799999999999999999999889999999986421 22223457789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++ +|.+++...... ++...+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTG-------LQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEcCCCC-CHHHHHHhccCC-------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCc
Confidence 99999985 898888754321 356777899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
+++...... .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...........
T Consensus 165 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~ 238 (311)
T 3niz_A 165 LARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD----QLPKIFSILGT 238 (311)
T ss_dssp TCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT----HHHHHHHHHCC
T ss_pred CceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHHCC
Confidence 997654322 12344578999999999876 568999999999999999999999986543221 22221111110
Q ss_pred ccc---cc------cccccCCC-CCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQL---HC------VLDKRVGP-PELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~---~~------~~d~~~~~-~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... .. ..+..... ..... ....+.+.+|+.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 00 00000000 00000 1123567899999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=350.13 Aligned_cols=270 Identities=19% Similarity=0.196 Sum_probs=211.8
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
..++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+|+++++.+ +|+|++++++++.+...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 346799999999999999999986 568999999886421 123467899999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc-----
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT----- 651 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~----- 651 (812)
.++||||+ +++|.+++..... .+++..+++++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~ 149 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGR-------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANM 149 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTC
T ss_pred eEEEEEec-CCCHHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCe
Confidence 99999999 9999999976532 1367888999999999999999998 999999999999987766
Q ss_pred EEEEeecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCch
Q 042346 652 ARVSDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~ 726 (812)
+||+|||++......... .......||+.|+|||++.+..++.++||||||++||||++|+.||....... ...
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~ 228 (298)
T 1csn_A 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-NKQ 228 (298)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-HHH
T ss_pred EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc-cHH
Confidence 999999999765432221 12345579999999999999999999999999999999999999996543211 111
Q ss_pred hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
................. ...+++.+.+++.+||+.||++|||+++|++.|+++++......
T Consensus 229 ~~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 229 KYERIGEKKQSTPLREL-----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HHHHHHHHHHHSCHHHH-----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HHHHHHhhccCccHHHH-----------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 11111111111110000 01234568899999999999999999999999999988765443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=364.25 Aligned_cols=272 Identities=24% Similarity=0.269 Sum_probs=203.8
Q ss_pred HHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 496 LAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 496 l~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
+....++|++.+.||+|+||.||++++. +++.||+|++.............+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445677999999999999999999874 588999999864221111234456788999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCC--------------------------------ccccccccHHHHHHHHHHHHHH
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTE--------------------------------KNSSIVNSWKMRIRIALDAARG 622 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~--------------------------------~~~~~~~~~~~~l~ia~~ia~g 622 (812)
+..++||||+++++|.+++....... ......+++...+.++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999996321110 0001223566778899999999
Q ss_pred HHHHhhcCCCCeEeeccCCCCEEEcCCC--cEEEEeecccccCCCCcc--cccccccccCCCccCcccccc--CcCCCcc
Q 042346 623 IDYLHNYAVPSIIHRDIKSSNILLDVNW--TARVSDFGLSLLGSECDQ--EFISTKAVGTVGYIDPEYYVM--NVLTAKT 696 (812)
Q Consensus 623 L~yLH~~~~~~ivHrDlKp~NILl~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~ks 696 (812)
|+|||+++ |+||||||+|||++.++ .+||+|||++........ ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999975432221 122345679999999999875 6789999
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCC
Q 042346 697 DIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKE 776 (812)
Q Consensus 697 DVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~ 776 (812)
||||||++||||++|+.||..... ......+.... ...+.......+..+.+|+.+||+.||.+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKK--------LCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC--------CCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcc--------cccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 999999999999999999854321 11222222221 11111112234567889999999999999
Q ss_pred CCCHHHHHHH
Q 042346 777 RPNITDIVAN 786 (812)
Q Consensus 777 RPt~~evl~~ 786 (812)
|||+.|++++
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.95 Aligned_cols=277 Identities=25% Similarity=0.366 Sum_probs=203.2
Q ss_pred HHHHHHhcCCcceeeeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEE
Q 042346 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLV 568 (812)
Q Consensus 493 ~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~ 568 (812)
+.++....++|.+.+.||+|+||.||+|++.. ++.||+|++..... .....+.+.+|++++++++||||++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS---SQREIEEFLSEAACMKDFSHPNVIRLL 102 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC---CHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc---chhHHHHHHHHHHHHhcCCCCCeeeee
Confidence 34444556789999999999999999998642 45899999864221 233456788999999999999999999
Q ss_pred EEEEeCCe-----EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCC
Q 042346 569 GFCQEKDE-----RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSN 643 (812)
Q Consensus 569 ~~~~~~~~-----~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~N 643 (812)
+++.+.+. .++||||+++++|.+++........ ...+++..+++++.||++||.|||+++ |+||||||+|
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~N 177 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG--PKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARN 177 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTS--CCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGG
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcC--CccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence 99987653 4999999999999999965432211 123477888999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 042346 644 ILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGS 722 (812)
Q Consensus 644 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~ 722 (812)
||++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 255 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-- 255 (313)
T ss_dssp EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--
Confidence 9999999999999999976554333233344567889999999999999999999999999999999 7777744321
Q ss_pred CCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 723 GPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
..... .+..+.. ... ....+..+.+++.+||..||++|||++|++++|+++++..++
T Consensus 256 --~~~~~----~~~~~~~-------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 256 --HEMYD----YLLHGHR-------LKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp --GGHHH----HHHTTCC-------CCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred --HHHHH----HHHcCCC-------CCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 11111 1222211 111 123345688999999999999999999999999999887653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=349.30 Aligned_cols=267 Identities=24% Similarity=0.390 Sum_probs=210.1
Q ss_pred HHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 496 LAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 496 l~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
+....++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+ +
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 3445577999999999999999999998888999999864221 23468899999999999999999999864 5
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.+++..... ..+++..+++++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 151 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSG------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 151 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHH------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred CcEEEEecCCCCCHHHHHhcCCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEEC
Confidence 68999999999999999964321 12367888999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......
T Consensus 152 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~ 222 (279)
T 1qpc_A 152 DFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQN 222 (279)
T ss_dssp CCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHH
T ss_pred CCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHH
Confidence 9999976554221 22234467889999999998889999999999999999999 8888743221 111222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
+..+. +...+ ...++.+.+++.+||+.||++|||++++++.|++++.......
T Consensus 223 ~~~~~-------~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 223 LERGY-------RMVRP----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp HHTTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred Hhccc-------CCCCc----ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 22211 11111 2334568899999999999999999999999999998766544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=363.34 Aligned_cols=276 Identities=23% Similarity=0.381 Sum_probs=215.1
Q ss_pred CCHHHHHHhcCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc
Q 042346 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL 564 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI 564 (812)
+..+++....++|++.+.||+|+||.||+|++. +++.||+|++.... .......+.+|+++++.++||||
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTB
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc----CHHHHHHHHHHHHHHHhcCCCCE
Confidence 444555667788999999999999999999864 36789999986422 22344568899999999999999
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCc--cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 565 VGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEK--NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 565 v~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~--~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
+++++++.+.+..++||||+++++|.+++........ ......++..+++++.||+.||+|||+++ |+||||||+
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~ 167 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAAR 167 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGG
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccc
Confidence 9999999999999999999999999999976431100 00112367888999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDG 721 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~ 721 (812)
|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-- 245 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-- 245 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--
T ss_pred eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC--
Confidence 99999999999999999976544332223344567899999999998899999999999999999999 778874322
Q ss_pred CCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 722 SGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
.......+..+... .. ....+..+.+++.+||+.||++|||+.|++++|++++.
T Consensus 246 ------~~~~~~~~~~~~~~-------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 246 ------NEQVLRFVMEGGLL-------DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------HHHHHHHHHTTCCC-------CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHHHHHHHHcCCcC-------CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11122222222211 11 12334568899999999999999999999999988655
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=359.99 Aligned_cols=256 Identities=20% Similarity=0.297 Sum_probs=203.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhH-HHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKL-REKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
++|.+.+.||+|+||.||+++.. +++.||+|++......... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45999999999999999999985 5899999998653222111 112456889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC----cEEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW----TARV 654 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kl 654 (812)
+||||+++++|.+++..... +++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 91 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKES--------LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSC--------CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEE
T ss_pred EEEEcCCCCCHHHHHHhcCC--------cCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEE
Confidence 99999999999999965432 367788899999999999999998 99999999999998887 8999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+|||++....... ......||+.|+|||++....++.++||||||+++|||++|+.||..... ......
T Consensus 160 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~ 228 (326)
T 2y0a_A 160 IDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLAN 228 (326)
T ss_dssp CCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHH
T ss_pred EECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHH
Confidence 9999997654322 23345799999999999988999999999999999999999999854321 111112
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..... ..+.......+..+.+|+.+||..||++|||++|++++
T Consensus 229 ~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 229 VSAVNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHTCC--------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhcCC--------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 211111 00100012234568899999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=360.60 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=198.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC----
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD---- 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---- 575 (812)
++|++.+.||+|+||.||+|+++ +++.||||++..... ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST----TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 46999999999999999999986 799999999864321 223457889999999999999999999986654
Q ss_pred -----------------------------------------------------eEEEEEEecCCCchhhhhhcCCCCCcc
Q 042346 576 -----------------------------------------------------ERLLVYEYMSNGALHDHLHNKNNTEKN 602 (812)
Q Consensus 576 -----------------------------------------------------~~~lV~ey~~~gsL~~~l~~~~~~~~~ 602 (812)
..++||||+++++|.+++........
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~- 160 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED- 160 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG-
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc-
Confidence 27899999999999999987654322
Q ss_pred ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCccc----------ccc
Q 042346 603 SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQE----------FIS 672 (812)
Q Consensus 603 ~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~----------~~~ 672 (812)
..+..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ ...
T Consensus 161 ----~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 161 ----REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp ----SCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred ----hhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 255667899999999999999998 999999999999999999999999999865543211 122
Q ss_pred cccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCC
Q 042346 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPE 752 (812)
Q Consensus 673 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 752 (812)
....||+.|+|||++.+..++.++||||||+++|||++|..|+.. ............. .
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~~~~~~-----------~ 292 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDVRNLKF-----------P 292 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHHHTTCC-----------C
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHhhccCC-----------C
Confidence 345799999999999999999999999999999999998766311 1111111111111 1
Q ss_pred CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 753 LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 753 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.........+.+|+.+||+.||++|||++|++++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 1123445667899999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=354.66 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=200.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
++|++.+.||+|+||.||++++ .++.||+|++... ...+.|.+|++++++++||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-------SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 5699999999999999999998 5789999998631 234578899999999999999999998763 47999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc-EEEEeecc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT-ARVSDFGL 659 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-~kl~DfGl 659 (812)
|||+++++|.+++...... ...++...++++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPL-----PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp EECCTTCBHHHHHHCSSSE-----ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred EEcCCCCCHHHHHhccCCC-----CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 9999999999999765421 12366778899999999999999932223999999999999998886 79999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... ......+.
T Consensus 153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~-~~~~~~~~ 221 (307)
T 2eva_A 153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRI-MWAVHNGT 221 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHH-HHHHHTTC
T ss_pred ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHH-HHHHhcCC
Confidence 9654321 23346899999999999999999999999999999999999998543211 1111 11111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
. .. .....+..+.+++.+||+.||++|||++|+++.|+.+.+......
T Consensus 222 ~-------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 222 R-------PP----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp C-------CC----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred C-------CC----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 1 00 112234568899999999999999999999999999988776554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=358.32 Aligned_cols=264 Identities=18% Similarity=0.199 Sum_probs=207.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 577 (812)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+|+++++.+ +||||+++++++.+++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 46799999999999999999987 4689999999864221 23577899999999 999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc-----E
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT-----A 652 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-----~ 652 (812)
++||||+ +++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~ 149 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDR-------TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVI 149 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSE
T ss_pred EEEEEeC-CCCHHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceE
Confidence 9999999 9999999976422 2367888999999999999999998 999999999999999887 9
Q ss_pred EEEeecccccCCCCcccc-----cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 653 RVSDFGLSLLGSECDQEF-----ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
||+|||+++......... ......||+.|+|||++.+..++.++||||||++||||++|+.||..... ......
T Consensus 150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-~~~~~~ 228 (330)
T 2izr_A 150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-DTLKER 228 (330)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-SSHHHH
T ss_pred EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-ccHHHH
Confidence 999999997654322211 12456899999999999999999999999999999999999999965432 111111
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
...+.......... .. ....+ .+.+++.+||+.||.+||++++|++.|+++++..
T Consensus 229 ----~~~i~~~~~~~~~~-~~------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 229 ----YQKIGDTKRATPIE-VL------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp ----HHHHHHHHHHSCHH-HH------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----HHHHHhhhccCCHH-HH------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11111111100000 00 00123 6889999999999999999999999999988765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=364.39 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=190.2
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||+|++. +++.||||++... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 4567999999999999999999986 4789999998642 1234678899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC---CCcEEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV---NWTARV 654 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kl 654 (812)
++||||+++++|.+++..... +++...+.++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl 192 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGY--------YSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKI 192 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEEeCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEE
Confidence 999999999999999975432 366778899999999999999998 999999999999975 889999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+|||+++..... .......||+.|+|||++.+..++.++||||||++||||++|+.||..... .+.....
T Consensus 193 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~ 262 (349)
T 2w4o_A 193 ADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-------DQFMFRR 262 (349)
T ss_dssp CCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-------HHHHHHH
T ss_pred ccCccccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-------cHHHHHH
Confidence 999999765432 123345799999999999998999999999999999999999999854331 1112222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..... ..+.....+.+..+.+|+.+||+.||++|||+.|++++
T Consensus 263 i~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 263 ILNCEY--------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHTTCC--------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhCCC--------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 332221 11111123345668899999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=350.45 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=195.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhh---------------------HHHHHHHHHHHHHHHH
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNK---------------------LREKESAFDSELALLS 557 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~---------------------~~~~~~~~~~Ei~~l~ 557 (812)
.++|++.+.||+|+||.||+|++. +++.||||++........ .....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999874 588999999864321110 1122356889999999
Q ss_pred hccCCCceEEEEEEEe--CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 042346 558 RVHHKHLVGLVGFCQE--KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSII 635 (812)
Q Consensus 558 ~l~H~nIv~l~~~~~~--~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~iv 635 (812)
+++||||+++++++.+ .+..++||||+++++|.+++... .+++...+.++.||++||+|||+++ |+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---iv 159 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---------PLSEDQARFYFQDLIKGIEYLHYQK---II 159 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 9999999999999987 56789999999999999876432 1367788899999999999999998 99
Q ss_pred eeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCc---CCCcchhHHHHHHHHHHHcCC
Q 042346 636 HRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV---LTAKTDIYGLGVVLLELLTGK 712 (812)
Q Consensus 636 HrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwS~Gvvl~elltG~ 712 (812)
||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+
T Consensus 160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 999999999999999999999999976544222 234567999999999997654 477899999999999999999
Q ss_pred CCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 713 KAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 713 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.||.... . ......+...... .+. ....++.+.+|+.+||+.||++|||++|++++
T Consensus 238 ~pf~~~~-------~-~~~~~~~~~~~~~--------~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 238 CPFMDER-------I-MCLHSKIKSQALE--------FPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CSSCCSS-------H-HHHHHHHHHCCCC--------CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCCcc-------H-HHHHHHHhcccCC--------CCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 9985422 1 1112222222111 110 11234568899999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=353.11 Aligned_cols=267 Identities=21% Similarity=0.355 Sum_probs=205.8
Q ss_pred CCcceeeeeccCCcEEEEEEEE-----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC-
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK- 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~- 574 (812)
++|++.+.||+|+||.||++++ .+++.||+|++.... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3489999999999999999984 358899999986421 122346788999999999999999999999876
Q ss_pred -CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 575 -DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 575 -~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
+..++||||+++++|.+++...... +++..+++++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNK-------INLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTT-------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred CceEEEEEEeCCCCcHHHHHHhcccc-------CCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEE
Confidence 5689999999999999999654321 367788999999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCC-------CCCCCc
Q 042346 654 VSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNE-------DGSGPL 725 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~-------~~~~~~ 725 (812)
|+|||++......... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.... ......
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence 9999999866543322 22344578889999999999999999999999999999999998863211 000011
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
.........+..+. +... ...+++.+.+|+.+||+.||++|||++|+++.|+++++
T Consensus 247 ~~~~~~~~~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 247 MTVTRLVNTLKEGK-------RLPC----PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp GHHHHHHHHHHTTC-------CCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred cCHHHHHHHHhccC-------CCCC----CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 11111111111111 1111 12344568899999999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=354.30 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=202.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.||+|++... ........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE--IVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 56999999999999999999985 6899999998631 11111234567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... ++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 v~e~~~gg~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQR--------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp EECCCCSCBHHHHHHHTSS--------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EEeCCCCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCc
Confidence 9999999999999976532 255667889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+.
T Consensus 153 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~ 219 (318)
T 1fot_A 153 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAE 219 (318)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCC
T ss_pred ceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence 9765431 2345799999999999999999999999999999999999999854321 11222233222
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
+..+. .....+.+++.+||..||++|| +++|++++
T Consensus 220 --------~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 --------LRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --------CCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11121 2334578899999999999999 89999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.85 Aligned_cols=270 Identities=25% Similarity=0.436 Sum_probs=207.2
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
.++|++.+.||+|+||.||+|++.. +..||||++.... .......+.+|+++++.++||||+++++++.+.
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 4578899999999999999998753 2359999986422 233455788999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
+..++||||+++++|.+++..... .+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl 188 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDG-------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKV 188 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEE
Confidence 999999999999999999976432 1367788999999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHH
Q 042346 655 SDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 655 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 732 (812)
+|||++......... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||..... ....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~ 260 (333)
T 1mqb_A 189 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVM 260 (333)
T ss_dssp CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH
T ss_pred CCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHH
Confidence 999999765432221 12223456789999999998899999999999999999999 9999854221 1122
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCSCTDS 802 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~~~~~ 802 (812)
..+..+. +...+ ...+..+.+++.+||+.||++||++.|+++.|+++++.......-..
T Consensus 261 ~~~~~~~-------~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~~~~ 319 (333)
T 1mqb_A 261 KAINDGF-------RLPTP----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 319 (333)
T ss_dssp HHHHTTC-------CCCCC----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSBCC
T ss_pred HHHHCCC-------cCCCc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhhhcC
Confidence 2222221 11111 23345688999999999999999999999999999987666553333
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=374.21 Aligned_cols=263 Identities=21% Similarity=0.292 Sum_probs=206.2
Q ss_pred HHHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEE
Q 042346 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFC 571 (812)
Q Consensus 493 ~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~ 571 (812)
+.++....++|++.++||+|+||.||+++++ +++.||+|++... ..........+.+|+++++.++||||+++++++
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~--~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 138 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 138 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehh--hhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4455666789999999999999999999986 4889999998631 111111233577899999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
.+++..+|||||+++|+|.++++... ++......++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 139 ~~~~~~~lV~E~~~gg~L~~~l~~~~---------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 139 QDDRYLYMVMEYMPGGDLVNLMSNYD---------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EECCEEEEEEeCCCCCcHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCC
Confidence 99999999999999999999997543 245667789999999999999998 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccccCc----CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV----LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
+||+|||+++...... ........||+.|+|||++.... ++.++|||||||+||||++|+.||.....
T Consensus 207 ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------- 278 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------- 278 (410)
T ss_dssp EEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-------
T ss_pred EEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-------
Confidence 9999999997654422 12234568999999999998655 88999999999999999999999964321
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKE--RPNITDIVAN 786 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 786 (812)
......+..+... +..+. ...++..+.+||.+||..+|.+ ||+++||++|
T Consensus 279 -~~~~~~i~~~~~~------~~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 279 -VGTYSKIMNHKNS------LTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -HHHHHHHHTHHHH------CCCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -hhHHHHHHhcccc------ccCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1122222222110 01111 1123456788999999999988 9999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=365.69 Aligned_cols=276 Identities=20% Similarity=0.258 Sum_probs=217.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC--e
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--E 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~ 576 (812)
.++|++.++||+|+||.||+|++.. ++.||||++..... ....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF----LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG----GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc----cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 3569999999999999999999864 89999999864221 122456778999999999999999999998765 6
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE----cCCCcE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNWTA 652 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~ 652 (812)
.++||||+++++|.+++....... .+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAY-----GLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEE
T ss_pred eEEEEecCCCCCHHHHHHhhhccc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeE
Confidence 799999999999999997643211 1467888999999999999999998 9999999999999 788889
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCcccccc--------CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM--------NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP 724 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~ 724 (812)
||+|||+++...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||.........
T Consensus 156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 999999997654422 2334579999999999865 56788999999999999999999999754433333
Q ss_pred chhHHHHHHHHHhccccc-------------cccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 725 LDVVEFAVSQILAGQLHC-------------VLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~-------------~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
...+. .+..+.-.. .+...+.............+.+++.+||+.||++||+++|+++.+++++
T Consensus 233 ~~~~~----~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 233 KEVMY----KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHHHH----HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred HHHHH----HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 22222 222221110 0111223333444778888999999999999999999999999999998
Q ss_pred Hhc
Q 042346 792 AIC 794 (812)
Q Consensus 792 ~~~ 794 (812)
+.-
T Consensus 309 ~~~ 311 (396)
T 4eut_A 309 HRM 311 (396)
T ss_dssp TCE
T ss_pred hce
Confidence 754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.79 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=203.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 578 (812)
++|++.+.||+|+||.||+++++ +++.||+|++..... ...+....+.+|..++.++ +||||+++++++.+.+..+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS--CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh--cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 46999999999999999999985 588999999864221 2233455678899999988 8999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++|+|.+++..... ++....+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 87 lv~e~~~gg~L~~~l~~~~~--------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRK--------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGG
T ss_pred EEEeCCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecc
Confidence 99999999999999976432 256777899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCc-hhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL-DVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~ 737 (812)
+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.......... .........+..
T Consensus 156 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 156 MCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp GCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred ccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 997533221 22345689999999999999999999999999999999999999996432211111 112222223332
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI------TDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~------~evl~~ 786 (812)
.. ...+. ..+..+.+|+.+||+.||++||++ +|++++
T Consensus 234 ~~--------~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 234 KQ--------IRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CC--------CCCCT----TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CC--------CCCCC----CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 22 11121 234557889999999999999995 677765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=358.95 Aligned_cols=270 Identities=23% Similarity=0.336 Sum_probs=208.6
Q ss_pred cceeeeeccCCcEEEEEEEEc-----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--C
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--D 575 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~ 575 (812)
|++.+.||+|+||.||++.+. +++.||||++.... .....+.+.+|++++++++||||+++++++.+. .
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA----GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc----ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 489999999999999998753 58899999986421 233456788999999999999999999999884 5
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.+++.... +++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHS---------IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred eEEEEEecccCCcHHHHHhhCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEEC
Confidence 6899999999999999997643 367788999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCC------CCCchhH
Q 042346 656 DFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG------SGPLDVV 728 (812)
Q Consensus 656 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~------~~~~~~~ 728 (812)
|||++......... .......+|..|+|||++.+..++.++||||||+++|||++|+.||...... .......
T Consensus 177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256 (318)
T ss_dssp CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence 99999876543321 2234456888999999999989999999999999999999999998532110 0000000
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
...... .+......+ ....++..+.+|+.+||+.||++|||++|+++.|+++.+..+..+
T Consensus 257 ~~~~~~--------~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 257 VLRLTE--------LLERGERLP--RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHHH--------HHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HHHHHH--------HHhcccCCC--CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 000111 111111111 112344568899999999999999999999999999998877654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.47 Aligned_cols=257 Identities=22% Similarity=0.337 Sum_probs=204.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC--CeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--DER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 577 (812)
.++|++.+.||+|+||.||+|++ +++.||||++.... ......+.|.+|++++++++||||+++++++.+. +..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRD---WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTT---CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 35699999999999999999998 58999999987532 1233446789999999999999999999999887 678
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++++|.+++...... .+++..+++++.|++.||+|||+++ ++|+||||||+|||++.++.++|.||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNF------VVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSC------CCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred EeeecccCCCcHHHHHhhcccC------CCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEec
Confidence 9999999999999999765431 2367888999999999999999976 45999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCC---cchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTA---KTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|++..... ....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||..... .+. ...
T Consensus 158 ~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~-~~~ 222 (271)
T 3kmu_A 158 DVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-------MEI-GMK 222 (271)
T ss_dssp GSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-------HHH-HHH
T ss_pred cceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-------HHH-HHH
Confidence 98754322 2346899999999998765554 79999999999999999999854221 111 111
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
....... ... +...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 223 ~~~~~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 223 VALEGLR------PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHSCCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHhcCCC------CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111111 111 12234568899999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.22 Aligned_cols=267 Identities=22% Similarity=0.351 Sum_probs=211.9
Q ss_pred cCCcceee-eeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLEN-KVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~-~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|.+.+ .||+|+||.||+|.+. +++.||+|++.... .....+.+.+|+++++.++||||+++++++ +.+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc----chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 34576766 9999999999999863 57889999986532 234456788999999999999999999999 456
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.+++..... .+++..+++++.|+++||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~ 152 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKRE-------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKIS 152 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT-------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEEC
Confidence 68999999999999999964322 1367888999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||++......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .++ ..
T Consensus 153 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~----~~ 224 (287)
T 1u59_A 153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEV----MA 224 (287)
T ss_dssp CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHH----HH
T ss_pred cccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HHH----HH
Confidence 99999866443222 12233457899999999998889999999999999999999 9999854321 111 12
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCCCC
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCSCT 800 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~~~ 800 (812)
.+..+. +... +...+..+.+++.+||+.||++||++.|++++|++++.........
T Consensus 225 ~i~~~~-------~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 225 FIEQGK-------RMEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp HHHTTC-------CCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred HHhcCC-------cCCC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 222221 1111 1234456889999999999999999999999999999888776633
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=371.72 Aligned_cols=267 Identities=24% Similarity=0.320 Sum_probs=207.1
Q ss_pred CHHHHHHhcCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEE
Q 042346 492 TLSELAAATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGF 570 (812)
Q Consensus 492 ~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 570 (812)
.+.++....++|++.++||+|+||+||++++++ ++.||+|++... ..........+.+|..++..++||||++++++
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHH--HHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHH--HhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 345566677899999999999999999999864 788999998631 11111222347889999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
|.+++..+|||||+++|+|.++|..... .+++.....++.||+.||+|||+.+ |+||||||+||||+.++
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSKFED-------RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNG 212 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTS
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHHccC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCC
Confidence 9999999999999999999999976322 1356777889999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCc
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL 725 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~ 725 (812)
.+||+|||+++...... ........||+.|+|||++. ...++.++|||||||+||||++|+.||..... .
T Consensus 213 ~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~----~ 287 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----V 287 (437)
T ss_dssp CEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----H
T ss_pred CEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh----h
Confidence 99999999997654422 22234468999999999987 56789999999999999999999999964321 1
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKE--RPNITDIVAN 786 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 786 (812)
+ ....+..... ++..+.. .....+.+.+||.+||..+|++ ||+++|++++
T Consensus 288 ~----~~~~i~~~~~------~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 288 E----TYGKIMNHKE------RFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp H----HHHHHHTHHH------HCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred H----HHHhhhhccc------cccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1 1222222110 0111111 0123445778999999888888 9999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=355.17 Aligned_cols=247 Identities=23% Similarity=0.256 Sum_probs=192.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 578 (812)
++|++.++||+|+||+||+|++. +++.||||++...... ......+..|+..+..+ +||||+++++++.+++..+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG---PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC---hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 56999999999999999999986 6999999987643222 22233444555555554 9999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+ +++|.+++..... .+++..+++++.||+.||+|||+.+ |+||||||+|||++.++++||+|||
T Consensus 134 lv~e~~-~~~L~~~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGA-------SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCS-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred EEEecc-CCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence 999999 6799999876532 2378889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++....... ......||+.|+|||++.+ .++.++||||||++||||++|+.|+.... .+..+..+
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~~~~ 267 (311)
T 3p1a_A 203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQLRQG 267 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHHHTTT
T ss_pred eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHhcc
Confidence 987654322 2344569999999998876 69999999999999999999987764321 11222222
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... .....++.+.+++.+||+.||++|||++|++++
T Consensus 268 ~~~~~----------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 268 YLPPE----------FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CCCHH----------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcc----------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11110 112234668899999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=361.11 Aligned_cols=260 Identities=22% Similarity=0.417 Sum_probs=197.2
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcE----EEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGRE----VAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
.++|++.++||+|+||.||+|++. +++. |++|.+.... .....+.+.+|+++++.++||||+++++++..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS----SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 357999999999999999999874 3444 5777664321 122345688999999999999999999999876
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
. .++|+||+++++|.+++...... +++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL 158 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDN-------IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEE
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCC-------CCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEE
Confidence 5 78999999999999999765432 366778899999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+. .
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~~----~ 230 (327)
T 3lzb_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEIS----S 230 (327)
T ss_dssp CCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHH----H
T ss_pred ccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHH----H
Confidence 99999987654433333444567889999999999999999999999999999999 9999854321 1111 1
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
.+..+. +...+ ...+..+.+++.+||+.||.+|||++|+++.|+++.+.
T Consensus 231 ~~~~~~-------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 231 ILEKGE-------RLPQP----PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHTTC-------CCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHcCC-------CCCCC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111111 11111 22344588999999999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=360.92 Aligned_cols=259 Identities=23% Similarity=0.410 Sum_probs=200.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-CcE----EEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GRE----VAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~----vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
++|++.+.||+|+||.||+|++.. ++. |++|.+..... ......+.+|+.+++.++||||+++++++. ++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG----RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS----CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 569999999999999999998753 443 78887643211 122235678999999999999999999986 45
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~ 157 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRG-------ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVA 157 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGG-------GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEEC
T ss_pred ccEEEEEeCCCCCHHHHHHHccc-------cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEEC
Confidence 68999999999999999975422 2255677899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+. ..
T Consensus 158 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~----~~ 229 (325)
T 3kex_A 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL----AEVP----DL 229 (325)
T ss_dssp SCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT----THHH----HH
T ss_pred CCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH----HHHH----HH
Confidence 9999987655444444455678889999999998999999999999999999999 9999854321 1111 11
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+..+. +...+. ..+..+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 230 ~~~~~-------~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 230 LEKGE-------RLAQPQ----ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHTTC-------BCCCCT----TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHcCC-------CCCCCC----cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 22211 111111 1223477899999999999999999999999998653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.79 Aligned_cols=259 Identities=30% Similarity=0.487 Sum_probs=201.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHH--HHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLR--EKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
.++|++.+.||+|+||.||++++. +++.||+|++.......... +..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 357999999999999999999984 68999999986433222111 11267889999999999999999999986654
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc-----
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT----- 651 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~----- 651 (812)
++||||+++++|.+++..... .+++..+++++.|++.||+|||+++ ++|+||||||+|||++.++.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH-------PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS-------CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred -eEEEEecCCCCHHHHHhcccC-------CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCcee
Confidence 799999999999999865432 2367888999999999999999987 45999999999999988776
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCcccc--ccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYY--VMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
+||+|||+++.... ......+|+.|+|||++ ....++.++||||||+++|||++|+.||...... ...
T Consensus 168 ~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~ 237 (287)
T 4f0f_A 168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-----KIK 237 (287)
T ss_dssp EEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-----HHH
T ss_pred EEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-----HHH
Confidence 99999999975433 23346799999999998 4556889999999999999999999998543321 111
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
. ........... . ....++..+.+++.+||+.||++|||++|+++.|++
T Consensus 238 ~-~~~~~~~~~~~------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 238 F-INMIREEGLRP------T----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp H-HHHHHHSCCCC------C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred H-HHHHhccCCCC------C----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1 11111111111 1 112334568899999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=382.24 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=208.9
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.++||+|+||.||+|+++. ++.||||++..... ..+.|.+|+++|++++||||+++++++.+.+..
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc------chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 44569999999999999999999865 88999999864221 245688999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+|||||+++|+|.++|...... .+++..++.|+.||++||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQ------EVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTT------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred EEEEEccCCCCHHHHHHhcCcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeec
Confidence 9999999999999999864432 1367788899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|+++...... ........++..|+|||++....++.++||||||++||||++ |+.||.... ...+.+ .+.
T Consensus 363 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~----~~~~~~----~~~ 433 (495)
T 1opk_A 363 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYE----LLE 433 (495)
T ss_dssp TCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC----GGGHHH----HHH
T ss_pred ccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC----HHHHHH----HHH
Confidence 9998764322 122234456789999999999999999999999999999999 888875422 112221 111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
.+ .++..+ ..+++.+.+|+.+||+.||++|||+.||++.|+.+++
T Consensus 434 ~~-------~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 434 KD-------YRMERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TT-------CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred cC-------CCCCCC----CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11 112222 2344568899999999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=354.38 Aligned_cols=267 Identities=21% Similarity=0.251 Sum_probs=199.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++. +++.||+|++.... .......+.+.+|++++++++||||+++++++.+++..+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL--SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG--GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc--ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 467999999999999999999975 68899999986421 222344567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... +++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 111 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGP--------LAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred EEEEecCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCc
Confidence 99999999999999976432 366788899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++........ .......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .. .......
T Consensus 180 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~-~~~~~~~ 249 (309)
T 2h34_A 180 IASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------SV-MGAHINQ 249 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HH-HHHHHHS
T ss_pred cCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HH-HHHHhcc
Confidence 9876543221 123345789999999999999999999999999999999999999854221 11 1111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHHhcccC
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-NITDIVANLERALAICQDC 797 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~Le~~~~~~~~~ 797 (812)
... .+.......+..+.+++.+||+.||++|| +++++++.|+++++.....
T Consensus 250 ~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 250 AIP--------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp CCC--------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred CCC--------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 111 01111123345688999999999999999 9999999999887665543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=375.83 Aligned_cols=262 Identities=28% Similarity=0.413 Sum_probs=204.0
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
...++|++.++||+|+||.||+|+++++..||||++..... ..+.|.+|+++|++++||||+++++++.+ +..
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 34567999999999999999999998888999999864221 23468899999999999999999999876 668
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++|+|.++|..... ..+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df 324 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF 324 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEehhhcCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCC
Confidence 999999999999999964321 12367788999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|+++...... ........++..|+|||.+....++.++||||||++||||++ |+.||.... . ......+.
T Consensus 325 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~----~----~~~~~~i~ 395 (452)
T 1fmk_A 325 GLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----N----REVLDQVE 395 (452)
T ss_dssp CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----H----HHHHHHHH
T ss_pred ccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC----H----HHHHHHHH
Confidence 9997654322 112233457889999999998899999999999999999999 888874322 1 11222222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcc
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 795 (812)
.+. ++..+ ..+++.+.+|+.+||+.||++|||+++|++.|+.++....
T Consensus 396 ~~~-------~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 396 RGY-------RMPCP----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp TTC-------CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred cCC-------CCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 221 12112 2345568899999999999999999999999998765443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=353.84 Aligned_cols=275 Identities=26% Similarity=0.391 Sum_probs=211.0
Q ss_pred CCHHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHh--ccCCCceEEE
Q 042346 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSR--VHHKHLVGLV 568 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~ 568 (812)
.++.......++|++.+.||+|+||.||++++ +++.||||++... ....+.+|.+++.. ++||||++++
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~ 102 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFI 102 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEE
Confidence 33444455667899999999999999999998 6899999998531 23456678888887 7899999999
Q ss_pred EEEEeCC----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHh--------hcCCCCeEe
Q 042346 569 GFCQEKD----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH--------NYAVPSIIH 636 (812)
Q Consensus 569 ~~~~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH--------~~~~~~ivH 636 (812)
+++.... ..++||||+++++|.+++.... +++..+++++.|++.||+||| +.+ |+|
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH 170 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAH 170 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHHCC---------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EEC
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhccC---------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eee
Confidence 9998876 7899999999999999997542 367888999999999999999 666 999
Q ss_pred eccCCCCEEEcCCCcEEEEeecccccCCCCccc--ccccccccCCCccCccccccC------cCCCcchhHHHHHHHHHH
Q 042346 637 RDIKSSNILLDVNWTARVSDFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVMN------VLTAKTDIYGLGVVLLEL 708 (812)
Q Consensus 637 rDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDVwS~Gvvl~el 708 (812)
|||||+|||++.++++||+|||++......... .......||+.|+|||++.+. .++.++||||||++||||
T Consensus 171 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el 250 (342)
T 1b6c_B 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250 (342)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence 999999999999999999999999754432221 123455799999999998765 344789999999999999
Q ss_pred HcC----------CCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC
Q 042346 709 LTG----------KKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP 778 (812)
Q Consensus 709 ltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 778 (812)
++| +.||......... .+.....+....+ ...+. ......+..+.|.+|+.+||+.||++||
T Consensus 251 ~tg~~~~~~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rp 322 (342)
T 1b6c_B 251 ARRCSIGGIHEDYQLPYYDLVPSDPS---VEEMRKVVCEQKL----RPNIP-NRWQSCEALRVMAKIMRECWYANGAARL 322 (342)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCC---HHHHHHHHTTSCC----CCCCC-GGGGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred HhccCcCCcccccccCccccCcCccc---HHHHHHHHHHHHh----CCCCc-ccccchhHHHHHHHHHHHHhccChhhCC
Confidence 999 6676543322211 1111222222111 11111 1112346778899999999999999999
Q ss_pred CHHHHHHHHHHHHHhc
Q 042346 779 NITDIVANLERALAIC 794 (812)
Q Consensus 779 t~~evl~~Le~~~~~~ 794 (812)
|++||+++|+++.+..
T Consensus 323 s~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 323 TALRIKKTLSQLSQQE 338 (342)
T ss_dssp CHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHHHh
Confidence 9999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=352.62 Aligned_cols=267 Identities=19% Similarity=0.251 Sum_probs=200.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.++||+|+||.||+|++. +++.||+|++...... ......+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc---CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 57999999999999999999985 5889999998653322 2234567789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++ +|.+++...... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~e~~~~-~l~~~~~~~~~~-------l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDSCNGD-------LDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEECCSE-EHHHHHHHTTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEecCCC-CHHHHHHhCCCC-------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 9999975 677666543221 366778899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCc-CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+....... .......+|+.|+|||++.+.. ++.++||||||+++|||++|+.|++.... ..+............
T Consensus 148 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~---~~~~~~~i~~~~~~~ 222 (292)
T 3o0g_A 148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTP 222 (292)
T ss_dssp CEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS---HHHHHHHHHHHHCCC
T ss_pred ceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC---HHHHHHHHHHHhCCC
Confidence 97654322 2234457899999999997765 89999999999999999999999754332 111111111111000
Q ss_pred ---c---ccccccccC-------CCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 ---Q---LHCVLDKRV-------GPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ---~---~~~~~d~~~-------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. .....+... .............+.+|+.+||+.||++|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000000000 00000112345667899999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=358.84 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=196.5
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe-
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE- 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~- 576 (812)
..++|++.+.||+|+||.||++++ .+++.||||++.... ....+....+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT--TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc--cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 346799999999999999999997 568999999986522 2223445678899999999999999999999876543
Q ss_pred ---EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 577 ---RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 577 ---~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
.++||||+++++|.++++.... +++...++++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGP--------MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEE
T ss_pred CcccEEEEecCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEE
Confidence 3999999999999999976432 366778899999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 654 VSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|+|||++......... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+...
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~ 229 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAY 229 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHH
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHH
Confidence 9999999765443221 223345789999999999999999999999999999999999999854321 11111
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHH-HHHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI-VANLERALA 792 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev-l~~Le~~~~ 792 (812)
........ ++.......+..+.+++.+||+.||++||+..++ ...|.++..
T Consensus 230 ~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 230 QHVREDPI---------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHCCCC---------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHhcCCCC---------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 11111110 0000011245568899999999999999965554 455555443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=357.45 Aligned_cols=272 Identities=21% Similarity=0.352 Sum_probs=207.0
Q ss_pred CCcceeeeeccCCcEEEEEEEE-----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE--e
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ--E 573 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~--~ 573 (812)
++|++.+.||+|+||.||++++ .+++.||||++... .....+.+.+|++++++++||||+++++++. +
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 5699999999999999999985 35889999998642 1334467889999999999999999999987 4
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
....++||||+++++|.+++..... .+++..+++++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRA-------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred CceEEEEEeecCCCCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEE
Confidence 4568999999999999999975422 2367888999999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCC-------CCCc
Q 042346 654 VSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG-------SGPL 725 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~-------~~~~ 725 (812)
|+|||++......... .......+|+.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 9999999865443322 2234456888999999999999999999999999999999999998542110 0000
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.........+..+. +... ...+++.+.+|+.+||+.||++|||++|++++|+++......+.
T Consensus 248 ~~~~~~~~~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 248 PALSRLLELLEEGQ-------RLPA----PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp CHHHHHHHHHHTTC-------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred ccHHHHHHHhhccc-------CCCC----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 11111111111111 1111 22345568899999999999999999999999999887766655
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.03 Aligned_cols=248 Identities=23% Similarity=0.294 Sum_probs=203.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++++. +++.||+|++... ........+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhH--HhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 56999999999999999999985 5899999998631 11112234577889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... ++....+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 119 v~e~~~gg~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGR--------FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EEECCTTCBHHHHHHHHCC--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEcCCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccccc
Confidence 9999999999999976432 256677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++..... .....||+.|+|||++.+..++.++||||||++||||++|+.||.... .......+..+.
T Consensus 188 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~ 254 (350)
T 1rdq_E 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGK 254 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC
T ss_pred ceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcCC
Confidence 9765432 234579999999999999999999999999999999999999985432 111222333332
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 786 (812)
. ..+. ..+..+.+|+.+||+.||++||+ ++||+++
T Consensus 255 ~--------~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 V--------RFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C--------CCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--------CCCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1 1121 23456889999999999999998 8999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=350.17 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=204.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe-CC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE-KD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~ 575 (812)
.+|++.++||+|+||.||+|++.+ ...+|+|++.... .....+.+.+|++++++++||||+++++++.+ ++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC----CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 458899999999999999998643 2358999876422 23345678899999999999999999998654 45
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.+++...... +++..+++++.|+++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 170 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHN-------PTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVA 170 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccC-------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEEC
Confidence 679999999999999999754321 266778899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCccc--ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||++......... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|++...... +...
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~---- 243 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITV---- 243 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHH----
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHH----
Confidence 99999765443221 12334567889999999999999999999999999999999666654433211 1111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccC
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDC 797 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~ 797 (812)
.+..+. +...+ ...+..+.+++.+||+.||++|||++|+++.|+++++.....
T Consensus 244 ~~~~~~-------~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 244 YLLQGR-------RLLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp HHHTTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred HHhcCC-------CCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 111111 11111 123345889999999999999999999999999998866543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=351.79 Aligned_cols=263 Identities=25% Similarity=0.382 Sum_probs=212.2
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
...++|++.+.||+|+||.||++.+.+ ++.||+|++.... ...+.+.+|+++++.++||||+++++++.+++.
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS------THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 456679999999999999999999864 8889999986421 124568899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++++|.+++...... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~D 154 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQ------EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 154 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTT------TSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcccC------CccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEcc
Confidence 99999999999999999765432 2367788899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
||++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....+ .+
T Consensus 155 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~----~~~~~----~~ 225 (288)
T 3kfa_A 155 FGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYE----LL 225 (288)
T ss_dssp CCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHHH----HH
T ss_pred CccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH----HH
Confidence 99998655432 222344567889999999998899999999999999999999 8888754321 11111 11
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcc
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 795 (812)
.... +...+ ...++.+.+|+.+||..||.+|||++|+++.|+++++...
T Consensus 226 ~~~~-------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 226 EKDY-------RMERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp HTTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hccC-------CCCCC----CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1110 11111 2334568899999999999999999999999999887644
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.31 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=203.2
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 357999999999999999999885 58899999986421 223346889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC--CCcEEEEe
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV--NWTARVSD 656 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--~~~~kl~D 656 (812)
+||||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|
T Consensus 125 lv~E~~~gg~L~~~l~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~D 194 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDY-------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIID 194 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTC-------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECC
T ss_pred EEEEcCCCCcHHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEe
Confidence 99999999999999975432 1367788999999999999999998 999999999999974 47899999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||++....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... . .....+.
T Consensus 195 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~----~~~~~i~ 263 (387)
T 1kob_A 195 FGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----L----ETLQNVK 263 (387)
T ss_dssp CTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----H----HHHHHHH
T ss_pred cccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----H----HHHHHHH
Confidence 99998654422 22344799999999999999999999999999999999999999854321 1 1112222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...+. .+.......+..+.+|+.+||..||++|||++|++++
T Consensus 264 ~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 264 RCDWE--------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HCCCC--------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hCCCC--------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 22111 1111112345568899999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.51 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=204.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|++.+.||+|+||.||+|++.+ +..||+|++.... ..+..+.+.+|+++++.++||||+++++++.+ +
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence 4579999999999999999998643 2359999986421 22345678899999999999999999999865 4
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.+++..... .+++..+++++.|+++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKN-------SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTT-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEEC
T ss_pred CCEEEEecCCCCCHHHHHHhccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeC
Confidence 56899999999999999976432 1366778899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+... .
T Consensus 156 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~----~~~~~----~ 226 (281)
T 3cc6_A 156 DFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN----KDVIG----V 226 (281)
T ss_dssp CCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG----GGHHH----H
T ss_pred ccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh----HHHHH----H
Confidence 9999976544221 12334467889999999998899999999999999999998 9999854321 11111 1
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
+..+. +...+ ...++.+.+++.+||..||++|||+.|++++|+++++...+
T Consensus 227 ~~~~~-------~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 227 LEKGD-------RLPKP----DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp HHHTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HhcCC-------CCCCC----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 11111 11111 12345688999999999999999999999999999887554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=361.78 Aligned_cols=273 Identities=24% Similarity=0.370 Sum_probs=211.7
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEE
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVG 569 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~ 569 (812)
....++|++.+.||+|+||.||+|.+.. .+.||+|++.... .....+.+.+|+++++.+ +||||+++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3445789999999999999999998743 2479999986432 123456788999999999 8999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhhcCCCCCcc------ccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCC
Q 042346 570 FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKN------SSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSN 643 (812)
Q Consensus 570 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~------~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~N 643 (812)
++.+.+..++||||+++|+|.+++......... ....+++..+++++.||+.||+|||+++ |+||||||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 194 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 194 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccce
Confidence 999999999999999999999999764321000 0112477888999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 042346 644 ILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGS 722 (812)
Q Consensus 644 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~ 722 (812)
||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 273 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN- 273 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-
T ss_pred EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-
Confidence 9999999999999999976543333223344567889999999998899999999999999999999 88887543211
Q ss_pred CCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 723 GPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
... ......+ . ....+. ..++.+.+++.+||+.||.+|||++|++++|+++.+..
T Consensus 274 ---~~~---~~~~~~~-~------~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 274 ---SKF---YKLVKDG-Y------QMAQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp ---HHH---HHHHHHT-C------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHH---HHHHhcC-C------CCCCCC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 111 1111111 1 111111 12356889999999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=358.69 Aligned_cols=254 Identities=24% Similarity=0.319 Sum_probs=201.8
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCC
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKD 575 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 575 (812)
...++|++.+.||+|+||.||+++++ +++.||+|++.... .........+..|.+++..+ +||||+++++++.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH--HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHH--hhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 34578999999999999999999985 58899999986311 11122345677899999877 8999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++|+|.+++..... +++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHK--------FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEe
Confidence 99999999999999999976432 256777889999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+
T Consensus 161 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i 230 (345)
T 1xjd_A 161 DFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSI 230 (345)
T ss_dssp CCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred EChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHH
Confidence 999997543221 123456899999999999999999999999999999999999999854321 1122222
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH-HHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT-DIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~~ 786 (812)
..+. ...+ ......+.+|+.+||..||++||++. |++++
T Consensus 231 ~~~~--------~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 231 RMDN--------PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHCC--------CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HhCC--------CCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 2221 1111 12345678999999999999999997 77643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=349.56 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=200.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-C-------cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-G-------REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFC 571 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g-------~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~ 571 (812)
.++|++.+.||+|+||.||++++.. + +.||+|++.... ....+.+.+|++++++++||||+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-----RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-----GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 3569999999999999999998643 3 479999985421 23345788999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
.+++..++||||+++++|.+++..... .+++..+++++.||++||.|||+++ |+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 151 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKN-------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREED 151 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCB
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCc
Confidence 999999999999999999999976432 1367778899999999999999998 999999999999998887
Q ss_pred --------EEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCC
Q 042346 652 --------ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS 722 (812)
Q Consensus 652 --------~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~ 722 (812)
+||+|||++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 152 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-- 223 (289)
T 4fvq_A 152 RKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-- 223 (289)
T ss_dssp GGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred ccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--
Confidence 99999999865433 123457899999999987 7799999999999999999997766543321
Q ss_pred CCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccC
Q 042346 723 GPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDC 797 (812)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~ 797 (812)
... .. ...... ..+..+ .+..+.+|+.+||+.||++|||++|++++|++++......
T Consensus 224 ----~~~-~~-~~~~~~------~~~~~~------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 224 ----SQR-KL-QFYEDR------HQLPAP------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp ----HHH-HH-HHHHTT------CCCCCC------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred ----hHH-HH-HHhhcc------CCCCCC------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 111 11 111110 011111 1234789999999999999999999999999887644433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=367.22 Aligned_cols=266 Identities=24% Similarity=0.282 Sum_probs=206.5
Q ss_pred CHHHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEE
Q 042346 492 TLSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGF 570 (812)
Q Consensus 492 ~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 570 (812)
.++++....++|++.+.||+|+||.||+++.+ +++.||+|++... ........+.+.+|.+++..++||||++++++
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~--~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW--DMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--HhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 45566667789999999999999999999985 6899999998631 11122233457889999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW 650 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~ 650 (812)
+.+++..||||||+++|+|.++|..... .+++.....++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g 199 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGE-------RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCG 199 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSS-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTS
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCC
Confidence 9999999999999999999999976432 1256677889999999999999998 99999999999999999
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccc-------cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV-------MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
++||+|||+++....... .......||+.|+|||++. ...++.++|||||||+||||++|+.||.....
T Consensus 200 ~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--- 275 (412)
T 2vd5_A 200 HIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--- 275 (412)
T ss_dssp CEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---
T ss_pred CEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---
Confidence 999999999976544221 2233468999999999997 35789999999999999999999999954321
Q ss_pred CchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 042346 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKER---PNITDIVAN 786 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~evl~~ 786 (812)
.. ....+..... .+..+. .....+..+.+||.+||. +|.+| |+++|+++|
T Consensus 276 -~~----~~~~i~~~~~------~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 276 -AE----TYGKIVHYKE------HLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -HH----HHHHHHTHHH------HCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -HH----HHHHHHhccc------CcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11 1122221110 011110 012345568899999999 99998 699999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=362.29 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=194.8
Q ss_pred ceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEE
Q 042346 504 SLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 504 ~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 582 (812)
...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 33678999999999999874 58999999986422 1334578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE--cCCCcEEEEeeccc
Q 042346 583 YMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL--DVNWTARVSDFGLS 660 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl--~~~~~~kl~DfGla 660 (812)
|+++++|.+++..... .+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 167 ~~~~~~L~~~l~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 167 YVDGGELFDRIIDESY-------NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp CCTTCEEHHHHHHTGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CCCCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 9999999999865421 2367778899999999999999998 9999999999999 56789999999999
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
+...... ......||+.|+|||++....++.++||||||++||||++|+.||..... ......+.....
T Consensus 237 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~ 305 (373)
T 2x4f_A 237 RRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILACRW 305 (373)
T ss_dssp EECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCC
T ss_pred eecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccC
Confidence 8654422 22345799999999999988999999999999999999999999854321 112222222211
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+......+.+.+.+|+.+||+.||++|||++|++++
T Consensus 306 --------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 306 --------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp --------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111112345668899999999999999999999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.05 Aligned_cols=265 Identities=25% Similarity=0.399 Sum_probs=208.5
Q ss_pred CcceeeeeccCCcEEEEEEEEcC-C---cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMD-G---REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~-g---~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
.|.+.++||+|+||.||+|++.+ + ..+|+|++.... .....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT----EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc----cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 46677999999999999998643 2 369999986422 233456788999999999999999999999876665
Q ss_pred -EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 578 -LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 578 -~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
++||||+.+++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~D 167 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQR-------NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVAD 167 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECC
T ss_pred cEEEEecccCCCHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCc
Confidence 999999999999999976432 1267788899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcc--cccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSECDQ--EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++|+.|++.... ..+... .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~---~~~~~~----~ 240 (298)
T 3pls_A 168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID---PFDLTH----F 240 (298)
T ss_dssp TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---GGGHHH----H
T ss_pred CCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC---HHHHHH----H
Confidence 999976544221 1223345688999999999999999999999999999999998777654332 122221 1
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
+..+. ....+ ...++.+.+++.+||+.||.+|||++|+++.|+++++......
T Consensus 241 ~~~~~-------~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 241 LAQGR-------RLPQP----EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp HHTTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred hhcCC-------CCCCC----ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 11111 11111 2234568899999999999999999999999999998876544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.48 Aligned_cols=256 Identities=19% Similarity=0.293 Sum_probs=195.5
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC--CCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH--KHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~~ 576 (812)
..++|++.+.||+|+||.||++...+++.||||++.... ........+.+|+++++.++| |||+++++++.+++.
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc---cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 346799999999999999999998889999999986432 223445678899999999976 999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++|||| .+++|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKS--------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred EEEEEeC-CCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEee
Confidence 9999995 57899999986542 256778899999999999999998 99999999999997 67899999
Q ss_pred ecccccCCCCcccccccccccCCCccCcccccc-----------CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCc
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-----------NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL 725 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~ 725 (812)
||+++...............||+.|+|||++.+ ..++.++||||||++||||++|+.||.....
T Consensus 151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----- 225 (343)
T 3dbq_A 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----- 225 (343)
T ss_dssp CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----
T ss_pred cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----
Confidence 999987654433333445689999999999865 6788999999999999999999999854221
Q ss_pred hhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.... ...+.... .....+... ...+.+|+.+||+.||++|||+.|++++.
T Consensus 226 -~~~~-~~~~~~~~------~~~~~~~~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 226 -QISK-LHAIIDPN------HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -HHHH-HHHHHCTT------SCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -HHHH-HHHHhcCC------cccCCcccC----CHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1111 11111111 111111111 24577899999999999999999998763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=350.49 Aligned_cols=266 Identities=20% Similarity=0.245 Sum_probs=197.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
++|++.+.||+|+||.||+|+..+++.||+|++...... ......+.+|++++++++||||+++++++.+++..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 579999999999999999999988999999998643221 12235677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++ +|.+++...... +++.....++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 79 ~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGG-------LESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp EECCSE-EHHHHHHTSTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred EEecCC-CHHHHHHhcccC-------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccc
Confidence 999975 999998754321 256677899999999999999998 999999999999999999999999998
Q ss_pred ccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
....... .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .+.............
T Consensus 148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~ 221 (288)
T 1ob3_A 148 RAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPN 221 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCC
T ss_pred cccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHHCCCC
Confidence 7543211 12234578999999999876 4589999999999999999999999854321 111111111110000
Q ss_pred ------ccc--cccccCCCCC-----CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 ------LHC--VLDKRVGPPE-----LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ------~~~--~~d~~~~~~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+ ..+....... .......+.+.+|+.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0011110000 0012245567899999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=346.46 Aligned_cols=265 Identities=23% Similarity=0.346 Sum_probs=207.1
Q ss_pred HhcCCcceee-eeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 498 AATNNFSLEN-KVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 498 ~~~~~~~~~~-~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
...++|.+.+ .||+|+||.||++.+. .++.||||++.... ......+.+.+|+++++.++||||+++++++ +
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3456788888 9999999999999653 36889999986421 2223356788999999999999999999999 5
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
.+..++||||+++++|.+++..... +++...++++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~k 157 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRH--------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAK 157 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTT--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcC--------CCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEE
Confidence 6678999999999999999976532 256778899999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHH
Q 042346 654 VSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 731 (812)
|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~ 229 (291)
T 1xbb_A 158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEV 229 (291)
T ss_dssp ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHH
T ss_pred EccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHH
Confidence 9999999765443322 12233456789999999998889999999999999999999 9999854221 111
Q ss_pred HHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 732 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
...+..+. +... +...+..+.+++.+||+.||++||++.|+++.|++++.....
T Consensus 230 ~~~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 230 TAMLEKGE-------RMGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp HHHHHTTC-------CCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHcCC-------CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 22222221 1111 123445688999999999999999999999999999876654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=358.73 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=200.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++++. +++.||+|++... ..........+.+|+++++.++||||+++++++.+.+..++
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~--~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ--KCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehh--hcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56999999999999999999875 4889999998631 11122334678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... ++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 v~e~~~gg~L~~~l~~~~~--------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVH--------FKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp EECCCTTEEHHHHHHTTCC--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEecCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccce
Confidence 9999999999999976432 256777889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc---CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM---NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
+....... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||....... .......+.
T Consensus 162 a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~~~~~ 233 (384)
T 4fr4_A 162 AAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIVHTFE 233 (384)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHHHHHH
T ss_pred eeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHh
Confidence 98654322 2345679999999999874 458999999999999999999999996433211 111122222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-ITDIVA 785 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~ 785 (812)
... ...+ ...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 234 ~~~--------~~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 TTV--------VTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HCC--------CCCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hcc--------cCCC----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111 1111 123456889999999999999998 777775
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.08 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=204.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||++.+. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 3567999999999999999999875 588999999864221 233446788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc---EEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT---ARV 654 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kl 654 (812)
++||||+++++|.+++..... +++...+.++.|++.||+|||+.+ |+||||||+|||++.++. +||
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl 149 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREF--------YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKL 149 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEE
Confidence 999999999999999876532 356778899999999999999998 999999999999987655 999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+|||++....... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ......
T Consensus 150 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~ 218 (284)
T 3kk8_A 150 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQ 218 (284)
T ss_dssp CCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred eeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHH
Confidence 9999997654322 22345799999999999999999999999999999999999999854321 112222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..+... .+.......+..+.+|+.+||+.||++|||++|++++
T Consensus 219 ~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 219 IKAGAYD--------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHTCCC--------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhcccc--------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 2222211 1111112344568899999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.90 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=181.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||+++. .+++.||+|++... .....+..+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKK--AMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehh--hhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 35699999999999999999987 46899999998531 1111222467889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... .+++..+++++.|+++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVK-------PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSS-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCT
T ss_pred EEEecCCCCcHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeec
Confidence 99999999999999975432 1366788899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++........ ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||....... .. .
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~----~----- 222 (278)
T 3cok_A 158 LATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN----TL----N----- 222 (278)
T ss_dssp TCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------
T ss_pred ceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH----HH----H-----
Confidence 9976543221 1234578999999999998889999999999999999999999986533211 00 0
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.........+ ...+..+.+++.+||+.||++|||++|++++
T Consensus 223 ---~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 223 ---KVVLADYEMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ----CCSSCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---HHhhcccCCc----cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0111111111 1234567899999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=354.81 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=199.9
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+.|++.+.||+|+||.||+|+. .+++.||||++..... ...+..+.+.+|++++++++||||+++++++.+++..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc--cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 4589999999999999999987 4689999999864322 223445678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+. |+|.+++..... .+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 132 v~e~~~-g~l~~~l~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKK-------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp EEECCS-EEHHHHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred EEecCC-CCHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence 999997 689888864332 2367788899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
+..... .....||+.|+|||++. ...++.++||||||++||||++|+.||.... .... ...+.
T Consensus 201 a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-------~~~~-~~~~~ 266 (348)
T 1u5q_A 201 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSA-LYHIA 266 (348)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHH-HHHHH
T ss_pred ceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------hHHH-HHHHH
Confidence 976543 23457999999999984 5678999999999999999999999985432 1111 11222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.. +.......++.+.+|+.+||+.||++|||++|++++
T Consensus 267 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 267 QNES----------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HSCC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred hcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2211 111112234568899999999999999999999865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=362.63 Aligned_cols=265 Identities=26% Similarity=0.451 Sum_probs=196.2
Q ss_pred CcceeeeeccCCcEEEEEEEEcC--C--cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe-CCe
Q 042346 502 NFSLENKVGIGSFGTVYKGKLMD--G--REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE-KDE 576 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~~--g--~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~ 576 (812)
.|.+.+.||+|+||.||+|++.+ + ..||+|.+.... .....+.|.+|++++++++||||+++++++.+ ++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS----CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 47788999999999999998642 2 368999875421 12345678899999999999999999998754 456
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++++|.+++...... .++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~D 235 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHN-------PTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVAD 235 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCC-------CBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECC
T ss_pred eEEEEECCCCCCHHHHHhhcccC-------CCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEee
Confidence 79999999999999999754321 267778899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCccc--ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
||+++........ .......+|+.|+|||.+.+..++.++||||||++||||++|..|++..... .+... .
T Consensus 236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~~~~~----~ 308 (373)
T 3c1x_A 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITV----Y 308 (373)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---SCHHH----H
T ss_pred ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---HHHHH----H
Confidence 9999765432211 1223446788999999999999999999999999999999954443332211 12221 1
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
+..+. +...+ ..++..+.+++.+||+.||++|||++|+++.|++++.......
T Consensus 309 ~~~~~-------~~~~p----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 309 LLQGR-------RLLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp HHTTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHcCC-------CCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 22221 11112 1234568899999999999999999999999999998776554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=348.10 Aligned_cols=271 Identities=22% Similarity=0.336 Sum_probs=201.4
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++.. .+++.||+|++..... ........+.+|++++++++||||+++++++.+++..++
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4699999999999999999987 4689999999864221 123445678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++....... ..++...+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQK----RLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred EEecCCCCCHHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 999999999999997532111 12366778899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+....... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ....+....
T Consensus 183 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~-~~~~~~~~~ 254 (310)
T 2wqm_A 183 GRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYS-LCKKIEQCD 254 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHH-HHHHHHTTC
T ss_pred eeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHH-HHHHhhccc
Confidence 87654322 122345789999999999998999999999999999999999999854321 1111 111222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.. .......+..+.+|+.+||+.||++|||++||++.|+++......++
T Consensus 255 ~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 255 YP----------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp SC----------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred CC----------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 11 11112344568899999999999999999999999999988887766
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.25 Aligned_cols=272 Identities=25% Similarity=0.374 Sum_probs=207.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEE------cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL------MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 573 (812)
.++|++.+.||+|+||.||+|++ .+++.||||++.... .......+.+|+.++++++||||+++++++.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 45799999999999999999983 347789999986321 12344578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC---CC
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV---NW 650 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~ 650 (812)
.+..++||||+++++|.+++......... ...+++..+++++.||+.||.|||+.+ |+||||||+|||++. +.
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQ-PSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSS-TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccc-cccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcc
Confidence 99999999999999999999876543222 123478888999999999999999998 999999999999984 45
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~ 729 (812)
.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~ 252 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQ 252 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HH
Confidence 699999999864433222222334567899999999998899999999999999999998 888874322 11
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.....+..+. +...+ ...+..+.+++.+||+.||.+|||+.|++++|+.+.+.....+
T Consensus 253 ~~~~~~~~~~-------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 310 (327)
T 2yfx_A 253 EVLEFVTSGG-------RMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 310 (327)
T ss_dssp HHHHHHHTTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHT
T ss_pred HHHHHHhcCC-------CCCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhc
Confidence 1122222221 11111 2234568899999999999999999999999999877554444
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=362.27 Aligned_cols=253 Identities=19% Similarity=0.297 Sum_probs=195.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc--CCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH--HKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~ 578 (812)
.+|++.+.||+|+||.||++...+++.||||++..... .......+.+|+++++.++ ||||+++++++..++..+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 45999999999999999999988899999999864322 2344567889999999996 599999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
|||| +.+++|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||
T Consensus 133 lv~E-~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG 199 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKS--------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG 199 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSS--------CCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCS
T ss_pred EEEe-cCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecC
Confidence 9999 567899999986542 255677899999999999999998 99999999999995 5799999999
Q ss_pred ccccCCCCcccccccccccCCCccCcccccc-----------CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVM-----------NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
+++...............||+.|+|||++.+ ..++.++|||||||+||||++|+.||..... .
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~ 273 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------Q 273 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------H
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------H
Confidence 9987654333333455689999999999865 3688999999999999999999999854221 1
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ....+..... ....+... ...+.+|+.+||..||++|||+.|++++
T Consensus 274 ~~-~~~~~~~~~~------~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 IS-KLHAIIDPNH------EIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HH-HHHHHHCTTS------CCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH-HHHHHhCccc------cCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 1112222111 11112211 3457889999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=342.46 Aligned_cols=269 Identities=21% Similarity=0.263 Sum_probs=205.8
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEE-EeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFC-QEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~-~~~~~ 576 (812)
..++|++.+.||+|+||.||++++ .+++.||||++... .....+.+|+++++.++|+|++..+..+ .+.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc-------ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 457899999999999999999997 56899999986532 1223577899999999988877666555 66777
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE---cCCCcEE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTAR 653 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~k 653 (812)
.++||||+ +++|.+++...... +++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+|
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRK-------FSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSC-------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEE
T ss_pred eEEEEEcc-CCCHHHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEE
Confidence 89999999 99999999754321 367888999999999999999998 9999999999999 7889999
Q ss_pred EEeecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 654 VSDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
|+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~ 227 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKY 227 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHH
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhh
Confidence 9999999765443221 1233567999999999999999999999999999999999999999754432222 222
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccC
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDC 797 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~ 797 (812)
............... . ..+++.+.+|+.+||+.||++|||++|+++.|+++++.....
T Consensus 228 ~~~~~~~~~~~~~~~-~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 228 ERISEKKMSTPIEVL-C----------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHHHHHSCHHHH-T----------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hhhhcccccchhhhh-h----------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 222222111110000 0 112456889999999999999999999999999998876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=351.57 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=193.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEE----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|++.+.||+|+||.||+++. .+++.||+|++...... ........+.+|+++++.++||||+++++++.+++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 35699999999999999999987 47899999998643211 11233456788999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++++|.+++..... ++....+.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGI--------FMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhCCC--------CCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEE
Confidence 99999999999999999976432 245667889999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+
T Consensus 164 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i 233 (327)
T 3a62_A 164 DFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKI 233 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHH
T ss_pred eCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHH
Confidence 999987543221 123445799999999999998999999999999999999999999854321 1122222
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
.... ...+ ......+.+|+.+||+.||++|| +++|++++
T Consensus 234 ~~~~--------~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 234 LKCK--------LNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHTC--------CCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HhCC--------CCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 2221 1111 12345678999999999999999 78898875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.30 Aligned_cols=253 Identities=22% Similarity=0.261 Sum_probs=202.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
..++|++.+.||+|+||.||+++.+. ++.||+|++... ........+.+.+|.+++..+ +||||+++++++.+.+.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~--~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD--VVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHH--HHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--HhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 34679999999999999999999864 788999998641 111122345677899999988 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.|+||||+++|+|.+++..... +++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGR--------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEe
Confidence 9999999999999999976432 256777889999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.
T Consensus 165 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~ 234 (353)
T 2i0e_A 165 FGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIM 234 (353)
T ss_dssp CTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred CCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHH
Confidence 99997543211 22345679999999999999999999999999999999999999985432 112222333
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 786 (812)
... ...+ ..++..+.+|+.+||..||++||+ ++|++++
T Consensus 235 ~~~--------~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 EHN--------VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HCC--------CCCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred hCC--------CCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 322 1112 123456889999999999999995 6888876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=356.72 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=180.0
Q ss_pred eeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEEEEEEe
Q 042346 506 ENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
.+.||+|+||.||++++. +++.||||++.. .....+.+|+++++.++ ||||+++++++.++...++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK--------RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG--------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh--------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 378999999999999985 589999999853 12345678999999997 99999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC---cEEEEeeccc
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW---TARVSDFGLS 660 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DfGla 660 (812)
+++++|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 88 ~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 88 LNGGELFERIKKKKH--------FSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp CCSCBHHHHHHHCSC--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred cCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 999999999976532 366778899999999999999998 99999999999997765 8999999999
Q ss_pred ccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (812)
+....... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||........... .......+..+.
T Consensus 157 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~~i~~~~- 232 (325)
T 3kn6_A 157 RLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS-AVEIMKKIKKGD- 232 (325)
T ss_dssp EECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC-HHHHHHHHTTTC-
T ss_pred eecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc-HHHHHHHHHcCC-
Confidence 76543222 23445789999999999999999999999999999999999999965433221111 122222332222
Q ss_pred cccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 741 ~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...+.......++.+.+|+.+||+.||++|||++|++++
T Consensus 233 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 233 -------FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp -------CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred -------CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 111111123456778899999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=361.55 Aligned_cols=253 Identities=22% Similarity=0.330 Sum_probs=191.2
Q ss_pred CCccee-eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHH-hccCCCceEEEEEEEe----
Q 042346 501 NNFSLE-NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLS-RVHHKHLVGLVGFCQE---- 573 (812)
Q Consensus 501 ~~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~-~l~H~nIv~l~~~~~~---- 573 (812)
++|.+. ++||+|+||.||++++. +++.||||++... ..+.+|++++. .++||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 456665 78999999999999875 5889999998531 23557888764 4589999999999876
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC---CC
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV---NW 650 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~ 650 (812)
....+|||||+++|+|.++|...... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQ------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCc
Confidence 45689999999999999999764321 2367888999999999999999998 999999999999988 78
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.............
T Consensus 202 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-- 276 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-- 276 (400)
T ss_dssp CEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH--
T ss_pred cEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH--
Confidence 99999999997654321 2345678999999999999999999999999999999999999996544322111111
Q ss_pred HHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
..+..+.+. .+......+...+.+|+.+||+.||++|||++|++++-
T Consensus 277 --~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 277 --TRIRMGQYE--------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp --HHHHHTCCC--------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred --HHHHcCccc--------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 122222211 11111123456688999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.95 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=199.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++. +++.||+|++... ..........+.+|+++++.++||||+++++++.+.+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecc--ccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 456999999999999999999875 4778999998531 1122223567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... +++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 86 lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSK--------FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCC
T ss_pred EEEecCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecc
Confidence 99999999999999976532 256778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+...
T Consensus 155 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~ 222 (279)
T 3fdn_A 155 WSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRV 222 (279)
T ss_dssp EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHT
T ss_pred ccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHhC
Confidence 98654332 1234578999999999999999999999999999999999999985322 11111222211
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
. ...+ ...++.+.+|+.+||+.||++|||++|++++-
T Consensus 223 ~--------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 223 E--------FTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp C--------CCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred C--------CCCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1 1111 12345578899999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=354.87 Aligned_cols=208 Identities=23% Similarity=0.327 Sum_probs=178.2
Q ss_pred CCCCHHHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-----CC
Q 042346 489 DNFTLSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-----HK 562 (812)
Q Consensus 489 ~~~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----H~ 562 (812)
..+++.+.....++|++.++||+|+||.||++++. +++.||||++... ......+..|+++++.++ ||
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 34556666667889999999999999999999984 6889999998631 223445677999999986 99
Q ss_pred CceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 563 nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
||+++++++...+..++||||+ +++|.+++....... +++...+.++.||+.||+|||+.+ |+||||||+
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 166 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNG------FHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPE 166 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCC------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcc
Confidence 9999999999999999999999 899999998654322 356778899999999999999998 999999999
Q ss_pred CEEEcC-------------------------CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcch
Q 042346 643 NILLDV-------------------------NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTD 697 (812)
Q Consensus 643 NILl~~-------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksD 697 (812)
|||++. ++.+||+|||++...... .....||+.|+|||++.+..++.++|
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 241 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSD 241 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccc
Confidence 999975 789999999999764432 23457899999999999999999999
Q ss_pred hHHHHHHHHHHHcCCCCCCC
Q 042346 698 IYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 698 VwS~Gvvl~elltG~~p~~~ 717 (812)
||||||+||||++|+.||..
T Consensus 242 iwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 242 MWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp HHHHHHHHHHHHHSSCSCCC
T ss_pred hHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=357.09 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=192.2
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT------SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc------ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 457999999999999999999986 689999999864221 1235778999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc--EEEEe
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT--ARVSD 656 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--~kl~D 656 (812)
+||||+++++|.+++..... +++...+.++.||++||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 93 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~D 161 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGR--------FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICD 161 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEee
Confidence 99999999999999975432 256778899999999999999998 999999999999987765 99999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCc-chhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAK-TDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
||+++..... .......||+.|+|||++.+..++.+ +||||||++||||++|+.||........ .......+
T Consensus 162 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~ 234 (361)
T 3uc3_A 162 FGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRI 234 (361)
T ss_dssp CCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHH
T ss_pred cCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHH
Confidence 9999743221 12344579999999999988877666 8999999999999999999965433221 12222222
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... ..+. ....+..+.+|+.+||..||++|||++|++++
T Consensus 235 ~~~~~--------~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 235 LSVKY--------SIPD--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HTTCC--------CCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcCCC--------CCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 22211 1111 11233557899999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=374.44 Aligned_cols=258 Identities=25% Similarity=0.302 Sum_probs=206.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||++++. +++.||+|++... ..........+.+|+++++.++||||+++++++.+++..
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~--~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK--RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhH--hhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 3467999999999999999999985 6899999998631 111222345678899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+|||||+++|+|.+++....... +++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~------l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAG------FPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCC------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEec
Confidence 99999999999999997654221 366778899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|+++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......... ......+..
T Consensus 331 Gla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~----~~i~~~i~~ 403 (576)
T 2acx_A 331 GLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKE 403 (576)
T ss_dssp TTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH----HHHHHHHHH
T ss_pred ccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH----HHHHHHhhc
Confidence 9997654322 223458999999999999999999999999999999999999999654322211 111222222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
.. ... ...++..+.+|+.+||+.||++|| +++|+++|
T Consensus 404 ~~--------~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 VP--------EEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CC--------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cc--------ccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11 011 122345688999999999999999 78999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.43 Aligned_cols=271 Identities=24% Similarity=0.295 Sum_probs=197.1
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc---cCCCceEEEEEEEeC
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV---HHKHLVGLVGFCQEK 574 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~ 574 (812)
..++|++.++||+|+||.||+|++ .+++.||+|++...............+.+|+++++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 456899999999999999999986 4689999999864221111111123455677766666 499999999999876
Q ss_pred C-----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC
Q 042346 575 D-----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 575 ~-----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 649 (812)
. ..++||||+. ++|.+++....... +++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~ 156 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPG------LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSG 156 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTC------SCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTT
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCC------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCC
Confidence 5 4789999997 59999997654321 367788999999999999999998 9999999999999999
Q ss_pred CcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 650 WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 650 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
+.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||..... .+...
T Consensus 157 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~ 229 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLG 229 (308)
T ss_dssp SCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH----HHHHH
T ss_pred CCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 999999999997654322 23456789999999999999999999999999999999999999854321 11111
Q ss_pred HHHHHHHhcc---cccc---ccccCCCCCCC-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 730 FAVSQILAGQ---LHCV---LDKRVGPPELN-----EAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 730 ~~~~~~~~~~---~~~~---~d~~~~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.......... +... ........... ..+..+.+.+|+.+||+.||++|||+.|++++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111110000 0000 00000000000 01244668899999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=379.94 Aligned_cols=265 Identities=23% Similarity=0.382 Sum_probs=205.1
Q ss_pred cCCcceee-eeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLEN-KVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~-~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.+++.+.+ .||+|+||.||+|.++ ++..||||++..... ....+.|.+|+++|++++||||+++++++.+ +
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS----STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 34555555 8999999999999874 466799999864321 2234578899999999999999999999976 5
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++|+|.++|..... .+++..+++|+.||++||+|||+++ |+||||||+||||+.++.+||+
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~ 478 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKRE-------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKIS 478 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTT-------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEEC
T ss_pred CeEEEEEeCCCCcHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEe
Confidence 68999999999999999965432 2367888999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccc-cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQEF-ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||+++......... ......+++.|+|||++....++.++|||||||+||||++ |+.||..... .++ ..
T Consensus 479 DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~----~~ 550 (613)
T 2ozo_A 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEV----MA 550 (613)
T ss_dssp CCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS----HHH----HH
T ss_pred eccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHH----HH
Confidence 999998764432211 1223346789999999998999999999999999999998 9999854321 122 22
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
.+..+. ++..+ ..++..+.+||.+||+.||++||++++|++.|+.+........
T Consensus 551 ~i~~~~-------~~~~p----~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 551 FIEQGK-------RMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp HHHTTC-------CCCCC----TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred HHHcCC-------CCCCC----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 222221 12222 2345568899999999999999999999999999887765544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=381.95 Aligned_cols=261 Identities=28% Similarity=0.416 Sum_probs=208.6
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
...++|++.++||+|+||.||+|++.++..||||++..... ..+.|.+|+++|++++||||+++++++.+ +..
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 34567999999999999999999998888999999864221 23468899999999999999999999876 668
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+|||||+++|+|.++|+.... ..+++..+++|+.||++||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF 407 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETG------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF 407 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCT
T ss_pred eEeeehhcCCcHHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccc
Confidence 999999999999999965321 12367788999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|+++...... ........++..|+|||++....++.++||||||++||||++ |+.||..... ......+.
T Consensus 408 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~ 478 (535)
T 2h8h_A 408 GLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVE 478 (535)
T ss_dssp TSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHH
T ss_pred ccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 9998654321 112233457789999999998899999999999999999999 8888743221 11222222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
.+. ++..+ ..+++.+.+||.+||+.||++|||+++|++.|+.++...
T Consensus 479 ~~~-------~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 479 RGY-------RMPCP----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp TTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred cCC-------CCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 221 11112 234556889999999999999999999999999876543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=343.26 Aligned_cols=269 Identities=22% Similarity=0.263 Sum_probs=208.4
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEE-EeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFC-QEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~-~~~~~ 576 (812)
..++|++.+.||+|+||.||+|++ .+++.||||++..... ...+.+|+++++.++|++++..+.++ .+.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-------CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-------hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 356899999999999999999997 5789999998764221 23577899999999988876666555 66777
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE---cCCCcEE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTAR 653 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~k 653 (812)
.++||||+ +++|.+++..... .+++..+++++.||+.||+|||+++ |+||||||+|||+ +.++.+|
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSR-------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEE
T ss_pred eEEEEEec-CCCHHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEE
Confidence 89999999 8999999974432 1367888999999999999999998 9999999999999 5889999
Q ss_pred EEeecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 654 VSDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
|+|||++......... .......||+.|+|||.+.+..++.++||||||++||||++|+.||....... .....
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~ 227 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-KRQKY 227 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-SSSHH
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh-hhhhh
Confidence 9999999765443221 11245579999999999999999999999999999999999999997543222 22222
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccC
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDC 797 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~ 797 (812)
.............. + ...+++.+.+++.+||+.||++|||++||++.|++++......
T Consensus 228 ~~~~~~~~~~~~~~-~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 228 ERISEKKMSTPIEV-L----------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHHHHHSCHHH-H----------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hhhcccccCCchHH-H----------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 22222211111000 0 0123356889999999999999999999999999998876544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.82 Aligned_cols=271 Identities=19% Similarity=0.186 Sum_probs=199.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHH------HHHHHHHHHHHHHHhccCCCceEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLR------EKESAFDSELALLSRVHHKHLVGLVG 569 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~~ 569 (812)
.++|++.+.||+|+||.||+|++. ++..+|+|++.........+ .....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999985 57889999987532211111 11234668899999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEE
Q 042346 570 FCQE----KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645 (812)
Q Consensus 570 ~~~~----~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 645 (812)
++.+ ....++||||+ +++|.+++.... .+++..+++++.||+.||+|||+++ |+||||||+|||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 183 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--------TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLL 183 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEE
Confidence 9988 67789999999 999999997543 2367888999999999999999998 999999999999
Q ss_pred EcCCC--cEEEEeecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCC
Q 042346 646 LDVNW--TARVSDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN 718 (812)
Q Consensus 646 l~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~ 718 (812)
++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++||||||++||||++|+.||...
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99887 9999999999765432211 1124457999999999999989999999999999999999999998542
Q ss_pred CCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 719 EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
... ............ ..+...+..... ...+++.+.+++.+||+.||++|||+++|++.|+++.
T Consensus 264 ~~~---~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 264 LKD---PVAVQTAKTNLL-DELPQSVLKWAP-----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TTC---HHHHHHHHHHHH-HTTTHHHHHHSC-----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccc---cHHHHHHHHhhc-ccccHHHHhhcc-----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 211 111111111111 111111100000 0134456889999999999999999999999998743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=366.72 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=203.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|.+.+.||+|+||.||+|++. +++.||||++... .....+....+.+|+++++.++||||+++++++.+.+..+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~--~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQ--KIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHH--HHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhh--hccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357999999999999999999985 6999999998631 1111223457889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... ++....+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 93 lv~E~~~gg~L~~~l~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGR--------LDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSS--------CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEeCCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence 99999999999999975432 356778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcC-CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++....... ......||+.|+|||++.+..+ +.++||||||++||||++|+.||..... . .....+..
T Consensus 162 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~----~~~~~i~~ 230 (476)
T 2y94_A 162 LSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----P----TLFKKICD 230 (476)
T ss_dssp SCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----H----HHHHHHHT
T ss_pred chhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----H----HHHHHHhc
Confidence 998654422 2344579999999999988765 6899999999999999999999854321 1 12222222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+. ...+. .....+.+|+.+||..||++|||++|++++
T Consensus 231 ~~--------~~~p~----~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 231 GI--------FYTPQ----YLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TC--------CCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CC--------cCCCc----cCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 22 11121 123457889999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=358.49 Aligned_cols=260 Identities=19% Similarity=0.242 Sum_probs=206.4
Q ss_pred HhcCCcceeeeeccCCcEEEEEEE------EcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc---CCCceEEE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGK------LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH---HKHLVGLV 568 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~------~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~ 568 (812)
...++|.+.++||+|+||.||+|. ..+++.||||++... ....+.+|+++++.++ |+||++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--------NPWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--------CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--------ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 345779999999999999999993 456899999998642 1235667777777776 99999999
Q ss_pred EEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 569 GFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 569 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
+++..++..+|||||+++|+|.+++....... ...+++..++.|+.||++||+|||+++ |+||||||+||||+.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTP---EKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGN 207 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTST---TCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECG
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhccc---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecc
Confidence 99999999999999999999999997543211 122478889999999999999999998 999999999999998
Q ss_pred -----------CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCC
Q 042346 649 -----------NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 649 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 717 (812)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||+||+.||..
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999754432333344566899999999999999999999999999999999999999864
Q ss_pred CCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHHHhcc
Q 042346 718 NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKER-PNITDIVANLERALAICQ 795 (812)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R-Pt~~evl~~Le~~~~~~~ 795 (812)
..... ..+...+... ...+.+.+++.+|++.+|.+| |+++++.+.|++.+....
T Consensus 288 ~~~~~-------------------~~~~~~~~~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 288 NEGGE-------------------CKPEGLFRRL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp EETTE-------------------EEECSCCTTC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CCCCc-------------------eeechhcccc-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 33211 0011111111 123456688889999999999 689999999999887643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=341.30 Aligned_cols=255 Identities=24% Similarity=0.302 Sum_probs=202.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++. +++.||+|++..... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 356999999999999999999985 689999999864221 123457889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... ++....+.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 150 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIG--------MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 150 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTB--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEecCCCcHHHHHhhccC--------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCC
Confidence 99999999999999965322 356778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcC-CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++................+|+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .. ...+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~-----~~~~~~ 223 (276)
T 2yex_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QE-----YSDWKE 223 (276)
T ss_dssp TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HH-----HHHHHT
T ss_pred CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HH-----HHHhhh
Confidence 9976543332233445678999999999987665 778999999999999999999986533211 11 111111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... . .......+..+.+|+.+||+.||++|||++|++++
T Consensus 224 ~~~------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 224 KKT------Y----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TCT------T----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccc------c----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 110 0 01112345568899999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=368.17 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=194.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||+++.. +++.||||++... ..........+.+|+++++.++||||+++++++.+.+..+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKE--VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--HHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhh--hhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 356999999999999999999874 5899999998631 1112333456778999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh-cCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN-YAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
|||||+++++|.+++..... +++.....++.||++||+|||+ .+ |+||||||+||||+.++.+||+||
T Consensus 225 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERV--------FSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSC--------CCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCC
T ss_pred EEEeeCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccC
Confidence 99999999999999976432 3567788999999999999998 77 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|+++...... .......||+.|+|||++.+..++.++||||||++||||++|+.||..... ......+..
T Consensus 294 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~ 363 (446)
T 4ejn_A 294 GLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILM 363 (446)
T ss_dssp CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH
T ss_pred CCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHh
Confidence 9997543322 223456899999999999999999999999999999999999999854321 112222222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
.. ...+. ..+..+.+|+.+||+.||++|| +++|++++
T Consensus 364 ~~--------~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 364 EE--------IRFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CC--------CCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC--------CCCCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 21 11111 2345678999999999999999 99999974
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=349.23 Aligned_cols=269 Identities=20% Similarity=0.360 Sum_probs=207.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
.++|++.+.||+|+||.||++++ .+++.||||++.... .+..+.+.+|++++++++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-----EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-----SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 35699999999999999999985 358899999986421 23445788999999999999999999998765
Q ss_pred C--eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 575 D--ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 575 ~--~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
+ ..++||||+++++|.+++...... +++..+++++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 184 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKER-------IDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRV 184 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTS-------SCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccC-------CCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcE
Confidence 4 579999999999999999765321 367788899999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCC-------CCCCC
Q 042346 653 RVSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNE-------DGSGP 724 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~-------~~~~~ 724 (812)
||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... .....
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCC
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccc
Confidence 99999999876543322 12233467788999999998889999999999999999999998874321 00000
Q ss_pred chhH-HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 725 LDVV-EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 725 ~~~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
.... ......+..+. +... ...++..+.+|+.+||+.||++|||+.|+++.|+++.+..
T Consensus 265 ~~~~~~~~~~~~~~~~-------~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 265 GQMIVFHLIELLKNNG-------RLPR----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp THHHHHHHHHHHHTTC-------CCCC----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHhhcCC-------CCCC----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0111 11111111110 1111 1234456889999999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=340.07 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=201.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe-----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE----- 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----- 573 (812)
.++|++.+.||+|+||.||++++. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 456999999999999999999986 68999999986421 245689999999999999999998865
Q ss_pred -----------CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 574 -----------KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 574 -----------~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
....++||||+++++|.+++...... .+++..+++++.||+.||.|||+++ |+||||||+
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~ 151 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE------KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPS 151 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHH
Confidence 33478999999999999999754321 2367788999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS 722 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~ 722 (812)
|||++.++.+||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 152 Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---- 224 (284)
T 2a19_B 152 NIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---- 224 (284)
T ss_dssp GEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----
T ss_pred HEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----
Confidence 9999999999999999987654422 223457899999999999999999999999999999999999886321
Q ss_pred CCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 723 GPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
......+..+.+ + ...+..+.+++.+||+.||++|||+.|++++|+.+.+....
T Consensus 225 ------~~~~~~~~~~~~----------~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 225 ------SKFFTDLRDGII----------S----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp ------HHHHHHHHTTCC----------C----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred ------HHHHHHhhcccc----------c----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 111112222111 1 11234578899999999999999999999999987654443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=350.12 Aligned_cols=257 Identities=22% Similarity=0.305 Sum_probs=203.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhH-HHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKL-REKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
.++|++.+.||+|+||.||++++. +++.||+|++......... ....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 346999999999999999999985 5899999998653221110 11245688999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC----cEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW----TAR 653 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~k 653 (812)
++||||+++++|.+++..... +++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKES--------LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSC--------EEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEE
T ss_pred EEEEEcCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEE
Confidence 999999999999999975432 367788899999999999999998 99999999999999887 799
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....
T Consensus 160 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~ 228 (321)
T 2a2a_A 160 LIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLA 228 (321)
T ss_dssp ECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHH
T ss_pred EccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHH
Confidence 99999997654422 22445799999999999999999999999999999999999999854321 11112
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+..... ..+.......+..+.+|+.+||..||++|||++|++++
T Consensus 229 ~i~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 229 NITSVSY--------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHTTCC--------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHhccc--------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2222111 00100012234568899999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.43 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=197.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++++. +++.||+|++.... ......+.+.+|++++++++||||+++++++.+.+..++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 57999999999999999999985 48999999886432 223445678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... +++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 80 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRG--------VPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGF 148 (311)
T ss_dssp EEECCSEEHHHHHHHTSSC--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCCchHHHHHhhhcC--------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCC
Confidence 9999999999998865432 256778899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH----
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ---- 734 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---- 734 (812)
+........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .+........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~ 222 (311)
T 4agu_A 149 ARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD----VDQLYLIRKTLGDL 222 (311)
T ss_dssp CEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCSC
T ss_pred chhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhccc
Confidence 976543221 2334578999999999876 6789999999999999999999999854321 1111111100
Q ss_pred -------HHhccccccccccCCCCCCC-h-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 -------ILAGQLHCVLDKRVGPPELN-E-----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 -------~~~~~~~~~~d~~~~~~~~~-~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
....... ....+..+... . ...+..+.+|+.+||+.||++|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 223 IPRHQQVFSTNQYF--SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CHHHHHHHHTCGGG--TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccc--ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 00011111100 0 1234568899999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.33 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=201.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++.. ++.+|+|++..... +..+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 4569999999999999999999854 77899999864221 22456889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE---cCCCcEEEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVS 655 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~ 655 (812)
+||||+++++|.+++..... +++..+++++.|++.||+|||+++ |+||||||+|||+ +.++.+||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~ 151 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRV--------FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLI 151 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEeccCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEE
Confidence 99999999999999976532 356778899999999999999998 9999999999999 788999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||++....... ......+|+.|+|||.+.+. ++.++||||||+++|||++|+.||..... ......+
T Consensus 152 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~ 219 (277)
T 3f3z_A 152 DFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKI 219 (277)
T ss_dssp CCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred ecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHH
Confidence 999997654322 23445799999999988764 89999999999999999999999854321 1122222
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+.. ..+.......+..+.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 220 REGTF--------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHCCC--------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HhCCC--------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22221 11110011345678899999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=355.35 Aligned_cols=270 Identities=15% Similarity=0.173 Sum_probs=208.2
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC---------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceE----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD---------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG---- 566 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~---- 566 (812)
.++|++.+.||+|+||.||+|++.. ++.||+|++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence 3679999999999999999998864 789999998642 35778999999999999887
Q ss_pred -----------EEEEEEe-CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042346 567 -----------LVGFCQE-KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSI 634 (812)
Q Consensus 567 -----------l~~~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~i 634 (812)
+++++.. +...++||||+ +++|.+++..... ..+++..+++++.||+.||+|||+++ |
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---i 180 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK------HVLSERSVLQVACRLLDALEFLHENE---Y 180 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc------CCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 6778876 67789999999 9999999986521 12477888999999999999999998 9
Q ss_pred EeeccCCCCEEEcCCC--cEEEEeecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHH
Q 042346 635 IHRDIKSSNILLDVNW--TARVSDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLE 707 (812)
Q Consensus 635 vHrDlKp~NILl~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~e 707 (812)
+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++||||||++|||
T Consensus 181 vH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 260 (352)
T 2jii_A 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260 (352)
T ss_dssp BCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 9999999999999998 9999999999765443221 11234579999999999999899999999999999999
Q ss_pred HHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 708 LLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 708 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
|++|+.||...... ............ .......+. .......+..+.+|+.+||+.||++|||++||++.|
T Consensus 261 l~~g~~pf~~~~~~---~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 261 WLYGFLPWTNCLPN---TEDIMKQKQKFV-DKPGPFVGP-----CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp HHHSCCTTGGGTTC---HHHHHHHHHHHH-HSCCCEECT-----TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHhCCCCcccCCcC---HHHHHHHHHhcc-CChhhhhhh-----ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 99999998653311 111111111111 111111111 101112345688999999999999999999999999
Q ss_pred HHHHHhcccCC
Q 042346 788 ERALAICQDCS 798 (812)
Q Consensus 788 e~~~~~~~~~~ 798 (812)
+++++......
T Consensus 332 ~~~~~~~~~~~ 342 (352)
T 2jii_A 332 EALLQDLRVSP 342 (352)
T ss_dssp HHHHHHTTCCT
T ss_pred HHHHHhcCCCc
Confidence 99998876544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=349.62 Aligned_cols=271 Identities=20% Similarity=0.291 Sum_probs=187.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||+|++. +++.||+|++..... ......+.+|++++++++||||+++++++.+++..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE----EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST----TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc----cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 357999999999999999999874 589999999864321 112345778999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||++ ++|.+++........ ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 153 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNT--PRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFG 153 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSC--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCS
T ss_pred EEEEecC-CCHHHHHHhcccccc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCc
Confidence 9999998 599999976432211 112367778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .............
T Consensus 154 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~ 227 (317)
T 2pmi_A 154 LARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND----EEQLKLIFDIMGT 227 (317)
T ss_dssp SCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCS
T ss_pred cceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCC
Confidence 9976543221 2334578999999999876 4689999999999999999999999854321 1111111111000
Q ss_pred c--c----cccc--ccccCCC--CCCC--------hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 G--Q----LHCV--LDKRVGP--PELN--------EAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~--~----~~~~--~d~~~~~--~~~~--------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. . .... ....+.. +... .......+.+|+.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0 0000 0000000 0000 01234568899999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=347.56 Aligned_cols=269 Identities=28% Similarity=0.457 Sum_probs=206.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEE--EEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREV--AVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~v--avK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
++|++.+.||+|+||.||++++. +++.+ ++|++... ......+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc----cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 56999999999999999999874 45544 89987532 1223445688999999999 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCc--------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEK--------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
.++||||+++++|.+++........ .....+++..+++++.||+.||+|||+++ |+||||||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcC
Confidence 9999999999999999976541100 00113477888999999999999999998 999999999999999
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchh
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 727 (812)
++.+||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 178 ~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------- 247 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------- 247 (327)
T ss_dssp GGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------
T ss_pred CCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------
Confidence 99999999999864322 112233457889999999998889999999999999999998 9999854321
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
......+..+. +...+ ...+..+.+|+.+||..||++|||++|++++|+++++......
T Consensus 248 -~~~~~~~~~~~-------~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 248 -AELYEKLPQGY-------RLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp -HHHHHHGGGTC-------CCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred -HHHHHHhhcCC-------CCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 11112221111 11111 2334568899999999999999999999999999988765443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=368.96 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=205.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|.+.+.||+|+||.||+++++ +++.||+|++... ..........+.+|++++++++||||+++++++.+.+..+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~--~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK--RLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhH--HhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 367999999999999999999985 5899999998631 1111223457888999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++|+|.+++....... ..+++...+.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDN----PGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTS----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEeccCCCHHHHHHHhhccc----ccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecc
Confidence 9999999999999997653211 12366777889999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+++....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||........ .......+...
T Consensus 335 la~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~~ 408 (543)
T 3c4z_A 335 LAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLEQ 408 (543)
T ss_dssp TCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHHC
T ss_pred eeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhhc
Confidence 9986544221 22345899999999999999999999999999999999999999965432211 11122222222
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI-----TDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 786 (812)
. ...+ ..++..+.+|+.+||+.||++||++ +||+++
T Consensus 409 ~--------~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 409 A--------VTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp C--------CCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred c--------cCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 1 1111 2334567889999999999999975 677753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=352.26 Aligned_cols=268 Identities=24% Similarity=0.312 Sum_probs=191.2
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEe-
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQE- 573 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~- 573 (812)
.....+|++.++||+|+||.||++++. +++.||||++... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 334557999999999999999999975 6899999987532 1334557889999999996 9999999999953
Q ss_pred -------CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 574 -------KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 574 -------~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
....++||||+. |+|.+++....... .+++..+++++.||+.||+|||+++ ++|+||||||+|||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRG-----PLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLL 171 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTC-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEE
Confidence 334789999996 79999987532211 2377888999999999999999986 459999999999999
Q ss_pred cCCCcEEEEeecccccCCCCcccc----------cccccccCCCccCcccc---ccCcCCCcchhHHHHHHHHHHHcCCC
Q 042346 647 DVNWTARVSDFGLSLLGSECDQEF----------ISTKAVGTVGYIDPEYY---VMNVLTAKTDIYGLGVVLLELLTGKK 713 (812)
Q Consensus 647 ~~~~~~kl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDVwS~Gvvl~elltG~~ 713 (812)
+.++.+||+|||++.......... ......+|+.|+|||++ .+..++.++||||||+++|||++|+.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 999999999999998654422211 11234689999999998 56678999999999999999999999
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 714 AVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 714 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
||...... .+..+... ...+ ......+.+|+.+||+.||++|||++|++++|+++.+.
T Consensus 252 p~~~~~~~------------~~~~~~~~------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 252 PFEDGAKL------------RIVNGKYS------IPPH----DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp CC------------------------CC------CCTT----CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcchhHH------------HhhcCccc------CCcc----cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 98542210 01111110 0111 11123477899999999999999999999999999887
Q ss_pred cccCC
Q 042346 794 CQDCS 798 (812)
Q Consensus 794 ~~~~~ 798 (812)
....+
T Consensus 310 ~~~~~ 314 (337)
T 3ll6_A 310 RNVNP 314 (337)
T ss_dssp TTCCT
T ss_pred cCCCC
Confidence 65554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.94 Aligned_cols=262 Identities=25% Similarity=0.354 Sum_probs=206.5
Q ss_pred HHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcch---hhHHHHHHHHHHHHHHHHhc-cCCCceEEEE
Q 042346 495 ELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKT---NKLREKESAFDSELALLSRV-HHKHLVGLVG 569 (812)
Q Consensus 495 el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~---~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~ 569 (812)
......++|++.+.||+|+||.||+|++. +|+.||||++...... ....+..+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445577999999999999999999985 6999999998643211 22234456788999999999 7999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC
Q 042346 570 FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 570 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 649 (812)
++......++||||+++++|.+++..... +++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKVA--------LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN 236 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 99999999999999999999999975422 367788899999999999999998 9999999999999999
Q ss_pred CcEEEEeecccccCCCCcccccccccccCCCccCcccccc------CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 650 WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM------NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 650 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||.....
T Consensus 237 ~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--- 310 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--- 310 (365)
T ss_dssp CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred CCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---
Confidence 999999999997655422 2345679999999999863 3588999999999999999999999854221
Q ss_pred CchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......+..+... .+.......+..+.+++.+||+.||++|||++|++++
T Consensus 311 -----~~~~~~i~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 311 -----ILMLRMIMEGQYQ--------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -----HHHHHHHHHTCCC--------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----HHHHHHHHhCCCC--------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112222222211 0000001234568899999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=350.02 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=195.7
Q ss_pred CCccee-eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeE
Q 042346 501 NNFSLE-NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 501 ~~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 577 (812)
+.|++. +.||+|+||.||+++.. +++.||||++..... .....+.+|++++.++ +||||+++++++.+++..
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 468874 78999999999999864 689999999864321 2234678899999885 799999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc---EEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT---ARV 654 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kl 654 (812)
++||||+++++|.+++..... +++...+.++.||+.||+|||+++ |+||||||+|||++.++. +||
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl 155 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRH--------FNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKI 155 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEE
T ss_pred EEEEEcCCCCcHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEE
Confidence 999999999999999976532 256777899999999999999998 999999999999988766 999
Q ss_pred EeecccccCCCCcc-----cccccccccCCCccCcccccc-----CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 042346 655 SDFGLSLLGSECDQ-----EFISTKAVGTVGYIDPEYYVM-----NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP 724 (812)
Q Consensus 655 ~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~ 724 (812)
+|||++........ ........||+.|+|||++.. ..++.++||||||+++|||++|+.||.........
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 99999875432211 111223469999999999875 56899999999999999999999999654322211
Q ss_pred chh-------HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 725 LDV-------VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 725 ~~~-------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... .......+..+.. ..+.......+..+.+|+.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 236 WDRGEACPACQNMLFESIQEGKY--------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp C----CCHHHHHHHHHHHHHCCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccccchhHHHHHHHHHhccCc--------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 110 1111222222211 11110011245668899999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=378.35 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=198.0
Q ss_pred eeeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEe
Q 042346 507 NKVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
++||+|+||.||+|.+. .++.||||++.... ......+.|.+|++++++++||||+++++++.+ +..+|||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~ 450 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM 450 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG---GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEc
Confidence 48999999999999763 46789999986421 222335678999999999999999999999965 458899999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccC
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
+++|+|.++|..... +++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 451 ~~~g~L~~~l~~~~~--------l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 451 AELGPLNKYLQQNRH--------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp CTTEEHHHHHHHCTT--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred cCCCCHHHHHhhCCC--------CCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 999999999975432 367788999999999999999998 999999999999999999999999999865
Q ss_pred CCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 664 SECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 664 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
...... .......+|+.|+|||++....++.++||||||++||||++ |+.||..... ......+..+.
T Consensus 520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~-- 589 (635)
T 4fl3_A 520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGE-- 589 (635)
T ss_dssp TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTC--
T ss_pred ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCC--
Confidence 443221 22333457889999999999999999999999999999998 9999854321 11222222221
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
++..+ ..++..+.+||.+||+.||++|||+++|++.|+++....
T Consensus 590 -----~~~~p----~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 590 -----RMGCP----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp -----CCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCC----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11112 234456889999999999999999999999999987643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=356.50 Aligned_cols=246 Identities=26% Similarity=0.314 Sum_probs=188.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHH-HHhccCCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELAL-LSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
++|++.+.||+|+||.||+++++ +++.||+|++..... ........+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAI--LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGB--C-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 46999999999999999999985 478899999864221 122334456667766 56789999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++|+|.+++..... ++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 116 lv~E~~~gg~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERC--------FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEeCCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCc
Confidence 99999999999999976432 245566789999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..+
T Consensus 185 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~ 254 (373)
T 2r5t_A 185 LCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNK 254 (373)
T ss_dssp BCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHS
T ss_pred cccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhc
Confidence 99753221 1223456899999999999999999999999999999999999999854321 1122233332
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT 781 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 781 (812)
.+ ..+. .....+.+|+.+||+.||++||++.
T Consensus 255 ~~--------~~~~----~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 255 PL--------QLKP----NITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CC--------CCCS----SSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred cc--------CCCC----CCCHHHHHHHHHHcccCHHhCCCCC
Confidence 21 1111 2344578899999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.43 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=199.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 577 (812)
.++|++.+.||+|+||.||+++++ +++.||+|++..... .+.+|++++.++ +||||+++++++.+++..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 456999999999999999999985 588999999864221 234688888887 799999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC----CcEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN----WTAR 653 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~----~~~k 653 (812)
++||||+++|+|.+++..... +++.....++.||+.||+|||+++ |+||||||+|||+..+ +.+|
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~--------~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~k 160 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKF--------FSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIR 160 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTT--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEE
T ss_pred EEEEeCCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEE
Confidence 999999999999999976532 356778899999999999999998 9999999999998443 3599
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|+|||++........ ......+|+.|+|||++.+..++.++||||||++||||++|+.||..... . .......
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~----~~~~~~~ 233 (342)
T 2qr7_A 161 ICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-D----TPEEILA 233 (342)
T ss_dssp ECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-S----CHHHHHH
T ss_pred EEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-C----CHHHHHH
Confidence 999999976543221 23445789999999999988899999999999999999999999864321 1 1222333
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+..+.+. .+.......++.+.+|+.+||..||++|||+.|++++
T Consensus 234 ~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 234 RIGSGKFS--------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHCCCC--------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHccCCcc--------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 33333321 1111122345568899999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.43 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=204.8
Q ss_pred CCCHHHHHHhcCCccee-eeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceE
Q 042346 490 NFTLSELAAATNNFSLE-NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVG 566 (812)
Q Consensus 490 ~~~~~el~~~~~~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~ 566 (812)
+..+.......++|.+. +.||+|+||.||+++.. +++.||+|++...... ......+.+|+.+++.+ +||||++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG---QDCRAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT---EECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHhccCCCCEEE
Confidence 44444455566678887 89999999999999875 5899999998643221 12245678899999999 5699999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 567 l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
+++++.+.+..++||||+++++|.+++...... .+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~ 164 (327)
T 3lm5_A 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAE------MVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILL 164 (327)
T ss_dssp EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred EEEEEEeCCeEEEEEEecCCCcHHHHHHHhccc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEE
Confidence 999999999999999999999999998643221 2367788999999999999999998 9999999999999
Q ss_pred cC---CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 647 DV---NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 647 ~~---~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
+. ++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 165 ~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--- 238 (327)
T 3lm5_A 165 SSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--- 238 (327)
T ss_dssp SCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred ecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---
Confidence 88 7899999999997654322 22345799999999999999999999999999999999999999854321
Q ss_pred CchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......+.... ...+..........+.+|+.+||+.||++|||++|++++
T Consensus 239 -----~~~~~~i~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 239 -----QETYLNISQVN--------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -----HHHHHHHHHTC--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -----hHHHHHHHhcc--------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11111111111 111111123345668899999999999999999999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=336.40 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=197.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe----CC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE----KD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~ 575 (812)
..|.+.+.||+|+||.||+|.+. ++..||+|++.... ......+.+.+|+++++.++||||+++++++.. ..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh---hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34888999999999999999874 57889999986422 223445678899999999999999999999876 34
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc-CCCcEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD-VNWTARV 654 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kl 654 (812)
..++||||+++++|.+++..... +++..+++++.||+.||.|||+.+ ++|+||||||+|||++ .++.+||
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl 173 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKV--------MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEE
T ss_pred eEEEEEEecCCCCHHHHHHHccC--------CCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEE
Confidence 57999999999999999976432 256778899999999999999986 4599999999999997 7899999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+|||++...... ......+|+.|+|||++.+ .++.++||||||+++|||++|+.||..... .......
T Consensus 174 ~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~ 241 (290)
T 1t4h_A 174 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRR 241 (290)
T ss_dssp CCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHH
T ss_pred eeCCCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHHHH
Confidence 999999754432 2234578999999998864 599999999999999999999999854321 1112222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..+.....+ .......+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 242 VTSGVKPASF----------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HTTTCCCGGG----------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhccCCcccc----------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 2222111111 11223458899999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=341.90 Aligned_cols=261 Identities=21% Similarity=0.314 Sum_probs=202.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhH-HHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKL-REKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
++|++.+.||+|+||.||++++. +++.||+|++......... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46999999999999999999986 5899999998653222111 112457889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC----cEEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW----TARV 654 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kl 654 (812)
+||||+++++|.+++..... +++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKES--------LTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEeecCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEE
Confidence 99999999999999975432 367788999999999999999998 99999999999998877 8999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+|||++....... ......+++.|+|||++....++.++||||||+++|||++|+.||..... ......
T Consensus 154 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~ 222 (283)
T 3bhy_A 154 IDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTN 222 (283)
T ss_dssp CCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH
T ss_pred EecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHH
Confidence 9999997654322 22345689999999999988999999999999999999999999854321 111122
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN--LERAL 791 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~ 791 (812)
+..... ..+.......++.+.+++.+||..||++|||+.|++++ ++.+.
T Consensus 223 ~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 223 ISAVNY--------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHTTCC--------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred hHhccc--------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 211110 00000012234568899999999999999999999984 44443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.93 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=197.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-eE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD-ER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~ 577 (812)
..++|++.+.||+|+||.||++++ +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 346799999999999999999988 58899999986421 2356889999999999999999999976544 68
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++++|.+++..... ..+++..+++++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Df 161 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGR------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF 161 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHH------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCCHHHHHHhccc------ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeec
Confidence 999999999999999975421 12366778899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|++...... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.. ..+.
T Consensus 162 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~----~~~~ 228 (278)
T 1byg_A 162 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVV----PRVE 228 (278)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHH----HHHT
T ss_pred ccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHH----HHHh
Confidence 998754332 223357889999999998899999999999999999998 9988854321 1111 1111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
.+. +... ....+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 229 ~~~-------~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 229 KGY-------KMDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TTC-------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC-------CCCC----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 111 1111 123345688999999999999999999999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.56 Aligned_cols=258 Identities=24% Similarity=0.302 Sum_probs=200.3
Q ss_pred CCcceeeeeccCCcEEEEEEEE----cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL----MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 575 (812)
++|++.+.||+|+||.||+++. .+++.||||++........ ....+.+.+|+++++.+ +||||+++++++.+++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh-hhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 5699999999999999999987 3689999999864221100 11223466799999999 6999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..+|||||+++++|.+++..... +++..++.++.||++||.|||+++ |+||||||+|||++.++++||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRER--------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEES
T ss_pred eEEEEeecCCCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEe
Confidence 99999999999999999976432 256777899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||+++...... ........||+.|+|||++.+ ..++.++||||||++||||++|+.||......... .....
T Consensus 202 DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~~~~ 276 (355)
T 1vzo_A 202 DFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISR 276 (355)
T ss_dssp CSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHH
T ss_pred eCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH----HHHHH
Confidence 999997654322 222344579999999999985 45789999999999999999999998654322211 11111
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVANL 787 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~L 787 (812)
.+.... ... ..++...+.+|+.+||..||++|| +++|++++.
T Consensus 277 ~~~~~~--------~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 277 RILKSE--------PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHCC--------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHhccC--------CCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 221111 111 123445688999999999999999 999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=365.53 Aligned_cols=263 Identities=21% Similarity=0.269 Sum_probs=194.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK---- 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---- 574 (812)
.++|++.+.||+|+||.||+|++. +++.||||++... .......+.+.+|+++++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 578999999999999999999875 5889999998642 22234456788999999999999999999999654
Q ss_pred --CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 575 --DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 575 --~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
...+|||||+++ +|.+.+... +++..+..++.||++||+|||+++ |+||||||+|||++.++.+
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~~----------l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~ 203 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQME----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 203 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred cCCeEEEEEeCCCC-CHHHHHhhc----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCE
Confidence 357999999975 677777432 256777889999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||+|||+++..... .......||+.|+|||++.+..|+.++|||||||+||||++|+.||..... .+......
T Consensus 204 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~----~~~~~~i~ 276 (464)
T 3ttj_A 204 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVI 276 (464)
T ss_dssp EECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH
T ss_pred EEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 99999999765432 223456899999999999999999999999999999999999999854321 11111111
Q ss_pred HHHHh------cc----ccccccccCC----------------CCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILA------GQ----LHCVLDKRVG----------------PPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~------~~----~~~~~d~~~~----------------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+-. .. ....+..... ............+.+|+.+||..||++|||++|++++
T Consensus 277 ~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 277 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 10000 00 0000000000 0000112235678899999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.61 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=199.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhh---HHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNK---LREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|++.+.||+|+||.||+|++. +++.||||++........ .......+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 457999999999999999999874 688999999865321111 0112235677999999999999999999999999
Q ss_pred eEEEEEEecCCC-chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 576 ERLLVYEYMSNG-ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 576 ~~~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
..++||||+..| +|.+++..... +++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~--------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL 171 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPR--------LDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKL 171 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCC--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEE
Confidence 999999999777 99999976542 366778899999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcC-CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
+|||++....... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 172 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------- 235 (335)
T 3dls_A 172 IDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------- 235 (335)
T ss_dssp CCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------------
T ss_pred eecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------------
Confidence 9999997654422 2234579999999999988776 7899999999999999999999853211
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
........+.. .++.+.+|+.+||+.||++|||++|++++
T Consensus 236 ---------~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---------TVEAAIHPPYL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------GTTTCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---------HHhhccCCCcc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111112222 33457899999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.54 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=195.0
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||++++. +++.||||++... .....+..+.+.+|+++++.++||||+++++++.+.+..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ--KIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccc--cccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 3467999999999999999999986 6899999998531 111222345788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++++|.+++..... +++...++++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGR--------VEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeec
Confidence 999999999999999976532 256778899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcC-CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|++....... ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.... .......+.
T Consensus 156 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~ 224 (276)
T 2h6d_A 156 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKIR 224 (276)
T ss_dssp CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred ccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhh
Confidence 9997654422 1234578999999999987765 689999999999999999999985322 111222222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.. ..+ ......+.+++.+||+.||++|||++|++++
T Consensus 225 ~~~~--------~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 225 GGVF--------YIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HCCC--------CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCcc--------cCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2211 111 1233457899999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.16 Aligned_cols=271 Identities=23% Similarity=0.269 Sum_probs=194.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||++++. +++.||||++.............+.+.+|+++++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4567999999999999999999875 589999999864322222222234678899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++ +|.+++...... +++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLV-------LTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSS-------CCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcC-------CCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEec
Confidence 999999986 899998764321 244566789999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
|+++...... .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .+..........
T Consensus 157 g~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----~~~~~~i~~~~~ 230 (346)
T 1ua2_A 157 GLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIFETLG 230 (346)
T ss_dssp GGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHC
T ss_pred ccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHcC
Confidence 9997654322 22345678999999999875 4589999999999999999999988754321 111111111110
Q ss_pred hcccccccc-----ccC---CCCCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLD-----KRV---GPPELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d-----~~~---~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
........+ ... ..+.... ......+.+|+.+||..||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000 000 0000000 2234678899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=367.30 Aligned_cols=249 Identities=13% Similarity=0.182 Sum_probs=191.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHH---HHHHhccCCCceEEE-------
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSEL---ALLSRVHHKHLVGLV------- 568 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei---~~l~~l~H~nIv~l~------- 568 (812)
.++|++.+.||+|+||.||+|++ .+++.||||++...... .....+.+.+|+ ++++.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C--CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc--chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 46799999999999999999986 46999999998642111 122345788899 455556899999998
Q ss_pred EEEEeCCe-----------------EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCC
Q 042346 569 GFCQEKDE-----------------RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV 631 (812)
Q Consensus 569 ~~~~~~~~-----------------~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~ 631 (812)
+++.+.+. .+|||||+ +|+|.+++......... ...+++..+++|+.||++||+|||+++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSST-HKSLVHHARLQLTLQVIRLLASLHHYG- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTT-THHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccc-cccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 77766532 78999999 68999999865332221 123467888899999999999999998
Q ss_pred CCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccC-----------cCCCcchhHH
Q 042346 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-----------VLTAKTDIYG 700 (812)
Q Consensus 632 ~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDVwS 700 (812)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||
T Consensus 227 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 227 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred --eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 99999999999999999999999999975332 2334567 999999999887 8999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH
Q 042346 701 LGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI 780 (812)
Q Consensus 701 ~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 780 (812)
|||+||||++|+.||......... ..+... . ..+++.+.+|+.+||+.||++|||+
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~----------------~~~~~~----~----~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGS----------------EWIFRS----C----KNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCS----------------GGGGSS----C----CCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred HHHHHHHHHHCCCCCcccccccch----------------hhhhhh----c----cCCCHHHHHHHHHHcCCCchhCCCH
Confidence 999999999999998543321110 011110 0 1123458899999999999999999
Q ss_pred HHHHH
Q 042346 781 TDIVA 785 (812)
Q Consensus 781 ~evl~ 785 (812)
.|+++
T Consensus 355 ~e~l~ 359 (377)
T 3byv_A 355 LQAME 359 (377)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99996
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=357.92 Aligned_cols=268 Identities=24% Similarity=0.325 Sum_probs=189.0
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCC-
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKD- 575 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~- 575 (812)
..++|++.+.||+|+||.||+|.+. +++.||||++... .........+.+|+.+++.+. ||||+++++++...+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc---ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 4578999999999999999999874 6899999998532 112334456778999999997 999999999998654
Q ss_pred -eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 576 -ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 576 -~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
..++||||++ ++|.+++.... ++...+..++.||++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~~---------~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRANI---------LEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred CEEEEEecccC-cCHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEe
Confidence 6899999997 59999997532 255667889999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCc-------------------ccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCC
Q 042346 655 SDFGLSLLGSECD-------------------QEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKA 714 (812)
Q Consensus 655 ~DfGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p 714 (812)
+|||+++...... .........||+.|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999997543211 1112334579999999999976 6799999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHHHHHHHhccc------------------cccccc-cCCCCCCCh------------HHHHHHHH
Q 042346 715 VFKNEDGSGPLDVVEFAVSQILAGQL------------------HCVLDK-RVGPPELNE------------AEAVELLA 763 (812)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~d~-~~~~~~~~~------------~~~~~~l~ 763 (812)
|..... .+........+..... ...... ......... ..+...+.
T Consensus 231 f~~~~~----~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (388)
T 3oz6_A 231 FPGSST----MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306 (388)
T ss_dssp CCCSSH----HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHH
T ss_pred CCCCCH----HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHH
Confidence 854321 1111111110000000 000000 000000000 02245678
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 042346 764 TTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 764 ~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+|+.+||..||++|||++|++++
T Consensus 307 dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 307 DLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhhccCcccCCCHHHHhCC
Confidence 99999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=339.07 Aligned_cols=253 Identities=19% Similarity=0.287 Sum_probs=204.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|.+.+.||+|+||.||++++. +++.+|+|++..... ......+.+.+|+++++.++||||+++++++.+++..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc--cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 356999999999999999999986 478899999864211 12344567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... +++..+++++.|+++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 92 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKA--------LTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEecCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEecc
Confidence 99999999999999875432 366778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++........ ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+...
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~ 230 (294)
T 2rku_A 161 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKN 230 (294)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTT
T ss_pred CceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhhc
Confidence 9976543221 23345789999999999998899999999999999999999999854221 1111222221
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
. ...+. .....+.+++.+||+.||++|||++|++++-
T Consensus 231 ~--------~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 231 E--------YSIPK----HINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp C--------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred c--------CCCcc----ccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1 11111 2334578899999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.99 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=203.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|.+.+.||+|+||.||++++. +++.+|+|++..... ......+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 356999999999999999999985 478899999864211 12344567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++..... +++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 118 lv~e~~~~~~L~~~~~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKA--------LTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEEecCCCCCHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeecc
Confidence 99999999999999875432 366788899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++........ ......+|+.|+|||++.+..++.++||||||++||||++|+.||.... .......+...
T Consensus 187 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~~ 256 (335)
T 2owb_A 187 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKKN 256 (335)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHT
T ss_pred CceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhcC
Confidence 9976543221 2334579999999999999889999999999999999999999985422 11111222222
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ..+. .....+.+|+.+||+.||++|||++|++++
T Consensus 257 ~~--------~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 257 EY--------SIPK----HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CC--------CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CC--------CCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1111 223457889999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=366.59 Aligned_cols=197 Identities=24% Similarity=0.353 Sum_probs=152.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK---- 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---- 574 (812)
.++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+.+|+++|+.++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 467999999999999999999875 68999999986421 2233456788999999999999999999998543
Q ss_pred -CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 575 -DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 575 -~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
...|+||||+ +++|.+++..... +++..+..++.||++||+|||+.+ |+||||||+||||+.++.+|
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~--------l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~k 196 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVY--------LTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVK 196 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCC--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEE
T ss_pred CceEEEEEecc-ccchhhhcccCCC--------CCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEe
Confidence 4689999998 4699999975432 356777899999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc-------------------------ccccccccCCCccCcccc-ccCcCCCcchhHHHHHHHHH
Q 042346 654 VSDFGLSLLGSECDQE-------------------------FISTKAVGTVGYIDPEYY-VMNVLTAKTDIYGLGVVLLE 707 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwS~Gvvl~e 707 (812)
|+|||+++........ ......+||+.|+|||++ ....++.++|||||||+|||
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 9999999865432111 123445789999999986 46679999999999999999
Q ss_pred HHcC
Q 042346 708 LLTG 711 (812)
Q Consensus 708 lltG 711 (812)
|++|
T Consensus 277 lltg 280 (458)
T 3rp9_A 277 LLNM 280 (458)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 9995
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=359.74 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=191.8
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchh---hHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTN---KLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
..++|.+.+.||+|+||.||+|.+. +++.||||++....... ........+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4678999999999999999999875 57999999986432111 112223457899999999999999999999754
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC---Cc
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN---WT 651 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~ 651 (812)
+..++||||+++++|.+++..... +++...+.++.|++.||+|||+++ |+||||||+|||++.+ ..
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKR--------LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCC
T ss_pred CceEEEEEcCCCCcHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcce
Confidence 568999999999999999865432 367778899999999999999998 9999999999999654 45
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCcccccc---CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM---NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
+||+|||+++..... .......||+.|+|||++.. ..++.++||||||++||||++|+.||....... .+.
T Consensus 281 ~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~ 354 (419)
T 3i6u_A 281 IKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLK 354 (419)
T ss_dssp EEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---CHH
T ss_pred EEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---HHH
Confidence 999999999875432 22345679999999999863 568889999999999999999999986533211 111
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+..+... .......+.++.+.+|+.+||+.||++|||++|++++
T Consensus 355 ----~~i~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 355 ----DQITSGKYN--------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ----HHHHTTCCC--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HHHhcCCCC--------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 112222111 0000012245668899999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.69 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=193.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.++||+|+||.||+++.. +++.+|+|++..... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS----QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc----chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 46999999999999999999874 588999999864221 1224568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE---cCCCcEEEEe
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVSD 656 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~D 656 (812)
||||+++++|.+++....... ..+++..+++++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARG----KALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEeCCCCcHHHHHHhhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEe
Confidence 999999999999986532111 12367788899999999999999998 9999999999999 4568899999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||++....... ......+|+.|+|||++. ..++.++||||||+++|||++|+.||.... .........
T Consensus 171 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~ 238 (285)
T 3is5_A 171 FGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKAT 238 (285)
T ss_dssp CCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred eecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhc
Confidence 99997654322 234557899999999876 468999999999999999999999985422 111111111
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... ... ......+.+.+|+.+||+.||++|||++|++++
T Consensus 239 ~~~~~------~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 239 YKEPN------YAV---ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HCCCC------CCC-----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCCcc------ccc---ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100 000 001123457789999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=354.59 Aligned_cols=263 Identities=10% Similarity=0.010 Sum_probs=182.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc--cCCCceEEE-------EE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV--HHKHLVGLV-------GF 570 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l--~H~nIv~l~-------~~ 570 (812)
.+|++.+.||+|+||.||+|++. +++.||||++..... ......+.+.+|+++++.| +||||++++ ++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE--NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST--THHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc--ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 45899999999999999999975 689999999875322 1234455677886555555 599988865 45
Q ss_pred EEeC-----------------CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCC
Q 042346 571 CQEK-----------------DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPS 633 (812)
Q Consensus 571 ~~~~-----------------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ 633 (812)
+... ...+|||||++ ++|.+++......... ........++.++.||++||+|||+++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~-~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF-RGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCC-CHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccch-hhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 5433 23799999998 8999999865322111 111112222678899999999999998
Q ss_pred eEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcC
Q 042346 634 IIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTG 711 (812)
Q Consensus 634 ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG 711 (812)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999865431 124567799999999987 7899999999999999999999
Q ss_pred CCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 712 KKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 712 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+.||........... ...............+. ....++.+.+|+.+||+.||++|||+.|++++
T Consensus 290 ~~Pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 290 FLPFGLVTPGIKGSW---------KRPSLRVPGTDSLAFGS--CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SCSTTBCCTTCTTCC---------CBCCTTSCCCCSCCCTT--SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCcCcccccch---------hhhhhhhccccccchhh--ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999965432211000 00000000011111111 12345668899999999999999999999753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.42 Aligned_cols=263 Identities=23% Similarity=0.332 Sum_probs=195.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC--Cc--EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD--GR--EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~--g~--~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|++.+.||+|+||.||+|++.. ++ .||+|++.... ....+..+.+.+|+++++.++||||+++++++.++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc--cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 3569999999999999999998642 33 68999876421 112234567889999999999999999999998765
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
.++||||+++++|.+++..... .+++..+++++.|+++||.|||+++ |+||||||+|||++.++.+||+
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~ 163 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQG-------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIG 163 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGG-------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEEC
T ss_pred -ceeeEecccCCCHHHHHHhccC-------CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEc
Confidence 8899999999999999975421 2367788899999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||++......... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~ 235 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILH 235 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHH
T ss_pred cccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHH
Confidence 99999766543322 22334567889999999998889999999999999999999 9999854321 11112
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
.+..... +... ....++.+.+++.+||..||++|||+.+++++|+++...
T Consensus 236 ~~~~~~~------~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 236 KIDKEGE------RLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHTSCC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHccCC------CCCC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 2221110 1111 123455688999999999999999999999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=336.69 Aligned_cols=249 Identities=19% Similarity=0.316 Sum_probs=201.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+++.. +++.||+|++... ..........+.+|+++++.++||||+++++++.+.+..++
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccc--ccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 56999999999999999999985 5788999998531 11112224578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... +++...+.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 92 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGR--------FDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGW 160 (284)
T ss_dssp EECCCTTEEHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEeCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccc
Confidence 9999999999999976532 256778899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+...... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 161 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~ 228 (284)
T 2vgo_A 161 SVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIVNVD 228 (284)
T ss_dssp CEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTC
T ss_pred cccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHhccc
Confidence 8654432 12345789999999999999999999999999999999999999854221 11122222211
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...+ ...+..+.+++.+||+.||.+|||++|++++
T Consensus 229 --------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 --------LKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --------CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --------cCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1111 1234567899999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.78 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=201.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 356999999999999999999985 68999999986422 122346789999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE---cCCCcEEEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVS 655 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~ 655 (812)
+||||+++++|.+++..... +++...+.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 83 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~ 151 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGV--------YTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMIT 151 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred EEEEcCCCccHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEc
Confidence 99999999999999975432 256777899999999999999998 9999999999999 788999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||++...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+
T Consensus 152 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i 219 (304)
T 2jam_A 152 DFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKI 219 (304)
T ss_dssp SCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHH
T ss_pred cCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH
Confidence 99998754331 12334689999999999999999999999999999999999999854321 1122223
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+... .+.......+..+.+++.+||..||++|||++|++++
T Consensus 220 ~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 220 KEGYYE--------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHCCCC--------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HcCCCC--------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 332211 1111122345668899999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.62 Aligned_cols=262 Identities=22% Similarity=0.350 Sum_probs=201.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++. +++.||+|++.... .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 357999999999999999999985 58999999986432 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+||||+++++|.+++..... +++....+++.|++.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 108 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGR--------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEECCCCCCHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEEC
Confidence 99999999999999976532 25677889999999999999996 7 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...........
T Consensus 177 g~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~ 247 (360)
T 3eqc_A 177 GVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK-----ELELMFGCQVE 247 (360)
T ss_dssp CCCHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH-----HHHHHHC----
T ss_pred CCCccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhccccc
Confidence 99864321 1223457899999999999999999999999999999999999998543210 00000000000
Q ss_pred c-------------------------------cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 G-------------------------------QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~-------------------------------~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+ .+...... ..+.......+..+.+|+.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------------------------CCCHHHHHHHHHHS--CCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhcc--CCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 00000000 01111122345568899999999999999999999986
Q ss_pred H
Q 042346 787 L 787 (812)
Q Consensus 787 L 787 (812)
-
T Consensus 326 p 326 (360)
T 3eqc_A 326 A 326 (360)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=336.90 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=205.1
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcc----hhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPK----TNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQ 572 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~----~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~ 572 (812)
..++|++.+.||+|+||.||++++. +++.||||++..... ........+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467999999999999999999985 588999999864321 1222344567889999999995 999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
+++..++||||+++++|.+++..... +++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 163 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVT--------LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI 163 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcE
Confidence 99999999999999999999976432 356778899999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccc------cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCch
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV------MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~ 726 (812)
||+|||++....... ......+++.|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 234 (298)
T 1phk_A 164 KLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------ 234 (298)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred EEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------
Confidence 999999997654322 233457899999999885 45688999999999999999999999854221
Q ss_pred hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......+..+.. ..+.......+..+.+++.+||+.||++|||+.|++++
T Consensus 235 --~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 235 --MLMLRMIMSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp --HHHHHHHHHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --HHHHHHHhcCCc--------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 112222222221 11111123455678899999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.98 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=196.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 577 (812)
.++|++.+.||+|+||.||++++. +++.||+|++...... ......+.+|+..+..+ +||||+++++++.+++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG---SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT---SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 456999999999999999999986 6899999998643222 22345678899999999 999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC--------
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-------- 649 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-------- 649 (812)
++||||+++++|.+++....... ..+++..+++++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIM----SYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------
T ss_pred EEEEEecCCCcHHHHHHhhcccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccc
Confidence 99999999999999997642210 12367788999999999999999998 9999999999999844
Q ss_pred -----------CcEEEEeecccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCC
Q 042346 650 -----------WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 650 -----------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~ 717 (812)
..+||+|||++...... ....+|+.|+|||.+.+. .++.++||||||+++|||++|+.++..
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 47999999999765432 234589999999999865 567899999999999999999877532
Q ss_pred CCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 718 NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ....+..+.... .+ ...+..+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~-----------~~~~~~~~~~~~-------~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 234 GD-----------QWHEIRQGRLPR-------IP----QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SH-----------HHHHHHTTCCCC-------CS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred hh-----------HHHHHHcCCCCC-------CC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11 122222222211 11 1234568899999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=339.31 Aligned_cols=261 Identities=21% Similarity=0.312 Sum_probs=202.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe--CCe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE--KDE 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~ 576 (812)
.++|++.+.||+|+||.||+++.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+ +..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 357999999999999999999985 689999999864322 23345678899999999999999999998864 567
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCC--CCeEeeccCCCCEEEcCCCcEEE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV--PSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~--~~ivHrDlKp~NILl~~~~~~kl 654 (812)
.++||||+++++|.+++...... ...+++..+++++.|++.||+|||+.+. .+|+||||||+|||++.++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl 157 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKE----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred EEEEEeCCCCCCHHHHHHhhccc----CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence 89999999999999999764321 1124678889999999999999999862 23999999999999999999999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+|||++........ ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......
T Consensus 158 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~ 227 (279)
T 2w5a_A 158 GDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGK 227 (279)
T ss_dssp CCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred ecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHH
Confidence 99999976543211 12334689999999999988999999999999999999999999854321 112222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le 788 (812)
+..+.... . ....+..+.+++.+||+.||++|||++|+++++.
T Consensus 228 i~~~~~~~-------~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 228 IREGKFRR-------I----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHTCCCC-------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred Hhhccccc-------C----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 33332211 1 1123456889999999999999999999998653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=361.78 Aligned_cols=202 Identities=24% Similarity=0.321 Sum_probs=165.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK---- 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---- 574 (812)
.++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+.+|+++++.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 467999999999999999999875 57889999986421 2233456788999999999999999999999776
Q ss_pred -CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 575 -DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 575 -~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
+..|+||||++ ++|.+++..... +++..++.++.||++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~--------l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~k 169 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIF--------LTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVK 169 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCC--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred CCeEEEEEecCC-cCHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEE
Confidence 56899999996 599999975432 366778899999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc--------------------ccccccccCCCccCcccc-ccCcCCCcchhHHHHHHHHHHHcCC
Q 042346 654 VSDFGLSLLGSECDQE--------------------FISTKAVGTVGYIDPEYY-VMNVLTAKTDIYGLGVVLLELLTGK 712 (812)
Q Consensus 654 l~DfGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwS~Gvvl~elltG~ 712 (812)
|+|||+++........ ......+||+.|+|||++ ....++.++|||||||+||||++|.
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 9999999865432211 123556899999999986 5667999999999999999999875
Q ss_pred CCCC
Q 042346 713 KAVF 716 (812)
Q Consensus 713 ~p~~ 716 (812)
.||.
T Consensus 250 ~p~~ 253 (432)
T 3n9x_A 250 QSHI 253 (432)
T ss_dssp TTTC
T ss_pred cccc
Confidence 5553
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=343.87 Aligned_cols=259 Identities=18% Similarity=0.272 Sum_probs=197.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEe--CC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQE--KD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~--~~ 575 (812)
.++|++.+.||+|+||.||+|++ .+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 35799999999999999999987 46899999998632 1345788999999997 9999999999998 56
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC-cEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW-TARV 654 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl 654 (812)
..++||||+++++|.+++.. ++...++.++.||+.||+|||+++ |+||||||+|||++.++ .+||
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~-----------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl 172 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT-----------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRL 172 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG-----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ceEEEEeccCchhHHHHHHh-----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEE
Confidence 78999999999999999853 255667889999999999999998 99999999999999776 8999
Q ss_pred EeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
+|||+++...... ......+|+.|+|||++.+ ..++.++||||||++||||++|+.||...... .+.......
T Consensus 173 ~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~l~~~~~ 246 (330)
T 3nsz_A 173 IDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVRIAK 246 (330)
T ss_dssp CCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH---HHHHHHHHH
T ss_pred EeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch---HHHHHHHHH
Confidence 9999997654422 2334578999999999876 67899999999999999999999998653321 111111111
Q ss_pred HHHhcccccccccc-------------------C--CCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKR-------------------V--GPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~-------------------~--~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......+...++.. . .............+.+|+.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000000000 0 00011112245678899999999999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=360.22 Aligned_cols=265 Identities=22% Similarity=0.265 Sum_probs=206.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC-CCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH-KHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~ 577 (812)
.++|++.++||+|+||.||++++ .+++.||||++..... ...+.+|+++++.|+| ++|..+..++.+.+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-------SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 46799999999999999999997 4689999998764221 2246789999999987 5566667777788889
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE---cCCCcEEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARV 654 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl 654 (812)
+|||||+ +++|.+++..... .+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL 147 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSR-------KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYI 147 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEE
T ss_pred EEEEECC-CCCHHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEE
Confidence 9999999 9999999975432 1377888999999999999999998 9999999999999 68899999
Q ss_pred EeecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 655 SDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 655 ~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
+|||+++........ .......||+.|+|||++.+..++.++||||||++||||++|+.||....... ......
T Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~ 226 (483)
T 3sv0_A 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYE 226 (483)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-HHHHHH
T ss_pred EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh-HHHHHH
Confidence 999999865443221 12235679999999999999999999999999999999999999996543221 111222
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
..........+..+. ..+++.+.+|+.+||+.||++||++++|++.|++++...
T Consensus 227 ~i~~~~~~~~~~~l~-----------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 227 KISEKKVATSIEALC-----------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHHHHSCHHHHH-----------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHhhccccccHHHHh-----------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 211111111111110 122456889999999999999999999999999987754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.02 Aligned_cols=264 Identities=21% Similarity=0.305 Sum_probs=200.1
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe----
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE---- 573 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~---- 573 (812)
..++|++.+.||+|+||.||+++. .+++.||||++... .....+.+.+|+++++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 446799999999999999999997 56899999988542 12345678899999999999999999999873
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
....++||||+++++|.+++....... ..+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~k 174 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKG----NFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPV 174 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEE
Confidence 336789999999999999997632111 12367888999999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc-------ccccccccCCCccCccccccC---cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 654 VSDFGLSLLGSECDQE-------FISTKAVGTVGYIDPEYYVMN---VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
|+|||++......... .......||+.|+|||++... .++.++||||||+++|||++|+.||........
T Consensus 175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 254 (317)
T 2buj_A 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254 (317)
T ss_dssp ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS
T ss_pred EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc
Confidence 9999998654321111 011234579999999998754 378999999999999999999999843111110
Q ss_pred CchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
... . . ..... .... ....+..+.+++.+||+.||++|||++|++++|+.+.
T Consensus 255 --~~~-~---~-~~~~~------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 255 --SVA-L---A-VQNQL------SIPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp --CHH-H---H-HHCC--------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --hhh-H---H-hhccC------CCCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 011 0 0 11110 0111 1223456889999999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.78 Aligned_cols=266 Identities=24% Similarity=0.354 Sum_probs=197.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||++++. +++.||+|++.... ......+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS---SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC---CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 56999999999999999999985 48999999986432 223345567899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++..... +++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNG--------LDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp EEECCSEEHHHHHHHSTTC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecCCcchHHHHHhhccC--------CCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCC
Confidence 9999999999888754332 367788899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH----
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ---- 734 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---- 734 (812)
+....... .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||...... +........
T Consensus 171 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~ 244 (331)
T 4aaa_A 171 ARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI----DQLYHIMMCLGNL 244 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSC
T ss_pred ceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCC
Confidence 97654322 123445789999999999875 7899999999999999999999998543311 111111100
Q ss_pred -------HHhc-cccccccccCCCCCCCh---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 -------ILAG-QLHCVLDKRVGPPELNE---AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 -------~~~~-~~~~~~d~~~~~~~~~~---~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... .......+.+....... ..+++.+.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00000001111000000 1245678899999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=366.02 Aligned_cols=257 Identities=23% Similarity=0.295 Sum_probs=200.9
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhh--------HHHHHHHHHHHHHHHHhccCCCceEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNK--------LREKESAFDSELALLSRVHHKHLVGLVG 569 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~--------~~~~~~~~~~Ei~~l~~l~H~nIv~l~~ 569 (812)
..++|++.++||+|+||.||+++.. +++.||+|++........ .....+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4567999999999999999999985 478999999864321110 0123467889999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC
Q 042346 570 FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 570 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 649 (812)
++.+....++||||+++|+|.+++..... +++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHK--------FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENK 182 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSC--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESST
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecC
Confidence 99999999999999999999999976432 367788899999999999999998 9999999999999877
Q ss_pred C---cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCch
Q 042346 650 W---TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726 (812)
Q Consensus 650 ~---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~ 726 (812)
+ .+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||.....
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------ 252 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND------ 252 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred CCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 5 69999999997654422 2345679999999999874 699999999999999999999999854321
Q ss_pred hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......+..+.+. .+.......+..+.+|+.+||..||.+|||++|++++
T Consensus 253 --~~~~~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 253 --QDIIKKVEKGKYY--------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp --HHHHHHHHHCCCC--------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHHcCCCC--------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1222333333211 0100012234668899999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.19 Aligned_cols=266 Identities=18% Similarity=0.241 Sum_probs=190.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.++||+|+||.||++++. +++.||||++.... ........+.+|++++++++||||+++++++.+++..+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc---cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 457999999999999999999874 68899999986432 22333456778999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE-----cCCCcEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL-----DVNWTAR 653 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl-----~~~~~~k 653 (812)
+||||++ ++|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+|
T Consensus 110 lv~e~~~-~~L~~~~~~~~~--------~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPD--------VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTT--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEE
T ss_pred EEEecCC-CCHHHHHhhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEE
Confidence 9999998 499999976543 256778899999999999999998 9999999999999 4556699
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|+|||++....... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+......
T Consensus 178 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~ 251 (329)
T 3gbz_A 178 IGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----IDQLFKIF 251 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH
T ss_pred ECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----HHHHHHHH
Confidence 99999997543221 123345789999999999864 589999999999999999999999854321 11111111
Q ss_pred HHHHhcc------cccccc--ccCCC-CCCCh-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQ------LHCVLD--KRVGP-PELNE-----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~------~~~~~d--~~~~~-~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
....... .....+ ..... ..... ....+.+.+|+.+||+.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 1100000 000000 00000 00000 1134667899999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.77 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=192.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+|++. +++.||+|++.... .......+.+|+++++.++||||+++++++.+++..++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc----ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 57999999999999999999985 68999999986421 11122245579999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||++ ++|.+++..... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 78 v~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCGN-------IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp EEECCS-EEHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSE
T ss_pred Eecccc-cCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcc
Confidence 999997 599999876533 2366778899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+....... .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .+......... ..
T Consensus 147 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~-~~ 219 (324)
T 3mtl_A 147 ARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV----EEQLHFIFRIL-GT 219 (324)
T ss_dssp EECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHH-CC
T ss_pred cccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHh-CC
Confidence 97544322 12334578999999999876 5689999999999999999999999854321 11111111111 00
Q ss_pred ccccccccc--------CCCCC---CC----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKR--------VGPPE---LN----EAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~--------~~~~~---~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......... ...+. .. .......+.+|+.+||+.||++|||++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 00000 00 01234567899999999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=364.28 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=200.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.++||+|+||.||++++. +++.||||++.... ........+.+|++++++++||||+++++++.+....+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS---AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHH---HBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 356999999999999999999985 68999999985311 11123456889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc---CCCcEEEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD---VNWTARVS 655 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kl~ 655 (812)
+||||+++++|.+++..... +++.....++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 98 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKR--------FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEcCCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEE
Confidence 99999999999999876532 256778899999999999999998 99999999999995 45679999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||++....... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ......+
T Consensus 167 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i 234 (486)
T 3mwu_A 167 DFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRV 234 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred ECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 999997654322 2344579999999999876 599999999999999999999999854321 1122223
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+.+. .+.......++.+.+|+.+||..||++|||+.|++++
T Consensus 235 ~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 235 ETGKYA--------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHTCCC--------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HhCCCC--------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 333211 1111123345668899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=337.46 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=202.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+.|++.+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC----STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 45999999999999999999874 588999999864322 1234578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++++|.+++.... +++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 98 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEPGP---------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp EEECCTTEEHHHHHTTSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCCCcHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeeccc
Confidence 999999999999996432 367788899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
+....... .......+|+.|+|||++.+..++.++||||||+++|||++|+.||..... .. ....+..+.
T Consensus 166 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~----~~~~~~~~~ 235 (303)
T 3a7i_A 166 AGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MK----VLFLIPKNN 235 (303)
T ss_dssp CEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HH----HHHHHHHSC
T ss_pred ceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HH----HHHHhhcCC
Confidence 97654322 123445789999999999999999999999999999999999999853221 11 111111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.. . .....+..+.+|+.+||+.||++|||++|++++.
T Consensus 236 ~~-----~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 236 PP-----T------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CC-----C------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CC-----C------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 10 0 1112344588999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.86 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=192.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
.++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 467999999999999999999974 68999999985422 12334567889999999999999999999998653
Q ss_pred ---eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 576 ---ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 576 ---~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
..++||||+ +++|.+++.... ++......++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~---------l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEK---------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred cCceEEEEEecC-CCCHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCE
Confidence 459999999 789999997532 255677889999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.....
T Consensus 168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i 238 (367)
T 1cm8_A 168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEI 238 (367)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 99999999765431 234578999999999887 6799999999999999999999999854321 1111111
Q ss_pred HHHHHhcccc----------------ccccccCCCCC--CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 732 VSQILAGQLH----------------CVLDKRVGPPE--LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 732 ~~~~~~~~~~----------------~~~d~~~~~~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... +... ..+. ...... .........+.+|+.+||..||++|||++|++++
T Consensus 239 ~~~~--g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 239 MKVT--GTPPAEFVQRLQSDEAKNYMKGLP-ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHH--CCCCHHHHHTCSCHHHHHHHHHSC-CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhc--CCCCHHHHHHhhhHHHHHHHHhCC-CCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 1100 0000 0000 000000 0011234567899999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=374.65 Aligned_cols=253 Identities=22% Similarity=0.271 Sum_probs=203.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
..++|++.++||+|+||.||+++++ +++.||||++... ........+.+..|.+++..+ +||||+++++++++.+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKD--VVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHH--HHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecc--ccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 4567999999999999999999975 4788999998631 111223345677899999887 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.||||||+++|+|.++|+.... +++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~D 485 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGR--------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 485 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEee
Confidence 9999999999999999986532 256777889999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||+++...... .......||+.|+|||++.+..|+.++||||||++||||++|+.||..... ......+.
T Consensus 486 FGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~ 555 (674)
T 3pfq_A 486 FGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIM 555 (674)
T ss_dssp CTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred cceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHH
Confidence 99997543222 224456899999999999999999999999999999999999999954321 12223333
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNI-----TDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~~ 786 (812)
... +..+. .+...+.+||.+||+.||++||++ +||+++
T Consensus 556 ~~~--------~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 556 EHN--------VAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp SSC--------CCCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred hCC--------CCCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 322 22222 344567899999999999999997 777764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=340.43 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=194.4
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcch---hhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKT---NKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~---~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|++.+.||+|+||.||++++. +++.||||++...... .........+.+|++++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 456999999999999999999875 5789999998643211 111223346789999999999999999999987665
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc---E
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT---A 652 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~ 652 (812)
.++||||+++++|.+++..... +++...+.++.||+.||+|||+++ |+||||||+|||++.++. +
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKR--------LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCC--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCE
T ss_pred -eEEEEecCCCCcHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeE
Confidence 8999999999999999965432 256777889999999999999998 999999999999987654 9
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
||+|||++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+..
T Consensus 157 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~ 230 (322)
T 2ycf_A 157 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKD 230 (322)
T ss_dssp EECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHH
T ss_pred EEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHH
Confidence 999999997654321 123456899999999974 4678999999999999999999999986533221 1111
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
.+..+.... ......+.++.+.+|+.+||+.||++|||+.|+++
T Consensus 231 ----~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 ----QITSGKYNF--------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----HHHHTCCCC--------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHHhCcccc--------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 112221110 00001223566889999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=345.56 Aligned_cols=272 Identities=23% Similarity=0.327 Sum_probs=186.2
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
...++|++.+.||+|+||.||++.+. +++.||||++.... .......+.+|+++++.++||||+++++++...+.
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 44678999999999999999999863 68999999875321 12334568889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++++|.+++.............+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEe
Confidence 999999999999999997532111111223477888999999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcc---cccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 657 FGLSLLGSECDQ---EFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 657 fGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||++........ ........+|+.|+|||++.. ..++.++||||||+++|||++|+.||..... .....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~--- 237 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP----MKVLM--- 237 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG----GGHHH---
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch----hhHHH---
Confidence 999876543221 112234578999999999875 5689999999999999999999999854321 11111
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......... .......+ ......+..+.+++.+||+.||++|||+.|++++
T Consensus 238 -~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 238 -LTLQNDPPS-LETGVQDK-EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -HHHTSSCCC-TTC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHhccCCCc-cccccccc-hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111111100 00000000 0011234568899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.23 Aligned_cols=257 Identities=20% Similarity=0.295 Sum_probs=187.5
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||++++ .+++.||+|++.... ......+.+.++...++.++||||+++++++.+++..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc---CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 346799999999999999999997 468999999986421 2223334455566668889999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
++||||++ ++|.+++....... ..+++..+++++.|++.||+|||++ + |+||||||+|||++.++.+||+|
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKG----QTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCC
T ss_pred EEEEehhc-cchHHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEee
Confidence 99999997 59988876421111 1236788899999999999999998 8 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCcccc----ccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYY----VMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||++....... ......+|+.|+|||++ ....++.++||||||+++|||++|+.||..... ... ..
T Consensus 154 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~-~~ 223 (290)
T 3fme_A 154 FGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQ-QL 223 (290)
T ss_dssp C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HHH-HH
T ss_pred cCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hHH-HH
Confidence 99997654322 22334799999999996 466789999999999999999999999853221 111 11
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
........ +.......+..+.+++.+||+.||++|||++|++++
T Consensus 224 ~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 224 KQVVEEPS----------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHHHSCC----------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhccCC----------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11111111 111122344568899999999999999999999984
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=363.58 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=199.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++. +++.||+|++..... .......+.+|+++++.++||||+++++++.+....+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV---STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc---CchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 346999999999999999999985 688999999864221 1222456889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC---CcEEEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN---WTARVS 655 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl~ 655 (812)
+||||+++|+|.+++..... +++.....++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 113 lv~e~~~~g~L~~~~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMK--------FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEecCCCCcHHHHHHHcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEE
Confidence 99999999999999876532 256777899999999999999998 9999999999999764 559999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||++....... ......||+.|+|||++. ..++.++|||||||++|||++|+.||..... ......+
T Consensus 182 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i 249 (494)
T 3lij_A 182 DFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKV 249 (494)
T ss_dssp CCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred ECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 999997654322 234567999999999886 4699999999999999999999999854321 1222333
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN--LERAL 791 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~ 791 (812)
..+... .+.......+..+.+|+.+||+.||.+|||++|++++ +.+..
T Consensus 250 ~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 250 EKGKYT--------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp HHTCCC--------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred HhCCCC--------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 333211 1111112344568899999999999999999999976 44443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=348.79 Aligned_cols=266 Identities=22% Similarity=0.248 Sum_probs=199.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc--------CCCceEEEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH--------HKHLVGLVGF 570 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--------H~nIv~l~~~ 570 (812)
.++|++.++||+|+||.||+|++. +++.||||++... ....+.+.+|+++++.++ |+||++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 467999999999999999999874 5889999998632 233456788999999986 7889999999
Q ss_pred EE----eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEE
Q 042346 571 CQ----EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNIL 645 (812)
Q Consensus 571 ~~----~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NIL 645 (812)
+. +....++||||+ +++|.+++...... .+++..+++++.||+.||+|||++ + |+||||||+|||
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIl 179 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQ------GLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENIL 179 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTS------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEE
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccC------CCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHee
Confidence 88 445689999999 66777777654321 136778889999999999999998 7 999999999999
Q ss_pred EcCCC-------------------------------------------------cEEEEeecccccCCCCcccccccccc
Q 042346 646 LDVNW-------------------------------------------------TARVSDFGLSLLGSECDQEFISTKAV 676 (812)
Q Consensus 646 l~~~~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~ 676 (812)
++.++ .+||+|||++...... .....
T Consensus 180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~ 254 (397)
T 1wak_A 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDI 254 (397)
T ss_dssp ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCC
T ss_pred EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCC
Confidence 98775 7999999999765432 33457
Q ss_pred cCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccc----------c-cccc
Q 042346 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL----------H-CVLD 745 (812)
Q Consensus 677 gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~-~~~d 745 (812)
||+.|+|||++.+..++.++|||||||+||||++|+.||......................+.. . ..+.
T Consensus 255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 8999999999999999999999999999999999999996544322111111111100011110 0 0000
Q ss_pred ccC--------C---------CCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 746 KRV--------G---------PPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 746 ~~~--------~---------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... . .......+....+.+|+.+||+.||++|||++|++++
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 0 0011235667789999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=340.00 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=196.9
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||++.+. +++.||+|++.... ....+.+|+++++.++||||+++++++.+.+..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3567999999999999999999985 48999999986421 234578899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 169 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNK-------TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADF 169 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEeecCCCCCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeec
Confidence 999999999999999964321 1366788899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|++....... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ..+..
T Consensus 170 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~-~~~~~ 239 (314)
T 3com_A 170 GVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------MRAI-FMIPT 239 (314)
T ss_dssp TTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHH-HHHHH
T ss_pred ccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------HHHH-HHHhc
Confidence 9997654321 123345789999999999998999999999999999999999999854221 1111 11111
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ... .......+..+.+|+.+||..||.+|||+.|++++
T Consensus 240 ~~-----~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 240 NP-----PPT----FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SC-----CCC----CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CC-----Ccc----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11 001 11122345568899999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=340.21 Aligned_cols=265 Identities=19% Similarity=0.289 Sum_probs=198.1
Q ss_pred CCCHHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc--CCCceEE
Q 042346 490 NFTLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH--HKHLVGL 567 (812)
Q Consensus 490 ~~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l 567 (812)
++.+..+....++|++.+.||+|+||.||++++.+++.||||++..... .......+.+|++++++++ ||||+++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~ 93 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRL 93 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc---cccchHHHHHHHHHHHhccccCCceEEE
Confidence 3444455556678999999999999999999988899999999864322 2334567889999999997 5999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc
Q 042346 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD 647 (812)
Q Consensus 568 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~ 647 (812)
++++.+++..++||| +.+++|.+++..... +++..+++++.||++||.|||+++ |+||||||+|||++
T Consensus 94 ~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~ 161 (313)
T 3cek_A 94 YDYEITDQYIYMVME-CGNIDLNSWLKKKKS--------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV 161 (313)
T ss_dssp EEEEECSSEEEEEEC-CCSEEHHHHHHHCSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE
T ss_pred EEEeecCCEEEEEEe-cCCCcHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE
Confidence 999999999999999 557899999976532 256777899999999999999998 99999999999996
Q ss_pred CCCcEEEEeecccccCCCCcccccccccccCCCccCcccccc-----------CcCCCcchhHHHHHHHHHHHcCCCCCC
Q 042346 648 VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-----------NVLTAKTDIYGLGVVLLELLTGKKAVF 716 (812)
Q Consensus 648 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVwS~Gvvl~elltG~~p~~ 716 (812)
+ +.+||+|||++................||+.|+|||.+.. ..++.++||||||+++|||++|+.||.
T Consensus 162 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 162 D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp T-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred C-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 4 8999999999986654333223345579999999999875 468889999999999999999999985
Q ss_pred CCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 717 KNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
.... .... ........ .....+.. ..+.+.+++.+||+.||++|||++|++++-
T Consensus 241 ~~~~------~~~~-~~~~~~~~------~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 241 QIIN------QISK-LHAIIDPN------HEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp TCCS------HHHH-HHHHHCTT------SCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hHHH------HHHH-HHHHHhcc------cccCCccc----chHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 4321 1111 11111111 11111111 134578899999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=366.32 Aligned_cols=254 Identities=25% Similarity=0.324 Sum_probs=203.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.++||+|+||.||+++.. +++.||||++...... .......+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK--QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc--cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356999999999999999999985 6899999998642211 1123456889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE---cCCCcEEEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---DVNWTARVS 655 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~ 655 (812)
+||||+.+++|.+++..... +++...+.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+
T Consensus 103 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKR--------FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSC--------CBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence 99999999999999976532 366778899999999999999998 9999999999999 567899999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||++....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||..... ......+
T Consensus 172 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i 239 (484)
T 3nyv_A 172 DFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKKV 239 (484)
T ss_dssp CTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred eeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH
Confidence 999997654322 2334579999999999876 699999999999999999999999854321 1122233
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+.+. .+.......++.+.+|+.+||+.||.+|||++|++++
T Consensus 240 ~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 240 EKGKYT--------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHCCCC--------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCC--------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 333221 1111123445678899999999999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=340.21 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=196.3
Q ss_pred CCHHHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEE
Q 042346 491 FTLSELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLV 568 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~ 568 (812)
+.+.++....++|++.+.||+|+||.||+|++. +++.||||++..... ....+.+|+++++++ +||||++++
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------TTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------cHHHHHHHHHHHHhccCCCCeeeee
Confidence 344455556788999999999999999999984 689999999864221 234678899999999 799999999
Q ss_pred EEEEe------CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 569 GFCQE------KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 569 ~~~~~------~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
+++.. .+..++||||+++++|.+++...... .++....+.++.||+.||.|||+.+ |+||||||+
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~ 158 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN------TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQ 158 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGG------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGG
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccC------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHH
Confidence 99987 45789999999999999999764321 2356777899999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCC
Q 042346 643 NILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 643 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 717 (812)
|||++.++.+||+|||++....... .......+|+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 159 NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 159 NVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp GEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999987654321 1223457899999999987 56789999999999999999999999853
Q ss_pred CCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 718 NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... .. ....+...... . ......+..+.+|+.+||..||++|||++|++++
T Consensus 237 ~~~-------~~-~~~~~~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 237 MHP-------MR-ALFLIPRNPAP-----R-----LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp SCH-------HH-HHHHHHHSCCC-----C-----CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CcH-------HH-HHHHhhcCccc-----c-----CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 221 11 11111111111 1 1112234568899999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=344.06 Aligned_cols=272 Identities=21% Similarity=0.274 Sum_probs=203.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhH------------HHHHHHHHHHHHHHHhccCCCceEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKL------------REKESAFDSELALLSRVHHKHLVGL 567 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~------------~~~~~~~~~Ei~~l~~l~H~nIv~l 567 (812)
.++|++.+.||+|+||.||++++ +++.||+|++......... ....+.+.+|+++++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999999 8999999998631110000 0011678899999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh-cCCCCeEeeccCCCCEEE
Q 042346 568 VGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN-YAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 568 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl 646 (812)
++++.+.+..++||||+++++|.+++.............+++..++.++.||+.||.|||+ .+ |+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999999432211111111234788889999999999999999 87 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccC-cCCC-cchhHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 042346 647 DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTA-KTDIYGLGVVLLELLTGKKAVFKNEDGSGP 724 (812)
Q Consensus 647 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDVwS~Gvvl~elltG~~p~~~~~~~~~~ 724 (812)
+.++.+||+|||++...... ......+|+.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence 99999999999999765432 23456799999999999877 6766 999999999999999999998643321
Q ss_pred chhHHHHHHHHHhcccccccccc-----CCC--CCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 725 LDVVEFAVSQILAGQLHCVLDKR-----VGP--PELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~d~~-----~~~--~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......+..+......+.. ... ........+..+.+|+.+||+.||++|||++|++++
T Consensus 259 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 ----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ----HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ----HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122222222211100000 000 000013345678899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.21 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=191.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc---CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 467999999999999999999875 58899999986422 12334567889999999999999999999997665
Q ss_pred ---eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 576 ---ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 576 ---~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
..++||||++ ++|.+++... +++.....++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 101 ~~~~~~lv~e~~~-~~l~~~~~~~----------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~ 166 (371)
T 2xrw_A 101 EFQDVYIVMELMD-ANLCQVIQME----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 166 (371)
T ss_dssp TCCEEEEEEECCS-EEHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred cccceEEEEEcCC-CCHHHHHhhc----------cCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCE
Confidence 6799999997 4898888532 256777899999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||+|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+......
T Consensus 167 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~ 239 (371)
T 2xrw_A 167 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH----IDQWNKVI 239 (371)
T ss_dssp EECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH
T ss_pred EEEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 99999999764331 123446799999999999999999999999999999999999999854321 11111000
Q ss_pred H------------------HHHhcc-------ccccccccCCCCCC--ChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 733 S------------------QILAGQ-------LHCVLDKRVGPPEL--NEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 733 ~------------------~~~~~~-------~~~~~d~~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
. ...... +...+. ....+.. ........+.+|+.+||..||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSC-GGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcc-cccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 000000 000000 0000111 11334677899999999999999999999998
Q ss_pred HH
Q 042346 786 NL 787 (812)
Q Consensus 786 ~L 787 (812)
+-
T Consensus 319 hp 320 (371)
T 2xrw_A 319 HP 320 (371)
T ss_dssp SH
T ss_pred Cc
Confidence 63
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.49 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=197.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe--CCe
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE--KDE 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~ 576 (812)
.++|++.+.||+|+||.||++.+. +++.||+|++...... ........+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 467999999999999999999874 5889999998642111 112335678899999999999999999999853 456
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||++++ |.+++...... .+++..+++++.||++||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEK------RFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTC------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEehhccCC-HHHHHHhCccc------ccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeec
Confidence 89999999875 77877654322 1367788899999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCc--CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNV--LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
||++................+|+.|+|||++.+.. ++.++||||||+++|||++|+.||.... .......
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~ 224 (305)
T 2wtk_C 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFEN 224 (305)
T ss_dssp CTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH
T ss_pred cccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHH
Confidence 99997665433333344567999999999987643 4779999999999999999999985422 1112222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..+.. ..+ ......+.+++.+||+.||++|||++|++++
T Consensus 225 i~~~~~--------~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 225 IGKGSY--------AIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHCCC--------CCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HhcCCC--------CCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222211 111 1234457889999999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.15 Aligned_cols=277 Identities=21% Similarity=0.243 Sum_probs=200.5
Q ss_pred CHHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcch------hhHHHHHHHHHHHHHHHHhccCCCce
Q 042346 492 TLSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKT------NKLREKESAFDSELALLSRVHHKHLV 565 (812)
Q Consensus 492 ~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~------~~~~~~~~~~~~Ei~~l~~l~H~nIv 565 (812)
.+.++....++|++.+.||+|+||.||++...+++.||||++...... .......+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 357788889999999999999999999999888999999988542211 12233456789999999999999999
Q ss_pred EEEEEEEeC-----CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccC
Q 042346 566 GLVGFCQEK-----DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIK 640 (812)
Q Consensus 566 ~l~~~~~~~-----~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlK 640 (812)
++++++... ...++||||++ ++|.+++..... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 161 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI-------VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLH 161 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCC
Confidence 999998653 25799999997 699999875432 2367788999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCC
Q 042346 641 SSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNE 719 (812)
Q Consensus 641 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~ 719 (812)
|+|||++.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999997543321 2344578999999999876 678999999999999999999999985432
Q ss_pred CCCCCchhHHHHHHHHHhccc-----------cccccccC-CCCCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHH
Q 042346 720 DGSGPLDVVEFAVSQILAGQL-----------HCVLDKRV-GPPELNE----AEAVELLATTAIHCVNLEGKERPNITDI 783 (812)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~d~~~-~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~ev 783 (812)
. ................ ...+.... ..+.... ......+.+|+.+||+.||++|||++|+
T Consensus 239 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 314 (362)
T 3pg1_A 239 F----YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314 (362)
T ss_dssp H----HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred H----HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 1 1111111111000000 00000000 0011111 1224568899999999999999999999
Q ss_pred HHH
Q 042346 784 VAN 786 (812)
Q Consensus 784 l~~ 786 (812)
+++
T Consensus 315 l~h 317 (362)
T 3pg1_A 315 LRH 317 (362)
T ss_dssp HTS
T ss_pred HcC
Confidence 975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=370.46 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=205.3
Q ss_pred HHHhcCCcceeeeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEE
Q 042346 496 LAAATNNFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFC 571 (812)
Q Consensus 496 l~~~~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~ 571 (812)
.....++|++.+.||+|+||.||+|++.. +..||+|++.... .....+.|.+|+.++++++||||+++++++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34455779999999999999999998743 4579999876422 233456788999999999999999999998
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
. ++..++||||+++|+|.+++..... .+++..++.++.|+++||+|||+++ |+||||||+|||++.++.
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~ 529 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRKF-------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDC 529 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTTT-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTE
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhccC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCC
Confidence 5 4568999999999999999976432 1367888899999999999999998 999999999999999999
Q ss_pred EEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHH
Q 042346 652 ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 730 (812)
+||+|||+++....... .......+|+.|+|||++....++.++||||||++||||++ |+.||..... . .
T Consensus 530 vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~----~ 600 (656)
T 2j0j_A 530 VKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----N----D 600 (656)
T ss_dssp EEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----H----H
T ss_pred EEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----H----H
Confidence 99999999987544221 22234467789999999998899999999999999999997 8888754221 1 1
Q ss_pred HHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
....+..+. +...+ ..++..+.+|+.+||..||++|||+.|+++.|+++++.
T Consensus 601 ~~~~i~~~~-------~~~~~----~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 601 VIGRIENGE-------RLPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHHTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCC-------CCCCC----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 122222221 11111 23345688999999999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=345.06 Aligned_cols=266 Identities=21% Similarity=0.309 Sum_probs=197.5
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC-----
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK----- 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----- 574 (812)
++|++.+.||+|+||.||+|++ .+++.||+|++...... ......+.+|+++++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS---SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc---ccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 5699999999999999999998 46899999988643222 12234567899999999999999999999874
Q ss_pred ---CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 575 ---DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 575 ---~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
+..++||||+++ +|.+.+...... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVK-------FTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGV 162 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSC-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCC-------CCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCC
Confidence 457999999975 888887654321 367788999999999999999998 999999999999999999
Q ss_pred EEEEeecccccCCCCcc--cccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 652 ARVSDFGLSLLGSECDQ--EFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
+||+|||+++....... ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ....
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~ 238 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE----QHQL 238 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh----HHHH
Confidence 99999999976543221 222345678999999999876 5689999999999999999999999854321 1111
Q ss_pred HHHHHHHHhccccccccc---------cC---CCCCCChHH------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 729 EFAVSQILAGQLHCVLDK---------RV---GPPELNEAE------AVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~---------~~---~~~~~~~~~------~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... .. .+......-+ .+ ........+ ....+.+|+.+||+.||++|||++|++++
T Consensus 239 ~~i~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 239 ALIS-QL-CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHH-HH-HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHH-HH-hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1111 11 1111000000 00 000000111 13457899999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=346.87 Aligned_cols=272 Identities=22% Similarity=0.337 Sum_probs=200.5
Q ss_pred HHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE
Q 042346 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ 572 (812)
Q Consensus 493 ~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 572 (812)
..++....++|++.+.||+|+||.||+|++.+ .+|+|++...... ....+.+.+|++++++++||||+++++++.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDN---EDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCC---CCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCC---HHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 34445567789999999999999999998843 5999988643211 112245678999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
+.+..++||||+++++|.+++..... .+++..+++++.||+.||+|||+++ |+||||||+|||++ ++.+
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~ 168 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKI-------VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKV 168 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCC-------CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CC
T ss_pred cCCceEEEeecccCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCE
Confidence 99999999999999999999976432 1255777899999999999999998 99999999999998 6799
Q ss_pred EEEeecccccCCCCcc---cccccccccCCCccCcccccc---------CcCCCcchhHHHHHHHHHHHcCCCCCCCCCC
Q 042346 653 RVSDFGLSLLGSECDQ---EFISTKAVGTVGYIDPEYYVM---------NVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720 (812)
Q Consensus 653 kl~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 720 (812)
||+|||++........ ........||+.|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999865432111 122234468999999999864 4578899999999999999999999854321
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
+.....+..+...... ....+..+.+++.+||..||++|||++|+++.|+++.+.....+
T Consensus 249 --------~~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~ 308 (319)
T 2y4i_B 249 --------EAIIWQMGTGMKPNLS----------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308 (319)
T ss_dssp --------HHHHHHHHTTCCCCCC----------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------
T ss_pred --------HHHHHHhccCCCCCCC----------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence 1122222222111111 11223458899999999999999999999999999887655543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=335.17 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=190.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK---- 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---- 574 (812)
.++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+++++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 456999999999999999999974 689999999853 123456788999999999999999999998653
Q ss_pred ---------CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEE
Q 042346 575 ---------DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNIL 645 (812)
Q Consensus 575 ---------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NIL 645 (812)
+..++||||+++++|.+++..... ..++...++++.|+++||+|||+++ |+||||||+|||
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil 148 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-------NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIF 148 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCG-------GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcccc-------ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEE
Confidence 457899999999999999976432 2256777899999999999999998 999999999999
Q ss_pred EcCCCcEEEEeecccccCCCCcc------------cccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCC
Q 042346 646 LDVNWTARVSDFGLSLLGSECDQ------------EFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGK 712 (812)
Q Consensus 646 l~~~~~~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~ 712 (812)
++.++.+||+|||++........ ........+|+.|+|||++.+. .++.++||||||+++|||++
T Consensus 149 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp ECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred EcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 99999999999999976543211 1122345789999999999764 68999999999999999998
Q ss_pred CCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 713 KAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 713 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
||.... + .......+... ....+.......+..+.+++.+||+.||++|||++|++++
T Consensus 227 -p~~~~~------~-~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 227 -PFSTGM------E-RVNILKKLRSV--------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -CCSSHH------H-HHHHHHHHHST--------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -ccCCch------h-HHHHHHhcccc--------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 442111 0 11111111111 1111222233445668899999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=336.35 Aligned_cols=254 Identities=21% Similarity=0.321 Sum_probs=196.1
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||++++. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 3467999999999999999999986 4889999998642 122345788899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++++|.+++...... +++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 161 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRG-------LTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADF 161 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEeCCCCcHHHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999998753321 367788899999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|++...... ........+|+.|+|||++. ...++.++||||||+++|||++|+.||..... ... .
T Consensus 162 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~-~ 231 (302)
T 2j7t_A 162 GVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRV-L 231 (302)
T ss_dssp HHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHH-H
T ss_pred CCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHH-H
Confidence 987532110 11123357899999999984 56789999999999999999999999854221 111 1
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+..... +........+..+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 232 LKIAKSDP---------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHSCC---------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHhccCC---------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111111 0111223345568899999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.28 Aligned_cols=261 Identities=20% Similarity=0.305 Sum_probs=200.4
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE-c-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC------ceEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL-M-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH------LVGLVGF 570 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~-~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~~~ 570 (812)
..++|++.+.||+|+||.||++.+ . +++.||||++... ....+.+.+|+++++.++|+| +++++++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 346799999999999999999987 3 5889999998632 233456778999999887664 9999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC--
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-- 648 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-- 648 (812)
+.+.+..++||||+ +++|.+++...... .+++..+++++.||++||+|||+++ |+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENGFL------PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSD 155 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCC
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcCCC------CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccc
Confidence 99999999999999 88999999765432 1356778899999999999999998 999999999999987
Q ss_pred -----------------CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcC
Q 042346 649 -----------------NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711 (812)
Q Consensus 649 -----------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG 711 (812)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence 668999999999764331 2345789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCchhHHHHHHHHHhcccccc----------c--------------------cccCCCCCCChHHHHHH
Q 042346 712 KKAVFKNEDGSGPLDVVEFAVSQILAGQLHCV----------L--------------------DKRVGPPELNEAEAVEL 761 (812)
Q Consensus 712 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~--------------------d~~~~~~~~~~~~~~~~ 761 (812)
+.||..... .+.... ..... +..... + ...............+.
T Consensus 231 ~~pf~~~~~----~~~~~~-~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (339)
T 1z57_A 231 FTVFPTHDS----KEHLAM-MERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304 (339)
T ss_dssp SCSCCCSCH----HHHHHH-HHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred CCCCCCCCh----HHHHHH-HHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHH
Confidence 999854321 111111 11110 000000 0 00000011122345677
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 042346 762 LATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 762 l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+.+|+.+||+.||++|||++|++++
T Consensus 305 l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 305 LFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHhCcCcccccCHHHHhcC
Confidence 8999999999999999999999865
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=346.14 Aligned_cols=199 Identities=23% Similarity=0.292 Sum_probs=169.4
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc------cCCCceEEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV------HHKHLVGLVGFC 571 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l------~H~nIv~l~~~~ 571 (812)
...+|++.++||+|+||.||+|++. +++.||||++... ......+.+|+++++.+ +|+||+++++++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 3467999999999999999999875 4889999998642 22334566788888777 577999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 572 QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 572 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
...+..++||||+. ++|.+++....... +++..+++++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~ 238 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQG------FSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGR 238 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCC------CCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTS
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCC------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCC
Confidence 99999999999996 69999998754322 367788999999999999999998 999999999999999987
Q ss_pred --EEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCC
Q 042346 652 --ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN 718 (812)
Q Consensus 652 --~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~ 718 (812)
+||+|||++...... .....+|+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 239 ~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 239 SGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999654331 23457899999999999999999999999999999999999998543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=342.39 Aligned_cols=266 Identities=20% Similarity=0.295 Sum_probs=199.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
.++|++.+.||+|+||.||++++. +++.||||++.... .....+.+.+|++++++++||||+++++++....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc----CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 457999999999999999999875 58889999986321 2334467889999999999999999999997653
Q ss_pred --eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 576 --ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 576 --~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
..++||||++ ++|.+++.... +++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~k 168 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKTQH---------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLK 168 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred cceEEEEEcccC-cCHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEE
Confidence 5799999997 59999997542 366778899999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCccc-ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 654 VSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 654 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
|+|||++......... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .+.....
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i 244 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY----LDQLNHI 244 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG----GGHHHHH
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh----HHHHHHH
Confidence 9999999765543221 12344589999999998754 5589999999999999999999999854331 2222221
Q ss_pred HHHHHhcc---cccc-------ccccCC-CCCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 732 VSQILAGQ---LHCV-------LDKRVG-PPELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 732 ~~~~~~~~---~~~~-------~d~~~~-~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
........ +... ...... ...... ......+.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11100000 0000 000000 000000 1224567899999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.96 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=194.4
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
+|....+||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 3555569999999999999974 58899999986432 12345688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC-CCcEEEEeecc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARVSDFGL 659 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DfGl 659 (812)
|||+++++|.+++....... ..++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPL-----KDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCC-----TTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred EEeCCCCCHHHHHHhhccCC-----CccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccc
Confidence 99999999999997653221 1246677889999999999999998 999999999999987 89999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCc--CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNV--LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
+........ ......+|+.|+|||++.... ++.++||||||+++|||++|+.||...... . .........
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~--~~~~~~~~~ 241 (295)
T 2clq_A 170 SKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP----Q--AAMFKVGMF 241 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH----H--HHHHHHHHH
T ss_pred ccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch----h--HHHHhhccc
Confidence 976543221 223457899999999987643 889999999999999999999998542210 0 001111011
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ... . ....+..+.+++.+||+.||++|||++|++++
T Consensus 242 ~~-----~~~--~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 242 KV-----HPE--I----PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CC-----CCC--C----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cc-----ccc--c----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 011 1 12334568899999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=345.55 Aligned_cols=272 Identities=20% Similarity=0.271 Sum_probs=194.7
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC-
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK- 574 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~- 574 (812)
....++|++.+.||+|+||.||+|++ .+++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---------~~~~E~~il~~l~hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---------YKNRELDIMKVLDHVNIIKLVDYFYTTG 73 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHHcCCCCccchhheeeecC
Confidence 34567899999999999999999987 4689999999864221 223699999999999999999998543
Q ss_pred -------------------------------------CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHH
Q 042346 575 -------------------------------------DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617 (812)
Q Consensus 575 -------------------------------------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~ 617 (812)
...++||||++ ++|.+.+....... ..+++..+..++.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~----~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSG----RSIPMNLISIYIY 148 (383)
T ss_dssp ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTT----CCCCHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcC----CCCCHHHHHHHHH
Confidence 33789999998 58888876421111 1236777889999
Q ss_pred HHHHHHHHHhhcCCCCeEeeccCCCCEEEc-CCCcEEEEeecccccCCCCcccccccccccCCCccCccccccC-cCCCc
Q 042346 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLD-VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAK 695 (812)
Q Consensus 618 ~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k 695 (812)
||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.+
T Consensus 149 qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~ 222 (383)
T 3eb0_A 149 QLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPS 222 (383)
T ss_dssp HHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred HHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcc
Confidence 9999999999998 99999999999998 68999999999998654322 23345789999999998764 58999
Q ss_pred chhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH----------hccccccccccCCCCC---CChHHHHHHH
Q 042346 696 TDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL----------AGQLHCVLDKRVGPPE---LNEAEAVELL 762 (812)
Q Consensus 696 sDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~d~~~~~~~---~~~~~~~~~l 762 (812)
+|||||||++|||++|+.||..... .+.......... ...+....-+...... ..+...+..+
T Consensus 223 ~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (383)
T 3eb0_A 223 IDLWSIGCVFGELILGKPLFSGETS----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298 (383)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH
T ss_pred hhhhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHH
Confidence 9999999999999999999854321 111111111000 0000000000000000 0011234568
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH--HHHHHH
Q 042346 763 ATTAIHCVNLEGKERPNITDIVAN--LERALA 792 (812)
Q Consensus 763 ~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~ 792 (812)
.+|+.+||..||++|||+.|++++ ++.+..
T Consensus 299 ~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 299 IDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 899999999999999999999964 444443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.90 Aligned_cols=265 Identities=18% Similarity=0.287 Sum_probs=190.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE------
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ------ 572 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~------ 572 (812)
.++|++.+.||+|+||.||+|++.. ++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 4679999999999999999999864 899999988642 1334567889999999999999999999874
Q ss_pred --------eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCE
Q 042346 573 --------EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNI 644 (812)
Q Consensus 573 --------~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NI 644 (812)
+....++||||++ ++|.+++.... ++....+.++.|++.||+|||+++ |+||||||+||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 151 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQGP---------LLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANL 151 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhcCC---------ccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHE
Confidence 3457899999997 69999996432 256677889999999999999998 99999999999
Q ss_pred EEc-CCCcEEEEeecccccCCCCcc-cccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCC
Q 042346 645 LLD-VNWTARVSDFGLSLLGSECDQ-EFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDG 721 (812)
Q Consensus 645 Ll~-~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~ 721 (812)
|++ +++.+||+|||+++....... ........+|+.|+|||.+.. ..++.++||||||+++|||++|+.||.....
T Consensus 152 l~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~- 230 (320)
T 2i6l_A 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE- 230 (320)
T ss_dssp EEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-
Confidence 997 567999999999986543211 112234467999999998865 6789999999999999999999999854321
Q ss_pred CCCchhHHHHHHHH----------HhccccccccccCCCCCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 722 SGPLDVVEFAVSQI----------LAGQLHCVLDKRVGPPELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 722 ~~~~~~~~~~~~~~----------~~~~~~~~~d~~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
........... ....+...+......+.... ...+..+.+++.+||+.||++|||++|++++
T Consensus 231 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 231 ---LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp ---HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11111111000 00000000001111111111 1235678899999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.12 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=200.8
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||.||+++.. +++.||+|++...... ......+.+|++++++++||||+++++++.+.+..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc---hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 4467999999999999999999985 6899999998642211 22345688999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC---CcEEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN---WTARV 654 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl 654 (812)
++||||+++++|.+++..... +++..+++++.||+.||+|||+.+ |+||||||+|||++.+ +.+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKR--------FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEEccCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEE
Confidence 999999999999999875432 366778899999999999999998 9999999999999764 47999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
+|||++....... ......+|+.|+|||.+.+. ++.++||||||+++|||++|+.||..... ......
T Consensus 166 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~ 233 (287)
T 2wei_A 166 IDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKR 233 (287)
T ss_dssp CSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred eccCcceeecCCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 9999997654322 12334688999999988764 89999999999999999999999854321 112222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..+.... +.......+..+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 234 VETGKYAF--------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHCCCCC--------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHcCCCCC--------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 33332111 111112334568899999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.90 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=196.7
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-----------CCCceEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-----------HKHLVGL 567 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l 567 (812)
.++|++.+.||+|+||.||+|++ .+++.||||++... ......+.+|++++++++ ||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 35799999999999999999987 46899999998632 223456778999988886 8999999
Q ss_pred EEEEEeCC----eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCC
Q 042346 568 VGFCQEKD----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSS 642 (812)
Q Consensus 568 ~~~~~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~ 642 (812)
++++...+ ..++||||+ +++|.+++....... +++..+++++.||+.||+|||++ + |+||||||+
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~------~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~ 161 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG------IPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPE 161 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSC------CCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGG
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccC------CcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChH
Confidence 99998654 678999999 889999997654321 36677889999999999999998 8 999999999
Q ss_pred CEEEc------CCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCC
Q 042346 643 NILLD------VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVF 716 (812)
Q Consensus 643 NILl~------~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~ 716 (812)
|||++ .++.+||+|||++...... .....+|+.|+|||++.+..++.++||||||++||||++|+.||.
T Consensus 162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 162 NVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp GEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred HeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99994 3458999999999765432 234578999999999999999999999999999999999999996
Q ss_pred CCCCCCCCchhHHHHHHHHH--hccccc-----------cccc-----cCC------------CCCCChHHHHHHHHHHH
Q 042346 717 KNEDGSGPLDVVEFAVSQIL--AGQLHC-----------VLDK-----RVG------------PPELNEAEAVELLATTA 766 (812)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~--~~~~~~-----------~~d~-----~~~------------~~~~~~~~~~~~l~~li 766 (812)
............ ....+. .+.... .++. .+. ..........+.+.+|+
T Consensus 237 ~~~~~~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 314 (373)
T 1q8y_A 237 PDEGHSYTKDDD--HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314 (373)
T ss_dssp --------CHHH--HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred CCcccccCChHH--HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHH
Confidence 543221111111 111111 011000 0000 000 00112356778899999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 042346 767 IHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 767 ~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+||+.||++|||++|++++
T Consensus 315 ~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 315 SPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp GGGGCSSTTTCBCHHHHHTC
T ss_pred HHHhccCccccCCHHHHhhC
Confidence 99999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=347.14 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=180.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK---- 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---- 574 (812)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+.+|+++++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 478999999999999999999874 58999999986421 1233455778999999999999999999998754
Q ss_pred --CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 575 --DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 575 --~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
...++||||+ +++|.+++.... +++..+..++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQK---------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCE
Confidence 4579999999 689999986421 366778899999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.....
T Consensus 172 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~l~~i 242 (367)
T 2fst_X 172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLI 242 (367)
T ss_dssp EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHH
T ss_pred EEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 99999999764331 334578999999999876 6789999999999999999999999854321 1111111
Q ss_pred HHHHHhc------c-----ccccccccCCCCCCChH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 732 VSQILAG------Q-----LHCVLDKRVGPPELNEA----EAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 732 ~~~~~~~------~-----~~~~~d~~~~~~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
....-.. . ....+..-...+..... .....+.+|+.+||..||++|||++|++++
T Consensus 243 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 1110000 0 00000000000111111 124567899999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=349.47 Aligned_cols=257 Identities=26% Similarity=0.306 Sum_probs=187.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 579 (812)
+.|...++||+|+||+||.+...+++.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 346667899999999998776678999999998531 123467899999886 89999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC----------
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN---------- 649 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---------- 649 (812)
||||+. |+|.+++.......... ....+...++++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENL-KLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EECCCS-EEHHHHHHTC-------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred EEecCC-CCHHHHHhccCCCchhh-hhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccC
Confidence 999996 69999998765432211 11122334679999999999999998 9999999999999754
Q ss_pred ---CcEEEEeecccccCCCCcccc--cccccccCCCccCcccccc-------CcCCCcchhHHHHHHHHHHHc-CCCCCC
Q 042346 650 ---WTARVSDFGLSLLGSECDQEF--ISTKAVGTVGYIDPEYYVM-------NVLTAKTDIYGLGVVLLELLT-GKKAVF 716 (812)
Q Consensus 650 ---~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gvvl~ellt-G~~p~~ 716 (812)
+.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 489999999998765432211 1234579999999999865 678999999999999999999 888884
Q ss_pred CCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 717 KNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
.... . . ..+..+... .. ..+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~-----~--~---~~i~~~~~~----~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 242 DKYS-----R--E---SNIIRGIFS----LD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp STTT-----H--H---HHHHHTCCC----CC-CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cchh-----h--H---HHHhcCCCC----cc-cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 3221 0 0 112222111 00 0122234567788999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=349.93 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=189.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC----C
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK----D 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----~ 575 (812)
.+|++.+.||+|+||.||+|++. +++.||||++.... ..+.+|+++++.++||||+++++++... +
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 45999999999999999999985 58999999986421 1234699999999999999999998642 2
Q ss_pred --eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-CcE
Q 042346 576 --ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTA 652 (812)
Q Consensus 576 --~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~ 652 (812)
..++||||+++ +|.+.+...... ...+++..++.++.||++||+|||+++ |+||||||+||||+.+ +.+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRA----KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEE
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeE
Confidence 25789999975 777766532111 112367778899999999999999998 9999999999999965 678
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||+||||++|+.||..... .+.....
T Consensus 197 kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i 269 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEI 269 (420)
T ss_dssp EECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred EeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 999999998654322 12345789999999998764 799999999999999999999999854321 1111111
Q ss_pred HHHH----------HhccccccccccCCCCC---CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 732 VSQI----------LAGQLHCVLDKRVGPPE---LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 732 ~~~~----------~~~~~~~~~d~~~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...+ ....+.+...+.+.... ......+..+.+|+.+||..||++|||+.|++++
T Consensus 270 ~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 270 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 1110 00111110000000000 0011234568899999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.14 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=171.5
Q ss_pred cCCcceee-eeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe----
Q 042346 500 TNNFSLEN-KVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE---- 573 (812)
Q Consensus 500 ~~~~~~~~-~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~---- 573 (812)
.++|.+.+ +||+|+||.||++++. +++.||||++... .. ...+....++.++||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PK---ARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 45688855 6999999999999986 5899999998641 11 11122334566799999999999976
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC---CC
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV---NW 650 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~ 650 (812)
+...++||||+++|+|.+++...... .+++..+++++.||+.||+|||+++ |+||||||+|||++. ++
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~------~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQ------AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTC
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCc
Confidence 34579999999999999999865421 2367888999999999999999998 999999999999976 45
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
.+||+|||++...... ......+|+.|+|||++....++.++||||||+++|||++|+.||......... ..
T Consensus 169 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~ 240 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS----PG 240 (336)
T ss_dssp CEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred eEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh----hh
Confidence 5999999999754432 223457899999999998889999999999999999999999998654321110 00
Q ss_pred HHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANL 787 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 787 (812)
....+..+ ....+.......+..+.+|+.+||+.||++|||++|++++-
T Consensus 241 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 241 MKRRIRLG--------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHhhhcc--------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 01111111 11111111123456688999999999999999999999853
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=332.81 Aligned_cols=268 Identities=22% Similarity=0.333 Sum_probs=197.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEE--cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc---cCCCceEEEEEEE-
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKL--MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV---HHKHLVGLVGFCQ- 572 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~- 572 (812)
..++|++.+.||+|+||.||++++ .+++.||+|++....... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT---SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc---cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 456799999999999999999998 358899999886422111 1112345677766666 8999999999987
Q ss_pred ----eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 573 ----EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 573 ----~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
.....++||||++ ++|.+++....... +++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~ 155 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG------VPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTS 155 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTC------SCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCC------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcC
Confidence 4456799999998 69999997654321 366778899999999999999998 999999999999999
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
++.+||+|||++...... .......+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ....
T Consensus 156 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~ 228 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQL 228 (326)
T ss_dssp TCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHH
T ss_pred CCCEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH----HHHH
Confidence 999999999999765432 123456789999999999998999999999999999999999999854321 1111
Q ss_pred HHHHHHHHhc---ccccc-------ccc-cCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 729 EFAVSQILAG---QLHCV-------LDK-RVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 729 ~~~~~~~~~~---~~~~~-------~d~-~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.......... .+... +.. ............+..+.+|+.+||..||++|||+.|++++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 229 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111111000 00000 000 0000000112345668899999999999999999999964
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.15 Aligned_cols=260 Identities=21% Similarity=0.287 Sum_probs=194.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE-
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER- 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~- 577 (812)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ........+.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc---cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 468999999999999999999875 58999999986422 2233456788999999999999999999999877654
Q ss_pred -----EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 578 -----LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 578 -----~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
++||||+. ++|.+++... +++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~ 183 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMGME----------FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCEL 183 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred cceeEEEEEcccc-ccHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCE
Confidence 99999997 6898888432 366778899999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||++||||++|+.||..... .+.....
T Consensus 184 kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i 254 (371)
T 4exu_A 184 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQI 254 (371)
T ss_dssp EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHH
T ss_pred EEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHH
Confidence 99999999754331 234578999999999887 7899999999999999999999999854321 1111111
Q ss_pred HHHHHhcccccc-----------ccccCC-CCCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 732 VSQILAGQLHCV-----------LDKRVG-PPELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 732 ~~~~~~~~~~~~-----------~d~~~~-~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... .....+. ....+. .+.... ......+.+|+.+||+.||++|||++|++++
T Consensus 255 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 255 LKVT-GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHH-CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHh-CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 1100 0000000 000000 000001 1234668899999999999999999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=344.63 Aligned_cols=263 Identities=20% Similarity=0.273 Sum_probs=190.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE--- 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~--- 576 (812)
..+|++.++||+|+||.||+|++.++..+|+|++..... ...+|+++++.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 346999999999999999999998888899998864221 12369999999999999999999965443
Q ss_pred ---EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc-CCCcE
Q 042346 577 ---RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD-VNWTA 652 (812)
Q Consensus 577 ---~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~ 652 (812)
.++||||+++ +|.+.+...... ...+++.....++.||++||+|||+++ |+||||||+|||++ .++.+
T Consensus 110 ~~~~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 110 EVFLNLVLEYVPE-TVYRASRHYAKL----KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp CEEEEEEEECCSE-EHHHHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred ceEEEEEeeccCc-cHHHHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcE
Confidence 7899999987 444443321110 012356777889999999999999998 99999999999999 79999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||+||||++|+.||..... .+.....
T Consensus 182 kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~l~~i 254 (394)
T 4e7w_A 182 KLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG----IDQLVEI 254 (394)
T ss_dssp EECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred EEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 999999997654322 23345789999999998764 589999999999999999999999854321 1111111
Q ss_pred HHHH----------HhccccccccccCCCCC---CChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 732 VSQI----------LAGQLHCVLDKRVGPPE---LNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 732 ~~~~----------~~~~~~~~~d~~~~~~~---~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.... ....+....-+...... ......+..+.+|+.+||..||++|||+.|++++
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 1100 00000000000000000 0001234568899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=350.53 Aligned_cols=273 Identities=20% Similarity=0.278 Sum_probs=181.6
Q ss_pred Ccce-eeeeccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe--CC
Q 042346 502 NFSL-ENKVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE--KD 575 (812)
Q Consensus 502 ~~~~-~~~LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~ 575 (812)
.|++ .++||+|+||.||+|+++ +++.||||++..... ...+.+|++++++++||||+++++++.. ..
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3655 458999999999999975 478999999864211 2356789999999999999999999965 56
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCC-ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE----cCCC
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTE-KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL----DVNW 650 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~ 650 (812)
..++||||++ ++|.+++....... ......+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCC
Confidence 7899999996 58988886432111 011122477888999999999999999998 9999999999999 7789
Q ss_pred cEEEEeecccccCCCCccc-ccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCC---CC-
Q 042346 651 TARVSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGS---GP- 724 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~---~~- 724 (812)
.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... .+
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999999865432211 22345679999999999987 458999999999999999999999996543211 01
Q ss_pred -chhHHHHHHHHHhc---ccccc------------ccccCCCCCCChH--------HHHHHHHHHHHHccccCCCCCCCH
Q 042346 725 -LDVVEFAVSQILAG---QLHCV------------LDKRVGPPELNEA--------EAVELLATTAIHCVNLEGKERPNI 780 (812)
Q Consensus 725 -~~~~~~~~~~~~~~---~~~~~------------~d~~~~~~~~~~~--------~~~~~l~~li~~Cl~~dP~~RPt~ 780 (812)
.+........+-.. .+..+ +.... ....... .....+.+|+.+||..||.+|||+
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNT-YTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGG-GTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccC-CCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 11111111110000 00000 00000 0000000 013457799999999999999999
Q ss_pred HHHHHH
Q 042346 781 TDIVAN 786 (812)
Q Consensus 781 ~evl~~ 786 (812)
+|++++
T Consensus 329 ~e~L~h 334 (405)
T 3rgf_A 329 EQAMQD 334 (405)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=335.23 Aligned_cols=267 Identities=19% Similarity=0.250 Sum_probs=196.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC---
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK--- 574 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--- 574 (812)
..++|++.+.||+|+||.||+|++. +++.||||++.... .......+.+|+++++.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD----KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS----SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc----cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 3467999999999999999999985 58899999986321 233445678899999999999999999998764
Q ss_pred --CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 575 --DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 575 --~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
...++||||+. ++|.+++.... +++..++.++.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~~~---------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~ 151 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVISTQM---------LSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDL 151 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred ccceEEEEEeccC-ccHHHHHhhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcE
Confidence 56899999997 59999987532 366778899999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccc--------cccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 653 RVSDFGLSLLGSECDQEF--------ISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
||+|||++.......... ......||+.|+|||++.. ..++.++||||||++||||++|+.||.....
T Consensus 152 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--- 228 (353)
T 2b9h_A 152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY--- 228 (353)
T ss_dssp EECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred EEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc---
Confidence 999999997654322111 1223478999999998764 6789999999999999999999999854321
Q ss_pred CchhHHHHHHHHHhcc----c--------cccccccCCCCCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 724 PLDVVEFAVSQILAGQ----L--------HCVLDKRVGPPELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 724 ~~~~~~~~~~~~~~~~----~--------~~~~d~~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
............... . .+.+......+.... ...+..+.+|+.+||+.||++|||++|++++
T Consensus 229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 229 -RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp -HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 011110000000000 0 000000000000000 1234668899999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=336.12 Aligned_cols=205 Identities=25% Similarity=0.289 Sum_probs=169.7
Q ss_pred HHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CC-----CceE
Q 042346 494 SELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HK-----HLVG 566 (812)
Q Consensus 494 ~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----nIv~ 566 (812)
.+.....++|++.+.||+|+||.||+|++. +++.||||++... ......+.+|+++++.++ |+ +|++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------KAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------HHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 334445678999999999999999999875 5789999998632 223455677888888885 55 4999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 567 l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
+++++...+..+|||||++ ++|.+++....... +++..+++++.|++.||.|||++. .+|+||||||+|||+
T Consensus 121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~------~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRG------VSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILL 192 (382)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSC------CCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEE
T ss_pred eeeeeccCCceEEEEecCC-CCHHHHHhhcCcCC------CCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEE
Confidence 9999999999999999996 59999998654321 367788899999999999999532 239999999999999
Q ss_pred c--CCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCC
Q 042346 647 D--VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFK 717 (812)
Q Consensus 647 ~--~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~ 717 (812)
+ .++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4 4788999999999765431 2345789999999999999999999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=333.72 Aligned_cols=258 Identities=23% Similarity=0.312 Sum_probs=175.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHH-HHHhccCCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELA-LLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
.++|++.+.||+|+||.||++.+. +++.||||++..... ......+..|+. +++.++||||+++++++.+++..
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 467999999999999999999985 689999999864321 222334445555 77788999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
++||||+++ +|.+++....... ...+++..+.+++.|++.||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVL---DDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTT---CCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECC
T ss_pred EEEEeecCC-ChHHHHHHHHhhh---cccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEcc
Confidence 999999985 8888876421110 11236777889999999999999998 8 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCcccc----ccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYY----VMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||++....... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 170 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------- 237 (327)
T 3aln_A 170 FGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------- 237 (327)
T ss_dssp CSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------
T ss_pred CCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------
Confidence 99997654321 22334789999999998 456789999999999999999999999854321100
Q ss_pred HHHHhccccccccccC-CCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRV-GPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+........ ..+.......+..+.+|+.+||+.||++|||+.|++++
T Consensus 238 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 238 ------QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ------HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0001111100 01111112344568899999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=330.13 Aligned_cols=261 Identities=20% Similarity=0.303 Sum_probs=198.1
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CC-cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC------ceEEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DG-REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH------LVGLVGF 570 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g-~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~~~ 570 (812)
..++|++.+.||+|+||.||++... ++ +.||+|++... ....+.+.+|+++++.++|+| ++.++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 3467999999999999999999874 34 68999998632 233456778999999998766 9999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE----
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL---- 646 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---- 646 (812)
+...+..++||||+ +++|.+++...... .+++..+++++.||+.||+|||+++ |+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~------~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQ------PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSE 160 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTC------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCC
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccc
Confidence 99999999999999 67888888665322 1367788999999999999999998 9999999999999
Q ss_pred ---------------cCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcC
Q 042346 647 ---------------DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTG 711 (812)
Q Consensus 647 ---------------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG 711 (812)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||++||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 235 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence 67889999999999764332 2345799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCchhHHHHHHHHHhccccc-----------ccc-------------------ccCCCCCCChHHHHHH
Q 042346 712 KKAVFKNEDGSGPLDVVEFAVSQILAGQLHC-----------VLD-------------------KRVGPPELNEAEAVEL 761 (812)
Q Consensus 712 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~d-------------------~~~~~~~~~~~~~~~~ 761 (812)
+.||..... ....... .... +.... ... ..+.............
T Consensus 236 ~~pf~~~~~----~~~~~~~-~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 236 FTLFQTHEN----REHLVMM-EKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp SCSCCCSSH----HHHHHHH-HHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred CCCCCCCCH----HHHHHHH-HHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 999854321 1111111 0100 00000 000 0000001112344567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 042346 762 LATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 762 l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+.+|+.+||+.||++|||+.|++++
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcC
Confidence 8899999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=337.72 Aligned_cols=261 Identities=21% Similarity=0.276 Sum_probs=194.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe--
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE-- 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-- 576 (812)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 467999999999999999999875 58999999986422 123345678899999999999999999999987654
Q ss_pred ----EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 577 ----RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 577 ----~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
.++||||++ ++|.+++... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~~----------~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~ 165 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMGLK----------FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCEL 165 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCE
T ss_pred cceeEEEEecccc-CCHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcE
Confidence 499999997 5998887432 356778899999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||++...... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .+.....
T Consensus 166 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~i 236 (353)
T 3coi_A 166 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----LDQLTQI 236 (353)
T ss_dssp EECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH----HHHHHHH
T ss_pred EEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 99999999764321 234578999999999876 6789999999999999999999999864321 1111111
Q ss_pred HHHHHh------cc---------ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 732 VSQILA------GQ---------LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 732 ~~~~~~------~~---------~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...... .. +..+..................+.+|+.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 110000 00 00000000000000112345678899999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=349.62 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=184.6
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 577 (812)
...+|.+.++||+|+||+||.....+++.||||++..... ..+.+|+++++.+ +||||+++++++.+....
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 3456999999999999997655566899999999864211 1245799999999 799999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC-----CCcE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-----NWTA 652 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-----~~~~ 652 (812)
+|||||+. |+|.+++......... ...+.++.||++||+|||+++ |+||||||+|||++. +..+
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~-------~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~ 162 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLG-------LEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKA 162 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCS-------SCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCE
T ss_pred EEEEECCC-CCHHHHHHhcCCCccc-------hhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeE
Confidence 99999996 5999999866532211 123579999999999999998 999999999999943 3468
Q ss_pred EEEeecccccCCCCccc-ccccccccCCCccCccccc---cCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchh
Q 042346 653 RVSDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYV---MNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~ 727 (812)
||+|||+++........ .......||+.|+|||++. ...++.++|||||||+||||++ |+.||..... ..
T Consensus 163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~ 237 (432)
T 3p23_A 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQ 237 (432)
T ss_dssp EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HH
T ss_pred EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HH
Confidence 89999999866543221 2234467999999999997 4567889999999999999999 8888743221 11
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
... ..+.. .. ............+.+|+.+||+.||++|||++|+++
T Consensus 238 ----~~~-~~~~~----~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 238 ----ANI-LLGAC----SL---DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----HHH-HTTCC----CC---TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----HHH-HhccC----Cc---cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111 11110 00 011112344556789999999999999999999994
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.95 Aligned_cols=272 Identities=21% Similarity=0.268 Sum_probs=185.2
Q ss_pred HHHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEE
Q 042346 494 SELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQ 572 (812)
Q Consensus 494 ~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 572 (812)
.+.....++|++.+.||+|+||.||++++. +++.||||++...... ...+.+|++.+..++||||+++++++.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF------RNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC------CCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc------cHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 445566789999999999999999999985 5899999988542211 123456788888999999999999997
Q ss_pred eCCe-------EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHh--hcCCCCeEeeccCCCC
Q 042346 573 EKDE-------RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH--NYAVPSIIHRDIKSSN 643 (812)
Q Consensus 573 ~~~~-------~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH--~~~~~~ivHrDlKp~N 643 (812)
.... .++||||+++ +|.+.+....... ...++.....++.|++.||.||| +.+ |+||||||+|
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~N 161 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ----VAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHN 161 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGG
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHH
Confidence 6443 7899999986 6655544311111 12256677889999999999999 877 9999999999
Q ss_pred EEEcC-CCcEEEEeecccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCC
Q 042346 644 ILLDV-NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDG 721 (812)
Q Consensus 644 ILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~ 721 (812)
||++. ++.+||+|||++....... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||.....
T Consensus 162 Ill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~- 237 (360)
T 3e3p_A 162 VLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS- 237 (360)
T ss_dssp EEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-
Confidence 99997 8999999999998655422 22345789999999998654 489999999999999999999999854321
Q ss_pred CCCchhHHHHHHHHHhcc--ccccccc-----cC-CCCCCC--------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 722 SGPLDVVEFAVSQILAGQ--LHCVLDK-----RV-GPPELN--------EAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~--~~~~~d~-----~~-~~~~~~--------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
............... ....++. .. ...... .......+.+|+.+||+.||++|||+.|+++
T Consensus 238 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 238 ---AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp ---HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111111111100000 0000000 00 000000 1123567889999999999999999999998
Q ss_pred H
Q 042346 786 N 786 (812)
Q Consensus 786 ~ 786 (812)
+
T Consensus 315 h 315 (360)
T 3e3p_A 315 H 315 (360)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=325.84 Aligned_cols=254 Identities=19% Similarity=0.290 Sum_probs=178.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||++++. +++.||||++..... .....+.+.++..+++.++||||+++++++.+++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 456999999999999999999985 689999999864322 2223344555666788889999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+||||+ ++.+..++..... .+++..+++++.|+++||.|||++ + |+||||||+|||++.++.+||+||
T Consensus 101 lv~e~~-~~~~~~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQG-------PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEecc-CCcHHHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEEC
Confidence 999999 4455555443221 135677889999999999999995 7 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|++....... ......+|+.|+|||++. ...++.++||||||+++|||++|+.||..... .....
T Consensus 170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~ 239 (318)
T 2dyl_A 170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFEVL 239 (318)
T ss_dssp TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHH
T ss_pred CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHHHH
Confidence 9997554321 223457899999999984 45688999999999999999999999854221 11112
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+..+... .... ....+..+.+++.+||+.||.+|||++|++++
T Consensus 240 ~~~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 240 TKVLQEEPP-----LLPG----HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHSCCC-----CCCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHhccCCC-----CCCc----cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 222222111 0110 11234558899999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.43 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=196.7
Q ss_pred HHHHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhH-HHHHHHHHHHHHHHHhcc--CCCceEEEEE
Q 042346 495 ELAAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKL-REKESAFDSELALLSRVH--HKHLVGLVGF 570 (812)
Q Consensus 495 el~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~--H~nIv~l~~~ 570 (812)
+.....++|++.+.||+|+||.||+|++. +++.||||++......... ......+.+|++++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 34445678999999999999999999874 6889999998642211100 011234667999999996 5999999999
Q ss_pred EEeCCeEEEEEEecCC-CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc-C
Q 042346 571 CQEKDERLLVYEYMSN-GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD-V 648 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~ 648 (812)
+.+.+..++||||+.+ ++|.+++..... +++..++.++.||++||+|||+.+ |+||||||+|||++ +
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~--------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGA--------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 185 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence 9999999999999986 899999976432 256777899999999999999998 99999999999999 7
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcC-CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
++.+||+|||++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------- 253 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------- 253 (320)
T ss_dssp TTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred CCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------
Confidence 899999999999765432 1234579999999999987665 678999999999999999999984311
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
....+.. ..+ ...++.+.+|+.+||+.||++|||++|++++
T Consensus 254 ------~~~~~~~--------~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 ------EIIRGQV--------FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------HHHHCCC--------CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------hhhcccc--------ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 111 1233458899999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.95 Aligned_cols=241 Identities=15% Similarity=0.114 Sum_probs=184.3
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.++|++.+.||+|+||.||+|++.. ++.||||++..... ...+..+.|.+|++++.+++||||+++++++.+++..|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV--LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC--SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc--cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 3579999999999999999999854 89999999865322 12344567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++++|.+++.... .....++|+.|++.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~~~----------~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTSP----------SPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTCC----------CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EEEEecCCCCHHHHHhcCC----------ChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc
Confidence 9999999999999995431 12345789999999999999998 9999999999999999999997443
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
|++| ++.++||||||++||||++|+.||............
T Consensus 175 ----------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----------- 214 (286)
T 3uqc_A 175 ----------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------- 214 (286)
T ss_dssp ----------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----------
T ss_pred ----------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----------
Confidence 3333 688999999999999999999999654322111000
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccCC
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCS 798 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~~ 798 (812)
..........+......+++.+.+|+.+||+.||++| |+.|+++.|+++........
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~ 271 (286)
T 3uqc_A 215 --ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTE 271 (286)
T ss_dssp --CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC------
T ss_pred --HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccC
Confidence 0000000100000012345668899999999999999 99999999999887665443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.32 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=189.3
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhH-HHHHHHHHHHHHHHHhc----cCCCceEEEEE
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKL-REKESAFDSELALLSRV----HHKHLVGLVGF 570 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l----~H~nIv~l~~~ 570 (812)
....++|++.+.||+|+||.||++++ .+++.||||++......... ......+.+|++++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34557899999999999999999986 46889999998643221111 12234456799999998 89999999999
Q ss_pred EEeCCeEEEEEEe-cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc-C
Q 042346 571 CQEKDERLLVYEY-MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD-V 648 (812)
Q Consensus 571 ~~~~~~~~lV~ey-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~ 648 (812)
+.+.+..++|||| +.+++|.+++..... +++..+++++.||+.||+|||+.+ |+||||||+|||++ .
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGP--------LGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLR 175 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETT
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCC
Confidence 9999999999999 789999999976432 367788999999999999999998 99999999999999 8
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCC-CcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLT-AKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
++.+||+|||++....... .....+|+.|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------- 243 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------- 243 (312)
T ss_dssp TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------
Confidence 8999999999997654422 2345689999999998876664 58999999999999999999984311
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.... ...+ ......+.+++.+||+.||++|||++|++++
T Consensus 244 ------~~~~~~--------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ------EILEAE--------LHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------HHHHTC--------CCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------HHhhhc--------cCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 1111 1234457899999999999999999999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=353.29 Aligned_cols=243 Identities=20% Similarity=0.273 Sum_probs=194.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc--CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe-
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM--DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE- 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~- 576 (812)
.++|++.+.||+|+||.||++.+. +++.||||++.... ..+....+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG----DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC----CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 367999999999999999999985 58999999875421 13345578899999999999999999999987665
Q ss_pred ----EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 577 ----RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 577 ----~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
.||||||+++++|.+++.. .+++.++++|+.||++||.|||+++ |+||||||+|||++.+ .+
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~ 220 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QL 220 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CE
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cE
Confidence 6999999999999988753 1378888999999999999999998 9999999999999986 99
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||+|||+++..... ....||+.|+|||++.+. ++.++||||||++||||++|..|+.......
T Consensus 221 kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------- 283 (681)
T 2pzi_A 221 KLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------- 283 (681)
T ss_dssp EECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------
T ss_pred EEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------
Confidence 99999999765432 345799999999998765 4889999999999999999988864321100
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHHh
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-NITDIVANLERALAI 793 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~Le~~~~~ 793 (812)
+ +...........+.+|+.+||+.||++|| +++++.+.|+.++..
T Consensus 284 ---------------~-~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 284 ---------------L-PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp ---------------C-CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred ---------------c-cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0 01111233446688999999999999999 677788877776543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=348.91 Aligned_cols=280 Identities=21% Similarity=0.279 Sum_probs=204.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe------
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE------ 573 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~------ 573 (812)
++|++.+.||+|+||.||++.+. +++.||||++.... .....+.+.+|++++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL----SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC----CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC----CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 57999999999999999999874 58999999986421 23345678899999999999999999998765
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc--
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT-- 651 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-- 651 (812)
++..++||||+++++|.+++....... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~-----~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCC-----GLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTT-----CCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence 566799999999999999998654211 1244566889999999999999998 999999999999987654
Q ss_pred -EEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH-H
Q 042346 652 -ARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV-E 729 (812)
Q Consensus 652 -~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~-~ 729 (812)
+||+|||++....... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||............. .
T Consensus 162 ~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~ 238 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238 (676)
T ss_dssp EEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred eEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence 9999999998654422 2344679999999999999999999999999999999999999985431100000000 0
Q ss_pred HHHHH-HHhcccc--ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHHHHhcc
Q 042346 730 FAVSQ-ILAGQLH--CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITD-----IVANLERALAICQ 795 (812)
Q Consensus 730 ~~~~~-~~~~~~~--~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e-----vl~~Le~~~~~~~ 795 (812)
..... ....... ..+......+.......+..+.+++.+||..||++|||+.| +.+.++.+++.-.
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ki 312 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCE
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccc
Confidence 00000 0000000 01112222333344567788999999999999999999988 6677777776553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=311.86 Aligned_cols=231 Identities=21% Similarity=0.329 Sum_probs=176.3
Q ss_pred CCccee-eeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHH-HhccCCCceEEEEEEEe----
Q 042346 501 NNFSLE-NKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALL-SRVHHKHLVGLVGFCQE---- 573 (812)
Q Consensus 501 ~~~~~~-~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~~~~~~---- 573 (812)
++|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|++++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 457776 7899999999999987 46899999998531 2355788887 55699999999999987
Q ss_pred CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC---CC
Q 042346 574 KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV---NW 650 (812)
Q Consensus 574 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~ 650 (812)
+...++||||+++++|.+++...... .+++...+.++.|++.||+|||+++ |+||||||+|||++. ++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 157 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQ------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNA 157 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTC
T ss_pred CceEEEEEeecCCCcHHHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCC
Confidence 56789999999999999999875432 2367788999999999999999998 999999999999998 78
Q ss_pred cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 651 TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 651 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
.+||+|||++.... +..++.++||||||++||||++|+.||........
T Consensus 158 ~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------- 206 (299)
T 3m2w_A 158 ILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------- 206 (299)
T ss_dssp CEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------
T ss_pred cEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------
Confidence 99999999985432 23577899999999999999999999854332110
Q ss_pred HHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...............+.......+..+.+|+.+||+.||++|||++|++++
T Consensus 207 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 207 -----SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000111111111100012345678899999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=326.43 Aligned_cols=249 Identities=12% Similarity=0.135 Sum_probs=178.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC-CCc-------------
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH-KHL------------- 564 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nI------------- 564 (812)
..+|.+.++||+|+||.||+|++. +++.||||++..... ......+.|.+|+.+++.++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~--~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC--ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 345888999999999999999964 689999999873222 222335678899999999987 221
Q ss_pred --------eEEEEEEEe-----CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCC
Q 042346 565 --------VGLVGFCQE-----KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV 631 (812)
Q Consensus 565 --------v~l~~~~~~-----~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~ 631 (812)
..++.++.. ....+++|+++ +++|.+++........ ....+++..++.|+.||++||+|||+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS-THKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 111122222 12346777765 6799999853211111 1123478888999999999999999998
Q ss_pred CCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCcccc----------ccCcCCCcchhHHH
Q 042346 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYY----------VMNVLTAKTDIYGL 701 (812)
Q Consensus 632 ~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDVwS~ 701 (812)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||
T Consensus 232 --iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred --cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 999999999999999999999999998764432 344567 999999999 55668899999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH
Q 042346 702 GVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT 781 (812)
Q Consensus 702 Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 781 (812)
||+||||++|+.||....... ....++.... .+++.+.+|+.+||+.||++|||+.
T Consensus 304 Gvil~elltg~~Pf~~~~~~~----------------~~~~~~~~~~--------~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALG----------------GSEWIFRSCK--------NIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGS----------------CSGGGGSSCC--------CCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHCCCCCCCcchhh----------------hHHHHHhhcc--------cCCHHHHHHHHHHccCChhhCcCHH
Confidence 999999999999985433211 0111111111 1235688999999999999999987
Q ss_pred HHHH
Q 042346 782 DIVA 785 (812)
Q Consensus 782 evl~ 785 (812)
|+++
T Consensus 360 ~~l~ 363 (413)
T 3dzo_A 360 QAME 363 (413)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 7754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.82 Aligned_cols=249 Identities=16% Similarity=0.167 Sum_probs=184.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchh---hHHHHHHHHHHHHHHHHhcc---------CCCceEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTN---KLREKESAFDSELALLSRVH---------HKHLVGL 567 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~---~~~~~~~~~~~Ei~~l~~l~---------H~nIv~l 567 (812)
.++|++.+.||+|+||.||+|++ +++.||||++....... ......+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688999999999999999998 78999999987532110 01122356778888888885 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHH
Q 042346 568 VGFCQ------------------------------EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617 (812)
Q Consensus 568 ~~~~~------------------------------~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~ 617 (812)
++.+. +++..+|||||+++|++.+.+.... +++...+.++.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~---------~~~~~~~~i~~ 168 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL---------SSLATAKSILH 168 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTC---------CCHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcC---------CCHHHHHHHHH
Confidence 88753 2677899999999998877774321 25677889999
Q ss_pred HHHHHHHHHh-hcCCCCeEeeccCCCCEEEcCCC--------------------cEEEEeecccccCCCCcccccccccc
Q 042346 618 DAARGIDYLH-NYAVPSIIHRDIKSSNILLDVNW--------------------TARVSDFGLSLLGSECDQEFISTKAV 676 (812)
Q Consensus 618 ~ia~gL~yLH-~~~~~~ivHrDlKp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~ 676 (812)
||+.||+||| +++ |+||||||+|||++.++ .+||+|||+++.... ....
T Consensus 169 qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~ 238 (336)
T 2vuw_A 169 QLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVV 238 (336)
T ss_dssp HHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEE
T ss_pred HHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEE
Confidence 9999999999 888 99999999999999887 999999999976432 2347
Q ss_pred cCCCccCccccccCcCCCcchhHHHHHH-HHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCCh
Q 042346 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVV-LLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNE 755 (812)
Q Consensus 677 gt~~y~aPE~~~~~~~~~ksDVwS~Gvv-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 755 (812)
||+.|||||++.+.. +.++|||||+++ .+++++|..||... .........+... .......+....
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~~~~~~~-----~~~~~~~~~~~~ 305 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLTDKMLKQ-----MTFKTKCNTPAM 305 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHHHHHHHT-----CCCSSCCCSHHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-------hhhhHHHHhhhhh-----hccCcccchhhh
Confidence 999999999998766 889999998766 78888898886210 0001111111111 011111112224
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHH-HH
Q 042346 756 AEAVELLATTAIHCVNLEGKERPNITDIV-AN 786 (812)
Q Consensus 756 ~~~~~~l~~li~~Cl~~dP~~RPt~~evl-~~ 786 (812)
...+..+.+|+.+||+.| |++|++ ++
T Consensus 306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 567888999999999966 999988 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=291.57 Aligned_cols=192 Identities=16% Similarity=0.108 Sum_probs=133.6
Q ss_pred eeeccCCcEEEEEEEE-cCCcEEEEEeeccCc-----chhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCeEEE
Q 042346 507 NKVGIGSFGTVYKGKL-MDGREVAVKREESCP-----KTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~-----~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 579 (812)
..++.|++|.+..++. --|+.+++|++.... .........++|.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4567778887776642 358999999986532 1222334456799999999999 79999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||++|++|.++|....... . .+|+.||+.||+|||+++ ||||||||+||||++++++||+|||+
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~--------~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGl 385 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEID--------R---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGS 385 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCC--------H---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecCCCCcHHHHHHhCCCCC--------H---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeeccc
Confidence 999999999999998765432 1 258999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCC
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAV 715 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~ 715 (812)
++....... .....+||+.|||||++.+. +..++|+||+|+++++|.++..++
T Consensus 386 Ar~~~~~~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 386 IVTTPQDCS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp EESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CeeCCCCCc--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 986554221 23456899999999998764 677899999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=266.79 Aligned_cols=190 Identities=16% Similarity=0.198 Sum_probs=148.1
Q ss_pred ceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchh---hHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 504 SLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTN---KLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 504 ~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
...++||+|+||.||++++ .++.+++|+........ ......+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467999999999999955 67889999865422211 2223356789999999999999999666666677788999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++++|.++++. +++++.|++++|+|||+++ |+||||||+|||++. ++||+|||++
T Consensus 418 mE~~~ggsL~~~l~~----------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla 476 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLG 476 (540)
T ss_dssp EECCCSEEHHHHSTT----------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTC
T ss_pred EECCCCCCHHHHHHH----------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccC
Confidence 999999999999965 1479999999999999998 999999999999998 9999999999
Q ss_pred ccCCCCcccc-----cccccccCCCccCcccccc--CcCCCcchhHHHHHHHHHHHcCCCCC
Q 042346 661 LLGSECDQEF-----ISTKAVGTVGYIDPEYYVM--NVLTAKTDIYGLGVVLLELLTGKKAV 715 (812)
Q Consensus 661 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltG~~p~ 715 (812)
+......... ......||+.|||||++.. ..|+...|+|+..+-.++.+.++.++
T Consensus 477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 8765432211 1235689999999999986 67888999999999999988877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=213.06 Aligned_cols=170 Identities=14% Similarity=0.066 Sum_probs=128.4
Q ss_pred HHHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcch-------------hhHHHHHHHHHHHHHHHHhc
Q 042346 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKT-------------NKLREKESAFDSELALLSRV 559 (812)
Q Consensus 493 ~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~-------------~~~~~~~~~~~~Ei~~l~~l 559 (812)
+..+......|.+.+.||+|+||.||+|.+.+++.||+|++...... .+.......+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34445556678888999999999999999977999999998532110 01112456788999999999
Q ss_pred cCCCceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeecc
Q 042346 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI 639 (812)
Q Consensus 560 ~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl 639 (812)
+|+++..+ +.. +..++||||+++++|.+ +... ....++.|+++||.|||+.+ |+||||
T Consensus 162 ~~~~v~~~---~~~-~~~~lvmE~~~g~~L~~-l~~~--------------~~~~i~~qi~~~l~~lH~~g---iiHrDl 219 (282)
T 1zar_A 162 QGLAVPKV---YAW-EGNAVLMELIDAKELYR-VRVE--------------NPDEVLDMILEEVAKFYHRG---IVHGDL 219 (282)
T ss_dssp TTSSSCCE---EEE-ETTEEEEECCCCEEGGG-CCCS--------------CHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred cCCCcCeE---Eec-cceEEEEEecCCCcHHH-cchh--------------hHHHHHHHHHHHHHHHHHCC---CEeCCC
Confidence 95545443 333 45699999999999998 5211 11369999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCcccccc----------CcCCCcchhHH
Q 042346 640 KSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM----------NVLTAKTDIYG 700 (812)
Q Consensus 640 Kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~ksDVwS 700 (812)
||+|||++ ++.+||+|||+++. +..|+|||++.. ..|...+|+|.
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999999 99999999999853 345789998753 33455556654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.4e-18 Score=178.94 Aligned_cols=143 Identities=15% Similarity=0.123 Sum_probs=107.0
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcE--EEEEeeccCcchhh-------------------HHHHHHHHHHHHHHHHh
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGRE--VAVKREESCPKTNK-------------------LREKESAFDSELALLSR 558 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~--vavK~~~~~~~~~~-------------------~~~~~~~~~~Ei~~l~~ 558 (812)
.-|++.+.||+|+||.||+|.+ .+|+. ||||++........ .......+.+|++++.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999988 68889 99998653211100 11223467889999999
Q ss_pred ccCCCc--eEEEEEEEeCCeEEEEEEecCC-C----chhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHh-hcC
Q 042346 559 VHHKHL--VGLVGFCQEKDERLLVYEYMSN-G----ALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLH-NYA 630 (812)
Q Consensus 559 l~H~nI--v~l~~~~~~~~~~~lV~ey~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH-~~~ 630 (812)
++|+++ ..++.. +..+|||||+.+ | +|.+++... +......++.|++.+|.||| +.+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~-----------~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL-----------KELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG-----------GGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc-----------ChHHHHHHHHHHHHHHHHHHHHCC
Confidence 988864 444442 246899999942 4 666664321 11223579999999999999 888
Q ss_pred CCCeEeeccCCCCEEEcCCCcEEEEeecccccC
Q 042346 631 VPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 631 ~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
|+||||||+|||++. .++|+|||++...
T Consensus 192 ---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 ---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=9.1e-16 Score=167.25 Aligned_cols=146 Identities=14% Similarity=0.099 Sum_probs=105.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcc-----------------hhhHHHHHHHHHHHHHHHHhccCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPK-----------------TNKLREKESAFDSELALLSRVHHK 562 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~-----------------~~~~~~~~~~~~~Ei~~l~~l~H~ 562 (812)
..=|++.+.||+|+||.||+|...+|+.||||+++.... ..+.........+|...|.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 344999999999999999999998999999998643110 011111222335688888888665
Q ss_pred CceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCC
Q 042346 563 HLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSS 642 (812)
Q Consensus 563 nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~ 642 (812)
++.-..-+... ..+|||||+++++|.++.... ...+++.||+.+|.|||+.+ ||||||||.
T Consensus 174 gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~~--------------~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 174 GFPVPEPIAQS--RHTIVMSLVDALPMRQVSSVP--------------DPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp TCSCCCEEEEE--TTEEEEECCSCEEGGGCCCCS--------------CHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred CCCCCeeeecc--CceEEEEecCCccHhhhcccH--------------HHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 54322222222 237999999998887664211 11367899999999999998 999999999
Q ss_pred CEEEcCCC----------cEEEEeecccccCC
Q 042346 643 NILLDVNW----------TARVSDFGLSLLGS 664 (812)
Q Consensus 643 NILl~~~~----------~~kl~DfGla~~~~ 664 (812)
|||+++++ .+.|+||+.+....
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99998876 48999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=6.8e-11 Score=123.38 Aligned_cols=145 Identities=15% Similarity=0.104 Sum_probs=111.9
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCC
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKD 575 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~ 575 (812)
......|++...++.|+++.||+... +++.+++|+...... .....+.+|+++++.+. |.++.++++++.+.+
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~-----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT-----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC-----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 33446798899999999999999975 478999999753110 11224778999999984 677889999999988
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcC-------------------------
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYA------------------------- 630 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~------------------------- 630 (812)
..|+||||++|.+|.+.+... .....++.++++.|+.||+..
T Consensus 84 ~~~lv~e~i~G~~l~~~~~~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYEDE-------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp EEEEEEECCSSEEHHHHCCTT-------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred ceEEEEEecCCeehhhccCCc-------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 999999999999998764211 011367889999999999811
Q ss_pred -------------------------------CCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 631 -------------------------------VPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 631 -------------------------------~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
.+.++|+|++|.|||++++..+.|+||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 134899999999999987666679999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.3e-10 Score=120.69 Aligned_cols=137 Identities=15% Similarity=0.074 Sum_probs=99.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC--ceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH--LVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~~~~~ 578 (812)
.++.+..+.+.|..+.||+....+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++...++..+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 345544444466679999998777888999987532 1134677999999986555 456888888877889
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcC----------------------------
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYA---------------------------- 630 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~---------------------------- 630 (812)
+||||+++.+|. .... . ...++.++++.|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~~~-----------~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SSHL-----------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ 155 (264)
T ss_dssp EEEECCSSEETT--TSCC-----------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred EEEEecCCcccC--cCcC-----------C---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence 999999998884 2110 0 1246677778888888643
Q ss_pred ---------------------------CCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 631 ---------------------------VPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 631 ---------------------------~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
.+.++|+|++|.|||++.+..+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.88 E-value=4.1e-09 Score=115.23 Aligned_cols=145 Identities=19% Similarity=0.249 Sum_probs=104.5
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeec--cCcchhhHHHHHHHHHHHHHHHHhcc--CCCceEEEEEEEeC---C
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREE--SCPKTNKLREKESAFDSELALLSRVH--HKHLVGLVGFCQEK---D 575 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~--~~~~~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~---~ 575 (812)
....+.|+.|.++.||+.... +..+++|+.. .. ........+.+|+++++.|. +..+.+++.++.+. +
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~----~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKS----KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS-SCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred CceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCC----CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 334678999999999998874 5688888764 21 11112346778999999997 45578899888776 3
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcC-------------------------
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYA------------------------- 630 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~------------------------- 630 (812)
..|+||||+++..+.+.... .++...+..++.++++.|+.||...
T Consensus 115 ~~~~vme~v~G~~l~~~~~~----------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQSLP----------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTK 184 (359)
T ss_dssp SCEEEEECCCCBCCCCTTCT----------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHH
T ss_pred CeEEEEEecCCeecCCCccc----------cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHH
Confidence 47999999998777542211 0134556788999999999999731
Q ss_pred ------------------------------CCCeEeeccCCCCEEEcCCCc--EEEEeeccccc
Q 042346 631 ------------------------------VPSIIHRDIKSSNILLDVNWT--ARVSDFGLSLL 662 (812)
Q Consensus 631 ------------------------------~~~ivHrDlKp~NILl~~~~~--~kl~DfGla~~ 662 (812)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 185 QYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=7.5e-09 Score=110.40 Aligned_cols=186 Identities=18% Similarity=0.186 Sum_probs=115.6
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCC--ceEEEEEEEeCC---eEEE
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKH--LVGLVGFCQEKD---ERLL 579 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--Iv~l~~~~~~~~---~~~l 579 (812)
.+.++.|.+..||+.. +.+++|+... ......+.+|.++++.+. +.. +.+++......+ ..|+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence 4568999999999863 5688998642 123456788999998884 333 345555443333 2489
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc------------------------------
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY------------------------------ 629 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~------------------------------ 629 (812)
|||+++|.+|.+..... ++..++..++.++++.|+.||+.
T Consensus 94 vm~~i~G~~l~~~~~~~----------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLLNN----------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp EEECCCCEECCHHHHHT----------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred EEcccCCeECCcccccc----------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 99999998887543211 12334456666777777776651
Q ss_pred -------------------------CCCCeEeeccCCCCEEEcC--CCcEEEEeecccccCCCCcccccccccccCCCcc
Q 042346 630 -------------------------AVPSIIHRDIKSSNILLDV--NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYI 682 (812)
Q Consensus 630 -------------------------~~~~ivHrDlKp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 682 (812)
..+.++|+|++|.|||++. +..+.|+||+.+........-...... . .-.
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~--~-~~~ 240 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED--D-EEY 240 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT--T-TSC
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh--c-ccc
Confidence 1145899999999999998 556889999988653221110000000 0 001
Q ss_pred Ccccccc--------------CcCCCcchhHHHHHHHHHHHcCCCCC
Q 042346 683 DPEYYVM--------------NVLTAKTDIYGLGVVLLELLTGKKAV 715 (812)
Q Consensus 683 aPE~~~~--------------~~~~~ksDVwS~Gvvl~elltG~~p~ 715 (812)
.|+.... .......+.|+++.++|++.+|..++
T Consensus 241 ~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 241 GMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2221110 01122368999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=6.3e-06 Score=87.75 Aligned_cols=75 Identities=12% Similarity=0.131 Sum_probs=55.6
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC---CceEEEEEEE-eCCeEEEEE
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK---HLVGLVGFCQ-EKDERLLVY 581 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~ 581 (812)
.+.++.|....||+. ++.+++|+... ......+.+|.++|+.|.+. .+.+.+.+.. ..+..++||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence 567889999999987 57788888532 22345688999999999753 2556676664 344578999
Q ss_pred EecCCCchhh
Q 042346 582 EYMSNGALHD 591 (812)
Q Consensus 582 ey~~~gsL~~ 591 (812)
||++|..|.+
T Consensus 93 e~i~G~~l~~ 102 (306)
T 3tdw_A 93 RKVQGQILGE 102 (306)
T ss_dssp ECCCSEECHH
T ss_pred eccCCeECch
Confidence 9999988876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=7.7e-06 Score=85.09 Aligned_cols=139 Identities=17% Similarity=0.189 Sum_probs=97.7
Q ss_pred CcceeeeeccCCcE-EEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCeEE
Q 042346 502 NFSLENKVGIGSFG-TVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 502 ~~~~~~~LG~G~fG-~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~ 578 (812)
.|+. +.+..|..+ .||+.... ++..+.+|+... .....+.+|...|+.|. +--+.+++.++.+.+..+
T Consensus 26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~ 96 (272)
T 4gkh_A 26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAW 96 (272)
T ss_dssp TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEE
Confidence 3443 355556655 68987654 467899998642 12345778999998884 334668889999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcC----------------------------
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYA---------------------------- 630 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~---------------------------- 630 (812)
+|||++++.++.+....... ....+..+++..|.-||...
T Consensus 97 lvme~l~G~~~~~~~~~~~~------------~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEEYPD------------SGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDA 164 (272)
T ss_dssp EEEECCCSEEHHHHHHHCGG------------GHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCG
T ss_pred EEEEeeCCccccccccCCHH------------HHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhh
Confidence 99999999888776543211 11245666666777777531
Q ss_pred ---------------------------CCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 631 ---------------------------VPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 631 ---------------------------~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
.+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 165 SDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0238999999999999988777899998773
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=1.2e-05 Score=87.39 Aligned_cols=85 Identities=8% Similarity=0.064 Sum_probs=55.5
Q ss_pred eeeee-ccCCcEEEEEEEEc-------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-C--CCceEEEEEEEe
Q 042346 505 LENKV-GIGSFGTVYKGKLM-------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-H--KHLVGLVGFCQE 573 (812)
Q Consensus 505 ~~~~L-G~G~fG~Vy~a~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H--~nIv~l~~~~~~ 573 (812)
..+.| +.|....+|+.... +++.+++|+.......... ....+.+|+.+++.|. + -.+.+++.++.+
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~--~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF--PTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS--SCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC--chhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 35678 88999999998764 2678899976431100000 0124567888888874 3 346678887765
Q ss_pred C---CeEEEEEEecCCCchhh
Q 042346 574 K---DERLLVYEYMSNGALHD 591 (812)
Q Consensus 574 ~---~~~~lV~ey~~~gsL~~ 591 (812)
. ...++||||+++..+.+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp STTTSSCEEEEECCCCBCCCB
T ss_pred CCccCCceEEEEecCCCChhh
Confidence 5 24689999999876653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00014 Score=78.02 Aligned_cols=146 Identities=16% Similarity=0.178 Sum_probs=79.0
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-----CCCceEEE-E--EEEeCCeE
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-----HKHLVGLV-G--FCQEKDER 577 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv~l~-~--~~~~~~~~ 577 (812)
.+.|+.|....||+....++ .+++|+.... . ..+..|.++++.|. .|.++... + +....+..
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~------~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP------E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC------H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC------H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 45676678899999987544 5899987641 1 12223444444442 34444310 0 12346678
Q ss_pred EEEEEecCCCchh--------------hhhhcCCCC---C--c-cccccccHHHHH------------------------
Q 042346 578 LLVYEYMSNGALH--------------DHLHNKNNT---E--K-NSSIVNSWKMRI------------------------ 613 (812)
Q Consensus 578 ~lV~ey~~~gsL~--------------~~l~~~~~~---~--~-~~~~~~~~~~~l------------------------ 613 (812)
+++|||+++..+. ..||..... . . .......|...+
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986542 112221110 0 0 000111232110
Q ss_pred -------HHHHHHHHHHHHHhh--------c--CCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 614 -------RIALDAARGIDYLHN--------Y--AVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 614 -------~ia~~ia~gL~yLH~--------~--~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
.+...+.+.+.+|+. . ..+.++|+|+++.|||++.++.+.|+||+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223446667763 1 22459999999999999888899999998763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=4.8e-05 Score=83.96 Aligned_cols=80 Identities=16% Similarity=0.123 Sum_probs=48.7
Q ss_pred eeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcc-hhhH-HHHHHHHHHHHHHHHhccC--CC-ceEEEEEEEeCCeEEE
Q 042346 506 ENKVGIGSFGTVYKGKLM-DGREVAVKREESCPK-TNKL-REKESAFDSELALLSRVHH--KH-LVGLVGFCQEKDERLL 579 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~-~~~~-~~~~~~~~~Ei~~l~~l~H--~n-Iv~l~~~~~~~~~~~l 579 (812)
.+.||.|.++.||+++.. +++.++||....... .... ......+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 578999999999999753 468899997643111 0000 0012345668888887742 33 3455543 3445689
Q ss_pred EEEecCCC
Q 042346 580 VYEYMSNG 587 (812)
Q Consensus 580 V~ey~~~g 587 (812)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00021 Score=75.99 Aligned_cols=146 Identities=19% Similarity=0.198 Sum_probs=94.2
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc---CCCceEEEEEEEeCCeEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH---HKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~l 579 (812)
..-.+.|+.|.+..+|+... +++.+++|+.... ....+..|.+.|+.|. ...+.+++.+....+..++
T Consensus 38 i~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~l 108 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND-EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFL 108 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEE
T ss_pred eeeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEE
Confidence 44567899999999999876 5778999986521 2346778999888884 2567888888888888999
Q ss_pred EEEecCCCchhh-----------hhhcCCC-C--Cccc-------c----ccccHHHHH---HHH--H------------
Q 042346 580 VYEYMSNGALHD-----------HLHNKNN-T--EKNS-------S----IVNSWKMRI---RIA--L------------ 617 (812)
Q Consensus 580 V~ey~~~gsL~~-----------~l~~~~~-~--~~~~-------~----~~~~~~~~l---~ia--~------------ 617 (812)
||||+++..+.. .||.... . .... . -..+|.... ++. .
T Consensus 109 vme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~ 188 (312)
T 3jr1_A 109 LLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGN 188 (312)
T ss_dssp EEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSC
T ss_pred EEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHH
Confidence 999999876521 2343321 0 0000 0 012454321 111 1
Q ss_pred --HHHHH-HHHHhh-cCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 618 --DAARG-IDYLHN-YAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 618 --~ia~g-L~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
.+..- ...|.. ...|.++|+|+.+.|+|++.++ +.|.||.
T Consensus 189 ~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 189 IDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 233432 2247799999999999999887 8888873
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=8.7e-05 Score=78.00 Aligned_cols=80 Identities=18% Similarity=0.216 Sum_probs=56.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC---CceEEEEEEEeCCeE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK---HLVGLVGFCQEKDER 577 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~~~~~~~~~~ 577 (812)
..+.-.+.+|.|....||+.++.||+.+.+|+...... .....|..|.+.|+.|.-. -+.+.+++. ..
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~ 85 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-----ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DR 85 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TT
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-----chhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cc
Confidence 45666789999999999999999999999998643211 1123467899999888421 244555542 24
Q ss_pred EEEEEecCCCch
Q 042346 578 LLVYEYMSNGAL 589 (812)
Q Consensus 578 ~lV~ey~~~gsL 589 (812)
++||||++.+..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00051 Score=73.15 Aligned_cols=163 Identities=15% Similarity=0.160 Sum_probs=87.1
Q ss_pred CCHHHHHHhcCCcce-----eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC--
Q 042346 491 FTLSELAAATNNFSL-----ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH-- 563 (812)
Q Consensus 491 ~~~~el~~~~~~~~~-----~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n-- 563 (812)
++.+++.....+|.+ .+.|+.|....+|+....++ .+++|+.... .....+..|+.+++.|....
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-------~~~~~l~~e~~~l~~L~~~g~~ 78 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-------VEKNDLPFFLGLMQHLAAKGLS 78 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-------CCHHHHHHHHHHHHHHHHCCCC
Confidence 344555555455543 45677788899999987555 6889987531 11123455777776664212
Q ss_pred ceEEEEE------EEeCCeEEEEEEecCCCchhh--------------hhhcCCCC-Cc---cccccccHHHHHH-----
Q 042346 564 LVGLVGF------CQEKDERLLVYEYMSNGALHD--------------HLHNKNNT-EK---NSSIVNSWKMRIR----- 614 (812)
Q Consensus 564 Iv~l~~~------~~~~~~~~lV~ey~~~gsL~~--------------~l~~~~~~-~~---~~~~~~~~~~~l~----- 614 (812)
+.+++.. ....+..+++|+|+++..+.. .||..... .. .......|...+.
T Consensus 79 vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~ 158 (322)
T 2ppq_A 79 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER 158 (322)
T ss_dssp CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred CCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHH
Confidence 2222211 123456789999998865321 12221110 00 0001123433111
Q ss_pred -------HHHHHHHHHHHHhhc----CCCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 615 -------IALDAARGIDYLHNY----AVPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 615 -------ia~~ia~gL~yLH~~----~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
+...+...+++|+.. ..+.++|+|+++.|||++.+..+.|+||+.+.
T Consensus 159 ~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 159 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455566532 12359999999999999987666899998663
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00059 Score=75.78 Aligned_cols=79 Identities=13% Similarity=0.080 Sum_probs=48.1
Q ss_pred CCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccC---cCCCcchhHHHHHHHHHH
Q 042346 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN---VLTAKTDIYGLGVVLLEL 708 (812)
Q Consensus 632 ~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVwS~Gvvl~el 708 (812)
+.++|+|++|.|||++.++ ++|+||+.+........- ...-..-...|++|+..... .-....++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4599999999999998876 999999988653321100 00000012345666554311 112235666888888888
Q ss_pred HcCC
Q 042346 709 LTGK 712 (812)
Q Consensus 709 ltG~ 712 (812)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0023 Score=68.39 Aligned_cols=148 Identities=12% Similarity=0.051 Sum_probs=73.2
Q ss_pred eeeeccCCcEE-EEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC--CCceEEEEEEEeCCeEEEEEE
Q 042346 506 ENKVGIGSFGT-VYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH--KHLVGLVGFCQEKDERLLVYE 582 (812)
Q Consensus 506 ~~~LG~G~fG~-Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e 582 (812)
.+.|..|.... +|+....+++.+++|...... ...+..|+++++.|.. -.+.+++.+..+.. +++||
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e 92 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIE 92 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT--------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEEC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC--------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEe
Confidence 34565565444 667655346778787653211 0223456667666642 23456666543332 78999
Q ss_pred ecCCCchhhhhhcCCC---------------------CCcc---ccc-------cccHHH--HH-----HHHHHHHHHHH
Q 042346 583 YMSNGALHDHLHNKNN---------------------TEKN---SSI-------VNSWKM--RI-----RIALDAARGID 624 (812)
Q Consensus 583 y~~~gsL~~~l~~~~~---------------------~~~~---~~~-------~~~~~~--~l-----~ia~~ia~gL~ 624 (812)
++.+..+.+++..... .... ... ...|.. .+ .....+...++
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 9987777655432211 0000 000 000100 00 00011122222
Q ss_pred HHh---hcCCCCeEeeccCCCCEEEcCC----CcEEEEeecccccC
Q 042346 625 YLH---NYAVPSIIHRDIKSSNILLDVN----WTARVSDFGLSLLG 663 (812)
Q Consensus 625 yLH---~~~~~~ivHrDlKp~NILl~~~----~~~kl~DfGla~~~ 663 (812)
.|. ....+.++|+|+.+.|||++.+ ..+.|+||+.+...
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 221 1123469999999999999875 68999999988653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0019 Score=71.76 Aligned_cols=73 Identities=18% Similarity=0.240 Sum_probs=49.0
Q ss_pred eeeeccCCcEEEEEEEEcC--------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc-eEEEEEEEeCCe
Q 042346 506 ENKVGIGSFGTVYKGKLMD--------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL-VGLVGFCQEKDE 576 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~ 576 (812)
.+.|+.|-...+|+....+ ++.+++|+.... . . ...+.+|..+++.|...++ .++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~--~----~~~li~E~~~l~~L~~~g~~P~l~~~~~--~- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E--T----ESHLVAESVIFTLLSERHLGPKLYGIFS--G- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C--C----HHHHHHHHHHHHHHHHTTSSSCEEEEET--T-
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-C--c----HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C-
Confidence 5678889999999998753 578999987421 1 0 1234468888888853344 56676553 2
Q ss_pred EEEEEEecCCCch
Q 042346 577 RLLVYEYMSNGAL 589 (812)
Q Consensus 577 ~~lV~ey~~~gsL 589 (812)
.+||||+++-+|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999986444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0033 Score=66.18 Aligned_cols=71 Identities=7% Similarity=0.086 Sum_probs=44.2
Q ss_pred eeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc-eEEEEEEEeCCeEEEEEEec
Q 042346 506 ENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL-VGLVGFCQEKDERLLVYEYM 584 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ey~ 584 (812)
.+.|..|....+|+. +.+++|+...... ......+|..+++.+....+ .+++.+ +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~------~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE------EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc------ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeec
Confidence 578999999999998 5688888653111 11122457777777643333 355544 333457899999
Q ss_pred -CCCch
Q 042346 585 -SNGAL 589 (812)
Q Consensus 585 -~~gsL 589 (812)
++.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 65444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0084 Score=67.04 Aligned_cols=74 Identities=15% Similarity=0.058 Sum_probs=47.8
Q ss_pred eeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc-eEEEEEEEeCCeEEEEEEe
Q 042346 506 ENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL-VGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ey 583 (812)
.+.|+.|-...+|+....+ ++.+++|+......... ...+|..+++.|...++ .++++.+ .+ .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII------NREREKKISCILYNKNIAKKIYVFF--TN--GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS------CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc------CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEe
Confidence 5678889999999998854 47888998643111111 11468888888865555 4677766 23 359999
Q ss_pred cCCCch
Q 042346 584 MSNGAL 589 (812)
Q Consensus 584 ~~~gsL 589 (812)
+++-+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0086 Score=63.66 Aligned_cols=76 Identities=13% Similarity=0.093 Sum_probs=47.0
Q ss_pred eeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC--ceEEEEE-----EEeCCeEEE
Q 042346 507 NKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH--LVGLVGF-----CQEKDERLL 579 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~-----~~~~~~~~l 579 (812)
+.|+ |....||+....+|+.+++|+...... ....+..|..+++.|.... +.+++.. ....+..++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~------~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC------CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 4566 888899998776777899998752111 1224555777777664222 3333332 223456688
Q ss_pred EEEecCCCch
Q 042346 580 VYEYMSNGAL 589 (812)
Q Consensus 580 V~ey~~~gsL 589 (812)
+|||+++..+
T Consensus 105 l~~~i~G~~~ 114 (328)
T 1zyl_A 105 VFPSVGGRQF 114 (328)
T ss_dssp EEECCCCEEC
T ss_pred EEEecCCCCC
Confidence 9999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.007 Score=65.91 Aligned_cols=145 Identities=17% Similarity=0.137 Sum_probs=79.3
Q ss_pred eeeeccCCcEEEEEEEEc--------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeCCe
Q 042346 506 ENKVGIGSFGTVYKGKLM--------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEKDE 576 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~ 576 (812)
.+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.|. +.-..++++++.+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~------~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI------LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc------cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---
Confidence 356777888899998764 2478999985321 111234557888888885 3323566666543
Q ss_pred EEEEEEecCCCchhhh-----------------hhcCCCCCccccccccHHHHHHHHHHHH-------------------
Q 042346 577 RLLVYEYMSNGALHDH-----------------LHNKNNTEKNSSIVNSWKMRIRIALDAA------------------- 620 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~-----------------l~~~~~~~~~~~~~~~~~~~l~ia~~ia------------------- 620 (812)
.+||||+++..|..- ||........... ..|.+..++..++.
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~-~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPH-WLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCC-HHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcc-cHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 289999988655321 1221111001010 01233333332221
Q ss_pred HHHHH----HhhcC-CCCeEeeccCCCCEEEcCC----CcEEEEeecccc
Q 042346 621 RGIDY----LHNYA-VPSIIHRDIKSSNILLDVN----WTARVSDFGLSL 661 (812)
Q Consensus 621 ~gL~y----LH~~~-~~~ivHrDlKp~NILl~~~----~~~kl~DfGla~ 661 (812)
..+.. |.... ...++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 12222 32222 1358999999999999876 789999998774
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0067 Score=65.86 Aligned_cols=74 Identities=11% Similarity=0.046 Sum_probs=43.9
Q ss_pred eeeeccCCcEEEEEEEEcC---------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC-ceEEEEEEEeCC
Q 042346 506 ENKVGIGSFGTVYKGKLMD---------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH-LVGLVGFCQEKD 575 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~ 575 (812)
.+.|+.|....+|+....+ ++.+++|+........ .....|.++++.|...+ ..++++.+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~------~~~~~E~~~l~~L~~~g~~P~~~~~~--~- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL------YNTISEFEVYKTMSKYKIAPQLLNTF--N- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT------SCHHHHHHHHHHHHHTTSSCCEEEEE--T-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce------ecHHHHHHHHHHHHhcCCCCceEEec--C-
Confidence 4678888889999998754 2688888864321110 12346777887775333 34666544 2
Q ss_pred eEEEEEEecCCCch
Q 042346 576 ERLLVYEYMSNGAL 589 (812)
Q Consensus 576 ~~~lV~ey~~~gsL 589 (812)
-++||||+++..+
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 3789999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.024 Score=60.74 Aligned_cols=31 Identities=23% Similarity=0.371 Sum_probs=27.2
Q ss_pred CCeEeeccCCCCEEEcCCCcEEEEeeccccc
Q 042346 632 PSIIHRDIKSSNILLDVNWTARVSDFGLSLL 662 (812)
Q Consensus 632 ~~ivHrDlKp~NILl~~~~~~kl~DfGla~~ 662 (812)
+.++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987644
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.81 E-value=0.099 Score=51.51 Aligned_cols=103 Identities=12% Similarity=0.043 Sum_probs=63.8
Q ss_pred CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCC
Q 042346 587 GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSEC 666 (812)
Q Consensus 587 gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~ 666 (812)
-+|.+.|...... ++-.+.+.++.|.++.|.-+-....+ ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~P-------lsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----- 97 (229)
T 2yle_A 33 LSLEEILRLYNQP-------INEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----- 97 (229)
T ss_dssp EEHHHHHHHHTSC-------CCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------
T ss_pred ccHHHHHHHcCCC-------cCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----
Confidence 4889999766543 35567788999998888665221111 1233457899999999988764 1110
Q ss_pred cccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCC
Q 042346 667 DQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKA 714 (812)
Q Consensus 667 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p 714 (812)
.....+.+||... ...+.+.=|||||++||.-+--..|
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888763 3456788999999999999975544
|
| >1p22_A F-BOX/WD-repeat protein 1A; ubiquitination, degradation, signaling protein; HET: SEP; 2.95A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 | Back alignment and structure |
|---|
Probab=94.18 E-value=7.6 Score=42.02 Aligned_cols=223 Identities=9% Similarity=0.095 Sum_probs=114.6
Q ss_pred eeEEeeCCceEEEEEeCCccceEEEccCCCc--ccC--CCCccEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCCCCc
Q 042346 34 TAAIIYKTSTVCGIIAGESIQRIQCYQNGST--IPV--LPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPK 109 (812)
Q Consensus 34 ~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~--~~~--~~~~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~~~~ 109 (812)
+.+++........-..|| .+..|-.... ... .....|.+++-.+...+.-..|| +|..|--.. |++ ..
T Consensus 136 v~~~~~d~~~l~~g~~dg---~i~iwd~~~~~~~~~~~~h~~~v~~l~~~~~~l~sg~~dg-~i~vwd~~~-~~~---~~ 207 (435)
T 1p22_A 136 VYCLQYDDQKIVSGLRDN---TIKIWDKNTLECKRILTGHTGSVLCLQYDERVIITGSSDS-TVRVWDVNT-GEM---LN 207 (435)
T ss_dssp EEEEECCSSEEEEEESSS---CEEEEESSSCCEEEEECCCSSCEEEEECCSSEEEEEETTS-CEEEEESSS-CCE---EE
T ss_pred EEEEEECCCEEEEEeCCC---eEEEEeCCCCeEEEEEcCCCCcEEEEEECCCEEEEEcCCC-eEEEEECCC-CcE---EE
Confidence 444555444444444555 6777753222 111 12336778877555555556788 899996543 221 11
Q ss_pred eecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccCCCCCCCceEEEeecCCeEEEEEccCCeEEEee
Q 042346 110 RLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWG 189 (812)
Q Consensus 110 ~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~~~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG 189 (812)
.+. .....|.+++......+.- ..||.|..|--......-. ..........+..++....+...- ..||+|..|=
T Consensus 208 ~~~-~h~~~v~~l~~~~~~l~s~-s~dg~i~vwd~~~~~~~~~--~~~~~~~~~~v~~~~~~~~~l~s~-~~dg~i~vwd 282 (435)
T 1p22_A 208 TLI-HHCEAVLHLRFNNGMMVTC-SKDRSIAVWDMASPTDITL--RRVLVGHRAAVNVVDFDDKYIVSA-SGDRTIKVWN 282 (435)
T ss_dssp EEC-CCCSCEEEEECCTTEEEEE-ETTSCEEEEECSSSSCCEE--EEEECCCSSCEEEEEEETTEEEEE-ETTSEEEEEE
T ss_pred EEc-CCCCcEEEEEEcCCEEEEe-eCCCcEEEEeCCCCCCcee--eeEecCCCCcEEEEEeCCCEEEEE-eCCCeEEEEE
Confidence 111 1233577777766555444 4899999995432111100 000011224566666655555444 6899999996
Q ss_pred cCCCCCcccccccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCCCCcceeeeeeeeccceeEEEEecCCeEEE
Q 042346 190 DSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGLVAC 269 (812)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~~~~~~~~~ia~G~~ht~al~~~~g~v~~ 269 (812)
.........-......+..++......+.-..||.|..|=-...-.+..-..... .+.+++..+.+ ++....||.|..
T Consensus 283 ~~~~~~~~~~~~~~~~v~~~~~~~~~l~~g~~dg~i~iwd~~~~~~~~~~~~h~~-~v~~~~~~~~~-l~sg~~dg~i~v 360 (435)
T 1p22_A 283 TSTCEFVRTLNGHKRGIACLQYRDRLVVSGSSDNTIRLWDIECGACLRVLEGHEE-LVRCIRFDNKR-IVSGAYDGKIKV 360 (435)
T ss_dssp TTTCCEEEEEECCSSCEEEEEEETTEEEEEETTSCEEEEETTTCCEEEEECCCSS-CEEEEECCSSE-EEEEETTSCEEE
T ss_pred CCcCcEEEEEcCCCCcEEEEEeCCCEEEEEeCCCeEEEEECCCCCEEEEEeCCcC-cEEEEEecCCE-EEEEeCCCcEEE
Confidence 4322111111112234566666666666667899999996543221111111111 11135553333 444445799999
Q ss_pred ec
Q 042346 270 WG 271 (812)
Q Consensus 270 WG 271 (812)
|=
T Consensus 361 wd 362 (435)
T 1p22_A 361 WD 362 (435)
T ss_dssp EE
T ss_pred EE
Confidence 95
|
| >1p22_A F-BOX/WD-repeat protein 1A; ubiquitination, degradation, signaling protein; HET: SEP; 2.95A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 | Back alignment and structure |
|---|
Probab=93.57 E-value=9.7 Score=41.14 Aligned_cols=226 Identities=7% Similarity=0.019 Sum_probs=117.4
Q ss_pred cEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCCCCceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCC
Q 042346 72 SFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKG 151 (812)
Q Consensus 72 ~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~~~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG 151 (812)
.|..++-.+.+.+.-..|| +|..|-... +++ ...+. .....|.+++..+ ..++.-..||+|..|-... ++.
T Consensus 135 ~v~~~~~d~~~l~~g~~dg-~i~iwd~~~-~~~---~~~~~-~h~~~v~~l~~~~-~~l~sg~~dg~i~vwd~~~-~~~- 205 (435)
T 1p22_A 135 GVYCLQYDDQKIVSGLRDN-TIKIWDKNT-LEC---KRILT-GHTGSVLCLQYDE-RVIITGSSDSTVRVWDVNT-GEM- 205 (435)
T ss_dssp CEEEEECCSSEEEEEESSS-CEEEEESSS-CCE---EEEEC-CCSSCEEEEECCS-SEEEEEETTSCEEEEESSS-CCE-
T ss_pred cEEEEEECCCEEEEEeCCC-eEEEEeCCC-CeE---EEEEc-CCCCcEEEEEECC-CEEEEEcCCCeEEEEECCC-CcE-
Confidence 5677777666666667788 799996432 211 11111 1233677888744 4445445899999995432 111
Q ss_pred CCcccCCCCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcc---cccccCceEEEEEeCCceeEEEeeCCcEEEE
Q 042346 152 QLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEI---QRGFKNLSMVGLVAGESHACGLSRNGALVCK 228 (812)
Q Consensus 152 ~~~~~~~~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~---~~~~~~~~~~~i~aG~~h~~al~~~G~v~~W 228 (812)
.. ........+..++--....+.- ..||+|..|=........ ........+..++....+.+.-..||.|..|
T Consensus 206 --~~-~~~~h~~~v~~l~~~~~~l~s~-s~dg~i~vwd~~~~~~~~~~~~~~~~~~~v~~~~~~~~~l~s~~~dg~i~vw 281 (435)
T 1p22_A 206 --LN-TLIHHCEAVLHLRFNNGMMVTC-SKDRSIAVWDMASPTDITLRRVLVGHRAAVNVVDFDDKYIVSASGDRTIKVW 281 (435)
T ss_dssp --EE-EECCCCSCEEEEECCTTEEEEE-ETTSCEEEEECSSSSCCEEEEEECCCSSCEEEEEEETTEEEEEETTSEEEEE
T ss_pred --EE-EEcCCCCcEEEEEEcCCEEEEe-eCCCcEEEEeCCCCCCceeeeEecCCCCcEEEEEeCCCEEEEEeCCCeEEEE
Confidence 00 0011224566666555554444 689999999643222211 1111233466777666677777889999999
Q ss_pred ecCCCCCCCcCCCCcceeeeeeeeccceeEEEEecCCeEEEecCCCCCccccCCccccceeEEEeccceEEEEEcCCCeE
Q 042346 229 GSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFESIVAGLDFVCGLTTRNLSM 308 (812)
Q Consensus 229 G~n~~gqlg~~~~~~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~~~~~~~~~i~ag~~~~c~~~~~~~~v 308 (812)
=-...-.+..-....... ..++....+ ++....||.|..|=....-.+..-......+..+...+.+ .+....|+.|
T Consensus 282 d~~~~~~~~~~~~~~~~v-~~~~~~~~~-l~~g~~dg~i~iwd~~~~~~~~~~~~h~~~v~~~~~~~~~-l~sg~~dg~i 358 (435)
T 1p22_A 282 NTSTCEFVRTLNGHKRGI-ACLQYRDRL-VVSGSSDNTIRLWDIECGACLRVLEGHEELVRCIRFDNKR-IVSGAYDGKI 358 (435)
T ss_dssp ETTTCCEEEEEECCSSCE-EEEEEETTE-EEEEETTSCEEEEETTTCCEEEEECCCSSCEEEEECCSSE-EEEEETTSCE
T ss_pred ECCcCcEEEEEcCCCCcE-EEEEeCCCE-EEEEeCCCeEEEEECCCCCEEEEEeCCcCcEEEEEecCCE-EEEEeCCCcE
Confidence 644322111111100011 124443333 3333346999999755322221101111234455443333 3444467899
Q ss_pred EEecC
Q 042346 309 ICWGP 313 (812)
Q Consensus 309 ~cWG~ 313 (812)
..|=-
T Consensus 359 ~vwd~ 363 (435)
T 1p22_A 359 KVWDL 363 (435)
T ss_dssp EEEEH
T ss_pred EEEEC
Confidence 99953
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.51 E-value=0.26 Score=54.28 Aligned_cols=74 Identities=7% Similarity=0.047 Sum_probs=47.6
Q ss_pred eeeeccCCcEEEEEEEEcC--------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCC-ceEEEEEEEeCCe
Q 042346 506 ENKVGIGSFGTVYKGKLMD--------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKH-LVGLVGFCQEKDE 576 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~~ 576 (812)
.+.|..|-...+|+....+ ++.+++|+....... .....+|.++++.|.-.+ ..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~------~idR~~E~~~l~~L~~~gi~P~l~~~~--~-- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK------FYDSKVELDVFRYLSNINIAPNIIADF--P-- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C------CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch------hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--
Confidence 5678788899999998753 578999986432111 112246777877774323 34555533 2
Q ss_pred EEEEEEecCCCch
Q 042346 577 RLLVYEYMSNGAL 589 (812)
Q Consensus 577 ~~lV~ey~~~gsL 589 (812)
-++||||+++..|
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2789999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.74 E-value=0.25 Score=54.05 Aligned_cols=29 Identities=31% Similarity=0.376 Sum_probs=24.4
Q ss_pred eEeeccCCCCEEE------cCCCcEEEEeeccccc
Q 042346 634 IIHRDIKSSNILL------DVNWTARVSDFGLSLL 662 (812)
Q Consensus 634 ivHrDlKp~NILl------~~~~~~kl~DfGla~~ 662 (812)
++|+|+.+.|||+ +++..++++||-++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988743
|
| >4gbf_A Phikz131; 7-bladed beta-propeller, possibly participates in binding of phage to the HOST cell, viral protein; 1.95A {Pseudomonas phage phikz} | Back alignment and structure |
|---|
Probab=92.30 E-value=0.13 Score=50.81 Aligned_cols=70 Identities=26% Similarity=0.356 Sum_probs=56.9
Q ss_pred eEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCCCCcceeeeeeeeccceeEEEEecCCeEEEecCCCCCc
Q 042346 205 SMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFE 277 (812)
Q Consensus 205 ~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~~~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gq 277 (812)
.+.+|+.-..|+..+-.|+.++.+|+|+.||+.+|....... ++.+|.++|.-+-. -..|.-||..-.-.
T Consensus 310 ~i~~VsG~y~H~vvi~gd~el~sFG~~sNGQ~~ip~tagPfl--a~~AG~~fTVTVn~-~nyv~FWGDSPDNS 379 (400)
T 4gbf_A 310 PIGGVSGLYTHYTVMYGDGQIAFFGNNDNGQCDVDDHAGPYI--QLAAGHNFTVTVNT-LNQVMFWGDSPDNS 379 (400)
T ss_dssp CCCCCBCSSSEEEC-CTTTCCCEEECCTTSTTCCCGGGCCEE--EEEECSSEEEEEET-TCCEEEEECCTTST
T ss_pred ccccccccccceEEEecCceeEEeccCCCCceecCCCcchHH--hHhccCCeEEEEec-eeeEEEecCCCCcc
Confidence 356788888999999999999999999999999886554433 49999999999986 48999999754333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.20 E-value=1.1 Score=44.10 Aligned_cols=116 Identities=10% Similarity=0.105 Sum_probs=78.7
Q ss_pred cCCCceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeecc
Q 042346 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDI 639 (812)
Q Consensus 560 ~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl 639 (812)
.||+++.. .+-++++...+.|+.-+.+.=+..++.. +...+++++.+|+.-..+++.. +|--|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~~-----------~~~eKlr~l~ni~~l~~~~~~r-----~tf~L 105 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKSF-----------TKNEKLRYLLNIKNLEEVNRTR-----YTFVL 105 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGGS-----------CHHHHHHHHHHGGGGGGGGGSS-----EECCC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHhc-----------CHHHHHHHHHHHHHHHHHhcCc-----eEEEE
Confidence 68989877 4666667666667665433333334322 4567889999999988766653 78889
Q ss_pred CCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCC
Q 042346 640 KSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVF 716 (812)
Q Consensus 640 Kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~ 716 (812)
.|+||+++.++.+++.-.|+-..+ +|.- ++...=.-.+=+++..+++++..|.
T Consensus 106 ~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 106 APDELFFTRDGLPIAKTRGLQNVV-------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp SGGGEEECTTSCEEESCCEETTTB-------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ecceEEEcCCCCEEEEEccCccCC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999999888764322 2221 1111223356788999999998873
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.89 E-value=0.27 Score=35.00 Aligned_cols=28 Identities=14% Similarity=0.137 Sum_probs=14.2
Q ss_pred eeehHHHHHHHHHHHHHHHHhhheeecc
Q 042346 402 SVVVGSAGCFAGICTVGYCFWAGFLHKR 429 (812)
Q Consensus 402 ~ii~~~v~~~~~~~~~~~~~~~~~~~~~ 429 (812)
.|++++++.+++++++++++|++.++|+
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 3556666655555555444444444333
|
| >4gbf_A Phikz131; 7-bladed beta-propeller, possibly participates in binding of phage to the HOST cell, viral protein; 1.95A {Pseudomonas phage phikz} | Back alignment and structure |
|---|
Probab=88.08 E-value=1.3 Score=43.79 Aligned_cols=63 Identities=21% Similarity=0.374 Sum_probs=51.6
Q ss_pred eeeeccceeEEEEecCCeEEEecCCCCCccccCCccccceeEEEeccceEEEEEcCCCeEEEecCC
Q 042346 249 GLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSFESIVAGLDFVCGLTTRNLSMICWGPG 314 (812)
Q Consensus 249 ~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~~~~~~~~~i~ag~~~~c~~~~~~~~v~cWG~~ 314 (812)
+|+.-..|+..+.. |++++.+|+|++||+-.+. ..-.|.++.||.++|.-+..-+ .|.-||+.
T Consensus 313 ~VsG~y~H~vvi~g-d~el~sFG~~sNGQ~~ip~-tagPfla~~AG~~fTVTVn~~n-yv~FWGDS 375 (400)
T 4gbf_A 313 GVSGLYTHYTVMYG-DGQIAFFGNNDNGQCDVDD-HAGPYIQLAAGHNFTVTVNTLN-QVMFWGDS 375 (400)
T ss_dssp CCBCSSSEEEC-CT-TTCCCEEECCTTSTTCCCG-GGCCEEEEEECSSEEEEEETTC-CEEEEECC
T ss_pred cccccccceEEEec-CceeEEeccCCCCceecCC-CcchHHhHhccCCeEEEEecee-eEEEecCC
Confidence 58888999999886 5999999999999997532 2336889999999999997645 99999975
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.66 E-value=0.33 Score=34.41 Aligned_cols=28 Identities=21% Similarity=0.222 Sum_probs=14.0
Q ss_pred eeehHHHHHHHHHHHHHHHHhhheeecc
Q 042346 402 SVVVGSAGCFAGICTVGYCFWAGFLHKR 429 (812)
Q Consensus 402 ~ii~~~v~~~~~~~~~~~~~~~~~~~~~ 429 (812)
.|+.++++.+++++++++++|++.++|+
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 3555666655555555444444444333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.19 E-value=1.9 Score=42.45 Aligned_cols=113 Identities=12% Similarity=0.131 Sum_probs=77.5
Q ss_pred cCCCceEEEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHH-HHhhcCCCCeEeec
Q 042346 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGID-YLHNYAVPSIIHRD 638 (812)
Q Consensus 560 ~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~-yLH~~~~~~ivHrD 638 (812)
.||++ -...-.+++...+.++.-+++.=+..++.. +...+++++.+|+.-.. +++. -+|--
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~~-----------~~~eKlrll~nl~~L~~~~~~~-----r~tf~ 109 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRKT-----------TLLSRIRAAIHLVSKVKHHSAR-----RLIFI 109 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHTS-----------CHHHHHHHHHHHHHHHSSCCSS-----SEECC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHhc-----------CHHHHHHHHHHHHHHHHHhhhC-----ceeEE
Confidence 68888 344447777777878776555444455332 45677889999888777 6655 37888
Q ss_pred cCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhH-HHHHHHHHHHcCCCCC
Q 042346 639 IKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIY-GLGVVLLELLTGKKAV 715 (812)
Q Consensus 639 lKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVw-S~Gvvl~elltG~~p~ 715 (812)
|.|+||++|.++.++|.-.|+-.. ++|.-+ + ..|.+ .+=+++..++.++..|
T Consensus 110 l~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 110 VCPENLMFNRALEPFFLHVGVKES-------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CCGGGEEECTTCCEEESCCEETTT-------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred EeCceEEEeCCCcEEEEEcCCccc-------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999999999988876422 233321 1 12333 4667888899888776
|
| >2ovr_B FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 domains, double phosphorylation, transcription-C complex; HET: TPO; 2.50A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 PDB: 2ovp_B* 2ovq_B* | Back alignment and structure |
|---|
Probab=85.70 E-value=42 Score=35.99 Aligned_cols=226 Identities=8% Similarity=0.036 Sum_probs=113.6
Q ss_pred cEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCCCCceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCC
Q 042346 72 SFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKG 151 (812)
Q Consensus 72 ~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~~~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG 151 (812)
.+.+++.-....+.-..|| +|..|--.. |+ ....+. .....|..++..+...++- ..||+|..|--.....+.
T Consensus 161 ~v~~~~~~~~~l~s~~~dg-~i~vwd~~~-~~---~~~~~~-~h~~~v~~~~~~~~~l~s~-s~dg~i~~wd~~~~~~~~ 233 (445)
T 2ovr_B 161 GVWSSQMRDNIIISGSTDR-TLKVWNAET-GE---CIHTLY-GHTSTVRCMHLHEKRVVSG-SRDATLRVWDIETGQCLH 233 (445)
T ss_dssp CEEEEEEETTEEEEEETTS-CEEEEETTT-TE---EEEEEC-CCSSCEEEEEEETTEEEEE-ETTSEEEEEESSSCCEEE
T ss_pred CEEEEEecCCEEEEEeCCC-eEEEEECCc-Cc---EEEEEC-CCCCcEEEEEecCCEEEEE-eCCCEEEEEECCCCcEEE
Confidence 5666665555555556788 899996533 11 111111 1223566676655554444 489999999543211110
Q ss_pred CCcccCCCCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccccccCceEEEEEeCCceeEEEeeCCcEEEEecC
Q 042346 152 QLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSN 231 (812)
Q Consensus 152 ~~~~~~~~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~~~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n 231 (812)
........+..++-.....+.- ..||.|..|=.........-......+.+++..+.+.+.-..||.|..|=-.
T Consensus 234 -----~~~~~~~~v~~~~~~~~~l~~~-~~dg~i~iwd~~~~~~~~~~~~~~~~v~~~~~~~~~l~~~~~d~~i~i~d~~ 307 (445)
T 2ovr_B 234 -----VLMGHVAAVRCVQYDGRRVVSG-AYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVWDVE 307 (445)
T ss_dssp -----EEECCSSCEEEEEECSSCEEEE-ETTSCEEEEEGGGTEEEEEECCCSSCEEEEEECSSEEEEEETTSCEEEEETT
T ss_pred -----EEcCCcccEEEEEECCCEEEEE-cCCCEEEEEECCCCcEeEEecCCCCceEEEEECCCEEEEEeCCCeEEEEECC
Confidence 0011223455665544444443 6899999996432111111111223466677666676666789999999654
Q ss_pred CCCCCCcCCCCcceeeeeeeeccceeEEEEecCCeEEEecCCCCCcccc---CCccccceeEEEeccceEEEEEcCCCeE
Q 042346 232 DSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDS---DVIQDVSFESIVAGLDFVCGLTTRNLSM 308 (812)
Q Consensus 232 ~~gqlg~~~~~~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~---~~~~~~~~~~i~ag~~~~c~~~~~~~~v 308 (812)
....+..-....... .+++....+- +....||.|..|=....-.+.. .......+..++-.+.+ .+....|+.|
T Consensus 308 ~~~~~~~~~~~~~~v-~~~~~~~~~l-~~~~~dg~i~vwd~~~~~~~~~~~~~~~~~~~v~~~~~~~~~-l~s~~~dg~v 384 (445)
T 2ovr_B 308 TGNCIHTLTGHQSLT-SGMELKDNIL-VSGNADSTVKIWDIKTGQCLQTLQGPNKHQSAVTCLQFNKNF-VITSSDDGTV 384 (445)
T ss_dssp TCCEEEEECCCCSCE-EEEEEETTEE-EEEETTSCEEEEETTTCCEEEEECSTTSCSSCEEEEEECSSE-EEEEETTSEE
T ss_pred CCCEEEEEcCCcccE-EEEEEeCCEE-EEEeCCCeEEEEECCCCcEEEEEccCCCCCCCEEEEEECCCE-EEEEeCCCeE
Confidence 322211101111111 1244433333 3333469999996543222211 00112234455544444 3333468899
Q ss_pred EEecC
Q 042346 309 ICWGP 313 (812)
Q Consensus 309 ~cWG~ 313 (812)
..|--
T Consensus 385 ~iwd~ 389 (445)
T 2ovr_B 385 KLWDL 389 (445)
T ss_dssp EEEET
T ss_pred EEEEC
Confidence 99964
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 812 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-21 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 1e-06 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 5e-04 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 1e-04 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 0.002 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-65
Identities = 78/294 (26%), Positives = 138/294 (46%), Gaps = 37/294 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
++ ++G GSFGTVYKGK +VAVK T ++ AF +E+ +L +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H +++ +G+ + +V ++ +L+ HLH I IA A
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK-------FEMIKLIDIARQTA 114
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
+G+DYLH SIIHRD+KS+NI L + T ++ DFGL+ + S + G++
Sbjct: 115 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 681 YIDPEYYVM---NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737
++ PE M N + ++D+Y G+VL EL+TG+ + N +
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINN---------------R 215
Query: 738 GQLHCVLDKRVGPPELNE--AEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
Q+ ++ + P+L++ + + + C+ + ERP I+A++E
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 6e-61
Identities = 78/305 (25%), Positives = 129/305 (42%), Gaps = 37/305 (12%)
Query: 505 LENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL 564
L+ +G G FG V++GK G EVAVK S + + RE E + + H+++
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAE------IYQTVMLRHENI 59
Query: 565 VGLVGFCQEKD----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
+G + + + + LV +Y +G+L D+L+ T + I++AL A
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT---------VEGMIKLALSTA 110
Query: 621 RGIDYLHNYAV-----PSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ--EFIST 673
G+ +LH V P+I HRD+KS NIL+ N T ++D GL++ +
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 674 KAVGTVGYIDPEYYVMNV------LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGP--- 724
VGT Y+ PE ++ + DIY +G+V E+ +ED P
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 725 LDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784
L + +V ++ L + P EA+ ++A C G R I
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNI-PNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 785 ANLER 789
L +
Sbjct: 290 KTLSQ 294
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-59
Identities = 62/288 (21%), Positives = 120/288 (41%), Gaps = 35/288 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
L ++G G FG V+ G +VAVK + AF +E L+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVK------SLKQGSMSPDAFLAEANLMKQLQ 66
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H+ LV L ++ ++ EYM NG+L D L + + + + +A A
Sbjct: 67 HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK------LTINKLLDMAAQIA 119
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
G+ ++ + IHRD++++NIL+ + +++DFGL+ L + ++ A +
Sbjct: 120 EGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIK 175
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740
+ PE T K+D++ G++L E++T + + + +E
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---------- 225
Query: 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
R+ P+ E +L+ C ++RP + + LE
Sbjct: 226 ----GYRMVRPDNCPEELYQLMR----LCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-59
Identities = 71/289 (24%), Positives = 129/289 (44%), Gaps = 35/289 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ + ++G G FG V+ G ++ +VA+K + E F E ++ ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT------IREGAMSEEDFIEEAEVMMKLS 58
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H LV L G C E+ LV+E+M +G L D+L + + + + + + LD
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-------LFAAETLLGMCLDVC 111
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
G+ YL +IHRD+ + N L+ N +VSDFG++ + DQ ST V
Sbjct: 112 EGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVK 167
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740
+ PE + + ++K+D++ GV++ E+ + K ++N +VVE I G
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVE----DISTG-- 218
Query: 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
R+ P L +++ HC ++RP + ++ L
Sbjct: 219 -----FRLYKPRLASTHVYQIMN----HCWKERPEDRPAFSRLLRQLAE 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 8e-59
Identities = 74/328 (22%), Positives = 127/328 (38%), Gaps = 50/328 (15%)
Query: 490 NFTLSELAAATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLR 543
N L L NN +G G+FG V++ + VAVK K
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM----LKEEASA 57
Query: 544 EKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNS 603
+ ++ F E AL++ + ++V L+G C L++EYM+ G L++ L + + S
Sbjct: 58 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 117
Query: 604 SIVN----------------SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD 647
+ S ++ IA A G+ YL +HRD+ + N L+
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVG 174
Query: 648 VNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLE 707
N +++DFGLS D + ++ PE N T ++D++ GVVL E
Sbjct: 175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234
Query: 708 LLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAI 767
+ + + G +V+ + G + PE E L+
Sbjct: 235 IFSYGLQPY---YGMAHEEVIY----YVRDG-------NILACPENCPLELYNLMR---- 276
Query: 768 HCVNLEGKERPNITDIVANLERALAICQ 795
C + +RP+ I L+R +C+
Sbjct: 277 LCWSKLPADRPSFCSIHRILQR---MCE 301
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (505), Expect = 3e-58
Identities = 69/319 (21%), Positives = 131/319 (41%), Gaps = 48/319 (15%)
Query: 489 DNFTLSELAAATNNFS---------LENKVGIGSFGTVYKGKLM----DGREVAVKREES 535
D FT + A F+ +E +G G FG V G L VA+K
Sbjct: 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT--- 61
Query: 536 CPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHN 595
K+ ++ F SE +++ + H +++ L G + +++ E+M NG+L L
Sbjct: 62 -LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 596 KNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655
+ + + + A G+ YL + + +HRD+ + NIL++ N +VS
Sbjct: 121 NDGQ-------FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVS 170
Query: 656 DFGLSLLGSECDQEFISTKAVG---TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
DFGLS + + T A+G + + PE T+ +D++ G+V+ E+++
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230
Query: 713 KAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNL 772
+ + + ++ +E D R+ PP + +L+ C
Sbjct: 231 ERPYWDMTNQDVINAIE--------------QDYRLPPPMDCPSALHQLML----DCWQK 272
Query: 773 EGKERPNITDIVANLERAL 791
+ RP IV L++ +
Sbjct: 273 DRNHRPKFGQIVNTLDKMI 291
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-58
Identities = 64/288 (22%), Positives = 122/288 (42%), Gaps = 35/288 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ + ++G G FG V GK +VA+K + E F E ++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM------IKEGSMSEDEFIEEAKVMMNLS 57
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H+ LV L G C ++ ++ EYM+NG L ++L + + + + D
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-------FQTQQLLEMCKDVC 110
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
++YL + +HRD+ + N L++ +VSDFGLS + D+ S + V
Sbjct: 111 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVR 166
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740
+ PE + + ++K+DI+ GV++ E+ + K + + + E I G
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY---ERFTNSETAE----HIAQG-- 217
Query: 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
R+ P L + ++ C + + ERP +++N+
Sbjct: 218 -----LRLYRPHLASEKVYTIMY----SCWHEKADERPTFKILLSNIL 256
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-57
Identities = 76/303 (25%), Positives = 133/303 (43%), Gaps = 40/303 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDG---REVAVKREESCPKTNKLREKESAFDSELALLS 557
N+ ++ +G G+FG V K ++ + A+KR K ++ F EL +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR----MKEYASKDDHRDFAGELEVLC 65
Query: 558 RV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN--------S 608
++ HH +++ L+G C+ + L EY +G L D L E + + S
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 609 WKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQ 668
+ + A D ARG+DYL IHRD+ + NIL+ N+ A+++DFGLS +
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS---RGQEV 179
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728
T V ++ E +V T +D++ GV+L E+++ + G ++
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY---CGMTCAELY 236
Query: 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
E ++ G R+ P + E +L+ C + ERP+ I+ +L
Sbjct: 237 E----KLPQG-------YRLEKPLNCDDEVYDLMR----QCWREKPYERPSFAQILVSLN 281
Query: 789 RAL 791
R L
Sbjct: 282 RML 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLS 557
++F +++G G+ G V+K G +A K + EL +L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL----IHLEIKPAIRNQIIRELQVLH 59
Query: 558 RVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
+ ++VG G E + E+M G+L L ++ ++++
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--------PEQILGKVSI 111
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVG 677
+G+ YL I+HRD+K SNIL++ ++ DFG+S + ++ VG
Sbjct: 112 AVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVG 165
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
T Y+ PE + ++DI+ +G+ L+E+ G+
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 7e-56
Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 35/288 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ LE K+G G FG V+ G VA+K AF E ++ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK------TLKPGTMSPEAFLQEAQVMKKLR 70
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H+ LV L ++ +V EYMS G+L D L + + +A A
Sbjct: 71 HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK------YLRLPQLVDMAAQIA 123
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
G+ Y+ + +HRD++++NIL+ N +V+DFGL+ L + ++ A +
Sbjct: 124 SGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIK 179
Query: 681 YIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQL 740
+ PE + T K+D++ G++L EL T + + G +V++ Q+ G
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---PGMVNREVLD----QVERGY- 231
Query: 741 HCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
+ PPE E +L+ C E +ERP + A LE
Sbjct: 232 -----RMPCPPECPE-SLHDLMC----QCWRKEPEERPTFEYLQAFLE 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (485), Expect = 1e-55
Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 38/302 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+ ++++K+G G +G VY+G VAVK + + F E A++ +
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT------LKEDTMEVEEFLKEAAVMKEI 70
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H +LV L+G C + ++ E+M+ G L D+L N E S + + +A
Sbjct: 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV------SAVVLLYMATQI 124
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
+ ++YL + IHRD+ + N L+ N +V+DFGLS L + D A +
Sbjct: 125 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPI 180
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739
+ PE N + K+D++ GV+L E+ T + + D S +++E
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------- 230
Query: 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDCSC 799
D R+ PE + EL+ C +RP+ +I E + Q+ S
Sbjct: 231 ----KDYRMERPEGCPEKVYELMR----ACWQWNPSDRPSFAEIHQAFET---MFQESSI 279
Query: 800 TD 801
+D
Sbjct: 280 SD 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-55
Identities = 67/290 (23%), Positives = 125/290 (43%), Gaps = 41/290 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
L +G G FG V G G +VAVK K AF +E ++++++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC-------IKNDATAQAFLAEASVMTQLR 58
Query: 561 HKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H +LV L+G E+ L +V EYM+ G+L D+L ++ + V ++ +LD
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS------VLGGDCLLKFSLDV 112
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
++YL + +HRD+ + N+L+ + A+VSDFGL+ S V
Sbjct: 113 CEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPV 164
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739
+ PE + K+D++ G++L E+ + + + ++ V ++ G
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKG- 216
Query: 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
++ P+ E++ +C +L+ RP+ + LE
Sbjct: 217 ------YKMDAPDGCPPAVYEVMK----NCWHLDAAMRPSFLQLREQLEH 256
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-55
Identities = 66/293 (22%), Positives = 120/293 (40%), Gaps = 38/293 (12%)
Query: 501 NNFSLENKV-GIGSFGTVYKGKLMD---GREVAVKREESCPKTNKLREKESAFDSELALL 556
+LE+K G G+FGTV KG + VAVK + +E ++
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI---LKNEANDPALKDELLAEANVM 62
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
++ + ++V ++G C E + +LV E G L+ +L + K I +
Sbjct: 63 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV--------KDKNIIELV 113
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKA 675
+ G+ YL + +HRD+ + N+LL A++SDFGLS L ++ + T
Sbjct: 114 HQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 676 VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735
V + PE ++K+D++ GV++ E + + ++ GS ++E
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE------ 224
Query: 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
+R+G P E +L+ C + + RP + L
Sbjct: 225 --------KGERMGCPAGCPREMYDLMN----LCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 59/310 (19%), Positives = 120/310 (38%), Gaps = 46/310 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELA 554
N +G G+FG V +VAVK K + A SEL
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM----LKEKADSSEREALMSELK 92
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN------ 607
+++++ H+++V L+G C L++EY G L ++L +K I
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 608 ---------SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658
+++ + A A+G+++L S +HRD+ + N+L+ ++ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKN 718
L+ + A V ++ PE + T K+D++ G++L E+ + +
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 719 EDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP 778
V+ +++ ++ P E ++ C + ++RP
Sbjct: 270 IP-------VDANFYKLIQN------GFKMDQPFYATEEIYIIMQ----SCWAFDSRKRP 312
Query: 779 NITDIVANLE 788
+ ++ + L
Sbjct: 313 SFPNLTSFLG 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-55
Identities = 68/309 (22%), Positives = 126/309 (40%), Gaps = 41/309 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELA 554
N S +G G+FG V + VAVK K + + A SEL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM----LKPSAHLTEREALMSELK 78
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTE----------KNS 603
+LS + +H ++V L+G C L++ EY G L + L K ++ ++
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 604 SIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
+ + + + A+G+ +L + + IHRD+ + NILL ++ DFGL+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723
+ A V ++ PE V T ++D++ G+ L EL + + +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--- 252
Query: 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
V+ +++ R+ PE AE +++ C + + +RP I
Sbjct: 253 ----VDSKFYKMIKEGF------RMLSPEHAPAEMYDIMK----TCWDADPLKRPTFKQI 298
Query: 784 VANLERALA 792
V +E+ ++
Sbjct: 299 VQLIEKQIS 307
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 4e-55
Identities = 63/299 (21%), Positives = 121/299 (40%), Gaps = 38/299 (12%)
Query: 495 ELAAATNNFSLEN-KVGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFD 550
+L +N + + ++G G+FG+V +G +VA+K K +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV----LKQGTEKADTEEMM 57
Query: 551 SELALLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWK 610
E ++ ++ + ++V L+G CQ + +LV E G LH L K
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEI-------PVS 109
Query: 611 MRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQE 669
+ + G+ YL + +HRD+ + N+LL A++SDFGLS LG++
Sbjct: 110 NVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166
Query: 670 FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
+ + + PE ++++D++ GV + E L+ + +K +V+
Sbjct: 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMA 223
Query: 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
I G KR+ P E L++ C + ++RP+ + +
Sbjct: 224 ----FIEQG-------KRMECPPECPPELYALMS----DCWIYKWEDRPDFLTVEQRMR 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-52
Identities = 68/298 (22%), Positives = 127/298 (42%), Gaps = 41/298 (13%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLS 557
+F +G G FG VY G L+D AVK ++ + F +E ++
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ----FLTEGIIMK 83
Query: 558 RVHHKHLVGLVGFCQEKDER-LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
H +++ L+G C + L+V YM +G L + + N+ + + K I
Sbjct: 84 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFG 136
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQEFISTK 674
L A+G + A +HRD+ + N +LD +T +V+DFGL+ + E D T
Sbjct: 137 LQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 193
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734
A V ++ E T K+D++ GV+L EL+T + + + D+ + +
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQ- 249
Query: 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792
+R+ PE E++ C + + + RP+ +++V+ + +
Sbjct: 250 ----------GRRLLQPEYCPDPLYEVML----KCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 63/285 (22%), Positives = 105/285 (36%), Gaps = 34/285 (11%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
++ L +G G++G V + VAVK + + E+ + +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI----VDMKRAVDCPENIKKEICINKML 60
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
+H+++V G +E + + L EY S G L D + R
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM--------PEPDAQRFFHQL 112
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
G+ YLH I HRDIK N+LLD ++SDFGL+ + ++E + K GT+
Sbjct: 113 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 680 GYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
Y+ PE D++ G+VL +L G+ + D S
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-------SCQEYSDWKEK 222
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
+ + K++ + LL + R I DI
Sbjct: 223 KTYLNPWKKIDS------APLALLH----KILVENPSARITIPDI 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 1e-51
Identities = 65/297 (21%), Positives = 122/297 (41%), Gaps = 38/297 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDG-----REVAVKREESCPKTNKLREKESAFDSELAL 555
+ + + +G G FG VYKG L VA+K K ++ F E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT----LKAGYTEKQRVDFLGEAGI 62
Query: 556 LSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI 615
+ + H +++ L G + +++ EYM NGAL L K+ S + +
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-------FSVLQLVGM 115
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTK 674
A G+ YL N + +HRD+ + NIL++ N +VSDFGLS +L + + + ++
Sbjct: 116 LRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734
+ + PE T+ +D++ G+V+ E++T + +
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------------ 220
Query: 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791
++ ++ P + + + C E RP DIV+ L++ +
Sbjct: 221 ----EVMKAINDGFRLP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 3e-51
Identities = 53/288 (18%), Positives = 120/288 (41%), Gaps = 30/288 (10%)
Query: 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
F +G G+FGTVYKG + +G +V + + + E +++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
H+ L+G C +L + + M G L D++ + + + + A+
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN-------IGSQYLLNWCVQIAK 122
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
G++YL + ++HRD+ + N+L+ +++DFGL+ L ++E+ + + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 682 IDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741
+ E + + T ++D++ GV + EL+T + S ++E
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------------ 227
Query: 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789
+R+ P + + ++ C ++ RP +++ +
Sbjct: 228 --KGERLPQPPICTIDVYMIMV----KCWMIDADSRPKFRELIIEFSK 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (456), Expect = 3e-51
Identities = 61/286 (21%), Positives = 107/286 (37%), Gaps = 41/286 (14%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
FS ++G GSFG VY + + + VA+K+ K + EK E+ L ++ H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRH 74
Query: 562 KHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAAR 621
+ + G + LV EY A +K + A +
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL--------QEVEIAAVTHGALQ 126
Query: 622 GIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGY 681
G+ YLH+ ++IHRD+K+ NILL ++ DFG + + + + VGT +
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYW 177
Query: 682 IDPEYYV---MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
+ PE + K D++ LG+ +EL K +F S A+ I
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQN 229
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784
+ + + C+ ++RP ++
Sbjct: 230 ESPALQSGHWSE------YFRNFVD----SCLQKIPQDRPTSEVLL 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 64/299 (21%), Positives = 127/299 (42%), Gaps = 33/299 (11%)
Query: 501 NNFSLENKVGIGSFGTVYKGKL------MDGREVAVKREESCPKTNKLREKESAFDSELA 554
++ ++G GSFG VY+G VA+K + F +E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT----VNEAASMRERIEFLNEAS 75
Query: 555 LLSRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVN--SWKMR 612
++ + H+V L+G + L++ E M+ G L +L + N+ ++ S
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIS 672
I++A + A G+ YL+ +HRD+ + N ++ ++T ++ DFG++ E D
Sbjct: 136 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732
K + V ++ PE V T +D++ GVVL E+ T + ++ E +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVL 245
Query: 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791
++ G + P+ EL+ C K RP+ +I+++++ +
Sbjct: 246 RFVMEG-------GLLDKPDNCPDMLFELMR----MCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 4e-51
Identities = 57/288 (19%), Positives = 112/288 (38%), Gaps = 33/288 (11%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
++ + +G GS+G K + DG+ + K + ++ SE+ LL +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 561 HKHLVGLVGFCQEKDERLL--VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H ++V ++ L V EY G L + + + +R+
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD----EEFVLRVMTQ 117
Query: 619 AARGIDYLH--NYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
+ H + +++HRD+K +N+ LD ++ DFGL+ + + + V
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFV 175
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736
GT Y+ PE K+DI+ LG +L EL ++ +I
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF----TAFSQKELAG----KIR 227
Query: 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784
G+ + P ++ E E++ +NL+ RP++ +I+
Sbjct: 228 EGKFRRI------PYRYSD-ELNEIIT----RMLNLKDYHRPSVEEIL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 5e-51
Identities = 64/288 (22%), Positives = 111/288 (38%), Gaps = 40/288 (13%)
Query: 503 FSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ ++G GSF TVYKG + EVA + + F E +L + H
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCE---LQDRKLTKSERQRFKEEAEMLKGLQH 67
Query: 562 KHLVGLVGFCQE----KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIAL 617
++V + K +LV E M++G L +L K+
Sbjct: 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM--------KIKVLRSWCR 119
Query: 618 DAARGIDYLHNYAVPSIIHRDIKSSNILL-DVNWTARVSDFGLSLLGSECDQEFISTKAV 676
+G+ +LH P IIHRD+K NI + + ++ D GL+ L + + +
Sbjct: 120 QILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVI 174
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736
GT ++ PE Y D+Y G+ +LE+ T + + ++ ++
Sbjct: 175 GTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVT 226
Query: 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784
+G DK P E E++ C+ ER +I D++
Sbjct: 227 SGVKPASFDKVAIP------EVKEIIE----GCIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 8e-51
Identities = 56/285 (19%), Positives = 105/285 (36%), Gaps = 38/285 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+F + +G G FG VY + +A+K E + E+ + S +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSHL 63
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H +++ L G+ + L+ EY G ++ L + + +
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF--------DEQRTATYITEL 115
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
A + Y H+ +IHRDIK N+LL +++DFG S+ + + GT+
Sbjct: 116 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTL 168
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739
Y+ PE + K D++ LGV+ E L GK F+
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANT---------------YQET 212
Query: 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIV 784
+ P+ A +L++ + +RP + +++
Sbjct: 213 YKRISRVEFTFPDFVTEGARDLIS----RLLKHNPSQRPMLREVL 253
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-50
Identities = 70/310 (22%), Positives = 128/310 (41%), Gaps = 42/310 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGKL--------MDGREVAVKREESCPKTNKLREKESAFDSE 552
+ L +G G+FG V + +VAVK K++ + S SE
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISE 68
Query: 553 LALLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKN--------NTEKNS 603
+ ++ + HK+++ L+G C + ++ EY S G L ++L + N N
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 604 SIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663
S K + A ARG++YL + IHRD+ + N+L+ + +++DFGL+
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 664 SECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723
D +T V ++ PE + T ++D++ GV+L E+ T + +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 242
Query: 724 PLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
VE + G R+ P E ++ C + +RP +
Sbjct: 243 ----VEELFKLLKEG-------HRMDKPSNCTNELYMMMR----DCWHAVPSQRPTFKQL 287
Query: 784 VANLERALAI 793
V +L+R +A+
Sbjct: 288 VEDLDRIVAL 297
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 51/290 (17%), Positives = 108/290 (37%), Gaps = 40/290 (13%)
Query: 500 TNNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ + + ++G G+FG VYK + + A K + K E+ + E+ +L+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILAS 65
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
H ++V L+ ++ ++ E+ + GA+ + + +
Sbjct: 66 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-------LTESQIQVVCKQ 118
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
++YLH+ IIHRD+K+ NIL ++ +++DFG+S + Q +GT
Sbjct: 119 TLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGT 173
Query: 679 VGYIDPEYYVMNVL-----TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733
++ PE + K D++ LG+ L+E+ + +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELN-----------PM 221
Query: 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
++L P + + L C+ R + +
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSS-NFKDFLK----KCLEKNVDARWTTSQL 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-49
Identities = 58/285 (20%), Positives = 125/285 (43%), Gaps = 37/285 (12%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
++ K+G G+ GTVY + G+EVA+++ + + K+ +E+ ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQ-----MNLQQQPKKELIINEILVMRE 73
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ ++V + DE +V EY++ G+L D + + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---------MDEGQIAAVCRE 124
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
+ +++LH+ +IHRDIKS NILL ++ + +++DFG + + + VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGT 179
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
++ PE K DI+ LG++ +E++ G+ + NE+ + L
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-YLNEN-----------PLRALYL 227
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
+ P +L+ + L C++++ ++R + ++
Sbjct: 228 IATNGTPELQNPEKLSA-IFRDFLN----RCLDMDVEKRGSAKEL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-48
Identities = 60/284 (21%), Positives = 111/284 (39%), Gaps = 36/284 (12%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESA-FDSELALLSRV 559
+F +G GSF TV + L RE A+K K + ++E + E ++SR+
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKI---LEKRHIIKENKVPYVTRERDVMSRL 65
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H V L Q+ ++ Y NG L ++ + +
Sbjct: 66 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--------DETCTRFYTAEI 117
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
++YLH IIHRD+K NILL+ + +++DFG + + S ++ + VGT
Sbjct: 118 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739
Y+ PE +D++ LG ++ +L+ G F+ +
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGN---------------EYLI 218
Query: 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
++ PE +A +L+ + L+ +R ++
Sbjct: 219 FQKIIKLEYDFPEKFFPKARDLVE----KLLVLDATKRLGCEEM 258
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-48
Identities = 65/306 (21%), Positives = 122/306 (39%), Gaps = 38/306 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKG------KLMDGREVAVKREESCPKTNKLREKESAFDSELA 554
+ L +G G+FG V + K R VAVK + E +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM---LKEGATHSEHRALMSELKI 69
Query: 555 LLSRVHHKHLVGLVGFCQEKDERL-LVYEYMSNGALHDHLHNKNNTEKNSSIVN------ 607
L+ HH ++V L+G C + L ++ E+ G L +L +K N +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 608 --SWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSE 665
+ + I + A+G+++L + IHRD+ + NILL ++ DFGL+ +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 666 CDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPL 725
A + ++ PE V T ++D++ GV+L E+ + + +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV------ 240
Query: 726 DVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785
+ E ++ G R+ P+ E + + + C + E +RP +++V
Sbjct: 241 KIDEEFCRRLKEG-------TRMRAPDYTTPEMYQTM----LDCWHGEPSQRPTFSELVE 289
Query: 786 NLERAL 791
+L L
Sbjct: 290 HLGNLL 295
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-48
Identities = 65/295 (22%), Positives = 107/295 (36%), Gaps = 35/295 (11%)
Query: 501 NNFSLENKVGIGSFGTVYKGKL----MDGREVAVKREESCPKTNKLREKESAFDSELALL 556
+ L K+G GSFG V +G+ VAVK + P E F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAM 65
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ H++L+ L G ++ V E G+L D L R A
Sbjct: 66 HSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH-------FLLGTLSRYA 117
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFISTKA 675
+ A G+ YL + IHRD+ + N+LL ++ DFGL L D +
Sbjct: 118 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 676 VGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735
+ PE + +D + GV L E+ T + + +GS L ++
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---- 230
Query: 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790
+R+ PE + ++ C + ++RP + L A
Sbjct: 231 ---------GERLPRPEDCPQDIYNVMV----QCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-47
Identities = 65/295 (22%), Positives = 115/295 (38%), Gaps = 38/295 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALL 556
L +G G FG V++G M VA+K ++C ++ +REK F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREK---FLQEALTM 62
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+ H H+V L+G E + ++ E + G L L + + I A
Sbjct: 63 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSL-------DLASLILYA 114
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
+ + YL + +HRDI + N+L+ N ++ DFGLS + + ++K
Sbjct: 115 YQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGK 170
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736
+ ++ PE T+ +D++ GV + E+L F+ + +I
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIE 223
Query: 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791
G+ R+ P L+ C + RP T++ A L L
Sbjct: 224 NGE-------RLPMPPNCPPTLYSLMT----KCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (424), Expect = 2e-46
Identities = 58/286 (20%), Positives = 117/286 (40%), Gaps = 37/286 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+ + + ++G G+FG V++ GR K + +E+++++++
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKF-----INTPYPLDKYTVKNEISIMNQL 83
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
HH L+ L ++K E +L+ E++S G L D + ++ S I A
Sbjct: 84 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM-------SEAEVINYMRQA 136
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV--SDFGLSLLGSECDQEFISTKAVG 677
G+ ++H SI+H DIK NI+ + + V DFGL+ ++ + + I
Sbjct: 137 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTA 190
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737
T + PE + TD++ +GV+ LL+G G L+ ++ +
Sbjct: 191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF----AGEDDLETLQ----NVKR 242
Query: 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
D ++ EA + + + + E ++R + D
Sbjct: 243 CDWEFDEDA---FSSVSP-EAKDFIK----NLLQKEPRKRLTVHDA 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (421), Expect = 4e-46
Identities = 54/286 (18%), Positives = 111/286 (38%), Gaps = 37/286 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+++ + ++G G+FG V++ G A K T +KE E+ +S +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKF----VMTPHESDKE-TVRKEIQTMSVL 80
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H LV L ++ +E +++YE+MS G L + + +++N S +
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM-------SEDEAVEYMRQV 133
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDV--NWTARVSDFGLSLLGSECDQEFISTKAVG 677
+G+ ++H + +H D+K NI+ + ++ DFGL+ + D + G
Sbjct: 134 CKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTG 187
Query: 678 TVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737
T + PE + TD++ +GV+ LL+G G + + + +
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF----GGENDDETLR----NVKS 239
Query: 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
+ G E + + + + + R I
Sbjct: 240 CDWNMDDSAFSGISE----DGKDFIR----KLLLADPNTRMTIHQA 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (410), Expect = 2e-44
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSE---LALL 556
N+FS+ +G G FG VY + D G+ A+K + K K+++ E+ +E L+L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKMKQGETLALNERIMLSLV 61
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
S +V + D+ + + M+ G LH HL S A
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--------FSEADMRFYA 113
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
+ G++++HN +++RD+K +NILLD + R+SD GL+ S+ +V
Sbjct: 114 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 166
Query: 677 GTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGK 712
GT GY+ PE V + D + LG +L +LL G
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 4e-44
Identities = 56/285 (19%), Positives = 107/285 (37%), Gaps = 32/285 (11%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ + + +G G+F V + + VA+K C L KE + ++E+A+L +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIK----CIAKKALEGKEGSMENEIAVLHK 63
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ H ++V L + L+ + +S G L D + K + + R+
Sbjct: 64 IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--------FYTERDASRLIFQ 115
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
+ YLH+ + + LD + +SDFGLS D + + A GT
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGT 172
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
GY+ PE + D + +GV+ LL G + + E QIL
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY----DENDAKLFE----QILKA 224
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
+ ++++ A + + H + + ++R
Sbjct: 225 EYEFDSPY---WDDISD-SAKDFIR----HLMEKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 158 bits (400), Expect = 4e-44
Identities = 63/301 (20%), Positives = 121/301 (40%), Gaps = 40/301 (13%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESA--FDSELALL 556
++ + L +G G V+ + L R+VAVK + + R+ F E
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV----LRADLARDPSFYLRFRREAQNA 61
Query: 557 SRVHHKHLVGLVGFCQEKDERL----LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMR 612
+ ++H +V + + + +V EY+ L D +H + + K
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM--------TPKRA 113
Query: 613 IRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSL-LGSECDQEFI 671
I + DA + +++ H IIHRD+K +NI++ +V DFG++ + +
Sbjct: 114 IEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 672 STKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731
+ +GT Y+ PE + + A++D+Y LG VL E+LTG+ F + P+ V
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-FTGDS---PVSVAY-- 224
Query: 732 VSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-NITDIVANLERA 790
Q + + G + ++ + + R ++ A+L R
Sbjct: 225 --QHVREDPIPPSARHEGLSA----DLDAVVL----KALAKNPENRYQTAAEMRADLVRV 274
Query: 791 L 791
Sbjct: 275 H 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (399), Expect = 7e-44
Identities = 62/296 (20%), Positives = 115/296 (38%), Gaps = 46/296 (15%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKR----EESCPKTNKLREKESAFDSELALL 556
N+ + +G G V + +E AVK +++E A E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 557 SRVH-HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRI 615
+V H +++ L + LV++ M G L D+L K S K +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL--------SEKETRKI 115
Query: 616 ALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKA 675
I LH +I+HRD+K NILLD + +++DFG S + D +
Sbjct: 116 MRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREV 169
Query: 676 VGTVGYIDPEYYVMNVL------TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729
GT Y+ PE ++ + D++ GV++ LL G + ++
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF----WHRKQMLMLR 225
Query: 730 FAVSQILAGQLHCVLDKRVGPPELNE--AEAVELLATTAIHCVNLEGKERPNITDI 783
I++G + G PE ++ +L++ + ++ ++R +
Sbjct: 226 ----MIMSGNY------QFGSPEWDDYSDTVKDLVS----RFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-42
Identities = 44/285 (15%), Positives = 108/285 (37%), Gaps = 38/285 (13%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ + +G G FG V++ + K + E+++L+
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAK------FVKVKGTDQVLVKKEISILNIAR 59
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H++++ L + +E ++++E++S + + ++ + + +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL-------NEREIVSYVHQVC 112
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV--SDFGLSLLGSECDQEFISTKAVGT 678
+ +LH+ +I H DI+ NI+ ++ + +FG + +
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTA 166
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
Y PE + +V++ TD++ LG ++ LL+G F E ++E I+
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-FLAET---NQQIIE----NIMNA 218
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
+ + E++ EA++ + + E K R ++
Sbjct: 219 EYTFDEEA---FKEISI-EAMDFVD----RLLVKERKSRMTASEA 255
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-42
Identities = 63/287 (21%), Positives = 104/287 (36%), Gaps = 35/287 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+F L +G GSFG V+ + + A+K + + E + L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAW 60
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H L + Q K+ V EY++ G L H+ + + A +
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--------FDLSRATFYAAEI 112
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
G+ +LH+ I++RD+K NILLD + +++DFG+ D + GT
Sbjct: 113 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739
YI PE + D + GV+L E+L G+ F +D
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP-FHGQD---------------EEEL 211
Query: 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786
H + P E EA +LL E ++R + +
Sbjct: 212 FHSIRMDNPFYPRWLEKEAKDLLV----KLFVREPEKRLGVRGDIRQ 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 8e-42
Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 41/280 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKE-SAFDSELALLSR 558
+F + +G GSFG V+ + +GR A+K K +R K+ + E +LS
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV---LKKEIVVRLKQVEHTNDERLMLSI 60
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
V H ++ + G Q+ + ++ +Y+ G L L + A +
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--------FPNPVAKFYAAE 112
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGT 678
++YLH+ II+RD+K NILLD N +++DFG + + GT
Sbjct: 113 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGT 164
Query: 679 VGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
YI PE D + G+++ E+L G S + E +IL
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF----YDSNTMKTYE----KILNA 216
Query: 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP 778
+L PP NE + +LL+ + + +R
Sbjct: 217 ELRF-------PPFFNE-DVKDLLS----RLITRDLSQRL 244
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 1e-41
Identities = 51/303 (16%), Positives = 94/303 (31%), Gaps = 42/303 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
++ + ++G GSFG +++G L++ ++VA+K E R E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE-------PRRSDAPQLRDEYRTYKLL 57
Query: 560 -HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ + F QE +LV + + S K A
Sbjct: 58 AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--------FSVKTVAMAAKQ 109
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLD-----VNWTARVSDFGLS-----LLGSECDQ 668
+ +H S+++RDIK N L+ V DFG+ + +
Sbjct: 110 MLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 669 EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728
GT Y+ ++ + + D+ LG V + L G ++ +
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL-PWQGLKAATNKQKY 225
Query: 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLE 788
E K+ P A E + NL P+ +
Sbjct: 226 E-----------RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
Query: 789 RAL 791
+ L
Sbjct: 275 KVL 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (381), Expect = 3e-41
Identities = 56/304 (18%), Positives = 99/304 (32%), Gaps = 46/304 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
N + L K+G GSFG +Y G + G EVA+K E ++ K E + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-------CVKTKHPQLHIESKIYKMM 59
Query: 560 HHKHLVGLVGFC-QEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ + +C E D ++V E + S K + +A
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--------FSLKTVLLLADQ 111
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNIL---LDVNWTARVSDFGLSLL-----GSECDQEF 670
I+Y+H+ + IHRD+K N L + DFGL+ +
Sbjct: 112 MISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730
+ GT Y ++ + + D+ LG VL+ G
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS-----------LPWQGLK 217
Query: 731 AVSQILAGQLHCVLDKRVGPPELNE---AEAVELLATTAIHCVNLEGKERPNITDIVANL 787
A ++ + L + +E L C +L ++P+ + +
Sbjct: 218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN----FCRSLRFDDKPDYSYLRQLF 273
Query: 788 ERAL 791
Sbjct: 274 RNLF 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 53/299 (17%), Positives = 102/299 (34%), Gaps = 27/299 (9%)
Query: 499 ATNNFSLENKVGIGSFGTVYKGKLM--DGREVAVKREESCPKTNKLREKESAFDSELALL 556
A + ++G G++G V+K + + GR VA+KR + + L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 557 SRVHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
H ++V L C + + L + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV--PTETIKDMM 122
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAV 676
RG+D+LH++ ++HRD+K NIL+ + +++DFGL+ + T V
Sbjct: 123 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALTSVV 176
Query: 677 GTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK------------KAVFKNEDGSGP 724
T+ Y PE + + D++ +G + E+ K + G
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 725 LDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
D A +++E +LL C+ +R +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDE-LGKDLLL----KCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 59/291 (20%), Positives = 106/291 (36%), Gaps = 31/291 (10%)
Query: 507 NKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV 565
+ +G G F TVYK + + VA+K+ + ++ E+ LL + H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
GL+ K LV+++M N L +G++Y
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLT--------PSHIKAYMLMTLQGLEY 115
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPE 685
LH + I+HRD+K +N+LLD N +++DFGL+ S T V T Y PE
Sbjct: 116 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLA--KSFGSPNRAYTHQVVTRWYRAPE 170
Query: 686 YYV-MNVLTAKTDIYGLGVVLLELLTGK---------KAVFKNEDGSGPLDVVEFAVSQI 735
+ D++ +G +L ELL + + + G ++
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 736 LAGQLHCVLDKRVGPPELNEA---EAVELLATTAIHCVNLEGKERPNITDI 783
L + + + A + ++L+ R T
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ----GLFLFNPCARITATQA 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 56/289 (19%), Positives = 107/289 (37%), Gaps = 36/289 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR-EESCPKTNKLREKESAFDSELALLSR 558
+ + ++G G F V K + G + A K ++ K+++ + E+++L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 559 VHHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALD 618
+ H +++ L + K + +L+ E ++ G L D L K + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT--------EEEATEFLKQ 121
Query: 619 AARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR----VSDFGLSLLGSECDQEFISTK 674
G+ YLH+ I H D+K NI+L + + DFGL+ + D
Sbjct: 122 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKN 175
Query: 675 AVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734
GT ++ PE L + D++ +GV+ LL+G + +
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------------QE 223
Query: 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
LA + A A + + + + K+R I D
Sbjct: 224 TLANVSAVNYEFEDEYFSNTSALAKDFIR----RLLVKDPKKRMTIQDS 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 53/306 (17%), Positives = 115/306 (37%), Gaps = 42/306 (13%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
++ + +G G++G V ++ VA+K+ + + E+ +L R
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI----SPFEHQTYCQRTLREIKILLR 62
Query: 559 VHHKHLVGLVGFCQEKD----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
H++++G+ + + + + ++ L+ L ++ S
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHL---------SNDHICY 113
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS-LLGSECDQEFIST 673
RG+ Y+H+ +++HRD+K SN+LL+ ++ DFGL+ + + D T
Sbjct: 114 FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170
Query: 674 KAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGK------------KAVFKNED 720
+ V T Y PE + + T DI+ +G +L E+L+ + +
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNE---AEAVELLATTAIHCVNLEGKER 777
D+ + L +V L ++A++LL + +R
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD----KMLTFNPHKR 286
Query: 778 PNITDI 783
+
Sbjct: 287 IEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 502 NFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
NF K+G G++G VYK + + G VA+K+ + S E++LL ++
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKK---IRLDTETEGVPSTAIREISLLKELN 59
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H ++V L+ +++ LV+E++ L + T +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTG------IPLPLIKSYLFQLL 112
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
+G+ + H+ ++HRD+K N+L++ +++DFGL+ + + T V T+
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLW 167
Query: 681 YIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGK 712
Y PE + + DI+ LG + E++T +
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 6e-38
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 29/220 (13%)
Query: 502 NFSLENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+++ +G GSFG VY+ KL D G VA+K K+ + + + EL ++ ++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---------KVLQDKRFKNRELQIMRKLD 71
Query: 561 HKHLVGLVGFCQEKDER------LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
H ++V L F E+ LV +Y+ H +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-----LPVIYVKL 126
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARVSDFGLSLLGSECDQEFIST 673
R + Y+H+ I HRDIK N+LLD + ++ DFG + + + +
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNV 180
Query: 674 KAVGTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGK 712
+ + Y PE T+ D++ G VL ELL G+
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-38
Identities = 56/289 (19%), Positives = 110/289 (38%), Gaps = 46/289 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR-EESCPKTNKLREKESAFDSELALLSR 558
+ + + +G G FG+VY G + D VA+K E+ + E+ LL +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 559 VHHKH--LVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
V ++ L+ + + D +L+ E + ++
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL-------QEELARSFF 116
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARVSDFGLSLLGSECDQEFISTKA 675
+ + HN ++HRDIK NIL+D+N ++ DFG ++ + T
Sbjct: 117 WQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS----GALLKDTVYTDF 169
Query: 676 VGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734
GT Y PE+ + ++ LG++L +++ G F++++ +
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-FEHDE-------------E 215
Query: 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
I+ GQ+ ++ E L+ C+ L +RP +I
Sbjct: 216 IIRGQVFF-------RQRVSS-ECQHLIR----WCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 60/293 (20%), Positives = 110/293 (37%), Gaps = 44/293 (15%)
Query: 501 NNFSLENKV-GIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+++ + ++V G+G G V + + A+K + CPK + E+ L R
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----------EVELHWR 60
Query: 559 V-HHKHLVGLVGFCQ----EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
H+V +V + + L+V E + G L + ++ + + +
Sbjct: 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ------AFTEREAS 114
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD---VNWTARVSDFGLSLLGSECDQEF 670
I I YLH+ +I HRD+K N+L N +++DFG + + +
Sbjct: 115 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 171
Query: 671 ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730
T Y+ PE D++ LGV++ LL G F + L +
Sbjct: 172 TPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP-FYSNH---GLAISPG 224
Query: 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
++I GQ + E E L+ + + E +R IT+
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSE----EVKMLIR----NLLKTEPTQRMTITEF 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (348), Expect = 5e-37
Identities = 49/297 (16%), Positives = 110/297 (37%), Gaps = 34/297 (11%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH 560
+ K+G G++G VYK + G A+K+ + S E+++L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKK---IRLEKEDEGIPSTTIREISILKELK 58
Query: 561 HKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAA 620
H ++V L K +LV+E++ + L
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--------LESVTAKSFLLQLL 110
Query: 621 RGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVG 680
GI Y H+ ++HRD+K N+L++ +++DFGL+ +++ + T+
Sbjct: 111 NGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLW 165
Query: 681 YIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGK---------KAVFKNEDGSGPLDVVEF 730
Y P+ + + DI+ +G + E++ G + + G + +
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 731 A-VSQILAGQLHCVLDKRVGPPELNE---AEAVELLATTAIHCVNLEGKERPNITDI 783
V+++ + + + + + ++LL+ + L+ +R
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS----KMLKLDPNQRITAKQA 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-37
Identities = 53/300 (17%), Positives = 109/300 (36%), Gaps = 38/300 (12%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+ K+G G++GTV+K K VA+KR + S+ E+ LL +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKR---VRLDDDDEGVPSSALREICLLKEL 58
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
HK++V L + LV+E+ + ++
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD--------LDPEIVKSFLFQL 110
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
+G+ + H+ +++HRD+K N+L++ N ++++FGL+ + + + V T+
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTL 165
Query: 680 GYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738
Y P+ + + D++ G + EL + +F D L + +
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 739 QLHCVL---------------DKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDI 783
Q + P+LN +LL + + +R + +
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA-TGRDLLQ----NLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 60/311 (19%), Positives = 124/311 (39%), Gaps = 46/311 (14%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+ + K+G G+FG V+K + G++VA+K+ N+ E+ +L +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLL 66
Query: 560 HHKHLVGLVGFCQEKDER--------LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKM 611
H+++V L+ C+ K LV+++ + + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--------FTLSE 118
Query: 612 RIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS--LLGSECDQE 669
R+ G+ Y+H I+HRD+K++N+L+ + +++DFGL+ ++ Q
Sbjct: 119 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 670 FISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKK-----------AVFK 717
T V T+ Y PE + D++G G ++ E+ T A+
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
Query: 718 NEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPE-----LNEAEAVELLATTAIHCVNL 772
GS +V + L +L V ++ + + + A++L+ + L
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID----KLLVL 291
Query: 773 EGKERPNITDI 783
+ +R + D
Sbjct: 292 DPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-36
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
N+F +G G+FG V + GR A+K + +++ + +E +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQNT 62
Query: 560 HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDA 619
H L L Q D V EY + G L HL + V + + +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--------VFTEERARFYGAEI 114
Query: 620 ARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTV 679
++YLH+ +++RDIK N++LD + +++DFGL G + GT
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTP 169
Query: 680 GYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGK 712
Y+ PE N D +GLGVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 4e-35
Identities = 59/267 (22%), Positives = 100/267 (37%), Gaps = 35/267 (13%)
Query: 448 SASMANDGSNLPPLRSFSTRQQSSRTFGRQRSGSSSFSVKADNFTLSELAAATNNFSLEN 507
+A+ A GS ++ F ++ F ++ S + + D F +
Sbjct: 2 NAAAAKKGSEQESVKEFL--AKAKEDFLKKWETPSQNTAQLDQFDRIK------------ 47
Query: 508 KVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKE-SAFDSELALLSRVHHKHLV 565
+G GSFG V K G A+K K ++ K+ +E +L V+ LV
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 566 GLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDY 625
L ++ +V EY++ G + HL S A +Y
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--------SEPHARFYAAQIVLTFEY 156
Query: 626 LHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPE 685
LH+ +I+RD+K N+L+D +V+DFG + GT + PE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPE 208
Query: 686 YYVMNVLTAKTDIYGLGVVLLELLTGK 712
+ D + LGV++ E+ G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (307), Expect = 3e-31
Identities = 42/226 (18%), Positives = 90/226 (39%), Gaps = 31/226 (13%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+++ L K+G G + V++ + + +V VK + K+ E+ +L +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENL 86
Query: 560 -HHKHLVGLVGFCQEKDERL--LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIA 616
+++ L ++ R LV+E+++N +
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL-----------TDYDIRFYM 135
Query: 617 LDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-NWTARVSDFGLSLLGSECDQEFISTKA 675
+ + +DY H+ I+HRD+K N+++D + R+ D+GL+ +
Sbjct: 136 YEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVR 189
Query: 676 VGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720
V + + PE V + D++ LG +L ++ K+ F D
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-31
Identities = 55/246 (22%), Positives = 93/246 (37%), Gaps = 40/246 (16%)
Query: 474 FGRQRSGSSSFSVKADNFTLSELAAATNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKR 532
F G S+F+V + +G G+ G V + R VA+K+
Sbjct: 3 FYSVEVGDSTFTV-------------LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK 49
Query: 533 EESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFC------QEKDERLLVYEYMSN 586
+ + + EL L+ V+HK+++ L+ +E + LV E M
Sbjct: 50 ---LSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106
Query: 587 GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646
+ + GI +LH+ IIHRD+K SNI++
Sbjct: 107 NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 152
Query: 647 DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLL 706
+ T ++ DFGL+ F+ T V T Y PE + DI+ +G ++
Sbjct: 153 KSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 707 ELLTGK 712
E++ K
Sbjct: 210 EMVRHK 215
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-31
Identities = 65/306 (21%), Positives = 114/306 (37%), Gaps = 48/306 (15%)
Query: 501 NNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRV 559
+ VG G++G V G +VA+K+ + + EL LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK---LYRPFQSELFAKRAYRELRLLKHM 74
Query: 560 HHKHLVGLVGFCQEKD------ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
H++++GL+ + + LV +M G L
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKL--------GEDRIQ 124
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIST 673
+ +G+ Y+H IIHRD+K N+ ++ + ++ DFGL+ + D E T
Sbjct: 125 FLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEM--T 176
Query: 674 KAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGK-----------KAVFKNEDG 721
V T Y PE + T DI+ +G ++ E++TGK G
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 722 SGPLDVVEFAVSQILAGQLHCV--LDKRVGPPELNEA--EAVELLATTAIHCVNLEGKER 777
+ P + V+ S + + L+K+ L A AV LL + L+ ++R
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE----KMLVLDAEQR 292
Query: 778 PNITDI 783
+
Sbjct: 293 VTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 22/220 (10%)
Query: 501 NNFSLENKVGIGSFGTVYKGKLM----DGREVAVK--REESCPKTNKLREKESAFDSELA 554
NF L +G G++G V+ + + G+ A+K ++ + + K E +E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH---TRTERQ 80
Query: 555 LLSRV-HHKHLVGLVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
+L + LV L Q + + L+ +Y++ G L HL + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--------FTEHEVQ 132
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIST 673
+ +++LH II+RDIK NILLD N ++DFGLS + E
Sbjct: 133 IYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189
Query: 674 KAVGTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGK 712
+ D + LGV++ ELLTG
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 6e-29
Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 19/231 (8%)
Query: 503 FSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH 561
+ L K+G G F TV+ K +++ VA+K + A + E+ LL RV+
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMK------IVRGDKVYTEAAEDEIKLLQRVND 68
Query: 562 KHLVGLVGFCQEKDERLL-VYEYMSNGALHDHL-------HNKNNTEKNSSIVNSWKMRI 613
+LL + + +H + + +K
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTARVSDFGLSLLGSECDQEFIS 672
+I+ G+DY+H IIH DIK N+L+++ + ++ LG+ C +
Sbjct: 129 QISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 673 TKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723
T ++ T Y PE + DI+ ++ EL+TG +F+ ++G
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHS 236
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 6e-28
Identities = 59/303 (19%), Positives = 113/303 (37%), Gaps = 40/303 (13%)
Query: 500 TNNFSLENKVGIGSFGTVYKGK-LMDGREVAVKREESCPKTNKLREKESAFDSELALLSR 558
+ + VG G++G+V G VAVK+ + + EL LL
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKH 73
Query: 559 VHHKHLVGLVGFCQEKD-----ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRI 613
+ H++++GL+ + + ++ GA +++
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLT--------DDHVQ 124
Query: 614 RIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFIST 673
+ RG+ Y+H+ IIHRD+K SN+ ++ + ++ DFGL+ + T
Sbjct: 125 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMT 176
Query: 674 KAVGTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV---- 728
V T Y PE + + DI+ +G ++ ELLTG + +F D L ++
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLILRLV 235
Query: 729 ----EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIH----CVNLEGKERPNI 780
+ +I + + P++N A A+ + L+ +R
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 781 TDI 783
Sbjct: 296 AQA 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.1 bits (220), Expect = 7e-21
Identities = 23/166 (13%), Positives = 45/166 (27%), Gaps = 28/166 (16%)
Query: 504 SLENKVGIGSFGTVYKGKLMDGREVAVK-----REESCPKTNKLREKESAFDSELALLSR 558
++ +G G V+ E VK K + F +R
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 559 VHHKHLVGLVGFCQEK----DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIR 614
+ L L G K + ++ E + L+ +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---------------RVENPDE 107
Query: 615 IALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660
+ + ++ I+H D+ N+L+ + DF S
Sbjct: 108 VLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQS 149
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 48.6 bits (114), Expect = 1e-06
Identities = 46/263 (17%), Positives = 78/263 (29%), Gaps = 33/263 (12%)
Query: 63 STIPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTD- 121
+T+P + AI+GG + L+ G + W N + A+ +
Sbjct: 18 ATVPAEAQSGVDAIAGGYFHGLALKGG--KVLGWGANLNGQLTMPAATQSGVDAIAAGNY 75
Query: 122 -------------------VSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGED 162
+ + + K + S G+
Sbjct: 76 HSLALKDGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYALKDGKVIAWGDDSDGQT 135
Query: 163 LKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQRGFKNLSMVGL----VAGESHACG 218
+ SG G + + V G D + VAG
Sbjct: 136 TVPAEAQSGVTALDGGVYTALAVKNGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSL 195
Query: 219 LSRNGALVCKGSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEF 278
++G ++ G N Q VP + S +A G ++ A+ ++G V WG +
Sbjct: 196 ALKDGKVIAWGDNRYKQTTVPTEALSGVS-AIASGEWYSLAL--KNGKVIAWGSSRTAP- 251
Query: 279 DSDVIQDVSFESIVAGLDFVCGL 301
S V VS SI AG + L
Sbjct: 252 -SSVQSGVS--SIEAGPNAAYAL 271
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 40.5 bits (93), Expect = 5e-04
Identities = 16/66 (24%), Positives = 27/66 (40%), Gaps = 12/66 (18%)
Query: 181 SNSEVFCWGDSG------IADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSG 234
+ + V WG + + E Q G ++ G H L G ++ G+N +G
Sbjct: 2 AATSVVAWGGNNDWGEATVPAEAQSGVDAIA-----GGYFHGLALK-GGKVLGWGANLNG 55
Query: 235 QLNVPF 240
QL +P
Sbjct: 56 QLTMPA 61
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 16/70 (22%), Positives = 22/70 (31%), Gaps = 11/70 (15%)
Query: 212 GESHACGLSRNGALVCKGSNDSGQL----NVPFSSAFEFSGGL------ALGANFTCAIR 261
SH + G ++ G D GQL NV G T +
Sbjct: 4 KVSHRSHSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLS 63
Query: 262 QRSGLVACWG 271
+ SG V +G
Sbjct: 64 K-SGQVYSFG 72
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 0.002
Identities = 16/69 (23%), Positives = 23/69 (33%), Gaps = 11/69 (15%)
Query: 179 LRSNSEVFCWGDS-----GIADEIQRGFK------NLSMVGLVAGESHACGLSRNGALVC 227
V G G+ + + K +V AG H LS++G +
Sbjct: 11 STEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKSGQVYS 70
Query: 228 KGSNDSGQL 236
G ND G L
Sbjct: 71 FGCNDEGAL 79
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 0.002
Identities = 34/254 (13%), Positives = 60/254 (23%), Gaps = 39/254 (15%)
Query: 39 YKTSTVCGIIAGESIQRIQCYQNGSTIPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDT 98
+ +A + + +G + Q + + G
Sbjct: 148 VQLDVPVVKVASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLE------ 201
Query: 99 NDLTNFSFQPKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSS 158
L K R V+ D G A G V + + G + S
Sbjct: 202 RLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHE-GHVYGFGLSNYHQLGTPGTESC 260
Query: 159 P--------GEDLKFSTITSGRGFTCGILRSNSEVFCW----------GDSGIADEIQRG 200
K SG + S + + G+ I
Sbjct: 261 FIPQNLTSFKNSTKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTL 320
Query: 201 FKNLSMVGLVA-GESHACGLSRNGALVCKGSNDSGQL--------NVPFSSAFEFSGG-- 249
L V VA G S ++++G + G + QL P +
Sbjct: 321 ISRLPAVSSVACGASVGYAVTKDGRVFAWGMGTNYQLGTGQDEDAWSPVEMMGKQLENRV 380
Query: 250 ---LALGANFTCAI 260
++ G T +
Sbjct: 381 VLSVSSGGQHTVLL 394
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 812 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1jtdb_ | 273 | beta-lactamase inhibitor protein-II, BLIP-II {Stre | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1a12a_ | 401 | Regulator of chromosome condensation RCC1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jtdb_ | 273 | beta-lactamase inhibitor protein-II, BLIP-II {Stre | 100.0 | |
| d1a12a_ | 401 | Regulator of chromosome condensation RCC1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.24 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.83 | |
| d1k3ia3 | 387 | Galactose oxidase, central domain {Fungi (Fusarium | 93.58 | |
| d1k3ia3 | 387 | Galactose oxidase, central domain {Fungi (Fusarium | 91.0 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=431.13 Aligned_cols=268 Identities=28% Similarity=0.455 Sum_probs=205.8
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
...++|++.++||+|+||+||+|+++ ..||||++...... .+..+.|.+|++++++++|||||++++++.+ +..
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 34577999999999999999999864 46999998643222 2335678999999999999999999998754 568
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
+|||||+++|+|.++|+.... .+++..+++|+.||++||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~-------~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIET-------KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCC-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCC
T ss_pred EEEEecCCCCCHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccc
Confidence 999999999999999975432 1377888999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCcccccc---CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVM---NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|+++...............||+.|||||++.+ ..|+.++|||||||+||||+||+.||..... .. .....
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----~~---~~~~~ 221 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RD---QIIFM 221 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HH---HHHHH
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh----HH---HHHHH
Confidence 99987655444444556789999999999864 4589999999999999999999999854321 11 11122
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcc
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 795 (812)
+..+.... .+ .....++++.+.+|+.+||+.||++|||++||+++|+.+.+..+
T Consensus 222 ~~~~~~~p----~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 222 VGRGYLSP----DL---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HHHTSCCC----CG---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HhcCCCCC----cc---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 22221110 00 01122345678899999999999999999999999999887544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=422.54 Aligned_cols=259 Identities=26% Similarity=0.443 Sum_probs=201.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.++|++.+.||+|+||.||+|++.+++.||||++..... ..++|.+|++++++++||||+++++++.+++..++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC------cHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 357999999999999999999998899999999864221 23468899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... .+++..+++|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 78 v~E~~~~g~L~~~l~~~~~-------~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl 147 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG-------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 147 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-
T ss_pred EEEecCCCcHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccch
Confidence 9999999999999876532 2367888999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++....... .......||+.|||||++.+..|+.++|||||||+||||+|++.|++.... . ......+..+.
T Consensus 148 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~----~~~~~~i~~~~ 219 (263)
T d1sm2a_ 148 TRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---N----SEVVEDISTGF 219 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---H----HHHHHHHHHTC
T ss_pred heeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---H----HHHHHHHHhcC
Confidence 986544322 223345789999999999999999999999999999999997666543221 1 11222222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+...|. ..++.+.+|+.+||+.||++||||+||+++|+++++.
T Consensus 220 -------~~~~p~----~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 220 -------RLYKPR----LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -------CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCcc----ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 111222 2234578999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=423.08 Aligned_cols=261 Identities=24% Similarity=0.397 Sum_probs=210.9
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
...++|++.++||+|+||+||+|++++++.||||++.... ...+.|.+|++++++++|||||++++++.+ +..
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc------CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence 3456799999999999999999999888999999986422 123468999999999999999999998754 567
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEee
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDF 657 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~Df 657 (812)
++||||+++|+|.+++..... ..++|..+++|+.||++||+|||+++ |+||||||+||||++++.+||+||
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~------~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSG------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHH------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEeCCCCcHHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccc
Confidence 999999999999998854322 22478999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|+++...... ........||+.|||||++....++.++|||||||+||||+||+.|++.... .......+..
T Consensus 154 Gla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~~ 225 (272)
T d1qpca_ 154 GLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLER 225 (272)
T ss_dssp TTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHT
T ss_pred cceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHh
Confidence 9998765432 2233456789999999999999999999999999999999998777654321 1112222222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+. +...+ ..+++.+.+|+.+||+.||++||||+||++.|+.....
T Consensus 226 ~~-------~~~~p----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 226 GY-------RMVRP----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cC-------CCCCc----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 21 11112 23345688999999999999999999999999987754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=419.63 Aligned_cols=254 Identities=24% Similarity=0.297 Sum_probs=203.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||+||+|+++ +++.||||++.... ..+..+.+.+|++++++++||||+++++++.+++..||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 56999999999999999999985 58999999986421 12334568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.++|..... +++.....++.||++||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 81 vmEy~~gg~L~~~l~~~~~--------l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIG--------MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp EEECCTTEEGGGGSBTTTB--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEeccCCCcHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchh
Confidence 9999999999999965432 356777899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcC-CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++..............+||+.|||||++.+..+ +.++|||||||+||||++|+.||....... .. .......
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~----~~~~~~~ 222 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QE----YSDWKEK 222 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---HH----HHHHHTT
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---HH----HHHHhcC
Confidence 987655444444556789999999999988776 578999999999999999999996543211 11 1111111
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ........++.+.+|+.+||+.||++|||++|++++
T Consensus 223 ~~----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 223 KT----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp CT----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC----------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 10 011123344567899999999999999999999763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-49 Score=421.22 Aligned_cols=259 Identities=24% Similarity=0.440 Sum_probs=198.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-C---cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-G---REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g---~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
++|++.++||+|+||+||+|+++. + ..||||++.... .....+.|.+|+++|++++|||||++++++.+++.
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc----CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 568889999999999999998753 2 258889875322 23345678999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++|+|.+++..... .++|.++++++.||++||+|||+++ |+||||||+||||+.++++||+|
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~-------~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~D 171 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDG-------QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSD 171 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECC
T ss_pred EEEEEEecCCCcceeeeccccC-------CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECC
Confidence 9999999999999999875432 2378889999999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccc---cccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHH
Q 042346 657 FGLSLLGSECDQEF---ISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 657 fGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 732 (812)
||+++......... ......+|+.|||||.+....++.++|||||||+||||+| |+.||.... ..+ ..
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~----~~~----~~ 243 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT----NQD----VI 243 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHH----HH
T ss_pred cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC----HHH----HH
Confidence 99998765433221 1223467999999999999999999999999999999998 788885422 111 22
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
..+..+ .++..+ .++++.+.+|+.+||+.||++|||++||++.|+++++
T Consensus 244 ~~i~~~-------~~~~~~----~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 244 NAIEQD-------YRLPPP----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHTT-------CCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcC-------CCCCCC----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 222222 122222 2345668899999999999999999999999999886
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-49 Score=422.28 Aligned_cols=262 Identities=25% Similarity=0.375 Sum_probs=212.1
Q ss_pred HHhcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 497 AAATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 497 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
+...++|++.++||+|+||+||+|+++ +++.||||++..... ..+.|.+|+++|++++|||||+++++|.+++
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------hHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 344567999999999999999999986 488999999864221 2346889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+++|+|.++|...... .+++..+++|+.||++||+|||+++ |+||||||+||||++++++||+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~------~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQ------EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTT------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred eeEEEeecccCcchHHHhhhcccc------chHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEc
Confidence 999999999999999999765432 2377888999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||+++...... ........|++.|||||++.+..|+.++|||||||+||||++|+.|++...+ . ......+
T Consensus 158 DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---~----~~~~~~i 229 (287)
T d1opja_ 158 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---L----SQVYELL 229 (287)
T ss_dssp CCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---H----HHHHHHH
T ss_pred cccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---H----HHHHHHH
Confidence 999998765432 2233445689999999999999999999999999999999998888754332 1 1111122
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
..+ .++..+ ..+++.+.+|+.+||+.||++|||++||++.|+.+++
T Consensus 230 ~~~-------~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 230 EKD-------YRMERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HTT-------CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred hcC-------CCCCCC----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 221 112222 2234568899999999999999999999999987643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-49 Score=410.55 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=204.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||+||+|+++ +++.||+|++... ........+.+.+|++++++++||||+++++++.+++..++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchH--HccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 35999999999999999999985 5889999998631 11222335678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.++|..... +++...+.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 vmEy~~~g~L~~~l~~~~~--------l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSK--------FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp EEECCTTCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred EEeecCCCcHHHHHhhcCC--------CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 9999999999999976543 256777899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++...... .....||+.|||||++.+..++.++|||||||+||||++|+.||.... .......+....
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~ 220 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVE 220 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTC
T ss_pred eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC
Confidence 97654322 234679999999999999999999999999999999999999985422 111222222222
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
...|. ..++.+.+|+.+||+.||++|||++|++++
T Consensus 221 --------~~~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 --------FTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --------CCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11122 234567889999999999999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=413.03 Aligned_cols=261 Identities=25% Similarity=0.432 Sum_probs=203.3
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCC-----cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDG-----REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
+.|++.++||+|+||+||+|.+++. ..||||++.... ..+....|.+|++++++++|||||++++++.+.+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 5688999999999999999987542 369999986422 2234457899999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++||||+.+++|.+++..... .++|.++++++.||+.||+|||+++ |+||||||+||||+.++.+||+
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~-------~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~ 152 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDG-------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVS 152 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred ceEEEEEecccCcchhhhhcccc-------cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEc
Confidence 99999999999999998866543 2378889999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++........ .......||+.|||||++.+..++.++|||||||+||||++++.|+..... . ......
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---~----~~~~~~ 225 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---N----HEVMKA 225 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---H----HHHHHH
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---H----HHHHHH
Confidence 99999876543222 223345689999999999999999999999999999999998777654321 1 112222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+..+. +...+ .+.+..+.+|+.+||+.||++||||+||++.|+++++.
T Consensus 226 i~~~~-------~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 226 INDGF-------RLPTP----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHTTC-------CCCCC----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HhccC-------CCCCc----hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 22221 11122 23445688999999999999999999999999998875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=408.99 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=209.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.++|++.++||+|+||+||+|++++++.||||++..... ..++|.+|++++++++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 357899999999999999999998888999999874322 23468899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... .+.+..+++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 77 v~Ey~~~g~l~~~~~~~~~-------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRH-------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGL 146 (258)
T ss_dssp EEECCTTEEHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEEccCCCcHHHhhhcccc-------CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchh
Confidence 9999999999999865433 2367788999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++....... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.... .......+..+
T Consensus 147 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i~~~ 217 (258)
T d1k2pa_ 147 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQG 217 (258)
T ss_dssp CCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTT
T ss_pred heeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHHHHhC
Confidence 987655332 23344679999999999999999999999999999999998 788874332 11222223332
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
. ++..|. ..++.+.+|+.+||+.||++|||++||+++|.+
T Consensus 218 ~-------~~~~p~----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 L-------RLYRPH----LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp C-------CCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred C-------CCCCcc----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1 222222 233568899999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=411.07 Aligned_cols=250 Identities=22% Similarity=0.392 Sum_probs=204.1
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.++||+|+||+||+|++ .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence 4699999999999999999987 4699999999864221 123568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..+. ++..+...++.||+.||+|||+++ |+||||||+|||++.++++||+|||+
T Consensus 95 vmEy~~gg~L~~~~~~~~---------l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~ 162 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTETC---------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162 (293)
T ss_dssp EEECCTTCBHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCcHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchh
Confidence 999999999999886543 255677899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++....... ......||+.|||||++.+..|+.++|||||||+||||++|+.||..... .+........+.
T Consensus 163 a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~~~~~~~ 233 (293)
T d1yhwa1 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGT 233 (293)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHHCS
T ss_pred heeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCCC
Confidence 987644222 23456899999999999999999999999999999999999999854221 111111111111
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+....+..+++.+.+|+.+||+.||++|||++|+++|
T Consensus 234 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 234 ----------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ----------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ----------CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111123455678899999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=411.94 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=194.2
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe--CCeE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE--KDER 577 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~ 577 (812)
++|++.+.||+|+||+||+|+++ +|+.||||++..... .+...+.+.+|++++++++|||||++++++.+ ++..
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS---CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC---CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 56999999999999999999875 589999999865322 23345678999999999999999999999865 3457
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCC--CCeEeeccCCCCEEEcCCCcEEEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAV--PSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~--~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
|+||||+++|+|.+++...... ...+++...+.++.||+.||+|||+++. .+|+||||||+||||+.++.+||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKE----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHHhcccc----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 9999999999999999653211 1123677889999999999999998752 349999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||+++...... .......||+.|||||++.+..|+.++|||||||+||||+||+.||.... . ......+
T Consensus 157 DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~----~----~~~~~~i 226 (269)
T d2java1 157 DFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----Q----KELAGKI 226 (269)
T ss_dssp CHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----H----HHHHHHH
T ss_pred eccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC----H----HHHHHHH
Confidence 999998765422 22345689999999999999999999999999999999999999985322 1 1222333
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+.... .+ ..+++.+.+|+.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~-------~~----~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 227 REGKFRR-------IP----YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHTCCCC-------CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCCC-------CC----cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 3333211 11 1234568899999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=407.17 Aligned_cols=264 Identities=23% Similarity=0.365 Sum_probs=209.5
Q ss_pred cCCcceeee-eccCCcEEEEEEEEc---CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 500 TNNFSLENK-VGIGSFGTVYKGKLM---DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~-LG~G~fG~Vy~a~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
.++|.+.+. ||+|+||+||+|.++ ++..||||++.... .....+.|.+|+++|++++|||||++++++.+ +
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc----CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 356777774 999999999999764 35579999986432 23345678999999999999999999999875 4
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..+|||||+++|+|.+++..... .+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~-------~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~ 151 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKRE-------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKIS 151 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT-------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEEC
T ss_pred eEEEEEEeCCCCcHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeec
Confidence 68999999999999999865432 2377888999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||+++........ .......||+.|||||++....++.++|||||||+||||+| |+.||..... .+ ...
T Consensus 152 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----~~----~~~ 223 (285)
T d1u59a_ 152 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PE----VMA 223 (285)
T ss_dssp CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HH----HHH
T ss_pred cchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH----HH----HHH
Confidence 99999876543332 22334578999999999999999999999999999999998 8999854321 12 222
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcccC
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQDC 797 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~~ 797 (812)
.+..+. ++..| ..+++.+.+|+.+||+.||++||||.+|++.|+.........
T Consensus 224 ~i~~~~-------~~~~p----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 224 FIEQGK-------RMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp HHHTTC-------CCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHHcCC-------CCCCC----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 233332 11222 234456889999999999999999999999998876544333
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=403.38 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=197.3
Q ss_pred cceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe----CCeE
Q 042346 503 FSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE----KDER 577 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~ 577 (812)
|++.++||+|+||+||+|++. +++.||+|++.... ......+.|.+|+++|++++|||||++++++++ +...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 467789999999999999985 58899999986422 123345678999999999999999999999875 3457
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc-CCCcEEEEe
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD-VNWTARVSD 656 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kl~D 656 (812)
+|||||+++|+|.+++..... +++...+.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~--------~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKV--------MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEeCCCCCcHHHHHhcccc--------ccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEee
Confidence 899999999999999976532 356777899999999999999987 5699999999999996 578999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||+++..... ......||+.|||||++.+ .++.++|||||||+||||++|+.||..... .......+.
T Consensus 159 FGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~i~ 226 (270)
T d1t4ha_ 159 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVT 226 (270)
T ss_dssp TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHT
T ss_pred cCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHHHHH
Confidence 9999764432 2345689999999998875 599999999999999999999999854321 111222222
Q ss_pred hccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+.....+ +....+.+.+|+.+||+.||++|||++|+++|
T Consensus 227 ~~~~~~~~----------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 227 SGVKPASF----------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TTCCCGGG----------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCCccc----------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 22211111 12223457899999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=420.48 Aligned_cols=267 Identities=22% Similarity=0.357 Sum_probs=208.5
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEcCC------cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLMDG------REVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGF 570 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~g------~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 570 (812)
...++|++.++||+|+||+||+|++... ..||+|++... ........|.+|+.++.++ +|||||+++++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK----ADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc----cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 3456799999999999999999987532 36999987532 1233445788999999998 89999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCc---------------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEK---------------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSII 635 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~---------------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~iv 635 (812)
+.+.+..+|||||+++|+|.++|+.+..... .....+++..++.++.||++||+|||+++ ||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---Ii 186 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV 186 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999999986543211 11234588999999999999999999998 99
Q ss_pred eeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCC
Q 042346 636 HRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKA 714 (812)
Q Consensus 636 HrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p 714 (812)
||||||+|||++.++++||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999999986555444334445678999999999999999999999999999999998 8888
Q ss_pred CCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 042346 715 VFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLER 789 (812)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~ 789 (812)
|...... ... ..+..+. .++..+. .+++.+.+||.+||+.||++|||++||+++|.-
T Consensus 267 f~~~~~~----~~~----~~~~~~~------~~~~~p~----~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 267 YPGIPVD----ANF----YKLIQNG------FKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp STTCCCS----HHH----HHHHHTT------CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHH----HHH----HHHHhcC------CCCCCCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 8543221 111 1112221 1122222 234568899999999999999999999999963
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=411.96 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=202.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||+||+|++. +++.||||++... ........+.+.+|++++++++||||+++++++.+++..||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehH--HccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 45999999999999999999984 6899999998631 11122334678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... ++......++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 86 vmEy~~gg~L~~~~~~~~~--------l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGS--------FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp EECCCTTEEHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEccCCCCHHHhhhccCC--------CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccccc
Confidence 9999999999999876543 255677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++...............||+.|||||++.+..|+.++|||||||+||||++|+.||.... . ......+..+.
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~----~~~~~~i~~~~ 226 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----E----YLIFQKIIKLE 226 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----H----HHHHHHHHTTC
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC----H----HHHHHHHHcCC
Confidence 987665444444456689999999999999999999999999999999999999985432 1 11222333322
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+ ..+. ..++.+.+||.+||+.||++|||++|++.+
T Consensus 227 ~--------~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 Y--------DFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp C--------CCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C--------CCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1 1121 234557899999999999999999997654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-48 Score=415.42 Aligned_cols=274 Identities=24% Similarity=0.349 Sum_probs=215.2
Q ss_pred HHHHHHhcCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceE
Q 042346 493 LSELAAATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVG 566 (812)
Q Consensus 493 ~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~ 566 (812)
+.+++...++|++.+.||+|+||.||+|+++ +++.||||++.... ..+..+.|.+|++++++++||||++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----ChHHHHHHHHHHHHHHhcCCCCccc
Confidence 3445556788999999999999999999874 35789999986422 2334567899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchhhhhhcCCCCCc----------------cccccccHHHHHHHHHHHHHHHHHHhhcC
Q 042346 567 LVGFCQEKDERLLVYEYMSNGALHDHLHNKNNTEK----------------NSSIVNSWKMRIRIALDAARGIDYLHNYA 630 (812)
Q Consensus 567 l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~----------------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~ 630 (812)
+++++.+.+..+++|||+++|+|.++|+....... .....+++..+++|+.|++.||+|||+++
T Consensus 81 ~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 99999999999999999999999999976442211 11223578899999999999999999998
Q ss_pred CCCeEeeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc
Q 042346 631 VPSIIHRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT 710 (812)
Q Consensus 631 ~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt 710 (812)
||||||||+|||||.++.+||+|||+++...............+|+.|+|||.+.+..|+.++|||||||+||||++
T Consensus 161 ---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 161 ---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp ---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 99999999999999999999999999976554444444455678999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 711 GKKAVFKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 711 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
|..|++.... . ......+..+... ..+ ..++..+.+|+.+||+.||++||||.||+++|+++
T Consensus 238 ~~~~p~~~~~---~----~e~~~~v~~~~~~-------~~p----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 238 YGLQPYYGMA---H----EEVIYYVRDGNIL-------ACP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTCCTTTTSC---H----HHHHHHHHTTCCC-------CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cCCCCCCCCC---H----HHHHHHHHcCCCC-------CCC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9755433221 1 1122333333321 111 22344688999999999999999999999999987
Q ss_pred H
Q 042346 791 L 791 (812)
Q Consensus 791 ~ 791 (812)
.
T Consensus 300 ~ 300 (301)
T d1lufa_ 300 C 300 (301)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=404.31 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=199.2
Q ss_pred eeeccCCcEEEEEEEEcC---CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEe
Q 042346 507 NKVGIGSFGTVYKGKLMD---GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 507 ~~LG~G~fG~Vy~a~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
++||+|+||+||+|.+++ ++.||||++.... ......+.|.+|+++|++++|||||++++++.+ +..+|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh---CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEc
Confidence 579999999999998753 4679999986421 223345679999999999999999999999965 457899999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccC
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
+++|+|.++++.... +++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 89 ~~~g~L~~~l~~~~~--------l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 89 AELGPLNKYLQQNRH--------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp CTTEEHHHHHHHCTT--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCCcHHHHHhhccC--------CCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhc
Confidence 999999999976542 367888999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHhcccc
Q 042346 664 SECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILAGQLH 741 (812)
Q Consensus 664 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (812)
...... .......||+.|||||.+....++.++|||||||+||||+| |+.||.... . ......+..+.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----~----~~~~~~i~~~~-- 227 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----G----SEVTAMLEKGE-- 227 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----H----HHHHHHHHTTC--
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC----H----HHHHHHHHcCC--
Confidence 543332 23344578999999999999999999999999999999998 898985322 1 11222233321
Q ss_pred ccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 742 CVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 742 ~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
++..|. .+++.+.+|+.+||+.||++|||++||++.|+....
T Consensus 228 -----~~~~p~----~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 228 -----RMGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -----CCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCc----ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 222222 334568899999999999999999999999887654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=408.70 Aligned_cols=252 Identities=19% Similarity=0.315 Sum_probs=202.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
+.|++.+.||+|+||+||+|++. +++.||||++..... +..+.|.+|+++|++++|||||++++++.+++..+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 35899999999999999999985 588999999864321 223567899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... .+++.++..++.||++||.|||+++ |+||||||+|||++.++++||+|||+
T Consensus 87 vmEy~~~g~L~~~~~~~~~-------~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~ 156 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELER-------PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGV 156 (288)
T ss_dssp EEECCTTEEHHHHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEecCCCCcHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechh
Confidence 9999999999999865432 1356777899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccc-----cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHH
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYV-----MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
++..... ........||+.|||||++. ...|+.++|||||||+||||+||+.||.... ..+.. ..
T Consensus 157 a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~----~~~~~----~~ 226 (288)
T d2jfla1 157 SAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN----PMRVL----LK 226 (288)
T ss_dssp CEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC----GGGHH----HH
T ss_pred hhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC----HHHHH----HH
Confidence 9654321 11234568999999999984 4568999999999999999999999985432 12222 12
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+..+... . ...+...++.+.+|+.+||+.||++|||++|++++
T Consensus 227 i~~~~~~-----~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 227 IAKSEPP-----T----LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHSCCC-----C----CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHcCCCC-----C----CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222111 1 11123445678899999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=407.32 Aligned_cols=278 Identities=24% Similarity=0.360 Sum_probs=206.9
Q ss_pred CHHHHHHhcCCcceeeeeccCCcEEEEEEEEcC------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCc
Q 042346 492 TLSELAAATNNFSLENKVGIGSFGTVYKGKLMD------GREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHL 564 (812)
Q Consensus 492 ~~~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nI 564 (812)
+..+++...++|++.++||+|+||.||+|++.. ++.||||++.... .....+.+.+|.+++.++ +|+||
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~i 79 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNV 79 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeE
Confidence 345565666789999999999999999998642 4689999986321 233345677788877776 78999
Q ss_pred eEEEEEEEeCC-eEEEEEEecCCCchhhhhhcCCCCCc--------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 042346 565 VGLVGFCQEKD-ERLLVYEYMSNGALHDHLHNKNNTEK--------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSII 635 (812)
Q Consensus 565 v~l~~~~~~~~-~~~lV~ey~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~iv 635 (812)
+.+++++.+.+ ..++||||+++|+|.++|+....... .....+++.++++++.||++||+|||+++ |+
T Consensus 80 v~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iv 156 (299)
T d1ywna1 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 156 (299)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred EEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---Cc
Confidence 99999987654 57999999999999999976543211 11234588999999999999999999998 99
Q ss_pred eeccCCCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCC
Q 042346 636 HRDIKSSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAV 715 (812)
Q Consensus 636 HrDlKp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~ 715 (812)
||||||+||||++++++||+|||+++...............||+.|||||++.+..++.++|||||||++|||+|+..|+
T Consensus 157 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp CSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765544444455668999999999999999999999999999999999986543
Q ss_pred CCCCCCCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 716 FKNEDGSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+..... . +.....+..+. ++..+. ..++.+.+|+.+||+.||++|||++||+++|+++++.
T Consensus 237 ~~~~~~---~---~~~~~~~~~~~-------~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 237 YPGVKI---D---EEFCRRLKEGT-------RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp STTCCC---S---HHHHHHHHHTC-------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCH---H---HHHHHHHhcCC-------CCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 322211 1 11122222222 111122 2344578999999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=406.54 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=203.8
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
.++|++.+.||+|+||+||+|+++++++||||++..... ..+.|.+|+.++++++|||||++++++.+ +..++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC------CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence 457999999999999999999998888999999864321 23568899999999999999999999854 56899
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++..... ..++|.++++|+.||+.||+|||+++ |+||||||+||||+.++++||+|||+
T Consensus 89 v~Ey~~~g~l~~~~~~~~~------~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETG------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp EECCCTTCBHHHHHSHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EEEecCCCchhhhhhhccc------ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccch
Confidence 9999999999999865421 22488999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++...... ........+|+.|+|||++....++.++||||||++||||++|+.|+..... .......+..+.
T Consensus 160 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~~~ 231 (285)
T d1fmka3 160 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGY 231 (285)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTC
T ss_pred hhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcC
Confidence 98654322 2233446789999999999999999999999999999999998887754332 111222222221
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+... ..++++.+.+||.+||+.||++||||++|++.|+..+..
T Consensus 232 -------~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 232 -------RMPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -------CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -------CCCC----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1111 123455688999999999999999999999999886643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=417.94 Aligned_cols=264 Identities=22% Similarity=0.350 Sum_probs=202.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.++||+|+||+||+|++. +++.||+|++..... ......+.+|+++|++++|||||+++++|.+++..
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3567999999999999999999975 689999999864321 22345788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhc-CCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNY-AVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~-~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
+|||||+++|+|.+++.+... +++.....++.||++||.|||++ + |+||||||+||||+.++++||+|
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~--------l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~D 148 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGR--------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCD 148 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEcCCCCcHHHHHhhcCC--------CCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEee
Confidence 999999999999999976542 35677789999999999999975 6 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQIL 736 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 736 (812)
||+|+.... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||....... .... .....
T Consensus 149 FGla~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~--~~~~---~~~~~ 219 (322)
T d1s9ja_ 149 FGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELM---FGCQV 219 (322)
T ss_dssp CCCCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH--HHHH---C----
T ss_pred CCCccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHH---HHHHh
Confidence 999975422 12345689999999999999999999999999999999999999996533211 0000 00000
Q ss_pred hcccc---------------ccccc--------------cCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 737 AGQLH---------------CVLDK--------------RVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 737 ~~~~~---------------~~~d~--------------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+... ...+. ...++.......+..+.+|+.+||..||++|||++|+++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000 00000 0011111122234568899999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-47 Score=407.26 Aligned_cols=247 Identities=25% Similarity=0.353 Sum_probs=200.8
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
.|+..+.||+|+||+||+|++. +++.||||++..... ...+..+.+.+|+++|++++|||||++++++.+++..|+|
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS--CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc--cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 4999999999999999999874 688999999865322 2234456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+++|+|..++..+.. +++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 94 ~E~~~~g~l~~~~~~~~~--------l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKP--------LQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (309)
T ss_dssp EECCSEEHHHHHHHHTSC--------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred EEecCCCchHHHHHhCCC--------CCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccc
Confidence 999999999877654432 367788899999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCCccCcccccc---CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVM---NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
..... .....||+.|||||++.+ ..|+.++|||||||+||||++|+.||..... . .....+..
T Consensus 163 ~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~-~~~~~i~~ 228 (309)
T d1u5ra_ 163 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------M-SALYHIAQ 228 (309)
T ss_dssp BSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------H-HHHHHHHH
T ss_pred cccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------H-HHHHHHHh
Confidence 76543 234579999999999864 4689999999999999999999999854221 1 11222222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVA 785 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 785 (812)
+... .......++.+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~----------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 229 NESP----------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCCC----------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC----------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2211 1111233456889999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-47 Score=409.48 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=190.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 578 (812)
.+.|++.+.||+|+||+||+|+++ +++.||||++..... ......+.+|+++|++++||||+++++++.+++..|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456999999999999999999985 589999999864221 223456889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc---CCCcEEEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD---VNWTARVS 655 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kl~ 655 (812)
|||||+++|+|.++|..... +++.....++.||+.||+|||+++ |+||||||+|||++ +++.+||+
T Consensus 84 lvmE~~~gg~L~~~l~~~~~--------l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~ 152 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGF--------YTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMIS 152 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEeccCCCcHHHhhhcccC--------CCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEe
Confidence 99999999999999976432 356777899999999999999998 99999999999994 57899999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||+++...... ......||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......+
T Consensus 153 DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i 221 (307)
T d1a06a_ 153 DFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQI 221 (307)
T ss_dssp CC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHH
T ss_pred ccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 999997654322 23456799999999999999999999999999999999999999854221 1122233
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+.. ..+.......++.+.+|+.+||+.||++|||++|++++
T Consensus 222 ~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 222 LKAEY--------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HTTCC--------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hccCC--------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 33221 11111223445668899999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=402.53 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=197.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC----CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD----GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK 574 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 574 (812)
..++|++.+.||+|+||.||+|++.. +..||||++... ......+.|.+|++++++++||||+++++++. +
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 34679999999999999999998753 346888887532 22344567899999999999999999999986 4
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
+..++||||+++|+|.+++...... +++..++.++.||++||+|||+++ |+||||||+|||++.++.+||
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~-------l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl 149 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYS-------LDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKL 149 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTT-------SCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEE
T ss_pred CeEEEEEEeccCCcHHhhhhccCCC-------CCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEE
Confidence 6789999999999999998755432 367888999999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
+|||+++...... ........||+.|+|||++....++.++|||||||+||||+| |+.||.... ..++. .
T Consensus 150 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~----~~~~~----~ 220 (273)
T d1mp8a_ 150 GDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK----NNDVI----G 220 (273)
T ss_dssp CC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC----GGGHH----H
T ss_pred ccchhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC----HHHHH----H
Confidence 9999998654422 223345678999999999999999999999999999999998 777774332 12222 2
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
.+..+. +...+ ..+++.+.+||.+||..||++|||++||+++|+++++.
T Consensus 221 ~i~~~~-------~~~~~----~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 221 RIENGE-------RLPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHTTC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCC-------CCCCC----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 222322 11111 23445688999999999999999999999999998865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-46 Score=410.10 Aligned_cols=252 Identities=19% Similarity=0.279 Sum_probs=205.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..+|
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 57999999999999999999974 68999999986422 2234578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc--CCCcEEEEee
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD--VNWTARVSDF 657 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~--~~~~~kl~Df 657 (812)
||||+++|+|.++|..... .+++...+.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+||
T Consensus 101 vmE~~~gg~L~~~l~~~~~-------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHN-------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp EECCCCSCBHHHHHTCTTS-------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCC
T ss_pred EEEcCCCCCHHHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeec
Confidence 9999999999999964432 1367788899999999999999998 99999999999995 4678999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|+++...... ......||+.|||||++.+..++.++|||||||+||||++|+.||.... .......+..
T Consensus 171 G~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~ 239 (350)
T d1koaa2 171 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKS 239 (350)
T ss_dssp TTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH
T ss_pred chheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHh
Confidence 9998765432 2345689999999999999999999999999999999999999985432 1122223333
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ..+......+++.+.+|+.+||..||++|||++|++++
T Consensus 240 ~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 240 CDW--------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp TCC--------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCC--------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 221 11111123345668899999999999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=401.89 Aligned_cols=257 Identities=20% Similarity=0.296 Sum_probs=206.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhh-HHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNK-LREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
.++|++.+.||+|+||+||+|+++ +|+.||||++........ .....+.|.+|+++|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357999999999999999999984 689999999864322211 112356788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC----cEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW----TAR 653 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~k 653 (812)
||||||+++|+|.++|..... +++...+.++.||+.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~--------l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES--------LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEE
T ss_pred EEEEEcCCCccccchhccccc--------cchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceE
Confidence 999999999999999976532 366778899999999999999998 99999999999998776 499
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|+|||++....... ......+|+.|||||++.+..++.++|||||||+||||++|+.||..... .....
T Consensus 158 l~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~ 226 (293)
T d1jksa_ 158 IIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLA 226 (293)
T ss_dssp ECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH
T ss_pred ecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHH
Confidence 99999998764432 23456799999999999999999999999999999999999999864321 11222
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+..... ..+.......+..+.+|+.+||+.||++|||++|++++
T Consensus 227 ~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 227 NVSAVNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHTTCC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHhcCC--------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222221 11111112344568899999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=400.20 Aligned_cols=272 Identities=27% Similarity=0.379 Sum_probs=204.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC----e
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD----E 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~ 576 (812)
.+|.+.++||+|+||.||+|++ +|+.||||++.... .....++.|+..+..++||||+++++++.+++ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 4688999999999999999997 68999999986311 11222345666777889999999999998754 5
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcC-----CCCeEeeccCCCCEEEcCCCc
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYA-----VPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~-----~~~ivHrDlKp~NILl~~~~~ 651 (812)
.++||||+++|+|.++|++.. ++|..+++++.|++.||+|||+.. .++|+||||||+||||+.+++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~---------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYT---------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCC---------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred EEEEEecccCCCHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 789999999999999997642 378999999999999999999751 145999999999999999999
Q ss_pred EEEEeecccccCCCCccc--ccccccccCCCccCccccccC------cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCC
Q 042346 652 ARVSDFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVMN------VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSG 723 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~ 723 (812)
+||+|||+++........ .......||+.|||||++... .++.++|||||||+||||+||..|+........
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 999999999765443222 233456899999999998754 367899999999999999999988754332221
Q ss_pred Cch-------hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 724 PLD-------VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 724 ~~~-------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+.. ..+........+.+ ++.+. ......+....+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKL----RPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCC----CCCCC-GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhcccc----CCCCC-cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 111 11222222222221 11111 1222345677899999999999999999999999999987753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=404.09 Aligned_cols=259 Identities=22% Similarity=0.422 Sum_probs=200.6
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCc----EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGR----EVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 575 (812)
++|++.++||+|+||+||+|++. +++ +||+|++... ...+..+.|.+|++++++++|||||+++++|.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 45999999999999999999874 343 5888887532 2223456789999999999999999999999865
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..++++||+.+++|.+++...... +++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~-------~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~ 153 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDN-------IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKIT 153 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSS-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEEC
T ss_pred CeeEEEEeccCCcccccccccccC-------CCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEee
Confidence 567889999999999998765432 367888999999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||.... ...+.. .
T Consensus 154 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~----~~~~~~----~ 225 (317)
T d1xkka_ 154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISS----I 225 (317)
T ss_dssp CCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----GGGHHH----H
T ss_pred ccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC----HHHHHH----H
Confidence 9999987665444444455678999999999999999999999999999999999 566664322 112221 2
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
+..+. ++..+ ..+++.+.+|+.+||+.||++|||++||+++|+++.+.
T Consensus 226 i~~~~-------~~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 226 LEKGE-------RLPQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHTC-------CCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHcCC-------CCCCC----cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 22221 22222 22345688999999999999999999999999987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=396.96 Aligned_cols=251 Identities=27% Similarity=0.450 Sum_probs=195.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC-CeEE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK-DERL 578 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~ 578 (812)
.++|++.+.||+|+||.||+|++ .+++||||+++.. ...+.|.+|++++++++||||+++++++.++ +..+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 35688999999999999999998 5789999998642 1235688999999999999999999998654 5579
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
+||||+++|+|.++|..... ..++|..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 78 lv~ey~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg 148 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGR------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFG 148 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHH------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEEeccCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccc
Confidence 99999999999999975421 23478899999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
+++..... .....+|+.|+|||++.+..+++++||||||+++|||+| |+.||.... ..++... +..
T Consensus 149 ~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~----~~~~~~~----i~~ 215 (262)
T d1byga_ 149 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPR----VEK 215 (262)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC----GGGHHHH----HTT
T ss_pred cceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC----HHHHHHH----HHc
Confidence 99765432 233467899999999999999999999999999999999 555553321 1222222 222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERAL 791 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~ 791 (812)
+. +...+ ...+..+.+|+.+||+.||++|||+.|++++|+++.
T Consensus 216 ~~-------~~~~~----~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 216 GY-------KMDAP----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TC-------CCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-------CCCCC----ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 21 11111 223456889999999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=401.44 Aligned_cols=273 Identities=24% Similarity=0.365 Sum_probs=217.1
Q ss_pred HhcCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEE
Q 042346 498 AATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGF 570 (812)
Q Consensus 498 ~~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 570 (812)
...++|++.++||+|+||.||+|++. +++.||||++.... .......|.+|+++++++ +|||||+++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc----CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 34467999999999999999999863 45789999986422 233455788999999999 69999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhhcCCCCCc----------cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccC
Q 042346 571 CQEKDERLLVYEYMSNGALHDHLHNKNNTEK----------NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIK 640 (812)
Q Consensus 571 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~----------~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlK 640 (812)
+.+++..++||||+++|+|.++|+....... .....+++..+++++.||++||+|||+++ |+|||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLK 172 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccc
Confidence 9999999999999999999999987653211 11224588999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCC
Q 042346 641 SSNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720 (812)
Q Consensus 641 p~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 720 (812)
|+|||++.++.+||+|||+++...............||+.|+|||++....++.++||||||++||||+|++.|++....
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999877665554455667899999999999999999999999999999999996666544332
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
.. ... ...+..+. +...+ ...+..+.+||.+||+.||++||||+||++.|+++++..
T Consensus 253 ~~---~~~---~~~i~~~~-------~~~~~----~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 253 VD---SKF---YKMIKEGF-------RMLSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp SS---HHH---HHHHHHTC-------CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HH---HHH---HHHHhcCC-------CCCCc----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 11 111 11111111 11111 223456889999999999999999999999999987764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-46 Score=407.33 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=205.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+++|++|+|||||++++++.+++..||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46999999999999999999974 69999999986422 2234568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc--CCCcEEEEee
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD--VNWTARVSDF 657 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~--~~~~~kl~Df 657 (812)
||||+++|+|.+++..... .++..+.+.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+||
T Consensus 104 vmE~~~gg~L~~~~~~~~~-------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DF 173 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDY-------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDF 173 (352)
T ss_dssp EEECCCCCBHHHHTTCTTC-------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEEcCCCChHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeec
Confidence 9999999999998865432 1356777899999999999999998 99999999999997 5789999999
Q ss_pred cccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 658 GLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 658 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
|++....... ......||+.|||||++.+..++.++|||||||+||||+||+.||..... ......+..
T Consensus 174 Gla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~ 242 (352)
T d1koba_ 174 GLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKR 242 (352)
T ss_dssp TTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHH
T ss_pred ccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh
Confidence 9998765432 23456799999999999999999999999999999999999999854321 112222333
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
+.. ..+......++..+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 243 CDW--------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCC--------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCC--------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 221 11222223445668899999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-46 Score=395.88 Aligned_cols=263 Identities=23% Similarity=0.367 Sum_probs=202.6
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe--
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE-- 576 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-- 576 (812)
.++|++.+.||+|+||+||+|++. +++.||||++.... ....+..+.|.+|+++++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh--ccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 467999999999999999999874 69999999986422 2224455678999999999999999999999986543
Q ss_pred --EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 577 --RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 577 --~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
.||||||+++++|.+++..... +++.+.+.++.||++||+|||+++ |+||||||+|||++.++..+|
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~--------l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGP--------MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEE
T ss_pred ceEEEEEECCCCCEehhhhcccCC--------CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCcccccee
Confidence 7899999999999999876543 366778899999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCcc-cccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 655 SDFGLSLLGSECDQ-EFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 655 ~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
+|||++........ ........||+.|||||++.+..++.++|||||||+||||+||+.||.... ..+....
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~ 225 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQ 225 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHH
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-------HHHHHHH
Confidence 99999875443222 223445689999999999999999999999999999999999999985422 1111122
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-NITDIVANLERAL 791 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~Le~~~ 791 (812)
.+..+.. ++.......++.+.+++.+||+.||++|| |++++++.|.++.
T Consensus 226 ~~~~~~~---------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 226 HVREDPI---------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHCCCC---------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHhcCCC---------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 2221111 11111223456688999999999999999 8999999998864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=394.19 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=195.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC--C--cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD--G--REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~--g--~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
++|++.+.||+|+||+||+|++.. + ..||||++..... ...+..+.|.+|++++++++||||+++++++.+ +.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 569999999999999999998642 2 3789998764221 223445678999999999999999999999975 46
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.++||||+++|+|.+++..... .+++..+++++.||++||.|||+++ |+||||||+||||+.++++||+|
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~-------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQG-------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG-------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred hheeeeeecCcchhhhhhcccC-------CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeecc
Confidence 7899999999999999875432 2478888999999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCccc-ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCCCCCCchhHHHHHHH
Q 042346 657 FGLSLLGSECDQE-FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNEDGSGPLDVVEFAVSQ 734 (812)
Q Consensus 657 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 734 (812)
||+++........ .......++..|+|||++.+..++.++||||||+++|||+| |+.||.... ..+ ....
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-------~~~-~~~~ 226 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQ-ILHK 226 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHH-HHHH
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-------HHH-HHHH
Confidence 9999876554332 23344567889999999999999999999999999999998 888885322 111 1222
Q ss_pred HHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 042346 735 ILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERA 790 (812)
Q Consensus 735 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~ 790 (812)
+.... .++..+ ...+..+.+|+.+||+.||++|||++||++.|+++
T Consensus 227 i~~~~------~~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 227 IDKEG------ERLPRP----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHTSC------CCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCC------CCCCCc----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22221 111111 23345688999999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=398.10 Aligned_cols=270 Identities=26% Similarity=0.408 Sum_probs=208.7
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEcC--------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLMD--------GREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVG 569 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~ 569 (812)
..++|++.+.||+|+||.||+|+... +..||||++.... ......++.+|...+.++ +|||||++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 34579999999999999999998632 2479999986422 123345678888888888 8999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhhcCCCCC--------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCC
Q 042346 570 FCQEKDERLLVYEYMSNGALHDHLHNKNNTE--------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKS 641 (812)
Q Consensus 570 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~--------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp 641 (812)
+|.+++..++||||+++|+|.++|....... ......+++.++++++.||+.||+|||+++ ||||||||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp 163 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA 163 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecc
Confidence 9999999999999999999999997664321 111234588999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHc-CCCCCCCCCC
Q 042346 642 SNILLDVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLT-GKKAVFKNED 720 (812)
Q Consensus 642 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-G~~p~~~~~~ 720 (812)
+|||++.++.+||+|||+++...............+|+.|+|||.+.+..|+.++||||||++||||++ |+.||....
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~- 242 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 242 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-
Confidence 999999999999999999987655444444556689999999999999999999999999999999998 566653211
Q ss_pred CCCCchhHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhc
Q 042346 721 GSGPLDVVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAIC 794 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~ 794 (812)
.+.....+..+. ++..+. ..++.+.+|+.+||+.||++|||+.||++.|+++++..
T Consensus 243 -------~~~~~~~i~~~~-------~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 243 -------VEELFKLLKEGH-------RMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp -------HHHHHHHHHTTC-------CCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------HHHHHHHHHcCC-------CCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 112222222221 111222 23456889999999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=400.34 Aligned_cols=267 Identities=27% Similarity=0.455 Sum_probs=206.8
Q ss_pred CCcceeeeeccCCcEEEEEEEEcC-Cc--EEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMD-GR--EVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 576 (812)
++|++.++||+|+||+||+|++++ +. .||||++... ...+..+.|.+|+++|+++ +||||+++++++.+++.
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc----cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 569999999999999999998754 43 4778876432 1223455789999999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCC--------ccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTE--------KNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV 648 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~--------~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~ 648 (812)
.++||||+++|+|.++|+...... ......+++..+++++.||++||.|||+++ |+||||||+|||++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcC
Confidence 999999999999999997653211 011234588999999999999999999998 999999999999999
Q ss_pred CCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 649 NWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 649 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
++.+||+|||+++...... ......+|..|+|||.+....++.++|||||||+||||++|..|++...+ ..+
T Consensus 163 ~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~-- 234 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAE-- 234 (309)
T ss_dssp GGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHH--
T ss_pred CCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHH--
Confidence 9999999999997544321 22345689999999999999999999999999999999998776543321 111
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcc
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 795 (812)
....+..+. ++..+ ...++.+.+||.+||+.||++||||+||+++|+++++...
T Consensus 235 --~~~~i~~~~-------~~~~~----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 235 --LYEKLPQGY-------RLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp --HHHHGGGTC-------CCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred --HHHHHHhcC-------CCCCC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 122222221 22222 2344568899999999999999999999999999987543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-46 Score=396.78 Aligned_cols=260 Identities=26% Similarity=0.464 Sum_probs=205.8
Q ss_pred eeeeeccCCcEEEEEEEEcCC----cEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEe-CCeEEE
Q 042346 505 LENKVGIGSFGTVYKGKLMDG----REVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQE-KDERLL 579 (812)
Q Consensus 505 ~~~~LG~G~fG~Vy~a~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~l 579 (812)
+.++||+|+||+||+|++.++ ..||||++.... .....+.|.+|++++++++||||+++++++.+ +...++
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC----CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc----CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 367899999999999997542 258999986321 23445779999999999999999999999876 457899
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.++++..... ..+..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+
T Consensus 107 v~E~~~~g~l~~~~~~~~~~-------~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~ 176 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHN-------PTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 176 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCC-------CBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred EEEEeecCchhhhhcccccc-------chHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccc
Confidence 99999999999998765432 256788999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCccc--ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHh
Q 042346 660 SLLGSECDQE--FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILA 737 (812)
Q Consensus 660 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 737 (812)
++........ .......||+.|+|||.+....++.++||||||++||||+||+.||...... .++.. .+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---~~~~~----~i~~ 249 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITV----YLLQ 249 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHH----HHHT
T ss_pred hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH---HHHHH----HHHc
Confidence 9876543322 2233457899999999999999999999999999999999999888653322 12222 2222
Q ss_pred ccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhccc
Q 042346 738 GQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQD 796 (812)
Q Consensus 738 ~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~~ 796 (812)
+. ++..|. ..++.+.+||.+||+.||++||||+||+++|+++++....
T Consensus 250 g~-------~~~~p~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 250 GR-------RLLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp TC-------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CC-------CCCCcc----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 22 222222 2345688999999999999999999999999999876444
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.5e-46 Score=397.60 Aligned_cols=260 Identities=23% Similarity=0.345 Sum_probs=209.0
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||+||+|+++ +|+.||||++... ........+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~--~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE--IVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchH--HccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 45999999999999999999984 5899999998631 11122335678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++...... +......++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 82 vmE~~~gg~l~~~~~~~~~~--------~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRF--------PNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSC--------CHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeeecCCccccccccccccc--------cccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 99999999999999876543 34556779999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++..... .....||+.|||||++.+..|+.++|||||||+||||++|+.||.... .......+..+.
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~ 217 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAE 217 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCC
T ss_pred ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHcCC
Confidence 9875442 235689999999999999999999999999999999999999995432 112222333332
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH-------HHHHHHhcccCC
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN-------LERALAICQDCS 798 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~-------Le~~~~~~~~~~ 798 (812)
. ..+. ..++.+.+++.+||..||.+|| |++|+++| .+++.+.-.+.|
T Consensus 218 ~--------~~p~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p 276 (316)
T d1fota_ 218 L--------RFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 276 (316)
T ss_dssp C--------CCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred C--------CCCC----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcC
Confidence 1 1111 2334578899999999999996 99999985 355554444443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=404.78 Aligned_cols=273 Identities=24% Similarity=0.400 Sum_probs=216.1
Q ss_pred HHHHhcCCcceeeeeccCCcEEEEEEEEc------CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEE
Q 042346 495 ELAAATNNFSLENKVGIGSFGTVYKGKLM------DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLV 568 (812)
Q Consensus 495 el~~~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~ 568 (812)
+++...++|++.++||+|+||+||+|.+. +++.||||++.... .......|.+|++++++++||||++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~----~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc----ChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 34455678999999999999999999863 35789999986321 233455789999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCchhhhhhcCCCCCc--cccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEE
Q 042346 569 GFCQEKDERLLVYEYMSNGALHDHLHNKNNTEK--NSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 569 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~--~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl 646 (812)
+++..++..++||||+++|+|.+++........ .....+++..+++++.|+++||.|||+++ |+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence 999999999999999999999999875432110 11122478889999999999999999998 9999999999999
Q ss_pred cCCCcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCch
Q 042346 647 DVNWTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLD 726 (812)
Q Consensus 647 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~ 726 (812)
+.++++||+|||+++...............+|+.|+|||.+.+..++.++||||||++||||+||+.|++....
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------ 240 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------ 240 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------
Confidence 99999999999999876554444445556799999999999999999999999999999999999755433221
Q ss_pred hHHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 042346 727 VVEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALA 792 (812)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~ 792 (812)
.......+..+.. +..+ ..++..+.+|+.+||+.||++||||+||+++|++.++
T Consensus 241 -~~~~~~~i~~~~~-------~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 241 -NEQVLRFVMEGGL-------LDKP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -HHHHHHHHHTTCC-------CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHHHHHHHhCCC-------CCCc----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1122223333321 1112 2234568899999999999999999999999987655
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-45 Score=388.74 Aligned_cols=256 Identities=23% Similarity=0.307 Sum_probs=208.2
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcch----hhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKT----NKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEK 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~----~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~ 574 (812)
++|++.+.||+|+||+||+|++ .+++.||||++...... ...+...+.+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999997 46899999998654322 122344567889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 575 DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 575 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
+..||||||+++|+|.++|+.+.. +++....+++.||++||+|||+++ |+||||||+|||++.++.+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~--------l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl 151 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVT--------LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL 151 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEE
Confidence 999999999999999999976542 367788999999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCcccccccccccCCCccCcccccc------CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 655 SDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM------NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 655 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
+|||+++...... ......||+.|+|||++.+ ..++.++||||+||+||||++|+.||.... .
T Consensus 152 ~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~ 220 (277)
T d1phka_ 152 TDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------Q 220 (277)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------H
T ss_pred ccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------H
Confidence 9999998765422 2345689999999999863 347889999999999999999999995432 1
Q ss_pred HHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 729 EFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......+..+.. ..+......+++.+.+|+.+||+.||++|||++|++++
T Consensus 221 ~~~~~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 221 MLMLRMIMSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHHHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhCCC--------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 122233333322 11222233455678899999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=398.00 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=204.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+|+.+ +++.||||++... ........+.+.+|+++|++++||||+++++++++++..|+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~--~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE--VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchh--hccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 46999999999999999999974 6999999998631 11122335678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+++|+|.+++...... +......++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 83 v~ey~~gg~L~~~~~~~~~~--------~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVF--------TEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCC--------CHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceeccCCCchhhhhhcccCC--------cHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccc
Confidence 99999999999999876543 33455779999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++...... .......||+.|||||++.+..|+.++|||||||+||||++|+.||..... ......+..+.
T Consensus 152 a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~~ 221 (337)
T d1o6la_ 152 CKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE 221 (337)
T ss_dssp CBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC
T ss_pred ccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcCC
Confidence 98654322 223456899999999999999999999999999999999999999865331 11222232222
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 786 (812)
+..|. .++..+.+||.+||+.||++||+ ++|+++|
T Consensus 222 --------~~~p~----~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 --------IRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------CCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------CCCCc----cCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 12222 23445788999999999999994 8999885
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-45 Score=396.63 Aligned_cols=248 Identities=24% Similarity=0.308 Sum_probs=203.5
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.+.||+|+||.||+|+++ +|+.||||++... ........+.+.+|+++|+.++||||+++++++.+....++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~--~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--HHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchH--HccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 46999999999999999999985 6999999998631 11122334578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+.+|+|.+++..... ++......++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 119 v~e~~~~g~l~~~l~~~~~--------l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGR--------FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EEECCTTCBHHHHHHHHCC--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ccccccccchhhhHhhcCC--------CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 9999999999999976543 255677889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
++..... .....||+.|||||++.+..++.++|||||||+||||+||+.||.... . ......+..+.
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~----~~~~~~i~~~~ 254 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----P----IQIYEKIVSGK 254 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----H----HHHHHHHHHCC
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC----H----HHHHHHHhcCC
Confidence 9876432 234679999999999999999999999999999999999999995422 1 11222233322
Q ss_pred ccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 740 LHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 740 ~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
...+. ..+..+.+|+.+||..||.+|+ |++|+++|
T Consensus 255 --------~~~p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 --------VRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --------CCCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --------CCCCc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 11121 2344578899999999999994 99999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=394.22 Aligned_cols=253 Identities=17% Similarity=0.250 Sum_probs=204.3
Q ss_pred hcCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeE
Q 042346 499 ATNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDER 577 (812)
Q Consensus 499 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 577 (812)
..++|++.+.||+|+||+||+|++. +++.||||++.... .....+.+|+++|+.++||||+++++++++++..
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 3567999999999999999999985 58899999986421 1234578999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC--CcEEEE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN--WTARVS 655 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~--~~~kl~ 655 (812)
||||||+++|+|.++|...... ++..+...++.||+.||+|||+++ |+||||||+|||++.+ ..+||+
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~-------l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~ 146 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFE-------LNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKII 146 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCC-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhcCCC-------CCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEc
Confidence 9999999999999999765321 256677889999999999999998 9999999999999854 589999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
|||+++...... ......+|+.|+|||.+.+..|+.++|||||||+||||++|+.||..... ......+
T Consensus 147 DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i 215 (321)
T d1tkia_ 147 EFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENI 215 (321)
T ss_dssp CCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH
T ss_pred ccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 999997654422 23445789999999999999999999999999999999999999854321 1222333
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+.. ..+......++..+.+|+.+||..||++|||++|++++
T Consensus 216 ~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 216 MNAEY--------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTCC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HhCCC--------CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 33221 11111112345568899999999999999999999984
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.8e-45 Score=399.27 Aligned_cols=252 Identities=25% Similarity=0.310 Sum_probs=197.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHH---HHHHHHHhccCCCceEEEEEEEeCCe
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFD---SELALLSRVHHKHLVGLVGFCQEKDE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~---~Ei~~l~~l~H~nIv~l~~~~~~~~~ 576 (812)
++|++.++||+|+||.||+|++. +|+.||||++.... .........+. +|+++++.++||||+++++++.+++.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR--IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--HHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHH--cchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 57999999999999999999985 58999999985311 11112222333 35677777889999999999999999
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEe
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSD 656 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 656 (812)
.||||||+++|+|.++|...... +......++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~--------~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVF--------SEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSC--------CHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECC
T ss_pred EEEEEEecCCCcHHHHHHhcccc--------cHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEee
Confidence 99999999999999999765432 45667889999999999999998 99999999999999999999999
Q ss_pred ecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHH
Q 042346 657 FGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQI 735 (812)
Q Consensus 657 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 735 (812)
||+++..... ......||+.|||||++.. ..|+.++|||||||+||||+||+.||....... .. ......
T Consensus 151 FGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~-~~~~~~ 221 (364)
T d1omwa3 151 LGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KH-EIDRMT 221 (364)
T ss_dssp CTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HH-HHHHHS
T ss_pred eceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----HH-HHHHhc
Confidence 9999865442 2345679999999999874 568999999999999999999999996533211 11 111111
Q ss_pred HhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 042346 736 LAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPN-----ITDIVAN 786 (812)
Q Consensus 736 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~~ 786 (812)
.......+ ..+++.+.+||.+||+.||++||| ++|+++|
T Consensus 222 --------~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 --------LTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --------SSCCCCCC----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --------ccCCCCCC----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11111111 223456889999999999999999 6899875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=391.83 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=198.2
Q ss_pred cCCcceee-eeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc-cCCCceEEEEEEEe---
Q 042346 500 TNNFSLEN-KVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRV-HHKHLVGLVGFCQE--- 573 (812)
Q Consensus 500 ~~~~~~~~-~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~--- 573 (812)
.++|.+.+ .||+|+||.||+|++ .+++.||||++... ..+.+|++++.++ +||||++++++|++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 35688765 699999999999987 46899999998631 2356789887654 89999999999876
Q ss_pred -CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC---C
Q 042346 574 -KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV---N 649 (812)
Q Consensus 574 -~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~ 649 (812)
+...||||||+++|+|.++|...... .+++.+...|+.||+.||+|||+++ |+||||||+|||++. +
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~------~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~ 150 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQ------AFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPN 150 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCC------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCC------CcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccc
Confidence 34579999999999999999764321 2367788899999999999999998 999999999999975 4
Q ss_pred CcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 650 WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 650 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
+.+||+|||+++...... ......||+.|||||++.+..|+.++|||||||+||||+||+.||........ ..
T Consensus 151 ~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~----~~ 223 (335)
T d2ozaa1 151 AILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SP 223 (335)
T ss_dssp CCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred ccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH----HH
Confidence 679999999998655422 23456899999999999999999999999999999999999999965432111 11
Q ss_pred HHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 730 FAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ..+.......+.......++.+.+|+.+||+.||++|||++|++++
T Consensus 224 ~~~--------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 224 GMK--------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHH--------HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 1111112222322334567789999999999999999999999885
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=390.68 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=199.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHH-hccCCCceEEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLS-RVHHKHLVGLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~-~l~H~nIv~l~~~~~~~~~~~ 578 (812)
++|++.+.||+|+||+||+|++. +++.||||++... .....+..+.+..|..++. .++||||+++++++.+++..|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~--~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD--VVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHH--HHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchh--hccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 57999999999999999999985 5899999998631 1111223345566666655 689999999999999999999
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeec
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFG 658 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfG 658 (812)
|||||+++|+|.++++..... +..+.+.++.||+.||+|||+++ |+||||||+|||+++++++||+|||
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~--------~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKF--------DLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSC--------CHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEeecCCCcHHHHhhccCCC--------CHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccc
Confidence 999999999999999865532 44567889999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 659 LSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 659 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.... .......+..+
T Consensus 149 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~ 218 (320)
T d1xjda_ 149 MCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMD 218 (320)
T ss_dssp TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC
T ss_pred hhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC
Confidence 998654322 23345689999999999999999999999999999999999999995432 11222233322
Q ss_pred cccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 042346 739 QLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNIT-DIVA 785 (812)
Q Consensus 739 ~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl~ 785 (812)
. ...+. ..+..+.+|+.+||..||++|||+. |+++
T Consensus 219 ~--------~~~p~----~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 N--------PFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C--------CCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C--------CCCCc----cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2 11121 2345578999999999999999995 7865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=385.62 Aligned_cols=265 Identities=23% Similarity=0.248 Sum_probs=191.8
Q ss_pred eeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEEEEe
Q 042346 505 LENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 505 ~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 583 (812)
.+++||+|+||+||+|+++ +++.||||++.............+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999974 589999999865332222222345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecccccC
Q 042346 584 MSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLSLLG 663 (812)
Q Consensus 584 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla~~~ 663 (812)
+.++++..++...... +......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~~~~~~~~~~~~l--------~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVL--------TPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp CSEEHHHHHTTCCSSC--------CSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred hcchHHhhhhhcccCC--------CHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccccc
Confidence 9988777776544322 23445789999999999999998 999999999999999999999999999765
Q ss_pred CCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhccccc
Q 042346 664 SECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQLHC 742 (812)
Q Consensus 664 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (812)
..... ......||+.|||||++.. ..|+.++|||||||+||||++|+.||....+ .+................
T Consensus 151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~----~~~l~~i~~~~~~~~~~~ 224 (299)
T d1ua2a_ 151 GSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIFETLGTPTEEQ 224 (299)
T ss_dssp TSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCTTT
T ss_pred CCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH----HHHHHHHHHhcCCCChhh
Confidence 44322 2344579999999999864 4689999999999999999999988854321 111111111110000000
Q ss_pred cccc-------cC-CCCCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 743 VLDK-------RV-GPPELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 743 ~~d~-------~~-~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..+. .. ..+.... ....+.+.+|+.+||+.||++|||++|+++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000 00 0001111 1234568899999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=375.91 Aligned_cols=267 Identities=21% Similarity=0.305 Sum_probs=197.1
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|++.++||+|+||+||+|++ .+++.||||++.... ......+.+.+|++++++++|||||++++++.+++..|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh---cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 5799999999999999999997 468999999986421 222335678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
||||+.+ ++.+++...... .+++.....++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 79 v~e~~~~-~~~~~~~~~~~~------~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 79 VFEFLHQ-DLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEECCSE-EHHHHHHHTTTT------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred EEeecCC-chhhhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCc
Confidence 9999975 555555443222 1367788899999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCc-CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++...... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||..... .+............
T Consensus 149 a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 149 ARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTP 222 (298)
T ss_dssp HHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCC
T ss_pred ceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHHHhcCCC
Confidence 97654322 2334568999999999887655 57899999999999999999999854321 11111111110000
Q ss_pred ------cccccccccCCCCCCC---h----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 ------QLHCVLDKRVGPPELN---E----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ------~~~~~~d~~~~~~~~~---~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......+.....+... . ....+.+.+|+.+||+.||++|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000000000000 0 1233567899999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=379.18 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=194.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhH-HHHHHHHHHHHHHHHhcc--CCCceEEEEEEEeCC
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKL-REKESAFDSELALLSRVH--HKHLVGLVGFCQEKD 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~-~~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~ 575 (812)
.++|++.++||+|+||+||+|++. +++.||||++......... ......+.+|++++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999974 6899999998642111110 011233568999999996 999999999999999
Q ss_pred eEEEEEEecCC-CchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC-CcEE
Q 042346 576 ERLLVYEYMSN-GALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN-WTAR 653 (812)
Q Consensus 576 ~~~lV~ey~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~k 653 (812)
..++||||+.+ +++.+++..... +++.....++.||++||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~--------l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vk 151 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGA--------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 151 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS--------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEE
T ss_pred eEEEEEEeccCcchHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEE
Confidence 99999999976 688888865433 256777889999999999999998 9999999999999855 7999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccCcC-CCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVL-TAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|+|||+++..... ......||+.|||||++.+..+ +.++|||||||+||||++|+.||....
T Consensus 152 l~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------- 214 (273)
T d1xwsa_ 152 LIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------- 214 (273)
T ss_dssp ECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred ECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------
Confidence 9999999765432 2345689999999999987665 567899999999999999999984311
Q ss_pred HHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.+..+.. ..+. ..++.+.+|+.+||+.||++|||++|++++
T Consensus 215 -~i~~~~~--------~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 -EIIRGQV--------FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -HHHHCCC--------CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHhhccc--------CCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1122211 1111 123557899999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-43 Score=374.36 Aligned_cols=266 Identities=19% Similarity=0.234 Sum_probs=196.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLLV 580 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 580 (812)
++|++.++||+|+||+||+|++++++.||||++..... .....+.+.+|+.+|++++||||+++++++.+++..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG---GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 57999999999999999999999999999999865322 122345788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 581 YEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 581 ~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
|||+.++.+..+...... ++......++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 79 ~e~~~~~~~~~~~~~~~~--------l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGG--------LESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp EECCSEEHHHHHHTSTTC--------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred EEeehhhhHHHHHhhcCC--------cchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccc
Confidence 999988777666654332 256677899999999999999998 999999999999999999999999999
Q ss_pred ccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhcc
Q 042346 661 LLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAGQ 739 (812)
Q Consensus 661 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (812)
....... .......+++.|+|||.+.+ ..++.++|||||||+||||++|+.||..... .+.........-...
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~~~~~~~~ 221 (286)
T d1ob3a_ 148 RAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPN 221 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCC
T ss_pred eecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH----HHHHHHHHHhhCCCC
Confidence 7654322 12334578999999999875 4578999999999999999999999854221 111111111100000
Q ss_pred ------ccccc--cccCCC--C---CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 740 ------LHCVL--DKRVGP--P---ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 740 ------~~~~~--d~~~~~--~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
..... +..... + ........+.+.+|+.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000000 0 00012234567899999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=371.79 Aligned_cols=266 Identities=22% Similarity=0.310 Sum_probs=192.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-C-CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhc---cCCCceEEEEEEEe-
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-D-GREVAVKREESCPKTNKLREKESAFDSELALLSRV---HHKHLVGLVGFCQE- 573 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~- 573 (812)
.++|++.++||+|+||+||+|++. + ++.||||++....... .....+.+|+++++.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT---SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc---hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 367999999999999999999974 4 5679999986422111 1122345677766665 79999999999864
Q ss_pred ----CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC
Q 042346 574 ----KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 574 ----~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 649 (812)
....+++|||++++.+......... .+++.....++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~ 152 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS 152 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCC
Confidence 2357899999988776655443322 1256667789999999999999998 9999999999999999
Q ss_pred CcEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHH
Q 042346 650 WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVE 729 (812)
Q Consensus 650 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 729 (812)
+.+||+|||+++..... .......||+.|||||++.+..|+.++|||||||+||||++|+.||..... .+...
T Consensus 153 ~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~ 225 (305)
T d1blxa_ 153 GQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLG 225 (305)
T ss_dssp CCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHH
T ss_pred CCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH----HHHHH
Confidence 99999999998764432 234567899999999999999999999999999999999999999854321 11111
Q ss_pred HHHHHHHhcccccccc------------ccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 730 FAVSQILAGQLHCVLD------------KRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 730 ~~~~~~~~~~~~~~~d------------~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
........ ....... ....+.........+.+.+|+.+||+.||++|||++|+++|
T Consensus 226 ~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 226 KILDVIGL-PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHHCC-CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhCC-CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11111100 0000000 00000000112334567889999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-42 Score=365.73 Aligned_cols=263 Identities=21% Similarity=0.255 Sum_probs=197.7
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCce-EEEEEEEeCCeEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLV-GLVGFCQEKDERL 578 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~ 578 (812)
++|++.++||+|+||+||+|++. +++.||||++.... ....+.+|+++++.++|+|++ .+..++.+++..+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-------TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-------cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 57999999999999999999874 58999999876421 123467899999999877654 5556667788889
Q ss_pred EEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEc---CCCcEEEE
Q 042346 579 LVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLD---VNWTARVS 655 (812)
Q Consensus 579 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kl~ 655 (812)
+||||+ +++|.+.+..... .+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+
T Consensus 80 ivme~~-~~~l~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSR-------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred EEEEEc-CCchhhhhhhccC-------CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeee
Confidence 999999 5577777654432 1367788999999999999999998 99999999999985 45679999
Q ss_pred eecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHH
Q 042346 656 DFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEF 730 (812)
Q Consensus 656 DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~ 730 (812)
|||+++........ .......||+.|||||.+.+..++.++|||||||++|||+||+.||...............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 99999865443221 2234568999999999999999999999999999999999999999654432222211111
Q ss_pred HHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 042346 731 AVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAI 793 (812)
Q Consensus 731 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~ 793 (812)
............ ...+++.+.+++.+|++.||++||+++++.+.|+.++..
T Consensus 229 -~~~~~~~~~~~~-----------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 229 -SEKKMSTPIEVL-----------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -HHHHHHSCHHHH-----------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -hcccCCCChhHh-----------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 111111110000 012345688999999999999999999999999988764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-41 Score=359.02 Aligned_cols=266 Identities=19% Similarity=0.200 Sum_probs=206.0
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC-CCceEEEEEEEeCCeE
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH-KHLVGLVGFCQEKDER 577 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~ 577 (812)
.++|++.++||+|+||+||+|++. +++.||||++..... ...+.+|+++++.|+| +|++.+++++.++...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-------cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 468999999999999999999975 588999998754221 2246678899999965 8999999999999999
Q ss_pred EEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcC-----CCcE
Q 042346 578 LLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDV-----NWTA 652 (812)
Q Consensus 578 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-----~~~~ 652 (812)
++||||+ +++|.++++..... +++...+.++.|++.||+|||+++ |+||||||+|||++. ++.+
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~-------~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~v 145 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRK-------FSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMI 145 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTC-------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCE
T ss_pred EEEEEec-CCCHHHHHHhhccc-------hhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCce
Confidence 9999999 68999998765432 266778899999999999999998 999999999999964 5789
Q ss_pred EEEeecccccCCCCccc-----ccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchh
Q 042346 653 RVSDFGLSLLGSECDQE-----FISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDV 727 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~ 727 (812)
||+|||+++........ .......||+.|||||++.+..++.++||||||+++|||+||+.||....... ....
T Consensus 146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~-~~~~ 224 (293)
T d1csna_ 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-NKQK 224 (293)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-HHHH
T ss_pred EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh-HHHH
Confidence 99999999865432211 12345679999999999999999999999999999999999999996543221 1111
Q ss_pred HHHHHHHHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhcc
Q 042346 728 VEFAVSQILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVANLERALAICQ 795 (812)
Q Consensus 728 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~Le~~~~~~~ 795 (812)
..............++ . ..+++.+.+++..|+..+|++||+++.+.+.|+++++...
T Consensus 225 ~~~i~~~~~~~~~~~l-~----------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 225 YERIGEKKQSTPLREL-C----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHHHHHSCHHHH-T----------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHhccCCCChHHh-c----------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 1111111111111000 0 1233568889999999999999999999999999887553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=364.21 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=191.4
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC-----
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK----- 574 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----- 574 (812)
++|++.++||+|+||+||+|++. +++.||||++...... ......+.+|+++|++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 57999999999999999999974 6899999997642221 22345678999999999999999999998653
Q ss_pred ---CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCc
Q 042346 575 ---DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWT 651 (812)
Q Consensus 575 ---~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~ 651 (812)
+..++||||+.++.+..+...... ........++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~--------~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVK--------FTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGV 155 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCC--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSC
T ss_pred ccCceEEEEEeccCCCccchhhhcccc--------cccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCc
Confidence 357899999988776655543322 144556789999999999999998 999999999999999999
Q ss_pred EEEEeecccccCCCCccc--ccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhH
Q 042346 652 ARVSDFGLSLLGSECDQE--FISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVV 728 (812)
Q Consensus 652 ~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~ 728 (812)
+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....+ ....
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~----~~~~ 231 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE----QHQL 231 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHH
T ss_pred EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH----HHHH
Confidence 999999999765543221 223345799999999998754 689999999999999999999999854221 1111
Q ss_pred HHHHHHHHhccccccccccC------------CCCCCChH------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 729 EFAVSQILAGQLHCVLDKRV------------GPPELNEA------EAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 729 ~~~~~~~~~~~~~~~~d~~~------------~~~~~~~~------~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... ... .+.......... ........ .....+.+|+.+||+.||++|||++|+++|
T Consensus 232 ~~i-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 232 ALI-SQL-CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHH-HHH-HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHH-HHh-cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 111 111 111110000000 00001111 123456789999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=363.90 Aligned_cols=266 Identities=18% Similarity=0.239 Sum_probs=202.1
Q ss_pred CCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCCeEEE
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 579 (812)
++|+++++||+|+||+||+|++. +++.||||++..... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC---ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 57999999999999999999974 688999999864322 12345678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEEeecc
Q 042346 580 VYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVSDFGL 659 (812)
Q Consensus 580 V~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DfGl 659 (812)
|+||+.+++|..++...... ++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 79 v~~~~~~~~l~~~~~~~~~~--------~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDL--------DPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCC--------CHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred Eeeecccccccccccccccc--------chhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecch
Confidence 99999999998888655332 45667889999999999999998 99999999999999999999999999
Q ss_pred cccCCCCcccccccccccCCCccCccccccCc-CCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHHHHHhc
Q 042346 660 SLLGSECDQEFISTKAVGTVGYIDPEYYVMNV-LTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVSQILAG 738 (812)
Q Consensus 660 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 738 (812)
++....... ......+++.|+|||.+.... ++.++|||||||++|||++|+.||+...+ ..+....... ....
T Consensus 148 a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~---~~~~~~~~~~-~~~~ 221 (292)
T d1unla_ 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFR-LLGT 221 (292)
T ss_dssp CEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS---HHHHHHHHHH-HHCC
T ss_pred hhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC---HHHHHHHHHh-hcCC
Confidence 986554322 233446788999999987654 68999999999999999999999865332 1111111111 1110
Q ss_pred cc-------cccccc-------cCCCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 739 QL-------HCVLDK-------RVGPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 739 ~~-------~~~~d~-------~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
.. ....+. .............+.+.+|+.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000000 0000111112344567889999999999999999999874
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Probab=100.00 E-value=9.6e-40 Score=343.78 Aligned_cols=242 Identities=19% Similarity=0.306 Sum_probs=196.0
Q ss_pred ceEEEccCCCc-----ccCCCCccEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCCCCceecccCCceEEEEEccCce
Q 042346 54 QRIQCYQNGST-----IPVLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSFQPKRLHFRKAVQLTDVSVGGDQ 128 (812)
Q Consensus 54 ~~~~~~g~~~~-----~~~~~~~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~~~~~~~~~~~~~v~~ia~G~~h 128 (812)
.+|.|||.+.. +|+....+|++|++|..|+|||+ || +|||||.|.+||||.+.. ....|++|++|..|
T Consensus 4 ~sv~~WG~~~~~~~~~~~~~~~~~i~~va~G~~h~~al~-dG-~v~~wG~N~~GQlG~~~~-----~~~~v~~v~~G~~~ 76 (273)
T d1jtdb_ 4 TSVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLALK-GG-KVLGWGANLNGQLTMPAA-----TQSGVDAIAAGNYH 76 (273)
T ss_dssp SEEEEESSCCSSSTTCCCGGGSSSEEEEEECSSEEEEEE-TT-EEEEEECCTTSTTSCCGG-----GGSCCCEEEECSSE
T ss_pred CEEEEECCCCCCCceeccccCCCCcEEEEccCCEEEEEE-CC-EEEEEeCCCCCceeeeec-----ccccceEEecCCCc
Confidence 37999996544 34444458999999999999998 89 899999999999996532 23468899999999
Q ss_pred EEEEEeCCCeEEEecCCCCCCCCCCcccCCCCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCcccccccCceEEE
Q 042346 129 VCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQRGFKNLSMVG 208 (812)
Q Consensus 129 ~~al~~~~g~v~~WG~n~~gqlG~~~~~~~~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~~~~~~~~~~ 208 (812)
+|+|+ ||+|||||.|.+||++.... ....+..|++|..|+|++ .||+|++||.+..............+..
T Consensus 77 ~~al~--dg~v~~wG~~~~gq~~~~~~-----~~~~~~~i~~~~~~~~~~--~dg~v~~~g~~~~~~~~~~~~~~~~v~~ 147 (273)
T d1jtdb_ 77 SLALK--DGEVIAWGGNEDGQTTVPAE-----ARSGVDAIAAGAWASYAL--KDGKVIAWGDDSDGQTTVPAEAQSGVTA 147 (273)
T ss_dssp EEEEE--TTEEEEEECCTTSTTCCCGG-----GGSSCCEEEEETTEEEEE--ETTEEEEEECCTTSTTSCCGGGGSSEEE
T ss_pred eeeee--eeeeeccCCCcceeeccccc-----cccceeEEeeeccccccc--ccccceecccCCCCceeeeccCCceEEE
Confidence 99974 79999999999999985322 224577899999999997 4899999998776665544444455666
Q ss_pred EEeCCceeEEEeeCCcEEEEecCCCCCCCcCCCCcceeeeeeeeccceeEEEEecCCeEEEecCCCCCccccCCccccce
Q 042346 209 LVAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVIQDVSF 288 (812)
Q Consensus 209 i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~~~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~~~~~~~ 288 (812)
++++ .|++++.++|.+||||.|.+||++.+........ +|++|.+|+|+|+ ||+|||||.|.+|||+.+......+
T Consensus 148 ~~~~-~~~~~~~~~g~~~~~G~~~~g~~~~~~~~~~~v~-~Is~G~~h~~~l~--dG~v~~WG~n~~Gql~~~~~~~~~v 223 (273)
T d1jtdb_ 148 LDGG-VYTALAVKNGGVIAWGDNYFGQTTVPAEAQSGVD-DVAGGIFHSLALK--DGKVIAWGDNRYKQTTVPTEALSGV 223 (273)
T ss_dssp EEEC-SSEEEEEETTEEEEEECCTTSTTSCCGGGSSSEE-EEEECSSEEEEEE--TTEEEEEECCTTSTTCCCGGGGSSC
T ss_pred Eecc-ceeeeeecccceeEeecccCCcccccccccCCcc-ceeccceeeEEEe--cCcEEEcCCCCCCccCCCccCCCCc
Confidence 6654 5667777899999999999999997765554444 5999999999987 4999999999999999876666678
Q ss_pred eEEEeccceEEEEEcCCCeEEEecCCCCC
Q 042346 289 ESIVAGLDFVCGLTTRNLSMICWGPGWSN 317 (812)
Q Consensus 289 ~~i~ag~~~~c~~~~~~~~v~cWG~~~~~ 317 (812)
.+|++|..|+|++. |++|||||++...
T Consensus 224 ~~I~~G~~~~~~l~--~g~v~~WG~~~~~ 250 (273)
T d1jtdb_ 224 SAIASGEWYSLALK--NGKVIAWGSSRTA 250 (273)
T ss_dssp CEEEECSSCEEEEE--TTEEEEESTTCCC
T ss_pred EEEEeCcceEEEEE--CCEEEEECCCCCC
Confidence 99999999999984 6799999987544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=371.34 Aligned_cols=268 Identities=21% Similarity=0.273 Sum_probs=193.2
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
.++|++.++||+|+||+||+|++. +++.||||++.... ......+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 467999999999999999999975 59999999986422 22334567889999999999999999999998655
Q ss_pred ---eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 576 ---ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 576 ---~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
..++||||+ +.+|.++++... ++......++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~ 160 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKHEK---------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL 160 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred ccceEEEEEecc-cccHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccc
Confidence 469999999 557877775432 356777899999999999999998 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA 731 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 731 (812)
||+|||+++..... .+...+|+.|+|||++.+ ..++.++|||||||+||||++|+.||..... .......
T Consensus 161 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~----~~~~~~~ 231 (346)
T d1cm8a_ 161 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----LDQLKEI 231 (346)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred ccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh----HHHHHHH
Confidence 99999999765432 345679999999999876 4578999999999999999999999854321 1111110
Q ss_pred HHHHHh-------c-------cccccccccCCCC--CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHHh
Q 042346 732 VSQILA-------G-------QLHCVLDKRVGPP--ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN--LERALAI 793 (812)
Q Consensus 732 ~~~~~~-------~-------~~~~~~d~~~~~~--~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~~~~ 793 (812)
...... . .....+ ...... ..........+.+|+.+||..||++|||++|+++| ++.+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 232 MKVTGTPPAEFVQRLQSDEAKNYMKGL-PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHS-CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HhccCCCcHHHHhhhcchhhhhhhccC-CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 000000 0 000000 000000 00011233457789999999999999999999986 6554433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=370.72 Aligned_cols=270 Identities=20% Similarity=0.275 Sum_probs=195.9
Q ss_pred cCCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC---
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD--- 575 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 575 (812)
.++|++.++||+|+||+||+|+. .+++.||||++.... .....+.+.+|+++|++++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 45799999999999999999987 479999999986422 2334557889999999999999999999987653
Q ss_pred -eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEE
Q 042346 576 -ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARV 654 (812)
Q Consensus 576 -~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl 654 (812)
..+++++|+.+|+|.+++.... +++...+.++.||++||+|||+++ ||||||||+|||++.++.+||
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~~---------l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQH---------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred cceEEEEEeecCCchhhhhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEE
Confidence 2355566777999999997542 256777899999999999999998 999999999999999999999
Q ss_pred EeecccccCCCCccc-ccccccccCCCccCccccc-cCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 655 SDFGLSLLGSECDQE-FISTKAVGTVGYIDPEYYV-MNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 655 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
+|||+++........ .......||+.|+|||++. ...++.++||||+||++|||++|+.||..... .+......
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~----~~~~~~~~ 226 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY----LDQLNHIL 226 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH----HHHHHHHh
Confidence 999999765443222 2235567999999999985 45678999999999999999999999854321 11111111
Q ss_pred HHHHhccccccc-----------cccCCC-CCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 042346 733 SQILAGQLHCVL-----------DKRVGP-PELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN--LERA 790 (812)
Q Consensus 733 ~~~~~~~~~~~~-----------d~~~~~-~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~ 790 (812)
.. ......... ...... ..... ......+.+|+.+||+.||++|||++|++++ |++.
T Consensus 227 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 227 GI-LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HH-HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hh-ccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00 000000000 000000 00000 1123457899999999999999999999986 5443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-41 Score=364.66 Aligned_cols=261 Identities=18% Similarity=0.267 Sum_probs=193.7
Q ss_pred CCcceeeeeccCCcEEEEEEEE-cCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEEeC--Ce
Q 042346 501 NNFSLENKVGIGSFGTVYKGKL-MDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQEK--DE 576 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~--~~ 576 (812)
++|++.++||+|+||+||+|++ .+++.||||++... ..+.+.+|+++|+.++ ||||+++++++... ..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 5799999999999999999998 46899999998642 1345778999999995 99999999999854 45
Q ss_pred EEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC-cEEEE
Q 042346 577 RLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW-TARVS 655 (812)
Q Consensus 577 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~ 655 (812)
.++||||+++++|.++.+. ++......++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 107 ~~~v~e~~~~~~L~~~~~~-----------l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLYQT-----------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp EEEEEECCCSCBGGGTTTS-----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred eeEEEeecCCCcHHHHhcC-----------CCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeec
Confidence 8999999999999877531 245667889999999999999999 99999999999998654 69999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHH---
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFA--- 731 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--- 731 (812)
|||+++...... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||............+...
T Consensus 173 DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 173 DWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp CGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred ccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence 999998655432 23456789999999998764 57999999999999999999999986543211100000000
Q ss_pred ---HHHHHhccc------cccccccC------CCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 732 ---VSQILAGQL------HCVLDKRV------GPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 732 ---~~~~~~~~~------~~~~d~~~------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
......... ........ .............+.+|+.+||..||++|||++|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 00000000 01111223345567899999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=365.78 Aligned_cols=257 Identities=25% Similarity=0.311 Sum_probs=198.9
Q ss_pred CCcceeeeeccCCcEEEEEEEEc----CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccC-CCceEEEEEEEeCC
Q 042346 501 NNFSLENKVGIGSFGTVYKGKLM----DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHH-KHLVGLVGFCQEKD 575 (812)
Q Consensus 501 ~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~ 575 (812)
++|++.+.||+|+||+||+|+.. +|+.||||++........ ....+.+.+|++++++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 45999999999999999999862 478999998864221111 1123457789999999976 89999999999999
Q ss_pred eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEEEE
Q 042346 576 ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTARVS 655 (812)
Q Consensus 576 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 655 (812)
..+++|||+.+|+|.+++....... ......++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~--------e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFT--------EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCC--------HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEES
T ss_pred ceeeeeecccccHHHHHHHhccccc--------HHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEe
Confidence 9999999999999999998765432 2445678999999999999998 9999999999999999999999
Q ss_pred eecccccCCCCcccccccccccCCCccCccccccC--cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHHH
Q 042346 656 DFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN--VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAVS 733 (812)
Q Consensus 656 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 733 (812)
|||+++....... .......|++.|++||.+... .++.++|||||||+||||++|+.||....... .......
T Consensus 172 DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~ 246 (322)
T d1vzoa_ 172 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISR 246 (322)
T ss_dssp CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHH
T ss_pred eccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH
Confidence 9999976544322 223456799999999999754 47889999999999999999999996544322 2222222
Q ss_pred HHHhccccccccccCCCCCCChHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 042346 734 QILAGQLHCVLDKRVGPPELNEAEAVELLATTAIHCVNLEGKERP-----NITDIVAN 786 (812)
Q Consensus 734 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 786 (812)
...... ...+ .+.+..+.+|+.+||..||++|| |++|+++|
T Consensus 247 ~~~~~~--------~~~~----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 247 RILKSE--------PPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHCC--------CCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred hcccCC--------CCCc----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 222211 1111 23455688899999999999999 58999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-41 Score=366.52 Aligned_cols=265 Identities=20% Similarity=0.267 Sum_probs=189.9
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeCC-----
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEKD----- 575 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 575 (812)
+|+..++||+|+||+||+|++. +++.||||++..... .+.+|+++|++++||||++++++|....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 4888999999999999999985 589999999864321 2346999999999999999999986532
Q ss_pred -eEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCC-cEE
Q 042346 576 -ERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNW-TAR 653 (812)
Q Consensus 576 -~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~k 653 (812)
..+|||||++++.+..+.+.... ...+++.....++.||+.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~-----~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~k 163 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLK 163 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEE
T ss_pred eEEEEEEeccCCccHHHHHhhhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCcee
Confidence 46899999986543333321111 112367778899999999999999998 99999999999999875 899
Q ss_pred EEeecccccCCCCcccccccccccCCCccCcccccc-CcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVM-NVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+......
T Consensus 164 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~----~~~l~~i~ 236 (350)
T d1q5ka_ 164 LCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEII 236 (350)
T ss_dssp ECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHHHH
T ss_pred EecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH----HHHHHHHH
Confidence 99999997654432 2344689999999998765 5789999999999999999999999854331 11111111
Q ss_pred HHH-------HhccccccccccCCC---C---CCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 042346 733 SQI-------LAGQLHCVLDKRVGP---P---ELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN--LERA 790 (812)
Q Consensus 733 ~~~-------~~~~~~~~~d~~~~~---~---~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~--Le~~ 790 (812)
... .........+..... . ..........+.+|+.+||..||++|||++|++++ ++++
T Consensus 237 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 000000000001000 0 00112234557899999999999999999999975 4444
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-40 Score=364.05 Aligned_cols=271 Identities=14% Similarity=0.135 Sum_probs=213.4
Q ss_pred CceEEEEEeCCccceEEEccCCCcc-------------c--CCCCccEEEEEccCceEEEEEeCCCeEEEccCCCCCCCC
Q 042346 41 TSTVCGIIAGESIQRIQCYQNGSTI-------------P--VLPNASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFS 105 (812)
Q Consensus 41 ~~~~c~l~~~g~~~~~~~~g~~~~~-------------~--~~~~~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg 105 (812)
-+|+|++.++| .|+|||.|... | ++...+|++|+||..|+|||+.+| .|||||.|.+||||
T Consensus 5 ~~h~~~~~~~G---~vy~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~i~~ia~G~~h~~al~~~G-~vy~wG~n~~GQLG 80 (401)
T d1a12a_ 5 VSHRSHSTEPG---LVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKSG-QVYSFGCNDEGALG 80 (401)
T ss_dssp CCCTTCCCCCB---EEEEEEECTTSTTCSCTTCCEEEEEEEECCSSCEEEEEECSSEEEEEETTS-CEEEEECCTTSTTC
T ss_pred eeEEEEECCCC---EEEEEeCCCCCCCCCCCCCceeccCEEeCCCCCeEEEEeCCCEEEEEeCCC-EEEEEeCCCCCCCC
Confidence 47999999999 99999986551 1 222348999999999999999999 79999999999999
Q ss_pred CC-------CceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCC--cccCC------CCCCCceEEEee
Q 042346 106 FQ-------PKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQL--FSFSS------PGEDLKFSTITS 170 (812)
Q Consensus 106 ~~-------~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~--~~~~~------~~~~~~~~~ia~ 170 (812)
.. +.+..+....++++|++|..|++|++ ++|+|||||.+..++++.. ..... .....+++.|++
T Consensus 81 ~g~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~~-~~g~v~~wG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~ 159 (401)
T d1a12a_ 81 RDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALT-DDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVAS 159 (401)
T ss_dssp SCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEEE-TTSCEEEEECEEETTEEEESSBBTBCEEEEEEECCSSCEEEEEE
T ss_pred cccccccccccccccccccceeeecccccceeecc-ccccceeccccccccccccccCCccccceeeeeccCCceeEEEe
Confidence 54 33444445668999999999999998 9999999998866664432 22111 122367999999
Q ss_pred cCCeEEEEEccCCeEEEeecCCCCCcccc----------------------------cccCceEEEEEeCCceeEEEeeC
Q 042346 171 GRGFTCGILRSNSEVFCWGDSGIADEIQR----------------------------GFKNLSMVGLVAGESHACGLSRN 222 (812)
Q Consensus 171 G~~h~cal~~~~g~v~~WG~~~~~~~~~~----------------------------~~~~~~~~~i~aG~~h~~al~~~ 222 (812)
|..|++++ +.+|.+|+||.+..++.... .....++.+|+||..|+++|+++
T Consensus 160 g~~~~~~~-~~~g~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~i~~v~~g~~~~~~l~~~ 238 (401)
T d1a12a_ 160 GNDHLVML-TADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHE 238 (401)
T ss_dssp CSSEEEEE-ETTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTEEEEEETT
T ss_pred cccceeee-ecCCcccccccCCccccCCCCccccccCCccccccccccceeeccccCCCCCceEEEEEecCCeEEEEecC
Confidence 99999998 89999999998665543110 11234689999999999999999
Q ss_pred CcEEEEecCCCCCCCcCCCC-------------cceeeeeeeeccceeEEEEecCCeEEEecCCCCCccccCCc------
Q 042346 223 GALVCKGSNDSGQLNVPFSS-------------AFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDSDVI------ 283 (812)
Q Consensus 223 G~v~~WG~n~~gqlg~~~~~-------------~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~~~~------ 283 (812)
|+||+||.|.+||+|..... .......+++|..|+++++. +|.|||||.|.+||||.+..
T Consensus 239 g~v~~~g~n~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~i~~g~~~~~~l~~-~g~v~~wG~n~~gqlG~g~~~~~~~~ 317 (401)
T d1a12a_ 239 GHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDS-EGKAYSLGRAEYGRLGLGEGAEEKSI 317 (401)
T ss_dssp CCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEEECSSEEEEEET-TSCEEEEECCGGGTTCSCTTCCCEEE
T ss_pred CeEeeecccceecccccccccceeccccccccccceeEEEEeeeccceeeecc-CCCEEEecccccCccCCCcccccccC
Confidence 99999999999999843211 01112359999999999996 69999999999999987321
Q ss_pred -----cccceeEEEeccceEEEEEcCCCeEEEecCCCCCCC
Q 042346 284 -----QDVSFESIVAGLDFVCGLTTRNLSMICWGPGWSNKP 319 (812)
Q Consensus 284 -----~~~~~~~i~ag~~~~c~~~~~~~~v~cWG~~~~~~~ 319 (812)
....+.+|++|.+|+|++++ ||+|||||.|..++.
T Consensus 318 P~~i~~~~~i~~Is~G~~hs~alt~-dG~v~~WG~n~~GQL 357 (401)
T d1a12a_ 318 PTLISRLPAVSSVACGASVGYAVTK-DGRVFAWGMGTNYQL 357 (401)
T ss_dssp EEECCSSSSEEEEEECSSEEEEEET-TSCEEEEECCTTSTT
T ss_pred CEEcCCCCCeEEEEeeCCEEEEEeC-CCeEEEEecCCCCCC
Confidence 11257899999999999985 779999998866543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-40 Score=357.06 Aligned_cols=263 Identities=20% Similarity=0.259 Sum_probs=189.1
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK---- 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---- 574 (812)
.++|++.++||+|+||+||+|++. +++.||||++..... .......+.+|+.++++++||||++++++|...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 367999999999999999999985 599999999864322 234456788999999999999999999999643
Q ss_pred --CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcE
Q 042346 575 --DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTA 652 (812)
Q Consensus 575 --~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~ 652 (812)
...|+||||+.+ ++.+.+... +++.....++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 93 ~~~~~~iv~Ey~~~-~l~~~~~~~----------~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 93 EFQDVYLVMELMDA-NLCQVIQME----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred cCceeEEEEeccch-HHHHhhhcC----------CCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccce
Confidence 578999999976 455555321 255677889999999999999999 9999999999999999999
Q ss_pred EEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 653 RVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 653 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
|++|||+++..... .......+|+.|+|||++.+..+++++||||+||++|||++|+.||..... ........
T Consensus 159 kl~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~----~~~~~~i~ 231 (355)
T d2b1pa1 159 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVI 231 (355)
T ss_dssp EECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH
T ss_pred eeechhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH----HHHHHHHH
Confidence 99999998754432 233456799999999999999999999999999999999999999854321 11111111
Q ss_pred H------------------HHHhccc-------cccccccC-CCCCCChHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 S------------------QILAGQL-------HCVLDKRV-GPPELNEAEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~------------------~~~~~~~-------~~~~d~~~-~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
. ....... ...+.... .............+.+|+.+||..||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0001000 00010011 11111124456778899999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=355.65 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=192.5
Q ss_pred cCCcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCceEEEEEEEeC----
Q 042346 500 TNNFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHLVGLVGFCQEK---- 574 (812)
Q Consensus 500 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~---- 574 (812)
.++|++.++||+|+||+||+|++. +++.||||++.... ......+.+.+|+++|++++||||+++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh---cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 567999999999999999999874 69999999986422 2233445688999999999999999999998643
Q ss_pred -CeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCCCcEE
Q 042346 575 -DERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVNWTAR 653 (812)
Q Consensus 575 -~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k 653 (812)
...+++++|+.+|+|.++++.+. ++......++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~~~---------l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~k 161 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKCQK---------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 161 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cCceEEEEEeecCCchhhhccccc---------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccc
Confidence 33467788888999999996532 256777899999999999999998 99999999999999999999
Q ss_pred EEeecccccCCCCcccccccccccCCCccCccccccC-cCCCcchhHHHHHHHHHHHcCCCCCCCCCCCCCCchhHHHHH
Q 042346 654 VSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMN-VLTAKTDIYGLGVVLLELLTGKKAVFKNEDGSGPLDVVEFAV 732 (812)
Q Consensus 654 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~ 732 (812)
++|||++..... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ........
T Consensus 162 l~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~----~~~~~~i~ 232 (348)
T d2gfsa1 162 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----IDQLKLIL 232 (348)
T ss_dssp ECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred ccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 999999865432 23456799999999987765 468899999999999999999999854321 11111111
Q ss_pred HHHHhcccccc------------ccccCCCCCCCh----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 042346 733 SQILAGQLHCV------------LDKRVGPPELNE----AEAVELLATTAIHCVNLEGKERPNITDIVAN 786 (812)
Q Consensus 733 ~~~~~~~~~~~------------~d~~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 786 (812)
... .....+. .......+.... ......+.+|+.+||..||++|||++|+++|
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 233 RLV-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHH-CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Hhc-CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 100 0000000 000000011111 1234557899999999999999999999985
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Probab=100.00 E-value=1e-37 Score=328.15 Aligned_cols=244 Identities=18% Similarity=0.254 Sum_probs=198.2
Q ss_pred ccceeEEeeCCceEEEEEeCCccceEEEccCCCcccCCC----CccEEEEEccCceEEEEEeCCCeEEEccCCCCCCCCC
Q 042346 31 SASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIPVLP----NASFQAISGGQNYFCGLRSGGFSLHCWDTNDLTNFSF 106 (812)
Q Consensus 31 ~~~~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~~~~~~----~~~~~~i~~G~~~~~al~~~g~~v~~WG~n~~gqlg~ 106 (812)
...+.+|++|..|+|+|. || .++|||.|..-++.. ...+++|++|..|+|+|+ || +|+|||.|.+||++.
T Consensus 25 ~~~i~~va~G~~h~~al~-dG---~v~~wG~N~~GQlG~~~~~~~~v~~v~~G~~~~~al~-dg-~v~~wG~~~~gq~~~ 98 (273)
T d1jtdb_ 25 QSGVDAIAGGYFHGLALK-GG---KVLGWGANLNGQLTMPAATQSGVDAIAAGNYHSLALK-DG-EVIAWGGNEDGQTTV 98 (273)
T ss_dssp SSSEEEEEECSSEEEEEE-TT---EEEEEECCTTSTTSCCGGGGSCCCEEEECSSEEEEEE-TT-EEEEEECCTTSTTCC
T ss_pred CCCcEEEEccCCEEEEEE-CC---EEEEEeCCCCCceeeeecccccceEEecCCCceeeee-ee-eeeccCCCcceeecc
Confidence 446889999999999997 78 899999998855432 338999999999999997 88 899999999999985
Q ss_pred CCceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccCCCCCCCceEEEeecCCeEEEEEccCCeEE
Q 042346 107 QPKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSSPGEDLKFSTITSGRGFTCGILRSNSEVF 186 (812)
Q Consensus 107 ~~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~~~~~~~~~~~ia~G~~h~cal~~~~g~v~ 186 (812)
+.. . ...+..|++|..|+|++. ||+|++||.+..++..... .....+..++++. |+|++ .++|.++
T Consensus 99 ~~~-~----~~~~~~i~~~~~~~~~~~--dg~v~~~g~~~~~~~~~~~-----~~~~~v~~~~~~~-~~~~~-~~~g~~~ 164 (273)
T d1jtdb_ 99 PAE-A----RSGVDAIAAGAWASYALK--DGKVIAWGDDSDGQTTVPA-----EAQSGVTALDGGV-YTALA-VKNGGVI 164 (273)
T ss_dssp CGG-G----GSSCCEEEEETTEEEEEE--TTEEEEEECCTTSTTSCCG-----GGGSSEEEEEECS-SEEEE-EETTEEE
T ss_pred ccc-c----ccceeEEeeecccccccc--cccceecccCCCCceeeec-----cCCceEEEEeccc-eeeee-eccccee
Confidence 432 1 234678999999999874 7999999999877765321 1224455665554 55665 4689999
Q ss_pred EeecCCCCCcccccccCceEEEEEeCCceeEEEeeCCcEEEEecCCCCCCCcCCCCcceeeeeeeeccceeEEEEecCCe
Q 042346 187 CWGDSGIADEIQRGFKNLSMVGLVAGESHACGLSRNGALVCKGSNDSGQLNVPFSSAFEFSGGLALGANFTCAIRQRSGL 266 (812)
Q Consensus 187 ~WG~~~~~~~~~~~~~~~~~~~i~aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~~~~~~~~~ia~G~~ht~al~~~~g~ 266 (812)
|||.+..++.........+|++|++|..|+|+|+ ||+|||||.|.+|||++|........ +|++|..|+|+|+ ||+
T Consensus 165 ~~G~~~~g~~~~~~~~~~~v~~Is~G~~h~~~l~-dG~v~~WG~n~~Gql~~~~~~~~~v~-~I~~G~~~~~~l~--~g~ 240 (273)
T d1jtdb_ 165 AWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLALK-DGKVIAWGDNRYKQTTVPTEALSGVS-AIASGEWYSLALK--NGK 240 (273)
T ss_dssp EEECCTTSTTSCCGGGSSSEEEEEECSSEEEEEE-TTEEEEEECCTTSTTCCCGGGGSSCC-EEEECSSCEEEEE--TTE
T ss_pred EeecccCCcccccccccCCccceeccceeeEEEe-cCcEEEcCCCCCCccCCCccCCCCcE-EEEeCcceEEEEE--CCE
Confidence 9999888887777777788999999999999997 89999999999999998764322222 5999999999985 599
Q ss_pred EEEecCCCCCccccCCccccceeEEEeccceEEEEE
Q 042346 267 VACWGGTNRFEFDSDVIQDVSFESIVAGLDFVCGLT 302 (812)
Q Consensus 267 v~~WG~n~~gqlg~~~~~~~~~~~i~ag~~~~c~~~ 302 (812)
|||||.|.+||++. ...+..|.+|.+|++|++
T Consensus 241 v~~WG~~~~~~~~~----~~~~~~i~~~~~~~~al~ 272 (273)
T d1jtdb_ 241 VIAWGSSRTAPSSV----QSGVSSIEAGPNAAYALK 272 (273)
T ss_dssp EEEESTTCCCCGGG----SSCEEEEEECSSCEEEEE
T ss_pred EEEECCCCCCCCCC----CCCceeEEeCcceEEEec
Confidence 99999999999765 335789999999999996
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-38 Score=346.45 Aligned_cols=266 Identities=16% Similarity=0.217 Sum_probs=208.8
Q ss_pred cceeEEeeCCceEEEEEeCCccceEEEccCCCccc----------------CCCCccEEEEEccCceEEEEEeCCCeEEE
Q 042346 32 ASTAAIIYKTSTVCGIIAGESIQRIQCYQNGSTIP----------------VLPNASFQAISGGQNYFCGLRSGGFSLHC 95 (812)
Q Consensus 32 ~~~~~~~~g~~~~c~l~~~g~~~~~~~~g~~~~~~----------------~~~~~~~~~i~~G~~~~~al~~~g~~v~~ 95 (812)
..++.|++|..|+|||.++| .|+|||.|...+ +....++++|++|..|+++++++| .|||
T Consensus 47 ~~i~~ia~G~~h~~al~~~G---~vy~wG~n~~GQLG~g~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~~~~g-~v~~ 122 (401)
T d1a12a_ 47 EDVVQAEAGGMHTVCLSKSG---QVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDG-RVFL 122 (401)
T ss_dssp SCEEEEEECSSEEEEEETTS---CEEEEECCTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEEETTS-CEEE
T ss_pred CCeEEEEeCCCEEEEEeCCC---EEEEEeCCCCCCCCcccccccccccccccccccceeeecccccceeeccccc-ccee
Confidence 45888999999999999999 899999765421 112337999999999999999999 7999
Q ss_pred ccCCCCCCCCCC--------CceecccCCceEEEEEccCceEEEEEeCCCeEEEecCCCCCCCCCCcccCC---------
Q 042346 96 WDTNDLTNFSFQ--------PKRLHFRKAVQLTDVSVGGDQVCAREVNSGVVKCWRGTKVKDKGQLFSFSS--------- 158 (812)
Q Consensus 96 WG~n~~gqlg~~--------~~~~~~~~~~~v~~ia~G~~h~~al~~~~g~v~~WG~n~~gqlG~~~~~~~--------- 158 (812)
||.|..++++.. +..+.......++.|++|..|+++++ .+|.+|+||.|.+||||.......
T Consensus 123 wG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~~-~~g~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~ 201 (401)
T d1a12a_ 123 WGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLT-ADGDLYTLGCGEQGQLGRVPELFANRGGRQGLE 201 (401)
T ss_dssp EECEEETTEEEESSBBTBCEEEEEEECCSSCEEEEEECSSEEEEEE-TTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHH
T ss_pred ccccccccccccccCCccccceeeeeccCCceeEEEecccceeeee-cCCcccccccCCccccCCCCccccccCCccccc
Confidence 999877765521 12223334458999999999999998 999999999999999996543110
Q ss_pred --------------CCCCCceEEEeecCCeEEEEEccCCeEEEeecCCCCCccccc--------------ccCceEEEEE
Q 042346 159 --------------PGEDLKFSTITSGRGFTCGILRSNSEVFCWGDSGIADEIQRG--------------FKNLSMVGLV 210 (812)
Q Consensus 159 --------------~~~~~~~~~ia~G~~h~cal~~~~g~v~~WG~~~~~~~~~~~--------------~~~~~~~~i~ 210 (812)
.....++.+|+||..|+|+| +++|+||+||.+..++..... .....++.|+
T Consensus 202 ~~~~p~~~~~~~~~~~~~~~i~~v~~g~~~~~~l-~~~g~v~~~g~n~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~i~ 280 (401)
T d1a12a_ 202 RLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAI-SHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFS 280 (401)
T ss_dssp HHHSCEECCCBCSSCCSBCCEEEEEEETTEEEEE-ETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEE
T ss_pred cccccceeeccccCCCCCceEEEEEecCCeEEEE-ecCCeEeeecccceecccccccccceeccccccccccceeEEEEe
Confidence 11125789999999999999 899999999987655532211 1234589999
Q ss_pred eCCceeEEEeeCCcEEEEecCCCCCCCcCCCC----------cceeeeeeeeccceeEEEEecCCeEEEecCCCCCcccc
Q 042346 211 AGESHACGLSRNGALVCKGSNDSGQLNVPFSS----------AFEFSGGLALGANFTCAIRQRSGLVACWGGTNRFEFDS 280 (812)
Q Consensus 211 aG~~h~~al~~~G~v~~WG~n~~gqlg~~~~~----------~~~~~~~ia~G~~ht~al~~~~g~v~~WG~n~~gqlg~ 280 (812)
+|..|+++|+++|.|||||.|.+||||..... ....+.+|+||.+|+|||++ ||+|||||+|.+||||.
T Consensus 281 ~g~~~~~~l~~~g~v~~wG~n~~gqlG~g~~~~~~~~P~~i~~~~~i~~Is~G~~hs~alt~-dG~v~~WG~n~~GQLG~ 359 (401)
T d1a12a_ 281 GGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVTK-DGRVFAWGMGTNYQLGT 359 (401)
T ss_dssp ECSSEEEEEETTSCEEEEECCGGGTTCSCTTCCCEEEEEECCSSSSEEEEEECSSEEEEEET-TSCEEEEECCTTSTTCS
T ss_pred eeccceeeeccCCCEEEecccccCccCCCcccccccCCEEcCCCCCeEEEEeeCCEEEEEeC-CCeEEEEecCCCCCCCC
Confidence 99999999999999999999999999843211 11122369999999999996 69999999999999998
Q ss_pred CCccc--------------cceeEEEeccceEEEEEcC
Q 042346 281 DVIQD--------------VSFESIVAGLDFVCGLTTR 304 (812)
Q Consensus 281 ~~~~~--------------~~~~~i~ag~~~~c~~~~~ 304 (812)
+...+ ..+..|++|..|+|+|+.+
T Consensus 360 G~~~~~~~P~~v~~~~~~~~~v~~v~~G~~hs~~l~~d 397 (401)
T d1a12a_ 360 GQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLLVKD 397 (401)
T ss_dssp SSCSCEEEEEECCSTTTTTEEEEEEEECSSEEEEEEEE
T ss_pred CCCCCEecCEEeeccCCCCCEEEEEEEccceEEEEEEC
Confidence 43221 2477889999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-36 Score=327.08 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=185.3
Q ss_pred CcceeeeeccCCcEEEEEEEEc-CCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-----------CCCceEEEE
Q 042346 502 NFSLENKVGIGSFGTVYKGKLM-DGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-----------HKHLVGLVG 569 (812)
Q Consensus 502 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~~ 569 (812)
+|++.++||+|+||+||+|+.. +|+.||||++... ....+.+.+|+++++.++ |+||+++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 5999999999999999999974 6999999998642 122345667888887775 578999998
Q ss_pred EEEe--CCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhh-cCCCCeEeeccCCCCEEE
Q 042346 570 FCQE--KDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHN-YAVPSIIHRDIKSSNILL 646 (812)
Q Consensus 570 ~~~~--~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl 646 (812)
++.. ....+++|+++..+............. .........++.||++||+|||+ .+ |+||||||+||||
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll 159 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR-----GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM 159 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred Eeeeccccceeeeeeeccccccccccccccccc-----CCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeee
Confidence 8764 345677777766654443332222111 12456678899999999999998 66 9999999999999
Q ss_pred cCCC------cEEEEeecccccCCCCcccccccccccCCCccCccccccCcCCCcchhHHHHHHHHHHHcCCCCCCCCCC
Q 042346 647 DVNW------TARVSDFGLSLLGSECDQEFISTKAVGTVGYIDPEYYVMNVLTAKTDIYGLGVVLLELLTGKKAVFKNED 720 (812)
Q Consensus 647 ~~~~------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltG~~p~~~~~~ 720 (812)
+.++ .+||+|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 8665 399999999875433 23456799999999999999999999999999999999999999865433
Q ss_pred CCCCchhHHHHHHHHHhccc-----------ccccc-----ccCCC------------CCCChHHHHHHHHHHHHHcccc
Q 042346 721 GSGPLDVVEFAVSQILAGQL-----------HCVLD-----KRVGP------------PELNEAEAVELLATTAIHCVNL 772 (812)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~-----------~~~~d-----~~~~~------------~~~~~~~~~~~l~~li~~Cl~~ 772 (812)
................-+.. ...++ ..+.. ...........+.+|+.+||..
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 22111111111100000000 00000 00000 1112345677889999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042346 773 EGKERPNITDIVAN 786 (812)
Q Consensus 773 dP~~RPt~~evl~~ 786 (812)
||.+|||++|+|+|
T Consensus 315 dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 315 DPRKRADAGGLVNH 328 (362)
T ss_dssp STTTCBCHHHHHTC
T ss_pred ChhHCcCHHHHhcC
Confidence 99999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.7e-22 Score=199.25 Aligned_cols=169 Identities=13% Similarity=0.085 Sum_probs=121.7
Q ss_pred cceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcc-------------hhhHHHHHHHHHHHHHHHHhccCCCceEEEE
Q 042346 503 FSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPK-------------TNKLREKESAFDSELALLSRVHHKHLVGLVG 569 (812)
Q Consensus 503 ~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~-------------~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~ 569 (812)
+.+.++||+|+||+||+|++.+|++||||++..... ..........+.+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 456899999999999999998999999998642110 0111223345567899999999999999886
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcCCCCeEeeccCCCCEEEcCC
Q 042346 570 FCQEKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYAVPSIIHRDIKSSNILLDVN 649 (812)
Q Consensus 570 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~ 649 (812)
+. ..+++|||+++..+.++-. ....+++.|++++|+|||+++ |+||||||+|||++++
T Consensus 82 ~~----~~~lvme~~~~~~~~~l~~---------------~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~ 139 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYRVRV---------------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE 139 (191)
T ss_dssp EE----TTEEEEECCCCEEGGGCCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred ec----CCEEEEEeeccccccchhh---------------HHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence 53 2379999998866544210 112468999999999999998 9999999999999865
Q ss_pred CcEEEEeecccccCCCCcccccccccccCCCccCc------cccccCcCCCcchhHHHHHHH
Q 042346 650 WTARVSDFGLSLLGSECDQEFISTKAVGTVGYIDP------EYYVMNVLTAKTDIYGLGVVL 705 (812)
Q Consensus 650 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~ksDVwS~Gvvl 705 (812)
.++|+|||+|......... .|... |.+ .+.|..++|+||+.--+
T Consensus 140 -~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp -EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 5899999999765432211 11111 111 35688899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=7.7e-07 Score=89.79 Aligned_cols=149 Identities=16% Similarity=0.112 Sum_probs=103.0
Q ss_pred HHHHHhcCCcceeeeeccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhcc-CCCceEEEEEEE
Q 042346 494 SELAAATNNFSLENKVGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVH-HKHLVGLVGFCQ 572 (812)
Q Consensus 494 ~el~~~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~ 572 (812)
.|+....++|+..+..+.++...||+... +++.+.+|+....... ....+.+|...+..|. +--+.+++.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~-----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~ 80 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG-----TTYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT-----STTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc-----chhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence 45666667888777766566679998865 5677888886532111 1223567888887774 333567888888
Q ss_pred eCCeEEEEEEecCCCchhhhhhcCCCCCccccccccHHHHHHHHHHHHHHHHHHhhcC----------------------
Q 042346 573 EKDERLLVYEYMSNGALHDHLHNKNNTEKNSSIVNSWKMRIRIALDAARGIDYLHNYA---------------------- 630 (812)
Q Consensus 573 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~~~~~~l~ia~~ia~gL~yLH~~~---------------------- 630 (812)
+++..++||+++++.++.+....... ..+++.++++.|+.||+..
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~~~~~~-------------~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEYEDEQS-------------PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN 147 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHTTTCSC-------------HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred cCCceEEEEEeccccccccccccccc-------------HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence 88889999999999888765432110 1235566666677777532
Q ss_pred ----------------------------------CCCeEeeccCCCCEEEcCCCcEEEEeecccc
Q 042346 631 ----------------------------------VPSIIHRDIKSSNILLDVNWTARVSDFGLSL 661 (812)
Q Consensus 631 ----------------------------------~~~ivHrDlKp~NILl~~~~~~kl~DfGla~ 661 (812)
.+.++|+|+.|.|||++++...-|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0238999999999999987667799998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=7.8e-06 Score=81.69 Aligned_cols=77 Identities=17% Similarity=0.146 Sum_probs=53.7
Q ss_pred eeeccCC-cEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCC--CceEEEEEEEeCCeEEEEEEe
Q 042346 507 NKVGIGS-FGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHK--HLVGLVGFCQEKDERLLVYEY 583 (812)
Q Consensus 507 ~~LG~G~-fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~~~~~~~lV~ey 583 (812)
+.+..|. -..||+....++..+.+|...... ...+.+|.+.++.|... .+.+++.+..+++..++||||
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 87 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCccC--------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence 3455555 367999988778889999865321 12355677777777433 356778888888888999999
Q ss_pred cCCCchhh
Q 042346 584 MSNGALHD 591 (812)
Q Consensus 584 ~~~gsL~~ 591 (812)
+++-++.+
T Consensus 88 i~G~~~~~ 95 (255)
T d1nd4a_ 88 VPGQDLLS 95 (255)
T ss_dssp CSSEETTT
T ss_pred eecccccc
Confidence 98866543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.12 E-value=0.00037 Score=74.03 Aligned_cols=82 Identities=16% Similarity=0.120 Sum_probs=47.0
Q ss_pred eeeeccCCcEEEEEEEEcC-CcEEEEEeeccCcchhh--HHHHHHHHHHHHHHHHhcc-C--CCceEEEEEEEeCCeEEE
Q 042346 506 ENKVGIGSFGTVYKGKLMD-GREVAVKREESCPKTNK--LREKESAFDSELALLSRVH-H--KHLVGLVGFCQEKDERLL 579 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~-g~~vavK~~~~~~~~~~--~~~~~~~~~~Ei~~l~~l~-H--~nIv~l~~~~~~~~~~~l 579 (812)
.+.||.|....||+....+ ++.++||.......... ..........|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4678999999999998644 67899996432110000 0000112335677776653 2 335556544 4555689
Q ss_pred EEEecCCCch
Q 042346 580 VYEYMSNGAL 589 (812)
Q Consensus 580 V~ey~~~gsL 589 (812)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.24 E-value=0.0052 Score=64.82 Aligned_cols=73 Identities=21% Similarity=0.296 Sum_probs=48.0
Q ss_pred eeeeccCCcEEEEEEEEcC--------CcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc-eEEEEEEEeCCe
Q 042346 506 ENKVGIGSFGTVYKGKLMD--------GREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL-VGLVGFCQEKDE 576 (812)
Q Consensus 506 ~~~LG~G~fG~Vy~a~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~ 576 (812)
.+.|..|-.-.+|+....+ .+.|.+++... ... .....+|..+++.+.-.++ .++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~------~idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET------ESHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC------HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch------hhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 4678889999999998754 34577776542 111 1223468888888753344 477777642
Q ss_pred EEEEEEecCCCch
Q 042346 577 RLLVYEYMSNGAL 589 (812)
Q Consensus 577 ~~lV~ey~~~gsL 589 (812)
.+||||+++..|
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 689999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.10 E-value=0.0022 Score=65.96 Aligned_cols=69 Identities=13% Similarity=0.071 Sum_probs=43.0
Q ss_pred cEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc-----eEE--EEEEEeCCeEEEEEEecCC
Q 042346 514 FGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL-----VGL--VGFCQEKDERLLVYEYMSN 586 (812)
Q Consensus 514 fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-----v~l--~~~~~~~~~~~lV~ey~~~ 586 (812)
--.||+.+.++|+.+++|+..... . ..+++..|...+..|....+ +.. -..+..+...+.++++++|
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~---~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER---W---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT---S---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC---C---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999999899999999865311 1 12345667777777642222 111 0123445667889999876
Q ss_pred Cc
Q 042346 587 GA 588 (812)
Q Consensus 587 gs 588 (812)
..
T Consensus 109 ~~ 110 (325)
T d1zyla1 109 RQ 110 (325)
T ss_dssp EE
T ss_pred cC
Confidence 43
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.83 E-value=0.013 Score=59.38 Aligned_cols=162 Identities=11% Similarity=0.067 Sum_probs=81.0
Q ss_pred CCHHHHHHhcCCcceeee-----eccCCcEEEEEEEEcCCcEEEEEeeccCcchhhHHHHHHHHHHHHHHHHhccCCCc-
Q 042346 491 FTLSELAAATNNFSLENK-----VGIGSFGTVYKGKLMDGREVAVKREESCPKTNKLREKESAFDSELALLSRVHHKHL- 564 (812)
Q Consensus 491 ~~~~el~~~~~~~~~~~~-----LG~G~fG~Vy~a~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI- 564 (812)
.+.+|+....++|.+.+. |..|---+.|+.+..++ ++++|+.... ....++..|++++..|.+.++
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~-------~~~~~l~~~~~~l~~L~~~g~p 74 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-------VEKNDLPFFLGLMQHLAAKGLS 74 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC-------CCHHHHHHHHHHHHhhhhcccc
Confidence 456777777788876433 44666678899887555 5899987531 112234456667766643222
Q ss_pred ----eEEE---EEEEeCCeEEEEEEecCCCchhh--------------hhhcCCCC---Ccccccccc------------
Q 042346 565 ----VGLV---GFCQEKDERLLVYEYMSNGALHD--------------HLHNKNNT---EKNSSIVNS------------ 608 (812)
Q Consensus 565 ----v~l~---~~~~~~~~~~lV~ey~~~gsL~~--------------~l~~~~~~---~~~~~~~~~------------ 608 (812)
+... .+.........++.+..+..... .++..... .........
T Consensus 75 vp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (316)
T d2ppqa1 75 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER 154 (316)
T ss_dssp CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred ccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHh
Confidence 1110 01122344566677665533211 11100000 000000000
Q ss_pred ----HHHHHHHHHHHHHHHHHHhhcC-CCCeEeeccCCCCEEEcCCCcEEEEeeccc
Q 042346 609 ----WKMRIRIALDAARGIDYLHNYA-VPSIIHRDIKSSNILLDVNWTARVSDFGLS 660 (812)
Q Consensus 609 ----~~~~l~ia~~ia~gL~yLH~~~-~~~ivHrDlKp~NILl~~~~~~kl~DfGla 660 (812)
.......+..+..-+.-.+... ..++||+|+.+.|||++.+...-|.||+.+
T Consensus 155 ~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 155 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred hhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 0001122222223233322211 134999999999999999877789999976
|
| >d1k3ia3 b.69.1.1 (A:151-537) Galactose oxidase, central domain {Fungi (Fusarium sp.) [TaxId: 29916]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: Galactose oxidase, central domain family: Galactose oxidase, central domain domain: Galactose oxidase, central domain species: Fungi (Fusarium sp.) [TaxId: 29916]
Probab=93.58 E-value=0.38 Score=48.87 Aligned_cols=60 Identities=18% Similarity=0.064 Sum_probs=36.7
Q ss_pred cceeEEEEecCCeEEEecCCCCCccccC----------CccccceeEEEe----ccceEEEEEcCCCeEEEecCC
Q 042346 254 ANFTCAIRQRSGLVACWGGTNRFEFDSD----------VIQDVSFESIVA----GLDFVCGLTTRNLSMICWGPG 314 (812)
Q Consensus 254 ~~ht~al~~~~g~v~~WG~n~~gqlg~~----------~~~~~~~~~i~a----g~~~~c~~~~~~~~v~cWG~~ 314 (812)
..|+.++.. ||+|+..|-+..+..... .+..-.++.+.. -..|+.++...||+|+..|.+
T Consensus 290 ~~~~~~~~~-dg~i~v~GG~~~~~~~~~~~~~~~ve~Ydp~~~~W~~~~~~~~~R~~Hs~a~l~~dG~v~v~GG~ 363 (387)
T d1k3ia3 290 TFHTSVVLP-DGSTFITGGQRRGIPFEDSTPVFTPEIYVPEQDTFYKQNPNSIVRVYHSISLLLPDGRVFNGGGG 363 (387)
T ss_dssp BSCEEEECT-TSCEEEECCBSBCCTTCCCSBCCCCEEEEGGGTEEEECCCCSSCCCTTEEEEECTTSCEEEEECC
T ss_pred ccceeeecc-CCeEEEECCcccCccCCCCcEeceEEEEECCCCeEEECCCCCCcccceEEEEECCCCEEEEEeCC
Confidence 456666664 699999987655543321 111223444432 236877776678899999975
|
| >d1k3ia3 b.69.1.1 (A:151-537) Galactose oxidase, central domain {Fungi (Fusarium sp.) [TaxId: 29916]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: Galactose oxidase, central domain family: Galactose oxidase, central domain domain: Galactose oxidase, central domain species: Fungi (Fusarium sp.) [TaxId: 29916]
Probab=91.00 E-value=0.59 Score=47.33 Aligned_cols=65 Identities=15% Similarity=0.086 Sum_probs=39.1
Q ss_pred CceeEEEeeCCcEEEEecCCCCCCCc------------CCCCcceeeeee-eeccceeEEEEecCCeEEEecCCCCCc
Q 042346 213 ESHACGLSRNGALVCKGSNDSGQLNV------------PFSSAFEFSGGL-ALGANFTCAIRQRSGLVACWGGTNRFE 277 (812)
Q Consensus 213 ~~h~~al~~~G~v~~WG~n~~gqlg~------------~~~~~~~~~~~i-a~G~~ht~al~~~~g~v~~WG~n~~gq 277 (812)
..|+.++..||+|+..|.+..+.... |........... .....|+.++...||+|+..|-+..+.
T Consensus 290 ~~~~~~~~~dg~i~v~GG~~~~~~~~~~~~~~~ve~Ydp~~~~W~~~~~~~~~R~~Hs~a~l~~dG~v~v~GG~~~~~ 367 (387)
T d1k3ia3 290 TFHTSVVLPDGSTFITGGQRRGIPFEDSTPVFTPEIYVPEQDTFYKQNPNSIVRVYHSISLLLPDGRVFNGGGGLCGD 367 (387)
T ss_dssp BSCEEEECTTSCEEEECCBSBCCTTCCCSBCCCCEEEEGGGTEEEECCCCSSCCCTTEEEEECTTSCEEEEECCCCTT
T ss_pred ccceeeeccCCeEEEECCcccCccCCCCcEeceEEEEECCCCeEEECCCCCCcccceEEEEECCCCEEEEEeCCCcCC
Confidence 35777888899999999876654331 111111110011 123468877654579999999765544
|